PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ramm, SA; Jonker, RM; Reinhold, K; Szekely, T; Trillmich, F; Schmoll, T; Schielzeth, H; Freckleton, RP				Ramm, Steven A.; Jonker, Rudy M.; Reinhold, Klaus; Szekely, Tamas; Trillmich, Fritz; Schmoll, Tim; Schielzeth, Holger; Freckleton, Robert P.			Comment on "Bateman in Nature: Predation on Offspring Reduces the Potential for Sexual Selection"	SCIENCE			English	Editorial Material							GRADIENT		[Ramm, Steven A.; Jonker, Rudy M.; Reinhold, Klaus; Szekely, Tamas; Trillmich, Fritz; Schmoll, Tim; Schielzeth, Holger] Univ Bielefeld, Bielefeld, Germany; [Szekely, Tamas] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Freckleton, Robert P.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Bielefeld; University of Bath; University of Sheffield	Ramm, SA (corresponding author), Univ Bielefeld, Bielefeld, Germany.	steven.ramm@uni-bielefeld.de	Freckleton, Rob P/B-6455-2013; Szekely, Tamas/I-7089-2016; Ramm, Steven/C-4907-2008; Schielzeth, Holger/F-1419-2011; Arnqvist, Goran/E-6782-2015	Szekely, Tamas/0000-0003-2093-0056; Ramm, Steven/0000-0001-7786-7364; Schielzeth, Holger/0000-0002-9124-2261; Freckleton, Robert/0000-0002-8338-864X; Arnqvist, Goran/0000-0002-3501-3376	European Research Council [294333] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		ARNOLD SJ, 1994, AM NAT, V143, P317, DOI 10.1086/285606; Byers J, 2012, SCIENCE, V338, P802, DOI 10.1126/science.1224660; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Jones AG, 2009, EVOLUTION, V63, P1673, DOI 10.1111/j.1558-5646.2009.00664.x; Kokko H, 2012, ECOL LETT, V15, P1340, DOI 10.1111/j.1461-0248.2012.01859.x; Mundry R, 2009, AM NAT, V173, P119, DOI 10.1086/593303; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Pelissie B, 2012, EVOLUTION, V66, P66, DOI 10.1111/j.1558-5646.2011.01442.x; Wade MJ, 2012, SCIENCE, V338, P749, DOI 10.1126/science.1230395	9	4	4	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 3	2013	340	6132								10.1126/science.1233298	http://dx.doi.org/10.1126/science.1233298			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23641095	Green Submitted			2022-12-28	WOS:000318268900025
J	Thayyil, S; Sebire, NJ; Chitty, LS; Wade, A; Chong, WK; Olsen, O; Gunny, RS; Offiah, AC; Owens, CM; Saunders, DE; Scott, RJ; Jones, R; Norman, W; Addison, S; Bainbridge, A; Cady, EB; De Vita, E; Robertson, NJ; Taylor, AM				Thayyil, Sudhin; Sebire, Neil J.; Chitty, Lyn S.; Wade, Angie; Chong, W. K.; Olsen, Oystein; Gunny, Roxana S.; Offiah, Amaka C.; Owens, Catherine M.; Saunders, Dawn E.; Scott, Rosemary J.; Jones, Rod; Norman, Wendy; Addison, Shea; Bainbridge, Alan; Cady, Ernest B.; De Vita, Enrico; Robertson, Nicola J.; Taylor, Andrew M.		MARIAS Collaborative Grp	Post-mortem MRI versus conventional autopsy in fetuses and children: a prospective validation study	LANCET			English	Article							INVASIVE AUTOPSY; PARENTAL CONSENT; VIRTUAL AUTOPSY; CLINICAL-VALUE; DEATH; FETAL; FEASIBILITY; DIAGNOSIS; BIOPSY; INFANT	Background Post-mortem MRI is a potential diagnostic alternative to conventional autopsy, but few large prospective studies have compared its accuracy with that of conventional autopsy. We assessed the accuracy of whole-body, post-mortem MRI for detection of major pathological lesions associated with death in a prospective cohort of fetuses and children. Methods In this prospective validation study, we did pre-autopsy, post-mortem, whole-body MRI at 1.5 T in an unselected population of fetuses (<= 24 weeks' or >24 weeks' gestation) and children (aged <16 years) at two UK centres in London between March 1, 2007 and Sept 30, 2011. With conventional autopsy as the diagnostic gold standard, we assessed MRI findings alone, or in conjunction with other minimally invasive post-mortem investigations (minimally invasive autopsy), for accuracy in detection of cause of death or major pathological abnormalities. A radiologist and pathologist who were masked to the autopsy findings indicated whether the minimally invasive autopsy would have been adequate. The primary outcome was concordance rate between minimally invasive and conventional autopsy. Findings We analysed 400 cases, of which 277 (69%) were fetuses and 123 (31%) were children. Cause of death or major pathological lesion detected by minimally invasive autopsy was concordant with conventional autopsy in 357 (89.3%, 95% CI 85.8-91.9) cases: 175 (94.6%, 90.3-97.0) of 185 fetuses at 24 weeks' gestation or less, 88 (95.7%, 89.3-98.3) of 92 fetuses at more than 24 weeks' gestation, 34 (81.0%, 67.7-90.0) of 42 newborns aged 1 month or younger, 45 (84.9%, 72.9-92.1) of 53 infants aged older than 1 month to 1 year or younger, and 15 (53.6%, 35.8-70.5) of 28 children aged older than 1 year to 16 years or younger. The dedicated radiologist or pathologist review of the minimally invasive autopsy showed that in 165 (41%) cases a full autopsy might not have been needed; in these cases, concordance between autopsy and minimally invasive autopsy was 99.4% (96.6-99.9). Interpretation Minimally invasive autopsy has accuracy similar to that of conventional autopsy for detection of cause of death or major pathological abnormality after death in fetuses, newborns, and infants, but was less accurate in older children. If undertaken jointly by pathologists and radiologists, minimally invasive autopsy could be an acceptable alternative to conventional autopsy in selected cases.	[Thayyil, Sudhin; Jones, Rod; Norman, Wendy; Taylor, Andrew M.] UCL, Inst Cardiovasc Sci, Ctr Cardiovasc Imaging, London, England; [Thayyil, Sudhin; Addison, Shea; Robertson, Nicola J.] UCL, Inst Womens Hlth, London, England; [Chitty, Lyn S.] UCL, Inst Child Hlth, Clin Mol Genet Unit, London, England; [Wade, Angie] UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England; [Sebire, Neil J.] UCL, Inst Child Hlth, Dept Histopathol, London, England; [Sebire, Neil J.] Great Ormond St Hosp Children NHS Fdn Trust, Dept Paediat Pathol, London WC1N 3JH, England; [Chong, W. K.; Olsen, Oystein; Gunny, Roxana S.; Owens, Catherine M.; Saunders, Dawn E.] Great Ormond St Hosp Children NHS Fdn Trust, Dept Paediat Radiol, London WC1N 3JH, England; [Offiah, Amaka C.] Sheffield Childrens NHS Fdn Trust, Acad Unit Child Hlth, Sheffield, S Yorkshire, England; [Scott, Rosemary J.] Univ Coll London Hosp, Dept Histopathol, London, England; [Bainbridge, Alan; Cady, Ernest B.] Univ Coll London Hosp, Dept Med Phys & Bioengn, London, England; [De Vita, Enrico] UCL Hosp NHS Fdn Trust, Natl Hosp Neurol & Neurosurg, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Sheffield Children's NHS Foundation Trust; University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Thayyil, S (corresponding author), Great Ormond St Hosp Children NHS Fdn Trust, Ctr Cardiovasc Imaging, Cardioresp Unit, London WC1N 3JH, England.	s.thayyil@ucl.ac.uk	Schievano, Silvia/B-6803-2009; Parkes, Harold G/I-7412-2012; De Vita, Enrico/AAD-3154-2019; Offiah, Amaka/G-2911-2010; Robertson, Nicola/GWR-2021-2022; Taylor, Andrew M/C-4311-2008	De Vita, Enrico/0000-0001-8068-1288; Offiah, Amaka/0000-0001-8991-5036; Chong, Kling/0000-0002-4335-3864; Schievano, Silvia/0000-0003-2037-5339; Thayyil, Sudhin/0000-0001-8795-5165; chitty, lyn/0000-0002-4857-7138; Sebire, Neil/0000-0001-5348-9063; Taylor, Andrew/0000-0003-4194-7113	Policy research Programme, Department of Health, UK; British Heart Foundation [FS/08/012/24454] Funding Source: researchfish; National Institute for Health Research [SRF/01/018, NIHR/CS/010/022] Funding Source: researchfish; Wellbeing of Women [RG1248] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1253] Funding Source: researchfish	Policy research Programme, Department of Health, UK; British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellbeing of Women(Wellbeing of Women (WoW)); Great Ormond Street Hospital Childrens Charity	Policy research Programme, Department of Health, UK.	Alderliesten ME, 2003, BJOG-INT J OBSTET GY, V110, P378, DOI 10.1016/S1470-0328(02)02076-1; [Anonymous], 2009, PER MORT 2007; Breeze ACG, 2008, VIRCHOWS ARCH, V452, P201, DOI 10.1007/s00428-007-0548-7; Breeze ACG, 2011, ULTRASOUND OBST GYN, V37, P317, DOI 10.1002/uog.8844; Brookes JAS, 1996, LANCET, V348, P1139, DOI 10.1016/S0140-6736(96)02287-8; Burton JL, 2007, LANCET, V369, P1471, DOI 10.1016/S0140-6736(07)60376-6; Cannie M, 2012, ULTRASOUND OBST GYN, V39, P659, DOI 10.1002/uog.10079; Cohen M, 2008, DISSENT, V55, P1; Griffiths PD, 2003, AM J NEURORADIOL, V24, P22; Huisman TAGM, 2002, FETAL DIAGN THER, V17, P58, DOI 10.1159/000048008; Lavanya T, 2008, Br J Radiol, V81, pe242, DOI 10.1259/bjr/77399621; NHS Implementation Sub-Group of the Department of Health Post Mortem Forensic and Disaster Imaging Group, 2012, CAN CROSS SECT IM AD; Pryce JW, 2012, J CLIN PATHOL, V65, P257, DOI 10.1136/jclinpath-2011-200264; Roberts ISD, 2012, LANCET, V379, P136, DOI 10.1016/S0140-6736(11)61483-9; Ross SG, 2012, RADIOLOGY, V264, P250, DOI 10.1148/radiol.12092415; Royal College of Paediatrics and Child Health, 2002, GUID AUT INV FET PER; Rutty GN, 2013, INT J LEGAL MED, V127, P465, DOI 10.1007/s00414-012-0782-7; Sebire NJ, 2012, J MATERN-FETAL NEO M, V25, P513, DOI 10.3109/14767058.2011.601368; Shojania KG, 2008, NEW ENGL J MED, V358, P873, DOI 10.1056/NEJMp0707996; Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849; Thayyil S, 2009, ARCH DIS CHILD, V94, P354, DOI 10.1136/adc.2008.150904; Thayyil S, 2008, LANCET, V372, P715, DOI 10.1016/S0140-6736(08)61298-2; Thayyil S, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-120; Thayyil S, 2011, ARCH DIS CHILD, V96, P681, DOI 10.1136/adc.2009.165704; Thayyil S, 2010, EUR J RADIOL, V75, pE142, DOI 10.1016/j.ejrad.2009.10.007; Thayyil S, 2009, LANCET, V374, P467, DOI 10.1016/S0140-6736(09)60913-2; [The Royal College of Pathologists The Royal College of Paediatrics and Child Health], 2004, SUDD EXP DEATH INF M; Votino C, 2012, ULTRASOUND OBST GYN, V39, P679, DOI 10.1002/uog.11150; Weber MA, 2012, J CLIN PATHOL, V65, P58, DOI 10.1136/jclinpath-2011-200224; Weustink AC, 2009, RADIOLOGY, V250, P897, DOI 10.1148/radiol.2503080421; Whitby EH, 2004, CLIN RADIOL, V59, P1114, DOI 10.1016/j.crad.2004.04.018; Wichmann D, 2012, ANN INTERN MED, V156, P123, DOI 10.7326/0003-4819-156-2-201201170-00008; Woodward PJ, 1997, AM J ROENTGENOL, V168, P41, DOI 10.2214/ajr.168.1.8976917	33	193	200	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 20	2013	382	9888					223	233		10.1016/S0140-6736(13)60134-8	http://dx.doi.org/10.1016/S0140-6736(13)60134-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193FL	23683720	Bronze			2022-12-28	WOS:000322543700032
J	Chen, Y; Liang, WF; Yang, SG; Wu, NP; Gao, HN; Sheng, JF; Yao, HP; Wo, JN; Fang, Q; Cui, DW; Li, YC; Yao, X; Zhang, YT; Wu, HB; Zheng, SF; Diao, HY; Xia, SC; Zhang, YJ; Chan, KH; Tsoi, HW; Teng, JLL; Song, WJ; Wang, P; Lau, SY; Zheng, M; Chan, JFW; To, KKW; Chen, HL; Li, LJ; Yuen, KY				Chen, Yu; Liang, Weifeng; Yang, Shigui; Wu, Nanping; Gao, Hainv; Sheng, Jifang; Yao, Hangping; Wo, Jianer; Fang, Qiang; Cui, Dawei; Li, Yongcheng; Yao, Xing; Zhang, Yuntao; Wu, Haibo; Zheng, Shufa; Diao, Hongyan; Xia, Shichang; Zhang, Yanjun; Chan, Kwok-Hung; Tsoi, Hoi-Wah; Teng, Jade Lee-Lee; Song, Wenjun; Wang, Pui; Lau, Siu-Ying; Zheng, Min; Chan, Jasper Fuk-Woo; To, Kelvin Kai-Wang; Chen, Honglin; Li, Lanjuan; Yuen, Kwok-Yung			Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome	LANCET			English	Article							PATHOGENESIS; CORONAVIRUS; DUCKS; MICE; ASIA	Background Human infection with avian influenza A H7N9 virus emerged in eastern China in February, 2013, and has been associated with exposure to poultry. We report the clinical and microbiological features of patients infected with influenza A H7N9 virus and compare genomic features of the human virus with those of the virus in market poultry in Zhejiang, China. Methods Between March 7 and April 8, 2013, we included hospital inpatients if they had new-onset respiratory symptoms, unexplained radiographic infiltrate, and laboratory-confirmed H7N9 virus infection. We recorded histories and results of haematological, biochemical, radiological, and microbiological investigations. We took throat and sputum samples, used RT-PCR to detect M, H7, and N9 genes, and cultured samples in Madin-Darby canine kidney cells. We tested for co-infections and monitored serum concentrations of six cytokines and chemokines. We collected cloacal swabs from 86 birds from epidemiologically linked wet markets and inoculated embryonated chicken eggs with the samples. We identified and subtyped isolates by RT-PCR sequencing. RNA extraction, complementary DNA synthesis, and PCR sequencing were done for one human and one chicken isolate. We characterised and phylogenetically analysed the eight gene segments of the viruses in the patient's and the chicken's isolates, and constructed phylogenetic trees of H, N, PB2, and NS genes. Findings We identified four patients (mean age 56 years), all of whom had contact with poultry 3-8 days before disease onset. They presented with fever and rapidly progressive pneumonia that did not respond to antibiotics. Patients were leucopenic and lymphopenic, and had impaired liver or renal function, substantially increased serum cytokine or chemokine concentrations, and disseminated intravascular coagulation with disease progression. Two patients died. Sputum specimens were more likely to test positive for the H7N9 virus than were samples from throat swabs. The viral isolate from the patient was closely similar to that from an epidemiologically linked market chicken. All viral gene segments were of avian origin. The H7 of the isolated viruses was closest to that of the H7N3 virus from domestic ducks in Zhejiang, whereas the N9 was closest to that of the wild bird H7N9 virus in South Korea. We noted Gln226Leu and Gly186Val substitutions in human virus H7 (associated with increased affinity for alpha-2,6-linked sialic acid receptors) and the PB2 Asp701Asn mutation (associated with mammalian adaptation). Ser31Asn mutation, which is associated with adamantane resistance, was noted in viral M2. Interpretation Cross species poultry-to-person transmission of this new reassortant H7N9 virus is associated with severe pneumonia and multiorgan dysfunction in human beings. Monitoring of the viral evolution and further study of disease pathogenesis will improve disease management, epidemic control, and pandemic preparedness.	[Chen, Yu; Liang, Weifeng; Yang, Shigui; Wu, Nanping; Gao, Hainv; Sheng, Jifang; Yao, Hangping; Wo, Jianer; Fang, Qiang; Cui, Dawei; Zhang, Yuntao; Wu, Haibo; Zheng, Shufa; Diao, Hongyan; Li, Lanjuan] Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Yu; Liang, Weifeng; Yang, Shigui; Wu, Nanping; Gao, Hainv; Sheng, Jifang; Yao, Hangping; Wo, Jianer; Wu, Haibo; Diao, Hongyan; Chen, Honglin; Li, Lanjuan; Yuen, Kwok-Yung] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Li, Yongcheng] Xiaoshan Peoples Hosp, Hangzhou, Zhejiang, Peoples R China; [Yao, Xing] Huzhou Cent Hosp, Huzhou, Peoples R China; [Xia, Shichang; Zhang, Yanjun] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Chan, Kwok-Hung; Tsoi, Hoi-Wah; Teng, Jade Lee-Lee; Song, Wenjun; Wang, Pui; Lau, Siu-Ying; Zheng, Min; Chan, Jasper Fuk-Woo; To, Kelvin Kai-Wang; Chen, Honglin; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Huzhou University; Zhejiang Provincial Center for Disease Control & Prevention; University of Hong Kong	Li, LJ (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn	Chan, Kwok Hung/ABD-5399-2021; Chen, Yu/Y-3292-2019; Chen, Yi/HIR-2608-2022; Chen, Honglin/C-4224-2009; Chan, Jasper F. W./D-8007-2013; Cui, Dawei/ABG-4534-2021; To, Kelvin/AAV-7007-2020; Song, Wenjun/HGB-4891-2022; gao, hainv/H-3868-2013	Chen, Honglin/0000-0001-5108-8338; Chan, Jasper F. W./0000-0001-6336-6657; To, Kelvin/0000-0002-1921-5824; gao, hainv/0000-0003-4590-9181; Yuen, Kwok-yung/0000-0002-2083-1552; LI, Lanjuan/0000-0001-6945-0593	National Key Program for Infectious Diseases of China	National Key Program for Infectious Diseases of China	Larry Chi-Kin Yung, National Key Program for Infectious Diseases of China.	Arzey GG, 2012, EMERG INFECT DIS, V18, P814, DOI 10.3201/eid1805.111852; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Chan JFW, 2012, J INFECTION, V65, P477, DOI 10.1016/j.jinf.2012.10.002; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; Cheng VCC, 2012, CLIN MICROBIOL REV, V25, P223, DOI 10.1128/CMR.05012-11; Cheng VCC, 2011, J INFECTION, V62, P394, DOI 10.1016/j.jinf.2011.02.007; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Estenssoro E, 2006, CRIT CARE, V10, DOI 10.1186/cc4941; Feng Y, 2011, INFECT IMMUN, V79, P229, DOI 10.1128/IAI.00709-10; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Hung IEN, 2013, CHEST, V144, P464, DOI 10.1378/chest.12-2907; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Law AHY, 2010, CELL MOL IMMUNOL, V7, P263, DOI 10.1038/cmi.2010.25; Li IWS, 2009, J CLIN VIROL, V46, P325, DOI 10.1016/j.jcv.2009.09.013; Li KS, 2003, J VIROL, V77, P6988, DOI 10.1128/JVI.77.12.6988-6994.2003; Ostrowsky B, 2012, EMERG INFECT DIS, V18, P1128, DOI 10.3201/eid1807.111913; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; To KKW, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.24; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Tweed SA, 2004, EMERG INFECT DIS, V10, P2196, DOI 10.3201/eid1012.040961; Wu HB, 2012, ARCH VIROL, V157, P2017, DOI 10.1007/s00705-012-1370-3; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang AJX, 2013, J INFECT DIS, V207, P1270, DOI 10.1093/infdis/jit031; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105; Zhou HB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006277	30	643	729	9	491	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 1	2013	381	9881					1916	1925		10.1016/S0140-6736(13)60903-4	http://dx.doi.org/10.1016/S0140-6736(13)60903-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163EV	23623390	Green Published, Bronze			2022-12-28	WOS:000320319500032
J	Holmberg, SD; Spradling, PR; Moorman, AC; Denniston, MM				Holmberg, Scott D.; Spradling, Philip R.; Moorman, Anne C.; Denniston, Maxine M.			Hepatitis C in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VIRUS-INFECTION; PREVALENCE; CARE		[Holmberg, Scott D.; Spradling, Philip R.; Moorman, Anne C.; Denniston, Maxine M.] Ctr Dis Control & Prevent, Epidemiol & Surveillance Branch, Div Viral Hepatitis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Holmberg, SD (corresponding author), Ctr Dis Control & Prevent, Epidemiol & Surveillance Branch, Div Viral Hepatitis, Atlanta, GA 30333 USA.			Moorman, Anne/0000-0003-2411-2798	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Centers for Disease Control and Prevention (USA), 2012, MMWR RECOMM REP, V61, P886; Denniston MM, 2012, HEPATOLOGY, V55, P1652, DOI 10.1002/hep.25556; Moorman AC, 2013, CLIN INFECT DIS, V56, P40, DOI 10.1093/cid/cis815; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Spradling PR, 2012, CLIN INFECT DIS, V55, P1047, DOI 10.1093/cid/cis616	6	252	253	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2013	368	20					1859	1861		10.1056/NEJMp1302973	http://dx.doi.org/10.1056/NEJMp1302973			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143VK	23675657	Green Accepted			2022-12-28	WOS:000318896200003
J	Zhao, K; Tseng, BS; Beckerman, B; Jin, F; Gibiansky, ML; Harrison, JJ; Luijten, E; Parsek, MR; Wong, GCL				Zhao, Kun; Tseng, Boo Shan; Beckerman, Bernard; Jin, Fan; Gibiansky, Maxsim L.; Harrison, Joe J.; Luijten, Erik; Parsek, Matthew R.; Wong, Gerard C. L.			Psl trails guide exploration and microcolony formation in Pseudomonas aeruginosa biofilms	NATURE			English	Article							POWER LAWS; BACTERIAL BIOFILMS; CYSTIC-FIBROSIS; IV PILI; MATRIX; EXOPOLYSACCHARIDE; POLYSACCHARIDE; INVOLVEMENT; INFECTIONS; ADHESION	Bacterial biofilms are surface-associated, multicellular, morphologically complex microbial communities(1-7). Biofilm-forming bacteria such as the opportunistic pathogen Pseudomonas aeruginosa are phenotypically distinct from their free-swimming, planktonic counterparts(7-10). Much work has focused on factors affecting surface adhesion, and it is known that P. aeruginosa secretes the Psl exopolysaccharide, which promotes surface attachment by acting as 'molecular glue'(11-15). However, how individual surface-attached bacteria self-organize into microcolonies, the first step in communal biofilm organization, is not well understood. Here we identify a new role for Psl in early biofilm development using a massively parallel cell-tracking algorithm to extract the motility history of every cell on a newly colonized surface(16). By combining this technique with fluorescent Psl staining and computer simulations, we show that P. aeruginosa deposits a trail of Psl as it moves on a surface, which influences the surface motility of subsequent cells that encounter these trails and thus generates positive feedback. Both experiments and simulations indicate that the web of secreted Psl controls the distribution of surface visit frequencies, which can be approximated by a power law. This Pareto-type(17) behaviour indicates that the bacterial community self-organizes in a manner analogous to a capitalist economic system(18), a 'rich-get-richer' mechanism of Psl accumulation that results in a small number of 'elite' cells becoming extremely enriched in communally produced Psl. Using engineered strains with inducible Psl production, we show that local Psl concentrations determine post-division cell fates and that high local Psl concentrations ultimately allow elite cells to serve as the founding population for initial microcolony development.	[Zhao, Kun; Gibiansky, Maxsim L.; Wong, Gerard C. L.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA; [Tseng, Boo Shan; Harrison, Joe J.; Parsek, Matthew R.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Beckerman, Bernard; Luijten, Erik] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Jin, Fan] Univ Sci & Technol China, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China; [Luijten, Erik] Northwestern Univ, Dept Engn Sci & Appl Math, Evanston, IL 60208 USA; [Wong, Gerard C. L.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Wong, Gerard C. L.] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; Northwestern University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Northwestern University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Wong, GCL (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.	luijten@northwestern.edu; parsem@u.washington.edu; gclwong@seas.ucla.edu	Tseng, Boo Shan/M-6279-2018; Luijten, Erik/E-3899-2010; zhao, kun/A-1998-2011; Harrison, Joe/AAV-6071-2021	Tseng, Boo Shan/0000-0001-7563-0232; Luijten, Erik/0000-0003-2364-1866; ZHAO, KUN/0000-0003-3928-1981; Harrison, Joe/0000-0003-0368-9539; fan, jin/0000-0003-2313-0388	US National Institutes of Health [NIH 1RO1HL087920]; US National Science Foundation [NSF DMR1106106]; UCLA Transdisciplinary Seed Grant; NIH [R01AI077628, R01AI081983, R56AI061396]; NSF [MCB0822405, DMR-1006430, DGE-0824162]; Cystic Fibrosis Foundation [TSENG11F0]; Natural Sciences and Engineering Research Council of Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081983, R01AI061396, R56AI061396, R01AI097511, R01AI077628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089507] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1006430] Funding Source: National Science Foundation	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); UCLA Transdisciplinary Seed Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	K.Z., B. S. T., M. R. P. and G. C. L. W. are supported by the US National Institutes of Health (NIH 1RO1HL087920). K.Z. and G. C. L. W. also acknowledge support from the US National Science Foundation (NSF DMR1106106) and a UCLA Transdisciplinary Seed Grant. B. S. T., J.J.H. and M. R. P. also acknowledge support from the NIH (R01AI077628, R01AI081983, R56AI061396) and NSF (MCB0822405). B. S. T. is supported by the Cystic Fibrosis Foundation Postdoctoral Fellowship (TSENG11F0). J.J.H. was supported by a postdoctoral fellowship from the Natural Sciences and Engineering Research Council of Canada. B. B. and E. L. acknowledge support from the NSF under DMR-1006430 (E. L.) and DGE-0824162 (B. B.). The authors would like to thank J. Copic for discussions and R. J. Siehnel for technical assistance. We dedicate this paper to the memory of M. Shannon.	Byrd MS, 2010, MBIO, V1, DOI 10.1128/mBio.00140-10; Byrd MS, 2009, MOL MICROBIOL, V73, P622, DOI 10.1111/j.1365-2958.2009.06795.x; Colvin KM, 2012, ENVIRON MICROBIOL, V14, P1913, DOI 10.1111/j.1462-2920.2011.02657.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; EAGON RG, 1962, CAN J MICROBIOL, V8, P585, DOI 10.1139/m62-075; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Gabaix X, 2009, ANNU REV ECON, V1, P255, DOI 10.1146/annurev.economics.050708.142940; Gibiansky ML, 2010, SCIENCE, V330, P197, DOI 10.1126/science.1194238; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Klausen M, 2003, MOL MICROBIOL, V50, P61, DOI 10.1046/j.1365-2958.2003.03677.x; Lecuyer S, 2011, BIOPHYS J, V100, P341, DOI 10.1016/j.bpj.2010.11.078; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Ma LY, 2007, J BACTERIOL, V189, P8353, DOI 10.1128/JB.00620-07; Ma L, 2006, J BACTERIOL, V188, P8213, DOI 10.1128/JB.01202-06; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Mann EE, 2012, FEMS MICROBIOL REV, V36, P893, DOI 10.1111/j.1574-6976.2011.00322.x; Monroe D, 2007, PLOS BIOL, V5, P2458, DOI 10.1371/journal.pbio.0050307; Newman JR, 1999, GENE, V227, P197, DOI 10.1016/S0378-1119(98)00601-5; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Solomon S, 2001, PHYSICA A, V299, P188, DOI 10.1016/S0378-4371(01)00295-3; Sternberg Claus, 2006, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b02s00; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; Tatterson LE, 2001, FRONT BIOSCI-LANDMRK, V6, pD890, DOI 10.2741/Tatterso; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487	32	209	221	8	223	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2013	497	7449					388	+		10.1038/nature12155	http://dx.doi.org/10.1038/nature12155			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23657259	Green Accepted			2022-12-28	WOS:000318952000042
J	Mills, EJ; Thorlund, K; Ioannidis, JPA				Mills, Edward J.; Thorlund, Kristian; Ioannidis, John P. A.			Demystifying trial networks and network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INCONSISTENCY; GEOMETRY		[Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON K1N 6N5, Canada; [Mills, Edward J.; Thorlund, Kristian; Ioannidis, John P. A.] Stanford Univ, Dept Med, Sch Humanities & Sci, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Thorlund, Kristian] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Sch Humanities & Sci, Stanford, CA 94305 USA	University of Ottawa; Stanford University; McMaster University; Stanford University; Stanford University	Mills, EJ (corresponding author), Univ Ottawa, Fac Hlth Sci, 35 Univ Dr, Ottawa, ON K1N 6N5, Canada.	Edward.mills@uottawa.ca	Ioannidis, John P. A./G-9836-2011					Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Coleman C. I., 2012, USE MIXED TREATMENT; Cooper NJ, 2006, ARCH INTERN MED, V166, P1269, DOI 10.1001/archinte.166.12.1269; Dias S, 2012, NICE DSU TECHNICAL S; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ioannidis JPA, 2009, CAN MED ASSOC J, V181, P488, DOI 10.1503/cmaj.081086; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P1089, DOI 10.1001/jama.279.14.1089; Jansen JP, 2011, VALUE HEALTH, V14, P417, DOI 10.1016/j.jval.2011.04.002; Kappagoda S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6512; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Mills EJ, 2012, JAMA-J AM MED ASSOC, V308, P1246, DOI 10.1001/2012.jama.11228; Mills EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016237; Pereira TV, 2012, JAMA-J AM MED ASSOC, V308, P1676, DOI 10.1001/jama.2012.13444; Pereira TV, 2010, RES SYNTH METHODS, V1, P149, DOI 10.1002/jrsm.13; Salanti G, 2008, ANN INTERN MED, V148, P544, DOI 10.7326/0003-4819-148-7-200804010-00011; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Song FJ, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4909; Sutton A, 2008, PHARMACOECONOMICS, V26, P753, DOI 10.2165/00019053-200826090-00006; Thorlund K, 2012, ANN RHEUM DIS; Thorlund K, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-41	21	450	454	2	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2013	346								f2914	10.1136/bmj.f2914	http://dx.doi.org/10.1136/bmj.f2914			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148OF	23674332	Bronze			2022-12-28	WOS:000319253900007
J	Ward, LD; Kellis, M				Ward, Lucas D.; Kellis, Manolis			Response to Comment on "Evidence of Abundant Purifying Selection in Humans for Recently Acquired Regulatory Functions"	SCIENCE			English	Editorial Material							ELEMENTS	Green and Ewing propose corrections to our methodology, which we incorporate and extend here. The improved methodology supports our initial conclusion of extensive lineage-specific constraint concentrated in ENCODE elements. We clarify that our estimate is dependent on the constrained and neutral references used, which can further increase the number of nucleotides involved, because a particularly stringent definition was initially used.	[Ward, Lucas D.; Kellis, Manolis] Massachusetts Inst Technol MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Ward, Lucas D.; Kellis, Manolis] Massachusetts Inst Technol MIT, Broad Inst, Cambridge, MA 02139 USA; [Ward, Lucas D.; Kellis, Manolis] Harvard Univ, Broad Inst, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Kellis, M (corresponding author), Massachusetts Inst Technol MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA.	manoli@mit.edu	Kellis, Manolis/ABE-7385-2020	Kellis, Manolis/0000-0001-7113-9630; Ward, Lucas/0000-0002-8017-809X	NHGRI NIH HHS [RC1 HG005334, R01 HG004037] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Asthana S, 2007, P NATL ACAD SCI USA, V104, P12410, DOI 10.1073/pnas.0705140104; Cheng C, 2012, GENOME RES, V22, P1658, DOI 10.1101/gr.136838.111; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Green P, 2013, SCIENCE, V340, DOI 10.1126/science.1233195; Gronau I, 2013, MOL BIOL EVOL, V30, P1159, DOI 10.1093/molbev/mst019; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Meader S, 2010, GENOME RES, V20, P1335, DOI 10.1101/gr.108795.110; Mu XJ, 2011, NUCLEIC ACIDS RES, V39, P7058, DOI 10.1093/nar/gkr342; Spivakov M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r49; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057	11	10	10	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133							1233195	10.1126/science.1233195	http://dx.doi.org/10.1126/science.1233195			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661743				2022-12-28	WOS:000318619000044
J	Ashrafi, MH; Bhatty, U; Hall, K; Mokete, M				Ashrafi, Mohammed Hayat; Bhatty, Usman; Hall, Katie; Mokete, Moeketsi			CASE REPORT A man with bilateral loin pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							STAGHORN CALCULI; CYSTIC-FIBROSIS; STONE FORMATION; MANAGEMENT; NEPHROLITHIASIS; UROLITHIASIS; LITHOTRIPSY; MONOTHERAPY; PREVENTION; RISK		[Ashrafi, Mohammed Hayat; Bhatty, Usman; Hall, Katie; Mokete, Moeketsi] Lancashire Teaching Hosp NHS Fdn Trust, Dept Urol, Preston PR2 9HT, Lancs, England		Ashrafi, MH (corresponding author), Lancashire Teaching Hosp NHS Fdn Trust, Dept Urol, Preston PR2 9HT, Lancs, England.	mohammedashrafi@doctors.org.uk		Bhatty, Usman/0000-0002-1658-4587				Basiri A, 2012, J ENDOUROL, V26, P235, DOI 10.1089/end.2011.0083; ECKFORD SD, 1992, BRIT J UROL, V70, P496, DOI 10.1111/bju.1992.70.5.496; Eggermann T, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-19; Freeman S, 2008, IMAGING, V20, P38; GLOWACKI LS, 1992, J UROLOGY, V147, P319, DOI 10.1016/S0022-5347(17)37225-7; Jungers P, 2004, AM J KIDNEY DIS, V44, P799, DOI 10.1053/j.ajkd.2004.08.014; KRISTENSEN C, 1987, KIDNEY INT, V32, P749, DOI 10.1038/ki.1987.270; Meretyk S, 1997, J UROLOGY, V157, P780, DOI 10.1016/S0022-5347(01)65039-0; NETTO NR, 1994, J ENDOUROL, V8, P195, DOI 10.1089/end.1994.8.195; Perez-Brayfield MR, 2002, J UROLOGY, V167, P480, DOI 10.1016/S0022-5347(01)69068-2; Preminger GM, 2005, J UROLOGY, V173, P1991, DOI 10.1097/01.ju.0000161171.67806.2a; Reynard J, 2010, OXFORD HDB UROLOGY; Seitz C, 2012, EUR UROL, V61, P146, DOI 10.1016/j.eururo.2011.09.016; Stanley K E, 1994, Semin Urol, V12, P15; Terribile M, 2006, NEPHROL DIAL TRANSPL, V21, P1870, DOI 10.1093/ndt/gfl067; Turk C, 2011, GUIDELINES UROLITHIA	16	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 9	2013	346								f2850	10.1136/bmj.f2850	http://dx.doi.org/10.1136/bmj.f2850			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144BU	23661114				2022-12-28	WOS:000318915200004
J	Yang, LX; Luquette, LJ; Gehlenborg, N; Xi, RB; Haseley, PS; Hsieh, CH; Zhang, CS; Ren, XJ; Protopopov, A; Chin, L; Kucherlapati, R; Lee, C; Park, PJ				Yang, Lixing; Luquette, Lovelace J.; Gehlenborg, Nils; Xi, Ruibin; Haseley, Psalm S.; Hsieh, Chih-Heng; Zhang, Chengsheng; Ren, Xiaojia; Protopopov, Alexei; Chin, Lynda; Kucherlapati, Raju; Lee, Charles; Park, Peter J.			Diverse Mechanisms of Somatic Structural Variations in Human Cancer Genomes	CELL			English	Article							DOUBLE-STRAND BREAKS; DOUBLE-MINUTE CHROMOSOMES; GENE; REARRANGEMENTS; SEQUENCES; PATTERNS; MUTATION; REPAIR; RECOMBINATION; AMPLIFICATION	Identification of somatic rearrangements in cancer genomes has accelerated through analysis of high-throughput sequencing data. However, characterization of complex structural alterations and their underlying mechanisms remains inadequate. Here, applying an algorithm to predict structural variations from short reads, we report a comprehensive catalog of somatic structural variations and the mechanisms generating them, using high-coverage whole-genome sequencing data from 140 patients across ten tumor types. We characterize the relative contributions of different types of rearrangements and their mutational mechanisms, find that 20% of the somatic deletions are complex deletions formed by replication errors, and describe the differences between the mutational mechanisms in somatic and germline alterations. Importantly, we provide detailed reconstructions of the events responsible for loss of CDKN2A/B and gain of EGFR in glioblastoma, revealing that these alterations can result from multiple mechanisms even in a single genome and that both DNA double-strand breaks and replication errors drive somatic rearrangements.	[Yang, Lixing; Luquette, Lovelace J.; Gehlenborg, Nils; Xi, Ruibin; Haseley, Psalm S.; Park, Peter J.] Harvard Univ, Sch Med, Ctr Informat Biol, Boston, MA 02115 USA; [Kucherlapati, Raju] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Gehlenborg, Nils] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02142 USA; [Xi, Ruibin] Peking Univ, Sch Math Sci, Beijing 100871, Peoples R China; [Xi, Ruibin] Peking Univ, Ctr Stat Sci, Beijing 100871, Peoples R China; [Haseley, Psalm S.; Ren, Xiaojia; Kucherlapati, Raju; Park, Peter J.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Hsieh, Chih-Heng; Zhang, Chengsheng; Lee, Charles] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Haseley, Psalm S.; Hsieh, Chih-Heng; Lee, Charles] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Protopopov, Alexei; Chin, Lynda] Univ Texas Houston, MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77054 USA; [Protopopov, Alexei; Chin, Lynda] Univ Texas Houston, MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77054 USA; [Lee, Charles] Seoul Natl Univ, Coll Med, Dept Med, Seoul 110799, South Korea; [Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Peking University; Peking University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Seoul National University (SNU); Harvard University; Boston Children's Hospital	Park, PJ (corresponding author), Harvard Univ, Sch Med, Ctr Informat Biol, Boston, MA 02115 USA.	peter_park@harvard.edu	Kucherlapati, Raju/ABC-8807-2021	Gehlenborg, Nils/0000-0003-0327-8297; Park, Peter/0000-0001-9378-960X; Xi, Ruibin/0000-0001-7545-7361	NIH [RC1HG005482, U24CA144025, UO1HG005209, UO1HG005725, U24CA143845]; NATIONAL CANCER INSTITUTE [U24CA143845, U24CA144025] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC1HG005482, U01HG005209, U01HG005725] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grants from NIH (RC1HG005482 to P.J.P., U24CA144025 to R.K., UO1HG005209 and UO1HG005725 to C.L. and U24CA143845 to L.C.). We thank The Cancer Genome Atlas project for providing the whole-genome data, the Information Technology Department at Harvard Medical School for providing computational resources, and Michael Talkowski and members of the Park laboratory for a careful reading of the manuscript. L.C. is founder and/or consultant for AVEO, Metamark, Karyopharm, and Eden. R.K. is on the board of directors of AVEO, Metamark, Enlight, and KEW Group.	Arlt MF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002981; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chiang C, 2012, NAT GENET, V44, P390, DOI 10.1038/ng.2202; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; De S, 2011, NAT BIOTECHNOL, V29, P1103, DOI 10.1038/nbt.2030; De S, 2011, NAT STRUCT MOL BIOL, V18, P950, DOI 10.1038/nsmb.2089; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; EDLUND T, 1981, NATURE, V292, P269, DOI 10.1038/292269a0; Fudenberg G, 2011, NAT BIOTECHNOL, V29, P1109, DOI 10.1038/nbt.2049; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Haffner MC, 2010, NAT GENET, V42, P668, DOI 10.1038/ng.613; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Haviv-Chesner A, 2007, NUCLEIC ACIDS RES, V35, P5192, DOI 10.1093/nar/gkm521; Hillmer AM, 2011, GENOME RES, V21, P665, DOI 10.1101/gr.113555.110; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kidd JM, 2010, CELL, V143, P837, DOI 10.1016/j.cell.2010.10.027; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lam HYK, 2010, NAT BIOTECHNOL, V28, P47, DOI 10.1038/nbt.1600; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; LISKAY RM, 1987, GENETICS, V115, P161; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Storlazzi CT, 2010, GENOME RES, V20, P1198, DOI 10.1101/gr.106252.110; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Thomas L, 2004, AM J HEMATOL, V77, P55, DOI 10.1002/ajh.20151; Van Roy N, 2006, GENE CHROMOSOME CANC, V45, P107, DOI 10.1002/gcc.20272; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Vogt N, 2004, P NATL ACAD SCI USA, V101, P11368, DOI 10.1073/pnas.0402979101; WALDMAN AS, 1988, MOL CELL BIOL, V8, P5350, DOI 10.1128/MCB.8.12.5350; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	49	208	211	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 9	2013	153	4					919	929		10.1016/j.cell.2013.04.010	http://dx.doi.org/10.1016/j.cell.2013.04.010			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663786	Green Accepted, Bronze			2022-12-28	WOS:000318844000019
J	Ecker, J				Ecker, Jeffrey			Elective Cesarean Delivery on Maternal Request	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; PLANNED VAGINAL BIRTH; TERM BREECH TRIAL; PREGNANT-WOMEN; SECTION; OUTCOMES; MODE; STILLBIRTH; CLINICIAN; MORBIDITY	Importance Some pregnant women prefer cesarean delivery and request it without maternal or fetal indication rather than proceeding with a plan for vaginal delivery. Objective To review approaches for counseling women who ask for cesarean delivery without maternal or fetal indication (known as cesarean delivery on maternal request [CDMR]). Evidence Review An Agency for Healthcare Research and Quality evidence report of studies published after 1990, a 2006 National Institutes of Health state-of-the-science conference report, and published literature were examined. Findings The prevalence of CDMR in the United States is not precisely known but probably occurs in less than 3% of all deliveries. Most practicing obstetricians have received requests for CDMR from patients. Compared with a plan for vaginal delivery, CDMR may be associated with lower rates of hemorrhage, maternal incontinence, and rare but serious neonatal outcomes. However, CDMR is associated with a higher risk of neonatal respiratory morbidity. Adverse consequences of CDMR may be manifested only in future pregnancies. Repeated cesarean deliveries have higher rates of operative complications, placental abnormalities such as placenta previa and accreta, and consequent gravid hysterectomy. Conclusions and Relevance There is no immediate expectation for CDMR to reduce the health risks of mothers or infants. Accordingly, counseling and decisions regarding CDMR should be made after considering a woman's full reproductive plans. JAMA. 2013;309(18):1930-1936 www.jama.com	[Ecker, Jeffrey] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Ecker, Jeffrey] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA	Harvard University; Harvard University; Massachusetts General Hospital	Ecker, J (corresponding author), Massachusetts Gen Hosp, 55 Fruit St,Founders 420A, Boston, MA 02114 USA.	jecker@partners.org						American College of Obstetricians and Gynecologists, 2008, Obstet Gynecol, V111, P243, DOI 10.1097/01.AOG.0000291581.16747.24; American College of Obstetricians and Gynecologists, 2007, Obstet Gynecol, V110, P1501; Barber EL, 2011, OBSTET GYNECOL, V118, P29, DOI 10.1097/AOG.0b013e31821e5f65; Bettes BA, 2007, OBSTET GYNECOL, V109, P57, DOI 10.1097/01.AOG.0000249608.11864.b6; Blanchette H, 2011, OBSTET GYNECOL, V118, P687, DOI 10.1097/AOG.0b013e318227b8d9; Cesarean Delivery on Maternal Request, 2006, AHRQ PUBLICATION, V06-E009; D'Alton ME, 2006, OBSTET GYNECOL, V107, P1386; Ecker JL, 2004, AM J OBSTET GYNECOL, V190, P314, DOI 10.1016/S0002-9378(03)00869-X; Ecker JL, 1997, OBSTET GYNECOL, V89, P643, DOI 10.1016/S0029-7844(97)00007-0; Fuglenes D, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.043; Gossman GL, 2006, OBSTET GYNECOL, V108, P1506, DOI 10.1097/01.AOG.0000242564.79349.b7; Gregory Kimberly D, 2012, Am J Perinatol, V29, P7, DOI 10.1055/s-0031-1285829; Handa VL, 2011, OBSTET GYNECOL, V118, P777, DOI 10.1097/AOG.0b013e3182267f2f; Hannah ME, 2004, AM J OBSTET GYNECOL, V191, P917, DOI 10.1016/j.ajog.2004.08.004; Hannah ME, 2000, LANCET, V356, P1375, DOI 10.1016/S0140-6736(00)02840-3; Hannah ME, 2002, JAMA-J AM MED ASSOC, V287, P1822, DOI 10.1001/jama.287.14.1822; Jackson S, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.09.023; Kalish RB, 2008, CURR OPIN OBSTET GYN, V20, P116, DOI 10.1097/GCO.0b013e3282f55df7; Lavender T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004660.pub3; Little MO, 2008, OBSTET GYNECOL, V112, P913, DOI 10.1097/AOG.0b013e3181888fd8; MacDorman MF, 2008, CLIN PERINATOL, V35, P293, DOI 10.1016/j.clp.2008.03.007; Martinez-Biarge M, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.09.031; MORRISON JJ, 1995, BRIT J OBSTET GYNAEC, V102, P101, DOI 10.1111/j.1471-0528.1995.tb09060.x; Nygaard I, 2011, OBSTET GYNECOL, V118, P774, DOI 10.1097/AOG.0b013e31822f8bca; Rosenstein MG, 2012, OBSTET GYNECOL, V120, P76, DOI 10.1097/AOG.0b013e31825bd286; Silver RM, 2006, OBSTET GYNECOL, V107, P1226, DOI 10.1097/01.AOG.0000219750.79480.84; Smith GCS, 2003, LANCET, V362, P1779, DOI 10.1016/S0140-6736(03)14896-9; Towner D, 1999, NEW ENGL J MED, V341, P1709, DOI 10.1056/NEJM199912023412301; Turner CE, 2008, BJOG-INT J OBSTET GY, V115, P1494, DOI 10.1111/j.1471-0528.2008.01892.x; Turner CE, 2008, AUST NZ J OBSTET GYN, V48, P542, DOI 10.1111/j.1479-828X.2008.00923.x; Visco AG, 2006, OBSTET GYNECOL, V108, P1517, DOI 10.1097/01.AOG.0000241092.79282.87; West S, 2002, AHRQ PUBLICATION, V02-E016	32	73	76	0	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2013	309	18					1930	1936		10.1001/jama.2013.3982	http://dx.doi.org/10.1001/jama.2013.3982			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138AZ	23652524				2022-12-28	WOS:000318481900028
J	Mackay, J; Ritthiphakdee, B; Reddy, KS				Mackay, Judith; Ritthiphakdee, Bungon; Reddy, K. Srinath			Tobacco Control 2 Tobacco control in Asia	LANCET			English	Article								For the purpose of this article, Asia refers to WHO's combined South-East Asia and Western Pacific regions and thus includes Australia and New Zealand. Asia has the highest number of tobacco users and is the prime target of transnational tobacco companies. The future of global tobacco control rests in this region and the challenges are clear. China, India, and Indonesia are key markets and Asia is a frontrunner in tobacco control measures, such as plain packaging of cigarettes. Some countries in Asia have a long history of tobacco control activities beginning in the 1970s, and WHO's Western Pacific Region is still the only region where all countries have ratified WHO's Framework Convention on Tobacco Control. We reviewed the history, research, epidemiology, tobacco control action, obstacles, and potential responses and solutions to the tobacco epidemic in this region. Levels of development, systems of government, and population size are very different between countries, with population size ranging from 1500 to 1.3 billion, but similarities exist in aspects of the tobacco epidemic, harms caused, obstacles faced, and tobacco control actions needed.	[Mackay, Judith] World Lung Fdn, Hong Kong, Hong Kong, Peoples R China; [Ritthiphakdee, Bungon] Southeast Asia Tobacco Control Alliance SEATCA, Bangkok, Thailand; [Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India	Public Health Foundation of India	Mackay, J (corresponding author), World Lung Fdn, Hong Kong, Hong Kong, Peoples R China.	jmackay1@netvigator.com		Reddy, K Srinath/0000-0003-3416-3548				Asian Development Bank, 2012, TOB TAX WIN WIN MEAS; Assunta M, 2004, TOB CONTROL, V13, P4, DOI 10.1136/tc.2003.005199; Bill & Melinda Gates Foundation, 2013, TOB CONTR STRAT OV; Campaign for Tobacco-Free Kids, TOB CONTR LAWS; Campaign for Tobacco-Free Kids, 2005, TOB CONTR LAWS HLTH; Centers for Disease Control and Prevention, 2012, SMOK TOB US; Centers for Disease Control and Prevention, 2010, GLOB YOUTH TOB SURV; Chaloupka F, 1996, US TRADE POLICY CIGA; Chitanondh H., 2001, DEFEAT TRADE VICTORY; Ding D, 2009, TOB CONTROL, V18, P354, DOI 10.1136/tc.2008.026112; Efroymson D, 2001, TOB CONTROL, V10, P212, DOI 10.1136/tc.10.3.212; Eriksen M, 2012, TOBACCO ATLAS; Gaisch H., 1987, PHILIP MORRIS ORG CO; HIRAYAMA T, 1981, BRIT MED J, V282, P183, DOI 10.1136/bmj.282.6259.183; International Tobacco Control Policy Evaluation Project, 2012, PROM EV BAS STRAT FI; Kwok MK, 2008, TOB CONTROL, V17, DOI 10.1136/tc.2007.023887; Mackay J, 1992, J Natl Cancer Inst Monogr, P25; Social Surveys Section, 2008, 36 CENS STAT DEP SOC; Sourcewatch, 2009, WHIT; Southeast Asia Tobacco Control Alliance, 2012, CAT CHANG; Southeast Asia Tobacco Control Alliance (SEATCA), 2012, AS PAC REP CARD; Tobacco Control Grants, BLOOMB IN RED TOB US; UN, 2011, UN POL DECL HIGH LEV; WHO South-East Asia, 2012, REG STRAT TOB CONTR; WHO Western Pacific, 2013, TOB FREE IN; World Health Organization, 2009, WHO FRAM CONV TOB CO; World Health Organization, 2012, WHO FRAM CONV TOB CO; World Health Organization, 2019, WHO REP GLOB TOB EP; World Health Organization (WHO), 2008, MPOWER MEAS; Yang L, 2011, TOB CONTROL, V20, P266, DOI 10.1136/tc.2010.042028	30	45	45	1	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 4	2013	381	9877					1581	1587		10.1016/S0140-6736(13)60854-5	http://dx.doi.org/10.1016/S0140-6736(13)60854-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139UF	23642699	Green Published, Bronze			2022-12-28	WOS:000318609600033
J	Schroeder, JI; Delhaize, E; Frommer, WB; Guerinot, ML; Harrison, MJ; Herrera-Estrella, L; Horie, T; Kochian, LV; Munns, R; Nishizawa, NK; Tsay, YF; Sanders, D				Schroeder, Julian I.; Delhaize, Emmanuel; Frommer, Wolf B.; Guerinot, Mary Lou; Harrison, Maria J.; Herrera-Estrella, Luis; Horie, Tomoaki; Kochian, Leon V.; Munns, Rana; Nishizawa, Naoko K.; Tsay, Yi-Fang; Sanders, Dale			Using membrane transporters to improve crops for sustainable food production	NATURE			English	Article							POTASSIUM UPTAKE; ABC TRANSPORTER; SALT TOLERANCE; NICOTIANAMINE-SYNTHASE; FUNCTIONAL EXPRESSION; PHOSPHATE TRANSPORTER; IRON BIOFORTIFICATION; ALUMINUM RESISTANCE; BACTERIAL-BLIGHT; NA+/H+ ANTIPORT	With the global population predicted to grow by at least 25 per cent by 2050, the need for sustainable production of nutritious foods is critical for human and environmental health. Recent advances show that specialized plant membrane transporters can be used to enhance yields of staple crops, increase nutrient content and increase resistance to key stresses, including salinity, pathogens and aluminium toxicity, which in turn could expand available arable land.	[Schroeder, Julian I.] Univ Calif San Diego, Div Biol Sci, Food & Fuel 21st Century Ctr, La Jolla, CA 92093 USA; [Delhaize, Emmanuel; Munns, Rana] CSIRO Plant Ind, Canberra, ACT 2601, Australia; [Frommer, Wolf B.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Guerinot, Mary Lou] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Harrison, Maria J.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Herrera-Estrella, Luis] Ctr Invest & Estudios Avanzados, Lab Nacl Genom Biodiversidad, Irapuato 36500, Mexico; [Horie, Tomoaki] Shinshu Univ, Fac Text Sci & Technol, Div Appl Biol, Nagano 3868567, Japan; [Kochian, Leon V.] Cornell Univ, USDA ARS, Robert Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Munns, Rana] Univ Western Australia, Sch Plant Biol, Crawley 6009, Australia; [Nishizawa, Naoko K.] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan; [Tsay, Yi-Fang] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan; [Sanders, Dale] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England	University of California System; University of California San Diego; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Carnegie Institution for Science; Dartmouth College; Cornell University; Boyce Thompson Institute for Plant Research; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Shinshu University; Cornell University; United States Department of Agriculture (USDA); University of Western Australia; Ishikawa Prefecture University; Academia Sinica - Taiwan; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Schroeder, JI (corresponding author), Univ Calif San Diego, Div Biol Sci, Food & Fuel 21st Century Ctr, La Jolla, CA 92093 USA.	jischroeder@ucsd.edu; dale.sanders@jic.ac.uk	Tsay, Yi-Fang/ABB-3662-2021; Herrera-Estrella, Luis/AAL-2472-2020; Frommer, Wolf B/K-5042-2017; Frommer, Wolf B/A-8256-2008; Kochian, Leon/ABH-6148-2020; Herrera-Estrella, Luis/ABC-7431-2020; Delhaize, Emmanuel/I-6536-2013; Munns, Rana E/B-4237-2013	Tsay, Yi-Fang/0000-0003-4271-0687; Herrera-Estrella, Luis/0000-0001-7936-3856; Frommer, Wolf B/0000-0001-6465-0115; Frommer, Wolf B/0000-0001-6465-0115; Kochian, Leon/0000-0003-3416-089X; Munns, Rana E/0000-0002-7519-2698; Schroeder, Julian/0000-0002-3283-5972; Delhaize, Emmanuel/0000-0002-0529-7160; Harrison, Maria J/0000-0001-8716-1875	Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences at the US Department of Energy (DOE) [DE-FG02-03ER15449, DE-FG02-04ER15542, DE-FG-2-06ER15809]; Grains Research and Development Corporation, Australia; US National Science Foundation [IOS:0842720, MCB0918220, IOS-091994, DBI 0701119]; UK Biotechnology and Biological Sciences Research Council [BB/J004561/1]; National Institutes of Health [GM060396-P42ES010337, GM078536, P42ES007373]; US Department of Agriculture [2009-02273]; Generation Challenge Grant [G7010.03.06]; Howard Hughes Medical Institute [55005946]; CREST Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan [23119507]; Academia Sinica, Taiwan; National Science Council, Taiwan [NSC 101-2321-B-001-005]; Grants-in-Aid for Scientific Research [23248011] Funding Source: KAKEN; Direct For Biological Sciences [0919941] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007373, P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078536, R01GM060396] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0651, BBS/E/J/000C0662] Funding Source: researchfish; BBSRC [BBS/E/J/000C0662, BBS/E/J/000C0651] Funding Source: UKRI	Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences at the US Department of Energy (DOE)(United States Department of Energy (DOE)); Grains Research and Development Corporation, Australia(Grains R&D Corp); US National Science Foundation(National Science Foundation (NSF)); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Agriculture(United States Department of Agriculture (USDA)); Generation Challenge Grant; Howard Hughes Medical Institute(Howard Hughes Medical Institute); CREST Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Academia Sinica, Taiwan(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Research in our laboratories was supported by: the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences at the US Department of Energy (DOE) under grant numbers DE-FG02-03ER15449 (to J.I.S.), DE-FG02-04ER15542 (to W.B.F.) and DE-FG-2-06ER15809 (to M. L. G.); by the Grains Research and Development Corporation, Australia (to R. M. and E. D.); by the US National Science Foundation under grant numbers IOS:0842720 (to M.J.H.), MCB0918220 (to J.I.S.) and IOS-091994 and DBI 0701119 (to M. L. G.); by the UK Biotechnology and Biological Sciences Research Council under grant number BB/J004561/1 (to D. S.); by the National Institutes of Health under grant numbers GM060396-P42ES010337 (to J.I.S.) and GM078536 and P42ES007373 (to M. L. G.); by the US Department of Agriculture under grant number 2009-02273 (to L. V. K.); by a Generation Challenge Grant under grant number G7010.03.06 (to L. V. K.); by the Howard Hughes Medical Institute under grant number 55005946 (to L. H. E.); the CREST Japan Science and Technology Agency (to N.K.N.); by the Ministry of Education, Culture, Sports, Science and Technology, Japan under grant number 23119507 (to T. H.); and by the Academia Sinica, Taiwan and the National Science Council, Taiwan under grant number NSC 101-2321-B-001-005 (to Y.F.T.).	[Anonymous], 2011, FOR FUT FOOD FARM; Antony G, 2010, PLANT CELL, V22, P3864, DOI 10.1105/tpc.110.078964; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Arpat AB, 2012, PLANT J, V71, P479, DOI 10.1111/j.1365-313X.2012.05004.x; Barragan V, 2012, PLANT CELL, V24, P1127, DOI 10.1105/tpc.111.095273; Beebe SE, 2006, CROP SCI, V46, P413, DOI 10.2135/cropsci2005.0226; BLUMWALD E, 1985, PLANT PHYSIOL, V78, P163, DOI 10.1104/pp.78.1.163; Cakmak I, 2002, PLANT SOIL, V247, P3, DOI 10.1023/A:1021194511492; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Chu ZH, 2006, THEOR APPL GENET, V112, P455, DOI 10.1007/s00122-005-0145-6; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Connor DJ, 2008, FIELD CROP RES, V106, P187, DOI 10.1016/j.fcr.2007.11.010; Conway G., 2012, ONE BILLION HUNGRY C, P125; Delhaize E, 2007, FEBS LETT, V581, P2255, DOI 10.1016/j.febslet.2007.03.057; Delhaize E, 2009, PLANT BIOTECHNOL J, V7, P391, DOI 10.1111/j.1467-7652.2009.00403.x; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Famoso AN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002221; FAO (Food and Agriculture Organization of the United Nations), 2010, STAT FOOD INS WORLD; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Furukawa J, 2007, PLANT CELL PHYSIOL, V48, P1081, DOI 10.1093/pcp/pcm091; Gamuyao R, 2012, NATURE, V488, P535, DOI 10.1038/nature11346; Gilbert-Diamond D, 2011, P NATL ACAD SCI USA, V108, P20656, DOI 10.1073/pnas.1109127108; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Horie T, 2007, EMBO J, V26, P3003, DOI 10.1038/sj.emboj.7601732; Hu HC, 2009, PLANT J, V57, P264, DOI 10.1111/j.1365-313X.2008.03685.x; Hu HH, 2010, NAT CELL BIOL, V12, P87, DOI 10.1038/ncb2009; Huang CF, 2012, PLANT J, V69, P857, DOI 10.1111/j.1365-313X.2011.04837.x; Huang SB, 2006, PLANT PHYSIOL, V142, P1718, DOI 10.1104/pp.106.088864; Ishikawa S, 2012, P NATL ACAD SCI USA, V109, P19166, DOI 10.1073/pnas.1211132109; Ishimaru Y, 2010, PLANT J, V62, P379, DOI 10.1111/j.1365-313X.2010.04158.x; Javot H, 2007, P NATL ACAD SCI USA, V104, P1720, DOI 10.1073/pnas.0608136104; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; Kiba T, 2012, PLANT CELL, V24, P245, DOI 10.1105/tpc.111.092221; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Krouk G, 2010, DEV CELL, V18, P927, DOI 10.1016/j.devcel.2010.05.008; Kuromori T, 2010, P NATL ACAD SCI USA, V107, P2361, DOI 10.1073/pnas.0912516107; Kusumi K, 2012, J EXP BOT, V63, P5635, DOI 10.1093/jxb/ers216; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Lee S, 2012, MOL CELLS, V33, P269, DOI 10.1007/s10059-012-2231-3; Lee S, 2011, PLANT BIOTECHNOL J, V9, P865, DOI 10.1111/j.1467-7652.2011.00606.x; Lee S, 2009, P NATL ACAD SCI USA, V106, P22014, DOI 10.1073/pnas.0910950106; Li CY, 2012, PLANT CELL REP, V31, P851, DOI 10.1007/s00299-011-1206-8; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Little DY, 2005, P NATL ACAD SCI USA, V102, P13693, DOI 10.1073/pnas.0504219102; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; Liu QS, 2011, PLANT CELL ENVIRON, V34, P1958, DOI 10.1111/j.1365-3040.2011.02391.x; Lopez-Arredondo DL, 2012, NAT BIOTECHNOL, V30, P889, DOI 10.1038/nbt.2346; Ma JF, 2008, P NATL ACAD SCI USA, V105, P9931, DOI 10.1073/pnas.0802361105; Magalhaes JV, 2007, NAT GENET, V39, P1156, DOI 10.1038/ng2074; Maron LG, 2010, PLANT J, V61, P728, DOI 10.1111/j.1365-313X.2009.04103.x; Maser P, 2002, FEBS LETT, V531, P157, DOI 10.1016/S0014-5793(02)03488-9; Masuda H, 2008, RICE, V1, P100, DOI 10.1007/s12284-008-9007-6; McAllister CH, 2012, PLANT BIOTECHNOL J, V10, P1011, DOI 10.1111/j.1467-7652.2012.00700.x; Mian A, 2011, PLANT J, V68, P468, DOI 10.1111/j.1365-313X.2011.04701.x; Moller IS, 2009, PLANT CELL, V21, P2163, DOI 10.1105/tpc.108.064568; Morrissey J, 2009, PLANT CELL, V21, P3326, DOI 10.1105/tpc.109.069401; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Munns R, 2012, NAT BIOTECHNOL, V30, P360, DOI 10.1038/nbt.2120; Nagarajan VK, 2011, PLANT PHYSIOL, V156, P1149, DOI 10.1104/pp.111.174805; Nour-Eldin HH, 2012, NATURE, V488, P531, DOI 10.1038/nature11285; Palmgren MG, 2008, TRENDS PLANT SCI, V13, P464, DOI 10.1016/j.tplants.2008.06.005; Patrick JW, 1997, ANNU REV PLANT PHYS, V48, P191, DOI 10.1146/annurev.arplant.48.1.191; Podar D, 2012, J BIOL CHEM, V287, P3185, DOI 10.1074/jbc.M111.305649; Remy E, 2012, NEW PHYTOL, V195, P356, DOI 10.1111/j.1469-8137.2012.04167.x; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; RIESMEIER JW, 1994, EMBO J, V13, P1; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rogers EE, 2002, PLANT CELL, V14, P1787, DOI 10.1105/tpc.001495; RUBIO F, 1995, SCIENCE, V270, P1660, DOI 10.1126/science.270.5242.1660; Ruffel S, 2011, P NATL ACAD SCI USA, V108, P18524, DOI 10.1073/pnas.1108684108; Ryan PR, 2001, ANNU REV PLANT PHYS, V52, P527, DOI 10.1146/annurev.arplant.52.1.527; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Sasaki T, 2004, PLANT J, V37, P645, DOI 10.1111/j.1365-313X.2003.01991.x; SCHACHTMAN DP, 1994, NATURE, V370, P655, DOI 10.1038/370655a0; Shin R, 2004, P NATL ACAD SCI USA, V101, P8827, DOI 10.1073/pnas.0401707101; Song WY, 2010, P NATL ACAD SCI USA, V107, P21187, DOI 10.1073/pnas.1013964107; Sunarpi, 2005, PLANT J, V44, P928, DOI 10.1111/j.1365-313X.2005.02595.x; The World Bank, 2006, REP NUTR CENTR DEV S, P42; Ueno D, 2010, P NATL ACAD SCI USA, V107, P16500, DOI 10.1073/pnas.1005396107; US Geological Survey, 2012, MIN COMM SUMM 2012, P118; Versaw WK, 2002, PLANT CELL, V14, P1751, DOI 10.1105/tpc.002220; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558; Wang RC, 1998, P NATL ACAD SCI USA, V95, P15134, DOI 10.1073/pnas.95.25.15134; Wang YY, 2012, TRENDS PLANT SCI, V17, P458, DOI 10.1016/j.tplants.2012.04.006; Weber A. P., 2012, CURR OPIN BIOTECHNOL; Wirth J, 2009, PLANT BIOTECHNOL J, V7, P631, DOI 10.1111/j.1467-7652.2009.00430.x; World Health Organization/FAO, 2003, DIET NUTR PREV CHRON, P4; Xia JX, 2010, P NATL ACAD SCI USA, V107, P18381, DOI 10.1073/pnas.1004949107; Yang SY, 2012, PLANT CELL, V24, P4236, DOI 10.1105/tpc.112.104901; Zhang Y, 2012, PLANT J, V72, P400, DOI 10.1111/j.1365-313X.2012.05088.x	93	318	341	14	752	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					60	66		10.1038/nature11909	http://dx.doi.org/10.1038/nature11909			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23636397	Green Accepted, Green Submitted			2022-12-28	WOS:000318221500034
J	Brent, DA; Silverstein, M				Brent, David A.; Silverstein, Michael			Shedding Light on the Long Shadow of Childhood Adversity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Brent, David A.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Brent, David A.] Western Psychiat Inst & Clin, Pittsburgh, PA 15213 USA; [Silverstein, Michael] Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; Boston University	Brent, DA (corresponding author), Western Psychiat Inst & Clin, 3811 OHara St,BT 311, Pittsburgh, PA 15213 USA.	brentda@upmc.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091871, R10MH056612, T32MH018951, R01MH064503, R01MH056612] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH091871, MH091871, MH84616, R01 MH056612, MH65638, T32 MH018951, R01 MH064503, MH64503, MH56612, R10 MH056612] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bonomi AE, 2008, J GEN INTERN MED, V23, P294, DOI 10.1007/s11606-008-0516-1; Costello EJ, 2003, JAMA-J AM MED ASSOC, V290, P2023, DOI 10.1001/jama.290.15.2023; Drew LM, 2011, J FAM PSYCHOL, V25, P751, DOI 10.1037/a0025259; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; Howard KS, 2009, FUTURE CHILD, V19, P119, DOI 10.1353/foc.0.0032; Johnson SB, 2013, PEDIATRICS, V131, P319, DOI 10.1542/peds.2012-0469; Pilowsky DJ, 2008, AM J PSYCHIAT, V165, P1136, DOI 10.1176/appi.ajp.2008.07081286	7	41	41	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2013	309	17					1777	1778		10.1001/jama.2013.4220	http://dx.doi.org/10.1001/jama.2013.4220			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	134SU	23632718	Green Accepted			2022-12-28	WOS:000318235600022
J	Okafor, OO; Crotty, JE				Okafor, Olubukola Olusade; Crotty, Jennifer Erin			Abdominal Swelling in a Teenaged Girl	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MATURE CYSTIC TERATOMA; OVARY		[Okafor, Olubukola Olusade] Kaiser Clin Longview Kelso, Longview, WA USA; [Crotty, Jennifer Erin] E Carolina Univ, Brody Sch Med, Dept Pediat, Greenville, NC 27834 USA	University of North Carolina; East Carolina University	Crotty, JE (corresponding author), E Carolina Univ, Brody Sch Med, Dept Pediat, 600 Moye Blvd, Greenville, NC 27834 USA.	crottyj@ecu.edu		Crotty, Jennifer/0000-0002-5034-750X				Bal Amanjit, 2007, Archives of Gynecology and Obstetrics, V275, P179, DOI 10.1007/s00404-006-0244-x; COMERCI JT, 1994, OBSTET GYNECOL, V84, P22; Michelotti B, 2010, J LAPAROENDOSC ADV S, V20, P261, DOI 10.1089/lap.2009.0137; O'Neill KE, 2011, J PEDIATR ADOL GYNEC, V24, P176, DOI 10.1016/j.jpag.2010.11.006; Outwater EK, 2001, RADIOGRAPHICS, V21, P475, DOI 10.1148/radiographics.21.2.g01mr09475; Pantoja E, 1975, Obstet Gynecol Surv, V30, P1, DOI 10.1097/00006254-197501000-00001; PETERSON WF, 1955, AM J OBSTET GYNECOL, V70, P368, DOI 10.1016/S0002-9378(16)37681-5; Savasi I, 2009, J PEDIATR ADOL GYNEC, V22, P360, DOI 10.1016/j.jpag.2008.12.008; SCOUTT LM, 1994, J COMPUT ASSIST TOMO, V18, P609, DOI 10.1097/00004728-199407000-00019; Stany MP, 2008, OBSTET GYN CLIN N AM, V35, P271, DOI 10.1016/j.ogc.2008.03.004	10	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2013	309	17					1828	1829		10.1001/jama.2013.3145	http://dx.doi.org/10.1001/jama.2013.3145			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134SU	23632727				2022-12-28	WOS:000318235600031
J	Zhang, B; Gaiteri, C; Bodea, LG; Wang, Z; McElwee, J; Podtelezhnikov, AA; Zhang, CS; Xie, T; Tran, L; Dobrin, R; Fluder, E; Clurman, B; Melquist, S; Narayanan, M; Suver, C; Shah, H; Mahajan, M; Gillis, T; Mysore, J; MacDonald, ME; Lamb, JR; Bennett, DA; Molony, C; Stone, DJ; Gudnason, V; Myers, AJ; Schadt, EE; Neumann, H; Zhu, J; Emilsson, V				Zhang, Bin; Gaiteri, Chris; Bodea, Liviu-Gabriel; Wang, Zhi; McElwee, Joshua; Podtelezhnikov, Alexei A.; Zhang, Chunsheng; Xie, Tao; Tran, Linh; Dobrin, Radu; Fluder, Eugene; Clurman, Bruce; Melquist, Stacey; Narayanan, Manikandan; Suver, Christine; Shah, Hardik; Mahajan, Milind; Gillis, Tammy; Mysore, Jayalakshmi; MacDonald, Marcy E.; Lamb, John R.; Bennett, David A.; Molony, Cliona; Stone, David J.; Gudnason, Vilmundur; Myers, Amanda J.; Schadt, Eric E.; Neumann, Harald; Zhu, Jun; Emilsson, Valur			Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer's Disease	CELL			English	Article							MOLECULAR NETWORKS; EXPRESSION; DYSFUNCTION; MICROGLIA; RISK	The genetics of complex disease produce alterations in the molecular interactions of cellular pathways whose collective effect may become clear through the organized structure of molecular networks. To characterize molecular systems associated with late-onset Alzheimer's disease (LOAD), we constructed gene-regulatory networks in 1,647 postmortem brain tissues from LOAD patients and nondemented subjects, and we demonstrate that LOAD reconfigures specific portions of the molecular interaction structure. Through an integrative network-based approach, we rank-ordered these network structures for relevance to LOAD pathology, highlighting an immune- and microglia-specific module that is dominated by genes involved in pathogen phagocytosis, contains TYROBP as a key regulator, and is upregulated in LOAD. Mouse microglia cells overexpressing intact or truncated TYROBP revealed expression changes that significantly overlapped the human brain TYROBP network. Thus the causal network structure is a useful predictor of response to gene perturbations and presents a framework to test models of disease mechanisms underlying LOAD.	[Zhang, Bin; Shah, Hardik; Mahajan, Milind; Schadt, Eric E.; Zhu, Jun] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Zhang, Bin; Shah, Hardik; Mahajan, Milind; Schadt, Eric E.; Zhu, Jun] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Zhang, Bin; Mahajan, Milind; Schadt, Eric E.; Zhu, Jun] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA; [Zhang, Bin; Gaiteri, Chris; Wang, Zhi; Tran, Linh; Suver, Christine] Sage Bionetworks, Seattle, WA 98109 USA; [Bodea, Liviu-Gabriel; Neumann, Harald] Univ Bonn, Neural Regenerat Grp, Inst Reconstruct Neurobiol, D-53127 Bonn, Germany; [McElwee, Joshua; Zhang, Chunsheng; Xie, Tao; Dobrin, Radu; Fluder, Eugene; Melquist, Stacey; Narayanan, Manikandan; Molony, Cliona] Merck & Co Inc, Merck Res Labs, Boston, MA 02115 USA; [Podtelezhnikov, Alexei A.; Stone, David J.] Merck & Co Inc, Merck Res Labs, West Point, PA 19486 USA; [Clurman, Bruce] Fred Hutch Canc Res Ctr, Seattle, WA 98109 USA; [Gillis, Tammy; Mysore, Jayalakshmi; MacDonald, Marcy E.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Lamb, John R.] GNF Novartis, San Diego, CA 92121 USA; [Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimer Dis Ctr, Chicago, IL 60612 USA; [Gudnason, Vilmundur; Emilsson, Valur] Iceland Heart Assoc, IS-201 Kopavogur, Iceland; [Gudnason, Vilmundur; Emilsson, Valur] Univ Iceland, IS-201 Kopavogur, Iceland; [Myers, Amanda J.] Univ Miami, Miller Sch Med, Div Neurosci, Dept Psychiat & Behav Sci, Miami, FL 33136 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Bonn; Merck & Company; Merck & Company; Fred Hutchinson Cancer Center; Harvard University; Massachusetts General Hospital; Rush University; Icelandic Heart Association; University of Iceland; University of Miami	Zhang, B (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, 1425 Madison Ave, New York, NY 10029 USA.	bin.zhang@mssm.edu; valur@hjarta.is	Gudnason, Vilmundur/AAE-7126-2019; Neumann, Harald/A-9718-2010; Gudnason, Vilmundur/K-6885-2015; Myers, Amanda J/B-1796-2010; Bodea, Liviu-Gabriel/F-9480-2012; Clurman, Bruce/AAV-3854-2021	Gudnason, Vilmundur/0000-0001-5696-0084; Neumann, Harald/0000-0002-5071-5202; Gudnason, Vilmundur/0000-0001-5696-0084; Myers, Amanda J/0000-0002-3100-9396; Bodea, Liviu-Gabriel/0000-0002-9604-9524; Suver, Christine/0000-0002-2986-385X; Gaiteri, Chris/0000-0001-7838-8664; Narayanan, Manikandan/0000-0002-8490-4087; Dobrin, Radu/0000-0002-3336-0091; Emilsson, Valur/0000-0001-9982-0524	Hertie-Foundation; Deutsche Forschungsgemeinschaft [FOR1336, SFB704, KFO177]; DFG; National Institutes of Health [R01 AG034504, R01 AG030146, P30 AG10161, R01 AG17917, R01 AG15819, K08 AG034290, R01 AG11101, NS032765]; Illinois Department of Public Health; University of Miami; Miller School of Medicine; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG034290, R01AG011101, P30AG010161, R01AG030146, R01AG015819, R01AG017917, R01AG034504] Funding Source: NIH RePORTER	Hertie-Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Illinois Department of Public Health; University of Miami; Miller School of Medicine; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	H.N. and L.-G.B. were supported by the Hertie-Foundation and the Deutsche Forschungsgemeinschaft (FOR1336, SFB704, KFO177). H.N. is a member of the DFG-funded excellence cluster ImmunoSensation. We thank Jessica Schumacher and Rita Hass for technical assistance. We are grateful to the HBTRC for the generous gift of human postmortem brain samples. The authors are also grateful to the participants in the Religious Orders Study and the Memory and Aging Project. This work is supported by the National Institutes of Health (R01 AG034504, R01 AG030146, P30 AG10161, R01 AG17917, R01 AG15819, K08 AG034290, P30 AG10161, R01 AG11101, and NS032765), the Illinois Department of Public Health, and start-up funding from the University of Miami, Miller School of Medicine. J.M., A.A.P., C.Z., T.X., R.D., E.F., S.M., M.N., C.M., and D.J.S. are employees and shareholders of Merck & Co., Inc. J.R.L. is an employee and shareholder of Novartis.	Ansari MA, 2010, J NEUROPATH EXP NEUR, V69, P155, DOI 10.1097/NEN.0b013e3181cb5af4; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Bettens K, 2013, LANCET NEUROL, V12, P92, DOI 10.1016/S1474-4422(12)70259-4; Bianchin MM, 2010, NAT REV NEUROL, V6, P1, DOI 10.1038/nrneurol.2010.17-c1; BOYLES JK, 1985, J CLIN INVEST, V76, P1501, DOI 10.1172/JCI112130; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Cameron B, 2010, NEUROBIOL DIS, V37, P503, DOI 10.1016/j.nbd.2009.10.006; Cechetto David F, 2008, Expert Rev Neurother, V8, P743, DOI 10.1586/14737175.8.5.743; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Coskun PE, 2004, P NATL ACAD SCI USA, V101, P10726, DOI 10.1073/pnas.0403649101; Dobrin R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r55; Dodel RC, 2003, LANCET NEUROL, V2, P215, DOI 10.1016/S1474-4422(03)00349-1; Duda R.O., 2000, PATTERN CLASSIFICATI; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Gusella JF, 2006, TRENDS BIOCHEM SCI, V31, P533, DOI 10.1016/j.tibs.2006.06.009; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Li G, 2009, CELL STEM CELL, V5, P634, DOI 10.1016/j.stem.2009.10.015; Luchsinger JA, 2008, EUR J PHARMACOL, V585, P119, DOI 10.1016/j.ejphar.2008.02.048; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mani KM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.2; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Morawski M, 2012, BRAIN PATHOL, V22, P547, DOI 10.1111/j.1750-3639.2011.00557.x; Murray IVJ, 2011, EXP BIOL MED, V236, P772, DOI 10.1258/ebm.2011.010355; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Qiu CX, 2010, J ALZHEIMERS DIS, V20, P689, DOI 10.3233/JAD-2010-091663; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schadt EE, 2009, NAT REV DRUG DISCOV, V8, P286, DOI 10.1038/nrd2826; Schafer S, 2008, DRUG DISCOV TODAY, V13, P913, DOI 10.1016/j.drudis.2008.03.026; Schiffman SS, 2002, NEUROBIOL AGING, V23, P397, DOI 10.1016/S0197-4580(01)00337-2; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Walker DG, 2006, J LEUKOCYTE BIOL, V79, P596, DOI 10.1189/jlb.0705377; Webber KM, 2005, MECH AGEING DEV, V126, P1019, DOI 10.1016/j.mad.2005.03.024; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	41	1032	1054	4	155	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 25	2013	153	3					707	720		10.1016/j.cell.2013.03.030	http://dx.doi.org/10.1016/j.cell.2013.03.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622250	Bronze, Green Accepted			2022-12-28	WOS:000318063500021
J	Jessop, EG				Jessop, Edmund G.			Health in the UK: could do even better?	LANCET			English	Editorial Material									UK Fac Publ Hlth, London NW1 4LB, England		Jessop, EG (corresponding author), UK Fac Publ Hlth, London NW1 4LB, England.	edmund.jessop@nhs.net						Hughes CE, 2010, BRIT J CRIMINOL, V50, P999, DOI 10.1093/bjc/azq038; Hunt J., 2012, CONSERVATIVE HO 1126; Joossens L, 2011, TOBACCO CONTROL SCAL; Joseph KS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e746; Marshall EG, 1998, BRIT MED J, V316, P1701, DOI 10.1136/bmj.316.7146.1701; Moodie C, 2012, PLAIN TOBACCO PACKAG; Murray C. J. L., 2013, LANCET; Scientific Advisory Committee on Nutrition, 2007, UPD TRANS FATT AC HL; Sheffield Alcohol Research Group, 2008, IND REV EFF ALC PRIC; *WHO, EUR HLTH ALL DAT HFA	10	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 23	2013	381	9871					970	972		10.1016/S0140-6736(13)60188-9	http://dx.doi.org/10.1016/S0140-6736(13)60188-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117EU	23668562				2022-12-28	WOS:000316936800005
J	Nishtar, S; Boerma, T; Amjad, S; Alam, AY; Khalid, F; ul Haq, I; Mirza, YA				Nishtar, Sania; Boerma, Ties; Amjad, Sohail; Alam, Ali Yawar; Khalid, Faraz; ul Haq, Ihsan; Mirza, Yasir A.			Pakistan's health system: performance and prospects after the 18th Constitutional Amendment	LANCET			English	Article							MEDICAL-EDUCATION; CARE; DECENTRALIZATION; MIGRATION; COUNTRIES; DOCTORS; SECTOR; NEEDS	Pakistan has undergone massive changes in its federal structure under the 18th Constitutional Amendment. To gain insights that will inform reform plans, we assessed several aspects of health-systems performance in Pakistan. Some improvements were noted in health-systems performance during the past 65 years but key health indicators lag behind those in peer countries. 78.08% of the population pay out of pocket at the point of health care. The private sector provides three-quarters of the health services, and physicians outnumber nurses and midwives by a ratio of about 2:1. Complex governance challenges and underinvestment in health have hampered progress. With devolution of the health mandate, an opportunity has arisen to reform health. The federal government has constitutional responsibility of health information, interprovincial coordination, global health, and health regulation. All other health responsibilities are a provincial mandate. With appropriate policy, institutional, and legislative action within and outside the health system, the existing challenges could be overcome.	[Nishtar, Sania; Amjad, Sohail; Alam, Ali Yawar; Khalid, Faraz; Mirza, Yasir A.] Heartfile, Islamabad 44000, Pakistan; [Nishtar, Sania] Govt Pakistan, Islamabad, Pakistan; [Boerma, Ties] WHO, Dept Evidence & Informat, CH-1211 Geneva, Switzerland; [ul Haq, Ihsan] Govt Pakistan, Pakistan Bur Stat, Islamabad, Pakistan	World Health Organization	Nishtar, S (corresponding author), Heartfile, 1 Pk Rd, Islamabad 44000, Pakistan.	sania@heartfile.org						Abdullah MT, 2007, INT J HEALTH PLAN M, V22, P45, DOI 10.1002/hpm.855; Alam AY, 2010, E MEDITER HLTH J S, V16; Ali O, 2009, PAK J PHARM SCI, V22, P220; Allen S, 2013, LANCET; [Anonymous], LEV TRENDS CHILD MOR; [Anonymous], NTS WORKING PAPER SE; [Anonymous], 2010, WORLD HLTH STAT 2010; [Anonymous], 1978, INT C PRIM HLTH CAR; Ariff S, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-319; Bhore J, 1946, REPORT HLTH SURVEY D; Bhutta ZA, 2013, LANCET; Bossert TJ, 2011, SOC SCI MED, V72, P39, DOI 10.1016/j.socscimed.2010.10.019; Butt ZA, 2005, INT J QUAL HEALTH C, V17, P307, DOI 10.1093/intqhc/mzi049; Collins CD, 2002, INT J HEALTH PLAN M, V17, P123, DOI 10.1002/hpm.657; Constitution of Pakistan, ART 151 INT TRAD; Donaldson L, INDEPENDENT MONITORI; Federal Bureau of Statistics, 2001, SURV PRIV MED DENT O; Federal Bureau of Statistics, PAK SOC LIV STAND ME; Federal Bureau of Statistics, 1999, PAK HLTH INC EXP SUR, P1999; Federal Bureau of Statistics Government of Pakistan, 2005, NAC ED CENS 2005; Federal Bureau of Statistics Statistics Division, 2001, PAK INT HOUS SURV 20; Federal Bureau of Statistics Statistics Division, 1998, 50 YEARS PAK; Federal Bureau of Statistics Statistics Divisions, 2012, PAK SOC LIV STAND ME; GATER R, 1991, PSYCHOL MED, V21, P761, DOI 10.1017/S003329170002239X; Green A, 2000, B WORLD HEALTH ORGAN, V78, P1025; Heartfile, REC HLTH SYSTEMS ISS; IHME, PAK WORLD HLTH SURV; Israr SM, 2006, INT J HEALTH PLAN M, V21, P313, DOI 10.1002/hpm.852; Jafar TH, 2013, LANCET; Jenkins R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009049; Kaufmann D., 2009, WORLD BANK POLICY RE; Khoja Shariq, 2008, World Hosp Health Serv, V44, P36; Local Government System National Reconstruction Bureau Government of Pakistan, 2006, S STRENGTH DEC PAK C; Loevinsohn B, 2005, LANCET, V366, P676, DOI 10.1016/S0140-6736(05)67140-1; McGinnis N., 2011, MEDIA REPORTS MED QU; Members National Assembly, 2008, TIBB E UN AYURV HOM; Ministry of Finance, 2012, POV RED STRAT PAP; Ministry of Finance Finance Division, 2009, PAK EC SURV 2009 10, P2009; Ministry of Social Welfare and Special Education, 2005, SOC PROT STRAT; National AIDS Control Programme, 2005, PIL STUD HIV AIDS SU; National AIDS Control Programme Ministry of Health, 2004, NAT STUD REPR TRACT; National Commission for Government Reforms, 2008, REF REF GOV PAK; National Institute of Population Studies, 2012, POP PROJ; National Institute of Population Studies, 1992, PAK DEM HLTH SURV 19; National Institute of Population Studies and Macro International Inc, 2008, PAK DEM HLTH SURV 20; Nishtar S, 2010, PROTECTING POOR HLTH; Nishtar S., 2006, GATEWAY PAPER HLTH S; Nishtar S, 2013, LANCET; Nishtar S., 2007, 2 GOV PAK MIN HLTH W; Nishtar S, 2010, CHOKED PIPES REFORMI; Nishtar S, HEARTFILE HLTH FINAN; Nishtar S, 2012, LANCET, V379, P1084, DOI 10.1016/S0140-6736(12)60277-3; Nishtar S, 2011, LANCET, V378, P648, DOI 10.1016/S0140-6736(11)60606-5; Nishtar Sania, 2009, J Pak Med Assoc, V59, pS3; Nishtar S, 2010, B WORLD HEALTH ORGAN, V88, P74, DOI 10.2471/BLT.09.067868; Office of the Chief Executive, 2003, EFF APPR REP KTH KMC; Oxford Policy Management, 2009, EXT EV NAT PROGR FAM; Pakistan Bureau of Statistics, PAK DEM SURV; Pakistan Bureau of Statistics Government of Pakistan, 2009, PAK SOC LIV STAND ME; Pakistan Bureau of Statistics Government of Pakistan, 2008, PAK SOC LIV STAND ME; Pakistan Bureau of Statistics Government of Pakistan, PAK DEM SURV; Pakistan Bureau of Statistics Government of Pakistan, PAK DEM SURV 2003; Pakistan Bureau of Statistics Government of Pakistan, PAK DEM SURV 2001 06; Pakistan Bureau of Statistics Government of Pakistan, PAK DEM SURV 2001; Pakistan Bureau of Statistics Government of Pakistan, 2006, PAK SOC LIV STAND ME; Pakistan Bureau of Statistics Statistics Divisions, PAK DEM SURV; Pakistan Bureau of Statistics Statistics Divisions, 2012, NAT HLTH ACC 2007 08; Pakistan Medical Research Council, 2008, NAT SURV HEP PREV; Pakistan Nishtar S., 2010, B WHO; Pakistan telecommunication authority, TEL IND; Planning Commission, 2005, MED TERM DEV FRAM, P2005; Qazi Muhammad Suleman, 2009, J Pak Med Assoc, V59, P10; Qazi MS, 2008, BIOSCI TRENDS, V2, P75; Qureshi AM, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-26; Rabbani F, 2005, MED SCI MONITOR, V11, pSR21; Riaz H, 2012, LANCET, V380, P97, DOI 10.1016/S0140-6736(12)61161-1; Riaz H, 2011, AFR J PHARM PHARMACO, V5, P596, DOI 10.5897/AJPP11.051; Sabih F, 2010, E MEDITERR HLTH J S, V16; SATHAR ZA, 1985, J BIOSOC SCI, V17, P351, DOI 10.1017/S0021932000015820; Sathar ZA, 2013, LANCET; State Bank of Pakistan, 2008, ANN REP STAT BANK PA; Talati JJ, 2006, ACAD MED, V81, pS55, DOI 10.1097/01.ACM.0000243543.99794.07; Transparency International, NAT CORR PERC SURV 2; Transparency International, CORR PERC IND; UNDP, EARL REC NEEDS ASS; United Nations Population Division, 2011, WORLD POP PROSP 2010; WHO, 2010, WOR HEALT REP, P1; WHO, 2007, WHOS FRAM ACT EV BUS; World Bank, 2005, PUBL HLTH SURV SYST; World Bank, WORLD DEV REP; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; Zafar SN, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-162	94	84	84	1	27	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 22	2013	381	9884					2193	2206		10.1016/S0140-6736(13)60019-7	http://dx.doi.org/10.1016/S0140-6736(13)60019-7			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171KH	23684254				2022-12-28	WOS:000320925600036
J	Dewan, A; Pacifico, R; Zhan, R; Rinberg, D; Bozza, T				Dewan, Adam; Pacifico, Rodrigo; Zhan, Ross; Rinberg, Dmitry; Bozza, Thomas			Non-redundant coding of aversive odours in the main olfactory pathway	NATURE			English	Article							AMINE-ASSOCIATED RECEPTORS; CHEMOSENSORY RECEPTORS; MOUSE; SUBSYSTEM; EVOLUTION; ODORANTS; NEURONS; MICE; BULB	Many species are critically dependent on olfaction for survival. In the main olfactory system of mammals, odours are detected by sensory neurons that express a large repertoire of canonical odorant receptors and a much smaller repertoire of trace amine-associated receptors (TAARs)(1-4). Odours are encoded in a combinatorial fashion across glomeruli in the main olfactory bulb, with each glomerulus corresponding to a specific receptor(5-7). The degree to which individual receptor genes contribute to odour perception is unclear. Here we show that genetic deletion of the olfactory Taar gene family, or even a single Taar gene (Taar4), eliminates the aversion that mice display to low concentrations of volatile amines and to the odour of predator urine. Our findings identify a role for the TAARs in olfaction, namely, in the high-sensitivity detection of innately aversive odours. In addition, our data reveal that aversive amines are represented in a non-redundant fashion, and that individual main olfactory receptor genes can contribute substantially to odour perception.	[Dewan, Adam; Pacifico, Rodrigo; Zhan, Ross; Bozza, Thomas] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA; [Rinberg, Dmitry] HHMI, Ashburn, VA USA	Northwestern University; Howard Hughes Medical Institute	Bozza, T (corresponding author), Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.	bozza@northwestern.edu	Pacifico, Rodrigo/L-6189-2017	Pacifico, Rodrigo/0000-0003-2581-6818; Dewan, Adam/0000-0003-1627-5730	NIH/NIDCD [R01DC009640, F32DC012004]; Whitehall Foundation; Brain Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013797, R01DC009640, F32DC012004] Funding Source: NIH RePORTER	NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Whitehall Foundation; Brain Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank T. Schmidt, C. Waldron, L. Tunmer, V. Dewan and the staff of the Philadelphia Zoo for collecting predator urine and for providing images of the animals. We thank D. Ferster for help with video tracking, D. Cawley, A. Ge and T. Alconada for help analysing behavioural data, the Northwestern University Center for Comparative Medicine for behavioural space, and the Northwestern University Biostatistics Collaboration Center for advice on statistical analyses. T. B. was a participant in the Visiting Scientist Program at HHMI Janelia Farm Research Campus. This work was supported by grants from the NIH/NIDCD (R01DC009640 to T.B. and F32DC012004 to A.D.), The Whitehall Foundation and The Brain Research Foundation (T.B.).	Ben-Shaul Y, 2010, P NATL ACAD SCI USA, V107, P5172, DOI 10.1073/pnas.0915147107; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; Fendt M, 2005, NEUROSCI BIOBEHAV R, V29, P1145, DOI 10.1016/j.neubiorev.2005.04.018; Ferrero DM, 2011, P NATL ACAD SCI USA, V108, P11235, DOI 10.1073/pnas.1103317108; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Johnson MA, 2012, P NATL ACAD SCI USA, V109, P13410, DOI 10.1073/pnas.1206724109; Kauer JS, 2001, ANNU REV NEUROSCI, V24, P963, DOI 10.1146/annurev.neuro.24.1.963; KAUER JS, 1991, TRENDS NEUROSCI, V14, P79, DOI 10.1016/0166-2236(91)90025-P; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Li Q, 2013, CURR BIOL, V23, P11, DOI 10.1016/j.cub.2012.10.047; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liberles SD, 2009, ANN NY ACAD SCI, V1170, P168, DOI 10.1111/j.1749-6632.2009.04014.x; Lindemann L, 2005, GENOMICS, V85, P372, DOI 10.1016/j.ygeno.2004.11.010; McGann JP, 2005, NEURON, V48, P1039, DOI 10.1016/j.neuron.2005.10.031; Munger SD, 2010, CURR BIOL, V20, P1438, DOI 10.1016/j.cub.2010.06.021; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Pacifico R, 2012, CELL REP, V2, P76, DOI 10.1016/j.celrep.2012.06.006; Papes F, 2010, CELL, V141, P692, DOI 10.1016/j.cell.2010.03.037; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; VERNETMAURY E, 1984, J CHEM ECOL, V10, P1007, DOI 10.1007/BF00987509; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Wu S, 2007, NAT GENET, V39, P922, DOI 10.1038/ng2060; Zhang JJ, 2013, J NEUROSCI, V33, P3228, DOI 10.1523/JNEUROSCI.4299-12.2013	27	124	142	2	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					486	+		10.1038/nature12114	http://dx.doi.org/10.1038/nature12114			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23624375	Green Accepted			2022-12-28	WOS:000319254000047
J	Holland, G; Lollar, BS; Li, L; Lacrampe-Couloume, G; Slater, GF; Ballentine, CJ				Holland, G.; Lollar, B. Sherwood; Li, L.; Lacrampe-Couloume, G.; Slater, G. F.; Ballentine, C. J.			Deep fracture fluids isolated in the crust since the Precambrian era	NATURE			English	Article							GREAT ARTESIAN BASIN; NOBLE-GASES; WITWATERSRAND BASIN; HYDROCARBON GASES; CONTINENTAL-CRUST; GROUNDWATER-FLOW; U-PB; XENON; ORIGIN; STRATIGRAPHY	Fluids trapped as inclusions within minerals can be billions of years old and preserve a record of the fluid chemistry and environment at the time of mineralization(1-3). Aqueous fluids that have had a similar residence time at mineral interfaces and in fractures (fracture fluids) have not been previously identified. Expulsion of fracture fluids from basement systems with low connectivity occurs through deformation and fracturing of the brittle crust(4). The fractal nature of this process must, at some scale, preserve pockets of interconnected fluid from the earliest crustal history. In one such system, 2.8 kilometres below the surface in a South African gold mine, extant chemoautotrophic microbes have been identified in fluids isolated from the photosphere on timescales of tens of millions of years(5). Deep fracture fluids with similar chemistry have been found in a mine in the Timmins, Ontario, area of the Canadian Precambrian Shield. Here we show that excesses of Xe-124, Xe-126 and Xe-128 in the Timmins mine fluids can be linked to xenon isotope changes in the ancient atmosphere(2) and used to calculate a minimum mean residence time for this fluid of about 1.5 billion years. Further evidence of an ancient fluid system is found in Xe-129 excesses that, owing to the absence of any identifiable mantle input, are probably sourced in sediments and extracted by fluid migration processes operating during or shortly after mineralization at around 2.64 billion years ago. We also provide closed-system radiogenic noble-gas (He-4, Ne-21, Ar-40, Xe-136) residence times. Together, the different noble gases show that ancient pockets of water can survive the crustal fracturing process and remain in the crust for billions of years.	[Holland, G.; Ballentine, C. J.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England; [Holland, G.] Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YQ, England; [Li, L.; Lacrampe-Couloume, G.] Univ Toronto, Dept Earth Sci, Toronto, ON M5S 3B1, Canada; [Slater, G. F.] McMaster Univ, Sch Geog & Geol, Hamilton, ON L8S 4K1, Canada	University of Manchester; Lancaster University; University of Toronto; McMaster University	Ballentine, CJ (corresponding author), Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England.	chris.ballentine@manchester.ac.uk	Lacrampe-Couloume, Georges/AAW-9291-2020; Lacrampe-Couloume, Georges/P-6093-2019	Ballentine, Chris/0000-0001-9382-070X	NSERC; UK-NERC; Deep Carbon Observatory; NERC [NE/F002823/1] Funding Source: UKRI; Natural Environment Research Council [ceh010010, NE/F002823/1] Funding Source: researchfish	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); UK-NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Deep Carbon Observatory; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank S. Shirey for discussion on the geological history of the study areas and P. Burnard for a review. This work was funded by NSERC Discovery and CRC grants to B. S. L., a UK-NERC grant to C.J.B. and Deep Carbon Observatory support to C.J.B. and B. S. L. We are indebted to P. Calloway, P. Jurenovski, A. Marcotte and L. Kieser for assistance in sample collection.	Aquilina L, 2004, GEOCHIM COSMOCHIM AC, V68, P2405, DOI 10.1016/j.gca.2003.08.023; Ballentine CJ, 2002, REV MINERAL GEOCHEM, V47, P481, DOI 10.2138/rmg.2002.47.12; Ballentine CJ, 2002, GEOCHIM COSMOCHIM AC, V66, P2483, DOI 10.1016/S0016-7037(02)00850-5; BALLENTINE CJ, 1991, EARTH PLANET SC LETT, V105, P229, DOI 10.1016/0012-821X(91)90133-3; Bethke CM, 1999, J GEOPHYS RES-SOL EA, V104, P12999, DOI 10.1029/1999JB900085; Bleeker W, 1996, CAN J EARTH SCI, V33, P1213, DOI 10.1139/e96-092; Bleeker W., 1999, EC GEOLOGY MONOGRAPH, V10, P43; Bottomley DJ, 2002, GEOLOGY, V30, P587, DOI 10.1130/0091-7613(2002)030<0587:ICORTO>2.0.CO;2; Bucher K, 2010, GEOFLUIDS, V10, P241, DOI 10.1111/j.1468-8123.2010.00279.x; Downes M. J., 1984, GOLD 82 GEOLOGY GEOC, P435; Ehlmann BL, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL042596; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Guillot L, 2000, EUR PHYS J-APPL PHYS, V9, P137, DOI 10.1051/epjap:2000211; Holland G, 2006, NATURE, V441, P186, DOI 10.1038/nature04761; Holland G, 2009, SCIENCE, V326, P1522, DOI 10.1126/science.1179518; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; Kendrick MA, 2011, PRECAMBRIAN RES, V189, P313, DOI 10.1016/j.precamres.2011.07.015; KENNEDY BM, 1990, EARTH PLANET SC LETT, V98, P277, DOI 10.1016/0012-821X(90)90030-2; Ketchum JWF, 2008, ECON GEOL, V103, P1151, DOI 10.2113/gsecongeo.103.6.1151; Kipfer R, 2002, REV MINERAL GEOCHEM, V47, P615, DOI 10.2138/rmg.2002.47.14; Kulongoski JT, 2003, CHEM GEOL, V202, P95, DOI 10.1016/j.chemgeo.2003.07.002; Lin LH, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000907; Lin LH, 2006, SCIENCE, V314, P479, DOI 10.1126/science.1127376; Lippmann J, 2003, GEOCHIM COSMOCHIM AC, V67, P4597, DOI 10.1016/S0016-7037(03)00414-9; Lippmann-Pipke J, 2011, CHEM GEOL, V283, P287, DOI 10.1016/j.chemgeo.2011.01.028; Lollar BS, 2008, GEOCHIM COSMOCHIM AC, V72, P4778, DOI 10.1016/j.gca.2008.07.004; Lollar BS, 2002, NATURE, V416, P522, DOI 10.1038/416522a; LOLLAR BS, 1993, GEOCHIM COSMOCHIM AC, V57, P5087; Marrocchi Y, 2011, GEOCHIM COSMOCHIM AC, V75, P6255, DOI 10.1016/j.gca.2011.07.048; MARTIN JB, 1993, GEOCHIM COSMOCHIM AC, V57, P4377, DOI 10.1016/0016-7037(93)90489-J; Moulton BJA, 2011, PRECAMBRIAN RES, V189, P389, DOI 10.1016/j.precamres.2011.07.002; Mumma MJ, 2009, SCIENCE, V323, P1041, DOI 10.1126/science.1165243; PEPIN RO, 1991, ICARUS, V92, P2, DOI 10.1016/0019-1035(91)90036-S; PRICE NB, 1973, GEOCHIM COSMOCHIM AC, V37, P2149, DOI 10.1016/0016-7037(73)90013-6; Pujol M, 2011, EARTH PLANET SC LETT, V308, P298, DOI 10.1016/j.epsl.2011.05.053; Pujol M, 2009, GEOCHIM COSMOCHIM AC, V73, P6834, DOI 10.1016/j.gca.2009.08.002; Ribas I, 2010, ASTROPHYS J, V714, P384, DOI 10.1088/0004-637X/714/1/384; Santos FJ, 2007, NUCL INSTRUM METH B, V259, P503, DOI 10.1016/j.nimb.2007.01.192; Schwarzenbach R., 1993, ENV ORGANIC CHEM; Sleep NH, 2007, ASTROBIOLOGY, V7, P1023, DOI 10.1089/ast.2006.0091; SRINIVASAN B, 1976, EARTH PLANET SC LETT, V31, P129, DOI 10.1016/0012-821X(76)90104-7; STAUDACHER T, 1987, NATURE, V325, P605, DOI 10.1038/325605a0; Stober I, 2000, WTR SCI TEC LIBR, V34, P53; Stober I, 2007, HYDROGEOL J, V15, P213, DOI 10.1007/s10040-006-0094-4; Stober I, 1997, AQUAT GEOCHEM, V3, P43, DOI 10.1023/A:1009623432059; Thompson P. H., 2005, ONTARIO GEOLOGICAL S, P1; Thurston PC, 2008, ECON GEOL, V103, P1097, DOI 10.2113/gsecongeo.103.6.1097; Torgersen T, 1999, EARTH PLANET SC LETT, V167, P239, DOI 10.1016/S0012-821X(99)00021-7; TORGERSEN T, 1985, GEOCHIM COSMOCHIM AC, V49, P1211, DOI 10.1016/0016-7037(85)90011-0; Torgersen T, 2004, EARTH PLANET SC LETT, V226, P477, DOI 10.1016/j.epsl.2004.07.030; WALKER RR, 1975, ECON GEOL, V70, P80, DOI 10.2113/gsecongeo.70.1.80; Ward JA, 2004, GEOCHIM COSMOCHIM AC, V68, P3239, DOI 10.1016/j.gca.2004.02.020; WIELER R, 1994, METEORITICS, V29, P570, DOI 10.1111/j.1945-5100.1994.tb00770.x; Zhou Z, 2012, GEOCHIM COSMOCHIM AC, V86, P257, DOI 10.1016/j.gca.2012.02.028	54	116	118	2	165	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2013	497	7449					357	+		10.1038/nature12127	http://dx.doi.org/10.1038/nature12127			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23676753				2022-12-28	WOS:000318952000035
J	Armstrong, AW				Armstrong, April W.			Do TNF Inhibitors Reduce the Risk of Myocardial Infarction in Psoriasis Patients?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISEASE; COHORT		Univ Calif Davis, Dept Dermatol, Sacramento, CA 95816 USA	University of California System; University of California Davis	Armstrong, AW (corresponding author), Univ Calif Davis, Dept Dermatol, 3301 C St,Ste 1400, Sacramento, CA 95816 USA.	aprilarmstrong@post.harvard.edu						Abuabara K, 2011, BRIT J DERMATOL, V165, P1066, DOI 10.1111/j.1365-2133.2011.10525.x; Ahlehoff O, 2013, J INTERN MED, V273, P197, DOI 10.1111/j.1365-2796.2012.02593.x; Armstrong AW, 2013, JAMA DERMATOL, V149, P84, DOI 10.1001/2013.jamadermatol.406; Armstrong AW, 2012, AM J CARDIOL, V109, P976, DOI 10.1016/j.amjcard.2011.11.025; Armstrong AW, 2011, EXP DERMATOL, V20, P544, DOI 10.1111/j.1600-0625.2011.01308.x; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Kurd Shanu Kohli, 2007, Expert Rev Clin Immunol, V3, P171, DOI 10.1586/1744666X.3.2.171; Love TJ, 2011, ARCH DERMATOL, V147, P419, DOI 10.1001/archdermatol.2010.370; Wu JJ, 2012, ARCH DERMATOL, V148, P1244, DOI 10.1001/archdermatol.2012.2502	9	18	37	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2013	309	19					2043	2044		10.1001/jama.2013.4695	http://dx.doi.org/10.1001/jama.2013.4695			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143GQ	23677316				2022-12-28	WOS:000318855500027
J	Cohen, JC; Hobbs, HH				Cohen, Jonathan C.; Hobbs, Helen H.			Simple Genetics for a Complex Disease	SCIENCE			English	Editorial Material							MOLECULAR CHARACTERIZATION; PCSK9; CHOLESTEROL; MUTATIONS		[Cohen, Jonathan C.; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Cohen, Jonathan C.; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Cohen, Jonathan C.] Univ Texas SW Med Ctr Dallas, Ctr Human Nutr, Dallas, TX 75390 USA; [Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Res Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cohen, JC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	jonathan.cohen@utsouthwestern.edu; helen.hobbs@utsouthwestern.edu			NHLBI NIH HHS [P01 HL020948] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Chen XW, 2013, ELIFE, V2, DOI 10.7554/eLife.00444; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Hooper AJ, 2007, ATHEROSCLEROSIS, V193, P445, DOI 10.1016/j.atherosclerosis.2006.08.039; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Stein EA, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0310-3; Wang Y, 2012, J LIPID RES, V53, P1932, DOI 10.1194/jlr.M028563; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	9	38	39	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					689	690		10.1126/science.1239101	http://dx.doi.org/10.1126/science.1239101			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661745	Green Accepted			2022-12-28	WOS:000318619000021
J	Teng, SW; Mukherji, S; Moffitt, JR; de Buyl, S; O'Shea, EK				Teng, Shu-Wen; Mukherji, Shankar; Moffitt, Jeffrey R.; de Buyl, Sophie; O'Shea, Erin K.			Robust Circadian Oscillations in Growing Cyanobacteria Require Transcriptional Feedback	SCIENCE			English	Article							KAIC PHOSPHORYLATION; MOLECULAR-BASES; GENE-EXPRESSION; CLOCK; RHYTHMS; SYSTEM; CELLS	The remarkably stable circadian oscillations of single cyanobacteria enable a population of growing cells to maintain synchrony for weeks. The cyanobacterial pacemaker is a posttranslational regulation (PTR) circuit that generates circadian oscillations in the phosphorylation state of the clock protein KaiC. Layered on top of the PTR is transcriptional-translational feedback regulation (TTR), common to all circadian systems, consisting of a negative feedback loop in which KaiC regulates its own production. We found that the PTR circuit is sufficient to generate oscillations in growing cyanobacteria. However, in the absence of TTR, individual oscillators were less stable and synchrony was not maintained in a population of cells. Experimentally constrained mathematical modeling reproduced sustained oscillations in the PTR circuit alone and demonstrated the importance of TTR for oscillator synchrony.	[Teng, Shu-Wen; Mukherji, Shankar; O'Shea, Erin K.] Harvard Univ, Howard Hughes Med Inst, Fac Arts & Sci, Ctr Syst Biol,Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Teng, Shu-Wen; Mukherji, Shankar; Moffitt, Jeffrey R.; O'Shea, Erin K.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [de Buyl, Sophie] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University	O'Shea, EK (corresponding author), Harvard Univ, Howard Hughes Med Inst, Fac Arts & Sci, Ctr Syst Biol,Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	erin_oshea@harvard.edu		de Buyl, Sophie/0000-0002-3314-9616	National Institute of Allergy and Infections Diseases [1R21AI094363-01A1]; Helen Hay Whitney Postdoctoral Fellowship; Fonds National de la Recherche Scientifique Belgium; Wallonie-Bruxelles International; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094363] Funding Source: NIH RePORTER	National Institute of Allergy and Infections Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Helen Hay Whitney Postdoctoral Fellowship; Fonds National de la Recherche Scientifique Belgium(Fonds de la Recherche Scientifique - FNRS); Wallonie-Bruxelles International; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Cluzel for the development of the microfluidics platform upon which the device used in this paper is based (funded via National Institute of Allergy and Infections Diseases award 1R21AI094363-01A1); B. Goetze and J. Wailes for assistance with microscopy; D. Zwicker, P. R. ten Wolde, and A. Subramaniam for stochastic simulation; J. Markson, A. Gutu, V. Vijayan, and A. Puszynska for strain construction and Western blotting; P. Cluzel, D. Gonze, and P. de Buyl for helpful discussion; and B. Stern, J. Markson, V. Vijayan, A. Rizvi, M. Rust, and A. Subramaniam for comments on the manuscript. Supported by the Helen Hay Whitney Postdoctoral Fellowship (J. R. M.), Fonds National de la Recherche Scientifique Belgium (postdoctoral researcher) (S.d.B.), Wallonie-Bruxelles International (S.d.B.), Wallonie-Bruxelles International (S.d.B.), and the Howard Hughes Medical Institute (E.K.O.).	Amdaoud M, 2007, P NATL ACAD SCI USA, V104, P7051, DOI 10.1073/pnas.0609315104; Chabot JR, 2007, NATURE, V450, P1249, DOI 10.1038/nature06395; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gonze D, 2002, P NATL ACAD SCI USA, V99, P673, DOI 10.1073/pnas.022628299; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Hosokawa N, 2011, P NATL ACAD SCI USA, V108, P15396, DOI 10.1073/pnas.1019612108; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Kitayama Y, 2008, GENE DEV, V22, P1513, DOI 10.1101/gad.1661808; Markson JS, 2009, FEBS LETT, V583, P3938, DOI 10.1016/j.febslet.2009.11.021; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Moffitt JR, 2012, LAB CHIP, V12, P1487, DOI 10.1039/c2lc00009a; Nakahira Y, 2004, P NATL ACAD SCI USA, V101, P881, DOI 10.1073/pnas.0307411100; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Qin XM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000394; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; Yang Q, 2010, SCIENCE, V327, P1522, DOI 10.1126/science.1181759; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zwicker D, 2010, P NATL ACAD SCI USA, V107, P22540, DOI 10.1073/pnas.1007613107	26	78	83	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					737	740		10.1126/science.1230996	http://dx.doi.org/10.1126/science.1230996			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661759	Green Submitted, Green Accepted			2022-12-28	WOS:000318619000037
J	Tsuang, WM; Vock, DM; Copeland, CAF; Lederer, DJ; Palmer, SM				Tsuang, Wayne M.; Vock, David M.; Copeland, C. Ashley Finlen; Lederer, David J.; Palmer, Scott M.			An Acute Change in Lung Allocation Score and Survival After Lung Transplantation A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							WAIT-LIST; IMPACT; THERAPY; HEART	Background: Lung transplantation is an effective treatment for patients with advanced lung disease. In the United States, lungs are allocated on the basis of the lung allocation score (LAS), a composite measure of transplantation urgency and utility. Clinical deteriorations result in increases to the LAS; however, whether the trajectory of the LAS has prognostic significance is uncertain. Objective: To determine whether an acute increase in the LAS before lung transplantation is associated with reduced posttransplant survival. Design: Retrospective cohort study of adult lung transplant recipients listed for at least 30 days between 4 May 2005 (LAS implementation) and 31 December 2010 in the United Network for Organ Sharing registry. An acute increase in the LAS was defined as an LAS change (LAS Delta) greater than 5 units between the 30 days before and the time of transplantation. Multivariable Cox proportional hazard models were used to examine the relationship between an LAS Delta >5 and posttransplant graft survival. Setting: All U. S. lung transplantation centers. Patients: 5749 lung transplant recipients. Measurements: Survival time after lung transplantation. Results: 702 (12.2%) patients experienced an LAS Delta >5. These patients had significantly worse posttransplant survival (hazard ratio, 1.31 [95% CI, 1.11 to 1.54]; P = 0.001]) after adjustment for the LAS at transplantation (LAS-T) and other clinical covariates. The effect of an LAS Delta >5 was independent of the LAS-T, underlying diagnosis, center volume, or donor characteristics. Limitation: Analysis was based on center-reported data. Conclusion: An acute increase in LAS before transplantation is associated with posttransplant survival after adjustment for LAS-T. Further emphasis on serial assessment of the LAS could improve the ability to offer accurate prediction of survival after transplantation.	Duke Univ, Med Ctr, Durham, NC 27710 USA; Duke Clin Res Inst, Durham, NC USA; N Carolina State Univ, Raleigh, NC 27695 USA; Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA; Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA	Duke University; Duke University; University of North Carolina; North Carolina State University; Columbia University; Columbia University	Palmer, SM (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Pulm Allergy & Crit Care Med, 106 Res Dr,DUMC Box 103002, Durham, NC 27710 USA.	vock@umn.edu; palme002@mc.duke.edu	Lederer, David/W-7957-2018	Lederer, David/0000-0001-5258-0228; Palmer, Scott/0000-0002-1370-3771; Vock, David M/0000-0002-5459-9579	National Institutes of Health; National Heart, Lung, and Blood Institute [T32-HL007538, 5K24-HL091140-05]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL091140, T32HL007538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institutes of Health.; Drs. Tsuang and Palmer were partly supported by the National Heart, Lung, and Blood Institute (awards T32-HL007538 and 5K24-HL091140-05, respectively).	[Anonymous], ALL THOR ORG; Arcasoy SM, 1999, NEW ENGL J MED, V340, P1081, DOI 10.1056/NEJM199904083401406; Asrani SK, 2011, CLIN LIVER DIS, V15, P685, DOI 10.1016/j.cld.2011.08.009; Bambha K, 2004, AM J TRANSPLANT, V4, P1798, DOI 10.1111/j.1600-6143.2004.00550.x; Cain LE, 2009, STAT MED, V28, P1725, DOI 10.1002/sim.3585; Chen H, 2009, AM J RESP CRIT CARE, V180, P468, DOI 10.1164/rccm.200810-1603OC; Christie JD, 2010, J HEART LUNG TRANSPL, V29, P1104, DOI 10.1016/j.healun.2010.08.004; Egan TM, 2006, AM J TRANSPLANT, V6, P1212, DOI 10.1111/j.1600-6143.2006.01276.x; Gran JM, 2010, STAT MED, V29, P2757, DOI 10.1002/sim.4048; Gries CJ, 2007, CHEST, V132, P1954, DOI 10.1378/chest.07-1160; Hadjiliadis D, 2007, CHEST, V131, P1224, DOI 10.1378/chest.06-1163; Hernan MA, 2008, EPIDEMIOLOGY, V19, P766, DOI 10.1097/EDE.0b013e3181875e61; Iribarne A, 2009, CHEST, V135, P923, DOI 10.1378/chest.08-2052; Kotloff RM, 2011, AM J RESP CRIT CARE, V184, P159, DOI 10.1164/rccm.201101-0134CI; Kozower BD, 2008, J THORAC CARDIOV SUR, V135, P166, DOI 10.1016/j.jtcvs.2007.08.044; Liou TG, 2008, TRANSPLANTATION, V86, P636, DOI 10.1097/TP.0b013e3181841551; Liu V, 2010, AM J TRANSPLANT, V10, P915, DOI 10.1111/j.1600-6143.2009.03003.x; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; Lu B, 2005, BIOMETRICS, V61, P721, DOI 10.1111/j.1541-0420.2005.00356.x; Merion RM, 2003, LIVER TRANSPLANT, V9, P12, DOI 10.1053/jlts.2003.50009; Merlo CA, 2009, J HEART LUNG TRANSPL, V28, P769, DOI 10.1016/j.healun.2009.04.024; Nunley DR, 2009, LUNG, V187, P383, DOI 10.1007/s00408-009-9180-4; Russo MJ, 2011, J THORAC CARDIOV SUR, V141, P1270, DOI 10.1016/j.jtcvs.2010.12.028; Russo MJ, 2010, CHEST, V137, P651, DOI 10.1378/chest.09-0319; Schaubel DE, 2006, BIOMETRICS, V62, P910, DOI 10.1111/j.1541-0420.2006.00527.x; Schaubel DE, 2009, J AM STAT ASSOC, V104, P49, DOI 10.1198/jasa.2009.0003; Thabut G, 2011, Rev Mal Respir, V28, pe1, DOI 10.1016/j.rmr.2011.04.007; Thabut G, 2010, JAMA-J AM MED ASSOC, V304, P53, DOI 10.1001/jama.2010.885; Therneau TM, 2000, MODELING SURVIVAL DA; van Houwelingen HC, 2007, SCAND J STAT, V34, P70, DOI 10.1111/j.1467-9469.2006.00529.x; Weiss ES, 2009, ANN THORAC SURG, V88, P1757, DOI 10.1016/j.athoracsur.2009.07.005; Yusen RD, 2010, AM J TRANSPLANT, V10, P1047, DOI 10.1111/j.1600-6143.2010.03055.x	32	34	35	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 7	2013	158	9					650	+		10.7326/0003-4819-158-9-201305070-00004	http://dx.doi.org/10.7326/0003-4819-158-9-201305070-00004			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146WV	23648947	Green Accepted			2022-12-28	WOS:000319126900002
J	Zhang, FS; Chen, XP; Vitousek, P				Zhang, Fusuo; Chen, Xinping; Vitousek, Peter			An experiment for the world	NATURE			English	Editorial Material							REDUCING ENVIRONMENTAL RISK; CROP SYSTEM MANAGEMENT; PRODUCTIVITY		[Zhang, Fusuo; Chen, Xinping] China Agr Univ, Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China; [Vitousek, Peter] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	China Agricultural University; Stanford University	Zhang, FS (corresponding author), China Agr Univ, Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China.	zhangfs@cau.edu.cn	Zhang, Fusuo/AAV-4517-2021	zhang, fusuo/0000-0001-8971-0129				Chen XP, 2011, P NATL ACAD SCI USA, V108, P6399, DOI 10.1073/pnas.1101419108; FAO, 2012, FAO STAT YB; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Huang JK, 2002, AUST J AGR RESOUR EC, V46, P367, DOI 10.1079/9780851996189.0393; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Liu XJ, 2013, NATURE, V494, P459, DOI 10.1038/nature11917; Qiu J, 2008, NATURE, V455, P850, DOI 10.1038/455850a; Zhang FS, 2012, ADV AGRON, V116, P1, DOI 10.1016/B978-0-12-394277-7.00001-4; Zhang FS, 2011, J ENVIRON QUAL, V40, P1051, DOI 10.2134/jeq2010.0292	9	252	318	26	562	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					33	35		10.1038/497033a	http://dx.doi.org/10.1038/497033a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	134OK	23636381	Bronze			2022-12-28	WOS:000318221500017
J	Altaf, F; Gibson, A; Dannawi, Z; Noordeen, H				Altaf, Farhaan; Gibson, Alexander; Dannawi, Zaher; Noordeen, Hilali			Adolescent idiopathic scoliosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CURVE PROGRESSION; BACK-PAIN; FOLLOW-UP; BRACE; GROWTH; METAANALYSIS; MATURITY; CHILDREN; GIRLS		[Altaf, Farhaan; Gibson, Alexander; Dannawi, Zaher; Noordeen, Hilali] Royal Natl Orthopaed Hosp, Spinal Surg Unit, London HA7 4LP, England	University of London; University College London; Royal National Orthopaedic Hospital NHS Trust	Altaf, F (corresponding author), Royal Natl Orthopaed Hosp, Spinal Surg Unit, London HA7 4LP, England.	farhaanaltaf@hotmail.com						BARNES PD, 1993, RADIOLOGY, V186, P247, DOI 10.1148/radiology.186.1.8416573; Bartie BA, 1993, ORTHOP T, V17, P176; Buckler J., 1990, LONGITUDINAL STUDY A; Charles YP, 2006, SPINE, V31, P1933, DOI 10.1097/01.brs.0000229230.68870.97; d'Amato CR, 2001, SPINE, V26, P2006; Danielsson AJ, 2007, SPINE, V32, P2198, DOI 10.1097/BRS.0b013e31814b851f; Diab M, 2007, SPINE, V32, P2759, DOI 10.1097/BRS.0b013e31815a5970; Dimeglio A, 2011, J PEDIATR ORTHOPED, V31, pS28, DOI 10.1097/BPO.0b013e318202c25d; Do T, 2001, J BONE JOINT SURG AM, V83A, P577, DOI 10.2106/00004623-200104000-00014; Duval-Beaupere G, 1970, Rev Chir Orthop Reparatrice Appar Mot, V56, P59; DUVALBEAUPERE G, 1971, SCOLIOSIS GROWTH, P58; Fairbank J, 2004, SPINE, V29, P1953, DOI 10.1097/01.brs.0000137072.41425.ec; Feldman DS, 2006, J PEDIATR ORTHOPED, V26, P353, DOI 10.1097/01.bpo.0000214928.25809.f9; Greulich WW., 1959, CALIF MED, V91, P53; Kesling KL, 1997, SPINE, V22, P2009, DOI 10.1097/00007632-199709010-00014; Kim H, 2010, RADIOGRAPHICS, V30, P1823, DOI 10.1148/rg.307105061; Lee CF, 2010, SPINE, V35, pE1492, DOI 10.1097/BRS.0b013e3181ecf3fe; LONSTEIN JE, 1984, J BONE JOINT SURG AM, V66A, P1061, DOI 10.2106/00004623-198466070-00013; LONSTEIN JE, 1994, LANCET, V344, P1407; NACHEMSON AL, 1995, J BONE JOINT SURG AM, V77A, P815, DOI 10.2106/00004623-199506000-00001; Noonan KJ, 1996, J BONE JOINT SURG AM, V78A, P557, DOI 10.2106/00004623-199604000-00009; Parent Stefan, 2005, Instr Course Lect, V54, P529; PEHRSSON K, 1992, SPINE, V17, P1091, DOI 10.1097/00007632-199209000-00014; Ramirez N, 1997, J BONE JOINT SURG AM, V79A, P364, DOI 10.2106/00004623-199703000-00007; RISSER J C, 1958, Clin Orthop, V11, P111; Rowe DE, 1997, J BONE JOINT SURG AM, V79A, P664, DOI 10.2106/00004623-199705000-00005; Sanders JO, 2007, J BONE JOINT SURG AM, V89A, P14, DOI 10.2106/JBJS.F.00318; Scoliosis Research Society, 1993, REP MORB COMM 1993; *TERM COMM SCOL RE, 1976, SPINE, V1, P57; Wang Shoufeng, 2007, J Orthop Surg Res, V2, P19, DOI 10.1186/1749-799X-2-19; WEINSTEIN SL, 1983, J BONE JOINT SURG AM, V65, P447, DOI 10.2106/00004623-198365040-00004; Weinstein SL, 2003, JAMA-J AM MED ASSOC, V289, P559, DOI 10.1001/jama.289.5.559; Weiss Hans-Rudolf, 2003, Pediatr Rehabil, V6, P23, DOI 10.1080/1363849031000095288; Wiley JW, 2000, SPINE, V25, P2326, DOI 10.1097/00007632-200009150-00010; ZADEH HG, 1995, J BONE JOINT SURG BR, V77, P762, DOI 10.1302/0301-620X.77B5.7559706	35	90	99	2	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2013	346								f2508	10.1136/bmj.f2508	http://dx.doi.org/10.1136/bmj.f2508			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139DR	23633006				2022-12-28	WOS:000318562300004
J	Warner, JH				Warner, John Harley			The art of medicine The Doctor in early Cold War America	LANCET			English	Editorial Material									Yale Univ, Sch Med, Sect Hist Med, New Haven, CT 06520 USA	Yale University	Warner, JH (corresponding author), Yale Univ, Sch Med, Sect Hist Med, 333 Cedar St, New Haven, CT 06520 USA.	john.warner@yale.edu							0	9	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 27	2013	381	9876					1452	1453		10.1016/S0140-6736(13)60915-0	http://dx.doi.org/10.1016/S0140-6736(13)60915-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	139TK	23630986				2022-12-28	WOS:000318607300018
J	Oomatia, A; Carroll, N; Safranek, PM				Oomatia, Amin; Carroll, Nicholas; Safranek, Peter M.			Acute gastric necrosis and air in the hepatic-portal vein secondary to a strangulated paraumbilical hernia	LANCET			English	Editorial Material									[Oomatia, Amin] Univ Cambridge, Sch Clin Med, Cambridge, England; [Carroll, Nicholas; Safranek, Peter M.] Addenbrookes Hosp, Cambridge Oesophagogastr Ctr, Cambridge CB2 0QQ, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Safranek, PM (corresponding author), Addenbrookes Hosp, Cambridge Oesophagogastr Ctr, Box 201,Hills Rd, Cambridge CB2 0QQ, England.	peter.safranek@addenbrookes.nhs.uk		Oomatia, Amin/0000-0002-0346-4535					0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 23	2013	382	9906					1733	1733		10.1016/S0140-6736(12)61778-4	http://dx.doi.org/10.1016/S0140-6736(12)61778-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	259PX	23664059	Bronze			2022-12-28	WOS:000327539900030
J	Li, DF; Lyons, JA; Pye, VE; Vogeley, L; Aragao, D; Kenyon, CP; Shah, STA; Doherty, C; Aherne, M; Caffrey, M				Li, Dianfan; Lyons, Joseph A.; Pye, Valerie E.; Vogeley, Lutz; Aragao, David; Kenyon, Colin P.; Shah, Syed T. A.; Doherty, Christine; Aherne, Margaret; Caffrey, Martin			Crystal structure of the integral membrane diacylglycerol kinase	NATURE			English	Article							PROTEIN-STRUCTURE DETERMINATION; ESCHERICHIA-COLI; SN-1,2-DIACYLGLYCEROL KINASE; CRYSTALLOGRAPHY; ENZYME; SEQUENCE; DESIGN; SYSTEM; SITES; NMR	Diacylglycerol kinase catalyses the ATP-dependent phosphorylation of diacylglycerol to phosphatidic acid for use in shuttling water-soluble components to membrane-derived oligosaccharide and lipopolysaccharide in the cell envelope of Gram-negative bacteria(1). For half a century, this 121-residue kinase has served as a model for investigating membrane protein enzymology(1-6), folding(7,8), assembly(9-12) and stability(1,13). Here we present crystal structures for three functional forms of this unique and paradigmatic kinase, one of which is wild type. These reveal a homo-trimeric enzyme with three transmembrane helices and an amino-terminal amphiphilic helix per monomer. Bound lipid substrate and docked ATP identify the putative active site that is of the composite, shared site type. The crystal structures rationalize extensive biochemical and biophysical data on the enzyme. They are, however, at variance with a published solution NMR model(14) in that domain swapping, a key feature of the solution form, is not observed in the crystal structures.	[Li, Dianfan; Lyons, Joseph A.; Pye, Valerie E.; Vogeley, Lutz; Aragao, David; Shah, Syed T. A.; Doherty, Christine; Aherne, Margaret; Caffrey, Martin] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland; [Li, Dianfan; Lyons, Joseph A.; Pye, Valerie E.; Vogeley, Lutz; Aragao, David; Shah, Syed T. A.; Doherty, Christine; Aherne, Margaret; Caffrey, Martin] Trinity Coll Dublin, Sch Med, Dublin 2, Ireland; [Kenyon, Colin P.] CSIR, ZA-0184 Pretoria, Gauteng, South Africa	Trinity College Dublin; Trinity College Dublin; Council for Scientific & Industrial Research (CSIR) - South Africa	Caffrey, M (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	martin.caffrey@tcd.ie	Aragao, David/A-1695-2012; Shah, Syed Tasadaque Ali/AAB-4890-2021; Lyons, Joseph/AAA-2528-2020; Aragao, David/AAV-5514-2021; Li, Dianfan/AHC-2751-2022	Aragao, David/0000-0002-6551-4657; Aragao, David/0000-0002-6551-4657; Li, Dianfan/0000-0003-4729-4678; Lyons, Joseph/0000-0003-0218-4862; Caffrey, Martin/0000-0002-2931-4551; Pye, Valerie E/0000-0001-9616-2992	Science Foundation Ireland [07/IN.1/B1836, 12/IA/1255]; National Institutes of Health [GM75915, P50GM073210, U54GM094599]; FP7 [COST CM0902]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075915, P50GM073210, U54GM094599, U54GM094625] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FP7; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge support from Science Foundation Ireland (grants 07/IN.1/B1836 and 12/IA/1255) and the National Institutes of Health (grants GM75915, P50GM073210, U54GM094599) and FP7 (COST CM0902). We thank C. R. Sanders for providing E. coli strain WH1061 and for his collegiality. The assistance and support of beamline scientists at the Advanced Photon Source (23-ID) and Diamond Light Source (I24) are gratefully acknowledged. We thank R. Sanishvili for assistance with zinc analysis, C. Boland and J. Tan for help with diffraction data collection, and A. Coughlan for help with lipid synthesis.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Badola P, 1997, J BIOL CHEM, V272, P24176, DOI 10.1074/jbc.272.39.24176; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; BOHNENBERGER E, 1983, EUR J BIOCHEM, V132, P645, DOI 10.1111/j.1432-1033.1983.tb07412.x; Caffrey M, 2009, CURR TOP MEMBR, V63, P83, DOI 10.1016/S1063-5823(09)63004-0; Caffrey M., 2010, JOVE-J VIS EXP, V45, pe1712, DOI DOI 10.3791/1712; Caffrey M, 2012, BIOCHEMISTRY-US, V51, P6266, DOI 10.1021/bi300010w; Cherezov V, 2009, J R SOC INTERFACE, V6, pS587, DOI 10.1098/rsif.2009.0142.focus; Diller DJ, 2001, PROTEINS, V43, P113, DOI 10.1002/1097-0134(20010501)43:2<113::AID-PROT1023>3.0.CO;2-T; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans G, 2011, ACTA CRYSTALLOGR D, V67, P261, DOI 10.1107/S0907444911007608; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fischetti RF, 2009, J SYNCHROTRON RADIAT, V16, P217, DOI 10.1107/S0909049508040612; Gorzelle BM, 1999, BIOCHEMISTRY-US, V38, P16373, DOI 10.1021/bi991292n; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel E, 2007, BIOINFORMATICS, V23, P717, DOI 10.1093/bioinformatics/btm006; Lahiri S, 2011, ANGEW CHEM INT EDIT, V50, P3988, DOI 10.1002/anie.201006686; Lau FW, 1999, BIOCHEMISTRY-US, V38, P5521, DOI 10.1021/bi982763t; Li D., 2013, CRYST GROWTH DES; Li D, 2012, JOVE-J VIS EXP, DOI 10.3791/4000; Li DF, 2012, JOVE-J VIS EXP, DOI 10.3791/4001; Li DF, 2011, P NATL ACAD SCI USA, V108, P8639, DOI 10.1073/pnas.1101815108; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lorch M, 2005, CHEMBIOCHEM, V6, P1693, DOI 10.1002/cbic.200500054; Martin JW, 2011, J COMPUT BIOL, V18, P1507, DOI 10.1089/cmb.2011.0173; Martin JW, 2011, PROTEIN SCI, V20, P970, DOI 10.1002/pro.620; Matte A., 2010, ELS; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nagy JK, 2000, BIOCHEMISTRY-US, V39, P4154, DOI 10.1021/bi991781n; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pilot JD, 2001, BIOCHEMISTRY-US, V40, P8188, DOI 10.1021/bi0103258; Sanders CR, 1996, BIOCHEMISTRY-US, V35, P8610, DOI 10.1021/bi9604892; SCHNEIDER EG, 1973, J BIOL CHEM, V248, P3739; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; SMITH RL, 1994, J BACTERIOL, V176, P5459, DOI 10.1128/JB.176.17.5459-5465.1994; Stokes-Rees I, 2010, P NATL ACAD SCI USA, V107, P21476, DOI 10.1073/pnas.1012095107; Ullrich SJ, 2011, NAT CHEM BIOL, V7, P263, DOI 10.1038/nchembio.543; Van Horn WD, 2012, ANNU REV BIOPHYS, V41, P81, DOI [10.1146/annurev-biophys-050511-102330, 10.1146/annurev-biophys-050511-182330]; Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716; Vinogradova O, 1997, BIOPHYS J, V72, P2688, DOI 10.1016/S0006-3495(97)78912-4; WALSH JP, 1990, J BIOL CHEM, V265, P4374; WALSH JP, 1986, J BIOL CHEM, V261, P6239; Wen JA, 1996, NAT STRUCT BIOL, V3, P141, DOI 10.1038/nsb0296-141; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Zhou YF, 2000, J BIOL CHEM, V275, P6975, DOI 10.1074/jbc.275.10.6975	50	77	80	2	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2013	497	7450					521	+		10.1038/nature12179	http://dx.doi.org/10.1038/nature12179			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23676677	Green Submitted, Green Accepted			2022-12-28	WOS:000319254000055
J	Paeschke, K; Bochman, ML; Garcia, PD; Cejka, P; Friedman, KL; Kowalczykowski, SC; Zakian, VA				Paeschke, Katrin; Bochman, Matthew L.; Garcia, P. Daniela; Cejka, Petr; Friedman, Katherine L.; Kowalczykowski, Stephen C.; Zakian, Virginia A.			Pif1 family helicases suppress genome instability at G-quadruplex motifs	NATURE			English	Article							GROSS-CHROMOSOMAL REARRANGEMENTS; REPLICATION FORK PROGRESSION; SACCHAROMYCES-CEREVISIAE; DNA HELICASE; YEAST; RRM3P; TELOMERASE; PROTEINS; GENES; LOCI	The Saccharomyces cerevisiae Pif1 helicase is the prototypical member of the Pif1 DNA helicase family, which is conserved from bacteria to humans. Here we show that exceptionally potent G-quadruplex unwinding is conserved among Pif1 helicases. Moreover, Pif1 helicases from organisms separated by more than 3 billion years of evolution suppressed DNA damage at G-quadruplex motifs in yeast. The G-quadruplex-induced damage generated in the absence of Pif1 helicases led to new genetic and epigenetic changes. Furthermore, when expressed in yeast, human PIF1 suppressed both G-quadruplex-associated DNA damage and telomere lengthening.	[Paeschke, Katrin; Bochman, Matthew L.; Garcia, P. Daniela; Zakian, Virginia A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Cejka, Petr; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Cejka, Petr; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Mol Genet, Davis, CA 95616 USA; [Cejka, Petr; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Friedman, Katherine L.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA	Princeton University; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Vanderbilt University	Zakian, VA (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	vzakian@princeton.edu	Bochman, Matthew L./I-2033-2019	Bochman, Matthew L./0000-0002-2807-0452; Cejka, Petr/0000-0002-9087-032X	National Institutes of Health; National Science Foundation; DFG; NJCCR; American Cancer Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043265, R01GM041347, R01GM026938] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); DFG(German Research Foundation (DFG)); NJCCR; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. B. Boule for early work on S. cerevisiae Pif1 biochemistry, P. Opresko for the gift of purified human WRN, E. Allen-Vercoe, K. Bidle, C. Parker, R. Johnson, H. L. Ayala-del-Rio and E. Sockett for materials and for cloning non-yeast Pif1 helicases, and M. Platts for multiplex PCR and Southern analysis methods to characterize GCR clones. We acknowledge financial support from the National Institutes of Health (V.A.Z., S. C. K.), National Science Foundation (K. L. F.), DFG and NJCCR (K. P.) and American Cancer Society (M.L.B.).	APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Azvolinsky A, 2006, GENE DEV, V20, P3104, DOI 10.1101/gad.1478906; Azvolinsky A, 2009, MOL CELL, V34, P722, DOI 10.1016/j.molcel.2009.05.022; Bachrati CZ, 2006, METHOD ENZYMOL, V409, P86, DOI 10.1016/S0076-6879(05)09005-1; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Bochman ML, 2011, MOL BIOL CELL, V22, P1955, DOI 10.1091/mbc.E11-01-0045; Bochman ML, 2010, DNA REPAIR, V9, P237, DOI 10.1016/j.dnarep.2010.01.008; Boule JB, 2005, NATURE, V438, P57, DOI 10.1038/nature04091; Boule JB, 2007, NUCLEIC ACIDS RES, V35, P5809, DOI 10.1093/nar/gkm613; Brosh RM, 2006, METHOD ENZYMOL, V409, P52, DOI 10.1016/S0076-6879(05)09004-X; Capra JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000861; Cejka Petr, 2010, J Biol Chem, V285, P8290, DOI 10.1074/jbc.M109.083196; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Chisholm KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030748; Fachinetti D, 2010, MOL CELL, V39, P595, DOI 10.1016/j.molcel.2010.07.024; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Ivessa AS, 2002, GENE DEV, V16, P1383, DOI 10.1101/gad.982902; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; LAHAYE A, 1993, J BIOL CHEM, V268, P26155; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Mondoux M., 2005, TELOMERES, P261; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Piazza A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003033; Pinter SF, 2008, MOL CELL BIOL, V28, P6594, DOI 10.1128/MCB.00191-08; Putnam Christopher D, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5492; RUNGE KW, 1989, MOL CELL BIOL, V9, P1488, DOI 10.1128/MCB.9.4.1488; Sarkies P, 2010, MOL CELL, V40, P703, DOI 10.1016/j.molcel.2010.11.009; Schmidt KH, 2006, METHOD ENZYMOL, V409, P462, DOI 10.1016/S0076-6879(05)09027-0; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith S, 2004, P NATL ACAD SCI USA, V101, P9039, DOI 10.1073/pnas.0403093101; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Zhou JQ, 2000, SCIENCE, V289, P771, DOI 10.1126/science.289.5480.771	45	312	325	3	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2013	497	7450					458	+		10.1038/nature12149	http://dx.doi.org/10.1038/nature12149			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23657261	Green Accepted, Green Submitted			2022-12-28	WOS:000319254000040
J	Gosden, R				Gosden, Roger			Robert Edwards (1925-2013) OBITUARY	NATURE			English	Biographical-Item									[Gosden, Roger] Weill Cornell Med Coll, New York, NY USA	Cornell University		roger.gosden@cantab.net						EDWARDS R, PUBLICATION LIST	1	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2013	497	7449					318	318		10.1038/497318a	http://dx.doi.org/10.1038/497318a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23676748	Bronze			2022-12-28	WOS:000318952000023
J	Roncaglioni, MC; Tombesi, M; Avanzini, F; Barlera, S; Caimi, V; Longoni, P; Marzona, I; Milani, V; Silletta, MG; Tognoni, G; Marchioli, R				Roncaglioni, Maria Carla; Tombesi, Massimo; Avanzini, Fausto; Barlera, Simona; Caimi, Vittorio; Longoni, Paolo; Marzona, Irene; Milani, Valentina; Silletta, Maria Giuseppina; Tognoni, Gianni; Marchioli, Roberto		Risk Prevention Study Collaborativ	n-3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								BACKGROUND Trials have shown a beneficial effect of n-3 polyunsaturated fatty acids in patients with a previous myocardial infarction or heart failure. We evaluated the potential benefit of such therapy in patients with multiple cardiovascular risk factors or atherosclerotic vascular disease who had not had a myocardial infarction. METHODS In this double-blind, placebo-controlled clinical trial, we enrolled a cohort of patients who were followed by a network of 860 general practitioners in Italy. Eligible patients were men and women with multiple cardiovascular risk factors or atherosclerotic vascular disease but not myocardial infarction. Patients were randomly assigned to n-3 fatty acids (1 g daily) or placebo (olive oil). The initially specified primary end point was the cumulative rate of death, nonfatal myocardial infarction, and nonfatal stroke. At 1 year, after the event rate was found to be lower than anticipated, the primary end point was revised as time to death from cardiovascular causes or admission to the hospital for cardiovascular causes. RESULTS Of the 12,513 patients enrolled, 6244 were randomly assigned to n-3 fatty acids and 6269 to placebo. With a median of 5 years of follow-up, the primary end point occurred in 1478 of 12,505 patients included in the analysis (11.8%), of whom 733 of 6239 (11.7%) had received n-3 fatty acids and 745 of 6266 (11.9%) had received placebo (adjusted hazard ratio with n-3 fatty acids, 0.97; 95% confidence interval, 0.88 to 1.08; P=0.58). The same null results were observed for all the secondary end points. CONCLUSIONS In a large general-practice cohort of patients with multiple cardiovascular risk factors, daily treatment with n-3 fatty acids did not reduce cardiovascular mortality and morbidity. (Funded by Societa Prodotti Antibiotici and others; ClinicalTrials.gov number, NCT00317707.)	[Roncaglioni, Maria Carla; Avanzini, Fausto; Barlera, Simona; Marzona, Irene; Milani, Valentina] IRCCS Ist Ric Farmacol Mario Negri, I-20156 Milan, Italy; [Tombesi, Massimo; Caimi, Vittorio; Longoni, Paolo] Ctr Studi & Ric Med Gen, Monza, Italy; [Silletta, Maria Giuseppina; Tognoni, Gianni; Marchioli, Roberto] Consorzio Mario Negri Sud, Chieti, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Consorzio Mario Negri Sud	Roncaglioni, MC (corresponding author), IRCCS Ist Ric Farmacol Mario Negri, Risk & Prevent Study Off, Via Giuseppe La Masa 19, I-20156 Milan, Italy.	rep@marionegri.it	roncaglioni, maria carla/AAB-1875-2020; Milani, Valentina/AAB-5367-2019; Maggioni, Aldo Pietro/AAL-5334-2020; Baviera, Marta/AAB-4299-2020; Roberto, Gasparri/J-5356-2019; Marzona, Irene/AAB-1859-2020; Zane, Daniela/AAY-1682-2020; Nicolis, Enrico Bjørn/ABG-8467-2020; Beghi, Ettore/AAA-7426-2020; Ianiro, Gianluca/K-5578-2016	roncaglioni, maria carla/0000-0002-2029-7847; Milani, Valentina/0000-0002-2989-981X; Maggioni, Aldo Pietro/0000-0003-2764-6779; Baviera, Marta/0000-0002-0264-151X; Roberto, Gasparri/0000-0001-7922-7061; Marzona, Irene/0000-0001-7952-8278; Zane, Daniela/0000-0001-6817-4451; Nicolis, Enrico Bjørn/0000-0001-9246-2533; Beghi, Ettore/0000-0003-2542-0469; SIMONATO, LORENZO/0000-0002-9914-1000; Avanzini, Fausto/0000-0002-4029-2891; Scigliano, Giulio/0000-0002-2436-3426; Aprile, Irene/0000-0001-8123-9977; Bertele', Vittorio/0000-0002-0032-7033; Barbieri, Andrea/0000-0002-7189-9602; Ianiro, Gianluca/0000-0002-8318-0515; Rigon, Giulio/0000-0001-6352-7553	Societa Prodotti Antibiotici; Pfizer; Sigma-Tau	Societa Prodotti Antibiotici; Pfizer(Pfizer); Sigma-Tau	Funded by Societa Prodotti Antibiotici and others; ClinicalTrials.gov number, NCT00317707.; Supported by Societa Prodotti Antibiotici, Pfizer, and Sigma-Tau.	Avanzini F, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-68; AVANZINI F, 1987, BRIT MED J, V294, P157, DOI 10.1136/bmj.294.6565.157; Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; De Caterina R, 2011, NEW ENGL J MED, V364, P2439, DOI 10.1056/NEJMra1008153; *GISSI PREV INV, 2001, LANCET, V357, P642; Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico, 2007, LANCET, V369, P106; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; Monesi L, 2005, EUR J CLIN PHARMACOL, V61, P595, DOI 10.1007/s00228-005-0948-z; Roccatagliata D, 2006, VASC HEALTH RISK MAN, V2, P507, DOI 10.2147/vhrm.2006.2.4.507; Roncaglioni MC, 2004, EUR J CARDIOV PREV R, V11, P233, DOI 10.1097/01.hjr.0000129737.84851.99; Tavazzi L, 2008, LANCET, V372, P1223, DOI 10.1016/S0140-6736(08)61239-8; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	14	368	402	0	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2013	368	19					1800	1808		10.1056/NEJMoa1205409	http://dx.doi.org/10.1056/NEJMoa1205409			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138WA	23656645				2022-12-28	WOS:000318540000008
J	Psaty, BM; Larson, EB				Psaty, Bruce M.; Larson, Eric B.			Investments in Infrastructure for Diverse Research Resources and the Health of the Public	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							QUALITY		[Psaty, Bruce M.; Larson, Eric B.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Psaty, BM (corresponding author), Cardiovasc Hlth Res Unit, 1730 Minor Ave,Ste 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu			NATIONAL CANCER INSTITUTE [U19CA079689] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [U54AT007748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080295, R01HL087652, R01HL078888, R01HL085251, R01HL103612, R01HL105756, U01HL080295] Funding Source: NIH RePORTER; NCCIH NIH HHS [1U54AT007748-01] Funding Source: Medline; NCI NIH HHS [3U19CA079689-12S2] Funding Source: Medline; NHLBI NIH HHS [HL080295, HL087652, R01 HL078888, HL105756, HL085251, R01 HL103612, HL103612, HL078888] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Califf RM, 2012, JAMA-J AM MED ASSOC, V308, P1747, DOI 10.1001/jama.2012.28745; Floyd JS, 2012, ARCH INTERN MED, V172, P1412, DOI 10.1001/archinternmed.2012.4306; Go AS, 2008, CIRC-CARDIOVASC QUAL, V1, P138, DOI 10.1161/CIRCOUTCOMES.108.801654; Platt R, 2012, PHARMACOEPIDEM DR S, V21, P1, DOI 10.1002/pds.2343; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Sentinel Initiative Public Workshop. The Brookings Institution, SENT IN PUBL WORKSH; Toh S, 2012, ARCH INTERN MED, V172, P1582, DOI 10.1001/2013.jamainternmed.34; United States Food and Drug Administration, PRAD DAB ET MES DRUG	8	7	8	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2013	309	18					1895	1896		10.1001/jama.2013.3445	http://dx.doi.org/10.1001/jama.2013.3445			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138AZ	23652519				2022-12-28	WOS:000318481900021
J	Hippisley-Cox, J; Coupland, C; Brindle, P				Hippisley-Cox, Julia; Coupland, Carol; Brindle, Peter			Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WALES PROSPECTIVE DERIVATION; CARDIOVASCULAR-DISEASE; EXTERNAL VALIDATION; ATRIAL-FIBRILLATION; UNITED-KINGDOM; STRATIFICATION SCHEMES; 10-YEAR RISK; THROMBOEMBOLISM; ENGLAND; QRISK	Objective To develop and validate a risk algorithm (QStroke) to estimate risk of stroke or transient ischaemic attack in patients without prior stroke or transient ischaemic attack at baseline; to compare (a) QStroke with CHADS(2) and CHA(2)DS(2)VASc scores in patients with atrial fibrillation and (b) the performance of QStroke with the Framingham stroke score in the full population free of stroke or transient ischaemic attack. Design Prospective open cohort study using routinely collected data from general practice during the study period 1 January 1998 to 1 August 2012. Setting 451 general practices in England and Wales contributing to the national QResearch database to develop the algorithm and 225 different QResearch practices to validate the algorithm. Participants 3.5 million patients aged 25-84 years with 24.8 million person years in the derivation cohort who experienced 77 578 stroke events. For the validation cohort, we identified 1.9 million patients aged 25-84 years with 12.7 million person years who experienced 38 404 stroke events. We excluded patients with a prior diagnosis of stroke or transient ischaemic attack and those prescribed oral anticoagulants at study entry. Main outcome measures Incident diagnosis of stroke or transient ischaemic attack recorded in general practice records or linked death certificates during follow-up. Risk factors Self assigned ethnicity, age, sex, smoking status, systolic blood pressure, ratio of total serum cholesterol to high density lipoprotein cholesterol concentrations, body mass index, family history of coronary heart disease in first degree relative under 60 years, Townsend deprivation score, treated hypertension, type 1 diabetes, type 2 diabetes, renal disease, rheumatoid arthritis, coronary heart disease, congestive cardiac failure, valvular heart disease, and atrial fibrillation Results The QStroke algorithm explained 57% of the variation in women and 55% in men without a prior stroke. The D statistic for QStroke was 2.4 in women and 2.3 in men. QStroke had improved performance on all measures of discrimination and calibration compared with the Framingham score in patients without a prior stroke. Among patients with atrial fibrillation, levels of discrimination were lower, but QStroke had some improved performance on all measures of discrimination compared with CHADS2 and CHA2DS2VASc. Conclusion QStroke provides a valid measure of absolute stroke risk in the general population of patients free of stroke or transient ischaemic attack as shown by its performance in a separate validation cohort. QStroke also shows some improvement on current risk scoring methods, CHADS2 and CHA2DS2VASc, for the subset of patients with atrial fibrillation for whom anticoagulation may be required. Further research is needed to evaluate the cost effectiveness of using these algorithms in primary care.	[Hippisley-Cox, Julia; Coupland, Carol] Div Primary Care, Nottingham NG2 7RD, England; [Brindle, Peter] Avon Primary Care Res Collaborat, Bristol Clin Commissioning Grp, Bristol BS1 3NX, Avon, England		Hippisley-Cox, J (corresponding author), Div Primary Care, Univ Pk, Nottingham NG2 7RD, England.	Julia.hippisley-cox@nottingham.ac.uk	Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Coupland, Carol/0000-0002-2327-3306				ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; British Heart Foundation, 2007, COR HEART DIS STAT S; Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/europace/eus305, 10.1093/eurheartj/ehs253]; Collins GS, 2011, DIABETIC MED, V28, P599, DOI 10.1111/j.1464-5491.2011.03237.x; Collins GS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4181; Collins GS, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3651; Collins GS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2442; Collins GS, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2584; *DEP HLTH, 2008, PUTT PREV 1 VASC CHE, P15; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Health & Social Care Information Centre, QUAL OUTC FRAM; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Hippisley- Cox J., 2005, COMP KEY PRACTICE CH; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Hippisley-Cox J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4656; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b880; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4229; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Lip GYH, 2012, NAT REV CARDIOL, V9, P71, DOI 10.1038/nrcardio.2011.203; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Majeed Azeem, 2004, Health Stat Q, P5; Maradit-Kremers H, 2005, ARTHRITIS RHEUM-US, V52, P402, DOI 10.1002/art.20853; *NAT COLL CTR PRIM, 2008, SECT 4 3 GUID CARD R, P43; NHS Improvement, 2012, GUID RISK ASS STROK; Olesen JB, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d124; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Steyerberg E., 2009, CLIN PREDICTION MODE; van Staa TP, 2011, J THROMB HAEMOST, V9, P39, DOI 10.1111/j.1538-7836.2010.04085.x; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	36	86	88	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 2	2013	346								f2573	10.1136/bmj.f2573	http://dx.doi.org/10.1136/bmj.f2573			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139ET	23641033	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000318565300002
J	Stinson, BM; Nager, AR; Glynn, SE; Schmitz, KR; Baker, TA; Sauer, RT				Stinson, Benjamin M.; Nager, Andrew R.; Glynn, Steven E.; Schmitz, Karl R.; Baker, Tania A.; Sauer, Robert T.			Nucleotide Binding and Conformational Switching in the Hexameric Ring of a AAA plus Machine	CELL			English	Article							DIFFRACTION DATA; PORE LOOPS; PROTEIN; CLPX; ATP; TRANSLOCATION; F-1-ATPASE	ClpX, a AAA+ ring homohexamer, uses the energy of ATP binding and hydrolysis to power conformational changes that unfold and translocate target proteins into the ClpP peptidase for degradation. In multiple crystal structures, some ClpX subunits adopt nucleotide-loadable conformations, others adopt unloadable conformations, and each conformational class exhibits substantial variability. Using mutagenesis of individual subunits in covalently tethered hexamers together with fluorescence methods to assay the conformations and nucleotide-binding properties of these subunits, we demonstrate that dynamic interconversion between loadable and unloadable conformations is required to couple ATP hydrolysis by ClpX to mechanical work. ATP binding to different classes of subunits initially drives staged allosteric changes, which set the conformation of the ring to allow hydrolysis and linked mechanical steps. Subunit switching between loadable and unloadable conformations subsequently isomerizes or resets the configuration of the nucleotide-loaded ring and is required for mechanical function.	[Stinson, Benjamin M.; Nager, Andrew R.; Glynn, Steven E.; Schmitz, Karl R.; Baker, Tania A.; Sauer, Robert T.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Baker, Tania A.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Sauer, RT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bobsauer@mit.edu		Sauer, Robert/0000-0002-1719-5399; Schmitz, Karl/0000-0003-1411-7624; Glynn, Steven/0000-0001-6247-8913	NIH [GM-101988]; NCRR [5P41RR015301-10]; NIGMS [8 P41 GM103403-10]; US DOE [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101988, P41GM103403] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Drennan, Y. Goldman, R. Grant, K. Knockenhauer, M. Lang, C. Lukehart, A. Olivares, O. Yosefson, and T. Schwartz for help and discussions. This work was supported by NIH grant GM-101988. T.A.B. is an employee of the Howard Hughes Medical Institute. Studies using the NE-CAT beamline were supported by the NCRR (5P41RR015301-10) and NIGMS (8 P41 GM103403-10). Use of the Advanced Photon Source at Argonne National Laboratory was supported by the US DOE (contract DE-AC02-06CH11357).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Glynn SE, 2012, NAT STRUCT MOL BIOL, V19, P616, DOI 10.1038/nsmb.2288; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kinosita K, 2000, PHILOS T R SOC B, V355, P473, DOI 10.1098/rstb.2000.0589; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Leslie AGW, 2000, PHILOS T ROY SOC B, V355, P465, DOI 10.1098/rstb.2000.0588; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nager AR, 2011, J MOL BIOL, V413, P4, DOI 10.1016/j.jmb.2011.07.041; NORBY JG, 1988, METHOD ENZYMOL, V156, P116; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Singh SK, 2001, J BIOL CHEM, V276, P29420, DOI 10.1074/jbc.M103489200; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; Wojtyra UA, 2003, J BIOL CHEM, V278, P48981, DOI 10.1074/jbc.M307825200; Yakamavich JA, 2008, J MOL BIOL, V380, P946, DOI 10.1016/j.jmb.2008.05.070; Zhou RB, 2011, NANO LETT, V11, P5482, DOI 10.1021/nl2032876	32	80	81	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 25	2013	153	3					628	639		10.1016/j.cell.2013.03.029	http://dx.doi.org/10.1016/j.cell.2013.03.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622246	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000318063500015
J	Xu, HP; Li, XY; Liu, D; Li, JF; Zhang, X; Chen, X; Hou, SY; Peng, LX; Xu, CG; Liu, WL; Zhang, LF; Qi, H				Xu, Heping; Li, Xuanying; Liu, Dan; Li, Jianfu; Zhang, Xu; Chen, Xin; Hou, Shiyue; Peng, Lixia; Xu, Chenguang; Liu, Wanli; Zhang, Lianfeng; Qi, Hai			Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility	NATURE			English	Article							INDUCIBLE COSTIMULATOR; LYMPH-NODE; DIFFERENTIATION; CHEMOTAXIS; RECEPTOR; 3-KINASE; PROTEIN; B7RP-1; BCL6	Germinal centres support antibody affinity maturation and memory formation(1). Follicular T-helper cells promote proliferation and differentiation of antigen-specific B cells inside the follicle(2,3). A genetic deficiency in the inducible co-stimulator (ICOS), a classic CD28 family co-stimulatory molecule highly expressed by follicular T-helper cells, causes profound germinal centre defects(4,5), leading to the view that ICOS specifically co-stimulates the follicular T-helper cell differentiation program(2,6,7). Here we show that ICOS directly controls follicular recruitment of activated T-helper cells in mice. This effect is independent from ICOS ligand (ICOSL)-mediated co-stimulation provided by antigen-presenting dendritic cells or cognate B cells, and does not rely on Bcl6-mediated programming as an intermediate step. Instead, it requires ICOSL expression by follicular bystander B cells, which do not present cognate antigen to T-helper cells but collectively form an ICOS-engaging field. Dynamic imaging reveals ICOS engagement drives coordinated pseudopod formation and promotes persistent T-cell migration at the border between the T-cell zone and the B-cell follicle in vivo. When follicular bystander B cells cannot express ICOSL, otherwise competent T-helper cells fail to develop into follicular T-helper cells normally, and fail to promote optimal germinal centre responses. These results demonstrate a co-stimulation-independent function of ICOS, uncover a key role for bystander B cells in promoting the development of follicular T-helper cells, and reveal unsuspected sophistication in dynamic T-cell positioning in vivo.	[Xu, Heping; Li, Xuanying; Liu, Dan; Zhang, Xu; Chen, Xin; Hou, Shiyue; Peng, Lixia; Qi, Hai] Tsinghua Univ, Sch Med, Lab Dynam Immunobiol, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Li, Jianfu] Tsinghua Univ, Sch Med, Dept Biomed Engn, Beijing 100084, Peoples R China; [Xu, Chenguang; Liu, Wanli] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Zhang, Lianfeng] Chinese Acad Med Sci, Inst Lab Anim Sci, Minist Hlth, Key Lab Human Dis Comparat Med, Beijing 100021, Peoples R China; [Zhang, Lianfeng] Peking Union Med Coll, Comparat Med Ctr, Beijing 100021, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Qi, H (corresponding author), Tsinghua Univ, Sch Med, Lab Dynam Immunobiol, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.	qihai@biomed.tsinghua.edu.cn	liu, wanli/H-5690-2011; Chen, Xin/GNH-1799-2022	liu, wanli/0000-0003-2624-6802; Chen, Xin/0000-0001-6212-2335; Liu, Wanli/0000-0003-0395-2800; Qi, Hai/0000-0001-5475-3989; Xu, Heping/0000-0003-2149-7004	National Natural Science Foundation of China [81072464, 81161120405]; Program for New Century Excellent Talents in University [20091042000]; Tsinghua-Yu-Yuan Medical Sciences Fund [20240000585]; Tsinghua University Initiative Scientific Research Program [2010Z02150]; Institut Merieux; Tsinghua-Peking Center for Life Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Tsinghua-Yu-Yuan Medical Sciences Fund; Tsinghua University Initiative Scientific Research Program; Institut Merieux; Tsinghua-Peking Center for Life Sciences	H. Q. is indebted to his late mother J. Wang for inspiration, and thanks Y. Hong for support. H. Q. was a Tsinghua-Bayer Investigator and a Tsinghua-Janssen Investigator. This work was funded in part by the National Natural Science Foundation of China (grant no. 81072464 and 81161120405), the Program for New Century Excellent Talents in University (no. 20091042000), Tsinghua-Yu-Yuan Medical Sciences Fund (no. 20240000585), Tsinghua University Initiative Scientific Research Program (no. 2010Z02150), Institut Merieux, and the Tsinghua-Peking Center for Life Sciences.	Arai Y, 2010, P NATL ACAD SCI USA, V107, P12399, DOI 10.1073/pnas.0908278107; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dong C, 2001, J IMMUNOL, V166, P3659, DOI 10.4049/jimmunol.166.6.3659; Gigoux M, 2009, P NATL ACAD SCI USA, V106, P20371, DOI 10.1073/pnas.0911573106; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Iglesias PA, 2012, CURR OPIN CELL BIOL, V24, P245, DOI 10.1016/j.ceb.2011.11.009; Insall RH, 2010, NAT REV MOL CELL BIO, V11, P453, DOI 10.1038/nrm2905; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kay RR, 2008, NAT REV MOL CELL BIO, V9, P455, DOI 10.1038/nrm2419; Liu WL, 2010, J IMMUNOL, V184, P1977, DOI 10.4049/jimmunol.0902334; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Norman P, 2011, EXPERT OPIN THER PAT, V21, P1773, DOI 10.1517/13543776.2011.629606; Nukada Y, 2006, INT IMMUNOL, V18, P1815, DOI 10.1093/intimm/dxl115; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Okamoto N, 2004, INT IMMUNOL, V16, P1515, DOI 10.1093/intimm/dxh153; Parry RV, 2003, J IMMUNOL, V171, P166, DOI 10.4049/jimmunol.171.1.166; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Simpson TR, 2010, CURR OPIN IMMUNOL, V22, P326, DOI 10.1016/j.coi.2010.01.001; Swallow MM, 1999, IMMUNITY, V11, P423, DOI 10.1016/S1074-7613(00)80117-X; Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Vinuesa CG, 2011, IMMUNITY, V35, P671, DOI 10.1016/j.immuni.2011.11.001; Yoshinaga SK, 2000, INT IMMUNOL, V12, P1439, DOI 10.1093/intimm/12.10.1439; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002	29	278	308	1	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 25	2013	496	7446					523	+		10.1038/nature12058	http://dx.doi.org/10.1038/nature12058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23619696				2022-12-28	WOS:000317984400045
J	Murray, CJL; Richards, MA; Newton, JN; Fenton, KA; Anderson, HR; Atkinson, C; Bennett, D; Bernab, E; Blencowe, H; Bourne, R; Braithwaite, T; Brayne, C; Bruce, NG; Brugha, TS; Burney, P; Dherani, M; Dolk, H; Edmond, K; Ezzati, M; Flaxman, AD; Fleming, TD; Freedman, G; Gunnell, D; Hay, RJ; Hutchings, SJ; Ohno, SL; Lozano, R; Lyons, RA; Marcenes, W; Naghavi, M; Newton, CR; Pearce, N; Pope, D; Rushton, L; Salomon, JA; Shibuya, K; Vos, T; Wang, HD; Williams, HC; Woolf, AD; Lopez, AD; Davis, A				Murray, Christopher J. L.; Richards, Michael A.; Newton, John N.; Fenton, Kevin A.; Anderson, H. Ross; Atkinson, Charles; Bennett, Derrick; Bernab, Eduardo; Blencowe, Hannah; Bourne, Rupert; Braithwaite, Tasanee; Brayne, Carol; Bruce, Nigel G.; Brugha, Traolach S.; Burney, Peter; Dherani, Mukesh; Dolk, Helen; Edmond, Karen; Ezzati, Majid; Flaxman, Abraham D.; Fleming, Tom D.; Freedman, Greg; Gunnell, David; Hay, Roderick J.; Hutchings, Sally J.; Ohno, Summer Lockett; Lozano, Rafael; Lyons, Ronan A.; Marcenes, Wagner; Naghavi, Mohsen; Newton, Charles R.; Pearce, Neil; Pope, Dan; Rushton, Lesley; Salomon, Joshua A.; Shibuya, Kenji; Vos, Theo; Wang, Haidong; Williams, Hywel C.; Woolf, Anthony D.; Lopez, Alan D.; Davis, Adrian			UK health performance: findings of the Global Burden of Disease Study 2010	LANCET			English	Article							CORONARY-HEART-DISEASE; SYSTEMATIC ANALYSIS; HYPERTENSION MANAGEMENT; SMOKING-CESSATION; MORTALITY-RATES; 187 COUNTRIES; RISK-FACTORS; 21 REGIONS; ENGLAND; CANCER	Background The UK has had universal free health care and public health programmes for more than six decades. Several policy initiatives and structural reforms of the health system have been undertaken. Health expenditure has increased substantially since 1990, albeit from relatively low levels compared with other countries. We used data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) to examine the patterns of health loss in the UK, the leading preventable risks that explain some of these patterns, and how UK outcomes compare with a set of comparable countries in the European Union and elsewhere in 1990 and 2010. Methods We used results of GBD 2010 for 1990 and 2010 for the UK and 18 other comparator nations (the original 15 members of the European Union, Australia, Canada, Norway, and the USA; henceforth EU15+). We present analyses of trends and relative performance for mortality, causes of death, years of life lost (YLLs), years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE). We present results for 259 diseases and injuries and for 67 risk factors or clusters of risk factors relevant to the UK. We assessed the UK's rank for age-standardised YLLs and DALYs for their leading causes compared with EU15+ in 1990 and 2010. We estimated 95% uncertainty intervals (UIs) for all measures. Findings For both mortality and disability, overall health has improved substantially in absolute terms in the UK from 1990 to 2010. Life expectancy in the UK increased by 4.2 years (95% UI 4.2-4.3) from 1990 to 2010. However, the UK performed significantly worse than the EU15+ for age-standardised death rates, age-standardised YLL rates, and life expectancy in 1990, and its relative position had worsened by 2010. Although in most age groups, there have been reductions in age-specific mortality, for men aged 30-34 years, mortality rates have hardly changed (reduction of 3.7%, 95% UI 2.7-4.9). In terms of premature mortality, worsening ranks are most notable for men and women aged 20-54 years. For all age groups, the contributions of Alzheimer's disease (increase of 137%, 16-277), cirrhosis (65%, -15 to 107), and drug use disorders (577%, 71-942) to premature mortality rose from 1990 to 2010. In 2010, compared with EU15+, the UK had significantly lower rates of age-standardised YLLs for road injury, diabetes, liver cancer, and chronic kidney disease, but significantly greater rates for ischaemic heart disease, chronic obstructive pulmonary disease, lower respiratory infections, breast cancer, other cardiovascular and circulatory disorders, oesophageal cancer, preterm birth complications, congenital anomalies, and aortic aneurysm. Because YLDs per person by age and sex have not changed substantially from 1990 to 2010 but age-specific mortality has been falling, the importance of chronic disability is rising. The major causes of YLDs in 2010 were mental and behavioural disorders (including substance abuse; 21.5% [95 UI 17.2-26.3] of YLDs), and musculoskeletal disorders (30.5% [25.5-35.7]). The leading risk factor in the UK was tobacco (11.8% [10.5-13.3] of DALYs), followed by increased blood pressure (9.0 % [7.5-10.5]), and high body-mass index (8.6% [7.4-9.8]). Diet and physical inactivity accounted for 14.3% (95% UI 12.8-15.9) of UK DALYs in 2010. Interpretation The performance of the UK in terms of premature mortality is persistently and significantly below the mean of EU15+ and requires additional concerted action. Further progress in premature mortality from several major causes, such as cardiovascular diseases and cancers, will probably require improved public health, prevention, early intervention, and treatment activities. The growing burden of disability, particularly from mental disorders, substance use, musculoskeletal disorders, and falls deserves an integrated and strategic response.	[Murray, Christopher J. L.; Atkinson, Charles; Flaxman, Abraham D.; Fleming, Tom D.; Freedman, Greg; Ohno, Summer Lockett; Lozano, Rafael; Naghavi, Mohsen; Vos, Theo; Wang, Haidong] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Richards, Michael A.] Natl Canc Programme, Natl Canc Action Team, London, England; [Fenton, Kevin A.] Publ Hlth England, London, England; [Anderson, H. Ross] Univ London, London, England; [Bennett, Derrick] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Bennett, Derrick] Univ Oxford, Epidemiol Studies Unit, Oxford, England; [Bernab, Eduardo] Kings Coll London, Inst Dent, London WC2R 2LS, England; [Bernab, Eduardo] Kings Coll London, Kings Coll Hosp NHS Trust, London WC2R 2LS, England; [Blencowe, Hannah; Edmond, Karen] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Bourne, Rupert] Anglia Ruskin Univ, Vis & Eye Res Unit, Cambridge, England; [Burney, Peter] Moorfields Eye Hosp, London, England; [Brayne, Carol] Univ Cambridge, Cambridge, England; [Brugha, Traolach S.] Univ Leicester, Leicester, Leics, England; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, London, England; [Dolk, Helen] Univ Ulster, Jordanstown, North Ireland; [Lyons, Ronan A.] Swansea Univ, Swansea, W Glam, Wales; [Marcenes, Wagner] Queen Mary Univ London, London, England; [Salomon, Joshua A.] Harvard Univ, Sch Med, Boston, MA USA; [Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan; [Williams, Hywel C.] Univ Nottingham, Nottingham NG7 2RD, England; [Woolf, Anthony D.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Public Health England; University of London; University of Oxford; University of Oxford; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine; Anglia Ruskin University; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Cambridge; University of Leicester; Imperial College London; Ulster University; Swansea University; University of London; Queen Mary University London; Harvard University; Harvard Medical School; University of Tokyo; University of Nottingham; University of Queensland	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	cjlm@uw.edu	Salomon, Joshua/S-1929-2019; Salomon, Joshua A/D-3898-2009; Bennett, Derrick/AFL-9254-2022; Braithwaite, Tasanee/AAZ-1118-2020; Naughton, Felix/B-4177-2011; Bernabe, Eduardo/R-3441-2017; Lopez, Alan D/F-1487-2010; Pope, Daniel P/C-3054-2014; , Bennett/O-7998-2019; Davis, Adrian C/E-6022-2015; Newton, John/HCH-8693-2022; Gunnell, David/ABE-6653-2020; Bennett, Derrick/AAH-1220-2022; Lopez, Alan/AAA-2734-2022; Newton, Charles/V-7872-2019; Brugha, Traolach/T-9326-2019; Lozano, Rafael/T-5352-2018; Newton, Charles RJC/B-7578-2014; Brayne, Carol/AAA-4285-2020; Anderson, Hugh R/A-7417-2016	Salomon, Joshua/0000-0003-3929-5515; Salomon, Joshua A/0000-0003-3929-5515; Bennett, Derrick/0000-0002-9170-8447; Braithwaite, Tasanee/0000-0002-3025-4066; Naughton, Felix/0000-0001-9790-2796; Bernabe, Eduardo/0000-0002-1858-3713; Lopez, Alan D/0000-0001-5818-6512; Davis, Adrian C/0000-0001-7134-7528; Gunnell, David/0000-0002-0829-6470; Bennett, Derrick/0000-0002-9170-8447; Newton, Charles/0000-0002-6999-5507; Brugha, Traolach/0000-0002-9786-9591; Lozano, Rafael/0000-0002-7356-8823; Newton, Charles RJC/0000-0002-6999-5507; Brayne, Carol/0000-0001-5307-663X; Burney, Peter/0000-0001-8635-5678; Pope, Daniel/0000-0003-2694-5478; Hutchings, Sally/0000-0003-0720-9707; williams, hywel/0000-0002-5646-3093; Pearce, Neil/0000-0002-9938-7852; Lyons, Ronan/0000-0001-5225-000X; Blencowe, Hannah/0000-0003-1556-3159; Shibuya, Kenji/0000-0003-2528-7530; Woolf, Anthony/0000-0001-8482-8056; Dherani, Mukesh/0000-0002-3055-9636; Newton, John/0000-0002-5641-6457	Bill & Melinda Gates Foundation; European Chemical Industry Council; Conservation of Clean Air and Water Europe; ESRC [ES/G007543/1] Funding Source: UKRI; MRC [MR/K006525/1, G0901214] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; Medical Research Council [G0901214, MR/K006525/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); European Chemical Industry Council; Conservation of Clean Air and Water Europe; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Bill & Melinda Gates Foundation.; MAR is the Director for Reducing Premature Mortality (Domain 1; NHS Commissioning Board). JNN is Chief Knowledge Officer for Public Health England. KAF is Director of Health and Wellbeing for Public Health England. LR has received honoraria for board membership of the European Centre for Ecotoxicology of Chemicals, and research grants to Imperial College London from the European Chemical Industry Council and Conservation of Clean Air and Water Europe. The other authors declare that they have no conflicts of interest.	Ahern RM, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-8; Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; Barr B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5142; British Thoracic Society, 2006, THE BURDEN OF LUNG D; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Davies SC, 2012, ANNUAL REPORT OF THE; Davy Melissa, 2006, Health Stat Q, P35; Dean NC, 2001, AM J MED, V110, P451, DOI 10.1016/S0002-9343(00)00744-0; Doll R, 2005, BRIT J CANCER, V92, P426, DOI 10.1038/sj.bjc.6602359; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Falaschetti E, 2009, HYPERTENSION, V53, P480, DOI 10.1161/HYPERTENSIONAHA.108.125617; GBD 2010 Country Collaboration, 2013, LANCET; Goldacre MJ, 2004, DIABETIC MED, V21, P936, DOI 10.1111/j.1464-5491.2004.01226.x; Goldacre MJ, 2004, J PUBLIC HEALTH, V26, P8, DOI 10.1093/pubmed/fdh099; Griffiths Clare, 2004, Health Stat Q, P14; Hansell AL, 2003, EUR RESPIR J, V22, P809, DOI 10.1183/09031936.03.00031403; Healey F, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d329; Health and Safety Executive, SELF REPORTED WORK R; Iacobucci G, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7874; Jakobsen MU, 2009, AM J CLIN NUTR, V89, P1425, DOI 10.3945/ajcn.2008.27124; Kannus P, 2005, LANCET, V366, P1885, DOI 10.1016/S0140-6736(05)67604-0; Keenan T, 2007, BRIT J OPHTHALMOL, V91, P901, DOI 10.1136/bjo.2006.108977; King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316; Knapp M, 2013, INT J GERIATR PSYCH, V28, P551, DOI 10.1002/gps.3864; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Logan S, 2012, LANCET, V379, P707, DOI 10.1016/S0140-6736(12)60270-0; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lyons RA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001140; Marmot MG., 2006, SOCIAL DETERMINANTS; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Mohan S, 2009, HYPERTENSION, V53, P450, DOI 10.1161/HYPERTENSIONAHA.108.127076; Mozaffarian D, 2009, EUR J CLIN NUTR, V63, pS22, DOI 10.1038/sj.ejcn.1602976; Mozaffarian D, 2012, CIRCULATION, V126, P1514, DOI 10.1161/CIR.0b013e318260a20b; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000262; Murray CJL, 1996, THE GLOBAL BURDEN OF; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; National Clinical Guideline Centre (UK), 2011, HYPERTENSION THE CLI; NHS Choices, 2011, NHS HEALTH CHECK; NHS Right Care, 2012, NHS ATLAS OF VARIATI; Nolte E, 2004, NUFFIELD TRUST FOR R; Obermeyer Z, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000260; Office for National Statistics, 2013, SUICIDES IN THE UNIT; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Peto R, 2006, MORTALITY FROM SMOKI; Pollock AM, 2012, LANCET, V379, P387, DOI 10.1016/S0140-6736(12)60119-6; Pollock AM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1695; Public Health Wales Observatory, 2012, MEASURING INEQUALITI; Quinn MJ, 2008, BRIT J CANCER, V99, pS53, DOI 10.1038/sj.bjc.6604587; Rajaratnam JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000253; Rawlins M, 1999, LANCET, V353, P1079, DOI 10.1016/S0140-6736(99)02381-8; Royal College of Physicians, 2013, ACTION ON OBESITY CO; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Scarborough P, 2012, J EPIDEMIOL COMMUN H, V66, P420, DOI 10.1136/jech.2010.114520; Smith P, 1999, LANCET, V353, P1185, DOI 10.1016/S0140-6736(05)74404-4; Taylor RS, 2006, EUR J CARDIOV PREV R, V13, P369, DOI 10.1097/00149831-200606000-00012; The Health and Social Care Information Centre Diabetes UK Diabetes Health Intelligence, 2012, NATIONAL DIABETES AU; The Scottish Government, 2010, THE SCOTTISH HEALTH, V1; Thomason MJ, 2005, DIABETIC MED, V22, P1031, DOI 10.1111/j.1464-5491.2005.01584.x; Thun M, 2012, TOB CONTROL, V21, P96, DOI 10.1136/tobaccocontrol-2011-050294; UK Department of Health, GUIDE TO NEW HEALTH; UK Department of Health, 2011, HEALTHY LIVES HEALTH; UK Department of Health, 2011, THE PUBLIC HEALTH RE; UK Department of Health, 2012, HEALTHY LIVES HEALTH; UK Department of Health, 2012, THE NEW PUBLIC HEALT; UK Department of Health, 2012, PUBLIC HEALTH COMMIS; UK Department of Health, 2012, MAND GOV NHS COMM BO; UK Department of Health, TRANSPARENCY STATIST; UK Office for National Statistics, 2012, DEATH CERTIFI CATION; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; WHO, 2011, NATIONAL HEALTH ACCO; Wyness LA, 2012, PUBLIC HEALTH NUTR, V15, P254, DOI 10.1017/S1368980011000966; Yorkshire and Humber Public Health Observatory, 2012, DIABETIC COMPLICATIO	80	378	385	4	37	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 23	2013	381	9871					997	1020		10.1016/S0140-6736(13)60355-4	http://dx.doi.org/10.1016/S0140-6736(13)60355-4			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117EU	23668584				2022-12-28	WOS:000316936800030
J	Joensuu, H; Hohenberger, P; Corless, CL				Joensuu, Heikki; Hohenberger, Peter; Corless, Christopher L.			Gastrointestinal stromal tumour	LANCET			English	Article							RECEPTOR TYROSINE KINASE; POSITRON-EMISSION-TOMOGRAPHY; OF-FUNCTION MUTATIONS; PHASE-II TRIAL; TERM-FOLLOW-UP; IMATINIB MESYLATE; C-KIT; GERMLINE MUTATION; SUCCINATE-DEHYDROGENASE; ADJUVANT IMATINIB	Gastrointestinal stromal tumours (GISTs) are mesenchymal neoplasms that arise in the gastrointestinal tract, usually in the stomach or the small intestine and rarely elsewhere in the abdomen. They can occur at any age, the median age being 60-65 years, and typically cause bleeding, anaemia, and pain. GISTs have variable malignant potential, ranging from small lesions with a benign behaviour to fatal sarcomas. Most tumours stain positively for the mast/stem cell growth factor receptor KIT and anoctamin 1 and harbour a kinase-activating mutation in either KIT or PDGFRA. Tumours without such mutations could have alterations in genes of the succinate dehydrogenase complex or in BRAF, or rarely RAS family genes. About 60% of patients are cured by surgery. Adjuvant treatment with imatinib is recommended for patients with a substantial risk of recurrence, if the tumour has an imatinib-sensitive mutation. Tyrosine kinase inhibitors substantially improve survival in advanced disease, but secondary drug resistance is common.	[Joensuu, Heikki] Univ Helsinki, Cent Hosp, Dept Oncol, FIN-00029 Helsinki, Finland; [Hohenberger, Peter] Heidelberg Univ, Mannheim Univ Med Ctr, Div Surg Oncol & Thorac Surg, Heidelberg, Germany; [Corless, Christopher L.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Corless, Christopher L.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA	University of Helsinki; Helsinki University Central Hospital; Ruprecht Karls University Heidelberg; Oregon Health & Science University; Oregon Health & Science University	Joensuu, H (corresponding author), Univ Helsinki, Cent Hosp, Dept Oncol, FIN-00029 Helsinki, Finland.	heikki.joensuu@hus.fi		Joensuu, Heikki/0000-0003-0281-2507	Novartis; Bayer AG; Pfizer; Bayer; Cancer Foundation Finland sr [130093, 120084, 110071] Funding Source: researchfish	Novartis(Novartis); Bayer AG(Bayer AG); Pfizer(Pfizer); Bayer(Bayer AG); Cancer Foundation Finland sr	The Clinical Research Institute of Helsinki University Central Hospital has received research support from Novartis and Bayer AG because HJ participated in advisory group meetings or speaking events. PH and CLC have received research support, consulting fees, and honoraria from Novartis, and CLC has received consulting fees from Pfizer and Bayer.	Abraham SC, 2007, AM J SURG PATHOL, V31, P1629, DOI 10.1097/PAS.0b013e31806ab2c3; Agaimy A, 2008, AM J SURG PATHOL, V32A, P867, DOI 10.1097/PAS.0b013e31815c0417; Agaimy A, 2007, AM J SURG PATHOL, V31, P113, DOI 10.1097/01.pas.0000213307.05811.f0; Agaimy A, 2009, LANGENBECK ARCH SURG, V394, P375, DOI 10.1007/s00423-008-0449-5; Agaram NP, 2008, GENE CHROMOSOME CANC, V47, P853, DOI 10.1002/gcc.20589; Aggarwal G, 2012, ANN DIAGN PATHOL, V16, P532, DOI 10.1016/j.anndiagpath.2012.07.005; Andersson J, 2006, GASTROENTEROLOGY, V130, P1573, DOI 10.1053/j.gastro.2006.01.043; Antonescu CR, 2005, CLIN CANCER RES, V11, P4182, DOI 10.1158/1078-0432.CCR-04-2245; Beghini A, 2001, CANCER, V92, P657, DOI 10.1002/1097-0142(20010801)92:3<657::AID-CNCR1367>3.0.CO;2-D; Blanke CD, 2008, J CLIN ONCOL, V26, P620, DOI 10.1200/JCO.2007.13.4403; Blanke CD, 2008, J CLIN ONCOL, V26, P626, DOI 10.1200/JCO.2007.13.4452; BLUMEJENSEN P, 1991, EMBO J, V10, P4121, DOI 10.1002/j.1460-2075.1991.tb04989.x; Bumming P, 2006, BRIT J SURG, V93, P836, DOI 10.1002/bjs.5350; Carney JA, 2002, AM J MED GENET, V108, P132, DOI 10.1002/ajmg.10235; CARNEY JA, 1977, NEW ENGL J MED, V296, P1517, DOI 10.1056/NEJM197706302962609; Cassier PA, 2012, CLIN CANCER RES, V18, P4458, DOI 10.1158/1078-0432.CCR-11-3025; Caterino S, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-13; Celestino R, 2013, EUR J HUM GENET, V21, P503, DOI 10.1038/ejhg.2012.205; Chan KH, 2006, WORLD J GASTROENTERO, V12, P2223, DOI 10.3748/wjg.v12.i14.2223; Chang PM, 2003, MOL CELL BIOL, V23, P3067, DOI 10.1128/MCB.23.9.3067-3078.2003; Chen LL, 2004, CANCER RES, V64, P5913, DOI 10.1158/0008-5472.CAN-04-0085; Cho MY, 2010, J KOREAN MED SCI, V25, P853, DOI 10.3346/jkms.2010.25.6.853; Choi H, 2007, J CLIN ONCOL, V25, P1753, DOI 10.1200/JCO.2006.07.3049; Chompret A, 2004, GASTROENTEROLOGY, V126, P318, DOI 10.1053/j.gastro.2003.10.079; Corless C, 2010, J CLIN ONCOL S, V28, P699; Corless CL, 2011, NAT REV CANCER, V11, P865, DOI 10.1038/nrc3143; Corless CL, 2002, AM J PATHOL, V160, P1567, DOI 10.1016/S0002-9440(10)61103-0; Corless CL, 2005, J CLIN ONCOL, V23, P5357, DOI 10.1200/JCO.2005.14.068; Davies HE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d947; Debiec-Rychter M, 2006, EUR J CANCER, V42, P1093, DOI 10.1016/j.ejca.2006.01.030; DeMatteo RP, 2008, CANCER-AM CANCER SOC, V112, P608, DOI 10.1002/cncr.23199; DeMatteo RP, 2007, ANN SURG, V245, P347, DOI 10.1097/01.sla.0000236630.93587.59; DeMatteo RP, 2009, LANCET, V373, P1097, DOI 10.1016/S0140-6736(09)60500-6; DeMatteo RP, 2000, ANN SURG, V231, P51, DOI 10.1097/00000658-200001000-00008; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Demetri GD, 2009, J CLIN ONCOL, V27, P3141, DOI 10.1200/JCO.2008.20.4818; Doyle LA, 2012, HISTOPATHOLOGY, V61, P801, DOI 10.1111/j.1365-2559.2012.04300.x; Ducimetiere F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020294; Dwight T, 2013, AM J SURG PATHOL, V37, P226, DOI 10.1097/PAS.0b013e3182671155; Eechoute K, 2012, CLIN CANCER RES, V18, P5780, DOI 10.1158/1078-0432.CCR-12-0490; Eisenberg BL, 2011, INT J CANCER, V129, P2533, DOI 10.1002/ijc.26234; El-Rifai W, 2000, CANCER RES, V60, P3899; Emile JF, 2012, MED ONCOL, V29, P1765, DOI 10.1007/s12032-011-0074-y; Falchook GS, 2012, LANCET, V379, P1893, DOI 10.1016/S0140-6736(12)60398-5; Fletcher CDM, 2002, HUM PATHOL, V33, P459, DOI 10.1053/hupa.2002.123545; Frilling A, 2010, TRANSPL P, V42, P3843, DOI 10.1016/j.transproceed.2010.06.016; Gold JS, 2009, LANCET ONCOL, V10, P1045, DOI 10.1016/S1470-2045(09)70242-6; Hasegawa J, 2007, INT J CLIN ONCOL, V12, P212, DOI 10.1007/s10147-007-0657-y; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; Heinrich MC, 2012, CLIN CANCER RES, V18, P4375, DOI 10.1158/1078-0432.CCR-12-0625; Heinrich MC, 2008, J CLIN ONCOL, V26, P5360, DOI 10.1200/JCO.2008.17.4284; Heinrich MC, 2008, J CLIN ONCOL, V26, P5352, DOI 10.1200/JCO.2007.15.7461; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hirota S, 2000, AM J SURG PATHOL, V24, P326, DOI 10.1097/00000478-200002000-00045; Hirota S, 2003, GASTROENTEROLOGY, V125, P660, DOI 10.1016/S0016-5085(03)01046-1; Hislop Jennifer, 2012, J Gastrointest Cancer, V43, P168, DOI 10.1007/s12029-011-9325-6; Hohenberger P, 2010, BRIT J SURG, V97, P1854, DOI 10.1002/bjs.7222; Hohenberger P, 2009, J CLIN ONCOL, V27, P548; Hohenberger P, 2010, ANN SURG ONCOL, V17, P2585, DOI 10.1245/s10434-010-1053-9; Isozaki K, 2000, AM J PATHOL, V157, P1581, DOI 10.1016/S0002-9440(10)64795-5; Italiano A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-408; Janeway KA, 2011, P NATL ACAD SCI USA, V108, P314, DOI 10.1073/pnas.1009199108; Janeway KA, 2009, PEDIATR BLOOD CANCER, V52, P767, DOI 10.1002/pbc.21909; Jiang J, 2012, WORLD J GASTROENTERO, V18, P2569, DOI 10.3748/wjg.v18.i20.2569; Joensuu H, 2002, LANCET ONCOL, V3, P655, DOI 10.1016/S1470-2045(02)00899-9; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Joensuu H, 2008, HUM PATHOL, V39, P1411, DOI 10.1016/j.humpath.2008.06.025; Joensuu H, 2012, JAMA-J AM MED ASSOC, V307, P1265, DOI 10.1001/jama.2012.347; Joensuu H, 2012, LANCET ONCOL, V13, P265, DOI 10.1016/S1470-2045(11)70299-6; Joensuu H, 2011, CANCER TREAT REV, V37, P75, DOI 10.1016/j.ctrv.2010.04.008; Jones RL, 2010, EJSO-EUR J SURG ONC, V36, P477, DOI 10.1016/j.ejso.2009.12.005; Judson I, 2012, CLIN CANCER RES, V18, P5517, DOI 10.1158/1078-0432.CCR-12-2570; Kawanowa K, 2006, HUM PATHOL, V37, P1527, DOI 10.1016/j.humpath.2006.07.002; Kim KH, 2012, ANTICANCER RES, V32, P923; Kindblom LG, 1998, AM J PATHOL, V152, P1259; Kinoshita K, 2004, J PATHOL, V202, P80, DOI 10.1002/path.1487; Knowlton CA, 2011, RARE TUMORS, V3, P111, DOI 10.4081/rt.2011.e35; Kobayashi K, 2009, AM J CLIN ONCOL-CANC, V32, P574, DOI 10.1097/COC.0b013e31819cca35; Lagarde P, 2012, CLIN CANCER RES, V18, P826, DOI 10.1158/1078-0432.CCR-11-1610; Le Cesne A, 2010, LANCET ONCOL, V11, P942, DOI 10.1016/S1470-2045(10)70222-9; Li FP, 2005, J CLIN ONCOL, V23, P2735, DOI 10.1200/JCO.2005.06.009; Liang YM, 2012, WORLD J GASTROENTERO, V18, P1664, DOI 10.3748/wjg.v18.i14.1664; Liegl B, 2008, J PATHOL, V216, P64, DOI 10.1002/path.2382; Lux ML, 2000, AM J PATHOL, V156, P791, DOI 10.1016/S0002-9440(10)64946-2; Maeyama H, 2001, GASTROENTEROLOGY, V120, P210; Matyakhina L, 2007, J CLIN ENDOCR METAB, V92, P2938, DOI 10.1210/jc.2007-0797; MAZUR MT, 1983, AM J SURG PATHOL, V7, P507, DOI 10.1097/00000478-198309000-00001; Medeiros F, 2004, AM J SURG PATHOL, V28, P889, DOI 10.1097/00000478-200407000-00007; Miettinen M, 2006, AM J SURG PATHOL, V30, P477, DOI 10.1097/00000478-200604000-00008; Miettinen M, 2005, AM J SURG PATHOL, V29, P52, DOI 10.1097/01.pas.0000146010.92933.de; Miettinen M, 2006, SEMIN DIAGN PATHOL, V23, P70, DOI 10.1053/j.semdp.2006.09.001; Miettinen M, 2011, J SURG ONCOL, V104, P865, DOI 10.1002/jso.21945; Mikami T, 1997, HUM PATHOL, V28, P1355, DOI 10.1016/S0046-8177(97)90223-9; Min KW, 2010, ULTRASTRUCT PATHOL, V34, P174, DOI 10.3109/01913121003689075; Miranda C, 2012, CLIN CANCER RES, V18, P1769, DOI 10.1158/1078-0432.CCR-11-2230; Mucciarini C, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-230; Mussi C, 2010, ANN ONCOL, V21, P403, DOI 10.1093/annonc/mdp310; National Comprehensive Cancer Network, 2014, CLIN PRACT GUID ONC; Nilsson B, 2005, CANCER-AM CANCER SOC, V103, P821, DOI 10.1002/cncr.20862; Nishida T, 1998, NAT GENET, V19, P323, DOI 10.1038/1209; Novelli M, 2010, HISTOPATHOLOGY, V57, P259, DOI 10.1111/j.1365-2559.2010.03624.x; Pasini B, 2007, J CLIN ENDOCR METAB, V92, P3728, DOI 10.1210/jc.2007-0894; Plaat BEC, 2000, J CLIN ONCOL, V18, P3211, DOI 10.1200/JCO.2000.18.18.3211; Raut CP, 2006, J CLIN ONCOL, V24, P2325, DOI 10.1200/JCO.2005.05.3439; Rege TA, 2011, AM J SURG PATHOL, V35, P495, DOI 10.1097/PAS.0b013e31820e5f7d; Reichardt P, 2011, EUR J CANCER, V47, P15, DOI 10.1016/S0959-8049(11)70130-7; Rossi S, 2011, AM J SURG PATHOL, V35, P1646, DOI 10.1097/PAS.0b013e31822d63a7; Rossi S, 2010, AM J SURG PATHOL, V34, P1480, DOI 10.1097/PAS.0b013e3181ef7431; Rubin BP, 2007, LANCET, V369, P1731, DOI 10.1016/S0140-6736(07)60780-6; Rutkowski P, 2011, EJSO-EUR J SURG ONC, V37, P890, DOI 10.1016/j.ejso.2011.06.005; Sarlomo-Rikala M, 1998, MODERN PATHOL, V11, P728; Schneider-Stock R, 2003, J CLIN ONCOL, V21, P1688, DOI 10.1200/JCO.2003.08.101; Sepe PS, 2009, GASTROINTEST ENDOSC, V70, P254, DOI 10.1016/j.gie.2008.11.038; Takazawa Y, 2005, AM J SURG PATHOL, V29, P755, DOI 10.1097/01.pas.0000163359.32734.f9; Tap WD, 2012, J CLIN ONCOL, V30, P1849, DOI 10.1200/JCO.2011.37.2359; Tran T, 2005, AM J GASTROENTEROL, V100, P162, DOI [10.1111/j.1572-0241.2005.40709.x, 10.1111/j.1572-0241.2005.41007.x]; Treglia G, 2012, CLIN IMAG, V36, P167, DOI 10.1016/j.clinimag.2011.08.012; Van Glabbeke M, 2010, J CLIN ONCOL, V28, P1247, DOI 10.1200/JCO.2009.24.2099; van Oosterom AT, 2001, LANCET, V358, P1421, DOI 10.1016/S0140-6736(01)06535-7; Vanel D, 2005, EUR J RADIOL, V54, P118, DOI 10.1016/j.ejrad.2005.01.012; Verweij J, 2003, EUR J CANCER, V39, P2006, DOI 10.1016/S0959-8049(02)00836-5; Verweij J, 2004, LANCET, V364, P1127, DOI 10.1016/S0140-6736(04)17098-0; Von Mehren M, 2011, J CLIN ONCOL S, V29, P609; Wagner AJ, 2013, MODERN PATHOL, V26, P289, DOI 10.1038/modpathol.2012.153; Wang D, 2012, ANN SURG ONCOL, V19, P1074, DOI 10.1245/s10434-011-2190-5; Wardelmann E, 2003, INT J CANCER, V106, P887, DOI 10.1002/ijc.11323; Wardelmann E, 2005, LANCET ONCOL, V6, P249, DOI 10.1016/S1470-2045(05)70097-8; Weisberg E, 2006, GASTROENTEROLOGY, V131, P1734, DOI 10.1053/j.gastro.2006.09.017; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8; Woodall CE, 2009, ARCH SURG-CHICAGO, V144, P670, DOI 10.1001/archsurg.2009.108; Yantiss RK, 2005, MODERN PATHOL, V18, P475, DOI 10.1038/modpathol.3800334; Ylipaa A, 2011, CANCER-AM CANCER SOC, V117, P380, DOI 10.1002/cncr.25594; Yoo C, 2010, J CLIN ONCOL, V28, P1554, DOI 10.1200/JCO.2009.26.5785; Yuzawa S, 2007, CELL, V130, P323, DOI 10.1016/j.cell.2007.05.055; Zhang LZ, 2010, AM J SURG PATHOL, V34, P53, DOI 10.1097/PAS.0b013e3181c20f4f; Zoller MET, 1997, CANCER-AM CANCER SOC, V79, P2125	139	380	420	6	90	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 14	2013	382	9896					973	983		10.1016/S0140-6736(13)60106-3	http://dx.doi.org/10.1016/S0140-6736(13)60106-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215VD	23623056				2022-12-28	WOS:000324238000030
J	Fernald, LCH				Fernald, Lia C. H.			Promise, and risks, of conditional cash transfer programmes	LANCET			English	Editorial Material							OBESITY; DETERMINANTS		Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Fernald, LCH (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	fernald@berkeley.edu		Fernald, Lia C.H./0000-0003-1555-4607				Alleyne G, 2013, LANCET, V381, P566, DOI 10.1016/S0140-6736(12)61806-6; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Engle PL, 2011, LANCET, V378, P1339, DOI 10.1016/S0140-6736(11)60889-1; Fernald LC., 2012, OXFORD HDB POVERTY C, P569; Fernald LCH, 2008, J NUTR, V138, P2250, DOI 10.3945/jn.108.090506; Forde I, 2011, AM J PUBLIC HEALTH, V101, P1365, DOI 10.2105/AJPH.2011.300140; Gupta N, 2012, ENDOCR REV, V33, P48, DOI 10.1210/er.2010-0028; Lignani JD, 2011, PUBLIC HEALTH NUTR, V14, P785, DOI 10.1017/S136898001000279X; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Rasella D, 2013, LANCET; Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4; WHO, 2011, NCD COUNTR PROF	13	18	18	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 6	2013	382	9886					7	9		10.1016/S0140-6736(13)61035-1	http://dx.doi.org/10.1016/S0140-6736(13)61035-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	177AD	23683598				2022-12-28	WOS:000321347000007
J	Nishtar, S; Bhutta, ZA; Jafar, TH; Ghaffar, A; Akhtar, T; Bengali, K; Isa, QA; Rahim, E				Nishtar, Sania; Bhutta, Zulfiqar A.; Jafar, Tazeen H.; Ghaffar, Abdul; Akhtar, Tasleem; Bengali, Kaiser; Isa, Qazi Asmat; Rahim, Ejaz			Health reform in Pakistan: a call to action	LANCET			English	Article							CARE	Pakistan's enormous macroeconomic, internal, and human security challenges coexist alongside the opportunity created by a huge desire for change. With democracy taking root and a new constitutionally ushered era in state governance, The Lancet Series about Pakistan and health focuses on health as a nation-building and social-welfare agenda at a time of unprecedented social upheaval and economic hardships in the country. We call for a unified vision for the goal of universal and equitable health access. We provide recommendations for six objectives for policy and action. Higher political priority for health, increased investments, a combination of targeted and universal approaches, action in terms of the social determinants, institutionalisation of the right organisational network, and frameworks for accountability are crucial for the attainment of the health goals in Pakistan.	[Nishtar, Sania] Heartfile, Islamabad 44000, Pakistan; [Nishtar, Sania] Govt Pakistan, Islamabad, Pakistan; [Bhutta, Zulfiqar A.; Jafar, Tazeen H.] Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan; [Ghaffar, Abdul] Alliance Hlth Policy & Syst Res, Geneva, Switzerland; [Isa, Qazi Asmat] Pakistan Poverty Alleviat Fund, Islamabad, Pakistan	Aga Khan University	Nishtar, S (corresponding author), Heartfile, 1 Pk Rd, Islamabad 44000, Pakistan.	sania@heartfile.org; zulfiqar.bhutta@aku.edu			Heartfile; Aga Khan University	Heartfile; Aga Khan University	SN and ZAB thank Heartfile and Aga Khan University, respectively, for their support.	Akhter S, TAX REFORM PROGRAMME; Allen S, 2013, LANCET; Armytage L, 2003, 13 COMM LAW C MELB V; Asian Development Bank, VAL REP; Atun R, 2013, LANCET, V381, P690, DOI 10.1016/S0140-6736(13)60063-X; Badruddin SH, 2008, ASIA PAC J CLIN NUTR, V17, P357; Bhutta ZA, 2013, LANCET; Bhutta ZA, 2013, E MEDITERR HEALTH J, V19, P104, DOI 10.26719/2013.19.2.104; Bhutta ZA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f280; Collins CD, 2002, INT J HEALTH PLAN M, V17, P123, DOI 10.1002/hpm.657; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Government of Pakistan, 2008, YB 2006 07; Government of Pakistan, 2008, REP NAT COMM GOV REF; Government of Pakistan, BEN INC SUPP PROGR; Jafar TH, 2013, LANCET; Kassim-Lakha S, 2013, LANCET; Khan SH., MAL YOUS SHOT; Loevinsohn B, 2005, LANCET, V366, P676, DOI 10.1016/S0140-6736(05)67140-1; Nishtar S, 2010, CHOKED PIPER REFORMI; Nishtar S, 2013, LANCET; Nishtar S, 2004, NATL ACTION PLAN PRE; Qureshi H, 2013, LANCET; Roberts M., 2008, GETTING HLTH REFORM, DOI DOI 10.1093/ACPROF:OSO/9780195371505.001.0001; Sathar ZA, 2013, LANCET; Sofia S, 2002, ANAL EXPERIENCE GOVT; Sultan F, 2013, LANCET; UNESCO, 2012, EFA GLOB MON REP; World Bank, 1999, FAM HLTH PROJ 02; World bank, IMPR FIN REP AUD PRO; World Bank WHO DFID USAID-TAUH, 2012, DEV HEATH SECT FOLL; World Economic Forum, 2014, GLOB GEND GAP REP 20	31	38	38	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 29	2013	381	9885					2291	2297		10.1016/S0140-6736(13)60813-2	http://dx.doi.org/10.1016/S0140-6736(13)60813-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	173SU	23684259				2022-12-28	WOS:000321100300034
J	Birnie, DH; Healey, JS; Wells, GA; Verma, A; Tang, AS; Krahn, AD; Simpson, CS; Ayala-Paredes, F; Coutu, B; Leiria, TLL; Essebag, V				Birnie, David H.; Healey, Jeff S.; Wells, George A.; Verma, Atul; Tang, Anthony S.; Krahn, Andrew D.; Simpson, Christopher S.; Ayala-Paredes, Felix; Coutu, Benoit; Leiria, Tiago L. L.; Essebag, Vidal		BRUISE CONTROL Investigators	Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MOLECULAR-WEIGHT HEPARIN; PERCUTANEOUS CORONARY INTERVENTION; ORAL ANTICOAGULATION; BRIDGING THERAPY; HIGH-RISK; IMPLANTATION; WARFARIN; METAANALYSIS; EFFICACY; STROKE	BACKGROUND Many patients requiring pacemaker or implantable cardioverter-defibrillator (ICD) surgery are taking warfarin. For patients at high risk for thromboembolic events, guidelines recommend bridging therapy with heparin; however, case series suggest that it may be safe to perform surgery without interrupting warfarin treatment. There have been few results from clinical trials to support the safety and efficacy of this approach. METHODS We randomly assigned patients with an annual risk of thromboembolic events of 5% or more to continued warfarin treatment or to bridging therapy with heparin. The primary outcome was clinically significant device-pocket hematoma, which was defined as device-pocket hematoma that necessitated prolonged hospitalization, interruption of anticoagulation therapy, or further surgery (e.g., hematoma evacuation). RESULTS The data and safety monitoring board recommended termination of the trial after the second prespecified interim analysis. Clinically significant device-pocket hematoma occurred in 12 of 343 patients (3.5%) in the continued-warfarin group, as compared with 54 of 338 (16.0%) in the heparin-bridging group (relative risk, 0.19; 95% confidence interval, 0.10 to 0.36; P<0.001). Major surgical and thromboembolic complications were rare and did not differ significantly between the study groups. They included one episode of cardiac tamponade and one myocardial infarction in the heparin-bridging group and one stroke and one transient ischemic attack in the continued-warfarin group. CONCLUSIONS As compared with bridging therapy with heparin, a strategy of continued warfarin treatment at the time of pacemaker or ICD surgery markedly reduced the incidence of clinically significant device-pocket hematoma.	[Birnie, David H.; Wells, George A.; Tang, Anthony S.] Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada; [Healey, Jeff S.] Populat Hlth Res Inst, Hamilton, ON, Canada; [Verma, Atul] Southlake Reg Hlth Ctr, Newmarket, ON, Canada; [Tang, Anthony S.] Univ British Columbia, Isl Med Program, Vancouver, BC V5Z 1M9, Canada; [Krahn, Andrew D.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Simpson, Christopher S.] Queens Univ, Kingston, ON, Canada; [Simpson, Christopher S.] Kingston Gen Hosp, Kingston, ON K7L 2V7, Canada; [Ayala-Paredes, Felix] Univ Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada; [Coutu, Benoit] Ctr Hosp Univ Montreal, Hop Hotel Dieu, Montreal, PQ, Canada; [Essebag, Vidal] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Essebag, Vidal] Hop Sacre Coeur, Montreal, PQ H4J 1C5, Canada; [Leiria, Tiago L. L.] Fundacao Univ Cardiol, Inst Cardiol, Porto Alegre, RS, Brazil	University of Ottawa; University of Ottawa Heart Institute; Population Health Research Institute; Southlake Regional Health Centre; University of British Columbia; University of British Columbia; Queens University - Canada; Queens University - Canada; University of Sherbrooke; Universite de Montreal; McGill University; Universite de Montreal; Fundacao Universitaria de Cardiologia	Birnie, DH (corresponding author), Univ Ottawa, Inst Heart, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.	dbirnie@ottawaheart.ca	Tang, Anthony S/E-6203-2014; Leong-Sit, Peter/G-3319-2011; L, Tiago Luiz Leiria/J-4364-2014; Gula, Lorne/G-3298-2011	Coyle, Doug/0000-0003-3492-2268; Ayala-Paredes, Felix/0000-0003-0670-6066; Essebag, Vidal/0000-0003-0107-5197; Morillo, Carlos/0000-0002-8739-2099; Luz Leiria, Tiago Luiz/0000-0002-3905-102X	Canadian Institutes of Health Research; Ministry of Health and Long-Term Care of Ontario; Canadian Institutes of Health Research (CIHR), a CIHR Clinician-Scientist Award; University of Ottawa Heart Institute Academic Medical Organization Alternate Funding Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ministry of Health and Long-Term Care of Ontario(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research (CIHR), a CIHR Clinician-Scientist Award(Canadian Institutes of Health Research (CIHR)); University of Ottawa Heart Institute Academic Medical Organization Alternate Funding Program	Funded by the Canadian Institutes of Health Research and the Ministry of Health and Long-Term Care of Ontario; BRUISE CONTROL ClinicalTrials.gov number, NCT00800137.; Supported by a grant from the Canadian Institutes of Health Research (CIHR), a CIHR Clinician-Scientist Award (to Dr. Essebag), and a grant from the University of Ottawa Heart Institute Academic Medical Organization Alternate Funding Program (funded by the Ministry of Health and Long-Term Care of Ontario).	Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Birnie D, 2009, CURR OPIN CARDIOL, V24, P82, DOI 10.1097/HCO.0b013e32831bef53; Cheng A, 2011, HEART RHYTHM, V8, P536, DOI 10.1016/j.hrthm.2010.12.016; Connolly SJ, 2010, NEW ENGL J MED, V363, P1877; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; de Oliveira JC, 2009, CIRC-ARRHYTHMIA ELEC, V2, P29, DOI 10.1161/CIRCEP.108.795906; Douketis JD, 2008, CHEST, V133, p299S, DOI 10.1378/chest.08-0675; Douketis JD, 2012, CHEST, V141, pE326S, DOI 10.1378/chest.11-2298; Edmunds I, 2010, J HAND SURG-ASIAN-PA, V15, P109, DOI 10.1142/S0218810410004680; Feng L, 2012, THROMB HAEMOSTASIS, V108, P1124, DOI 10.1160/TH12-07-0498; Friedland S, 2009, WORLD J GASTROENTERO, V15, P1973, DOI 10.3748/wjg.15.1973; Ghanbari H, 2012, AM J CARDIOL, V110, P1482, DOI 10.1016/j.amjcard.2012.06.057; Goupille P, 2008, JOINT BONE SPINE, V75, P311, DOI 10.1016/j.jbspin.2007.06.020; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Greenspon AJ, 2004, J AM COLL CARDIOL, V43, P1617, DOI 10.1016/j.jacc.2003.09.067; Jamula E, 2010, CHEST, V138, P840, DOI 10.1378/chest.09-2603; Khadim MF, 2011, J PLAST RECONSTR AES, V64, pE213, DOI 10.1016/j.bjps.2011.03.005; Kovacs MJ, 2004, CIRCULATION, V110, P1658, DOI 10.1161/01.CIR.0000142859.77578.C9; Larson BJG, 2005, CHEST, V127, P922, DOI 10.1378/chest.127.3.922; Marquie C, 2006, EUROPACE, V8, P283, DOI 10.1093/europace/eul011; Michaud GF, 2000, J AM COLL CARDIOL, V35, P1915, DOI 10.1016/S0735-1097(00)00633-1; Mond HG, 2011, PACE, V34, P1013, DOI 10.1111/j.1540-8159.2011.03150.x; Nielsen JC, 2011, EUR HEART J, V32, P686, DOI 10.1093/eurheartj/ehr022; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Raad D, 2012, EUR J CLIN MICROBIOL, V31, P3015, DOI 10.1007/s10096-012-1655-1; Reynolds MR, 2006, J AM COLL CARDIOL, V47, P2493, DOI 10.1016/j.jacc.2006.02.049; Robinson M, 2009, PACE, V32, P378, DOI 10.1111/j.1540-8159.2008.02247.x; Siegal D, 2012, CIRCULATION, V126, P1630, DOI 10.1161/CIRCULATIONAHA.112.105221; Spyropoulos AC, 2004, CHEST, V125, P1642, DOI 10.1378/chest.125.5.1642; Tang ASL, 2010, NEW ENGL J MED, V363, P2385, DOI 10.1056/NEJMoa1009540; Tischenko A, 2009, AM HEART J, V158, P252, DOI 10.1016/j.ahj.2009.06.005; Tolosana JM, 2009, EUR HEART J, V30, P1880, DOI 10.1093/eurheartj/ehp194; Woo HH, 2011, UROLOGY, V78, P142, DOI 10.1016/j.urology.2010.12.082; Wrigley BJ, 2010, CHEST, V138, P771, DOI 10.1378/chest.10-0789	34	359	369	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2013	368	22					2084	2093		10.1056/NEJMoa1302946	http://dx.doi.org/10.1056/NEJMoa1302946			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AT	23659733				2022-12-28	WOS:000319574200006
J	Cho, EA; Moloney, FJ; Cai, H; Au-Yeung, A; China, C; Scolyer, RA; Yosufi, B; Raftery, MJ; Deng, JZ; Morton, SW; Hammond, PT; Arkenau, HT; Damian, DL; Francis, DJ; Chesterman, CN; Barnetson, RS; Halliday, GM; Khachigian, LM				Cho, Eun-Ae; Moloney, Fergal J.; Cai, Hong; Au-Yeung, Annie; China, Carlos; Scolyer, Richard A.; Yosufi, Benafsha; Raftery, Mark J.; Deng, Jason Z.; Morton, Stephen W.; Hammond, Paula T.; Arkenau, Hendrik-Tobias; Damian, Diona L.; Francis, Douglas J.; Chesterman, Colin N.; Barnetson, Ross St C.; Halliday, Gary M.; Khachigian, Levon M.			Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: a phase 1 first-in-human trial (DISCOVER)	LANCET			English	Article							NONMELANOMA SKIN-CANCER; TARGETING C-JUN; DNA ENZYME; TUMOR-GROWTH; EXPRESSION; AP-1; TUMORIGENESIS; TRANSCRIPTION; ANGIOGENESIS; MICE	Background The nuclear transcription factor c-Jun is preferentially expressed in basal-cell carcinoma. Dz13 is a deoxyribozyme that targets JUN messenger RNA and has inhibited the growth of a range of tumours in mice. We did a phase 1 study to assess safety and tolerability in human beings. Methods Adults with nodular basal-cell carcinoma were recruited from Royal Prince Alfred Hospital, Sydney, Australia, between September, 2010, and October, 2011. Patients were assigned to receive one intratumoral injected dose of 10, 30, or 100 mu g Dz13, in a 50 mu L volume of lipid carrier, and were assessed for adverse effects in the first 24 h then at 7, 14, and 28 days after injection. Treated tumours were surgically excised 14 days after injection and compared with the baseline biopsy samples for expression of c-Jun and tumorigenesis markers. Findings Nine patients were recruited, of whom three received each dose of Dz13. All patients completed the study with no drug-related serious adverse events. No systemic Dz13 exposure was detected. c-Jun expression was reduced in the excised tumours of all nine (100%) patients, compared with baseline, and histological tumour depth had decreased in five (56%) of nine. Pro portions of cells positive for caspases 3, 8, and 9 and P53 were increased, but those of cells positive for Bcl-2 and MMP-9 were decreased. Infiltration by inflammatory and immune cells was stimulated. Interpretation Dz13 was safe and well tolerated after single intratumoral injections at all doses.	[Cho, Eun-Ae; Moloney, Fergal J.; Damian, Diona L.; Barnetson, Ross St C.; Halliday, Gary M.] Univ Sydney, Royal Prince Alfred Hosp, Bosch Inst, Sydney Med Sch, Sydney, NSW 2006, Australia; [Moloney, Fergal J.] Mater Misericordiae Univ Hosp, Dept Dermatol, Dublin, Ireland; [Cai, Hong; Au-Yeung, Annie; Chesterman, Colin N.; Khachigian, Levon M.] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [China, Carlos] Woolcock Inst Med Res, Sydney, NSW, Australia; [Scolyer, Richard A.] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Scolyer, Richard A.; Yosufi, Benafsha; Damian, Diona L.] Melanoma Inst Australia, Sydney, NSW, Australia; [Raftery, Mark J.] Univ New S Wales, Wainwright Analyt Ctr, Sydney, NSW, Australia; [Deng, Jason Z.; Morton, Stephen W.; Hammond, Paula T.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Arkenau, Hendrik-Tobias] Sarah Cannon Res UK, London, England; [Francis, Douglas J.] DF Preclinl Serv Pty Ltd, Canberra, ACT, Australia	University of Sydney; Mater Misericordiae University Hospital; University College Dublin; University of New South Wales Sydney; University of Sydney; Woolcock Institute of Medical Research; University of Sydney; Melanoma Institute Australia; University of New South Wales Sydney; Massachusetts Institute of Technology (MIT)	Khachigian, LM (corresponding author), Univ New S Wales, Ctr Vasc Res, Gate 9 C25,High St, Randwick, NSW 2052, Australia.	gary.halliday@sydney.edu.au; khachigian@unsw.edu.au	Scolyer, Richard/AAE-8511-2019; Khachigian, Levon/AAZ-7458-2020	Scolyer, Richard/0000-0002-8991-0013; Khachigian, Levon/0000-0003-3446-0323	Cancer Institute NSW; Cancer Council Australia; National Health and Medical Research Council; NATIONAL CANCER INSTITUTE [P30CA014051] Funding Source: NIH RePORTER	Cancer Institute NSW; Cancer Council Australia(Cancer Council Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Cancer Institute NSW, Cancer Council Australia, and National Health and Medical Research Council.	American Cancer Society, 2012, CANC FACTS FIG 2012; Australian Institute of Health and Welfare, 2010, AUSTR HLTH 2010; Australian Institute of Health and Welfare & Australasian Association of Cancer Registries, 2004, CANC AUSTR 2001; Bhindi R, 2007, AM J PATHOL, V171, P1079, DOI 10.2353/ajpath.2007.070120; BRESLOW A, 1970, ANN SURG, V172, P902, DOI 10.1097/00000658-197011000-00017; Cai H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003960; Chen NY, 2001, CANCER RES, V61, P3908; Dass CR, 2008, CANCER BIOL THER, V7, P1297, DOI 10.4161/cbt.7.8.6301; Dass CR, 2008, MOL CANCER RES, V6, P1289, DOI 10.1158/1541-7786.MCR-08-0036; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; Jin JY, 2011, J INVEST DERMATOL, V131, P1149, DOI 10.1038/jid.2011.1; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Khachigian LM, 2002, J BIOL CHEM, V277, P22985, DOI 10.1074/jbc.M200977200; Lacour JP, 2002, BRIT J DERMATOL, V146, P17, DOI 10.1046/j.1365-2133.146.s61.5.x; Laner-Plamberger S, 2009, ONCOGENE, V28, P1639, DOI 10.1038/onc.2009.10; Luo X, 2009, ARTERIOSCL THROM VAS, V29, P1836, DOI 10.1161/ATVBAHA.109.189753; MILLER SJ, 1991, J AM ACAD DERMATOL, V24, P161, DOI 10.1016/0190-9622(91)70022-T; MILLER SJ, 1991, J AM ACAD DERMATOL, V24, P1, DOI 10.1016/0190-9622(91)70001-I; Murrell M, 2007, ATHEROSCLEROSIS, V194, P364, DOI 10.1016/j.atherosclerosis.2006.11.016; Ni J, 2010, J BIOL CHEM, V285, P4038, DOI 10.1074/jbc.M109.078345; Rogers HW, 2010, ARCH DERMATOL, V146, P283, DOI 10.1001/archdermatol.2010.19; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Scolyer RA, 2003, AM J SURG PATHOL, V27, P1571, DOI 10.1097/00000478-200312000-00011; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Staples MP, 2006, MED J AUSTRALIA, V184, P6, DOI 10.5694/j.1326-5377.2006.tb00086.x; Tan ML, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-9; Vleugel MM, 2006, HUM PATHOL, V37, P668, DOI 10.1016/j.humpath.2006.01.022; Vogt PK, 2002, NAT REV CANCER, V2, P465, DOI 10.1038/nrc818; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Young MR, 1999, P NATL ACAD SCI USA, V96, P9827, DOI 10.1073/pnas.96.17.9827; Yucel T, 2005, EXP MOL PATHOL, V79, P151, DOI 10.1016/j.yexmp.2005.05.003; Zhang G, 2006, ONCOGENE, V25, P7260, DOI 10.1038/sj.onc.1209726; Zhang GS, 2004, JNCI-J NATL CANCER I, V96, P683, DOI 10.1093/jnci/djh120; Zhang WH, 2005, AM J CLIN PATHOL, V124, P11, DOI 10.1309/T1H2Y2CHWY7PD2BN	36	59	61	0	38	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 25	2013	381	9880					1835	1843		10.1016/S0140-6736(12)62166-7	http://dx.doi.org/10.1016/S0140-6736(12)62166-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151EO	23660123	Green Accepted, Green Submitted			2022-12-28	WOS:000319443700029
J	Kuwahara, H				Kuwahara, Hiroya			Persistent Hemichorea	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Tokyo Metropolitan Bokutoh Hosp, Tokyo, Japan		Kuwahara, H (corresponding author), Tokyo Metropolitan Bokutoh Hosp, Tokyo, Japan.								0	2	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2013	368	20					E26	E26		10.1056/NEJMicm1204276	http://dx.doi.org/10.1056/NEJMicm1204276			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143VK	23675673				2022-12-28	WOS:000318896200001
J	Schneider, C; Rahimi-Iman, A; Kim, NY; Fischer, J; Savenko, IG; Amthor, M; Lermer, M; Wolf, A; Worschech, L; Kulakovskii, VD; Shelykh, IA; Kamp, M; Reitzenstein, S; Forchel, A; Yamamoto, Y; Hofling, S				Schneider, Christian; Rahimi-Iman, Arash; Kim, Na Young; Fischer, Julian; Savenko, Ivan G.; Amthor, Matthias; Lermer, Matthias; Wolf, Adriana; Worschech, Lukas; Kulakovskii, Vladimir D.; Shelykh, Ivan A.; Kamp, Martin; Reitzenstein, Stephan; Forchel, Alfred; Yamamoto, Yoshihisa; Hoefling, Sven			An electrically pumped polariton laser	NATURE			English	Article							BOSE-EINSTEIN CONDENSATION; SEMICONDUCTOR MICROCAVITY; EXCITON-POLARITONS	Conventional semiconductor laser emission relies on stimulated emission of photons(1,2), which sets stringent requirements on the minimum amount of energy necessary for its operation(3,4). In comparison, exciton-polaritons in strongly coupled quantum well microcavities(5) can undergo stimulated scattering that promises more energy-efficient generation of coherent light by 'polariton lasers'(3,6). Polariton laser operation has been demonstrated in optically pumped semiconductor microcavities at temperatures up to room temperature(7-12), and such lasers can outperform their weak-coupling counterparts in that they have a lower threshold density(12,13). Even though polariton diodes have been realized(14-16), electrically pumped polariton laser operation, which is essential for practical applications, has not been achieved until now. Here we present an electrically pumped polariton laser based on a microcavity containing multiple quantum wells. To prove polariton laser emission unambiguously, we apply a magnetic field and probe the hybrid light-matter nature of the polaritons. Our results represent an important step towards the practical implementation of polaritonic light sources and electrically injected condensates, and can be extended to room-temperature operation using wide-bandgap materials.	[Schneider, Christian; Rahimi-Iman, Arash; Fischer, Julian; Amthor, Matthias; Lermer, Matthias; Wolf, Adriana; Worschech, Lukas; Kamp, Martin; Reitzenstein, Stephan; Forchel, Alfred; Hoefling, Sven] Univ Wurzburg, Tech Phys & Wilhelm Conrad Rontgen Res Ctr Comple, Hubland, D-97074 Wurzburg, Germany; [Kim, Na Young; Yamamoto, Yoshihisa] Stanford Univ, EL Ginzton Lab, Stanford, CA 94305 USA; [Kim, Na Young] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Savenko, Ivan G.; Shelykh, Ivan A.] Univ Iceland, Inst Sci, IS-107 Reykjavik, Iceland; [Savenko, Ivan G.; Shelykh, Ivan A.] Nanyang Technol Univ, Div Phys & Appl Phys, Singapore 637371, Singapore; [Kulakovskii, Vladimir D.] Russian Acad Sci, Inst Solid State Phys, Chernogolovka 142432, Russia; [Reitzenstein, Stephan] Tech Univ Berlin, Inst Festkorperphys, D-10623 Berlin, Germany; [Yamamoto, Yoshihisa] Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan	University of Wurzburg; Stanford University; University of Tokyo; University of Iceland; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Russian Academy of Sciences; Osipyan Institute of Solid State Physics RAS; Technical University of Berlin; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan	Hofling, S (corresponding author), Univ Wurzburg, Tech Phys & Wilhelm Conrad Rontgen Res Ctr Comple, Hubland, D-97074 Wurzburg, Germany.	christian.schneider@physik.uni-wuerzburg.de; sven.hoefling@physik.uni-wuerzburg.de	Kulakovskii, Vladimir/AAM-9718-2020; Savenko, Ivan/AAN-8112-2020; Reitzenstein, Stephan/AAG-5399-2019; Shelykh, Ivan A./J-6460-2015; Hofling, Sven/C-3140-2013	Savenko, Ivan/0000-0002-5515-1127; Reitzenstein, Stephan/0000-0002-1381-9838; Shelykh, Ivan A./0000-0001-5393-821X; Hofling, Sven/0000-0003-0034-4682; Forchel, Alfred/0000-0002-9377-9935	State of Bavaria; National Science Foundation; JSPS through its FIRST programme; Eimskip foundation; 'Center of excellence in polaritonics', IRSES SPINMET project; 'Center of excellence in polaritonics', POLAPHEN project; German National Academic Foundation	State of Bavaria; National Science Foundation(National Science Foundation (NSF)); JSPS through its FIRST programme; Eimskip foundation; 'Center of excellence in polaritonics', IRSES SPINMET project; 'Center of excellence in polaritonics', POLAPHEN project; German National Academic Foundation	This work was supported by the State of Bavaria, the National Science Foundation and by JSPS through its FIRST programme. I. G. S. acknowledges support from the Eimskip foundation. I. A. S. acknowledges support from the 'Center of excellence in polaritonics', IRSES SPINMET and POLAPHEN projects. A.R.-I. acknowledges a German National Academic Foundation fellowship. The authors thank T. Sunner, I. Lederer and A. Schade for experimental and technical support.	Bajoni D, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.113303; Bajoni D, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.201305; Balili R, 2007, SCIENCE, V316, P1007, DOI 10.1126/science.1140990; BERNARD MGA, 1961, PHYS STATUS SOLIDI, V1, P699, DOI 10.1002/pssb.19610010703; Byrnes T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.186402; Christopoulos S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.126405; Coldren L.A., 1995, DIODE LASERS PHOTONI; Dang LS, 1998, PHYS REV LETT, V81, P3920, DOI 10.1103/PhysRevLett.81.3920; Deng H, 2003, P NATL ACAD SCI USA, V100, P15318, DOI 10.1073/pnas.2634328100; Deng H, 2002, SCIENCE, V298, P199, DOI 10.1126/science.1074464; Dorodnyy AA, 2010, JETP LETT+, V92, P547, DOI 10.1134/S0021364010200117; Einstein A., 1916, VERH DTSCH PHYS GES, V18, P318; Imamoglu A, 1996, PHYS REV A, V53, P4250, DOI 10.1103/PhysRevA.53.4250; Kammann E, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/10/105003; Kappei L, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.147403; Kasprzak J, 2006, NATURE, V443, P409, DOI 10.1038/nature05131; Kavokin A., 2003, CAVITY POLARITONS; Keeling J, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.115320; Khalifa AA, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2844860; Kotlyar R, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.085310; Kulakovskii VD, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.155322; Larionov AV, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.256401; Nelsen B, 2009, J APPL PHYS, V105, DOI 10.1063/1.3140822; Ohadi H, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.016404; Rahimi-Iman A, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.165325; Rubo YG, 2006, PHYS LETT A, V358, P227, DOI 10.1016/j.physleta.2006.05.015; Sun L., 2010, PREPRINT; Tassone F, 1999, PHYS REV B, V59, P10830, DOI 10.1103/PhysRevB.59.10830; Tsintzos SI, 2008, NATURE, V453, P372, DOI 10.1038/nature06979; Tsotsis P, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/2/023060; WEISBUCH C, 1992, PHYS REV LETT, V69, P3314, DOI 10.1103/PhysRevLett.69.3314; Wertz E, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3192408	32	348	354	16	341	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2013	497	7449					348	352		10.1038/nature12036	http://dx.doi.org/10.1038/nature12036			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23676752				2022-12-28	WOS:000318952000033
J	Shinkins, B; Thompson, M; Mallett, S; Perera, R				Shinkins, Bethany; Thompson, Matthew; Mallett, Susan; Perera, Rafael			Diagnostic accuracy studies: how to report and analyse inconclusive test results	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LIKELIHOOD RATIOS; GRAY ZONE; QUALITY; STARD; INDETERMINATE; TOMOGRAPHY; VERSIONS; LESIONS; RISK; HIV		[Shinkins, Bethany; Thompson, Matthew; Mallett, Susan; Perera, Rafael] Univ Oxford, Dept Primary Care Hlth Sci, Radcliffe Observ Quarter, Oxford OX2 6GG, England	University of Oxford	Shinkins, B (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Radcliffe Observ Quarter, Oxford OX2 6GG, England.	bethany.shinkins@phc.ox.ac.uk	Shinkins, Bethany/AAX-4045-2020; Mallett, Sue/GPS-9933-2022	Mallett, Sue/0000-0002-0596-8200; Shinkins, Bethany/0000-0001-5350-1018; Perera, Rafael/0000-0003-2418-2091	National School for Primary Care Research Capacity Building Award; National Institute for Health Research (NIHR) [RP-PG-0407-10347, RP-PG-0407-10338]	National School for Primary Care Research Capacity Building Award; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	BS is funded by the National School for Primary Care Research Capacity Building Award. MT, RP, and SM receive funding by the National Institute for Health Research (NIHR) under its programme grants for applied research funding scheme (RP-PG-0407-10347 and RP-PG-0407-10338). This paper presents independent research funded by the National Institute for Health Research (NIHR). The views expressed in this paper are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health	Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Areia M, 2010, ENDOSCOPY, V42, P138, DOI 10.1055/s-0029-1243846; Ayad RF, 2011, AM J CARDIOL, V108, P1589, DOI 10.1016/j.amjcard.2011.09.006; Baloch ZW, 2002, DIAGN CYTOPATHOL, V26, P41, DOI 10.1002/dc.10043; BEGG CB, 1986, J CHRON DIS, V39, P575; Blick CGT, 2012, BJU INT, V110, P84, DOI 10.1111/j.1464-410X.2011.10664.x; Bossuyt PM, 2003, LANCET, V361, P71, DOI 10.1016/S0140-6736(03)12122-8; Bowden SC, 2009, J INT NEUROPSYCH SOC, V15, P769, DOI 10.1017/S1355617709990373; Coppus SFPJ, 2006, FERTIL STERIL, V86, P1321, DOI 10.1016/j.fertnstert.2006.03.050; Coste J, 2006, CLIN CHEM, V52, P2229, DOI 10.1373/clinchem.2006.072280; Delmas MC, 2000, AIDS, V14, P1775, DOI 10.1097/00002030-200008180-00013; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P109, DOI 10.1016/0895-4356(90)90064-V; Fontela PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007753; Freeman K, 2009, EUR J OBSTET GYN R B, V142, P91, DOI 10.1016/j.ejogrb.2008.10.010; Furukawa TA, 2002, PSYCHOL MED, V32, P743, DOI 10.1017/S0033291702005494; Furukawa TA, 2001, PSYCHOL MED, V31, P519, DOI 10.1017/S0033291701003713; Glaser JE, 2011, J NUCL MED, V52, P1508, DOI 10.2967/jnumed.111.090753; Hing W, 2009, J MAN MANIP THER, V17, P22, DOI 10.1179/106698109790818250; Jahromi AS, 2005, J VASC SURG, V41, P962, DOI 10.1016/j.jvs.2005.02.044; Johnson ZK, 2007, OPHTHALMOLOGY, V114, P1607, DOI 10.1016/j.ophtha.2006.11.036; Kamath BM, 2012, J PEDIATR GASTR NUTR, V55, P612, DOI 10.1097/MPG.0b013e31825eff61; Knottnerus JA., 2002, EVIDENCE BASE CLIN D; Krzych LJ, 2009, MED SCI MONITOR, V15, pSR5; Legare F, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-30; Lumbreras Blanca, 2006, Gac Sanit, V20, P368, DOI 10.1016/S0213-9111(06)71522-9; Mahoney J, 2007, CLIN CHEM, V53, P1122, DOI 10.1373/clinchem.2006.083493; MIDTHUN K, 1990, J INFECT DIS, V162, P1379, DOI 10.1093/infdis/162.6.1379; Miller E, 2009, ACAD RADIOL, V16, P739, DOI 10.1016/j.acra.2009.01.012; Paranjothy B, 2007, J GLAUCOMA, V16, P670, DOI 10.1097/IJG.0b013e3180457c6d; PEIRCE JC, 1993, MED DECIS MAKING, V13, P141, DOI 10.1177/0272989X9301300208; Perry AE, 2010, INT J OFFENDER THER, V54, P803, DOI 10.1177/0306624X09359757; Poynard T, 1982, Med Decis Making, V2, P285, DOI 10.1177/0272989X8200200305; Rama KRBS, 2006, CLIN ORTHOP RELAT R, P237, DOI 10.1097/01.blo.0000205906.44103.a3; Rifkin R D, 1985, Med Decis Making, V5, P179, DOI 10.1177/0272989X8500500207; Roposch A, 2006, RADIOLOGY, V241, P854, DOI 10.1148/radiol.2413051358; Santuz P, 2008, CLIN BIOCHEM, V41, P1150, DOI 10.1016/j.clinbiochem.2008.05.015; Schuetz GM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6717; Selman TJ, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-8; Selman TJ, 2005, GYNECOL ONCOL, V96, P575, DOI 10.1016/j.ygyno.2004.09.053; Shunmugam M, 2006, INVEST OPHTH VIS SCI, V47, P2317, DOI 10.1167/iovs.05-1250; Siddiqui MAR, 2005, BRIT J OPHTHALMOL, V89, P261, DOI 10.1136/bjo.2004.051862; SIMEL DL, 1987, MED DECIS MAKING, V7, P107, DOI 10.1177/0272989X8700700208; Smidt Nynke, 2006, BMC Med Res Methodol, V6, P12, DOI 10.1186/1471-2288-6-12; Sonis J, 1999, Fam Med, V31, P432; Spencer JA, 2008, CLIN RADIOL, V63, P843, DOI 10.1016/j.crad.2007.11.025; Straus SE, 2005, EVIDENCE BASED MED P; Subhas N, 2012, AM J ROENTGENOL, V198, pW575, DOI 10.2214/AJR.11.7226; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting PF, 2011, UPDATING QUADAS EVID; Zafar A, 2008, CLIN EXP OPHTHALMOL, V36, P537, DOI 10.1111/j.1442-9071.2008.01826.x	50	76	78	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	2013	346								f2778	10.1136/bmj.f2778	http://dx.doi.org/10.1136/bmj.f2778			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148OI	23682043	Green Submitted, Bronze			2022-12-28	WOS:000319254400001
J	Geddes, JR; Miklowitz, DJ				Geddes, John R.; Miklowitz, David J.			Bipolar Disorder 3 Treatment of bipolar disorder	LANCET			English	Article							FAMILY-FOCUSED TREATMENT; COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; WEEKLY SYMPTOMATIC STATUS; GROUP PSYCHOEDUCATION; PSYCHOSOCIAL TREATMENTS; RELAPSE PREVENTION; FUNCTIONAL IMPAIRMENT; OUTPATIENT TREATMENT; LONGITUDINAL COURSE	We review recent developments in the acute and long-term treatment of bipolar disorder and identify promising future routes to therapeutic innovation. Overall, advances in drug treatment remain quite modest. Antipsychotic drugs are effective in the acute treatment of mania; their efficacy in the treatment of depression is variable with the clearest evidence for quetiapine. Despite their widespread use, considerable uncertainty and controversy remains about the use of antidepressant drugs in the management of depressive episodes. Lithium has the strongest evidence for long-term relapse prevention; the evidence for anticonvulsants such as divalproex and lamotrigine is less robust and there is much uncertainty about the longer term benefits of antipsychotics. Substantial progress has been made in the development and assessment of adjunctive psychosocial interventions. Long-term maintenance and possibly acute stabilisation of depression can be enhanced by the combination of psychosocial treatments with drugs. The development of future treatments should consider both the neurobiological and psychosocial mechanisms underlying the disorder. We should continue to repurpose treatments and to recognise the role of serendipity. We should also investigate optimum combinations of pharmacological and psychotherapeutic treatments at different stages of the illness. Clarification of the mechanisms by which different treatments affect sleep and circadian rhythms and their relation with daily mood fluctuations is likely to help with the treatment selection for individual patients. To be economically viable, existing psychotherapy protocols need to be made briefer and more efficient for improved scalability and sustainability in widespread implementation.	[Geddes, John R.; Miklowitz, David J.] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England; [Miklowitz, David J.] Univ Calif Los Angeles, Sch Med, Div Child & Adolescent Psychiat, Los Angeles, CA USA	University of Oxford; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Geddes, JR (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.		Geddes, John/B-8240-2011; Miklowitz, David/AAE-3065-2022	Geddes, John/0000-0002-5281-5960; 	UK Medical Research Council; European Union; National Institute of Health Research; Stanley Medical Research Institute; National Institute of Mental Health; National Alliance for Research on Schizophrenia and Depression; Danny Alberts Foundation; Daniel and Diana Attias Family Foundation; Carl and Roberta Deutsch Foundation; Kayne Foundation; MRC [G0700477] Funding Source: UKRI; Medical Research Council [G0700477] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10150] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH097007, R01MH093676] Funding Source: NIH RePORTER	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); National Institute of Health Research(National Institute for Health Research (NIHR)); Stanley Medical Research Institute; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Alliance for Research on Schizophrenia and Depression(NARSAD); Danny Alberts Foundation; Daniel and Diana Attias Family Foundation; Carl and Roberta Deutsch Foundation; Kayne Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	JRG receives research funding from UK Medical Research Council, the European Union, the National Institute of Health Research, and the Stanley Medical Research Institute. He was expert witness for Dr Reddys Laboratories (India) and is Chief Investigator on the CEQUEL trial to which GlaxoSmithKline have contributed and supplied investigational drugs and placebo. DJM receives research funding from the National Institute of Mental Health, the National Alliance for Research on Schizophrenia and Depression, Danny Alberts Foundation, Daniel and Diana Attias Family Foundation, Carl and Roberta Deutsch Foundation, and the Kayne Foundation. We declare that we have no other conflicts of interest.	Agam G, 2002, BIPOLAR DISORD, V4, P15, DOI 10.1034/j.1399-5618.4.s1.2.x; Altshuler LL, 2006, J CLIN PSYCHIAT, V67, P1551, DOI 10.4088/JCP.v67n1009; Anderson IM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e8508; Andreazza AC, 2013, INT J NEUROPSYCHOPH, V17, P1, DOI DOI 10.1017/S1461145713000096; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Ball JR, 2006, J CLIN PSYCHIAT, V67, P277, DOI 10.4088/JCP.v67n0215; Bauer MS, 2006, PSYCHIAT SERV, V57, P937, DOI 10.1176/appi.ps.57.7.937; Beck AT, 1987, COGNITIVE THERAPY DE; Benedetti F, 2003, AM J MED GENET B, V123B, P23, DOI 10.1002/ajmg.b.20038; Birmaher B, 2009, AM J PSYCHIAT, V166, P795, DOI 10.1176/appi.ajp.2009.08101569; Bopp JM, 2010, BIPOLAR DISORD, V12, P327, DOI 10.1111/j.1399-5618.2010.00807.x; CADE JFJ, 1949, MED J AUSTRALIA, V2, P349, DOI 10.5694/j.1326-5377.1949.tb36912.x; Cipriani A, 2005, AM J PSYCHIAT, V162, P1805, DOI 10.1176/appi.ajp.162.10.1805; Cipriani A, 2011, LANCET, V378, P1306, DOI 10.1016/S0140-6736(11)60873-8; Cipriani A, 2009, LANCET, V373, P746, DOI 10.1016/S0140-6736(09)60046-5; Clarkin JF, 1998, PSYCHIAT SERV, V49, P531, DOI 10.1176/ps.49.4.531; COCHRAN SD, 1984, J CONSULT CLIN PSYCH, V52, P873, DOI 10.1037/0022-006X.52.5.873; Colom F, 2009, BRIT J PSYCHIAT, V194, P260, DOI 10.1192/bjp.bp.107.040485; Colom F, 2003, ARCH GEN PSYCHIAT, V60, P402, DOI 10.1001/archpsyc.60.4.402; Cousins DA, 2009, BIPOLAR DISORD, V11, P787, DOI 10.1111/j.1399-5618.2009.00760.x; De Fruyt J, 2012, J PSYCHOPHARMACOL, V26, P603, DOI 10.1177/0269881111408461; Diazgranados N, 2010, ARCH GEN PSYCHIAT, V67, P793, DOI 10.1001/archgenpsychiatry.2010.90; Dilsaver SC, 2011, J AFFECT DISORDERS, V129, P79, DOI 10.1016/j.jad.2010.08.030; Frank E, 2005, ARCH GEN PSYCHIAT, V62, P996, DOI 10.1001/archpsyc.62.9.996; Fristad MA, 2009, ARCH GEN PSYCHIAT, V66, P1013, DOI 10.1001/archgenpsychiatry.2009.112; Frye MA, 2011, J CLIN PSYCHIAT, V72, P1295, DOI [10.4088/JCP.10123colc, 10.4088/JCP.10123co1c]; Geddes JR, 2010, LANCET, V375, P385, DOI 10.1016/S0140-6736(09)61828-6; Geddes JR, 2009, BRIT J PSYCHIAT, V194, P4, DOI 10.1192/bjp.bp.107.048504; Geddes JR, 2004, AM J PSYCHIAT, V161, P217, DOI 10.1176/appi.ajp.161.2.217; Gelenberg AJ, 2008, J CLIN PSYCHIAT, V69, P1513, DOI 10.4088/JCP.v69n1001; Gijsman HJ, 2004, AM J PSYCHIAT, V161, P1537, DOI 10.1176/appi.ajp.161.9.1537; GITLIN MJ, 1995, AM J PSYCHIAT, V152, P1635; Goodwin GM, 2009, J PSYCHOPHARMACOL, V23, P346, DOI 10.1177/0269881109102919; Goodwin GM, 2004, J CLIN PSYCHIAT, V65, P432; Grskovic M, 2011, NAT REV DRUG DISCOV, V10, P915, DOI 10.1038/nrd3577; Harvey AG, 2011, ANNU REV CLIN PSYCHO, V7, P297, DOI 10.1146/annurev-clinpsy-032210-104550; Harwood AJ, 2005, MOL PSYCHIATR, V10, P117, DOI 10.1038/sj.mp.4001618; Hayes J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028725; Hollon SD, 2002, BIOL PSYCHIAT, V52, P610, DOI 10.1016/S0006-3223(02)01384-7; Holmes EA, 2008, BEHAV RES THER, V46, P1251, DOI 10.1016/j.brat.2008.09.005; Hooley JM, 2007, ANNU REV CLIN PSYCHO, V3, P329, DOI 10.1146/annurev.clinpsy.2.022305.095236; Johnson SL, 2008, J ABNORM PSYCHOL, V117, P268, DOI 10.1037/0021-843X.117.2.268; Judd LL, 2005, ARCH GEN PSYCHIAT, V62, P1322, DOI 10.1001/archpsyc.62.12.1322; Judd LL, 2002, ARCH GEN PSYCHIAT, V59, P530, DOI 10.1001/archpsyc.59.6.530; Judd LL, 2003, ARCH GEN PSYCHIAT, V60, P261, DOI 10.1001/archpsyc.60.3.261; Kessing LV, 2013, BRIT J PSYCHIAT, V202, P212, DOI 10.1192/bjp.bp.112.113548; Lam DH, 2005, AM J PSYCHIAT, V162, P324, DOI 10.1176/appi.ajp.162.2.324; Lam DH, 2009, BIPOLAR DISORD, V11, P474, DOI 10.1111/j.1399-5618.2009.00724.x; Li XH, 2012, NEUROPSYCHOPHARMACOL, V37, P77, DOI 10.1038/npp.2011.198; Loebel A, 2012, LURASIDONE MONOTHERA; Macritchie KA, 2001, COCHRANE DB SYST REV, V3, DOI [10.1002/14651858, 10.1002/14651858.CD003196, DOI 10.1002/14651858.CD003196]; Malkoff-Schwartz S, 1998, ARCH GEN PSYCHIAT, V55, P702, DOI 10.1001/archpsyc.55.8.702; McElroy SL, 2010, J CLIN PSYCHIAT, V71, P163, DOI 10.4088/JCP.08m04942gre; McKnight RF, 2012, LANCET, V379, P721, DOI 10.1016/S0140-6736(11)61516-X; Merikangas KR, 2007, ARCH GEN PSYCHIAT, V64, P543, DOI 10.1001/archpsyc.64.5.543; Merikangas KR, 2011, ARCH GEN PSYCHIAT, V68, P241, DOI 10.1001/archgenpsychiatry.2011.12; Meyer TD, 2012, PSYCHOL MED, V42, P1429, DOI 10.1017/S0033291711002522; Michalak E, 2011, CHRONIC ILLN, V7, P209, DOI 10.1177/1742395310395959; Miklowitz D. J., 2008, BIPOLAR DISORDER FAM; Miklowitz DJ, 2008, AM J PSYCHIAT, V165, P1408, DOI 10.1176/appi.ajp.2008.08040488; Miklowitz DJ, 2008, ARCH GEN PSYCHIAT, V65, P1053, DOI 10.1001/archpsyc.65.9.1053; Miklowitz DJ, 2007, AM J PSYCHIAT, V164, P1340, DOI 10.1176/appi.ajp.2007.07020311; Miklowitz DJ, 2007, ARCH GEN PSYCHIAT, V64, P419, DOI 10.1001/archpsyc.64.4.419; Miklowitz DJ, 2013, J AM ACAD CHILD PSY, V52, P121, DOI 10.1016/j.jaac.2012.10.007; Miklowitz DJ, 2012, BIPOLAR DISORD, V14, P185, DOI 10.1111/j.1399-5618.2012.00998.x; Miklowitz DJ, 2009, CLIN PSYCHOL-SCI PR, V16, P470, DOI 10.1111/j.1468-2850.2009.01185.x; Miklowitz DJ, 2009, BIPOLAR DISORD, V11, P110, DOI 10.1111/j.1399-5618.2009.00715.x; Miklowitz DJ, 2008, J PSYCHIATR PRACT, V14, P77, DOI 10.1097/01.pra.0000314314.94791.c9; Miklowitz DJ, 2003, ARCH GEN PSYCHIAT, V60, P904, DOI 10.1001/archpsyc.60.9.904; Miller IW, 2008, J CLIN PSYCHIAT, V69, P732, DOI 10.4088/JCP.v69n0506; Newberg Andrew R, 2008, Expert Rev Neurother, V8, P93, DOI 10.1586/14737175.8.1.93; Parikh SV, 2012, J CLIN PSYCHIAT, V73, P803, DOI 10.4088/JCP.11m07343; Perlick DA, 2010, BIPOLAR DISORD, V12, P627, DOI 10.1111/j.1399-5618.2010.00852.x; Perlis RH, 2006, AM J PSYCHIAT, V163, P217, DOI 10.1176/appi.ajp.163.2.217; Perry A, 1999, BRIT MED J, V318, P149, DOI 10.1136/bmj.318.7177.149; Phillips ML, 2013, LANCET, V381, P1663, DOI 10.1016/S0140-6736(13)60989-7; Rea MM, 2003, J CONSULT CLIN PSYCH, V71, P482, DOI 10.1037/0022-006X.71.3.482; Reinares M, 2008, BIPOLAR DISORD, V10, P511, DOI 10.1111/j.1399-5618.2008.00588.x; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Sachs GS, 2007, NEW ENGL J MED, V356, P1711, DOI 10.1056/NEJMoa064135; Scott J, 2006, BRIT J PSYCHIAT, V188, P313, DOI 10.1192/bjp.188.4.313; Scott J, 2007, INT J NEUROPSYCHOPH, V10, P123, DOI 10.1017/S1461145706006900; Scott J, 2009, J CLIN PSYCHIAT, V70, P378, DOI 10.4088/JCP.08m04333; Sidor MM, 2012, CURR PSYCHIAT REP, V14, P696, DOI 10.1007/s11920-012-0323-6; Sienaert P, 2013, BIPOLAR DISORD, V15, P61, DOI 10.1111/bdi.12026; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P500, DOI 10.1001/archpsyc.63.5.500; Simoneau TL, 1999, J ABNORM PSYCHOL, V108, P588, DOI 10.1037/0021-843X.108.4.588; Singh N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2320; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Stockmeier CA, 2003, J PSYCHIAT RES, V37, P357, DOI 10.1016/S0022-3956(03)00050-5; Strakowski SM, 1998, ARCH GEN PSYCHIAT, V55, P49, DOI 10.1001/archpsyc.55.1.49; Strakowski SM, 2012, BIPOLAR DISORD, V14, P313, DOI 10.1111/j.1399-5618.2012.01022.x; Swartz HA, 2012, BIPOLAR DISORD, V14, P211, DOI 10.1111/j.1399-5618.2012.00988.x; Tohen M, 2003, ARCH GEN PSYCHIAT, V60, P1079, DOI 10.1001/archpsyc.60.11.1079; Torrent C, 2013, AM J PSYCHIAT, V170, P852, DOI 10.1176/appi.ajp.2012.12070971; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Weinstock LM, 2008, BIPOLAR DISORD, V10, P437, DOI 10.1111/j.1399-5618.2007.00551.x; Weinstock LM, 2010, COMPR PSYCHIAT, V51, P497, DOI 10.1016/j.comppsych.2010.02.001; Weisler RH, 2008, J AFFECT DISORDERS, V108, P1, DOI 10.1016/j.jad.2007.09.012; Weisler RH, 2011, J CLIN PSYCHIAT, V72, P1452, DOI 10.4088/JCP.11m06878; Weisler RH, 2012, INT CLIN PSYCHOPHARM, V27, P27, DOI 10.1097/YIC.0b013e32834d6f91; Weiss RD, 2007, AM J PSYCHIAT, V164, P100, DOI 10.1176/appi.ajp.164.1.100; Yatham LN, 2013, BIPOLAR DISORD, V15, P1, DOI 10.1111/bdi.12025; Zarate CA, 2012, BIOL PSYCHIAT, V71, P939, DOI 10.1016/j.biopsych.2011.12.010; Zaretsky A, 2008, CAN J PSYCHIAT, V53, P441, DOI 10.1177/070674370805300709	105	440	447	6	181	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 11	2013	381	9878					1672	1682		10.1016/S0140-6736(13)60857-0	http://dx.doi.org/10.1016/S0140-6736(13)60857-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146SX	23663953	Green Accepted			2022-12-28	WOS:000319112400035
J	Crowe, JE				Crowe, James E., Jr.			Crowdsourcing Immunity	SCIENCE			English	Editorial Material							MEMORY B-CELLS; NEUTRALIZING ANTIBODIES; PLASMA-CELLS; DESIGN; BROAD		Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA	Vanderbilt University	Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA.	james.crowe@vanderbilt.edu	Crowe, James/B-5549-2009	Crowe, James/0000-0002-0049-1079				Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Krause JC, 2011, J IMMUNOL, V187, P3704, DOI 10.4049/jimmunol.1101823; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; Scharf L, 2013, P NATL ACAD SCI USA, V110, P6049, DOI 10.1073/pnas.1303682110; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231; Zhu J, 2013, P NATL ACAD SCI USA, V110, P6470, DOI 10.1073/pnas.1219320110	13	0	0	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					692	693		10.1126/science.1238628	http://dx.doi.org/10.1126/science.1238628			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661747				2022-12-28	WOS:000318619000023
J	Winstead, CJ; Weaver, CT				Winstead, Colleen J.; Weaver, Casey T.			Dwelling on T Cell Fate Decisions	CELL			English	Editorial Material							EFFECTOR; MEMORY		[Winstead, Colleen J.; Weaver, Casey T.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham	Weaver, CT (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35233 USA.	cweaver@uab.edu		Weaver, Casey/0000-0002-2180-1793	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007051] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007051] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Choi YS, 2013, J IMMUNOL, V190, P4014, DOI 10.4049/jimmunol.1202963; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Govern CC, 2010, P NATL ACAD SCI USA, V107, P8724, DOI 10.1073/pnas.1000966107; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; King CG, 2012, IMMUNITY, V37, P709, DOI 10.1016/j.immuni.2012.06.021; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007	10	7	11	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 9	2013	153	4					739	741		10.1016/j.cell.2013.04.026	http://dx.doi.org/10.1016/j.cell.2013.04.026			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663773	Bronze			2022-12-28	WOS:000318844000003
J	Brearley, S				Brearley, Stephen			EASILY MISSED? Acute leg ischaemia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE LIMB ISCHEMIA; MANAGEMENT		Whipps Cross Univ Hosp, London E11 1NR, England	University of London; Queen Mary University London	Brearley, S (corresponding author), Whipps Cross Univ Hosp, London E11 1NR, England.	vascusurg@btconnect.com						BREARLEY S, 1992, ANN ROY COLL SURG, V74, P169; Campbell WB, 1998, BRIT J SURG, V85, P1498; Creager MA, 2012, NEW ENGL J MED, V366, P2198, DOI 10.1056/NEJMcp1006054; Earnshaw JJ, 2010, RUTHERFORDS VASCULAR, P2389; Henke PK, 2009, SEMIN VASC SURG, V22, P34, DOI 10.1053/j.semvascsurg.2009.01.002; National Institute for Health and Clinical Excellence, 2012, LOW LIMB PER ART DIS, V147; National Patient Safety Agency, 2011, EARL DET TREATM AC L; Shearman A, ASS SURG GREAT BRIT; Trummer G, 2010, MINERVA CHIR, V65, P319	9	10	10	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2013	346								f2681	10.1136/bmj.f2681	http://dx.doi.org/10.1136/bmj.f2681			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	144BS	23657181				2022-12-28	WOS:000318915000009
J	Eikermann, M; Gluud, C; Perleth, M; Wild, C; Sauerland, S; Gutierrez-Ibarluzea, I; Antoine, SL; Demotes-Mainard, J; Neugebauer, EAM				Eikermann, Michaela; Gluud, Christian; Perleth, Matthias; Wild, Claudia; Sauerland, Stefan; Gutierrez-Ibarluzea, Inaki; Antoine, Sunya-Lee; Demotes-Mainard, Jacques; Neugebauer, Edmund A. M.		Signatories Our Open Letter Europe	Commentary: Europe needs a central, transparent, and evidence based regulation process for devices	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Eikermann, Michaela; Antoine, Sunya-Lee; Neugebauer, Edmund A. M.] Univ Witten Herdecke, Sch Med, Fac Hlth, Inst Res Operat Med, D-51109 Cologne, Germany; [Gluud, Christian] Copenhagen Univ Hosp, Ctr Clin Intervent Res, Copenhagen Trial Unit, Copenhagen, Denmark; [Perleth, Matthias] German Soc Technol Assessment Hlth Care, Berlin, Germany; [Wild, Claudia] Ludwig Boltzmann Inst Hlth Technol Assessment, Vienna, Austria; [Sauerland, Stefan] Inst Qual & Efficiency Healthcare IQWiG, Cologne, Germany; [Gutierrez-Ibarluzea, Inaki] Osteba, Basque Off Hlth Technol Assessment, Vitoria, Spain; [Demotes-Mainard, Jacques] INSERM, Inst Themat Sante Publ, Paris, France	Witten Herdecke University; University of Copenhagen; Ludwig Boltzmann Institute; Institut National de la Sante et de la Recherche Medicale (Inserm)	Neugebauer, EAM (corresponding author), Univ Witten Herdecke, Sch Med, Fac Hlth, Inst Res Operat Med, D-51109 Cologne, Germany.	Edmund.Neugebauer@uni-wh.de	Gerhardus, Ansgar/L-9746-2018; Gutierrez-Ibarluzea, Iñaki/AAH-6732-2019; Perleth, Matthias/C-6438-2016; Gluud, Christian/HGB-3191-2022; Gluud, Christian/AAY-1027-2021; Siebert, Uwe/M-5057-2019; Borry, Pascal/B-5836-2012	Gerhardus, Ansgar/0000-0003-3637-7419; Gutierrez-Ibarluzea, Iñaki/0000-0002-4080-7963; Perleth, Matthias/0000-0001-5574-8356; Gluud, Christian/0000-0002-8861-0799; Siebert, Uwe/0000-0001-6425-7671; Makela, Marjukka/0000-0001-5111-1358; Borry, Pascal/0000-0002-4931-9560; Sauerland, Stefan/0000-0003-1048-796X; Redekop, Ken/0000-0001-9538-4083	MRC [G0501892] Funding Source: UKRI; Medical Research Council [G0501892] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Campbell B, 2013, BRIT MED J, V346, pf2374; Eikermann M, 2013, EVIDENCE LIVE; Storz-Pfennig P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1646	3	27	27	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2013	346								f2771	10.1136/bmj.f2771	http://dx.doi.org/10.1136/bmj.f2771			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	144BQ	23653340				2022-12-28	WOS:000318914800001
J	Cornfield, DN; Lane, R; Abman, SH				Cornfield, David N.; Lane, Robert; Abman, Steven H.			Creation and Retention of the Next Generation of Physician-Scientists for Child Health Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACADEMIC MEDICINE; WOMEN; PEDIATRICS; FACULTY		[Cornfield, David N.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Lane, Robert] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Abman, Steven H.] Univ Colorado, Sch Med, Aurora, CO USA	Stanford University; Medical College of Wisconsin; University of Colorado System; University of Colorado Anschutz Medical Campus	Cornfield, DN (corresponding author), Stanford Univ, Sch Med, Dept Pediat, 701 Welch Rd,Bldg B,Ste 310, Stanford, CA 94305 USA.	cornfield@stanford.edu						Alexander D, 2009, J PEDIAT, V154, pe2; Alexander D, 2009, J PEDIATR-US, V154, P1, DOI 10.1016/j.jpeds.2008.08.010; Barkin SL, 2010, PEDIATRICS, V126, P1055, DOI 10.1542/peds.2010-2050; Dickler HB, 2007, JAMA-J AM MED ASSOC, V297, P2496, DOI 10.1001/jama.297.22.2496; Dixon-Woods M, 2008, MED HEALTH CARE PHIL, V11, P381, DOI 10.1007/s11019-008-9152-0; Landrigan CP, 2008, PEDIATRICS, V122, P250, DOI 10.1542/peds.2007-2306; Levine RB, 2011, ACAD MED, V86, P752, DOI 10.1097/ACM.0b013e318217e83b; Ley TJ, 2005, JAMA-J AM MED ASSOC, V294, P1343, DOI 10.1001/jama.294.11.1343; Pololi LH, 2012, ACAD MED, V87, P859, DOI 10.1097/ACM.0b013e3182582b18; Zemlo TR, 2000, FASEB J, V14, P221, DOI 10.1096/fasebj.14.2.221	10	15	15	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2013	309	17					1781	1782		10.1001/jama.2013.2258	http://dx.doi.org/10.1001/jama.2013.2258			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134SU	23632720				2022-12-28	WOS:000318235600024
J	Dobson, SRM; McNeil, S; Dionne, M; Dawar, M; Ogilvie, G; Krajden, M; Sauvageau, C; Scheifele, DW; Kollmann, TR; Halperin, SA; Langley, JM; Bettinger, JA; Singer, J; Money, D; Miller, D; Naus, M; Marra, F; Young, E				Dobson, Simon R. M.; McNeil, Shelly; Dionne, Marc; Dawar, Meena; Ogilvie, Gina; Krajden, Mel; Sauvageau, Chantal; Scheifele, David W.; Kollmann, Tobias R.; Halperin, Scott A.; Langley, Joanne M.; Bettinger, Julie A.; Singer, Joel; Money, Deborah; Miller, Dianne; Naus, Monika; Marra, Fawziah; Young, Eric			Immunogenicity of 2 Doses of HPV Vaccine in Younger Adolescents vs 3 Doses in Young Women A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-6; PARTICLE VACCINE; NEUTRALIZING EPITOPES; ANTIBODIES; RESPONSES; EFFICACY; SAFETY; 2-DOSE; ASSAY	Importance Global use of human papillomavirus (HPV) vaccines to prevent cervical cancer is impeded by cost. A 2-dose schedule for girls may be possible. Objective To determine whether mean antibody levels to HPV-16 and HPV-18 among girls receiving 2 doses was noninferior to women receiving 3 doses. Design, Setting, and Patients Randomized, phase 3, postlicensure, multicenter, age-stratified, noninferiority immunogenicity study of 830 Canadian females from August 2007 through February 2011. Follow-up blood samples were provided by 675 participants (81%). Intervention Girls (9-13 years) were randomized 1:1 to receive 3 doses of quadrivalent HPV vaccine at 0, 2, and 6 months (n=261) or 2 doses at 0 and 6 months (n=259). Young women (16-26 years) received 3 doses at 0, 2, and 6 months (n=310). Antibody levels were measured at 0, 7, 18, 24, and 36 months. Main Outcomes and Measures Primary outcome was noninferiority (95% CI, lower bound >0.5) of geometric mean titer (GMT) ratios for HPV-16 and HPV-18 for girls (2 doses) compared with young women (3 doses) 1 month after last dose. Secondary outcomes were noninferiority of GMT ratios of girls receiving 2 vs 3 doses of vaccine; and durability of noninferiority to 36 months. Results The GMT ratios were noninferior for girls (2 doses) to women (3 doses): 2.07 (95% CI, 1.62-2.65) for HPV-16 and 1.76 (95% CI, 1.41-2.19) for HPV-18. Girls (3 doses) had GMT responses 1 month after last vaccination for HPV-16 of 7736 milli-Merck units per mL (mMU/mL) (95% CI, 6651-8999) and HPV-18 of 1730 mMU/mL (95% CI, 1512-1980). The GMT ratios were noninferior for girls (2 doses) to girls (3 doses): 0.95 (95% CI, 0.73-1.23) for HPV-16 and 0.68 (95% CI, 0.54-0.85) for HPV-18. The GMT ratios for girls (2 doses) to women (3 doses) remained noninferior for all genotypes to 36 months. Antibody responses in girls were noninferior after 2 doses vs 3 doses for all 4 vaccine genotypes at month 7, but not for HPV-18 by month 24 or HPV-6 by month 36. Conclusions and Relevance Among girls who received 2 doses of HPV vaccine 6 months apart, responses to HPV-16 and HPV-18 one month after the last dose were noninferior to those among young women who received 3 doses of the vaccine within 6 months. Because of the loss of noninferiority to some genotypes at 24 to 36 months in girls given 2 doses vs 3 doses, more data on the duration of protection are needed before reduced-dose schedules can be recommended.	[Dobson, Simon R. M.; Scheifele, David W.; Kollmann, Tobias R.; Bettinger, Julie A.] Univ British Columbia, Dept Pediat, Vancouver, BC V5Z 4H4, Canada; [Dawar, Meena; Ogilvie, Gina; Singer, Joel; Naus, Monika] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 4H4, Canada; [Krajden, Mel] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 4H4, Canada; [Money, Deborah; Miller, Dianne] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 4H4, Canada; [Marra, Fawziah] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V5Z 4H4, Canada; [Dobson, Simon R. M.; Scheifele, David W.; Kollmann, Tobias R.; Bettinger, Julie A.] Vaccine Evaluat Ctr, Vancouver, BC, Canada; [McNeil, Shelly] Dalhousie Univ, IWK Hlth Ctr & Capital Hlth, Canadian Ctr Vaccinol, Dept Med, Halifax, NS B3H 3J5, Canada; [Halperin, Scott A.; Langley, Joanne M.] Dalhousie Univ, IWK Hlth Ctr & Capital Hlth, Canadian Ctr Vaccinol, Dept Pediat, Halifax, NS B3H 3J5, Canada; [Dionne, Marc; Sauvageau, Chantal] Ctr Hosp Univ Quebec, Quebec City, PQ, Canada; [Dawar, Meena] Vancouver Coastal Hlth Author, Vancouver, BC, Canada; [Ogilvie, Gina; Krajden, Mel; Naus, Monika; Marra, Fawziah] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Miller, Dianne] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Young, Eric] British Columbia Minist Hlth, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; Dalhousie University; Dalhousie University; Laval University; Vancouver Coastal Health Research Institute; British Columbia Cancer Agency	Dobson, SRM (corresponding author), Univ British Columbia, British Columbia Childrens Hosp, Vaccine Evaluat Ctr, 950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.	sdobson@cw.bc.ca		Langley, Joanne/0000-0003-3270-7345; Halperin, Scott/0000-0003-0525-589X; Scheifele, David/0000-0001-6078-7843; McNeil, Shelly/0000-0001-5444-4166; Ogilvie, Gina/0000-0001-5783-4493; Kollmann, Tobias/0000-0003-2403-9762; Bettinger, Julie/0000-0002-2118-4174	Michael Smith Health Foundation; Merck; Michael Smith Foundation; Nova Scotia Department of Health and Wellness; GlaxoSmithKline; Roche; Gen-Probe; Siemens; British Columbia Ministry of Health; Pfizer; aventis sanofi; Novartis; Advaxis; Spimaco; Nova Scotia Department of Health; Ministry of Health in the province of British Columbia; Ministry of Health in the province of Nova Scotia; Ministry of Health in the province of Quebec	Michael Smith Health Foundation(Michael Smith Foundation for Health Research); Merck(Merck & Company); Michael Smith Foundation(Michael Smith Foundation for Health Research); Nova Scotia Department of Health and Wellness; GlaxoSmithKline(GlaxoSmithKline); Roche(Roche Holding); Gen-Probe; Siemens(Siemens AG); British Columbia Ministry of Health; Pfizer(Pfizer); aventis sanofi; Novartis(Novartis); Advaxis; Spimaco; Nova Scotia Department of Health; Ministry of Health in the province of British Columbia; Ministry of Health in the province of Nova Scotia; Ministry of Health in the province of Quebec	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Dobson reports receiving grant support from the Michael Smith Health Foundation, serving on the advisory board and consulting for GlaxoSmithKline, and receiving travel and accommodations expenses from Merck. Dr McNeil reports receiving grant support from the Michael Smith Foundation, Nova Scotia Department of Health and Wellness, and GlaxoSmithKline, receiving payment for lectures from GlaxoSmithKline and Merck, and conducting clinical trials supported by Merck and GlaxoSmithKline. Dr Dionne reports receiving grant support and travel expenses from GlaxoSmithKline. Dr Krajden reports receiving support from Roche, Gen-Probe, Siemens, and Merck. Dr Sauvageau reports receiving consulting and lecture fees from GlaxoSmithKline and Merck, receiving grant support from GlaxoSmithKline. Dr Scheifele reports receiving grant support from British Columbia Ministry of Health, the Michael Smith Foundation, Pfizer, GlaxoSmithKline, aventis sanofi, and Novartis, and consulting for Novartis, GlaxoSmithKline, aventis sanofi, and Pfizer. Dr Kollmann reports receiving grant support from Merck and Advaxis, receiving lecture fees from Spimaco, and receiving travel, accommodations, and meeting expenses from GlaxoSmithKline. Dr Halperin reports receiving grant support from the Michael Smith Foundation, the Nova Scotia Department of Health, and multiple vaccine manufacturers and receiving consulting fees on ad hoc advisory boards for multiple vaccine manufacturers and provincial and federal advisory committees. Dr Money reports receiving support from, and consulting for, Merck. No other disclosures were reported.; Ministries of Health in the provinces of British Columbia, Nova Scotia, and Quebec provided the funding for this project. The HPV DNA assays were conducted by Provincial Health Services Authority. Merck Laboratories Inc conducted the antibody assays at no cost to the study.	[Anonymous], 2006, GARD QUADR HUM PAP T; Block SL, 2006, PEDIATRICS, V118, P2135, DOI 10.1542/peds.2006-0461; Brown DR, 2011, HUM VACCINES, V7, P230, DOI 10.4161/hv.7.2.13948; Cassidy WM, 2001, PEDIATRICS, V107, P626, DOI 10.1542/peds.107.4.626; Day PM, 2010, CELL HOST MICROBE, V8, P260, DOI 10.1016/j.chom.2010.08.003; Dessy FJ, 2008, HUM VACCINES, V4, P425, DOI 10.4161/hv.4.6.6912; Dias D, 2005, CLIN DIAGN LAB IMMUN, V12, P959, DOI 10.1128/CDLI.12.8.959-969.2005; Dorell Christina, 2011, Morbidity and Mortality Weekly Report, V60, P1117; Hirth JM, 2012, CANCER-AM CANCER SOC, V118, P5623, DOI 10.1002/cncr.27598; Kou J, STAT REV EVALUATION; Krajden M, 2011, CLIN VACCINE IMMUNOL, V18, P418, DOI 10.1128/CVI.00489-10; Kreimer AR, 2011, JNCI-J NATL CANCER I, V103, P1444, DOI 10.1093/jnci/djr319; Lenth RV, JAVA APPLETS POWER S; Longet S, 2011, J VIROL, V85, P13253, DOI 10.1128/JVI.06093-11; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115; Olsson SE, 2007, VACCINE, V25, P4931, DOI 10.1016/j.vaccine.2007.03.049; Opalka D, 2003, CLIN DIAGN LAB IMMUN, V10, P108, DOI 10.1128/CDLI.10.1.108-115.2003; Public Health Agency of Canada, CAN HUM PAP VACC RES, V32S1; Reisinger KS, 2007, PEDIATR INFECT DIS J, V26, P201, DOI 10.1097/01.inf.0000253970.29190.5a; Romanowski B, 2011, HUM VACCINES, V7, P1374, DOI 10.4161/hv.7.12.18322; Smolen KK, 2012, VACCINE, V30, P3572, DOI 10.1016/j.vaccine.2012.03.051; Syrjanen K, 2011, EUR J GYNAECOL ONCOL, V32, P17; Villa LL, 2006, BRIT J CANCER, V95, P1459, DOI 10.1038/sj.bjc.6603469; Villa LL, 2006, VACCINE, V24, P5571, DOI 10.1016/j.vaccine.2006.04.068; Wang WWB, 2006, J BIOPHARM STAT, V16, P429, DOI 10.1080/10543400600719251	26	292	309	3	45	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2013	309	17					1793	1802		10.1001/jama.2013.1625	http://dx.doi.org/10.1001/jama.2013.1625			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134SU	23632723	Bronze			2022-12-28	WOS:000318235600027
J	Mukherjee, R				Mukherjee, Rupali			Can India stop drug companies giving gifts to doctors?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRESCRIBE GENERIC DRUGS		Times India, Bombay, Maharashtra, India		Mukherjee, R (corresponding author), Times India, Bombay, Maharashtra, India.	mukherjee.rupali@gmail.com						[Anonymous], 2012, INADMISSIBILITY EXPE; Bhaumik S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f564; Department of Pharmaceuticals, COD MARK PRACT IND P; IMS Health Total Sales Audit, 2013, IND DRUG MARK; Kay M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f802; Medical Council of India, MCI2112GEN2012; Organization of Pharmaceutical Producers of India, OPPI COD PHARM PRACT; Parliamentary standing committee on health and family welfare, 2010, 45 PARL STAND COMM H; Planning Commission of India, 2011, HIGH LEV EXP GROUP R; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373	10	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2013	346								f2635	10.1136/bmj.f2635	http://dx.doi.org/10.1136/bmj.f2635			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139DK	23628750				2022-12-28	WOS:000318561600003
J	Kim, SV; Xiang, WKV; Kwak, C; Yang, Y; Lin, XYW; Ota, M; Sarpel, U; Rifkin, DB; Xu, RL; Littman, DR				Kim, Sangwon V.; Xiang, Wenkai V.; Kwak, Changsoo; Yang, Yi; Lin, Xiyao W.; Ota, Mitsuhiko; Sarpel, Umut; Rifkin, Daniel B.; Xu, Ruliang; Littman, Dan R.			GPR15-Mediated Homing Controls Immune Homeostasis in the Large Intestine Mucosa	SCIENCE			English	Article							REGULATORY T-CELLS; RECEPTORS; INDUCTION; BREAKDOWN	Lymphocyte homing, which contributes to inflammation, has been studied extensively in the small intestine, but there is little known about homing to the large intestine, the site most commonly affected in inflammatory bowel disease. GPR15, an orphan heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptor, controlled the specific homing of T cells, particularly FOXP3(+) regulatory T cells (T-regs), to the large intestine lamina propria (LILP). GPR15 expression was modulated by gut microbiota and transforming growth factor-beta 1, but not by retinoic acid. GPR15-deficient mice were prone to develop more severe large intestine inflammation, which was rescued by the transfer of GPR15-sufficient T-regs. Our findings thus describe a T cell-homing receptor for LILP and indicate that GPR15 plays a role in mucosal immune tolerance largely by regulating the influx of T-regs.	[Kim, Sangwon V.; Xiang, Wenkai V.; Kwak, Changsoo; Yang, Yi; Lin, Xiyao W.; Littman, Dan R.] NYU, Sch Med, Skirball Inst, Mol Pathogenesis Program,Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Ota, Mitsuhiko; Rifkin, Daniel B.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Sarpel, Umut] Mt Sinai Sch Med, Div Surg Oncol, New York, NY 10029 USA; [Xu, Ruliang; Littman, Dan R.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA	New York University; New York University; Icahn School of Medicine at Mount Sinai; New York University; Howard Hughes Medical Institute; New York University	Littman, DR (corresponding author), NYU, Sch Med, Skirball Inst, Mol Pathogenesis Program,Kimmel Ctr Biol & Med, New York, NY 10016 USA.	dan.littman@med.nyu.edu	; Kim, Sangwon V./S-1166-2016	Sarpel, Umut/0000-0002-4346-3641; xu, ruliang/0000-0002-9165-4610; Kwak, Changsoo/0000-0003-1503-5671; Kim, Sangwon V./0000-0001-8453-7080	Irvington Institute fellowship program of the Cancer Research Institute; NIH National Research Service [1T32AI100853-01]; Arthritis National Research Foundation; National Cancer Institute (NCI), NIH [5P30CA016087-32]; NCI-NIH [5P30CA016087-33, P30 CA016087-30]; National Center for Research Resources, NIH [UL1RR029893]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI100853] Funding Source: NIH RePORTER	Irvington Institute fellowship program of the Cancer Research Institute; NIH National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis National Research Foundation(National Research Foundation of Korea); National Cancer Institute (NCI), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank R. Min and P. Oh for technical assistance; M. Sellars for a critical reading of the manuscript; J. M. Weiss, J. J. Lafaille, and A. Y. Rudensky for their advice; and E. Newman (NYU School of Medicine, New York) for providing surgical specimens. Foxp3<SUP>ires</SUP> <SUP>mrfp</SUP> mice were provided by R. A. Flavell (Yale University School of Medicine, Howard Hughes Medical Institute) and subject to a Materials Transfer Agreement. A patent application related to the work in this paper has been filed (S.V.K. and D.R.L. as inventors). The data in this paper are tabulated in the main paper and in the supplementary materials, and are deposited in National Center for Biotechnology Information's Gene Expression Omnibus (GSE45773). S.V.K. was supported by the Irvington Institute fellowship program of the Cancer Research Institute and by NIH National Research Service Award grant 1T32AI100853-01. Y.Y. was supported by the Arthritis National Research Foundation. D.R.L. is a Howard Hughes Medical Institute Investigator. This work was supported in part by National Cancer Institute (NCI), NIH, grant 5P30CA016087-32 (BioRepository Center, Genome Technology Center, and Histopathology Core), NCI-NIH grant 5P30CA016087-33 (Cytometry and Cell Sorting Core), National Center for Research Resources, NIH, grant UL1RR029893 (BioRepository Center), and NCI-NIH P30 CA016087-30 (for data collected on the Affymetrix GeneChip System).	Agace WW, 2008, TRENDS IMMUNOL, V29, P514, DOI 10.1016/j.it.2008.08.003; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Chase AJ, 2007, J VIROL, V81, P12748, DOI 10.1128/JVI.00841-07; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; Farzan M, 1997, J EXP MED, V186, P405, DOI 10.1084/jem.186.3.405; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Hansen W, 2006, J IMMUNOL, V177, P209, DOI 10.4049/jimmunol.177.1.209; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sigmundsdottir H, 2008, NAT IMMUNOL, V9, P981, DOI 10.1038/ni.f.208; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Yoshinaga K, 2008, P NATL ACAD SCI USA, V105, P18758, DOI 10.1073/pnas.0805411105	28	185	192	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	2013	340	6139					1456	1459		10.1126/science.1237013	http://dx.doi.org/10.1126/science.1237013			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23661644	Green Accepted			2022-12-28	WOS:000320647000043
J	Doshi, P				Doshi, Peter			Influenza: marketing vaccine by marketing disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							IMMUNIZATION PRACTICES ACIP; ADVISORY-COMMITTEE; RECOMMENDATIONS; PREVENTION; MORTALITY; RISK		Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA	Johns Hopkins University	Doshi, P (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	pdoshi@post.harvard.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS019488] Funding Source: NIH RePORTER; AHRQ HHS [#T32HS019488] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; [Anonymous], 2011, EUR MED AG REC RESTR; Australian Government Department of Health, 2010, INV FEBR REACT YOUNG; Braun MM, 2007, NEW ENGL J MED, V357, P2730; Brownlee S, 2009, ATLANTIC; Eurich DT, 2008, AM J RESP CRIT CARE, V178, P527, DOI 10.1164/rccm.200802-282OC; European Medicines Agency, 2012, EUR MED AG REV HYP P; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Gardam M, 2013, CANADIAN MED ASS J; Greene JA, 2005, B HIST MED, V79, P749, DOI 10.1353/bhm.2005.0153; Grohskopf Lisa, 2012, Morbidity and Mortality Weekly Report, V61, P613; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; Harper Scott A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; Immunization Action Coalition, 2013, HON ROLL PAT SAF HON; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jackson LA, 2006, INT J EPIDEMIOL, V35, P345, DOI 10.1093/ije/dyi275; Jackson L, 2013, MMWR-MORBID MORTAL W, V62, P119; Jackson L, 2013, MMWR-MORBID MORTAL W, V62, P32; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub4; LANGMUIR AD, 1964, AM J PUBLIC HEALTH N, V54, P563, DOI 10.2105/AJPH.54.4.563; Layton C, 2005, INFLUENZA VACCINE DE; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Miller E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f794; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; NBCNews.com video, 2013, VID CHURCH HOSP FLU; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Osterholm MT, 2011, INFLUENZA VACCINE EF; Reichert Tom, 2003, EROTIC HIST ADVERTIS; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Simonsen L, 2007, NEW ENGL J MED, V357, P2729; US Centers for Disease Control, 1984, MMWR-MORBID MORTAL W, V33, P253; US Centers for Disease Control, 1984, MMWR-MORBID MORTAL W, V33, P265; US Centers for Disease Control and Prevention, 2007 8 US INFL SEAS; US Centers for Disease Control and Prevention, INFL VIR IS WHO NREV; US Centers for Disease Control and Prevention, 2010, SHOTS AR JUST KIDS; US Centers for Disease Control and Prevention, 2013, PRESS BRIEF TRANSCR; US Centers for Disease Control and Prevention, 2012, SPREAD MUS NOT FLU; US Centers for Disease Control and Prevention, 2000 2001 LAB DAT SU; US Centers for Disease Control and Prevention, 2002, 1999 2000 INFL SEAS; US Centers for Disease Control and Prevention, 2006 07 US INFL SEAS	41	16	18	0	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 16	2013	346								f3037	10.1136/bmj.f3037	http://dx.doi.org/10.1136/bmj.f3037			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148OI	23682040				2022-12-28	WOS:000319254400002
J	Dvinge, H; Git, A; Graf, S; Salmon-Divon, M; Curtis, C; Sottoriva, A; Zhao, YJ; Hirst, M; Armisen, J; Miska, EA; Chin, SF; Provenzano, E; Turashvili, G; Green, A; Ellis, I; Aparicio, S; Caldas, C				Dvinge, Heidi; Git, Anna; Graef, Stefan; Salmon-Divon, Mali; Curtis, Christina; Sottoriva, Andrea; Zhao, Yongjun; Hirst, Martin; Armisen, Javier; Miska, Eric A.; Chin, Suet-Feung; Provenzano, Elena; Turashvili, Gulisa; Green, Andrew; Ellis, Ian; Aparicio, Sam; Caldas, Carlos			The shaping and functional consequences of the microRNA landscape in breast cancer	NATURE			English	Article							GENE-EXPRESSION; ESTROGEN-RECEPTOR; MESSENGER-RNA; METASTASIS; REVEALS; INDUCE; TUMORS	MicroRNAs (miRNAs) show differential expression across breast cancer subtypes, and have both oncogenic and tumour-suppressive roles(1-6). Here we report the miRNA expression profiles of 1,302 breast tumours with matching detailed clinical annotation, long-term follow-up and genomic and messenger RNA expression data(7). This provides a comprehensive overview of the quantity, distribution and variation of the miRNA population and provides information on the extent to which genomic, transcriptional and post-transcriptional events contribute to miRNA expression architecture, suggesting an important role for post-transcriptional regulation. The key clinical parameters and cellular pathways related to the miRNA landscape are characterized, revealing context-dependent interactions, for example with regards to cell adhesion and Wnt signalling. Notably, only prognostic miRNA signatures derived from breast tumours devoid of somatic copy-number aberrations (CNA-devoid) are consistently prognostic across several other subtypes and can be validated in external cohorts. We then use a data-driven approach(8) to seek the effects of miRNAs associated with differential co-expression of mRNAs, and find that miRNAs act as modulators of mRNA-mRNA interactions rather than as on-off molecular switches. We demonstrate such an important modulatory role for miRNAs in the biology of CNA-devoid breast cancers, a common subtype in which the immune response is prominent. These findings represent a new framework for studying the biology of miRNAs in human breast cancer.	[Dvinge, Heidi; Git, Anna; Graef, Stefan; Chin, Suet-Feung; Caldas, Carlos] Canc Res UK Cambridge Inst, Cambridge CB2 0RE, England; [Dvinge, Heidi; Git, Anna; Graef, Stefan; Chin, Suet-Feung; Caldas, Carlos] Univ Cambridge, Li Ka Shing Ctr, Dept Oncol, Cambridge CB2 0RE, England; [Salmon-Divon, Mali] European Bioinformat Inst, European Mol Biol Lab, Cambridge CB10 1SD, England; [Salmon-Divon, Mali] Ariel Univ, Ctr Samaria, Dept Mol Biol, IL-40700 Ariel, Israel; [Curtis, Christina; Sottoriva, Andrea] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90033 USA; [Zhao, Yongjun; Hirst, Martin] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Zhao, Yongjun; Hirst, Martin; Turashvili, Gulisa; Aparicio, Sam] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Armisen, Javier; Miska, Eric A.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Armisen, Javier; Miska, Eric A.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England; [Provenzano, Elena; Caldas, Carlos] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Cambridge Breast Unit, Cambridge CB2 2QQ, England; [Provenzano, Elena; Caldas, Carlos] NIHR Cambridge Biomed Res Ctr, Cambridge CB2 2QQ, England; [Turashvili, Gulisa; Aparicio, Sam] British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada; [Green, Andrew; Ellis, Ian] Univ Nottingham, Sch Mol Med Sci, Dept Histopathol, Nottingham NG5 1PB, England; [Caldas, Carlos] Cambridge Expt Canc Med Ctr, Cambridge CB2 0RE, England	Cancer Research UK; CRUK Cambridge Institute; CRUK Cambridge Institute; University of Cambridge; European Molecular Biology Laboratory (EMBL); Ariel University; University of Southern California; British Columbia Cancer Agency; University of British Columbia; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; British Columbia Cancer Agency; University of Nottingham	Git, A (corresponding author), Canc Res UK Cambridge Inst, Robinson Way, Cambridge CB2 0RE, England.	anna.git@cruk.cam.ac.uk; saparicio@bccrc.ca; carlos.caldas@cruk.cam.ac.uk	Hirst, Martin/B-7684-2016; Salmon-Divon, Mali/AAG-4479-2019; Caldas, Carlos/U-7250-2019; Green, Andrew/AAF-1991-2020	Salmon-Divon, Mali/0000-0002-7272-0846; Caldas, Carlos/0000-0003-3547-1489; Green, Andrew/0000-0002-0488-5913; Ellis, Ian/0000-0001-5292-8474; Turashvili, Gulisa/0000-0001-6125-5865; Sottoriva, Andrea/0000-0001-6709-9533; chin, suet-feung/0000-0001-5697-1082; Miska, Eric/0000-0002-4450-576X; Dvinge, Heidi/0000-0003-1741-0738; Aparicio, Samuel/0000-0002-0487-9599; Curtis, Christina/0000-0003-0166-3802	Cancer Research UK; British Columbia Cancer Foundation; University of Cambridge; Hutchinson Whampoa; NIHR Cambridge Biomedical Research Centre; Cambridge Experimental Cancer Medicine Centre; Cancer Research UK [11832, 16942] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10154] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); British Columbia Cancer Foundation; University of Cambridge(University of Cambridge); Hutchinson Whampoa; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridge Experimental Cancer Medicine Centre; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	The study was funded by Cancer Research UK and the British Columbia Cancer Foundation. The authors also acknowledge the support of the University of Cambridge, Hutchinson Whampoa, the NIHR Cambridge Biomedical Research Centre, and the Cambridge Experimental Cancer Medicine Centre. We thank S. McGuire for help in sample management; S. Fulmer-Smentek and T. Hill for help with array design; L. Goldstein for initial processing of sequencing data; O. Rueda for statistical advice; and O. Rueda, J. Carroll and R. Ali for reading of the manuscript. We are very grateful to the patients who donated tissue and associated pseudo-anonymized clinical data.	Andreopoulos B, 2012, CANCER INFORM, V11, P61, DOI 10.4137/CIN.S9037; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Bezman NA, 2011, J EXP MED, V208, P2717, DOI 10.1084/jem.20111386; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Boquest AC, 2005, MOL BIOL CELL, V16, P1131, DOI 10.1091/mbc.E04-10-0949; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Enerly E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016915; Fabbri M, 2012, P NATL ACAD SCI USA, V109, pE2110, DOI 10.1073/pnas.1209414109; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Git A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2109; Guo HY, 2012, INT J BIOCHEM CELL B, V44, P1465, DOI 10.1016/j.biocel.2012.05.015; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Le Quesne J, 2010, MOL ONCOL, V4, P230, DOI 10.1016/j.molonc.2010.04.009; Li B, 2012, FEBS J, V279, P2393, DOI 10.1111/j.1742-4658.2012.08618.x; Luqmani YA, 2009, INT J ONCOL, V34, P231, DOI 10.3892/ijo_00000145; Lyng MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036170; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Peng XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020341; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Schmidt WM, 2009, BIOCHEM BIOPH RES CO, V380, P437, DOI 10.1016/j.bbrc.2008.12.190; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; Valastyan S, 2010, CELL CYCLE, V9, P2124, DOI 10.4161/cc.9.11.11843; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Xu WD, 2012, INFLAMMATION, V35, P1525, DOI 10.1007/s10753-012-9467-0	30	314	328	0	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2013	497	7449					378	382		10.1038/nature12108	http://dx.doi.org/10.1038/nature12108			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23644459				2022-12-28	WOS:000318952000040
J	Brewer, C				Brewer, Colin			Plain cigarette packets could reduce nicotine addiction	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												brewerismo@gmail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 15	2013	346								f3105	10.1136/bmj.f3105	http://dx.doi.org/10.1136/bmj.f3105			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148OH	23676426				2022-12-28	WOS:000319254200016
J	Insel, TR; Landis, SC; Collins, FS				Insel, Thomas R.; Landis, Story C.; Collins, Francis S.			The NIH BRAIN Initiative	SCIENCE			English	Editorial Material							ACTIVITY MAP		[Insel, Thomas R.; Landis, Story C.; Collins, Francis S.] NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Insel, TR (corresponding author), NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	insel@mail.nih.gov; slandis@codon.nih.gov; collinsf@od.nih.gov						Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Alivisatos AP, 2013, SCIENCE, V339, P1284, DOI 10.1126/science.1236939; Alivisatos AP, 2012, NEURON, V74, P970, DOI 10.1016/j.neuron.2012.06.006; Bloom DE, 2011, GLOBAL EC BURDEN NON; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280; Wilt BA, 2009, ANNU REV NEUROSCI, V32, P435, DOI 10.1146/annurev.neuro.051508.135540; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	12	212	224	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					687	688		10.1126/science.1239276	http://dx.doi.org/10.1126/science.1239276			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	139XR	23661744	Green Published			2022-12-28	WOS:000318619000020
J	Ott, C; Kaldun, A; Raith, P; Meyer, K; Laux, M; Evers, J; Keitel, CH; Greene, CH; Pfeifer, T				Ott, Christian; Kaldun, Andreas; Raith, Philipp; Meyer, Kristina; Laux, Martin; Evers, Joerg; Keitel, Christoph H.; Greene, Chris H.; Pfeifer, Thomas			Lorentz Meets Fano in Spectral Line Shapes: A Universal Phase and Its Laser Control	SCIENCE			English	Article							ELECTROMAGNETICALLY INDUCED TRANSPARENCY; HELIUM; STATES; LIGHT; HE	Symmetric Lorentzian and asymmetric Fano line shapes are fundamental spectroscopic signatures that quantify the structural and dynamical properties of nuclei, atoms, molecules, and solids. This study introduces a universal temporal-phase formalism, mapping the Fano asymmetry parameter q to a phase. of the time-dependent dipole response function. The formalism is confirmed experimentally by laser-transforming Fano absorption lines of autoionizing helium into Lorentzian lines after attosecond-pulsed excitation. We also demonstrate the inverse, the transformation of a naturally Lorentzian line into a Fano profile. A further application of this formalism uses quantum-phase control to amplify extreme-ultraviolet light resonantly interacting with He atoms. The quantum phase of excited states and its response to interactions can thus be extracted from line-shape analysis, with applications in many branches of spectroscopy.	[Ott, Christian; Kaldun, Andreas; Raith, Philipp; Meyer, Kristina; Laux, Martin; Evers, Joerg; Keitel, Christoph H.; Pfeifer, Thomas] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Pfeifer, Thomas] Heidelberg Univ, Ctr Quantum Dynam, D-69120 Heidelberg, Germany; [Greene, Chris H.] Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA	Max Planck Society; Ruprecht Karls University Heidelberg; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Pfeifer, T (corresponding author), Max Planck Inst Kernphys, D-69117 Heidelberg, Germany.	thomas.pfeifer@mpi-hd.mpg.de	Evers, Jörg/AAB-2018-2019; Ott, Christian/GXV-1144-2022; Greene, Chris H/C-3821-2011	Ott, Christian/0000-0003-4110-0916; Greene, Chris H/0000-0002-2096-6385; Evers, Jorg/0000-0001-7864-6029	Max-Planck Research Group program; Deutsche Forschungsgemeinschaft [PF 790/1-1]; U.S. Department of Energy, Office of Science	Max-Planck Research Group program; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); U.S. Department of Energy, Office of Science(United States Department of Energy (DOE))	We acknowledge helpful discussions with R. Moshammer and J. Ullrich. Financial support from the Max-Planck Research Group program and the Deutsche Forschungsgemeinschaft (grant no. PF 790/1-1) is gratefully acknowledged. The work of C. H. G. is supported in part by the U.S. Department of Energy, Office of Science. The authors declare no competing financial interest.	Blatt J. M., 1952, THEORETICAL NUCL PHY, DOI 10.1119/1.1933407; Chini M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.073601; Chu WC, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.013415; Corkum PB, 2007, NAT PHYS, V3, P381, DOI 10.1038/nphys620; Fan JA, 2010, SCIENCE, V328, P1135, DOI 10.1126/science.1187949; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; FANO U, 1968, REV MOD PHYS, V40, P441, DOI 10.1103/RevModPhys.40.441; Fano U., 1935, NUOVO CIMENTO 1924 1, V12, P154, DOI DOI 10.1007/BF02958288; Gilbertson S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.263003; Harris SE, 1997, PHYS TODAY, V50, P36, DOI 10.1063/1.881806; ITO K, 1987, PHYS SCRIPTA, V36, P88, DOI 10.1088/0031-8949/36/1/014; KOCHAROVSKAYA O, 1992, PHYS REP, V219, P175, DOI 10.1016/0370-1573(92)90135-M; Kroner M, 2008, NATURE, V451, P311, DOI 10.1038/nature06506; LAMBROPOULOS P, 1981, PHYS REV A, V24, P379, DOI 10.1103/PhysRevA.24.379; LINN SH, 1983, J CHEM PHYS, V78, P50, DOI 10.1063/1.444475; Loh ZH, 2008, CHEM PHYS, V350, P7, DOI 10.1016/j.chemphys.2007.11.005; MADDEN RP, 1963, PHYS REV LETT, V10, P516, DOI 10.1103/PhysRevLett.10.516; Miroshnichenko AE, 2010, REV MOD PHYS, V82, P2257, DOI 10.1103/RevModPhys.82.2257; Riffe DM, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.064308; Rost JM, 1997, J PHYS B-AT MOL OPT, V30, P4663, DOI 10.1088/0953-4075/30/21/010; Safavi-Naeini AH, 2011, NATURE, V472, P69, DOI 10.1038/nature09933; Schmidt AR, 2010, NATURE, V465, P570, DOI 10.1038/nature09073; SCULLY MO, 1992, PHYS REP, V219, P191, DOI 10.1016/0370-1573(92)90136-N; Shakhmuratov RN, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.043820; SZYMANOWSKI C, 1995, J MOD OPTIC, V42, P985, DOI 10.1080/09500349514550891; Wang H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.143002	26	348	352	11	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					716	720		10.1126/science.1234407	http://dx.doi.org/10.1126/science.1234407			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661754	Green Submitted			2022-12-28	WOS:000318619000031
J	Randow, F; MacMicking, JD; James, LC				Randow, Felix; MacMicking, John D.; James, Leo C.			Cellular Self-Defense: How Cell-Autonomous Immunity Protects Against Pathogens	SCIENCE			English	Review							ANTIBACTERIAL AUTOPHAGY; BACTERIAL-INFECTION; PROMOTES IMMUNITY; INNATE IMMUNITY; RECEPTOR NDP52; HOST; SYSTEM; DNA; MEMBRANE; HIV-1	Our prevailing view of vertebrate host defense is strongly shaped by the notion of a specialized set of immune cells as sole guardians of antimicrobial resistance. Yet this view greatly underestimates a capacity for most cell lineages-the majority of which fall outside the traditional province of the immune system-to defend themselves against infection. This ancient and ubiquitous form of host protection is termed cell-autonomous immunity and operates across all three domains of life. Here, we discuss the organizing principles that govern cellular self-defense and how intracellular compartmentalization has shaped its activities to provide effective protection against a wide variety of microbial pathogens.	[Randow, Felix; James, Leo C.] MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Cambridge CB2 0QH, England; [MacMicking, John D.] Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Microbial Pathogenesis, New Haven, CT 06510 USA	MRC Laboratory Molecular Biology; Yale University	Randow, F (corresponding author), MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Francis Crick Ave, Cambridge CB2 0QH, England.	randow@mrc-lmb.cam.ac.uk; john.macmicking@yale.edu; lcj@mrc-lmb.cam.ac.uk			Medical Research Council [U105170648, U105181010]; National Association for Colitis and Crohn's Disease [M/11/3]; European Research Council [281627-IAI]; NIH [AI068041-06]; Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award [1007845]; Searle Foundation Scholars Program [05-F-114]; Cancer Research Institute [CRI06-10]; Crohn's and Colitis Foundation of America [R09928]; Yale's W. W. Winchester Fund; Medical Research Council [MC_U105181010, MC_U105170648] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068041] Funding Source: NIH RePORTER; MRC [MC_U105170648, MC_U105181010] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Association for Colitis and Crohn's Disease; European Research Council(European Research Council (ERC)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award(Burroughs Wellcome Fund); Searle Foundation Scholars Program; Cancer Research Institute; Crohn's and Colitis Foundation of America; Yale's W. W. Winchester Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We apologize to colleagues whose work could not be cited due to space constraints. Work in the authors' laboratories was supported by the Medical Research Council (U105170648 and U105181010) (F. R. and L.C.J.), the National Association for Colitis and Crohn's Disease (M/11/3) (F. R.), European Research Council (281627-IAI) (L.C.J.), NIH grant AI068041-06 (J.D.M.), Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award (1007845) (J.D.M.), Searle Foundation Scholars Program (05-F-114) (J.D.M.), Cancer Research Institute Investigator Award Program (CRI06-10) (J.D.M.), Crohn's and Colitis Foundation of America Senior Investigator Award (R09928) (J.D.M.), and Yale's W. W. Winchester Fund (J.D.M.).	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alix E, 2011, J CELL BIOL, V195, P943, DOI 10.1083/jcb.201105019; Baxt LA, 2013, SCIENCE, V340, P697, DOI 10.1126/science.1235771; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Botteaux A, 2009, MICROBES INFECT, V11, P537, DOI 10.1016/j.micinf.2009.02.009; Caines MEC, 2012, NAT STRUCT MOL BIOL, V19, P411, DOI 10.1038/nsmb.2253; Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108; Creasey EA, 2012, P NATL ACAD SCI USA, V109, P3481, DOI 10.1073/pnas.1121286109; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Dupont N, 2009, CELL HOST MICROBE, V6, P137, DOI 10.1016/j.chom.2009.07.005; Ferguson BJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00047; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439; Holm CK, 2012, NAT IMMUNOL, V13, P737, DOI 10.1038/ni.2350; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Huett A, 2012, CELL HOST MICROBE, V12, P778, DOI 10.1016/j.chom.2012.10.019; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kagan JC, 2012, CELL, V151, P1168, DOI 10.1016/j.cell.2012.11.011; Kajaste-Rudnitski A, 2011, J VIROL, V85, P5183, DOI 10.1128/JVI.02302-10; Kim BH, 2012, CELL HOST MICROBE, V12, P432, DOI 10.1016/j.chom.2012.09.007; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003730; MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210; Maier O, 2012, J VIROL, V86, P10821, DOI 10.1128/JVI.01428-12; Mallery DL, 2010, P NATL ACAD SCI USA, V107, P19985, DOI 10.1073/pnas.1014074107; McEwan WA, 2013, NAT IMMUNOL, V14, P327, DOI 10.1038/ni.2548; McGettigan J, 2005, INSECT BIOCHEM MOLEC, V35, P741, DOI 10.1016/j.ibmb.2005.02.017; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Mostowy S, 2010, CELL HOST MICROBE, V8, P433, DOI 10.1016/j.chom.2010.10.009; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Ponpuak M, 2010, IMMUNITY, V32, P329, DOI 10.1016/j.immuni.2010.02.009; Randow F, 2012, TRENDS IMMUNOL, V33, P475, DOI 10.1016/j.it.2012.06.003; Ronald PC, 2010, SCIENCE, V330, P1061, DOI 10.1126/science.1189468; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Sloan RD, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-52; Stuart LM, 2013, NAT REV IMMUNOL, V13, P199, DOI 10.1038/nri3398; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Tiwari S, 2009, NAT IMMUNOL, V10, P907, DOI 10.1038/ni.1759; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; von Muhlinen N, 2012, MOL CELL, V48, P329, DOI 10.1016/j.molcel.2012.08.024; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Wilson SJ, 2012, CELL HOST MICROBE, V12, P585, DOI 10.1016/j.chom.2012.08.012; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Yamamoto M, 2012, IMMUNITY, V37, P302, DOI 10.1016/j.immuni.2012.06.009; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Yoder K, 2006, P NATL ACAD SCI USA, V103, P4622, DOI 10.1073/pnas.0509828103; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441	60	170	178	2	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					701	706		10.1126/science.1233028	http://dx.doi.org/10.1126/science.1233028			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661752	Green Accepted			2022-12-28	WOS:000318619000028
J	Potok, ME; Nix, DA; Parnell, TJ; Cairns, BR				Potok, Magdalena E.; Nix, David A.; Parnell, Timothy J.; Cairns, Bradley R.			Reprogramming the Maternal Zebrafish Genome after Fertilization to Match the Paternal Methylation Pattern	CELL			English	Article							PROMOTER DNA METHYLATION; PREIMPLANTATION DEVELOPMENT; HISTONE MODIFICATIONS; GENE-EXPRESSION; CHROMATIN; EMBRYOGENESIS; EMBRYO; CELLS; DEMETHYLATION; PLURIPOTENT	Early vertebrate embryos must achieve totipotency and prepare for zygotic genome activation (ZGA). To understand this process, we determined the DNA methylation (DNAme) profiles of zebrafish gametes, embryos at different stages, and somatic muscle and compared them to gene activity and histone modifications. Sperm chromatin patterns are virtually identical to those at ZGA. Unexpectedly, the DNA of many oocyte genes important for germline functions (i.e., piwil1) or early development (i.e., hox genes) is methylated, but the loci are demethylated during zygotic cleavage stages to precisely the state observed in sperm, even in parthenogenetic embryos lacking a replicating paternal genome. Furthermore, this cohort constitutes the genes and loci that acquire DNAme during development (i.e., ZGA to muscle). Finally, DNA methyltransferase inhibition experiments suggest that DNAnne silences particular gene and chromatin cohorts at ZGA, preventing their precocious expression. Thus, zebrafish achieve a totipotent chromatin state at ZGA through paternal genome competency and maternal genonne DNAme reprogramming.	[Potok, Magdalena E.; Parnell, Timothy J.; Cairns, Bradley R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Potok, Magdalena E.; Nix, David A.; Parnell, Timothy J.; Cairns, Bradley R.] Univ Utah, Sch Med, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Cairns, BR (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	brad.cairns@hci.utah.edu		Parnell, Timothy/0000-0002-3632-3691	NICHD [5R01HD058506]; HHMI; NHLBI [U01HL0981];  [CA24014]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058506] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL000981] Funding Source: NIH RePORTER	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); HHMI(Howard Hughes Medical Institute); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Brian Daily for genomics advice and Mengyao Tan, Meesha Last, and Minhtu Nguyen for help in oocyte collection. We thank Kazuyiki Hoshijima, Timothy Dahlem, and David Grunwald for homozygous golden fish and for advice regarding maternal haploid fish. We thank Saher Sue Hammoud, Shan-Fu Wu, Rod Stewart, David Jones, and Cairns lab members for advice. This work is supported by NICHD 5R01HD058506 (support of M.E.P. and supplies), HHMI (support of B.R.C. and T.J.P.), NHLBI U01HL0981 (support of T.J.P.), and CA24014 to the Huntsman Cancer Institute (for core facilities).	Almeida RD, 2012, EPIGENETICS-US, V7, P383, DOI 10.4161/epi.19375; Andersen IS, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r65; Arpanahi A, 2009, GENOME RES, V19, P1338, DOI 10.1101/gr.094953.109; Bogdanovic O, 2012, GENOME RES, V22, P2043, DOI 10.1101/gr.134833.111; Bogdanovic O, 2011, GENOME RES, V21, P1313, DOI 10.1101/gr.114843.110; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; FLACH G, 1982, EMBO J, V1, P681, DOI 10.1002/j.1460-2075.1982.tb01230.x; Goll MG, 2011, PROG MOL BIOL TRANSL, V101, P193, DOI 10.1016/B978-0-12-387685-0.00005-6; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hoffman TL, 2007, J EXP ZOOL PART B, V308B, P679, DOI 10.1002/jez.b.21189; HOWLETT SK, 1991, DEVELOPMENT, V113, P119; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; KANE DA, 1993, DEVELOPMENT, V119, P447; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lindeman LC, 2011, DEV CELL, V21, P993, DOI 10.1016/j.devcel.2011.10.008; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Long HK, 2013, ELIFE, V2, DOI 10.7554/eLife.00348; Macleod D, 1999, NAT GENET, V23, P139, DOI 10.1038/13767; Martin CC, 1999, DEV BIOL, V206, P189, DOI 10.1006/dbio.1998.9105; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; McGowan RA, 1997, BIOCHEM CELL BIOL, V75, P499, DOI 10.1139/bcb-75-5-499; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mhanni AA, 2004, DEV GENES EVOL, V214, P412, DOI 10.1007/s00427-004-0418-0; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tan L, 2012, DEVELOPMENT, V139, P1895, DOI 10.1242/dev.070771; Thisse B., 2001, R01RR15402 NIH ZFIN; Vastenhouw NL, 2012, CURR OPIN CELL BIOL, V24, P374, DOI 10.1016/j.ceb.2012.03.009; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wu SF, 2011, METHOD CELL BIOL, V104, P327, DOI 10.1016/B978-0-12-374814-0.00018-5; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	48	258	269	1	62	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 9	2013	153	4					759	772		10.1016/j.cell.2013.04.030	http://dx.doi.org/10.1016/j.cell.2013.04.030			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663776	Bronze, Green Accepted			2022-12-28	WOS:000318844000007
J	Wang, Q				Wang, Qiang			China's citizens must act to save their environment	NATURE			English	Editorial Material									Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Western Res Ctr Energy & Ecoenvironm Policy, Urumqi, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Wang, Q (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Western Res Ctr Energy & Ecoenvironm Policy, Urumqi, Peoples R China.	qiangwang7@gmail.com	WANG, Qiang/F-4618-2011	WANG, Qiang/0000-0002-8751-8093					0	45	47	1	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2013	497	7448					159	159		10.1038/497159a	http://dx.doi.org/10.1038/497159a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	139CD	23657314	Bronze			2022-12-28	WOS:000318558200004
J	Hoeksma, J				Hoeksma, Jon			Making the digital future a reality	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									EHlth Insider, London, England		Hoeksma, J (corresponding author), EHlth Insider, London, England.	Jon@e-health-media.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2013	346								f2648	10.1136/bmj.f2648	http://dx.doi.org/10.1136/bmj.f2648			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139DK	23628875				2022-12-28	WOS:000318561600004
J	Fligner, CL; Dighe, MK				Fligner, Corinne L.; Dighe, Manjiri K.			Post-mortem diagnosis: evolving a team approach	LANCET			English	Editorial Material							INTENSIVE-CARE-UNIT; AUTOPSY; ISSUES		[Fligner, Corinne L.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Fligner, Corinne L.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Dighe, Manjiri K.] Univ Washington, Med Ctr, Dept Radiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Fligner, CL (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	fligner@u.washington.edu	Dighe, Manjiri/D-9294-2018	Dighe, Manjiri/0000-0003-0047-5148				Breeze ACG, 2011, ULTRASOUND OBST GYN, V37, P317, DOI 10.1002/uog.8844; Burton EC, 2012, ANN INTERN MED, V156, P158, DOI 10.7326/0003-4819-156-2-201201170-00014; Combes A, 2004, ARCH INTERN MED, V164, P389, DOI 10.1001/archinte.164.4.389; Davis GG, 2013, ACAD FORENSIC PATHOL, V3, P62; Gordijn SJ, 2007, EUR J OBSTET GYN R B, V132, P3, DOI 10.1016/j.ejogrb.2006.10.031; NMS Implementation Sub-Group of the Department of Health Post Mortem Forensic and Disaster Imaging Group (PMFDI), 2012, NMS IMPL SUBGROUP DE; Roberts ISD, 2012, LANCET, V379, P136, DOI 10.1016/S0140-6736(11)61483-9; Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849; Thayyil S, 2010, PRENATAL DIAG, V30, P713, DOI 10.1002/pd.2534; Thayyil S, 2013, LANCET; Traill Z., 2010, DIAGNOSTIC HISTOPATH, V16, P560; Wichmann D, 2012, ANN INTERN MED, V156, P123, DOI 10.7326/0003-4819-156-2-201201170-00008	12	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 20	2013	382	9888					186	188		10.1016/S0140-6736(13)60890-9	http://dx.doi.org/10.1016/S0140-6736(13)60890-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	193FL	23683719				2022-12-28	WOS:000322543700007
J	Payne, MR				Payne, Mark R.			FISHERIES Climate change at the dinner table	NATURE			English	Editorial Material									Tech Univ Denmark, Ctr Ocean Life, Natl Inst Aquat Resources DTU Aqua, DK-2920 Charlottenlund, Denmark	Technical University of Denmark	Payne, MR (corresponding author), Tech Univ Denmark, Ctr Ocean Life, Natl Inst Aquat Resources DTU Aqua, DK-2920 Charlottenlund, Denmark.	mpa@aqua.dtu.dk	Payne, Mark/C-6844-2008	Payne, Mark/0000-0001-5795-2481	Villum Fonden [00007178] Funding Source: researchfish	Villum Fonden(Villum Fonden)		Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; Beare D, 2005, J SEA RES, V53, P205, DOI 10.1016/j.seares.2004.06.003; Cheung WWL, 2013, NATURE, V497, P365, DOI 10.1038/nature12156; Collie JS, 2008, CAN J FISH AQUAT SCI, V65, P1352, DOI 10.1139/F08-048; Costello C, 2012, SCIENCE, V338, P517, DOI 10.1126/science.1223389; Drinkwater KF, 2010, J MARINE SYST, V79, P374, DOI 10.1016/j.jmarsys.2008.12.014; Gruber N, 2011, PHILOS T R SOC A, V369, P1980, DOI 10.1098/rsta.2011.0003; IPCC, 2007, CONTRIBUTION WORKING; Pauly D, 2013, NATURE, V494, P303, DOI 10.1038/494303a; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	11	6	9	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2013	497	7449					320	321		10.1038/497320a	http://dx.doi.org/10.1038/497320a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	144PN	23676749				2022-12-28	WOS:000318952000024
J	Shen, J; Xia, WY; Khotskaya, YB; Huo, LF; Nakanishi, K; Lim, SO; Du, Y; Wang, Y; Chang, WC; Chen, CH; Hsu, JL; Wu, Y; Lam, YC; James, BP; Liu, XP; Liu, CG; Patel, DJ; Hung, MC				Shen, Jia; Xia, Weiya; Khotskaya, Yekaterina B.; Huo, Longfei; Nakanishi, Kotaro; Lim, Seung-Oe; Du, Yi; Wang, Yan; Chang, Wei-Chao; Chen, Chung-Hsuan; Hsu, Jennifer L.; Wu, Yun; Lam, Yung Carmen; James, Brian P.; Liu, Xiuping; Liu, Chang-Gong; Patel, Dinshaw J.; Hung, Mien-Chie			EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2	NATURE			English	Article							PROTEINS; ENDOCYTOSIS; COMPLEX; CANCER	MicroRNAs (miRNAs) are generated by two-step processing to yield small RNAs that negatively regulate target gene expression at the post-transcriptional level(1). Deregulation of miRNAs has been linked to diverse pathological processes, including cancer(2,3). Recent studies have also implicated miRNAs in the regulation of cellular response to a spectrum of stresses(4), such as hypoxia, which is frequently encountered in the poorly angiogenic core of a solid tumour(5). However, the upstream regulators of miRNA biogenesis machineries remain obscure, raising the question of how tumour cells efficiently coordinate and impose specificity on miRNA expression and function in response to stresses. Here we show that epidermal growth factor receptor (EGFR), which is the product of a well-characterized oncogene in human cancers, suppresses the maturation of specific tumour-suppressor-like miRNAs in response to hypoxic stress through phosphorylation of argonaute 2 (AGO2) at Tyr 393. The association between EGFR and AGO2 is enhanced by hypoxia, leading to elevated AGO2-Y393 phosphorylation, which in turn reduces the binding of Dicer to AGO2 and inhibits miRNA processing from precursor miRNAs to mature miRNAs. We also identify a long-loop structure in precursor miRNAs as a critical regulatory element in phospho-Y393-AGO2-mediated miRNA maturation. Furthermore, AGO2-Y393 phosphorylation mediates EGFR-enhanced cell survival and invasiveness under hypoxia, and correlates with poorer overall survival in breast cancer patients. Our study reveals a previously unrecognized function of EGFR in miRNA maturation and demonstrates how EGFR is likely to function as a regulator of AGO2 through novel post-translational modification. These findings suggest that modulation of miRNA biogenesis is important for stress response in tumour cells and has potential clinical implications.	[Shen, Jia; Xia, Weiya; Khotskaya, Yekaterina B.; Huo, Longfei; Lim, Seung-Oe; Du, Yi; Wang, Yan; Hsu, Jennifer L.; Lam, Yung Carmen; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Shen, Jia; Du, Yi; Hung, Mien-Chie] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77030 USA; [Nakanishi, Kotaro; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Chang, Wei-Chao; Hsu, Jennifer L.; Hung, Mien-Chie] China Med Univ, Ctr Mol Med, Taichung 402, Taiwan; [Chang, Wei-Chao; Hsu, Jennifer L.; Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung 402, Taiwan; [Chang, Wei-Chao; Chen, Chung-Hsuan] Acad Sinica, Genom Res Ctr, Taipei 105, Taiwan; [Hsu, Jennifer L.; Hung, Mien-Chie] Asia Univ, Taichung 413, Taiwan; [Wu, Yun] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [James, Brian P.; Liu, Xiuping; Liu, Chang-Gong] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; China Medical University Taiwan; China Medical University Taiwan; Academia Sinica - Taiwan; Asia University Taiwan; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Hung, MC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	mhung@mdanderson.org	Chen, Chung-Hsuan/F-7940-2012; Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740; Du, Yi/0000-0002-3969-2652; Nakanishi, Kotaro/0000-0002-9857-6010	US National Institutes of Health [CA109311, CA099031, CA16672]; US National Breast Cancer Foundation; Center for Biological Pathway at the UT MD Anderson Cancer Center, S. G. Komen [SAC110016]; Sister Institution Fund of China Medical University and Hospital; UT MD Anderson Cancer Center; Cancer Research Center of Excellence, Taiwan [D0H102-TD-C-111-005]; Private University grant, Taiwan [NSC99-2632-B-039-001-MY3]; Program for Stem Cell and Regenerative Medicine Frontier Research, Taiwan [NSC101-2321-B-039-001]; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA099031, P30CA016672, R01CA109311] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Breast Cancer Foundation; Center for Biological Pathway at the UT MD Anderson Cancer Center, S. G. Komen; Sister Institution Fund of China Medical University and Hospital; UT MD Anderson Cancer Center; Cancer Research Center of Excellence, Taiwan; Private University grant, Taiwan; Program for Stem Cell and Regenerative Medicine Frontier Research, Taiwan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank B. Pickering, D. Yu, and A.-B. Shyu for suggestions and technical assistance with northern blot analysis. This work was supported by the US National Institutes of Health (CA109311 and CA099031 to M.-C. H., and CCSG Core Grant CA16672), the US National Breast Cancer Foundation, The Center for Biological Pathway at the UT MD Anderson Cancer Center, S. G. Komen (SAC110016 to M.-C. H.), The Sister Institution Fund of China Medical University and Hospital and the UT MD Anderson Cancer Center, the Cancer Research Center of Excellence (D0H102-TD-C-111-005, Taiwan), a Private University grant (NSC99-2632-B-039-001-MY3, Taiwan), and the Program for Stem Cell and Regenerative Medicine Frontier Research (NSC101-2321-B-039-001, Taiwan).	Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cikaluk DE, 1999, MOL BIOL CELL, V10, P3357, DOI 10.1091/mbc.10.10.3357; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Franovic A, 2007, P NATL ACAD SCI USA, V104, P13092, DOI 10.1073/pnas.0702387104; Gould GW, 2009, NAT REV MOL CELL BIO, V10, P287, DOI 10.1038/nrm2652; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lee OH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001628; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Leung AKL, 2007, CELL, V130, P581, DOI 10.1016/j.cell.2007.08.010; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tahbaz N, 2004, EMBO REP, V5, P189, DOI 10.1038/sj.embor.7400070; Tsutsumi A, 2011, NAT STRUCT MOL BIOL, V18, P1153, DOI 10.1038/nsmb.2125; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Wang Y, 2009, NAT MED, V15, P319, DOI 10.1038/nm.1922	27	264	271	2	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2013	497	7449					383	387		10.1038/nature12080	http://dx.doi.org/10.1038/nature12080			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23636329	Green Accepted			2022-12-28	WOS:000318952000041
J	Agaku, IT; Vardavas, CI; Ayo-Yusuf, OA; Alpert, HR; Connolly, GN				Agaku, Israel T.; Vardavas, Constantine I.; Ayo-Yusuf, Olalekan A.; Alpert, Hillel R.; Connolly, Gregory N.			Temporal Trends in Smokeless Tobacco Use Among US Middle and High School Students, 2000-2011	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							UNITED-STATES		[Agaku, Israel T.; Vardavas, Constantine I.; Alpert, Hillel R.; Connolly, Gregory N.] Harvard Univ, Sch Publ Hlth, Ctr Global Tobacco Control, Boston, MA 02115 USA; [Ayo-Yusuf, Olalekan A.] Univ Pretoria, Dept Community Dent, ZA-0002 Pretoria, South Africa	Harvard University; Harvard T.H. Chan School of Public Health; University of Pretoria	Agaku, IT (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Global Tobacco Control, 665 Huntington Ave, Boston, MA 02115 USA.	iagaku@post.harvard.edu	Vardavas, Constantine/O-4961-2016; Vardavas, Constantine I/G-7598-2011; Alpert, Hillel/AFZ-0656-2022; Ayo-Yusuf, Olalekan/A-1512-2008	Vardavas, Constantine/0000-0003-0171-9570; Ayo-Yusuf, Olalekan/0000-0003-0689-7018				Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; Carpenter CM, 2009, TOB CONTROL, V18, P54, DOI 10.1136/tc.2008.026583; Nelson DE, 2006, AM J PUBLIC HEALTH, V96, P897, DOI 10.2105/AJPH.2004.061580; Ribisl KM, 2012, NICOTINE TOB RES, V14, P43, DOI 10.1093/ntr/ntr098; Tynan M., 2010, Morbidity and Mortality Weekly Report, V59, P487; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO	6	14	14	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2013	309	19					1992	1994		10.1001/jama.2013.4412	http://dx.doi.org/10.1001/jama.2013.4412			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143GQ	23677308				2022-12-28	WOS:000318855500016
J	Bird, J; Biggs, TC; Thomas, M; Salib, RJ				Bird, J.; Biggs, T. C.; Thomas, M.; Salib, R. J.			10-MINUTE CONSULTATION Adult acute rhinosinusitis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bird, J.; Biggs, T. C.; Salib, R. J.] Univ Hosp Southampton NHS Fdn Trust, Dept Otolaryngol Head & Neck Surg, Southampton SO16 6YD, Hants, England; [Thomas, M.] Univ Southampton, Aldermoor Hlth Ctr, Southampton SO9 5NH, Hants, England; [Salib, R. J.] Univ Southampton, Fac Med, Clin Expt Sci Acad Unit, Southampton SO9 5NH, Hants, England	University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University of Southampton	Bird, J (corresponding author), Univ Hosp Southampton NHS Fdn Trust, Dept Otolaryngol Head & Neck Surg, Southampton SO16 6YD, Hants, England.	jonathan.bird83@googlemail.com		Thomas, Mike/0000-0001-5939-1155; Salib, Rami/0000-0002-6753-7844					0	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2013	346								f2687	10.1136/bmj.f2687	http://dx.doi.org/10.1136/bmj.f2687			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	144BV	23667070				2022-12-28	WOS:000318915300001
J	Harris, E; Sinha, B; van Pinxteren, D; Tilgner, A; Fomba, KW; Schneider, J; Roth, A; Gnauk, T; Fahlbusch, B; Mertes, S; Lee, T; Collett, J; Foley, S; Borrmann, S; Hoppe, P; Herrmann, H				Harris, Eliza; Sinha, Baerbel; van Pinxteren, Dominik; Tilgner, Andreas; Fomba, Khanneh Wadinga; Schneider, Johannes; Roth, Anja; Gnauk, Thomas; Fahlbusch, Benjamin; Mertes, Stephan; Lee, Taehyoung; Collett, Jeffrey; Foley, Stephen; Borrmann, Stephan; Hoppe, Peter; Herrmann, Hartmut			Enhanced Role of Transition Metal Ion Catalysis During In-Cloud Oxidation of SO2	SCIENCE			English	Article							SULFUR ISOTOPE FRACTIONATION; AEROSOL LIGHT-SCATTERING; HETEROGENEOUS OXIDATION; SULFATE PRODUCTION; GLOBAL-MODEL; CHEMISTRY; IRON; IMPACT; CYCLE; DUST	Global sulfate production plays a key role in aerosol radiative forcing; more than half of this production occurs in clouds. We found that sulfur dioxide oxidation catalyzed by natural transition metal ions is the dominant in-cloud oxidation pathway. The pathway was observed to occur primarily on coarse mineral dust, so the sulfate produced will have a short lifetime and little direct or indirect climatic effect. Taking this into account will lead to large changes in estimates of the magnitude and spatial distribution of aerosol forcing. Therefore, this oxidation pathway-which is currently included in only one of the 12 major global climate models-will have a significant impact on assessments of current and future climate.	[Harris, Eliza; Sinha, Baerbel; Schneider, Johannes; Roth, Anja; Borrmann, Stephan; Hoppe, Peter] Max Planck Inst Chem, Particle Chem Dept, D-55128 Mainz, Germany; [Sinha, Baerbel] IISER Mohali, Dept Earth Sci, Manauli 140306, India; [van Pinxteren, Dominik; Tilgner, Andreas; Fomba, Khanneh Wadinga; Gnauk, Thomas; Fahlbusch, Benjamin; Mertes, Stephan; Herrmann, Hartmut] Leibniz Inst Tropospher Res TROPOS, D-04318 Leipzig, Germany; [Lee, Taehyoung; Collett, Jeffrey] Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA; [Foley, Stephen] Johannes Gutenberg Univ Mainz, Inst Geosci, Earth Syst Sci Res Ctr, D-55128 Mainz, Germany; [Borrmann, Stephan] Johannes Gutenberg Univ Mainz, Inst Atmospher Phys, D-55128 Mainz, Germany	Max Planck Society; Indian Institute of Science Education & Research (IISER) - Mohali; Leibniz Institut fur Tropospharenforschung (TROPOS); Colorado State University; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Harris, E (corresponding author), MIT, Cambridge, MA 02142 USA.	elizah@mit.edu; baerbel.sinha@mpic.de	Mertes, Stephan/Y-4487-2018; Herrmann, Hartmut/C-2486-2009; Tilgner, Andreas/AAS-4610-2021; Harris, Eliza/AAM-7953-2020; Schneider, Johannes/A-2674-2010; Borrmann, Stephan/E-3868-2010; Foley, Stephen/I-1759-2013; Sinha, Baerbel/H-1250-2012; Hoppe, Peter/B-3032-2015; Collett, Jeffrey L/F-2862-2010; Lee, Taehyoung/I-6246-2015; Borrmann, Steffen/G-1838-2013	Herrmann, Hartmut/0000-0001-7044-2101; Tilgner, Andreas/0000-0003-4021-4874; Harris, Eliza/0000-0002-7102-8305; Schneider, Johannes/0000-0001-7169-3973; Borrmann, Stephan/0000-0002-4774-9380; Sinha, Baerbel/0000-0001-8614-7473; Hoppe, Peter/0000-0003-3681-050X; Collett, Jeffrey L/0000-0001-9180-508X; Lee, Taehyoung/0000-0003-3792-0663; Foley, Stephen/0000-0001-7510-0223; Borrmann, Steffen/0000-0001-9189-4393	Max Planck Society; Max Planck Graduate Centre; Deutsche Forschungsgemeinschaft [HE 3086/15-1]; TROPOS Leipzig; NSF [AGS 1050052]; Directorate For Geosciences [1050052] Funding Source: National Science Foundation	Max Planck Society(Max Planck SocietyFoundation CELLEX); Max Planck Graduate Centre; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); TROPOS Leipzig; NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank E. Groner for his support with the NanoSIMS analyses, J. Huth for his help with the scanning electron microscopy and energy-dispersive x-ray spectroscopy analyses, and all the participants of HCCT-2010 for an interesting and successful campaign. This research was funded by the Max Planck Society and the Max Planck Graduate Centre. The HCCT-2010 campaign was partially funded by the Deutsche Forschungsgemeinschaft under contract HE 3086/15-1. Participation of Colorado State University scientists was supported by grants from TROPOS Leipzig and by NSF grant AGS 1050052.	Alexander B, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010486; Andreae MO, 2005, NATURE, V435, P1187, DOI 10.1038/nature03671; Barrie LA, 2001, TELLUS B, V53, P615, DOI 10.1034/j.1600-0889.2001.530507.x; Berglen TF, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003948; BOTHA CF, 1994, ATMOS ENVIRON, V28, P3207, DOI 10.1016/1352-2310(94)00174-J; Bower KN, 1997, ATMOS ENVIRON, V31, P2527, DOI 10.1016/S1352-2310(96)00317-2; Chin M, 1996, J GEOPHYS RES-ATMOS, V101, P18667, DOI 10.1029/96JD01221; GERVAT GP, 1988, NATURE, V333, P241, DOI 10.1038/333241a0; Goto D, 2011, ATMOS CHEM PHYS, V11, P10889, DOI 10.5194/acp-11-10889-2011; GRAEDEL TE, 1986, J GEOPHYS RES-ATMOS, V91, P5205, DOI 10.1029/JD091iD04p05205; GRGIC I, 1991, ATMOS ENVIRON A-GEN, V25, P1591, DOI 10.1016/0960-1686(91)90017-2; Harris E, 2012, ATMOS CHEM PHYS, V12, P4619, DOI 10.5194/acp-12-4619-2012; Harris E, 2012, ATMOS CHEM PHYS, V12, P4867, DOI 10.5194/acp-12-4867-2012; Harris E, 2012, ATMOS CHEM PHYS, V12, P407, DOI 10.5194/acp-12-407-2012; Hegg DA, 2004, TELLUS B, V56, P285, DOI 10.1111/j.1600-0889.2004.00099.x; Hegg DA, 1996, GEOPHYS RES LETT, V23, P2613, DOI 10.1029/96GL02419; IBUSUKI T, 1987, ATMOS ENVIRON, V21, P1555, DOI 10.1016/0004-6981(87)90317-9; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Kulmala M, 2000, NATURE, V404, P66, DOI 10.1038/35003550; Laj P, 1997, ATMOS ENVIRON, V31, P2589, DOI 10.1016/S1352-2310(97)00040-X; Laj P, 1997, ATMOS ENVIRON, V31, P2503, DOI 10.1016/S1352-2310(96)00217-8; LANGNER J, 1992, NATURE, V359, P712, DOI 10.1038/359712a0; McCabe JR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025164; Mertes S, 2005, ATMOS ENVIRON, V39, P4233, DOI 10.1016/j.atmosenv.2005.02.009; Plessow K, 2001, ATMOS ENVIRON, V35, P367, DOI 10.1016/S1352-2310(00)00134-5; Pozzoli L, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009007; RANI A, 1992, ATMOS ENVIRON A-GEN, V26, P667, DOI 10.1016/0960-1686(92)90178-N; Redington AL, 2009, ATMOS ENVIRON, V43, P3227, DOI 10.1016/j.atmosenv.2009.03.041; Rotstayn LD, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002128; Sedlak DL, 1997, ATMOS ENVIRON, V31, P2515, DOI 10.1016/S1352-2310(96)00080-5; Sofen ED, 2011, ATMOS CHEM PHYS, V11, P3565, DOI 10.5194/acp-11-3565-2011; Solomon S., 2007, PHYS SCI BASIS WORKI; TILLY J, 1991, J CHEM TECHNOL BIOT, V52, P301	33	228	236	13	379	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					727	730		10.1126/science.1230911	http://dx.doi.org/10.1126/science.1230911			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661757				2022-12-28	WOS:000318619000034
J	Rajabali, A; Caton, H				Rajabali, Alefiyah; Caton, Harmony			BOSTON MARATHON BOMBING A tale of two physicians: reflections on the Boston Marathon bombing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Rajabali, Alefiyah; Caton, Harmony] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Rajabali, A (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02114 USA.	arajabali@partners.org							0	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2013	346								f2993	10.1136/bmj.f2993	http://dx.doi.org/10.1136/bmj.f2993			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	144BV	23667127				2022-12-28	WOS:000318915300006
J	Pasquier, M; Hugli, O; Carron, PN				Pasquier, Mathieu; Hugli, Olivier; Carron, Pierre-Nicolas			Needle Aspiration of Primary Spontaneous Pneumothorax	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MANAGEMENT; TUBE		[Pasquier, Mathieu; Hugli, Olivier; Carron, Pierre-Nicolas] Univ Lausanne Hosp, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Carron, PN (corresponding author), Univ Lausanne Hosp, Emergency Serv, BH06, CH-1011 Lausanne Chuv, Switzerland.	Pierre-Nicolas-Carron@chuv.ch	Hugli, Olivier/AAA-7057-2020	Hugli, Olivier/0000-0003-2312-1625				Ho KK, 2011, AM J EMERG MED, V29, P1152, DOI 10.1016/j.ajem.2010.05.017; Kosowsky JM, 2010, ROSENS EMERGENCY MED, V1, P939; MacDuff A, 2010, THORAX, V65, P18, DOI 10.1136/thx.2010.136986; Sahn SA, 2000, NEW ENGL J MED, V342, P868, DOI 10.1056/NEJM200003233421207; WAKAI A, 2007, COCHRANE DATABASE SY; Zehtabchi S, 2008, ANN EMERG MED, V51, P309; Zehtabchi S, 2008, ANN EMERG MED, V51, P91, DOI 10.1016/j.annemergmed.2007.06.009	7	8	8	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2013	368	19								10.1056/NEJMvcm1111468	http://dx.doi.org/10.1056/NEJMvcm1111468			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138WA	23656667	Green Published			2022-12-28	WOS:000318540000011
J	Emanuel, EJ				Emanuel, Ezekiel J.			The art of medicine Reconsidering the Declaration of Helsinki	LANCET			English	Editorial Material									Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Emanuel, EJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA.	vp-global@upenn.edu						Council for International Organizations of Medical Sciences WHO, 2002, INTERNATIONAL ETHICA; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Forster HP, 2001, LANCET, V358, P1449, DOI 10.1016/S0140-6736(01)06534-5; Levine RJ, 1999, NEW ENGL J MED, V341, P531, DOI 10.1056/NEJM199908123410713; World Medical Association, 2008, DECLARATION OF HELSI	5	39	40	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 4	2013	381	9877					1532	1533		10.1016/S0140-6736(13)60970-8	http://dx.doi.org/10.1016/S0140-6736(13)60970-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139UF	23650661				2022-12-28	WOS:000318609600015
J	Chiu, HY; Liao, YH				Chiu, Hsien-Yi; Liao, Yi-Hua			Elephantiasis Neuromatosa	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chiu, Hsien-Yi; Liao, Yi-Hua] Natl Taiwan Univ Hosp, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital	Chiu, HY (corresponding author), Natl Taiwan Univ Hosp, Taipei, Taiwan.	yihualiao@ntu.edu.tw		Chiu, Hsien-Yi/0000-0002-0493-9707; LIAO, YI-HUA/0000-0002-4434-3780					0	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 2	2013	368	18					E23	E23		10.1056/NEJMicm1206146	http://dx.doi.org/10.1056/NEJMicm1206146			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134MN	23635072				2022-12-28	WOS:000318214400008
J	Norton, R; Kobusingye, O				Norton, Robyn; Kobusingye, Olive			GLOBAL HEALTH Injuries	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RURAL SOUTH-AFRICA; SYSTEMATIC ANALYSIS; CHILD MALTREATMENT; SEXUAL-BEHAVIOR; TRAUMA CARE; PREVENTION; MORTALITY; VIOLENCE; IMPACT; DISPARITIES		[Norton, Robyn] Univ Oxford, George Inst Global Hlth, Oxford, England; [Norton, Robyn] Univ Sydney, Sydney, NSW 2006, Australia; [Kobusingye, Olive] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Kobusingye, Olive] Univ S Africa, Inst Social & Hlth Sci, Johannesburg, South Africa	University of Oxford; University of Sydney; Makerere University; University of South Africa	Norton, R (corresponding author), George Inst Global Hlth, New Richards Bldg,Old Rd Campus,Roosevelt Dr, Oxford OX3 7LF, England.	rnorton@georgeinstitute.org		Kobusingye, Olive/0000-0003-2413-599X				Ameratunga S, 2006, LANCET, V367, P1533, DOI 10.1016/S0140-6736(06)68654-6; Andrews G, 2004, COMPARATIVE QUANTIFI, V2; [Anonymous], 2011, WORLD REPORT ON DISA; [Anonymous], 2011, GLOBAL PLAN FOR THE; [Anonymous], 2010, STATUS REPORT ON ROA; [Anonymous], 2009, GLOBAL FORUM ON TRAU; [Anonymous], CAUSE SPECIFIC MORTA; [Anonymous], 2010, INJURIES AND VIOLENC; [Anonymous], 2009, SEAT BELTS AND CHILD; Arias I, 2004, J WOMENS HEALTH, V13, P468, DOI 10.1089/1540999041280990; Atiyeh BS, 2010, INT J SURG, V8, P581, DOI 10.1016/j.ijsu.2010.07.291; Bhalla K, 2011, INT J INJ CONTROL SA, V18, P249, DOI 10.1080/17457300.2011.561928; Branche C., 2008, WORLD REPORT CHILD I; Briere J, 2009, TRAUMA VIOLENCE ABUS, V10, P375, DOI 10.1177/1524838009339757; Brown DW, 2009, B WORLD HEALTH ORGAN, V87, P447, DOI 10.2471/BLT.07.047423; Chu K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000078; Chu Kathryn M, 2011, Confl Health, V5, P12, DOI 10.1186/1752-1505-5-12; Cooper DJ, 2011, NEW ENGL J MED, V365, P2040; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; DiGuiseppi C, 2001, COCHRANE DB SYST REV, V2; Edwards P, 2005, LANCET, V365, P1957; EVANS C, 2009, COCHRANE DB SYST REV, V4, P7590; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Hu GQ, 2011, B WORLD HEALTH ORGAN, V89, P41, DOI 10.2471/BLT.10.080317; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Kendrick D, 2008, CHILD CARE HLTH DEV, V34, P682, DOI 10.1111/j.1365-2214.2008.00849.x; Kobusingye OC, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1261; Kopits E, 2003, POLICY RESEARCH WORK; Kristiansen T, 2010, INJURY, V41, P444, DOI 10.1016/j.injury.2009.05.027; Lalor K, 2010, TRAUMA VIOLENCE ABUS, V11, P159, DOI 10.1177/1524838010378299; Liberman M, 2004, J TRAUMA, V56, P1330, DOI 10.1097/01.TA.0000071297.76727.8B; Liberman M, 2007, CURR OPIN CRIT CARE, V13, P691, DOI 10.1097/MCC.0b013e3282f1e77e; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luboga S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000200; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Meddings DR, 2010, INJURY PREV, V16, P143, DOI 10.1136/ip.2010.026468; Meddings D, 2007, INJURY PREV, V13, P69, DOI 10.1136/ip.2006.014852; Murad MK, 2010, PREHOSP DISASTER MED, V25, P533, DOI 10.1017/S1049023X00008724; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Norton R, 2011, GLOBAL HEALTH DISEAS, P407; Olds DL, 2007, J CHILD PSYCHOL PSYC, V48, P355, DOI 10.1111/j.1469-7610.2006.01702.x; Passmore J, 2010, TRAFFIC INJ PREV, V11, P202, DOI 10.1080/15389580903497121; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Pervin A, 2009, B WORLD HEALTH ORGAN, V87, P369, DOI 10.2471/BLT.08.057109; Petrosyan M, 2009, J TRAUMA, V67, pS114, DOI 10.1097/TA.0b013e3181ad3251; Prinz RJ, 2009, PREV SCI, V10, P1, DOI 10.1007/s11121-009-0123-3; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Rivara FP, 1997, NEW ENGL J MED, V337, P543, DOI 10.1056/NEJM199708213370807; Seedat M, 2009, LANCET, V374, P978; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Ship AN, 2010, NEW ENGL J MED, V362, P2145, DOI 10.1056/NEJMp0910137; Sleet D, 2004, WORLD REPORT ON ROAD; Thompson D. C., 2000, COCHRANE DB SYST REV, V2; Timmermann A, 2008, CURR OPIN ANESTHESIO, V21, P222, DOI 10.1097/ACO.0b013e3282f5f4f7; Turner HA, 2006, SOC SCI MED, V62, P13, DOI 10.1016/j.socscimed.2005.05.030; Van Heng Y, 2008, PREHOSP DISASTER MED, V23, P483, DOI 10.1017/S1049023X00006282; WHO, 2009, GLOBAL STATUS REPORT; World Health Organization, 2002, WORLD REPORT VIOLENC; World Health Organization, 2008, GLOB BURD DIS 2004 U	61	222	236	4	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 2	2013	368	18					1723	1730		10.1056/NEJMra1109343	http://dx.doi.org/10.1056/NEJMra1109343			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	134MN	23635052				2022-12-28	WOS:000318214400006
J	Rao, DA; Lakdawala, NK; Miller, AL; Loscalzo, J				Rao, Deepak A.; Lakdawala, Neal K.; Miller, Amy Leigh; Loscalzo, Joseph			In the Thick of It	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANDERSON-FABRY-DISEASE; HYPERTROPHIC CARDIOMYOPATHY; INVOLVEMENT; PREVALENCE; THERAPY		Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Miller, AL (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	almiller@partners.org	Loscalzo, Joseph/ABD-8980-2021	Rao, Deepak/0000-0001-9672-7746	Genzyme	Genzyme(Sanofi-AventisGenzyme Corporation)	Dr. Lakdawala reports receiving grant support through his institution from Genzyme. No other potential conflict of interest relevant to this article was reported.	ANAN R, 1995, CIRCULATION, V91, P955, DOI 10.1161/01.CIR.91.4.955; Arad M, 2005, NEW ENGL J MED, V352, P362, DOI 10.1056/NEJMoa033349; Aryana A, 2008, PACE, V31, P782, DOI 10.1111/j.1540-8159.2008.01088.x; Banikazemi M, 2007, ANN INTERN MED, V146, P77, DOI 10.7326/0003-4819-146-2-200701160-00148; Bobkowski W, 2007, J APPL GENET, V48, P185, DOI 10.1007/BF03194677; Elliott P, 2011, HEART, V97, P1957, DOI 10.1136/heartjnl-2011-300364; Gambarin FI, 2010, AM J CARDIOL, V106, P1492, DOI 10.1016/j.amjcard.2010.07.016; Germain DP, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-30; Linthorst GE, 2010, J MED GENET, V47, P217, DOI 10.1136/jmg.2009.072116; Pisani A, 2012, MOL GENET METAB, V107, P267, DOI 10.1016/j.ymgme.2012.08.003; Sachdev B, 2002, CIRCULATION, V105, P1407, DOI 10.1161/01.CIR.0000012626.81324.38; Sega R, 2001, CIRCULATION, V104, P1385, DOI 10.1161/hc3701.096100; Shah JS, 2005, AM J CARDIOL, V96, P842, DOI 10.1016/j.amjcard.2005.05.033; Wilcox WR, 2008, MOL GENET METAB, V93, P112, DOI 10.1016/j.ymgme.2007.09.013; Wu JC, 2010, EUR HEART J, V31, P1088, DOI 10.1093/eurheartj/ehp588	15	3	4	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 2	2013	368	18					1732	1738		10.1056/NEJMcps1209279	http://dx.doi.org/10.1056/NEJMcps1209279			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134MN	23635054				2022-12-28	WOS:000318214400009
J	Anzellini, S; Dewaele, A; Mezouar, M; Loubeyre, P; Morard, G				Anzellini, S.; Dewaele, A.; Mezouar, M.; Loubeyre, P.; Morard, G.			Melting of Iron at Earth's Inner Core Boundary Based on Fast X-ray Diffraction	SCIENCE			English	Article							PHASE-TRANSITIONS; TEMPERATURES; CURVE	Earth's core is structured in a solid inner core, mainly composed of iron, and a liquid outer core. The temperature at the inner core boundary is expected to be close to the melting point of iron at 330 gigapascal (GPa). Despite intensive experimental and theoretical efforts, there is little consensus on the melting behavior of iron at these extreme pressures and temperatures. We present static laser-heated diamond anvil cell experiments up to 200 GPa using synchrotron-based fast x-ray diffraction as a primary melting diagnostic. When extrapolating to higher pressures, we conclude that the melting temperature of iron at the inner core boundary is 6230 +/- 500 kelvin. This estimation favors a high heat flux at the core-mantle boundary with a possible partial melting of the mantle.	[Anzellini, S.; Dewaele, A.; Loubeyre, P.] CEA, Direct Applicat Mil Ile de France, F-91297 Arpajon, France; [Mezouar, M.] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Morard, G.] Univ Paris 06, CNRS, UMR 7590, Inst Mineral & Phys Milieux Condenses, F-75005 Paris, France	CEA; European Synchrotron Radiation Facility (ESRF); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD)	Anzellini, S (corresponding author), CEA, Direct Applicat Mil Ile de France, F-91297 Arpajon, France.	simone.anzellini@cea.fr	Anzellini, Simone/O-7404-2019; Morard, Guillaume/AAX-8454-2020	Anzellini, Simone/0000-0003-0091-3902; Morard, Guillaume/0000-0002-4225-0767	 [ANR-12-BS04-001504]		The authors acknowledge the European Synchrotron Radiation Facility for provision of beamtime. G. M. is funded by grant ANR-12-BS04-001504. We thank G. Garbarino and A. Salamat for experimental help and C. Sanloup and D. Spaulding for their comments on this manuscript. Data are available in the supplementary materials.	Alfe D, 2007, CONTEMP PHYS, V48, P63, DOI 10.1080/00107510701529653; Alfe D, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.165118; Alfe D, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.060101; Belonoshko AB, 2000, PHYS REV LETT, V84, P3638, DOI 10.1103/PhysRevLett.84.3638; Belonoshko AB, 2003, NATURE, V424, P1032, DOI 10.1038/nature01954; BOEHLER R, 1993, NATURE, V363, P534, DOI 10.1038/363534a0; Boehler R, 2008, J PHYS CONF SER, V121, DOI 10.1088/1742-6596/121/2/022018; BOEHLER R, 1990, J GEOPHYS RES-SOLID, V95, P21731, DOI 10.1029/JB095iB13p21731; Brown JM, 2001, GEOPHYS RES LETT, V28, P4339, DOI 10.1029/2001GL013759; BROWN JM, 1986, J GEOPHYS RES-SOLID, V91, P7485, DOI 10.1029/JB091iB07p07485; Dewaele A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.215504; Dewaele A, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.255701; Fiquet G, 2010, SCIENCE, V329, P1516, DOI 10.1126/science.1192448; Geballe ZM, 2012, J APPL PHYS, V111, DOI 10.1063/1.4729905; Gubbins D, 2011, NATURE, V473, P361, DOI 10.1038/nature10068; Jackson JM, 2013, EARTH PLANET SC LETT, V362, P143, DOI 10.1016/j.epsl.2012.11.048; Komabayashi T, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006442; Komabayashi T, 2009, EARTH PLANET SC LETT, V282, P252, DOI 10.1016/j.epsl.2009.03.025; Lay T, 2008, NAT GEOSCI, V1, P25, DOI 10.1038/ngeo.2007.44; Luo SN, 2004, PHYS EARTH PLANET IN, V143, P369, DOI 10.1016/j.pepi.2003.04.001; Ma Y. Z., 2004, PHYS EARTH PLANET IN, V143-444, P155; Nguyen JH, 2004, NATURE, V427, P339, DOI 10.1038/nature02248; POIRIER JP, 1994, PHYS EARTH PLANET IN, V85, P319, DOI 10.1016/0031-9201(94)90120-1; Pozzo M, 2012, NATURE, V485, P355, DOI 10.1038/nature11031; Shen GY, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.185701; Sola E, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.078501; Swartzendruber L., 1982, J PHASE EQUILIB, V3, P161, DOI [10.1007/BF02892374, DOI 10.1007/BF02892374]; Tateno S, 2010, SCIENCE, V330, P359, DOI 10.1126/science.1194662; Tateno S, 2009, EARTH PLANET SC LETT, V277, P130, DOI 10.1016/j.epsl.2008.10.004; WILLIAMS Q, 1987, SCIENCE, V236, P181, DOI 10.1126/science.236.4798.181; WILLIAMS Q, 1991, J GEOPHYS RES-SOLID, V96, P2171, DOI 10.1029/90JB01999; YOO CS, 1993, PHYS REV LETT, V70, P3931, DOI 10.1103/PhysRevLett.70.3931	32	368	374	6	235	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					464	466		10.1126/science.1233514	http://dx.doi.org/10.1126/science.1233514			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620049				2022-12-28	WOS:000318016700038
J	Leathers, ML; Olson, CR				Leathers, Marvin L.; Olson, Carl R.			Response to Comment on "In Monkeys Making Value-Based Decisions, LIP Neurons Encode Cue Salience and Not Action Value"	SCIENCE			English	Editorial Material							LATERAL INTRAPARIETAL CORTEX		[Leathers, Marvin L.; Olson, Carl R.] Carnegie Mellon Univ, Mellon Inst, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA; [Leathers, Marvin L.; Olson, Carl R.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Leathers, ML (corresponding author), Carnegie Mellon Univ, Mellon Inst, Ctr Neural Basis Cognit, Room 115,4400 5th Ave, Pittsburgh, PA 15213 USA.	mleathers@cnbc.cmu.edu						Klein JT, 2008, CURR BIOL, V18, P419, DOI 10.1016/j.cub.2008.02.047; Leathers ML, 2012, SCIENCE, V338, P132, DOI 10.1126/science.1226405; Louie K, 2010, J NEUROSCI, V30, P5498, DOI 10.1523/JNEUROSCI.5742-09.2010; Meister MLR, 2013, J NEUROSCI, V33, P2254, DOI 10.1523/JNEUROSCI.2984-12.2013; Newsome WT, 2013, SCIENCE, V340, DOI 10.1126/science.1233214; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Premereur E, 2011, J NEUROSCI, V31, P12307, DOI 10.1523/JNEUROSCI.2241-11.2011; Rorie AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009308; Seo H, 2009, J NEUROSCI, V29, P7278, DOI 10.1523/JNEUROSCI.1479-09.2009; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666	11	7	7	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131								10.1126/science.1233367	http://dx.doi.org/10.1126/science.1233367			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620038				2022-12-28	WOS:000318016700022
J	Reed, TE; Grotan, V; Jenouvrier, S; Saether, BE; Visser, ME				Reed, Thomas E.; Grotan, Vidar; Jenouvrier, Stephanie; Saether, Bernt-Erik; Visser, Marcel E.			Population Growth in a Wild Bird Is Buffered Against Phenological Mismatch	SCIENCE			English	Article							CLIMATE-CHANGE; DENSITY-DEPENDENCE; GREAT TITS; SELECTION; EVOLUTION; ADAPTATION; FITNESS; DYNAMICS; BIOLOGY; SHIFTS	Broad-scale environmental changes are altering patterns of natural selection in the wild, but few empirical studies have quantified the demographic cost of sustained directional selection in response to these changes. We tested whether population growth in a wild bird is negatively affected by climate change-induced phenological mismatch, using almost four decades of individual-level life-history data from a great tit population. In this population, warmer springs have generated a mismatch between the annual breeding time and the seasonal food peak, intensifying directional selection for earlier laying dates. Interannual variation in population mismatch has not, however, affected population growth. We demonstrated a mechanism contributing to this uncoupling, whereby fitness losses associated with mismatch are counteracted by fitness gains due to relaxed competition. These findings imply that natural populations may be able to tolerate considerable maladaptation driven by shifting climatic conditions without undergoing immediate declines.	[Reed, Thomas E.; Visser, Marcel E.] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, NL-6700 AB Wageningen, Netherlands; [Grotan, Vidar; Saether, Bernt-Erik] Norwegian Univ Sci & Technol, Dept Biol, Ctr Conservat Biol, NO-7491 Trondheim, Norway; [Jenouvrier, Stephanie] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Jenouvrier, Stephanie] CNRS, Ctr Etud Biol Chize, F-79360 Villiers En Bois, France	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Norwegian University of Science & Technology (NTNU); Woods Hole Oceanographic Institution; Centre National de la Recherche Scientifique (CNRS)	Reed, TE (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, POB 50, NL-6700 AB Wageningen, Netherlands.	t.reed@nioo.knaw.nl	Grøtan, Vidar/A-4056-2008; Visser, Marcel E/A-9151-2009; Reed, Thomas E/A-5788-2012; Grøtan, Vidar/O-9453-2019; KNAW, NIOO-KNAW/A-4320-2012	Grøtan, Vidar/0000-0003-1222-0724; Visser, Marcel E/0000-0002-1456-1939; Reed, Thomas E/0000-0002-2993-0477; Grøtan, Vidar/0000-0003-1222-0724; jenouvrier, stephanie/0000-0003-3324-2383; KNAW, NIOO-KNAW/0000-0002-3835-159X	Netherlands Organisation for Scientific Research-VICI grant	Netherlands Organisation for Scientific Research-VICI grant	Stichting Nationaal Park De Hoge Veluwe kindly gave permission to work in their woodlands. The authors thank the many fieldworkers who have contributed to data collection over the years. M. Kinnison, R. Waples, K. Lessells, and P. Gienapp provided valuable comments. M. E. V. is supported by a Netherlands Organisation for Scientific Research-VICI grant. M. E. V. supervised the long-term population study; T. E. R., M. E. V., B.-E. S., V. G., and S.J. conceived the questions and analyses; T. E. R. and V. G. analyzed the data; and T. E. R. and M. E. V. wrote the paper. Data, results, and the R code for the simulation model are available on Dryad (http://datadryad.org).	Bauchau V, 1995, J APPL STAT, V22, P1031, DOI 10.1080/02664769524775; Both C, 1999, P ROY SOC B-BIOL SCI, V266, P465, DOI 10.1098/rspb.1999.0660; Boyce MS, 1999, OIKOS, V87, P419, DOI 10.2307/3546808; BURGER R, 1995, EVOLUTION, V49, P151, DOI 10.1111/j.1558-5646.1995.tb05967.x; Burger R, 2004, EVOLUTIONARY CONSERV, P171; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Falconer DS, 1996, INTRO QUANTITATIVE G, V4; Gienapp P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0289; GOMULKIEWICZ R, 1995, EVOLUTION, V49, P201, DOI 10.1111/j.1558-5646.1995.tb05971.x; Gosler A, 1993, GREAT TIT; Grotan V, 2009, J ANIM ECOL, V78, P447, DOI 10.1111/j.1365-2656.2008.01488.x; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Hellmann JJ, 2007, BIOL CONSERV, V137, P599, DOI 10.1016/j.biocon.2007.03.018; Kingsolver JG, 2007, BIOSCIENCE, V57, P561, DOI 10.1641/B570706; Kinnison MT, 2007, FUNCT ECOL, V21, P444, DOI 10.1111/j.1365-2435.2007.01278.x; Lande R, 1996, EVOLUTION, V50, P434, DOI 10.2307/2410812; Lande R, 2007, EVOLUTION, V61, P1835, DOI 10.1111/j.1558-5646.2007.00170.x; Lande R, 2009, PHILOS T R SOC B, V364, P1511, DOI 10.1098/rstb.2009.0017; Lane JE, 2012, NATURE, V489, P554, DOI 10.1038/nature11335; LYNCH M, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P234; Miller-Rushing AJ, 2010, PHILOS T R SOC B, V365, P3177, DOI 10.1098/rstb.2010.0148; Reed TE, 2013, J ANIM ECOL, V82, P131, DOI 10.1111/j.1365-2656.2012.02020.x; Rose KA, 2001, FISH FISH, V2, P293, DOI 10.1046/j.1467-2960.2001.00056.x; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Thomas DW, 2001, SCIENCE, V291, P2598, DOI 10.1126/science.1057487; VANNOORDWIJK AJ, 1995, J ANIM ECOL, V64, P451, DOI 10.2307/5648; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Wilson S, 2003, P NATL ACAD SCI USA, V100, P11139, DOI 10.1073/pnas.1931407100	32	131	139	3	223	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					488	491		10.1126/science.1232870	http://dx.doi.org/10.1126/science.1232870			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620055				2022-12-28	WOS:000318016700045
J	Helwak, A; Kudla, G; Dudnakova, T; Tollervey, D				Helwak, Aleksandra; Kudla, Grzegorz; Dudnakova, Tatiana; Tollervey, David			Mapping the Human miRNA Interactome by CLASH Reveals Frequent Noncanonical Binding	CELL			English	Article							RNA INTERACTIONS; MICRORNA; PROTEIN; DETERMINANTS; RECOGNITION; ARGONAUTE2; PREDICTION; STABILITY; CLEAVAGE; GENES	MicroRNAs (miRNAs) play key roles in gene regulation, but reliable bioinformatic or experimental identification of their targets remains difficult. To provide an unbiased view of human miRNA targets, we developed a technique for ligation and sequencing of miRNA-target RNA duplexes associated with human AGO1. Here, we report data sets of more than 18,000 high-confidence miRNA-mRNA interactions. The binding of most miRNAs includes the 5' seed region, but around 60% of seed interactions are noncanonical, containing bulged or mismatched nucleotides. Moreover, seed interactions are generally accompanied by specific, nonseed base pairing. 18% of miRNA-mRNA interactions involve the miRNA 3' end, with little evidence for 5' contacts, and some of these were functionally validated. Analyses of miRNA: mRNA base pairing showed that miRNA species systematically differ in their target RNA interactions, and strongly overrepresented motifs were found in the interaction sites of several miRNAs. We speculate that these affect the response of RISC to miRNA-target binding.	[Helwak, Aleksandra; Kudla, Grzegorz; Dudnakova, Tatiana; Tollervey, David] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh	Tollervey, D (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland.	d.tollervey@ed.ac.uk	Tollervey, David/AAR-6662-2020	Tollervey, David/0000-0003-2894-2772; Dudnakova, Tatyana/0000-0002-8388-8871; Kudla, Grzegorz/0000-0002-7924-2744	Wellcome Trust [077248, 097383, 092076]	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank Amy Buck and Gracjan Michlewski for critical comments on the manuscript, Sander Granneman for helpful technical suggestions, Guido Sanguinetti and members of the Tollervey lab for discussions, and Ricardo Almeida and Markus Bohnsack for vectors. This work was supported by Wellcome Trust grants to D.T. (077248) and G.K. (097383). Work in the in the Wellcome Trust Centre for Cell Biology is supported by Wellcome Trust core funding (092076). A.H., G.K., T.D., and D.T. designed the experiments; A.H. and T.D. performed experiments; A.H., G.K., and D.T. analyzed the data; and A.H., G.K., and D.T. wrote the paper.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Broderick JA, 2011, RNA, V17, P1858, DOI 10.1261/rna.2778911; Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.8.1.14300; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Chen PS, 2011, J CLIN INVEST, V121, P3442, DOI 10.1172/JCI45390; Chi SW, 2012, NAT STRUCT MOL BIOL, V19, P321, DOI 10.1038/nsmb.2230; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Elefant N, 2011, BIOINFORMATICS, V27, P3093, DOI 10.1093/bioinformatics/btr534; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Grey F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000967; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Ha I, 1996, GENE DEV, V10, P3041, DOI 10.1101/gad.10.23.3041; Hafner Markus, 2010, J Vis Exp, DOI 10.3791/2034; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kudla G, 2011, P NATL ACAD SCI USA, V108, P10010, DOI 10.1073/pnas.1017386108; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Y, 2010, CANCER RES, V70, P7894, DOI 10.1158/0008-5472.CAN-10-1675; Liang XH, 2011, NUCLEIC ACIDS RES, V39, P4875, DOI 10.1093/nar/gkr076; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Nelson PT, 2011, NUCLEIC ACIDS RES, V39, P8163, DOI 10.1093/nar/gkr532; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Politz JCR, 2006, P NATL ACAD SCI USA, V103, P18957, DOI 10.1073/pnas.0609466103; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Tang R, 2012, CELL RES, V22, P504, DOI 10.1038/cr.2011.137; Vella MC, 2004, CHEM BIOL, V11, P1619, DOI 10.1016/j.chembiol.2004.09.010; Wang WX, 2010, RNA BIOL, V7, P373, DOI 10.4161/rna.7.3.11693; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873	46	844	876	4	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 25	2013	153	3					654	665		10.1016/j.cell.2013.03.043	http://dx.doi.org/10.1016/j.cell.2013.03.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622248	Green Published, hybrid			2022-12-28	WOS:000318063500017
J	Natkanski, E; Lee, WY; Mistry, B; Casal, A; Molloy, JE; Tolar, P				Natkanski, Elizabeth; Lee, Wing-Yiu; Mistry, Bhakti; Casal, Antonio; Molloy, Justin E.; Tolar, Pavel			B Cells Use Mechanical Energy to Discriminate Antigen Affinities	SCIENCE			English	Article							SUBCAPSULAR SINUS MACROPHAGES; MYOSIN-II; DYNAMICS; ADHESION; CAPTURE	The generation of high-affinity antibodies depends on the ability of B cells to extract antigens from the surfaces of antigen-presenting cells. B cells that express high-affinity B cell receptors (BCRs) acquire more antigen and obtain better T cell help. However, the mechanisms by which B cells extract antigen remain unclear. Using fluid and flexible membrane substrates to mimic antigen-presenting cells, we showed that B cells acquire antigen by dynamic myosin IIa-mediated contractions that pull out and invaginate the presenting membranes. The forces generated by myosin IIa contractions ruptured most individual BCR-antigen bonds and promoted internalization of only high-affinity, multivalent BCR microclusters. Thus, B cell contractility contributes to affinity discrimination by mechanically testing the strength of antigen binding.	[Natkanski, Elizabeth; Lee, Wing-Yiu; Mistry, Bhakti; Casal, Antonio; Tolar, Pavel] Natl Inst Med Res, MRC, Div Immune Cell Biol, London NW7 1AA, England; [Molloy, Justin E.] Natl Inst Med Res, MRC, Div Phys Biochem, London NW7 1AA, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research	Tolar, P (corresponding author), Natl Inst Med Res, MRC, Div Immune Cell Biol, Mill Hill, London NW7 1AA, England.	ptolar@nimr.mrc.ac.uk	Lee, Wing-Yiu/AAC-8824-2019	Lee, Wing-Yiu/0000-0002-8524-3874; Molloy, Justin/0000-0002-8307-2450; Tolar, Pavel/0000-0003-4693-7299	Medical Research Council UK [U117597138, U117570592]; MRC [MC_U117570592, MC_U117597138] Funding Source: UKRI; Medical Research Council [MC_U117570592, MC_U117597138] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank S. Martin for help with binding studies. B1-8<SUP>flox/flox</SUP> mice were a gift from K. Rajewsky, obtained under material transfer agreement with Mouse Genetics Cologne Foundation. This work was supported by Medical Research Council UK (Unit Programmes numbers U117597138 and U117570592).	Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Batista FD, 2000, EMBO J, V19, P513, DOI 10.1093/emboj/19.4.513; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Boulant S, 2011, NAT CELL BIOL, V13, P1124, DOI 10.1038/ncb2307; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Chaturvedi A, 2011, NAT IMMUNOL, V12, P1119, DOI 10.1038/ni.2116; Cureton DK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001127; Dudko OK, 2008, P NATL ACAD SCI USA, V105, P15755, DOI 10.1073/pnas.0806085105; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; Fleire SJ, 2006, SCIENCE, V312, P738, DOI 10.1126/science.1123940; Gonzalez SF, 2010, NAT IMMUNOL, V11, P427, DOI 10.1038/ni.1856; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Levayer R, 2011, NAT CELL BIOL, V13, P529, DOI 10.1038/ncb2224; Liu WL, 2010, J EXP MED, V207, P1095, DOI 10.1084/jem.20092123; MOORE MS, 1987, SCIENCE, V236, P558, DOI 10.1126/science.2883727; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Stoddart A, 2005, MOL BIOL CELL, V16, P2339, DOI 10.1091/mbc.e05-01-0025; Suzuki K, 2009, J EXP MED, V206, P1485, DOI 10.1084/jem.20090209; Tolar P, 2009, IMMUNITY, V30, P44, DOI 10.1016/j.immuni.2008.11.007; Treanor B, 2010, IMMUNITY, V32, P187, DOI 10.1016/j.immuni.2009.12.005; Vascotto F, 2007, J CELL BIOL, V176, P1007, DOI 10.1083/jcb.200611147; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Yuseff MI, 2011, IMMUNITY, V35, P361, DOI 10.1016/j.immuni.2011.07.008	28	160	163	2	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 28	2013	340	6140					1587	1590		10.1126/science.1237572	http://dx.doi.org/10.1126/science.1237572			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	172ME	23686338	Green Accepted			2022-12-28	WOS:000321007000046
J	Holmes, D				Holmes, David			Sadiqua Jafarey: mother to a nation	LANCET			English	Biographical-Item																		JAFAREY S, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 22	2013	381	9884					2155	2155		10.1016/S0140-6736(13)61028-4	http://dx.doi.org/10.1016/S0140-6736(13)61028-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KH	23684260				2022-12-28	WOS:000320925600015
J	Horton, R				Horton, Richard			Pakistan: health is an opportunity to be seized	LANCET			English	Editorial Material							CLUSTER RANDOMIZED-TRIAL		The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Ahmed QA, 2013, LANCET; Bari A, 2011, LANCET, V378, P1796, DOI 10.1016/S0140-6736(11)61140-9; Bhutta ZA, 2013, LANCET; Bhutta ZA, 2011, LANCET, V377, P403, DOI 10.1016/S0140-6736(10)62274-X; Jafar TH, 2009, ANN INTERN MED, V151, P593, DOI 10.7326/0003-4819-151-9-200911030-00004; Jafar TH, 2013, LANCET; Nishtar S, 2013, LANCET; Nishtar S, 2012, LANCET, V379, P1084, DOI 10.1016/S0140-6736(12)60277-3; Nishtar S, 2011, LANCET, V378, P648, DOI 10.1016/S0140-6736(11)60606-5; RAB SM, 1976, LANCET, V2, P1211; Rahman A, 1998, LANCET, V352, P1022, DOI 10.1016/S0140-6736(98)02381-2; Soofi S, 2013, LANCET; UN Development Programme, 2013, COUNTR PROF INT HUM	13	13	13	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 22	2013	381	9884					2137	2138		10.1016/S0140-6736(13)60946-0	http://dx.doi.org/10.1016/S0140-6736(13)60946-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171KH	23684251				2022-12-28	WOS:000320925600005
J	Shalek, AK; Satija, R; Adiconis, X; Gertner, RS; Gaublomme, JT; Raychowdhury, R; Schwartz, S; Yosef, N; Malboeuf, C; Lu, DN; Trombetta, JJ; Gennert, D; Gnirke, A; Goren, A; Hacohen, N; Levin, JZ; Park, H; Regev, A				Shalek, Alex K.; Satija, Rahul; Adiconis, Xian; Gertner, Rona S.; Gaublomme, Jellert T.; Raychowdhury, Raktima; Schwartz, Schraga; Yosef, Nir; Malboeuf, Christine; Lu, Diana; Trombetta, John J.; Gennert, Dave; Gnirke, Andreas; Goren, Alon; Hacohen, Nir; Levin, Joshua Z.; Park, Hongkun; Regev, Aviv			Single-cell transcriptomics reveals bimodality in expression and splicing in immune cells	NATURE			English	Article							MESSENGER-RNA-SEQ; PATHWAY; LEVEL	Recent molecular studies have shown that, even when derived from a seemingly homogenous population, individual cells can exhibit substantial differences in gene expression, protein levels and phenotypic output(1-5), with important functional consequences(4,5). Existing studies of cellular heterogeneity, however, have typically measured only a few pre-selected RNAs1,2 or proteins(5,6) simultaneously, because genomic profiling methods(3) could not be applied to single cells until very recently(7-10). Here we use single-cell RNA sequencing to investigate heterogeneity in the response of mouse bone-marrow-derived dendritic cells (BMDCs) to lipopolysaccharide. We find extensive, and previously unobserved, bimodal variation in messenger RNA abundance and splicing patterns, which we validate by RNA-fluorescence in situ hybridization for select transcripts. In particular, hundreds of key immune genes are bimodally expressed across cells, surprisingly even for genes that are very highly expressed at the population average. Moreover, splicing patterns demonstrate previously unobserved levels of heterogeneity between cells. Some of the observed bimodality can be attributed to closely related, yet distinct, known maturity states of BMDCs; other portions reflect differences in the usage of key regulatory circuits. For example, we identify a module of 137 highly variable, yet co-regulated, antiviral response genes. Using cells from knockout mice, we show that variability in this module may be propagated through an interferon feedback circuit, involving the transcriptional regulators Stat2 and Irf7. Our study demonstrates the power and promise of single-cell genomics in uncovering functional diversity between cells and in deciphering cell states and circuits.	[Shalek, Alex K.; Gertner, Rona S.; Gaublomme, Jellert T.; Park, Hongkun] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Shalek, Alex K.; Gertner, Rona S.; Gaublomme, Jellert T.; Park, Hongkun] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Satija, Rahul; Adiconis, Xian; Raychowdhury, Raktima; Schwartz, Schraga; Yosef, Nir; Malboeuf, Christine; Lu, Diana; Trombetta, John J.; Gennert, Dave; Gnirke, Andreas; Goren, Alon; Hacohen, Nir; Levin, Joshua Z.; Park, Hongkun; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Goren, Alon] Massachusetts Gen Hosp, Dept Pathol, Charlestown, MA 02129 USA; [Goren, Alon] Massachusetts Gen Hosp, Ctr Syst Biol, Charlestown, MA 02129 USA; [Goren, Alon] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Dept Med, Charlestown, MA 02129 USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02140 USA	Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Park, H (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	Hongkun_Park@harvard.edu; aregev@broad.mit.edu	Shalek, Alex/Y-2434-2019; Satija, Rahul/AAF-9564-2019; Park, Hongkun/R-9842-2019	Shalek, Alex/0000-0001-5670-8778; Park, Hongkun/0000-0001-9576-8829; Goren, Alon/0000-0001-5669-9357; Levin, Joshua/0000-0002-0170-3598; Schwartz, Schraga/0000-0002-3671-9709	National Institutes of Health (NIH) [1F32HD075541-01, U54 AI057159, DP2 OD002230, 5DP1OD003893-03, DP1OD003958-01]; Charles H. Hood Foundation; NIH CEGS Award [1P50HG006193-01]; Broad Institute; HHMI; Klarman Cell Observatory at the Broad Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD075541] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [DP1CA174427] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA035083] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003893, DP2OD002230, DP1OD003958] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles H. Hood Foundation; NIH CEGS Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Institute; HHMI(Howard Hughes Medical Institute); Klarman Cell Observatory at the Broad Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank N. Chevrier, C. Villani, M. Jovanovic, M. Bray and J. Shuga for scientific discussions; N. Friedman and E. Lander for comments on the manuscript; B. Tilton, T. Rogers and M. Tam for assistance with cell sorting; J. Bochicchio, E. Shefler and C. Guiducci for project management; the Broad Genomics Platform for all sequencing work; K. Fitzgerald for the Irf7<SUP>-/-</SUP> bone marrow; and L. Gaffney for help with artwork. Work was supported by a National Institutes of Health (NIH) Postdoctoral Fellowship (1F32HD075541-01, to R. S.), a Charles H. Hood Foundation Postdoctoral Fellowship (to A. Goren), an NIH grant (U54 AI057159, to N. H.), an NIH New Innovator Award (DP2 OD002230, to N. H.), an NIH CEGS Award (1P50HG006193-01, to H. P., A. R. and N. H.), NIH Pioneer Awards (5DP1OD003893-03 to H. P., DP1OD003958-01 to A. R.), the Broad Institute (to H. P. and A. R.), HHMI (to A. R.), and the Klarman Cell Observatory at the Broad Institute (to A.R.).	Anko ML, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r17; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Feinerman O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.90; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Gurskaya NG, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1314; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Kalisky T, 2011, ANNU REV GENET, V45, P431, DOI 10.1146/annurev-genet-102209-163607; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Ning SB, 2005, J BIOL CHEM, V280, P12262, DOI 10.1074/jbc.M404260200; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Rand U, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.17; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Waks Z, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.32; Zhao MW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001249	30	771	826	15	278	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 13	2013	498	7453					236	240		10.1038/nature12172	http://dx.doi.org/10.1038/nature12172			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23685454	Green Accepted, Green Submitted			2022-12-28	WOS:000320283400050
J	Jamieson, AM; Pasman, L; Yu, S; Gamradt, P; Homer, RJ; Decker, T; Medzhitov, R				Jamieson, Amanda M.; Pasman, Lesley; Yu, Shuang; Gamradt, Pia; Homer, Robert J.; Decker, Thomas; Medzhitov, Ruslan			Role of Tissue Protection in Lethal Respiratory Viral-Bacterial Coinfection	SCIENCE			English	Article							LEGIONELLA-PNEUMOPHILA INFECTION; INFLUENZA-VIRUS INFECTION; LUNG; TOLERANCE; RESISTANCE; DISEASE; MICE; IMMUNOPATHOLOGY; NEURAMINIDASE; RECOGNITION	Secondary bacterial pneumonia leads to increased morbidity and mortality from influenza virus infections. What causes this increased susceptibility, however, is not well defined. Host defense from infection relies not only on immune resistance mechanisms but also on the ability to tolerate a given level of pathogen burden. Failure of either resistance or tolerance can contribute to disease severity, making it hard to distinguish their relative contribution. We employ a coinfection mouse model of influenza virus and Legionella pneumophila in which we can separate resistance and tolerance. We demonstrate that influenza virus can promote susceptibility to lethal bacterial coinfection, even when bacterial infection is controlled by the immune system. We propose that this failure of host defense is due to impaired ability to tolerate tissue damage.	[Jamieson, Amanda M.; Pasman, Lesley; Yu, Shuang; Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Jamieson, Amanda M.; Pasman, Lesley; Yu, Shuang; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunol, New Haven, CT 06520 USA; [Jamieson, Amanda M.; Gamradt, Pia; Decker, Thomas] Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Homer, Robert J.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Homer, Robert J.] VA Connecticut Healthcare Syst, Pathol & Lab Med Serv, West Haven, CT 06516 USA	Howard Hughes Medical Institute; Yale University; Yale University; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Jamieson, AM (corresponding author), Brown Univ, Dept Mol Microbiol & Immunol, 171 Meeting St, Providence, RI 02912 USA.	amanda_jamieson@brown.edu; ruslan.medzhitov@yale.edu	Jamieson, Amanda/U-7169-2019; homer, robert/P-3884-2019	Jamieson, Amanda/0000-0002-5781-9231; homer, robert/0000-0002-2055-5885; Gamradt, Pia/0000-0002-5567-9722	Howard Hughes Medical Institute; NIH [R01 046688, AI R01 055502]; Ellison Foundation; New England Regional Center of Excellence; FWF (Austrian Science Fund) [P25235-B13]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046688, R01AI055502, R37AI046688] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [P 25235] Funding Source: researchfish	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Foundation(Lawrence Ellison Foundation); New England Regional Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FWF (Austrian Science Fund)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank S. Holley and C. Annicelli for technical assistance; T. Ichinohe, M. Linehan, and A. Iwasaki for viral strains and advice; T. Ren, M. Fontana, R. Vance, K. Archer, S. Shin, and C. Roy for L. pneumophila strains and advice; M. Gillum for assistance with experiments; and M. Mueller and C. Lassnig for mouse infection infrastructure. The data presented in the manuscript are tabulated in the main paper and in the supplementary materials. This work was supported by the Howard Hughes Medical Institute (R. M.), NIH grants R01 046688 and AI R01 055502 (R. M.), the Ellison Foundation (R. M.), the New England Regional Center of Excellence (R. M.), and FWF (Austrian Science Fund) grant P25235-B13 (A.M.J.). A.M.J. was a Berger Foundation fellow of the Damon Runyon Cancer Research Foundation. The authors have no conflicts of interest.	Archer KA, 2006, INFECT IMMUN, V74, P3325, DOI 10.1128/IAI.02049-05; Beadling C, 2004, CURR OPIN INFECT DIS, V17, P185, DOI 10.1097/00001432-200406000-00003; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Bhalla DK, 1999, J TOXICOL ENV HEAL B, V2, P31, DOI 10.1080/109374099281232; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Didierlaurent A, 2008, J EXP MED, V205, P323, DOI 10.1084/jem.20070891; Fontana MF, 2012, INFECT IMMUN, V80, P3570, DOI 10.1128/IAI.00557-12; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Hament JM, 1999, FEMS IMMUNOL MED MIC, V26, P189, DOI 10.1111/j.1574-695X.1999.tb01389.x; Iannuzzi Michele, 2011, J Med Case Rep, V5, P520, DOI 10.1186/1752-1947-5-520; Ichinohe T, 2010, EXPERT REV VACCINES, V9, P1315, DOI 10.1586/ERV.10.118; Iverson AR, 2011, J INFECT DIS, V203, P880, DOI 10.1093/infdis/jiq113; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Mendel DB, 1998, ANTIMICROB AGENTS CH, V42, P640, DOI 10.1128/AAC.42.3.640; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Peiris JSM, 2010, CURR OPIN IMMUNOL, V22, P475, DOI 10.1016/j.coi.2010.06.003; Peltola VT, 2004, PEDIATR INFECT DIS J, V23, pS87, DOI 10.1097/01.inf.0000108197.81270.35; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; Sporri R, 2006, J IMMUNOL, V176, P6162, DOI 10.4049/jimmunol.176.10.6162; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Wong HR, 1997, AM J PHYSIOL-LUNG C, V273, pL1, DOI 10.1152/ajplung.1997.273.1.L1; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305	31	185	190	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1230	1234		10.1126/science.1233632	http://dx.doi.org/10.1126/science.1233632			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23618765	Green Accepted			2022-12-28	WOS:000319972800050
J	Fray, D				Fray, Derek			METALLURGY Iron production electrified	NATURE			English	Editorial Material									Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England	University of Cambridge	Fray, D (corresponding author), Univ Cambridge, Dept Mat Sci & Met, Pembroke St, Cambridge CB2 3QZ, England.	djf25@cam.ac.uk						Allanore A, 2013, NATURE, V497, P353, DOI 10.1038/nature12134; Habashi F., 1997, HDB EXTRACTIVE METAL; Kim H, 2011, J ELECTROCHEM SOC, V158, pE101, DOI 10.1149/1.3623446; Sadoway DR, 2001, JOM-J MIN MET MAT S, V53, P34, DOI 10.1007/s11837-001-0206-5; Sanderson K., 2009, NATURE; Schwandt C, 2012, PLANET SPACE SCI, V74, P49, DOI 10.1016/j.pss.2012.06.011	6	8	8	4	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2013	497	7449					324	325		10.1038/nature12102	http://dx.doi.org/10.1038/nature12102			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	144PN	23657253				2022-12-28	WOS:000318952000027
J	Schneider, WH				Schneider, William H.			The difficult art of giving	NATURE			English	Editorial Material							ROCKEFELLER-FOUNDATION; PUBLIC-HEALTH		Indiana Univ, Indianapolis, IN 46204 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Schneider, WH (corresponding author), Indiana Univ, Indianapolis, IN 46204 USA.	whschnei@iupui.edu						Birn AE, 2005, LANCET, V366, P514, DOI 10.1016/S0140-6736(05)66479-3; KOHLER RE, 1976, MINERVA, V14, P279, DOI 10.1007/BF01096274; Mandel Richard, 1996, HALF CENTURY PEER RE; Nevins A., 1963, FORD DECLINE REBIRTH, V3, P417; Penfield W., 1967, DIFFICULT ART GIVING, P295; RICHARDSON M, 1990, MINERVA, V28, P21, DOI 10.1007/BF01096325; Rockefeller Foundation, 1953, ANN REPORT, P36; SCHNEIDER William, 2002, ROCKEFELLER PHILANTH, P7; US National Institutes of Health, 1966, BAS DAT REL NIH 1966, P22; WEINDLING P, 1993, MINERVA, V31, P253, DOI 10.1007/BF01098623	10	2	2	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2013	497	7449					311	312		10.1038/497311a	http://dx.doi.org/10.1038/497311a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	144PN	23676738	Bronze			2022-12-28	WOS:000318952000014
J	Gossett, DR; Kiley, JW; Hammond, C				Gossett, Dana R.; Kiley, Jessica W.; Hammond, Cassing			Contraception Is a Fundamental Primary Care Service	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNINTENDED PREGNANCY; UNITED-STATES		[Gossett, Dana R.; Kiley, Jessica W.; Hammond, Cassing] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Kiley, Jessica W.; Hammond, Cassing] Northwestern Univ, Feinberg Sch Med, Sect Family Planning, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Gossett, DR (corresponding author), Northwestern Univ, Feinberg Sch Med, 680 N Lake Shore Dr,Ste 1015, Chicago, IL 60611 USA.	dana.gossett@nmff.org	Gossett, Dana/AAI-2929-2021	Gossett, Dana/0000-0002-7306-3606				Berg CJ, 2010, OBSTET GYNECOL, V116, P1302, DOI 10.1097/AOG.0b013e3181fdfb11; Finer LB, 2011, CONTRACEPTION, V84, P478, DOI 10.1016/j.contraception.2011.07.013; Frost JJ, 2013, CONTRACEPTION, V87, P465, DOI 10.1016/j.contraception.2012.08.012; HealthyPeople.gov, 2020 TOPICS AND OBJE; Jones R.K., 2011, COUNTERING CONVENTIO; Monea E, 2011, PERSPECT SEX REPRO H, V43, P88, DOI 10.1363/4308811; Peipert JF, 2012, OBSTET GYNECOL, V120, P1291, DOI [10.1097/AOG.0b013e318273eb56, http://10.1097/AOG.0b013e318273eb56]; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; Trussell J, 2006, CONTRACEPTION, V73, P437, DOI 10.1016/j.contraception.2006.01.008; US Dept of Health and Human Services Health Resources and Services Administration, WOMENS PREVENTIVE SE	10	9	9	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2013	309	19					1997	1998		10.1001/jama.2013.4262	http://dx.doi.org/10.1001/jama.2013.4262			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143GQ	23677310				2022-12-28	WOS:000318855500019
J	Zimmer, EA; Welie, JVM; Rendell, MS				Zimmer, Eric A.; Welie, Jos V. M.; Rendell, Marc S.			Contraceptives and the Law A View From a Catholic Medical Institution	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VENOUS THROMBOEMBOLISM; ORAL-CONTRACEPTIVES; HEALTH		Creighton Univ, Sch Med, Omaha, NE USA; Creighton Ctr Hlth Policy Eth, Omaha, NE USA	Creighton University	Rendell, MS (corresponding author), Creighton Diabet Ctr, 601 N 30th St, Omaha, NE 68131 USA.	Rendell@asndi.com						[Anonymous], FAST FACTS CAR PROV; Cleland J, 2012, LANCET, V380, P149, DOI 10.1016/S0140-6736(12)60609-6; Jost TS, 2013, NEW ENGL J MED, V368, P4, DOI 10.1056/NEJMp1214605; Paul VI, 1968, HUMANAE VITAE ENCYCL; Pear Robert, NY TIMES; Samuelsson E, 2005, EUR J EPIDEMIOL, V20, P509, DOI 10.1007/s10654-005-4266-7; United States Conference of Catholic Bishops, 2009, ETH REL DIR CATH HLT, V5th; Wu O, 2005, THROMB HAEMOSTASIS, V94, P17, DOI 10.1160/TH04-11-0759	8	4	4	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2013	309	19					1999	2000		10.1001/jama.2013.3730	http://dx.doi.org/10.1001/jama.2013.3730			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143GQ	23677311				2022-12-28	WOS:000318855500020
J	Moynihan, R				Moynihan, Ray			REALITY CHECK The future of medicine lies in truly shared decision making	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Bond Univ, Southport, Qld 4229, Australia	Bond University	Moynihan, R (corresponding author), Bond Univ, Southport, Qld 4229, Australia.	RayMoynihan@bond.edu.au	Moynihan, Ray/ABC-3010-2020					Goldacre Ben, 2012, BAD PHARM; Marshall M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2117; Moore TJ, 1995, DEADLY MED; Moynihan R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5160; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Salzburg Global Seminar, 2011, BMJ, V342, pd1745, DOI 10.1136/bmj.d1745	6	3	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2013	346								f2789	10.1136/bmj.f2789	http://dx.doi.org/10.1136/bmj.f2789			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148OF	23674138				2022-12-28	WOS:000319253900004
J	Daube, M; Chapman, S				Daube, Mike; Chapman, Simon			TOBACCO CONTROL Cameron's cave-in on plain packaging is a boost to industry	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Daube, Mike] Curtin Univ, Perth, WA, Australia; [Chapman, Simon] Univ Sydney, Sydney, NSW 2006, Australia	Curtin University; University of Sydney	Daube, M (corresponding author), Curtin Univ, Perth, WA, Australia.	M.Daube@curtin.edu.au; Simon.chapman@sydney.edu.au	Chapman, Simon/D-4114-2009	Daube, Mike/0000-0002-3479-2785				Limb B., 2013, BRIT MED J, V346, pf3024	1	2	2	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2013	346								f3069	10.1136/bmj.f3069	http://dx.doi.org/10.1136/bmj.f3069			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	144BV	23667131				2022-12-28	WOS:000318915300012
J	Georgiev, IS; Doria-Rose, NA; Zhou, TQ; Do Kwon, Y; Staupe, RP; Moquin, S; Chuang, GY; Louder, MK; Schmidt, SD; Altae-Tran, HR; Bailer, RT; McKee, K; Nason, M; O'Dell, S; Ofek, G; Pancera, M; Srivatsan, S; Shapiro, L; Connors, M; Migueles, SA; Morris, L; Nishimura, Y; Martin, MA; Mascola, JR; Kwong, PD				Georgiev, Ivelin S.; Doria-Rose, Nicole A.; Zhou, Tongqing; Do Kwon, Young; Staupe, Ryan P.; Moquin, Stephanie; Chuang, Gwo-Yu; Louder, Mark K.; Schmidt, Stephen D.; Altae-Tran, Han R.; Bailer, Robert T.; McKee, Krisha; Nason, Martha; O'Dell, Sijy; Ofek, Gilad; Pancera, Marie; Srivatsan, Sanjay; Shapiro, Lawrence; Connors, Mark; Migueles, Stephen A.; Morris, Lynn; Nishimura, Yoshiaki; Martin, Malcolm A.; Mascola, John R.; Kwong, Peter D.			Delineating Antibody Recognition in Polyclonal Sera from Patterns of HIV-1 Isolate Neutralization	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; HEPATITIS-C VIRUS; MEMORY B-CELLS; POTENT NEUTRALIZATION; INFLUENZA-VIRUS; STRUCTURAL DEFINITION; BROAD NEUTRALIZATION; CD4-BINDING SITE; RATIONAL DESIGN	Serum characterization and antibody isolation are transforming our understanding of the humoral immune response to viral infection. Here, we show that epitope specificities of HIV-1-neutralizing antibodies in serum can be elucidated from the serum pattern of neutralization against a diverse panel of HIV-1 isolates. We determined "neutralization fingerprints" for 30 neutralizing antibodies on a panel of 34 diverse HIV-1 strains and showed that similarity in neutralization fingerprint correlated with similarity in epitope. We used these fingerprints to delineate specificities of polyclonal sera from 24 HIV-1-infected donors and a chimeric siman-human immunodeficiency virus-infected macaque. Delineated specificities matched published specificities and were further confirmed by antibody isolation for two sera. Patterns of virus-isolate neutralization can thus afford a detailed epitope-specific understanding of neutralizing-antibody responses to viral infection.	[Georgiev, Ivelin S.; Doria-Rose, Nicole A.; Zhou, Tongqing; Do Kwon, Young; Staupe, Ryan P.; Moquin, Stephanie; Chuang, Gwo-Yu; Louder, Mark K.; Schmidt, Stephen D.; Altae-Tran, Han R.; Bailer, Robert T.; McKee, Krisha; Nason, Martha; O'Dell, Sijy; Ofek, Gilad; Pancera, Marie; Srivatsan, Sanjay; Shapiro, Lawrence; Mascola, John R.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Shapiro, Lawrence] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Connors, Mark; Migueles, Stephen A.] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Morris, Lynn] Natl Inst Communicable Dis, ZA-2131 Johannesburg, South Africa; [Morris, Lynn] Univ Witwatersrand, ZA-2001 Johannesburg, South Africa; [Morris, Lynn] Ctr AIDS Programme Res South Africa CAPRISA, ZA-4013 Durban, South Africa; [Nishimura, Yoshiaki; Martin, Malcolm A.] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institute for Communicable Diseases (NICD); University of Witwatersrand; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Mascola, JR (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jmascola@nih.gov; pdkwong@nih.gov	Zhou, Tongqing/A-6880-2010; Shapiro, Lawrence/AAE-7172-2019; Mascola, John/AAI-7193-2021; Morris, Lynn/V-3941-2018; Schmidt, Stephen/B-5398-2012; Do Kwon, Young/A-6957-2010; Schmidt, Stephen/AAC-6967-2019	Zhou, Tongqing/0000-0002-3935-4637; Morris, Lynn/0000-0003-3961-7828; Do Kwon, Young/0000-0002-1188-7458; Moquin, Stephanie/0000-0002-8696-4315; Staupe, Ryan/0000-0003-0793-524X	Intramural Research Program of the Vaccine Research Center, NIAID, NIH; International AIDS Vaccine Initiative; NIAID, NIH [U19 AI51794]; South African Department of Science and Technology; U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051794, ZIAAI000415, ZIAAI005010, ZIAAI005022, ZIAAI001090, ZIAAI005089, ZICAI005111] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); International AIDS Vaccine Initiative; NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); South African Department of Science and Technology; U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work was provided by the Intramural Research Program of the Vaccine Research Center, NIAID, NIH, and by the International AIDS Vaccine Initiative. The CAPRISA cohort was established through grants from NIAID, NIH (U19 AI51794) and the South African Department of Science and Technology. The authors are grateful to J. Stuckey for assistance with graphics and thank B. Korber, D. Montefiori, and M. Roederer and members of the Structural Biology Section, Structural Bioinformatics Core, Humoral Immunology Section, and Humoral Immunology Core at the NIH Vaccine Research Center for helpful discussions or comments on the manuscript. We thank J. Baalwa, D. Ellenberger, D. Gabuzda, F. Gao, B. Hahn, K. Hong, J. Kim, F. McCutchan, D. Montefiori, L. Morris, J. Overbaugh, E. Sanders-Buell, G. Shaw, R. Swanstrom, M. Thomson, S. Tovanabutra, C. Williamson, and L. Zhang for contributing the HIV-1 Envelope plasmids used in our neutralization panels. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. The NIH has filed a patent relating to neutralizing antibodies in this manuscript: WIPO no. WO 2011/038290 A2, titled "Neutralizing antibodies to HIV-1 and their use," with inventors J. R. M., P. D. K., M. C., L. S., and G.O. Structure factors and coordinates for the VRC06 and VRC23 antibody cocrystal structures with HIV-1 gp120 have been deposited with the Protein Data Bank under accession codes 4JB9 and 4J6R, respectively. Scripts for the neutralization-based antibody clustering and serologic analysis are included in the online supplementary material and methods (appendix S2) and are available from I. S. G. or P. D. K. upon request. Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract no. W-31-109-Eng-38.	Bartosch B, 2003, P NATL ACAD SCI USA, V100, P14199, DOI 10.1073/pnas.2335981100; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Bonsignori M, 2012, TRENDS MICROBIOL, V20, P532, DOI 10.1016/j.tim.2012.08.011; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Cai ZP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000949; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Delwart E, 2012, J INFECT DIS, V205, P875, DOI 10.1093/infdis/jir862; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P17107, DOI 10.1073/pnas.1002717107; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Korber B, 2009, CURR OPIN HIV AIDS, V4, P408, DOI 10.1097/COH.0b013e32832f129e; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2012, J VIROL, V86, P11231, DOI 10.1128/JVI.01543-12; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Meunier JC, 2008, J VIROL, V82, P966, DOI 10.1128/JVI.01872-07; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Perotti M, 2008, J VIROL, V82, P1047, DOI 10.1128/JVI.01986-07; Sattentau Quentin J, 2010, F1000 Biol Rep, V2, P60, DOI 10.3410/B2-60; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Walker LM, 2011, P NATL ACAD SCI USA, V108, P20125, DOI 10.1073/pnas.1117531108; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou T, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-S2-P57; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhu ZY, 2011, J VIROL, V85, P11401, DOI 10.1128/JVI.05312-11	50	157	183	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					751	756		10.1126/science.1233989	http://dx.doi.org/10.1126/science.1233989			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661761	Green Published			2022-12-28	WOS:000318619000041
J	Burns, LD				Burns, Lawrence D.			A vision of our transport future	NATURE			English	Editorial Material									[Burns, Lawrence D.] Univ Michigan, Ann Arbor, MI 48109 USA; [Burns, Lawrence D.] Columbia Univ, Earth Inst, Program Sustainable Mobil, New York, NY USA	University of Michigan System; University of Michigan; Columbia University	Burns, LD (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.	lawrencedburns@gmail.com						[Anonymous], 2011, SUMM TRAV TRENDS 200; Burns L.D., 2013, TRANSFORMING PERSONA; Mitchell W. J., 2010, REINVENTING AUTOMOBI; SACKS D, 2011, FAST CO; Shankar V., 2012, STRATEGIC ANAL BENCH	5	149	151	7	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2013	497	7448					181	182		10.1038/497181a	http://dx.doi.org/10.1038/497181a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	139CD	23657333	Bronze			2022-12-28	WOS:000318558200012
J	Solow, AR				Solow, Andrew R.			A call for peace on climate and conflict	NATURE			English	Editorial Material							CIVIL; WARS		Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Solow, AR (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	asolow@whoi.edu						Buhaug H., 2010, SENSITIVITY ANAL CLI; Buhaug H, 2010, P NATL ACAD SCI USA, V107, P16477, DOI 10.1073/pnas.1005739107; Burke MB, 2010, P NATL ACAD SCI USA, V107, pE185, DOI 10.1073/pnas.1014879107; Burke MB, 2009, P NATL ACAD SCI USA, V106, P20670, DOI 10.1073/pnas.0907998106; Deininger K, 2003, OXFORD ECON PAP, V55, P579, DOI 10.1093/oep/55.4.579; Homer-Dixon T.F., 1999, ENV SCARCITY VIOLENC; Hsiang SM, 2011, NATURE, V476, P438, DOI 10.1038/nature10311; Kalyvas S., 2008, ORDER CONFLICT VIOLE, P1, DOI [10.1017/CBO9780511755903.002, DOI 10.1017/CBO9780511755903.002]; Miguel E, 2004, J POLIT ECON, V112, P725, DOI 10.1086/421174; Theisen OM, 2011, INT SECURITY, V36, P79	10	41	43	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2013	497	7448					179	180		10.1038/497179a	http://dx.doi.org/10.1038/497179a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	139CD	23657332	Bronze			2022-12-28	WOS:000318558200011
J	Birren, SJ; Marder, E				Birren, Susan J.; Marder, Eve			Plasticity in the Neurotransmitter Repertoire	SCIENCE			English	Editorial Material							RAT SYMPATHETIC NEURONS; MICROCULTURES; PHENOTYPE; RELEASE		[Birren, Susan J.] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Volen Ctr, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Birren, SJ (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.	marder@brandeis.edu						Arborelius L, 1999, J ENDOCRINOL, V160, P1, DOI 10.1677/joe.0.1600001; BURNSTOCK G, 1976, NEUROSCIENCE, V1, P239, DOI 10.1016/0306-4522(76)90054-3; DALE HENRY, 1935, PROC ROY SOC MED, V28, P319; Dulcis D, 2008, NATURE, V456, P195, DOI 10.1038/nature07569; Dulcis D, 2013, SCIENCE, V340, P449, DOI 10.1126/science.1234152; FURSHPAN EJ, 1976, P NATL ACAD SCI USA, V73, P4225, DOI 10.1073/pnas.73.11.4225; Gutierrez R, 2005, TRENDS NEUROSCI, V28, P297, DOI 10.1016/j.tins.2005.04.005; JAN YN, 1979, P NATL ACAD SCI USA, V76, P1501, DOI 10.1073/pnas.76.3.1501; LANDIS SC, 1976, P NATL ACAD SCI USA, V73, P4220, DOI 10.1073/pnas.73.11.4220; Nusbaum MP, 2001, TRENDS NEUROSCI, V24, P146, DOI 10.1016/S0166-2236(00)01723-9; Praschak-Rieder Nicole, 2012, Curr Top Behav Neurosci, V11, P149, DOI 10.1007/7854_2011_174; SCHOTZINGER RJ, 1988, NATURE, V335, P637, DOI 10.1038/335637a0; Spitzer NC, 2012, NAT REV NEUROSCI, V13, P94, DOI 10.1038/nrn3154; Yang B, 2002, NAT NEUROSCI, V5, P539, DOI 10.1038/nn853	14	13	13	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					436	437		10.1126/science.1238518	http://dx.doi.org/10.1126/science.1238518			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620040				2022-12-28	WOS:000318016700026
J	Little, SC; Gregor, T				Little, Shawn C.; Gregor, Thomas			Sorting Sloppy Sonic	CELL			English	Editorial Material							PATTERN	In the classic picture of morphogen-mediated patterning, cells acquire the correct spatial arrangement of specified fates by reading a precisely distributed gradient of morphogen. Xiong et al. now provide evidence for an alternate strategy-cells of the zebrafish neural tube actively sort to their correct positions following disordered specification by Sonic hedgehog.	[Little, Shawn C.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Little, Shawn C.] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Gregor, Thomas] Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA; [Gregor, Thomas] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Princeton University; Howard Hughes Medical Institute; Princeton University; Princeton University; Princeton University	Gregor, T (corresponding author), Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA.	tg2@princeton.edu		Gregor, Thomas/0000-0001-9460-139X; Little, Shawn/0000-0002-2815-3696	NIGMS NIH HHS [R01 GM098407, R01 GM097275] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097275, R01GM098407] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amack JD, 2012, SCIENCE, V338, P212, DOI 10.1126/science.1223953; Aulehla A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000869; Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Clarke J, 2009, CURR OPIN NEUROBIOL, V19, P134, DOI 10.1016/j.conb.2009.04.010; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Lander AD, 2011, CELL, V144, P955, DOI 10.1016/j.cell.2011.03.009; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Rogers KW, 2011, ANNU REV CELL DEV BI, V27, P377, DOI 10.1146/annurev-cellbio-092910-154148; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Xiong FZ, 2013, CELL, V153, P550, DOI 10.1016/j.cell.2013.03.023	10	1	1	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 25	2013	153	3					509	510		10.1016/j.cell.2013.04.021	http://dx.doi.org/10.1016/j.cell.2013.04.021			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622235	Green Accepted, Bronze			2022-12-28	WOS:000318063500003
J	Yadlapalli, S; Yamashita, YM				Yadlapalli, Swathi; Yamashita, Yukiko M.			Chromosome-specific nonrandom sister chromatid segregation during stem-cell division	NATURE			English	Article							DROSOPHILA OOGENESIS; NUCLEAR MIGRATION; DNA METHYLATION; DOMAIN PROTEIN; GERMLINE; CENTROSOME; GENE; RETROTRANSPOSON; ENCODES; DNMT2	Adult stem cells undergo asymmetric cell division to self-renew and give rise to differentiated cells that comprise mature tissue(1). Sister chromatids may be distinguished and segregated nonrandomly in asymmetrically dividing stem cells(2), although the underlying mechanism and the purpose it may serve remain elusive. Here we develop the CO-FISH(chromosome orientation fluorescence in situ hybridization) technique(3) with single-chromosome resolution and show that sister chromatids of X and Y chromosomes, but not autosomes, are segregated nonrandomly during asymmetric divisions of Drosophila male germline stem cells. This provides the first direct evidence, to our knowledge, that two sister chromatids containing identical genetic information can be distinguished and segregated nonrandomly during asymmetric stem-cell divisions. We further show that the centrosome, SUN-KASH nuclear envelope proteins and Dnmt2 (also known as Mt2) are required for nonrandom sister chromatid segregation. Our data indicate that the information on X and Y chromosomes that enables nonrandom segregation is primed during gametogenesis in the parents. Moreover, we show that sister chromatid segregation is randomized in germline stem cell overproliferation and dedifferentiated germline stem cells. We propose that nonrandom sister chromatid segregation may serve to transmit distinct information carried on two sister chromatids to the daughters of asymmetrically dividing stem cells.	[Yadlapalli, Swathi; Yamashita, Yukiko M.] Univ Michigan, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; [Yadlapalli, Swathi; Yamashita, Yukiko M.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Yamashita, Yukiko M.] Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Yadlapalli, S (corresponding author), Univ Michigan, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA.	swathi@umich.edu; yukikomy@umich.edu		Yamashita, Yukiko/0000-0001-5541-0216	University of Michigan (Life Sciences Institute and Office of the Provost and Executive Vice President for Academic Affairs); AHA [12PRE9630000]; NIH [1F31HD071727-01]; MacArthur Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F31HD071727] Funding Source: NIH RePORTER	University of Michigan (Life Sciences Institute and Office of the Provost and Executive Vice President for Academic Affairs); AHA(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MacArthur Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank F. Lyko, M. Schaefer, G. Reuter, P. Zamore, A. Aravin, D. Glover, L. Cooley, J. Kim, V. Gvozdev, M. Pia Bozzetti, the Bloomington Drosophila Stock Center and the Vienna Drosophila RNAi Center for reagents and helpful information, and Yamashita laboratory members for discussions. This study was supported by the University of Michigan (Life Sciences Institute and Office of the Provost and Executive Vice President for Academic Affairs) (to Y.M.Y.) and AHA (12PRE9630000) and NIH grants (1F31HD071727-01) (to S.Y.). Y.M.Y. is supported by the MacArthur Foundation.	Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Conrad T, 2012, NAT REV GENET, V13, P123, DOI 10.1038/nrg3124; Dernburg A. F., 2000, DROSOPHILA PROTOCOLS; Falconer E, 2010, NATURE, V463, P93, DOI 10.1038/nature08644; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Fung JC, 1998, J CELL BIOL, V141, P5, DOI 10.1083/jcb.141.1.5; Hense W, 2007, PLOS BIOL, V5, P2288, DOI 10.1371/journal.pbio.0050273; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kracklauer MP, 2007, FLY, V1, P75, DOI 10.4161/fly.4254; Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716; Li KJ, 1996, CELL, V85, P585, DOI 10.1016/S0092-8674(00)81258-1; Makunin IV, 1999, MOL GEN GENET, V261, P381, DOI 10.1007/s004380050979; Minestrini G, 2002, J CELL SCI, V115, P725; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Mosley-Bishop KL, 1999, CURR BIOL, V9, P1211, DOI 10.1016/S0960-9822(99)80501-6; Petrella LN, 2007, DEVELOPMENT, V134, P703, DOI 10.1242/dev.02766; Phalke S, 2009, NAT GENET, V41, P696, DOI 10.1038/ng.360; Razafsky D, 2009, J CELL BIOL, V186, P461, DOI 10.1083/jcb.200906068; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Sheng XR, 2009, CELL STEM CELL, V5, P191, DOI 10.1016/j.stem.2009.05.024; Tajbakhsh S, 2009, NAT REV MOL CELL BIO, V10, P804, DOI 10.1038/nrm2784; Tulin AV, 1997, GENETICS, V146, P253; Tran V, 2012, SCIENCE, V338, P679, DOI 10.1126/science.1226028; Yadlapalli S, 2011, J CELL SCI, V124, P933, DOI 10.1242/jcs.079798; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	30	88	92	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 13	2013	498	7453					251	+		10.1038/nature12106	http://dx.doi.org/10.1038/nature12106			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23644460	Green Accepted			2022-12-28	WOS:000320283400053
J	McLellan, JS; Chen, M; Leung, S; Graepel, KW; Du, XL; Yang, YP; Zhou, TQ; Baxa, U; Yasuda, E; Beaumont, T; Kumar, A; Modjarrad, K; Zheng, ZZ; Zhao, M; Xia, NS; Kwong, PD; Graham, BS				McLellan, Jason S.; Chen, Man; Leung, Sherman; Graepel, Kevin W.; Du, Xiulian; Yang, Yongping; Zhou, Tongqing; Baxa, Ulrich; Yasuda, Etsuko; Beaumont, Tim; Kumar, Azad; Modjarrad, Kayvon; Zheng, Zizheng; Zhao, Min; Xia, Ningshao; Kwong, Peter D.; Graham, Barney S.			Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody	SCIENCE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; F-GLYCOPROTEIN; MONOCLONAL-ANTIBODIES; PROTEIN; INFECTION; SEQUENCE; EPITOPE; FORM	The prefusion state of respiratory syncytiat virus (RSV) fusion (F) glycoprotein is the target of most RSV-neutralizing activity in human sera, but its metastability has hindered characterization. To overcome this obstacle, we identified prefusion-specific antibodies that were substantially more potent than the prophylactic antibody palivizumab. The cocrystal structure for one of these antibodies, D25, in complex with the F glycoprotein revealed D25 to lock F in its prefusion state by binding to a quaternary epitope at the trimer apex. Electron microscopy showed that two other antibodies, AM22 and 5C4, also bound to the newly identified site of vulnerability, which we named antigenic site empty set. These studies should enable design of improved vaccine antigens and define new targets for passive prevention of RSV-induced disease,	[McLellan, Jason S.; Chen, Man; Leung, Sherman; Graepel, Kevin W.; Du, Xiulian; Yang, Yongping; Zhou, Tongqing; Kumar, Azad; Modjarrad, Kayvon; Kwong, Peter D.; Graham, Barney S.] NIAID, Vaccine Res Ctr, Bethesda, MD 20892 USA; [Baxa, Ulrich] SAIC Frederick Inc, Electron Microscopy Lab, Adv Technol Program, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Yasuda, Etsuko; Beaumont, Tim] Univ Amsterdam, Acad Med Ctr, AIMM Therapeut, NL-1105 AZ Amsterdam, Netherlands; [Zheng, Zizheng; Zhao, Min; Xia, Ningshao] Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen 361005, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Amsterdam; Academic Medical Center Amsterdam; Xiamen University	McLellan, JS (corresponding author), NIAID, Vaccine Res Ctr, 9000 Rockville Pike, Bethesda, MD 20892 USA.	mclellanja@niaid.nih.gov; pdkwong@nih.gov	Zhou, Tongqing/A-6880-2010; Kumar, Azad/AAD-2093-2020; Graham, Barney S./AAC-5898-2019	Zhou, Tongqing/0000-0002-3935-4637; Graham, Barney S./0000-0001-8112-0853; Xia, Ningshao/0000-0003-0179-5266; Baxa, Ulrich/0000-0002-7263-5078; McLellan, Jason/0000-0003-3991-542X	Intramural Research Program (National Institute of Allergy and Infectious Diseases); National Natural Science Foundation of China [81161120419]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005024, ZIAAI005061, ZIAAI005023] Funding Source: NIH RePORTER	Intramural Research Program (National Institute of Allergy and Infectious Diseases); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Structural Biology Section, Structural Bioinformatics Core Section, and Viral Pathogenesis Laboratory at the Vaccine Research Center for helpful comments, and J. Chrzas, J. Gonczy, U. Chinte, and staff at SER-CAT (Southeast Regional Collaborative Access Team) for help with x-ray diffraction data collection. The data presented in this manuscript are tabulated in the main paper and supplementary materials. Atomic coordinates and structure factors of the reported crystal structures have been deposited in the Protein Data Bank under accession codes 4JHA and 4JHW. Support for this work was provided by the Intramural Research Program (National Institute of Allergy and Infectious Diseases) and the National Natural Science Foundation of China (81161120419). Use of insertion device 22 (SER-CAT) at the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract W-31-109-Eng-38. T.B. is an inventor on an international patent application describing the technology used to isolate D25 and AM22 (Means and methods for influencing the stability of antibody producing cells, WO2007067046A1). E.Y. and T.B. are inventors on international patent applications for antibody D25 (RSV-specific binding molecules and means for producing them, WO2008147196A2) and antibody AM22 (RSV-specific binding molecule, WO2011043643A1). J.S.M., P.D.K, and B.S.G. are inventors on a U.S. patent application describing the use of prefusion-stabilized RSV F glycoproteins as vaccine antigens (Prelusion RSV F proteins and their use, 61(798,389). J.S.M, MC., Z.Z., M.Z., N.X., and B.S.G. are inventors on a Chinese patent application for antibody 5C4 and its epitope (Anti-RSV high neutralization antibody and the peptide can be used for prevention of RSV infection and related disease, 201310082338.1).	ARBIZA J, 1992, J GEN VIROL, V73, P2225, DOI 10.1099/0022-1317-73-9-2225; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Beaumont T., 2012, Patent Application, Patent No. [12/898,325, 12898325]; BEELER JA, 1989, J VIROL, V63, P2941, DOI 10.1128/JVI.63.7.2941-2950.1989; Chaiwatpongsakorn S, 2011, J VIROL, V85, P3968, DOI 10.1128/JVI.01813-10; CHAMBERS P, 1992, J GEN VIROL, V73, P1717, DOI 10.1099/0022-1317-73-7-1717; Collarini EJ, 2009, J IMMUNOL, V183, P6338, DOI 10.4049/jimmunol.0901373; Connor AL, 2001, J MED VIROL, V63, P168, DOI 10.1002/1096-9071(20000201)63:2&lt;168::AID-JMV1012&gt;3.0.CO;2-U; Corvaisier C, 1997, ARCH VIROL, V142, P1073, DOI 10.1007/s007050050143; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Graham BS, 2011, IMMUNOL REV, V239, P149, DOI 10.1111/j.1600-065X.2010.00972.x; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Johnson S, 1997, J INFECT DIS, V176, P1215, DOI 10.1086/514115; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; LOPEZ JA, 1990, J VIROL, V64, P927; Lopez JA, 1998, J VIROL, V72, P6922; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Magro M, 2012, P NATL ACAD SCI USA, V109, P3089, DOI 10.1073/pnas.1115941109; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; McLellan JS, 2010, NAT STRUCT MOL BIOL, V17, P248, DOI 10.1038/nsmb.1723; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Pancera M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055701; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Spits H., 2010, Patent Application, Patent No. [12/600,950, 12600950]; Swanson KA, 2011, P NATL ACAD SCI USA, V108, P9619, DOI 10.1073/pnas.1106536108; WALSH EE, 1983, J VIROL, V47, P171, DOI 10.1128/JVI.47.1.171-177.1983; Welch BD, 2012, P NATL ACAD SCI USA, V109, P16672, DOI 10.1073/pnas.1213802109; Wen XL, 2012, NAT STRUCT MOL BIOL, V19, P461, DOI 10.1038/nsmb.2250; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Wu H, 2007, J MOL BIOL, V368, P652, DOI 10.1016/j.jmb.2007.02.024; Yin HS, 2006, NATURE, V439, P38, DOI 10.1038/nature04322	34	475	558	7	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2013	340	6136					1113	1117		10.1126/science.1234914	http://dx.doi.org/10.1126/science.1234914			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	154HJ	23618766	Green Accepted			2022-12-28	WOS:000319664500049
J	Sistla, SA; Moore, JC; Simpson, RT; Gough, L; Shaver, GR; Schimel, JP				Sistla, Seeta A.; Moore, John C.; Simpson, Rodney T.; Gough, Laura; Shaver, Gaius R.; Schimel, Joshua P.			Long-term warming restructures Arctic tundra without changing net soil carbon storage	NATURE			English	Article							MICROBIAL BIOMASS; ORGANIC-MATTER; FUNGAL ABUNDANCE; ALASKAN TUNDRA; ECOSYSTEMS; NITROGEN; BACTERIAL; FERTILIZATION; RESPIRATION; COMMUNITY	High latitudes contain nearly half of global soil carbon, prompting interest in understanding how the Arctic terrestrial carbon balance will respond to rising temperatures(1,2). Low temperatures suppress the activity of soil biota, retarding decomposition and nitrogen release, which limits plant and microbial growth(3). Warming initially accelerates decomposition(4-6), increasing nitrogen availability, productivity and woody-plant dominance(3,7). However, these responses may be transitory, because coupled abiotic-biotic feedback loops that alter soil-temperature dynamics and change the structure and activity of soil communities, can develop(8,9). Here we report the results of a two-decade summer warming experiment in an Alaskan tundra ecosystem. Warming increased plant biomass and woody dominance, indirectly increased winter soil temperature, homogenized the soil trophic structure across horizons and suppressed surface-soil-decomposer activity, but did not change total soil carbon or nitrogen stocks, thereby increasing net ecosystem carbon storage. Notably, the strongest effects were in the mineral horizon, where warming increased decomposer activity and carbon stock: a 'biotic awakening' at depth.	[Sistla, Seeta A.; Schimel, Joshua P.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93108 USA; [Moore, John C.; Simpson, Rodney T.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Moore, John C.] Colorado State Univ, Dept Ecosyst Sci & Sustainabil, Ft Collins, CO 80523 USA; [Gough, Laura] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Shaver, Gaius R.] Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA	University of California System; University of California Santa Barbara; Colorado State University; Colorado State University; University of Texas System; University of Texas Arlington; Marine Biological Laboratory - Woods Hole	Sistla, SA (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93108 USA.	sistla@lifesci.ucsb.edu	Schimel, Joshua/AAE-7380-2019; Moore, John/E-9802-2011	Schimel, Joshua/0000-0002-1022-6623; 	DOE; Leal Anne Kerry Mertes scholarship; Explorer's Club grant; NSF [OPP-1023524, OPP-0425606, OPP-0909441, OPP-0425827, OPP-0909507]; Arctic LTER program NSF-DEB [1026843]; Directorate For Geosciences [0902038] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [0909441, 0909507] Funding Source: National Science Foundation	DOE(United States Department of Energy (DOE)); Leal Anne Kerry Mertes scholarship; Explorer's Club grant; NSF(National Science Foundation (NSF)); Arctic LTER program NSF-DEB; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by a DOE Global Change Education Program Graduate Fellowship, a Leal Anne Kerry Mertes scholarship, and Explorer's Club grant to S.A.S., NSF OPP-1023524 to J.P.S., NSF OPP-0425606 and NSF OPP-0909441 to J.C.M., NSF OPP-0425827 and NSF OPP-0909507 to L.G., and the Arctic LTER program NSF-DEB 1026843 to G.R.S. We thank J. Laundre for temperature and thaw depth data. We also thank three anonymous reviewers, C. D'Antonio, J. King, and S. Viswanathan for comments that greatly improved this manuscript.	ANDERSON JPE, 1978, SOIL BIOL BIOCHEM, V10, P215, DOI 10.1016/0038-0717(78)90099-8; Anisimov OA, 1997, GLOBAL PLANET CHANGE, V15, P61, DOI 10.1016/S0921-8181(97)00009-X; Beck T, 1997, SOIL BIOL BIOCHEM, V29, P1023, DOI 10.1016/S0038-0717(97)00030-8; Bloem J., 1995, MOL MICROBIAL ECOLOG, P1; Blok D, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/035502; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Clemmensen KE, 2006, NEW PHYTOL, V171, P391, DOI 10.1111/j.1469-8137.2006.01778.x; DARBYSHIRE JF, 1974, REV ECOL BIOL SOL, V11, P465; Deslippe JR, 2011, GLOBAL CHANGE BIOL, V17, P1625, DOI 10.1111/j.1365-2486.2010.02318.x; Deslippe JR, 2012, FEMS MICROBIOL ECOL, V82, P303, DOI 10.1111/j.1574-6941.2012.01350.x; Fahnestock JT, 1999, GLOBAL BIOGEOCHEM CY, V13, P775, DOI 10.1029/1999GB900006; Fierer N, 2002, SOIL BIOL BIOCHEM, V34, P777, DOI 10.1016/S0038-0717(02)00007-X; Frey SD, 1999, SOIL BIOL BIOCHEM, V31, P573, DOI 10.1016/S0038-0717(98)00161-8; Gough L, 2012, ECOLOGY, V93, P1683, DOI 10.1890/11-1631.1; Hobbie SE, 2005, J ECOL, V93, P770, DOI 10.1111/j.1365-2745.2005.01006.x; Hobbie SE, 1998, ECOLOGY, V79, P1526; Hodkinson ID, 1998, ARCTIC ALPINE RES, V30, P306, DOI 10.2307/1551978; Ilic B, 2001, J VAC SCI TECHNOL B, V19, P2825, DOI 10.1116/1.1421572; Lavoie M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001629; Loya WM, 2004, SOIL BIOL BIOCHEM, V36, P655, DOI 10.1016/j.soilbio.2003.11.009; Loya WM, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001464; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; McKane RB, 1997, ECOLOGY, V78, P1170, DOI 10.1890/0012-9658(1997)078[1170:CEOTCS]2.0.CO;2; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; Natali SM, 2012, J ECOL, V100, P488, DOI 10.1111/j.1365-2745.2011.01925.x; OADES JM, 1984, PLANT SOIL, V76, P319, DOI 10.1007/BF02205590; Oberbauer SF, 2007, ECOL MONOGR, V77, P221, DOI 10.1890/06-0649; OECHEL WC, 1993, NATURE, V361, P520, DOI 10.1038/361520a0; Pollierer MM, 2007, ECOL LETT, V10, P729, DOI 10.1111/j.1461-0248.2007.01064.x; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Schuur EAG, 2009, NATURE, V459, P556, DOI 10.1038/nature08031; Shaver GR, 2006, J ECOL, V94, P740, DOI 10.1111/j.1365-2745.2006.01139.x; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; Sturm M, 2005, BIOSCIENCE, V55, P17, DOI 10.1641/0006-3568(2005)055[0017:WBPCHC]2.0.CO;2; Sullivan PF, 2007, OECOLOGIA, V153, P643, DOI 10.1007/s00442-007-0753-8; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Wallenstein MD, 2007, FEMS MICROBIOL ECOL, V59, P428, DOI 10.1111/j.1574-6941.2006.00260.x; WEST AW, 1986, J MICROBIOL METH, V5, P177, DOI 10.1016/0167-7012(86)90012-6	38	284	296	34	645	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2013	497	7451					615	+		10.1038/nature12129	http://dx.doi.org/10.1038/nature12129			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23676669				2022-12-28	WOS:000319556100043
J	Stenson, BJ; Tarnow-Mordi, WO; Darlow, BA; Simes, J; Juszczak, E; Askie, L; Battin, M; Bowler, U; Broadbent, R; Cairns, P; Davis, PG; Deshpande, S; Donoghoe, M; Doyle, L; Fleck, BW; Ghadge, A; Hague, W; Halliday, HL; Hewson, M; King, A; Kirby, A; Marlow, N; Meyer, M; Morley, C; Simmer, K; Tin, W; Wardle, SP; Brocklehurst, P				Stenson, Ben J.; Tarnow-Mordi, William O.; Darlow, Brian A.; Simes, John; Juszczak, Edmund; Askie, Lisa; Battin, Malcolm; Bowler, Ursula; Broadbent, Roland; Cairns, Pamela; Davis, Peter Graham; Deshpande, Sanjeev; Donoghoe, Mark; Doyle, Lex; Fleck, Brian W.; Ghadge, Alpana; Hague, Wendy; Halliday, Henry L.; Hewson, Michael; King, Andrew; Kirby, Adrienne; Marlow, Neil; Meyer, Michael; Morley, Colin; Simmer, Karen; Tin, Win; Wardle, Stephen P.; Brocklehurst, Peter		Boost II United Kingdom; Boost II; Boost II New Zealand	Oxygen Saturation and Outcomes in Preterm Infants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEVERE RETINOPATHY; PULSE OXIMETRY; TARGET RANGES; PREMATURITY; GESTATION; CROSSOVER; TRIAL	BACKGROUND The clinically appropriate range for oxygen saturation in preterm infants is unknown. Previous studies have shown that infants had reduced rates of retinopathy of prematurity when lower targets of oxygen saturation were used. METHODS In three international randomized, controlled trials, we evaluated the effects of targeting an oxygen saturation of 85 to 89%, as compared with a range of 91 to 95%, on disability-free survival at 2 years in infants born before 28 weeks' gestation. Halfway through the trials, the oximeter-calibration algorithm was revised. Recruitment was stopped early when an interim analysis showed an increased rate of death at 36 weeks in the group with a lower oxygen saturation. We analyzed pooled data from patients and now report hospital-discharge outcomes. RESULTS A total of 2448 infants were recruited. Among the 1187 infants whose treatment used the revised oximeter-calibration algorithm, the rate of death was significantly higher in the lower-target group than in the higher-target group (23.1% vs. 15.9%; relative risk in the lower-target group, 1.45; 95% confidence interval [CI], 1.15 to 1.84; P = 0.002). There was heterogeneity for mortality between the original algorithm and the revised algorithm (P = 0.006) but not for other outcomes. In all 2448 infants, those in the lower-target group for oxygen saturation had a reduced rate of retinopathy of prematurity (10.6% vs. 13.5%; relative risk, 0.79; 95% CI, 0.63 to 1.00; P = 0.045) and an increased rate of necrotizing enterocolitis (10.4% vs. 8.0%; relative risk, 1.31; 95% CI, 1.02 to 1.68; P = 0.04). There were no significant between-group differences in rates of other outcomes or adverse events. CONCLUSIONS Targeting an oxygen saturation below 90% with the use of current oximeters in extremely preterm infants was associated with an increased risk of death.	[Stenson, Ben J.] Univ Edinburgh, Dept Child Life & Hlth, Royal Infirm Edinburgh, Neonatal Unit, Edinburgh, Midlothian, Scotland; [Tarnow-Mordi, William O.] Univ Sydney, Westmead Hosp, Westmead Int Network Neonatal Educ & Res WINNER C, Natl Hlth & Med Res Council NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia; [Darlow, Brian A.] Univ Otago, Christchurch, New Zealand; [Simes, John; Askie, Lisa; Donoghoe, Mark; Ghadge, Alpana; Hague, Wendy; Kirby, Adrienne] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia; [Juszczak, Edmund; Bowler, Ursula; King, Andrew] Univ Oxford, Clin Trials Unit, NPEU, Oxford, England; [Battin, Malcolm] Univ Auckland, Auckland City Hosp, Newborn Serv, Auckland 1, New Zealand; [Battin, Malcolm] Univ Auckland, Dept Paediat, Auckland, New Zealand; [Broadbent, Roland] Univ Otago, Dunedin Sch Med, Dept Womens & Childrens Hlth, Dunedin, New Zealand; [Cairns, Pamela] Univ Hosp Bristol Natl Hlth Serv NHS Trust, Bristol, Avon, England; [Davis, Peter Graham] Univ Melbourne, Royal Melbourne Hosp, Melbourne, Vic 3050, Australia; [Davis, Peter Graham] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Deshpande, Sanjeev] Shrewsbury & Telford Hosp NHS Trust, Shrewsbury, Salop, England; [Doyle, Lex] Univ Melbourne, Royal Womens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Fleck, Brian W.] Princess Alexandra Eye Pavil, NHS Lothian, Edinburgh, Midlothian, Scotland; [Halliday, Henry L.] Queens Univ Belfast, Belfast, Antrim, North Ireland; [Hewson, Michael] Wellington Hosp, Neonatal Intens Care Unit, Wellington, New Zealand; [Marlow, Neil] UCL, Inst Womens Hlth, London WC1E 6BT, England; [Meyer, Michael] Univ Auckland, Middlemore Hosp, Auckland, New Zealand; [Morley, Colin] Royal Womens Hosp, Dept Neonatal Res, Melbourne, Vic, Australia; [Simmer, Karen] Univ Western Australia, Ctr Neonatal Res & Educ, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Tin, Win] James Cook Univ Hosp, Middlesbrough, Cleveland, England; [Wardle, Stephen P.] Nottingham Univ Hosp NHS Trust, Nottingham, England; [Brocklehurst, Peter] UCL Med Sch, Inst Womens Hlth, London, England	Royal Infirmary of Edinburgh; University of Edinburgh; University of Sydney; University of Otago; University of Sydney; University of Oxford; Auckland City Hospital; University of Auckland; University of Auckland; University of Otago; Royal Melbourne Hospital; University of Melbourne; University of Melbourne; Murdoch Children's Research Institute; University of Melbourne; Queens University Belfast; University of London; University College London; University of Auckland; University of Western Australia; James Cook University Hospital; Nottingham University Hospital NHS Trust; University of London; University College London	Stenson, BJ (corresponding author), Royal Infirm Edinburgh NHS Trust, Dept Neonatol, Edinburgh EH16 4SA, Midlothian, Scotland.	ben.stenson@luht.scot.nhs.uk	Marlow, Neil/D-2918-2009; Simes, Robert John/P-1497-2014; D'ESTE, CATHERINE ANNE/G-7392-2013; Doyle, Lex/AAJ-5205-2021; Colditz, Paul B/F-6772-2010; Simmer, Karen N/H-5834-2014	Marlow, Neil/0000-0001-5890-2953; Doyle, Lex/0000-0002-7667-7312; Colditz, Paul B/0000-0002-6408-8238; Morley, Colin/0000-0001-5388-0214; Simmer, Karen/0000-0003-4777-9069; Couper, Jennifer/0000-0003-4448-8629; Wright, Ian/0000-0001-5337-0134; Wardle, Stephen/0000-0001-5727-3315; Broadbent, Roland/0000-0002-4628-7276; Halliday, Henry/0000-0001-7978-4992; Jamieson, Nina/0000-0002-8776-5000	Australian National Health and Medical Research Council [352386]; Medical Research Council [73460]; New Zealand Health Research Council [05-145]; United Kingdom's Biomedical Research Centres of the National Institute for Health Research; MRC [G0400415] Funding Source: UKRI; Medical Research Council [G0400415] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10034] Funding Source: researchfish	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); New Zealand Health Research Council(Health Research Council of New Zealand); United Kingdom's Biomedical Research Centres of the National Institute for Health Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by the Australian National Health and Medical Research Council and others; BOOST II Current Controlled Trials number, ISRCTN00842661, and Australian New Zealand Clinical Trials Registry numbers, ACTRN12605000055606 and ACTRN12605000253606.; Supported by the National Health and Medical Research Council (project grant 352386, to the Australian trial), the Medical Research Council (grant number 73460, to the United Kingdom trial), and the New Zealand Health Research Council (project grant number 05-145, to the New Zealand trial); and by a grant from the United Kingdom's Biomedical Research Centres of the National Institute for Health Research (to Dr. Marlow). Masimo supplied the study oximeters under lease.	American Academy of Pediatrics American College of Obstetricans and Gynecologists, 2007, GUID PER CAR; Anderson Christina G, 2004, J Perinatol, V24, P164, DOI 10.1038/sj.jp.7211067; Askie LM, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-6; Askie LM, 2003, NEW ENGL J MED, V349, P959, DOI 10.1056/NEJMoa023080; Askie LM, 2009, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD001077.PUB2; Bancalari E, 2012, EARLY HUM DEV, V88, pS78, DOI 10.1016/S0378-3782(12)70021-X; Carlo WA, 2010, NEW ENGL J MED, V362, P1959, DOI 10.1056/NEJMoa0911781; Chow LC, 2003, PEDIATRICS, V111, P339, DOI 10.1542/peds.111.2.339; Claure N, 2011, PEDIATRICS, V127, pE76, DOI 10.1542/peds.2010-0939; Darlow BA, 2008, CLIN EXP OPHTHALMOL, V36, P43, DOI 10.1111/j.1442-9071.2007.01652.x; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Good WV, 2003, ARCH OPHTHALMOL-CHIC, V121, P1684; Johnston ED, 2011, ARCH DIS CHILD-FETAL, V96, pF429, DOI 10.1136/adc.2010.206011; Myers Timothy R, 2002, Respir Care, V47, P707; Quine D, 2008, ARCH DIS CHILD-FETAL, V93, pF347, DOI 10.1136/adc.2007.132282; Quine D, 2009, ARCH DIS CHILD-FETAL, V94, pF51, DOI 10.1136/adc.2007.135285; Quinn GE, 2013, PEDIAT OPHTHALMOLOGY, P432; Stenson B, 2011, NEW ENGL J MED, V364, P1680, DOI 10.1056/NEJMc1101319; Tarnow-Mordi WO, 2010, NEW ENGL J MED, V363, P1285, DOI 10.1056/NEJMc1007912; Tin W, 2001, ARCH DIS CHILD-FETAL, V84, pF106, DOI 10.1136/fn.84.2.F106; Vaucher YE, 2012, NEW ENGL J MED, V367, P2495, DOI 10.1056/NEJMoa1208506; Yusuf S, 2000, AM HEART J, V139, pS136, DOI 10.1016/S0002-8703(00)90061-9	22	299	309	0	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2013	368	22					2094	2104		10.1056/NEJMoa1302298	http://dx.doi.org/10.1056/NEJMoa1302298			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AT	23642047	Green Published			2022-12-28	WOS:000319574200007
J	Moosmann, J; Ershov, A; Altapova, V; Baumbach, T; Prasad, MS; LaBonne, C; Xiao, XH; Kashef, J; Hofmann, R				Moosmann, Julian; Ershov, Alexey; Altapova, Venera; Baumbach, Tilo; Prasad, Maneeshi S.; LaBonne, Carole; Xiao, Xianghui; Kashef, Jubin; Hofmann, Ralf			X-ray phase-contrast in vivo microtomography probes new aspects of Xenopus gastrulation	NATURE			English	Article							SYNCHROTRON-RADIATION; EMBRYONIC-DEVELOPMENT; IMAGE-ANALYSIS; OPTICAL-FLOW; BOTTLE CELLS; LAEVIS; MICROSCOPY; INTERNALIZATION; EXTENSION; MOVEMENT	An ambitious goal in biology is to understand the behaviour of cells during development by imaging-in vivo and with subcellular resolution-changes of the embryonic structure. Important morphogenetic movements occur throughout embryogenesis, but in particular during gastrulation when a series of dramatic, coordinated cell movements drives the reorganization of a simple ball or sheet of cells into a complex multi-layered organism(1). In Xenopus laevis, the South African clawed frog and also in zebrafish, cell and tissue movements have been studied in explants(2,3), in fixed embryos(4), in vivo using fluorescence microscopy(5,6) or microscopic magnetic resonance imaging(7). None of these methods allows cell behaviours to be observed with micrometre-scale resolution throughout the optically opaque, living embryo over developmental time. Here we use non-invasive in vivo, time-lapse X-ray microtomography, based on single-distance phase contrast and combined with motion analysis, to examine the course of embryonic development. We demonstrate that this powerful four-dimensional imaging technique provides high-resolution views of gastrulation processes in wildtype X. laevis embryos, including vegetal endoderm rotation, archenteron formation, changes in the volumes of cavities within the porous interstitial tissue between archenteron and blastocoel, migration/confrontation of mesendoderm and closure of the blastopore. Differential flow analysis separates collective from relative cell motion to assign propulsion mechanisms. Moreover, digitally determined volume balances confirm that early archenteron inflation occurs through the uptake of external water. A transient ectodermal ridge, formed in association with the confrontation of ventral and head mesendoderm on the blastocoel roof, is identified. When combined with perturbation experiments to investigate molecular and biomechanical underpinnings of morphogenesis, our technique should help to advance our understanding of the fundamentals of development.	[Moosmann, Julian; Ershov, Alexey; Baumbach, Tilo; Hofmann, Ralf] Karlsruhe Inst Technol, Inst Photon Sci & Synchrotron Radiat, D-76344 Eggenstein Leopoldshafen, Germany; [Ershov, Alexey] Natl Res Tomsk Polytech Univ, Inst Phys & Technol, Dept Gen Phys, Tomsk 634050, Russia; [Altapova, Venera; Baumbach, Tilo] Karlsruhe Inst Technol, Lab Applicat Synchrotron Radiat, D-76128 Karlsruhe, Germany; [Prasad, Maneeshi S.; LaBonne, Carole] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Xiao, Xianghui] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Kashef, Jubin] Karlsruhe Inst Technol, Inst Zool 2, D-76131 Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Tomsk Polytechnic University; Helmholtz Association; Karlsruhe Institute of Technology; Northwestern University; United States Department of Energy (DOE); Argonne National Laboratory; Helmholtz Association; Karlsruhe Institute of Technology	Hofmann, R (corresponding author), Karlsruhe Inst Technol, Inst Photon Sci & Synchrotron Radiat, Hermann von Helmholtz Pl 1, D-76344 Eggenstein Leopoldshafen, Germany.	jubin.kashef@kit.edu; ralf.hofmann2@kit.edu	Moosmann, Julian/D-7075-2013; Baumbach, Tilo Gerd/K-5355-2013; Weinhardt, Venera/T-3932-2017	Moosmann, Julian/0000-0002-6761-7182; Weinhardt, Venera/0000-0002-9774-3833; Ershov, Alexey/0000-0002-5774-5068	US DOE [DE-AC02-06CH11357]; Karlsruhe Institute of Technology within the framework of the German Excellence Initiative; German Federal Ministry of Education and Research [05K12CK2, 05K12VH1]; NATIONAL CANCER INSTITUTE [R01CA114058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077288] Funding Source: NIH RePORTER	US DOE(United States Department of Energy (DOE)); Karlsruhe Institute of Technology within the framework of the German Excellence Initiative; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to acknowledge discussions with J. Wittbrodt, H. Stein beisser, R. Winklbauer and D. Moss. R. Keller and D. Shook helped us with interpreting the data. D. Wedlich and M. Kohl commented on the manuscript. Discussions with M. Kohl on data analysis are gratefully acknowledged. We also would like to thank T. van de Kamp and D. Karpov for their help visualising the set-up, as well as F. de Carlo and K. Fezza for allocating beamtime at 2-BM-B station and at 32-ID, respectively, of Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source, an Office of Science User Facility operated for the US Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the US DOE under Contract No. DE-AC02-06CH11357. E. Becker, C. Huang, A. Merks and R. Langhe helped analysing blastopore radii. J.K.'s Young Investigator Group received financial support from the 'Concept for the Future' programme of Karlsruhe Institute of Technology within the framework of the German Excellence Initiative. This research partially was funded by the German Federal Ministry of Education and Research under grant numbers 05K12CK2 and 05K12VH1.	Baker S, 2011, INT J COMPUT VISION, V92, P1, DOI 10.1007/s11263-010-0390-2; Blanchard GB, 2011, CURR OPIN GENET DEV, V21, P653, DOI 10.1016/j.gde.2011.08.008; Brox T, 2004, LECT NOTES COMPUT SC, V2034, P25, DOI 10.1007/978-3-540-24673-2_3; Cheng KC, 2011, CURR OPIN GENET DEV, V21, P620, DOI 10.1016/j.gde.2011.08.006; Cloetens P, 1999, J PHYS D APPL PHYS, V32, pA145, DOI 10.1088/0022-3727/32/10A/330; Damm EW, 2011, DEVELOPMENT, V138, P565, DOI 10.1242/dev.056903; Deans S. R., 1983, RADON TRANSFORM SOME; Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194; Ewald AJ, 2004, DEVELOPMENT, V131, P6195, DOI 10.1242/dev.01542; Ewald AJ, 2002, DEV DYNAM, V225, P369, DOI 10.1002/dvdy.10169; Greger K, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2428277; HARDIN J, 1988, DEVELOPMENT, V103, P211; Hofmann R, 2011, OPT EXPRESS, V19, P25881, DOI 10.1364/OE.19.025881; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Huisken J, 2009, DEVELOPMENT, V136, P1963, DOI 10.1242/dev.022426; Kashef J, 2009, GENE DEV, V23, P1393, DOI 10.1101/gad.519409; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Keller R, 2003, DIFFERENTIATION, V71, P171, DOI 10.1046/j.1432-0436.2003.710301.x; KELLER R, 1988, DEVELOPMENT, V103, P193; Keller R, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015007; KELLER RE, 1981, J EXP ZOOL, V216, P81, DOI 10.1002/jez.1402160109; Nugent KA, 1996, PHYS REV LETT, V77, P2961, DOI 10.1103/PhysRevLett.77.2961; Paganin D, 1998, PHYS REV LETT, V80, P2586, DOI 10.1103/PhysRevLett.80.2586; Papan C, 2001, DEV BIOL, V235, P189; Rohani N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000597; Ruffins SW, 2002, CURR OPIN NEUROBIOL, V12, P580, DOI 10.1016/S0959-4388(02)00366-5; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Snigirev A, 1995, REV SCI INSTRUM, V66, P5486, DOI 10.1063/1.1146073; TUFT PH, 1962, J EXP BIOL, V39, P1; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; WEISZ PB, 1945, ANAT REC, V93, P161, DOI 10.1002/ar.1090930207; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Winklbauer R, 1999, DEVELOPMENT, V126, P3703	34	67	67	1	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2013	497	7449					374	+		10.1038/nature12116	http://dx.doi.org/10.1038/nature12116			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23676755	Green Accepted			2022-12-28	WOS:000318952000039
J	Romling, U				Romling, Ute			MICROBIOLOGY Bacterial communities as capitalist economies	NATURE			English	Editorial Material							PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; IV PILI		Karolinska Inst, Dept Microbiol Cell & Tumor Biol, S-17177 Stockholm, Sweden	Karolinska Institutet	Romling, U (corresponding author), Karolinska Inst, Dept Microbiol Cell & Tumor Biol, S-17177 Stockholm, Sweden.	ute.romling@ki.se		Romling, Ute/0000-0003-3812-6621				Barken KB, 2008, ENVIRON MICROBIOL, V10, P2331, DOI 10.1111/j.1462-2920.2008.01658.x; Gibiansky ML, 2010, SCIENCE, V330, P197, DOI 10.1126/science.1194238; Grantcharova N, 2010, J BACTERIOL, V192, P456, DOI 10.1128/JB.01826-08; Irie Y, 2012, P NATL ACAD SCI USA, V109, P20632, DOI 10.1073/pnas.1217993109; Li GL, 2012, MOL MICROBIOL, V83, P41, DOI 10.1111/j.1365-2958.2011.07909.x; Mann EE, 2012, FEMS MICROBIOL REV, V36, P893, DOI 10.1111/j.1574-6976.2011.00322.x; Misselwitz B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002810; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Pultz IS, 2012, MOL MICROBIOL, V86, P1424, DOI 10.1111/mmi.12066; Thomas WE, 2004, MOL MICROBIOL, V53, P1545, DOI 10.1111/j.1365-2958.2004.04226.x; Zhao K, 2013, NATURE, V497, P388, DOI 10.1038/nature12155	11	10	11	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2013	497	7449					321	322		10.1038/nature12103	http://dx.doi.org/10.1038/nature12103			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	144PN	23657260				2022-12-28	WOS:000318952000025
J	Sartor, C; Bornet, C; Guinard, D; Fournier, PE				Sartor, Catherine; Bornet, Charleric; Guinard, Didier; Fournier, Pierre-Edouard			Transmission of Aeromonas hydrophila by leeches	LANCET			English	Editorial Material							ANTIMICROBIAL RESISTANCE; ANIMALS; FOOD		[Sartor, Catherine] Hop Conception, Equipe Operat Hyg Hosp, F-13385 Marseille, France; [Bornet, Charleric] Hop Conception, F-13385 Marseille, France; [Guinard, Didier] Hop Conception, Serv Chirurg Plast, F-13385 Marseille, France; [Fournier, Pierre-Edouard] Aix Marseille Univ, Unite Rech Malad Infect & Trop Emergentes, F-13385 Marseille, France; [Fournier, Pierre-Edouard] Hop St Marguerite, Com Lutte Infect Nosocomiales, F-13009 Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Fournier, PE (corresponding author), Aix Marseille Univ, Inserm 1095, Unite Rech Malad Infect & Trop Emergentes, Fac Med,CNRS 7278,IRD 198, F-13385 Marseille, France.	pierre-edouard.fournier@univmed.fr	Fournier, Pierre-Edouard/AAC-6155-2021	Fournier, Pierre-Edouard/0000-0001-8463-8885				Aidara-Kane A, 2012, REV SCI TECH OIE, V31, P277; Mumcuoglu KY, 2010, CLIN MICROBIOL INFEC, V16, P563, DOI 10.1111/j.1469-0691.2009.02868.x; Patel KM, 2013, J PLAST RECONSTR AES, V66, pE20, DOI 10.1016/j.bjps.2012.10.002; Sartor C, 2002, CLIN INFECT DIS, V35, pE1, DOI 10.1086/340711; Vieira AR, 2011, FOODBORNE PATHOG DIS, V8, P1295, DOI 10.1089/fpd.2011.0950	5	16	17	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 11	2013	381	9878					1686	1686		10.1016/S0140-6736(13)60316-5	http://dx.doi.org/10.1016/S0140-6736(13)60316-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146SX	23663954				2022-12-28	WOS:000319112400037
J	Leinwand, LA; Harrison, BC				Leinwand, Leslie A.; Harrison, Brooke C.			Young at Heart	CELL			English	Editorial Material							MICE; DIFFERENTIATION; MYOSTATIN; GDF11		[Leinwand, Leslie A.; Harrison, Brooke C.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Leinwand, Leslie A.; Harrison, Brooke C.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Leinwand, LA (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	leslie.leinwand@colorado.edu		LEINWAND, LESLIE/0000-0003-1470-4810	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029090] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Dai DF, 2009, TRENDS CARDIOVAS MED, V19, P213, DOI 10.1016/j.tcm.2009.12.004; Dichmann DS, 2006, DEV DYNAM, V235, P3016, DOI 10.1002/dvdy.20953; FINERTY JC, 1952, PHYSIOL REV, V32, P277, DOI 10.1152/physrev.1952.32.3.277; Harmon EB, 2004, DEVELOPMENT, V131, P6163, DOI 10.1242/dev.01535; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Kitzman DW, 2007, HEART FAIL CLIN, V3, P437, DOI DOI 10.1016/J.HFC.2007.07.008; Lakatta EG, 2003, CIRCULATION, V107, P346, DOI 10.1161/01.CIR.0000048893.62841.F7; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; McPherron Alexandra C., 2010, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V10, P217; McPherron AC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-24	12	6	6	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 9	2013	153	4					743	745		10.1016/j.cell.2013.04.038	http://dx.doi.org/10.1016/j.cell.2013.04.038			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663775	Bronze			2022-12-28	WOS:000318844000005
J	Mukherji, A; Kobiita, A; Ye, T; Chambon, P				Mukherji, Atish; Kobiita, Ahmad; Ye, Tao; Chambon, Pierre			Homeostasis in Intestinal Epithelium Is Orchestrated by the Circadian Clock and Microbiota Cues Transduced by TLRs	CELL			English	Article							REV-ERB-ALPHA; GLUCOCORTICOID-RECEPTOR; GUT MICROBIOTA; C-JUN; METABOLISM; EXPRESSION; RECOGNITION; REPRESSION; COMPONENTS; ADIPOSITY	Alterations of symbiosis between microbiota and intestinal epithelial cells (IEC) are associated with intestinal and systemic pathologies. Interactions between bacterial products (MAMPs) and Toll-like receptors (TLRs) are known to be mandatory for IEC homeostasis, but how TLRs may time homeostatic functions with circadian changes is unknown. Our functional and molecular dissections of the IEC circadian clock demonstrate that its integrity is required for microbiota-IEC dialog. In IEC, the antiphasic expression of the ROR alpha activator and RevErb alpha repressor clock output regulators generates a circadian rhythmic TLR expression that converts the temporally arrhythmic microbiota signaling into circadian rhythmic JNK and IKK beta activities, which prevents RevErba activation by PPAR alpha that would disrupt the circadian clock. Moreover, through activation of AP1 and NF-kappa B, these activities, together with ROR alpha and RevErb alpha, enable timing homeostatic functions of numerous genes with IEC circadian events. Interestingly, microbiota signaling deficiencies induce a prediabetic syndrome due to ileal corticosterone overproduction consequent to clock disruption.	[Mukherji, Atish; Kobiita, Ahmad; Ye, Tao; Chambon, Pierre] Univ Strasbourg, Coll France, CNRS,UMR7104,Inserm,U964, Inst Genet & Biol Mol & Cellulaire,Inst Etud Avan, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Chambon, P (corresponding author), Univ Strasbourg, Coll France, CNRS,UMR7104,Inserm,U964, Inst Genet & Biol Mol & Cellulaire,Inst Etud Avan, F-67404 Illkirch Graffenstaden, France.	chambon@igbmc.fr			CNRS; INSERM; ANR [ANR 07-Physio 002-01]; University of Strasbourg Institute for Advanced Studies (USIAS); Association pour la Recherche a l'IGBMC (ARI); ARI fellowships	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR(French National Research Agency (ANR)); University of Strasbourg Institute for Advanced Studies (USIAS); Association pour la Recherche a l'IGBMC (ARI); ARI fellowships	We thank Dr. Daniel Metzger for discussions, Dr. Patricia Lopez (CDTA) for GF mice, and Mrs. Estelle Meyer for secretariat help. We are grateful to Marie-France Champy (ICS) for metabolism analysis, and Armelle Van Es for bacterial scoring. We are grateful to S. Akira for floxed MyD88 mice. We also thank the staff of the animal facilities of the IGBMC/ICS. This work was supported by the CNRS, the INSERM, the ANR (ANR 07-Physio 002-01), the University of Strasbourg Institute for Advanced Studies (USIAS), and the Association pour la Recherche a l'IGBMC (ARI). A.M. and A.K. were supported by ARI fellowships.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Aguilera C, 2011, NATURE, V469, P231, DOI 10.1038/nature09607; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Cima I, 2004, J EXP MED, V200, P1635, DOI 10.1084/jem.20031958; Cowell IG, 2002, BIOESSAYS, V24, P1023, DOI 10.1002/bies.10176; Cross HS, 2011, MOL CELL ENDOCRINOL, V347, P70, DOI 10.1016/j.mce.2011.07.022; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Drosatos K, 2011, J BIOL CHEM, V286, P36331, DOI 10.1074/jbc.M111.272146; Duez H, 2008, FEBS LETT, V582, P19, DOI 10.1016/j.febslet.2007.08.032; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Froy O, 2007, MOL IMMUNOL, V44, P1954, DOI 10.1016/j.molimm.2006.09.026; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Hu W, 2011, IMMUNITY, V35, P1010, DOI 10.1016/j.immuni.2011.10.013; Hussain MM, 2009, TRENDS ENDOCRIN MET, V20, P177, DOI 10.1016/j.tem.2009.01.001; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Larsson E, 2012, GUT, V61, P1124, DOI 10.1136/gutjnl-2011-301104; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; Lemke U, 2008, CELL METAB, V8, P212, DOI 10.1016/j.cmet.2008.08.001; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Masri S, 2010, NAT NEUROSCI, V13, P1324, DOI 10.1038/nn.2668; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Mueller M, 2006, J EXP MED, V203, P2057, DOI 10.1084/jem.20060357; Noti M, 2010, J EXP MED, V207, P1057, DOI 10.1084/jem.20090849; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; So AYL, 2009, P NATL ACAD SCI USA, V106, P17582, DOI 10.1073/pnas.0909733106; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Vegiopoulos A, 2007, MOL CELL ENDOCRINOL, V275, P43, DOI 10.1016/j.mce.2007.05.015; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050	42	337	354	0	98	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 9	2013	153	4					812	827		10.1016/j.cell.2013.04.020	http://dx.doi.org/10.1016/j.cell.2013.04.020			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663780	Bronze			2022-12-28	WOS:000318844000011
J	Farrell, L				Farrell, Liam			THE BEST MEDICINE Run wild, run free	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												drfarrell@hotmail.co.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2013	346								f2870	10.1136/bmj.f2870	http://dx.doi.org/10.1136/bmj.f2870			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144BQ	23653135				2022-12-28	WOS:000318914800004
J	Steneck, NH				Steneck, Nicholas H.			Global Research Integrity Training	SCIENCE			English	Editorial Material							ETHICAL DECISION-MAKING; RESPONSIBLE CONDUCT; SCIENTISTS; FUTURE		Univ Michigan, Michigan Inst Clin & Hlth Res, Res Eth & Integr Program, Ann Arbor, MI 48103 USA	University of Michigan System; University of Michigan	Steneck, NH (corresponding author), Univ Michigan, Michigan Inst Clin & Hlth Res, Res Eth & Integr Program, Ann Arbor, MI 48103 USA.	nsteneck@umich.edu			NCATS NIH HHS [2UL1TR000433] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Alcohol Drug Abuse and Mental Health Administration NIH, 1989, NIH GUIDE GRANTS CON, V18, P1; Anderson MS, 2007, ACAD MED, V82, P853, DOI 10.1097/ACM.0b013e31812f764c; Antes AL, 2007, J EMPIR RES HUM RES, V2, P15, DOI 10.1525/jer.2007.2.4.15; Djulbegovic B, 2008, ARCH INTERN MED, V168, P632, DOI 10.1001/archinte.168.6.632; Errami M, 2009, NUCLEIC ACIDS RES, V37, pD921, DOI 10.1093/nar/gkn546; Fanelli D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005738; Freyd JJ, 2011, J TRAUMA DISSOCIATIO, V12, P475, DOI 10.1080/15299732.2011.602290; Heitman Elizabeth, 2005, Account Res, V12, P207, DOI 10.1080/08989620500217420; InterAcademy Council and InterAcademy Panel, 2012, RESP COND GLOB RES E; Kalichman MW, 2007, ACAD MED, V82, P846, DOI 10.1097/ACM.0b013e31812f78bf; Keith-Spiegel P, 2005, ETHICS BEHAV, V15, P339, DOI 10.1207/s15327019eb1504_5; Martinson BC, 2005, NATURE, V435, P737, DOI 10.1038/435737a; Martinson BC, 2013, SCI ENG ETHICS, V19, P813, DOI 10.1007/s11948-012-9410-7; Martinson BC, 2010, J EMPIR RES HUM RES, V5, P67, DOI 10.1525/jer.2010.5.3.67; Michalek AM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000318; Mumford MD, 2007, ETHICS BEHAV, V17, P337, DOI 10.1080/10508420701519510; Mumford M, 2008, ETHICS BEHAV, V18, P315, DOI 10.1080/10508420802487815; National Science Foundation (NSF), 2009, FED REG, V74, P42126; Office of the Director NIH, 2011, NOTOD10019 NIH OFF D; Steneck N. H., 2012, PROMOTING RES INTEGR; Steneck NH, 2006, SCI ENG ETHICS, V12, P53, DOI 10.1007/PL00022268; Steneck NH, 2007, ACAD MED, V82, P829, DOI 10.1097/ACM.0b013e31812f7d4d; Stretton S, 2012, CURR MED RES OPIN, V28, P1575, DOI 10.1185/03007995.2012.728131; Suresh S, 2011, SCIENCE, V333, P802, DOI 10.1126/science.1210025; Universitas 21, 2013, U 21 NEWS       0109; Universities UK, 2012, CONC SUPP RES INT; World Conference on Research Integrity, 2010, 2 WORLD C RES INT SI	27	36	38	3	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2013	340	6132					552	553		10.1126/science.1236373	http://dx.doi.org/10.1126/science.1236373			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	135EA	23641099				2022-12-28	WOS:000318268900030
J	Wagner, F; Mono, ML; Kondgen, H; Wiest, R; Meier, N				Wagner, Franca; Mono, Marie-Luise; Kondgen, Harold; Wiest, Roland; Meier, Niklaus			Cervical polyradiculopathy caused by vertebral artery dissection	LANCET			English	Editorial Material							RADICULOPATHY		[Wagner, Franca; Wiest, Roland] Univ Hosp Bern, Inselspital, Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland; [Mono, Marie-Luise; Kondgen, Harold; Meier, Niklaus] Univ Hosp Bern, Inselspital, Dept Neurol, CH-3010 Bern, Switzerland; [Wiest, Roland] Univ Bern, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern	Wiest, R (corresponding author), Univ Hosp Bern, Inselspital, Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland.	roland.wiest@insel.ch						Carette S, 2005, NEW ENGL J MED, V353, P392, DOI 10.1056/NEJMcp043887; Crum B, 2000, NEUROLOGY, V55, P304, DOI 10.1212/WNL.55.2.304; Gottesman RF, 2012, NEUROLOGIST, V18, P245, DOI 10.1097/NRL.0b013e31826754e1; Hardmeier M, 2007, J NEUROL, V254, P672, DOI 10.1007/s00415-006-0331-8; RADHAKRISHNAN K, 1994, BRAIN, V117, P325, DOI 10.1093/brain/117.2.325	5	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 27	2013	381	9876					1510	1510		10.1016/S0140-6736(13)60180-4	http://dx.doi.org/10.1016/S0140-6736(13)60180-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139TK	23622284				2022-12-28	WOS:000318607300041
J	Horby, P				Horby, Peter			H7N9 is a virus worth worrying about	NATURE			English	Editorial Material									Univ Oxford, Clin Res Unit, Wellcome Trust Programme Vietnam & Singapore Infe, Oxford OX1 2JD, England	University of Oxford	Horby, P (corresponding author), Univ Oxford, Clin Res Unit, Wellcome Trust Programme Vietnam & Singapore Infe, Oxford OX1 2JD, England.	phorby@oucru.org	Hay, Simon Iain/F-8967-2015	Hay, Simon Iain/0000-0002-0611-7272; Tatem, Andrew/0000-0002-7270-941X; Horby, Peter/0000-0002-9822-1586	Wellcome Trust [093724, 095066, 089276] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)			0	38	48	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 25	2013	496	7446					399	399		10.1038/496399a	http://dx.doi.org/10.1038/496399a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	131HU	23619655	Bronze, Green Published			2022-12-28	WOS:000317984400004
J	Spong, CY				Spong, Catherine Y.			Defining "Term" Pregnancy Recommendations From the Defining "Term" Pregnancy Workgroup	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH; CARE		[Spong, Catherine Y.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Spong, CY (corresponding author), NICHHD, NIH, 6100 Execut Blvd,Room 4B03,MSC 7510, Bethesda, MD 20892 USA.	spongc@mail.nih.gov						[Anonymous], 2007, PRETERM BIRTH CAUSES; MacDorman MF, 2012, NATL VITAL STAT REP, V61; Oshiro BT, 2009, OBSTET GYNECOL, V113, P804, DOI 10.1097/AOG.0b013e31819b5c8c; Raju TNK, 2006, PEDIATRICS, V118, P1207, DOI 10.1542/peds.2006-0018; Souza JP, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-286; Tita ATN, 2009, NEW ENGL J MED, V360, P111, DOI 10.1056/NEJMoa0803267; World Health Organization, ICD 10 INT STAT CLAS, V2; 1970, ARCH DIS CHILD, V45, P730	8	302	318	0	20	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2013	309	23					2445	2446		10.1001/jama.2013.6235	http://dx.doi.org/10.1001/jama.2013.6235			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165SW	23645117				2022-12-28	WOS:000320505100023
J	Walls, RM; Zinner, MJ				Walls, Ron M.; Zinner, Michael J.			The Boston Marathon Response Why Did It Work So Well?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Walls, Ron M.; Zinner, Michael J.] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Zinner, MJ (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	mzinner@partners.org							0	33	34	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2013	309	23					2441	2442		10.1001/jama.2013.5965	http://dx.doi.org/10.1001/jama.2013.5965			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165SW	23632605				2022-12-28	WOS:000320505100021
J	Diaz, JM; Hansel, CM; Voelker, BM; Mendes, CM; Andeer, PF; Zhang, T				Diaz, Julia M.; Hansel, Colleen M.; Voelker, Bettina M.; Mendes, Chantal M.; Andeer, Peter F.; Zhang, Tong			Widespread Production of Extracellular Superoxide by Heterotrophic Bacteria	SCIENCE			English	Article							IRON REDOX CHEMISTRY; HYDROGEN-PEROXIDE; GENERATION; REDUCTION; SUNLIGHT; MERCURY; OCEAN; H2O2	Superoxide and other reactive oxygen species (ROS) originate from several natural sources and profoundly influence numerous elemental cycles, including carbon and trace metals. In the deep ocean, the permanent absence of light precludes currently known ROS sources, yet ROS production mysteriously occurs. Here, we show that taxonomically and ecologically diverse heterotrophic bacteria from aquatic and terrestrial environments are a vast, unrecognized, and light-independent source of superoxide, and perhaps other ROS derived from superoxide. Superoxide production by a model bacterium within the ubiquitous Roseobacter clade involves an extracellular oxidoreductase that is stimulated by the reduced form of nicotinamide adenine dinucleotide (NADH), suggesting a surprising homology with eukaryotic organisms. The consequences of ROS cycling in immense aphotic zones representing key sites of nutrient regeneration and carbon export must now be considered, including potential control of carbon remineralization and metal bioavailability.	[Diaz, Julia M.; Hansel, Colleen M.; Mendes, Chantal M.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Hansel, Colleen M.; Andeer, Peter F.; Zhang, Tong] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Voelker, Bettina M.] Colorado Sch Mines, Dept Chem & Geochem, Golden, CO 80401 USA	Harvard University; Woods Hole Oceanographic Institution; Colorado School of Mines	Hansel, CM (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	chansel@whoi.edu	Voelker, Bettina M/C-1815-2013	Zhang, Tong/0000-0002-8151-3697	National Science Foundation [OCE-1129594, OCE-1131734, EAR-1024817, EAR-1025077]; Radcliffe Institute for Advanced Study at Harvard University; Ford Foundation Fellowship Program	National Science Foundation(National Science Foundation (NSF)); Radcliffe Institute for Advanced Study at Harvard University; Ford Foundation Fellowship Program	This study was supported by the National Science Foundation under grants OCE-1129594, OCE-1131734, EAR-1024817, and EAR-1025077 and by the Radcliffe Institute for Advanced Study at Harvard University and the Ford Foundation Fellowship Program. We thank E. D. Ingall for manuscript comments, D. W. King for technical assistance, and the thoughtful comments of four anonymous reviewers. We also thank the following individuals for contributing bacterial isolates for analysis in this study: H. Ehrlich, D. Emerson, S. Fendorf, Y. Masue-Slowey, T. Mincer, M. A. Moran, B. Tebo, R. Belas, and A. Templeton. The GenBank accession numbers for 16S ribosomal RNA (rRNA) gene sequences generated in this study are as follows: Bacillus sp. AzsLept-1c, JX515653; Tencibaculum sp. UAzPsLept-5, JX515654; Marinobacter sp. AzsJAc-4c, JX515655; Marinobacter sp. AzsJAc-4, JX515656; Halomonas sp. VMMm1-3c, JX515657; Microbulbifer sp. HLm1-1, JX515658; Paracoccus sp. HIJAc-3c, JX515659; Alteromonas sp. BIII82, JX524853; Alteromonas sp. BIII45, JX524854; Pseudoalteromonas sp. SSW22, JX524855; Marinobacter sp. LCB-12, JX524856; Halomonas sp. LOB-22, JX524857; and Citreicella sp. LOB-21, JX524858.	Bedard K, 2007, BIOCHIMIE, V89, P1107, DOI 10.1016/j.biochi.2007.01.012; Buchan A, 2005, APPL ENVIRON MICROB, V71, P5665, DOI 10.1128/AEM.71.10.5665-5677.2005; Buesseler KO, 2007, SCIENCE, V316, P567, DOI 10.1126/science.1137959; Chen C, 2008, ECOHEALTH, V5, P399, DOI 10.1007/s10393-008-0201-1; Cooper W.J., 1989, ADV CHEM SER, P333; Croot P., 2010, OCEANS, V115; FRIDOVICH I, 1975, ANNU REV BIOCHEM, V44, P147, DOI 10.1146/annurev.bi.44.070175.001051; Hansard SP, 2010, DEEP-SEA RES PT I, V57, P1111, DOI 10.1016/j.dsr.2010.05.007; Huycke MM, 2001, MOL MICROBIOL, V42, P729, DOI 10.1046/j.1365-2958.2001.02638.x; Kim D, 2000, BBA-GEN SUBJECTS, V1524, P220, DOI 10.1016/S0304-4165(00)00161-6; Korshunov S, 2006, J BACTERIOL, V188, P6326, DOI 10.1128/JB.00554-06; Kustka AB, 2005, LIMNOL OCEANOGR, V50, P1172, DOI 10.4319/lo.2005.50.4.1172; Learman DR, 2011, NAT GEOSCI, V4, P95, DOI [10.1038/ngeo1055, 10.1038/NGEO1055]; Lin PC, 2007, J BACTERIOL, V189, P3902, DOI 10.1128/JB.01651-06; Marshall JA, 2005, MAR BIOL, V147, P533, DOI 10.1007/s00227-005-1596-7; Minibayeva FV, 2001, PROTOPLASMA, V217, P125, DOI 10.1007/BF01289421; Oda T, 1997, BIOSCI BIOTECH BIOCH, V61, P1658, DOI 10.1271/bbb.61.1658; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; PALENIK B, 1988, LIMNOL OCEANOGR, V33, P1606, DOI 10.4319/lo.1988.33.6_part_2.1606; Pullin MJ, 2004, LIMNOL OCEANOGR, V49, P2011, DOI 10.4319/lo.2004.49.6.2011; Rose AL, 2005, ENVIRON SCI TECHNOL, V39, P3708, DOI 10.1021/es048766c; Rose AL, 2008, ENVIRON SCI TECHNOL, V42, P2387, DOI 10.1021/es7024609; Rose AL, 2008, ANAL CHEM, V80, P1215, DOI 10.1021/ac7018975; Rose AL, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00124; Siciliano SD, 2002, ENVIRON SCI TECHNOL, V36, P3064, DOI 10.1021/es010774v; Vermilyea AW, 2010, ENVIRON SCI TECHNOL, V44, P3066, DOI 10.1021/es100209h; Yuan JC, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018439; Yuan JC, 2001, DEEP-SEA RES PT II, V48, P2947, DOI 10.1016/S0967-0645(01)00026-1; Zhang H, 2001, ENVIRON SCI TECHNOL, V35, P928, DOI 10.1021/es001521p	29	174	186	35	406	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1223	1226		10.1126/science.1237331	http://dx.doi.org/10.1126/science.1237331			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23641059				2022-12-28	WOS:000319972800048
J	Goralnick, E; Gates, J				Goralnick, Eric; Gates, Jonathan			We Fight Like We Train	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Goralnick, Eric] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Gates, Jonathan] Brigham & Womens Hosp, Dept Surg, Div Trauma Burns & Surg Crit Care, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Goralnick, E (corresponding author), Brigham & Womens Hosp, Dept Emergency Med, 75 Francis St, Boston, MA 02115 USA.								0	15	15	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2013	368	21					1960	1961		10.1056/NEJMp1305359	http://dx.doi.org/10.1056/NEJMp1305359			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194KD	23635019	Bronze			2022-12-28	WOS:000322630700005
J	Ho, CY; Jaalouk, DE; Vartiainen, MK; Lammerding, J				Ho, Chin Yee; Jaalouk, Diana E.; Vartiainen, Maria K.; Lammerding, Jan			Lamin A/C and emerin regulate MKL1-SRF activity by modulating actin dynamics	NATURE			English	Article							A-TYPE LAMINS; NUCLEAR-ENVELOPE; DILATED CARDIOMYOPATHY; TRANSCRIPTION FACTORS; MUSCLE REGENERATION; MUSCULAR-DYSTROPHY; CELL-NUCLEUS; RPEL MOTIFS; BINDING; LOCALIZATION	Laminopathies, caused by mutations in the LMNA gene encoding the nuclear envelope proteins lamins A and C, represent a diverse group of diseases that include Emery-Dreifuss muscular dystrophy (EDMD), dilated cardiomyopathy (DCM), limb-girdle muscular dystrophy, and Hutchison-Gilford progeria syndrome(1). Most LMNA mutations affect skeletal and cardiac muscle by mechanisms that remain incompletely understood. Loss of structural function and altered interaction of mutant lamins with (tissue-specific) transcription factors have been proposed to explain the tissue-specific phenotypes(1). Here we report in mice that lamin-A/C-deficient (Lmna(-/-)) and Lmna(N195K/N195K) mutant cells have impaired nuclear translocation and downstream signalling of the mechanosensitive transcription factor megakaryoblastic leukaemia 1 (MKL1), a myocardin family member that is pivotal in cardiac development and function(2). Altered nucleo-cytoplasmic shuttling of MKL1 was caused by altered actin dynamics in Lmna(-/-) and Lmna(N195K/N195K) mutant cells. Ectopic expression of the nuclear envelope protein emerin, which is mislocalized in Lmna mutant cells and also linked to EDMD and DCM, restored MKL1 nuclear translocation and rescued actin dynamics in mutant cells. These findings present a novel mechanism that could provide insight into the disease aetiology for the cardiac phenotype in many laminopathies, whereby lamin A/C and emerin regulate gene expression through modulation of nuclear and cytoskeletal actin polymerization.	[Ho, Chin Yee; Lammerding, Jan] Cornell Univ, Dept Biomed Engn, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA; [Ho, Chin Yee; Jaalouk, Diana E.; Lammerding, Jan] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Vartiainen, Maria K.] Univ Helsinki, Inst Biotechnol, Helsinki 00014, Finland	Cornell University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Helsinki	Lammerding, J (corresponding author), Cornell Univ, Dept Biomed Engn, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA.	jan.lammerding@cornell.edu	Vartiainen, Maria K/F-4767-2013; Vartiainen, Maria/P-7043-2019; Lammerding, Jan/A-9498-2016	Vartiainen, Maria K/0000-0002-2017-0475; Vartiainen, Maria/0000-0002-2017-0475; Lammerding, Jan/0000-0003-4335-8611	National Institutes of Health [R01 NS059348, R01 HL082792]; Department of Defense Breast Cancer Idea Award [BC102152]; Progeria Research Foundation [PRF 2011-035]; American Heart Association [09POST2320042]; Academy of Finland; Sigrid Juselius Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Idea Award(United States Department of Defense); Progeria Research Foundation; American Heart Association(American Heart Association); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Stewart for the mouse models and cell lines. We thank J. Gannon for TAC surgeries and M. Cupesi for collecting the cardiac samples from the pressure-overload model. This work was supported by National Institutes of Health awards (R01 NS059348 and R01 HL082792); the Department of Defense Breast Cancer Idea Award (BC102152); an award from the Progeria Research Foundation (PRF 2011-035); and a postdoctoral fellowship from the American Heart Association to D. E. J. (AHA award 09POST2320042). The work in the laboratory of M. K. V. is funded by the Academy of Finland and the Sigrid Juselius Foundation.	Cupesi M, 2010, J MOL CELL CARDIOL, V48, P1290, DOI 10.1016/j.yjmcc.2009.10.024; Fairley EAL, 1999, J CELL SCI, V112, P2571; Guettler S, 2008, MOL CELL BIOL, V28, P732, DOI 10.1128/MCB.01623-07; Hale CM, 2008, BIOPHYS J, V95, P5462, DOI 10.1529/biophysj.108.139428; Hirano H, 2011, BIOCHEM BIOPH RES CO, V414, P373, DOI 10.1016/j.bbrc.2011.09.079; Ho CY, 2012, J CELL SCI, V125, P2087, DOI 10.1242/jcs.087288; Holaska JM, 2004, PLOS BIOL, V2, P1354, DOI 10.1371/journal.pbio.0020231; KNOWLES GC, 1992, J HISTOCHEM CYTOCHEM, V40, P1605, DOI 10.1177/40.10.1527379; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Lammerding J, 2005, J CELL BIOL, V170, P781, DOI 10.1083/jcb.200502148; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; McDonald D, 2006, J CELL BIOL, V172, P541, DOI 10.1083/jcb.200507101; Melcon G, 2006, HUM MOL GENET, V15, P637, DOI 10.1093/hmg/ddi479; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Mokalled MH, 2012, GENE DEV, V26, P190, DOI 10.1101/gad.179663.111; Morita T, 2007, EXP CELL RES, V313, P3432, DOI 10.1016/j.yexcr.2007.07.008; Mouilleron S, 2008, EMBO J, V27, P3198, DOI 10.1038/emboj.2008.235; Mounkes LC, 2005, HUM MOL GENET, V14, P2167, DOI 10.1093/hmg/ddi221; Muchir A, 2009, HUM MOL GENET, V18, P241, DOI 10.1093/hmg/ddn343; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Nikolova-Krstevski V, 2011, J MOL CELL CARDIOL, V50, P479, DOI 10.1016/j.yjmcc.2010.12.001; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Parlakian A, 2005, CIRCULATION, V112, P2930, DOI 10.1161/CIRCULATIONAHA.105.533778; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Pawlowski R, 2010, EMBO J, V29, P3448, DOI 10.1038/emboj.2010.216; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Rowat AC, 2006, BIOPHYS J, V91, P4649, DOI 10.1529/biophysj.106.086454; Salpingidou G, 2007, J CELL BIOL, V178, P897, DOI 10.1083/jcb.200702026; Simon DN, 2010, NUCLEUS-PHILA, V1, P264, DOI 10.4161/nucl.1.3.11799; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Wilson KL, 2010, J CELL SCI, V123, P1973, DOI 10.1242/jcs.019042	33	314	321	0	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					507	+		10.1038/nature12105	http://dx.doi.org/10.1038/nature12105			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23644458	Green Submitted, Green Accepted			2022-12-28	WOS:000319254000052
J	Zheng, JM; Jia, ZC				Zheng, Jimin; Jia, Zongchao			STRUCTURAL BIOLOGY Tiny enzyme uses context to succeed	NATURE			English	Editorial Material							DIACYLGLYCEROL KINASE; ESCHERICHIA-COLI		[Zheng, Jimin] Beijing Normal Univ, Coll Chem, Beijing 100875, Peoples R China; [Jia, Zongchao] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	Beijing Normal University; Queens University - Canada	Zheng, JM (corresponding author), Beijing Normal Univ, Coll Chem, Beijing 100875, Peoples R China.	jia@queensu.ca						Badola P, 1997, J BIOL CHEM, V272, P24176, DOI 10.1074/jbc.272.39.24176; Li DF, 2013, NATURE, V497, P521, DOI 10.1038/nature12179; PIERINGE.RA, 1965, J BIOL CHEM, V240, P2833; Taylor SS, 2012, PHILOS T R SOC B, V367, P2517, DOI 10.1098/rstb.2012.0054; Van Horn WD, 2012, ANNU REV BIOPHYS, V41, P81, DOI [10.1146/annurev-biophys-050511-102330, 10.1146/annurev-biophys-050511-182330]; Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716	6	5	5	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					445	446		10.1038/nature12245	http://dx.doi.org/10.1038/nature12245			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23676672				2022-12-28	WOS:000319254000035
J	Lewycka, S; Mwansambo, C; Rosato, M; Kazembe, P; Phiri, T; Mganga, A; Chapota, H; Malamba, F; Kainja, E; Newell, ML; Greco, G; Pulkki-Brannstrom, AM; Skordis-Worrall, J; Vergnano, S; Osrin, D; Costello, A				Lewycka, Sonia; Mwansambo, Charles; Rosato, Mikey; Kazembe, Peter; Phiri, Tambosi; Mganga, Andrew; Chapota, Hilda; Malamba, Florida; Kainja, Esther; Newell, Marie-Louise; Greco, Giulia; Pulkki-Braennstroem, Anni-Maria; Skordis-Worrall, Jolene; Vergnano, Stefania; Osrin, David; Costello, Anthony			Effect of women's groups and volunteer peer counselling on rates of mortality, morbidity, and health behaviours in mothers and children in rural Malawi (MaiMwana): a factorial, cluster-randomised controlled trial	LANCET			English	Article							PROMOTION; INTERVENTION; BANGLADESH; CHILDHOOD; ILLNESS; AFRICA	Background Women's groups and health education by peer counsellors can improve the health of mothers and children. We assessed their effects on mortality and breastfeeding rates in rural Malawi. Methods We did a 2x2 factorial, cluster-randomised trial in 185 888 people in Mchinji district. 48 equal-sized clusters were randomly allocated to four groups with a computer-generated number sequence. 24 facilitators guided groups through a community action cycle to tackle maternal and child health problems. 72 trained volunteer peer counsellors made home visits at five timepoints during pregnancy and after birth to support breastfeeding and infant care. Primary outcomes for the women's group intervention were maternal, perinatal, neonatal, and infant mortality rates (MMR, PMR, NMR, and IMR, respectively); and for the peer counselling were IMR and exclusive breastfeeding (EBF) rates. Analysis was by intention to treat. The trial is registered as ISRCTN06477126. Findings We monitored outcomes of 26 262 births between 2005 and 2009. In a factorial model adjusted only for clustering and the volunteer peer counselling intervention, in women's group areas, for years 2 and 3, we noted non-significant decreases in NMR (odds ratio 0.93, 0.64-1.35) and MMR (0.54, 0.28-1.04). After adjustment for parity, socioeconomic quintile, and baseline measures, effects were larger for NMR (0.85, 0.59-1.22) and MMR (0.48, 0.26-0.91). Because of the interaction between the two interventions, a stratified analysis was done. For women's groups, in adjusted analyses, MMR fell by 74% (0.26, 0.10-0.70), and NMR by 41% (0.59, 0.40-0.86) in areas with no peer counsellors, but there was no effect in areas with counsellors (1.09, 0.40-2.98, and 1.38, 0.75-2.54). Factorial analysis for the peer counselling intervention for years 1-3 showed a fall in IMR of 18% (0.82, 0.67-1.00) and an improvement in EBF rates (2.42, 1.48-3.96). The results of the stratified, adjusted analysis showed a 36% reduction in IMR (0.64, 0.48-0.85) but no effect on EBF (1.18, 0.63-2.25) in areas without women's groups, and in areas with women's groups there was no effect on IMR (1.05, 0.82-1.36) and an increase in EBF (5.02, 2.67-9.44). The cost of women's groups was US$114 per year of life lost (YLL) averted and that of peer counsellors was $33 per YLL averted, using stratified data from single intervention comparisons. Interpretation Community mobilisation through women's groups and volunteer peer counsellor health education are methods to improve maternal and child health outcomes in poor rural populations in Africa.	[Lewycka, Sonia; Rosato, Mikey; Pulkki-Braennstroem, Anni-Maria; Skordis-Worrall, Jolene; Vergnano, Stefania; Osrin, David; Costello, Anthony] UCL, Inst Global Hlth, London WC1N 1EH, England; [Mwansambo, Charles] Govt Malawi, Minist Hlth, Lilongwe, Malawi; [Kazembe, Peter] Baylor Coll Med, Childrens Fdn, Lilongwe, Malawi; [Phiri, Tambosi; Mganga, Andrew; Chapota, Hilda; Malamba, Florida; Kainja, Esther] MaiMwana Project, Mchinji, Malawi; [Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Kwa Zulu, South Africa; [Greco, Giulia] London Sch Hyg & Trop Med, Hlth Econ & Financing Programme, London WC1, England	University of London; University College London; Baylor College of Medicine; University of Kwazulu Natal; University of London; London School of Hygiene & Tropical Medicine	Costello, A (corresponding author), UCL, Inst Global Hlth, 30 Guilford St, London WC1N 1EH, England.	anthony.costello@ucl.ac.uk	Newell, Marie-Louise/AAE-8222-2019; Lewycka, Sonia/J-1234-2019; Vergnano, Stefi/AAR-3647-2020	Newell, Marie-Louise/0000-0002-1074-7699; Lewycka, Sonia/0000-0002-5923-9468; Pulkki-Brannstrom, Anni-Maria/0000-0001-8723-8131; Greco, Giulia/0000-0002-5448-9521; Skordis, Jolene/0000-0002-8633-0208	Saving Newborn Lives; UK Department for International Development; Wellcome Trust; Institute of Child Health; UNICEF Malawi	Saving Newborn Lives; UK Department for International Development; Wellcome Trust(Wellcome TrustEuropean Commission); Institute of Child Health; UNICEF Malawi	Saving Newborn Lives, UK Department for International Development, and Wellcome Trust.; Trial funding was provided mainly by Saving Newborn Lives with later contributions from the UK Department for International Development, Wellcome Trust, Institute of Child Health, and UNICEF Malawi. We thank the Malawi Ministry of Health, Mchinji District Hospital, Mchinji district assembly and traditional leaders, MaiMwana women's group facilitators, volunteer counsellors, participating community members, and all field staff for their contributions to this study.	Aidam BA, 2005, J NUTR, V135, P1691, DOI 10.1093/jn/135.7.1691; Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Azad K, 2010, LANCET, V375, P1193, DOI 10.1016/S0140-6736(10)60142-0; Beck B, 2004, CARE NEWBORN REFEREN; Bhandari N, 2003, LANCET, V361, P1418, DOI 10.1016/S0140-6736(03)13134-0; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Britton C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001141.pub3; Coovadia H, 2009, CURR OPIN HIV AIDS, V4, P319, DOI 10.1097/COH.0b013e32832a9a17; Grabman LH, 2002, WARMI PROJECT PARTIC; Grant AM, 2005, LANCET, V365, P711; Haider R, 2000, LANCET, V356, P1643, DOI 10.1016/S0140-6736(00)03159-7; Int Mon Fund, 2011, WOR ECON OUTLOOK, P1; Jakobsen MS, 2008, ACTA PAEDIATR, V97, P68, DOI 10.1111/j.1651-2227.2007.00532.x; Kramer M. S, 2009, COCHRANE DB SYST REV; Leite AJM, 2005, ACTA PAEDIATR, V94, P741, DOI 10.1080/08035250410023854; Lewin S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub3; Lewycka S, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-88; Linkages, 1999, REC FEED DIET PRACT; Malawi Ministry of Health, 2010, 2 MAL MIN HLTH, P1; Malawi National Statistical Office, 2011, MAL DEM HLTH SURV 20, P1; Malawi National Statistical Office Macro ORC, 2005, MAL DEM HLTH SURV 20, P454; Malawi National Statistical Office UNICEF-Malawi, 2008, MULT IND CLUST SURV; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rosato M, VOLUNTEER INFANT FEE; Rosato M, 2010, UMODZI TOGETHER FILM; Rosato M, 2010, MALAWI MED J, V22, P112; Sachs JD, 2001, MACROECONOMICS HLTH, P1; Taha TE, 2006, B WORLD HEALTH ORGAN, V84, P546, DOI 10.2471/BLT.05.027664; Tripathy P, 2010, LANCET, V375, P1182, DOI 10.1016/S0140-6736(09)62042-0; Tylleskar T, 2011, LANCET, V378, P420, DOI 10.1016/S0140-6736(11)60738-1; Victora CG, 2005, LANCET, V366, P1460, DOI 10.1016/S0140-6736(05)67599-X; WHO & UNICEF (World Health Organization & UNICEF), 1993, BREASTF COUNS TRAIN; World Bank, 2010, WORLD DEV REP 2010 P	34	124	124	0	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 18	2013	381	9879					1721	1735		10.1016/S0140-6736(12)61959-X	http://dx.doi.org/10.1016/S0140-6736(12)61959-X			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146TA	23683639	Green Accepted			2022-12-28	WOS:000319112800037
J	Ross, AGP; Olds, GR; Cripps, AW; Farrar, JJ; McManus, DP				Ross, Allen G. P.; Olds, G. Richard; Cripps, Allan W.; Farrar, Jeremy J.; McManus, Donald P.			Enteropathogens and Chronic Illness in Returning Travelers	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CAMPYLOBACTER-JEJUNI; STRONGYLOIDES-STERCORALIS; SALMONELLA DISEASE; SHIGELLOSIS; INFECTIONS; MECHANISMS; MANAGEMENT; DIAGNOSIS; UPDATE; SCHISTOSOMIASIS		[Ross, Allen G. P.; Cripps, Allan W.] Griffith Univ, Griffith Hlth Inst, Gold Coast, Qld, Australia; [McManus, Donald P.] Queensland Inst Med Res, Div Infect Dis, Brisbane, Qld 4006, Australia; [Olds, G. Richard] Univ Calif Riverside, Sch Med, Riverside, CA 92521 USA; [Farrar, Jeremy J.] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam	Griffith University; Menzies Health Institute Queensland; QIMR Berghofer Medical Research Institute; University of California System; University of California Riverside; University of Oxford	Ross, AGP (corresponding author), Griffith Univ, Griffith Hlth Inst, Gold Coast, Qld, Australia.	a.ross@griffith.edu.au	McManus, Donald P./G-2678-2013; Farrar, Jeremy J./HGA-7610-2022; McManus, Don/AAC-5394-2020	McManus, Don/0000-0001-6443-1449; Farrar, Jeremy/0000-0002-2700-623X; Ross, Allen/0000-0002-2329-0907	Probiotec; Danisco; GlaxoSmithKline	Probiotec; Danisco; GlaxoSmithKline(GlaxoSmithKline)	Dr. Cripps reports receiving through his institution consulting fees from Probiotec, grant support from Danisco and GlaxoSmithKline, and travel support from GlaxoSmithKline and holding stock in Bioxyne. He also has a pending patent application through Danisco regarding probiotics. No other potential conflict of interest relevant to this article was reported.	Adachi JA, 2006, CLIN INFECT DIS, V42, P541, DOI 10.1086/499950; Andersen MD, 2007, REV MED MICROBIOL, V18, P35; Ankarklev J, 2010, NAT REV MICROBIOL, V8, P413, DOI 10.1038/nrmicro2317; Ansart S, 2005, J TRAVEL MED, V12, P312, DOI 10.2310/7060.2005.12603; Bhavnani D, 2012, AM J EPIDEMIOL, V176, P387, DOI 10.1093/aje/kws220; Buret AG, 2002, PARASITOLOGY, V125, P11, DOI 10.1017/S0031182002001853; Carranza PG, 2010, MICROBES INFECT, V12, P71, DOI 10.1016/j.micinf.2009.09.008; Carrero JC, 2010, EXP PARASITOL, V126, P359, DOI 10.1016/j.exppara.2010.03.007; Cartwright Rodney, 2004, Euro Surveill, V9, P5; Casburn-Jones AC, 2004, GUT, V53, P296, DOI 10.1136/gut.2003.022103; Cotton JA, 2011, INT J PARASITOL, V41, P925, DOI 10.1016/j.ijpara.2011.05.002; Da'Dara AA, 2008, VACCINE, V26, P3617, DOI 10.1016/j.vaccine.2008.04.080; Dasti JI, 2010, INT J MED MICROBIOL, V300, P205, DOI 10.1016/j.ijmm.2009.07.002; Debnath A, 2012, NAT MED, V18, P956, DOI 10.1038/nm.2758; Dougan G, 2011, IMMUNOL REV, V240, P196, DOI 10.1111/j.1600-065X.2010.00999.x; DuPont HL, 2012, CURR OPIN GASTROEN, V28, P39, DOI 10.1097/MOG.0b013e32834d3208; DuPont HL, 2009, NEW ENGL J MED, V361, P1560, DOI 10.1056/NEJMcp0904162; DuPont HL, 2005, CURR OPIN INFECT DIS, V18, P407, DOI 10.1097/01.qco.0000182535.54081.68; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Freedman DO, 2006, NEW ENGL J MED, V355, P967; Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331; Gorbach SL, 2005, ANN INTERN MED, V142, P861, DOI 10.7326/0003-4819-142-10-200505170-00012; Gordon MA, 2011, CURR OPIN INFECT DIS, V24, P484, DOI 10.1097/QCO.0b013e32834a9980; Gray DJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2651; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Han J, 2012, FRONT CELL INFECT MI, V2, P21; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; Hill DR, 2006, NEW ENGL J MED, V354, P115, DOI 10.1056/NEJMp058292; Hu L, 2008, INFECT IMMUN, V76, P5294, DOI 10.1128/IAI.01408-07; Hung CC, 2012, LANCET INFECT DIS, V12, P729, DOI 10.1016/S1473-3099(12)70147-0; Iriemenam NC, 2010, PARASITOL INT, V59, P9, DOI 10.1016/j.parint.2009.10.009; Jenikova G, 2011, VACCINE, V29, P9529, DOI 10.1016/j.vaccine.2011.09.126; Jerlstrom-Hultqvist J, 2010, GUT MICROBES, V1, P379, DOI 10.4161/gmic.1.6.13608; Jess T, 2011, GUT, V60, P318, DOI 10.1136/gut.2010.223396; Kirkpatrick BD, 2011, CURR OPIN GASTROEN, V27, P1, DOI 10.1097/MOG.0b013e3283413763; Kosek M, 2010, CURR OPIN INFECT DIS, V23, P475, DOI 10.1097/QCO.0b013e32833da204; Kweon MN, 2008, CURR OPIN INFECT DIS, V21, P313, DOI 10.1097/QCO.0b013e3282f88b92; Man SM, 2011, NAT REV GASTRO HEPAT, V8, P669, DOI 10.1038/nrgastro.2011.191; Marano C, 2009, CURR OPIN INFECT DIS, V22, P423, DOI 10.1097/QCO.0b013e32832ee896; Marotta F, 2013, MOL BIOTECHNOL, V53, P182, DOI 10.1007/s12033-012-9512-0; Mejia R, 2012, CURR OPIN INFECT DIS, V25, P458, DOI 10.1097/QCO.0b013e3283551dbd; Mortimer L, 2010, EXP PARASITOL, V126, P366, DOI 10.1016/j.exppara.2010.03.005; Mukherjee S, 2012, J MICROIMMUNOL  0626; Musher DM, 2004, NEW ENGL J MED, V351, P2417, DOI 10.1056/NEJMra041837; Navaneethan U, 2011, CURR OPIN GASTROEN, V27, P66, DOI 10.1097/MOG.0b013e3283400755; Nicolls DJ, 2008, AM J TROP MED HYG, V79, P729, DOI 10.4269/ajtmh.2008.79.729; Olsen A, 2009, T ROY SOC TROP MED H, V103, P967, DOI 10.1016/j.trstmh.2009.02.013; Parr JB, 2007, AM J TROP MED HYG, V76, P938, DOI 10.4269/ajtmh.2007.76.938; Pasetti MF, 2011, IMMUNOL REV, V239, P125, DOI 10.1111/j.1600-065X.2010.00970.x; Pawlowski SW, 2009, GASTROENTEROLOGY, V136, P1874, DOI 10.1053/j.gastro.2009.02.072; Phalipon A, 2003, CRIT REV IMMUNOL, V23, P371, DOI 10.1615/CritRevImmunol.v23.i56.20; Pritt BS, 2008, MAYO CLIN PROC, V83, P1154, DOI 10.4065/83.10.1154; Ramana J, 2012, INFECT GENET EVOL, V12, P1647, DOI 10.1016/j.meegid.2012.08.002; Ross AG, 2007, LANCET INFECT DIS, V7, P218, DOI 10.1016/S1473-3099(07)70053-1; Rossignol JF, 2012, T ROY SOC TROP MED H, V106, P167, DOI 10.1016/j.trstmh.2011.11.007; Sanchez-Vargas FM, 2011, TRAVEL MED INFECT DI, V9, P263, DOI 10.1016/j.tmaid.2011.11.001; Schlenker C, 2009, BEST PRACT RES CL GA, V23, P89, DOI 10.1016/j.bpg.2008.11.014; Scott KGE, 2004, INFECT IMMUN, V72, P3536, DOI 10.1128/IAI.72.6.3536-3542.2004; Segarra-Newnham M, 2007, ANN PHARMACOTHER, V41, P1992, DOI 10.1345/aph.1K302; Shah N, 2009, AM J TROP MED HYG, V80, P609, DOI 10.4269/ajtmh.2009.80.609; Singh Anjana, 2009, Interdiscip Perspect Infect Dis, V2009, P547090, DOI 10.1155/2009/547090; Solaymani-Mohammadi S, 2010, EXP PARASITOL, V126, P292, DOI 10.1016/j.exppara.2010.06.014; Swaminathan A, 2009, J INFECTION, V59, P19, DOI 10.1016/j.jinf.2009.05.008; ten Hove R, 2007, CLIN MICROBIOL INFEC, V13, P1001, DOI 10.1111/j.1469-0691.2007.01788.x; Thielman NM, 2004, NEW ENGL J MED, V350, P38, DOI 10.1056/NEJMcp031534; Tran MH, 2006, NAT MED, V12, P835, DOI 10.1038/nm1430; United Nations, 2012, UNWTO TOUR HIGHL; van Putten JPM, 2009, CURR TOP MICROBIOL, V337, P197, DOI 10.1007/978-3-642-01846-6_7	68	74	76	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2013	368	19					1817	1825		10.1056/NEJMra1207777	http://dx.doi.org/10.1056/NEJMra1207777			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138WA	23656647	Bronze, Green Published			2022-12-28	WOS:000318540000010
J	Siddiqi, K; Khan, A; Ahmad, M; Dogar, O; Kanaan, M; Newell, JN; Thomson, H				Siddiqi, Kamran; Khan, Amir; Ahmad, Maqsood; Dogar, Omara; Kanaan, Mona; Newell, James N.; Thomson, Heather			Action to Stop Smoking in Suspected Tuberculosis (ASSIST) in Pakistan A Cluster Randomized, Controlled Trial	ANNALS OF INTERNAL MEDICINE			English	Article							NON-INFERIORITY TRIAL; INTEGRATED APPROACH; CONSORT STATEMENT; CESSATION TRIALS; TOBACCO USE; METAANALYSIS; RISK; INTERVENTION; PREVALENCE; EXTENSION	Background: Tobacco use is responsible for a large proportion of the total disease burden from tuberculosis. Pakistan is one of the 10 high-burden countries for both tuberculosis and tobacco use. Objective: To assess the effectiveness of a behavioral support intervention and bupropion in achieving 6-month continuous abstinence in adult smokers with suspected pulmonary tuberculosis. Design: Cluster randomized, controlled trial. (Current Controlled Trials: ISRCTN08829879) Setting: Health centers in the Jhang and Sargodha districts in Pakistan. Patients: 1955 adult smokers with suspected tuberculosis. Intervention: Health centers were randomly assigned to provide 2 brief behavioral support sessions (BSS), BSS plus 7 weeks of bupropion therapy (BSS+), or usual care. Measurements: The primary end point was continuous abstinence at 6 months after the quit date and was determined by carbon monoxide levels in patients. Secondary end points were point abstinence at 1 and 6 months. Results: Both treatments led to statistically significant relative risks (RRs) for abstinence compared with usual care (RR for BSS+, 8.2 [95% CI, 3.7 to 18.2]; RR for BSS, 7.4 [CI, 3.4 to 16.4]). Equivalence between the treatments could not be established. In the BSS+ group, 275 of 606 patients (45.4% [CI, 41.4% to 49.4%]) achieved continuous abstinence compared with 254 of 620 (41.0% [CI, 37.1% to 45.0%]) in the BSS group and 52 of 615 (8.5% [CI, 6.4% to 10.9%]) in the usual care group. There was substantial heterogeneity of program effects across clusters. Limitations: Imbalances in the urban and rural proportions and smoking habits among treatment groups, and inability to confirm adherence to bupropion treatment and validate longer-term abstinence or the effect of smoking cessation on tuberculosis outcomes. Conclusion: Behavioral support alone or in combination with bupropion is effective in promoting cessation in smokers with suspected tuberculosis.	Univ York, York YO10 5DD, N Yorkshire, England; Hull York Med Sch, York, N Yorkshire, England; Assoc Social Dev, Islamabad, Pakistan; Univ Leeds, Leeds, W Yorkshire, England; NHS Leeds, Leeds, W Yorkshire, England	University of York - UK; University of Hull; University of York - UK; University of Leeds	Siddiqi, K (corresponding author), Univ York, Hull York Med Sch, Seebohm Rowntree Bldg, York YO10 5DD, N Yorkshire, England.	kamran.siddiqi@york.ac.uk	Siddiqi, Kamran/AAD-8801-2021; Dogar, Omara F/J-2041-2019	Siddiqi, Kamran/0000-0003-1529-7778; dogar, omara/0000-0002-7122-8403	International Development Research Centre [104825-002]	International Development Research Centre	By grant 104825-002 from the International Development Research Centre.	Alam AY, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-50; Awaisu A, 2011, SUBST ABUSE TREAT PR, V6, DOI 10.1186/1747-597X-6-26; Awaisu Ahmed, 2010, Tob Induc Dis, V8, P3, DOI 10.1186/1617-9625-8-3; Basu S, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5506; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Bile K M, 2010, East Mediterr Health J, V16 Suppl, pS24; Brunet L, 2011, EUR RESPIR J, V38, P139, DOI 10.1183/09031936.00137710; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Castaneda H, 2010, HEALTH PROMOT PRACT, V11, P483, DOI 10.1177/1524839908318288; COOK DG, 1993, THORAX, V48, P14, DOI 10.1136/thx.48.1.14; El Sony A, 2007, INT J TUBERC LUNG D, V11, P150; Hughes JR, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000031.pub4, 10.1002/14651858.CD000031.pub3]; JARVIS MJ, 1987, AM J PUBLIC HEALTH, V77, P1435, DOI 10.2105/AJPH.77.11.1435; Lancaster T, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001292.pub2, 10.1002/14651858.CD001292.pub3]; Lee ACK, 2010, J SMOK CESS, V5, P145, DOI 10.1375/jsc.5.2.145; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lindson N, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-69; Batista JDL, 2008, INT J EPIDEMIOL, V37, P841, DOI 10.1093/ije/dyn113; Michie S, 2011, ADDICT BEHAV, V36, P315, DOI 10.1016/j.addbeh.2010.11.016; Neergaard J, 2007, NICOTINE TOB RES, V9, P987, DOI 10.1080/14622200701591591; Parker DR, 2005, CONTEMP CLIN TRIALS, V26, P260, DOI 10.1016/j.cct.2005.01.002; PIERCE JP, 1989, AM J PUBLIC HEALTH, V79, P152, DOI 10.2105/AJPH.79.2.152; Pierce JP, 2003, NICOTINE TOB RES, V5, P151, DOI 10.1080/0955300031000083427; Pradeepkumar AS, 2008, INT J TUBERC LUNG D, V12, P1139; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Siddiqi K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-160; Siddiqi K, 2009, TROP MED INT HEALTH, V14, P420, DOI 10.1111/j.1365-3156.2009.02238.x; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; Walker N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-880; West R, 2005, ADDICTION, V100, P299, DOI 10.1111/j.1360-0443.2004.00995.x; West R, 2007, ADDICTION, V102, P506, DOI 10.1111/j.1360-0443.2007.01750.x; World Health Organisation, 2011, WHOHTMTB201116; World Health Organization, 2007, WHO UN MON TB TOB CO; World Health Organization, 2019, WHO REPORT GLOBAL TO; Wu P, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-300; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	36	77	78	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 7	2013	158	9					667	+		10.7326/0003-4819-158-9-201305070-00006	http://dx.doi.org/10.7326/0003-4819-158-9-201305070-00006			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146WV	23648948				2022-12-28	WOS:000319126900004
J	Ardejani, MS; Orner, BP				Ardejani, Maziar S.; Orner, Brendan P.			Obey the Peptide Assembly Rules	SCIENCE			English	Editorial Material							SYNTHETIC BIOLOGY; PROTEIN; DESIGN		[Ardejani, Maziar S.] Nanyang Technol Univ, Div Chem & Biol Chem, Singapore 639798, Singapore; [Ardejani, Maziar S.; Orner, Brendan P.] Kings Coll London, Dept Chem, London WC2R 2LS, England	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of London; King's College London	Ardejani, MS (corresponding author), Nanyang Technol Univ, Div Chem & Biol Chem, Singapore 639798, Singapore.	brendan.orner@kcl.ac.uk	Ardejani, Maziar/F-9109-2010	Ardejani, Maziar/0000-0001-7037-9157				Ardejani MS, 2013, CHEM COMMUN, V49, P3528, DOI 10.1039/c3cc40886h; Bromley EHC, 2008, ACS CHEM BIOL, V3, P38, DOI 10.1021/cb700249v; Fletcher JM, 2013, SCIENCE, V340, P595, DOI 10.1126/science.1233936; GHADIRI MR, 1993, NATURE, V366, P324, DOI 10.1038/366324a0; Israelachvili J. N., 1976, FARADAY T, V2, P1525; Johnson S., 2001, EMERGENCE CONNECTED; Kim J, 2012, J AM CHEM SOC, V134, P20573, DOI 10.1021/ja3088482; King NP, 2012, SCIENCE, V336, P1171, DOI 10.1126/science.1219364; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; Pandya MJ, 2000, BIOCHEMISTRY-US, V39, P8728, DOI 10.1021/bi000246g; Reedy CJ, 2004, CHEM REV, V104, P617, DOI 10.1021/cr0206115; Ruder WC, 2011, SCIENCE, V333, P1248, DOI 10.1126/science.1206843; Tarabout C, 2011, P NATL ACAD SCI USA, V108, P7679, DOI 10.1073/pnas.1017343108; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998	14	17	17	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2013	340	6132					561	562		10.1126/science.1237708	http://dx.doi.org/10.1126/science.1237708			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23641105				2022-12-28	WOS:000318268900036
J	Bergeron, P; Martin, AM; Garant, D; Pelletier, F				Bergeron, P.; Martin, A. M.; Garant, D.; Pelletier, F.			Comment on "Bateman in Nature: Predation on Offspring Reduces the Potential for Sexual Selection"	SCIENCE			English	Editorial Material							OPPORTUNITY		[Bergeron, P.] Dartmouth Coll, Life Sci Ctr, Hanover, NH 03755 USA; [Martin, A. M.; Garant, D.; Pelletier, F.] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada	Dartmouth College; University of Sherbrooke	Bergeron, P (corresponding author), Dartmouth Coll, Life Sci Ctr, Hanover, NH 03755 USA.	patrick.bergeron@dartmouth.edu	Garant, Dany/D-7406-2013	Garant, Dany/0000-0002-8091-1044				Anthes N, 2010, AM NAT, V176, P249, DOI 10.1086/655218; ARNOLD SJ, 1994, AM NAT, V144, pS126, DOI 10.1086/285656; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Byers J, 2012, SCIENCE, V338, P802, DOI 10.1126/science.1224660; Jennions MD, 2012, J EVOLUTION BIOL, V25, P591, DOI 10.1111/j.1420-9101.2011.02451.x; Jones AG, 2009, EVOLUTION, V63, P1673, DOI 10.1111/j.1558-5646.2009.00664.x; Klug H, 2010, J EVOLUTION BIOL, V23, P447, DOI 10.1111/j.1420-9101.2009.01921.x; Krakauer AH, 2011, J EVOLUTION BIOL, V24, P2064, DOI 10.1111/j.1420-9101.2011.02317.x	8	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 3	2013	340	6132								10.1126/science.1233246	http://dx.doi.org/10.1126/science.1233246			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	135EA	23641093				2022-12-28	WOS:000318268900024
J	Howard, AW				Howard, Andrew W.			Observed Properties of Extrasolar Planets	SCIENCE			English	Review							PERIOD DISTRIBUTION; HOST STARS; MASS; SYSTEMS; ARCHITECTURE; CONSTRAINTS; EXOPLANETS; FREQUENCY; MIGRATION; RADII	Observational surveys for extrasolar planets probe the diverse outcomes of planet formation and evolution. These surveys measure the frequency of planets with different masses, sizes, orbital characteristics, and host star properties. Small planets between the sizes of Earth and Neptune substantially outnumber Jupiter-sized planets. The survey measurements support the core accretion model, in which planets form by the accumulation of solids and then gas in protoplanetary disks. The diversity of exoplanetary characteristics demonstrates that most of the gross features of the solar system are one outcome in a continuum of possibilities. The most common class of planetary system detectable today consists of one or more planets approximately one to three times Earth's size orbiting within a fraction of the Earth-Sun distance.	Univ Hawaii Manoa, Inst Astron, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Howard, AW (corresponding author), Univ Hawaii Manoa, Inst Astron, 2680 Woodlawn Dr, Honolulu, HI 96822 USA.	howard@ifa.hawaii.edu	Howard, Andrew/D-4148-2015	Howard, Andrew/0000-0001-8638-0320	NASA [NNX12AJ23G]	NASA(National Aeronautics & Space Administration (NASA))	I thank K. Teramura for assistance preparing the graphics and G. Marcy, D. Fischer, J. Wright, T. Currie, E. Petigura, H. Isaacson, R. Dawson, I. Crossfield, S. Kane, J. Steffen, J. Maurer, and S. Howard for comments on this manuscript. I also thank three anonymous reviewers for constructive criticism. I acknowledge partial funding from NASA grant NNX12AJ23G.	Agol E, 2005, MON NOT R ASTRON SOC, V359, P567, DOI 10.1111/j.1365-2966.2005.08922.x; Albrecht S, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/18; Barclay T, 2013, NATURE, V494, P452, DOI 10.1038/nature11914; Batalha NM, 2013, ASTROPHYS J SUPPL S, V204, DOI 10.1088/0067-0049/204/2/24; Batalha NM, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/27; Berta ZK, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/1/35; Borucki WJ, 2013, SCIENCE, V340, P587, DOI 10.1126/science.1234702; Buchhave LA, 2012, NATURE, V486, P375, DOI 10.1038/nature11121; Burke C. J., 2013, AM ASTR SOC M; Chiang E., 2012, MONTHLY NOTICES ROYA; Cumming A, 2008, PUBL ASTRON SOC PAC, V120, P531, DOI 10.1086/588487; Dressing CD, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/95; Dumusque X, 2012, NATURE, V491, P207, DOI 10.1038/nature11572; Fabrycky D. C., 2012, ASTROPHYS J; Fang J., 2013, ASTROPHYS J; Figueira P, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201219017; Fischer DA, 2005, ASTROPHYS J, V622, P1102, DOI 10.1086/428383; Fressin F., 2013, ASTROPHYS J; Gaudi BS, 2012, ANNU REV ASTRON ASTR, V50, P411, DOI 10.1146/annurev-astro-081811-125518; Gould A, 2010, ASTROPHYS J, V720, P1073, DOI 10.1088/0004-637X/720/2/1073; Hansen BMS, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/2/158; Holman MJ, 2005, SCIENCE, V307, P1288, DOI 10.1126/science.1107822; Howard AW, 2012, ASTROPHYS J SUPPL S, V201, DOI 10.1088/0067-0049/201/2/15; Howard AW, 2010, SCIENCE, V330, P653, DOI 10.1126/science.1194854; Ida S, 2008, ASTROPHYS J, V685, P584, DOI 10.1086/590401; Johnson JA, 2010, PUBL ASTRON SOC PAC, V122, P905, DOI 10.1086/655775; Lissauer JJ, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/1/8; Lissauer JJ, 2011, NATURE, V470, P53, DOI 10.1038/nature09760; Lithwick Y, 2012, ASTROPHYS J LETT, V756, DOI 10.1088/2041-8205/756/1/L11; Marcy G, 2005, PROG THEOR PHYS SUPP, P24, DOI 10.1143/PTPS.158.24; Marcy G., 2013, AM ASTR SOC M; Mayor M, 2011, ASTRON ASTROPHYS; Mordasini C, 2009, ASTRON ASTROPHYS, V501, P1139, DOI 10.1051/0004-6361/200810301; Morton TD, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/170; Nielsen EL, 2010, ASTROPHYS J, V717, P878, DOI 10.1088/0004-637X/717/2/878; Petigura EA, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/69; Plavchan P., 2012, ASTROPHYS J LETT; Rogers LA, 2010, ASTROPHYS J, V716, P1208, DOI 10.1088/0004-637X/716/2/1208; Seager S, 2007, ASTROPHYS J, V669, P1279, DOI 10.1086/521346; Seager S, 2013, SCIENCE, V340, P577, DOI 10.1126/science.1232226; Seager S, 2010, ANNU REV ASTRON ASTR, V48, P631, DOI 10.1146/annurev-astro-081309-130837; Steffen JH, 2012, P NATL ACAD SCI USA, V109, P7982, DOI 10.1073/pnas.1120970109; Udry S, 2003, ASTRON ASTROPHYS, V407, P369, DOI 10.1051/0004-6361:20030843; Vigan A, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201218991; Weiss LM, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/14; Wright JT, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/160; Wright JT, 2011, PUBL ASTRON SOC PAC, V123, P412, DOI 10.1086/659427; Wright JT, 2009, ASTROPHYS J, V693, P1084, DOI 10.1088/0004-637X/693/2/1084; Wyatt MC, 2008, ANNU REV ASTRON ASTR, V46, P339, DOI 10.1146/annurev.astro.45.051806.110525	54	120	122	1	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 3	2013	340	6132					572	576		10.1126/science.1233545	http://dx.doi.org/10.1126/science.1233545			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23641110	Green Submitted, Green Accepted			2022-12-28	WOS:000318268900039
J	Baicker, K; Taubman, SL; Allen, HL; Bernstein, M; Gruber, JH; Newhouse, JP; Schneider, EC; Wright, BJ; Zaslavsky, AM; Finkelstein, AN				Baicker, Katherine; Taubman, Sarah L.; Allen, Heidi L.; Bernstein, Mira; Gruber, Jonathan H.; Newhouse, Joseph P.; Schneider, Eric C.; Wright, Bill J.; Zaslavsky, Alan M.; Finkelstein, Amy N.		Oregon Hlth Study Grp	The Oregon Experiment - Effects of Medicaid on Clinical Outcomes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARE; TERMINATION	BACKGROUND Despite the imminent expansion of Medicaid coverage for low-income adults, the effects of expanding coverage are unclear. The 2008 Medicaid expansion in Oregon based on lottery drawings from a waiting list provided an opportunity to evaluate these effects. METHODS Approximately 2 years after the lottery, we obtained data from 6387 adults who were randomly selected to be able to apply for Medicaid coverage and 5842 adults who were not selected. Measures included blood-pressure, cholesterol, and glycated hemoglobin levels; screening for depression; medication inventories; and self-reported diagnoses, health status, health care utilization, and out-of-pocket spending for such services. We used the random assignment in the lottery to calculate the effect of Medicaid coverage. RESULTS We found no significant effect of Medicaid coverage on the prevalence or diagnosis of hypertension or high cholesterol levels or on the use of medication for these conditions. Medicaid coverage significantly increased the probability of a diagnosis of diabetes and the use of diabetes medication, but we observed no significant effect on average glycated hemoglobin levels or on the percentage of participants with levels of 6.5% or higher. Medicaid coverage decreased the probability of a positive screening for depression (-9.15 percentage points; 95% confidence interval, -16.70 to -1.60; P = 0.02), increased the use of many preventive services, and nearly eliminated catastrophic out-of-pocket medical expenditures. CONCLUSIONS This randomized, controlled study showed that Medicaid coverage generated no significant improvements in measured physical health outcomes in the first 2 years, but it did increase use of health care services, raise rates of diabetes detection and management, lower rates of depression, and reduce financial strain.	[Baicker, Katherine; Newhouse, Joseph P.; Schneider, Eric C.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Newhouse, Joseph P.; Schneider, Eric C.; Zaslavsky, Alan M.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Schneider, Eric C.] RAND Corp, Boston, MA USA; [Baicker, Katherine; Taubman, Sarah L.; Bernstein, Mira; Gruber, Jonathan H.; Newhouse, Joseph P.; Finkelstein, Amy N.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Newhouse, Joseph P.] Harvard Univ, Kennedy Sch, Cambridge, MA 02138 USA; [Gruber, Jonathan H.; Finkelstein, Amy N.] MIT, Dept Econ, Cambridge, MA 02139 USA; [Allen, Heidi L.] Columbia Univ, Sch Social Work, New York, NY USA; [Wright, Bill J.] Providence Portland Med Ctr, Ctr Outcomes Res & Educ, Portland, OR USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; RAND Corporation; National Bureau of Economic Research; Harvard University; Massachusetts Institute of Technology (MIT); Columbia University; Providence Portland Medical Center	Baicker, K (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	kbaicker@hsph.harvard.edu	Newhouse, Joseph/AGJ-5632-2022; Newhouse, Joseph/AAD-9763-2019	Schneider, Eric/0000-0002-1132-5084	Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services; California HealthCare Foundation; John D. and Catherine T. MacArthur Foundation; National Institute on Aging [P30AG012810, RC2AGO36631, R01AG0345151]; Robert Wood Johnson Foundation; Alfred P. Sloan Foundation; Smith Richardson Foundation; Social Security Administration [5 RRC 08098400-03-00]; Centers for Medicare and Medicaid Services; NATIONAL INSTITUTE ON AGING [R01AG034151, P30AG012810, RC2AG036631] Funding Source: NIH RePORTER	Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services; California HealthCare Foundation; John D. and Catherine T. MacArthur Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Smith Richardson Foundation; Social Security Administration; Centers for Medicare and Medicaid Services; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services; the California HealthCare Foundation; the John D. and Catherine T. MacArthur Foundation; the National Institute on Aging (P30AG012810, RC2AGO36631, and R01AG0345151); the Robert Wood Johnson Foundation; the Alfred P. Sloan Foundation; the Smith Richardson Foundation; and the Social Security Administration (5 RRC 08098400-03-00, to the National Bureau of Economic Research as part of the Retirement Research Consortium of the Social Security Administration); and by the Centers for Medicare and Medicaid Services.	Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Arroll B, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007954; Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Congressional Budget Office, 2011, CBOS AN MAJ HLTH CAR; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Dennett J, OREGON HLTH INSURANC; Eisenberg JM, 2000, JAMA-J AM MED ASSOC, V284, P2100, DOI 10.1001/jama.284.16.2100; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; LURIE N, 1984, NEW ENGL J MED, V311, P480, DOI 10.1056/NEJM198408163110735; LURIE N, 1986, NEW ENGL J MED, V314, P1266, DOI 10.1056/NEJM198605083141934; Mcdade TW, 2007, DEMOGRAPHY, V44, P899, DOI 10.1353/dem.2007.0038; Sommers BD, 2012, NEW ENGL J MED, V367, P1025, DOI 10.1056/NEJMsa1202099; StataCorp, 2011, STAT STAT SOFTW REL, P173; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; Ware JE Jr, 2001, SCORE INTERPRET SING	17	667	667	3	102	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 2	2013	368	18					1713	1722		10.1056/NEJMsa1212321	http://dx.doi.org/10.1056/NEJMsa1212321			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	134MN	23635051	Bronze, Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000318214400005
J	Mosholder, AD; Mathew, J; Alexander, JJ; Smith, H; Nambiar, S				Mosholder, Andrew D.; Mathew, Justin; Alexander, John J.; Smith, Harry; Nambiar, Sumathi			Cardiovascular Risks with Azithromycin and Other Antibacterial Drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MORTALITY		[Mosholder, Andrew D.; Mathew, Justin] US FDA, Ctr Drug Evaluat & Res, Off Surveillance & Epidemiol, Div Epidemiol 2, Silver Spring, MD USA; [Alexander, John J.; Nambiar, Sumathi] US FDA, Ctr Drug Evaluat & Res, Off Antimicrobial Prod, Div Antiinfect Prod, Silver Spring, MD USA; [Smith, Harry] US FDA, Ctr Drug Evaluat & Res, Off Commun, Div Hlth Commun, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Mosholder, AD (corresponding author), US FDA, Ctr Drug Evaluat & Res, Off Surveillance & Epidemiol, Div Epidemiol 2, Silver Spring, MD USA.		Alexander, John/GVS-7271-2022					Asadi L, 2012, CLIN INFECT DIS, V55, P371, DOI 10.1093/cid/cis414; Asadi L, 2012, RESP MED, V106, P451, DOI 10.1016/j.rmed.2011.11.017; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Lapi F, 2012, CLIN INFECT DIS, V55, P1457, DOI 10.1093/cid/cis664; Ray WA, 2004, NEW ENGL J MED, V351, P1089, DOI 10.1056/NEJMoa040582	5	75	81	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 2	2013	368	18					1665	1668		10.1056/NEJMp1302726	http://dx.doi.org/10.1056/NEJMp1302726			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134MN	23635046				2022-12-28	WOS:000318214400014
J	Allen, J; Weinrich, M; Hoppitt, W; Rendell, L				Allen, Jenny; Weinrich, Mason; Hoppitt, Will; Rendell, Luke			Network-Based Diffusion Analysis Reveals Cultural Transmission of Lobtail Feeding in Humpback Whales	SCIENCE			English	Article							BEHAVIOR	We used network-based diffusion analysis to reveal the cultural spread of a naturally occurring foraging innovation, lobtail feeding, through a population of humpback whales (Megaptera novaeangliae) over a period of 27 years. Support for models with a social transmission component was 6 to 23 orders of magnitude greater than for models without. The spatial and temporal distribution of sand lance, a prey species, was also important in predicting the rate of acquisition. Our results, coupled with existing knowledge about song traditions, show that this species can maintain multiple independently evolving traditions in its populations. These insights strengthen the case that cetaceans represent a peak in the evolution of nonhuman culture, independent of the primate lineage.	[Allen, Jenny; Rendell, Luke] Univ St Andrews, Sch Biol, Sea Mammal Res Unit, St Andrews KY16 8LB, Fife, Scotland; [Allen, Jenny; Rendell, Luke] Univ St Andrews, Sch Biol, Ctr Social Learning & Cognit Evolut, St Andrews KY16 8LB, Fife, Scotland; [Allen, Jenny; Weinrich, Mason] Whale Ctr New England, Gloucester, MA 01931 USA; [Hoppitt, Will] Anglia Ruskin Univ, Dept Life Sci, Cambridge CB1 1PT, England	University of St Andrews; University of St Andrews; Anglia Ruskin University	Rendell, L (corresponding author), Univ St Andrews, Sch Biol, Sea Mammal Res Unit, St Andrews KY16 8LB, Fife, Scotland.	ler4@st-andrews.ac.uk	Allen, Jennifer/AAQ-7333-2020; Hoppitt, William/A-8216-2008; Rendell, Luke/G-2594-2010; Allen, Jennifer/W-4610-2018; Rendell, Luke/AAF-9070-2019	Allen, Jennifer/0000-0003-4658-7380; Hoppitt, William/0000-0003-0815-5720; Rendell, Luke/0000-0002-1121-9142; Allen, Jennifer/0000-0003-4658-7380; 	Stellwagen Bank National Marine Sanctuary, Office of National Marine Sanctuaries, National Oceanographic Partnership Program, National Marine Fisheries Service; MASTS pooling initiative (Marine Alliance for Science and Technology for Scotland); Scottish Funding Council [HR09011]; Natural Environment Research Council [smru10001] Funding Source: researchfish	Stellwagen Bank National Marine Sanctuary, Office of National Marine Sanctuaries, National Oceanographic Partnership Program, National Marine Fisheries Service; MASTS pooling initiative (Marine Alliance for Science and Technology for Scotland); Scottish Funding Council; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the WCNE staff, interns, and volunteers for the field collection of this data and the crews of the various whale-watching companies for the use of their vessels. We are grateful to K. Sardi-Sampson, S. Garland, and D. Brown for their assistance in compiling the WCNE data. Data were collected under a Marine Mammal Protection Act/Endangered Species Act Research and Enhancement Permit (current permit no. 605-1904). Funding was provided by the Stellwagen Bank National Marine Sanctuary, Office of National Marine Sanctuaries, National Oceanographic Partnership Program, National Marine Fisheries Service, and the MASTS pooling initiative (Marine Alliance for Science and Technology for Scotland), and their support is gratefully acknowledged. MASTS is funded by the Scottish Funding Council (grant reference HR09011) and contributing institutions. We are grateful to V. Janik, D. Wiley, P. Tyack, and members of the Centre for Social Learning and Cognitive Evolution Behavioral Discussion Group for discussion, comments, and advice. We thank H. Whitehead, K. Laland, and four anonymous reviewers for comments that improved the manuscript. The data analyzed in this paper are included in the supplementary materials. M. W. led the collection of the behavior and association data, with assistance from J.A. J.A., M. W., W. H., and L. R. planned the study; J.A. performed the data processing; and J.A., W. H., and L. R. carried out the analyses and wrote the manuscript.	BORGATTI S. P., 2002, NETDRAW SOFTWARE FOR; Clapham PJ, 2000, CETACEAN SOCIETIES, P173; Donaldson R, 2012, ANIM CONSERV, V15, P427, DOI 10.1111/j.1469-1795.2012.00548.x; Fragaszy DM., 2003, BIOL TRADITIONS MODE, P1, DOI DOI 10.1017/CBO9780511584022.002; Franz M, 2009, P R SOC B, V276, P1829, DOI 10.1098/rspb.2008.1824; Garland EC, 2011, CURR BIOL, V21, P687, DOI 10.1016/j.cub.2011.03.019; HAIN JHW, 1982, FISH B-NOAA, V80, P259; Hoppitt W, 2011, AM J PRIMATOL, V73, P834, DOI 10.1002/ajp.20920; Hoppitt W, 2010, J THEOR BIOL, V263, P544, DOI 10.1016/j.jtbi.2010.01.004; Kendal RL, 2010, LEARN BEHAV, V38, P220, DOI 10.3758/LB.38.3.220; Krutzen M, 2011, CURR BIOL, V21, P1808, DOI 10.1016/j.cub.2011.09.017; Laland KN, 2006, TRENDS ECOL EVOL, V21, P542, DOI 10.1016/j.tree.2006.06.005; National Marine Fisheries Service (NMFS) National Oceanic and Atmospheric Administration (NOAA), TABULAR DIGITAL DATA; Noad MJ, 2000, NATURE, V408, P537, DOI 10.1038/35046199; PAYNE PM, 1990, FISH B-NOAA, V88, P687; Perry S, 2003, CURR ANTHROPOL, V44, P241, DOI 10.1086/345825; Ramp C, 2010, BEHAV ECOL SOCIOBIOL, V64, P1563, DOI 10.1007/s00265-010-0970-8; Read AJ, 2001, P ROY SOC B-BIOL SCI, V268, P573, DOI 10.1098/rspb.2000.1419; Reader SM, 2004, LEARN BEHAV, V32, P90; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Rendell L, 2001, BEHAV BRAIN SCI, V24, P324, DOI DOI 10.1017/S0140525X0100396X; Schwager S. J., 1987, ANIM BEHAV, V35, P1454; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; WEINRICH MT, 1992, ANIM BEHAV, V44, P1059, DOI 10.1016/S0003-3472(05)80318-5; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2008, PHILOS T R SOC B, V363, P3477, DOI 10.1098/rstb.2008.0134; Wiley D, 2011, BEHAVIOUR, V148, P575, DOI 10.1163/000579511X570893	27	231	231	10	276	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					485	488		10.1126/science.1231976	http://dx.doi.org/10.1126/science.1231976			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620054				2022-12-28	WOS:000318016700044
J	Tiscareno, MS; Mitchell, CJ; Murray, CD; Di Nino, D; Hedman, MM; Schmidt, J; Burns, JA; Cuzzi, JN; Porco, CC; Beurle, K; Evans, MW				Tiscareno, Matthew S.; Mitchell, Colin J.; Murray, Carl D.; Di Nino, Daiana; Hedman, Matthew M.; Schmidt, Juergen; Burns, Joseph A.; Cuzzi, Jeffrey N.; Porco, Carolyn C.; Beurle, Kevin; Evans, Michael W.			Observations of Ejecta Clouds Produced by Impacts onto Saturn's Rings	SCIENCE			English	Article								We report observations of dusty clouds in Saturn's rings, which we interpret as resulting from impacts onto the rings that occurred between 1 and 50 hours before the clouds were observed. The largest of these clouds was observed twice; its brightness and cant angle evolved in a manner consistent with this hypothesis. Several arguments suggest that these clouds cannot be due to the primary impact of one solid meteoroid onto the rings, but rather are due to the impact of a compact stream of Saturn-orbiting material derived from previous breakup of a meteoroid. The responsible interplanetary meteoroids were initially between 1 centimeter and several meters in size, and their influx rate is consistent with the sparse prior knowledge of smaller meteoroids in the outer solar system.	[Tiscareno, Matthew S.; Hedman, Matthew M.; Evans, Michael W.] Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA; [Mitchell, Colin J.; Di Nino, Daiana; Porco, Carolyn C.] Space Sci Inst, CICLOPS, Boulder, CO 80301 USA; [Murray, Carl D.; Beurle, Kevin] Queen Mary Univ London, Astron Unit, London E1 4NS, England; [Schmidt, Juergen] Univ Oulu, Dept Phys, Astron Div, FI-90014 Oulu, Finland; [Schmidt, Juergen] Univ Potsdam, Inst Phys & Astron, D-14476 Potsdam, Germany; [Burns, Joseph A.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Burns, Joseph A.] Cornell Univ, Coll Engn, Ithaca, NY 14853 USA; [Cuzzi, Jeffrey N.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	Cornell University; University of London; Queen Mary University London; University of Oulu; University of Potsdam; Cornell University; Cornell University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Tiscareno, MS (corresponding author), Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA.	matthewt@astro.cornell.edu	Evans, Michael W/AAG-4117-2020	Hedman, Matthew/0000-0002-8592-0812	NASA Cassini Data Analysis program [NNX08AQ72G, NNX10AG67G]; Cassini project; Science and Technology Facilities Council [ST/F007566/1]; Science and Technology Facilities Council [ST/J001546/1] Funding Source: researchfish; STFC [ST/F007566/1, ST/J001546/1] Funding Source: UKRI	NASA Cassini Data Analysis program(National Aeronautics & Space Administration (NASA)); Cassini project; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank M. Showalter for helpful discussions and for the use of Mie scattering code. We thank the Cassini project and the Cassini Imaging Team for making these observations possible. M. S. T. acknowledges funding from the NASA Cassini Data Analysis program (NNX08AQ72G and NNX10AG67G) and the Cassini project. C. D. M. acknowledges funding from the Science and Technology Facilities Council (grant ST/F007566/1).	Bouley S, 2012, ICARUS, V218, P115, DOI 10.1016/j.icarus.2011.11.028; Chambers LS, 2008, ICARUS, V194, P623, DOI 10.1016/j.icarus.2007.11.017; Charnoz S, 2009, SATURN FROM CASSINI-HUYGENS, P537, DOI 10.1007/978-1-4020-9217-6_17; Colwell JE, 2009, SATURN FROM CASSINI-HUYGENS, P375, DOI 10.1007/978-1-4020-9217-6_13; Cook A. F., 1983, B AM ASTRON SOC, V15, P814; COOK AF, 1981, J GEOPHYS RES-SPACE, V86, P8815, DOI 10.1029/JA086iA10p08815; Cuzzi JN, 1998, ICARUS, V132, P1, DOI 10.1006/icar.1997.5863; CUZZI JN, 1990, ICARUS, V84, P467, DOI 10.1016/0019-1035(90)90049-F; DURISEN RH, 1992, ICARUS, V100, P364, DOI 10.1016/0019-1035(92)90106-H; French RS, 2012, ICARUS, V219, P181, DOI 10.1016/j.icarus.2012.02.020; GOERTZ CK, 1983, ICARUS, V53, P219, DOI 10.1016/0019-1035(83)90143-4; GRUN E, 1985, ICARUS, V62, P244, DOI 10.1016/0019-1035(85)90121-6; Grun E., 1984, ADV SPACE RES, V4, P143, DOI [10.1016/0273-1177(84)90019-X, DOI 10.1016/0273-1177(84)90019-X]; Hedman MM, 2011, SCIENCE, V332, P708, DOI 10.1126/science.1202238; Mitchell CJ, 2013, ICARUS, V225, P446, DOI 10.1016/j.icarus.2013.02.011; Nicholson PD, 2010, ICARUS, V206, P410, DOI 10.1016/j.icarus.2009.07.028; Poppe AR, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052530; Porco CC, 2004, SPACE SCI REV, V115, P363, DOI 10.1007/s11214-004-1456-7; Showalter MR, 1998, SCIENCE, V282, P1099, DOI 10.1126/science.282.5391.1099; Tisareno M. S., PLANETS STA IN PRESS, V3; van Helden A., 1984, SATURN, P23	21	24	24	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					460	464		10.1126/science.1233524	http://dx.doi.org/10.1126/science.1233524			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620048				2022-12-28	WOS:000318016700037
J							GBD 2001 Country Collaboration	GBD 2010 country results: a global public good	LANCET			English	Editorial Material							SYSTEMATIC ANALYSIS; 21 REGIONS; DISEASE; BURDEN; INJURIES						Orchard, Jessica/O-4350-2019; Lee, Yong Yi/C-1373-2015; Patten, Scott/B-4434-2011; Ronfani, Luca/B-6668-2013; Montico, Marcella/B-5290-2013; Monasta, Lorenzo/B-1388-2012; Phillips, Michael Robert/AAE-7585-2021; Lu, Yuan/D-4941-2015	Orchard, Jessica/0000-0002-5702-7277; Lee, Yong Yi/0000-0003-2359-6823; Patten, Scott/0000-0001-9871-4041; Ronfani, Luca/0000-0001-5710-3914; Montico, Marcella/0000-0003-0377-8232; Monasta, Lorenzo/0000-0001-7774-548X; Phillips, Michael Robert/0000-0002-5973-2439; Shibuya, Kenji/0000-0003-2528-7530; Lu, Yuan/0000-0001-5264-2169	Medical Research Council [MR/K006525/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Murray C. J. L., 2013, LANCET; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2055, DOI 10.1016/S0140-6736(12)62134-5; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Naghavi M, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-9; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X	11	33	33	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 23	2013	381	9871					965	970		10.1016/S0140-6736(13)60283-4	http://dx.doi.org/10.1016/S0140-6736(13)60283-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117EU	23668561				2022-12-28	WOS:000316936800004
J	Brigham-Grette, J; Melles, M; Minyuk, P; Andreev, A; Tarasov, P; DeConto, R; Koenig, S; Nowaczyk, N; Wennrich, V; Rosen, P; Haltia, E; Cook, T; Gebhardt, C; Meyer-Jacob, C; Snyder, J; Herzschuh, U				Brigham-Grette, Julie; Melles, Martin; Minyuk, Pavel; Andreev, Andrei; Tarasov, Pavel; DeConto, Robert; Koenig, Sebastian; Nowaczyk, Norbert; Wennrich, Volker; Rosen, Peter; Haltia, Eeva; Cook, Tim; Gebhardt, Catalina; Meyer-Jacob, Carsten; Snyder, Jeff; Herzschuh, Ulrike			Pliocene Warmth, Polar Amplification, and Stepped Pleistocene Cooling Recorded in NE Arctic Russia	SCIENCE			English	Article							ICE-SHEET; LAKE ELGYGYTGYN; SEA-LEVEL; GLACIATION; HISTORY; CLIMATE; OCEAN; TEMPERATURES; EVOLUTION; SEASONALITY	Understanding the evolution of Arctic polar climate from the protracted warmth of the middle Pliocene into the earliest glacial cycles in the Northern Hemisphere has been hindered by the lack of continuous, highly resolved Arctic time series. Evidence from Lake El'gygytgyn, in northeast (NE) Arctic Russia, shows that 3.6 to 3.4 million years ago, summer temperatures were similar to 8 degrees C warmer than today, when the partial pressure of CO2 was similar to 400 parts per million. Multiproxy evidence suggests extreme warmth and polar amplification during the middle Pliocene, sudden stepped cooling events during the Pliocene-Pleistocene transition, and warmer than present Arctic summers until similar to 2.2 million years ago, after the onset of Northern Hemispheric glaciation. Our data are consistent with sea-level records and other proxies indicating that Arctic cooling was insufficient to support large-scale ice sheets until the early Pleistocene.	[Brigham-Grette, Julie; DeConto, Robert; Koenig, Sebastian] Univ Massachusetts, Dept Geosci, Amherst, MA 01003 USA; [Melles, Martin; Andreev, Andrei; Wennrich, Volker] Univ Cologne, Inst Geol & Mineral, D-50674 Cologne, Germany; [Minyuk, Pavel] Russian Acad Sci, Far East Branch, North East Interdisciplinary Sci Res Inst, Magadan 685000, Russia; [Tarasov, Pavel] Free Univ Berlin, Inst Geol Sci, D-12249 Berlin, Germany; [Nowaczyk, Norbert; Haltia, Eeva] GFZ German Res Ctr Geosci, Helmholtz Ctr Potsdam, D-14473 Potsdam, Germany; [Rosen, Peter; Meyer-Jacob, Carsten] Umea Univ, Dept Ecol & Environm Sci, SE-90187 Umea, Sweden; [Cook, Tim] Worcester State Univ, Dept Phys & Earth Sci, Worcester, MA 01602 USA; [Gebhardt, Catalina] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Snyder, Jeff] Bowling Green State Univ, Dept Geol, Bowling Green, OH 43403 USA; [Herzschuh, Ulrike] Alfred Wegener Inst Polar & Marine Res, Res Unit Potsdam, D-14473 Potsdam, Germany	University of Massachusetts System; University of Massachusetts Amherst; University of Cologne; Russian Academy of Sciences; Free University of Berlin; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Umea University; Massachusetts System of Public Higher Education; Worcester State University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University System of Ohio; Bowling Green State University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Brigham-Grette, J (corresponding author), Univ Massachusetts, Dept Geosci, 611 North Pleasant St, Amherst, MA 01003 USA.	juliebg@geo.umass.edu	Melles, Martin/J-4070-2012; Andreev, Andrei A/J-2701-2015; Meyer-Jacob, Carsten/B-8248-2014; Wennrich, Volker/I-3435-2012; Tarasov, Pavel/ABG-3993-2020; Gebhardt, Catalina/C-4817-2009	Melles, Martin/0000-0003-0977-9463; Andreev, Andrei A/0000-0002-8745-9636; Meyer-Jacob, Carsten/0000-0002-8208-496X; Wennrich, Volker/0000-0003-3617-1963; Tarasov, Pavel/0000-0002-7219-5009; Cook, Timothy/0000-0002-4982-6415; Herzschuh, Ulrike/0000-0003-0999-1261; Gebhardt, Catalina/0000-0002-3227-0676	ICDP; U.S. National Science Foundation (NSF); German Federal Ministry of Education and Research (BMBF); Alfred Wegener Institute; Helmholtz Centre Potsdam; Far East Branch of the Russian Academy of Sciences; Russian Foundation for Basic Research; Austrian Federal Ministry of Science and Research (BMWF); BMBF [03G0642]; German Research Foundation (DFG) [ME 1169/21, ME 1169/24]; NSF [0602471]; Global Civilian Research and Development Foundation (CGP-RFBR IV) [RUG1-2987-MA-10]; Vetenskapsradet, the Swedish Research Council Formas; Kempe Foundation; DFG [TA 540/5]; Directorate For Geosciences [1204087] Funding Source: National Science Foundation	ICDP; U.S. National Science Foundation (NSF)(National Science Foundation (NSF)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Alfred Wegener Institute; Helmholtz Centre Potsdam; Far East Branch of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Austrian Federal Ministry of Science and Research (BMWF); BMBF(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); NSF(National Science Foundation (NSF)); Global Civilian Research and Development Foundation (CGP-RFBR IV); Vetenskapsradet, the Swedish Research Council Formas; Kempe Foundation; DFG(German Research Foundation (DFG)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Drilling operations were funded by the ICDP, the U.S. National Science Foundation (NSF), the German Federal Ministry of Education and Research (BMBF), the Alfred Wegener Institute and Helmholtz Centre Potsdam, the Far East Branch of the Russian Academy of Sciences, the Russian Foundation for Basic Research, and the Austrian Federal Ministry of Science and Research (BMWF). The Russian GLAD 800 drilling system was developed and operated by DOSECC Inc. We thank all participants of the expedition for their engagement during the recovery of the ICDP 5011-1 cores. Funding of core analyses was provided by BMBF (grant no. 03G0642), the German Research Foundation (DFG, grant nos. ME 1169/21 and ME 1169/24), NSF (grant no. 0602471), the Global Civilian Research and Development Foundation (CGP-RFBR IV, grant no. RUG1-2987-MA-10), Vetenskapsradet, the Swedish Research Council Formas, and the Kempe Foundation. P.T. acknowledges DFG Heisenberg Program (grant no. TA 540/5). We are grateful to N. Mantke, A. Shahnazarian, and various students (Univ. of Cologne) for their help in core processing and to T. Matrosova for contributing modern surface pollen data. Thanks to A. Dolan for supplying PlioMIP model output and I. Castaneda for discussions and help with figures. The data reported in this paper are archived in the databases of PANGAEA (doi:10.1594/PANGAEA.808834) and the U.S. National Geophysical Data Center (ftp://ftp.ncdc.noaa.gov/pub/data/paleo/paleolimnology/asia/russia/elgygytgyn2013.xls).	Andreev A. A., 2012, 12 INT PAL S GLASG S, P197; Balco G, 2010, GEOLOGY, V38, P795, DOI 10.1130/G30946.1; Ballantyne AP, 2010, GEOLOGY, V38, P603, DOI 10.1130/G30815.1; Bartoli G, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002055; Brierley CM, 2009, SCIENCE, V323, P1714, DOI 10.1126/science.1167625; Brierley CM, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001809; BRIGHAMGRETTE J, 1992, ARCTIC, V45, P74; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Clark PU, 1998, PALEOCEANOGRAPHY, V13, P1, DOI 10.1029/97PA02660; Csank AZ, 2011, EARTH PLANET SC LETT, V304, P291, DOI 10.1016/j.epsl.2011.02.030; Darby DA, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001479; De Schepper S, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001725; DeConto RM, 2008, NATURE, V455, P652, DOI 10.1038/nature07337; Dowsett H, 2010, STRATIGRAPHY, V7, P123; Duk-Rodkin A, 2010, CAN J EARTH SCI, V47, P1003, DOI 10.1139/E10-060; Dwyer GS, 2009, PHILOS T R SOC A, V367, P157, DOI 10.1098/rsta.2008.0222; Elias SA, 2002, CAN J EARTH SCI, V39, P911, DOI 10.1139/E01-096; ENGLAND J, 1987, GEOLOGY, V15, P419, DOI 10.1130/0091-7613(1987)15<419:GATEOT>2.0.CO;2; Froese DG, 2000, CAN J EARTH SCI, V37, P863, DOI 10.1139/e00-014; Gebhardt AC, 2006, GEOLOGY, V34, P145, DOI 10.1130/G22278.1; Glushkova OY, 2007, J PALEOLIMNOL, V37, P37, DOI 10.1007/s10933-006-9021-x; Hamilton T. D., 1986, GLACIATION ALASKA GE; Haug GH, 2005, NATURE, V433, P821, DOI 10.1038/nature03332; Haywood A. M., 2012, CLIM PAST DISCUSS, V8, P2969, DOI DOI 10.5194/CPD-8-2969-2012; Herbert TD, 2010, SCIENCE, V328, P1530, DOI 10.1126/science.1185435; Hidy AJ, 2013, QUATERNARY SCI REV, V61, P77, DOI 10.1016/j.quascirev.2012.11.009; Jansen E, 2000, PALEOCEANOGRAPHY, V15, P709, DOI 10.1029/1999PA000435; Juschus O, 2007, QUAT GEOCHRONOL, V2, P187, DOI 10.1016/j.quageo.2006.05.006; Kaufman DS, 2004, QUATERNARY SCI REV, V23, P529, DOI 10.1016/j.quascirev.2003.09.007; Knies J, 2009, QUATERNARY SCI REV, V28, P812, DOI 10.1016/j.quascirev.2008.12.002; Koenig SJ, 2011, CLIM DYNAM, V37, P1247, DOI 10.1007/s00382-011-1050-0; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lawrence KT, 2010, EARTH PLANET SC LETT, V300, P329, DOI 10.1016/j.epsl.2010.10.013; Lawrence KT, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001669; Layer PW, 2000, METEORIT PLANET SCI, V35, P591, DOI 10.1111/j.1945-5100.2000.tb01439.x; Levis S, 1999, GEOPHYS RES LETT, V26, P747, DOI 10.1029/1999GL900107; Lisiecki L.E., 2005, PALEOCEANOGRAPHY, V20, DOI [10.1029/2004PA001071, DOI 10.1029/2004PA001071]; Matthews J.V., 1997, INSECTS YUKON, P911; Matthiessen J, 2009, PHILOS T R SOC A, V367, P21, DOI 10.1098/rsta.2008.0203; McKay R, 2012, P NATL ACAD SCI USA, V109, P6423, DOI 10.1073/pnas.1112248109; Melles M, 2012, SCIENCE, V337, P315, DOI 10.1126/science.1222135; Melles M, 2011, SCI DRILL, V11, P29, DOI 10.2204/iodp.sd.11.03.2011; Miller GH, 2010, QUATERNARY SCI REV, V29, P1679, DOI 10.1016/j.quascirev.2010.03.001; Miller KG, 2012, GEOLOGY, V40, P407, DOI 10.1130/G32869.1; Naish T, 2009, NATURE, V458, P322, DOI 10.1038/nature07867; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Nolan M., 2012, CLIM PAST DISCUSS, V8, P1443, DOI DOI 10.5194/CPD-8-1443-2012; Nolan M, 2007, J PALEOLIMNOL, V37, P17, DOI 10.1007/s10933-006-9020-y; O'Regan M, 2011, OCEANOGRAPHY, V24, P66, DOI 10.5670/oceanog.2011.57; Pagani M, 2010, NAT GEOSCI, V3, P27, DOI 10.1038/NGEO724; Pollard D, 2009, NATURE, V458, P329, DOI 10.1038/nature07809; Polyak L, 2010, QUATERNARY SCI REV, V29, P1757, DOI 10.1016/j.quascirev.2010.02.010; Prokopenko AA, 2001, QUATERN INT, V80-1, P37, DOI 10.1016/S1040-6182(01)00017-9; Raymo ME, 2011, NAT GEOSCI, V4, P328, DOI [10.1038/ngeo1118, 10.1038/NGEO1118]; Rybczynski N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2516; Schweger C, 2011, QUATERNARY SCI REV, V30, P2124, DOI 10.1016/j.quascirev.2011.01.020; Seki O, 2010, EARTH PLANET SC LETT, V292, P201, DOI 10.1016/j.epsl.2010.01.037; St John K, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001483; Stein R., 2012, POLARFORSCHUNG, V82, P37; Stickley CE, 2009, NATURE, V460, P376, DOI 10.1038/nature08163; Studer AS, 2012, EARTH PLANET SC LETT, V351, P84, DOI 10.1016/j.epsl.2012.07.029; Takahashi K, 2011, SCI DRILL, V11, P4, DOI 10.5194/sd-11-4-2011	62	162	173	4	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	2013	340	6139					1421	1427		10.1126/science.1233137	http://dx.doi.org/10.1126/science.1233137			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23661643				2022-12-28	WOS:000320647000034
J	Gifford, CA; Ziller, MJ; Gu, HC; Trapnell, C; Donaghey, J; Tsankov, A; Shalek, AK; Kelley, DR; Shishkin, AA; Issner, R; Zhang, XL; Coyne, M; Fostel, JL; Holmes, L; Meldrim, J; Guttman, M; Epstein, C; Park, H; Kohlbacher, O; Rinn, J; Gnirke, A; Lander, ES; Bernstein, BE; Meissner, A				Gifford, Casey A.; Ziller, Michael J.; Gu, Hongcang; Trapnell, Cole; Donaghey, Julie; Tsankov, Alexander; Shalek, Alex K.; Kelley, David R.; Shishkin, Alexander A.; Issner, Robbyn; Zhang, Xiaolan; Coyne, Michael; Fostel, Jennifer L.; Holmes, Laurie; Meldrim, Jim; Guttman, Mitchell; Epstein, Charles; Park, Hongkun; Kohlbacher, Oliver; Rinn, John; Gnirke, Andreas; Lander, Eric S.; Bernstein, Bradley E.; Meissner, Alexander			Transcriptional and Epigenetic Dynamics during Specification of Human Embryonic Stem Cells	CELL			English	Article							DNA METHYLATION; MAMMALIAN DEVELOPMENT; HISTONE MODIFICATIONS; REGULATORY REGIONS; HUMAN ES; DIFFERENTIATION; CHROMATIN; EXPRESSION; GENERATION; ENHANCERS	Differentiation of human embryonic stem cells (hESCs) provides a unique opportunity to study the regulatory mechanisms that facilitate cellular transitions in a human context. To that end, we performed comprehensive transcriptional and epigenetic profiling of populations derived through directed differentiation of hESCs representing each of the three embryonic germ layers. Integration of whole-genome bisulfite sequencing, chromatin immunoprecipitation sequencing, and RNA sequencing reveals unique events associated with specification toward each lineage. Lineage-specific dynamic alterations in DNA methylation and H3K4me1 are evident at putative distal regulatory elements that are frequently bound by pluripotency factors in the undifferentiated hESCs. In addition, we identified germ-layer-specific H3K27me3 enrichment at sites exhibiting high DNA methylation in the undifferentiated state. A better understanding of these initial specification events will facilitate identification of deficiencies in current approaches, leading to more faithful differentiation strategies as well as providing insights into the rewiring of human regulatory programs during cellular transitions.	[Gifford, Casey A.; Ziller, Michael J.; Gu, Hongcang; Trapnell, Cole; Donaghey, Julie; Tsankov, Alexander; Kelley, David R.; Shishkin, Alexander A.; Issner, Robbyn; Zhang, Xiaolan; Coyne, Michael; Fostel, Jennifer L.; Holmes, Laurie; Meldrim, Jim; Guttman, Mitchell; Epstein, Charles; Rinn, John; Gnirke, Andreas; Lander, Eric S.; Bernstein, Bradley E.; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Gifford, Casey A.; Ziller, Michael J.; Donaghey, Julie; Tsankov, Alexander; Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Gifford, Casey A.; Ziller, Michael J.; Trapnell, Cole; Donaghey, Julie; Tsankov, Alexander; Kelley, David R.; Rinn, John; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Shalek, Alex K.; Park, Hongkun] Harvard Univ, Dept Chem, Cambridge, MA 02138 USA; [Kohlbacher, Oliver] Univ Tubingen, Ctr Bioinformat, D-72076 Tubingen, Germany; [Kohlbacher, Oliver] Univ Tubingen, Quantitat Biol Ctr, D-72076 Tubingen, Germany; [Rinn, John] Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Bernstein, Bradley E.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; [Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard University; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Harvard University; Beth Israel Deaconess Medical Center; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Meissner, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	alexander_meissner@harvard.edu	Kohlbacher, Oliver/B-7310-2008; Kohlbacher, Oliver/AAF-3297-2021; Park, Hongkun/R-9842-2019; Shalek, Alex/Y-2434-2019	Kohlbacher, Oliver/0000-0003-1739-4598; Kohlbacher, Oliver/0000-0003-1739-4598; Park, Hongkun/0000-0001-9576-8829; Shalek, Alex/0000-0001-5670-8778; Epstein, Charles B./0000-0001-8358-8345; Gifford, Casey/0000-0002-7757-573X; Gu, Hongcang/0000-0002-1439-7606; Rinn, John/0000-0002-7231-7539; Issner, Robbyn/0000-0003-4132-9219	Pew Charitable Trusts; US National Institutes of Health (NIH) [U01ES017155, P01GM099117]; New York Stem Cell Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK095537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER	Pew Charitable Trusts; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Kendell Clement for support of the WGBS data visualization and Loyal Goff for RNA-seq visualization, as well as Zachary Smith and Jing Liao for critical reading of the manuscript, and the SCRB FACS Core for advice regarding FACS analysis. We also thank other members of the Meissner Lab and Epigenomics Platform at the Broad Institute for helpful discussion. A. M. is supported by the Pew Charitable Trusts and is a New York Stem Cell Foundation (NYSCF) Robertson Investigator. The work was funded by the US National Institutes of Health (NIH) grants (U01ES017155 and P01GM099117) and The New York Stem Cell Foundation.	Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Brinkman AB, 2012, GENOME RES, V22, P1128, DOI 10.1101/gr.133728.111; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Chen YF, 2012, HEPATOLOGY, V55, P1193, DOI 10.1002/hep.24790; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Deaton AM, 2011, GENOME RES, V21, P1074, DOI 10.1101/gr.118703.110; DeLaForest A, 2011, DEVELOPMENT, V138, P4143, DOI 10.1242/dev.062547; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Evseenko D, 2010, P NATL ACAD SCI USA, V107, P13742, DOI 10.1073/pnas.1002077107; Gifford CA, 2012, CURR OPIN GENET DEV, V22, P409, DOI 10.1016/j.gde.2012.08.002; Hay DC, 2008, P NATL ACAD SCI USA, V105, P12301, DOI 10.1073/pnas.0806522105; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lee G, 2010, NAT PROTOC, V5, P688, DOI 10.1038/nprot.2010.35; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li ZY, 2012, CELL, V151, P1608, DOI 10.1016/j.cell.2012.11.018; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Ostler K, 2007, ONCOGENE, V26, P5553, DOI 10.1038/sj.onc.1210351; Ostrom M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002841; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; Serandour AA, 2011, GENOME RES, V21, P555, DOI 10.1101/gr.111534.110; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Taberlay PC, 2011, CELL, V147, P1283, DOI 10.1016/j.cell.2011.10.040; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; van Arensbergen J, 2010, GENOME RES, V20, P722, DOI 10.1101/gr.101709.109; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Wei HM, 2012, STEM CELL RES, V9, P87, DOI 10.1016/j.scr.2012.04.003; Wendling O, 2000, DEVELOPMENT, V127, P1553; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yu XY, 2001, DEVELOPMENT, V128, P1005; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	48	303	309	1	82	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 23	2013	153	5					1149	1163		10.1016/j.cell.2013.04.037	http://dx.doi.org/10.1016/j.cell.2013.04.037			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23664763	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000319456800020
J	Shirey, KA; Lai, WD; Scott, AJ; Lipsky, M; Mistry, P; Pletneva, LM; Karp, CL; McAlees, J; Gioannini, TL; Weiss, J; Chen, WH; Ernst, RK; Rossignol, DP; Gusovsky, F; Blanco, JCG; Vogel, SN				Shirey, Kari Ann; Lai, Wendy; Scott, Alison J.; Lipsky, Michael; Mistry, Pragnesh; Pletneva, Lioubov M.; Karp, Christopher L.; McAlees, Jaclyn; Gioannini, Theresa L.; Weiss, Jerrold; Chen, Wilbur H.; Ernst, Robert K.; Rossignol, Daniel P.; Gusovsky, Fabian; Blanco, Jorge C. G.; Vogel, Stefanie N.			The TLR4 antagonist Eritoran protects mice from lethal influenza infection	NATURE			English	Article							1918 SPANISH INFLUENZA; ENDOTOXIN ANTAGONIST; TETRASODIUM E5564; CRYSTAL-STRUCTURE; UNITED-STATES; SEVERE SEPSIS; VIRUS; LIPOPOLYSACCHARIDE; ACTIVATION; INHIBITORS	There is a pressing need to develop alternatives to annual influenza vaccines and antiviral agents licensed for mitigating influenza infection. Previous studies reported that acute lung injury caused by chemical or microbial insults is secondary to the generation of host-derived, oxidized phospholipid that potently stimulates Toll-like receptor 4 (TLR4)-dependent inflammation(1). Subsequently, we reported that Tlr4(-/-) mice are highly refractory to influenza-induced lethality(2), and proposed that therapeutic antagonism of TLR4 signalling would protect against influenza-induced acute lung injury. Here we report that therapeutic administration of Eritoran (also known as E5564)-a potent, well-tolerated, synthetic TLR4 antagonist(3,4)-blocks influenza-induced lethality in mice, as well as lung pathology, clinical symptoms, cytokine and oxidized phospholipid expression, and decreases viral titres. CD14 and TLR2 are also required for Eritoran-mediated protection, and CD14 directly binds Eritoran and inhibits ligand binding to MD2. Thus, Eritoran blockade of TLR signalling represents a novel therapeutic approach for inflammation associated with influenza, and possibly other infections.	[Shirey, Kari Ann; Lai, Wendy; Mistry, Pragnesh; Vogel, Stefanie N.] Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Scott, Alison J.; Ernst, Robert K.] Univ Maryland, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA; [Lipsky, Michael] Univ Maryland, Dept Pathol, Baltimore, MD 21201 USA; [Pletneva, Lioubov M.; Blanco, Jorge C. G.] Sigmovir Biosyst Inc, Rockville, MD 20850 USA; [Karp, Christopher L.; McAlees, Jaclyn] Cincinnati Childrens Hosp Res Fdn, Div Mol Immunol, Cincinnati, OH 45229 USA; [Gioannini, Theresa L.; Weiss, Jerrold] Univ Iowa, Inflammat Program, Coralville, IA 52241 USA; [Gioannini, Theresa L.] Dept Vet Affairs Med Ctr, Iowa City, IA 52241 USA; [Chen, Wilbur H.] Univ Maryland, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Rossignol, Daniel P.; Gusovsky, Fabian] Eisai Inc, Andover, MA 01810 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University System of Maryland; University of Maryland Baltimore; Eisai Co Ltd	Vogel, SN (corresponding author), Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	svogel@som.umaryland.edu	Blanco, Jorge/AAW-3752-2020	Karp, Christopher/0000-0002-0832-2659; Weiss, Jerrold/0000-0003-1476-4485; Ernst, Robert/0000-0001-5016-8694; Scott, Alison/0000-0001-6969-4707; Blanco, Jorge/0000-0002-6173-0213	National Institutes of Health [AI057575, AI018797, AI059372]; NCRR [K12-RR-023250]; VA Merit Award [1I01BX0000949-01A1]; Cystic Fibrosis Foundation RDP Center; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057575, R37AI018797, R01AI059372, R01AI018797, R56AI018797, T32AI007540] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); VA Merit Award(US Department of Veterans Affairs); Cystic Fibrosis Foundation RDP Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health grants AI057575 (J.C.G.B.), AI018797 (S.N.V.), AI059372 (J.W.) and NCRR K12-RR-023250 (W. H. C.), VA Merit Award 1I01BX0000949-01A1 (T. L. G.) and Cystic Fibrosis Foundation RDP Center Grant (C.L.K.).	Blanco JCG, 2013, J VIROL, V87, P2036, DOI 10.1128/JVI.00638-12; Cohen J, 2012, LANCET INFECT DIS, V12, P503, DOI 10.1016/S1473-3099(12)70136-6; Esparza GA, 2012, INNATE IMMUN-LONDON, V18, P478, DOI 10.1177/1753425911422723; Gioannini TL, 2002, J BIOL CHEM, V277, P47818, DOI 10.1074/jbc.M206404200; GOLDBLUM SE, 1993, J CELL PHYSIOL, V157, P13, DOI 10.1002/jcp.1041570103; Hurt AC, 2009, J VIROL, V83, P10366, DOI 10.1128/JVI.01200-09; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Kalil AC, 2011, SHOCK, V36, P327, DOI 10.1097/SHK.0b013e318227980e; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Lee RM, 2006, SCAND J IMMUNOL, V63, P81, DOI 10.1111/j.1365-3083.2005.01714.x; McKimm-Breschkin JL, 1998, J VIROL, V72, P2456, DOI 10.1128/JVI.72.3.2456-2462.1998; Means TK, 1999, J IMMUNOL, V163, P6748; Mishin VP, 2005, ANTIMICROB AGENTS CH, V49, P4515, DOI 10.1128/AAC.49.11.4515-4520.2005; Mullarkey M, 2003, J PHARMACOL EXP THER, V304, P1093, DOI 10.1124/jpet.102.044487; Nhu QM, 2010, MUCOSAL IMMUNOL, V3, P29, DOI 10.1038/mi.2009.120; Ottolini MG, 2005, J GEN VIROL, V86, P2823, DOI 10.1099/vir.0.81145-0; Pauligk C, 2004, IMMUNOBIOLOGY, V209, P3, DOI 10.1016/j.imbio.2004.04.002; Polakos NK, 2006, AM J PATHOL, V168, P1169, DOI 10.2353/ajpath.2006.050875; Reid AH, 2001, MICROBES INFECT, V3, P81, DOI 10.1016/S1286-4579(00)01351-4; Shinya K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-97; Shirey KA, 2011, J LEUKOCYTE BIOL, V89, P351, DOI 10.1189/jlb.0410216; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Taubenberger JK, 2001, PHILOS T ROY SOC B, V356, P1829, DOI 10.1098/rstb.2001.1020; Thomas KE, 2006, J BIOL CHEM, V281, P31119, DOI 10.1074/jbc.M604958200; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Tidswell M, 2010, CRIT CARE MED, V38, P72, DOI 10.1097/CCM.0b013e3181b07b78; Verhoeven D, 2009, VIROLOGY, V390, P151, DOI 10.1016/j.virol.2009.05.004; Wong YN, 2003, J CLIN PHARMACOL, V43, P735, DOI 10.1177/0091270003254804; Yoon SI, 2010, P NATL ACAD SCI USA, V107, P10990, DOI 10.1073/pnas.1004153107	30	314	328	3	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					498	+		10.1038/nature12118	http://dx.doi.org/10.1038/nature12118			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23636320	Green Accepted, Bronze			2022-12-28	WOS:000319254000050
J	Shirley, MD; Tang, H; Gallione, CJ; Baugher, JD; Frelin, LP; Cohen, B; North, PE; Marchuk, DA; Comi, AM; Pevsner, J				Shirley, Matthew D.; Tang, Hao; Gallione, Carol J.; Baugher, Joseph D.; Frelin, Laurence P.; Cohen, Bernard; North, Paula E.; Marchuk, Douglas A.; Comi, Anne M.; Pevsner, Jonathan			Sturge-Weber Syndrome and Port-Wine Stains Caused by Somatic Mutation in GNAQ	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GTPASE-ACTIVATING PROTEINS; PHAKOMATOSIS PIGMENTOVASCULARIS; PHOSPHOLIPASE-C; UVEAL MELANOMA; ALPHA; RECEPTORS; GAIP; RGS4	BACKGROUND The Sturge-Weber syndrome is a sporadic congenital neurocutaneous disorder characterized by a port-wine stain affecting the skin in the distribution of the ophthalmic branch of the trigeminal nerve, abnormal capillary venous vessels in the leptomeninges of the brain and choroid, glaucoma, seizures, stroke, and intellectual disability. It has been hypothesized that somatic mosaic mutations disrupting vascular development cause both the Sturge-Weber syndrome and port-wine stains, and the severity and extent of presentation are determined by the developmental time point at which the mutations occurred. To date, no such mutation has been identified. METHODS We performed whole-genome sequencing of DNA from paired samples of visibly affected and normal tissue from 3 persons with the Sturge-Weber syndrome. We tested for the presence of a somatic mosaic mutation in 97 samples from 50 persons with the Sturge-Weber syndrome, a port-wine stain, or neither (controls), using amplicon sequencing and SNaPshot assays, and investigated the effects of the mutation on downstream signaling, using phosphorylation-specific antibodies for relevant effectors and a luciferase reporter assay. RESULTS We identified a nonsynonymous single-nucleotide variant (c.548G -> A, p.Arg183Gln) in GNAQ in samples of affected tissue from 88% of the participants (23 of 26) with the Sturge-Weber syndrome and from 92% of the participants (12 of 13) with apparently nonsyndromic port-wine stains, but not in any of the samples of affected tissue from 4 participants with an unrelated cerebrovascular malformation or in any of the samples from the 6 controls. The prevalence of the mutant allele in affected tissues ranged from 1.0 to 18.1%. Extracellular signal-regulated kinase activity was modestly increased during transgenic expression of mutant G alpha(q). CONCLUSIONS The Sturge-Weber syndrome and port-wine stains are caused by a somatic activating mutation in GNAQ. This finding confirms a long-standing hypothesis.	[Shirley, Matthew D.; Baugher, Joseph D.; Pevsner, Jonathan] Johns Hopkins Sch Med, Biochem Cellular & Mol Biol Program, Baltimore, MD USA; [Cohen, Bernard] Johns Hopkins Sch Med, Dept Dermatol, Baltimore, MD USA; [Comi, Anne M.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Comi, Anne M.] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA; [Pevsner, Jonathan] Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Shirley, Matthew D.; Baugher, Joseph D.; Frelin, Laurence P.; Comi, Anne M.; Pevsner, Jonathan] Hugo W Moser Res Inst Kennedy Krieger, Dept Neurol & Dev Med, Baltimore, MD USA; [Tang, Hao; Gallione, Carol J.; Marchuk, Douglas A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA; [North, Paula E.] Med Coll Wisconsin, Dept Pathol, Div Pediat Pathol, Milwaukee, WI 53226 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Duke University; Medical College of Wisconsin	Pevsner, J (corresponding author), Kennedy Krieger Inst, Dept Neurol, 707 N Broadway, Baltimore, MD 21205 USA.	pevsner@kennedykrieger.org		Marchuk, Douglas/0000-0002-3110-6671; Baugher, Joseph/0000-0003-2466-3047; Shirley, Matthew/0000-0003-0855-9274	National Institutes of Health; Hunter's Dream for a Cure Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS065705] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hunter's Dream for a Cure Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by the National Institutes of Health and Hunter's Dream for a Cure Foundation.	Al Robaee A, 2004, PEDIATR DERMATOL, V21, P642, DOI 10.1111/j.0736-8046.2004.21605.x; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Ch'ng S, 2008, J PLAST RECONSTR AES, V61, P889, DOI 10.1016/j.bjps.2007.05.011; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Comi Anne M., 2007, Lymphatic Research and Biology, V5, P257, DOI 10.1089/lrb.2007.1016; CONKLIN BR, 1992, J BIOL CHEM, V267, P31; Greene AK, 2009, J CRANIOFAC SURG, V20, P617, DOI 10.1097/SCS.0b013e318192988e; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Kajio F, 1997, HEART VESSELS, V12, P300, DOI 10.1007/BF02766807; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Orth JHC, 2009, P NATL ACAD SCI USA, V106, P7179, DOI 10.1073/pnas.0900160106; Piram M, 2012, PEDIATR DERMATOL, V29, P32, DOI 10.1111/j.1525-1470.2011.01485.x; Shields CL, 2011, ARCH OPHTHALMOL-CHIC, V129, P746, DOI 10.1001/archophthalmol.2011.135; Shirazi Farheen, 2007, Lymphatic Research and Biology, V5, P233, DOI 10.1089/lrb.2007.1012; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Vaque JP, 2013, MOL CELL, V49, P94, DOI 10.1016/j.molcel.2012.10.018; Vissers W, 2003, EUR J DERMATOL, V13, P238; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403	22	545	576	6	68	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2013	368	21					1971	1979		10.1056/NEJMoa1213507	http://dx.doi.org/10.1056/NEJMoa1213507			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194KD	23656586	Green Accepted, Bronze			2022-12-28	WOS:000322630700007
J	Pham, JC; Pronovost, PJ; Skipper, GE				Pham, Julius Cuong; Pronovost, Peter J.; Skipper, Gregory E.			Identification of Physician Impairment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Pham, Julius Cuong] Johns Hopkins Univ, Dept Emergency Med, Baltimore, MD 21202 USA; [Pham, Julius Cuong; Pronovost, Peter J.] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21202 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Dept Surg & Hlth Policy & Management, Baltimore, MD 21202 USA; [Pham, Julius Cuong; Pronovost, Peter J.] Johns Hopkins Med, Armstrong Inst Patient Safety & Qual, Baltimore, MD USA; [Skipper, Gregory E.] Promises Treatment Ctr, Profess Hlth Serv, Santa Monica, CA USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Pham, JC (corresponding author), Johns Hopkins Univ, Sch Med, Armstrong Inst Patient Safety & Qual, 750 E Pratt St,15th Floor, Baltimore, MD 21202 USA.	jpham3@jhmi.edu						Classen DC, 2011, HEALTH AFFAIR, V30, P581, DOI 10.1377/hlthaff.2011.0190; Fitzsimons MG, 2008, ANESTH ANALG, V107, P630, DOI 10.1213/ane.0b013e318176fefa; Leape LL, 2006, ANN INTERN MED, V144, P107, DOI 10.7326/0003-4819-144-2-200601170-00008; McLellan AT, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2038; SHORE J H, 1987, Journal of the American Medical Association, V257, P2931, DOI 10.1001/jama.257.21.2931; Substance Abuse and Mental Health Services Administration, 2010, FED REG, V75, P22809; Zacher JL, 2004, ANN PHARMACOTHER, V38, P1525, DOI 10.1345/aph.1D632; ZWERLING C, 1992, JAMA-J AM MED ASSOC, V267, P91, DOI 10.1001/jama.267.1.91	8	17	17	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2013	309	20					2101	2102		10.1001/jama.2013.4635	http://dx.doi.org/10.1001/jama.2013.4635			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148FU	23629590				2022-12-28	WOS:000319229600022
J	Karim, R; Ali, SHM				Karim, Raj; Ali, Siti Hasmah Mohamad			Maternal health in Malaysia: progress and potential	LANCET			English	Editorial Material												raj.abdulkarim@gmail.com						[Anonymous], 2005, FAM HLTH SUBS HLTH M; [Anonymous], 2013, ACC CONTR AB SERV; Arabi Idid S, 2007, MALAYSIA 50 ACHIEVEM; Yadav H., 2012, IEJSME, V6, pS142, DOI [10.56026/imu.6.Suppl1.S142, DOI 10.56026/IMU.6.SUPPL1.S142]	4	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 18	2013	381	9879					1690	1691		10.1016/S0140-6736(13)60904-6	http://dx.doi.org/10.1016/S0140-6736(13)60904-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146TA	23683616				2022-12-28	WOS:000319112800007
J	Vyas, JM; Gonzalez, RG; Pierce, VM				Vyas, Jatin M.; Gonzalez, R. Gilberto; Pierce, Virginia M.			Case 15-2013: A 76-Year-Old Man with Fever, Worsening Renal Function, and Altered Mental Status	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFECTIONS; VIRUS		[Vyas, Jatin M.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Gonzalez, R. Gilberto] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Pierce, Virginia M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Vyas, Jatin M.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Gonzalez, R. Gilberto] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Pierce, Virginia M.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Vyas, JM (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.		Vyas, Jatin/Q-1627-2016	Vyas, Jatin/0000-0002-9985-9565; Pierce, Virginia/0000-0002-3723-1326				[Anonymous], 2012, ARBOVIRUSES MASSACHU; [Anonymous], 2012, NEW ENGL J MED, V366, P1434; Bode AV, 2006, CLIN INFECT DIS, V42, P1234, DOI 10.1086/503038; Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467; CDC Division of Vector-borne Diseases, 2012, W NIL VIR; Centers for Disease Control and Prevention, W NIL VIR; Centers for Disease Control and Prevention, SAINT LOUIS ENC EP G; Centers for Disease Control and Prevention, 2012, MULT FUNG MEN OUTBR; Cushing H, 1901, B JOHNS HOPKINS HOSP, V12, P290; Gubler D.J., 2007, FIELDS VIROLOGY, VVolume 1; Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024; Kainer MA, 2012, NEW ENGL J MED, V367, P2194, DOI 10.1056/NEJMoa1212972; Kerkering TM, 2013, ANN INTERN MED, V158, P154, DOI 10.7326/0003-4819-158-3-201302050-00568; Petersen LR, 2012, NEW ENGL J MED, V367, P1281, DOI 10.1056/NEJMp1210537; Ram S, 2010, CLIN MICROBIOL REV, V23, P740, DOI 10.1128/CMR.00048-09; U.S. Geological Survey, HUM E EQ ENC CUM 201; Vaughn DW, 2010, PRINCIPLES PRACTICE, V2, P2133	17	3	3	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2013	368	20					1919	1927		10.1056/NEJMcpc1302330	http://dx.doi.org/10.1056/NEJMcpc1302330			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143VK	23675661				2022-12-28	WOS:000318896200012
J	Wang, C; Wu, HX; Katritch, V; Han, GW; Huang, XP; Liu, W; Siu, FY; Roth, BL; Cherezov, V; Stevens, RC				Wang, Chong; Wu, Huixian; Katritch, Vsevolod; Han, Gye Won; Huang, Xi-Ping; Liu, Wei; Siu, Fai Yiu; Roth, Bryan L.; Cherezov, Vadim; Stevens, Raymond C.			Structure of the human smoothened receptor bound to an antitumour agent	NATURE			English	Article							RESOLUTION CRYSTAL-STRUCTURE; PROTEIN-COUPLED RECEPTOR; OPIOID RECEPTOR; INTERNATIONAL UNION; LIPIDIC MESOPHASES; FRIZZLED RECEPTORS; MEMBRANE-PROTEINS; HEDGEHOG; ACTIVATION; PATHWAY	The smoothened (SMO) receptor, a key signal transducer in the hedgehog signalling pathway, is responsible for the maintenance of normal embryonic development and is implicated in carcinogenesis. It is classified as a class frizzled (class F) G-protein-coupled receptor (GPCR), although the canonical hedgehog signalling pathway involves the GLI transcription factors and the sequence similarity with class A GPCRs is less than 10%. Here we report the crystal structure of the transmembrane domain of the human SMO receptor bound to the small-molecule antagonist LY2940680 at 2.5 angstrom resolution. Although the SMO receptor shares the seven-transmembrane helical fold, most of the conserved motifs for class A GPCRs are absent, and the structure reveals an unusually complex arrangement of long extracellular loops stabilized by four disulphide bonds. The ligand binds at the extracellular end of the seven-transmembrane-helix bundle and forms extensive contacts with the loops.	[Wang, Chong; Wu, Huixian; Katritch, Vsevolod; Han, Gye Won; Liu, Wei; Siu, Fai Yiu; Cherezov, Vadim; Stevens, Raymond C.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina Chapel Hill, Natl Inst Mental Hlth Psychoact Drug Screening Pr, Dept Pharmacol, Sch Med, Chapel Hill, NC 27514 USA; [Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina Chapel Hill, Sch Med, Div Chem Biol & Med Chem, Chapel Hill, NC 27514 USA	Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Stevens, RC (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	stevens@scripps.edu	Roth, Bryan L/F-3928-2010; Stevens, Raymond/K-7272-2015; Wu, Huixian/N-6353-2014; Katritch, Vsevolod/Y-2721-2019; Roth, Bryan/ABE-7032-2020; Han, Gye Won/GLQ-8673-2022; Katritch, Vsevolod/Q-8357-2016; Cherezov, Vadim/L-9812-2013; Han, Gye Won/GLT-1531-2022; Han, Gye Won/GLQ-8724-2022	Stevens, Raymond/0000-0002-4522-8725; Wu, Huixian/0000-0003-1357-9747; Roth, Bryan/0000-0002-0561-6520; Katritch, Vsevolod/0000-0003-3883-4505; Cherezov, Vadim/0000-0002-5265-3914; Han, Gye Won/0000-0003-4107-835X; Huang, Xi-Ping/0000-0002-2585-653X	National Institutes of Health [P50 GM073197, U54 GM094618]; NIMH Psychoactive Drug Screening Program; Michael Hooker Chair of Pharmacology; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104];  [F32 DK088392];  [R01 MH61887];  [U19 MH82441];  [R01 DA27170]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK088392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197, U54GM094618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U19MH082441, R01MH061887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017204, R01DA027170] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH Psychoactive Drug Screening Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Michael Hooker Chair of Pharmacology; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health Common Fund grant P50 GM073197 for technology development (V. C. and R. C. S.), PSI:Biology grant U54 GM094618 for biological studies and structure production (target GPCR-131) (V. K., V. C. and R. C. S.); F32 DK088392 (F.Y.S.); R01 MH61887, U19 MH82441, R01 DA27170 and the NIMH Psychoactive Drug Screening Program (X.-P. H. and B. L. R.) and the Michael Hooker Chair of Pharmacology (B. L. R.). We thank J. Velasquez for help with molecular biology, T. Trinh and M. Chu for help with baculovirus expression, K. Kadyshevskaya for assistance with figure preparation, A. Walker for assistance with manuscript preparation, D. Wacker for assistance with SAD data collection and processing and J. Smith, R. Fischetti and N. Sanishvili for assistance in development and use of the minibeam and beamtime at beamline 23-ID at the Advanced Photon Source, which is supported by National Cancer Institute grant Y1-CO-1020 and National Institute of General Medical Sciences grant Y1-GM-1104.	Ayers KL, 2010, TRENDS CELL BIOL, V20, P287, DOI 10.1016/j.tcb.2010.02.002; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bender MH, 2011, CANCER RES, V71, DOI 10.1158/1538-7445.AM2011-2819; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Carroll CE, 2012, DEVELOPMENT, V139, P612, DOI 10.1242/dev.075614; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Cherezov V, 2004, ACTA CRYSTALLOGR D, V60, P1795, DOI 10.1107/S0907444904019109; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cherezov V, 2009, J R SOC INTERFACE, V6, pS587, DOI 10.1098/rsif.2009.0142.focus; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Heretsch P, 2010, BIOORGAN MED CHEM, V18, P6613, DOI 10.1016/j.bmc.2010.07.038; Hipskind P. A., 2010, US patent, Patent No. [8,273,742 B2, 8273742]; Huang HC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-234; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Krishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029817; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Polizio AH, 2011, J BIOL CHEM, V286, P19589, DOI 10.1074/jbc.M110.197111; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Rominger CM, 2009, J PHARMACOL EXP THER, V329, P995, DOI 10.1124/jpet.109.152090; Schulte G, 2010, PHARMACOL REV, V62, P632, DOI 10.1124/pr.110.002931; Schwartz TW, 1996, TRENDS PHARMACOL SCI, V17, P213, DOI 10.1016/0165-6147(96)10017-1; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225	49	369	382	2	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2013	497	7449					338	+		10.1038/nature12167	http://dx.doi.org/10.1038/nature12167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23636324	Green Accepted, Green Submitted			2022-12-28	WOS:000318952000031
J	Garg, A; Jack, B; Zuckerman, B				Garg, Arvin; Jack, Brian; Zuckerman, Barry			Addressing the Social Determinants of Health Within the Patient-Centered Medical Home Lessons From Pediatrics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BRITISH CIVIL-SERVANTS; HEART		[Garg, Arvin; Zuckerman, Barry] Boston Univ, Sch Med, Boston Med Ctr, Dept Pediat, Boston, MA 02118 USA; [Jack, Brian] Boston Univ, Sch Med, Boston Med Ctr, Dept Family Med, Boston, MA 02118 USA	Boston Medical Center; Boston University; Boston Medical Center; Boston University	Garg, A (corresponding author), Boston Univ, Sch Med, Boston Med Ctr, Dept Pediat,Div Gen Pediat, Boston, MA 02118 USA.	arvin.garg@bmc.org		Jack, Brian/0000-0002-6497-2437; Zuckerman, Barry/0000-0002-0044-2592; Garg, Arvin/0000-0003-0839-2611				Garg A, 2007, PEDIATRICS, V120, P547, DOI 10.1542/peds.2007-0398; Hagan JF, 2008, BRIGHT FUTURES GUIDE; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MARMOT MG, 1978, J EPIDEMIOL COMMUN H, V32, P244, DOI 10.1136/jech.32.4.244; Marmot MG, 2012, JAMA-J AM MED ASSOC, V307, P2033, DOI 10.1001/jama.2012.3534; Powell Davies G, 2006, COORDINATION CARE PR; Sia C, 2004, PEDIATRICS, V113, P1473; Zuckerman B, 2009, PEDIATRICS, V124, P1660, DOI 10.1542/peds.2009-1207	8	74	75	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2013	309	19					2001	2002		10.1001/jama.2013.1471	http://dx.doi.org/10.1001/jama.2013.1471			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143GQ	23619825				2022-12-28	WOS:000318855500021
J	Peterson, PN; Varosy, PD; Heidenreich, PA; Wang, YF; Dewland, TA; Curtis, JP; Go, AS; Greenlee, RT; Magid, DJ; Normand, SLT; Masoudi, FA				Peterson, Pamela N.; Varosy, Paul D.; Heidenreich, Paul A.; Wang, Yongfei; Dewland, Thomas A.; Curtis, Jeptha P.; Go, Alan S.; Greenlee, Robert T.; Magid, David J.; Normand, Sharon-Lise T.; Masoudi, Frederick A.			Association of Single- vs Dual-Chamber ICDs With Mortality, Readmissions, and Complications Among Patients Receiving an ICD for Primary Prevention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; INAPPROPRIATE THERAPY; DETECTION ENHANCEMENTS; COST-EFFECTIVENESS; LONGEVITY; REGISTRY; DEVICES	Importance Randomized trials of implantable cardioverter-defibrillators (ICDs) for primary prevention predominantly used single-chamber devices. In clinical practice, patients often receive dual-chamber ICDs, even without clear indications for pacing. The outcomes of dual-vs single-chamber devices are uncertain. Objective To compare outcomes of single-and dual-chamber ICDs for primary prevention of sudden cardiac death. Design, Setting, and Participants Retrospective cohort study of admissions in the National Cardiovascular Data Registry's (NCDR) ICD registry from 2006-2009 that could be linked to Centers for Medicare & Medicaid Services fee-for-service Medicare claims data. Patients were included if they received an ICD for primary prevention and did not have a documented indication for pacing. Main Outcomes and Measures Adjusted risks of 1-year mortality, all-cause readmission, heart failure readmission, and device-related complications within 90 days were estimated with propensity-score matching based on patient, clinician, and hospital factors. Results Among 32 034 patients, 12 246 (38%) received a single-chamber device and 19 788 (62%) received a dual-chamber device. In a propensity-matched cohort, rates of complications were lower for single-chamber devices (3.51% vs 4.72%; P<.001; risk difference, -1.20 [95% CI, -1.72 to -0.69]), but device type was not significantly associated with 1-year mortality (unadjusted rate, 9.85% vs 9.77%; hazard ratio [HR], 0.99 [95% CI, 0.91 to 1.07]; P=.79), 1-year all-cause hospitalization (unadjusted rate, 43.86% vs 44.83%; HR, 1.00 [95% CI, 0.97-1.04]; P=.82), or hospitalization for heart failure (unadjusted rate, 14.73% vs 15.38%; HR, 1.05 [95% CI, 0.99-1.12]; P=.19). Conclusions and Relevance Among patients receiving an ICD for primary prevention without indications for pacing, the use of a dual-chamber device compared with a single-chamber device was associated with a higher risk of device-related complications and similar 1-year mortality and hospitalization outcomes. Reasons for preferentially using dual-chamber ICDs in this setting remains unclear.	[Peterson, Pamela N.] Denver Hlth Med Ctr, Dept Med, Denver, CO 80204 USA; [Peterson, Pamela N.; Varosy, Paul D.; Magid, David J.] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Magid, David J.] Univ Colorado Denver, Dept Hlth Syst Management & Policy, Aurora, CO USA; [Peterson, Pamela N.; Varosy, Paul D.; Magid, David J.; Masoudi, Frederick A.] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO USA; [Varosy, Paul D.] Eastern Colorado VA Hlth Care Syst, Dept Med, Denver, CO USA; [Heidenreich, Paul A.] VA Palo Alto Hlth Care Syst, Dept Med, Palo Alto, CA USA; [Wang, Yongfei; Curtis, Jeptha P.] Yale Univ, Dept Med, New Haven, CT 06520 USA; [Dewland, Thomas A.; Go, Alan S.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Dewland, Thomas A.; Go, Alan S.] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA; [Go, Alan S.] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA; [Greenlee, Robert T.] Marshfield Clin Fdn Med Res & Educ, Dept Epidemiol, Marshfield, WI USA; [Greenlee, Robert T.] Marshfield Clin Res Fdn, Marshfield, WI USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Denver Health Medical Center; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Kaiser Permanente; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Yale University; University of California System; University of California San Francisco; Kaiser Permanente; Stanford University; Marshfield Clinic; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Peterson, PN (corresponding author), Denver Hlth Med Ctr, 777 Bannock St,MC 0960, Denver, CO 80204 USA.	Pamela.Peterson@ucdenver.edu	Go, Alan S./AAE-7745-2019; Masoudi, Frederick/Q-7467-2019; Heidenreich, Paul/AAU-6864-2021	Heidenreich, Paul/0000-0001-7730-8490; Normand, Sharon-Lise/0000-0001-7027-4769	Agency for Healthcare Research and Quality [K08 HS019814-01]; American College of Cardiology Foundation's National Cardiovascular Data Registry (NCDR); Boston Scientific; Oklahoma Foundation for Medical Quality; American College of Cardiology Foundation; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS019814] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); American College of Cardiology Foundation's National Cardiovascular Data Registry (NCDR)(General Electric); Boston Scientific(Boston Scientific); Oklahoma Foundation for Medical Quality; American College of Cardiology Foundation(General Electric); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Masoudi reported that he has contracts with the Oklahoma Foundation for Medical Quality and the American College of Cardiology Foundation. Dr Dewland reported that he has received an educational travel grant from Boston Scientific. No other disclosures were reported.; Dr Peterson is supported by grant K08 HS019814-01 from the Agency for Healthcare Research and Quality. This research was supported by the American College of Cardiology Foundation's National Cardiovascular Data Registry (NCDR).	Al-Khatib SM, 2008, CIRC-ARRHYTHMIA ELEC, V1, P240, DOI 10.1161/CIRCEP.108.777888; Almendral J, 2008, EUROPACE, V10, P528, DOI 10.1093/europace/eun072; Brennan JM, 2012, CIRC-CARDIOVASC QUAL, V5, P134, DOI 10.1161/CIRCOUTCOMES.111.963280; Centers for Medicare & Medicaid Services, NCD IMPL AUT DEF 20; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Deisenhofer I, 2001, J CARDIOVASC ELECTR, V12, P134, DOI 10.1046/j.1540-8167.2001.00134.x; Dewland TA, 2011, J AM COLL CARDIOL, V58, P1007, DOI 10.1016/j.jacc.2011.04.039; Dorian P, 2004, HEART RHYTHM, V1, P540, DOI 10.1016/j.hrthm.2004.07.017; Epstein AE, 2008, CIRCULATION, V117, pE350, DOI 10.1161/CIRCUALTIONAHA.108.189742; Friedman PA, 2006, CIRCULATION, V113, P2871, DOI 10.1161/CIRCULATIONAHA.105.594531; Goldberger Z, 2005, J AM COLL CARDIOL, V46, P850, DOI 10.1016/j.jacc.2005.05.061; Gu Xing S., 1993, J COMPUTATIONAL GRAP, V2, P405, DOI [DOI 10.1080/10618600.1993.10474623, DOI 10.7326/0003-4819-152-6-201003160-00008]; Hammill SC, 2007, HEART RHYTHM, V4, P1260, DOI 10.1016/j.hrthm.2007.07.021; Hammill SC, 2010, HEART RHYTHM, V7, P1340, DOI 10.1016/j.hrthm.2010.07.015; Mark DB, 2006, CIRCULATION, V114, P135, DOI 10.1161/CIRCULATIONAHA.105.581884; Matlock DD, 2012, ARCH INTERN MED, V172, P634, DOI 10.1001/archinternmed.2012.394; McClellan MB, 2005, NEW ENGL J MED, V352, P222, DOI 10.1056/NEJMp048354; Messenger JC, 2012, J AM COLL CARDIOL, V60, P1484, DOI 10.1016/j.jacc.2012.07.020; Moss AJ, 2012, NEW ENGL J MED, V367, P2275, DOI 10.1056/NEJMoa1211107; National Quality Forum, 2011, NAT VOL CONS STAND P, pA1; Olshansky B, 2007, CIRCULATION, V115, P9, DOI 10.1161/CIRCULATIONAHA.106.629428; Reynolds MR, 2006, J AM COLL CARDIOL, V47, P2493, DOI 10.1016/j.jacc.2006.02.049; Russo AM, 2012, HEART RHYTHM, V9, P520, DOI 10.1016/j.hrthm.2011.12.008; Sanders GD, 2005, NEW ENGL J MED, V353, P1471, DOI 10.1056/NEJMsa051989; Sweeney MO, 2010, HEART RHYTHM, V7, P1552, DOI 10.1016/j.hrthm.2010.05.038; Theuns DAMJ, 2004, J AM COLL CARDIOL, V44, P2362, DOI 10.1016/j.jacc.2004.09.039; Thijssen J, 2012, HEART RHYTHM, V9, P513, DOI 10.1016/j.hrthm.2011.11.022; Wilkoff BL, 2002, JAMA-J AM MED ASSOC, V288, P3115; Wilkoff BL, 2009, J AM COLL CARDIOL, V53, P872, DOI 10.1016/j.jacc.2008.10.057	29	75	77	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2013	309	19					2025	2034		10.1001/jama.2013.4982	http://dx.doi.org/10.1001/jama.2013.4982			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143GQ	23677314	Bronze, Green Accepted			2022-12-28	WOS:000318855500025
J	Hawkes, N				Hawkes, Nigel			NHS ORGANISATION How different are NHS systems across the UK since devolution?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												Nigel.hawkes1@btinternet.com						Bevan G., 2011, FUNDING PERFORMANCE; Findlay R, 2013, WAITING SCOTLAND ENG; National Audit Office, 2012, HEALTHC UK COMP NHS; UK Statistics Authority, MON REV OUTL HOSP WA	4	3	4	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2013	346								f3066	10.1136/bmj.f3066	http://dx.doi.org/10.1136/bmj.f3066			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148OF	23674337				2022-12-28	WOS:000319253900012
J	Craddock, N; Sklar, P				Craddock, Nick; Sklar, Pamela			Bipolar Disorder 1 Genetics of bipolar disorder	LANCET			English	Article							GENOME-WIDE ASSOCIATION; COPY NUMBER VARIANTS; PSYCHIATRIC-DISORDERS; NEUROPSYCHIATRIC DISORDERS; KRAEPELINIAN DICHOTOMY; I DISORDER; SCHIZOPHRENIA; METAANALYSIS; PHENOTYPE; RISK	Studies of families and twins show the importance of genetic factors affecting susceptibility to bipolar disorder and suggest substantial genetic and phenotypic complexity. Robust and replicable genome-wide significant associations have recently been reported in genome-wide association studies at several common polymorphisms, including variants within the genes CACNA1C, ODZ4, and NCAN. Strong evidence exists for a polygenic contribution to risk (ie, many risk alleles of small effect). A notable finding is the overlap of susceptibility between bipolar disorder and schizophrenia for several individual risk alleles and for the polygenic risk. By contrast, genomic structural variation seems to play a smaller part in bipolar disorder than it does in schizophrenia. Together, these genetic findings suggest directions for future studies to delineate the aetiology and pathogenesis of bipolar disorder, indicate the need to re-evaluate our diagnostic classifications, and might eventually pave the way for major improvements in clinical management.	[Craddock, Nick] Cardiff Univ, Sch Med, Inst Psychol Med & Clin Neurosci, Cardiff CF14 4XN, S Glam, Wales; [Sklar, Pamela] Mt Sinai, Icahn Sch Med, Friedman Brain Inst, Div Psychiat Genom,Dept Psychiat, New York, NY USA; [Sklar, Pamela] Mt Sinai, Icahn Sch Med, Inst Genom & Multiscale Biol, New York, NY USA	Cardiff University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Craddock, N (corresponding author), Cardiff Univ, Sch Med, Inst Psychol Med & Clin Neurosci, Henry Wellcome Bldg, Cardiff CF14 4XN, S Glam, Wales.	craddockn@cardiff.ac.uk			Medical Research Council [G0801418B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Badner JA, 2012, MOL PSYCHIATR, V17, P818, DOI 10.1038/mp.2011.89; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Bergen SE, 2012, MOL PSYCHIATR, V17, P880, DOI 10.1038/mp.2012.73; Brennand KJ, 2012, DIS MODEL MECH, V5, P26, DOI 10.1242/dmm.008268; Breuer R, 2011, MOL PSYCHIATR, V16, P587, DOI 10.1038/mp.2010.67; Burdick KE, 2011, NEUROPSYCHOPHARMACOL, V36, P1587, DOI 10.1038/npp.2011.36; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Casamassima F, 2010, AM J MED GENET B, V153B, P1373, DOI 10.1002/ajmg.b.31122; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chen DT, 2013, MOL PSYCHIATR, V18, P195, DOI 10.1038/mp.2011.157; Cichon S, 2011, AM J HUM GENET, V88, P396, DOI [10.1016/j.ajhg.2011.01.017, 10.1016/j.ajhg.2011.03.001]; Cichon S, 2009, AM J PSYCHIAT, V166, P540, DOI 10.1176/appi.ajp.2008.08091354; Corvin A, 2010, PSYCHOL MED, V40, P1063, DOI 10.1017/S0033291709991723; Craddock N, 2008, MOL PSYCHIATR, V13, P649, DOI 10.1038/mp.2008.45; Craddock N, 2005, BRIT J PSYCHIAT, V186, P364, DOI 10.1192/bjp.186.5.364; CRADDOCK N, 1994, BRIT J PSYCHIAT, V164, P507, DOI 10.1192/bjp.164.4.507; Craddock N, 1999, J MED GENET, V36, P585, DOI 10.1136/jmg.36.8.585; CRADDOCK N, 1995, AM J HUM GENET, V57, P690; Craddock N, 2010, MOL PSYCHIATR, V15, P146, DOI 10.1038/mp.2008.66; Craddock N, 2007, BRIT J PSYCHIAT, V190, P200, DOI 10.1192/bjp.bp.106.033761; Craddock N, 2010, BRIT J PSYCHIAT, V196, P92, DOI 10.1192/bjp.bp.109.073429; Craddock N, 2009, BRIT J PSYCHIAT, V195, P97, DOI 10.1192/bjp.bp.108.063156; Craddock N, 2009, TRENDS GENET, V25, P99, DOI 10.1016/j.tig.2008.12.002; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Goes FS, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.106; Green EK, 2013, MOL PSYCHIATR, V18, P1302, DOI 10.1038/mp.2012.142; Green EK, 2013, MOL PSYCHIATR, V18, P614, DOI 10.1038/mp.2012.48; Green EK, 2010, MOL PSYCHIATR, V15, P1016, DOI 10.1038/mp.2009.49; Greenwood TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053804; Grozeva D, 2010, ARCH GEN PSYCHIAT, V67, P318, DOI 10.1001/archgenpsychiatry.2010.25; Hamshere ML, 2013, MOL PSYCHIATR, V18, P708, DOI 10.1038/mp.2012.67; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Hyman SE, 2011, SCIENCE, V331, P1026, DOI 10.1126/science.1203544; Kendler KS, 2006, AM J PSYCHIAT, V163, P1138, DOI 10.1176/appi.ajp.163.7.1138; Kieseppa T, 2004, AM J PSYCHIAT, V161, P1814, DOI 10.1176/appi.ajp.161.10.1814; Kraepelin E., 1919, MANIC DEPRESSIVE INS; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Malhotra D, 2011, NEURON, V72, P951, DOI 10.1016/j.neuron.2011.11.007; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; MCGUFFIN P, 1989, BRIT J PSYCHIAT, V155, P294, DOI 10.1192/bjp.155.3.294; McGuffin P, 2003, ARCH GEN PSYCHIAT, V60, P497, DOI 10.1001/archpsyc.60.5.497; McMahon FJ, 2010, NAT GENET, V42, P128, DOI 10.1038/ng.523; Meier S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.81; Miro X, 2012, AM J PSYCHIAT, V169, P982, DOI 10.1176/appi.ajp.2012.11101585; Moskvina V, 2009, MOL PSYCHIATR, V14, P252, DOI 10.1038/mp.2008.133; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Olsen L, 2011, PSYCHIAT GENET, V21, P319, DOI 10.1097/YPG.0b013e3283463deb; Owen MJ, 2011, BRIT J PSYCHIAT, V198, P173, DOI 10.1192/bjp.bp.110.084384; Papolos DF, 1996, AM J PSYCHIAT, V153, P1541; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Perlis RH, 2010, AM J PSYCHIAT, V167, P1499, DOI 10.1176/appi.ajp.2010.10040541; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Scott LJ, 2009, P NATL ACAD SCI USA, V106, P7501, DOI 10.1073/pnas.0813386106; Seifuddin F, 2012, AM J MED GENET B, V159B, P508, DOI 10.1002/ajmg.b.32057; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Smith EN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002134; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Soni S, 2008, PSYCHOL MED, V38, P1; Steinberg S, 2014, MOL PSYCHIATR, V19, P108, DOI 10.1038/mp.2012.157; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Sullivan PF, 2012, ARCH GEN PSYCHIAT, V69, P1099, DOI 10.1001/archgenpsychiatry.2012.730; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Tsuang M, 1990, GENETICS MOOD DISORD; TSUANG MT, 1980, BRIT J PSYCHIAT, V137, P497, DOI 10.1192/bjp.137.6.497; Van Den Bossche MJ, 2012, AM J MED GENET B, V159B, P812, DOI 10.1002/ajmg.b.32088; Van Snellenberg JX, 2009, ARCH GEN PSYCHIAT, V66, P748, DOI 10.1001/archgenpsychiatry.2009.64; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Williams HJ, 2011, HUM MOL GENET, V20, P387, DOI 10.1093/hmg/ddq471; Xiao R, 2009, GENET EPIDEMIOL, V33, P453, DOI 10.1002/gepi.20398; Zhang D, 2009, MOL PSYCHIATR, V14, P376, DOI 10.1038/mp.2008.144	76	355	363	5	149	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 11	2013	381	9878					1654	1662		10.1016/S0140-6736(13)60855-7	http://dx.doi.org/10.1016/S0140-6736(13)60855-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146SX	23663951				2022-12-28	WOS:000319112400033
J	Taljaard, M; Weijer, C; Grimshaw, JM; Eccles, MP				Taljaard, Monica; Weijer, Charles; Grimshaw, Jeremy M.; Eccles, Martin P.		Ottawa Ethics Cluster Randomised T	The Ottawa Statement on the ethical design and conduct of cluster randomised trials: precis for researchers and research ethics committees	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH RESEARCH; INFORMED-CONSENT; ISSUES; SAMPLE		Ottawa Hosp, Clin Epidemiol Program, Ottawa Hosp Res Inst, Ottawa, ON K1Y 4E9, Canada; [Taljaard, Monica] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Weijer, Charles] Univ Western Ontario, Dept Philosophy, Rotman Inst Philosophy, London, ON, Canada; [Weijer, Charles] Univ Western Ontario, Dept Med, London, ON, Canada; [Weijer, Charles] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; [Grimshaw, Jeremy M.] Ottawa Hosp, Ottawa Hosp Res Inst, Clin Epidemiol Program, Ctr Practice Changing Res, Ottawa, ON, Canada; [Grimshaw, Jeremy M.] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Eccles, Martin P.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Newcastle University - UK	Taljaard, M (corresponding author), Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada.	mtaljaard@ohri.ca	Eccles, Martin P/AAD-4029-2020; Zwarenstein, Merrick/P-5210-2014	Eldridge, Sandra/0000-0001-5638-2317; Weijer, Charles/0000-0002-5510-1074; Lohr, Kathleen/0000-0002-3825-0713; Grimshaw, Jeremy/0000-0001-8015-8243; Taljaard, Monica/0000-0002-3978-8961; Zwarenstein, Merrick/0000-0003-0162-7027	Canadian Institutes of Health Research [MOP85066, MOP89790]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research (operating grants MOP85066 and MOP89790). The funding agency had no role in the study design, collection, analysis or interpretation of data, writing of the manuscript, or decision to submit the manuscript for publication. JMG and CW both hold Canada research chairs.	Binik A, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-118; Bland J Martin, 2004, BMC Med Res Methodol, V4, P21, DOI 10.1186/1471-2288-4-21; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Campbell MK, 2000, FAM PRACT, V17, P192, DOI 10.1093/fampra/17.2.192; Chaudhry SH, 2013, CLIN TRIALS, V10, P257, DOI 10.1177/1740774513475530; Donner A, 1996, J CLIN EPIDEMIOL, V49, P435, DOI 10.1016/0895-4356(95)00511-0; Edwards SJL, 1999, BMJ-BRIT MED J, V318, P1407, DOI 10.1136/bmj.318.7195.1407; Eldridge S, 2012, PRACTICAL GUIDE CLUS; Eldridge S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4006; Gallo A, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-116; Hayes RJ, 2009, INTERD STAT, P3; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Hutton JL, 2001, STAT MED, V20, P473, DOI 10.1002/1097-0258(20010215)20:3<473::AID-SIM805>3.0.CO;2-D; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Klar N, 2007, WILEY ENCY CLIN TRIA, DOI [10.1002/9780471462422.eoct050, DOI 10.1002/9780471462422.EOCT050]; LEVINE ROBERT J., 1988, ETHICS REGULATION CL, V2nd; McRae AD, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-1; McRae AD, 2011, TRIALS, V12, DOI [10.1186/1745-6215-12-202, 10.1186/1745-6215-12-183]; Taljaard M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2496; Taljaard M, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-61; Weijer C, 2004, NAT MED, V10, P570, DOI 10.1038/nm0604-570; Weijer C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001346; Weijer C, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-100	23	54	54	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 9	2013	346								f2838	10.1136/bmj.f2838	http://dx.doi.org/10.1136/bmj.f2838			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144BU	23661113	Green Submitted, Bronze			2022-12-28	WOS:000318915200003
J	Roehr, B				Roehr, Bob			Study shows Medicaid coverage has little clinical benefit	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												BobRoehr@aol.com						Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321	1	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 2	2013	346								f2878	10.1136/bmj.f2878	http://dx.doi.org/10.1136/bmj.f2878			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139ET	23641051				2022-12-28	WOS:000318565300010
J	Mendelsohn, BA				Mendelsohn, Bryce A.			What Is Natural?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Mendelsohn, BA (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	mendelsohnb@peds.ucsf.edu							0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2013	309	17					1783	1784		10.1001/jama.2012.205105	http://dx.doi.org/10.1001/jama.2012.205105			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134SU	23632721				2022-12-28	WOS:000318235600025
J	Chen, Y; Dorn, GW				Chen, Yun; Dorn, Gerald W., II			PINK1-Phosphorylated Mitofusin 2 Is a Parkin Receptor for Culling Damaged Mitochondria	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; MECHANISMS; DISEASE	Senescent and damaged mitochondria undergo selective mitophagic elimination through mechanisms requiring two Parkinson's disease factors, the mitochondrial kinase PINK1 (PTEN-induced putative kinase protein 1; PTEN is phosphatase and tensin homolog) and the cytosolic ubiquitin ligase Parkin. The nature of the PINK-Parkin interaction and the identity of key factors directing Parkin to damaged mitochondria are unknown. We show that the mitochondrial outer membrane guanosine triphosphatase mitofusin (Mfn) 2 mediates Parkin recruitment to damaged mitochondria. Parkin bound to Mfn2 in a PINK1-dependent manner; PINK1 phosphorylated Mfn2 and promoted its Parkin-mediated ubiqitination. Ablation of Mfn2 in mouse cardiac myocytes prevented depolarization-induced translocation of Parkin to the mitochondria and suppressed mitophagy. Accumulation of morphologically and functionally abnormal mitochondria induced respiratory dysfunction in Mfn2-deficient mouse embryonic fibroblasts and cardiomyocytes and in Parkin-deficient Drosophila heart tubes, causing dilated cardiomyopathy. Thus, Mfn2 functions as a mitochondrial receptor for Parkin and is required for quality control of cardiac mitochondria.	[Chen, Yun; Dorn, Gerald W., II] Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogen, St Louis, MO 63110 USA	Washington University (WUSTL)	Dorn, GW (corresponding author), Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogen, St Louis, MO 63110 USA.	gdorn@dom.wustl.edu			NIH [R01 HL059888, R21 HL107276]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL107276, R01HL059888] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Y.C. performed experiments and analyzed data. G. W. D. designed the studies, analyzed data, and wrote the manuscript. We thank P. Bhandaria and S. Anwar for assistance with Drosophila studies and Y. Liu, Q. Huang, and Y. Zhang for technical assistance. Supported by NIH grants R01 HL059888 and R21 HL107276.	Baloh RH, 2007, J NEUROSCI, V27, P422, DOI 10.1523/JNEUROSCI.4798-06.2007; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chen Y, 2011, CIRC RES, V109, P1327, DOI 10.1161/CIRCRESAHA.111.258723; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Dutta D, 2012, CIRC RES, V110, P1125, DOI 10.1161/CIRCRESAHA.111.246108; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Karbowski M, 2011, CURR OPIN CELL BIOL, V23, P476, DOI 10.1016/j.ceb.2011.05.007; Lee S, 2012, HUM MOL GENET, V21, P4827, DOI 10.1093/hmg/dds352; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Rakovic A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016746; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zesiewicz TA, 2004, PARKINSONISM RELAT D, V10, P417, DOI 10.1016/j.parkreldis.2004.04.001	16	857	893	8	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					471	475		10.1126/science.1231031	http://dx.doi.org/10.1126/science.1231031			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620051	Green Accepted			2022-12-28	WOS:000318016700040
J	Kim, HK; Hanson, GW; Geller, DA				Kim, Hong Koo; Hanson, George W.; Geller, David A.			Are Gold Clusters in RF Fields Hot or Not?	SCIENCE			English	Editorial Material							NANOPARTICLES		[Kim, Hong Koo] Univ Pittsburgh, Petersen Inst Nanosci & Engn, Dept Elect & Comp Engn, Pittsburgh, PA 15261 USA; [Hanson, George W.] Univ Wisconsin, Dept Elect Engn, Milwaukee, WI 53211 USA; [Geller, David A.] Univ Pittsburgh, Dept Surg, UPMC Liver Canc Ctr, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Wisconsin System; University of Wisconsin Milwaukee; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kim, HK (corresponding author), Univ Pittsburgh, Petersen Inst Nanosci & Engn, Dept Elect & Comp Engn, Pittsburgh, PA 15261 USA.	gellerda@upmc.edu	Hanson, George/T-5018-2019					Cardinal J, 2008, SURGERY, V144, P125, DOI 10.1016/j.surg.2008.03.036; GRIFFITHS H, 1984, BRIT J RADIOL, V57, P254, DOI 10.1259/0007-1285-57-675-254; Hanson GW, 2011, J APPL PHYS, V109, DOI 10.1063/1.3600222; Kruse DE, 2011, IEEE T BIO-MED ENG, V58, P2002, DOI 10.1109/TBME.2011.2124460; Li DX, 2012, IEEE T BIO-MED ENG, V59, P3468, DOI 10.1109/TBME.2012.2219049; Li DX, 2011, J COLLOID INTERF SCI, V358, P47, DOI 10.1016/j.jcis.2011.01.059; Liu XM, 2012, NANOSCALE, V4, P3945, DOI 10.1039/c2nr30166k; Mccoy RS, 2013, ACS NANO, V7, P2610, DOI 10.1021/nn306015c; Moran CH, 2009, NANO RES, V2, P400, DOI [10.1007/S12274-009-9048-1, 10.1007/s12274-009-9048-1]	9	33	33	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					441	442		10.1126/science.1237303	http://dx.doi.org/10.1126/science.1237303			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620043				2022-12-28	WOS:000318016700030
J	Taori, SK; Jameson, LJ; Campbell, A; Drew, PJ; McCarthy, ND; Hart, J; Osborne, JC; Sudhanva, M; Brooks, TJG				Taori, Surabhi K.; Jameson, Lisa J.; Campbell, Andrew; Drew, Peter J.; McCarthy, Noel D.; Hart, Judy; Osborne, Jane C.; Sudhanva, Malur; Brooks, Timothy J. G.			UK hantavirus, renal failure, and pet rats	LANCET			English	Editorial Material									[Taori, Surabhi K.; Osborne, Jane C.; Sudhanva, Malur; Brooks, Timothy J. G.] Hlth Protect Agcy, Rare & Imported Pathogens Dept, Salisbury SP4 0JG, Wilts, England; [Jameson, Lisa J.] Hlth Protect Agcy, Virol & Pathogenesis Microbiol Serv, Salisbury SP4 0JG, Wilts, England; [Campbell, Andrew] Betsi Cadwaladr Univ, Anaesthesia & Crit Care Dept, Hlth Board, N Wales, PA USA; [Drew, Peter J.] Betsi Cadwaladr Univ, Renal Unit, Hlth Board, N Wales, PA USA; [Drew, Peter J.] Betsi Cadwaladr Univ, Wrexham Maelor Hosp, Hlth Board, N Wales, PA USA; [McCarthy, Noel D.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [McCarthy, Noel D.] Hlth Protect Agcy, Valley Hlth Protect Unit, Ctr Radiat Chem & Environm Hazards, Chilton, England; [Hart, Judy] Publ Hlth Wales, Hlth Protect Team, Preswylfa, Flinshire, Wales	Health Protection Agency; Health Protection Agency; University of Oxford; Health Protection Agency	Taori, SK (corresponding author), Hlth Protect Agcy, Rare & Imported Pathogens Dept, Salisbury SP4 0JG, Wilts, England.	surabhi.taori@nhs.net	McCarthy, Noel D/K-3314-2012	McCarthy, Noel/0000-0003-1113-1017; Taori, Surabhi/0000-0002-2976-4106; Jameson, Lisa Jane/0000-0002-6409-3547; Sudhanva, Malur/0000-0001-8415-4469	Department of Health [DRF-2011-04-077] Funding Source: Medline; National Institute for Health Research [DRF-2011-04-077] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Jameson L.J., 2013, EURO SURVEILL, V18, P20344; Kramski M, 2007, CLIN CHEM, V53, P1899, DOI 10.1373/clinchem.2007.093245; Krautkramer E, 2013, KIDNEY INT, V83, P23, DOI 10.1038/ki.2012.360; Reusken C, 2013, CURR OPIN VIROL, V3, P92, DOI 10.1016/j.coviro.2013.01.002	4	16	16	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 23	2013	381	9871					1070	1070		10.1016/S0140-6736(13)60599-1	http://dx.doi.org/10.1016/S0140-6736(13)60599-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117EU	23668557				2022-12-28	WOS:000316936800036
J	Vlaar, APJ; Juffermans, NP				Vlaar, Alexander P. J.; Juffermans, Nicole P.			Transfusion-related acute lung injury: a clinical review	LANCET			English	Review							FRESH-FROZEN PLASMA; RED-BLOOD-CELLS; CLASS-II ANTIBODIES; CRITICALLY-ILL; CIRCULATORY OVERLOAD; CONSENSUS CONFERENCE; ENDOTHELIAL-CELLS; BIOACTIVE LIPIDS; PULMONARY-EDEMA; HLA ANTIBODIES	Three decades ago, transfusion-related acute lung injury (TRALI) was considered a rare complication of transfusion medicine. Nowadays, the US Food and Drug Administration acknowledge the syndrome as the leading cause of transfusion-related mortality. Understanding of the pathogenesis of TRALI has resulted in the design of preventive strategies from a blood-bank perspective. A major breakthrough in efforts to reduce the incidence of TRALI has been to exclude female donors of products with high plasma volume, resulting in a decrease of roughly two-thirds in incidence. However, this strategy has not completely eradicated the complication. In the past few years, research has identified patient-related risk factors for the onset of TRALI, which have empowered physicians to take an individualised approach to patients who need transfusion.	[Vlaar, Alexander P. J.; Juffermans, Nicole P.] Univ Amsterdam, Acad Med Ctr, Dept Intens Care Med, NL-1105 AZ Amsterdam, Netherlands; [Vlaar, Alexander P. J.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands; [Juffermans, Nicole P.] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Vlaar, APJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands.	a.p.vlaar@amc.uva.nl		Vlaar, Alexander/0000-0002-3453-7186				Benson AB, 2010, INTENS CARE MED, V36, P1710, DOI 10.1007/s00134-010-1954-x; BERNARD GR, 1994, AM J RESP CRIT CARE, V149, P818, DOI 10.1164/ajrccm.149.3.7509706; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Bux J, 2007, BRIT J HAEMATOL, V136, P788, DOI 10.1111/j.1365-2141.2007.06492.x; CARLOS TM, 1994, BLOOD, V84, P2068; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; CLARKE G, 1994, BLOOD, V84, pA465; CORWIN HL, 1995, CHEST, V108, P767, DOI 10.1378/chest.108.3.767; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Curtis BR, 2006, CRIT CARE MED, V34, pS118, DOI 10.1097/01.CCM.0000214293.72918.D8; Davis A, 2008, TRANSFUSION, V48, P541, DOI 10.1111/j.1537-2995.2007.01567.x; Eder AF, 2007, TRANSFUSION, V47, P599, DOI 10.1111/j.1537-2995.2007.01102.x; Eder AF, 2010, TRANSFUSION, V50, P1732, DOI 10.1111/j.1537-2995.2010.02652.x; Ellison MA, 2012, CURR PHARM DESIGN, V18, P3255; Engelfriet CP, 2001, VOX SANG, V81, P269, DOI 10.1046/j.0042-9007.2001.00115_1.x; Fadeyi EA, 2007, TRANSFUSION, V47, P545, DOI 10.1111/j.1537-2995.2006.01148.x; Fergusson DA, 2012, JAMA-J AM MED ASSOC, V308, P1443, DOI 10.1001/2012.jama.11953; Flesland O, 2007, Intensive Care Med, V33 Suppl 1, pS17, DOI 10.1007/s00134-007-2875-1; Gajic O, 2006, CRIT CARE MED, V34, pS109, DOI 10.1097/01.CCM.0000214311.56231.23; Gajic O, 2007, AM J RESP CRIT CARE, V176, P886, DOI 10.1164/rccm.200702-271OC; Goldman M, 2005, TRANSFUS MED REV, V19, P2, DOI 10.1016/j.tmrv.2004.10.001; Grundy JE, 1998, J INFECT DIS, V177, P1465, DOI 10.1086/515300; Guichard C, 2005, J BIOL CHEM, V280, P37021, DOI 10.1074/jbc.M506594200; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; HENDERSON RA, 1990, NEW ZEAL MED J, V103, P509; Ho J, 2003, CRIT CARE MED, V31, pS687, DOI 10.1097/01.CCM.0000099349.17094.A3; Holness L, 2004, TRANSFUS MED REV, V18, P184, DOI 10.1016/j.tmrv.2004.03.004; Jones HP, 1998, TRANSFUSION MED, V8, P37; Kakaiya RM, 2010, TRANSFUSION, V50, P1328, DOI 10.1111/j.1537-2995.2009.02556.x; Kelher MR, 2009, BLOOD, V113, P2079, DOI 10.1182/blood-2008-09-177857; Khan SY, 2006, BLOOD, V108, P2455, DOI 10.1182/blood-2006-04-017251; Kian H, 2007, CHEST, V131, P1308, DOI 10.1378/chest.06-3048; Kleinman S, 2004, TRANSFUSION, V44, P1774, DOI 10.1111/j.0041-1132.2004.04347.x; Kleinman S, 2006, TRANSFUSION, V46, P1465, DOI 10.1111/j.1537-2995.2006.00956.x; Kopko PM, 2002, JAMA-J AM MED ASSOC, V287, P1968, DOI 10.1001/jama.287.15.1968; Kopko PM, 2001, TRANSFUSION, V41, P1244, DOI 10.1046/j.1537-2995.2001.41101244.x; Leger R, 1999, ANESTHESIOLOGY, V91, P1529, DOI 10.1097/00000542-199911000-00048; Li GX, 2009, TRANSFUSION, V49, P13, DOI 10.1111/j.1537-2995.2008.01941.x; Lin YL, 2012, TRANSFUSION, V52, P567, DOI 10.1111/j.1537-2995.2011.03330.x; Looney MR, 2006, J CLIN INVEST, V116, P1615, DOI 10.1172/JCI27238; Looney MR, 2009, J CLIN INVEST, V119, P3450, DOI 10.1172/JCI38432; Luk C, 2002, CAN MED ASSOC J, V166, P1539; Mangalmurti NS, 2009, BLOOD, V113, P1158, DOI 10.1182/blood-2008-07-166264; Marik PE, 2008, CRIT CARE MED, V36, P3080, DOI 10.1097/CCM.0b013e31818c3801; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; Maslanka K, 2012, ARCH IMMUNOL THER EX, V60, P55, DOI 10.1007/s00005-011-0154-x; Middelburg RA, 2011, VOX SANG, V100, P327, DOI 10.1111/j.1423-0410.2010.01420.x; Middelburg RA, 2012, TRANSFUSION, V52, P658, DOI 10.1111/j.1537-2995.2011.03352.x; Moore SB, 2006, CRIT CARE MED, V34, pS114, DOI 10.1097/01.CCM.0000214312.20718.3E; Moylan S, 2008, INTERN MED J, V38, P686, DOI 10.1111/j.1445-5994.2008.01730.x; Nakazawa H, 2009, TRANSFUSION, V49, P2434, DOI 10.1111/j.1537-2995.2009.02321.x; Napolitano LM, 2004, CRIT CARE CLIN, V20, P255, DOI 10.1016/j.ccc.2003.12.002; Neisser-Svae A, 2009, VOX SANG, V97, P226, DOI 10.1111/j.1423-0410.2009.01206.x; Nicolle AL, 2004, TRANSFUSION MED, V14, P225, DOI 10.1111/j.0958-7578.2004.00504.x; Palfi M, 2001, TRANSFUSION, V41, P317, DOI 10.1046/j.1537-2995.2001.41030317.x; Partrick DA, 1999, J SURG RES, V86, P42, DOI 10.1006/jsre.1999.5702; POPOVSKY MA, 1983, AM REV RESPIR DIS, V128, P185, DOI 10.1164/arrd.1983.128.1.185; POPOVSKY MA, 1985, TRANSFUSION, V25, P573, DOI 10.1046/j.1537-2995.1985.25686071434.x; Popovsky MA, 2001, TRANSFUS CLIN BIOL, V8, P272, DOI 10.1016/S1246-7820(01)00111-2; Rana R, 2006, TRANSFUSION, V46, P1478, DOI 10.1111/j.1537-2995.2006.00930.x; Rollins MD, 2012, CRIT CARE MED, V40, P2488, DOI 10.1097/CCM.0b013e3182544f85; Sachs UJH, 2005, TRANSFUSION, V45, P1628, DOI 10.1111/j.1537-2995.2005.00587.x; Sachs UJH, 2011, BLOOD, V117, P669, DOI 10.1182/blood-2010-05-286146; Serious Hazards of Transfusion (SHOT), 2006, SERIOUS HAZARDDS TRA; Silliman CC, 1998, J CLIN INVEST, V101, P1458, DOI 10.1172/JCI1841; Silliman CC, 2006, CRIT CARE MED, V34, pS124, DOI 10.1097/01.CCM.0000214292.62276.8E; Silliman CC, 2003, BLOOD, V101, P454, DOI 10.1182/blood-2002-03-0958; Silliman CC, 2003, TRANSFUSION, V43, P633, DOI 10.1046/j.1537-2995.2003.00385.x; Stainsby D, 2006, TRANSFUS MED REV, V20, P273, DOI 10.1016/j.tmrv.2006.05.002; Thomas GM, 2012, BLOOD, V119, P6335, DOI 10.1182/blood-2012-01-405183; Toy P, 2005, CRIT CARE MED, V33, P721, DOI 10.1097/01.CCM.0000159849.94750.51; Toy P, 2004, TRANSFUSION, V44, P1683, DOI 10.1111/j.0041-1132.2004.04193.x; Toy P, 2012, BLOOD, V119, P1757, DOI 10.1182/blood-2011-08-370932; Triulzi DJ, 2009, TRANSFUSION, V49, P1825, DOI 10.1111/j.1537-2995.2009.02206.x; VANBUREN NL, 1990, TRANSFUSION, V30, P42; Vincent JL, 2006, CRIT CARE MED, V34, pS96, DOI 10.1097/01.CCM.0000214314.57109.CD; Vlaar AP, 2009, NETH J MED, V67, P320; Vlaar APJ, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/720950; Vlaar APJ, 2010, INTENS CARE MED, V36, P879, DOI 10.1007/s00134-010-1802-z; Vlaar AP, 2010, TRANSFUSION, V50, P443, DOI 10.1111/j.1537-2995.2009.02415.x; Vlaar APJ, 2012, CRIT CARE MED, V40, P2813, DOI 10.1097/CCM.0b013e31825b8e20; Vlaar APJ, 2011, TRANSFUSION, V51, P2358, DOI 10.1111/j.1537-2995.2011.03177.x; Vlaar APJ, 2011, BLOOD, V117, P4218, DOI 10.1182/blood-2010-10-313973; Vlaar APJ, 2010, MED SCI MONITOR, V16, pCS129; Vlaar APJ, 2010, BLOOD, V116, P1360, DOI 10.1182/blood-2009-10-248732; Vlaar APJ, 2010, ANESTHESIOLOGY, V113, P92, DOI 10.1097/ALN.0b013e3181de6f25; Vlaar APJ, 2010, CRIT CARE MED, V38, P771, DOI 10.1097/CCM.0b013e3181cc4d4b; Vlaar APJ, 2008, CRIT CARE MED, V36, P3283, DOI 10.1097/CCM.0b013e31818f2f37; Wallis JP, 2004, TRANSFUSION, V44, P1674, DOI 10.1111/j.0041-1132.2004.00427.x; Wallis JP, 2003, TRANSFUSION, V43, P1053, DOI 10.1046/j.1537-2995.2003.00466.x; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; Wiersum-Osselton J C, 2008, Ned Tijdschr Geneeskd, V152, P1784; Wiersum-Osselton JC, 2011, TRANSFUSION, V51, P1278, DOI 10.1111/j.1537-2995.2010.02969.x; Win N, 2008, TRANSFUSION MED, V18, P276, DOI 10.1111/j.1365-3148.2008.00885.x; Wright SE, 2008, CRIT CARE MED, V36, P1796, DOI 10.1097/CCM.0b013e3181743c6e; Yilmaz M, 2007, CRIT CARE MED, V35, P1660, DOI 10.1097/01.CCM.0000269037.66955.F0; YOMTOVIAN R, 1984, LANCET, V1, P244; Zeerleder S, 2003, CLIN DIAGN LAB IMMUN, V10, P529, DOI 10.1128/CDLI.10.4.529-535.2003; Zhu HM, 2011, CRIT CARE MED, V39, P2478, DOI 10.1097/CCM.0b013e318225754f; ZIMMERMAN GA, 1982, AM J MED, V73, P25, DOI 10.1016/0002-9343(82)90920-2	100	222	228	0	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 14	2013	382	9896					984	994		10.1016/S0140-6736(12)62197-7	http://dx.doi.org/10.1016/S0140-6736(12)62197-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	215VD	23642914				2022-12-28	WOS:000324238000031
J	Grassi, G; Grassi, M				Grassi, Gabriele; Grassi, Mario			First-in-human trial of Dz13 for nodular basal-cell carcinoma	LANCET			English	Editorial Material							DNA ENZYME; C-JUN		[Grassi, Gabriele] Univ Trieste, Dept Life Sci, I-34149 Trieste, Italy; [Grassi, Mario] Univ Trieste, Dept Ind Engn & Informat Technol, I-34149 Trieste, Italy; [Grassi, Gabriele] Univ Hosp Cattinara, Dept Med Surg & Hlth Sci, Trieste, Italy	University of Trieste; University of Trieste; University of Trieste	Grassi, G (corresponding author), Univ Trieste, Dept Life Sci, I-34149 Trieste, Italy.	ggrassi@units.it	Grassi, Mario/GRS-8130-2022	Grassi, Mario/0000-0002-3532-3200; GRASSI, GABRIELE/0000-0001-9704-6651				Achenbach JC, 2004, CURR PHARM BIOTECHNO, V5, P321, DOI 10.2174/1389201043376751; Cai H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003960; Cairns MJ, 1999, NAT BIOTECHNOL, V17, P480, DOI 10.1038/8658; Cho E-A, 2013, LANCET; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; Fahmy RG, 2006, NAT BIOTECHNOL, V24, P856, DOI 10.1038/nbt1225; Grassi M, 2010, CURR SIGNAL TRANSD T, V5, P92, DOI 10.2174/157436210791112163; Grassi M., 2006, UNDERSTANDING DRUG R; Jin JY, 2011, J INVEST DERMATOL, V131, P1149, DOI 10.1038/jid.2011.1; Luo X, 2009, ARTERIOSCL THROM VAS, V29, P1836, DOI 10.1161/ATVBAHA.109.189753; Phillips MA, 2010, NANO TODAY, V5, P143, DOI 10.1016/j.nantod.2010.03.003; Santiago FS, 1999, NAT MED, V5, P1264, DOI 10.1038/15215; Santoro SW, 1997, P NATL ACAD SCI USA, V94, P4262, DOI 10.1073/pnas.94.9.4262; Zhang L, 2002, CANCER RES, V62, P5463	14	5	7	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 25	2013	381	9880					1797	1798		10.1016/S0140-6736(13)60633-9	http://dx.doi.org/10.1016/S0140-6736(13)60633-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151EO	23660122				2022-12-28	WOS:000319443700007
J	Regev-Rudzki, N; Wilson, DW; Carvalho, TG; Sisquella, X; Coleman, BM; Rug, M; Bursac, D; Angrisano, F; Gee, M; Hill, AF; Baum, J; Cowman, AF				Regev-Rudzki, Neta; Wilson, Danny W.; Carvalho, Teresa G.; Sisquella, Xavier; Coleman, Bradley M.; Rug, Melanie; Bursac, Dejan; Angrisano, Fiona; Gee, Michelle; Hill, Andrew F.; Baum, Jake; Cowman, Alan F.			Cell-Cell Communication between Malaria-Infected Red Blood Cells via Exosome-like Vesicles	CELL			English	Article							PLASMODIUM-FALCIPARUM; MICROPARTICLES; MEMBRANE; PROTEINS; NANOTUBES; MECHANISM; BINDING; DIFFERENTIATION; PFEMP1; GENE	Cell-cell communication is an important mechanism for information exchange promoting cell survival for the control of features such as population density and differentiation. We determined that Plasmodium falciparum-infected red blood cells directly communicate between parasites within a population using exosome-like vesicles that are capable of delivering genes. Importantly, communication via exosome-like vesicles promotes differentiation to sexual forms at a rate that suggests that signaling is involved. Furthermore, we have identified a P. falciparum protein, PfPTP2, that plays a key role in efficient communication. This study reveals a previously unidentified pathway of P. falciparum biology critical for survival in the host and transmission to mosquitoes. This identifies a pathway for the development of agents to block parasite transmission from the human host to the mosquito.	[Regev-Rudzki, Neta; Wilson, Danny W.; Carvalho, Teresa G.; Sisquella, Xavier; Rug, Melanie; Bursac, Dejan; Angrisano, Fiona; Baum, Jake; Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Div Infect & Immun, Parkville, Vic 3052, Australia; [Regev-Rudzki, Neta; Wilson, Danny W.; Carvalho, Teresa G.; Sisquella, Xavier; Rug, Melanie; Bursac, Dejan; Angrisano, Fiona; Baum, Jake; Cowman, Alan F.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Coleman, Bradley M.; Hill, Andrew F.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Coleman, Bradley M.; Hill, Andrew F.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Gee, Michelle] Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne	Cowman, AF (corresponding author), Walter & Eliza Hall Inst Med Res, Div Infect & Immun, Parkville, Vic 3052, Australia.	cowman@wehi.edu.au	Hill, Andrew F./AAH-2854-2020; Hill, Andrew F/B-4527-2009; Carvalho, Teresa/P-4333-2019; Wilson, Danny W/E-6186-2019; Hill, Andrew F./GZL-4124-2022; Rug, Melanie/B-5417-2015	Hill, Andrew F/0000-0001-5581-2354; Carvalho, Teresa/0000-0002-4947-371X; Wilson, Danny W/0000-0002-5073-1405; Hill, Andrew F./0000-0001-5581-2354; Angrisano, Fiona/0000-0002-0457-5982; Baum, Jake/0000-0002-0275-352X	National Health and Medical Research Council (NHMRC) of Australia	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	We thank the Red Cross Blood Service for erythrocytes and M. O'Neill, A. Maier, D. Dorin-Semblat, and C. Doerig for transgenic lines. We thank F. Fowkes for statistical advice and N. Dahan, M. Duffy, and J. Thompson for their advice in carrying out various assays. We thank the Advanced Microscopy Facility, Bio21 Molecular Science and Biotechnology Institute, and the Melbourne Materials Institute (MMI) for microscopy equipment. 3D-SIM was performed at the Biological Optical Microscopy Platform, University of Melbourne (http://www.microscopy.unimelb.edu.au/bomp.html). This work was supported by National Health and Medical Research Council (NHMRC) of Australia and Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. N.R.-R. is supported by a Rothschild Fellowship and the Hebrew University of Jerusalem. D.W. and N.R.-R. are supported by Early Career Fellowships from NHMRC. A.F.H. is an ARC Future Fellow and honorary NHMRC Senior Research Fellow. A.F.C. is a Howard Hughes International Scholar.	Alano P, 2007, MOL MICROBIOL, V66, P291, DOI 10.1111/j.1365-2958.2007.05904.x; Anderluh G, 1996, BIOCHEM BIOPH RES CO, V220, P437, DOI 10.1006/bbrc.1996.0391; Ataide R., 2010, PLOS ONE, V5; Bang C, 2012, INT J BIOCHEM CELL B, V44, P2060, DOI 10.1016/j.biocel.2012.08.007; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Belting M, 2008, J CELL BIOL, V183, P1187, DOI 10.1083/jcb.200810038; Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728; Campos FMF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-327; Coleman BM, 2012, FASEB J, V26, P4160, DOI 10.1096/fj.11-202077; Combes V, 2005, AM J PATHOL, V166, P295, DOI 10.1016/S0002-9440(10)62253-5; Couper KN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000744; Delabranche X, 2012, MED MALADIES INFECT, V42, P335, DOI 10.1016/j.medmal.2012.05.011; DIECKMANN A, 1986, PARASITOLOGY, V93, P275, DOI 10.1017/S0031182000051441; DIECKMANNSCHUPPERT A, 1989, CELL BIOL INT REP, V13, P207, DOI 10.1016/0309-1651(89)90067-2; Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Gerdes HH, 2008, CURR OPIN CELL BIOL, V20, P470, DOI 10.1016/j.ceb.2008.03.005; GUPTA SK, 1985, J PROTOZOOL, V32, P91, DOI 10.1111/j.1550-7408.1985.tb03020.x; Hanssen E, 2010, INT J PARASITOL, V40, P1127, DOI 10.1016/j.ijpara.2010.04.012; Jackson KE, 2007, BIOCHEM J, V403, P167, DOI 10.1042/BJ20061725; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Kriek N, 2003, MOL MICROBIOL, V50, P1215, DOI 10.1046/j.1365-2958.2003.03784.x; Kulzer S, 2010, CELL MICROBIOL, V12, P1398, DOI 10.1111/j.1462-5822.2010.01477.x; Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10; Lopez MA, 2011, CURR OPIN MICROBIOL, V14, P642, DOI 10.1016/j.mib.2011.09.012; MacGregor P, 2011, CELL HOST MICROBE, V9, P310, DOI 10.1016/j.chom.2011.03.013; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2007, BLOOD, V109, P1289, DOI 10.1182/blood-2006-08-043364; Mantel PY, 2013, CELL HOST MICROBE, V13, P521, DOI 10.1016/j.chom.2013.04.009; Marzo L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00072; Nantakomol D, 2011, J INFECT DIS, V203, P700, DOI 10.1093/infdis/jiq104; Papakrivos J, 2005, MOL MICROBIOL, V55, P1272, DOI 10.1111/j.1365-2958.2004.04468.x; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Reuner B, 1997, MOL BIOCHEM PARASIT, V90, P269, DOI 10.1016/S0166-6851(97)00160-6; Rupp I, 2011, CELL RES, V21, P683, DOI 10.1038/cr.2010.176; Shaw MK, 2000, J CELL SCI, V113, P1241; Sustar V, 2009, BLOOD CELL MOL DIS, V42, P223, DOI 10.1016/j.bcmd.2009.01.012; Vassella E, 1997, J CELL SCI, V110, P2661; Volz J, 2010, INT J PARASITOL, V40, P109, DOI 10.1016/j.ijpara.2009.09.002; Volz JC, 2012, CELL HOST MICROBE, V11, P7, DOI 10.1016/j.chom.2011.11.011; Wilson DW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-152	42	358	372	2	139	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 23	2013	153	5					1120	1133		10.1016/j.cell.2013.04.029	http://dx.doi.org/10.1016/j.cell.2013.04.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23683579	Green Submitted, Bronze			2022-12-28	WOS:000319456800018
J	Znamenskiy, P; Zador, AM				Znamenskiy, Petr; Zador, Anthony M.			Corticostriatal neurons in auditory cortex drive decisions during auditory discrimination	NATURE			English	Article							SUPERIOR COLLICULUS; BASAL GANGLIA; SUBSTANTIA NIGRA; OVERLYING AREAS; ALBINO-RAT; IN-VIVO; STRIATUM; MICROSTIMULATION; ORGANIZATION; PERFORMANCE	The neural pathways by which information about the acoustic world reaches the auditory cortex are well characterized, but how auditory representations are transformed into motor commands is not known. Here we use a perceptual decision-making task in rats to study this transformation. We demonstrate the role of corticostriatal projection neurons in auditory decisions by manipulating the activity of these neurons in rats performing an auditory frequency-discriminationtask. Targeted channelrhodopsin-2(ChR2)(1,2)-mediated stimulation of corticostriatal neurons during the task biased decisions in the direction predicted by the frequency tuning of the stimulated neurons, whereas archaerhodopsin-3 (Arch)(3)-mediated inactivation biased decisions in the opposite direction. Striatal projections are widespread in cortex and may provide a general mechanism for the control of motor decisions by sensory cortex.	[Znamenskiy, Petr] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Znamenskiy, Petr; Zador, Anthony M.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory	Zador, AM (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	zador@cshl.edu		Zador, Anthony/0000-0002-8431-9136; Znamenskiy, Petr/0000-0002-4658-6807	Swartz Foundation; National Institutes of Health [25041001, 55120101]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012565, R01DC005415] Funding Source: NIH RePORTER	Swartz Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank B. Burbach for technical assistance, A. Reid for generating the AAV-FLEX-Arch-GFP construct and members of the Kepecs laboratory (CSHL) for the tetrode and fibre drive design. We thank K. Britten for comments and suggestions on the manuscript. AAV-CAGGS-ChR2-Venus plasmid was provided by K. Svoboda. AAV-CAGGS-FLEX-ChR2-tdTomato virus was a gift from A. Kepecs. AAV-CAG-Arch-GFP plasmid was provided by E. Boyden. AAV-EF1a-FLEX-ChR2-YFP was provided by K. Deisseroth. HSV-iCre-2A-Venus and HSV-mCherry-IRES-iCre constructs were provided by A. Luthi and packaged by BioVex. This work was supported by grants from the Swartz Foundation and the National Institutes of Health (grant numbers 25041001 and 55120101).	Allen Brain Institute, 2012, ALL MOUS CONN ATL; BECKSTEAD RM, 1979, BRAIN RES, V175, P191, DOI 10.1016/0006-8993(79)91001-1; BORDI F, 1993, BEHAV NEUROSCI, V107, P757, DOI 10.1037/0735-7044.107.5.757; BORDI F, 1992, J NEUROSCI, V12, P2493; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Ding L, 2010, J NEUROSCI, V30, P15747, DOI 10.1523/JNEUROSCI.2894-10.2010; Felsen G, 2008, NEURON, V60, P137, DOI 10.1016/j.neuron.2008.09.019; HOPKINS DA, 1976, NEUROSCI LETT, V2, P253, DOI 10.1016/0304-3940(76)90156-7; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Jiang H, 2011, J PHYSIOL-LONDON, V589, P5785, DOI 10.1113/jphysiol.2011.213553; KELLY JB, 1977, J COMP PHYSIOL PSYCH, V91, P930, DOI 10.1037/h0077356; Kimchi EY, 2009, J NEUROSCI, V29, P3148, DOI 10.1523/JNEUROSCI.5206-08.2009; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Lilley CE, 2001, J VIROL, V75, P4343, DOI 10.1128/JVI.75.9.4343-4356.2001; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; MCGEORGE AJ, 1989, NEUROSCIENCE, V29, P503, DOI 10.1016/0306-4522(89)90128-0; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; REALE RA, 1983, NEUROSCIENCE, V8, P67, DOI 10.1016/0306-4522(83)90026-X; Reiner A, 2003, J COMP NEUROL, V457, P420, DOI 10.1002/cne.10541; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; SALLY SL, 1988, J NEUROPHYSIOL, V59, P1627, DOI 10.1152/jn.1988.59.5.1627; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142	29	204	207	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					482	+		10.1038/nature12077	http://dx.doi.org/10.1038/nature12077			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23636333	Green Accepted			2022-12-28	WOS:000319254000046
J	Shah, S; Cotliar, J				Shah, Sonal; Cotliar, Jonathan			Pyostomatitis Vegetans	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Shah, Sonal] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Cotliar, Jonathan] Northwestern Univ, Chicago, IL 60611 USA	University of California System; University of California San Francisco; Northwestern University	Shah, S (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	shahs@derm.ucsf.edu	Shah, Sonal/AAX-9247-2021						0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2013	368	20					1918	1918		10.1056/NEJMicm1211738	http://dx.doi.org/10.1056/NEJMicm1211738			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143VK	23675660				2022-12-28	WOS:000318896200011
J	Gerada, C				Gerada, Clare			PERSONAL VIEW India must raise the status of primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Royal Coll Gen Practitioners, London, England		Gerada, C (corresponding author), Royal Coll Gen Practitioners, London, England.		Gerada, Clare/O-8264-2019					Dutta N, 2012, WHAT AILS INDIAS HEA; Gaikwad V, 2012, INT J BIOL MED RES, V3, P1577; Kumar Raman, 2012, J Family Med Prim Care, V1, P10, DOI 10.4103/2249-4863.94442; Royal College of General Practitioners, 2012, RCGP MED GEN WHY EXP; Sinha K, 2012, TIMES INDIA     0512; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x	6	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2013	346								f2986	10.1136/bmj.f2986	http://dx.doi.org/10.1136/bmj.f2986			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148OF	23674335				2022-12-28	WOS:000319253900010
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA Antibiotics for back pain: hope or hype?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BONE EDEMA					margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Albert HB, 2008, BRIT J SPORT MED, V42, P969, DOI 10.1136/bjsm.2008.050369; Albert HB, 2013, EUR SPINE J, V22, P697, DOI 10.1007/s00586-013-2675-y; [Anonymous], 2013, SKY NEWS        0508; [Anonymous], 2013, DAILY MAIL; [Anonymous], 2013, GUARDIAN; Barton A., 2013, GLOBE MAIL; ClinicalTrials.gov, ANT TREATM PAT LOW B; Jensen RK, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-183; Laurance J., 2013, INDEPENDENT; O'Connell N, 2013, BODY MIND       0322; Stirling A, 2001, LANCET, V357, P2024, DOI 10.1016/S0140-6736(00)05109-6; Wedderkopp N, 2009, ACTA RADIOL, V50, P65, DOI 10.1080/02841850802524485	12	5	6	2	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2013	346								f3122	10.1136/bmj.f3122	http://dx.doi.org/10.1136/bmj.f3122			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148OF	23674340				2022-12-28	WOS:000319253900015
J	Jangi, S				Jangi, Sushrut			STEM CELL THERAPY Problems of creating bone marrow donor registries in emerging economies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Jangi, S (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.	sjangi@bidmc.harvard.edu						Kirby T, 2012, LANCET, V379, P2138, DOI 10.1016/S0140-6736(12)60929-5; Switzer GE, 2013, BLOOD, V121, P1469, DOI 10.1182/blood-2012-06-437343; The Economist, 2012, ECONOMIST	3	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2013	346								f2976	10.1136/bmj.f2976	http://dx.doi.org/10.1136/bmj.f2976			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	144BV	23667072				2022-12-28	WOS:000318915300004
J	Laine, CM; Joeng, KS; Campeau, PM; Kiviranta, R; Tarkkonen, K; Grover, M; Lu, JT; Pekkinen, M; Wessman, M; Heino, TJ; Nieminen-Pihala, V; Aronen, M; Laine, T; Kroger, H; Cole, WG; Lehesjoki, AE; Nevarez, L; Krakow, D; Curry, CJR; Cohn, DH; Gibbs, RA; Lee, BH; Makitie, O				Laine, Christine M.; Joeng, Kyu Sang; Campeau, Philippe M.; Kiviranta, Riku; Tarkkonen, Kati; Grover, Monica; Lu, James T.; Pekkinen, Minna; Wessman, Maija; Heino, Terhi J.; Nieminen-Pihala, Vappu; Aronen, Mira; Laine, Tero; Kroger, Heikki; Cole, William G.; Lehesjoki, Anna-Elina; Nevarez, Lisette; Krakow, Deborah; Curry, Cynthia J. R.; Cohn, Daniel H.; Gibbs, Richard A.; Lee, Brendan H.; Makitie, Outi			WNT1 Mutations in Early-Onset Osteoporosis and Osteogenesis Imperfecta	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISEASE; DIFFERENTIATION; OSTEOBLASTS; PROTEIN; MOUSE; CELLS; FORM	This report identifies human skeletal diseases associated with mutations in WNT1. In 10 family members with dominantly inherited, early-onset osteoporosis, we identified a heterozygous missense mutation in WNT1, c.652T -> G (p.Cys218Gly). In a separate family with 2 siblings affected by recessive osteogenesis imperfecta, we identified a homozygous nonsense mutation, c.884C -> A, p.Ser295(star). In vitro, aberrant forms of the WNT1 protein showed impaired capacity to induce canonical WNT signaling, their target genes, and mineralization. In mice, Wnt1 was clearly expressed in bone marrow, especially in B-cell lineage and hematopoietic progenitors; lineage tracing identified the expression of the gene in a subset of osteocytes, suggesting the presence of altered cross-talk in WNT signaling between the hematopoietic and osteoblastic lineage cells in these diseases.	[Laine, Christine M.; Pekkinen, Minna; Wessman, Maija; Aronen, Mira; Lehesjoki, Anna-Elina; Makitie, Outi] Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland; [Wessman, Maija] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Lehesjoki, Anna-Elina] Univ Helsinki, Haartman Inst, Dept Med Genet, Helsinki, Finland; [Lehesjoki, Anna-Elina] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Lehesjoki, Anna-Elina] Univ Helsinki, Ctr Neurosci, Helsinki, Finland; [Makitie, Outi] Univ Helsinki, Dept Pediat, Helsinki, Finland; [Makitie, Outi] Univ Helsinki, Childrens Hosp, Cent Hosp, Helsinki, Finland; Univ Turku, Dept Med Biochem & Genet, Turku, Finland; [Kiviranta, Riku; Tarkkonen, Kati; Nieminen-Pihala, Vappu] Univ Turku, Dept Med, Turku, Finland; [Heino, Terhi J.] Univ Turku, Dept Cell Biol & Anat, Turku, Finland; [Kiviranta, Riku] Turku Univ Hosp, Dept Med, FIN-20520 Turku, Finland; [Kroger, Heikki] Univ Eastern Finland, Bone & Cartilage Res Unit, Kuopio, Finland; [Kroger, Heikki] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Laine, Christine M.] Sahlgrens Univ Hosp, Dept Endocrinol, Inst Med, Gothenburg, Sweden; [Laine, Tero] Sahlgrens Univ Hosp, Dept Orthoped, Inst Clin Sci, Gothenburg, Sweden; Univ Gothenburg, Gothenburg, Sweden; [Joeng, Kyu Sang; Campeau, Philippe M.; Grover, Monica; Gibbs, Richard A.; Lee, Brendan H.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX USA; [Lu, James T.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX USA; [Lu, James T.] Baylor Coll Med, Dept Struct & Computat Biol & Mol Biophys, Houston, TX USA; [Lee, Brendan H.] Howard Hughes Med Inst, Houston, TX 77030 USA; [Cole, William G.] Univ Alberta, Div Pediat Surg, Edmonton, AB, Canada; [Nevarez, Lisette; Cohn, Daniel H.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Krakow, Deborah; Cohn, Daniel H.] Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA USA; [Krakow, Deborah] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Curry, Cynthia J. R.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Curry, Cynthia J. R.] Genet Med Cent Calif, Fresno, CA USA	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Turku; University of Turku; University of Turku; University of Turku; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Sahlgrenska University Hospital; Sahlgrenska University Hospital; University of Gothenburg; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Alberta; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Francisco	Lee, BH (corresponding author), 1 Baylor Plaza,Rm R814, Houston, TX 77030 USA.	blee@bcm.edu	Krakow, Deborah/B-5778-2009; Campeau, Philippe/J-8614-2015	Krakow, Deborah/0000-0001-9906-4968; Campeau, Philippe/0000-0001-9713-7107; /0000-0002-7184-1945; Heino, Terhi/0000-0003-2274-6834; Makitie, Outi/0000-0002-4547-001X	Folkhalsan Research Foundation; Sigrid Juselius Foundation; Foundation for Pediatric Research; Waldemar von Frenckell Foundation; Helsinki University Research Funds; Rolanette and Berdon Lawrence Bone Disease Program of Texas; O'Malley Foundation; Academy of Finland [139165, 132894, 250780]; National Institutes of Health [R01 AR062651, R01 DE019567, PO1 HD22657, PO1 HD070394]; Baylor College of Medicine Intellectual and Developmental Disabilities Research Center [HD024064]; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Helsinki and European Calcified Tissue Society Career Establishment Award; Canadian Institutes of Health Research Clinician Scientist Training Award; National Research Service Award [F32 AR063616]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064, P01HD070394] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062651, F32AR063616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019567] Funding Source: NIH RePORTER	Folkhalsan Research Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Foundation for Pediatric Research; Waldemar von Frenckell Foundation; Helsinki University Research Funds; Rolanette and Berdon Lawrence Bone Disease Program of Texas; O'Malley Foundation; Academy of Finland(Academy of Finland); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor College of Medicine Intellectual and Developmental Disabilities Research Center; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Helsinki and European Calcified Tissue Society Career Establishment Award; Canadian Institutes of Health Research Clinician Scientist Training Award(Canadian Institutes of Health Research (CIHR)); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Supported by grants from the Folkhalsan Research Foundation (to Drs. Laine, Makitie, Wessman, and Lehesjoki), the Sigrid Juselius Foundation (to Drs. Kiviranta and Makitie), the Foundation for Pediatric Research (to Dr. Makitie), the Waldemar von Frenckell Foundation (to Dr. Laine), the Helsinki University Research Funds (to Dr. Makitie), the Rolanette and Berdon Lawrence Bone Disease Program of Texas (to Dr. Lee), the O'Malley Foundation (to Dr. Campeau), the Academy of Finland (139165, to Dr. Kiviranta; and 132894 and 250780, to Dr. Makitie), the National Institutes of Health (R01 AR062651, to Dr. Cohn; R01 DE019567, to Drs. Cohn and Krakow; and PO1 HD22657 and PO1 HD070394, to Drs. Lee, Krakow, and Cohn), and the Baylor College of Medicine Intellectual and Developmental Disabilities Research Center (HD024064, funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development); and by a Helsinki and European Calcified Tissue Society Career Establishment Award (to Dr. Kiviranta), a Canadian Institutes of Health Research Clinician Scientist Training Award (to Dr. Campeau), and a National Research Service Award (F32 AR063616, to Dr. Joeng).	Albers J, 2011, J CELL BIOL, V192, P1057, DOI 10.1083/jcb.201008012; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; BRADLEY RS, 1995, MOL CELL BIOL, V15, P4616; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Byers PH, 2012, ANNU REV GENET, V46, P475, DOI 10.1146/annurev-genet-110711-155608; Campeau PM, 2012, AM J HUM GENET, V90, P282, DOI 10.1016/j.ajhg.2011.11.023; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Haver S, 2008, J BONE MINER RES, V23, P1650, DOI [10.1359/JBMR.080508, 10.1359/jbmr.080508]; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Ichii M, 2012, BLOOD, V119, P1683, DOI 10.1182/blood-2011-07-369199; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Monroe DG, 2012, GENE, V492, P1, DOI 10.1016/j.gene.2011.10.044; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Richards JB, 2012, NAT REV GENET, V13, P576, DOI 10.1038/nrg3228; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; van den Bergh JP, 2012, NAT REV RHEUMATOL, V8, P163, DOI 10.1038/nrrheum.2011.217; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9	22	238	253	2	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2013	368	19					1809	1816		10.1056/NEJMoa1215458	http://dx.doi.org/10.1056/NEJMoa1215458			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138WA	23656646	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000318540000009
J	Wang, HY; Yang, H; Shivalila, CS; Dawlaty, MM; Cheng, AW; Zhang, F; Jaenisch, R				Wang, Haoyi; Yang, Hui; Shivalila, Chikdu S.; Dawlaty, Meelad M.; Cheng, Albert W.; Zhang, Feng; Jaenisch, Rudolf			One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering	CELL			English	Article							ZINC-FINGER NUCLEASES; EMBRYO MICROINJECTION; POSTNATAL-DEVELOPMENT; KNOCKOUT RATS; BACTERIA; SYSTEMS; CELLS; CAS9; TET2; ENDONUCLEASE	Mice carrying mutations in multiple genes are traditionally generated by sequential recombination in embryonic stem cells and/or time-consuming inter-crossing of mice with a single mutation. The CRISPR/Cas system has been adapted as an efficient gene-targeting technology with the potential for multiplexed genome editing. We demonstrate that CRISPR/Cas-mediated gene editing allows the simultaneous disruption of five genes (Tet1, 2, 3, Sry, Uty - 8 alleles) in mouse embryonic stem (ES) cells with high efficiency. Coinjection of Cas9 mRNA and single-guide RNAs (sgRNAs) targeting Tet1 and Tet2 into zygotes generated mice with biallelic mutations in both genes with an efficiency of 80%. Finally, we show that coinjection of Cas9 mRNA/sgRNAs with mutant oligos generated precise point mutations simultaneously in two target genes. Thus, the CRISPR/Cas system allows the one-step generation of animals carrying mutations in multiple genes, an approach that will greatly accelerate the in vivo study of functionally redundant genes and of epistatic gene interactions.	[Wang, Haoyi; Yang, Hui; Shivalila, Chikdu S.; Dawlaty, Meelad M.; Cheng, Albert W.; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Shivalila, Chikdu S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Cheng, Albert W.; Jaenisch, Rudolf] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Zhang, Feng] MIT, McGovern Inst Brain Res, Dept Brain & Cognit Sci, Dept Biol Engn, Cambridge, MA 02139 USA; [Zhang, Feng] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	Macrae, Rhiannon/AAX-1536-2020	Cheng, Albert/0000-0003-2653-5743; yang, hui/0000-0003-3590-722X	Croucher scholarship; NIH [R37-HD045022, R01-CA084198]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA084198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER	Croucher scholarship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Ruth Flannery and Kibibi Ganz for support with animal care and experiments. We thank Jaenisch lab members for helpful discussions on the manuscript. We are also grateful to G. Grant Welstead and Daniel B. Dadon for the help of editing the manuscript. M.M.D is a Damon Runyon Postdoctoral Fellow. A.W.C. is supported by a Croucher scholarship. R.J. is an adviser to Stemgent and a cofounder of Fate Therapeutics. This work was supported by NIH grants R37-HD045022 and R01-CA084198 to RJ.	Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Carbery ID, 2010, GENETICS, V186, P451, DOI 10.1534/genetics.110.117002; Carroll Dana, 2008, V435, P63, DOI 10.1007/978-1-59745-232-8_5; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Copeland NG, 2010, NAT REV CANCER, V10, P696, DOI 10.1038/nrc2916; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kool J, 2009, NAT REV CANCER, V9, P389, DOI 10.1038/nrc2647; Li Z, 2011, BLOOD, V118, P4509, DOI 10.1182/blood-2010-12-325241; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Shen B., 2013, CELL RES IN PRESS; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Sung YH, 2013, NAT BIOTECHNOL, V31, P23, DOI 10.1038/nbt.2477; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Wefers B, 2013, P NATL ACAD SCI USA, V110, P3782, DOI 10.1073/pnas.1218721110; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886	34	2385	2881	33	1479	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 9	2013	153	4					910	918		10.1016/j.cell.2013.04.025	http://dx.doi.org/10.1016/j.cell.2013.04.025			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23643243	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000318844000018
J	Korhonen, N; Niemi, S; Parkkari, J; Sievanen, H; Kannus, P				Korhonen, Niina; Niemi, Seppo; Parkkari, Jari; Sievanen, Harri; Kannus, Pekka			Incidence of Fall-Related Traumatic Brain Injuries Among Older Finnish Adults Between 1970 and 2011	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Korhonen, Niina; Niemi, Seppo; Sievanen, Harri] UKK Inst Hlth Promot Res, Injury & Osteoporosis Res Ctr, Tampere, Finland; [Parkkari, Jari] UKK Inst Hlth Promot Res, Tampere Res Ctr Sports Med, Tampere, Finland; [Kannus, Pekka] Tampere Univ Hosp, Dept Trauma Musculoskeletal Surg & Rehabil, Tampere, Finland	UKK Institute; UKK Institute; Tampere University; Tampere University Hospital	Korhonen, N (corresponding author), UKK Inst Hlth Promot Res, Injury & Osteoporosis Res Ctr, Tampere, Finland.	njkorhon@student.uef.fi		Korhonen, Niina/0000-0003-2990-679X				Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Kannus P, 1999, JAMA-J AM MED ASSOC, V281, P1895, DOI 10.1001/jama.281.20.1895; Kannus P, 2001, JAMA-J AM MED ASSOC, V286, P673, DOI 10.1001/jama.286.6.673; Keskimaki I, 1991, J HEALTH SCI, V2, P15; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024	6	36	36	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2013	309	18					1891	1892		10.1001/jama.2013.3356	http://dx.doi.org/10.1001/jama.2013.3356			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138AZ	23652518				2022-12-28	WOS:000318481900019
J	Yin, CM; Rancic, M; de Boo, GG; Stavrias, N; McCallum, JC; Sellars, MJ; Rogge, S				Yin, Chunming; Rancic, Milos; de Boo, Gabriele G.; Stavrias, Nikolas; McCallum, Jeffrey C.; Sellars, Matthew J.; Rogge, Sven			Optical addressing of an individual erbium ion in silicon	NATURE			English	Article							SINGLE-SHOT READOUT; ELECTRON-SPIN; ER3+; ATOM; ENTANGLEMENT; DONOR	The detection of electron spins associated with single defects in solids is a critical operation for a range of quantum information and measurement applications under development(1-9). So far, it has been accomplished for only two defect centres in crystalline solids: phosphorus dopants in silicon, for which electrical read-out based on a single-electron transistor is used(1), and nitrogen-vacancy centres in diamond, for which optical read-out is used(4-6). A spin readout fidelity of about 90 per cent has been demonstrated with both electrical read-out(1) and optical read-out(10,11); however, the thermal limitations of the former and the poor photon collection efficiency of the latter make it difficult to achieve the higher fidelities required for quantum information applications. Here we demonstrate a hybrid approach in which optical excitation is used to change the charge state (conditional on its spin state) of an erbium defect centre in a silicon-based single-electron transistor, and this change is then detected electrically. The high spectral resolution of the optical frequency-addressing step overcomes the thermal broadening limitation of the previous electrical read-out scheme, and the charge-sensing step avoids the difficulties of efficient photon collection. This approach could lead to new architectures for quantum information processing devices and could drastically increase the range of defect centres that can be exploited. Furthermore, the efficient electrical detection of the optical excitation of single sites in silicon represents a significant step towards developing interconnects between optical-based quantum computing and silicon technologies.	[Yin, Chunming; de Boo, Gabriele G.; Rogge, Sven] Univ New S Wales, Sch Phys, Ctr Excellence Quantum Computat & Commun Technol, Sydney, NSW 2052, Australia; [Rancic, Milos; Sellars, Matthew J.] Australian Natl Univ, RSPE, Ctr Excellence Quantum Computat & Commun Technol, Canberra, ACT 0200, Australia; [Stavrias, Nikolas; McCallum, Jeffrey C.] Univ Melbourne, Sch Phys, Ctr Excellence Quantum Computat & Commun Technol, Melbourne, Vic 3010, Australia	University of New South Wales Sydney; Australian National University; University of Melbourne	Rogge, S (corresponding author), Univ New S Wales, Sch Phys, Ctr Excellence Quantum Computat & Commun Technol, Sydney, NSW 2052, Australia.	s.rogge@unsw.edu.au	Sellars, Matthew/J-3130-2014; Yin, Chunming/F-5763-2011; Rogge, Sven/G-3709-2010	Sellars, Matthew/0000-0002-0502-0444; Yin, Chunming/0000-0003-0117-8225; Rogge, Sven/0000-0003-1078-9482; McCallum, Jeffrey/0000-0002-6692-7728; Rancic, Milos/0000-0002-8672-6771; De Boo, Gabriele/0000-0001-7925-6540	ARC Centre of Excellence for Quantum Computation and Communication Technology [CE110001027]; Future Fellowships [FT100100589, FT110100919]	ARC Centre of Excellence for Quantum Computation and Communication Technology(Australian Research Council); Future Fellowships	We thank R. Ahlefeldt, J. Bartholomew, R. Elliman, N. Manson and A. Morello for discussions. We also thank M. Hedges and T. Lucas for their help in the initial phase of the experiments. The devices were fabricated by N. Collaert and S. Biesemans. This work was financially supported by the ARC Centre of Excellence for Quantum Computation and Communication Technology (CE110001027) and the Future Fellowships (FT100100589 and FT110100919).	Baldit E, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.144303; Bertaina S, 2007, NAT NANOTECHNOL, V2, P39, DOI 10.1038/nnano.2006.174; Fuechsle M, 2012, NAT NANOTECHNOL, V7, P242, DOI [10.1038/nnano.2012.21, 10.1038/NNANO.2012.21]; Gaebel T, 2006, NAT PHYS, V2, P408, DOI 10.1038/nphys318; Guillot-Noel O, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.214409; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Hedges MP, 2010, NATURE, V465, P1052, DOI 10.1038/nature09081; Jiang L, 2009, SCIENCE, V326, P267, DOI 10.1126/science.1176496; Kenyon AJ, 2005, SEMICOND SCI TECH, V20, pR65, DOI 10.1088/0268-1242/20/12/R02; Kolesov R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2034; Lansbergen GP, 2008, NAT PHYS, V4, P656, DOI 10.1038/nphys994; Maze JR, 2008, NATURE, V455, P644, DOI 10.1038/nature07279; McAuslan DL, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.032339; MICHEL J, 1991, J APPL PHYS, V70, P2672, DOI 10.1063/1.349382; Morello A, 2010, NATURE, V467, P687, DOI 10.1038/nature09392; Morton JJL, 2011, NATURE, V479, P345, DOI 10.1038/nature10681; Neumann P, 2010, SCIENCE, V329, P542, DOI 10.1126/science.1189075; Pioda A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.146804; Pla JJ, 2012, NATURE, V489, P541, DOI 10.1038/nature11449; Priolo F, 1998, PHYS REV B, V57, P4443, DOI 10.1103/PhysRevB.57.4443; Robledo L, 2011, NATURE, V477, P574, DOI 10.1038/nature10401; Sellier H, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2476343; Simmons S, 2011, NATURE, V470, P69, DOI 10.1038/nature09696; Sleiter DJ, 2013, NANO LETT, V13, P116, DOI 10.1021/nl303663n; SMITH KF, 1965, P PHYS SOC LOND, V86, P1249, DOI 10.1088/0370-1328/86/6/311; Steger M, 2012, SCIENCE, V336, P1280, DOI 10.1126/science.1217635; Sun Y, 2002, J LUMIN, V98, P281, DOI 10.1016/S0022-2313(02)00281-8; Tettamanzi GC, 2011, IEEE ELECTR DEVICE L, V32, P440, DOI 10.1109/LED.2011.2106150; Togan E, 2010, NATURE, V466, P730, DOI 10.1038/nature09256; Vinh NQ, 2009, P IEEE, V97, P1269, DOI 10.1109/JPROC.2009.2018220; Yang S, 2009, J APPL PHYS, V105, DOI 10.1063/1.3065532; Ziegler JF, 2010, NUCL INSTRUM METH B, V268, P1818, DOI 10.1016/j.nimb.2010.02.091; Zwanenburg F. A., 2012, PREPRINT	33	119	120	3	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					91	94		10.1038/nature12081	http://dx.doi.org/10.1038/nature12081			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23636400	Green Submitted			2022-12-28	WOS:000318221500039
J	Gallo, S; Comeau, K; Vanstone, C; Agellon, S; Sharma, A; Jones, G; L'Abbe, M; Khamessan, A; Rodd, C; Weiler, H				Gallo, Sina; Comeau, Kathryn; Vanstone, Catherine; Agellon, Sherry; Sharma, Atul; Jones, Glenville; L'Abbe, Mary; Khamessan, Ali; Rodd, Celia; Weiler, Hope			Effect of Different Dosages of Oral Vitamin D Supplementation on Vitamin D Status in Healthy, Breastfed Infants A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MINERAL CONTENT; SERUM 25-HYDROXYVITAMIN-D; D METABOLITES; LINEAR GROWTH; D DEFICIENCY; MASS; EXPOSURE; MILK	Importance Vitamin D supplementation in infancy is required to support healthy bone mineral accretion. A supplement of 400 IU of vitamin D per day is thought to support plasma 25-hydroxyvitamin D (25[OH]D) concentrations between 40 and 50 nmol/L; some advocate 75 to 150 nmol/L for bone health. Objective To investigate the efficacy of different dosages of vitamin D in supporting 25(OH)D concentrations in infants. Design, Setting, and Participants Double-blind randomized clinical trial conducted among 132 one-month-old healthy, term, breastfed infants from Montreal, Quebec, Canada, between March 2007 and August 2010. Infants were followed up for 11 months ending August 2011 (74% completed study). Intervention Participants were randomly assigned to receive oral cholecalciferol (vitamin D-3) supplements of 400 IU/d (n=39), 800 IU/d (n=39), 1200 IU/d (n=38), or 1600 IU/d (n=16). Main Outcomes and Measures The primary outcome was a plasma 25(OH)D concentration of 75 nmol/L or greater in 97.5% of infants at 3 months. Secondary outcomes included 25(OH)D concentrations of 75 nmol/L or greater in 97.5% of infants at 6, 9, and 12 months; 25(OH)D concentrations of 50 nmol/L or greater across all times; growth; and whole body and regional bone mineral content. Data were analyzed by intention to treat using available data, logistic regression, and mixed-model analysis of variance. Results By 3 months, 55% (95% CI, 38%-72%) of infants in the 400-IU/d group achieved a 25(OH)D concentration of 75 nmol/L or greater vs 81%(95% CI, 65%-91%) in the 800-IU/d group, 92% (95% CI, 77%-98%) in the 1200-IU/d group, and 100% in the 1600-IU/d group. This concentration was not sustained in 97.5% of infants at 12 months in any of the groups. The 1600-IU/d dosage was discontinued prematurely because of elevated plasma 25(OH)D concentrations. All dosages established 25(OH)D concentrations of 50 nmol/L or greater in 97% (95% CI, 94%-100%) of infants at 3 months and sustained this in 98% (95% CI, 94%-100%) to 12 months. Growth and bone mineral content did not differ by dosage. Conclusions and Relevance Among healthy, term, breastfed infants, only a vitamin D supplement dosage of 1600 IU/d (but not dosages of 400, 800, or 1200 IU/d) increased plasma 25(OH)D concentration to 75 nmol/L or greater in 97.5% of infants at 3 months. However, this dosage increased 25(OH)D concentrations to levels that have been associated with hypercalcemia.	[Gallo, Sina; Comeau, Kathryn; Vanstone, Catherine; Agellon, Sherry; Rodd, Celia; Weiler, Hope] McGill Univ, Sch Dietet & Human Nutr, Ste Anne De Bellevue, PQ H9X 3V9, Canada; [Sharma, Atul; Rodd, Celia] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Montreal, PQ H3H 1P3, Canada; [Khamessan, Ali] Europharm Int Canada Inc, Montreal, PQ, Canada; [Jones, Glenville] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Jones, Glenville] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada; [L'Abbe, Mary] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada	McGill University; McGill University; Queens University - Canada; Queens University - Canada; University of Toronto	Weiler, H (corresponding author), McGill Univ, Sch Dietet & Human Nutr, 21111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X 3V9, Canada.	hope.weiler@mcgill.ca	labbe, mary/AAC-3392-2020	Gallo, Sina/0000-0002-6839-9834	CIHR Human Development Child and Youth Health; American Society for Bone and Mineral Research; Genzyme/Sanofi; Canadian Institutes for Health Research; Nutricia Research Foundation; Canadian Foundation for Innovation; Fonds de la Recherche en Sante du Quebec; Canada Research Chairs	CIHR Human Development Child and Youth Health(Canadian Institutes of Health Research (CIHR)); American Society for Bone and Mineral Research; Genzyme/Sanofi(Sanofi-AventisGenzyme Corporation); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Nutricia Research Foundation(Danone Nutricia); Canadian Foundation for Innovation(Canada Foundation for Innovation); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canada Research Chairs(Canada Research ChairsCGIAR)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Ms Gallo reports travel support from CIHR Human Development Child and Youth Health and the American Society for Bone and Mineral Research. Dr Sharma reports consulting fees for analyses prepared for Drs Weiler and Rodd. Dr Jones reports that he is cofounder and scientific advisory board member for Cytochroma Inc and has received payment for speakers bureaus from Genzyme/Sanofi. No other disclosures were reported.; This work was supported by funding from the Canadian Institutes for Health Research, Nutricia Research Foundation, and the Canadian Foundation for Innovation and in-kind support from Europharm International Canada Inc for provision of the supplements. Fonds de la Recherche en Sante du Quebec provided personal funding for the doctoral student (Ms Gallo) and the Canada Research Chairs provided a salary award to Dr Weiler.	Abrams SA, 2011, ANNU REV NUTR, V31, P285, DOI 10.1146/annurev-nutr-072610-145216; Aronov PA, 2008, ANAL BIOANAL CHEM, V391, P1917, DOI 10.1007/s00216-008-2095-8; Barger-Lux MJ, 2002, J CLIN ENDOCR METAB, V87, P4952, DOI 10.1210/jc.2002-020636; Carter GD, 2011, CURR DRUG TARGETS, V12, P19; Ding SJ, 2010, ANAL BIOANAL CHEM, V398, P779, DOI 10.1007/s00216-010-3993-0; Gallo S, 2012, J OSTEOPOROS, V2012, DOI 10.1155/2012/672403; Glendenning P, 2005, J CLIN ENDOCR METAB, V90, P3129, DOI 10.1210/jc.2004-2399; Godel JC, 2007, PAED CHILD HEALT-CAN, V12, P583, DOI 10.1093/pch/12.7.583; GREER FR, 1989, J PEDIATR-US, V114, P204, DOI 10.1016/S0022-3476(89)80784-X; GREER FR, 1982, J PEDIATR-US, V100, P919, DOI 10.1016/S0022-3476(82)80514-3; Health Canada, TRENDS BREASTF PRACT; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Holmlund-Suila E, 2012, J CLIN ENDOCR METAB, V97, P4139, DOI 10.1210/jc.2012-1575; Hypponen E, 2011, J NUTR, V141, P843, DOI 10.3945/jn.110.133009; Institute of Medicine, 2011, DIETARY REFERENCE IN; Jeans PC, 1938, J PEDIATR-US, V13, P730, DOI 10.1016/S0022-3476(38)80162-1; Looker AC, 2002, BONE, V30, P771, DOI 10.1016/S8756-3282(02)00692-0; Looker AC, 2008, AM J CLIN NUTR, V88, P1519, DOI 10.3945/ajcn.2008.26182; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Phinney KW, 2012, ANAL CHEM, V84, P956, DOI 10.1021/ac202047n; Rauch F, 2001, J BONE MINER RES, V16, P597, DOI 10.1359/jbmr.2001.16.4.597; REEVE LE, 1982, AM J CLIN NUTR, V36, P122, DOI 10.1093/ajcn/36.1.122; Scanlon KS, 2002, NUTR REV, V60, P235, DOI 10.1301/002966402320289368; Shieh Y-Y, IMPUTATION METHODS G; Singh RJ, 2006, J CLIN ENDOCR METAB, V91, P3055, DOI 10.1210/jc.2006-0710; Singh RJ, 2010, METHODS MOL BIOL, V603, P509, DOI 10.1007/978-1-60761-459-3_50; Siomou E, 2003, CALCIFIED TISSUE INT, V73, P319, DOI 10.1007/s00223-002-2099-x; Vidailhet M, 2010, ARCH PEDIATRIE, V17, P808, DOI 10.1016/S0929-693X(10)70122-6; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Weiler H, 2005, CAN MED ASSOC J, V172, P757, DOI 10.1503/cmaj.1040508; Weiler HA, 2008, GROWTH DEVELOP AGING, V71, P35; World Health Organization, 2006, WHO CHILD GROWTH STA; Zamora SA, 1999, J CLIN ENDOCR METAB, V84, P4541, DOI 10.1210/jc.84.12.4541	33	142	148	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2013	309	17					1785	1792		10.1001/jama.2013.3404	http://dx.doi.org/10.1001/jama.2013.3404			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134SU	23632722	Bronze			2022-12-28	WOS:000318235600026
J	Cho-Park, PF; Steller, H				Cho-Park, Park F.; Steller, Hermann			Proteasome Regulation by ADP-Ribosylation	CELL			English	Article							26S PROTEASOME; POLY(ADP-RIBOSE) POLYMERASE; STRUCTURAL BASIS; UBIQUITIN SYSTEM; ASSEMBLY PATHWAY; TELOMERE LENGTH; CDNA CLONING; TANKYRASE; PROTEIN; SUBUNIT	Protein degradation by the ubiquitin-proteasome system is central to cell homeostasis and survival. Defects in this process are associated with diseases such as cancer and neurodegenerative disorders. The 26S proteasome is a large protease complex that degrades ubiquitinated proteins. Here, we show that ADP-ribosylation promotes 26S proteasome activity in both Drosophila and human cells. We identify the ADP-ribosyltransferase tankyrase (TNKS) and the 19S assembly chaperones dp27 and dS5b as direct binding partners of the proteasome regulator PI31. TNKS-mediated ADP-ribosylation of PI31 drastically reduces its affinity for 20S proteasome alpha subunits to relieve 20S repression by PI31. Additionally, PI31 modification increases binding to and sequestration of dp27 and dS5b from 19S regulatory particles, promoting 26S assembly. Inhibition of TNKS by either RNAi or a small-molecule inhibitor, XAV939, blocks this process to reduce 26S assembly. These results unravel a mechanism of proteasome regulation that can be targeted with existing small-molecule inhibitors.	[Cho-Park, Park F.; Steller, Hermann] Rockefeller Univ, Howard Hughes Med Inst, Strang Lab Apoptosis & Canc Biol, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Steller, H (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Strang Lab Apoptosis & Canc Biol, 1230 York Ave, New York, NY 10021 USA.	steller@rockefeller.edu			National Institutes of Health [RO1GM60124]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	In alphabetical order, we thank J. Belote for providing fly strains; G. DeMartino, A. Goldberg, and S. Larisch for critical comments on the manuscript; S. Benjamin-Hong, O. Cho, I.B. Cho-Park, Y.A. Cho-Park, D. Ferres-Marco, N. Gandagar, T. Hsiao, A. Kelkar, L.I. Park, C. Pham, J. Rodriguez, I. Sachrai, C. Sandu, and members of our lab for valuable discussions; and J. Gee-Esposito, T. Gorenc, O. Matthew, and A. Persaud for logistical support. H.S. is an investigator of the Howard Hughes Medical Institute. This work was supported by National Institutes of Health grant RO1GM60124 to H.S.	Bader M, 2011, CELL, V145, P371, DOI 10.1016/j.cell.2011.03.021; Barrault MB, 2012, P NATL ACAD SCI USA, V109, pE1001, DOI 10.1073/pnas.1116538109; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Belote JM, 2002, GENESIS, V34, P80, DOI 10.1002/gene.10131; Besche HC, 2009, CELL, V138, P25, DOI 10.1016/j.cell.2009.06.035; Besche HC, 2009, BIOCHEMISTRY-US, V48, P2538, DOI 10.1021/bi802198q; Chambers JE, 2012, J CELL BIOL, V198, P371, DOI 10.1083/jcb.201202005; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chiang YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002639; Chiang YJ, 2006, MOL CELL BIOL, V26, P2037, DOI 10.1128/MCB.26.6.2037-2043.2006; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; DEVERAUX Q, 1995, J BIOL CHEM, V270, P23726, DOI 10.1074/jbc.270.40.23726; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Gagne JP, 2006, CURR OPIN CELL BIOL, V18, P145, DOI 10.1016/j.ceb.2006.02.013; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Gillette TG, 2008, J BIOL CHEM, V283, P31813, DOI 10.1074/jbc.M805935200; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2007, NEW ENGL J MED, V357, P1150, DOI 10.1056/NEJMcibr073962; Goldberg AL, 2012, J CELL BIOL, V199, P583, DOI 10.1083/jcb.201210077; Gomes AV, 2006, CIRC RES, V99, P362, DOI 10.1161/01.RES.0000237386.98506.f7; Guettler S, 2011, CELL, V147, P1340, DOI 10.1016/j.cell.2011.10.046; Hanna J, 2007, CELL, V129, P747, DOI 10.1016/j.cell.2007.03.042; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hsiao SJ, 2006, MOL CELL BIOL, V26, P2044, DOI 10.1128/MCB.26.6.2044-2054.2006; Hsiao SJ, 2008, BIOCHIMIE, V90, P83, DOI 10.1016/j.biochi.2007.07.012; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kisselev AF, 2012, CHEM BIOL, V19, P99, DOI 10.1016/j.chembiol.2012.01.003; Kurucz E, 2002, BIOCHEM J, V365, P527, DOI 10.1042/BJ20011520; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Lee SYC, 2011, J BIOL CHEM, V286, P36641, DOI 10.1074/jbc.M111.280875; Levaot N, 2011, CELL, V147, P1324, DOI 10.1016/j.cell.2011.10.045; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; MA CP, 1992, BIOCHIM BIOPHYS ACTA, V1119, P303, DOI 10.1016/0167-4838(92)90218-3; McCutchen-Maloney SL, 2000, J BIOL CHEM, V275, P18557, DOI 10.1074/jbc.M001697200; Morrone S, 2012, P NATL ACAD SCI USA, V109, P1500, DOI 10.1073/pnas.1116618109; Narwal M, 2012, J MED CHEM, V55, P1360, DOI 10.1021/jm201510p; Nickell S, 2007, BIOCHEM BIOPH RES CO, V353, P115, DOI 10.1016/j.bbrc.2006.11.141; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Park Y, 2005, MOL CELL BIOL, V25, P3842, DOI 10.1128/MCB.25.9.3842-3853.2005; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Peth A, 2013, J BIOL CHEM, V288, P7781, DOI 10.1074/jbc.M112.441907; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Princiotta MF, 2001, P NATL ACAD SCI USA, V98, P513, DOI 10.1073/pnas.021132398; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Shim SM, 2012, CELL REP, V2, P603, DOI 10.1016/j.celrep.2012.07.013; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Tai HC, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00012; Takagi K, 2012, J BIOL CHEM, V287, P12172, DOI 10.1074/jbc.M112.345876; Tanahashi N, 1999, MOL BIOL REP, V26, P3, DOI 10.1023/A:1006909522731; Tanaka K, 2012, BIOL CHEM, V393, P217, DOI 10.1515/hsz-2011-0285; Tomko RJ, 2011, CELL BIOCHEM BIOPHYS, V60, P13, DOI 10.1007/s12013-011-9178-4; Varshavsky A, 2012, ANNU REV BIOCHEM, V81, P167, DOI 10.1146/annurev-biochem-051910-094049; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Watanabe TK, 1998, GENOMICS, V50, P241, DOI 10.1006/geno.1998.5301; Yeh TYJ, 2009, DIABETES, V58, P2476, DOI 10.2337/db08-1781; Zaiss DMW, 2002, P NATL ACAD SCI USA, V99, P14344, DOI 10.1073/pnas.212257299	65	103	120	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 25	2013	153	3					614	627		10.1016/j.cell.2013.03.040	http://dx.doi.org/10.1016/j.cell.2013.03.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622245	Green Accepted, Bronze			2022-12-28	WOS:000318063500014
J	Ding, N; Yu, RT; Subramaniam, N; Sherman, MH; Wilson, C; Rao, R; Leblanc, M; Coulter, S; He, MX; Scott, C; Lau, SL; Atkins, AR; Barish, GD; Gunton, JE; Liddle, C; Downes, M; Evans, RM				Ding, Ning; Yu, Ruth T.; Subramaniam, Nanthakumar; Sherman, Mara H.; Wilson, Caroline; Rao, Renuka; Leblanc, Mathias; Coulter, Sally; He, Mingxiao; Scott, Christopher; Lau, Sue L.; Atkins, Annette R.; Barish, Grant D.; Gunton, Jenny E.; Liddle, Christopher; Downes, Michael; Evans, Ronald M.			A Vitamin D Receptor/SMAD Genomic Circuit Gates Hepatic Fibrotic Response	CELL			English	Article							FAT-STORING CELLS; NUCLEAR RECEPTOR; LIVER FIBROSIS; TGF-BETA; MOLECULAR-MECHANISMS; STELLATE CELLS; LYSYL OXIDASE; EXPRESSION; DISEASE; METALLOPROTEINASES	Liver fibrosis is a reversible wound-healing response involving TGF beta 1/SMAD activation of hepatic stellate cells (HSCs). It results from excessive deposition of extracellular matrix components and can lead to impairment of liver function. Here, we show that vitamin D receptor (VDR) ligands inhibit HSC activation by TGF beta 1 and abrogate liver fibrosis, whereas Vdr knockout mice spontaneously develop hepatic fibrosis. Mechanistically, we show that TGF beta 1 signaling causes a redistribution of genome-wide VDR-binding sites (VDR cistrome) in HSCs and facilitates VDR binding at SMAD3 profibrotic target genes via TGF beta 1-dependent chromatin remodeling. In the presence of VDR ligands, VDR binding to the coregulated genes reduces SMAD3 occupancy at these sites, inhibiting fibrosis. These results reveal an intersecting VDR/SMAD genomic circuit that regulates hepatic fibrogenesis and define a role for VDR as an endocrine checkpoint to modulate the wound-healing response in liver. Furthermore, the findings suggest VDR ligands as a potential therapy for liver fibrosis.	[Ding, Ning; Yu, Ruth T.; Sherman, Mara H.; Leblanc, Mathias; He, Mingxiao; Atkins, Annette R.; Barish, Grant D.; Downes, Michael; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Subramaniam, Nanthakumar; Wilson, Caroline; Rao, Renuka; Coulter, Sally; Liddle, Christopher] Westmead Millennium Inst, Storr Liver Unit, Westmead, NSW 2145, Australia; [Subramaniam, Nanthakumar; Wilson, Caroline; Rao, Renuka; Coulter, Sally; Liddle, Christopher] Univ Sydney, Westmead Hosp, Westmead, NSW 2145, Australia; [Scott, Christopher; Lau, Sue L.; Gunton, Jenny E.] Garvan Inst Med Res, Diabet & Transcript Factors Grp, Sydney, NSW 2010, Australia	Salk Institute; Howard Hughes Medical Institute; Salk Institute; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Garvan Institute of Medical Research	Downes, M (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	downes@salk.edu; evans@salk.edu	Gunton, Jenny E/AAH-7719-2021; Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965; , Caroline/0000-0002-9016-6025; Atkins, Annette/0000-0003-2558-7058; Yu, Ruth/0000-0002-9527-9627	Genentech Foundation; National Institutes of Health [DK057978, HL105278, DK090962, HL088093, ES010337, CA014195]; National Health and Medical Research Council of Australia [512354, 632886]; Helmsley Charitable Trust; Samuel Waxman Cancer Research Foundation; Ipsen/Biomeasure; Stand Up to Cancer Dream Team translational cancer research grant, a Program of the Entertainment Industry Foundation [SU2C-AACR-DT0509];  [K08HL092298]; NATIONAL CANCER INSTITUTE [P30CA060553, T32CA009370, P30CA014195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL092298, R01HL105278, P01HL088093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK090962, P30DK063491, R37DK057978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER	Genentech Foundation(Roche HoldingGenentech); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Helmsley Charitable Trust; Samuel Waxman Cancer Research Foundation; Ipsen/Biomeasure(Ipsen); Stand Up to Cancer Dream Team translational cancer research grant, a Program of the Entertainment Industry Foundation; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank C. Brondos and E. Ong for administrative assistance, J. Nery for assistance with DNA sequencing, C. Benner for assistance with HOMER software, and H. Juguilon and J. Alvarez for technical assistance. N.D. was supported by a postdoctoral fellowship from Genentech Foundation. G.D.B. was supported by grant K08HL092298. This work was funded by grants from the National Institutes of Health (DK057978, HL105278, DK090962, HL088093, ES010337, and CA014195) and National Health and Medical Research Council of Australia project grants 512354 and 632886 (to C.L. and M.D.), as well as by the Helmsley Charitable Trust, Samuel Waxman Cancer Research Foundation, and Ipsen/Biomeasure. R.M.E. and M.D. are supported in part by a Stand Up to Cancer Dream Team translational cancer research grant, a Program of the Entertainment Industry Foundation (SU2C-AACR-DT0509). R.M.E is an investigator of the Howard Hughes Medical Institute and March of Dimes chair in molecular and developmental biology at the Salk Institute.	Abramovitch S, 2011, GUT, V60, P1728, DOI 10.1136/gut.2010.234666; Agmon-Levin N, 2013, CLIN REV ALLERG IMMU, V45, P256, DOI 10.1007/s12016-012-8342-y; Amling M, 1999, ENDOCRINOLOGY, V140, P4982, DOI 10.1210/en.140.11.4982; Arthur MJP, 2000, AM J PHYSIOL-GASTR L, V279, pG245; Barish GD, 2005, MOL ENDOCRINOL, V19, P2466, DOI 10.1210/me.2004-0529; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Baur K, 2012, LIVER INT, V32, P635, DOI 10.1111/j.1478-3231.2011.02674.x; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Breitkopf K, 2006, Z GASTROENTEROL, V44, P57, DOI 10.1055/s-2005-858989; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Friedman Scott L., 1999, American Journal of Medicine, V107, p27S; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; Friedman SL, 2006, HEPATOLOGY, V43, pS82, DOI 10.1002/hep.20974; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; FRIEDMAN SL, 1985, P NATL ACAD SCI USA, V82, P8681, DOI 10.1073/pnas.82.24.8681; Gascon-Barre M, 2003, HEPATOLOGY, V37, P1034, DOI 10.1053/jhep.2003.50176; Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Goltzman D, 2004, J STEROID BIOCHEM, V89-90, P485, DOI 10.1016/j.jsbmb.2004.03.058; Han SX, 2010, MOL ENDOCRINOL, V24, P1151, DOI 10.1210/me.2009-0482; Han YP, 2006, J GASTROEN HEPATOL, V21, pS88, DOI 10.1111/j.1440-1746.2006.04586.x; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; HENDRIKS HFJ, 1985, EXP CELL RES, V160, P138, DOI 10.1016/0014-4827(85)90243-5; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; Janssens W, 2011, VITAM HORM, V86, P379, DOI 10.1016/B978-0-12-386960-9.00017-4; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kim WR, 2002, HEPATOLOGY, V36, P227, DOI 10.1053/jhep.2002.34734; KNOOK DL, 1982, EXP CELL RES, V139, P468, DOI 10.1016/0014-4827(82)90283-X; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Lim Lei Yuan, 2012, Curr Gastroenterol Rep, V14, P67, DOI 10.1007/s11894-011-0231-7; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Nagpal S, 2005, ENDOCR REV, V26, P662, DOI 10.1210/er.2004-0002; Patsenker E, 2011, AM J PHYSIOL-GASTR L, V301, pG425, DOI 10.1152/ajpgi.00050.2011; Petta S, 2010, HEPATOLOGY, V51, P1158, DOI 10.1002/hep.23489; Ramagopalan SV, 2011, ANN NEUROL, V70, P881, DOI 10.1002/ana.22678; Reynaert H, 2002, GUT, V50, P571, DOI 10.1136/gut.50.4.571; Rosenbloom J, 2010, ANN INTERN MED, V152, P159, DOI 10.7326/0003-4819-152-3-201002020-00007; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Seki E, 2012, J PHYSIOL-LONDON, V590, P447, DOI 10.1113/jphysiol.2011.219691; Shigeki TA, 2006, CLIN CHIM ACTA, V364, P33, DOI 10.1016/j.cca.2005.06.014; Siegmund SV, 2005, DIGEST DIS, V23, P264, DOI 10.1159/000090174; Tanaka A, 2009, J HEPATOL, V50, P1202, DOI 10.1016/j.jhep.2009.01.015; Terrier B, 2011, J HEPATOL, V55, P756, DOI 10.1016/j.jhep.2011.01.041; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; Vadasz Z, 2005, J HEPATOL, V43, P499, DOI 10.1016/j.jhep.2005.02.052; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yoshiji H, 2002, HEPATOLOGY, V36, P850, DOI 10.1053/jhep.2002.35625	64	419	438	4	89	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 25	2013	153	3					601	613		10.1016/j.cell.2013.03.028	http://dx.doi.org/10.1016/j.cell.2013.03.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622244	Green Accepted, Bronze			2022-12-28	WOS:000318063500013
J	Natchu, UCM; Bhatnagar, S				Natchu, Uma Chandra Mouli; Bhatnagar, Shinjini			Diarrhoea in children: identifying the cause and burden	LANCET			English	Editorial Material							DOUBLE-BLIND; MORTALITY; INFANTS; COHORT; ZINC		[Natchu, Uma Chandra Mouli; Bhatnagar, Shinjini] Translat Hlth Sci & Technol Inst, Pediat Biol Ctr, Gurgaon 122016, Haryana, India	Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI)	Bhatnagar, S (corresponding author), Translat Hlth Sci & Technol Inst, Pediat Biol Ctr, Gurgaon 122016, Haryana, India.	shinjini.bhatnagar@thsti.res.in		bhatnagar, shinjini/0000-0003-1703-5296				Assis AMO, 2005, EUR J CLIN NUTR, V59, P1317, DOI 10.1038/sj.ejcn.1602245; Baqui AH, 2002, BRIT MED J, V325, P1059, DOI 10.1136/bmj.325.7372.1059; BHAN MK, 1989, J INFECT DIS, V159, P1061, DOI 10.1093/infdis/159.6.1061; Bhandari N, 2009, J INFECT DIS, V200, P421, DOI 10.1086/600104; Bhatnagar S, 2012, LANCET, V379, P2072, DOI 10.1016/S0140-6736(12)60477-2; Islam MA, 1996, J TROP PEDIATRICS, V42, P342, DOI 10.1093/tropej/42.6.342; Kotloff KL, 2013, LANCET; Lindsay B, 2011, EMERG INFECT DIS, V17, P606, DOI 10.3201/eid1704.100939; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Serazin Andrew C, 2010, Nat Immunol, V11, P769, DOI 10.1038/ni0910-769; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519	12	8	9	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 20	2013	382	9888					184	186		10.1016/S0140-6736(13)60941-1	http://dx.doi.org/10.1016/S0140-6736(13)60941-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193FL	23680351				2022-12-28	WOS:000322543700006
J	Commisso, C; Davidson, SM; Soydaner-Azeloglu, RG; Parker, SJ; Kamphorst, JJ; Hackett, S; Grabocka, E; Nofal, M; Drebin, JA; Thompson, CB; Rabinowitz, JD; Metallo, CM; Vander Heiden, MG; Bar-Sagi, D				Commisso, Cosimo; Davidson, Shawn M.; Soydaner-Azeloglu, Rengin G.; Parker, Seth J.; Kamphorst, Jurre J.; Hackett, Sean; Grabocka, Elda; Nofal, Michel; Drebin, Jeffrey A.; Thompson, Craig B.; Rabinowitz, Joshua D.; Metallo, Christian M.; Vander Heiden, Matthew G.; Bar-Sagi, Dafna			Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells	NATURE			English	Article							MASS ISOTOPOMER DISTRIBUTIONS; K-RAS; GLUTAMINE-METABOLISM; H-RAS; CANCER; SRC; FIBROBLASTS; CARCINOMA; PATHWAYS; GROWTH	Macropinocytosis is a highly conserved endocytic process by which extracellular fluid and its contents are internalized into cells through large, heterogeneous vesicles known as macropinosomes. Oncogenic Ras proteins have been shown to stimulate macropinocytosis but the functional contribution of this uptake mechanism to the transformed phenotype remains unknown(1-3). Here we show that Ras-transformed cells use macropinocytosis to transport extracellular protein into the cell. The internalized protein undergoes proteolytic degradation, yielding amino acids including glutamine that can enter central carbon metabolism. Accordingly, the dependence of Ras-transformed cells on free extracellular glutamine for growth can be suppressed by the macropinocytic uptake of protein. Consistent with macropinocytosis representing an important route of nutrient uptake in tumours, its pharmacological inhibition compromises the growth of Ras-transformed pancreatic tumour xenografts. These results identify macropinocytosis as a mechanism by which cancer cells support their unique metabolic needs and point to the possible exploitation of this process in the design of anticancer therapies.	[Commisso, Cosimo; Soydaner-Azeloglu, Rengin G.; Grabocka, Elda; Bar-Sagi, Dafna] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Davidson, Shawn M.; Vander Heiden, Matthew G.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Davidson, Shawn M.; Vander Heiden, Matthew G.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Parker, Seth J.; Metallo, Christian M.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Kamphorst, Jurre J.; Hackett, Sean; Nofal, Michel; Rabinowitz, Joshua D.] Princeton Univ, Carl Icahn Lab, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Drebin, Jeffrey A.] Hosp Univ Penn, Dept Surg, Philadelphia, PA 19104 USA; [Thompson, Craig B.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Vander Heiden, Matthew G.] Dana Farber Canc Inst, Boston, MA 02115 USA	New York University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of California System; University of California San Diego; Princeton University; University of Pennsylvania; Pennsylvania Medicine; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute	Bar-Sagi, D (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA.	dafna.bar-sagi@nyumc.org	Metallo, Christian/HCH-3476-2022; Rabinowitz, Joshua/GPP-4019-2022	Metallo, Christian/0000-0003-2404-3040; Rabinowitz, Joshua/0000-0002-1247-4727; Parker, Seth/0000-0001-7971-8848; Kamphorst, Jurre/0000-0002-2042-5474; Bar-Sagi, Dafna/0000-0003-2597-8948; Grabocka, E/0000-0001-7196-8498	National Institutes of Health (NIH) [R01CA055360, 5 P30CA016087-32]; Canadian Institutes of Health Research; AACR provided by the Pancreatic Cancer Action Network; Burroughs Wellcome Fund; Damon Runyon Cancer Research Foundation; Smith Family; Stern family; Broad Institute; National Cancer Institute [P01-CA117969, P30-CA14051-39]; Hope Funds for Cancer Research Fellowship [HFCR-11-03-01]; Stand Up To Cancer (SU2C) Pancreatic Cancer Dream Team Award; NICHD; NATIONAL CANCER INSTITUTE [P30CA016087, P01CA117969, R01CA055360, R01CA105463, P30CA014051, R01CA163591, P01CA104838] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); AACR provided by the Pancreatic Cancer Action Network; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Damon Runyon Cancer Research Foundation; Smith Family; Stern family; Broad Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hope Funds for Cancer Research Fellowship; Stand Up To Cancer (SU2C) Pancreatic Cancer Dream Team Award; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to members of the Bar-Sagi laboratory for their comments and discussions, and N. Fehrenbacher and M. Philips for sharing cell lines. This work was supported National Institutes of Health (NIH) grant R01CA055360 to D.B.-S. C.C. was supported by a Canadian Institutes of Health Research postdoctoral fellowship and an AACR postdoctoral fellowship provided by the Pancreatic Cancer Action Network. M.G.V.H. acknowledges support from the Burroughs Wellcome Fund, the Damon Runyon Cancer Research Foundation, the Smith Family, the Stern family, the Broad Institute and the National Cancer Institute (P01-CA117969 and P30-CA14051-39). J.J.K. was supported by a Hope Funds for Cancer Research Fellowship (HFCR-11-03-01). C.B.T., J.A.D. and J.D.R. acknowledge support by the Stand Up To Cancer (SU2C) Pancreatic Cancer Dream Team Award. All animal care and procedures were approved by the Institutional Animal Care and Use Committee at NYU School of Medicine. The Histopathology Core of NYU School of Medicine is partially supported by the National Institutes of Health (grant 5 P30CA016087-32). Troma I, an antibody that recognizes CK8, was contributed by P. Brulet and R. Kemler and made available by the Developmental Studies Hybridoma Bank under the auspices of the NICHD.	Antoniewicz MR, 2007, ANAL CHEM, V79, P7554, DOI 10.1021/ac0708893; AOKI K, 1995, CANCER RES, V55, P3810; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; BOS JL, 1989, CANCER RES, V49, P4682; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Gaglio D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.56; Gaglio D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004715; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; HIRAI H, 1990, GENE DEV, V4, P2342, DOI 10.1101/gad.4.12b.2342; HOLM E, 1995, CANCER RES, V55, P1373; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kasahara K, 2007, J CELL PHYSIOL, V211, P220, DOI 10.1002/jcp.20931; KNOWLES MA, 1993, CANCER RES, V53, P133; LopezCrapez E, 1997, CLIN CHEM, V43, P936; Mates JM, 2009, INT J BIOCHEM CELL B, V41, P2051, DOI 10.1016/j.biocel.2009.03.003; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mettlen M, 2006, TRAFFIC, V7, P589, DOI 10.1111/j.1600-0854.2006.00412.x; NEWSHOLME EA, 1985, Q J EXP PHYSIOL CMS, V70, P473, DOI 10.1113/expphysiol.1985.sp002935; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Porat-Shliom N, 2008, MOL BIOL CELL, V19, P765, DOI 10.1091/mbc.E07-08-0841; Reis RCM, 1998, EUR J CELL BIOL, V75, P192, DOI 10.1016/S0171-9335(98)80061-7; Stehle G, 1997, CRIT REV ONCOL HEMAT, V26, P77, DOI 10.1016/S1040-8428(97)00015-2; Tsakraklides V, 2010, J BIOL CHEM, V285, P9437, DOI 10.1074/jbc.M109.072504; Veithen A, 1996, J CELL SCI, V109, P2005; Wagner M, 2001, GENE DEV, V15, P286, DOI 10.1101/gad.184701; Walsh AB, 2001, J BIOL CHEM, V276, P15609, DOI 10.1074/jbc.M010573200; WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; WU MC, 1978, INT J CANCER, V22, P728, DOI 10.1002/ijc.2910220615	31	969	995	12	195	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2013	497	7451					633	+		10.1038/nature12138	http://dx.doi.org/10.1038/nature12138			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23665962	Green Submitted, Green Accepted			2022-12-28	WOS:000319556100047
J	Dumont, A; Bouvier-Colle, MH				Dumont, Alexandre; Bouvier-Colle, Marie-Helene			Care assessment's difficult relation with maternal mortality	LANCET			English	Editorial Material							MORBIDITY; MISSES		[Dumont, Alexandre] IRD Paris Descartes, UMR 216, F-75006 Paris, France; [Bouvier-Colle, Marie-Helene] INSERM, U953, Paris, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Dumont, A (corresponding author), IRD Paris Descartes, UMR 216, F-75006 Paris, France.	alexandre.dumont@ird.fr	Dumont, Alexandre/I-9429-2016	Dumont, Alexandre/0000-0003-3826-0193				Bouvier-Colle MH, 2012, BJOG-INT J OBSTET GY, V119, P880, DOI 10.1111/j.1471-0528.2012.03330.x; de Bernis L, 2000, BRIT J OBSTET GYNAEC, V107, P68; Filippi V, 1998, LANCET, V351, P145, DOI 10.1016/S0140-6736(05)78106-X; Geller Stacie E, 2002, J Am Med Womens Assoc (1972), V57, P135; Pattinson RC, 2003, BRIT MED BULL, V67, P231, DOI 10.1093/bmb/ldg007; Prual A, 2000, B WORLD HEALTH ORGAN, V78, P593; Roberts CL, 2008, MED CARE, V46, P786, DOI 10.1097/MLR.0b013e318178eae4; Say Lale, 2004, Reprod Health, V1, P3, DOI 10.1186/1742-4755-1-3; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Vincent C, 2003, NEW ENGL J MED, V348, P1051, DOI 10.1056/NEJMhpr020760; World Health Organization, 2004, NUMB REV MAT DEATHS; Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x	13	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 18	2013	381	9879					1695	1696		10.1016/S0140-6736(13)60983-6	http://dx.doi.org/10.1016/S0140-6736(13)60983-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146TA	23683619				2022-12-28	WOS:000319112800010
J	Myer, L				Myer, Landon			Maternal deaths and HIV treatment in sub-Saharan Africa	LANCET			English	Editorial Material							MORTALITY; WOMEN		Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa	University of Cape Town	Myer, L (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa.	landon.myer@uct.ac.za						Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Coutsoudis A, 2013, LANCET, V381, P269, DOI 10.1016/S0140-6736(12)61807-8; Cross S, 2010, B WORLD HEALTH ORGAN, V88, P147, DOI 10.2471/BLT.09.063537; Hargrove JW, 2010, AIDS, V24, pF11, DOI 10.1097/QAD.0b013e328335749d; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Horton R, 2009, LANCET, V374, P1400, DOI 10.1016/S0140-6736(09)61669-X; Kruk ME, 2012, HEALTH AFFAIR, V31, P1478, DOI 10.1377/hlthaff.2012.0197; McIntyre J, 2003, BRIT MED BULL, V67, P127, DOI 10.1093/bmb/ldg012; Moodley J, 2011, BJOG-INT J OBSTET GY, V118, P219, DOI 10.1111/j.1471-0528.2010.02726.x; Schouten EJ, 2011, LANCET, V378, P282, DOI 10.1016/S0140-6736(10)62303-3; WHO, 2010, TRENDS MAT MORT 1990; Zaba B, 2013, LANCET, V381, P1763, DOI 10.1016/S0140-6736(13)60803-X; Zureick-Brown S, 2013, INT PERSPECT SEX R H, V39, P32, DOI 10.1363/3903213	13	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 18	2013	381	9879					1699	1700		10.1016/S0140-6736(13)61000-4	http://dx.doi.org/10.1016/S0140-6736(13)61000-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146TA	23683621				2022-12-28	WOS:000319112800012
J	Allanore, A; Yin, L; Sadoway, DR				Allanore, Antoine; Yin, Lan; Sadoway, Donald R.			A new anode material for oxygen evolution in molten oxide electrolysis	NATURE			English	Article							IRON-OXIDE; CORROSION; CHROMIUM	Molten oxide electrolysis (MOE) is an electrometallurgical technique that enables the direct production of metal in the liquid state from oxide feedstock(1,2), and compared with traditional methods of extractive metallurgy offers both a substantial simplification of the process and a significant reduction in energy consumption(3). MOE is also considered a promising route for mitigation of CO2 emissions in steelmaking(3-5), production of metals free of carbon(6), and generation of oxygen for extra-terrestrial exploration(7,8). Until now, MOE has been demonstrated using anode materials that are consumable (graphite for use with ferro-alloys and titanium(6,9)) or unaffordable for terrestrial applications (iridium for use with iron(10,11)). To enable metal production without process carbon, MOE requires an anode material that resists depletion while sustaining oxygen evolution. The challenges for iron production are threefold. First, the process temperature is in excess of 1,538 degrees Celsius (ref. 10). Second, under anodic polarization most metals inevitably corrode in such conditions(11-13). Third, iron oxide undergoes spontaneous reduction on contact with most refractory metals(14) and even carbon. Here we show that anodes comprising chromium-based alloys exhibit limited consumption during iron extraction and oxygen evolution by MOE. The anode stability is due to the formation of an electronically conductive solid solution of chromium(III) and aluminium oxides in the corundum structure. These findings make practicable larger-scale evaluation of MOE for the production of steel, and potentially provide a key material component enabling mitigation of greenhouse-gas emissions while producing metal of superior metallurgical quality.	[Allanore, Antoine; Yin, Lan; Sadoway, Donald R.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Allanore, A (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	allanore@mit.edu	Sadoway, Donald/AAE-7708-2019; Yin, Lan/G-7513-2014	Sadoway, Donald/0000-0003-1978-8654; Allanore, Antoine/0000-0002-2594-0264	American Iron and Steel Institute	American Iron and Steel Institute	The financial support of the American Iron and Steel Institute is acknowledged; we thank H. Kim and J. Paramore for assistance with the experimental set-up and for discussions.	Aiken R. H, 1906, US patent, Patent No. [816. 142, 816142]; Birat JP, 2009, REV METALL-PARIS, V106, P325, DOI 10.1051/metal/2009060; Carton A, 2006, J ELECTROCHEM SOC, V153, pB121, DOI 10.1149/1.2165745; Di Martino J, 2004, CORROS SCI, V46, P1865, DOI 10.1016/j.corsci.2003.10.025; EGERTON TA, 1974, J CATAL, V33, P299, DOI 10.1016/0021-9517(74)90274-7; ESIN OA, 1956, ZH FIZ KHIM+, V30, P3; Halper M., 2011, TIME, V177, P7; International Energy Agency, 2010, EN TECHN PERSP, P179; Kim H, 2011, J ELECTROCHEM SOC, V158, pE101, DOI 10.1149/1.3623446; Macdonald DD, 2011, ELECTROCHIM ACTA, V56, P1761, DOI 10.1016/j.electacta.2010.11.005; Nguyen T, 2006, LIGHT MET, P385; Oppenheim M. J., 1968, MINERAL MAG, V36, P1104; Sadoway D. R., 1991, JOM-US, V43, P15, DOI DOI 10.1007/BF03220614; Sadoway DR, 2001, JOM-J MIN MET MAT S, V53, P34, DOI 10.1007/s11837-001-0206-5; Sanderson F., NATURE; Takahashi N, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.174302; Wang DH, 2011, J ELECTROCHEM SOC, V158, pE51, DOI 10.1149/1.3560477; Winand R., 1977, INT S MOLT SALT EL M, P42	18	121	140	14	445	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2013	497	7449					353	+		10.1038/nature12134	http://dx.doi.org/10.1038/nature12134			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23657254	Green Submitted			2022-12-28	WOS:000318952000034
J	Saye, RI; Sethian, JA				Saye, Robert I.; Sethian, James A.			Multiscale Modeling of Membrane Rearrangement, Drainage, and Rupture in Evolving Foams	SCIENCE			English	Article							IMPLICIT INTERFACE METHOD; SURFACE-TENSION; THIN-FILMS; FLOW	Modeling the physics of foams and foamlike materials, such as soapy froths, fire retardants, and lightweight crash-absorbent structures, presents challenges, because of the vastly different time and space scales involved. By separating and coupling these disparate scales, we have designed a multiscale framework to model dry foam dynamics. This leads to a predictive and flexible computational methodology linking, with a few simplifying assumptions, foam drainage, rupture, and topological rearrangement, to coupled interface-fluid motion under surface tension, gravity, and incompressible fluid dynamics. Our computed results match theoretical analyses and experimentally observed physical effects, including thin-film drainage and interference, and are used to study bubble rupture cascades and macroscopic rearrangement. The developed multiscale model allows quantitative computation of complex foam evolution phenomena.	[Sethian, James A.] Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; [Saye, Robert I.; Sethian, James A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Sethian, JA (corresponding author), Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA.	sethian@math.berkeley.edu		Saye, Robert/0000-0001-7256-6941	Applied Mathematical Sciences subprogram of the Office of Energy Research, U.S. Department of Energy [DE-AC02-05CH11231]; Division of Mathematical Sciences of the NSF; National Cancer Institute [U54CA143833]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Miller Foundation at University of California, Berkeley; American Australian Association Sir Keith Murdoch Fellowship; Direct For Mathematical & Physical Scien [1319276] Funding Source: National Science Foundation	Applied Mathematical Sciences subprogram of the Office of Energy Research, U.S. Department of Energy(United States Department of Energy (DOE)); Division of Mathematical Sciences of the NSF; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Miller Foundation at University of California, Berkeley(University of California System); American Australian Association Sir Keith Murdoch Fellowship; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This research was supported in part by the Applied Mathematical Sciences subprogram of the Office of Energy Research, U.S. Department of Energy, under contract DE-AC02-05CH11231, by the Division of Mathematical Sciences of the NSF, and by National Cancer Institute U54CA143833. Some computations used the resources of the National Energy Research Scientific Computing Center, which is supported by the Office of Science of the U.S. Department of Energy under contract DE-AC02-05CH11231. J.A.S. was also supported by the Miller Foundation at University of California, Berkeley, and as an Einstein Visiting Fellow of the Einstein Foundation, Berlin. R. I. S. was also supported by an American Australian Association Sir Keith Murdoch Fellowship.	Bird JC, 2010, NATURE, V465, P759, DOI 10.1038/nature09069; BRACKBILL JU, 1992, J COMPUT PHYS, V100, P335, DOI 10.1016/0021-9991(92)90240-Y; Brakke K.A., 1992, EXP MATH, V1, P141, DOI [DOI 10.1080/10586458.1992.10504253, 10.1080/10586458.1992.10504253]; Breward CJW, 2002, J FLUID MECH, V458, P379, DOI 10.1017/S0022112002007930; CHOPP DL, 1993, J COMPUT PHYS, V106, P77, DOI 10.1006/jcph.1993.1092; CHORIN AJ, 1968, MATH COMPUT, V22, P745, DOI 10.2307/2004575; Durand M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.226101; Hilgenfeldt S, 2001, PHYS REV LETT, V86, P2685, DOI 10.1103/PhysRevLett.86.2685; Howell PD, 2005, EUR J APPL MATH, V16, P569, DOI 10.1017/S095679250500625X; Kim Y, 2010, J COMPUT PHYS, V229, P5194, DOI 10.1016/j.jcp.2010.03.035; Koehler SA, 2004, J COLLOID INTERF SCI, V276, P420, DOI 10.1016/j.jcis.2003.12.061; Kornek U, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/7/073031; MacPherson RD, 2007, NATURE, V446, P1053, DOI 10.1038/nature05745; MULLINS WW, 1956, J APPL PHYS, V27, P900, DOI 10.1063/1.1722511; Myers TG, 1998, SIAM REV, V40, P441, DOI 10.1137/S003614459529284X; Oron A, 1997, REV MOD PHYS, V69, P931, DOI 10.1103/RevModPhys.69.931; Plateau J., 1873, STATIQUE EXPT THEORI; Polthier K., 2005, GLOBAL THEORY MINIMA; Saye RI, 2012, J COMPUT PHYS, V231, P6051, DOI 10.1016/j.jcp.2012.04.004; Saye RI, 2011, P NATL ACAD SCI USA, V108, P19498, DOI 10.1073/pnas.1111557108; von Neumann J, 1952, METAL INTERFACES, P108; Weaire DL., 2001, PHYS FOAMS	22	69	73	6	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					720	724		10.1126/science.1230623	http://dx.doi.org/10.1126/science.1230623			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661755	Green Published			2022-12-28	WOS:000318619000032
J	George, S; Sandal, S				George, Sharon; Sandal, Shaifali			A Ticking Time Bomb	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[George, Sharon] Wayne State Univ, Detroit, MI 48202 USA; [Sandal, Shaifali] Univ Rochester, Med Ctr, Rochester, NY 14642 USA	Wayne State University; University of Rochester	George, S (corresponding author), Wayne State Univ, Detroit, MI 48202 USA.	george.sharon15@gmail.com							0	1	1	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2013	368	19					1826	1826		10.1056/NEJMicm1214469	http://dx.doi.org/10.1056/NEJMicm1214469			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	138WA	23656648				2022-12-28	WOS:000318540000012
J	Mandegaran, R; Saha, S; Desai, A				Mandegaran, Ramin; Saha, Shouvik; Desai, Amidevi			PICTURE QUIZ Chronic lower back pain in a 24 year old man	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OSTEOID OSTEOMA; COMPUTED-TOMOGRAPHY; OSTEOBLASTOMA; BONE; MANAGEMENT; CT		[Mandegaran, Ramin] Royal Free London NHS Fdn Trust, London NW3 2QG, England; [Saha, Shouvik; Desai, Amidevi] Guys & St Thomas NHS Trust, Dept Radiol, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust	Mandegaran, R (corresponding author), Royal Free London NHS Fdn Trust, London NW3 2QG, England.	ramin1986@hotmail.com						ASSOUN J, 1994, RADIOLOGY, V191, P217, DOI 10.1148/radiology.191.1.8134575; BAHLOUL K, 2003, EUR J RADIOL EXTRA, V46, P74; Barei DP, 1999, OPERATIVE TECHNIQUES, V9, P72; BILCHIK T, 1992, J NUCL MED, V33, P269; Birjandinejad A, 2009, ORTHOPEDICS, V32, P409, DOI [10.3928/01477447-20090511-12, 10.3928/01477447-20090922-23]; BOWN SG, 1983, WORLD J SURG, V7, P700, DOI 10.1007/BF01655209; Busser WMH, 2011, CARDIOVASC INTER RAD, V34, P180, DOI 10.1007/s00270-010-9950-7; Campanacci M, 1999, J BONE JOINT SURG BR, V81B, P814, DOI 10.1302/0301-620X.81B5.9313; Chai JW, 2010, RADIOGRAPHICS, V30, P737, DOI 10.1148/rg.303095120; COHEN MD, 1983, SEMIN ARTHRITIS RHEU, V12, P265, DOI 10.1016/0049-0172(83)90010-0; GAMBA JL, 1984, AM J ROENTGENOL, V142, P769, DOI 10.2214/ajr.142.4.769; Ghanem I, 2006, CURR OPIN PEDIATR, V18, P36, DOI 10.1097/01.mop.0000193277.47119.15; HEALEY JH, 1986, CLIN ORTHOP RELAT R, P76; Ilaslan H, 2006, ORTHOP CLIN N AM, V37, P375, DOI 10.1016/j.ocl.2006.05.003; Jankharia Bhavin, 2009, Indian J Radiol Imaging, V19, P36, DOI 10.4103/0971-3026.44523; Kitsoulis Panagotis, 2006, Acta Orthop Belg, V72, P119; Lee EH, 2006, J PEDIATR ORTHOPED, V26, P695, DOI 10.1097/01.bpo.0000233807.80046.7c; Lindner NJ, 2001, J BONE JOINT SURG BR, V83B, P391, DOI 10.1302/0301-620X.83B3.11679; Mungo DV, 2002, J ORTHOP RES, V20, P159, DOI 10.1016/S0736-0266(01)00065-1; National Institute for Health and Clinical Excellence, 2009, LOW BACK PAIN EARL M; Rajeswaran G, 2013, SKELETAL RADIOL, V42, P3, DOI 10.1007/s00256-012-1437-y; RANSFORD AO, 1984, J BONE JOINT SURG BR, V66, P16, DOI 10.1302/0301-620X.66B1.6693471; Refshauge KM, 2006, BRIT J SPORT MED, V40, P494, DOI 10.1136/bjsm.2004.016659; Royal College of Radiologists, 2012, AC BACK PAIN POT SER; Sans N, 1999, RADIOLOGY, V212, P687, DOI 10.1148/radiology.212.3.r99se06687; Sherazi Z, 1996, CLIN RADIOL, V51, P644, DOI 10.1016/S0009-9260(96)80060-2; Sluga M, 2002, J BONE JOINT SURG BR, V84B, P249, DOI 10.1302/0301-620X.84B2.12347; TILLOTSON CL, 1989, INVEST RADIOL, V24, P888, DOI 10.1097/00004424-198911000-00009; WELLS RG, 1987, CLIN NUCL MED, V12, P39, DOI 10.1097/00003072-198701000-00010; Witt JD, 2000, J BONE JOINT SURG BR, V82B, P1125, DOI 10.1302/0301-620X.82B8.11307; Yang Wen-Ta, 2007, J Chin Med Assoc, V70, P545, DOI 10.1016/S1726-4901(08)70058-3; Zenmyo M, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-10	32	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2013	346								f2817	10.1136/bmj.f2817	http://dx.doi.org/10.1136/bmj.f2817			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	144BS	23657241				2022-12-28	WOS:000318915000010
J	Mitsnefes, MM; Laskin, BL; Dahhou, M; Zhang, X; Foster, BJ				Mitsnefes, Mark M.; Laskin, Benjamin L.; Dahhou, Mourad; Zhang, Xun; Foster, Bethany J.			Mortality Risk Among Children Initially Treated With Dialysis for End-Stage Kidney Disease, 1990-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR-DISEASE; RENAL-DISEASE; YOUNG-ADULTS; SURVIVAL; HEMODIALYSIS; INFANTS; ANEMIA	Importance Most children with end-stage kidney disease (ESKD) are treated with dialysis prior to transplant. It is not known whether their outcomes have changed in recent years. Objective To determine if all-cause, cardiovascular, and infection-related mortality rates for children and adolescents beginning dialysis improved between 1990 and 2010. Design, Setting, and Participants Retrospective cohort study of patients younger than 21 years initially treated with dialysis for ESKD, recorded in the United States Renal Data System between 1990 and 2010. Children with a prior kidney transplant were excluded. We used Cox proportional hazard models to estimate the hazard ratios (HRs) for mortality associated with a 5-year increment in year of ESKD treatment initiation. Primary analyses censored observation at kidney transplant. Main Outcomes and Measures All-cause, cardiovascular, and infection-related mortality. Results A total of 23 401 children and adolescents who initiated ESKD treatment with dialysis at younger than 21 years between 1990 and 2010 were identified. Crude mortality rates during dialysis treatment were higher among children younger than 5 years at the start of dialysis compared with those who were 5 years and older. Mortality rates for both children and adolescents being treated for ESKD with dialysis decreased significantly between 1990 and 2010. [GRAPHICS] Conclusions and Relevance In the United States, there was a substantial decrease in mortality rates over time among children and adolescents initiating ESKD treatment with dialysis between 1990 and 2010. Further research is needed to determine the specific factors responsible for this decrease. JAMA. 2013;309(18):1921-1929 Published online May 4, 2013. doi:10.1001/jama.2013.4208 www.jama.com	[Mitsnefes, Mark M.] Cincinnati Childrens Hosp Med Ctr, Div Nephrol & Hypertens, Cincinnati, OH USA; [Laskin, Benjamin L.] Childrens Hosp Philadelphia, Div Nephrol, Philadelphia, PA 19104 USA; [Dahhou, Mourad; Zhang, Xun; Foster, Bethany J.] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Montreal, PQ H3H 1P3, Canada; [Foster, Bethany J.] McGill Univ, Fac Med, Dept Pediat, Div Nephrol, Montreal, PQ, Canada; [Foster, Bethany J.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	Cincinnati Children's Hospital Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; McGill University; McGill University; McGill University	Foster, BJ (corresponding author), Montreal Childrens Hosp, 2300 Tupper St,E-222, Montreal, PQ H3H 1P3, Canada.	beth.foster@muhc.mcgill.ca	Zhang, Xun/HHM-9059-2022	Zhang, Xun/0000-0001-5411-2727	National Institutes of Health [R01DK07695, K24DK090070, U01DK-03-012]; Career Development Award in Comparative Effectiveness Research [1KM1CA156715-01]; Fonds de la recherche en sante du Quebec [FRSQ]; FRSQ; Health Resources and Services Administration [234-2005-370011C]; NATIONAL CANCER INSTITUTE [KM1CA156715] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK066143, K24DK090070] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Development Award in Comparative Effectiveness Research; Fonds de la recherche en sante du Quebec [FRSQ](Fonds de la Recherche en Sante du Quebec); FRSQ(Fonds de la Recherche en Sante du Quebec); Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr Mitsnefes is supported by the National Institutes of Health (R01DK07695, K24DK090070, and U01DK-03-012). Dr Laskin is supported by a Career Development Award in Comparative Effectiveness Research (1KM1CA156715-01). Dr Foster, a member of the McGill University Health Centre Research Institute (supported in part by the Fonds de la recherche en sante du Quebec [FRSQ]), received salary support from the FRSQ. This work was supported in part by Health Resources and Services Administration contract 234-2005-370011C. Data were supplied by the USRDS.	[Anonymous], 2006, AM J KIDNEY DIS, V48, pS4, DOI 10.1053/j.ajkd.2006.07.015; [Anonymous], DRUG APPR DAT DRUGS; [Anonymous], 2012 ANN DAT REP ATL; Balas EA, YB MED INFORM 2000 P; Bond TC, 2012, AM J KIDNEY DIS, V60, P959, DOI 10.1053/j.ajkd.2012.04.018; Borzych-Duzalka D, 2013, J AM SOC NEPHROL, V24, P665, DOI 10.1681/ASN.2012050433; Chavers BM, 2007, J AM SOC NEPHROL, V18, P952, DOI 10.1681/ASN.2006040406; Chavers BM, 2002, KIDNEY INT, V62, P648, DOI 10.1046/j.1523-1755.2002.00472.x; Dell'Aquila R, 2007, PERITON DIALYSIS INT, V27, pS130; DEVRIES JPPM, 1993, KIDNEY INT, V44, P851, DOI 10.1038/ki.1993.321; Eisenstein I, 2011, CLIN J AM SOC NEPHRO, V6, P793, DOI 10.2215/CJN.04810610; Fischbach M, 2005, PEDIATR NEPHROL, V20, P1054, DOI 10.1007/s00467-005-1876-y; Foley RN, 2013, CLIN J AM SOC NEPHRO, V8, P845, DOI 10.2215/CJN.06840712; Foster BJ, 2011, AM J TRANSPLANT, V11, P2432, DOI 10.1111/j.1600-6143.2011.03691.x; Groothoff JW, 2002, KIDNEY INT, V61, P621, DOI 10.1046/j.1523-1755.2002.00156.x; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Hoyert D, 2012, NATL VITAL STAT REP, V61; Ing TS, 2012, DIALYSIS: HISTORY, DEVELOPMENT AND PROMISE, pVII; Kucirka LM, 2011, JAMA-J AM MED ASSOC, V306, P620, DOI 10.1001/jama.2011.1127; Leonard MB, 2003, KIDNEY INT, V63, P744, DOI 10.1046/j.1523-1755.2003.00788.x; Matas AJ, 2013, AM J TRANSPLANT, V13, P11, DOI 10.1111/ajt.12019; Mathews TJ, 2011, PEDIATRICS, V127, P146, DOI 10.1542/peds.2010-3175; McDonald SP, 2004, NEW ENGL J MED, V350, P2654, DOI 10.1056/NEJMoa031643; Miskulin DC, 2003, AM J KIDNEY DIS, V41, P149, DOI 10.1053/ajkd.2003.50034; Mitsnefes MM, 2012, J AM SOC NEPHROL, V23, P578, DOI 10.1681/ASN.2011111115; Oh J, 2002, CIRCULATION, V106, P100, DOI 10.1161/01.CIR.0000020222.63035.C0; Parekh RS, 2002, J PEDIATR-US, V141, P191, DOI 10.1067/mpd.2002.125910; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Sebestyen JF, 2011, ADV CHRONIC KIDNEY D, V18, P376, DOI 10.1053/j.ackd.2011.07.003; Tetta C, 2011, EXPERT REV CARDIOVAS, V9, P155, DOI [10.1586/erc.10.194, 10.1586/ERC.10.194]; Verrina E, 2009, PEDIATR NEPHROL, V24, P1453, DOI 10.1007/s00467-008-0848-4; Vidal E, 2012, NEPHROL DIAL TRANSPL, V27, P388, DOI 10.1093/ndt/gfr322; Warady BA, 2012, PEDIATRIC DIALYSIS, SECOND EDITION, P1, DOI 10.1007/978-1-4614-0721-8; Warady BA, 2003, PEDIATR NEPHROL, V18, P1055, DOI 10.1007/s00467-003-1214-1; Wedekin M, 2010, CLIN J AM SOC NEPHRO, V5, P18, DOI 10.2215/CJN.03670609; Woodward R S, 2008, Am J Transplant, V8, P2636, DOI 10.1111/j.1600-6143.2008.02422.x	37	119	119	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2013	309	18					1921	1929		10.1001/jama.2013.4208	http://dx.doi.org/10.1001/jama.2013.4208			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138AZ	23645144	Bronze, Green Accepted			2022-12-28	WOS:000318481900027
J	Raman, G; Moorthy, D; Hadar, N; Dahabreh, IJ; O'Donnell, TF; Thaler, DE; Feldmann, E; Lau, J; Kitsios, GD				Raman, Gowri; Moorthy, Denish; Hadar, Nira; Dahabreh, Issa J.; O'Donnell, Thomas F.; Thaler, David E.; Feldmann, Edward; Lau, Joseph; Kitsios, Georgios D.			Management Strategies for Asymptomatic Carotid Stenosis A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							VASCULAR-SURGERY GUIDELINES; ARTERY STENOSIS; NATURAL-HISTORY; MEDICARE BENEFICIARIES; PLAQUE CHARACTERISTICS; UNITED-STATES; RISK PATIENTS; ENDARTERECTOMY; STROKE; DISEASE	Background: Adults with asymptomatic carotid artery stenosis are at increased risk for ipsilateral carotid territory ischemic stroke. Purpose: To examine comparative evidence on management strategies for asymptomatic carotid stenosis and the incidence of ipsilateral stroke with medical therapy alone. Data Sources: MEDLINE, Cochrane Central Register of Controlled Trials, U. S. Food and Drug Administration documents, and review of references through 31 December 2012. Study Selection: Randomized, controlled trials (RCTs) and prospective or retrospective nonrandomized, comparative studies of medical therapy alone, carotid endarterectomy (CEA) plus medical therapy, or carotid artery stenting (CAS) plus medical therapy for adults with asymptomatic carotid stenosis, as well as single-group prospective cohort studies of medical therapy, were reviewed. Data Extraction: Two investigators extracted information on study and population characteristics, results, and risk of bias. Data Synthesis: Forty-seven studies in 56 publications were eligible. The RCTs comparing CAS and CEA were clinically heterogeneous; 1 RCT reported more but not statistically significant ipsilateral stroke events (including any periprocedural stroke) in CAS compared with CEA, whereas another RCT, in a population at high surgical risk for CEA, did not. Three RCTs showed that CEA reduced the risk for ipsilateral stroke (including any periprocedural stroke) compared with medical therapy alone, but these results may no longer be applicable to contemporary clinical practice. No RCT compared CAS versus medical therapy alone. The summary incidence of ipsilateral stroke across 26 cohorts receiving medical therapy alone was 1.68% per year. Limitations: Studies defined asymptomatic status heterogeneously. Participants in RCTs did not receive best-available medical therapy. Conclusion: Future RCTs of asymptomatic carotid artery stenosis should explore whether revascularization interventions provide benefit to patients treated by best-available medical therapy.	Tufts Med Ctr, Ctr Clin Evidence Synth, Boston, MA 02111 USA; Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; Brown Univ, Ctr Evidence Based Med, Providence, RI 02912 USA; Lahey Clin Med Ctr, Burlington, MA 01803 USA	Tufts Medical Center; Tufts Medical Center; Brown University; Lahey Hospital & Medical Center	Raman, G (corresponding author), Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Tufts Ctr Clin Evidence Synth, Box 63,800 Washington St, Boston, MA 02111 USA.	graman@tuftsmedicalcenter.org		MOORTHY, DENISH/0000-0003-2818-6102; Kitsios, Georgios/0000-0002-1018-948X	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services [290 2007 10055 I]; Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services (contract 290 2007 10055 I).; Agency for Healthcare Research and Quality.	Abbott AL, 2009, STROKE, V40, pE573, DOI 10.1161/STROKEAHA.109.556068; AbuRahma AF, 2003, J VASC SURG, V38, P1154, DOI 10.1016/j.jvs.2003.07.028; AbuRahma AF, 2003, ANN SURG, V238, P551, DOI 10.1097/01.sla.0000089856.64262.66; Agency for Healthcare Research and Quality, 2011, AHRQ PUBLICATION, V10; ANDERSON DC, 2002, STROKE, V33, P1963, DOI DOI 10.1161/01.STR.0000023445.A8; [Anonymous], 1995, Lancet, V345, P209; Ballotta E, 2007, J VASC SURG, V45, P516, DOI 10.1016/j.jvs.2006.11.011; Bangalore S, 2011, ARCH NEUROL-CHICAGO, V68, P172, DOI 10.1001/archneurol.2010.262; Bangalore S, 2010, CIRCULATION, V122, P1091, DOI 10.1161/CIRCULATIONAHA.109.933341; BOGOUSSLAVSKY J, 1986, NEUROLOGY, V36, P861, DOI 10.1212/WNL.36.6.861; Bonati Leo H, 2012, Cochrane Database Syst Rev, pCD000515, DOI 10.1002/14651858.CD000515.pub4; Bosiers M, 2005, VASCULAR, V13, P92, DOI 10.2310/6670.2005.00057; Brooks WH, 2004, NEUROSURGERY, V54, P318, DOI 10.1227/01.NEU.0000103447.30087.D3; Brott TG, 2011, CIRCULATION, V124, pE54, DOI [10.1161/CIR.0b013e31820d8c98, 10.1161/CIR.0b0113e31820d8c98]; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; CARACCI BF, 1989, J VASC SURG, V9, P361, DOI 10.1067/mva.1989.vs0090361; Curtis LH, 2010, CIRC-CARDIOVASC QUAL, V3, P599, DOI 10.1161/CIRCOUTCOMES.110.950279; De Rango P, 2011, J AM COLL CARDIOL, V57, P664, DOI 10.1016/j.jacc.2010.09.041; de Weerd M, 2009, STROKE, V40, P1105, DOI 10.1161/STROKEAHA.108.532218; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DIENER HC, 1991, STROKE, V22, P1229; Dumont TM, 2012, J NEUROSURG, V116, P1251, DOI 10.3171/2012.3.JNS111320; Economopoulos KP, 2011, STROKE, V42, P687, DOI 10.1161/STROKEAHA.110.606079; Eden J, 2011, FINDING WHAT WORKS IN HEALTH CARE: STANDARDS FOR SYSTEMATIC REVIEWS, P1; Eslami MH, 2011, J VASC SURG, V53, P307, DOI 10.1016/j.jvs.2010.08.080; Fiorella D, 2012, STROKE, V43, P2682, DOI 10.1161/STROKEAHA.112.661173; Giacovelli JK, 2010, J VASC SURG, V52, P906, DOI 10.1016/j.jvs.2010.05.010; Goessens BMB, 2007, STROKE, V38, P1470, DOI 10.1161/STROKEAHA.106.477091; Gronholdt MLM, 2001, CIRCULATION, V104, P68, DOI 10.1161/hc2601.091704; Guay J, 2012, J CARDIOTHOR VASC AN, V26, P835, DOI 10.1053/j.jvca.2012.01.044; Guay J, 2011, J CARDIOTHOR VASC AN, V25, P1024, DOI 10.1053/j.jvca.2011.01.009; Gur AY, 1996, STROKE, V27, P2188, DOI 10.1161/01.STR.27.12.2188; Gurm HS, 2008, NEW ENGL J MED, V358, P1572, DOI 10.1056/NEJMoa0708028; Halliday A, 2004, LANCET, V363, P1491; Halliday A, 2010, LANCET, V376, P1074, DOI 10.1016/S0140-6736(10)61197-X; Hertzer NR, 2012, SEMIN VASC SURG, V25, P13, DOI 10.1053/j.semvascsurg.2012.02.003; HERTZER NR, 1986, ANN SURG, V204, P163, DOI 10.1097/00000658-198608000-00010; Hirt LS, 2011, STROKE; HOBSON RW, 1993, NEW ENGL J MED, V328, P221, DOI 10.1056/NEJM199301283280401; Howard VJ, 2011, LANCET NEUROL, V10, P530, DOI 10.1016/S1474-4422(11)70080-1; Inzitari D, 2000, NEW ENGL J MED, V342, P1693, DOI 10.1056/NEJM200006083422302; Jim J, 2012, J VASC SURG, V55, P1313, DOI 10.1016/j.jvs.2011.11.128; JOHNSON BF, 1995, J VASC SURG, V21, P120, DOI 10.1016/S0741-5214(95)70250-4; JOHNSON JM, 1985, ARCH SURG-CHICAGO, V120, P1010; Kakisis JD, 2012, EUR J VASC ENDOVASC, V44, P238, DOI 10.1016/j.ejvs.2012.04.015; Kakkos SK, 2005, INT ANGIOL, V24, P221; KARTCHNER MM, 1977, SURGERY, V82, P840; LEVIEN LJ, 1984, S AFR J SURG, V22, P249; Liapis CD, 2001, STROKE, V32, P2782, DOI 10.1161/hs1201.099797; LIBMAN RB, 1994, SURG NEUROL, V41, P443, DOI 10.1016/0090-3019(94)90005-1; Lindstrom D, 2012, EUR J VASC ENDOVASC, V43, P499, DOI 10.1016/j.ejvs.2012.01.024; Longstreth WT, 1998, STROKE, V29, P2371, DOI 10.1161/01.STR.29.11.2371; Mackey AE, 1997, NEUROLOGY, V48, P896, DOI 10.1212/WNL.48.4.896; Mansour MA, 1999, J VASC SURG, V29, P217, DOI 10.1016/S0741-5214(99)70375-7; Marine LA, 2006, J VASC SURG, V43, P953, DOI 10.1016/j.jvs.2006.01.008; Markus HS, 2010, LANCET NEUROL, V9, P663, DOI 10.1016/S1474-4422(10)70120-4; Marquardt L, 2010, STROKE, V41, pE11, DOI 10.1161/STROKEAHA.109.561837; McPhee JT, 2007, J VASC SURG, V46, P1112, DOI 10.1016/j.jvs.2007.08.030; McPhee JT, 2008, J VASC SURG, V48, P1442, DOI 10.1016/j.jvs.2008.07.017; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Murad MH, 2011, J VASC SURG, V53, P792, DOI 10.1016/j.jvs.2010.10.101; Nicolaides AN, 2005, EUR J VASC ENDOVASC, V30, P275, DOI 10.1016/j.ejvs.2005.04.031; Ogata T, 2012, J STROKE CEREBROVASC, V21, P24, DOI 10.1016/j.jstrokecerebrovasdis.2010.03.016; Paraskevas KI, 2012, J VASC SURG, V55, P585, DOI 10.1016/j.jvs.2011.10.034; Poulias G E, 1994, Cardiovasc Surg, V2, P586; Ricotta JJ, 2011, J VASC SURG, V54, pE1, DOI 10.1016/j.jvs.2011.07.031; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sherif C, 2005, J ENDOVASC THER, V12, P145, DOI 10.1583/04-1452R.1; Sidawy AN, 2009, J VASC SURG, V49, P71, DOI 10.1016/j.jvs.2008.08.039; Silver FL, 2011, STROKE, V42, P675, DOI 10.1161/STROKEAHA.110.610212; Silvestrini M, 2000, JAMA-J AM MED ASSOC, V283, P2122, DOI 10.1001/jama.283.16.2122; Spence JD, 2010, ARCH NEUROL-CHICAGO, V67, P180, DOI 10.1001/archneurol.2009.289; Spence JD, 2005, STROKE, V36, P2373, DOI 10.1161/01.STR.0000185922.49809.46; Stijnen T, 2010, STAT MED, V29, P3046, DOI 10.1002/sim.4040; Takaya N, 2006, STROKE, V37, P818, DOI 10.1161/01.STR.0000204638.91099.91; Tendera M, 2011, EUR HEART J, V32, P2851, DOI 10.1093/eurheartj/ehr211; THOMPSON JE, 1978, ANN SURG, V188, P308, DOI 10.1097/00000658-197809000-00005; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; White RA, 2005, J VASC SURG, V42, P213, DOI 10.1016/j.jvs.2005.04.023; WIEBERS DO, 1992, MAYO CLIN PROC, V67, P513; Wolff T, 2007, ANN INTERN MED, V147, P860, DOI 10.7326/0003-4819-147-12-200712180-00006; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127; Zafar AM, 2012, AM J ROENTGENOL, V198, P866, DOI 10.2214/AJR.11.7411; Zhang CM, 2009, SCAND CARDIOVASC J, V43, P345, DOI 10.1080/14017430802699232	85	97	102	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 7	2013	158	9					676	+		10.7326/0003-4819-158-9-201305070-00007	http://dx.doi.org/10.7326/0003-4819-158-9-201305070-00007			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146WV	23648949				2022-12-28	WOS:000319126900005
J	Moore, A; Derry, S; Eccleston, C; Kalso, E				Moore, Andrew; Derry, Sheena; Eccleston, Christopher; Kalso, Eija			Expect analgesic failure; pursue analgesic success	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PLACEBO-CONTROLLED TRIAL; CHRONIC PAIN; POSTHERPETIC NEURALGIA; RANDOMIZED-TRIAL; FIBROMYALGIA; IMPROVEMENT; PREGABALIN; EFFICACY; ETORICOXIB; WITHDRAWAL		[Moore, Andrew; Derry, Sheena] Univ Oxford, Churchill Hosp, Oxford OX3 7LJ, England; [Moore, Andrew; Derry, Sheena] Univ Oxford, Churchill Hosp, Nuffield Div Anaesthet, Oxford OX3 7LJ, England; [Eccleston, Christopher] Univ Bath, Ctr Pain Res, Bath BA2 7AY, Avon, England; [Kalso, Eija] Univ Helsinki, Cent Hosp, Dept Anaesthesiol, Pain Clin, FIN-00014 Helsinki, Finland	University of Oxford; University of Oxford; University of Bath; University of Helsinki; Helsinki University Central Hospital	Moore, A (corresponding author), Univ Oxford, Churchill Hosp, S Parks Rd, Oxford OX3 7LJ, England.	andrew.moore@ndcn.ox.ac.uk		Kalso, Eija/0000-0002-4899-605X; Eccleston, Christopher/0000-0003-0698-1543				Arnold LM, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3359; CONNOR S, 2003, INDEPENDENT; Crofford LJ, 2008, PAIN, V136, P419, DOI 10.1016/j.pain.2008.02.027; Farmer K., 2010, EFFECT VOLUNATARY EX; Hoffman DL, 2010, PAIN, V149, P194, DOI 10.1016/j.pain.2009.09.017; Kroenke K, 2001, JAMA-J AM MED ASSOC, V286, P2947, DOI 10.1001/jama.286.23.2947; Lin HY, 2010, INT J RHEUM DIS, V13, P144, DOI 10.1111/j.1756-185X.2010.01468.x; McQuay HJ, 2008, PAIN, V135, P217, DOI 10.1016/j.pain.2008.01.014; Moore RA, 2013, ANAESTHESIA, V68, P400, DOI 10.1111/anae.12148; Moore RA, 2010, PAIN, V149, P173, DOI 10.1016/j.pain.2009.08.007; Moore RA, 2010, ANN RHEUM DIS, V69, P374, DOI 10.1136/ard.2009.107805; Moore RA, 2012, PAIN, V153, P265, DOI 10.1016/j.pain.2011.10.004; Moore RA, 2011, PAIN, V152, P982, DOI 10.1016/j.pain.2010.11.030; Moore RA, 2010, PAIN, V151, P592, DOI 10.1016/j.pain.2010.07.013; Moore RA, 2010, PAIN, V150, P386, DOI 10.1016/j.pain.2010.05.011; Moore RA, 2010, PAIN, V149, P360, DOI 10.1016/j.pain.2010.02.039; Moore RA, 1998, PAIN, V78, P209, DOI 10.1016/S0304-3959(98)00140-7; National Collaborating Centre for Chronic Conditions, 2008, OST NAT CLIN GUID CA; Simon G, 2001, JAMA-J AM MED ASSOC, V286, P3003, DOI 10.1001/jama.286.23.3003; Smith R., 2003, BRIT MED J, V327, P09; Stacey BR, 2008, J PAIN, V9, P1006, DOI 10.1016/j.jpain.2008.05.014; Straube S, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-125; Wang FJ, 2011, J PAIN, V12, P1088, DOI 10.1016/j.jpain.2011.05.002; Watson CPN, 1998, NEUROLOGY, V51, P1166, DOI 10.1212/WNL.51.4.1166	24	162	163	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2013	346								f2690	10.1136/bmj.f2690	http://dx.doi.org/10.1136/bmj.f2690			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139FC	23645858	Green Accepted, Green Published			2022-12-28	WOS:000318566200003
J	Baca, SC; Prandi, D; Lawrence, MS; Mosquera, JM; Romanel, A; Drier, Y; Park, K; Kitabayashi, N; MacDonald, TY; Ghandi, M; Van Allen, E; Kryukov, GV; Sboner, A; Theurillat, JP; Soong, TD; Nickerson, E; Auclair, D; Tewari, A; Beltran, H; Onofrio, RC; Boysen, G; Guiducci, C; Barbieri, CE; Cibulskis, K; Sivachenko, A; Carter, SL; Saksena, G; Voet, D; Ramos, AH; Winckler, W; Cipicchio, M; Ardlie, K; Kantoff, PW; Berger, MF; Gabriel, SB; Golub, TR; Meyerson, M; Lander, ES; Elemento, O; Getz, G; Demichelis, F; Rubin, MA; Garraway, LA				Baca, Sylvan C.; Prandi, Davide; Lawrence, Michael S.; Mosquera, Juan Miguel; Romanel, Alessandro; Drier, Yotam; Park, Kyung; Kitabayashi, Naoki; MacDonald, Theresa Y.; Ghandi, Mahmoud; Van Allen, Eliezer; Kryukov, Gregory V.; Sboner, Andrea; Theurillat, Jean-Philippe; Soong, T. David; Nickerson, Elizabeth; Auclair, Daniel; Tewari, Ashutosh; Beltran, Himisha; Onofrio, Robert C.; Boysen, Gunther; Guiducci, Candace; Barbieri, Christopher E.; Cibulskis, Kristian; Sivachenko, Andrey; Carter, Scott L.; Saksena, Gordon; Voet, Douglas; Ramos, Alex H.; Winckler, Wendy; Cipicchio, Michelle; Ardlie, Kristin; Kantoff, Philip W.; Berger, Michael F.; Gabriel, Stacey B.; Golub, Todd R.; Meyerson, Matthew; Lander, Eric S.; Elemento, Olivier; Getz, Gad; Demichelis, Francesca; Rubin, Mark A.; Garraway, Levi A.			Punctuated Evolution of Prostate Cancer Genomes	CELL			English	Article							TMPRSS2-ERG FUSION; REARRANGEMENTS; CHD1; MUTATIONS; EVENT	The analysis of exonic DNA from prostate cancers has identified recurrently mutated genes, but the spectrum of genome-wide alterations has not been profiled extensively in this disease. We sequenced the genomes of 57 prostate tumors and matched normal tissues to characterize somatic alterations and to study how they accumulate during oncogenesis and progression. By modeling the genesis of genomic rearrangements, we identified abundant DNA translocations and deletions that arise in a highly interdependent manner. This phenomenon, which we term "chromoplexy," frequently accounts for the dysregulation of prostate cancer genes and appears to disrupt multiple cancer genes coordinately. Our modeling suggests that chromoplexy may induce considerable genomic derangement over relatively few events in prostate cancer and other neoplasms, supporting a model of punctuated cancer evolution. By characterizing the clonal hierarchy of genomic lesions in prostate tumors, we charted a path of oncogenic events along which chromoplexy may drive prostate carcinogenesis.	[Baca, Sylvan C.; Kryukov, Gregory V.; Ramos, Alex H.; Kantoff, Philip W.; Meyerson, Matthew; Lander, Eric S.; Garraway, Levi A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Baca, Sylvan C.; Lawrence, Michael S.; Drier, Yotam; Ghandi, Mahmoud; Van Allen, Eliezer; Kryukov, Gregory V.; Theurillat, Jean-Philippe; Nickerson, Elizabeth; Auclair, Daniel; Onofrio, Robert C.; Guiducci, Candace; Cibulskis, Kristian; Sivachenko, Andrey; Carter, Scott L.; Saksena, Gordon; Voet, Douglas; Ramos, Alex H.; Winckler, Wendy; Cipicchio, Michelle; Ardlie, Kristin; Gabriel, Stacey B.; Golub, Todd R.; Meyerson, Matthew; Lander, Eric S.; Getz, Gad; Garraway, Levi A.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Baca, Sylvan C.; Van Allen, Eliezer; Kantoff, Philip W.; Meyerson, Matthew; Garraway, Levi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Golub, Todd R.; Meyerson, Matthew; Garraway, Levi A.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02215 USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Prandi, Davide; Romanel, Alessandro; Demichelis, Francesca] Univ Trento, Ctr Integrat Biol, I-38123 Povo, Trento, Italy; [Drier, Yotam] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Mosquera, Juan Miguel; Park, Kyung; Kitabayashi, Naoki; MacDonald, Theresa Y.; Sboner, Andrea; Boysen, Gunther; Barbieri, Christopher E.; Rubin, Mark A.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Sboner, Andrea; Soong, T. David; Elemento, Olivier; Demichelis, Francesca] Weill Cornell Med Coll, Dept Physiol & Biophys, Inst Computat Biomed, New York, NY 10065 USA; [Tewari, Ashutosh] Weill Cornell Med Coll, Lefrak Ctr Robot Surg, New York, NY 10065 USA; [Tewari, Ashutosh] Weill Cornell Med Coll, Ctr Prostate Canc Res & Clin Care, New York, NY 10065 USA; [Tewari, Ashutosh; Barbieri, Christopher E.; Rubin, Mark A.] Weill Cornell Med Coll, Brady Fdn Dept Urol, New York, NY 10065 USA; [Beltran, Himisha] Weill Cornell Med Coll, Div Hematol & Med Oncol, Dept Med, New York, NY 10065 USA; [Kryukov, Gregory V.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Berger, Michael F.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lander, Eric S.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of Trento; Weizmann Institute of Science; Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Cornell University; Harvard University; Brigham & Women's Hospital; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Demichelis, F (corresponding author), Univ Trento, Ctr Integrat Biol, I-38123 Povo, Trento, Italy.	demichelis@science.unitn.it; levi_garraway@dfci.harvard.edu	Kryukov, Gregory V/A-9592-2008; Cibulskis, Kristian/AAC-7380-2019; Lawrence, Michael/AAC-8202-2020; Drier, Yotam/K-5208-2012; Romanel, Alessandro/J-8864-2018; Sboner, Andrea/C-6487-2008; Demichelis, Francesca/J-9829-2016	Drier, Yotam/0000-0003-1725-2995; Romanel, Alessandro/0000-0003-4855-8620; Sboner, Andrea/0000-0001-6915-3070; Demichelis, Francesca/0000-0002-8266-8631; Rubin, Mark/0000-0002-8321-9950; Kantoff, Philip/0000-0001-7275-0597; Boysen, Gunther/0000-0002-7610-6085; Ghandi, Mahmoud/0000-0003-1897-2265; Cibulskis, Kristian/0000-0003-1343-1582; Van Allen, Eliezer/0000-0002-0201-4444; Prandi, Davide/0000-0001-9885-6074; Barbieri, Christopher/0000-0002-0381-1947; Meyerson, Matthew/0000-0002-9133-8108; Romanel, Alessandro/0000-0002-2376-8552; Kryukov, Gregory/0000-0002-6131-9483	US National Human Genome Research Institute (NHGRI) Large Scale Sequencing Program [U54 HG003067]; Kohlberg Foundation; Starr Cancer Consortium; Prostate Cancer Foundation; US Department of Defense Synergy Awards [PC101020]; Dana-Farber/Harvard Cancer Center Prostate Cancer SPORE (US National Institutes of Health [NIH]) [P50 CA090381]; US National Cancer Institute, Early Detection Research Network [U01CA111275]; NCI EDRN; US National Cancer Institute [R01 CA125612]; Fondazione Trentina per la Ricerca sui Tumori; Swiss Science Foundation [PASMP3_134379/1]; National Institute of General Medical Sciences [T32GM007753]; US NIH Director's New Innovator Award [DP2OD002750]; Novartis;  [PC094516]; NATIONAL CANCER INSTITUTE [P50CA090381, R33CA155554, U01CA162148, R01CA125612, U01CA111275] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002750] Funding Source: NIH RePORTER	US National Human Genome Research Institute (NHGRI) Large Scale Sequencing Program; Kohlberg Foundation; Starr Cancer Consortium; Prostate Cancer Foundation; US Department of Defense Synergy Awards(United States Department of Defense); Dana-Farber/Harvard Cancer Center Prostate Cancer SPORE (US National Institutes of Health [NIH])(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Cancer Institute, Early Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI EDRN(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fondazione Trentina per la Ricerca sui Tumori; Swiss Science Foundation(Swiss National Science Foundation (SNSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US NIH Director's New Innovator Award; Novartis(Novartis); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the members of the Broad Institute Genome Sequencing Platform for their part in this work. This study was supported by the US National Human Genome Research Institute (NHGRI) Large Scale Sequencing Program (U54 HG003067 to the Broad Institute, E.S.L.), the Kohlberg Foundation (L.A.G.), the Starr Cancer Consortium (M.A.R., F.D., A.T., G.G., and L.A.G.), the Prostate Cancer Foundation (M.A.R.), US Department of Defense Synergy Awards (PC101020 to F.D., L.A.G., and M.A.R.) and a New Investigator Award (PC094516 to F.D.), the Dana-Farber/Harvard Cancer Center Prostate Cancer SPORE (US National Institutes of Health [NIH] P50 CA090381), the US National Cancer Institute, Early Detection Research Network (U01CA111275 and NCI EDRN to F.D. and M.A.R.), the US National Cancer Institute (R01 CA125612 to F.D. and M.A.R.), the Fondazione Trentina per la Ricerca sui Tumori (F.D.), the Swiss Science Foundation (PASMP3_134379/1 to J.-P.T.), the National Institute of General Medical Sciences (T32GM007753 to S.C.B.), and a US NIH Director's New Innovator Award (DP2OD002750 to L.A.G.). L.A.G. is an equity holder and consultant in Foundation Medicine, a consultant to Novartis and Millenium/Takeda, and a recipient of a grant from Novartis.	Baca Sylvan C, 2012, Front Endocrinol (Lausanne), V3, P69, DOI 10.3389/fendo.2012.00069; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Burrow AA, 2010, NUCLEIC ACIDS RES, V38, P2865, DOI 10.1093/nar/gkp1245; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; De S, 2011, NAT BIOTECHNOL, V29, P1103, DOI 10.1038/nbt.2030; Demichelis F, 2009, GENE CHROMOSOME CANC, V48, P366, DOI 10.1002/gcc.20647; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Drier Y, 2013, GENOME RES, V23, P228, DOI 10.1101/gr.141382.112; EMMERTBUCK MR, 1995, CANCER RES, V55, P2959; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Forment JV, 2012, NAT REV CANCER, V12, P663, DOI 10.1038/nrc3352; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; GOULD S J, 1977, Paleobiology, V3, P115; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Haffner MC, 2010, NAT GENET, V42, P668, DOI 10.1038/ng.613; Halvorsen OJ, 2003, CLIN CANCER RES, V9, P1474; Huang S, 2012, ONCOGENE, V31, P4164, DOI 10.1038/onc.2011.590; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Liu W, 2012, ONCOGENE, V31, P3939, DOI 10.1038/onc.2011.554; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Perner S, 2007, AM J SURG PATHOL, V31, P882, DOI 10.1097/01.pas.0000213424.38503.aa; Perner S, 2006, CANCER RES, V66, P8337, DOI 10.1158/0008-5472.CAN-06-1482; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Sun C, 2008, ONCOGENE, V27, P5348, DOI 10.1038/onc.2008.183; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024	38	825	844	2	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 25	2013	153	3					666	677		10.1016/j.cell.2013.03.021	http://dx.doi.org/10.1016/j.cell.2013.03.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622249	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000318063500018
J	Fishell, G				Fishell, Gordon			After the deluge	NATURE			English	Editorial Material									NYU, Inst Neurosci, New York, NY 10016 USA	New York University	Fishell, G (corresponding author), NYU, Inst Neurosci, 550 1st Ave, New York, NY 10016 USA.	fisheg01@nyumc.org		Fishell, Gordon/0000-0002-9640-9278					0	3	3	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 25	2013	496	7446					421	422		10.1038/496421a	http://dx.doi.org/10.1038/496421a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	131HU	23619676				2022-12-28	WOS:000317984400014
J	Heymann, DL; Mackenzie, JS; Peiris, M				Heymann, David L.; Mackenzie, John S.; Peiris, Malik			SARS legacy: outbreak reporting is expected and respected	LANCET			English	Editorial Material							CORONAVIRUS		[Heymann, David L.] Ctr Global Hlth Secur, London, England; [Heymann, David L.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Mackenzie, John S.] Curtin Univ Technol, Fac Hlth Sci, Perth, WA, Australia; [Mackenzie, John S.] Burnet Inst, Melbourne, Vic, Australia; [Peiris, Malik] Univ Hong Kong, Sch Publ Hlth, Ctr Influenza Res, Hong Kong, Hong Kong, Peoples R China	University of London; London School of Hygiene & Tropical Medicine; Curtin University; Burnet Institute; University of Hong Kong	Heymann, DL (corresponding author), Ctr Global Hlth Secur, Chatham House, London, England.	david.heymann@lshtm.ac.uk	/S-4986-2019	/0000-0002-5918-2190				Annan A, 2013, EMERG INFECT DIS; Fleck F, 2003, B WORLD HEALTH ORGAN, V81, P625; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Heymann DL, 2004, EMERG INFECT DIS, V10, P173, DOI 10.3201/eid1002.031038; Heymann DL, 2004, PHILOS T ROY SOC B, V359, P1127, DOI 10.1098/rstb.2004.1484; Liang GD, 2004, EMERG INFECT DIS, V10, P1774, DOI 10.3201/eid1010.040445; Mackenzie JS, 2004, LEARNING FROM SARS, P41; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Stohr K, 2003, LANCET, V361, P1730, DOI 10.1016/S0140-6736(03)13376-4; The FAO-OIE-WHO Collaboration, 2010, SHAR RESP COORD GLOB; WHO, GLOB AL RESP SEV AC; WHO Regional Office for the Western Pacific, 2006, SARS GLOB EP WAS STO; Wong YCR, 2005, SEVERE ACUTE RESPIRATORY SYNDROME, P213; World Health Organization, 2008, INT HLTH REG 2005, V2nd; World Health Organization, BACKGR SUMM NOV COR; World Health Organization, 2003, SEV AC RESP SYNDR SA; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	17	27	31	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 9	2013	381	9869					779	781		10.1016/S0140-6736(13)60185-3	http://dx.doi.org/10.1016/S0140-6736(13)60185-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	105IL	23668493	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000316060600005
J	Rasmussen, B; Allen, S; Rasmussen, ZA; Bajwa, R				Rasmussen, Bruce; Allen, Sheldon; Rasmussen, Zeba A.; Bajwa, Rashid			Learning from disasters to save lives every day in Pakistan	LANCET			English	Editorial Material							FUTURE IMPLICATIONS; NEWBORN SURVIVAL; DECADE; FLOODS		[Rasmussen, Zeba A.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Bajwa, Rashid] Natl Rural Support Programme, Islamabad, Pakistan	National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)		rasmussenbruce@hotmail.com						Ahmad N., 2010, ANN REP 2010; Association of Medical Doctors of Asia, 2010, AMDA EM B, V5; Bhutto ZA, 2010, LANCET, V376, P664, DOI 10.1016/S0140-6736(10)61306-2; Carraro L., 2005, EST IMP LARG NAT DIS; Cochrane H., 2008, ROLE AFFECTED STATE; Cross P, 2010, FINAL PROGRAM REPORT; Emerson S., 2010, STATE ENV MIGRATION; Inter-Agency Standing Committee, 2010, IASC PRINC TRANSF AG; Khan A, 2012, HEALTH POLICY PLANN, V27, P72, DOI 10.1093/heapol/czs047; Pradhan YV, 2012, HEALTH POLICY PLANN, V27, P57, DOI 10.1093/heapol/czs052; Purdin S, 2009, INT J GYNECOL OBSTET, V105, P82, DOI 10.1016/j.ijgo.2008.12.021; Save the Children, 2006, SAV CHILDR PROV MUCH; SOBERON G, 1986, AM J PUBLIC HEALTH, V76, P673, DOI 10.2105/AJPH.76.6.673; Solberg K, 2010, LANCET, V376, P1039, DOI 10.1016/S0140-6736(10)61469-9; Warraich H, 2011, B WORLD HEALTH ORGAN, V89, P236, DOI 10.2471/BLT.10.083386; Zulfiqar T, 2010, ENDL KNOWL PRACT COV	16	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 29	2013	381	9885					2232	2234		10.1016/S0140-6736(13)60652-2	http://dx.doi.org/10.1016/S0140-6736(13)60652-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	173SU	23684253				2022-12-28	WOS:000321100300008
J	Howell, A; Evans, DG				Howell, Anthony; Evans, D. Gareth			Breast cancer prevention: SERMs come of age	LANCET			English	Editorial Material							TAMOXIFEN; RISK; LASOFOXIFENE; DENSITY; WOMEN		[Howell, Anthony; Evans, D. Gareth] Univ S Manchester Hosp, Genesis Breast Canc Prevent Ctr, Manchester M20 8LR, Lancs, England; [Evans, D. Gareth] Univ Manchester, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Cent Manchester Hosp Fdn Trust, Manchester M13 0JH, Lancs, England; [Howell, Anthony] Christie NHS Fdn Trust, Dept Med Oncol, Manchester M20 4BX, Lancs, England	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; Christie NHS Foundation Trust	Howell, A (corresponding author), Univ S Manchester Hosp, Genesis Breast Canc Prevent Ctr, Manchester M20 8LR, Lancs, England.	anthony.howell@christie.nhs.uk	Evans, D Gareth/AAB-4308-2022	Evans, D Gareth/0000-0002-8482-5784; Howell, Anthony/0000-0002-6233-719X	Breast Cancer Now [MAN-Q1] Funding Source: researchfish	Breast Cancer Now		Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Cummings SR, 2010, NEW ENGL J MED, V362, P686, DOI 10.1056/NEJMoa0808692; CUZICK J, 1985, LANCET, V2, P282; Cuzick J, 2013, LANCET; Cuzick J, 2007, JNCI-J NATL CANCER I, V99, P272, DOI 10.1093/jnci/djk049; Cuzick J, 2011, J NATL CANCER I, V103, P744, DOI 10.1093/jnci/djr079; Freedman AN, 2011, J CLIN ONCOL, V29, P2327, DOI 10.1200/JCO.2010.33.0258; Goss PE, 2011, NEW ENGL J MED, V364, P2381, DOI 10.1056/NEJMoa1103507; JORDAN VC, 1976, EUR J CANCER, V12, P419, DOI 10.1016/0014-2964(76)90030-X; LaCroix AZ, 2010, JNCI-J NATL CANCER I, V102, P1706, DOI 10.1093/jnci/djq415; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; National Institute for Health and Clinical Excellence, 2006, FAMILIAL BREAST CANC; Schmidt C, 2010, J NATL CANCER I, V102, P1690, DOI 10.1093/jnci/djq477	14	6	6	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 25	2013	381	9880					1795	1797		10.1016/S0140-6736(13)60443-2	http://dx.doi.org/10.1016/S0140-6736(13)60443-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151EO	23639489				2022-12-28	WOS:000319443700006
J	Fukuda, T; Takeda, S; Xu, R; Ochi, H; Sunamura, S; Sato, T; Shibata, S; Yoshida, Y; Gu, ZR; Kimura, A; Ma, CS; Xu, C; Bando, W; Fujita, K; Shinomiya, K; Hirai, T; Asou, Y; Enomoto, M; Okano, H; Okawa, A; Itoh, H				Fukuda, Toru; Takeda, Shu; Xu, Ren; Ochi, Hiroki; Sunamura, Satoko; Sato, Tsuyoshi; Shibata, Shinsuke; Yoshida, Yutaka; Gu, Zirong; Kimura, Ayako; Ma, Chengshan; Xu, Cheng; Bando, Waka; Fujita, Koji; Shinomiya, Kenichi; Hirai, Takashi; Asou, Yoshinori; Enomoto, Mitsuhiro; Okano, Hideyuki; Okawa, Atsushi; Itoh, Hiroshi			Sema3A regulates bone-mass accrual through sensory innervations	NATURE			English	Article							SYMPATHETIC INNERVATION; IMMUNE-RESPONSES; SEMAPHORIN; CELLS; MAINTENANCE; EXPRESSION; ABLATION; ROLES	Semaphorin 3A (Sema3A) is a diffusible axonal chemorepellent that has an important role in axon guidance(1-5). Previous studies have demonstrated that Sema3a(-/-) mice have multiple developmental defects due to abnormal neuronal innervations(6,7). Here we show in mice that Sema3A is abundantly expressed in bone, and cell-based assays showed that Sema3A affected osteoblast differentiation in a cell-autonomous fashion. Accordingly, Sema3a(-/-) mice had a low bone mass due to decreased bone formation. However, osteoblast-specific Sema3A-deficient mice (Sema3a(coli)(-/-) and Sema3a(osx)(-/-) mice) had normal bone mass, even though the expression of Sema3A in bone was substantially decreased. In contrast, mice lacking Sema3A in neurons (Sema3a(synapsin)(-/-) and Sema3a(nestin)(-/-) mice) had low bone mass, similar to Sema3a(-/-) mice, indicating that neuron-derived Sema3A is responsible for the observed bone abnormalities independent of the local effect of Sema3A in bone. Indeed, the number of sensory innervations of trabecular bone was significantly decreased in Sema3a(synapsin)(-/-) mice, whereas sympathetic innervations of trabecular bone were unchanged. Moreover, ablating sensory nerves decreased bone mass in wild-type mice, whereas it did not reduce the low bone mass in Sema3a(nestin)(-/-) mice further, supporting the essential role of the sensory nervous system in normal bone homeostasis. Finally, neuronal abnormalities in Sema3a(-/-) mice, such as olfactory development, were identified in Sema3a(synasin)(-/-) mice, demonstrating that neuron-derived Sema3A contributes to the abnormal neural development seen in Sema3a(-/-) mice, and indicating that Sema3A produced in neurons regulates neural development in an autocrine manner. This study demonstrates that Sema3A regulates bone remodelling indirectly by modulating sensory nerve development, but not directly by acting on osteoblasts.	[Fukuda, Toru; Takeda, Shu; Ochi, Hiroki; Sunamura, Satoko] Keio Univ, Sch Med, Dept Internal Med, Shinjyuku Ku, Tokyo 1608582, Japan; [Xu, Ren; Kimura, Ayako; Ma, Chengshan; Xu, Cheng; Fujita, Koji; Shinomiya, Kenichi; Hirai, Takashi; Asou, Yoshinori; Enomoto, Mitsuhiro; Okawa, Atsushi] Tokyo Med & Dent Univ, Dept Orthoped Surg, Bunkyo Ku, Tokyo 1138549, Japan; [Xu, Ren; Ma, Chengshan; Xu, Cheng; Fujita, Koji; Okawa, Atsushi] Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence GCOE Program, Bunkyo Ku, Tokyo 1138549, Japan; [Sato, Tsuyoshi] Saitama Med Univ, Dept Oral & Maxillofacial Surg, Moroyama, Saitama 3500495, Japan; [Shibata, Shinsuke; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjyuku Ku, Tokyo 1608582, Japan; [Yoshida, Yutaka; Gu, Zirong] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Kimura, Ayako] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Bunkyo Ku, Tokyo 1138549, Japan; [Bando, Waka; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Sect Nephrol Endocrinol & Metab,Shinjyuku Ku, Tokyo 1608582, Japan	Keio University; Tokyo Medical & Dental University (TMDU); Saitama Medical University; Keio University; Cincinnati Children's Hospital Medical Center; Tokyo Medical & Dental University (TMDU); Keio University	Takeda, S (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Shinjyuku Ku, Shinanomachi 35, Tokyo 1608582, Japan.	shu-tky@umin.ac.jp	Fujita, Koji/K-3905-2019; Okano, Hideyuki/I-7584-2019; Shibata, Shinsuke/AAM-6620-2020	Fujita, Koji/0000-0003-3733-0188; Xu, Cheng/0000-0002-2076-6527	Funding Program for Next Generation World-Leading Researchers (NEXT Program); Japan Society for the Promotion of Science; National Institute of Neurological Disorders and Stroke [NS065048]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065048] Funding Source: NIH RePORTER	Funding Program for Next Generation World-Leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Taniguchi and G. Karsenty for discussions; F. Suto and H. Fujisawa for Plxna4<SUP>-/-</SUP> mice; M. Ukegawa, H. Inose, M. Iwata, S. Ohba, T. Hara and G. Itai for technical assistance. This work was supported by the Funding Program for Next Generation World-Leading Researchers (NEXT Program) to S. T., a grant-in-aid for scientific research from the Japan Society for the Promotion of Science to S. T. and T. F., and grants from the National Institute of Neurological Disorders and Stroke (NS065048) to Y.Y.	Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Fujita K, 2012, NAT MED, V18, P589, DOI 10.1038/nm.2659; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; Ieda M, 2007, NAT MED, V13, P604, DOI 10.1038/nm1570; Imayoshi I, 2006, GENESIS, V44, P233, DOI 10.1002/dvg.20212; Inose H, 2009, P NATL ACAD SCI USA, V106, P20794, DOI 10.1073/pnas.0909311106; Kimura A, 2010, DEVELOPMENT, V137, P1159, DOI 10.1242/dev.045005; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Kusano K, 2011, NEUROSCI LETT, V492, P64, DOI 10.1016/j.neulet.2011.01.058; Maayan C, 2002, OSTEOPOROSIS INT, V13, P429, DOI 10.1007/s001980200050; Mach DB, 2002, NEUROSCIENCE, V113, P155, DOI 10.1016/S0306-4522(02)00165-3; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Moret F, 2007, DEVELOPMENT, V134, P4491, DOI 10.1242/dev.011452; Nakamura F, 2009, J COMP NEUROL, V516, P360, DOI 10.1002/cne.22125; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Offley SC, 2005, J BONE MINER RES, V20, P257, DOI 10.1359/JBMR.041108; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Okuda N, 2007, BONE, V40, P281, DOI 10.1016/j.bone.2006.08.017; Pasterkamp RJ, 2009, CURR OPIN NEUROBIOL, V19, P263, DOI 10.1016/j.conb.2009.06.001; Potiron V, 2007, ADV EXP MED BIOL, V600, P132; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Roth L, 2009, CELL MOL LIFE SCI, V66, P649, DOI 10.1007/s00018-008-8518-z; Sato S, 2007, NAT MED, V13, P1234, DOI 10.1038/nm1640; Shibata S, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-31; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Takeda S, 2008, J NEUROENDOCRINOL, V20, P802, DOI 10.1111/j.1365-2826.2008.01732.x; Takegahara N, 2006, NAT CELL BIOL, V8, P615, DOI 10.1038/ncb1416; Tamagnone L, 2004, EMBO REP, V5, P356, DOI 10.1038/sj.embor.7400114; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Tian L, 2009, TRENDS IMMUNOL, V30, P91, DOI 10.1016/j.it.2008.11.002; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	36	237	262	5	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2013	497	7450					490	+		10.1038/nature12115	http://dx.doi.org/10.1038/nature12115			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23644455				2022-12-28	WOS:000319254000048
J	Kasuga, H; Fukuyama, M; Kitazawa, A; Kontani, K; Katada, T				Kasuga, Hidefumi; Fukuyama, Masamitsu; Kitazawa, Aya; Kontani, Kenji; Katada, Toshiaki			The microRNA miR-235 couples blast-cell quiescence to the nutritional state	NATURE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; STEM-CELL; NUCLEAR FACTOR; ARREST; LIN-4; EXPRESSION; GERMLINE; LINEAGES; BEHAVIOR	The coordination of stem-and blast-cell behaviours, such as self-renewal, differentiation and quiescence, with physiological changes underlies growth, regeneration and tissue homeostasis(1-3). Germline stem and somatic blast cells in newly hatched Caenorhabditis elegans larvae can suspend postembryonic development, which consists of diverse cellular events such as migration, proliferation and differentiation, until the nutritional state becomes favourable (termed L1 diapause(4-6)). Although previous studies showed that the insulin/insulin-like growth factor (IGF) signalling (IIS) pathway regulates this developmental quiescence(5-8), the detailed mechanism by which the IIS pathway enables these multipotent cells to respond to nutrient availability is unknown. Here we show in C. elegans that the microRNA (miRNA) miR-235, a sole orthologue of mammalian miR-92 from the oncogenicmiR-17-92 cluster(9,10), acts in the hypodermis and glial cells to arrest postembryonic developmental events in both neuroblasts and mesoblasts. Expression of mir-235 persists during L1 diapause, and decreases upon feeding in a manner dependent on the IIS pathway. Upregulation of one of the miR-235 targets, nhr-91, which encodes an orthologue of mammalian germ cell nuclear factor, is responsible for defects caused by loss of the miRNA. Our findings establish a novel role of a miR-92 orthologue in coupling blast-cell behaviours to the nutritional state.	[Kasuga, Hidefumi; Fukuyama, Masamitsu; Kitazawa, Aya; Kontani, Kenji; Katada, Toshiaki] Univ Tokyo, Grad Sch Pharmaceut Sci, Physiol Chem Lab, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Fukuyama, M (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Physiol Chem Lab, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mfukuyam@mol.f.u-tokyo.ac.jp			National Institutes of Health National Center for Research Resources; MITANI Lab through the National Bio-Resource Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Society for the Promotion of Science KAKENHI [23229001, 23370083]; MEXT KAKENHI [24657081, 23116703]	National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); MITANI Lab through the National Bio-Resource Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank A. Fire, A. Frand, Y. Iino, S. Mitani, X. Wei and K. Shen for reagents and strains, and K. Iki for comments on the manuscript. Some C. elegans strains used in this study were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources, and the MITANI Lab through the National Bio-Resource Project of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. This work was supported by Japan Society for the Promotion of Science KAKENHI grant numbers 23229001 (T. K.), 23370083 (K. K.), and MEXT KAKENHI grant numbers 24657081 (T. K.), 23116703 (M.F.).	Ables ET, 2011, CELL STEM CELL, V8, P352, DOI 10.1016/j.stem.2011.03.004; Akamatsu W, 2009, J NEUROSCI, V29, P2113, DOI 10.1523/JNEUROSCI.4527-08.2009; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Feinbaum R, 1999, DEV BIOL, V210, P87, DOI 10.1006/dbio.1999.9272; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; Fukuyama M, 2006, CURR BIOL, V16, P773, DOI 10.1016/j.cub.2006.02.073; Fukuyama M, 2012, BIOL OPEN, V1, P929, DOI 10.1242/bio.2012836; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gems D, 1998, GENETICS, V150, P129; Gissendanner CR, 2004, DEV BIOL, V266, P399, DOI 10.1016/j.ydbio.2003.10.014; Harfe BD, 1998, GENE DEV, V12, P2623, DOI 10.1101/gad.12.16.2623; Hong Y, 1998, DEVELOPMENT, V125, P3585; Ibanez-Ventoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002818; Jasper H, 2010, CELL METAB, V12, P561, DOI 10.1016/j.cmet.2010.11.010; Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Meli VS, 2010, MOL BIOL CELL, V21, P1648, DOI 10.1091/mbc.E08-07-0708; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Monsalve GC, 2011, CURR BIOL, V21, P2033, DOI 10.1016/j.cub.2011.10.054; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nakada D, 2011, NEURON, V70, P703, DOI 10.1016/j.neuron.2011.05.011; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163	29	38	39	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					503	+		10.1038/nature12117	http://dx.doi.org/10.1038/nature12117			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23644454				2022-12-28	WOS:000319254000051
J	Park, S; Li, XM; Kim, HM; Singh, CR; Tian, G; Hoyt, MA; Lovell, S; Battaile, KP; Zolkiewski, M; Coffino, P; Roelofs, J; Cheng, YF; Finley, D				Park, Soyeon; Li, Xueming; Kim, Ho Min; Singh, Chingakham Ranjit; Tian, Geng; Hoyt, Martin A.; Lovell, Scott; Battaile, Kevin P.; Zolkiewski, Michal; Coffino, Philip; Roelofs, Jeroen; Cheng, Yifan; Finley, Daniel			Reconfiguration of the proteasome during chaperone-mediated assembly	NATURE			English	Article							YEAST 26S PROTEASOME; REGULATORY PARTICLE; STRUCTURAL BASIS; 20S PROTEASOMES; S PROTEASOME; ATPASES; SUBUNIT; PATHWAY; CORE; GATE	The proteasomal ATPase ring, comprising Rpt1-Rpt6, associates with the heptameric alpha-ring of the proteasome core particle (CP) in the mature proteasome, with the Rpt carboxy-terminal tails inserting into pockets of the alpha-ring(1-4). Rpt ring assembly is mediated by four chaperones, each binding a distinct Rpt subunit(5-10). Here we report that the base subassembly of the Saccharomyces cerevisiae proteasome, which includes the Rpt ring, forms a high-affinity complex with the CP. This complex is subject to active dissociation by the chaperones Hsm3, Nas6 and Rpn14. Chaperone-mediated dissociation was abrogated by a non-hydrolysable ATP analogue, indicating that chaperone action is coupled to nucleotide hydrolysis by the Rpt ring. Unexpectedly, synthetic Rpt tail peptides bound alpha-pockets with poor specificity, except for Rpt6, which uniquely bound the alpha 2/alpha 3-pocket. Although the Rpt6 tail is not visualized within an alpha-pocket in mature proteasomes(2-4), it inserts into the alpha 2/alpha 3-pocket in the base-CP complex and is important for complex formation. Thus, the Rpt-CP interface is reconfigured when the lid complex joins the nascent proteasome to form the mature holoenzyme.	[Park, Soyeon; Tian, Geng; Finley, Daniel] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Park, Soyeon] Univ Colorado, MCD Biol, Boulder, CO 80309 USA; [Li, Xueming; Kim, Ho Min; Cheng, Yifan] Univ Calif San Francisco, Dept Biochem & Biophys, WM Keck Adv Microscopy Lab, San Francisco, CA 94158 USA; [Singh, Chingakham Ranjit; Roelofs, Jeroen] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Hoyt, Martin A.; Coffino, Philip] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Lovell, Scott] Univ Kansas, Del Shankel Struct Biol Ctr, Prot Struct Lab, Lawrence, KS 66047 USA; [Battaile, Kevin P.] IMCA CAT Hauptman Woodward Med Res Inst, Argonne, IL 60439 USA; [Zolkiewski, Michal] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA	Harvard University; Harvard Medical School; University of Colorado System; University of Colorado Boulder; University of California System; University of California San Francisco; Kansas State University; University of California System; University of California San Francisco; University of Kansas; Hauptman Woodward Medical Research Institute; Kansas State University	Roelofs, J (corresponding author), Kansas State Univ, Div Biol, 338 Ackert Hall, Manhattan, KS 66506 USA.	jroelofs@ksu.edu; ycheng@ucsf.edu; daniel_finley@hms.harvard.edu	Kim, Ho Min/G-2712-2011; Roelofs, Jeroen/AAC-5119-2021	Roelofs, Jeroen/0000-0003-0944-2465; Cheng, Yifan/0000-0001-9535-0369; Battaile, Kevin/0000-0003-0833-3259	National Institutes of Health (NIH) [R01GM082893, 1S10RR026814-01]; University of California San Francisco Program for Breakthrough Biomedical Research (New Technology Award); Johnson Cancer Research Center; National Center for Research Resources [5P20RR017708, P20 RR016475]; NIH [8 P20 GM103420, P20 GM103418, R01GM045335, R37GM043601]; Charles A. King Trust Postdoctoral Research Fellowship Program of the Medical Foundation; US Department of Energy [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026814, P20RR017708, P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103420, P20GM103418, R01GM098672, R37GM043601, R01GM082893, R01GM045335] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco Program for Breakthrough Biomedical Research (New Technology Award); Johnson Cancer Research Center; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles A. King Trust Postdoctoral Research Fellowship Program of the Medical Foundation; US Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Schmidt, T. Walz, C. Chen, and Finley laboratory members for suggestions, and C. Mann for antibodies. This work was supported in part by grants from the National Institutes of Health (NIH; R01GM082893 and 1S10RR026814-01), the University of California San Francisco Program for Breakthrough Biomedical Research (New Technology Award) to Y.C.; the Johnson Cancer Research Center, the National Center for Research Resources (5P20RR017708 and P20 RR016475) and NIH (8 P20 GM103420 and P20 GM103418) to J.R.; and grants from the NIH to P. C. (R01GM045335) and D. F. (R37GM043601). S. P. was supported by the Charles A. King Trust Postdoctoral Research Fellowship Program of the Medical Foundation. Use of IMCA-CAT was supported by the Industrial Macromolecular Crystallography Association though a contract with the Hauptman-Woodward MRI. Use of the Advanced Photon Source was supported by the US Department of Energy (contract no. DE-AC02-06CH11357).	Barrault MB, 2012, P NATL ACAD SCI USA, V109, pE1001, DOI 10.1073/pnas.1116538109; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kish-Trier E, 2013, ANNU REV BIOPHYS, V42, P29, DOI 10.1146/annurev-biophys-083012-130417; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Nakamura Y, 2007, BIOCHEM BIOPH RES CO, V359, P503, DOI 10.1016/j.bbrc.2007.05.138; Park S, 2011, J BIOL CHEM, V286, P36652, DOI 10.1074/jbc.M111.285924; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Pathare GR, 2012, P NATL ACAD SCI USA, V109, P149, DOI 10.1073/pnas.1117648108; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Takagi K, 2012, J BIOL CHEM, V287, P12172, DOI 10.1074/jbc.M112.345876; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Tian G, 2011, NAT STRUCT MOL BIOL, V18, P1259, DOI 10.1038/nsmb.2147; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035	25	54	55	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2013	497	7450					512	516		10.1038/nature12123	http://dx.doi.org/10.1038/nature12123			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23644457	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000319254000053
J	Zhu, J; Peng, T; Johnston, C; Phasouk, K; Kask, AS; Klock, A; Jin, L; Diem, K; Koelle, DM; Wald, A; Robins, H; Corey, L				Zhu, Jia; Peng, Tao; Johnston, Christine; Phasouk, Khamsone; Kask, Angela S.; Klock, Alexis; Jin, Lei; Diem, Kurt; Koelle, David M.; Wald, Anna; Robins, Harlan; Corey, Lawrence			Immune surveillance by CD8 alpha alpha(+) skin-resident T cells in human herpes virus infection	NATURE			English	Article							SIMPLEX-VIRUS; REACTIVATION; TISSUE; EXIT	Most herpes simplex virus 2 (HSV-2) reactivations in humans are subclinical and associated with rapid expansion and containment of virus. Previous studies have shown that CD8(+) T cells persist in genital skin and mucosa at the dermal-epidermal junction (DEJ)-the portal of neuronal release of reactivating virus-for prolonged time periods after herpes lesions are cleared(1,2). The phenotype and function of this persistent CD8(+) T-cell population remain unknown. Here, using cell-type-specific laser capture microdissection, transcriptional profiling and T-cell antigen receptor beta-chain (TCR beta) genotyping on sequential genital skin biopsies, we show that CD8 alpha alpha(+) T cells are the dominant resident population of DEJ CD8(+) T cells that persist at the site of previous HSV-2 reactivation. CD8 alpha alpha(+) T cells located at the DEJ lack chemokine-receptor expression required for lymphocyte egress and recirculation, express gene signatures of T-cell activation and antiviral activity, and produce cytolytic granules during clinical and virological quiescent time periods. Sequencing of the TCR beta-chain repertoire reveals that the DEJ CD8 alpha alpha(+) T cells are oligoclonal with diverse usage of TCR variable-beta genes, which differ from those commonly described for mucosa-associated invariant T cells and natural killer T cells. Dominant clonotypes are shown to overlap among multiple recurrences over a period of two-and-a-half years. Episodes of rapid asymptomatic HSV-2 containment were also associated with a high CD8 effector-to-target ratio and focal enrichment of CD8 alpha alpha(+) T cells. These studies indicate that DEJ CD8 alpha alpha(+) T cells are tissue-resident cells that seem to have a fundamental role in immune surveillance and in initial containment of HSV-2 reactivation in human peripheral tissue. Elicitation of CD8 alpha alpha(+) T cells may be a critical component for developing effective vaccines against skin and mucosal infections.	[Zhu, Jia; Kask, Angela S.; Klock, Alexis; Jin, Lei; Diem, Kurt; Koelle, David M.; Wald, Anna; Corey, Lawrence] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Zhu, Jia; Peng, Tao; Phasouk, Khamsone; Koelle, David M.; Wald, Anna; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA; [Peng, Tao; Johnston, Christine; Koelle, David M.; Wald, Anna; Corey, Lawrence] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Koelle, David M.; Corey, Lawrence] Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA; [Koelle, David M.] Benaroya Res Inst, Seattle, WA 98104 USA; [Wald, Anna] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Robins, Harlan] Fred Hutchinson Canc Res Ctr, Program Computat Biol, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Benaroya Research Institute; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Zhu, J (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.	jiazhu@u.washington.edu; lcorey@fhcrc.org	Koelle, David/Q-6529-2016; Corey, Lawrence/AAE-1796-2020; Wald, Anna/B-6272-2012	Koelle, David/0000-0003-1255-9023; Corey, Lawrence/0000-0002-2179-2436; Wald, Anna/0000-0003-3486-6438; Zhu, Jia/0000-0002-8676-5105; Johnston, Christine/0000-0002-3073-0843	National Institutes of Health [R37AI042528, R01AI04252815, P01AI030731, R56AI093746]; James B. Pendleton Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042528, P01AI030731, R37AI042528, R56AI093746, R01AI094019] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James B. Pendleton Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Huang, H. Xie, J. Vazquez and D. McDonald for technical assistance; M. Prlic and C. Desmarais for discussion and reading the manuscript and M. Miner for editing. We also thank our study participants and S. Kuntz and M. Stern for clinical assistance. This work was supported by grants from the National Institutes of Health (R37AI042528, R01AI04252815, P01AI030731 and R56AI093746) and the James B. Pendleton Charitable Trust.	Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Chi HB, 2005, J IMMUNOL, V174, P2485, DOI 10.4049/jimmunol.174.5.2485; Clark RA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003008; CUNNINGHAM AL, 1985, J CLIN INVEST, V75, P226, DOI 10.1172/JCI111678; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Hayday A, 2001, NAT IMMUNOL, V2, P997, DOI 10.1038/ni1101-997; Huang YJ, 2011, NAT IMMUNOL, V12, P1086, DOI 10.1038/ni.2106; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Jing LC, 2012, J CLIN INVEST, V122, P654, DOI 10.1172/JCI60556; Khanna KM, 2003, IMMUNITY, V18, P593, DOI 10.1016/S1074-7613(03)00112-2; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; Magaret AS, 2007, J CLIN MICROBIOL, V45, P1618, DOI 10.1128/JCM.01405-06; Mark KE, 2008, J INFECT DIS, V198, P1141, DOI 10.1086/591913; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Peng T, 2012, J VIROL, V86, P10587, DOI 10.1128/JVI.01237-12; Purwar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016245; RIDDELL SR, 1992, SCIENCE, V257, P238; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Schiffer Joshua T, 2010, Proc Natl Acad Sci U S A, V107, P18973, DOI 10.1073/pnas.1006614107; Schiffer JT, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000193; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Trautmann L, 2005, J IMMUNOL, V175, P6123, DOI 10.4049/jimmunol.175.9.6123; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Wald A, 2000, NEW ENGL J MED, V342, P844, DOI 10.1056/NEJM200003233421203; WALD A, 1995, NEW ENGL J MED, V333, P770, DOI 10.1056/NEJM199509213331205; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792; Zhu J, 2009, NAT MED, V15, P886, DOI 10.1038/nm.2006	30	202	224	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2013	497	7450					494	+		10.1038/nature12110	http://dx.doi.org/10.1038/nature12110			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23657257	Green Accepted			2022-12-28	WOS:000319254000049
J	Iglehart, JK				Iglehart, John K.			Expanding the Role of Advanced Nurse Practitioners - Risks and Rewards	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PRIMARY-CARE; RETAIL CLINICS; PHYSICIANS; EXPANSION; WORKFORCE											Agency for Healthcare Research and Quality (AHRQ), 2012, AHRQ PUBLICATION; AIKEN L, 2007, PENNSYLVANIA WORKFOR; Aiken LH, 2011, NEW ENGL J MED, V364, P196, DOI 10.1056/NEJMp1011639; Aiken LH, 2009, HEALTH AFFAIR, V28, pW646, DOI 10.1377/hlthaff.28.4.w646; AIZENMAN NC, 2013, WASH POST, pA1; Altschuler J, 2012, ANN FAM MED, V10, P396, DOI 10.1370/afm.1400; *AM MED ASS, 2012, STRUCT FUNCT INT HLT; *AM MED ASS ADV RE, 2012, IND NURS PRACT DO AD; *AM MED ASS ADV RE, 2012, COMP QUAL PAT SAT PH; American Academy of Family Physicians, 2012, PRIM CAR 21 CENT ENS; American Medical Association, 2010, TRUTH ADV CAMP; [Anonymous], 2012, COMMUNICATION; [Anonymous], 2012, COMMUNICATION; Association of American Medical Colleges, 2012, AAMC PHYS WORKF POL; Auerbach DI, 2012, MED CARE, V50, P606, DOI 10.1097/MLR.0b013e318249d6e7; Bauer JC, 2010, J AM ACAD NURSE PRAC, V22, P228, DOI 10.1111/j.1745-7599.2010.00498.x; BECK M, 2013, WALL STREET J, pA3; Bednash G. D., 2012, 2011 2012 ENROLLMENT; Brassard A, 2013, AM J NURS, V113, P48, DOI 10.1097/01.NAJ.0000427880.25795.d3; Buchmueller TC, 2005, MED CARE RES REV, V62, P3, DOI 10.1177/1077558704271718; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P2151, DOI 10.1001/jama.2012.3966; Congressional Budget Office, 2013, BUDG EC OUTL FISC YE; DeSanti SS, 2012, COMMUNICATION; Fairman JA, 2011, NEW ENGL J MED, V364, P193, DOI 10.1056/NEJMp1012121; Federal Trade Commission, 2011, COMMUNICATION; Federal Trade Commission, 2013, COMMUNICATION; Goolsby MJ, 2011, J AM ACAD NURSE PRAC, V23, P266, DOI 10.1111/j.1745-7599.2011.00611.x; HANSENTURTON T, 2010, TEMPLE LAW REV, V82, P1235; Harris Gardiner, 2011, NY TIMES, pA1; *HLTH RES SERV ADM, 2010, REG NURS POP IN FIND; Hofer AN, 2011, MILBANK Q, V89, P69, DOI 10.1111/j.1468-0009.2011.00620.x; Horrocks S, 2002, BRIT MED J, V324, P819, DOI 10.1136/bmj.324.7341.819; Institute of Medicine, 2010, FUT NURS LEAD CHANG; *J MAC FDN, 2012, C INT ED; Kutney-Lee A, 2013, HEALTH AFFAIR, V32, P579, DOI 10.1377/hlthaff.2012.0504; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; Lazarus Jeremy A, 2012, J Ark Med Soc, V109, P124; Lee TH, 2012, NEW ENGL J MED, V367, P466, DOI 10.1056/NEJMhpr1204386; MAKAROFF LA, 2013, AM FAM PHYSICIAN, V87, P7; McWilliams JM, 2007, NEW ENGL J MED, V357, P143, DOI 10.1056/NEJMsa067712; Medical Group Management Association, 2012, PHYS COMP PROD SURV; Mehrotra A, 2009, ANN INTERN MED, V151, P321, DOI 10.7326/0003-4819-151-5-200909010-00006; Morgan P, CHARACTERISTICS PRIM; Morgan PA, 2010, HEALTH AFFAIR, V29, P887, DOI 10.1377/hlthaff.2008.0835; Mundinger MO, 2000, JAMA-J AM MED ASSOC, V283, P59, DOI 10.1001/jama.283.1.59; National Governors Association, 2012, ROL NURS PRACT M INC; Naylor MD, 2010, HEALTH AFFAIR, V29, P893, DOI 10.1377/hlthaff.2010.0440; Newhouse RR, 2011, NURS ECON, V29, P230; Phillips RL, 2002, HEALTH AFFAIR, V21, P133, DOI 10.1377/hlthaff.21.5.133; Pohl JM, 2010, HEALTH AFFAIR, V29, P900, DOI 10.1377/hlthaff.2010.0374; Robert Wood Johnson Foundation, 2011, COMM GROUND AGR NURS; Robert Wood Johnson Foundation, 2013, FOST INT COLL PHYS N; Rudavsky R, 2009, ANN INTERN MED, V151, P315, DOI 10.7326/0003-4819-151-5-200909010-00005; *RW JOHNS FDN, 2011, PHYS NURS DIAL COLL; Safriet B. J., 2002, YALE J REGUL, V19, P317; Safriet BJ, 2010, FEDERAL OPTIONS MAXI; Schwartz MD, 2012, JAMA-J AM MED ASSOC, V308, P2252, DOI 10.1001/jama.2012.77034; Susman J, 2010, J FAM PRACTICE, V59, P672; Torrisi DL, 2005, COMMUNITY NURSE MANA	59	79	79	0	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2013	368	20					1935	1941		10.1056/NEJMhpr1301084	http://dx.doi.org/10.1056/NEJMhpr1301084			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	143VK	23675663				2022-12-28	WOS:000318896200016
J	Appleby, J				Appleby, John			DATA BRIEFING Are "friends and family tests" useful: agree, disagree, neither, don't know?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London, England		Appleby, J (corresponding author), Kings Fund, London, England.	j.appleby@kingsfund.org.uk						Department of Health, 2011, FAM FRIENDS TEST IMP; Department of Health, 2013, NHS FRIENDS FAM TEST; Ipsos MORI, 2012, SCOR PRES FRIENDS FA; National NHS Staff Survey Coordination Centre, NHS STAFF SURV HIST; National NHS Staff Survey Coordination Centre, 2012 NHS STAFF SURV; NHS Choices, EX PAT REV WHITT HOS; Reichheld FF, 2003, HARVARD BUS REV	7	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2013	346								f2960	10.1136/bmj.f2960	http://dx.doi.org/10.1136/bmj.f2960			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148OF	23674334				2022-12-28	WOS:000319253900009
J	Cebula, A; Seweryn, M; Rempala, GA; Pabla, SS; McIndoe, RA; Denning, TL; Bry, L; Kraj, P; Kisielow, P; Ignatowicz, L				Cebula, Anna; Seweryn, Michal; Rempala, Grzegorz A.; Pabla, Simarjot Singh; McIndoe, Richard A.; Denning, Timothy L.; Bry, Lynn; Kraj, Piotr; Kisielow, Pawel; Ignatowicz, Leszek			Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota	NATURE			English	Article							SELF; SELECTION; ANTIGEN	Peripheral mechanisms preventing autoimmunity and maintaining tolerance to commensal microbiota involve CD4(+) Foxp3(+) regulatory T (T-reg) cells(1,2) generated in the thymus or extrathymically by induction of naive CD4(+) Foxp3(-) T cells. Previous studies suggested that the T-cell receptor repertoires of thymic T-reg cells and induced T-reg cells are biased towards self and non-self antigens, respectively(3-6), but their relative contribution in controlling immunopathology, such as colitis and other untoward inflammatory responses triggered by different types of antigens, remains unresolved(7). The intestine, and especially the colon, is a particularly suitable organ to study this question, given the variety of self-, microbiota- and food-derived antigens to which T-reg cells and other T-cell populations are exposed. Intestinal environments can enhance conversion to a regulatory lineage(8,9) and favour tolerogenic presentation of antigens to naive CD4(+) T cells(10,11), suggesting that intestinal homeostasis depends on microbiota-specific induced T-reg cells(12-15). Here, to identify the origin and antigen-specificity of intestinal T-reg cells, we performed single-cell and high-throughput sequencing of the T-cell receptor repertoires of CD4(+) Foxp3(+) and CD4(+) Foxp3(-) T cells, and analysed their reactivity against specific commensal species. We show that thymus-derived T-reg cells constitute most T-reg cells in all lymphoid and intestinal organs, including the colon, where their repertoire is heavily influenced by the composition of the microbiota. Our results suggest that thymic T-reg cells, and not induced T-reg cells, dominantly mediate tolerance to antigens produced by intestinal commensals.	[Cebula, Anna; Pabla, Simarjot Singh; McIndoe, Richard A.; Kraj, Piotr; Ignatowicz, Leszek] Georgia Regents Univ, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA; [Seweryn, Michal; Rempala, Grzegorz A.] Ohio State Univ, Coll Publ Hlth, Math Biosci Inst, Columbus, OH 43210 USA; [Seweryn, Michal] Univ Lodz, Fac Math & Comp Sci, PL-90238 Lodz, Poland; [Denning, Timothy L.] Emory Univ, Dept Pediat, Atlanta, GA 30329 USA; [Bry, Lynn] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Kisielow, Pawel] Ludwik Hirszfeld Inst Immunol & Expt Therapy, Dept Tumor Immunol, PL-53114 Wroclaw, Poland	University System of Georgia; Augusta University; University System of Ohio; Ohio State University; University of Lodz; Emory University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences	Ignatowicz, L (corresponding author), Georgia Regents Univ, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA.	lignatowicz@gru.edu		Seweryn, Michal/0000-0002-9090-3435; McIndoe, Richard/0000-0002-3040-3631; Denning, Timothy/0000-0002-1072-7444; Bry, Lynn/0000-0002-8792-8527	National Institutes of Health (NIH) [AI 5R01AI079277, DMS1106485, R01CA152158]; Brigham and Women's Hospital in Boston, Massachusetts;  [P30-DK034854]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061916] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA152158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER; Division Of Mathematical Sciences [1318886] Funding Source: National Science Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brigham and Women's Hospital in Boston, Massachusetts; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by basic research grants from the National Institutes of Health (NIH; AI 5R01AI079277 to L. I., and DMS1106485 and R01CA152158 to G. A. R.). The Harvard Digestive Disease Center (HDDC) Microbiome Core facility is supported by P30-DK034854 and Brigham and Women's Hospital in Boston, Massachusetts. Microbiological analyses were performed by M. Delaney, A. Dubois and Q. Liu in the HDDC Microbiome Core, with additional review of findings by A. B. Onderdonk. We thank J. Pihkala and H. Ignatowicz for technical assistance, M. Kuczma, L. Wojciech, E. Szurek, A. Miazek and P. Muranski for discussion and R. Markowitz for editing the manuscript.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Coutinho A, 2005, CURR TOP MICROBIOL, V293, P43, DOI 10.1007/3-540-27702-1_3; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Haribhai D, 2011, IMMUNITY, V35, P109, DOI 10.1016/j.immuni.2011.03.029; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kuczma M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013623; Kuczma M, 2009, J IMMUNOL, V183, P3731, DOI 10.4049/jimmunol.0800601; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lathrop SK, 2008, J EXP MED, V205, P3105, DOI 10.1084/jem.20081359; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Rempala G. A., 2012, J MATH BIOL; Renyi A., 1961, P 4 BERK S MATH STAT, V1, P547; Ribot J, 2006, J IMMUNOL, V177, P1101, DOI 10.4049/jimmunol.177.2.1101; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sakaguchi S, 2012, NAT MED, V18, P54, DOI 10.1038/nm.2622; Singh N, 2011, METHODS MOL BIOL, V707, P39, DOI 10.1007/978-1-61737-979-6_3; Suffia IJ, 2006, J EXP MED, V203, P777, DOI 10.1084/jem.20052056; Wong J, 2007, J EXP MED, V204, P2039, DOI 10.1084/jem.20070822	30	264	273	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2013	497	7448					258	+		10.1038/nature12079	http://dx.doi.org/10.1038/nature12079			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23624374	Green Accepted, Green Submitted			2022-12-28	WOS:000318558200040
J	Fromm, G; Gilchrist, DA; Adelman, K				Fromm, George; Gilchrist, Daniel A.; Adelman, Karen			SnapShot! Transcription Regulation: Pausing	CELL			English	Editorial Material							ELONGATION; COMPLEX		[Fromm, George; Gilchrist, Daniel A.; Adelman, Karen] NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Fromm, G (corresponding author), NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA.		Fromm, George/GYA-1316-2022	Fromm, George/0000-0002-7049-0274; Gilchrist, Daniel/0000-0003-1668-2790; Adelman, Karen/0000-0001-5364-334X	Intramural NIH HHS Funding Source: Medline; NIEHS NIH HHS [Z01 ES101987] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101987, ZIAES101987] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Conaway RC, 2013, BBA-GENE REGUL MECH, V1829, P69, DOI 10.1016/j.bbagrm.2012.08.017; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Yamaguchi Y, 2013, BBA-GENE REGUL MECH, V1829, P98, DOI 10.1016/j.bbagrm.2012.11.007; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	11	6	6	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 9	2013	153	4					930	+		10.1016/j.cell.2013.04.011	http://dx.doi.org/10.1016/j.cell.2013.04.011			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663787	Bronze			2022-12-28	WOS:000318844000020
J	Hublin, JJ				Hublin, Jean-Jacques			Free digital scans of human fossils	NATURE			English	Editorial Material									Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany	Max Planck Society	Hublin, JJ (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany.	hublin@eva.mpg.de						Skinner MM, 2013, J HUM EVOL, V64, P434, DOI 10.1016/j.jhevol.2013.01.007	1	12	12	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2013	497	7448					183	183		10.1038/497183a	http://dx.doi.org/10.1038/497183a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	139CD	23657334				2022-12-28	WOS:000318558200013
J	Mathias, JS; Baker, DW				Mathias, Jason S.; Baker, David W.			Developing Quality Measures to Address Overuse	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PERFORMANCE; SERVICES		[Mathias, Jason S.] Northwestern Univ, Feinberg Sch Med, Div Gen Internal Med, Chicago, IL 60611 USA; [Baker, David W.] Northwestern Univ, Feinberg Sch Med, Inst Publ Hlth & Med, Div Gen Internal Med & Geriatr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Baker, DW (corresponding author), Northwestern Univ, Feinberg Sch Med, Inst Publ Hlth & Med, Div Gen Internal Med & Geriatr, 750 N Lakeshore Dr,10th Floor, Chicago, IL 60611 USA.	dwbaker@northwestern.edu						Baker DW, 2013, ANN INTERN MED, V158, P55, DOI 10.7326/0003-4819-158-1-201301010-00560; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSS QUAL CHASM NEW; Mathias JS, 2012, MED CARE, V50, P808, DOI 10.1097/MLR.0b013e31825a8c48; Miller DC, 2011, JAMA-J AM MED ASSOC, V306, P2719, DOI 10.1001/jama.2011.1879; National Priorities Partnership, 2008, NAT PRIOR GOALS ALL; Volk RJ, 2011, JAMA-J AM MED ASSOC, V306, P2715, DOI 10.1001/jama.2011.1893; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009	7	29	29	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2013	309	18					1897	1898		10.1001/jama.2013.3588	http://dx.doi.org/10.1001/jama.2013.3588			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138AZ	23652520				2022-12-28	WOS:000318481900022
J	Garrett, WS				Garrett, Wendy S.			Kwashiorkor and the Gut Microbiota	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Garrett, WS (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.			Garrett, Wendy/0000-0002-5092-0150	NATIONAL CANCER INSTITUTE [R01CA154426] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA154426] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Oren A, 2011, NAT REV MICROBIOL, V9, P279; Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000; Trehan I, 2013, NEW ENGL J MED, V368, P425, DOI 10.1056/NEJMoa1202851; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	5	12	12	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 2	2013	368	18					1746	1747		10.1056/NEJMcibr1301297	http://dx.doi.org/10.1056/NEJMcibr1301297			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	134MN	23635056				2022-12-28	WOS:000318214400013
J	Holmes, D				Holmes, David			Joseph Sung: marking the tenth anniversary of SARS Profile	LANCET			English	Biographical-Item																		SUNG J, PUBLICATION LIST, P65207	1	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 9	2013	381	9869					797	797		10.1016/S0140-6736(13)60616-9	http://dx.doi.org/10.1016/S0140-6736(13)60616-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105IL	23668501	Green Published, Bronze			2022-12-28	WOS:000316060600015
J	Tsai, JN; Uihlein, AV; Lee, H; Kumbhani, R; Siwila-Sackman, E; McKay, EA; Burnett-Bowie, SAM; Neer, RM; Leder, BZ				Tsai, Joy N.; Uihlein, Alexander V.; Lee, Hang; Kumbhani, Ruchit; Siwila-Sackman, Erica; McKay, Elizabeth A.; Burnett-Bowie, Sherri-Ann M.; Neer, Robert M.; Leder, Benjamin Z.			Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial	LANCET			English	Article								Background Osteoporosis medications increase bone-mineral density (BMD) and lower but do not eliminate fracture risk. The combining of anabolic agents with bisphosphonates has not improved efficacy. We compared combined teriparatide and denosumab with both agents alone. Methods From September, 2009, to January, 2011, we enrolled postmenopausal women with osteoporosis into this randomised, controlled trial. Patients were assigned in a 1: 1: 1 ratio to receive 20 mu g teriparatide daily, 60 mg denosumab every 6 months, or both. BMD was measured at 0, 3, 6, and 12 months. Women who completed at least one study visit after baseline were assessed in a modified intention-to-treat analysis. This trial is registered with ClinicalTrials.gov, number NCT00926380. Findings 94 (94%) of 100 eligible women completed at least one study visit after baseline. At 12 months, posterior-anterior lumbar spine BMD increased more in the combination group (9.1%, [SD 3.9]) than in the teriparatide (6.2% [4.6], p=0.0139) or denosumab (5.5% [3.3], p=0.0005) groups. Femoral-neck BMD also increased more in the combination group (4.2% [3.0]) than in the teriparatide (0.8% [4.1], p=0.0007) and denosumab (2.1% [3.8], p=0.0238) groups, as did total-hip BMD (combination, 4.9% [2.9]; teriparatide, 0.7% [2.7], p<0.0001; denosumab 2.5% [2.6], p=0.0011). Interpretation Combined teriparatide and denosumab increased BMD more than either agent alone and more than has been reported with approved therapies. Combination treatment might, therefore, be useful to treat patients at high risk of fracture.	[Tsai, Joy N.; Uihlein, Alexander V.; Kumbhani, Ruchit; Siwila-Sackman, Erica; McKay, Elizabeth A.; Burnett-Bowie, Sherri-Ann M.; Neer, Robert M.; Leder, Benjamin Z.] Massachusetts Gen Hosp, Dept Med, Endocrine Unit, Boston, MA 02114 USA; [Lee, Hang] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Leder, BZ (corresponding author), Massachusetts Gen Hosp, Dept Med, Endocrine Unit, 50 Blossom St,Thier 1051, Boston, MA 02114 USA.	bzleder@partners.org		Burnett-Bowie, Sherri-Ann/0000-0002-0064-096X	Amgen; Eli Lilly; National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007028] Funding Source: NIH RePORTER	Amgen(Amgen); Eli Lilly(Eli Lilly); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Amgen, Eli Lilly, National Center for Research Resources.		0	279	299	0	51	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 6	2013	382	9886					50	56		10.1016/S0140-6736(13)60856-9	http://dx.doi.org/10.1016/S0140-6736(13)60856-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177AD	23683600	Green Accepted			2022-12-28	WOS:000321347000028
J	Koopmans, M; de Jong, MD				Koopmans, Marion; de Jong, Menno D.			Avian influenza A H7N9 in Zhejiang, China	LANCET			English	Editorial Material									[Koopmans, Marion] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Lab Infect Dis Res Diag & Screening, Div Virol, NL-3720 BA Bilthoven, Netherlands; [Koopmans, Marion] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [de Jong, Menno D.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam	Koopmans, M (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Lab Infect Dis Res Diag & Screening, Div Virol, NL-3720 BA Bilthoven, Netherlands.	marion.koopmans@rivm.nl	Koopmans, Marion/Y-9170-2019	Koopmans, Marion/0000-0002-5204-2312				[Anonymous], 2013, HUM INF INFL A H7N9; Chen Y, 2013, LANCET; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Jonges M, 2013, EURO SURVEILLANCE, V18; Lee N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026050; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; van Asten L, 2009, J CLIN VIROL, V45, P185, DOI 10.1016/j.jcv.2009.05.024; WHO Western Pacific Region, 2013, COMMUNICATION	11	15	21	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 1	2013	381	9881					1882	1883		10.1016/S0140-6736(13)60936-8	http://dx.doi.org/10.1016/S0140-6736(13)60936-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163EV	23628442				2022-12-28	WOS:000320319500007
J	Zolla-Pazner, S				Zolla-Pazner, Susan			Saving Specimens after Sandy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zolla-Pazner, Susan] Dept Vet Affairs New York Harbor Healthcare Syst, Res Serv, New York, NY USA; [Zolla-Pazner, Susan] NYU, Sch Med, Dept Pathol, New York, NY USA	New York University	Zolla-Pazner, S (corresponding author), Dept Vet Affairs New York Harbor Healthcare Syst, Res Serv, New York, NY USA.		Zolla-Pazner, Susan/S-1864-2019	Zolla-Pazner, Susan/0000-0002-0750-2666					0	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2013	368	21					E27	E27		10.1056/NEJMp1303024	http://dx.doi.org/10.1056/NEJMp1303024			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194KD	23656587	Bronze			2022-12-28	WOS:000322630700001
J	Malhi, GS				Malhi, Gin S.			Diagnosis of bipolar disorder: who is in a mixed state?	LANCET			English	Editorial Material									[Malhi, Gin S.] Univ Sydney, Discipline Psychiat, Sydney Med Sch, Sydney, NSW 2006, Australia; [Malhi, Gin S.] Royal N Shore Hosp, CADE Clin, Sydney, NSW, Australia	University of Sydney; Royal North Shore Hospital; University of Sydney	Malhi, GS (corresponding author), Univ Sydney, Discipline Psychiat, Sydney Med Sch, Sydney, NSW 2006, Australia.	gin.malhi@sydney.edu.au	Malhi, Gin/Z-2418-2019	Malhi, Gin/0000-0002-4524-9091				Cassidy F, 2008, BIPOLAR DISORD, V10, P131, DOI 10.1111/j.1399-5618.2007.00558.x; Judd LL, 2012, J AFFECT DISORDERS, V138, P440, DOI 10.1016/j.jad.2011.12.046; Kraepelin E., 1899, PSYCHIAT LEHRBUCH ST; Malhi GS, 2012, BIPOLAR DISORD, V14, P66, DOI 10.1111/j.1399-5618.2012.00993.x; Malhi GS, 2012, AUST NZ J PSYCHIAT, V46, P192, DOI 10.1177/0004867412437346; McIntyre RS, 2012, BIPOLAR DISORD, V14, P22, DOI 10.1111/j.1399-5618.2012.00990.x; Naylor AT, 2013, ART ADVERSITY LIFE B; Swann AC, 2013, AM J PSYCHIAT, V170, P31, DOI 10.1176/appi.ajp.2012.12030301; Wegandt W, 1899, MISCHZUSTANDE MANISC; Zimmerman M, 2011, WORLD PSYCHIATRY, V10, P188	10	31	31	1	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 11	2013	381	9878					1599	1600		10.1016/S0140-6736(13)60893-4	http://dx.doi.org/10.1016/S0140-6736(13)60893-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146SX	23663937				2022-12-28	WOS:000319112400004
J	Falk, A; Szech, N				Falk, Armin; Szech, Nora			Morals and Markets	SCIENCE			English	Article							CONSEQUENCES; PUNISHMENT; SOCIETIES; CHOICE; SIZE	The possibility that market interaction may erode moral values is a long-standing, but controversial, hypothesis in the social sciences, ethics, and philosophy. To date, empirical evidence on decay of moral values through market interaction has been scarce. We present controlled experimental evidence on how market interaction changes how human subjects value harm and damage done to third parties. In the experiment, subjects decide between either saving the life of a mouse or receiving money. We compare individual decisions to those made in a bilateral and a multilateral market. In both markets, the willingness to kill the mouse is substantially higher than in individual decisions. Furthermore, in the multilateral market, prices for life deteriorate tremendously. In contrast, for morally neutral consumption choices, differences between institutions are small.	[Falk, Armin] Univ Bonn, Ctr Econ & Neurosci, Bonn, Germany; [Szech, Nora] Univ Bamberg, Dept Econ, Bamberg, Germany	University of Bonn; Otto Friedrich University Bamberg	Falk, A (corresponding author), Univ Bonn, Ctr Econ & Neurosci, Bonn, Germany.	armin.falk@uni-bonn.de; nora.szech@uni-bamberg.de	Arkes, Hal R/A-4794-2008		German Science Foundation (Deutsche Forschungsgemeinschaft) through the Leibniz Program	German Science Foundation (Deutsche Forschungsgemeinschaft) through the Leibniz Program	We thank F. Kosse and S. Walter for excellent research assistance. For technical, programming, or administrative support, we thank in particular M. Antony as well as T. Deckers, U. Fischbacher, H. Gerhardt, B. Jendrock, J. Radbruch, S. Schmid, and B. Vogt. We also thank J. Abeler, K. Albrecht, S. Altmann, J. Costard, T. Dohmen, M. Gabriel, S. Gachter, H.-M. von Gaudecker, J. von Hagen, D. Harsch, P. Heidhues, D. Huffman, S. Jager, S. Kube, G. Loewenstein, C. May, A. Oswald, F. Rosar, N. Schweizer, A. Shaked, G. Wagner, M. Wibral, F. Zimmermann, and participants at various seminars for helpful comments. Finally, we thank all students, colleagues, and post-docs for helping to run the experiments. We acknowledge financial support by the German Science Foundation (Deutsche Forschungsgemeinschaft) through the Leibniz Program. Data reported in the paper are available at www.cens.uni-bonn.de/experiments/falk-szech/. This study was approved by the Ethics Committee of the University of Bonn (reference no. 066/12).	Arrow K. J., 1974, LIMITS ORG; Barnes J., 1984, COMPLETE WORKS ARIST, V1, P447; Bowles S, 1998, J ECON LIT, V36, P75; Bowles S, 2011, PHILOS PUBLIC AFF, V39, P46, DOI 10.1111/j.1088-4963.2011.01201.x; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; de Montesquieu Charles-Louis, THESIS; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; FRANK RH, 1993, J ECON PERSPECT, V7, P159, DOI 10.1257/jep.7.2.159; Haidt J., 2010, HDB SOCIAL PSYCHOL; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; HIRSCHMAN AO, 1982, J ECON LIT, V20, P1463; Kant I., 1785, GROUNDWORK METAPHYSI, P93; Kay AC, 2004, ORGAN BEHAV HUM DEC, V95, P83, DOI 10.1016/j.obhdp.2004.06.003; Krupka E, 2009, J ECON PSYCHOL, V30, P307, DOI 10.1016/j.joep.2008.11.005; Lane R., 1991, MARKET EXPERIENCE; LATANE B, 1981, PSYCHOL BULL, V89, P308, DOI 10.1037/0033-2909.89.2.308; LATANE B, 1968, J PERS SOC PSYCHOL, V10, P215, DOI 10.1037/h0026570; Liberman V, 2004, PERS SOC PSYCHOL B, V30, P1175, DOI 10.1177/0146167204264004; Lukes S., 2005, WORLDS CAPITALISM I; Marx K., 1904, CONTRIBUTION CRITIFI; Plott C.R., 2008, HDB EXPT EC RESULTS, V1; Polanyi K., 2001, GREAT TRANSFORMATION; Roth AE, 2007, J ECON PERSPECT, V21, P37, DOI 10.1257/jep.21.3.37; SANDEL MICHAEL J., 2012, WHAT MONEY CANT BUY, P202; Shleifer A, 2004, AM ECON REV, V94, P414, DOI 10.1257/0002828041301498; Simmel G., 1990, PHILOS MONEY; Sobel J, 2010, MARKETS OTHER REGARD; SPRANCA M, 1991, J EXP SOC PSYCHOL, V27, P76, DOI 10.1016/0022-1031(91)90011-T; Vohs KD, 2006, SCIENCE, V314, P1154, DOI 10.1126/science.1132491; Weber M., 1978, EC SOC OUTLINE INTER	32	183	184	8	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					707	711		10.1126/science.1231566	http://dx.doi.org/10.1126/science.1231566			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	139XR	23661753				2022-12-28	WOS:000318619000029
J	Freund, J; Brandmaier, AM; Lewejohann, L; Kirste, I; Kritzler, M; Kruger, A; Sachser, N; Lindenberger, U; Kempermann, G				Freund, Julia; Brandmaier, Andreas M.; Lewejohann, Lars; Kirste, Imke; Kritzler, Mareike; Krueger, Antonio; Sachser, Norbert; Lindenberger, Ulman; Kempermann, Gerd			Emergence of Individuality in Genetically Identical Mice	SCIENCE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; LABORATORY MICE; MOUSE BEHAVIOR; NEURONS; ENVIRONMENT; ENRICHMENT; MODEL	Brain plasticity as a neurobiological reflection of individuality is difficult to capture in animal models. Inspired by behavioral-genetic investigations of human monozygotic twins reared together, we obtained dense longitudinal activity data on 40 inbred mice living in one large enriched environment. The exploratory activity of the mice diverged over time, resulting in increasing individual differences with advancing age. Individual differences in cumulative roaming entropy, indicating the active coverage of territory, correlated positively with individual differences in adult hippocampal neurogenesis. Our results show that factors unfolding or emerging during development contribute to individual differences in structural brain plasticity and behavior. The paradigm introduced here serves as an animal model for identifying mechanisms of plasticity underlying nonshared environmental contributions to individual differences in behavior.	[Freund, Julia; Kirste, Imke; Kempermann, Gerd] Tech Univ Dresden, CRTD DFG Res Ctr Regenerat Therapies Dresden, D-01307 Dresden, Germany; [Brandmaier, Andreas M.; Lindenberger, Ulman] Max Planck Inst Human Dev, Ctr Lifespan Psychol, D-14195 Berlin, Germany; [Lewejohann, Lars; Sachser, Norbert] Univ Munster, Dept Behav Biol, D-48149 Munster, Germany; [Kritzler, Mareike; Krueger, Antonio] Univ Munster, Inst Geoinformat, D-48151 Munster, Germany; [Krueger, Antonio] German Res Ctr Artificial Intelligence, D-66123 Saarbrucken, Germany; [Kempermann, Gerd] German Ctr Neurodegenerat Dis DZNE Dresden, D-01307 Dresden, Germany	Technische Universitat Dresden; Max Planck Society; University of Munster; University of Munster; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technische Universitat Dresden	Kempermann, G (corresponding author), Tech Univ Dresden, CRTD DFG Res Ctr Regenerat Therapies Dresden, D-01307 Dresden, Germany.	gerd.kempermann@dzne.de	Lewejohann, Lars/H-3717-2013; Brandmaier, Andreas M/E-9096-2014; Kempermann, Gerd/F-5416-2010	Lewejohann, Lars/0000-0002-0202-4351; Brandmaier, Andreas M/0000-0001-8765-6982; Kempermann, Gerd/0000-0002-5304-4061; Lindenberger, Ulman/0000-0001-8428-6453	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was financed from basic institutional funds. J.F. and I. K. were fellows of the International Max Planck Research School on the Life Course (LIFE), Berlin. M. K. has been supported by the International Research Training Group on Semantic Integration of Geospatial Information, funded by the German Research Foundation (DFG). The authors thank S. Vogler for drawing the cage in Fig. 1A and D. Lasse for technical support. G. K. and U. L. would also like to thank J. Nesselroade for inspiring discussions that helped shape the ideas presented in this report.	Amrein I, 2009, BIOL LETTERS, V5, P141, DOI 10.1098/rsbl.2008.0511; BAILEY DW, 1982, IMMUNOL TODAY, V3, P210, DOI 10.1016/0167-5699(82)90093-7; BALTES PB, 1978, MULTIVAR BEHAV RES, V13, P127, DOI 10.1207/s15327906mbr1302_1; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Fabel K, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.002.2009; Friston KJ, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00044; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Jang KL, 1998, J PERS SOC PSYCHOL, V74, P1556, DOI 10.1037/0022-3514.74.6.1556; JULIER C, 1990, P NATL ACAD SCI USA, V87, P4585, DOI 10.1073/pnas.87.12.4585; Kempermann G, 2002, J NEUROSCI, V22, P635, DOI 10.1523/JNEUROSCI.22-03-00635.2002; Kempermann G, 2008, TRENDS NEUROSCI, V31, P163, DOI 10.1016/j.tins.2008.01.002; Kempermann G, 2012, NAT REV NEUROSCI, V13, P727, DOI 10.1038/nrn3319; Kempermann G, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00189; Lathe R, 2004, GENES BRAIN BEHAV, V3, P317, DOI 10.1111/j.1601-183X.2004.00083.x; Lewejohann L, 2006, GENES BRAIN BEHAV, V5, P64, DOI 10.1111/j.1601-183X.2005.00140.x; Lewejohann L, 2011, DEV PSYCHOBIOL, V53, P624, DOI 10.1002/dev.20553; Lewejohann L, 2009, BEHAV RES METHODS, V41, P850, DOI 10.3758/BRM.41.3.850; Lewin K., 1935, DYNAMIC THEORY PERS; Molenaar P. C. M., 1991, PROBLEMS METHODS LON, P250; MOLENAAR PCM, 1993, BEHAV GENET, V23, P519, DOI 10.1007/BF01068142; Raijmakers MEJ, 2004, DEVELOPMENTAL SCI, V7, P149, DOI 10.1111/j.1467-7687.2004.00332.x; Rosenzweig MR, 1996, BEHAV BRAIN RES, V78, P57, DOI 10.1016/0166-4328(95)00216-2; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; Talens RP, 2012, AGING CELL, V11, P694, DOI 10.1111/j.1474-9726.2012.00835.x; Turkheimer E, 2011, PSYCHOL BULL, V137, P825, DOI 10.1037/a0024306; Van de Weerd Heleen A., 2002, Journal of Applied Animal Welfare Science, V5, P87, DOI 10.1207/S15327604JAWS0502_01; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; WHIMBEY AE, 1967, BEHAVIOUR, V29, P296, DOI 10.1163/156853967X00163; Wolfer DP, 2004, NATURE, V432, P821, DOI 10.1038/432821a	29	273	276	3	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					756	759		10.1126/science.1235294	http://dx.doi.org/10.1126/science.1235294			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661762	Green Submitted			2022-12-28	WOS:000318619000042
J	Reinke, AW; Baek, J; Ashenberg, O; Keating, AE				Reinke, Aaron W.; Baek, Jiyeon; Ashenberg, Orr; Keating, Amy E.			Networks of bZIP Protein-Protein Interactions Diversified Over a Billion Years of Evolution	SCIENCE			English	Article							DNA-BINDING SPECIFICITY; TRANSCRIPTION; DIMERIZATION; DIVERGENCE	Differences in biomolecular sequence and function underlie dramatic ranges of appearance and behavior among species. We studied the basic region-leucine zipper (bZIP) transcription factors and quantified bZIP dimerization networks for five metazoan and two single-cell species, measuring interactions in vitro for 2891 protein pairs. Metazoans have a higher proportion of heteromeric bZIP interactions and more network complexity than the single-cell species. The metazoan bZIP interactomes have broadly similar structures, but there has been extensive rewiring of connections compared to the last common ancestor, and each species network is highly distinct. Many metazoan bZIP orthologs and paralogs have strikingly different interaction specificities, and some differences arise from minor sequence changes. Our data show that a shifting landscape of biochemical functions related to signaling and gene expression contributes to species diversity.	[Reinke, Aaron W.; Baek, Jiyeon; Ashenberg, Orr; Keating, Amy E.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Keating, AE (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	keating@mit.edu		Reinke, Aaron/0000-0001-7612-5342; Keating, Amy/0000-0003-4074-8980	NIH [GM067681]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067681] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH award GM067681. We thank the MIT BioMicro center for use of the Tecan liquid-handling robot, J.J. Sims for guidance with intein protein labeling chemistry, L. Reich for analytical models for curve fitting, and A. M. Safer for the C. elegans used for making cDNA. All interaction data are available in the supplementary materials in table S2.	Acharya A, 2006, BIOCHEMISTRY-US, V45, P11324, DOI 10.1021/bi060822u; Amoutzias GD, 2007, MOL BIOL EVOL, V24, P827, DOI 10.1093/molbev/msl211; Baker CR, 2011, P NATL ACAD SCI USA, V108, P7493, DOI 10.1073/pnas.1019177108; Brayer KJ, 2011, P NATL ACAD SCI USA, V108, pE414, DOI 10.1073/pnas.1100990108; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Grigoryan G, 2006, J MOL BIOL, V355, P1125, DOI 10.1016/j.jmb.2005.11.036; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Kuo D, 2010, GENOME RES, V20, P1672, DOI 10.1101/gr.111765.110; Lynch VJ, 2011, NATURE, V480, P383, DOI 10.1038/nature10595; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Qian WF, 2011, P NATL ACAD SCI USA, V108, P8725, DOI 10.1073/pnas.1104695108; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Shou C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001050; Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904	16	109	111	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					730	734		10.1126/science.1233465	http://dx.doi.org/10.1126/science.1233465			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661758	Green Accepted, Green Submitted			2022-12-28	WOS:000318619000035
J	Csibi, A; Fendt, SM; Li, CG; Poulogiannis, G; Choo, AY; Chapski, DJ; Jeong, SM; Dempsey, JM; Parkhitko, A; Morrison, T; Henske, EP; Haigis, MC; Cantley, LC; Stephanopoulos, G; Yu, J; Blenis, J				Csibi, Alfred; Fendt, Sarah-Maria; Li, Chenggang; Poulogiannis, George; Choo, Andrew Y.; Chapski, Douglas J.; Jeong, Seung Min; Dempsey, Jamie M.; Parkhitko, Andrey; Morrison, Tasha; Henske, Elizabeth P.; Haigis, Marcia C.; Cantley, Lewis C.; Stephanopoulos, Gregory; Yu, Jane; Blenis, John			The mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4	CELL			English	Article							GREEN TEA POLYPHENOLS; CALORIE RESTRICTION; RAG GTPASES; ATF4; CANCER; SURVIVAL; COMPLEX; STRESS; LYMPHANGIOLEIOMYOMATOSIS; TRANSCRIPTION	Proliferating mammalian cells use glutamine as a source of nitrogen and as a key anaplerotic source to provide metabolites to the tricarboxylic acid cycle (TCA) for biosynthesis. Recently, mammalian target of rapamycin complex 1 (mTORC1) activation has been correlated with increased nutrient uptake and metabolism, but no molecular connection to glutaminolysis has been reported. Here, we show that mTORC1 promotes glutamine anaplerosis by activating glutamate dehydrogenase (GDH). This regulation requires transcriptional repression of SIRT4, the mitochondrial-localized sirtuin that inhibits GDH. Mechanistically, mTORC1 represses SIRT4 by promoting the proteasome-mediated destabilization of cAMP-responsive element binding 2 (CREB2). Thus, a relationship between mTORC1, SIRT4, and cancer is suggested by our findings. Indeed, SIRT4 expression is reduced in human cancer, and its overexpression reduces cell proliferation, transformation, and tumor development. Finally, our data indicate that targeting nutrient metabolism in energy-addicted cancers with high nnTORC1 signaling may be an effective therapeutic approach.	[Csibi, Alfred; Choo, Andrew Y.; Chapski, Douglas J.; Jeong, Seung Min; Dempsey, Jamie M.; Haigis, Marcia C.; Blenis, John] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Fendt, Sarah-Maria; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Li, Chenggang; Parkhitko, Andrey; Morrison, Tasha; Henske, Elizabeth P.; Yu, Jane] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Poulogiannis, George; Cantley, Lewis C.] Harvard Univ, Sch Med, Beth Israel Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Poulogiannis, George; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School	Blenis, J (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	john_blenis@hms.harvard.edu	Poulogiannis, George/AAE-1966-2019; Poulogiannis, George/AAY-2210-2021; Cantley, Lewis C/D-1800-2014	Poulogiannis, George/0000-0002-0529-8614; Cantley, Lewis C/0000-0002-1298-7653; Parkhitko, Andrey/0000-0001-9852-8329; Fendt, Sarah-Maria/0000-0001-6018-9296; Chapski, Douglas/0000-0002-6730-7627	National Research Foundation of Korea; Korean Government; National Heart, Lung, and Blood Institute [HL098216]; NIH [AG032375, GM51405]; Glenn Foundation for Medical Research; NATIONAL CANCER INSTITUTE [R01CA160458] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032375] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Blenis laboratory for critical discussions and technical assistance. We are also grateful to Li-Huei Tsai (MIT), David Kwiatkowski (BWH), Brendan Manning (HSPH), Wade Harper (HMS), Chi V. Dang (U.Penn), and Takashi Tsukamoto (John Hopkins) for providing critical reagents. We thank Alexandra Grassian and Jonathan Coloff in Joan Brugge's lab (HMS). We thank the Nikon Imaging Center for advice and assistance with microscopy. A.C. is a LAM Foundation Postdoctoral Fellow. S.-M.F. is a German Research Foundation Fellow (FE-1185). G.P. is a Pfizer Fellow of the Life Sciences Research Foundation. S.M.J. was supported in part by a National Research Foundation of Korea Grant funded by the Korean Government. This work was funded by the National Heart, Lung, and Blood Institute grant HL098216 to J.Y., NIH grant AG032375 and Glenn Foundation for Medical Research to M.C.H., and NIH Grant GM51405 to J.B.	Antoniewicz MR, 2007, ANAL CHEM, V79, P7554, DOI 10.1021/ac0708893; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Cherasse Y, 2007, NUCLEIC ACIDS RES, V35, P5954, DOI 10.1093/nar/gkm642; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Fendt SM, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.11; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Frank CL, 2010, J BIOL CHEM, V285, P33324, DOI 10.1074/jbc.M110.140699; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Khan N, 2008, CANCER LETT, V269, P269, DOI 10.1016/j.canlet.2008.04.014; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim SG, 2013, MOL CELL, V49, P172, DOI 10.1016/j.molcel.2012.10.003; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Li CH, 2006, J BIOL CHEM, V281, P10214, DOI 10.1074/jbc.M512792200; Lieberman BP, 2011, J NUCL MED, V52, P1947, DOI 10.2967/jnumed.111.093815; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Menon S, 2008, Oncogene, V27 Suppl 2, pS43, DOI 10.1038/onc.2009.352; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Qing GL, 2012, CANCER CELL, V22, P631, DOI 10.1016/j.ccr.2012.09.021; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Shanware NP, 2011, J MOL MED, V89, P229, DOI 10.1007/s00109-011-0731-9; Wang CX, 2010, CELL RES, V20, P174, DOI 10.1038/cr.2010.4; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; West MJ, 1998, ONCOGENE, V17, P769, DOI 10.1038/sj.onc.1201990; Whitney ML, 2009, BIOCHEM BIOPH RES CO, V379, P451, DOI 10.1016/j.bbrc.2008.12.079; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; XU Y, 1992, CANCER RES, V52, P3875; Yamaguchi S, 2008, CELL METAB, V7, P269, DOI 10.1016/j.cmet.2008.01.008; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Yecies JL, 2011, J MOL MED, V89, P221, DOI 10.1007/s00109-011-0726-6; Yoshizawa T, 2009, J CLIN INVEST, V119, P2807, DOI 10.1172/JCI39366; Young LR, 2009, CHEST, V136, P926, DOI 10.1378/chest.09-0336; Zhang D, 2010, AM J OBSTET GYNECOL, V289, pe1; Zhang D, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.885; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	52	396	429	3	111	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 9	2013	153	4					840	854		10.1016/j.cell.2013.04.023	http://dx.doi.org/10.1016/j.cell.2013.04.023			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663782	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000318844000013
J	Gutlerner, JL; Van Vactor, D				Gutlerner, Johanna L.; Van Vactor, David			Catalyzing Curriculum Evolution in Graduate Science Education	CELL			English	Editorial Material									[Gutlerner, Johanna L.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Van Vactor, David] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Gutlerner, JL (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	johanna_gutlerner@hms.harvard.edu; davie_vanvactor@hms.harvard.edu		Gutlerner, Johanna/0000-0002-6817-6147; Van Vactor, Jr., David L./0000-0001-8156-9482				Allen Deborah, 2005, Cell Biol Educ, V4, P262, DOI 10.1187/cbe.05-08-0113; American Association For The Advancement of Science, 2009, VIS CHANG UND BIOL E; Association of American Medical Colleges and Howard Hughes Medical Institute, 2009, SCI FDN FUT PHYS REP; Bentley AM, 2008, CBE-LIFE SCI EDUC, V7, P175, DOI 10.1187/cbe.07-07-0049; Carnegie Institute for Advanced Study Commission on Mathematics and Science Education, 2009, OPP EQ TRANSF MATH S; Coil D, 2010, CBE-LIFE SCI EDUC, V9, P524, DOI 10.1187/cbe.10-01-0005; D'Avanzo C, 2008, BIOSCIENCE, V58, P1079, DOI 10.1641/B581111; Desantis N, 2012, HARVARD MIT PUT 60 M; Feldon DF, 2011, SCIENCE, V333, P1037, DOI 10.1126/science.1204109; Gross LJ, 2000, SCIENCE, V288, P807, DOI 10.1126/science.288.5467.807; Handelsman J, 2004, SCIENCE, V304, P521, DOI 10.1126/science.1096022; Handelsman J., 2006, SCI TEACHING, V1; Lorsch JR, 2011, CELL, V146, P506, DOI 10.1016/j.cell.2011.08.004; Marbach-Ad Gili, 2007, CBE Life Sci Educ, V6, P155, DOI 10.1187/cbe.06-12-0212; *NAT RES COUNC, 2009, NEW BIOL 21 CENT ENS; National Institutes of Health, 2012, BIOM RES WORKF WORK; National Research Council, 2003, BIO2010 TRANSF UND E; Prensky M., 2011, EDUC TECHNOL, P1; Wendler C., 2010, ED TESTING SERVICE; Wlodkowski R., 2008, ENHANCING ADULT MOTI	20	12	12	0	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 9	2013	153	4					731	736		10.1016/j.cell.2013.04.027	http://dx.doi.org/10.1016/j.cell.2013.04.027			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663771	Bronze			2022-12-28	WOS:000318844000001
J	Yi, P; Park, JS; Melton, DA				Yi, Peng; Park, Ji-Sun; Melton, Douglas A.			RETRACTED: Betatrophin: A Hormone that Controls Pancreatic beta Cell Proliferation (Retracted article. See vol. 168, pg. 326, 2017)	CELL			English	Article; Retracted Publication							HYDRODYNAMICS-BASED TRANSFECTION; INSULIN-RESISTANT STATES; ADULT-MOUSE PANCREAS; GLUCOSE-INFUSION; COMPENSATORY GROWTH; PRIMARY MECHANISM; DIABETIC-RATS; PLASMID DNA; MICE; MASS	Replenishing insulin-producing pancreatic beta cell mass will benefit both type I and type II diabetics. In adults, pancreatic beta cells are generated primarily by self-duplication. We report on a mouse model of insulin resistance that induces dramatic pancreatic beta cell proliferation and beta cell mass expansion. Using this model, we identify a hormone, betatrophin, that is primarily expressed in liver and fat. Expression of betatrophin correlates with beta cell proliferation in other mouse models of insulin resistance and during gestation. Transient expression of betatrophin in mouse liver significantly and specifically promotes pancreatic beta cell proliferation, expands beta cell mass, and improves glucose tolerance. Thus, betatrophin treatment could augment or replace insulin injections by increasing the number of endogenous insulin-producing cells in diabetics.	[Yi, Peng; Park, Ji-Sun; Melton, Douglas A.] Harvard Univ, Howard Hughes Med Inst, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Melton, DA (corresponding author), Harvard Univ, Howard Hughes Med Inst, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	dmelton@harvard.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	NIH [RC4DK090781]; Harvard Stem Cell Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC4DK090781] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Lauge Schaffer and Aaron Tward for sharing reagents. P.Y. was supported by a fellowship from the Helen Hay Whitney Foundation. D.A.M is an Investigator of the Howard Hughes Medical Institute. This work was supported by grants from the NIH (RC4DK090781) and the Harvard Stem Cell Institute. D.A.M. and P.Y. are listed as inventors on a U.S. Patent Application based on this work. Further studies on betatrophin are being pursued as a joint effort with Evotec and Janssen. We thank Dena Cohen, Sinisa Hrvatin, Ornella Barrandon, and Peter Carolan for comments on the manuscript.	Alonso LC, 2007, DIABETES, V56, P1792, DOI 10.2337/db06-1513; Bernard C, 1998, DIABETES, V47, P1058, DOI 10.2337/diabetes.47.7.1058; Bock T, 2003, DIABETES, V52, P1716, DOI 10.2337/diabetes.52.7.1716; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; Cano DA, 2008, DIABETES, V57, P958, DOI 10.2337/db07-0913; Crabtree JS, 2003, MOL CELL BIOL, V23, P6075, DOI 10.1128/MCB.23.17.6075-6085.2003; Dong XY, 2004, INT J CANCER, V112, P239, DOI 10.1002/ijc.20363; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; El Ouaamari A, 2013, CELL REP, V3, P401, DOI 10.1016/j.celrep.2013.01.007; Fajas L, 2004, J CLIN INVEST, V113, P1288, DOI 10.1172/JCI200418555; Flier SN, 2001, P NATL ACAD SCI USA, V98, P7475, DOI 10.1073/pnas.131192998; GAPP DA, 1983, DIABETOLOGIA, V25, P439, DOI 10.1007/BF00282525; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; HARVEY M, 1995, CANCER RES, V55, P1146; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Iglesias A, 2004, J CLIN INVEST, V113, P1398, DOI 10.1172/JCI200418879; Imai J, 2008, SCIENCE, V322, P1250, DOI 10.1126/science.1163971; Karnik SK, 2007, SCIENCE, V318, P806, DOI 10.1126/science.1146812; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Latres E, 2000, EMBO J, V19, P3496, DOI 10.1093/emboj/19.13.3496; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Paris M, 2003, ENDOCRINOLOGY, V144, P2717, DOI 10.1210/en.2002-221112; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; Pei XH, 2004, MOL CELL BIOL, V24, P6653, DOI 10.1128/mcb.24.15.6653-6664.2004; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Quagliarini F, 2012, P NATL ACAD SCI USA, V109, P19751, DOI 10.1073/pnas.1217552109; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Ren G, 2012, AM J PHYSIOL-ENDOC M, V303, pE334, DOI 10.1152/ajpendo.00084.2012; Rieck S, 2009, MOL ENDOCRINOL, V23, P1702, DOI 10.1210/me.2009-0144; Sachdeva MM, 2009, MOL ENDOCRINOL, V23, P747, DOI 10.1210/me.2008-0400; Schaffer L, 2008, BIOCHEM BIOPH RES CO, V376, P380, DOI 10.1016/j.bbrc.2008.08.151; Scheen AJ, 1996, DIABETES METAB, V22, P105; Song YK, 2002, METHOD ENZYMOL, V346, P92; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; TOMITA T, 1992, PANCREAS, V7, P367, DOI 10.1097/00006676-199205000-00015; Uchida T, 2005, NAT MED, V11, P175, DOI 10.1038/nm1187; Wang Q, 2002, DIABETOLOGIA, V45, P1263, DOI 10.1007/s00125-002-0828-3; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; WILLIAMS BO, 1994, NAT GENET, V7, P480, DOI 10.1038/ng0894-480; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yant SR, 2000, NAT GENET, V25, P35, DOI 10.1038/75568; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734; Zhang R, 2012, BIOCHEM BIOPH RES CO, V424, P786, DOI 10.1016/j.bbrc.2012.07.038	56	369	413	0	120	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 9	2013	153	4					747	758		10.1016/j.cell.2013.04.008	http://dx.doi.org/10.1016/j.cell.2013.04.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23623304	Green Accepted, Bronze			2022-12-28	WOS:000318844000006
J	Sokol, DK				Sokol, Daniel K.			ETHICS MAN Seven ways to hone your ethics skills	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Coll London, London, England	University of London; King's College London	Sokol, DK (corresponding author), Kings Coll London, London, England.	daniel.sokol@talk21.com						Gillon Ranan., 1985, PHILOS MED ETHICS; Levinsky NG, 2001, ETHICS KIDNEY; Sokol D. K., 2012, DOING CLIN ETHICS HA; Sokol DK, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c3256; [No title captured]	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2013	346								f2911	10.1136/bmj.f2911	http://dx.doi.org/10.1136/bmj.f2911			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	144BS	23657187				2022-12-28	WOS:000318915000012
J	Wijbrandts, CA; van Schaardenburg, D				Wijbrandts, Carla Ann; van Schaardenburg, Dirkjan			Pain in the Thumb Related to Disease in the Lung	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wijbrandts, Carla Ann] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [van Schaardenburg, Dirkjan] Jan van Breemen Res Inst, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Wijbrandts, CA (corresponding author), Univ Amsterdam, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 2	2013	368	18					1731	1731		10.1056/NEJMicm1212346	http://dx.doi.org/10.1056/NEJMicm1212346			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134MN	23635053				2022-12-28	WOS:000318214400007
J	Ajamian, M; Kosofsky, BE; Wormser, GP; Rajadhyaksha, AM; Alaedini, A				Ajamian, Mary; Kosofsky, Barry E.; Wormser, Gary P.; Rajadhyaksha, Anjali M.; Alaedini, Armin			Serologic Markers of Lyme Disease in Children With Autism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Ajamian, Mary; Alaedini, Armin] Columbia Univ, Dept Med, Med Ctr, New York, NY 10027 USA; [Kosofsky, Barry E.; Rajadhyaksha, Anjali M.] Weill Cornell Med Coll, Dept Pediat, New York, NY USA; [Wormser, Gary P.] New York Med Coll, Div Infect Dis, Valhalla, NY 10595 USA	Columbia University; Cornell University; New York Medical College	Ajamian, M (corresponding author), Columbia Univ, Dept Med, Med Ctr, New York, NY 10027 USA.	aa819@columbia.edu		Ajamian, Mary/0000-0001-5819-7078	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI093763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH081810] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000457, UL1 TR000457-06] Funding Source: Medline; NIAID NIH HHS [1R56 AI093763-01, R56 AI093763] Funding Source: Medline; NIMH NIH HHS [U24 MH081810, 1U24MH081810] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bransfield RC, 2008, MED HYPOTHESES, V70, P967, DOI 10.1016/j.mehy.2007.09.006; Centers for Disease Control and Prevention (CDC), 1995, MMWR MORB MORTAL WKL, V44, P590; Chandra A, 2011, CLIN IMMUNOL, V141, P103, DOI 10.1016/j.clim.2011.06.005; Kuhn M, 2012, MED HYPOTHESES, V78, P606, DOI 10.1016/j.mehy.2012.01.037	4	8	8	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2013	309	17					1771	1773		10.1001/jama.2013.618	http://dx.doi.org/10.1001/jama.2013.618			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134SU	23632714	Bronze, Green Accepted			2022-12-28	WOS:000318235600018
J	van Vugt, SF; Broekhuizen, BDL; Lammens, C; Zuithoff, NPA; de Jong, PA; Coenen, S; Ieven, M; Butler, CC; Goossens, H; Little, P; Verheij, TJM				van Vugt, Saskia F.; Broekhuizen, Berna D. L.; Lammens, Christine; Zuithoff, Nicolaas P. A.; de Jong, Pim A.; Coenen, Samuel; Ieven, Margareta; Butler, Chris C.; Goossens, Herman; Little, Paul; Verheij, Theo J. M.		GRACE Consortium	Use of serum C reactive protein and procalcitonin concentrations in addition to symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough: diagnostic study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RESPIRATORY-TRACT INFECTIONS; COMMUNITY-ACQUIRED PNEUMONIA; ANTIBIOTIC USE; CLINICAL-PREDICTION; ADULTS; REGRESSION; MODELS; POINT; RELIABILITY; OUTPATIENTS	Objectives To quantify the diagnostic accuracy of selected inflammatory markers in addition to symptoms and signs for predicting pneumonia and to derive a diagnostic tool. Design Diagnostic study performed between 2007 and 2010. Participants had their history taken, underwent physical examination and measurement of C reactive protein (CRP) and procalcitonin in venous blood on the day they first consulted, and underwent chest radiography within seven days. Setting Primary care centres in 12 European countries. Participants Adults presenting with acute cough. Main outcome measures Pneumonia as determined by radiologists, who were blind to all other information when they judged chest radiographs. Results Of 3106 eligible patients, 286 were excluded because of missing or inadequate chest radiographs, leaving 2820 patients (mean age 50, 40% men) of whom 140 (5%) had pneumonia. Re-assessment of a subset of 1675 chest radiographs showed agreement in 94% (kappa 0.45, 95% confidence interval 0.36 to 0.54). Six published "symptoms and signs models" varied in their discrimination (area under receiver operating characteristics curve (ROC) ranged from 0.55 (95% confidence interval 0.50 to 0.61) to 0.71 (0.66 to 0.76)). The optimal combination of clinical prediction items derived from our patients included absence of runny nose and presence of breathlessness, crackles and diminished breath sounds on auscultation, tachycardia, and fever, with an ROC area of 0.70 (0.65 to 0.75). Addition of CRP at the optimal cut off of >30 mg/L increased the ROC area to 0.77 (0.73 to 0.81) and improved the diagnostic classification (net reclassification improvement 28%). In the 1556 patients classified according to symptoms, signs, and CRP >30 mg/L as "low risk" (<2.5%) for pneumonia, the prevalence of pneumonia was 2%. In the 132 patients classified as "high risk" (>20%), the prevalence of pneumonia was 31%. The positive likelihood ratio of low, intermediate, and high risk for pneumonia was 0.4, 1.2, and 8.6 respectively. Measurement of procalcitonin added no relevant additional diagnostic information. A simplified diagnostic score based on symptoms, signs, and CRP >30 mg/L resulted in proportions of pneumonia of 0.7%, 3.8%, and 18.2% in the low, intermediate, and high risk group respectively. Conclusions A clinical rule based on symptoms and signs to predict pneumonia in patients presenting to primary care with acute cough performed best in patients with mild or severe clinical presentation. Addition of CRP concentration at the optimal cut off of >30 mg/L improved diagnostic information, but measurement of procalcitonin concentration did not add clinically relevant information in this group.	[van Vugt, Saskia F.; Broekhuizen, Berna D. L.; Zuithoff, Nicolaas P. A.; Verheij, Theo J. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Lammens, Christine; Coenen, Samuel; Ieven, Margareta; Goossens, Herman] Univ Antwerp, Lab Med Microbiol, Vaccine & Infect Dis Inst VAXINFECTIO, B-2020 Antwerp, Belgium; [de Jong, Pim A.] Univ Med Ctr Utrecht, Dept Radiol, NL-3508 GA Utrecht, Netherlands; [Butler, Chris C.] Cardiff Univ, Sch Med, Inst Primary Care & Publ Hlth, Cardiff CF10 3AX, S Glam, Wales; [Little, Paul] Univ Southampton, Sch Med, Primary Care Med Grp, Southampton, Hants, England	Utrecht University; Utrecht University Medical Center; University of Antwerp; Utrecht University; Utrecht University Medical Center; Cardiff University; University of Southampton	Broekhuizen, BDL (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, POB 85500, NL-3508 GA Utrecht, Netherlands.	b.d.l.broekhuizen@umcutrecht.nl	Torres, Antoni/H-6128-2017; Hood, Kerenza/C-2528-2008; Moore, Michael/C-3447-2011; Coenen, Samuel JA/A-6410-2011; de Jong, Pim A/G-7220-2014; Almirall, Jordi/H-6850-2013	Torres, Antoni/0000-0002-8643-2167; Hood, Kerenza/0000-0002-5268-8631; Moore, Michael/0000-0002-5127-4509; Coenen, Samuel JA/0000-0002-1238-8052; de Jong, Pim A/0000-0003-4840-6854; Almirall, Jordi/0000-0002-3821-4341; Little, Paul/0000-0003-3664-1873; Butler, Christopher/0000-0002-0102-3453; Godycki-Cwirko, Maciej/0000-0002-9204-5518	European Commission [LSHM-CT-2005-518226]; Research Foundation, Flanders (Belgium) [G.0274.08N]; Orion Diagnostica Oy; Brahms Germany	European Commission(European CommissionEuropean Commission Joint Research Centre); Research Foundation, Flanders (Belgium)(FWO); Orion Diagnostica Oy; Brahms Germany	This study was part of the GRACE project (www.grace-lrti.org), funded by 6th Framework Program of the European Commission (ref LSHM-CT-2005-518226). In Flanders (Belgium) this work was supported by the Research Foundation, Flanders (G.0274.08N). Orion Diagnostica Oy and Brahms Germany provided and paid for the kits for CRP and PCT testing, respectively.	Albaum MN, 1996, CHEST, V110, P343, DOI 10.1378/chest.110.2.343; Austin PC, 2001, CAN J PUBLIC HEALTH, V92, P150, DOI 10.1007/BF03404950; Boersma WG, 2006, RESP MED, V100, P926, DOI 10.1016/j.rmed.2005.06.018; Broekhuizen BDL, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X601398; Burkhardt O, 2010, EUR RESPIR J, V36, P601, DOI 10.1183/09031936.00163309; Butler CC, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2242; Cals JWL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1374; Christ-Crain M, 2004, LANCET, V363, P600, DOI 10.1016/S0140-6736(04)15591-8; DIEHR P, 1984, J CHRON DIS, V37, P215, DOI 10.1016/0021-9681(84)90149-8; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Engel MF, 2012, FAM PRACT, V29, P383, DOI 10.1093/fampra/cmr119; Falk G, 2009, FAM PRACT, V26, P10, DOI 10.1093/fampra/cmn095; Flanders SA, 2004, AM J MED, V116, P529, DOI 10.1016/j.amjmed.2003.11.023; Gennis P, 1989, J Emerg Med, V7, P263, DOI 10.1016/0736-4679(89)90358-2; Graffelman AW, 2007, J FAM PRACTICE, V56, P465; Greenland S, 2000, INT J EPIDEMIOL, V29, P158, DOI 10.1093/ije/29.1.158; Greenland S, 2000, BIOMETRICS, V56, P915, DOI 10.1111/j.0006-341X.2000.00915.x; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HECKERLING PS, 1990, ANN INTERN MED, V113, P664, DOI 10.7326/0003-4819-113-9-664; Holm A, 2007, BRIT J GEN PRACT, V57, P555; Hopstaken RM, 2005, J CLIN EPIDEMIOL, V58, P175, DOI 10.1016/j.jclinepi.2004.08.004; Hopstaken RM, 2004, CLIN RADIOL, V59, P743, DOI 10.1016/j.crad.2004.01.011; Hopstaken RM, 2003, BRIT J GEN PRACT, V53, P358; Kelder JC, 2011, CIRCULATION, V124, P2865, DOI 10.1161/CIRCULATIONAHA.111.019216; Khalil A, 2007, EMERG MED J, V24, P336, DOI 10.1136/emj.2007.045989; Kok L, 2012, CLIN CHEM, V58, P989, DOI 10.1373/clinchem.2011.177980; LITTLE RJA, 1992, J AM STAT ASSOC, V87, P1227, DOI 10.2307/2290664; Macfarlane J, 2001, THORAX, V56, P109, DOI 10.1136/thorax.56.2.109; MELBYE H, 1992, Scandinavian Journal of Primary Health Care, V10, P226, DOI 10.3109/02813439209014066; MELBYE H, 1992, Scandinavian Journal of Primary Health Care, V10, P234, DOI 10.3109/02813439209014067; Metlay JP, 2003, ANN INTERN MED, V138, P109, DOI 10.7326/0003-4819-138-2-200301210-00012; MILLER ME, 1991, STAT MED, V10, P1213, DOI 10.1002/sim.4780100805; Moons KGM, 2004, J CLIN EPIDEMIOL, V57, P1262, DOI 10.1016/j.jclinepi.2004.01.020; Nolt BR, 2007, AM J EMERG MED, V25, P631, DOI 10.1016/j.ajem.2006.11.031; ORTIZ MAG, 1995, MED CLIN-BARCELONA, V105, P521; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Schrecengost JE, 2003, CLIN CHEM, V49, P1483, DOI 10.1373/49.9.1483; Seamark DA, 2003, ANN CLIN BIOCHEM, V40, P178, DOI 10.1258/000456303763046139; Sin DD, 2004, AM J RESP CRIT CARE, V170, P760, DOI 10.1164/rccm.200404-543OC; SINGAL BM, 1989, ANN EMERG MED, V18, P13, DOI 10.1016/S0196-0644(89)80304-X; Smith SM, 2004, COCHRANE DB SYST REV, V4; Steyerberg E.W., 2019, CLIN PREDICTION MODE, DOI [10.1007/978-3-030-16399-0, DOI 10.1007/978-3-030-16399-0]; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; Team RC., 2022, LANG ENV STAT COMP; Urbach DR, 2005, J CLIN EPIDEMIOL, V58, P391, DOI 10.1016/j.jclinepi.2004.12.001; Woodhead M, 2011, CLIN MICROBIOL INFEC, V17, pE1, DOI 10.1111/j.1469-0691.2011.03672.x	48	131	133	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2013	346								f2450	10.1136/bmj.f2450	http://dx.doi.org/10.1136/bmj.f2450			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139DR	23633005	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000318562300002
J	Poland, GA; Poland, CM; Howe, CL				Poland, Gregory A.; Poland, Caroline M.; Howe, Charles L.			Influenza vaccine and Guillain-Barre syndrome: making informed decisions	LANCET			English	Editorial Material							VIRUS		[Poland, Gregory A.; Howe, Charles L.] Mayo Clin & Mayo Fdn, Mayo Vaccine Res Grp, Rochester, MN 55905 USA; [Poland, Caroline M.] Taylor Univ, Upland, IN USA	Mayo Clinic	Poland, GA (corresponding author), Mayo Clin & Mayo Fdn, Mayo Vaccine Res Grp, Rochester, MN 55905 USA.	poland.gregory@mayo.edu		Howe, Charles/0000-0002-3889-8739				CDC, 2009, UPD CDC EST 2009 H1N; Deeks SL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-329; Institute of Medicine, 2011, ADVERSE EFFECTS VACC; Kurland LT, 1986, NEUROLOGY, P249; Lehmann HC, 2010, LANCET INFECT DIS, V10, P643, DOI 10.1016/S1473-3099(10)70140-7; Poland CM, 2011, VACCINE, V29, P6145, DOI 10.1016/j.vaccine.2011.07.131; Poland GA, 2012, VACCINE, V30, P5801, DOI 10.1016/j.vaccine.2012.06.093; Rajabally YA, 2012, J NEUROL NEUROSUR PS, V83, P711, DOI 10.1136/jnnp-2011-301882; Salmon DA, 2013, LANCET, V381, P1461, DOI 10.1016/S0140-6736(12)62189-8; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; Sivadon-Tardy V, 2009, CLIN INFECT DIS, V48, P48, DOI 10.1086/594124; Stowe J, 2009, AM J EPIDEMIOL, V169, P382, DOI 10.1093/aje/kwn310; Stratton K., 2004, IMMUNIZATION SAFETY	13	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 27	2013	381	9876					1437	1439		10.1016/S0140-6736(13)60182-8	http://dx.doi.org/10.1016/S0140-6736(13)60182-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139TK	23622271				2022-12-28	WOS:000318607300011
J	Newsome, WT; Glimcher, PW; Gottlieb, J; Lee, D; Platt, ML				Newsome, William T.; Glimcher, Paul W.; Gottlieb, Jacqueline; Lee, Daeyeol; Platt, Michael L.			Comment on "In Monkeys Making Value-Based Decisions, LIP Neurons Encode Cue Salience and Not Action Value"	SCIENCE			English	Editorial Material							LATERAL INTRAPARIETAL AREA; POSTERIOR PARIETAL CORTEX; MOTOR INTENTION ACTIVITY; SACCADE-RELATED ACTIVITY; PERCEPTUAL DECISION; REPRESENTATION; MOTION; PLAN		[Newsome, William T.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Newsome, William T.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Glimcher, Paul W.] NYU, Ctr Neurosci, New York, NY 10003 USA; [Glimcher, Paul W.] NYU, Ctr Neuroecon, New York, NY 10003 USA; [Gottlieb, Jacqueline] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Gottlieb, Jacqueline] Columbia Univ, Kavli Inst Brain Res, New York, NY 10032 USA; [Lee, Daeyeol] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Platt, Michael L.] Duke Univ, Sch Med, Dept Evolutionary Anthropol, Dept Neurobiol, Durham, NC 27708 USA; [Platt, Michael L.] Duke Univ, Sch Med, Ctr Cognit Sci, Durham, NC 27708 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; New York University; New York University; Columbia University; Columbia University; Yale University; Duke University; Duke University	Newsome, WT (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	bnewsome@stanford.edu	Newsome, William T./W-7171-2019		NIMH NIH HHS [R01 MH096875] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096875] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARASH S, 1991, J NEUROPHYSIOL, V66, P1109, DOI 10.1152/jn.1991.66.3.1109; BARASH S, 1991, J NEUROPHYSIOL, V66, P1095, DOI 10.1152/jn.1991.66.3.1095; Bennur S, 2011, J NEUROSCI, V31, P913, DOI 10.1523/JNEUROSCI.4417-10.2011; Bracewell RM, 1996, J NEUROPHYSIOL, V76, P1457, DOI 10.1152/jn.1996.76.3.1457; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Coe B, 2002, J NEUROSCI, V22, P5081, DOI 10.1523/JNEUROSCI.22-12-05081.2002; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Hanks TD, 2011, J NEUROSCI, V31, P6339, DOI 10.1523/JNEUROSCI.5613-10.2011; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Klein JT, 2008, CURR BIOL, V18, P419, DOI 10.1016/j.cub.2008.02.047; Leathers ML, 2012, SCIENCE, V338, P132, DOI 10.1126/science.1226405; Louie K, 2011, J NEUROSCI, V31, P10627, DOI 10.1523/JNEUROSCI.1237-11.2011; Louie K, 2010, J NEUROSCI, V30, P5498, DOI 10.1523/JNEUROSCI.5742-09.2010; Mazzoni P, 1996, J NEUROPHYSIOL, V76, P1439, DOI 10.1152/jn.1996.76.3.1439; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Peck CJ, 2009, J NEUROSCI, V29, P11182, DOI 10.1523/JNEUROSCI.1929-09.2009; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rao V, 2012, J NEUROSCI, V32, P10063, DOI 10.1523/JNEUROSCI.5948-11.2012; Roitman JD, 2002, J NEUROSCI, V22, P9475; Rorie AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009308; Seo H, 2009, J NEUROSCI, V29, P7278, DOI 10.1523/JNEUROSCI.1479-09.2009; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765	27	12	12	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131								10.1126/science.1233214	http://dx.doi.org/10.1126/science.1233214			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620037	Green Accepted			2022-12-28	WOS:000318016700021
J	Stahl, R; Walcher, T; Romero, CD; Pilz, GA; Cappello, S; Irmler, M; Sanz-Aquela, JM; Beckers, J; Blum, R; Borrell, V; Gotz, M				Stahl, Ronny; Walcher, Tessa; De Juan Romero, Camino; Pilz, Gregor Alexander; Cappello, Silvia; Irmler, Martin; Miguel Sanz-Aquela, Jose; Beckers, Johannes; Blum, Robert; Borrell, Victor; Goetz, Magdalena			Trnp1 Regulates Expansion and Folding of the Mammalian Cerebral Cortex by Control of Radial Glial Fate	CELL			English	Article							DEVELOPING MOUSE NEOCORTEX; OUTER SUBVENTRICULAR ZONE; LISSENCEPHALIC PRIMATE; EMBRYONIC NEOCORTEX; PROGENITOR-CELL; GERMINAL ZONES; EVOLUTION; NEUROGENESIS; EXPRESSION; DIFFERENTIATION	Evolution of the mammalian brain encompassed a remarkable increase in size of the cerebral cortex, which includes tangential and radial expansion. However, the mechanisms underlying these key features are still largely unknown. Here, we identified the DNA-associated protein Trnp1 as a regulator of cerebral cortex expansion in both of these dimensions. Gain- and loss-of-function experiments in the mouse cerebral cortex in vivo demonstrate that high Trnp1 levels promote neural stem cell self-renewal and tangential expansion. In contrast, lower levels promote radial expansion, with a potent increase of the number of intermediate progenitors and basal radial glial cells leading to folding of the otherwise smooth murine cerebral cortex. Remarkably, TRNP1 expression levels exhibit regional differences in the cerebral cortex of human fetuses, anticipating radial or tangential expansion. Thus, the dynamic regulation of Trnp1 is critical to control tangential and radial expansion of the cerebral cortex in mammals.	[Stahl, Ronny; Blum, Robert; Goetz, Magdalena] Univ Munich, Inst Physiol, D-80336 Munich, Germany; [Stahl, Ronny; Goetz, Magdalena] Munich Ctr Integrated Prot Sci CIPSM, D-81377 Munich, Germany; [Stahl, Ronny; Walcher, Tessa; Pilz, Gregor Alexander; Cappello, Silvia; Goetz, Magdalena] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Stem Cell Res, D-85764 Neuherberg, Germany; [Irmler, Martin; Beckers, Johannes] Helmholtz Ctr Munich, Inst Expt Genet, D-85764 Neuherberg, Germany; [De Juan Romero, Camino; Borrell, Victor] Univ Miguel Hernandez, CSIC, Inst Neurociencias, Sant Joan dAlacant, Spain; [Miguel Sanz-Aquela, Jose] Hosp Univ Principe de Asturias, Serv Pathol, Alcala De Henares 28805, Spain; [Beckers, Johannes] Tech Univ Munich, Chair Expt Genet, D-85350 Freising Weihenstephan, Germany; [Goetz, Magdalena] Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Prince of Asturias University Hospital; Technical University of Munich; University of Munich	Gotz, M (corresponding author), Univ Munich, Inst Physiol, Schillerstr 46, D-80336 Munich, Germany.	magdalena.goetz@helmholtz-muenchen.de	Cappello, Silvia/AAQ-4590-2021; Blum, Robert/E-8899-2013; Borrell, Victor/U-1802-2017; Irmler, Martin/B-3317-2013; Beckers, Johannes/K-7237-2012; de Juan Romero, Camino/G-9934-2015	Cappello, Silvia/0000-0003-1553-6775; Blum, Robert/0000-0002-5270-3854; Borrell, Victor/0000-0002-7833-3978; Irmler, Martin/0000-0003-3169-479X; Beckers, Johannes/0000-0001-7874-3822; de Juan, Camino/0000-0001-7890-8447	MICINN; "Juan de la Cierva" contract; CONSOLIDER [CSD2007-00023]; DFG via the Gottfried-Wilhelm Leibniz Award; German Excellence Program (LMU Excellent, CIPS);  [SAF2009-07367];  [SFB 870]	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); "Juan de la Cierva" contract; CONSOLIDER(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); DFG via the Gottfried-Wilhelm Leibniz Award(Fondazione Telethon); German Excellence Program (LMU Excellent, CIPS); ; 	We are particularly grateful to Gabriele Jager, Andrea Steiner-Mezzadri, and Emily Violette Baumgart for excellent technical support and to Alexandra Lepier and Simone Bauer for support in regard to viral vector production. We thank Judith Fischer-Sternjak for help with flow cytometry. Particular thanks to Atsunori Shitamukai and Fumio Matsuzaki for the constructs used for electroporation to visualize the morphology of basal radial glial cells by live imaging. We also thank Paolo Malatesta for the pCAG destination vectors. Special thanks to Olga Diez Jambrina (Service of Pathology, Hospital Universitario Principe de Asturias, Alcala de Henares, Spain) for invaluable help in processing the tissue from human fetal brains and to Wolfgang Enard for great discussions and very helpful comments on the manuscript. This work was funded by MICINN with a "Juan de la Cierva" contract to C.D.J.R. and grants SAF2009-07367 and CONSOLIDER CSD2007-00023 to V.B., and by the DFG via the Gottfried-Wilhelm Leibniz Award, the German Excellence Program (LMU Excellent, CIPS), and the SFB 870 to M.G.	Asami M, 2011, DEVELOPMENT, V138, P5067, DOI 10.1242/dev.074591; Bayatti N, 2008, CEREB CORTEX, V18, P1536, DOI 10.1093/cercor/bhm184; Borrell V, 2012, NEURON, V76, P338, DOI 10.1016/j.neuron.2012.08.003; Borrell V, 2012, DEV NEUROBIOL, V72, P955, DOI 10.1002/dneu.22013; Cappello S, 2012, NEURON, V73, P911, DOI 10.1016/j.neuron.2011.12.030; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Costa MR, 2008, DEVELOPMENT, V135, P11, DOI 10.1242/dev.009951; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Farkas LM, 2008, NEURON, V60, P40, DOI 10.1016/j.neuron.2008.09.020; Fietz SA, 2011, CURR OPIN NEUROBIOL, V21, P23, DOI 10.1016/j.conb.2010.10.002; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Garcia-Moreno F, 2012, CEREB CORTEX, V22, P482, DOI 10.1093/cercor/bhr312; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Haubst N, 2004, DEVELOPMENT, V131, P6131, DOI 10.1242/dev.01524; Heinrich C, 2011, NAT PROTOC, V6, P214, DOI 10.1038/nprot.2010.188; Kelava I, 2012, CEREB CORTEX, V22, P469, DOI 10.1093/cercor/bhr301; Kooistra SM, 2010, STEM CELLS, V28, P1703, DOI 10.1002/stem.497; Krubitzer L, 2007, NEURON, V56, P201, DOI 10.1016/j.neuron.2007.10.002; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Martinez-Cerdeno V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030178, 10.1371/journal.pone.0041386]; Miyoshi G, 2012, NEURON, V74, P1045, DOI 10.1016/j.neuron.2012.04.025; Pinto L, 2008, MOL CELL NEUROSCI, V38, P15, DOI 10.1016/j.mcn.2008.01.012; Pinto L, 2009, NAT NEUROSCI, V12, P1229, DOI 10.1038/nn.2399; Plageman TF, 2011, DEVELOPMENT, V138, P5177, DOI 10.1242/dev.067868; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Reillo I, 2012, CEREB CORTEX, V22, P2039, DOI 10.1093/cercor/bhr284; Reillo I, 2011, CEREB CORTEX, V21, P1674, DOI 10.1093/cercor/bhq238; Shitamukai A, 2011, J NEUROSCI, V31, P3683, DOI 10.1523/JNEUROSCI.4773-10.2011; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; True JR, 2002, ANNU REV CELL DEV BI, V18, P53, DOI 10.1146/annurev.cellbio.18.020402.140619; van den Boom V, 2007, J CELL BIOL, V178, P913, DOI 10.1083/jcb.200702058; Volpe M, 2006, DNA CELL BIOL, V25, P331, DOI 10.1089/dna.2006.25.331; Wang XQ, 2011, NAT NEUROSCI, V14, P555, DOI 10.1038/nn.2807	38	184	188	2	44	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 25	2013	153	3					535	549		10.1016/j.cell.2013.03.027	http://dx.doi.org/10.1016/j.cell.2013.03.027			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622239	Bronze			2022-12-28	WOS:000318063500008
J	Cziczo, DJ; Froyd, KD; Hoose, C; Jensen, EJ; Diao, MH; Zondlo, MA; Smith, JB; Twohy, CH; Murphy, DM				Cziczo, Daniel J.; Froyd, Karl D.; Hoose, Corinna; Jensen, Eric J.; Diao, Minghui; Zondlo, Mark A.; Smith, Jessica B.; Twohy, Cynthia H.; Murphy, Daniel M.			Clarifying the Dominant Sources and Mechanisms of Cirrus Cloud Formation	SCIENCE			English	Article							BIOLOGICAL PARTICLES; MIXED-PHASE; ICE; AEROSOLS; NUCLEI; NUCLEATION; DUST	Formation of cirrus clouds depends on the availability of ice nuclei to begin condensation of atmospheric water vapor. Although it is known that only a small fraction of atmospheric aerosols are efficient ice nuclei, the critical ingredients that make those aerosols so effective have not been established. We have determined in situ the composition of the residual particles within cirrus crystals after the ice was sublimated. Our results demonstrate that mineral dust and metallic particles are the dominant source of residual particles, whereas sulfate and organic particles are underrepresented, and elemental carbon and biological materials are essentially absent. Further, composition analysis combined with relative humidity measurements suggests that heterogeneous freezing was the dominant formation mechanism of these clouds.	[Cziczo, Daniel J.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Froyd, Karl D.; Murphy, Daniel M.] NOAA, Earth Syst Res Lab, Div Chem Sci, Boulder, CO 80305 USA; [Froyd, Karl D.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Hoose, Corinna] Karlsruhe Inst Technol, Inst Meteorol & Climate Res Atmospher Aerosol Res, D-76021 Karlsruhe, Germany; [Jensen, Eric J.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Diao, Minghui; Zondlo, Mark A.] Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA; [Smith, Jessica B.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Twohy, Cynthia H.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	Massachusetts Institute of Technology (MIT); National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; Helmholtz Association; Karlsruhe Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Princeton University; Harvard University; Oregon State University	Cziczo, DJ (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	djcziczo@mit.edu	Hoose, Corinna/A-4295-2009; Froyd, Karl D/H-6607-2013; Diao, Minghui/A-4437-2015; Zondlo, Mark A/R-6173-2016; Murphy, Daniel/J-4357-2012	Hoose, Corinna/0000-0003-2827-5789; Froyd, Karl D/0000-0002-0797-6028; Diao, Minghui/0000-0003-0324-0897; Zondlo, Mark A/0000-0003-2302-9554; Murphy, Daniel/0000-0002-8091-7235	NSF [AGS-0840732, AGS-1036275]; NASA [NNX07AL11G, NNX08AH57G]; NASA Earth Science Division Atmospheric Composition program [NNH11AQ58UI]	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); NASA Earth Science Division Atmospheric Composition program	We thank D. S. Thomson and G. Kulkarni for assistance with the measurements; S. Solomon for advice on manuscript preparation; all participants of the field studies for their efforts, in particular the air and ground crews of the NASA WB-57F and DC-8 and NSF G-V; and O. Seland, D. Olivie, and A. Kirkevag for providing particle surface area densities from CAM4-Oslo simulations. The MDC12C1 2011 Land Cover Type data were obtained through the online Data Pool at the NASA Land Processes Distributed Active Archive Center, U.S. Geological Survey/Earth Resources Observation and Science Center, Sioux Falls, South Dakota (https://lpdaac.usgs.gov/get_data). M.A.Z. acknowledges support from NSF AGS-0840732 and AGS-1036275, M. D. acknowledges a NASA Earth and Space Science Graduate Fellowship, and C. H. T. acknowledges support from the NASA Radiation Sciences Program award numbers NNX07AL11G and NNX08AH57G. This research was supported by the NASA Earth Science Division Atmospheric Composition program award number NNH11AQ58UI. Author contributions: single-particle MS, EM, data analysis, and paper writing (D.J.C.); counterflow virtual impactor development, mass spectrometer development, single-particle MS, data analysis, and paper writing (K. D. F.); compilation of INAS densities from laboratory data, deriving the model-based estimates of upper tropospheric IN, and paper writing (C. H.); measurement of water vapor mixing ratio, analysis of relative humidity data, and paper writing (J.B.S., M.A.Z, and M. D.); mission planning, data analysis, and paper writing (E.J.J); TC4 instrument design and data acquisition, paper writing (C. H. T.); and mass spectrometer development, single-particle MS, data analysis, and paper writing (D.M.M.).	Abbatt JPD, 2006, SCIENCE, V313, P1770, DOI 10.1126/science.1129726; Cziczo DJ, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044013; Cziczo DJ, 2009, NAT GEOSCI, V2, P333, DOI 10.1038/NGEO499; Cziczo DJ, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004032; DeMott PJ, 2003, P NATL ACAD SCI USA, V100, P14655, DOI 10.1073/pnas.2532677100; Dymarska M, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006627; Ebert M, 2011, ATMOS CHEM PHYS, V11, P2805, DOI 10.5194/acp-11-2805-2011; Froyd KD, 2010, ATMOS CHEM PHYS, V10, P209, DOI 10.5194/acp-10-209-2010; Gettelman A, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017950; Heymsfield AJ, 1998, GEOPHYS RES LETT, V25, P1343, DOI 10.1029/98GL01089; Hoose C, 2012, ATMOS CHEM PHYS, V12, P9817, DOI 10.5194/acp-12-9817-2012; Hoose C, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/024009; Jensen E.J., 2012, 16 INT C CLOUDS PREC; Kirkevag A, 2013, GEOSCI MODEL DEV, V6, P207, DOI 10.5194/gmd-6-207-2013; Kojima T, 2006, ATMOS RES, V82, P698, DOI 10.1016/j.atmosres.2006.02.024; Koop T, 2000, NATURE, V406, P611, DOI 10.1038/35020537; Kramer M, 2009, ATMOS CHEM PHYS, V9, P3505; Lohmann U, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014357; Lynch D.K., 2002, CIRRUS; Mohler O, 2007, BIOGEOSCIENCES, V4, P1059; Murphy DM, 2007, ATMOS CHEM PHYS, V7, P3195, DOI 10.5194/acp-7-3195-2007; Murphy DM, 1998, SCIENCE, V282, P1664, DOI 10.1126/science.282.5394.1664; Murray BJ, 2010, NAT GEOSCI, V3, P233, DOI [10.1038/ngeo817, 10.1038/NGEO817]; Pratt KA, 2009, NAT GEOSCI, V2, P397, DOI 10.1038/NGEO521; Pruppacher H. R., 1997, MICROPHYSICS CLOUDS, V2, P309; Solomon S., 2007, PHYS SCI BASIS WORKI; Targino AC, 2006, ATMOS CHEM PHYS, V6, P1977, DOI 10.5194/acp-6-1977-2006; Twohy CH, 2005, ATMOS CHEM PHYS, V5, P2289, DOI 10.5194/acp-5-2289-2005; WEINSTOCK EM, 1994, REV SCI INSTRUM, V65, P3544, DOI 10.1063/1.1144536; Wiacek A, 2010, ATMOS CHEM PHYS, V10, P8649, DOI 10.5194/acp-10-8649-2010; Zondlo MA, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014445	31	339	342	14	321	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1320	1324		10.1126/science.1234145	http://dx.doi.org/10.1126/science.1234145			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23661645	Green Submitted			2022-12-28	WOS:000320320200042
J	Tachibana, M; Amato, P; Sparman, M; Gutierrez, NM; Tippner-Hedges, R; Ma, H; Kang, EJ; Fulati, A; Lee, HS; Sritanaudomchai, H; Masterson, K; Larson, J; Eaton, D; Sadler-Fredd, K; Battaglia, D; Lee, D; Wu, DA; Jensen, J; Patton, P; Gokhale, S; Stouffer, RL; Wolf, D; Mitalipov, S				Tachibana, Masahito; Amato, Paula; Sparman, Michelle; Gutierrez, Nuria Marti; Tippner-Hedges, Rebecca; Ma, Hong; Kang, Eunju; Fulati, Alimujiang; Lee, Hyo-Sang; Sritanaudomchai, Hathaitip; Masterson, Keith; Larson, Janine; Eaton, Deborah; Sadler-Fredd, Karen; Battaglia, David; Lee, David; Wu, Diana; Jensen, Jeffrey; Patton, Phillip; Gokhale, Sumita; Stouffer, Richard L.; Wolf, Don; Mitalipov, Shoukhrat			Human Embryonic Stem Cells Derived by Somatic Cell Nuclear Transfer	CELL			English	Article							PREIMPLANTATION DEVELOPMENT; TRICHOSTATIN-A; OOCYTES; CLONING; NUMBER; ACTIVATION; PRIMATES; MOUSE; MG132; IVF	Reprogramming somatic cells into pluripotent embryonic stem cells (ESCs) by somatic cell nuclear transfer (SCNT) has been envisioned as an approach for generating patient-matched nuclear transfer (NT)-ESCs for studies of disease mechanisms and for developing specific therapies. Past attempts to produce human NT-ESCs have failed secondary to early embryonic arrest of SCNT embryos. Here, we identified premature exit from meiosis in human oocytes and suboptimal activation as key factors that are responsible for these outcomes. Optimized SCNT approaches designed to circumvent these limitations allowed derivation of human NT-ESCs. When applied to premium quality human oocytes, NT-ESC lines were derived from as few as two oocytes. NT-ESCs displayed normal diploid karyotypes and inherited their nuclear genome exclusively from parental somatic cells. Gene expression and differentiation profiles in human NT-ESCs were similar to embryo-derived ESCs, suggesting efficient reprogramming of somatic cells to a pluripotent state.	[Tachibana, Masahito; Sparman, Michelle; Gutierrez, Nuria Marti; Tippner-Hedges, Rebecca; Ma, Hong; Kang, Eunju; Fulati, Alimujiang; Lee, Hyo-Sang; Jensen, Jeffrey; Stouffer, Richard L.; Wolf, Don; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Div Reprod & Dev Sci, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Amato, Paula; Masterson, Keith; Larson, Janine; Eaton, Deborah; Sadler-Fredd, Karen; Battaglia, David; Lee, David; Wu, Diana; Patton, Phillip; Stouffer, Richard L.; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Div Reprod Endocrinol, Portland, OR 97239 USA; [Sritanaudomchai, Hathaitip] Mahidol Univ, Fac Dent, Dept Oral Biol, Bangkok 10400, Thailand; [Jensen, Jeffrey] Oregon Hlth & Sci Univ, Womens Hlth Res Unit, Portland, OR 97239 USA; [Gokhale, Sumita] Boston Univ, Sch Med, Boston, MA 02118 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Mahidol University; Oregon Health & Science University; Boston University	Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Div Reprod & Dev Sci, Oregon Natl Primate Res Ctr, 505 NW 185th Ave, Beaverton, OR 97006 USA.	mitalipo@ohsu.edu	Jensen, Jeffrey T/C-7421-2014	Jensen, Jeffrey T/0000-0002-4733-1224	National Institutes of Health [HD063276, HD057121, HD059946, EY021214, 8P51OD011092]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD063276, R01HD057121, R01HD059946] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021214] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to acknowledge the OHSU Embryonic Stem Cell Research Oversight Committee and the Institutional Review Board for providing oversight and guidance with human embryo and ESC studies. We thank egg donor volunteers and the staff at the Women's Health Research Unit at the Center for Women's Health, the Division of Reproductive Endocrinology & Infertility of the Department of Obstetrics & Gynecology of Oregon Health & Science University for their support and procurement of human gametes. The Division of Animal Resources, Surgery Team, Assisted Reproductive Technology & Embryonic Stem Cell Core, Endocrine Technology Core, and Imaging & Morphology Core at the Oregon National Primate Research Center provided expertise and services for the nonhuman primate studies. Hamilton Thorne donated the XYClone laser system for this study. We are grateful to Dr. Warren Sanger and Dianna Zaleski for karyotyping services, Dr. Cecilia Penedo for microsatellite analysis, and Dr. Cary Harding for assistance with nuclear donor cells. We are also indebted to Vanessa Domush, Elizabeth Smolens, Cathy Ramsey, Ying Li, Riffat Ahmed, Brittany Daughtry, and Erin Wolff for their technical support. The human oocyte/embryo research was supported by OHSU institutional funds and by the grant from Leducq Foundation. The nonhuman primate studies were supported by grants from the National Institutes of Health HD063276, HD057121, HD059946, EY021214, and 8P51OD011092.	Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Choi I, 2010, REPROD FERT DEVELOP, V22, P1000, DOI 10.1071/RD09144; Daley GQ, 2011, NATURE, V478, P40, DOI 10.1038/478040a; Danan C, 1999, AM J HUM GENET, V65, P463, DOI 10.1086/302484; Ding X, 2008, THERIOGENOLOGY, V70, P622, DOI 10.1016/j.theriogenology.2008.04.042; Egli D, 2008, NAT REV MOL CELL BIO, V9, P505, DOI 10.1038/nrm2439; Egli D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1503; Fan Y, 2011, STEM CELLS DEV, V20, P1951, DOI 10.1089/scd.2010.0451; French AJ, 2008, STEM CELLS, V26, P485, DOI 10.1634/stemcells.2007-0252; Gleicher N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018781; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Lanza RP, 1999, NAT BIOTECHNOL, V17, P1171, DOI 10.1038/70709; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Li J, 2008, THERIOGENOLOGY, V70, P800, DOI 10.1016/j.theriogenology.2008.05.046; Mitalipov SM, 2007, HUM REPROD, V22, P2232, DOI 10.1093/humrep/dem136; Mitalipov SM, 2001, BIOL REPROD, V65, P253, DOI 10.1095/biolreprod65.1.253; Nakajima N, 2008, CLONING STEM CELLS, V10, P461, DOI 10.1089/clo.2008.0038; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; PELLICER A, 1989, HUM REPROD, V4, P536, DOI 10.1093/oxfordjournals.humrep.a136940; Santos MA, 2010, REPRODUCTION, V139, P23, DOI 10.1530/REP-09-0187; Solter D, 2000, NAT REV GENET, V1, P199, DOI 10.1038/35042066; Sparman M, 2009, STEM CELLS, V27, P1255, DOI 10.1002/stem.60; Sparman ML, 2010, INT J DEV BIOL, V54, P1671, DOI 10.1387/ijdb.103196ms; SUSKOPARRISH JL, 1994, DEV BIOL, V166, P729, DOI 10.1006/dbio.1994.1351; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; van der Gaast MH, 2006, REPROD BIOMED ONLINE, V13, P476, DOI 10.1016/S1472-6483(10)60633-5; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Wilmut I, 2002, NATURE, V419, P583, DOI 10.1038/nature01079; Wu YG, 2007, CLONING STEM CELLS, V9, P417, DOI 10.1089/clo.2006.0023; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	39	502	541	7	313	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 6	2013	153	6					1228	1238		10.1016/j.cell.2013.05.006	http://dx.doi.org/10.1016/j.cell.2013.05.006			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	158NQ	23683578	Bronze, Green Accepted			2022-12-28	WOS:000319979200009
J	Mirkin, SM				Mirkin, Sergei M.			DNA REPLICATION Driving past four-stranded snags	NATURE			English	Editorial Material									Tufts Univ, Dept Biol, Medford, MA 02155 USA	Tufts University	Mirkin, SM (corresponding author), Tufts Univ, Dept Biol, Medford, MA 02155 USA.	sergei.mirkin@tufts.edu	Mirkin, Sergei/A-7310-2010; Mirkin, Sergei/AAR-7226-2020	Mirkin, Sergei/0000-0003-4576-7582				Anand RP, 2012, NUCLEIC ACIDS RES, V40, P1091, DOI 10.1093/nar/gkr836; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Bochman ML, 2010, DNA REPAIR, V9, P237, DOI 10.1016/j.dnarep.2010.01.008; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Lopes J, 2011, EMBO J, V30, P4033, DOI 10.1038/emboj.2011.316; Maizels N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003468; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Perrod S, 2003, CELL MOL LIFE SCI, V60, P2303, DOI 10.1007/s00018-003-3246-x; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; WOODFORD KJ, 1994, J BIOL CHEM, V269, P27029	12	9	9	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2013	497	7450					449	450		10.1038/nature12244	http://dx.doi.org/10.1038/nature12244			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23657255				2022-12-28	WOS:000319254000038
J	Patel, P; Roberts, B				Patel, Preeti; Roberts, Bayard			Aid for reproductive health: progress and challenges	LANCET			English	Editorial Material							CHILD HEALTH; ASSISTANCE; COUNTDOWN; NEWBORN		[Patel, Preeti] Kings Coll London, Dept War Studies, London WC2R 2LS, England; [Roberts, Bayard] London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1, England	University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine	Patel, P (corresponding author), Kings Coll London, Dept War Studies, London WC2R 2LS, England.	preeti.patel@kcl.ac.uk		Roberts, Bayard/0000-0003-4482-5859; Patel, Preeti/0000-0003-3875-453X				[Anonymous], 2012, FIN GLOB HLTH 2012 E; Easterly W., 2007, WHITE MANS BURDEN WH; Fan V, 2013, SIZING CHINAS ROLE G; Farag M, 2009, HEALTH AFFAIR, V28, P1045, DOI 10.1377/hlthaff.28.4.1045; Greco G, 2008, LANCET, V371, P1268, DOI 10.1016/S0140-6736(08)60561-9; Hsu J, 2013, LANCET, V381, P1772, DOI 10.1016/S0140-6736(13)60762-X; Hsu J, 2012, LANCET, V380, P1157, DOI 10.1016/S0140-6736(12)61415-9; Institute for Health Metrics and Evaluation, 2011, FIN GLOB HLTH 2011 C; Lane C, 2007, HEALTH AFFAIR, V26, P935, DOI 10.1377/hlthaff.26.4.935; Patel P, 2011, HEALTH POLICY, V100, P116, DOI 10.1016/j.healthpol.2010.08.007; Patel P, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000090; Pitt C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001332; UN Population Fund, 2010, SEX REPR HLTH ALL RE; United Nations Population Fund, 2010, FIN RES FLOWS POP AC; World Bank, 2010, BETT HLTH WOM FAM WO	15	3	3	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 18	2013	381	9879					1701	1702		10.1016/S0140-6736(13)60956-3	http://dx.doi.org/10.1016/S0140-6736(13)60956-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146TA	23683622				2022-12-28	WOS:000319112800013
J	Pollack, IF				Pollack, Ian F.			Tumor-Stromal Interactions in Medulloblastoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Pittsburgh, Sch Med, Dept Neurosurg, Childrens Hosp Pittsburgh,UPMC, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Pollack, IF (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurosurg, Childrens Hosp Pittsburgh,UPMC, Pittsburgh, PA 15261 USA.							Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Packer RJ, 2006, J CLIN ONCOL, V24, P4202, DOI 10.1200/JCO.2006.06.4980; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Snuderl M, 2013, CELL, V152, P1065, DOI 10.1016/j.cell.2013.01.036	5	5	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2013	368	20					1942	1943		10.1056/NEJMcibr1302851	http://dx.doi.org/10.1056/NEJMcibr1302851			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143VK	23675664				2022-12-28	WOS:000318896200017
J	Zimmerman, BA				Zimmerman, Brigitte Aimee			Patient's Sister, Seeking Job	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Calif San Diego, Dept Polit Sci, San Diego, CA 92103 USA	University of California System; University of California San Diego	Zimmerman, BA (corresponding author), Univ Calif San Diego, Dept Polit Sci, San Diego, CA 92103 USA.	bazimmer@ucsd.edu							0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2013	309	19					2003	2004		10.1001/jama.2013.2864	http://dx.doi.org/10.1001/jama.2013.2864			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143GQ	23677312				2022-12-28	WOS:000318855500022
J	Birn, AE; Fee, E				Birn, Anne-Emanuelle; Fee, Elizabeth			The art of medicine The Rockefeller Foundation and the international health agenda	LANCET			English	Editorial Material									[Birn, Anne-Emanuelle] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada; [Fee, Elizabeth] NIH, Natl Lib Med, Bethesda, MD 20892 USA	University of Toronto; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Birn, AE (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada.	ae.birn@utoronto.ca						Birn Anne-Emanuelle, 2006, MARRIAGE OF CONVENIE; Cueto Marcos, 1994, MISSIONARIES OF SCIE; Farley J., 2004, TO CAST OUT DISEASE; Fee E., 1987, DISEASE AND DISCOVER; Hewa Soma, 1995, COLONIALISM TROPICAL; PALMER Steven, 2010, LAUNCHING GLOBAL HEA	6	15	15	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 11	2013	381	9878					1618	1619		10.1016/S0140-6736(13)61013-2	http://dx.doi.org/10.1016/S0140-6736(13)61013-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146SX	23671918				2022-12-28	WOS:000319112400013
J	Campbell, B; Stainthorpe, AC; Longson, CM				Campbell, Bruce; Stainthorpe, Andrew C.; Longson, Carole M.			How can we get high quality routine data to monitor the safety of devices and procedures?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTERVENTIONAL PROCEDURES; MEDICAL DEVICES		[Campbell, Bruce] Natl Inst Hlth & Care Excellence, London SW1A 2BU, England; [Stainthorpe, Andrew C.; Longson, Carole M.] Natl Inst Hlth & Care Excellence, Ctr Hlth Technol Evaluat, London, England	National Institute for Health & Care Excellence; National Institute for Health & Care Excellence	Campbell, B (corresponding author), Natl Inst Hlth & Care Excellence, London SW1A 2BU, England.	Bruce.Campbell@NICE.org.uk						Baum Mary, 2011, Health Manag Technol, V32, P24; British Orthopaedic Association, MET ON MET HIPS; Campbell B, 2012, BRIT J SURG, V99, P744, DOI 10.1002/bjs.8791; Cohen D, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2748; Dent T, 2004, BRIT MED J, V329, P3, DOI 10.1136/bmj.329.7456.3; Dhruva SS, 2009, JAMA-J AM MED ASSOC, V302, P2679, DOI 10.1001/jama.2009.1899; EU Business, 2012, EU REG FRAM MED DEV; Food and Drug Administration, 2012, MED DEV; Heneghan C, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000155; International Health Terminology Standards Development Organisation, SNOMED CT; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; McCulloch P, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7126; National Joint Registry, FUND; NICE, INT PROC; Plumb J, 2009, INT J TECHNOL ASSESS, V25, P124, DOI 10.1017/S0266462309090175; Sveriges Kommuner och Landsting, QUAL REG; The Bristol Royal Infirmary Inquiry, 2001, LEARN BRIST REP PUBL; [No title captured]	18	14	14	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2013	346								f2782	10.1136/bmj.f2782	http://dx.doi.org/10.1136/bmj.f2782			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	144BQ	23653341				2022-12-28	WOS:000318914800002
J	Elliott, JE; Elliott, KH				Elliott, John E.; Elliott, Kyle H.			Tracking Marine Pollution	SCIENCE			English	Editorial Material							TEMPORAL TRENDS; SEABIRD EGGS; CONTAMINANTS; MERCURY		[Elliott, John E.] Environm Canada, Sci & Technol Branch, Delta, BC V4K 3N2, Canada; [Elliott, Kyle H.] Univ Manitoba, Dept Biol Sci, Winnipeg, MB R3T 2N2, Canada	Environment & Climate Change Canada; University of Manitoba	Elliott, JE (corresponding author), Environm Canada, Sci & Technol Branch, Delta, BC V4K 3N2, Canada.	john.elliott@ec.gc.ca	Elliott, Kyle/S-9185-2019	Elliott, Kyle/0000-0001-5304-3993				ANDERSON DW, 1975, SCIENCE, V190, P806, DOI 10.1126/science.1239078; Braune BM, 2007, SCI TOTAL ENVIRON, V378, P403, DOI 10.1016/j.scitotenv.2007.03.003; Bridge ES, 2011, BIOSCIENCE, V61, P689, DOI 10.1525/bio.2011.61.9.7; Crosse JD, 2012, ENVIRON POLLUT, V161, P93, DOI 10.1016/j.envpol.2011.10.003; Day RD, 2012, ENVIRON SCI TECHNOL, V46, P5327, DOI 10.1021/es2047156; Elliott J. E., 2012, ANN C N PAC MAR SCI, P83; Finkelstein M, 2006, ECOL APPL, V16, P678, DOI 10.1890/1051-0761(2006)016[0678:ASDRDI]2.0.CO;2; Gilbertson M., 1987, USES BIRDS, P231; Hebert CE, 2006, ENVIRON SCI TECHNOL, V40, P5624, DOI 10.1021/es0520621; Helgason LB, 2009, ENVIRON TOXICOL CHEM, V28, P1096, DOI 10.1897/08-404.1; Holmstrom KE, 2005, ENVIRON SCI TECHNOL, V39, P80, DOI 10.1021/es049257d; Muir D, 1999, SCI TOTAL ENVIRON, V230, P83, DOI 10.1016/S0048-9697(99)00037-6; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; van den Brink NW, 2011, MAR POLLUT BULL, V62, P128, DOI 10.1016/j.marpolbul.2010.09.002; Vo ATE, 2011, P NATL ACAD SCI USA, V108, P7466, DOI 10.1073/pnas.1013865108	15	121	133	2	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2013	340	6132					556	558		10.1126/science.1235197	http://dx.doi.org/10.1126/science.1235197			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23641102				2022-12-28	WOS:000318268900033
J	Hennessy, ET; Betley, TA				Hennessy, Elisabeth T.; Betley, Theodore A.			Complex N-Heterocycle Synthesis via Iron-Catalyzed, Direct C-H Bond Amination	SCIENCE			English	Article							ARYL AZIDES; FUNCTIONALIZATION; HYDROXYLATION; ACTIVATION; MECHANISMS	The manipulation of traditionally unreactive functional groups is of paramount importance in modern chemical synthesis. We have developed an iron-dipyrrinato catalyst that leverages the reactivity of iron-borne metal-ligand multiple bonds to promote the direct amination of aliphatic C-H bonds. Exposure of organic azides to the iron dipyrrinato catalyst furnishes saturated, cyclic amine products (N-heterocycles) bearing complex core-substitution patterns. This study highlights the development of C-H bond functionalization chemistry for the formation of saturated, cyclic amine products and should find broad application in the context of both pharmaceuticals and natural product synthesis.	[Hennessy, Elisabeth T.; Betley, Theodore A.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University	Betley, TA (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	betley@chemistry.harvard.edu			NSF [CHE-0955885]; Harvard University; U.S. Department of Energy Office of Science Graduate Fellowship Program [DE-AC05-060R23100]	NSF(National Science Foundation (NSF)); Harvard University; U.S. Department of Energy Office of Science Graduate Fellowship Program	This work was supported by a grant from the NSF (CHE-0955885) and Harvard University. E. T. H. is grateful for a predoctoral fellowship from the U.S. Department of Energy Office of Science Graduate Fellowship Program (DE-AC05-060R23100) administered by Oak Ridge Institute for Science Education-Oak Ridge Associated Universities. T. A. B. is grateful for a George W. Merck Fellowship. We thank S.-L. Zheng for assistance with crystallography; J. Hong, A. Saghatelian, and B. Milgram for helpful discussions; and E. N. Jacobsen and T. Ritter for the generous use of their high-performance liquid chromatography and GC/MS instruments, respectively. The crystallographic data CCDC-905454 - 905461 can be obtained free of charge from the Cambridge Crystallographic Data Centre (www.ccdc.cam.ac.uk/data_request/cif).	Au SM, 1999, J AM CHEM SOC, V121, P9120, DOI 10.1021/ja9913481; Badiei YM, 2008, ANGEW CHEM INT EDIT, V47, P9961, DOI 10.1002/anie.200804304; BARTON DHR, 1965, J CHEM SOC, P2444, DOI 10.1039/jr9650002444; Beesley RM, 1915, J CHEM SOC, V107, P1080, DOI 10.1039/ct9150701080; Chen MS, 2007, SCIENCE, V318, P783, DOI 10.1126/science.1148597; Davies HML, 2008, NATURE, V451, P417, DOI 10.1038/nature06485; Dick AR, 2006, TETRAHEDRON, V62, P2439, DOI 10.1016/j.tet.2005.11.027; Driver TG, 2010, ORG BIOMOL CHEM, V8, P3831, DOI 10.1039/c005219c; DROUIN J, 1980, TETRAHEDRON, V36, P1195, DOI 10.1016/0040-4020(80)87018-9; Fiori KW, 2009, TETRAHEDRON, V65, P3042, DOI 10.1016/j.tet.2008.11.073; Groves JT, 2006, J INORG BIOCHEM, V100, P434, DOI 10.1016/j.jinorgbio.2006.01.012; GROVES JT, 1978, BIOCHEM BIOPH RES CO, V81, P154, DOI 10.1016/0006-291X(78)91643-1; Hoffman A. W., 1885, BERICHTE, V18, P109; King AO, 2004, TOP ORGANOMETAL CHEM, V6, P205; King ER, 2011, J AM CHEM SOC, V133, P4917, DOI 10.1021/ja110066j; Labinger JA, 2002, NATURE, V417, P507, DOI 10.1038/417507a; Laskowski CA, 2011, J AM CHEM SOC, V133, P771, DOI 10.1021/ja1101213; Liang CG, 2008, J AM CHEM SOC, V130, P343, DOI 10.1021/ja076519d; Lyaskovskyy V, 2011, J AM CHEM SOC, V133, P12264, DOI 10.1021/ja204800a; Mukaiyama T, 2010, HETEROCYCLES, V80, P63, DOI 10.3987/REV-09-SR(S)1; Newcomb M, 2000, ACCOUNTS CHEM RES, V33, P449, DOI 10.1021/ar960058b; Nugent W. A., 1988, METAL LIGAND MULTIPL; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Paradine SM, 2012, J AM CHEM SOC, V134, P2036, DOI 10.1021/ja211600g; Que L, 2007, ACCOUNTS CHEM RES, V40, P493, DOI 10.1021/ar700024g; Nguyen Q, 2013, J AM CHEM SOC, V135, P620, DOI 10.1021/ja3113565; Nguyen Q, 2012, J AM CHEM SOC, V134, P7262, DOI 10.1021/ja301519q; RYABOV AD, 1990, CHEM REV, V90, P403, DOI 10.1021/cr00100a004; SOROKIN A, 1993, J AM CHEM SOC, V115, P7293, DOI 10.1021/ja00069a031; Wiese S, 2012, J AM CHEM SOC, V134, P10114, DOI 10.1021/ja302149k; Zalatan DN, 2010, TOP CURR CHEM, V292, P347, DOI 10.1007/128_2009_19	31	426	426	8	416	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2013	340	6132					591	595		10.1126/science.1233701	http://dx.doi.org/10.1126/science.1233701			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23641113				2022-12-28	WOS:000318268900043
J	Hilton, D				Hilton, Douglas			Australian science needs more female fellows	NATURE			English	Editorial Material									[Hilton, Douglas] Univ Melbourne, Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3010, Australia; [Hilton, Douglas] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia	University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne	Hilton, D (corresponding author), Univ Melbourne, Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3010, Australia.	hilton@wehi.edu.au	Hilton, Douglas J/C-7250-2013	Hilton, Douglas J/0000-0002-7698-2392					0	3	3	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 2	2013	497	7447					7	7		10.1038/497007a	http://dx.doi.org/10.1038/497007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	134OK	23636356	Bronze			2022-12-28	WOS:000318221500004
J	Ball, P				Ball, Philip			Celebrate the unknowns	NATURE			English	Editorial Material												p.ball@btinternet.com						Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Doolittle WF, 2013, P NATL ACAD SCI USA, V110, P5294, DOI 10.1073/pnas.1221376110; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Jarosz DF, 2010, SCIENCE, V330, P1820, DOI 10.1126/science.1195487; Lynch M, 2012, P NATL ACAD SCI USA, V109, P18851, DOI 10.1073/pnas.1216130109; Mattick JS, 2012, P NATL ACAD SCI USA, V109, P16400, DOI 10.1073/pnas.1214129109; Mattick JS, 2011, FEBS LETT, V585, P1600, DOI 10.1016/j.febslet.2011.05.001; Wagner A, 2011, TRENDS ECOL EVOL, V26, P577, DOI 10.1016/j.tree.2011.07.001; Wagner A, 2011, TRENDS GENET, V27, P397, DOI 10.1016/j.tig.2011.06.002	10	33	33	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2013	496	7446					419	420		10.1038/496419a	http://dx.doi.org/10.1038/496419a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	131HU	23619675	Bronze			2022-12-28	WOS:000317984400013
J	Wynn, TA; Chawla, A; Pollard, JW				Wynn, Thomas A.; Chawla, Ajay; Pollard, Jeffrey W.			Macrophage biology in development, homeostasis and disease	NATURE			English	Review							ENDOTHELIAL GROWTH-FACTOR; TUMOR-ASSOCIATED MACROPHAGES; COLONY-STIMULATING FACTOR; ALTERNATIVE ACTIVATION; ADIPOSE-TISSUE; MYELOID CELLS; MOUSE MODEL; CD16-POSITIVE MONOCYTES; INSULIN-RESISTANCE; LANGERHANS CELLS	Macrophages, the most plastic cells of the haematopoietic system, are found in all tissues and show great functional diversity. They have roles in development, homeostasis, tissue repair and immunity. Although tissue macrophages are anatomically distinct from one another, and have different transcriptional profiles and functional capabilities, they are all required for the maintenance of homeostasis. However, these reparative and homeostatic functions can be subverted by chronic insults, resulting in a causal association of macrophages with disease states. In this Review, we discuss how macrophages regulate normal physiology and development, and provide several examples of their pathophysiological roles in disease. We define the 'hallmarks' of macrophages according to the states that they adopt during the performance of their various roles, taking into account new insights into the diversity of their lineages, identities and regulation. It is essential to understand this diversity because macrophages have emerged as important therapeutic targets in many human diseases.	[Wynn, Thomas A.] NIAID, Immunopathogenesis Sect, Program Tissue Immun & Repair, NIH, Gaithersburg, MD 20877 USA; [Wynn, Thomas A.] NIAID, Parasit Dis Lab, NIH, Gaithersburg, MD 20877 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Physiol & Med, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Pollard, Jeffrey W.] Univ Edinburgh, Queens Med Res Inst, Med Res Council Ctr Reprod Hlth, Edinburgh EH16 4TJ, Midlothian, Scotland; [Pollard, Jeffrey W.] Albert Einstein Coll Med, Dept Dev & Mol Biol, Ctr Study Reprod Biol & Womens Hlth, New York, NY 10461 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Francisco; University of Edinburgh; Yeshiva University	Wynn, TA (corresponding author), NIAID, Immunopathogenesis Sect, Program Tissue Immun & Repair, NIH, Gaithersburg, MD 20877 USA.	twynn@niaid.nih.gov; ajay.chawla@ucsf.edu; jeff.pollard@ed.ac.uk	Wynn, Thomas A/AAO-3523-2021	Wynn, Thomas A/0000-0002-7244-8731	National Institutes of Allergy and Infectious Diseases (National Institutes of Health (NIH)); National Cancer Institute of the NIH [R01CA131270S, U54HD058155, PO1CA100324, HL076746, DK094641]; Diabetes Family Fund; American Heart Association (AHA) [12PILT11840038]; NIH [DP1AR064158]; Medical Research Council [G1002033] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD058155] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA100324, R01CA131270] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [DP1AR064158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094641, R01DK081405] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006415] Funding Source: NIH RePORTER; MRC [G1002033] Funding Source: UKRI	National Institutes of Allergy and Infectious Diseases (National Institutes of Health (NIH)); National Cancer Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Diabetes Family Fund; American Heart Association (AHA)(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors apologize to colleagues whose papers they were unable to cite on this occasion. T. A. W. is supported by the intramural research program of the National Institutes of Allergy and Infectious Diseases (National Institutes of Health (NIH)). This work was supported by the National Cancer Institute of the NIH (award numbers R01CA131270S, U54HD058155 and PO1CA100324 (to J.W.P.), and HL076746, DK094641 and DK094641 (to A. C.)); the Diabetes Family Fund (to the University of California, San Francisco), an American Heart Association (AHA) Innovative Award (12PILT11840038) and a NIH Director's Pioneer Award (DP1AR064158 to A.C.).	Ahn GO, 2010, P NATL ACAD SCI USA, V107, P8363, DOI 10.1073/pnas.0911378107; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Balkwill FR, 2012, SEMIN CANCER BIOL, V22, P33, DOI 10.1016/j.semcancer.2011.12.005; Bigley V, 2011, J EXP MED, V208, P227, DOI 10.1084/jem.20101459; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chen JQ, 2011, CANCER CELL, V19, P541, DOI 10.1016/j.ccr.2011.02.006; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Coussens LM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003285; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; DeNardo D, 2010, CANCER METAST REV, V29, P309, DOI 10.1007/s10555-010-9223-6; Deng L, 2010, AM J PATHOL, V176, P952, DOI 10.2353/ajpath.2010.090622; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Edwards JR, 2011, NAT REV RHEUMATOL, V7, P235, DOI 10.1038/nrrheum.2011.23; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Entenberg D, 2011, NAT PROTOC, V6, P1500, DOI 10.1038/nprot.2011.376; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Ford AQ, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-6; Frankenberger M, 2013, IMMUNOBIOLOGY, V218, P169, DOI 10.1016/j.imbio.2012.02.013; Frankenberger M, 2012, EUR J IMMUNOL, V42, P957, DOI 10.1002/eji.201141907; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gelderman KA, 2007, J CLIN INVEST, V117, P3020, DOI 10.1172/JCI31935; Gil-Bernabe AM, 2012, BLOOD, V119, P3164, DOI 10.1182/blood-2011-08-376426; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gordon EJ, 2010, DEVELOPMENT, V137, P3899, DOI 10.1242/dev.050021; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordy C, 2011, BLOOD, V117, P618, DOI 10.1182/blood-2010-01-265959; Gyorki DE, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2353; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Hamilton JA, 2013, TRENDS IMMUNOL, V34, P81, DOI 10.1016/j.it.2012.08.006; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Hume D. A., 2012, J LEUKOC BIOL; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Julia V, 2002, IMMUNITY, V16, P271, DOI 10.1016/S1074-7613(02)00276-5; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Li Y, 2012, DEV CELL, V23, P1189, DOI 10.1016/j.devcel.2012.10.027; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lin EY, 2007, MOL ONCOL, V1, P288, DOI 10.1016/j.molonc.2007.10.003; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; London A, 2011, J EXP MED, V208, P23, DOI 10.1084/jem.20101202; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Mason SD, 2011, TRENDS CELL BIOL, V21, P228, DOI 10.1016/j.tcb.2010.12.002; Mazzieri R, 2011, CANCER CELL, V19, P512, DOI 10.1016/j.ccr.2011.02.005; Melgert BN, 2011, J ALLERGY CLIN IMMUN, V127, P831, DOI 10.1016/j.jaci.2010.10.045; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Moreira AP, 2010, J ALLERGY CLIN IMMUN, V126, P712, DOI 10.1016/j.jaci.2010.06.010; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nieuwenhuizen NE, 2012, J ALLERGY CLIN IMMUN, V130, P743, DOI 10.1016/j.jaci.2012.03.011; Niida S, 1999, J EXP MED, V190, P293, DOI 10.1084/jem.190.2.293; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Pello OM, 2012, BLOOD, V119, P411, DOI 10.1182/blood-2011-02-339911; Platt AM, 2010, J IMMUNOL, V184, P6843, DOI 10.4049/jimmunol.0903987; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Rademakers R, 2012, NAT GENET, V44, P200, DOI 10.1038/ng.1027; Rao S, 2007, DEVELOPMENT, V134, P4449, DOI 10.1242/dev.012187; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Salegio EAA, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-11; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; Stefater III J. A., 2011, TRENDS MOL MED; Stefater JA, 2011, NATURE, V474, P511, DOI 10.1038/nature10085; Stockmann C, 2008, NATURE, V456, P814, DOI 10.1038/nature07445; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tammela T, 2011, NAT CELL BIOL, V13, P1202, DOI 10.1038/ncb2331; Thomas JA, 2011, HEPATOLOGY, V53, P2003, DOI 10.1002/hep.24315; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu Y, 2012, CANCER MICROENVIRON, V5, P195, DOI 10.1007/s12307-012-0113-z; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zabuawala T, 2010, CANCER RES, V70, P1323, DOI 10.1158/0008-5472.CAN-09-1474; Zaidi MR, 2011, NATURE, V469, P548, DOI 10.1038/nature09666	125	2569	2712	38	736	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2013	496	7446					445	455		10.1038/nature12034	http://dx.doi.org/10.1038/nature12034			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23619691	Green Accepted			2022-12-28	WOS:000317984400031
J	Sulkowski, MS; Sherman, KE; Dieterich, DT; Bsharat, M; Mahnke, L; Rockstroh, JK; Gharakhanian, S; McCallister, S; Henshaw, J; Girard, PM; Adiwijaya, B; Garg, V; Rubin, RA; Adda, N; Soriano, V				Sulkowski, Mark S.; Sherman, Kenneth E.; Dieterich, Douglas T.; Bsharat, Mohammad; Mahnke, Lisa; Rockstroh, Juergen K.; Gharakhanian, Shahin; McCallister, Scott; Henshaw, Joshua; Girard, Pierre-Marie; Adiwijaya, Bambang; Garg, Varun; Rubin, Raymond A.; Adda, Nathalie; Soriano, Vincent			Combination Therapy With Telaprevir for Chronic Hepatitis C Virus Genotype 1 Infection in Patients With HIV A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							ALPHA-2A PLUS RIBAVIRIN; VIROLOGICAL RESPONSE; HCV; MANAGEMENT; ASSOCIATION; BOCEPREVIR; PREDICTORS; ANEMIA	Background: Telaprevir (TVR) plus peginterferon-alpha 2a (PEG-IFN-alpha 2a) and ribavirin substantially increases treatment efficacy for genotype 1 chronic hepatitis C virus (HCV) infection versus PEG-IFN-alpha 2a-ribavirin alone. Its safety and efficacy in patients with HCV and HIV-1 are unknown. Objective: To assess the safety and efficacy of TVR plus PEG-IFN-alpha 2a-ribavirin in patients with genotype 1 HCV and HIV-1 and to evaluate pharmacokinetics of TVR and antiretrovirals during coadministration. Design: Phase 2a, randomized, double-blind, placebo-controlled study. (ClinicalTrials.gov: NCT00983853) Setting: 16 international multicenter sites. Patients: 62 patients with HCV genotype 1 and HIV-1 who were HCV treatment-naive and receiving 0 or 1 of 2 antiretroviral regimens were randomly assigned to TVR plus PEG-IFN-alpha 2a-ribavirin or placebo plus PEG-IFN-alpha 2a-ribavirin for 12 weeks, plus 36 weeks of PEG-IFN-alpha 2a-ribavirin. Measurements: HCV RNA concentrations. Results: Pruritus, headache, nausea, rash, and dizziness were higher with TVR plus PEG-IFN-alpha 2a-ribavirin during the first 12 weeks. During this period, serious adverse events occurred in 5% (2 in 38) of those receiving TVR plus PEG-IFN-alpha 2a-ribavirin and 0% (0 in 22) of those receiving placebo plus PEG-IFN-alpha 2a-ribavirin; the same number in both groups discontinued treatment due to adverse events. Sustained virologic response occurred in 74% (28 in 38) of patients receiving TVR plus PEG-IFN-alpha 2a-ribavirin and 45% (10 in 22) of patients receiving placebo plus PEG-IFN-alpha 2a-ribavirin. Rapid HCV suppression was seen with TVR plus PEG-IFN-alpha 2a-ribavirin (68% [26 in 38 patients] vs. 0% [0 in 22 patients] undetectable HCV RNA levels by week 4). Two patients had on-treatment HCV breakthrough with TVR-resistant variants. Patients treated with antiretroviral drugs had no HIV breakthroughs; antiretroviral exposure was not substantially modified by TVR. Limitation: Small sample size and appreciable dropout rate. Conclusion: In patients with HCV and HIV-1, more adverse events occurred with TVR versus placebo plus PEG-IFN-alpha 2a-ribavirin; these were similar in nature and severity to those in patients with HCV treated with TVR. With or without concomitant antiretrovirals, sustained virologic response rates were higher in patients treated with TVR versus placebo plus PEG-IFN-alpha 2a-ribavirin.	[Sulkowski, Mark S.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA; [Sherman, Kenneth E.] Univ Cincinnati, Coll Med, Cincinnati, OH 45267 USA; [Dieterich, Douglas T.] Mt Sinai Sch Med, New York, NY 10029 USA; Univ Bonn, Bonn, Germany; Vertex Pharmaceut, Cambridge, MA USA; Hop St Antoine, F-75571 Paris, France; Hosp Carlos III, Madrid, Spain	Johns Hopkins University; University System of Ohio; University of Cincinnati; Icahn School of Medicine at Mount Sinai; University of Bonn; Vertex Pharmaceuticals; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Hospital Carlos III	Sulkowski, MS (corresponding author), Johns Hopkins Univ, Sch Med, 600 North Wolfe St,1830 Bldg,Room 445, Baltimore, MD 21287 USA.	msulkowski@jhmi.edu; raymond_rubin@vrtx.com	Rubin, Raymond/AAI-2579-2021; Soriano, Vicente/O-5730-2018	Soriano, Vicente/0000-0002-4624-5199	Vertex Pharmaceuticals; Janssen Pharmaceuticals; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK070528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R34MH099930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016065, K24DA034621] Funding Source: NIH RePORTER	Vertex Pharmaceuticals(Vertex Pharmaceuticals); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Primary Funding Source: Vertex Pharmaceuticals and Janssen Pharmaceuticals.	Alberti A, 2005, J HEPATOL, V42, P615, DOI 10.1016/j.jhep.2005.03.003; Alvarez D, 2006, J VIRAL HEPATITIS, V13, P683, DOI 10.1111/j.1365-2893.2006.00749.x; [Anonymous], 2009, RIB TEV EMEA SUMM PR; [Anonymous], 2011, INC SUMM PROD CHAR; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Berenguer J, 2009, HEPATOLOGY, V50, P407, DOI 10.1002/hep.23020; Burgess J, 2005, AM J GASTROENTEROL, V100, P2338, DOI 10.1111/j.1572-0241.2005.00222.x; Butt AA, 2011, ALIMENT PHARM THER, V33, P1234, DOI 10.1111/j.1365-2036.2011.04648.x; Cachay ER, 2013, CLIN INFECT DIS, V56, P163, DOI 10.1093/cid/cis826; Chung RT, 2004, NEW ENGL J MED, V351, P451, DOI 10.1056/NEJMoa032653; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Garg V, 2013, BRIT J CLIN PHARMACO, V75, P431, DOI 10.1111/j.1365-2125.2012.04345.x; Genentech, 2013, COP RIB TABL PACK IN; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Le MP, 2013, J ANTIMICROB CHEMOTH, V68, P1208, DOI 10.1093/jac/dks518; Merck, 2011, PEG PROD MON; Mira JA, 2007, ANTIVIR THER, V12, P1225; Morgan TR, 2010, HEPATOLOGY, V52, P833, DOI 10.1002/hep.23744; Naggie S, 2012, GASTROENTEROLOGY, V142, P1324, DOI 10.1053/j.gastro.2012.02.012; Phillips AN, 2010, AIDS, V24, P1561, DOI 10.1097/QAD.0b013e32833a6056; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Rockstroh JK, 2008, HIV MED, V9, P82, DOI 10.1111/j.1468-1293.2007.00535.x; Rodriguez-Torres M, 2012, HIV CLIN TRIALS, V13, P142, DOI 10.1310/hct1303-142; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Soriano V, 2007, AIDS, V21, P1073, DOI 10.1097/QAD.0b013e3281084e4d; Soriano V, 2006, AIDS, V20, P2225, DOI 10.1097/01.aids.0000247583.38943.95; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Vertex Pharmaceuticals, 2012, INC; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	31	166	170	0	41	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 16	2013	159	2					86	W35		10.7326/0003-4819-159-2-201307160-00654	http://dx.doi.org/10.7326/0003-4819-159-2-201307160-00654			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	187IX	23685940				2022-12-28	WOS:000322112000014
J	Zhang, Y; Zhang, QY; Kong, HH; Jiang, YP; Gao, YW; Deng, GH; Shi, JZ; Tian, GB; Liu, LL; Liu, JX; Guan, YT; Bu, ZG; Chen, HL				Zhang, Ying; Zhang, Qianyi; Kong, Huihui; Jiang, Yongping; Gao, Yuwei; Deng, Guohua; Shi, Jianzhong; Tian, Guobin; Liu, Liling; Liu, Jinxiong; Guan, Yuntao; Bu, Zhigao; Chen, Hualan			H5N1 Hybrid Viruses Bearing 2009/H1N1 Virus Genes Transmit in Guinea Pigs by Respiratory Droplet	SCIENCE			English	Article							INFLUENZA-A VIRUS; AVIAN FLU TRANSMISSION; H1N1 2009 VIRUS; RECEPTOR SPECIFICITY; MAMMALIAN HOST; MOUSE MODEL; HEMAGGLUTININ; FERRETS; HUMANS; ORIGIN	In the past, avian influenza viruses have crossed species barriers to trigger human pandemics by reassorting with mammal-infective viruses in intermediate livestock hosts. H5N1 viruses are able to infect pigs, and some of them have affinity for the mammalian type alpha-2,6-linked sialic acid airway receptor. Using reverse genetics, we systematically created 127 reassortant viruses between a duck isolate of H5N1, specifically retaining its hemagglutinin (HA) gene throughout, and a highly transmissible, human-infective H1N1 virus. We tested the virulence of the reassortants in mice as a correlate for virulence in humans and tested transmissibility in guinea pigs, which have both avian and mammalian types of airway receptor. Transmission studies showed that the H1N1 virus genes encoding acidic polymerase and nonstructural protein made the H5N1 virus transmissible by respiratory droplet between guinea pigs without killing them. Further experiments implicated other H1N1 genes in the enhancement of mammal-to-mammal transmission, including those that encode nucleoprotein, neuraminidase, and matrix, as well as mutations in H5 HA that improve affinity for humanlike airway receptors. Hence, avian H5N1 subtype viruses do have the potential to acquire mammalian transmissibility by reassortment in current agricultural scenarios.	[Zhang, Ying; Zhang, Qianyi; Kong, Huihui; Jiang, Yongping; Gao, Yuwei; Deng, Guohua; Shi, Jianzhong; Tian, Guobin; Liu, Liling; Liu, Jinxiong; Guan, Yuntao; Bu, Zhigao; Chen, Hualan] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin 150001, Peoples R China; [Zhang, Qianyi; Chen, Hualan] Gansu Agr Univ, Coll Vet Med, Lanzhou 730030, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Gansu Agricultural University	Chen, HL (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin 150001, Peoples R China.	chenhualan@caas.cn			National Natural Science Foundation of China [30825032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank S. Watson for editing the manuscript, Y. Shu of the China Centers for Disease Control and Prevention for providing the 2009/H1N1 virus A/Sichuan/1/2009, and the Consortium for Functional Glycomics (Department of Molecular Biology, Scripps Research Institute) for providing the glycans. Supported by National Natural Science Foundation of China grant 30825032. Virus sequence data from this study were deposited in GISAID with accession numbers EPI1431518 to EPI1432533 and EPI438129 to EPI438136.	Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; Chen LM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000072; Chou YY, 2011, J VIROL, V85, P11235, DOI 10.1128/JVI.05794-11; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; Fouchier RAM, 2012, SCIENCE, V335, P400, DOI [10.1126/science.1219412, 10.1126/science.335.6067.400]; Fouchier RAM, 2012, NATURE, V481, P443, DOI 10.1038/481443a; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Lakdawala SS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002443; Li CJ, 2010, P NATL ACAD SCI USA, V107, P4687, DOI 10.1073/pnas.0912807107; Li YB, 2010, J VIROL, V84, P8389, DOI 10.1128/JVI.00413-10; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lindstrom SE, 2004, VIROLOGY, V328, P101, DOI 10.1016/j.virol.2004.06.009; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Massin P, 2001, J VIROL, V75, P5398, DOI 10.1128/JVI.75.11.5398-5404.2001; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Nidom CA, 2010, EMERG INFECT DIS, V16, P1515, DOI 10.3201/eid1610.100508; Pasma T, 2010, EMERG INFECT DIS, V16, P706, DOI 10.3201/eid1604.091636; Pleschka S, 1996, J VIROL, V70, P4188, DOI 10.1128/JVI.70.6.4188-4192.1996; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Seibert CW, 2010, J VIROL, V84, P11219, DOI 10.1128/JVI.01424-10; Sreta D, 2010, EMERG INFECT DIS, V16, P1587, DOI 10.3201/eid1610.100665; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Yan JH, 2012, EMERG INFECT DIS, V18, P357, DOI 10.3201/eid1802.111346; Yen HL, 2011, P NATL ACAD SCI USA, V108, P14264, DOI 10.1073/pnas.1111000108; Zhang Y, 2012, J VIROL, V86, P9666, DOI 10.1128/JVI.00958-12; Zhu QY, 2008, J VIROL, V82, P220, DOI 10.1128/JVI.00978-07; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	40	170	189	5	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2013	340	6139					1459	1463		10.1126/science.1229455	http://dx.doi.org/10.1126/science.1229455			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23641061				2022-12-28	WOS:000320647000044
J	Ravassard, P; Kees, A; Willers, B; Ho, D; Aharoni, D; Cushman, J; Aghajan, ZM; Mehta, MR				Ravassard, Pascal; Kees, Ashley; Willers, Bernard; Ho, David; Aharoni, Daniel; Cushman, Jesse; Aghajan, Zahra M.; Mehta, Mayank R.			Multisensory Control of Hippocampal Spatiotemporal Selectivity	SCIENCE			English	Article							THETA-RHYTHM; PLACE CELLS; VIRTUAL NAVIGATION; ENTORHINAL CORTEX; PHASE PRECESSION; RAT HIPPOCAMPUS; UNIT-ACTIVITY; SPATIAL MAP; GRID CELLS; INTERFERENCE	The hippocampal cognitive map is thought to be driven by distal visual cues and self-motion cues. However, other sensory cues also influence place cells. Hence, we measured rat hippocampal activity in virtual reality (VR), where only distal visual and nonvestibular self-motion cues provided spatial information, and in the real world (RW). In VR, place cells showed robust spatial selectivity; however, only 20% were track active, compared with 45% in the RW. This indicates that distal visual and nonvestibular self-motion cues are sufficient to provide selectivity, but vestibular and other sensory cues present in RW are necessary to fully activate the place-cell population. In addition, bidirectional cells preferentially encoded distance along the track in VR, while encoding absolute position in RW. Taken together, these results suggest the differential contributions of these sensory cues in shaping the hippocampal population code. Theta frequency was reduced, and its speed dependence was abolished in VR, but phase precession was unaffected, constraining mechanisms governing both hippocampal theta oscillations and temporal coding. These results reveal cooperative and competitive interactions between sensory cues for control over hippocampal spatiotemporal selectivity and theta rhythm.	[Ravassard, Pascal; Kees, Ashley; Willers, Bernard; Ho, David; Aharoni, Daniel; Cushman, Jesse; Aghajan, Zahra M.; Mehta, Mayank R.] Univ Calif Los Angeles, WM Keck Ctr Neurophys, Integrat Ctr Learning & Memory, Los Angeles, CA 90095 USA; [Ravassard, Pascal; Kees, Ashley; Willers, Bernard; Ho, David; Aharoni, Daniel; Cushman, Jesse; Aghajan, Zahra M.; Mehta, Mayank R.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Ravassard, Pascal; Willers, Bernard; Aharoni, Daniel; Cushman, Jesse; Aghajan, Zahra M.; Mehta, Mayank R.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Kees, Ashley; Ho, David; Mehta, Mayank R.] Univ Calif Los Angeles, Neurosci Interdept Program, Los Angeles, CA 90095 USA; [Mehta, Mayank R.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; [Mehta, Mayank R.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Mehta, MR (corresponding author), Univ Calif Los Angeles, WM Keck Ctr Neurophys, Integrat Ctr Learning & Memory, Los Angeles, CA 90095 USA.	mayankmehta@ucla.edu		Mehta, Mayank/0000-0003-2005-2468; Kees, Ashley/0000-0002-1611-2803; Ravassard, Pascal/0000-0002-7500-3623; M. Aghajan, Zahra/0000-0003-4245-3975; Aharoni, Daniel/0000-0003-4931-8514	NSF; NIH [5R01MH092925-02]; W. M. Keck foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092925] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the NSF Career award and grants from NIH 5R01MH092925-02 and the W. M. Keck foundation. These findings were presented as two abstracts and posters at the Society for Neuroscience Meeting entitled: P. Ravassard, B. Willers, A. L. Kees, D. Ho, D. Aharoni, M. R. Mehta, "Directional tuning of place cells in rats performing a virtual landmark navigation task," Soc. Neurosci. Abs. no. 812.05 (2012); and A. Kees, B. Willers, P. M. Ravassard, D. Ho, D. Aharoni, M. R. Mehta, "Hippocampal rate and temporal codes in a virtual visual navigation task," Soc. Neurosci. Abs. no. 812.07 (2012). We thank L. Acharya, Z. Chen, and J. Moore for technical help. Author contributions: P. R., A. K., D. H., and J. C. performed data collection; B. W. and D. A. A. developed the virtual reality system; B. W. and Z. M. A. performed analysis; P. R., A. K., B. W., and Z. M. A. wrote the manuscript; P. R., A. K., B. W., D. H., D. A. A., and J.C.	Battaglia FP, 2004, J NEUROSCI, V24, P4541, DOI 10.1523/JNEUROSCI.4896-03.2004; Blair HT, 2007, J NEUROSCI, V27, P3211, DOI 10.1523/JNEUROSCI.4724-06.2007; Burgess N, 2008, HIPPOCAMPUS, V18, P1157, DOI 10.1002/hipo.20518; Deshmukh SS, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00069; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Gothard KM, 1996, J NEUROSCI, V16, P8027; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Hahn TTG, 2006, NAT NEUROSCI, V9, P1359, DOI 10.1038/nn1788; Hahn TTG, 2012, NAT NEUROSCI, V15, P1531, DOI 10.1038/nn.3236; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hasselmo ME, 2007, HIPPOCAMPUS, V17, P1252, DOI 10.1002/hipo.20374; Itskov PM, 2012, J NEUROPHYSIOL, V107, P1822, DOI 10.1152/jn.00404.2011; Iurilli G, 2012, NEURON, V73, P814, DOI 10.1016/j.neuron.2011.12.026; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mizuseki K, 2012, HIPPOCAMPUS, V22, P1659, DOI 10.1002/hipo.22002; MULLER RU, 1987, J NEUROSCI, V7, P1951; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Resnik E, 2012, J NEUROSCI, V32, P8952, DOI 10.1523/JNEUROSCI.6460-11.2012; Russell NA, 2006, J NEUROPHYSIOL, V96, P4, DOI 10.1152/jn.00953.2005; Save E, 2000, HIPPOCAMPUS, V10, P64, DOI 10.1002/(SICI)1098-1063(2000)10:1<64::AID-HIPO7>3.3.CO;2-P; Stackman RW, 2002, HIPPOCAMPUS, V12, P291, DOI 10.1002/hipo.1112; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; YOUNG BJ, 1994, J NEUROSCI, V14, P6553	31	183	189	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1342	1346		10.1126/science.1232655	http://dx.doi.org/10.1126/science.1232655			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23641063	Green Accepted			2022-12-28	WOS:000320320200048
J	Ibarra-Laclette, E; Lyons, E; Hernandez-Guzman, G; Perez-Torres, CA; Carretero-Paulet, L; Chang, TH; Lan, TY; Welch, AJ; Juarez, MJA; Simpson, J; Fernandez-Cortes, A; Arteaga-Vazquez, M; Gongora-Castillo, E; Acevedo-Hernandez, G; Schuster, SC; Himmelbauer, H; Minoche, AE; Xu, S; Lynch, M; Oropeza-Aburto, A; Cervantes-Perez, SA; Ortega-Estrada, MD; Cervantes-Luevano, JI; Michael, TP; Mockler, T; Bryant, D; Herrera-Estrella, A; Albert, VA; Herrera-Estrella, L				Ibarra-Laclette, Enrique; Lyons, Eric; Hernandez-Guzman, Gustavo; Anahi Perez-Torres, Claudia; Carretero-Paulet, Lorenzo; Chang, Tien-Hao; Lan, Tianying; Welch, Andreanna J.; Abraham Juarez, Maria Jazmin; Simpson, June; Fernandez-Cortes, Araceli; Arteaga-Vazquez, Mario; Gongora-Castillo, Elsa; Acevedo-Hernandez, Gustavo; Schuster, Stephan C.; Himmelbauer, Heinz; Minoche, Andre E.; Xu, Sen; Lynch, Michael; Oropeza-Aburto, Araceli; Alan Cervantes-Perez, Sergio; de Jesus Ortega-Estrada, Maria; Israel Cervantes-Luevano, Jacob; Michael, Todd P.; Mockler, Todd; Bryant, Douglas; Herrera-Estrella, Alfredo; Albert, Victor A.; Herrera-Estrella, Luis			Architecture and evolution of a minute plant genome	NATURE			English	Article							BLADDERWORT UTRICULARIA; ARABIDOPSIS; SEQUENCE; SIZE; LENTIBULARIACEAE; IDENTIFICATION; GENES	It has been argued that the evolution of plant genome size is principally unidirectional and increasing owing to the varied action of whole-genome duplications (WGDs) and mobile element proliferation(1). However, extreme genome size reductions have been reported in the angiosperm family tree. Here we report the sequence of the 82-megabase genome of the carnivorous bladderwort plant Utricularia gibba. Despite its tiny size, the U. gibba genome accommodates a typical number of genes for a plant, with the main difference from other plant genomes arising from a drastic reduction in non-genic DNA. Unexpectedly, we identified at least three rounds of WGD in U. gibba since common ancestry with tomato (Solanum) and grape (Vitis). The compressed architecture of the U. gibba genome indicates that a small fraction of intergenic DNA, with few or no active retrotransposons, is sufficient to regulate and integrate all the processes required for the development and reproduction of a complex organism.	[Ibarra-Laclette, Enrique; Hernandez-Guzman, Gustavo; Anahi Perez-Torres, Claudia; Fernandez-Cortes, Araceli; Oropeza-Aburto, Araceli; Alan Cervantes-Perez, Sergio; de Jesus Ortega-Estrada, Maria; Israel Cervantes-Luevano, Jacob; Herrera-Estrella, Alfredo; Herrera-Estrella, Luis] CINVESTAV, Lab Nacl Genom Biodiversidad LANGEBI, Guanajuato 36821, Mexico; [Lyons, Eric] Univ Arizona, Sch Plant Sci & iPlant Collaborat, Tucson, AZ 85721 USA; [Hernandez-Guzman, Gustavo] Univ Guanajuato, Dept Alimentos, Div Ciencias Vida, Guanajuato 36500, Mexico; [Carretero-Paulet, Lorenzo; Chang, Tien-Hao; Lan, Tianying; Welch, Andreanna J.; Albert, Victor A.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Lan, Tianying] Chongqing Univ Sci & Technol, Dept Biol, Chongqing 4000042, Peoples R China; [Abraham Juarez, Maria Jazmin; Simpson, June] CINVESTAV, Dept Genet, Unidad Irapuato, Guanajuato 36821, Mexico; [Arteaga-Vazquez, Mario] Univ Veracruzana, Inst Biotecnol & Ecol Aplicada, Xalapa 91090, Veracruz, Mexico; [Gongora-Castillo, Elsa] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Acevedo-Hernandez, Gustavo] Univ Guadalajara, Ctr Univ Cienega, Ocotlan 47840, Jalisco, Mexico; [Schuster, Stephan C.] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Schuster, Stephan C.] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 637551, Singapore; [Himmelbauer, Heinz; Minoche, Andre E.] CRG, Barcelona 08003, Spain; [Himmelbauer, Heinz; Minoche, Andre E.] UPF, Barcelona 08018, Spain; [Minoche, Andre E.] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Xu, Sen; Lynch, Michael] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Michael, Todd P.] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08854 USA; [Michael, Todd P.] Rutgers State Univ, Dept Plant Biol & Pathol, Piscataway, NJ 08854 USA; [Mockler, Todd; Bryant, Douglas] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; University of Arizona; Universidad de Guanajuato; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Chongqing University of Science & Technology; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Universidad Veracruzana; Michigan State University; Universidad de Guadalajara; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Max Planck Society; Indiana University System; Indiana University Bloomington; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Donald Danforth Plant Science Center	Albert, VA (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	vaalbert@buffalo.edu; lherrera@langebio.cinvestav.mx	Herrera-Estrella, Alfredo/J-8210-2019; Herrera-Estrella, Alfredo/F-3185-2011; Carretero-Paulet, Lorenzo/Z-2744-2019; Abraham-Juarez, Maria Jazmin/AAG-2539-2020; Arteaga-Vazquez, Mario/M-1545-2019; Arteaga-Vazquez, Mario Alberto/AAB-7979-2022; Herrera-Estrella, Luis/AAL-2472-2020; Simpson, June/I-1057-2012; Góngora-Castillo, Elsa B/R-8854-2016; Herrera-Estrella, Luis/ABC-7431-2020; Oropeza-Aburto, Araceli/ABD-1331-2020; Mockler, Todd C/L-2609-2013; Cervantes-Pérez, Sergio Alan/AAQ-6317-2021; Cervantes-Pérez, Sergio Alan/AAD-2822-2019; Acevedo-Hernandez, Gustavo J./D-5745-2011	Herrera-Estrella, Alfredo/0000-0002-4589-6870; Herrera-Estrella, Alfredo/0000-0002-4589-6870; Carretero-Paulet, Lorenzo/0000-0001-6697-827X; Abraham-Juarez, Maria Jazmin/0000-0002-5468-8176; Arteaga-Vazquez, Mario Alberto/0000-0002-9435-0049; Herrera-Estrella, Luis/0000-0001-7936-3856; Simpson, June/0000-0002-1891-4914; Góngora-Castillo, Elsa B/0000-0001-6327-6993; Oropeza-Aburto, Araceli/0000-0002-1222-906X; Mockler, Todd C/0000-0002-0462-5775; Acevedo-Hernandez, Gustavo J./0000-0002-3959-9220; Michael, Todd/0000-0001-6272-2875; Hernandez-Guzman, Gustavo/0000-0002-3686-8122; Lyons, Eric/0000-0002-3348-8845; Himmelbauer, Heinz/0000-0001-8897-2928; Xu, Sen/0000-0002-1304-9968	CONACyT (Mexico) [4367]; College of Arts and Sciences, University at Buffalo; NSF [0922742]; CONACyT (Mexico); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036827] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [0922742] Funding Source: National Science Foundation	CONACyT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); College of Arts and Sciences, University at Buffalo; NSF(National Science Foundation (NSF)); CONACyT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank I. Bravo-Carmona for growing plants for this research. We also thank T. Mailund for discussion and critical comments on the manuscript, M. Stanke and K. Hoff for their assistance in the use of AUGUSTUS software, and P. Guzman-Villate for providing the cell suspension used for transient expression assays. Special thanks goes to the members of the 'laboratorio de servicios genomicos' of LANGEBIO, CINVESTAV for sequencing services and their help. This research was supported by CONACyT (Mexico) via general support to LANGEBIO, HHMI grant 4367 (to L. H.-E.), the College of Arts and Sciences, University at Buffalo (to V. A. A.), and the NSF (0922742 to V. A. A.). E. I.-L. is indebted to CONACyT (Mexico) for a PhD fellowship. We acknowledge the US Department of Energy Joint Genome Institute for Mimulus data (available at http://www.phytozome.net/mimulus).	Aagaard JE, 2005, AM J BOT, V92, P1284, DOI 10.3732/ajb.92.8.1284; Albert VA, 2010, J EXP BOT, V61, P5, DOI 10.1093/jxb/erp349; Assis R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002508; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Bennetzen JL, 1997, PLANT CELL, V9, P1509, DOI 10.1105/tpc.9.9.1509; Devos KM, 2002, GENOME RES, V12, P1075, DOI 10.1101/gr.132102; Duarte JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-61; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Greilhuber J, 2006, PLANT BIOLOGY, V8, P770, DOI 10.1055/s-2006-924101; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Ibarra-Laclette E, 2011, PLANT SIGNAL BEHAV, V6, P1631, DOI 10.4161/psb.6.11.17657; Ibarra-Laclette E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-101; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kibriya S, 2007, FRESHWATER BIOL, V52, P500, DOI 10.1111/j.1365-2427.2006.01719.x; Kirik A, 2000, EMBO J, V19, P5562, DOI 10.1093/emboj/19.20.5562; Leitch IJ, 2008, ANN BOT-LONDON, V101, P805, DOI 10.1093/aob/mcm326; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; Nam K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002680; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Plachno BJ, 2010, PROTOPLASMA, V239, P69, DOI 10.1007/s00709-009-0084-1; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Taylor P, 1989, GENUS UTRICULARIA TA; Woodhouse MR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000409	25	227	232	5	234	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 6	2013	498	7452					94	+		10.1038/nature12132	http://dx.doi.org/10.1038/nature12132			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158DC	23665961	Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000319947800040
J	Grepin, KA; Klugman, J				Grepin, Karen A.; Klugman, Jeni			Maternal health: a missed opportunity for development	LANCET			English	Editorial Material							CASH TRANSFER PROGRAM; IMPACT EVALUATION; WOMEN; SERVICES; INDIA		[Grepin, Karen A.] NYU, Robert F Wagner Grad Sch Publ Serv, New York, NY 10012 USA; [Klugman, Jeni] World Bank, Washington, DC 20433 USA	New York University; The World Bank	Grepin, KA (corresponding author), NYU, Robert F Wagner Grad Sch Publ Serv, 550 1St Ave, New York, NY 10012 USA.	karen.grepin@nyu.edu	Grepin, Karen Ann/P-1248-2018	Grepin, Karen Ann/0000-0003-4368-0045				Almond D, 2011, J ECON PERSPECT, V25, P153, DOI 10.1257/jep.25.3.153; Baird S, 2010, HEALTH ECON, V19, P55, DOI 10.1002/hec.1569; Barber SL, 2009, HEALTH POLICY PLANN, V24, P18, DOI 10.1093/heapol/czn039; Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; Beegle K, 2006, AM J AGR ECON, V88, P1266, DOI 10.1111/j.1467-8276.2006.00943.x; Bellows NM, 2011, TROP MED INT HEALTH, V16, P84, DOI 10.1111/j.1365-3156.2010.02667.x; Bjorkman M, 2009, Q J ECON, V124, P735, DOI 10.1162/qjec.2009.124.2.735; Duflo E, 2012, J ECON LIT, V50, P1051, DOI 10.1257/jel.50.4.1051; FAO, 2009, GEND AGR SOURC; Jayachandran S, 2009, Q J ECON, V124, P349, DOI 10.1162/qjec.2009.124.1.349; Jensen R, 2012, Q J ECON, V127, P753, DOI 10.1093/qje/qjs002; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Miller G, 2010, ECON J, V120, P709, DOI 10.1111/j.1468-0297.2009.02306.x; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990	15	9	9	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 18	2013	381	9879					1691	1693		10.1016/S0140-6736(13)60981-2	http://dx.doi.org/10.1016/S0140-6736(13)60981-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146TA	23683617				2022-12-28	WOS:000319112800008
J	Peterson, HB; Darmstadt, GL; Bongaarts, J				Peterson, Herbert B.; Darmstadt, Gary L.; Bongaarts, John			Meeting the unmet need for family planning: now is the time	LANCET			English	Editorial Material							HEALTH		[Peterson, Herbert B.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Maternal & Child Hlth, Chapel Hill, NC 27599 USA; [Peterson, Herbert B.] Univ N Carolina, Sch Med, Dept Obstet & Gynecol, Chapel Hill, NC 27599 USA; [Darmstadt, Gary L.] Bill & Melinda Gates Fdn, Family Hlth Program, Seattle, WA USA; [Bongaarts, John] Populat Council, New York, NY 10021 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Bill & Melinda Gates Foundation; Population Council	Peterson, HB (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Maternal & Child Hlth, Chapel Hill, NC 27599 USA.	herbert_peterson@unc.edu	Darmstadt, Gary/AAU-7488-2020	Darmstadt, Gary/0000-0002-7522-5824				Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; Alkema L, 2013, LANCET, V381, P1642, DOI 10.1016/S0140-6736(12)62204-1; Canning D, 2012, LANCET, V380, P165, DOI 10.1016/S0140-6736(12)60827-7; Cleland J, 2012, LANCET, V380, P149, DOI 10.1016/S0140-6736(12)60609-6; Cottingham J, 2012, LANCET, V380, P172, DOI 10.1016/S0140-6736(12)60732-6; Darroch JE, 2013, LANCET, V381, P1756, DOI 10.1016/S0140-6736(13)60597-8; Ezeh AC, 2012, LANCET, V380, P142, DOI 10.1016/S0140-6736(12)60696-5; Foege WH, 2011, CAL MILBANK BOOK HEA, V21, P1; Horton R, 2012, LANCET, V380, P77, DOI 10.1016/S0140-6736(12)61026-5; United Nations Department of Economic and Social Affairs, 2012, WORLD CONTR US 2012	10	25	25	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 18	2013	381	9879					1696	1699		10.1016/S0140-6736(13)60999-X	http://dx.doi.org/10.1016/S0140-6736(13)60999-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146TA	23683620				2022-12-28	WOS:000319112800011
J	Read, P				Read, Peter			PLANETARY SCIENCE Plumbing the depths of Uranus and Neptune	NATURE			English	Editorial Material							JUPITER; SATURN; MODELS; WINDS		Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England	University of Oxford	Read, P (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England.	p.read1@physics.ox.ac.uk	Read, Peter Leonard/AAS-2773-2020		STFC [ST/K00106X/1, ST/I001948/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/I001948/1, ST/K00106X/1] Funding Source: researchfish	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Atkinson DH, 1997, NATURE, V388, P649, DOI 10.1038/41718; BUSSE FH, 1976, ICARUS, V29, P255, DOI 10.1016/0019-1035(76)90053-1; Hubbard WB, 1999, ICARUS, V137, P357, DOI 10.1006/icar.1998.6064; HUBBARD WB, 1991, SCIENCE, V253, P648, DOI 10.1126/science.253.5020.648; HUBBARD WB, 1989, ICARUS, V78, P102, DOI 10.1016/0019-1035(89)90072-9; INGERSOLL AP, 1990, SCIENCE, V248, P308, DOI 10.1126/science.248.4953.308; Kaspi Y, 2013, NATURE, V497, P344, DOI 10.1038/nature12131; Liu J, 2008, ICARUS, V196, P653, DOI 10.1016/j.icarus.2007.11.036; Podolak M, 1995, PLANET SPACE SCI, V43, P1517, DOI 10.1016/0032-0633(95)00061-5; Proudman J, 1916, P R SOC LOND A-CONTA, V92, P408, DOI 10.1098/rspa.1916.0026; Showman AP, 2011, ICARUS, V211, P1258, DOI 10.1016/j.icarus.2010.11.004; TAYLOR GI, 1917, P ROY SOC LOND A MAT, V93, P92	12	0	0	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2013	497	7449					323	324		10.1038/497323a	http://dx.doi.org/10.1038/497323a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	144PN	23676750				2022-12-28	WOS:000318952000026
J	Bian, GW; Joshi, D; Dong, YM; Lu, P; Zhou, GL; Pan, XL; Xu, Y; Dimopoulos, G; Xi, ZY				Bian, Guowu; Joshi, Deepak; Dong, Yuemei; Lu, Peng; Zhou, Guoli; Pan, Xiaoling; Xu, Yao; Dimopoulos, George; Xi, Zhiyong			Wolbachia Invades Anopheles stephensi Populations and Induces Refractoriness to Plasmodium Infection	SCIENCE			English	Article							AEDES-ALBOPICTUS; DENGUE VIRUS; MOSQUITO; ESTABLISHMENT; SYMBIONT; MALARIA	Wolbachia is a maternally transmitted symbiotic bacterium of insects that has been proposed as a potential agent for the control of insect-transmitted diseases. One of the major limitations preventing the development of Wolbachia for malaria control has been the inability to establish inherited infections of Wolbachia in anopheline mosquitoes. Here, we report the establishment of a stable Wolbachia infection in an important malaria vector, Anopheles stephensi. In A. stephensi, Wolbachia strain wAlbB displays both perfect maternal transmission and the ability to induce high levels of cytoplasmic incompatibility. Seeding of naturally uninfected A. stephensi populations with infected females repeatedly resulted in Wolbachia invasion of laboratory mosquito populations. Furthermore, wAlbB conferred resistance in the mosquito to the human malaria parasite Plasmodium falciparum.	[Bian, Guowu; Joshi, Deepak; Lu, Peng; Zhou, Guoli; Pan, Xiaoling; Xu, Yao; Xi, Zhiyong] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Bian, Guowu] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Dept Parasitol,Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China; [Dong, Yuemei; Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Xi, Zhiyong] Sun Yat Sen Univ Michigan State Univ Joint Ctr Ve, Guangzhou 510080, Guangdong, Peoples R China	Michigan State University; Sun Yat Sen University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Sun Yat Sen University	Xi, ZY (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	xizy@msu.edu	Xi, Zhiyong/AAD-7936-2022; Pan, Xiaoling/AAH-1387-2021	Xi, Zhiyong/0000-0001-7786-012X; Dimopoulos, George/0000-0001-6755-8111; Dong, Yuemei/0000-0002-7902-2899	NIH [R01AI080597, R21AI082141, R01AI061576]; Foundation for the NIH through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080597, R21AI082141, R01AI061576] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the NIH through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants R01AI080597, R21AI082141, and R01AI061576 and a grant from the Foundation for the NIH through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation. We are grateful to the Johns Hopkins Malaria Research Institute Parasitology and Insectary Core Facilities and thank S. O'Neill, A. A. Hoffmann, and S. L. Dobson for their comments and suggestions and D. McClellan and S. Thiem for editorial assistance. Z.X. is also affiliated with Guangzhou WolbaKi Biotech Co., LTD. Data for this report are archived as supplementary materials on Science Online.	Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Brelsfoard CL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000129; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Dobson SL, 2002, GENETICS, V160, P1087; Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000209; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hughes GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036277; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043; Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143; Kittayapong P, 2000, J MED ENTOMOL, V37, P340, DOI 10.1603/0022-2585(2000)037[0340:DADOWI]2.0.CO;2; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754; malERA Consultative Group on Vector Control, 2011, PLoS Med, V8, pe1000401, DOI 10.1371/journal.pmed.1000401; McMeniman CJ, 2011, J MED ENTOMOL, V48, P76, DOI 10.1603/ME09188; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108; Sinden RE, 2004, INSECT BIOCHEM MOLEC, V34, P625, DOI 10.1016/j.ibmb.2004.03.015; Sinka ME, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-89; Tram U, 2003, MICROBES INFECT, V5, P999, DOI 10.1016/S1286-4579(03)00192-8; Xi ZY, 2005, INSECT BIOCHEM MOLEC, V35, P903, DOI 10.1016/j.ibmb.2005.03.015; Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607	22	307	337	9	264	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					748	751		10.1126/science.1236192	http://dx.doi.org/10.1126/science.1236192			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661760				2022-12-28	WOS:000318619000040
J	Gaffney, LP; Butler, PA; Scheck, M; Hayes, AB; Wenander, F; Albers, M; Bastin, B; Bauer, C; Blazhev, A; Bonig, S; Bree, N; Cederkall, J; Chupp, T; Cline, D; Cocolios, TE; Davinson, T; DeWitte, H; Diriken, J; Grahn, T; Herzan, A; Huyse, M; Jenkins, DG; Joss, DT; Kesteloot, N; Konki, J; Kowalczyk, M; Kroll, T; Kwan, E; Lutter, R; Moschner, K; Napiorkowski, P; Pakarinen, J; Pfeiffer, M; Radeck, D; Reiter, P; Reynders, K; Rigby, SV; Robledo, LM; Rudigier, M; Sambi, S; Seidlitz, M; Siebeck, B; Stora, T; Thoele, P; Van Duppen, P; Vermeulen, MJ; von Schmid, M; Voulot, D; Warr, N; Wimmer, K; Wrzosek-Lipska, K; Wu, CY; Zielinska, M				Gaffney, L. P.; Butler, P. A.; Scheck, M.; Hayes, A. B.; Wenander, F.; Albers, M.; Bastin, B.; Bauer, C.; Blazhev, A.; Boenig, S.; Bree, N.; Cederkall, J.; Chupp, T.; Cline, D.; Cocolios, T. E.; Davinson, T.; DeWitte, H.; Diriken, J.; Grahn, T.; Herzan, A.; Huyse, M.; Jenkins, D. G.; Joss, D. T.; Kesteloot, N.; Konki, J.; Kowalczyk, M.; Kroell, Th.; Kwan, E.; Lutter, R.; Moschner, K.; Napiorkowski, P.; Pakarinen, J.; Pfeiffer, M.; Radeck, D.; Reiter, P.; Reynders, K.; Rigby, S. V.; Robledo, L. M.; Rudigier, M.; Sambi, S.; Seidlitz, M.; Siebeck, B.; Stora, T.; Thoele, P.; Van Duppen, P.; Vermeulen, M. J.; von Schmid, M.; Voulot, D.; Warr, N.; Wimmer, K.; Wrzosek-Lipska, K.; Wu, C. Y.; Zielinska, M.			Studies of pear-shaped nuclei using accelerated radioactive beams	NATURE			English	Article							E4 TRANSITION MOMENTS; COULOMB-EXCITATION; REFLECTION ASYMMETRY; DIPOLE-MOMENTS; DATA SHEETS; STATES; QUADRUPOLE; ISOTOPES; DETECTOR; MODEL	There is strong circumstantial evidence that certain heavy, unstable atomic nuclei are 'octupole deformed', that is, distorted into a pear shape. This contrasts with the more prevalent rugby-ball shape of nuclei with reflection-symmetric, quadrupole deformations. The elusive octupole deformed nuclei are of importance for nuclear structure theory, and also in searches for physics beyond the standard model; any measurable electric-dipole moment (a signature of the latter) is expected to be amplified in such nuclei. Here we determine electric octupole transition strengths (a direct measure of octupole correlations) for short-lived isotopes of radon and radium. Coulomb excitation experiments were performed using accelerated beams of heavy, radioactive ions. Our data on Rn-220 and Ra-224 show clear evidence for stronger octupole deformation in the latter. The results enable discrimination between differing theoretical approaches to octupole correlations, and help to constrain suitable candidates for experimental studies of atomic electric-dipole moments that might reveal extensions to the standard model.	[Gaffney, L. P.; Butler, P. A.; Scheck, M.; Joss, D. T.; Rigby, S. V.] Univ Liverpool, Oliver Lodge Lab, Liverpool L69 7ZE, Merseyside, England; [Scheck, M.; Bauer, C.; Boenig, S.; Kroell, Th.; von Schmid, M.] Tech Univ Darmstadt, Inst Kernphys, D-64289 Darmstadt, Germany; [Hayes, A. B.; Cline, D.] Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA; [Wenander, F.; Cocolios, T. E.; Pakarinen, J.; Stora, T.; Voulot, D.] CERN Org Europeenne Rech Nucl, ISOLDE, CH-1211 Geneva, Switzerland; [Albers, M.; Blazhev, A.; Moschner, K.; Pfeiffer, M.; Radeck, D.; Reiter, P.; Rudigier, M.; Seidlitz, M.; Siebeck, B.; Thoele, P.; Warr, N.] Univ Cologne, Inst Kernphys, D-50937 Cologne, Germany; [Bastin, B.] GANIL, F-14076 Caen, France; [Bree, N.; DeWitte, H.; Diriken, J.; Huyse, M.; Kesteloot, N.; Reynders, K.; Sambi, S.; Van Duppen, P.; Wrzosek-Lipska, K.] Katholieke Univ Leuven, Inst Kern & Stralingsfys, B-3001 Louvain, Belgium; [Cederkall, J.] Lund Univ, Dept Nucl Phys, S-22100 Lund, Sweden; [Chupp, T.] Univ Michigan, Dept Phys, Ann Arbor, MI 48104 USA; [Davinson, T.] Univ Edinburgh, Sch Phys & Astron, Edinburgh EH9 3JZ, Midlothian, Scotland; [Diriken, J.; Kesteloot, N.] Ctr Etud Energie Nucl, SCK CEN Studiectr Kernenergie, B-2400 Mol, Belgium; [Grahn, T.; Herzan, A.; Konki, J.; Pakarinen, J.] Univ Jyvaskyla, Dept Phys, FI-40014 Jyvaskyla, Finland; [Grahn, T.; Herzan, A.; Konki, J.; Pakarinen, J.] Helsinki Inst Phys, FI-00014 Helsinki, Finland; [Jenkins, D. G.; Vermeulen, M. J.] Univ York, Dept Phys, York YO10 5DD, N Yorkshire, England; [Kowalczyk, M.; Napiorkowski, P.; Wrzosek-Lipska, K.; Zielinska, M.] Univ Warsaw, Heavy Ion Lab, PL-02093 Warsaw, Poland; [Kwan, E.; Wu, C. Y.] Lawrence Livermore Natl Lab, Div Phys, Livermore, CA 94551 USA; [Lutter, R.] Univ Munich, Maier Leibnitz Lab, D-85748 Garching, Germany; [Lutter, R.] Tech Univ Munich, D-85748 Garching, Germany; [Robledo, L. M.] Univ Autonoma Madrid, Dept Fis Teor, E-28049 Madrid, Spain; [Wimmer, K.] Tech Univ Munich, Phys Dept E12, D-85748 Garching, Germany; [Zielinska, M.] CEA Saclay, DSM IRFU SPhN, F-91191 Gif Sur Yvette, France	University of Liverpool; Technical University of Darmstadt; University of Rochester; University of Cologne; CEA; KU Leuven; Lund University; University of Michigan System; University of Michigan; University of Edinburgh; Belgian Nuclear Research Centre (SCK-CEN); University of Jyvaskyla; Helsinki Institute of Physics; University of York - UK; University of Warsaw; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Munich; Technical University of Munich; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - UAM - Institut de Fisica Teorica (IFT); Technical University of Munich; CEA; UDICE-French Research Universities; Universite Paris Saclay	Butler, PA (corresponding author), Univ Liverpool, Oliver Lodge Lab, Liverpool L69 7ZE, Merseyside, England.	peter.butler@liverpool.ac.uk	, bastin/A-7272-2019; Kroell, Thorsten/AAB-8739-2020; Wimmer, Kathrin/P-5701-2017; Albers, Michael/AAQ-8444-2020; Gaffney, Liam Paul/N-6346-2019; Pakarinen, Janne/F-6695-2010; Robledo, Luis Miguel/L-2557-2013; Scheck, Marcus/M-2839-2018; Butler, Peter/AAL-1876-2021; Gaffney, Liam/G-3169-2014; Grahn, Tuomas/AAH-9629-2019; Cocolios, Thomas Elias/I-3223-2019; Huyse, Mark/ABC-7645-2020; Herzáň, Andrej/AAI-2715-2020	, bastin/0000-0001-5959-0875; Wimmer, Kathrin/0000-0001-8178-0405; Gaffney, Liam Paul/0000-0002-2938-3696; Pakarinen, Janne/0000-0001-8944-8757; Robledo, Luis Miguel/0000-0002-6061-1319; Scheck, Marcus/0000-0002-9624-3909; Gaffney, Liam/0000-0002-2938-3696; Grahn, Tuomas/0000-0002-6255-2279; Cocolios, Thomas Elias/0000-0002-0456-7878; Herzáň, Andrej/0000-0002-6736-7638; Reiter, Peter/0000-0003-3016-8210; Van Duppen, Piet/0000-0002-5053-7370; Butler, Peter/0000-0001-6080-9205; Hayes, Adam/0000-0003-3739-5141; Konki, Joonas/0000-0001-6200-323X	ISOLDE; STFC (UK); BMBF(Germany) [05P12RDCIA, 06DA9036I, 06KY9136I, 06KY205I]; HIC for FAIR (Germany); FWO-Vlaanderen (Belgium); Belgian Science Policy Office (IAP-BriX network) [P7/12]; Academy of Finland [131665]; DOE (US) [DE-AC52-07NA27344, DE-FG02-04ER41331]; NSF (US); MICINN (Spain) [FPA2009-08958, FIS2009-07277]; Consolider-Ingenio Programmes (Spain) [CPAN CSD2007-00042, MULTIDARK CSD2009-00064]; Polish Ministry for Science and Higher Education [589/N-G-POOL/2009/0]; EC via I3-EURONS (FP6) [RII3-CT-2004-506065]; MC Fellowship scheme (FP7) [PIEF-GA-2008-219175]; IA-ENSAR (FP7) [262010]; STFC [ST/J00006X/1, ST/J000094/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/J000094/1, ST/J00006X/1] Funding Source: researchfish	ISOLDE; STFC (UK)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); BMBF(Germany)(Federal Ministry of Education & Research (BMBF)); HIC for FAIR (Germany); FWO-Vlaanderen (Belgium)(FWO); Belgian Science Policy Office (IAP-BriX network); Academy of Finland(Academy of Finland); DOE (US)(United States Department of Energy (DOE)); NSF (US)(National Science Foundation (NSF)); MICINN (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consolider-Ingenio Programmes (Spain); Polish Ministry for Science and Higher Education(Ministry of Science and Higher Education, Poland); EC via I3-EURONS (FP6); MC Fellowship scheme (FP7); IA-ENSAR (FP7); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The support of the ISOLDE Collaboration and technical teams is acknowledged. This work was supported by the following Research Councils: STFC (UK), BMBF(Germany; 05P12RDCIA, 06DA9036I, 06KY9136I and 06KY205I), HIC for FAIR (Germany), FWO-Vlaanderen (Belgium), Belgian Science Policy Office (IAP-BriX network P7/12), Academy of Finland (contract no. 131665), DOE (US; DE-AC52-07NA27344 and DE-FG02-04ER41331), NSF (US), MICINN (Spain; FPA2009-08958 and FIS2009-07277), Consolider-Ingenio 2010 Programmes (Spain; CPAN CSD2007-00042 and MULTIDARK CSD2009-00064), Polish Ministry for Science and Higher Education (grant no. 589/N-G-POOL/2009/0), EC via I3-EURONS (FP6 contract no. RII3-CT-2004-506065), MC Fellowship scheme (FP7 contract PIEF-GA-2008-219175) and IA-ENSAR (FP7 contract 262010).	ACKERMANN B, 1989, Z PHYS A-HADRON NUCL, V332, P375, DOI 10.1007/BF01292422; Artna-Cohen A., 1997, Nuclear Data Sheets, V80, P723, DOI 10.1006/ndsh.1997.0007; Artna-Cohen A., 1997, Nuclear Data Sheets, V80, P227, DOI 10.1006/ndsh.1997.0003; BAKTASH C, 1974, PHYS REV C, V10, P1136, DOI 10.1103/PhysRevC.10.1136; Bell R. E., 1960, KGL DANSKE VIDENSKAB, V32, P1; BEMIS CE, 1973, PHYS REV C, V8, P1466, DOI 10.1103/PhysRevC.8.1466; BONCHE P, 1986, PHYS LETT B, V175, P387, DOI 10.1016/0370-2693(86)90609-X; Buck B, 2008, J PHYS G NUCL PARTIC, V35, DOI 10.1088/0954-3899/35/8/085101; Butler PA, 1996, REV MOD PHYS, V68, P349, DOI 10.1103/RevModPhys.68.349; BUTLER PA, 1991, NUCL PHYS A, V533, P249, DOI 10.1016/0375-9474(91)90489-S; CLINE D, 1993, NUCL PHYS A, V557, pC615, DOI 10.1016/0375-9474(93)90574-H; Cocks JFC, 1999, NUCL PHYS A, V645, P61, DOI 10.1016/S0375-9474(98)00586-7; DAHLINGER M, 1988, NUCL PHYS A, V484, P337, DOI 10.1016/0375-9474(88)90076-0; Dobaczewski J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.232502; Eberth J, 2001, PROG PART NUCL PHYS, V46, P389, DOI 10.1016/S0146-6410(01)00145-4; EGIDO JL, 1989, NUCL PHYS A, V494, P85, DOI 10.1016/0375-9474(89)90199-1; Ellis J, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP02(2011)045; Engel J, 2003, PHYS REV C, V68, DOI 10.1103/PhysRevC.68.025501; Frauendorf S, 2008, PHYS REV C, V77, DOI 10.1103/PhysRevC.77.021304; Goriely S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.242501; Greenlees PT, 1998, J PHYS G NUCL PARTIC, V24, pL63, DOI 10.1088/0954-3899/24/10/001; Griffith WC, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.101601; Guest JR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.093001; Ibbotson RW, 1997, NUCL PHYS A, V619, P213, DOI 10.1016/S0375-9474(97)00145-0; LEANDER GA, 1988, PHYS REV C, V37, P2744, DOI 10.1103/PhysRevC.37.2744; LIANG CF, 1989, J PHYS G NUCL PARTIC, V15, pL31, DOI 10.1088/0954-3899/15/3/002; Martin MJ, 2007, NUCL DATA SHEETS, V108, P1583, DOI 10.1016/j.nds.2007.07.001; MCGOWAN FK, 1974, PHYS REV C, V10, P1146, DOI 10.1103/PhysRevC.10.1146; MCGOWAN FK, 1993, NUCL PHYS A, V562, P241, DOI 10.1016/0375-9474(93)90198-7; Moller P, 2008, ATOM DATA NUCL DATA, V94, P758, DOI 10.1016/j.adt.2008.05.002; NAZAREWICZ W, 1984, NUCL PHYS A, V429, P269, DOI 10.1016/0375-9474(84)90208-2; NAZAREWICZ W, 1992, PHYS REV C, V45, P2226, DOI 10.1103/PhysRevC.45.2226; NEAL WR, 1965, PHYS REV, V137, P1164; NOSEK D, 1993, Z PHYS A-HADRON NUCL, V344, P277; Ostrowski AN, 2002, NUCL INSTRUM METH A, V480, P448, DOI 10.1016/S0168-9002(01)00954-8; Penescu L, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3271245; Pospelov M, 2005, ANN PHYS-NEW YORK, V318, P119, DOI 10.1016/j.aop.2005.04.002; POYNTER RJ, 1989, PHYS LETT B, V232, P447, DOI 10.1016/0370-2693(89)90439-5; Riley LA, 2000, PHYS REV C, V62, DOI 10.1103/PhysRevC.62.021301; Robledo LM, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.054306; Robledo LM, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.054302; RUTZ K, 1995, NUCL PHYS A, V590, P680, DOI 10.1016/0375-9474(95)00192-4; Rzaca-Urban T, 2012, PHYS REV C, V86, DOI 10.1103/PhysRevC.86.044324; Shneidman TM, 2003, PHYS REV C, V67, DOI 10.1103/PhysRevC.67.014313; Singh S, 2011, NUCL DATA SHEETS, V112, P2851, DOI 10.1016/j.nds.2011.10.002; Spevak V, 1997, PHYS REV C, V56, P1357, DOI 10.1103/PhysRevC.56.1357; Voulot D, 2008, NUCL INSTRUM METH B, V266, P4103, DOI 10.1016/j.nimb.2008.05.129; Wolf BH, 2003, NUCL INSTRUM METH B, V204, P428, DOI 10.1016/S0168-583X(02)02108-0; WOLLERSHEIM HJ, 1993, NUCL PHYS A, V556, P261, DOI 10.1016/0375-9474(93)90351-W; Zamfir NV, 2001, PHYS REV C, V63, DOI 10.1103/PhysRevC.63.054306	50	217	220	2	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2013	497	7448					199	204		10.1038/nature12073	http://dx.doi.org/10.1038/nature12073			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23657348	Green Accepted			2022-12-28	WOS:000318558200028
J	Lee, KA; Kim, SH; Kim, EK; Ha, EM; You, H; Kim, B; Kim, MJ; Kwon, Y; Ryu, JH; Lee, WJ				Lee, Kyung-Ah; Kim, Sung-Hee; Kim, Eun-Kyoung; Ha, Eun-Mi; You, Hyejin; Kim, Boram; Kim, Min-Ji; Kwon, Youngjoo; Ryu, Ji-Hwan; Lee, Won-Jae			Bacterial-Derived Uracil as a Modulator of Mucosal Immunity and Gut-Microbe Homeostasis in Drosophila	CELL			English	Article							HOST-DEFENSE; COMMENSAL BACTERIA; DUAL OXIDASE; SYSTEM; MELANOGASTER; RECOGNITION; ACTIVATION; INFECTION; PATHWAYS; MODEL	All metazoan guts are subjected to immunologically unique conditions in which an efficient antimicrobial system operates to eliminate pathogens while tolerating symbiotic commensal microbiota. However, the molecular mechanisms controlling this process are only partially understood. Here, we show that bacterial-derived uracil acts as a ligand for dual oxidase (DUOX)-dependent reactive oxygen species generation in Drosophila gut and that the uracil production in bacteria causes inflammation in the gut. The acute and controlled uracil-induced immune response is required for efficient elimination of bacteria, intestinal cell repair, and host survival during infection of nonresident species. Among resident gut microbiota, uracil production is absent in symbionts, allowing harmonious colonization without DUOX activation, whereas uracil release from opportunistic pathobionts provokes chronic inflammation. These results reveal that bacteria with distinct abilities to activate uracil-induced gut inflammation, in terms of intensity and duration, act as critical factors that determine homeostasis or pathogenesis in gut microbe interactions.	[Lee, Kyung-Ah; Kim, Sung-Hee; Kim, Eun-Kyoung; You, Hyejin; Kim, Boram; Lee, Won-Jae] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Lee, Kyung-Ah; Kim, Sung-Hee; Kim, Eun-Kyoung; You, Hyejin; Kim, Boram; Lee, Won-Jae] Natl Creat Res Initiat Ctr Symbiosyst, Seoul 151742, South Korea; [Ha, Eun-Mi] Catholic Univ, Coll Pharm, Taegu 712702, South Korea; [You, Hyejin; Kwon, Youngjoo] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Kim, Min-Ji; Ryu, Ji-Hwan] Yonsei Univ, Coll Med, Res Ctr Human Nat Def Syst, Seoul 120752, South Korea	Seoul National University (SNU); Catholic University of Korea; Ewha Womans University; Yonsei University; Yonsei University Health System	Lee, WJ (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	lwj@snu.ac.kr	Kwon, Youngjoo/AAF-6120-2020	Kwon, Youngjoo/0000-0001-6256-3042; Kim, Minji/0000-0002-8484-6817	National Creative Research Initiative Program [2006-0050687]; BK 21 program; SNU research grant [3344-20110017]	National Creative Research Initiative Program(Ministry of Science & Technology (MOST), Republic of Korea); BK 21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); SNU research grant	This study was supported by the National Creative Research Initiative Program (grant no. 2006-0050687 to W.-J.L), the BK 21 program, and an SNU research grant (no. 3344-20110017). We are grateful to S.-J. Lee, B. Seo, and J. Lee for assistance with the C. elegans work. We thank J. Yoon, S.W. Kang, J.-F. Gavin, Z. Zheng, Y.Y. Seo, D. Kim, and Y.M. Park for assistance with laboratory analyses and D. Daffonchio (supported by the Italy-Korea Researcher Exchange Program) for valuable discussion.	Andoh A, 2009, CURR PHARM DESIGN, V15, P2066, DOI 10.2174/138161209788489186; Apidianakis Y, 2011, DIS MODEL MECH, V4, P21, DOI 10.1242/dmm.003970; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Attila C, 2009, APPL MICROBIOL BIOT, V82, P525, DOI 10.1007/s00253-009-1860-8; Bae YS, 2010, TRENDS IMMUNOL, V31, P278, DOI 10.1016/j.it.2010.05.003; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Broderick NA, 2012, GUT MICROBES, V3, P307, DOI 10.4161/gmic.19896; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Chambers MC, 2012, CURR OPIN IMMUNOL, V24, P10, DOI 10.1016/j.coi.2011.11.003; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Charroux B, 2012, SEMIN IMMUNOL, V24, P17, DOI 10.1016/j.smim.2011.11.003; Chatterjee M, 2009, J CELL PHYSIOL, V220, P664, DOI 10.1002/jcp.21808; Chen X, 2011, CHEM COMMUN, V47, P4373, DOI 10.1039/c1cc10589b; Corby-Harris V, 2007, APPL ENVIRON MICROB, V73, P3470, DOI 10.1128/AEM.02120-06; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; El Hassani RA, 2005, AM J PHYSIOL-GASTR L, V288, pG933, DOI 10.1152/ajpgi.00198.2004; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; GRISHAM MB, 1994, LANCET, V344, P859, DOI 10.1016/S0140-6736(94)92831-2; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; Hooper LV, 2009, NAT REV MICROBIOL, V7, P367, DOI 10.1038/nrmicro2114; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Koo MS, 2003, EMBO J, V22, P2614, DOI 10.1093/emboj/cdg252; Lee WJ, 2009, GENE DEV, V23, P2260, DOI 10.1101/gad.1858709; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; MERGEAY M, 1974, MOL GEN GENET, V133, P299, DOI 10.1007/BF00332706; Moskwa P, 2007, AM J RESP CRIT CARE, V175, P174, DOI 10.1164/rccm.200607-1029OC; Paredes JC, 2011, IMMUNITY, V35, P770, DOI 10.1016/j.immuni.2011.09.018; Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006; RINAS U, 1995, APPL ENVIRON MICROB, V61, P4147, DOI 10.1128/AEM.61.12.4147-4151.1995; Roh SW, 2008, APPL ENVIRON MICROB, V74, P6171, DOI 10.1128/AEM.00301-08; Rokutan K, 2008, SEMIN IMMUNOPATHOL, V30, P315, DOI 10.1007/s00281-008-0124-5; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Ryu JH, 2006, EMBO J, V25, P3693, DOI 10.1038/sj.emboj.7601233; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Selbie LA, 1998, TRENDS PHARMACOL SCI, V19, P87, DOI 10.1016/S0165-6147(97)01166-8; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Sokol H, 2010, CURR OPIN GASTROEN, V26, P327, DOI 10.1097/MOG.0b013e328339536b; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Ueda A, 2009, MICROB BIOTECHNOL, V2, P62, DOI 10.1111/j.1751-7915.2008.00060.x; van der Hoeven R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002453; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x	52	231	249	1	90	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 9	2013	153	4					797	811		10.1016/j.cell.2013.04.009	http://dx.doi.org/10.1016/j.cell.2013.04.009			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663779	Bronze			2022-12-28	WOS:000318844000010
J	de Waal, FBM				de Waal, Frans B. M.			Animal Conformists	SCIENCE			English	Editorial Material							CULTURAL TRANSMISSION; CHIMPANZEES		Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA	Emory University	de Waal, FBM (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.	dewaal@emory.edu			OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER; NIH HHS [P51 OD011132] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Allen J, 2013, SCIENCE, V340, P485, DOI 10.1126/science.1231976; de Waal FBM, 2001, APE SUSHI MASTER; Dindo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007858; Hopper LM, 2008, P ROY SOC B-BIOL SCI, V275, P835, DOI 10.1098/rspb.2007.1542; Horner V, 2006, P NATL ACAD SCI USA, V103, P13878, DOI 10.1073/pnas.0606015103; Itani J., 1973, PRECULTURAL PRIMATE, P26; Perry S, 2009, ANIM COGN, V12, P705, DOI 10.1007/s10071-009-0230-3; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495, DOI 10.1017/S0140525X0003123X; van de Waal E, 2013, SCIENCE, V340, P483, DOI 10.1126/science.1232769; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047	10	12	13	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					437	438		10.1126/science.1237521	http://dx.doi.org/10.1126/science.1237521			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620041				2022-12-28	WOS:000318016700027
J	Dulcis, D; Jamshidi, P; Leutgeb, S; Spitzer, NC				Dulcis, Davide; Jamshidi, Pouya; Leutgeb, Stefan; Spitzer, Nicholas C.			Neurotransmitter Switching in the Adult Brain Regulates Behavior	SCIENCE			English	Article							FAT SAND RAT; TYROSINE-HYDROXYLASE; RECEPTOR SUBTYPES; DOPAMINE; SOMATOSTATIN; NUCLEUS; HYPOTHALAMUS; EXPRESSION; DEPRESSION; NEURONS	Neurotransmitters have been thought to be fixed throughout life, but whether sensory stimuli alter behaviorally relevant transmitter expression in the mature brain is unknown. We found that populations of interneurons in the adult rat hypothalamus switched between dopamine and somatostatin expression in response to exposure to short- and long-day photoperiods. Changes in postsynaptic dopamine receptor expression matched changes in presynaptic dopamine, whereas somatostatin receptor expression remained constant. Pharmacological blockade or ablation of these dopaminergic neurons led to anxious and depressed behavior, phenocopying performance after exposure to the long-day photoperiod. Induction of newly dopaminergic neurons through exposure to the short-day photoperiod rescued the behavioral consequences of lesions. Natural stimulation of other sensory modalities may cause changes in transmitter expression that regulate different behaviors.	[Dulcis, Davide; Jamshidi, Pouya; Leutgeb, Stefan; Spitzer, Nicholas C.] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Dulcis, Davide; Jamshidi, Pouya; Leutgeb, Stefan; Spitzer, Nicholas C.] Univ Calif San Diego, Ctr Neural Circuits & Behav, La Jolla, CA 92093 USA; [Dulcis, Davide; Leutgeb, Stefan; Spitzer, Nicholas C.] Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Dulcis, D (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	ddulcis@gmail.com	Dulcis, Davide/GSN-9883-2022	Spitzer, Nicholas/0000-0002-3523-1103; Dulcis, Davide/0000-0003-4672-7996	Ellison Medical Foundation [AG-SS-2432-10, AG-NS-0724-10]; W. M. Keck Foundation grant	Ellison Medical Foundation(Lawrence Ellison Foundation); W. M. Keck Foundation grant	We thank D. Berg, M. Gorman, and M. Scanziani for comments on the manuscript; H. Karten and A. Brzozowska-Prechtl for their expert advice on hypothalamic neuroanatomy and immunostaining protocols; Y. Zou and K. Onishi for technical help with FFN511 confocal imaging; and U. Kumar for a generous gift of SST receptor and CRF antibodies. We are grateful to M. I. Bharmal and M. Kucharski for stereological quantification and A. Guemez-Gamboa for the CRF-immunoassay. This work was supported by Ellison Medical Foundation grants AG-SS-2432-10 to N.C.S. and D. D., AG-NS-0724-10 to S. L., and a W. M. Keck Foundation grant to N.C.S. and D. D. We declare no conflict of interest. The data are included in the main article and in the supplementary materials.	Arancibia S, 2000, EXP BRAIN RES, V134, P261, DOI 10.1007/s002210000462; Ashkenazy T, 2009, INT J NEUROPSYCHOPH, V12, P83, DOI 10.1017/S1461145708009115; Aumann TD, 2011, J NEUROCHEM, V116, P646, DOI 10.1111/j.1471-4159.2010.07151.x; Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185; BJORKLUND A, 1975, BRAIN RES, V89, P29, DOI 10.1016/0006-8993(75)90131-6; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; BUIJS RM, 1993, J COMP NEUROL, V335, P42, DOI 10.1002/cne.903350104; CUMMINGS S, 1983, J NEUROSCI, V3, P1355; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Dulcis D, 2008, NATURE, V456, P195, DOI 10.1038/nature07569; Dulcis D, 2012, DEV NEUROBIOL, V72, P465, DOI 10.1002/dneu.20920; Eagle DM, 2011, J NEUROSCI, V31, P7349, DOI 10.1523/JNEUROSCI.6182-10.2011; Flames N, 2009, NATURE, V458, P885, DOI 10.1038/nature07929; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Gubernator NG, 2009, SCIENCE, V324, P1441, DOI 10.1126/science.1172278; Hahn JD, 2010, BRAIN RES REV, V64, P14, DOI 10.1016/j.brainresrev.2010.02.002; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Jeanneteau FD, 2012, P NATL ACAD SCI USA, V109, P1305, DOI 10.1073/pnas.1114122109; Kageyama K, 2009, ENDOCR J, V56, P335, DOI 10.1507/endocrj.K09E-075; Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krivisky K, 2011, NEUROPSYCHOBIOLOGY, V63, P191, DOI 10.1159/000321805; Kumar U, 2007, J COMP NEUROL, V504, P185, DOI 10.1002/cne.21444; Lam RW, 2006, AM J PSYCHIAT, V163, P805, DOI 10.1176/appi.ajp.163.5.805; LeGates TA, 2012, NATURE, V491, P594, DOI 10.1038/nature11673; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Marder E, 2011, P NATL ACAD SCI USA, V108, P15542, DOI 10.1073/pnas.1010674108; NEMEROFF CB, 1984, SCIENCE, V226, P1342, DOI 10.1126/science.6334362; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Pierce AA, 2010, J NEUROSCI, V30, P723, DOI 10.1523/JNEUROSCI.2479-09.2010; Pocock R, 2010, NAT NEUROSCI, V13, P610, DOI 10.1038/nn.2537; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; SAKANAKA M, 1990, BRAIN RES, V516, P313, DOI 10.1016/0006-8993(90)90933-3; Simmons DM, 2009, J COMP NEUROL, V516, P423, DOI 10.1002/cne.22126; Swanson L., 2011, HDB PHYSL S4, P317; Thor S, 1997, NEURON, V18, P397, DOI 10.1016/S0896-6273(00)81241-6; Tursun B, 2011, SCIENCE, V331, P304, DOI 10.1126/science.1199082; Vogels TP, 2011, SCIENCE, V334, P1569, DOI 10.1126/science.1211095; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44	41	178	179	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					449	453		10.1126/science.1234152	http://dx.doi.org/10.1126/science.1234152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620046				2022-12-28	WOS:000318016700034
J	Jackson, BA; Bikson, TK; Gunn, PP				Jackson, Brian A.; Bikson, Tora K.; Gunn, Patrick P.			Human Subjects Protection and Research on Terrorism and Conflict	SCIENCE			English	Editorial Material									[Jackson, Brian A.] RAND Corp, Arlington, VA 22202 USA; [Bikson, Tora K.] RAND Corp, Santa Monica, CA 90401 USA; [Gunn, Patrick P.] Cooley LLP, San Francisco, CA 94111 USA	RAND Corporation; RAND Corporation	Jackson, BA (corresponding author), RAND Corp, Arlington, VA 22202 USA.	bjackson@rand.org						Atran S., 2011, OBSERVER, V24; Berrett D., 2011, CHRON HIGH ED, V58; Beskow LM, 2008, SCIENCE, V322, P1054, DOI 10.1126/science.1164100; Dolnik A., 2011, PERSPECTIVES TERRORI, V5, P3; Gunn P. P., 2007, ETHICAL PRINCIPLES S; National Institutes of Health, CERT CONF KIOSK; Office for Human Research Protections HHS, ANPRM REV COMM RUL; Rubinstein RA, 2012, ANTHROPOL TODAY, V28, P3, DOI 10.1111/j.1467-8322.2012.00847.x; Shopes Linda, ORAL HIST HUMAN SUBJ	9	2	2	2	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					434	435		10.1126/science.1231747	http://dx.doi.org/10.1126/science.1231747			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	131SQ	23620039				2022-12-28	WOS:000318016700025
J	Rambo, RP; Tainer, JA				Rambo, Robert P.; Tainer, John A.			Accurate assessment of mass, models and resolution by small-angle scattering	NATURE			English	Article							X-RAY-SCATTERING; BIOLOGICAL MACROMOLECULES; STRUCTURAL-ANALYSES; SAXS; RNA; CRYSTALLOGRAPHY; COMPUTATION; PROTEINS; QUALITY; SCALE	Modern small-angle scattering (SAS) experiments with X-rays or neutrons provide a comprehensive, resolution-limited observation of the thermodynamic state. However, methods for evaluating mass and validating SAS-based models and resolution have been inadequate. Here we define the volume of correlation, V-c, a SAS invariant derived from the scattered intensities that is specific to the structural state of the particle, but independent of concentration and the requirements of a compact, folded particle. We show that V-c defines a ratio, Q(R), that determines the molecular mass of proteins or RNA ranging from 10 to 1,000 kilodaltons. Furthermore, we propose a statistically robust method for assessing model-data agreements (chi(2)(free)) akin to cross-validation. Our approach prevents over-fitting of the SAS data and can be used with a newly defined metric, R-SAS, for quantitative evaluation of resolution. Together, these metrics (V-c, Q(R), chi(2)(free) and R-SAS) provide analytical tools for unbiased and accurate macromolecular structural characterizations in solution.	[Rambo, Robert P.; Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Div Life Sci, Berkeley, CA 94720 USA; [Tainer, John A.] Scripps Res Inst, Skaggs Inst Chem Biol, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Scripps Research Institute	Rambo, RP (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Div Life Sci, Berkeley, CA 94720 USA.	rprambo@lbl.gov; jat@scripps.edu	Tainer, John/GWQ-4878-2022	Tainer, John/0000-0003-1659-2429	Office of Science, US Department of Energy on Novel Technology for Structural Biology; United States Department of Energy program Integrated Diffraction Analysis Technologies [DEAC02-05CH11231]; National Institutes of Health [R01GM105404]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404] Funding Source: NIH RePORTER	Office of Science, US Department of Energy on Novel Technology for Structural Biology(United States Department of Energy (DOE)); United States Department of Energy program Integrated Diffraction Analysis Technologies(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. L. Hura, M. Hammel, R. T. Batey, J. Tanamachi and the staff of SIBYLS Beamline 12.3.1 at the Advanced Light Source for discussions and P. Adams for suggestions regarding simulations with CNS. We thank E. Rambo, G. Williams and E. D. Getzoff for manuscript comments. This work is supported in part by funding to foster collaboration with Bruker and the Berkeley Laboratory Directed Research and Development (LDRD) program provided by the Director, Office of Science, US Department of Energy on Novel Technology for Structural Biology. The SIBYLS Beamline 12.3.1 facility and team at the Advanced Light Source is supported by United States Department of Energy program Integrated Diffraction Analysis Technologies (DEAC02-05CH11231) and by National Institutes of Health grant R01GM105404.	Bai Y, 2005, P NATL ACAD SCI USA, V102, P1035, DOI 10.1073/pnas.0404448102; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1993, SCIENCE, V261, P328, DOI 10.1126/science.8332897; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; deGroot BL, 1997, PROTEINS, V29, P240, DOI 10.1002/(SICI)1097-0134(199710)29:2<240::AID-PROT11>3.0.CO;2-O; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Fulle S, 2008, BIOPHYS J, V94, P4202, DOI 10.1529/biophysj.107.113415; Glatter O., 1982, SMALL ANGLE XRAY SCA; Hammond JA, 2010, J MOL BIOL, V399, P450, DOI 10.1016/j.jmb.2010.04.016; Harrison SC, 2007, STRUCTURE, V15, P1344, DOI 10.1016/j.str.2007.10.004; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351; Jie Y., 2006, IEEE SOC C COMP VIS; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Keel AY, 2012, RNA, V18, P88, DOI 10.1261/rna.030007.111; MOORE PB, 1980, J APPL CRYSTALLOGR, V13, P168, DOI 10.1107/S002188988001179X; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Rambo RP, 2010, CURR OPIN STRUC BIOL, V20, P128, DOI 10.1016/j.sbi.2009.12.015; Rambo RP, 2010, RNA, V16, P638, DOI 10.1261/rna.1946310; Rambo RP, 2004, BIOCHEMISTRY-US, V43, P6486, DOI 10.1021/bi049912u; Rousseeuw P. J., 1987, ROBUST REGRESSION OU; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Sosnick TR, 2011, BIOPOLYMERS, V95, P503, DOI 10.1002/bip.21643; Stoddard CD, 2010, STRUCTURE, V18, P787, DOI 10.1016/j.str.2010.04.006; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S	32	517	519	6	184	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 25	2013	496	7446					477	+		10.1038/nature12070	http://dx.doi.org/10.1038/nature12070			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23619693	Green Accepted			2022-12-28	WOS:000317984400035
J	Xing, MZ; Haugen, BR; Schlumberger, M				Xing, Mingzhao; Haugen, Bryan R.; Schlumberger, Martin			Progress in molecular-based management of differentiated thyroid cancer	LANCET			English	Article							FINE-NEEDLE-ASPIRATION; 2ND PRIMARY MALIGNANCIES; BRAF V600E MUTATION; LONG-TERM SURVEILLANCE; LYMPH-NODE METASTASIS; PHASE-II TRIAL; RADIOACTIVE IODINE; BRAF(V600E) MUTATION; GENETIC ALTERATIONS; RADIOIODINE UPTAKE	Substantial developments have occurred in the past 5-10 years in clinical translational research of thyroid cancer. Diagnostic molecular markers, such as RET-PTC, RAS, and BRAF(V600E) mutations; galectin 3; and a new gene expression classifier, are outstanding examples that have improved diagnosis of thyroid nodules. BRAF mutation is a prognostic genetic marker that has improved risk stratification and hence tailored management of patients with thyroid cancer, including those with conventionally low risks. Novel molecular-targeted treatments hold great promise for radioiodine-refractory and surgically inoperable thyroid cancers as shown in clinical trials; such treatments are likely to become a component of the standard treatment regimen for patients with thyroid cancer in the near future. These novel molecular-based management strategies for thyroid nodules and thyroid cancer are the most exciting developments in this unprecedented era of molecular thyroid-cancer medicine.	[Xing, Mingzhao] Johns Hopkins Univ, Lab Cellular & Mol Thyroid Res, Div Endocrinol & Metab, Sch Med, Baltimore, MD 21287 USA; [Haugen, Bryan R.] Univ Colorado, Div Endocrinol Metab & Diabet, Sch Med, Aurora, CO USA; [Schlumberger, Martin] Inst Gustave Roussy, Dept Nucl Med & Endocrine Oncol, Ctr Reference Tumeurs Refractaires Thyroide, Villejuif, France; [Schlumberger, Martin] Univ Paris Sud, Villejuif, France	Johns Hopkins University; University of Colorado System; University of Colorado Anschutz Medical Campus; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay	Xing, MZ (corresponding author), Johns Hopkins Univ, Div Endocrinol & Metab, Sch Med, Baltimore, MD 21287 USA.	mxing1@jhmi.edu			Ardea Biosciences; Veracyte; Amgen; AstraZeneca; Bayer; Eisai; Exelixis; Genzyme; United States National Institutes of Health [R01CA134225, R01CA113507]; French National Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA113507, R01CA134225] Funding Source: NIH RePORTER	Ardea Biosciences; Veracyte; Amgen(Amgen); AstraZeneca(AstraZeneca); Bayer(Bayer AG); Eisai(Eisai Co Ltd); Exelixis; Genzyme(Sanofi-AventisGenzyme Corporation); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French National Cancer Institute(Institut National du Cancer (INCA) France); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	MX is coholder of a patent related to BRAF mutation and has received research support from Ardea Biosciences; BRH has received research support from Veracyte; and MS has received research funding from Amgen, AstraZeneca, Bayer, Eisai, Exelixis, and Genzyme.; The authors' effort for this manuscript is supported by the United States National Institutes of Health grants R01CA134225 and R01CA113507 to MX; Mary Rossick Kern and Jerome H Kern endowment for BRH; and a grant from the French National Cancer Institute to MS.	Abubaker J, 2008, J CLIN ENDOCR METAB, V93, P611, DOI 10.1210/jc.2007-1717; Agretti P, 2012, EUR J ENDOCRINOL, V167, P393, DOI 10.1530/EJE-12-0400; Ahmed M, 2011, EUR J ENDOCRINOL, V165, P315, DOI 10.1530/EJE-11-0129; Alexander EK, 2012, NEW ENGL J MED, V367, P705, DOI 10.1056/NEJMoa1203208; Alzahrani AS, 2013, ENDOCR-RELAT CANCER, V20, P13, DOI 10.1530/ERC-12-0309; Ball DW, 2012, ASCO ANN M JUN 1 5 C; Baloch ZW, 2008, DIAGN CYTOPATHOL, V36, P425, DOI 10.1002/dc.20830; Barollo S, 2010, EUR J ENDOCRINOL, V163, P659, DOI 10.1530/EJE-10-0290; Bartolazzi A, 2008, LANCET ONCOL, V9, P543, DOI 10.1016/S1470-2045(08)70132-3; Basolo F, 2010, J CLIN ENDOCR METAB, V95, P4197, DOI 10.1210/jc.2010-0337; Bass MB, 2010, J CLIN ENDOCR METAB, V95, P5018, DOI 10.1210/jc.2010-0947; Bayer HealthCare Pharmaceuticals Onyx Pharmaceuticals, 2013, PHAS 3 DECISION TRIA; Bible KC, 2010, LANCET ONCOL, V11, P962, DOI 10.1016/S1470-2045(10)70203-5; Brown AP, 2008, J CLIN ENDOCR METAB, V93, P504, DOI 10.1210/jc.2007-1154; Brown RL, 2011, J CANCER, V2, P193, DOI 10.7150/jca.2.193; Bunone G, 1999, AM J PATHOL, V155, P1967, DOI 10.1016/S0002-9440(10)65515-0; Cabanillas ME, 2012, J CLIN ONCOL, V30; Cantara S, 2010, J CLIN ENDOCR METAB, V95, P1365, DOI 10.1210/jc.2009-2103; Carr LL, 2010, CLIN CANCER RES, V16, P5260, DOI 10.1158/1078-0432.CCR-10-0994; Chakravarty D, 2011, J CLIN INVEST, V121, P4700, DOI 10.1172/JCI46382; Chudova D, 2010, J CLIN ENDOCR METAB, V95, P5296, DOI 10.1210/jc.2010-1087; Cohen EEW, 2008, J CLIN ONCOL, V26, P4708, DOI 10.1200/JCO.2007.15.9566; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Crouzeix G, 2012, J CLIN ENDOCR METAB, V97, P3046, DOI 10.1210/jc.2012-1630; de la Chapelle A, 2011, J CLIN ENDOCR METAB, V96, P3326, DOI 10.1210/jc.2011-1004; Deandreis D, 2011, ENDOCR-RELAT CANCER, V18, P159, DOI 10.1677/ERC-10-0233; DONGHI R, 1993, J CLIN INVEST, V91, P1753, DOI 10.1172/JCI116385; Durante C, 2006, J CLIN ENDOCR METAB, V91, P2892, DOI 10.1210/jc.2005-2838; Durante C, 2012, J CLIN ENDOCR METAB, V97, P2748, DOI 10.1210/jc.2012-1123; Elisei R, 2008, J CLIN ENDOCR METAB, V93, P3943, DOI 10.1210/jc.2008-0607; Elisei R, 2012, J CLIN ENDOCR METAB, V97, P4390, DOI 10.1210/jc.2012-1775; Fadda G, 2011, EUR J ENDOCRINOL, V165, P447, DOI 10.1530/EJE-11-0181; Fagin JA, 2004, J ENDOCRINOL, V183, P249, DOI 10.1677/joe.1.05895; FAGIN JA, 1993, J CLIN INVEST, V91, P179, DOI 10.1172/JCI116168; Fallahi B, 2011, CLIN NUCL MED, V36, P277, DOI 10.1097/RLU.0b013e31820a9fe3; Faroux MJ, 1997, PATHOL RES PRACT, V193, P705, DOI 10.1016/S0344-0338(97)80030-1; Ferraz C, 2011, J CLIN ENDOCR METAB, V96, P2016, DOI 10.1210/jc.2010-2567; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Franco C, 2009, APPL IMMUNOHISTO M M, V17, P211, DOI 10.1097/PAI.0b013e31818935a9; Fukahori M, 2012, THYROID, V22, P683, DOI 10.1089/thy.2011.0261; Garcia-Rostan G, 2003, J CLIN ONCOL, V21, P3226, DOI 10.1200/JCO.2003.10.130; Guerra A, 2011, ENDOCR J, V58, P31, DOI 10.1507/endocrj.K10E-260; Gupta-Abramson V, 2008, J CLIN ONCOL, V26, P4714, DOI 10.1200/JCO.2008.16.3279; Guth S, 2009, EUR J CLIN INVEST, V39, P699, DOI 10.1111/j.1365-2362.2009.02162.x; Hay ID, 2008, SURGERY, V144, P980, DOI 10.1016/j.surg.2008.08.035; Henderson YC, 2009, CLIN CANCER RES, V15, P485, DOI 10.1158/1078-0432.CCR-08-0933; Ho AL, 2013, NEW ENGL J MED, V368, P623, DOI 10.1056/NEJMoa1209288; Hoftijzer H, 2009, EUR J ENDOCRINOL, V161, P923, DOI 10.1530/EJE-09-0702; Hou P, 2007, CLIN CANCER RES, V13, P1161, DOI 10.1158/1078-0432.CCR-06-1125; Hou P, 2010, J CLIN ENDOCR METAB, V95, P820, DOI 10.1210/jc.2009-1888; Howell GM, 2013, ANN SURG ONCOL, V20, P47, DOI 10.1245/s10434-012-2611-0; Howlader N, 2011, SEER CANC STAT REV 1; Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jonklaas J, 2010, THYROID, V20, P1423, DOI 10.1089/thy.2010.0308; Joo JY, 2012, J CLIN ENDOCR METAB, V97, P3996, DOI 10.1210/jc.2012-2444; Kebebew E, 2007, ANN SURG, V246, P466, DOI 10.1097/SLA.0b013e318148563d; Keutgen XM, 2012, CLIN CANCER RES, V18, P2032, DOI 10.1158/1078-0432.CCR-11-2487; Kim TH, 2012, CANCER-AM CANCER SOC, V118, P1764, DOI 10.1002/cncr.26500; Kim TY, 2006, CLIN ENDOCRINOL, V65, P364, DOI 10.1111/j.1365-2265.2006.02605.x; Kloos RT, 2009, J CLIN ONCOL, V27, P1675, DOI 10.1200/JCO.2008.18.2717; Kouniavsky G, 2012, J SURG ONCOL, V105, P438, DOI 10.1002/jso.21935; Lang BHH, 2012, SURGERY, V151, P844, DOI 10.1016/j.surg.2011.12.019; Leboulleux S, 2012, LANCET ONCOL, V13, P897, DOI 10.1016/S1470-2045(12)70335-2; Leenhardt L, 2004, THYROID, V14, P1056, DOI 10.1089/thy.2004.14.1056; Li H, 2011, J CLIN ENDOCR METAB, V96, pE1719, DOI 10.1210/jc.2011-0459; Lin KL, 2010, ANN SURG ONCOL, V17, P3294, DOI 10.1245/s10434-010-1129-6; Liu DX, 2007, CLIN CANCER RES, V13, P1341, DOI 10.1158/1078-0432.CCR-06-1753; Liu DX, 2009, CANCER RES, V69, P7311, DOI 10.1158/0008-5472.CAN-09-1077; Liu RX, 2011, J CLIN ENDOCR METAB, V96, pE577, DOI 10.1210/jc.2010-2644; Liu Z, 2008, J CLIN ENDOCR METAB, V93, P3106, DOI 10.1210/jc.2008-0273; Mallick U, 2012, NEW ENGL J MED, V366, P1674, DOI 10.1056/NEJMoa1109589; Massicotte M, 2012, 82 ANN M AM THYR ASS; MAZZAFERRI EL, 1994, AM J MED, V97, P418, DOI 10.1016/0002-9343(94)90321-2; MAZZAFERRI EL, 1993, NEW ENGL J MED, V328, P553; McLeod DSA, 2013, LANCET, V381, P1046, DOI 10.1016/S0140-6736(12)62205-3; Mian C, 2008, CLIN ENDOCRINOL, V68, P108, DOI 10.1111/j.1365-2265.2007.03008.x; Milas M, 2010, ANN SURG, V252, P643, DOI 10.1097/SLA.0b013e3181f5ba51; Miyauchi A, 2011, THYROID, V21, P707, DOI 10.1089/thy.2010.0355; Moses W, 2010, WORLD J SURG, V34, P2589, DOI 10.1007/s00268-010-0720-0; Murugan AK, 2011, CANCER RES, V71, P4403, DOI 10.1158/0008-5472.CAN-10-4041; Musuuza JS, 2012, J CLIN ONCOL, V30; Nikiforov YE, 2011, J CLIN ENDOCR METAB, V96, P3390, DOI 10.1210/jc.2011-1469; Nikiforov YE, 2009, J CLIN ENDOCR METAB, V94, P2092, DOI 10.1210/jc.2009-0247; Nikiforova MN, 2009, THYROID, V19, P1351, DOI 10.1089/thy.2009.0240; Noguchi S, 2008, WORLD J SURG, V32, P747, DOI 10.1007/s00268-007-9453-0; O'Neill CJ, 2010, SURGERY, V148, P1139, DOI 10.1016/j.surg.2010.09.005; Pelizzo MR, 2011, CLIN CHEM LAB MED, V49, P325, DOI 10.1515/CCLM.2011.031; Popadich A, 2011, SURGERY, V150, P1048, DOI 10.1016/j.surg.2011.09.003; Prescott JD, 2012, SURGERY, V152, P984, DOI 10.1016/j.surg.2012.08.039; Ricarte-Filho JC, 2009, CANCER RES, V69, P4885, DOI 10.1158/0008-5472.CAN-09-0727; Riesco-Eizaguirre G, 2006, ENDOCR-RELAT CANCER, V13, P257, DOI 10.1677/erc.1.01119; Ringel MD, 2001, CANCER RES, V61, P6105; Robbins RJ, 2006, J CLIN ENDOCR METAB, V91, P498, DOI 10.1210/jc.2005-1534; Rossi M, 2012, J CLIN ENDOCR METAB, V97, P2354, DOI 10.1210/jc.2011-3494; Rubino C, 2003, BRIT J CANCER, V89, P1638, DOI 10.1038/sj.bjc.6601319; Sacks W, 2010, THYROID, V20, P1235, DOI 10.1089/thy.2009.0455; Saggiorato E, 2005, ENDOCR-RELAT CANCER, V12, P305, DOI 10.1677/erc.1.00944; Samija I, 2011, DIAGN MOL PATHOL, V20, P233, DOI 10.1097/PDM.0b013e31821a59f1; Sawka AM, 2008, ENDOCRIN METAB CLIN, V37, P457, DOI 10.1016/j.ecl.2008.02.007; Schlumberger M, 2011, ANN ENDOCRINOL-PARIS, V72, P149, DOI 10.1016/j.ando.2011.03.020; Schlumberger M, 2012, NEW ENGL J MED, V366, P1663, DOI 10.1056/NEJMoa1108586; Schvartz C, 2012, J CLIN ENDOCR METAB, V97, P1526, DOI 10.1210/jc.2011-2512; Shen RL, 2012, THYROID, V22, P9, DOI 10.1089/thy.2011.0081; Sherman SI, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.5503; Sherman SI, 2010, CLIN ONCOL-UK, V22, P464, DOI 10.1016/j.clon.2010.03.014; Sherman SI, 2008, NEW ENGL J MED, V359, P31, DOI 10.1056/NEJMoa075853; Smallridge RC, 2010, CLIN ONCOL-UK, V22, P486, DOI 10.1016/j.clon.2010.03.013; Spano JP, 2012, MED ONCOL, V29, P1421, DOI 10.1007/s12032-011-0070-2; Sprague BL, 2008, CANCER CAUSE CONTROL, V19, P585, DOI 10.1007/s10552-008-9122-0; Theoharis C, 2012, CURR OPIN ONCOL, V24, P35, DOI 10.1097/CCO.0b013e32834dcfca; Tsimberidou AM, 2009, J CLIN ENDOCR METAB, V94, P4423, DOI 10.1210/jc.2009-0743; Tufano RP, 2012, LARYNGOSCOPE, V122, P1634, DOI 10.1002/lary.23371; Umbricht CB, 2004, CLIN CANCER RES, V10, P5762, DOI 10.1158/1078-0432.CCR-03-0389; Volante M, 2009, J CLIN ENDOCR METAB, V94, P4735, DOI 10.1210/jc.2009-1233; Wang CCC, 2011, THYROID, V21, P243, DOI 10.1089/thy.2010.0243; Williams MD, 2009, ANN SURG ONCOL, V16, P3146, DOI 10.1245/s10434-009-0666-3; Xing M, JAMA IN PRESS; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431; Xing MZ, 2010, THYROID, V20, P697, DOI 10.1089/thy.2010.1646; Xing MZ, 2010, MOL CELL ENDOCRINOL, V321, P86, DOI 10.1016/j.mce.2009.10.012; Xing MZ, 2009, J CLIN ONCOL, V27, P2977, DOI 10.1200/JCO.2008.20.1426; Xing MZ, 2005, J CLIN ENDOCR METAB, V90, P6373, DOI 10.1210/jc.2005-0987; Xing MZ, 2004, J CLIN ENDOCR METAB, V89, P2867, DOI 10.1210/jc.2003-032050; Yang J, 2007, CANCER CYTOPATHOL, V111, P306, DOI 10.1002/cncr.22955; Yip L, 2012, J CLIN ENDOCR METAB, V97, P1905, DOI 10.1210/jc.2011-3048; Yip L, 2009, SURGERY, V146, P1215, DOI 10.1016/j.surg.2009.09.011	128	380	408	8	103	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 23	2013	381	9871					1058	1069		10.1016/S0140-6736(13)60109-9	http://dx.doi.org/10.1016/S0140-6736(13)60109-9			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EU	23668556	Green Accepted			2022-12-28	WOS:000316936800035
J	Steffens, DC				Steffens, David C.			Exercise for late-life depression? It depends	LANCET			English	Editorial Material							PHARMACOTHERAPY		Univ Connecticut, Ctr Hlth, Farmington, CT 06030 USA	University of Connecticut	Steffens, DC (corresponding author), Univ Connecticut, Ctr Hlth, Farmington, CT 06030 USA.	steffens@uchc.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH070027] Funding Source: NIH RePORTER; NIMH NIH HHS [K24 MH070027] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Barcelos-Ferreira R, 2013, J AFFECT DISORDERS, V150, P616, DOI 10.1016/j.jad.2013.02.024; Blumenthal JA, 1999, ARCH INTERN MED, V159, P2349, DOI 10.1001/archinte.159.19.2349; Blumenthal JA, 2007, PSYCHOSOM MED, V69, P587, DOI 10.1097/PSY.0b013e318148c19a; Bridle C, 2012, BRIT J PSYCHIAT, V201, P180, DOI 10.1192/bjp.bp.111.095174; Jarnum H, 2011, ACTA PSYCHIAT SCAND, V124, P435, DOI 10.1111/j.1600-0447.2011.01766.x; Lam LCW, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2012.03.008; Lavretsky H, 2011, AM J GERIAT PSYCHIAT, V19, P839, DOI 10.1097/JGP.0b013e31820ee9ef; Potter R, 2011, INT J GERIATR PSYCH, V26, P1000, DOI 10.1002/gps.2641; Roose SP, 2004, AM J PSYCHIAT, V161, P2050, DOI 10.1176/appi.ajp.161.11.2050; Rosenberg D, 2010, AM J GERIAT PSYCHIAT, V18, P221, DOI 10.1097/JGP.0b013e3181c534b5; Tsang HWH, 2006, INT J GERIATR PSYCH, V21, P890, DOI 10.1002/gps.1582; Underwood M, 2013, LANCET	12	3	4	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 6	2013	382	9886					4	5		10.1016/S0140-6736(13)60860-0	http://dx.doi.org/10.1016/S0140-6736(13)60860-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	177AD	23643109	Green Accepted			2022-12-28	WOS:000321347000005
J	Gordon, DM				Gordon, Deborah M.			The rewards of restraint in the collective regulation of foraging by harvester ant colonies	NATURE			English	Article							POGONOMYRMEX-RUGOSUS; PLASTICITY; METABOLISM; ECOLOGY; SIZE; MASS	Collective behaviour, arising from local interactions(1), allows groups to respond to changing conditions. Long-term studies have shown that the traits of individual mammals and birds are associated with their reproductive success(2-6), but little is known about the evolutionary ecology of collective behaviour in natural populations. An ant colony operates without central control, regulating its activity through a network of local interactions(7). This work shows that variation among harvester ant (Pogonomyrmex barbatus) colonies in collective response to changing conditions(8) is related to variation in colony lifetime reproductive success in the production of offspring colonies. Desiccation costs are high for harvester ants foraging in the desert(9,10). More successful colonies tend to forage less when conditions are dry, and show relatively stable foraging activity when conditions are more humid. Restraint from foraging does not compromise a colony's long-term survival; colonies that fail to forage at all on many days survive as long, over the colony's 20-30-year lifespan, as those that forage more regularly. Sensitivity to conditions in which to reduce foraging activity may be transmissible from parent to offspring colony. These results indicate that natural selection is shaping the collective behaviour that regulates foraging activity, and that the selection pressure, related to climate, may grow stronger if the current drought in their habitat persists.	Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Gordon, DM (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	dmgordon@stanford.edu			Stanford Office of the Dean of Research; Stanford Emergence of Cooperation Project; National Science Foundation [IOS-0718631]	Stanford Office of the Dean of Research; Stanford Emergence of Cooperation Project; National Science Foundation(National Science Foundation (NSF))	Thanks to the many people who helped with field work: in 1986 and 1987, K. Roth; in 2011, X. Ampuero, K. Dektar, M. Greene, J. Hickman, A. Merrell and N. Pinter-Wollman; in 2012, J. Queirolo, J. Rasiel, C. Wayne; in both 2011 and 2012, S. Crow, L. Howard and E. Pless. Many thanks to M. Coram for statistical advice and help. I am grateful to D. Kennedy and J. Ober for helpful discussions and to M. Feldman and W. Flesch for comments on the manuscript. The work was funded by the Stanford Office of the Dean of Research, Stanford Emergence of Cooperation Project and the National Science Foundation grant IOS-0718631.	Adler FR, 2003, AM NAT, V162, P529, DOI 10.1086/378856; ALTMANN SA, 1991, P NATL ACAD SCI USA, V88, P420, DOI 10.1073/pnas.88.2.420; [Anonymous], 2010, ANT ENCOUNTERS INTER; Beverly BD, 2009, BEHAV ECOL, V20, P633, DOI 10.1093/beheco/arp041; CASSILL DL, 1995, ANIM BEHAV, V50, P801, DOI 10.1016/0003-3472(95)80140-5; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; DAVIDSON DW, 1980, AM NAT, V116, P92, DOI 10.1086/283613; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Garant D, 2004, AM NAT, V164, pE115, DOI 10.1086/424764; GORDON D M L, 1987, Psyche (Cambridge), V94, P341, DOI 10.1155/1987/63930; Gordon DM, 2008, BEHAV ECOL, V19, P217, DOI 10.1093/beheco/arm125; Gordon DM, 2011, BEHAV ECOL, V22, P429, DOI 10.1093/beheco/arq218; GORDON DM, 1992, BEHAV ECOL SOCIOBIOL, V31, P417, DOI 10.1007/BF00170609; Gordon DM, 1998, J ANIM ECOL, V67, P141, DOI 10.1046/j.1365-2656.1998.00169.x; Gordon DM, 1996, ECOLOGY, V77, P2393, DOI 10.2307/2265741; GORDON DM, 1995, ANIM BEHAV, V49, P649, DOI 10.1016/0003-3472(95)80198-7; GORDON DM, 1991, AM NAT, V138, P379, DOI 10.1086/285223; GORDON DM, 1993, OECOLOGIA, V95, P479, DOI 10.1007/BF00317431; Ingram KK, 2013, J ANIM ECOL, V82, P540, DOI 10.1111/1365-2656.12036; Ingram Krista K., 2011, BMC Ecology, V11, P19, DOI 10.1186/1472-6785-11-19; Johnson RA, 2004, J INSECT PHYSIOL, V50, P943, DOI 10.1016/j.jinsphys.2004.07.006; LIGHTON JRB, 1988, P NATL ACAD SCI USA, V85, P4765, DOI 10.1073/pnas.85.13.4765; LIGHTON JRB, 1989, PHYSIOL ZOOL, V62, P1232, DOI 10.1086/physzool.62.6.30156211; Moyes K, 2009, J ANIM ECOL, V78, P406, DOI 10.1111/j.1365-2656.2008.01497.x; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Prabhakar B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002670; Pratt SC, 2006, P NATL ACAD SCI USA, V103, P15906, DOI 10.1073/pnas.0604801103	27	98	98	2	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 6	2013	498	7452					91	+		10.1038/nature12137	http://dx.doi.org/10.1038/nature12137			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158DC	23676676				2022-12-28	WOS:000319947800039
J	Liu, D; Shi, WF; Shi, Y; Wang, DY; Xiao, HX; Li, W; Bi, YH; Wu, Y; Li, XB; Yan, JH; Liu, WJ; Zhao, GP; Yang, WZ; Wang, Y; Ma, JC; Shu, YL; Lei, FM; Gao, GF				Liu, Di; Shi, Weifeng; Shi, Yi; Wang, Dayan; Xiao, Haixia; Li, Wei; Bi, Yuhai; Wu, Ying; Li, Xianbin; Yan, Jinghua; Liu, Wenjun; Zhao, Guoping; Yang, Weizhong; Wang, Yu; Ma, Juncai; Shu, Yuelong; Lei, Fumin; Gao, George F.			Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses	LANCET			English	Article								Background On March 30, 2013, a novel avian influenza A H7N9 virus that infects human beings was identified. This virus had been detected in six provinces and municipal cities in China as of April 18, 2013. We correlated genomic sequences from avian influenza viruses with ecological information and did phylogenetic and coalescent analyses to extrapolate the potential origins of the virus and possible routes of reassortment events. Methods We downloaded H7N9 virus genome sequences from the Global Initiative on Sharing Avian Influenza Data (GISAID) database and public sequences used from the Influenza Virus Resource. We constructed phylogenetic trees and did 1000 bootstrap replicates for each tree. Two rounds of phylogenetic analyses were done. We used at least 100 closely related sequences for each gene to infer the overall topology, removed suspicious sequences from the trees, and focused on the closest clades to the novel H7N9 viruses. We compared our tree topologies with those from a bayesian evolutionary analysis by sampling trees (BEAST) analysis. We used the bayesian Markov chain Monte Carlo method to jointly estimate phylogenies, divergence times, and other evolutionary parameters for all eight gene fragments. We used sequence alignment and homology-modelling methods to study specific mutations regarding phenotypes, specifically addressing the human receptor binding properties. Findings The novel avian influenza A H7N9 virus originated from multiple reassortment events. The HA gene might have originated from avian influenza viruses of duck origin, and the NA gene might have transferred from migratory birds infected with avian influenza viruses along the east Asian flyway. The six internal genes of this virus probably originated from two different groups of H9N2 avian influenza viruses, which were isolated from chickens. Detailed analyses also showed that ducks and chickens probably acted as the intermediate hosts leading to the emergence of this virulent H7N9 virus. Genotypic and potential phenotypic differences imply that the isolates causing this outbreak form two separate subclades. Interpretation The novel avian influenza A H7N9 virus might have evolved from at least four origins. Diversity among isolates implies that the H7N9 virus has evolved into at least two different lineages. Unknown intermediate hosts involved might be implicated, extensive global surveillance is needed, and domestic-poultry-to-person transmission should be closely watched in the future.	[Liu, Di; Shi, Yi; Bi, Yuhai; Wu, Ying; Yan, Jinghua; Liu, Wenjun; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Liu, Di; Li, Wei; Ma, Juncai] Chinese Acad Sci, Inst Microbiol, Network Informat Ctr, Beijing 100101, Peoples R China; [Shi, Weifeng] Taishan Med Coll, Sch Basic Med Sci, Taishan, Shandong, Peoples R China; [Shi, Weifeng; Lei, Fumin] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing 100101, Peoples R China; [Shi, Yi; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Beijing 100101, Peoples R China; [Wang, Dayan; Shu, Yuelong; Gao, George F.] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Xiao, Haixia] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China; [Li, Xianbin] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Li, Xianbin; Gao, George F.] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhao, Guoping] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Yang, Weizhong; Wang, Yu; Gao, George F.] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Shandong First Medical University & Shandong Academy of Medical Sciences; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Center for Disease Control & Prevention	Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, 1 West Beichen Rd, Beijing 100101, Peoples R China.	gaof@im.ac.cn	Liu, Di/G-6135-2014; Xiao, Haixia/AAZ-3374-2020; Liu, Di/ABD-2729-2021; Gao, George Fu/ABD-5229-2021	Liu, Di/0000-0003-3693-2726; Xiao, Haixia/0000-0003-0032-5430; Liu, Di/0000-0003-3693-2726; Zhao, Guo-Ping/0000-0002-7621-6620; Bi, Yuhai/0000-0002-5595-363X	China Ministry of Science and Technology Project 973; National Natural Science Foundation of China; China Health and Family Planning Commission; Chinese Academy of Sciences	China Ministry of Science and Technology Project 973; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Health and Family Planning Commission; Chinese Academy of Sciences(Chinese Academy of Sciences)	China Ministry of Science and Technology Project 973, National Natural Science Foundation of China, China Health and Family Planning Commission, Chinese Academy of Sciences.	Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Belser JA, 2009, EMERG INFECT DIS, V15, P859, DOI 10.3201/eid1506.090072; Cheng TX, 1979, FAUNA SINICA AVES; COLMAN PM, 1992, IMMUNOL CELL BIOL, V70, P209, DOI 10.1038/icb.1992.26; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Kageyama T, 2013, EURO SURVEILL, V18; Kim HR, 2012, J GEN VIROL, V93, P1278, DOI 10.1099/vir.0.041269-0; Kiso M, 2011, J VIROL, V85, P4667, DOI 10.1128/JVI.00047-11; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Nguyen-Van-Tam JS, 2006, EUROSURVEILLANCE, V11; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stegeman A, 2004, J INFECT DIS, V190, P2088, DOI 10.1086/425583	19	429	501	7	289	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 1	2013	381	9881					1926	1932		10.1016/S0140-6736(13)60938-1	http://dx.doi.org/10.1016/S0140-6736(13)60938-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163EV	23643111				2022-12-28	WOS:000320319500033
J	Styrkarsdottir, U; Thorleifsson, G; Sulem, P; Gudbjartsson, DF; Sigurdsson, A; Jonasdottir, A; Jonasdottir, A; Oddsson, A; Helgason, A; Magnusson, OT; BragiWalters, G; Frigge, ML; Helgadottir, HT; Johannsdottir, H; Bergsteinsdottir, K; Ogmundsdottir, MH; Center, JR; Nguyen, TV; Eisman, JA; Christiansen, C; Steingrimsson, E; Jonasson, JG; Tryggvadottir, L; Eyjolfsson, GI; Theodors, A; Jonsson, T; Ingvarsson, T; Olafsson, I; Rafnar, T; Kong, A; Sigurdsson, G; Masson, G; Thorsteinsdottir, U; Stefansson, K				Styrkarsdottir, Unnur; Thorleifsson, Gudmar; Sulem, Patrick; Gudbjartsson, Daniel F.; Sigurdsson, Asgeir; Jonasdottir, Aslaug; Jonasdottir, Adalbjorg; Oddsson, Asmundur; Helgason, Agnar; Magnusson, Olafur T.; BragiWalters, G.; Frigge, Michael L.; Helgadottir, Hafdis T.; Johannsdottir, Hrefna; Bergsteinsdottir, Kristin; Ogmundsdottir, Margret H.; Center, Jacqueline R.; Nguyen, Tuan V.; Eisman, John A.; Christiansen, Claus; Steingrimsson, Erikur; Jonasson, Jon G.; Tryggvadottir, Laufey; Eyjolfsson, Gudmundur I.; Theodors, Asgeir; Jonsson, Thorvaldur; Ingvarsson, Thorvaldur; Olafsson, Isleifur; Rafnar, Thorunn; Kong, Augustine; Sigurdsson, Gunnar; Masson, Gisli; Thorsteinsdottir, Unnur; Stefansson, Kari			Nonsense mutation in the LGR4 gene is associated with several human diseases and other traits	NATURE			English	Article							BONE-MINERAL DENSITY; OSTEOPOROSIS; GPR48; RECEPTORS; KNOCKOUT; LEADS; LOCI	Low bone mineral density (BMD) is used as a parameter of osteoporosis. Genome-wide association studies of BMD have hitherto focused on BMD as a quantitative trait, yielding common variants of small effects that contribute to the population diversity in BMD1-7. Here we use BMD as a dichotomous trait, searching for variants that may have a direct effect on the risk of pathologically low BMD rather than on the regulation of BMD in the healthy population. Through whole-genome sequencing of Icelandic individuals, we found a rare nonsense mutation within the leucinerich-repeat-containing G-protein-coupled receptor 4 (LGR4) gene (c.376C>T) that is strongly associated with low BMD, and with osteoporotic fractures. This mutation leads to termination of LGR4 at position 126 and fully disrupts its function. The c.376C>T mutation is also associated with electrolyte imbalance, late onset of menarche and reduced testosterone levels, as well as an increased risk of squamous cell carcinoma of the skin and biliary tract cancer. Interestingly, the phenotype of carriers of the c.376C>T mutation overlaps that of Lgr4 mutant mice.	[Styrkarsdottir, Unnur; Thorleifsson, Gudmar; Sulem, Patrick; Gudbjartsson, Daniel F.; Sigurdsson, Asgeir; Jonasdottir, Aslaug; Jonasdottir, Adalbjorg; Oddsson, Asmundur; Helgason, Agnar; Magnusson, Olafur T.; BragiWalters, G.; Frigge, Michael L.; Helgadottir, Hafdis T.; Johannsdottir, Hrefna; Rafnar, Thorunn; Kong, Augustine; Masson, Gisli; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet Amgen, IS-101 Reykjavik, Iceland; [Oddsson, Asmundur] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Bergsteinsdottir, Kristin; Ogmundsdottir, Margret H.; Steingrimsson, Erikur] Univ Iceland, Biomed Ctr, Fac Med, Dept Biochem & Mol Biol, IS-101 Reykjavik, Iceland; [Center, Jacqueline R.; Nguyen, Tuan V.; Eisman, John A.] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Center, Jacqueline R.; Eisman, John A.] St Vincents Hosp, Sydney, NSW 2010, Australia; [Center, Jacqueline R.; Nguyen, Tuan V.; Eisman, John A.] Univ New S Wales, Sydney, NSW 2010, Australia; [Eisman, John A.] UNDA, Sydney, NSW 2010, Australia; [Christiansen, Claus] CCBR, DK-2750 Ballerup, Denmark; [Jonasson, Jon G.] Natl Univ Hosp Iceland, Landspitali, Dept Pathol, IS-101 Reykjavik, Iceland; [Jonasson, Jon G.; Tryggvadottir, Laufey; Jonsson, Thorvaldur; Sigurdsson, Gunnar; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Jonasson, Jon G.; Tryggvadottir, Laufey] Iceland Canc Registry, IS-105 Reykjavik, Iceland; [Eyjolfsson, Gudmundur I.] Iceland Med Ctr Laeknasetrid, Lab Mjodd RAM, IS-109 Reykjavik, Iceland; [Theodors, Asgeir] Natl Univ Hosp Iceland, Landspitali, Dept Gastroenterol, IS-101 Reykjavik, Iceland; [Jonsson, Thorvaldur] Natl Univ Hosp Iceland, Landspitali, Dept Surg, IS-101 Reykjavik, Iceland; [Ingvarsson, Thorvaldur] Akureyri Hosp, Dept Orthoped Surg, IS-600 Akureyri, Iceland; [Ingvarsson, Thorvaldur] Univ Akureyri, Inst Hlth Sci, IS-600 Akureyri, Iceland; [Olafsson, Isleifur] Natl Univ Hosp Iceland, Landspitali, Dept Clin Biochem, IS-101 Reykjavik, Iceland; [Sigurdsson, Gunnar] Natl Univ Hosp Iceland, Landspitali, Dept Endocrinol & Metab, IS-101 Reykjavik, Iceland	Karolinska Institutet; University of Iceland; Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney; University of Notre Dame Australia; Center Clinical & Basic Research; Synarc; Landspitali National University Hospital; University of Iceland; Landspitali National University Hospital; Landspitali National University Hospital; University of Akureyri; Landspitali National University Hospital; Landspitali National University Hospital	Thorsteinsdottir, U (corresponding author), deCODE Genet Amgen, IS-101 Reykjavik, Iceland.	unnurth@decode.is; kstefans@decode.is	Center, Jacqueline/AAY-8712-2021; Eisman, John A/C-2886-2014; Walters, G. Bragi/L-4215-2013; Stefansson, Kari/AAE-7187-2019; Helgason, Agnar/K-1522-2015; Nguyen, Tuan V./AAD-9503-2020	Center, Jacqueline/0000-0002-5278-4527; Walters, G. Bragi/0000-0002-5415-6487; Nguyen, Tuan V./0000-0002-3246-6281; Steingrimsson, Eirikur/0000-0001-5826-7486; Gudbjartsson, Daniel/0000-0002-5222-9857; Kong, Augustine/0000-0001-8193-5438; Tryggvadottir, Laufey/0000-0001-8067-9030; Helgason, Agnar/0000-0002-8545-3767; Styrkarsdottir, Unnur/0000-0001-8146-8278; Oddsson, Asmundur/0000-0002-4606-5163; Helgadottir, Hafdis/0000-0003-4352-152X; Jonasson, Jon G./0000-0002-2635-5032	European Commission [HEALTH-F2-2008-201865-GEFOS]; Lung GO Sequencing Project [HL-102923]; WHI Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]	European Commission(European CommissionEuropean Commission Joint Research Centre); Lung GO Sequencing Project; WHI Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project	We thank the subjects of the Icelandic deCODE study, the Danish PERF study and the Australian DOES study for their participation. We also thank the staff at deCODE Genetics core facilities and all our colleagues for their important contribution to this work. The authors would like to thank the NHLBI GO Exome Sequencing Project and its continuing studies, which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923); the WHI Sequencing Project (HL-102924); the Broad GO Sequencing Project (HL-102925); the Seattle GO Sequencing Project (HL-102926); and the Heart GO Sequencing Project (HL-103010). This work was supported in part by the European Commission (HEALTH-F2-2008-201865-GEFOS).	Bagger YZ, 2007, OSTEOPOROSIS INT, V18, P505, DOI 10.1007/s00198-006-0255-2; Balasubramanian S, 2011, GENE DEV, V25, P1, DOI 10.1101/gad.1968411; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Duncan EL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001372; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Jin C, 2008, INVEST OPHTH VIS SCI, V49, P4245, DOI 10.1167/iovs.08-1860; Kanis JA, 2008, BONE, V42, P467, DOI 10.1016/j.bone.2007.11.001; Kato S, 2006, NEPHRON EXP NEPHROL, V104, pE63, DOI 10.1159/000093999; Kung AWC, 2010, AM J HUM GENET, V86, P229, DOI 10.1016/j.ajhg.2009.12.014; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Luo J, 2009, DEVELOPMENT, V136, P2747, DOI 10.1242/dev.033571; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; Nguyen TV, 1997, J BONE MINER RES, V12, P124, DOI 10.1359/jbmr.1997.12.1.124; NHLBI. Exome Sequencing Project, 2012, EX SEQ PROJ EX VAR S; Oyama K, 2011, SEX DEV, V5, P205, DOI 10.1159/000329476; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Ralston SH, 2010, ENDOCR REV, V31, P629, DOI 10.1210/er.2009-0044; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Richards JB, 2012, NAT REV GENET, V13, P576, DOI 10.1038/nrg3228; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; Wang J, 2012, J AM SOC NEPHROL, V23, P281, DOI 10.1681/ASN.2011040351; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; Yamashita R, 2009, DEV DYNAM, V238, P993, DOI 10.1002/dvdy.21900; Yoon JK, 2012, CELL SIGNAL, V24, P369, DOI 10.1016/j.cellsig.2011.09.023	29	183	194	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2013	497	7450					517	520		10.1038/nature12124	http://dx.doi.org/10.1038/nature12124			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	148OG	23644456				2022-12-28	WOS:000319254000054
J	Wolfe, SA; Pisano, DJ; Lockman, FJ; McGaugh, SS; Shaya, EJ				Wolfe, Spencer A.; Pisano, D. J.; Lockman, Felix J.; McGaugh, Stacy S.; Shaya, Edward J.			Discrete clouds of neutral gas between the galaxies M31 and M33	NATURE			English	Article							TULLY-FISHER RELATION; HIGH-VELOCITY CLOUDS; INTERGALACTIC MEDIUM; ANDROMEDA GALAXY; HI CLOUDS; BARYONS; HALOS; FIELD; MASS	Spiral galaxies must acquire gas to maintain their observed level of star formation beyond the next few billion years(1). A source of this material may be the gas that resides between galaxies, but our understanding of the state and distribution of this gas is incomplete(2). Radio observations(3) of the Local Group of galaxies have revealed hydrogen gas extending from the disk of the galaxy M31 at least halfway to M33. This feature has been interpreted to be the neutral component of a condensing intergalactic filament(4), which would be able to fuel star formation in M31 and M33, but simulations suggest that such a feature could also result from an interaction between both galaxies within the past few billion years (ref. 5). Here we report radio observations showing that about 50 per cent of this gas is composed of clouds, with the rest distributed in an extended, diffuse component. The clouds have velocities comparable to those of M31 and M33, and have properties suggesting that they are unrelated to other Local Group objects. We conclude that the clouds are likely to be transient condensations of gas embedded in an intergalactic filament and are therefore a potential source of fuel for future star formation in M31 and M33.	[Wolfe, Spencer A.; Pisano, D. J.] W Virginia Univ, Dept Phys, Morgantown, WV 26506 USA; [Lockman, Felix J.] Natl Radio Astron Observ, Green Bank, WV 24944 USA; [McGaugh, Stacy S.] Case Western Reserve Univ, Dept Astron, Cleveland, OH 44106 USA; [Shaya, Edward J.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA	West Virginia University; National Radio Astronomy Observatory (NRAO); Case Western Reserve University; University System of Maryland; University of Maryland College Park	Wolfe, SA (corresponding author), W Virginia Univ, Dept Phys, POB 6315, Morgantown, WV 26506 USA.	swolfe4@mix.wvu.edu	McGaugh, Stacy/AAC-2757-2022	McGaugh, Stacy/0000-0002-9762-0980; Wolfe, Spencer/0000-0001-6250-7438; Pisano, D.J./0000-0001-7996-7860	NSF [AST-1149491, AST-0908370]; Direct For Mathematical & Physical Scien [0908370] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	D.J.P. is an Adjunct Assistant Astronomer at the National Radio Astronomy Observatory; F.J.L. is an Adjunct Professor in the Department of Physics, West Virginia University. S. A. W. acknowledges the student observing support (GSSP11-012) provided by the NRAO for this project. The NRAO is a facility of the NSF operated under cooperative agreement by Associated Universities, Inc. D.J.P. acknowledges support from NSF CAREER grant AST-1149491. S. S. M. acknowledges support in part by NSF grant AST-0908370.	Bekki K, 2008, MON NOT R ASTRON SOC, V390, pL24, DOI 10.1111/j.1745-3933.2008.00528.x; Boothroyd AI, 2011, ASTRON ASTROPHYS, V536, DOI 10.1051/0004-6361/201117656; Braun R, 2004, ASTRON ASTROPHYS, V417, P421, DOI 10.1051/0004-6361:20034423; Chynoweth KM, 2008, ASTRON J, V135, P1983, DOI 10.1088/0004-6256/135/6/1983; Dave R, 2001, ASTROPHYS J, V552, P473, DOI 10.1086/320548; Fernandez X, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/2/181; Fukugita M, 2004, ASTROPHYS J, V616, P643, DOI 10.1086/425155; Gentile G, 2007, ASTRON ASTROPHYS, V472, pL25, DOI 10.1051/0004-6361:20078081; Grossi M, 2008, ASTRON ASTROPHYS, V487, P161, DOI 10.1051/0004-6361:200810220; Ibata R, 2007, ASTROPHYS J, V671, P1591, DOI 10.1086/522574; Leroy AK, 2008, ASTRON J, V136, P2782, DOI 10.1088/0004-6256/136/6/2782; Lewis GF, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/1/4; Lockman FJ, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/2/52; Maller AH, 2004, MON NOT R ASTRON SOC, V355, P694, DOI 10.1111/j.1365-2966.2004.08349.x; MALONEY P, 1993, ASTROPHYS J, V414, P41, DOI 10.1086/173055; McConnachie AW, 2009, NATURE, V461, P66, DOI 10.1038/nature08327; McGaugh SS, 2000, ASTROPHYS J, V533, pL99, DOI 10.1086/312628; McGaugh SS, 2012, ASTRON J, V143, DOI 10.1088/0004-6256/143/2/40; McGaugh SS, 2010, ASTROPHYS J, V722, P248, DOI 10.1088/0004-637X/722/1/248; Popping A, 2009, ASTRON ASTROPHYS, V504, P15, DOI 10.1051/0004-6361/200911811; Putman ME, 2009, ASTROPHYS J, V703, P1486, DOI 10.1088/0004-637X/703/2/1486; Shull JM, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/1/23; Thilker DA, 2004, ASTROPHYS J, V601, pL39, DOI 10.1086/381703; Tollerud EJ, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/45; TULLY RB, 1977, ASTRON ASTROPHYS, V54, P661; Westmeier T, 2008, MON NOT R ASTRON SOC, V390, P1691, DOI 10.1111/j.1365-2966.2008.13858.x	26	53	53	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2013	497	7448					224	226		10.1038/nature12082	http://dx.doi.org/10.1038/nature12082			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23657349	Green Submitted			2022-12-28	WOS:000318558200032
J	De Vita, S				De Vita, Salvatore			Tocilizumab versus adalimumab for rheumatoid arthritis	LANCET			English	Editorial Material							EULAR RECOMMENDATIONS; DOUBLE-BLIND; MANAGEMENT; THERAPY		Univ Hosp Santa Maria della Misericordia, Clin Rheumatol, Dept Med & Biol Sci, I-133100 Udine, Italy	Hospital Santa Maria della Misericordia	De Vita, S (corresponding author), Univ Hosp Santa Maria della Misericordia, Clin Rheumatol, Dept Med & Biol Sci, I-133100 Udine, Italy.	devita.salvatore@aoud.sanita.fvg.it		, Salvatore/0000-0002-2757-3373				Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Fabris M, 2013, ARTHRITIS RHEUM-US, V65, P88, DOI 10.1002/art.37707; Gabay C, 2013, LANCET, V381, P1541, DOI 10.1016/S0140-6736(13)60250-0; Nam JL, 2010, ANN RHEUM DIS, V69, P976, DOI 10.1136/ard.2009.126573; O'Mahony R, 2010, ANN RHEUM DIS, V69, P1823, DOI 10.1136/ard.2008.105577; Schoels M, 2010, ANN RHEUM DIS, V69, P995, DOI 10.1136/ard.2009.126714; Schoels MM, 2013, ANN RHEUM DIS, V72, P583, DOI 10.1136/annrheumdis-2012-202470; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Tanaka Y, 2012, CURR OPIN RHEUMATOL, V24, P319, DOI 10.1097/BOR.0b013e3283524e4c	9	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 4	2013	381	9877					1515	1517		10.1016/S0140-6736(13)60634-0	http://dx.doi.org/10.1016/S0140-6736(13)60634-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139UF	23642688				2022-12-28	WOS:000318609600006
J	Armstrong, PM; Andreadis, TG				Armstrong, Philip M.; Andreadis, Theodore G.			Eastern Equine Encephalitis Virus - Old Enemy, New Threat	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Armstrong, Philip M.; Andreadis, Theodore G.] Connecticut Agr Expt Stn, Dept Environm Sci, Ctr Vector Biol & Zoonot Dis, New Haven, CT 06504 USA	Connecticut Agricultural Experiment Station	Armstrong, PM (corresponding author), Connecticut Agr Expt Stn, Dept Environm Sci, Ctr Vector Biol & Zoonot Dis, New Haven, CT 06504 USA.		Armstrong, Philip/GWU-8253-2022					[Anonymous], 2006, MMWR-MORBID MORTAL W, p[55, 56]; Armstrong PM, 2008, AM J TROP MED HYG, V79, P291, DOI 10.4269/ajtmh.2008.79.291; Deresiewicz RL, 1997, NEW ENGL J MED, V336, P1867, DOI 10.1056/NEJM199706263362604; VILLARI P, 1995, AM J TROP MED HYG, V52, P8, DOI 10.4269/ajtmh.1995.52.8; WEAVER SC, 2001, ENCY ARTHROPOD TRANS, P151	5	50	50	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 2	2013	368	18					1670	1673		10.1056/NEJMp1213696	http://dx.doi.org/10.1056/NEJMp1213696			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	134MN	23635048				2022-12-28	WOS:000318214400016
J	Serenius, F; Kallen, K; Blennow, M; Ewald, U; Fellman, V; Holmstrom, G; Lindberg, E; Lundqvist, P; Marsal, K; Norman, M; Olhager, E; Stigson, L; Stjernqvist, K; Vollmer, B; Stromberg, B				Serenius, Fredrik; Kallen, Karin; Blennow, Mats; Ewald, Uwe; Fellman, Vineta; Holmstrom, Gerd; Lindberg, Eva; Lundqvist, Pia; Marsal, Karel; Norman, Mikael; Olhager, Elisabeth; Stigson, Lennart; Stjernqvist, Karin; Vollmer, Brigitte; Stromberg, Bo		EXPRESS Grp	Neurodevelopmental Outcome in Extremely Preterm Infants at 2.5 Years After Active Perinatal Care in Sweden	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BIRTH-WEIGHT INFANTS; COGNITIVE-DEVELOPMENT; DEVELOPMENTAL DELAY; EXTREMELY PREMATURE; GENDER-DIFFERENCES; CHILDREN BORN; FOLLOW-UP; GROWTH; AGE; DISABILITY	Importance Active perinatal care increases survival of extremely preterm infants; however, improved survival might be associated with increased disability among survivors. Objective To determine neurodevelopmental outcome in extremely preterm children at 2.5 years (corrected age). Design, Setting, and Participants Population-based prospective cohort of consecutive extremely preterm infants born before 27 weeks of gestation in Sweden between 2004 and 2007. Of 707 live-born infants, 491 (69%) survived to 2.5 years. Survivors were assessed and compared with singleton control infants who were born at term and matched by sex, ethnicity, and municipality. Assessments ended in February 2010 and comparison estimates were adjusted for demographic differences. Main Outcomes and Measures Cognitive, language, and motor development was assessed with Bayley Scales of Infant and Toddler Development (3rd edition; Bayley-III), which are standardized to mean (SD) scores of 100 (15). Clinical examination and parental questionnaires were used for diagnosis of cerebral palsy and visual and hearing impairments. Assessments were made by week of gestational age. Results At a median age of 30.5 months (corrected), 456 of 491 (94%) extremely preterm children were evaluated (41 by chart review only). For controls, 701 had information on health status and 366 had Bayley-III assessments. Mean (SD) composite Bayley-III scores (cognition, 94 [12.3]; language, 98 [16.5]; motor, 94 [15.9]) were lower than the corresponding mean scores for controls (cognition, 104 [10.6]; P < .001; adjusted difference in mean scores, 9.2 [99% CI, 6.9-11.5]; language, 109 [12.3]; P < .001; adjusted difference in mean scores, 9.3 [99% Cl, 6.4-12.3]; and motor, 107 [13.7]; P < .001; adjusted difference in mean scores, 12.6 [99% Cl, 9.5-15.6]). Cognitive disability was moderate in 5% of the extremely preterm group vs 0.3% in controls (P < .001) and it was severe in 6.3% of the extremely preterm group vs 0.3% in controls (P < .001). Language disability was moderate in 9.4% of the extremely preterm group vs 2.5% in controls (P < .001) and severe in 6.6% of the extremely preterm group vs 0% in controls (P < .001). Other comparisons between the extremely preterm group vs controls were for cerebral palsy (7.0% vs 0.1%; P < .001), for blindness (0.9% vs 0%; P = .02), and for hearing impairment (moderate and severe, 0.9% vs 0%; P = .02, respectively). Overall, 42% (99% CI, 36%-48%) of extremely preterm children had no disability, 31% (99% CI, 25%-36%) had mild disability, 16% (99% CI, 12%-21%) had moderate disability, and 11% (99% CI, 7.2%-15%) had severe disability. Moderate or severe overall disability decreased with gestational age at birth (22 weeks, 60%; 23 weeks, 51%; 24 weeks, 34%; 25 weeks, 27%; and 26 weeks, 17%; P for trend < .001). Conclusions and Relevance Of children born extremely preterm and receiving active perinatal care, 73% had mild or no disability and neurodevelopmental outcome improved with each week of gestational age. These results are relevant for clinicians counseling families facing extremely preterm birth. JAMA. 2013;309(17):1810-1820	[Serenius, Fredrik; Ewald, Uwe; Stromberg, Bo] Uppsala Univ, Dept Womens & Childrens Hlth, Sect Pediat, S-75185 Uppsala, Sweden; [Holmstrom, Gerd] Uppsala Univ, Dept Neurosci Ophthalmol, S-75185 Uppsala, Sweden; [Serenius, Fredrik] Umea Univ, Dept Pediat, Inst Clin Sci, Umea, Sweden; [Kallen, Karin] Lund Univ, Ctr Reprod Epidemiol, Lund, Sweden; [Fellman, Vineta] Lund Univ, Dept Pediat, Clin Sci Lund, Lund, Sweden; [Lundqvist, Pia] Lund Univ, Dept Hlth Sci, Lund, Sweden; [Marsal, Karel] Lund Univ, Dept Obstet & Gynecol, Clin Sci Lund, Lund, Sweden; [Stjernqvist, Karin] Lund Univ, Dept Psychol, Lund, Sweden; [Blennow, Mats; Norman, Mikael] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Vollmer, Brigitte] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Lindberg, Eva] Univ Orebro, Dept Pediat, Orebro, Sweden; [Olhager, Elisabeth] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Stigson, Lennart] Gothenburg Univ, Dept Pediat, Inst Clin Sci, Sahlgrenska Acad, S-41124 Gothenburg, Sweden	Uppsala University; Uppsala University; Umea University; Lund University; Lund University; Lund University; Lund University; Lund University; Karolinska Institutet; Karolinska Institutet; Orebro University; Linkoping University; University of Gothenburg	Serenius, F (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Sect Pediat, S-75185 Uppsala, Sweden.	fredrik.serenius@kbh.uu.se	Blennow, Mats/AAX-6202-2021; vollmer, brigitte/AAB-3132-2020	vollmer, brigitte/0000-0003-4088-5336; Hellstrom-Westas, Lena/0000-0003-3498-6069; Norman, Mikael/0000-0003-4191-3781; Blennow, Mats/0000-0001-9517-0261; Hellstrom, Ann/0000-0002-9259-1244	Swedish Research Council [2006-3855, 2009-4250]; Uppsala-Orebro Regional Research Council [RFR-10324]; Research Council South East Region of Sweden; Swedish government; University of Umea; Vasterbotten County Council; Stockholm County Council; Karolinska Institute; "Lilla Barnets Fond" Children's fund; Evy and Gunnar Sandberg Foundation; Birgit and Hakan Ohlsson Foundation; EU	Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala-Orebro Regional Research Council; Research Council South East Region of Sweden; Swedish government; University of Umea; Vasterbotten County Council; Stockholm County Council(Stockholm County Council); Karolinska Institute(Karolinska Institutet); "Lilla Barnets Fond" Children's fund; Evy and Gunnar Sandberg Foundation; Birgit and Hakan Ohlsson Foundation; EU(European Commission)	This study was supported by the Swedish Research Council grants 2006-3855 and 2009-4250, the Uppsala-Orebro Regional Research Council grant RFR-10324, a grant from the Research Council South East Region of Sweden, and grants to Researchers in the Public Health Care from the Swedish government. Financial support was also provided through a regional agreement between the University of Umea and Vasterbotten County Council and through a regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institute. The study also received support from The "Lilla Barnets Fond" Children's fund. Dr Kallen reported support from the Evy and Gunnar Sandberg and from the Birgit and Hakan Ohlsson Foundations and Dr Vollmer was supported by the Marie Curie Individual Intra-European Fellowship within the EU FP6 Framework Program.	Anderson PJ, 2010, ARCH PEDIAT ADOL MED, V164, P352, DOI 10.1001/archpediatrics.2010.20; Austeng D, 2010, ACTA PAEDIATR, V99, P978, DOI 10.1111/j.1651-2227.2010.01846.x; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; Bayley N, 1993, BAYLEY SCALES INFANT; Bayley N., 2019, BAYLEY SCALES INFANT; Blennow M, 2009, JAMA-J AM MED ASSOC, V301, P2225, DOI 10.1001/jama.2009.771; Carlo WA, 2011, JAMA-J AM MED ASSOC, V306, P2348, DOI 10.1001/jama.2011.1752; Claas MJ, 2011, ARCH DIS CHILD-FETAL, V96, pF169, DOI 10.1136/adc.2009.174433; COCKBURN F, 1993, LANCET, V342, P193; De Groote I, 2007, OBSTET GYNECOL, V110, P855, DOI 10.1097/01.AOG.0000284447.43442.55; Delobel-Ayoub M, 2009, PEDIATRICS, V123, P1485, DOI 10.1542/peds.2008-1216; Doyle LW, 2010, J PEDIATR-US, V156, P49, DOI 10.1016/j.jpeds.2009.07.013; Ehrenkranz RA, 2006, PEDIATRICS, V117, P1253, DOI 10.1542/peds.2005-1368; Gargus RA, 2009, PEDIATRICS, V124, P112, DOI 10.1542/peds.2008-2742; Hack M, 2000, ARCH PEDIAT ADOL MED, V154, P725, DOI 10.1001/archpedi.154.7.725; Hack M, 2000, Semin Neonatol, V5, P89, DOI 10.1053/siny.1999.0001; Hindmarsh GJ, 2000, EARLY HUM DEV, V60, P115, DOI 10.1016/S0378-3782(00)00105-5; Hintz SR, 2006, ACTA PAEDIATR, V95, P1239, DOI 10.1080/08035250600599727; Hintz SR, 2011, PEDIATRICS, V127, P62, DOI 10.1542/peds.2010-1150; Markestad T, 2005, PEDIATRICS, V115, P1289, DOI 10.1542/peds.2004-1482; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; McCarton CM, 1997, JAMA-J AM MED ASSOC, V277, P126, DOI 10.1001/jama.277.2.126; Ment LR, 2003, JAMA-J AM MED ASSOC, V289, P705, DOI 10.1001/jama.289.6.705; Mercier CE, 2010, NEONATOLOGY, V97, P329, DOI 10.1159/000260136; Moore T, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7961; Msall ME, 2010, J PEDIATR-US, V157, P863, DOI 10.1016/j.jpeds.2010.09.022; Rattihalli RR, 2011, ARCH DIS CHILD-FETAL, V96, pF329, DOI 10.1136/adc.2010.192559; Shepherd EG, 2012, J PERINATOL, V32, P33, DOI 10.1038/jp.2011.45; Spittle A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005495.pub3; Stjernqvist K, 1999, ACTA PAEDIATR, V88, P557, DOI 10.1080/08035259950169594; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; THOMAS DG, 1971, APPLIED STATISTICS, V20, P105, DOI DOI 10.2307/2346643; Tommiska V, 2003, ARCH DIS CHILD-FETAL, V88, P29; Tommiska V, 2007, PEDIATRICS, V119, P29, DOI 10.1542/peds.2006-1472; UNESCO Institute for Statistics, 2006, INT STAND CLASS ED I; Vohr BR, 2006, PEDIATRICS, V118, pE115, DOI 10.1542/peds.2005-2382; Vohr BR, 2012, J PEDIATR-US, V161, P222, DOI 10.1016/j.jpeds.2012.01.057; Vohr BR, 2005, PEDIATRICS, V116, P635, DOI 10.1542/peds.2004-2247; Walden RV, 2007, PEDIATRICS, V120, pE1512, DOI 10.1542/peds.2007-0354; WEISGLASKUPERUS N, 1993, PEDIATRICS, V92, P658; Weiss B, 1997, MENT RETARD DEV D R, V3, P246, DOI 10.1002/(SICI)1098-2779(1997)3:3<246::AID-MRDD5>3.0.CO;2-N; Wilson-Costello D, 2005, PEDIATRICS, V115, P997, DOI 10.1542/peds.2004-0221; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	44	343	354	4	66	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2013	309	17					1810	1820		10.1001/jama.2013.3786	http://dx.doi.org/10.1001/jama.2013.3786			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134SU	23632725	Bronze			2022-12-28	WOS:000318235600029
J	Spence, D				Spence, Des			Bad medicine: the way we manage diabetes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INSULIN					destwo@yahoo.co.uk						Black C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004654.pub2; Cohen D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c7139; Davidson MB, 2005, DIABETES CARE, V28, P1531, DOI 10.2337/diacare.28.6.1531; Gale EAM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3974; Health and Social Care Information Centre, 2013, PRESCR COST AN ENGL; Hemmingsen B, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008143.pub2; Horvath K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005613.pub3; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; National Institute for Health and Care Excellence (NICE), 2013, BLOOD GLUC LOW THER; Ooi CP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009361.pub2; Richter B, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006063; Shyangdan DS, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006423.pub2; Singh S, 2013, JAMA INTERN MED, V173, P534, DOI 10.1001/jamainternmed.2013.2720; Van de Laar FA, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003639.pub2	14	5	5	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2013	346								f2695	10.1136/bmj.f2695	http://dx.doi.org/10.1136/bmj.f2695			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139DK	23628877				2022-12-28	WOS:000318561600006
J	van de Waal, E; Borgeaud, C; Whiten, A				van de Waal, Erica; Borgeaud, Christele; Whiten, Andrew			Potent Social Learning and Conformity Shape a Wild Primate's Foraging Decisions	SCIENCE			English	Article							CULTURE; TRANSMISSION; EVOLUTION; CHIMPANZEES; INFORMATION; DIFFUSION; INSIGHTS	Conformity to local behavioral norms reflects the pervading role of culture in human life. Laboratory experiments have begun to suggest a role for conformity in animal social learning, but evidence from the wild remains circumstantial. Here, we show experimentally that wild vervet monkeys will abandon personal foraging preferences in favor of group norms new to them. Groups first learned to avoid the bitter-tasting alternative of two foods. Presentations of these options untreated months later revealed that all new infants naive to the foods adopted maternal preferences. Males who migrated between groups where the alternative food was eaten switched to the new local norm. Such powerful effects of social learning represent a more potent force than hitherto recognized in shaping group differences among wild animals.	[van de Waal, Erica; Whiten, Andrew] Univ St Andrews, Sch Psychol & Neurosci, Ctr Social Learning & Cognit Evolut, St Andrews KY16 9JP, Fife, Scotland; [van de Waal, Erica; Whiten, Andrew] Univ St Andrews, Sch Psychol & Neurosci, Scottish Primate Res Grp, St Andrews KY16 9JP, Fife, Scotland; [van de Waal, Erica; Borgeaud, Christele; Whiten, Andrew] Mawana Game Reserve, Inkawu Vervet Project, ZA-3115 Swart Mfolozi, KwaZulu Natal, South Africa; [Borgeaud, Christele] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland	University of St Andrews; University of St Andrews; University of Neuchatel	Whiten, A (corresponding author), Univ St Andrews, Sch Psychol & Neurosci, Ctr Social Learning & Cognit Evolut, St Andrews KY16 9JP, Fife, Scotland.	aw2@st-andrews.ac.uk		van de Waal, Erica/0000-0001-7778-418X; Whiten, Andrew/0000-0003-2426-5890	Swiss National Science Foundation [CRSI33_133040]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This project was supported by a Sinergia grant (CRSI33_133040) from the Swiss National Science Foundation to R. Bshary, C. P. van Schaik, and A. W. We are grateful to K. van der Walt for permission to conduct the study in his reserve and A. Driescher for support in the field. The study was registered with Ezemvelo KZN Wildlife in South Africa and gained approval from the Ethics Committee of the School of Psychology and Neuroscience, University of St Andrews. We are grateful to J. Arsenau, A. Brotz, S. Delley, K. Gordon, M. Mignini, Z. Mills, S. Salcedo, T. Sharky, A. Taucher, K. Vega, L. Violetti, and J. Watzek for assistance in data collection during experimental trials. We thank C. van Schaik, R. Bshary, N. Claidiere, and E. Willems for comments on the manuscript. All data are publically available in the supplementary materials.	ASCH SE, 1956, PSYCHOL MONOGR, V70, P1, DOI 10.1037/h0093718; Battesti M, 2012, CURR BIOL, V22, P309, DOI 10.1016/j.cub.2011.12.050; Claidiere N, 2012, PSYCHOL BULL, V138, P126, DOI 10.1037/a0025868; Dean LG, 2012, SCIENCE, V335, P1114, DOI 10.1126/science.1213969; Dindo M, 2008, P ROY SOC B-BIOL SCI, V275, P187, DOI 10.1098/rspb.2007.1318; Galef BG, 2008, ANIM BEHAV, V75, P2035, DOI 10.1016/j.anbehav.2007.11.012; Haun DBM, 2012, CURR BIOL, V22, P727, DOI 10.1016/j.cub.2012.03.006; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; HINDE R. A., 1951, British Birds, V44, P393; Hopper LM, 2011, ANIM BEHAV, V81, P1195, DOI 10.1016/j.anbehav.2011.03.002; Kawamura S., 1959, Primates, V2, P43, DOI 10.1007/BF01666110; Kendal RL, 2010, LEARN BEHAV, V38, P220, DOI 10.3758/LB.38.3.220; Kendal RL, 2010, LEARN BEHAV, V38, P187, DOI 10.3758/LB.38.3.187; Laland KN, 2011, PHILOS T R SOC B, V366, P958, DOI 10.1098/rstb.2010.0328; Pagel M, 2012, NATURE, V482, P297, DOI 10.1038/482297a; Perry S, 2009, ANIM COGN, V12, P705, DOI 10.1007/s10071-009-0230-3; Pike TW, 2010, BIOL LETTERS, V6, P466, DOI 10.1098/rsbl.2009.1014; Rendell L, 2010, SCIENCE, V328, P208, DOI 10.1126/science.1184719; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Rendell L, 2001, BEHAV BRAIN SCI, V24, P324, DOI DOI 10.1017/S0140525X0100396X; Richerson P. J, 2005, NOT GENES ALONE; Schnoell AV, 2012, ANIM COGN, V15, P505, DOI 10.1007/s10071-012-0477-y; Slagsvold T, 2011, PHILOS T R SOC B, V366, P969, DOI 10.1098/rstb.2010.0343; Thornton A, 2011, PHILOS T R SOC B, V366, P978, DOI 10.1098/rstb.2010.0312; Thornton A, 2009, ANIM BEHAV, V78, P255, DOI 10.1016/j.anbehav.2009.04.021; van de Waal E, 2010, P ROY SOC B-BIOL SCI, V277, P2105, DOI 10.1098/rspb.2009.2260; van Schaik CP, 2012, CURR BIOL, V22, pR402, DOI 10.1016/j.cub.2012.04.001; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 2005, NATURE, V437, P52, DOI 10.1038/nature04023; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2008, PHILOS T R SOC B, V363, P3477, DOI 10.1098/rstb.2008.0134; Whiten A, 2007, CURR BIOL, V17, P1038, DOI 10.1016/j.cub.2007.05.031; Whiten A, 2011, PHILOS T R SOC B, V366, P938, DOI 10.1098/rstb.2010.0372	34	250	251	10	216	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					483	485		10.1126/science.1232769	http://dx.doi.org/10.1126/science.1232769			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620053				2022-12-28	WOS:000318016700043
J	Cobb, M				Cobb, Matthew			1953: When Genes Became "Information"	CELL			English	Editorial Material								In 1953, Watson and Crick not only described the double-helix structure of DNA, but also embraced the idea that genes contained a code that expresses information and thereby changed our view of life. This article traces how these ideas entered biological thinking and highlights the connections between different branches of science at the time, exploring the power of metaphor in science.	Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Cobb, M (corresponding author), Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.	cobb@manchester.ac.uk						CHARGAFF E, 1950, EXPERIENTIA, V6, P201, DOI 10.1007/BF02173653; CHARGAFF E, 1947, COLD SPRING HARB SYM, V12, P28, DOI 10.1101/SQB.1947.012.01.006; EPHRUSSI B, 1953, NATURE, V171, P701, DOI 10.1038/171701a0; Gleick James, 2011, NY TIMES BK REV; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; KALMUS H, 1950, J HERED, V41, P19, DOI 10.1093/oxfordjournals.jhered.a106044; Kay L. E., 2000, WHO WROTE BOOK LIFE; Kay LE, 1995, SCI CONTEXT, V8, P609, DOI 10.1017/S0269889700002210; Pauling L, 1987, SCHRODINGER CENTENAR, P225; Schrodinger E, 1944, WHAT IS LIFE; STERN KG, 1947, YALE J BIOL MED, V19, P937; Watson J.D., 2012, ANNOTATED ILLUSTRATE; WATSON JD, 1953, NATURE, V171, P964, DOI 10.1038/171964b0; WATSON JD, 2001, GENES GIRLS GAMOW; Yoxen E J, 1979, Hist Sci, V17, P17	15	17	18	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 25	2013	153	3					503	506		10.1016/j.cell.2013.04.012	http://dx.doi.org/10.1016/j.cell.2013.04.012			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622233	Bronze			2022-12-28	WOS:000318063500001
J	Li, SB; Liu, L; Zhuang, XH; Yu, Y; Liu, XG; Cui, X; Ji, LJ; Pan, ZQ; Cao, XF; Mo, BX; Zhang, FC; Raikhel, N; Jiang, LW; Chen, XM				Li, Shengben; Liu, Lin; Zhuang, Xiaohong; Yu, Yu; Liu, Xigang; Cui, Xia; Ji, Lijuan; Pan, Zhiqiang; Cao, Xiaofeng; Mo, Beixin; Zhang, Fuchun; Raikhel, Natasha; Jiang, Liwen; Chen, Xuemei			MicroRNAs Inhibit the Translation of Target mRNAs on the Endoplasmic Reticulum in Arabidopsis	CELL			English	Article							TRANS-ACTING SIRNAS; DECAPPING COMPLEX; FREE POLYSOMES; GENE; PROTEIN; REPRESSION; MUTATIONS; AMP1; COMPONENTS; ARGONAUTE1	Translation inhibition is a major but poorly understood mode of action of microRNAs (miRNAs) in plants and animals. In particular, the subcellular location where this process takes place is unknown. Here, we show that the translation inhibition, but not the mRNA cleavage activity, of Arabidopsis miRNAs requires ALTERED MERISTEM PROGRAM1 (AMP1). AMP1 encodes an integral membrane protein associated with endoplasmic reticulum (ER) and ARGONAUTE1, the miRNA effector and a peripheral ER membrane protein. Large differences in polysome association of miRNA target RNAs are found between wild-type and the amp1 mutant for membrane-bound, but not total, polysomes. This, together with AMP1-independent recruitment of miRNA target transcripts to membrane fractions, shows that miRNAs inhibit the translation of target RNAs on the ER. This study demonstrates that translation inhibition is an important activity of plant miRNAs, reveals the subcellular location of this activity, and uncovers a previously unknown function of the ER.	[Li, Shengben; Liu, Lin; Yu, Yu; Liu, Xigang; Ji, Lijuan; Raikhel, Natasha; Chen, Xuemei] Univ Calif Riverside, Dept Bot & Plant Sci, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Chen, Xuemei] Univ Calif Riverside, Howard Hughes Med Inst, Riverside, CA 92521 USA; [Liu, Lin; Zhang, Fuchun] Xinjiang Univ, Coll Life Sci & Technol, Xinjiang Key Lab Biol Resources & Genet Engn, Urumqi 830046, Peoples R China; [Zhuang, Xiaohong; Jiang, Liwen] Chinese Univ Hong Kong, Sch Life Sci, Ctr Cell & Dev Biol, Shatin, Hong Kong, Peoples R China; [Yu, Yu; Mo, Beixin] Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Microbial Genet Engn, Shenzhen 518060, Peoples R China; [Cui, Xia; Cao, Xiaofeng] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China; [Pan, Zhiqiang] Univ Mississippi, ARS, USDA, University, MS 38677 USA	University of California System; University of California Riverside; Howard Hughes Medical Institute; University of California System; University of California Riverside; Xinjiang University; Chinese University of Hong Kong; Shenzhen University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; United States Department of Agriculture (USDA); University of Mississippi	Chen, XM (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Inst Integrat Genome Biol, Riverside, CA 92521 USA.	xuemei.chen@ucr.edu	ZHUANG, Xiaohong/J-3915-2014; JIANG, Liwen/S-6046-2018	ZHUANG, Xiaohong/0000-0002-2480-8210; JIANG, Liwen/0000-0002-7829-1472; Ji, Lijuan/0000-0003-0678-6131; Chen, Xuemei/0000-0002-5209-1157	National Institutes of Health [GM061146]; Howard Hughes Medical Institute; Gordon and Betty Moore Foundation [GBMF3046]; Research Grants Council of Hong Kong [CUHK466610, CUHK466011, CUHK2/CRF/11G]; National Science Foundation of China; China Scholarship Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Research Grants Council of Hong Kong(Hong Kong Research Grants Council); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Dr. Julia Bailey-Serres for technical advice on polysome profiling. We thank Drs. Kathryn Barton, Nam-Hai Chua, Daniel Kleibenstein, Elliot Meyerowitz, and Zhiyong Wang for sharing plasmids, seeds, or antibodies. We thank Julia Bailey-Serres, Theresa Dinh, Elizabeth Luscher, Kestrel Rogers, and Yuanyuan Zhao for comments on the manuscript. The work was funded by National Institutes of Health (GM061146) and by Howard Hughes Medical Institute and Gordon and Betty Moore Foundation (through Grant GBMF3046) to X.Chen, by the Research Grants Council of Hong Kong (CUHK466610, CUHK466011, and CUHK2/CRF/11G) to L.J., and by National Science Foundation of China to X. Cao and B.M. L.L. was supported by a fellowship from China Scholarship Council.	Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; BIRCKBICHLER PJ, 1973, EUR J BIOCHEM, V33, P368, DOI 10.1111/j.1432-1033.1973.tb02692.x; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Brodersen P, 2012, P NATL ACAD SCI USA, V109, P1778, DOI 10.1073/pnas.1112500109; Carbonell A, 2012, PLANT CELL, V24, P3613, DOI 10.1105/tpc.112.099945; CHAUDHURY AM, 1993, PLANT J, V4, P907, DOI 10.1046/j.1365-313X.1993.04060907.x; Chen J, 2004, PLANT CELL, V16, P1302, DOI 10.1105/tpc.018986; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Cikaluk DE, 1999, MOL BIOL CELL, V10, P3357, DOI 10.1091/mbc.10.10.3357; Conway LJ, 1997, P NATL ACAD SCI USA, V94, P10209, DOI 10.1073/pnas.94.19.10209; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fukaya T, 2012, MOL CELL, V48, P825, DOI 10.1016/j.molcel.2012.09.024; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Gibbings D, 2012, NAT CELL BIOL, V14, P1314, DOI 10.1038/ncb2611; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Goeres DC, 2007, PLANT CELL, V19, P1549, DOI 10.1105/tpc.106.047621; Helliwell CA, 2001, PLANT CELL, V13, P2115, DOI 10.1105/tpc.13.9.2115; HOU YM, 1993, PLANT CELL, V5, P329, DOI 10.1105/tpc.5.3.329; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; JURGENS G, 1991, DEVELOPMENT, P27; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kraut-Cohen J, 2010, TRENDS BIOCHEM SCI, V35, P459, DOI 10.1016/j.tibs.2010.02.006; Lanet E, 2009, PLANT CELL, V21, P1762, DOI 10.1105/tpc.108.063412; Lee BH, 2009, J MICROBIOL BIOTECHN, V19, P542, DOI 10.4014/jmb.0901.0082; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Lerner RS, 2003, RNA, V9, P1123, DOI 10.1261/rna.5610403; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Mordhorst AP, 1998, GENETICS, V149, P549; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Mustroph A, 2009, METHODS MOL BIOL, V553, P109, DOI 10.1007/978-1-60327-563-7_6; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; NOLL M, 1974, J MOL BIOL, V90, P215, DOI 10.1016/0022-2836(74)90369-6; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Reid DW, 2012, J BIOL CHEM, V287, P5518, DOI 10.1074/jbc.M111.312280; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; SCHWARTZ BW, 1994, DEVELOPMENT, V120, P3235; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vidaurre DP, 2007, DEVELOPMENT, V134, P2561, DOI 10.1242/dev.006759; Won S.Y., 2012, SILENCE, V3, DOI [10.1186/1758-907X-3-6, DOI 10.1186/1758-907X-3-6]; Xu J, 2006, PLANT CELL, V18, P3386, DOI 10.1105/tpc.106.047605; Yang L, 2012, P NATL ACAD SCI USA, V109, P315, DOI 10.1073/pnas.1114673109	56	326	349	11	230	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 25	2013	153	3					562	574		10.1016/j.cell.2013.04.005	http://dx.doi.org/10.1016/j.cell.2013.04.005			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622241	Bronze, Green Accepted			2022-12-28	WOS:000318063500010
J	Osotimehin, B				Osotimehin, Babatunde			A breakthrough for the health and rights of women and girls	LANCET			English	Editorial Material									UNFPA, United Nations Populat Fund, New York, NY 10158 USA	United Nations Population Fund	Osotimehin, B (corresponding author), UNFPA, United Nations Populat Fund, New York, NY 10158 USA.	dungus@unfpa.org						[Anonymous], CONVENTION ON THE EL; [Anonymous], 2009, UNFPA STRATEGY AND F; United Nations, 1995, REPORT OF THE INTERN; United Nations Economic and Social Council, 2013, THE ELIMINATION AND	4	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 13	2013	382	9887					110	111		10.1016/S0140-6736(13)60848-X	http://dx.doi.org/10.1016/S0140-6736(13)60848-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	187JY	23683602				2022-12-28	WOS:000322115300008
J	Underwood, M; Lamb, SE; Eldridge, S; Sheehan, B; Slowther, AM; Spencer, A; Thorogood, M; Atherton, N; Bremner, SA; Devine, A; Diaz-Ordaz, K; Ellard, DR; Potter, R; Spanjers, K; Taylor, SJC				Underwood, Martin; Lamb, Sarah E.; Eldridge, Sandra; Sheehan, Bart; Slowther, Anne-Marie; Spencer, Anne; Thorogood, Margaret; Atherton, Nicky; Bremner, Stephen A.; Devine, Angela; Diaz-Ordaz, Karla; Ellard, David R.; Potter, Rachel; Spanjers, Kathleen; Taylor, Stephanie J. C.			Exercise for depression in elderly residents of care homes: a cluster-randomised controlled trial	LANCET			English	Article								Background Depression is common and is associated with poor outcomes among elderly care-home residents. Exercise is a promising low-risk intervention for depression in this population. We tested the hypothesis that a moderate intensity exercise programme would reduce the burden of depressive symptoms in residents of care homes. Methods We did a cluster-randomised controlled trial in care homes in two regions in England; northeast London, and Coventry and Warwickshire. Residents aged 65 years or older were eligible for inclusion. A statistician independent of the study randomised each home (1 to 1.5 ratio, stratified by location, minimised by type of home provider [ local authority, voluntary, private and care home, private and nursing home] and size of home [<32 or >= 32 residents]) into intervention and control groups. The intervention package included depression awareness training for care-home staff, 45 min physiotherapist-led group exercise sessions for residents (delivered twice weekly), and a whole home component designed to encourage more physical activity in daily life. The control consisted of only the depression awareness training. Researchers collecting follow-up data from individual participants and the participants themselves were inevitably aware of home randomisation because of the physiotherapists' activities within the home. A researcher masked to study allocation coded NHS routine data. The primary outcome was number of depressive symptoms on the geriatric depression scale-15 (GDS-15). Follow-up was for 12 months. This trial is registered with ISRCTN Register, number ISRCTN43769277. Findings Care homes were randomised between Dec 15, 2008, and April 9, 2010. At randomisation, 891 individuals in 78 care homes (35 intervention, 43 control) had provided baseline data. We delivered 3191 group exercise sessions attended on average by five study participants and five non-study residents. Of residents with a GDS-15 score, 374 of 765 (49%) were depressed at baseline; 484 of 765 (63%) provided 12 month follow-up scores. Overall the GDS-15 score was 0.13 (95% CI -0.33 to 0.60) points higher (worse) at 12 months for the intervention group compared with the control group. Among residents depressed at baseline, GDS-15 score was 0.22 (95% CI -0.52 to 0.95) points higher at 6 months in the intervention group than in the control group. In an end of study cross-sectional analysis, including 132 additional residents joining after randomisation, the odds of being depressed were 0.76 (95% CI 0.53 to 1.09) for the intervention group compared with the control group. Interpretation This moderately intense exercise programme did not reduce depressive symptoms in residents of care homes. In this frail population, alternative strategies to manage psychological symptoms are required.	[Underwood, Martin; Lamb, Sarah E.; Slowther, Anne-Marie; Atherton, Nicky; Ellard, David R.; Potter, Rachel; Spanjers, Kathleen] Univ Warwick, Warwick Med Sch, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; [Thorogood, Margaret] Univ Warwick, Warwick Med Sch, Div Hlth Sci, Coventry CV4 7AL, W Midlands, England; [Sheehan, Bart] Univ Warwick, Warwick Med Sch, Div Mental Hlth & Wellbeing, Coventry CV4 7AL, W Midlands, England; [Eldridge, Sandra; Bremner, Stephen A.; Devine, Angela; Diaz-Ordaz, Karla; Taylor, Stephanie J. C.] Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England; [Spencer, Anne] Univ Exeter, Sch Med, Exeter, Devon, England	University of Warwick; University of Warwick; University of Warwick; University of London; Queen Mary University London; University of Exeter	Underwood, M (corresponding author), Univ Warwick, Div Hlth Sci, Warwick Med Sch, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England.	m.underwood@warwick.ac.uk	TAYLOR, STEPHANIE/GYV-4768-2022; Bremner, Stephen/R-4038-2016; Underwood, Martin/D-6364-2015; Devine, Angela/A-6295-2012	Bremner, Stephen/0000-0003-0790-7070; Underwood, Martin/0000-0002-0309-1708; Devine, Angela/0000-0002-3321-8706; Eldridge, Sandra/0000-0001-5638-2317; Lamb, Sarah/0000-0003-4349-7195; Spencer, Anne/0000-0002-8163-3103; DiazOrdaz, Karla/0000-0003-3155-1561; Ellard, David/0000-0002-2992-048X; Taylor, Stephanie/0000-0001-7454-6354	National Institute for Health Research Health Technology Assessment; National Institute for Health Research [NF-SI-0512-10103, 06/02/01] Funding Source: researchfish	National Institute for Health Research Health Technology Assessment; National Institute for Health Research(National Institute for Health Research (NIHR))	National Institute for Health Research Health Technology Assessment.		0	77	82	0	66	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 6	2013	382	9886					41	49		10.1016/S0140-6736(13)60649-2	http://dx.doi.org/10.1016/S0140-6736(13)60649-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177AD	23643112	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000321347000027
J	Sathar, ZA				Sathar, Zeba A.			Family planning: a missing priority in Pakistan's health sector?	LANCET			English	Editorial Material									Populat Council Pakistan, Islamabad 44000, Pakistan		Sathar, ZA (corresponding author), Populat Council Pakistan, Islamabad 44000, Pakistan.	zsathar@popcouncil.org						Bloom D, 2012, INVEST FAMILY PLANNI; Bongaarts J., 2012, FAMILY PLANNING PROG; Bongaarts J, 2013, CAPTURING DEMOGRAPHI; Canning D, 2012, LANCET, V380, P165, DOI 10.1016/S0140-6736(12)60827-7; Ezeh AC, 2012, LANCET, V380, P142, DOI 10.1016/S0140-6736(12)60696-5; Mahmood A., 2012, BIRTH SPACING FAMILY; Population Council, 2009, EX FERT CHANG ITS IM, P66; Population Council, 2012, FAM PLANN IMP PAK DE; Sathar Z, 201107 UN DEP EC SOC; Sathar Z, 2012, STATUS FAMILY PLANNI	10	11	11	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 22	2013	381	9884					2140	2141		10.1016/S0140-6736(13)60763-1	http://dx.doi.org/10.1016/S0140-6736(13)60763-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171KH	23684258				2022-12-28	WOS:000320925600007
J	Thompson, JD; Tiecke, TG; de Leon, NP; Feist, J; Akimov, AV; Gullans, M; Zibrov, AS; Vuletic, V; Lukin, MD				Thompson, J. D.; Tiecke, T. G.; de Leon, N. P.; Feist, J.; Akimov, A. V.; Gullans, M.; Zibrov, A. S.; Vuletic, V.; Lukin, M. D.			Coupling a Single Trapped Atom to a Nanoscale Optical Cavity	SCIENCE			English	Article								Hybrid quantum devices, in which dissimilar quantum systems are combined in order to attain qualities not available with either system alone, may enable far-reaching control in quantum measurement, sensing, and information processing. A paradigmatic example is trapped ultracold atoms, which offer excellent quantum coherent properties, coupled to nanoscale solid-state systems, which allow for strong interactions. We demonstrate a deterministic interface between a single trapped rubidium atom and a nanoscale photonic crystal cavity. Precise control over the atom's position allows us to probe the cavity near-field with a resolution below the diffraction limit and to observe large atom-photon coupling. This approach may enable the realization of integrated, strongly coupled quantum nano-optical circuits.	[Thompson, J. D.; Tiecke, T. G.; de Leon, N. P.; Feist, J.; Akimov, A. V.; Gullans, M.; Zibrov, A. S.; Lukin, M. D.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Tiecke, T. G.; Vuletic, V.] Massachusetts Inst Technol MIT Harvard Ctr Ultrac, Dept Phys, Cambridge, MA 02139 USA; [Tiecke, T. G.; Vuletic, V.] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [de Leon, N. P.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Feist, J.] Harvard Smithsonian Ctr Astrophys, Inst Theoret Atom Mol & Opt Phys ITAMP, Cambridge, MA 02138 USA; [Akimov, A. V.] Russian Quantum Ctr, Skolkovo 143025, Moscow Region, Russia	Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Russian Quantum Center	Lukin, MD (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	lukin@physics.harvard.edu	Zibrov, Alexander S/G-7419-2014; Feist, Johannes/J-7394-2012; Akimov, Alexey/J-6385-2015; Vuletic, Vladan/M-8736-2019	Feist, Johannes/0000-0002-7972-0646; Akimov, Alexey/0000-0002-4167-5085; de Leon, Nathalie/0000-0003-1324-1412; Thompson, Jeff/0000-0001-8673-052X; Gullans, Michael/0000-0003-3974-2987	NSF [ECS-0335765]; Center for Ultracold Atoms; Defense Advanced Research Projects Agency (QUASAR program); Air Force Office of Scientific Research Multidisciplinary University Research Initiative; European Union project AQUTE; Packard Foundation; Fannie and John Hertz Foundation; NSF Graduate Research Fellowship Program; NSF through ITAMP	NSF(National Science Foundation (NSF)); Center for Ultracold Atoms; Defense Advanced Research Projects Agency (QUASAR program)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Air Force Office of Scientific Research Multidisciplinary University Research Initiative(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); European Union project AQUTE; Packard Foundation(The David & Lucile Packard Foundation); Fannie and John Hertz Foundation; NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); NSF through ITAMP(National Science Foundation (NSF))	We acknowledge helpful discussions with O. Painter, D. Chang, M. Loncar, Q. Quan, E. Kuznetsova, S. Yelin, H. Park, and M. Greiner. Financial support was provided by the NSF, the Center for Ultracold Atoms, the Defense Advanced Research Projects Agency (QUASAR program), the Air Force Office of Scientific Research Multidisciplinary University Research Initiative, European Union project AQUTE, and the Packard Foundation. J.D.T. acknowledges support from the Fannie and John Hertz Foundation and the NSF Graduate Research Fellowship Program, N.P.d.L. acknowledges an Element Six postdoctoral fellowship, and J.F. acknowledges a grant from the NSF through ITAMP. This work was performed in part at the Center for Nanoscale Systems (CNS), a member of the National Nanotechnology Infrastructure Network, which is supported by NSF award ECS-0335765. CNS is part of Harvard University.	Andre A, 2006, NAT PHYS, V2, P636, DOI 10.1038/nphys386; Bakr WS, 2009, NATURE, V462, P74, DOI 10.1038/nature08482; Beugnon J, 2007, NAT PHYS, V3, P696, DOI 10.1038/nphys698; Chang DE, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.123004; Chang DE, 2007, NAT PHYS, V3, P807, DOI 10.1038/nphys708; Cornelussen RA, 2002, EUR PHYS J D, V21, P347, DOI 10.1140/epjd/e2002-00205-1; Dayan B, 2008, SCIENCE, V319, P1062, DOI 10.1126/science.1152261; Dotsenko I, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.033002; Eichenfield M, 2009, NATURE, V459, P550, DOI 10.1038/nature08061; Foresi JS, 1997, NATURE, V390, P143, DOI 10.1038/36514; Fushman I, 2008, SCIENCE, V320, P769, DOI 10.1126/science.1154643; Gehr R, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.203602; Goban A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.033603; Greentree AD, 2006, NAT PHYS, V2, P856, DOI 10.1038/nphys466; Gullans M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.235309; Hartmann MJ, 2006, NAT PHYS, V2, P849, DOI 10.1038/nphys462; Hennessy K, 2007, NATURE, V445, P896, DOI 10.1038/nature05586; Hijlkema M, 2007, NAT PHYS, V3, P253, DOI 10.1038/nphys569; Hung C. L., 2013, TRAPPED ATOMS ONE DI; Hunger D, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.143002; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Lev B, 2004, NANOTECHNOLOGY, V15, pS556, DOI 10.1088/0957-4484/15/10/010; Lin YJ, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.050404; Monroe C, 2008, PHYS WORLD, V21, P32; Nolleke C, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.140403; Romero-Isart O., 2013, SUPERCONDUCTING VORT; Schlosser N, 2001, NATURE, V411, P1024, DOI 10.1038/35082512; Thompson JD, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.133001; Vetsch E, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.203603; Wallquist M, 2009, PHYS SCRIPTA, VT137, DOI 10.1088/0031-8949/2009/T137/014001	30	342	346	3	218	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 7	2013	340	6137					1202	1205		10.1126/science.1237125	http://dx.doi.org/10.1126/science.1237125			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158LP	23618764	Green Submitted			2022-12-28	WOS:000319972800041
J	Kim, J; Xiao, H; Bonanno, JB; Kalyanaraman, C; Brown, S; Tang, XY; Al-Obaidi, NF; Patskovsky, Y; Babbitt, PC; Jacobson, MP; Lee, YS; Almo, SC				Kim, Jungwook; Xiao, Hui; Bonanno, Jeffrey B.; Kalyanaraman, Chakrapani; Brown, Shoshana; Tang, Xiangying; Al-Obaidi, Nawar F.; Patskovsky, Yury; Babbitt, Patricia C.; Jacobson, Matthew P.; Lee, Young-Sam; Almo, Steven C.			Structure-guided discovery of the metabolite carboxy-SAM that modulates tRNA function	NATURE			English	Article							URIDINE-5-OXYACETIC ACID; CHORISMIC ACID; METHYLTRANSFERASE; DATABASE; MODEL; DNA; PREPHENATE; REVEALS; ENZYME; TIME	The identification of novel metabolites and the characterization of their biological functions are major challenges in biology. X-ray crystallography can reveal unanticipated ligands that persist through purification and crystallization. These adventitious protein-ligand complexes provide insights into new activities, pathways and regulatory mechanisms. We describe a new metabolite, carboxy-S-adenosyl-L-methionine (Cx-SAM), its biosynthetic pathway and its role in transfer RNA modification. The structure of CmoA, a member of the SAM-dependent methyltransferase superfamily, revealed a ligand consistent with Cx-SAM in the catalytic site. Mechanistic analyses showed an unprecedented role for prephenate as the carboxyl donor and the involvement of a unique ylide intermediate as the carboxyl acceptor in the CmoA-mediated conversion of SAM to Cx-SAM. A second member of the SAM-dependent methyltransferase superfamily, CmoB, recognizes Cx-SAM and acts as a carboxymethyltransferase to convert 5-hydroxyuridine into 5-oxyacetyl uridine at the wobble position of multiple tRNAs in Gram-negative bacteria(1), resulting in expanded codon-recognition properties(2,3). CmoA and CmoB represent the first documented synthase and transferase for Cx-SAM. These findings reveal new functional diversity in the SAM-dependent methyltransferase superfamily and expand the metabolic and biological contributions of SAM-based biochemistry. These discoveries highlight the value of structural genomics approaches in identifying ligands within the context of their physiologically relevant macromolecular binding partners, and in revealing their functions.	[Kim, Jungwook; Bonanno, Jeffrey B.; Tang, Xiangying; Al-Obaidi, Nawar F.; Patskovsky, Yury; Almo, Steven C.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Xiao, Hui] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Kalyanaraman, Chakrapani; Jacobson, Matthew P.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Brown, Shoshana; Babbitt, Patricia C.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Lee, Young-Sam] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Almo, Steven C.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University; Yeshiva University; Albert Einstein College of Medicine	Kim, J (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA.	jungwook.kim@einstein.yu.edu; steve.almo@einstein.yu.edu	Kim, Jungwook/AAP-1322-2020; Jacobson, Matthew/Y-5161-2018	Kim, Jungwook/0000-0001-5213-9299; Jacobson, Matthew/0000-0001-6262-655X; Al Obaidi, Nawar/0000-0002-3659-9233	US National Institutes of Health [GM094662, GM093342]; Albert Einstein Cancer Center; National Institute of Biomedical Imaging and Bioengineering (NIBIB) [P30-EB-009998]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094662, U54GM093342] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein Cancer Center; National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Parker and C. T. Walsh for providing the Aerobacter aerogenes 62-1 strain. We are indebted to V. Schramm and J. Gerlt for critical discussions and reading of the manuscript. This work was supported by US National Institutes of Health grants GM094662 (to S. C. A.), GM093342 (to S. C. A., M. P. J. and P. C. B.) and the Albert Einstein Cancer Center. This publication was made possible by the Center for Synchrotron Biosciences grant P30-EB-009998 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB). Use of the National Synchrotron Light Source, Brookhaven National Laboratory, was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract no. DE-AC02-98CH10886.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Binda O, 2011, CHEMBIOCHEM, V12, P330, DOI 10.1002/cbic.201000433; BJORK GR, 1980, J MOL BIOL, V140, P391, DOI 10.1016/0022-2836(80)90391-5; BORDWELL FG, 1988, ACCOUNTS CHEM RES, V21, P456, DOI 10.1021/ar00156a004; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; CROSBY J, 1970, J CHEM SOC B, P671, DOI 10.1039/j29700000671; Czerwoniec A, 2009, NUCLEIC ACIDS RES, V37, pD118, DOI 10.1093/nar/gkn710; Dalhoff C, 2006, NAT CHEM BIOL, V2, P31, DOI 10.1038/nchembio754; Dalhoff C, 2006, NAT PROTOC, V1, P1879, DOI 10.1038/nprot.2006.253; DOPHEIDE TA, 1972, J BIOL CHEM, V247, P4447; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GIBSON F, 1964, BIOCHEM J, V90, P256, DOI 10.1042/bj0900256; HAGERVALL TG, 1990, J BACTERIOL, V172, P252, DOI 10.1128/JB.172.1.252-259.1990; Horowitz S, 2011, J BIOL CHEM, V286, P18658, DOI 10.1074/jbc.M111.232876; Kalyanaraman C, 2005, BIOCHEMISTRY-US, V44, P2059, DOI 10.1021/bi0481186; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; Lim K, 2001, PROTEINS, V45, P397, DOI 10.1002/prot.10004; Lorenz MA, 2011, ANAL CHEM, V83, P3406, DOI 10.1021/ac103313x; Luka Z, 2009, J BIOL CHEM, V284, P22507, DOI 10.1074/jbc.R109.019273; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nasvall SJ, 2007, RNA, V13, P2151, DOI 10.1261/rna.731007; Nasvall SJ, 2004, RNA, V10, P1662, DOI 10.1261/rna.7106404; Parker JB, 2012, BIOCHEMISTRY-US, V51, P3241, DOI 10.1021/bi300254u; Pegg SCH, 2006, BIOCHEMISTRY-US, V45, P2545, DOI 10.1021/bi052101l; Punta M., 2008, NUCLEIC ACIDS RES, V40, pD290; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Van Vleet J, 2010, BBA-PROTEINS PROTEOM, V1804, P752, DOI 10.1016/j.bbapap.2009.11.018; Vevodova J, 2004, J MOL BIOL, V344, P419, DOI 10.1016/j.jmb.2004.09.020; Weixlbaumer A, 2007, NAT STRUCT MOL BIOL, V14, P498, DOI 10.1038/nsmb1242	36	57	59	0	58	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 6	2013	498	7452					123	+		10.1038/nature12180	http://dx.doi.org/10.1038/nature12180			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158DC	23676670	Green Submitted, Green Accepted			2022-12-28	WOS:000319947800046
J	Kesselheim, AS; Robertson, CT; Siri, K; Batra, P; Franklin, JM				Kesselheim, Aaron S.; Robertson, Christopher T.; Siri, Kent; Batra, Puneet; Franklin, Jessica M.			Distributions of Industry Payments to Massachusetts Physicians	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kesselheim, Aaron S.; Franklin, Jessica M.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Kesselheim, Aaron S.; Franklin, Jessica M.] Harvard Univ, Sch Med, Boston, MA USA; [Siri, Kent; Batra, Puneet] Kyruus, Boston, MA USA; [Kesselheim, Aaron S.; Robertson, Christopher T.] Harvard Univ, Edmond J Safra Ctr Eth, Cambridge, MA 02138 USA; [Robertson, Christopher T.] Univ Arizona, James E Rogers Coll Law, Tucson, AZ USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; University of Arizona	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Franklin, Jessica/0000-0002-8941-4116				[Anonymous], 2012, KYRUUSONE BIG DAT PL; Campbell, 2010, ARCH INTERN MED, V170, P1966; Campbell EG, 2010, ARCH INTERN MED, V170, P1820, DOI 10.1001/archinternmed.2010.383; Chimonas S, 2010, HEALTH SERV RES, V45, P98, DOI 10.1111/j.1475-6773.2009.01048.x; Dana J, 2003, JAMA-J AM MED ASSOC, V290, P252, DOI 10.1001/jama.290.2.252; Massachusetts Department of Health and Human Services, DAT REP	6	40	41	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2013	368	22					2049	2052		10.1056/NEJMp1302723	http://dx.doi.org/10.1056/NEJMp1302723			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	153AT	23635021				2022-12-28	WOS:000319574200001
J	Xie, W; Schultz, MD; Lister, R; Hou, ZG; Rajagopal, N; Ray, P; Whitaker, JW; Tian, S; Hawkins, RD; Leung, D; Yang, HB; Wang, T; Lee, AY; Swanson, SA; Zhang, JC; Zhu, Y; Kim, A; Nery, JR; Urich, MA; Kuan, S; Yen, CA; Klugman, S; Yu, PZ; Suknuntha, K; Propson, NE; Chen, HM; Edsall, LE; Wagner, U; Li, Y; Ye, Z; Kulkarni, A; Xuan, ZY; Chung, WY; Chi, NC; Antosiewicz-Bourget, JE; Slukvin, I; Stewart, R; Zhang, MQ; Wang, W; Thomson, JA; Ecker, JR; Ren, B				Xie, Wei; Schultz, Matthew D.; Lister, Ryan; Hou, Zhonggang; Rajagopal, Nisha; Ray, Pradipta; Whitaker, John W.; Tian, Shulan; Hawkins, R. David; Leung, Danny; Yang, Hongbo; Wang, Tao; Lee, Ah Young; Swanson, Scott A.; Zhang, Jiuchun; Zhu, Yun; Kim, Audrey; Nery, Joseph R.; Urich, Mark A.; Kuan, Samantha; Yen, Chia-an; Klugman, Sarit; Yu, Pengzhi; Suknuntha, Kran; Propson, Nicholas E.; Chen, Huaming; Edsall, Lee E.; Wagner, Ulrich; Li, Yan; Ye, Zhen; Kulkarni, Ashwinikumar; Xuan, Zhenyu; Chung, Wen-Yu; Chi, Neil C.; Antosiewicz-Bourget, Jessica E.; Slukvin, Igor; Stewart, Ron; Zhang, Michael Q.; Wang, Wei; Thomson, James A.; Ecker, Joseph R.; Ren, Bing			Epigenomic Analysis of Multilineage Differentiation of Human Embryonic Stem Cells	CELL			English	Article							DNA METHYLATION; DEVELOPMENTAL REGULATORS; GENOME; CHROMATIN; MOUSE; PLURIPOTENT; POLYCOMB; STATE; GENES; METHYLOME	Epigenetic mechanisms have been proposed to play crucial roles in mammalian development, but their precise functions are only partially understood. To investigate epigenetic regulation of embryonic development, we differentiated human embryonic stem cells into mesendoderm, neural progenitor cells, trophoblast-like cells, and mesenchymal stem cells and systematically characterized DNA methylation, chromatin modifications, and the transcriptome in each lineage. We found that promoters that are active in early developmental stages tend to be CG rich and mainly engage H3K27me3 upon silencing in nonexpressing lineages. By contrast, promoters for genes expressed preferentially at later stages are often CG poor and primarily employ DNA methylation upon repression. Interestingly, the early developmental regulatory genes are often located in large genomic domains that are generally devoid of DNA methylation in most lineages, which we termed DNA methylation valleys (DMVs). Our results suggest that distinct epigenetic mechanisms regulate early and late stages of ES cell differentiation.	[Xie, Wei; Rajagopal, Nisha; Hawkins, R. David; Leung, Danny; Lee, Ah Young; Kim, Audrey; Kuan, Samantha; Yen, Chia-an; Klugman, Sarit; Edsall, Lee E.; Wagner, Ulrich; Li, Yan; Ye, Zhen; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Schultz, Matthew D.; Lister, Ryan; Nery, Joseph R.; Urich, Mark A.; Chen, Huaming; Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, Genom Anal Lab, La Jolla, CA 92037 USA; [Hou, Zhonggang; Tian, Shulan; Swanson, Scott A.; Zhang, Jiuchun; Yu, Pengzhi; Propson, Nicholas E.; Antosiewicz-Bourget, Jessica E.; Stewart, Ron; Thomson, James A.] Morgridge Inst Res, Madison, WI 53707 USA; [Whitaker, John W.; Wang, Tao; Zhu, Yun; Wang, Wei] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Inst Genom Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Wang, Wei] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Yang, Hongbo; Chi, Neil C.] Univ Calif San Diego, Dept Med, Div Cardiol, La Jolla, CA 92093 USA; [Zhang, Jiuchun; Slukvin, Igor] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; [Slukvin, Igor; Thomson, James A.] Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI 53715 USA; [Thomson, James A.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Ray, Pradipta; Kulkarni, Ashwinikumar; Xuan, Zhenyu; Chung, Wen-Yu; Zhang, Michael Q.] Univ Texas Dallas, Ctr Syst Biol, Dept Mol & Cell Biol, Richardson, TX 75080 USA; [Suknuntha, Kran; Slukvin, Igor] Univ Wisconsin, Sch Med, Dept Pathol & Lab Med, Madison, WI 53792 USA; [Zhang, Michael Q.] Tsinghua Univ, Tsinghua Natl Lab Informat Sci & Technol, Ctr Synthet & Syst Biol, Bioinformat Div, Beijing 100084, Peoples R China	Ludwig Institute for Cancer Research; Howard Hughes Medical Institute; Salk Institute; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Santa Barbara; University of Texas System; University of Texas Dallas; University of Wisconsin System; University of Wisconsin Madison; Tsinghua University	Thomson, JA (corresponding author), Morgridge Inst Res, Madison, WI 53707 USA.	jthomson@morgridgeinstitute.org; ecker@salk.edu; biren@ucsd.edu	Wang, Tao/E-5900-2015; Ecker, Joseph R/B-9144-2008; Kulkarni, Ashwinikumar/M-7057-2019; Lister, Ryan/B-5168-2012; Suknuntha, Kran/AAA-1777-2019; Xie, Wei/J-1380-2017; Zhang, Jiuchun/C-7021-2012; Nery, Joseph/AAE-8422-2019; Yu, Pengzhi/I-3182-2016	Wang, Tao/0000-0002-1646-6863; Ecker, Joseph R/0000-0001-5799-5895; Kulkarni, Ashwinikumar/0000-0003-0951-2427; Lister, Ryan/0000-0001-6637-7239; Suknuntha, Kran/0000-0002-6648-8235; Xie, Wei/0000-0003-2126-3849; Nery, Joseph/0000-0003-0153-5659; Xuan, Zhenyu/0000-0001-9344-8493; Edsall, Lee Elizabeth/0000-0002-0326-2829; Yu, Pengzhi/0000-0001-7637-404X; Ray, Pradipta/0000-0003-0931-4201; Whitaker, John W./0000-0002-0585-9119; Leung, Danny Chi Yeu/0000-0002-2472-894X; Chen, Huaming/0000-0001-5289-7882	NIH [U01 ES017166, R01 HG001696, P01 GM081629]; NSFC [91019016]; CIRM [RN2-00905-1]; NIH/NHLBI; American Heart Association [12POST12050080]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099773, U01HL107442] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081629] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007464] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC(National Natural Science Foundation of China (NSFC)); CIRM(California Institute for Regenerative Medicine); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by the NIH Epigenome Roadmap Project (U01 ES017166) and also in part by NSFC 91019016 and NIH R01 HG001696 (M.Q.Z.), NIH P01 GM081629 (J.A.T.), and CIRM RN2-00905-1 (B. R.). J.R.E. is a Howard Hughes Medical Institute and Gordon and Betty Moore Investigator. N. C. C. is funded by grants from the NIH/NHLBI. H. Y. is funded by grants from the American Heart Association (12POST12050080). We thank Drs. Tomek Swigut and Joanna Wysocka for sharing the zebrafish enhancer reporter vector. We thank Dr. John Stamatoyannopoulos for generating and providing access to the DNase-seq data sets. We also thank members of the Ren lab for helpful comments of the manuscript. B. R., J.A.T., J. R. E., W. W., and M. Q. Z. designed and supervised the research. Z. H., J. Z., P. Y., N. E. P., K. S., J. E. A.-B., and I. S. performed/supervised the H1 differentiation experiments. W. X., R. D. H., D. L., A. Y. L., A. K., S. Kuan, C. Y., and S. Klugman performed ChIP-seq experiments. R. L. and J. R. N. performed MethylC-seq experiments. M. A. U., Y. L., and Y. Z. performed RNA-seq experiments. H. Y. and N. C. C. performed/supervised the enhancer-reporter assay in zebrafish. W. X., M. D. S., N. R., P. R., J. W. W., S. T., T. W., S. A. S., Y. Z., R. L., H. C., L. E. E., U. W., A. K., Z. X., W. Y. C., and R. S. analyzed data. W. X., B. R., and R. S. prepared the manuscript. B. R., J. A. T., J. R. E., W. W., and M. Q. Z. are equally responsible for the analysis results. M. D. S., R. L., Z. H., N. R., P. R., J. W. W., S. T., R. D. H., and D. L. contributed equally to this work.	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Barrera LO, 2008, GENOME RES, V18, P46, DOI 10.1101/gr.6654808; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; CHANG C, 2011, FILM COMMENT, V47, P6, DOI DOI 10.1371/J0URNAL.P0NE.0022859; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Irizarry RA, 2009, MAMM GENOME, V20, P674, DOI 10.1007/s00335-009-9222-5; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Leung DC, 2012, TRENDS BIOCHEM SCI, V37, P127, DOI 10.1016/j.tibs.2011.11.006; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Molaro A, 2011, CELL, V146, P1028, DOI 10.1016/j.cell.2011.08.016; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Paige SL, 2012, CELL, V151, P221, DOI 10.1016/j.cell.2012.08.027; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rajagopal N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002968; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Vastenhouw NL, 2012, CURR OPIN CELL BIOL, V24, P374, DOI 10.1016/j.ceb.2012.03.009; Vodyanik MA, 2010, CELL STEM CELL, V7, P718, DOI 10.1016/j.stem.2010.11.011; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	57	510	521	12	137	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 23	2013	153	5					1134	1148		10.1016/j.cell.2013.04.022	http://dx.doi.org/10.1016/j.cell.2013.04.022			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23664764	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000319456800019
J	Darroch, JE; Singh, S				Darroch, Jacqueline E.; Singh, Susheela			Trends in contraceptive need and use in developing countries in 2003, 2008, and 2012: an analysis of national surveys	LANCET			English	Article								Background Data for trends in contraceptive use and need are necessary to guide programme and policy decisions and to monitor progress towards Millennium Development Goal 5, which calls for universal access to contraceptive services. We therefore aimed to estimate trends in contraceptive use and unmet need in developing countries in 2003, 2008, and 2012. Methods We obtained data from national surveys for married and unmarried women aged 15-49 years in regions and subregions of developing countries. We estimated trends in the numbers and proportions of women wanting to avoid pregnancy, according to whether they were using modern contraceptives, or had unmet need for modern methods (ie, using no methods or a traditional method). We used comparable data sources and methods for three reference years (2003, 2008, and 2012). National survey data were available for 81-98% of married women using and with unmet need for modern methods. Findings The number of women wanting to avoid pregnancy and therefore needing effective contraception increased substantially, from 716 million (54%) of 1321 million in 2003, to 827 million (57%) of 1448 million in 2008, to 867 million (57%) of 1520 million in 2012. Most of this increase (108 million) was attributable to population growth. Use of modern contraceptive methods also increased, and the overall proportion of women with unmet need for modern methods among those wanting to avoid pregnancy decreased from 29% (210 million) in 2003, to 26% (222 million) in 2012. However, unmet need for modern contraceptives was still very high in 2012, especially in sub-Saharan Africa (53 million [60%] of 89 million), south Asia (83 million [34%] of 246 million), and western Asia (14 million [50%] of 27 million). Moreover, a shift in the past decade away from sterilisation, the most effective method, towards injectable drugs and barrier methods, might have led to increases in unintended pregnancies in women using modern methods. Interpretation Achievement of the desired number and healthy timing of births has important benefits for women, families, and societies. To meet the unmet need for modern contraception, countries need to increase resources, improve access to contraceptive services and supplies, and provide high-quality services and large-scale public education interventions to reduce social barriers. Our findings confirm a substantial and unfinished agenda towards meeting of couples' reproductive needs.	[Darroch, Jacqueline E.; Singh, Susheela] Guttmacher Inst, New York, NY 10038 USA		Darroch, JE (corresponding author), Guttmacher Inst, New York, NY 10038 USA.	jedarroch@guttmacher.org			UK Department for International Development; Bill & Melinda Gates Foundation; UN Population Fund (UNFPA)	UK Department for International Development; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); UN Population Fund (UNFPA)	UK Department for International Development, the Bill & Melinda Gates Foundation, and the UN Population Fund (UNFPA).	Ametepi P, 2012, DHS ANAL STUD; [Anonymous], 2011, CONTRACEPTIVE TECHNO; [Anonymous], 2003, ADDING IT BENEFITS I; Bankole A, 1998, INT FAM PLAN PERSPEC, V24, P15, DOI 10.2307/2991915; Baschieri A, 2012, J BIOSOC SCI, V20, P1; Bill & Melinda Gates Foundation Department for International Development, 2012, LANDM SUMM FAM PLANN; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Croft TV, 2012, SPECIAL TABULATIONS; Darroch JE, 2013, CONTRACEPTION, V87, P259, DOI 10.1016/j.contraception.2012.08.029; Darroch JacquelineE., 2011, ADDING IT COSTS BENE; Darroch JacquelineE., 2011, CONTRACEPTIVE TECHNO; DFID and Bill and Melinda Gates Foundation, 2013, LOND SUMM FAM PLANN; FishelJoy D, 2012, DHS ANAL STUDIES, V25; International Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS FAC S; Lloyd Cynthia B., 2005, GROWING GLOBAL CHANG; Ross JA, 2002, INT FAM PLAN PERSPEC, V28, P138, DOI 10.2307/3088256; Save the Children, 2012, EV WOM RIGHT FAM PLA; Sedgh G., 2007, WOMEN UNMET NEED CON; Singh S, 2012, ADDING IT COSTS BENE; Singh S, 2009, ADDING IT COSTS BENE; The World Bank, GNI PER CAP ATL METH; UN Department of Economic and Social Affairs Population Division, 2006, LEV TRENDS CONTR US; United Nations Department of Economic and Social Affairs Population Division, 2011, WORLD CONTR US 2011; United Nations Statistics Division, 2009, COMP MACR CONT REG G; Vlassoff M., 2004, ASSESSING COSTS BENE; Westoff C., 2012, DHS ANAL STUDIES, V28; Westoff CF, 2010, DHS COMP REP, V25	27	177	179	0	27	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 18	2013	381	9879					1756	1762		10.1016/S0140-6736(13)60597-8	http://dx.doi.org/10.1016/S0140-6736(13)60597-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146TA	23683642				2022-12-28	WOS:000319112800040
J	Zaba, B; Calvert, C; Marston, M; Isingo, R; Nakiyingi-Miiro, J; Lutalo, T; Crampin, A; Robertson, L; Herbst, K; Newell, ML; Todd, J; Byass, P; Boerma, T; Ronsmans, C				Zaba, Basia; Calvert, Clara; Marston, Milly; Isingo, Raphael; Nakiyingi-Miiro, Jessica; Lutalo, Tom; Crampin, Amelia; Robertson, Laura; Herbst, Kobus; Newell, Marie-Louise; Todd, Jim; Byass, Peter; Boerma, Ties; Ronsmans, Carine			Effect of HIV infection on pregnancy-related mortality in sub-Saharan Africa: secondary analyses of pooled community-based data from the network for Analysing Longitudinal Population-based HIV/AIDS data on Africa (ALPHA)	LANCET			English	Article							RURAL RAKAI DISTRICT; MATERNAL MORTALITY; SEXUAL-BEHAVIOR; SOUTH-AFRICA; IMPACT; TRENDS; DEATH; PREVALENCE; ZIMBABWE; MALAWI	Background Model-based estimates of the global proportions of maternal deaths that are in HIV-infected women range from 7% to 21%, and the effects of HIV on the risk of maternal death is highly uncertain. We used longitudinal data from the Analysing Longitudinal Population-based HIV/AIDS data on Africa (ALPHA) network to estimate the excess mortality associated with HIV during pregnancy and the post-partum period in sub-Saharan Africa. Methods The ALPHA network pooled data gathered between June, 1989 and April, 2012 in six community-based studies in eastern and southern Africa with HIV serological surveillance and verbal-autopsy reporting. Deaths occurring during pregnancy and up to 42 days post partum were defined as pregnancy related. Pregnant or postpartum person-years were calculated for HIV-infected and HIV-uninfected women, and HIV-infected to HIV-uninfected mortality rate ratios and HIV-attributable rates were compared between pregnant or post-partum women and women who were not pregnant or post partum. Findings 138 074 women aged 15-49 years contributed 636 213 person-years of observation. 49 568 women had 86 963 pregnancies. 6760 of these women died, 235 of them during pregnancy or the post-partum period. Mean prevalence of HIV infection across all person-years in the pooled data was 17.2% (95% CI 17.0-17.3), but 60 of 118 (50.8%) of the women of known HIV status who died during pregnancy or post partum were HIV infected. The mortality rate ratio of HIV-infected to HIV-uninfected women was 20.5 (18.9-22.4) in women who were not pregnant or post partum and 8.2 (5.7-11.8) in pregnant or post-partum women. Excess mortality attributable to HIV was 51.8 (47.8-53.8) per 1000 person-years in women who were not pregnant or post partum and 11.8 (8.4-15.3) per 1000 person-years in pregnant or post-partum women. Interpretation HIV-infected pregnant or post-partum women had around eight times higher mortality than did their HIV-uninfected counterparts. On the basis of this estimate, we predict that roughly 24% of deaths in pregnant or post-partum women are attributable to HIV in sub-Saharan Africa, suggesting that safe motherhood programmes should pay special attention to the needs of HIV-infected pregnant or post-partum women.	[Zaba, Basia; Calvert, Clara; Marston, Milly; Crampin, Amelia; Todd, Jim; Ronsmans, Carine] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Isingo, Raphael] Natl Inst Med Res, Mwanza, Tanzania; [Nakiyingi-Miiro, Jessica] MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda; [Lutalo, Tom] Rakai Hlth Sci Program, Rakai, Uganda; [Crampin, Amelia] Karonga Prevent Study, Karonga, Malawi; [Robertson, Laura] Univ London Imperial Coll Sci Technol & Med, London, England; [Herbst, Kobus; Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Kwa Zulu, South Africa; [Byass, Peter] Umea Univ, Umea, Sweden; [Byass, Peter] INDEPTH Network, Accra, Ghana; [Boerma, Ties] WHO, CH-1211 Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research; Rakai Health Sciences Program; Malawi Epidemiology and Intervention Research Unit; Imperial College London; University of Kwazulu Natal; Umea University; INDEPTH Network; World Health Organization	Zaba, B (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	basia.zaba@lshtm.ac.uk	Newell, Marie-Louise/AAE-8222-2019; Herbst, Abraham J/E-4848-2010	Newell, Marie-Louise/0000-0002-1074-7699; Herbst, Abraham J/0000-0002-5436-9386; Todd, Jim/0000-0001-5918-4914; Crampin, Amelia/0000-0002-1513-4330; Byass, Peter/0000-0001-5474-4361	ALPHA Network; Wellcome Trust; Global Fund to Fight AIDS, Tuberculosis and Malaria; US National Institutes of Health; UK Medical Research Council; Health Metrics Network (WHO); Economic and Social Research Council; Economic and Social Research Council [1081714] Funding Source: researchfish	ALPHA Network; Wellcome Trust(Wellcome TrustEuropean Commission); Global Fund to Fight AIDS, Tuberculosis and Malaria; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health Metrics Network (WHO); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	All authors received travel grants through the ALPHA Network to attend short workshops hosted at the study sites, at which they prepared and analysed the data and discussed the provisional results. We declare that we have no conflicts of interest.; The ALPHA network is funded by the Wellcome Trust. The six study sites contributing data (the ALPHA network members) are funded by the Wellcome Trust, Global Fund to Fight AIDS, Tuberculosis and Malaria, US National Institutes of Health, and UK Medical Research Council. Workshops at which the data were collated, cleaned, and analysed were funded by the Health Metrics Network (WHO). CC was supported by an Economic and Social Research Council PhD fellowship.	Ahmed Y, 1999, INT J TUBERC LUNG D, V3, P675; Baiden F, 2007, B WORLD HEALTH ORGAN, V85, P570, DOI 10.2471/BLT.07.043745; Bicego G, 2002, AIDS, V16, P1078, DOI 10.1097/00002030-200205030-00019; Black V, 2009, OBSTET GYNECOL, V114, P292, DOI 10.1097/AOG.0b013e3181af33e6; Boerma JT, 1999, AIDS, V13, P1233, DOI 10.1097/00002030-199907090-00013; Calvert C, 2013, AIDS, V27, P1631, DOI 10.1097/QAD.0b013e32835fd940; Chweneyagae D, 2012, SAJOG-S AFR J OBSTET, V18, P70, DOI 10.7196/SAJOG.581; Crampin AC, 2003, AIDS, V17, P1817, DOI 10.1097/00002030-200308150-00011; Gregson S, 2001, INT J STD AIDS, V12, P189, DOI 10.1258/0956462011917009; Jahn A, 2007, DEMOGR RES, V16, P219, DOI 10.4054/DemRes.2007.16.8; Kamali A, 2000, AIDS, V14, P427, DOI 10.1097/00002030-200003100-00017; KengeyaKayondo JF, 1996, INT J EPIDEMIOL, V25, P1077, DOI 10.1093/ije/25.5.1077; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kirkwood B. R., 2003, MED STAT; KondeLule JK, 1997, AIDS, V11, P791, DOI 10.1097/00002030-199706000-00012; Kongnyuy EJ, 2009, WOMEN HEALTH ISS, V19, P14, DOI 10.1016/j.whi.2008.09.008; Le Coeur S, 2005, AIDS, V19, P69, DOI 10.1097/00002030-200501030-00008; Lewis JJC, 2004, AIDS, V18, pS35, DOI 10.1097/00002030-200406002-00005; Lopman B, 2008, INT J EPIDEMIOL, V37, P88, DOI 10.1093/ije/dym255; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Maher D, 2010, TROP MED INT HEALTH, V15, P321, DOI 10.1111/j.1365-3156.2009.02456.x; Mwaluko G, 2003, AIDS, V17, P2645, DOI 10.1097/00002030-200312050-00012; National Committee on Confidential Enquiries into Maternal Deaths, SAV MOTH 2005 2007 4; Nyirenda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012370; Porter K, 2004, AIDS, V18, pS9, DOI 10.1097/00002030-200406002-00002; Ronsmans C, 2001, INT J EPIDEMIOL, V30, P467, DOI 10.1093/ije/30.3.467; Rosen JE, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/958262; Setel PW, 2006, PLOS MED, V3, P1282, DOI 10.1371/journal.pmed.0030268; Sewankambo NK, 2000, AIDS, V14, P2391, DOI 10.1097/00002030-200010200-00021; Soleman N, 2006, B WORLD HEALTH ORGAN, V84, P239, DOI 10.2471/BLT.05.027003; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; UNAIDS, 2012, GLOB REP UNAID UNPUB; UNAIDS, 2011, COUNTD ZER GLOB PLAN; Van Dillen J, 2006, ACTA OBSTET GYN SCAN, V85, P499, DOI 10.1080/00016340600555884; Welz T, 2008, SEX TRANSM DIS, V35, P372, DOI 10.1097/OLQ.0b013e31815fd3fc; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; WHO, 2010, INT STAT CLASS DIS R; World Health Organization, 2021, ANT DRUGS TREAT PREG; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; Zaba B, 2007, AIDS, V21, pS87, DOI 10.1097/01.aids.0000299415.67646.26	40	83	83	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 18	2013	381	9879					1763	1771		10.1016/S0140-6736(13)60803-X	http://dx.doi.org/10.1016/S0140-6736(13)60803-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146TA	23683643	Green Accepted, Green Published			2022-12-28	WOS:000319112800041
J	Liang, TJ; Ghany, MG				Liang, T. Jake; Ghany, Marc G.			Current and Future Therapies for Hepatitis C Virus Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SUSTAINED VIROLOGICAL RESPONSE; PROTEASE INHIBITOR; TREATMENT-NAIVE; PLUS RIBAVIRIN; VIRAL LOAD; BOCEPREVIR; TELAPREVIR; COMBINATION; RESISTANCE; SOFOSBUVIR		[Liang, T. Jake; Ghany, Marc G.] NIDDKD, Liver Dis Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Liang, TJ (corresponding author), NIDDKD, Liver Dis Branch, NIH, Bldg 10-9B16,10 Ctr Dr, Bethesda, MD 20892 USA.	jakel@bldg10.niddk.nih.gov	Ghany, Marc/AAU-4238-2021	Ghany, Marc/0000-0003-2837-0188	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054504, ZIADK054503, ZIADK054511, ZIADK054505] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA DK054511-07, Z99 DK999999, ZIA DK054504-16, ZIA DK054505-16, ZIA DK054511-06, ZIA DK054505-17, ZIA DK054504-17] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Afdhal NH, 2011, HEPATOLOGY, V53, P336, DOI 10.1002/hep.24052; Alvisi G, 2011, RNA BIOL, V8, P258, DOI 10.4161/rna.8.2.15011; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; [Anonymous], 2002, HEPATOLOGY, V36, pS3, DOI 10.1053/jhep.2002.37117; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bronowicki JP, 2012, J HEPATOL, V56, pS6, DOI 10.1016/S0168-8278(12)60025-7; Brown RS, 2005, NATURE, V436, P973, DOI 10.1038/nature04083; Bruno S, 2010, HEPATOLOGY, V51, P2069, DOI 10.1002/hep.23528; Chayama K, 2012, HEPATOLOGY, V55, P742, DOI 10.1002/hep.24724; Cho NJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000331; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; De Meyer S, 2012, HEPATOLOGY, V56, P2106, DOI 10.1002/hep.25962; Einav S, 2008, NAT BIOTECHNOL, V26, P1019, DOI 10.1038/nbt.1490; Fattovich G, 2011, ALIMENT PHARM THER, V33, P1162, DOI 10.1111/j.1365-2036.2011.04635.x; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Flisiak R, 2008, HEPATOLOGY, V47, P817, DOI 10.1002/hep.22131; Flisiak R, 2009, HEPATOLOGY, V49, P1460, DOI 10.1002/hep.22835; Fontana RJ, 2012, LIVER TRANSPLANT, V18, P1053, DOI 10.1002/lt.23482; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Gane EJ, 2010, LANCET, V376, P1467, DOI 10.1016/S0140-6736(10)61384-0; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Ghosal A, 2011, DRUG METAB DISPOS, V39, P510, DOI 10.1124/dmd.110.036996; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hopkins S, 2012, ANTIMICROB AGENTS CH, V56, P3888, DOI 10.1128/AAC.00693-12; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jonsson JR, 2008, MOL DIAGN THER, V12, P209, DOI 10.1007/BF03256286; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kiser JJ, 2012, HEPATOLOGY, V55, P1620, DOI 10.1002/hep.25653; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lawitz E, 2011, ANTIVIR RES, V89, P238, DOI 10.1016/j.antiviral.2011.01.003; Li YH, 2009, J HEPATOL, V51, P750, DOI 10.1016/j.jhep.2009.04.027; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Liu S, 2012, ANN INTERN MED, V156, P279, DOI 10.7326/0003-4819-156-4-201202210-00005; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Luscombe CA, 2010, ANTIVIR RES, V86, P144, DOI 10.1016/j.antiviral.2010.02.312; Ly KN, 2012, ANN INTERN MED, V156, P840; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Mallolas J, 2012, J HEPATOL, V56, pS22, DOI 10.1016/S0168-8278(12)60064-6; Marcellin P, 2011, GASTROENTEROLOGY, V140, P459, DOI 10.1053/j.gastro.2010.10.046; Meredith LW, 2012, REV MED VIROL, V22, P182, DOI 10.1002/rmv.723; Moreno C, 2012, J HEPATOL, V56, P1247, DOI 10.1016/j.jhep.2011.12.033; Morgan TR, 2010, HEPATOLOGY, V52, P833, DOI 10.1002/hep.23744; Ni F, 2011, BIOORG MED CHEM LETT, V21, P2198, DOI 10.1016/j.bmcl.2011.03.014; Pavlovic D, 2003, P NATL ACAD SCI USA, V100, P6104, DOI 10.1073/pnas.1031527100; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Smith BD, 2012, ANN INTERN MED, V157, P817, DOI 10.7326/0003-4819-157-9-201211060-00529; Sulkowski MS, 2012, J HEPATOL, V56, pS459, DOI 10.1016/S0168-8278(12)61174-X; Sulkowski MS, 2013, HEPATOLOGY, V57, P974, DOI 10.1002/hep.26096; Susser S, 2011, J CLIN VIROL, V52, P321, DOI 10.1016/j.jcv.2011.08.015; Susser S, 2009, HEPATOLOGY, V50, P1709, DOI 10.1002/hep.23192; Thomas Emmanuel, 2012, Antiviral Chemistry & Chemotherapy, V23, P1, DOI 10.3851/IMP2125; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003; Werner CR, 2012, LIVER TRANSPLANT, V18, P1464, DOI 10.1002/lt.23542; Zeuzem S, 2012, HEPATOLOGY, V55, P749, DOI 10.1002/hep.24744; Zeuzem S, 2011, GASTROENTEROLOGY, V141, P2047, DOI 10.1053/j.gastro.2011.08.051; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zhu HH, 2012, J INFECT DIS, V205, P656, DOI 10.1093/infdis/jir802; 2011, INC TEL PRESCR INF; 2011, VICTR BOC PRESCR INF	72	338	347	2	91	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2013	368	20					1907	1917		10.1056/NEJMra1213651	http://dx.doi.org/10.1056/NEJMra1213651			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143VK	23675659	Green Accepted			2022-12-28	WOS:000318896200010
J	Kehlet, H				Kehlet, Henrik			Fast-track hip and knee arthroplasty	LANCET			English	Editorial Material							ENHANCED RECOVERY; REPLACEMENT; PATIENT; SURGERY; STILL; PAIN		[Kehlet, Henrik] Univ Copenhagen, Sect Surg Pathophysiol, DK-2100 Copenhagen, Denmark; [Kehlet, Henrik] Univ Copenhagen, Rigshosp, Lundbeck Fdn Ctr Fast Track Hip & Knee Replacemen, DK-2100 Copenhagen, Denmark	University of Copenhagen; Lundbeckfonden; Rigshospitalet; University of Copenhagen	Kehlet, H (corresponding author), Univ Copenhagen, Sect Surg Pathophysiol, DK-2100 Copenhagen, Denmark.	henrik.kehlet@rh.regionh.dk		Kehlet, Henrik/0000-0002-2209-1711				Antrobus JD, 2011, CAN J ANESTH, V58, P891, DOI 10.1007/s12630-011-9564-9; Bandholm T, 2012, ARCH PHYS MED REHAB, V93, P1292, DOI 10.1016/j.apmr.2012.02.014; Husted H, 2011, ACTA ORTHOP, V82, P679, DOI 10.3109/17453674.2011.636682; Jans O, 2012, BRIT J ANAESTH, V108, P436, DOI 10.1093/bja/aer403; Kehlet H, 2011, ACTA ANAESTH SCAND, V55, P778, DOI 10.1111/j.1399-6576.2011.02429.x; Kehlet H, 2003, LANCET, V362, P1921, DOI 10.1016/S0140-6736(03)14966-5; Kehlet H, 2011, BRIT J ANAESTH, V106, P289, DOI 10.1093/bja/aeq408; Kehlet H, 2008, LANCET, V371, P791, DOI 10.1016/S0140-6736(08)60357-8; Kirksey M, 2012, ANESTH ANALG, V115, P321, DOI 10.1213/ANE.0b013e31825b6824; Kjaersgaard-Andersen P, 2012, ACTA ORTHOP, V83, P105, DOI 10.3109/17453674.2012.672094; Krenk L, 2012, BRIT J ANAESTH, V108, P607, DOI 10.1093/bja/aer493; Lunn TH, 2011, BRIT J ANAESTH, V106, P230, DOI 10.1093/bja/aeq333; Malviya A, 2011, ACTA ORTHOP, V82, P577, DOI 10.3109/17453674.2011.618911; McDonald DA, 2012, KNEE, V19, P525, DOI 10.1016/j.knee.2011.07.012; NHS Enhanced Recovery Partnership Programme, 2010, DEL ENH REC HELP PAT; Raphael M, 2011, CAN J ANESTH, V58, P902, DOI 10.1007/s12630-011-9565-8; Shander A, 2012, BRIT J ANAESTH, V109, P55, DOI 10.1093/bja/aes139; Wu CL, 2011, LANCET, V377, P2215, DOI 10.1016/S0140-6736(11)60245-6	18	214	224	0	28	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 11	2013	381	9878					1600	1602		10.1016/S0140-6736(13)61003-X	http://dx.doi.org/10.1016/S0140-6736(13)61003-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146SX	23663938				2022-12-28	WOS:000319112400005
J	Toubiana, J; Heilbronner, C; Gitiaux, C; Oualha, M; Taha, MK; Rousseau, C; Picard, C; Mira, JP; Gendrel, D				Toubiana, Julie; Heilbronner, Claire; Gitiaux, Cyril; Oualha, Mehdi; Taha, Muhamed-Kheir; Rousseau, Christophe; Picard, Capucine; Mira, Jean-Paul; Gendrel, Dominique			Pachymeningitis after meningococcal infection	LANCET			English	Editorial Material									[Toubiana, Julie; Heilbronner, Claire; Gendrel, Dominique] Univ Paris 05, Necker Hosp, Dept Paediat & Infect Dis, Paris, France; [Gitiaux, Cyril] Univ Paris 05, Necker Hosp, Dept Paediat & Neurol, Paris, France; [Oualha, Mehdi] Univ Paris 05, Necker Hosp, Dept Paediat Intens Care Unit, Paris, France; [Picard, Capucine] Univ Paris 05, Necker Hosp, Study Ctr Primary Immunodeficiencies, Paris, France; [Toubiana, Julie; Rousseau, Christophe; Mira, Jean-Paul] INSERM, Infect Immun & Inflammat Cochin Inst, U1016, Paris, France; [Taha, Muhamed-Kheir] Inst Pasteur, Natl Reference Ctr Meningococci, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Toubiana, J (corresponding author), Necker Univ Hosp, Dept Paediat & Infect Dis, 149 Rue Sevres, F-75015 Paris, France.	julie.toubiana@nck.aphp.fr	Gitiaux, Cyril/AAB-9102-2020; Oualha, Mehdi/AAW-7706-2021; Toubiana, Julie/AAZ-8996-2020; Picard, Capucine/H-3914-2017	Toubiana, Julie/0000-0001-9561-669X; Picard, Capucine/0000-0001-8788-5056; Gitiaux, Cyril/0000-0002-2190-6843				Brouwer MC, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004405.pub3; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Evans DJ, 2008, RESP MED, V102, P793, DOI 10.1016/j.rmed.2008.01.018; Thwaites GE, 2005, LANCET NEUROL, V4, P160, DOI 10.1016/S1474-4422(05)01013-6; VANDEUREN M, 1995, J INFECT DIS, V172, P433, DOI 10.1093/infdis/172.2.433	5	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 4	2013	381	9877					1596	1596		10.1016/S0140-6736(13)60315-3	http://dx.doi.org/10.1016/S0140-6736(13)60315-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139UF	23642701				2022-12-28	WOS:000318609600035
J	Gillan, E				Gillan, Evelyn			DOCTORS AND THE ALCOHOL INDUSTRY The meaning of "partnership working" to the alcohol industry	BMJ-BRITISH MEDICAL JOURNAL			English	Letter									Alcohol Focus Scotland, Glasgow G1 2LW, Lanark, Scotland		Gillan, E (corresponding author), Alcohol Focus Scotland, Glasgow G1 2LW, Lanark, Scotland.	evelyn.gillan@alcohol-focus-scotland.org.uk						Babor T., 2010, ALCOHOL NO ORDINARY, V2nd; Babor TF, 2013, AM J PUBLIC HEALTH, V103, P206, DOI 10.2105/AJPH.2012.300847; Gornall J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1889; Jernigan DH, 2012, AM J PUBLIC HEALTH, V102, P80, DOI 10.2105/AJPH.2011.300269; Parsons R, 2013, MARKETING WEEK	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2013	346								f2655	10.1136/bmj.f2655	http://dx.doi.org/10.1136/bmj.f2655			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139EK	23635538				2022-12-28	WOS:000318564300012
J	Elliman, D; Bedford, H				Elliman, David; Bedford, Helen			Should the UK introduce compulsory vaccination?	LANCET			English	Editorial Material							IMMUNIZATION; MEASLES; RUBELLA; MUMPS		[Elliman, David] Whittington Hlth, Community Child Hlth, London, England; [Bedford, Helen] UCL Inst Child Hlth, Ctr Epidemiol & Biostat, London WC1N 1EH, England	University of London; University College London	Bedford, H (corresponding author), UCL Inst Child Hlth, Ctr Epidemiol & Biostat, London WC1N 1EH, England.	h.bedford@ucl.ac.uk	Elliman, David/AAK-4595-2020					Benin AL, 2006, PEDIATRICS, V117, P1532, DOI 10.1542/peds.2005-1728; Centers for Disease Control and Prevention, 2012, NAT IMM SURV NIS CHI; Haverkate M, 2012, EUROSURVEILLANCE, V17; Health and Social Care Information Centre Screening and Immunisations Team, 2011, NHS IMM STAT ENGL 20; Health Protection Agency, 1966, COMPL PRIM COURS 2 Y; Offit PA, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2434; Omer SB, 2009, NEW ENGL J MED, V360, P1981, DOI 10.1056/NEJMsa0806477; PELTOLA H, 1994, NEW ENGL J MED, V331, P1397, DOI 10.1056/NEJM199411243312101; Petrovic M, 2001, BRIT MED J, V322, P82, DOI 10.1136/bmj.322.7278.82; Public Health Wales, 2013, MEASL OUTBR; ROBBINS KB, 1981, AM J PUBLIC HEALTH, V71, P270, DOI 10.2105/AJPH.71.3.270; Salmon DA, 2006, LANCET, V367, P436, DOI 10.1016/S0140-6736(06)68144-0; Samad L, 2006, VACCINE, V24, P6823, DOI 10.1016/j.vaccine.2006.06.039; Samad L, 2006, BMJ-BRIT MED J, V332, P1312, DOI 10.1136/bmj.332.7553.1312; Strebel P, 2008, VACCINES, P355	15	11	11	1	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 27	2013	381	9876					1434	1436		10.1016/S0140-6736(13)60907-1	http://dx.doi.org/10.1016/S0140-6736(13)60907-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139TK	23623214				2022-12-28	WOS:000318607300009
J	Xiong, FZ; Tentner, AR; Huang, P; Gelas, A; Mosaliganti, KR; Souhait, L; Rannou, N; Swinburne, IA; Obholzer, ND; Cowgill, PD; Schier, AF; Megason, SG				Xiong, Fengzhu; Tentner, Andrea R.; Huang, Peng; Gelas, Arnaud; Mosaliganti, Kishore R.; Souhait, Lydie; Rannou, Nicolas; Swinburne, Ian A.; Obholzer, Nikolaus D.; Cowgill, Paul D.; Schier, Alexander F.; Megason, Sean G.			Specified Neural Progenitors Sort to Form Sharp Domains after Noisy Shh Signaling	CELL			English	Article							SONIC-HEDGEHOG; SPINAL-CORD; HOMEODOMAIN PROTEIN; MORPHOGEN GRADIENT; FLOOR PLATE; IN-VIVO; CELL; TUBE; SPECIFICATION; EXPRESSION	Sharply delineated domains of cell types arise in developing tissues under instruction of inductive signal (morphogen) gradients, which specify distinct cell fates at different signal levels. The translation of a morphogen gradient into discrete spatial domains relies on precise signal responses at stable cell positions. However, cells in developing tissues undergoing morphogenesis and proliferation often experience complex movements, which may affect their morphogen exposure, specification, and positioning. How is a clear pattern achieved with cells moving around? Using in toto imaging of the zebrafish neural tube, we analyzed specification patterns and movement trajectories of neural progenitors. We found that specified progenitors of different fates are spatially mixed following heterogeneous Sonic Hedgehog signaling responses. Cell sorting then rearranges them into sharply bordered domains. Ectopically induced motor neuron progenitors also robustly sort to correct locations. Our results reveal that cell sorting acts to correct imprecision of spatial patterning by noisy inductive signals.	[Xiong, Fengzhu; Tentner, Andrea R.; Gelas, Arnaud; Mosaliganti, Kishore R.; Souhait, Lydie; Rannou, Nicolas; Swinburne, Ian A.; Obholzer, Nikolaus D.; Cowgill, Paul D.; Megason, Sean G.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Huang, Peng; Schier, Alexander F.] Harvard Univ, Broad Inst, Harvard Stem Cell Inst, Dept Mol & Cellular Biol,Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Megason, SG (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	megason@hms.harvard.edu	XIONG, FENGZHU/A-9590-2015; Huang, Peng/U-8384-2019	XIONG, FENGZHU/0000-0002-6153-0254; Huang, Peng/0000-0001-7954-8869; Schier, Alexander Franz/0000-0001-7645-5325	NIH [HG004071, DC010791]; graduate program of Biological Sciences in Dental Medicine at Harvard University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K25HD071969, R01HD067140] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC012097, R01DC010791] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); graduate program of Biological Sciences in Dental Medicine at Harvard University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank D. D'India for fish care, H. Otsuna for movie making, R. Koster, D. Meyer, U. Strahle, B. Appel, S. Higashijima, S. Lin, and L. Zon for sharing reagents, D. Tulga and T. Hiscock for technical assistance, and Q. Mao, R. Noche, A. Green, Y. Chen, W. Ma, R. Ward, A. McMahon, M. Kirschner, C. Cepko, and T. Mitchison for comments. This work is supported by NIH grants HG004071 and DC010791. F.X. is also supported by the graduate program of Biological Sciences in Dental Medicine at Harvard University. F.X. and S.G.M. conceived this study. F.X., A.R.T., and P.H. performed the experiments. F.X. analyzed the data. A.G., K.R.M., L.S., and N.R. provided tools and assistance for data analysis. P.H., I.A.S., N.D.O., P.D.C, and A.F.S. provided reagents and technical assistance. F.X. and S.G.M. wrote the manuscript. All authors discussed the manuscript and contributed to writing.	Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Chamberlain CE, 2008, DEVELOPMENT, V135, P1097, DOI 10.1242/dev.013086; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Clarke J, 2009, CURR OPIN NEUROBIOL, V19, P134, DOI 10.1016/j.conb.2009.04.010; Das RM, 2012, EMBO REP, V13, P1030, DOI 10.1038/embor.2012.159; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Dessaud E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000382; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Ericson J, 1997, COLD SPRING HARB SYM, V62, P451; Erskine L, 1998, DEV BIOL, V199, P26, DOI 10.1006/dbio.1998.8912; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Huang P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002762; Inoue T, 2000, DEV BIOL, V219, P373, DOI 10.1006/dbio.2000.9616; Jeong JH, 2005, DEVELOPMENT, V132, P143, DOI 10.1242/dev.01566; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jessen JR, 1998, P NATL ACAD SCI USA, V95, P5121, DOI 10.1073/pnas.95.9.5121; Kay RR, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001503; KIMMEL CB, 1994, DEVELOPMENT, V120, P265; KORZH V, 1993, DEVELOPMENT, V118, P417; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Lander AD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002022; Lawrence PA, 1999, DEVELOPMENT, V126, P2441; LEBER SM, 1995, J NEUROSCI, V15, P1236; Lek M, 2010, DEVELOPMENT, V137, P4051, DOI 10.1242/dev.054288; Lele Z, 2002, DEVELOPMENT, V129, P3281; Lewis KE, 2003, PROG NEUROBIOL, V69, P419, DOI 10.1016/S0301-0082(03)00052-2; Lin JT, 2012, J COMP NEUROL, V520, P1509, DOI 10.1002/cne.22808; MARTI E, 1995, DEVELOPMENT, V121, P2537; Megason SG, 2003, MECH DEVELOP, V120, P1407, DOI 10.1016/j.mod.2003.07.005; Mosaliganti KR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002780; Nicol A, 1999, J CELL SCI, V112, P3923; Park HC, 2004, DEVELOPMENT, V131, P5959, DOI 10.1242/dev.01456; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Rieger S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000240; Schaffer M, 2005, MECH DEVELOP, V122, P43, DOI 10.1016/j.mod.2004.09.002; SCHOENWOLF GC, 1991, DEVELOPMENT, P157; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Shkumatava A, 2004, DEVELOPMENT, V131, P3849, DOI 10.1242/dev.01247; Smith JL, 1997, TRENDS NEUROSCI, V20, P510, DOI 10.1016/S0166-2236(97)01121-1; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; Surmeli G, 2011, CELL, V147, P653, DOI 10.1016/j.cell.2011.10.012; Takamiya M, 2006, DEV DYNAM, V235, P978, DOI 10.1002/dvdy.20720; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wendik B, 2004, DEV BIOL, V268, P372, DOI 10.1016/j.ydbio.2003.12.026; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O; Yamaguchi Y, 2011, J CELL BIOL, V195, P1047, DOI 10.1083/jcb.201104057	52	102	102	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 25	2013	153	3					550	561		10.1016/j.cell.2013.03.023	http://dx.doi.org/10.1016/j.cell.2013.03.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622240	Green Accepted, Bronze			2022-12-28	WOS:000318063500009
J	McLeod, DSA; Sawka, AM; Cooper, DS				McLeod, Donald S. A.; Sawka, Anna M.; Cooper, David S.			Controversies in primary treatment of low-risk papillary thyroid cancer	LANCET			English	Article							THYROTROPIN-SUPPRESSIVE THERAPY; LYMPH-NODE DISSECTION; QUALITY-OF-LIFE; EXOGENOUS SUBCLINICAL HYPERTHYROIDISM; RADIOIODINE REMNANT ABLATION; CENTRAL NECK DISSECTION; RECOMBINANT HUMAN THYROTROPIN; RADIOACTIVE IODINE TREATMENT; RANDOMIZED CONTROLLED-TRIAL; 2ND PRIMARY MALIGNANCIES	In many parts of the world, incidence of papillary thyroid cancer is increasing faster than any other malignancy. Most papillary thyroid cancers that are diagnosed are small and are generally regarded as being low risk, with little or no effect on mortality. Papillary thyroid cancer is a clinical challenge because it is difficult to prove benefit from the traditional therapeutic triad for this disorder (ie, total thyroidectomy with or without prophylactic central neck dissection, radioiodine remnant ablation, and suppression of serum thyroid-stimulating hormone with levothyroxine). However, risk of disease recurrence might be reduced by these therapies in a subset of patients with more aggressive disease. In the past decade, professional societies and other groups have established evidence-based clinical practice guidelines for management of papillary thyroid cancer, but these efforts have been made difficult by a paucity of randomised controlled trials. In this review, we summarise epidemiological data for disease incidence, discuss some controversies in disease management, and outline a therapeutic framework founded in the best available medical evidence and existing recommendations from clinical practice guidelines.	[McLeod, Donald S. A.] Royal Brisbane & Womens Hosp, Dept Internal Med & Aged Care, Herston, Qld, Australia; [McLeod, Donald S. A.] Queensland Inst Med Res, Canc Control Grp, Herston, Qld 4006, Australia; [Sawka, Anna M.] Univ Hlth Network, Dept Med, Div Endocrinol, Toronto, ON, Canada; [Sawka, Anna M.] Univ Toronto, Toronto, ON, Canada; [Cooper, David S.] Johns Hopkins Univ, Sch Med, Div Endocrinol & Metab, Baltimore, MD 21287 USA	Royal Brisbane & Women's Hospital; QIMR Berghofer Medical Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Johns Hopkins University	Cooper, DS (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA.	dscooper@jhmi.edu	McLeod, Donald/ABC-6047-2021; Sawka, Anna/AAA-4336-2020; McLeod, Donald/O-1051-2019; McLeod, Donald S. A./C-4242-2014	McLeod, Donald/0000-0003-1131-020X; McLeod, Donald S. A./0000-0003-1131-020X	Royal Australasian College of Physicians IMS Travelling Fellowship; Cancer Council Queensland PhD scholarship; Cancer Care Ontario Infrastructure Funding Programme	Royal Australasian College of Physicians IMS Travelling Fellowship; Cancer Council Queensland PhD scholarship(Cancer Council Queensland); Cancer Care Ontario Infrastructure Funding Programme	DSAM was supported by a Royal Australasian College of Physicians IMS Travelling Fellowship and a Cancer Council Queensland PhD scholarship. AMS holds a Cancer Care Ontario Research Chair in Health Services Research, and has received funding from the Cancer Care Ontario Infrastructure Funding Programme to support literature-review associated expenses.	Abdulrahman RM, 2011, THYROID, V21, P471, DOI 10.1089/thy.2010.0319; Abonowara A, 2012, CLIN INVEST MED, V35, pE152; [Anonymous], HONG KONG CANC REG S; ATTIE JN, 1988, EUR J CANCER CLIN ON, V24, P315, DOI 10.1016/0277-5379(88)90274-X; Bardet S, 2008, EUR J ENDOCRINOL, V158, P551, DOI 10.1530/EJE-07-0603; Barney BM, 2011, HEAD NECK-J SCI SPEC, V33, P645, DOI 10.1002/hed.21504; Baudin E, 1998, CANCER, V83, P553, DOI 10.1002/(SICI)1097-0142(19980801)83:3<553::AID-CNCR25>3.0.CO;2-U; Bauer DC, 2001, ANN INTERN MED, V134, P561, DOI 10.7326/0003-4819-134-7-200104030-00009; Bauer DC, 2007, AM J MED, V120, P343, DOI 10.1016/j.amjmed.2006.04.034; Bilimoria KY, 2007, ANN SURG, V246, P375, DOI 10.1097/SLA.0b013e31814697d9; Biondi B, 1996, J CLIN ENDOCR METAB, V81, P4224, DOI 10.1210/jc.81.12.4224; BIONDI B, 1993, J CLIN ENDOCR METAB, V77, P334, DOI 10.1210/jc.77.2.334; Biondi B, 1998, J CLIN ENDOCR METAB, V83, P2643, DOI 10.1210/jc.83.8.2643; Biondi B, 2010, THYROID, V20, P135, DOI 10.1089/thy.2009.0311; Blomberg M, 2012, INT J CANCER, V131, P2360, DOI 10.1002/ijc.27497; Bonnet S, 2009, J CLIN ENDOCR METAB, V94, P1162, DOI 10.1210/jc.2008-1931; Brown AP, 2008, J CLIN ENDOCR METAB, V93, P504, DOI 10.1210/jc.2007-1154; Burns JA, 2004, OPHTHAL PLAST RECONS, V20, P126, DOI 10.1097/01.IOP.0000117340.41849.81; Cady B, 1997, AM J SURG, V174, P462, DOI 10.1016/S0002-9610(97)00162-1; CADY B, 1988, SURGERY, V104, P947; Canadian Cancer Society's Steering Committee on Cancer Statistics, 2012, CAN CANC STAT; Cancer Institute NSW, NSW CANC REG STAT RE; Cancer Research UK, CANC STATS CANC STAT; Carling T, 2012, THYROID, V22, P237, DOI 10.1089/thy.2011.0317; Carty SE, 2009, THYROID, V19, P1153, DOI 10.1089/thy.2009.0159; Castagna MG, 2011, EUR J ENDOCRINOL, V165, P441, DOI 10.1530/EJE-11-0466; Chen AY, 2009, CANCER-AM CANCER SOC, V115, P3801, DOI 10.1002/cncr.24416; Chisholm EJ, 2009, LARYNGOSCOPE, V119, P1135, DOI 10.1002/lary.20236; Colonna M, 2007, EUR J CANCER, V43, P891, DOI 10.1016/j.ejca.2006.11.024; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Cross S, 2006, J SURG ONCOL, V94, P678, DOI 10.1002/jso.20698; Dal Maso L, 2011, ANN ONCOL, V22, P957, DOI 10.1093/annonc/mdq467; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Davies L, 2010, LARYNGOSCOPE, V120, P2446, DOI 10.1002/lary.21076; DEGROOT LJ, 1990, J CLIN ENDOCR METAB, V71, P414, DOI 10.1210/jcem-71-2-414; Diessl S, 2012, CLIN ENDOCRINOL, V76, P586, DOI 10.1111/j.1365-2265.2011.04272.x; Durante C, 2012, J CLIN ENDOCR METAB, V97, P2748, DOI 10.1210/jc.2012-1123; Edge SB, 2010, AJCC CANC STAGING MA, P87; Enewold LR, 2011, CANCER EPIDEM BIOMAR, V20, P2369, DOI 10.1158/1055-9965.EPI-11-0596; Esnaola NF, 2001, SURGERY, V130, P921, DOI 10.1067/msy.2001.118370; Eustatia-Rutten CFA, 2006, CLIN ENDOCRINOL, V64, P284, DOI 10.1111/j.1365-2265.2006.02458.x; Eustatia-Rutten CFA, 2004, CLIN ENDOCRINOL, V61, P61, DOI 10.1111/j.1365-2265.2004.02060.x; FAZIO S, 1995, J CLIN ENDOCR METAB, V80, P2222, DOI 10.1210/jc.80.7.2222; Ferlay J., IARC CANCERBASE; Flynn RW, 2010, J CLIN ENDOCR METAB, V95, P186, DOI 10.1210/jc.2009-1625; Giordano D, 2012, THYROID, V22, P911, DOI 10.1089/thy.2012.0011; Grodski S, 2008, SURGERY, V144, P1038, DOI 10.1016/j.surg.2008.08.023; Haigh PI, 2005, ANN SURG ONCOL, V12, P81, DOI 10.1007/s10434-004-1165-1; Hall SF, 2009, WORLD J SURG, V33, P2567, DOI 10.1007/s00268-009-0226-9; Hartl DM, 2012, ANN SURG, V255, P777, DOI 10.1097/SLA.0b013e31824b7b68; Hay Ian D, 2002, Trans Am Clin Climatol Assoc, V113, P241; Hay ID, 2008, SURGERY, V144, P980, DOI 10.1016/j.surg.2008.08.035; Hay ID, 1998, SURGERY, V124, P958, DOI 10.1067/msy.1998.91825; HAY ID, 1993, SURGERY, V114, P1050; Haymart MR, 2011, JAMA-J AM MED ASSOC, V306, P721, DOI 10.1001/jama.2011.1139; Haymart MR, 2008, J CLIN ENDOCR METAB, V93, P809, DOI 10.1210/jc.2007-2215; Hoftijzer HC, 2008, J CLIN ENDOCR METAB, V93, P200, DOI 10.1210/jc.2007-1203; Hovens GC, 2007, J CLIN ENDOCR METAB, V92, P2610, DOI 10.1210/jc.2006-2566; Howlader N., 2021, SEER CANC STAT REV, P1975; Hughes DT, 2010, SURGERY, V148, P1100, DOI 10.1016/j.surg.2010.09.019; Ito Y, 2011, SURG TODAY, V41, P1486, DOI 10.1007/s00595-010-4494-7; Ito Y, 2010, ENDOCR J, V57, P523, DOI 10.1507/endocrj.K10E-019; Iyer NG, 2011, CANCER-AM CANCER SOC, V117, P4439, DOI 10.1002/cncr.26070; Jonklaas J, 2012, J CLIN ENDOCR METAB, V97, pE878, DOI 10.1210/jc.2011-2864; Jonklaas J, 2008, JAMA-J AM MED ASSOC, V299, P769, DOI 10.1001/jama.299.7.769; Jonklaas J, 2006, THYROID, V16, P1229, DOI 10.1089/thy.2006.16.1229; KATOH R, 1992, CANCER-AM CANCER SOC, V70, P1585, DOI 10.1002/1097-0142(19920915)70:6<1585::AID-CNCR2820700623>3.0.CO;2-Z; Kazaure HS, 2012, ANN SURG ONCOL, V19, P1874, DOI 10.1245/s10434-011-2129-x; Kebebew E, 2000, WORLD J SURG, V24, P1295, DOI 10.1007/s002680010215; Kung AWC, 1996, J CLIN ENDOCR METAB, V81, P1232, DOI 10.1210/jc.81.3.1232; Lang BHH, 2007, ANN SURG, V246, P114, DOI 10.1097/01.sla.0000262785.46403.9b; Liu S, 2001, BRIT J CANCER, V85, P1335, DOI 10.1054/bjoc.2001.2061; Mallick U, 2012, CLIN ONCOL-UK, V24, P159, DOI 10.1016/j.clon.2012.01.001; Mallick U, 2012, NEW ENGL J MED, V366, P1674, DOI 10.1056/NEJMoa1109589; Mazzaferri EL, 2009, THYROID, V19, P683, DOI 10.1089/thy.2009.1578; McGriff NJ, 2002, ANN MED, V34, P554, DOI 10.1080/078538902321117760; McLeod DSA, 2012, J CLIN ENDOCR METAB, V97, P2682, DOI 10.1210/jc.2012-1083; Mendelsohn AH, 2010, ARCH OTOLARYNGOL, V136, P1055, DOI 10.1001/archoto.2010.181; Mercuro G, 2000, J CLIN ENDOCR METAB, V85, P159, DOI 10.1210/jc.85.1.159; Montanaro F, 2006, EUR J CANCER PREV, V15, P178, DOI 10.1097/01.cej.0000197450.94980.36; Moreno MA, 2012, THYROID, V22, P347, DOI 10.1089/thy.2011.0121; Morris LGT, 2010, AM J SURG, V200, P454, DOI 10.1016/j.amjsurg.2009.11.008; New Zealand Ministry of Health, CANC DAT STATS; Nixon IJ, 2012, SURGERY, V151, P571, DOI 10.1016/j.surg.2011.08.016; Pacini F, 2006, J CLIN ENDOCR METAB, V91, P926, DOI 10.1210/jc.2005-1651; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; Panico A, 2009, THYROID, V19, P437, DOI 10.1089/thy.2008.0428; Perrino M, 2009, ENDOCR-RELAT CANCER, V16, P201, DOI 10.1677/ERC-08-0119; Perros P., 2007, GUIDELINES MANAGEMEN, V3; Pitoia F, 2009, ARQ BRAS ENDOCRINOL, V53, P884, DOI 10.1590/S0004-27302009000700014; Popadich A, 2011, SURGERY, V150, P1048, DOI 10.1016/j.surg.2011.09.003; Randolph GW, 2012, THYROID, V22, P1144, DOI 10.1089/thy.2012.0043; Rochon PA, 2011, BMJ-BRIT MED J, V342, pd2238; Rosario PW, 2012, THYROID, DOI [10.1089/thy.2012-0190, DOI 10.1089/THY.2012-0190]; Ross DS, 2009, THYROID, V19, P1043, DOI 10.1089/thy.2008.0407; Rubino C, 2003, BRIT J CANCER, V89, P1638, DOI 10.1038/sj.bjc.6601319; Sacks W, 2010, THYROID, V20, P1235, DOI 10.1089/thy.2009.0455; SAMAAN NA, 1992, J CLIN ENDOCR METAB, V75, P714, DOI 10.1210/jc.75.3.714; Samsung Medical Center, 2000, PROPH CENTR LYMPH NO; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; Sawka AM, 2008, ENDOCRIN METAB CLIN, V37, P457, DOI 10.1016/j.ecl.2008.02.007; Sawka AM, 2012, J CLIN ONCOL, V30, P2906, DOI 10.1200/JCO.2011.41.2734; Sawka AM, 2009, THYROID, V19, P451, DOI 10.1089/thy.2008.0392; Schlumberger M, 2012, NEW ENGL J MED, V366, P1663, DOI 10.1056/NEJMoa1108586; Schvartz C, 2012, J CLIN ENDOCR METAB, V97, P1526, DOI 10.1210/jc.2011-2512; Sciuto R, 2009, ANN ONCOL, V20, P1728, DOI 10.1093/annonc/mdp050; Segovia IG, 2004, THYROID, V14, P277, DOI 10.1089/105072504323030933; Shaha AR, 1997, ANN SURG ONCOL, V4, P328, DOI 10.1007/BF02303583; Shaha A, 2006, J SURG ONCOL, V94, P683, DOI 10.1002/jso.20697; Shan CX, 2012, LARYNGOSCOPE, V122, P797, DOI 10.1002/lary.22162; Sherman SI, 2003, LANCET, V361, P501, DOI 10.1016/S0140-6736(03)12488-9; Shrime MG, 2007, ARCH OTOLARYNGOL, V133, P1245, DOI 10.1001/archotol.133.12.1245; Sisson JC, 2011, THYROID, V21, P335, DOI 10.1089/thy.2010.0403; Smit JWA, 2005, J CLIN ENDOCR METAB, V90, P6041, DOI 10.1210/jc.2005-0620; Sosa JA, 1998, ANN SURG, V228, P320, DOI 10.1097/00000658-199809000-00005; Sugitani I, 2011, SURGERY, V150, P1250, DOI 10.1016/j.surg.2011.09.013; Sugitani I, 2010, J CLIN ENDOCR METAB, V95, P4576, DOI 10.1210/jc.2010-0161; Taieb D, 2009, CLIN ENDOCRINOL, V71, P115, DOI 10.1111/j.1365-2265.2008.03424.x; Takami H, 2011, WORLD J SURG, V35, P111, DOI 10.1007/s00268-010-0832-6; Tan LGL, 2007, LARYNGOSCOPE, V117, P507, DOI 10.1097/MLG.0b013e31802e3739; Tanaka K, 2012, SURG TODAY, V42, P633, DOI 10.1007/s00595-011-0091-7; Tuttle RM, 2010, THYROID, V20, P1341, DOI 10.1089/thy.2010.0178; Tuttle RM, 2012, THYROID CARCINOMA; Udelsman R, 2005, LANCET ONCOL, V6, P529, DOI 10.1016/S1470-2045(05)70247-3; Udelsman R, 1996, WORLD J SURG, V20, P88, DOI 10.1007/s002689900016; Vaisman A, 2010, HEAD NECK-J SCI SPEC, V32, P689, DOI 10.1002/hed.21371; Vaisman F, 2011, THYROID, V21, P1317, DOI 10.1089/thy.2011.0232; Van Nostrand D, 2011, ORAL DIS, V17, P154, DOI 10.1111/j.1601-0825.2010.01726.x; Wang TS, 2010, J CLIN ENDOCR METAB, V95, P1672, DOI 10.1210/jc.2009-1803; Xing MZ, 2013, LANCET, V381, P1058, DOI 10.1016/S0140-6736(13)60109-9; Zetoune T, 2010, ANN SURG ONCOL, V17, P3287, DOI 10.1245/s10434-010-1137-6	131	176	189	0	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 23	2013	381	9871					1046	1057		10.1016/S0140-6736(12)62205-3	http://dx.doi.org/10.1016/S0140-6736(12)62205-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EU	23668555				2022-12-28	WOS:000316936800034
J	Pallansch, MA; Oberste, MS				Pallansch, Mark A.; Oberste, M. Steven			Enterovirus 71 encephalitis: a new vaccine on the horizon?	LANCET			English	Editorial Material							MALAYSIA; CHILDREN; SARAWAK		[Pallansch, Mark A.; Oberste, M. Steven] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Pallansch, MA (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	map1@cdc.gov						Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Lin TY, 2003, EMERG INFECT DIS, V9, P291, DOI 10.3201/eid0903.020285; Podin Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-180; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; World Health Organization (WHO): Western Pacific Region, 2011, GUID CLIN MAN PUBL H; Zhu FC, 2013, LANCET, V381, P1037, DOI 10.1016/S0140-6736(12)61764-4	6	6	9	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 23	2013	381	9871					976	977		10.1016/S0140-6736(13)60286-X	http://dx.doi.org/10.1016/S0140-6736(13)60286-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EU	23668563				2022-12-28	WOS:000316936800008
J	Chavala, SH; Williamson, JF				Chavala, Sai H.; Williamson, Jennifer F.			Retinal arteriolar tortuosity and artery occlusion	LANCET			English	Editorial Material									[Chavala, Sai H.] Univ N Carolina, Dept Ophthalmol, Chapel Hill, NC 27514 USA; [Williamson, Jennifer F.] Univ N Carolina, Sch Med, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Chavala, SH (corresponding author), Univ N Carolina, Dept Opthalmol, 5151 Bioinformat Bldg,CB 7040, Chapel Hill, NC 27514 USA.	schavala@med.unc.edu							0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 16	2013	382	9905					1655	1655		10.1016/S0140-6736(13)60143-9	http://dx.doi.org/10.1016/S0140-6736(13)60143-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	254CN	23623391				2022-12-28	WOS:000327140700024
J	Kaplon, J; Zheng, L; Meissl, K; Chaneton, B; Selivanov, VA; Mackay, G; van der Burg, SH; Verdegaal, EME; Cascante, M; Shlomi, T; Gottlieb, E; Peeper, DS				Kaplon, Joanna; Zheng, Liang; Meissl, Katrin; Chaneton, Barbara; Selivanov, Vitaly A.; Mackay, Gillian; van der Burg, Sjoerd H.; Verdegaal, Elizabeth M. E.; Cascante, Marta; Shlomi, Tomer; Gottlieb, Eyal; Peeper, Daniel S.			A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence	NATURE			English	Article							CELL SENESCENCE; KINASE; COMPLEX; CANCER	In response to tenacious stress signals, such as the unscheduled activation of oncogenes, cells can mobilize tumour suppressor networks to avert the hazard of malignant transformation. A large body of evidence indicates that oncogene-induced senescence (OIS) acts as such a break, withdrawing cells from the proliferative pool almost irreversibly, thus crafting a vital pathophysiological mechanism that protects against cancer(1-5). Despite the widespread contribution of OIS to the cessation of tumorigenic expansion in animal models and humans, we have only just begun to define the underlying mechanism and identify key players(6). Although deregulation of metabolism is intimately linked to the proliferative capacity of cells(7-10), and senescent cells are thought to remain metabolically active(11), little has been investigated in detail about the role of cellular metabolism in OIS. Here we show, by metabolic profiling and functional perturbations, that the mitochondrial gatekeeper pyruvate dehydrogenase (PDH) is a crucial mediator of senescence induced by BRAF(V600E), an oncogene commonly mutated in melanoma and other cancers. BRAF(V600E)-induced senescence was accompanied by simultaneous suppression of the PDH-inhibitory enzyme pyruvate dehydrogenase kinase 1 (PDK1) and induction of the PDH-activating enzyme pyruvate dehydrogenase phosphatase 2 (PDP2). The resulting combined activation of PDH enhanced the use of pyruvate in the tricarboxylic acid cycle, causing increased respiration and redox stress. Abrogation of OIS, a rate-limiting step towards oncogenic transformation, coincided with reversion of these processes. Further supporting a crucial role of PDH in OIS, enforced normalization of either PDK1 or PDP2 expression levels inhibited PDH and abrogated OIS, thereby licensing BRAF(V600E)-driven melanoma development. Finally, depletion of PDK1 eradicated melanoma subpopulations resistant to targeted BRAF inhibition, and caused regression of established melanomas. These results reveal a mechanistic relationship between OIS and a key metabolic signalling axis, which may be exploited therapeutically.	[Kaplon, Joanna; Meissl, Katrin; Peeper, Daniel S.] Netherlands Canc Inst, Div Mol Oncol, NL-1066 CX Amsterdam, Netherlands; [Zheng, Liang; Chaneton, Barbara; Mackay, Gillian; Gottlieb, Eyal] Canc Res UK, Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Selivanov, Vitaly A.; Cascante, Marta] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; [Selivanov, Vitaly A.; Cascante, Marta] Univ Barcelona, Fac Biol, IBUB, E-08028 Barcelona, Spain; [Selivanov, Vitaly A.; Cascante, Marta] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona 08036, Spain; [van der Burg, Sjoerd H.; Verdegaal, Elizabeth M. E.] Leiden Univ, Med Ctr, Dept Clin Oncol, NL-2333 ZA Leiden, Netherlands; [Shlomi, Tomer] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel; [Shlomi, Tomer] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ USA	Netherlands Cancer Institute; Beatson Institute; Cancer Research UK; University of Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Technion Israel Institute of Technology; Princeton University	Gottlieb, E (corresponding author), Canc Res UK, Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland.	e.gottlieb@beatson.gla.ac.uk; d.peeper@nki.nl	CASCANTE, MARTA/AFK-5991-2022; Peeper, Daniel/AAA-2430-2020; CASCANTE, MARTA/AAG-4355-2022; Gottlieb, Eyal/G-6450-2010; van der Burg, Sjoerd H/T-1875-2017; Verdegaal, Elizabeth/Y-2597-2018	CASCANTE, MARTA/0000-0002-2062-4633; CASCANTE, MARTA/0000-0002-2062-4633; Gottlieb, Eyal/0000-0002-9770-0956; van der Burg, Sjoerd H/0000-0002-6556-0354; Verdegaal, Elizabeth/0000-0002-4449-8707; Zheng, Liang/0000-0002-5346-4111; Selivanov, Vitaly/0000-0002-7937-9249; Meissl, Katrin/0000-0003-2731-6657	Cancer Research UK, Spanish Government-EU-FEDER [SAF2011-25726, ISCIII-RTICC-RD6/0020/0046]; ICREA-Academia; Israel Cancer Research Foundation; Israel Science Foundation; Netherlands Organization for Scientific Research (NWO); Dutch Cancer Society (KWF Kankerbestrijding)	Cancer Research UK, Spanish Government-EU-FEDER; ICREA-Academia(ICREA); Israel Cancer Research Foundation; Israel Science Foundation(Israel Science Foundation); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society (KWF Kankerbestrijding)(KWF Kankerbestrijding)	We thank J.-Y. Song for pathological analysis, M. McMahon for providing Braf<SUP>CA</SUP> mice, C. Vogel for sharing cell lines, R. van Amerongen for critical reading of the manuscript, and all members of the Gottlieb and Peeper laboratories for their input. This work was supported by Cancer Research UK, Spanish Government-EU-FEDER (grants SAF2011-25726 and ISCIII-RTICC-RD6/0020/0046) and ICREA-Academia to M. C., Israel Cancer Research Foundation and Israel Science Foundation to T. S., a Vici grant from the Netherlands Organization for Scientific Research (NWO) and a Queen Wilhelmina Award grant from the Dutch Cancer Society (KWF Kankerbestrijding) to D.S.P.	Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801; Campisi J, 1996, CELL, V84, P497, DOI 10.1016/S0092-8674(00)81023-5; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Flaherty KT, 2011, NAT REV DRUG DISCOV, V10, P811, DOI 10.1038/nrd3579; Frezza C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024411; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; Roche TE, 2001, PROG NUCLEIC ACID RE, V70, P33, DOI 10.1016/S0079-6603(01)70013-X; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sviderskaya EV, 1997, J INVEST DERMATOL, V108, P30, DOI 10.1111/1523-1747.ep12285621; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Vredeveld LCW, 2012, GENE DEV, V26, P1055, DOI 10.1101/gad.187252.112; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; WIELAND OH, 1982, REV PHYSIOL BIOCH P, V96, P123, DOI 10.1007/BFb0031008	33	404	417	5	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 6	2013	498	7452					109	+		10.1038/nature12154	http://dx.doi.org/10.1038/nature12154			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158DC	23685455				2022-12-28	WOS:000319947800043
J	Biddinger, PD; Baggish, A; Harrington, L; d'Hemecourt, P; Hooley, J; Jones, J; Kue, R; Troyanos, C; Dyer, KS				Biddinger, Paul D.; Baggish, Aaron; Harrington, Lori; d'Hemecourt, Pierre; Hooley, James; Jones, Jerrilyn; Kue, Ricky; Troyanos, Chris; Dyer, K. Sophia			Be Prepared - The Boston Marathon and Mass-Casualty Events	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Biddinger, Paul D.; Baggish, Aaron] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Biddinger, Paul D.; Baggish, Aaron] Harvard Univ, Sch Med, Boston, MA USA; [Biddinger, Paul D.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Harrington, Lori; Hooley, James; Jones, Jerrilyn; Kue, Ricky; Dyer, K. Sophia] Boston EMS Police & Fire, Boston, MA USA; [Harrington, Lori; Jones, Jerrilyn; Kue, Ricky; Dyer, K. Sophia] Boston Med Ctr, Boston, MA USA; [Harrington, Lori; Jones, Jerrilyn; Kue, Ricky; Dyer, K. Sophia] Boston Univ, Sch Med, Boston, MA 02118 USA; [Baggish, Aaron; d'Hemecourt, Pierre; Troyanos, Chris; Dyer, K. Sophia] Boston Athlet Assoc, Boston, MA USA; [Hooley, James] Boston Publ Hlth Commiss, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Boston Medical Center; Boston University	Biddinger, PD (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.			Kue, Ricky/0000-0002-2295-1101				Cheney Kyle, 2013, POLITICO; Gawande A., 2013, NEW YORKER; Kotz Deborah, 2013, BOSTON GLOBE, pB3; Kragh JF, 2011, J EMERG MED, V41, P590, DOI 10.1016/j.jemermed.2009.07.022	4	78	78	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2013	368	21					1958	1960		10.1056/NEJMp1305480	http://dx.doi.org/10.1056/NEJMp1305480			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194KD	23635020				2022-12-28	WOS:000322630700004
J	Gao, P; Ascano, M; Wu, Y; Barchet, W; Gaffney, BL; Zillinger, T; Serganov, AA; Liu, YZ; Jones, RA; Hartmann, G; Tuschl, T; Patel, DJ				Gao, Pu; Ascano, Manuel; Wu, Yang; Barchet, Winfried; Gaffney, Barbara L.; Zillinger, Thomas; Serganov, Artem A.; Liu, Yizhou; Jones, Roger A.; Hartmann, Gunther; Tuschl, Thomas; Patel, Dinshaw J.			Cyclic [G(2 ',5 ') pA(3 ',5 ')p] Is the Metazoan Second Messenger Produced by DNA-Activated Cyclic GMP-AMP Synthase	CELL			English	Article							C-DI-GMP; STRUCTURAL BASIS; CYTOSOLIC DNA; INTRACELLULAR DNA; I INTERFERON; BACTERIAL 2ND-MESSENGER; DIGUANYLIC ACID; LIGAND-BINDING; SENSOR; INFLAMMASOME	Recent studies identified cyclic GMP-AMP (cGAMP) as a metazoan second messenger triggering an interferon response. cGAMP is generated from GTP and ATP by cytoplasmic dsDNA sensor cGAMP synthase (cGAS). Wecombined structural, chemical, biochemical, and cellular assays to demonstrate that this second messenger contains G(2',5')pA and A(3',5')pG phosphodiester linkages, designated c[G(2',5') pA(3',5')p]. We show that, upon dsDNA binding, cGAS is activated through conformational transitions, resulting in formation of a catalytically competent and accessible nucleotide-binding pocket for generation of c[G(2',5')pA(3',5')p]. We demonstrate that cyclization occurs in a stepwise manner through initial generation of 5'-pppG(2',5') pA prior to cyclization to c[G(2',5')pA(3',5')p], with the latter positioned precisely in the catalytic pocket. Mutants of cGAS dsDNA-binding or catalytic pocket residues exhibit reduced or abrogated activity. Our studies have identified c[G(2',5')pA(3',5')p] as a founding member of a family of metazoan 2',5'-containing cyclic heterodinucleotide second messengers distinct from bacterial 3',5' cyclic dinucleotides.	[Gao, Pu; Wu, Yang; Liu, Yizhou; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Ascano, Manuel; Serganov, Artem A.; Tuschl, Thomas] Rockefeller Univ, Lab RNA Mol Biol, Howard Hughes Med Inst, New York, NY 10065 USA; [Barchet, Winfried; Zillinger, Thomas; Hartmann, Gunther] Univ Bonn, Univ Hosp Bonn, Inst Clin Chem & Clin Pharmacol, D-53127 Bonn, Germany; [Gaffney, Barbara L.; Jones, Roger A.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Rockefeller University; University of Bonn; Rutgers State University New Brunswick	Tuschl, T (corresponding author), Rockefeller Univ, Lab RNA Mol Biol, Howard Hughes Med Inst, New York, NY 10065 USA.	ttuschl@mail.rockefeller.edu; pateld@mskcc.org	Wu, Yang/N-8460-2014; Hartmann, Gunther/P-7492-2017; Ascano, Manuel/ABA-3586-2020; Zillinger, Thomas/AAD-7320-2020; Jones, Roger A./GRY-0637-2022	Wu, Yang/0000-0002-1544-1947; Hartmann, Gunther/0000-0003-1021-2018; Ascano, Manuel/0000-0002-9370-5493; Zillinger, Thomas/0000-0002-0866-4835; Barchet, Winfried/0000-0002-6745-6606; Jones, Roger A./0000-0002-6835-6615	Abby Rockefeller Trust; Maloris; STARR Foundations; HHMI; DFG [BA3544/1-1]; NIH [GM79760];  [SFB670];  [SFB704]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079760] Funding Source: NIH RePORTER	Abby Rockefeller Trust; Maloris; STARR Foundations; HHMI(Howard Hughes Medical Institute); DFG(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the synchrotron beam line staffs at the Brookhaven and Argonne National laboratories for their assistance. D.J.P. is supported by grants from the Abby Rockefeller Trust and the Maloris and STARR Foundations. T.T. is supported by HHMI. W.B. and G.H. are members of the DFG Excellence Cluster ImmunoSensation. W.B. is supported by DFG grant BA3544/1-1, G.H. by SFB670, and both by SFB704. R.A.J. is supported by NIH GM79760.	Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Donovan J, 2013, P NATL ACAD SCI USA, V110, P1652, DOI 10.1073/pnas.1218528110; EGLI M, 1990, P NATL ACAD SCI USA, V87, P3235, DOI 10.1073/pnas.87.8.3235; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gaffney B.L., 2012, CURR PROTOC NUCL ACI, V14; Gaffney BL, 2010, ORG LETT, V12, P3269, DOI 10.1021/ol101236b; Hartmann R, 2003, MOL CELL, V12, P1173, DOI 10.1016/S1097-2765(03)00433-7; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Huang YH, 2012, NAT STRUCT MOL BIOL, V19, P728, DOI 10.1038/nsmb.2333; Huffman JL, 2002, CURR OPIN STRUC BIOL, V12, P98, DOI 10.1016/S0959-440X(02)00295-6; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jin TC, 2012, IMMUNITY, V36, P561, DOI 10.1016/j.immuni.2012.02.014; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Krasteva PV, 2012, PROTEIN SCI, V21, P929, DOI 10.1002/pro.2093; Kubota K, 2004, J BIOL CHEM, V279, P37832, DOI 10.1074/jbc.M400089200; Kulshina N, 2009, NAT STRUCT MOL BIOL, V16, P1212, DOI 10.1038/nsmb.1701; Lee ER, 2010, SCIENCE, V329, P845, DOI 10.1126/science.1190713; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; O'Neill LAJ, 2013, SCIENCE, V339, P763, DOI 10.1126/science.1234724; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Shu C, 2012, NAT STRUCT MOL BIOL, V19, P722, DOI 10.1038/nsmb.2331; Smith KD, 2009, NAT STRUCT MOL BIOL, V16, P1218, DOI 10.1038/nsmb.1702; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wolkowicz UM, 2012, NUCLEIC ACIDS RES, V40, P9356, DOI 10.1093/nar/gks696; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	37	581	628	5	106	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 23	2013	153	5					1094	1107		10.1016/j.cell.2013.04.046	http://dx.doi.org/10.1016/j.cell.2013.04.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	151JN	23647843	Bronze, Green Accepted			2022-12-28	WOS:000319456800016
J	Schmidt, B; Whyte, RK; Asztalos, EV; Moddemann, D; Poets, C; Rabi, Y; Solimano, A; Roberts, RS				Schmidt, Barbara; Whyte, Robin K.; Asztalos, Elizabeth V.; Moddemann, Diane; Poets, Christian; Rabi, Yacov; Solimano, Alfonso; Roberts, Robin S.		Canadian Oxygen Trial COT Grp	Effects of Targeting Higher vs Lower Arterial Oxygen Saturations on Death or Disability in Extremely Preterm Infants A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BIRTH-WEIGHT INFANTS; PULSE OXIMETRY; PREMATURE-INFANTS; RETINOPATHY; THERAPY; METAANALYSIS; UNCERTAINTY; GESTATION; CHILDREN	Importance The goal of oxygen therapy is to deliver sufficient oxygen to the tissues while minimizing oxygen toxicity and oxidative stress. It remains uncertain what values of arterial oxygen saturations achieve this balance in preterm infants. Objective To compare the effects of targeting lower or higher arterial oxygen saturations on the rate of death or disability in extremely preterm infants. Design, Setting, and Participants Randomized, double-blind trial in 25 hospitals in Canada, the United States, Argentina, Finland, Germany, and Israel in which 1201 infants with gestational ages of 23 weeks 0 days through 27 weeks 6 days were enrolled within 24 hours after birth between December 2006 and August 2010. Follow-up assessments began in October 2008 and ended in August 2012. Interventions Study participants were monitored until postmenstrual ages of 36 to 40 weeks with pulse oximeters that displayed saturations of either 3% above or below the true values. Caregivers adjusted the concentration of oxygen to achieve saturations between 88% and 92%, which produced 2 treatment groups with true target saturations of 85% to 89% (n=602) or 91% to 95% (n=599). Alarms were triggered when displayed saturations decreased to 86% or increased to 94%. Main Outcomes and Measures The primary outcome was a composite of death, gross motor disability, cognitive or language delay, severe hearing loss, or bilateral blindness at a corrected age of 18 months. Secondary outcomes included retinopathy of prematurity and brain injury. Results Of the 578 infants with adequate data for the primary outcome who were assigned to the lower target range, 298 (51.6%) died or survived with disability compared with 283 of the 569 infants (49.7%) assigned to the higher target range (odds ratio adjusted for center, 1.08; 95% CI, 0.85 to 1.37; P=.52). The rates of death were 16.6% for those in the 85% to 89% group and 15.3% for those in the 91% to 95% group (adjusted odds ratio, 1.11; 95% CI, 0.80 to 1.54; P=.54). Targeting lower saturations reduced the postmenstrual age at last use of oxygen therapy (adjusted mean difference, -0.8 weeks; 95% CI, -1.5 to -0.1; P=.03) but did not alter any other outcomes. Conclusion and Relevance In extremely preterm infants, targeting oxygen saturations of 85% to 89% compared with 91% to 95% had no significant effect on the rate of death or disability at 18 months. These results may help determine the optimal target oxygen saturation.	[Schmidt, Barbara] Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA; [Schmidt, Barbara] Univ Penn, Philadelphia, PA 19104 USA; [Schmidt, Barbara; Roberts, Robin S.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Whyte, Robin K.] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; [Asztalos, Elizabeth V.] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada; [Moddemann, Diane] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada; [Poets, Christian] Univ Tubingen, Dept Neonatol, Tubingen, Germany; [Rabi, Yacov] Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; [Solimano, Alfonso] Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; McMaster University; Dalhousie University; University of Toronto; University of Manitoba; Eberhard Karls University of Tubingen; University of Calgary; University of British Columbia	Schmidt, B (corresponding author), Hosp Univ Penn, Div Neonatol, Ravdin 8,3400 Spruce St, Philadelphia, PA 19104 USA.	barbara.schmidt@uphs.upenn.edu	Asztalos, Elizabeth/L-8834-2019; Shah, Prakesh S/I-8098-2013; Kelly, Edmond/P-5857-2015	Asztalos, Elizabeth/0000-0002-9468-2860; Bairam, Aida/0000-0003-3475-6546; Bassler, Dirk/0000-0003-2358-4419	Canadian Institutes of Health Research [MCT-79217]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funded exclusively by the Canadian Institutes of Health Research, grant MCT-79217.	Ahmed SJM, 2010, PEDIATRICS, V125, pE115, DOI 10.1542/peds.2008-1749; Anderson PJ, 2010, ARCH PEDIAT ADOL MED, V164, P352, DOI 10.1001/archpediatrics.2010.20; Armbruster J, 2010, J PERINATOL, V30, P531, DOI 10.1038/jp.2009.189; Askie LM, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-6; Askie LM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001077.pub2; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Bayley N, 2006, MANUAL BAYLEY SCALES; Brocklehurst P, 2011, BOOST 2 UK BENEFITS; Carlo WA, 2010, NEW ENGL J MED, V362, P1959, DOI 10.1056/NEJMoa0911781; Cole CH, 2003, PEDIATRICS, V112, P1415, DOI 10.1542/peds.112.6.1415; Deans Katherine J, 2004, Curr Opin Crit Care, V10, P579, DOI 10.1097/01.ccx.0000145097.36069.44; Greenspan JS, 2006, PEDIATRICS, V118, P1740, DOI 10.1542/peds.2006-1834; Hagadorn JI, 2006, PEDIATRICS, V118, P1574, DOI 10.1542/peds.2005-0413; Higgins RD, 2007, PEDIATRICS, V119, P790, DOI 10.1542/peds.2006-2200; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Johnston ED, 2011, ARCH DIS CHILD-FETAL, V96, pF429, DOI 10.1136/adc.2010.206011; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Lichtenstein SJ, 2006, PEDIATRICS, V117, P572, DOI 10.1542/peds.2005-2749; Msall ME, 2004, PEDIATRICS, V113, P790, DOI 10.1542/peds.113.4.790; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Rich W, 2012, PEDIATRICS, V129, P480, DOI 10.1542/peds.2011-2121; Saugstad OD, 2005, BIOL NEONATE, V88, P228, DOI 10.1159/000087586; Saugstad OD, 2011, NEONATOLOGY, V100, P1, DOI 10.1159/000322001; Silverman W. A., 1980, RETROLENTAL FIBROPLA; Silverman WA, 2004, PEDIATRICS, V113, P394, DOI 10.1542/peds.113.2.394; Stenson B, 2011, NEW ENGL J MED, V364, P1680, DOI 10.1056/NEJMc1101319; Tin W, 2001, ARCH DIS CHILD-FETAL, V84, pF106, DOI 10.1136/fn.84.2.F106; Tin W, 2002, PEDIATRICS, V110, P615, DOI 10.1542/peds.110.3.615; Vagedes J, 2013, ARCH DIS CHILD-FETAL, V98, pF265, DOI 10.1136/archdischild-2012-302543; Vaucher YE, 2012, NEW ENGL J MED, V367, P2495, DOI 10.1056/NEJMoa1208506; Weinberger B, 2002, TOXICOL APPL PHARM, V181, P60, DOI 10.1006/taap.2002.9387; WHYTE RK, 1992, BRIT MED J, V304, P343, DOI 10.1136/bmj.304.6823.343	32	250	259	1	46	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2013	309	20					2111	2120		10.1001/jama.2013.5555	http://dx.doi.org/10.1001/jama.2013.5555			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148FU	23644995	Bronze			2022-12-28	WOS:000319229600027
J	Prost, A; Colbourn, T; Seward, N; Azad, K; Coomarasamy, A; Copas, A; Houweling, TAJ; Fottrell, E; Kuddus, A; Lewycka, S; MacArthur, C; Manandhar, D; Morrison, J; Mwansambo, C; Nair, N; Nambiar, B; Osrin, D; Pagel, C; Phiri, T; Pulkki-Brannstrom, AM; Rosato, M; Skordis-Worrall, J; Saville, N; More, NS; Shrestha, B; Tripathy, P; Wilson, A; Costello, A				Prost, Audrey; Colbourn, Tim; Seward, Nadine; Azad, Kishwar; Coomarasamy, Arri; Copas, Andrew; Houweling, Tanja A. J.; Fottrell, Edward; Kuddus, Abdul; Lewycka, Sonia; MacArthur, Christine; Manandhar, Dharma; Morrison, Joanna; Mwansambo, Charles; Nair, Nirmala; Nambiar, Bejoy; Osrin, David; Pagel, Christina; Phiri, Tambosi; Pulkki-Braennstroem, Anni-Maria; Rosato, Mikey; Skordis-Worrall, Jolene; Saville, Naomi; More, Neena Shah; Shrestha, Bhim; Tripathy, Prasanta; Wilson, Amie; Costello, Anthony			Women's groups practising participatory learning and action to improve maternal and newborn health in low-resource settings: a systematic review and meta-analysis	LANCET			English	Review							BIRTH OUTCOMES; MORTALITY; INTERVENTION; CARE; BANGLADESH	Background Maternal and neonatal mortality rates remain high in many low-income and middle-income countries. Different approaches for the improvement of birth outcomes have been used in community-based interventions, with heterogeneous effects on survival. We assessed the effects of women's groups practising participatory learning and action, compared with usual care, on birth outcomes in low-resource settings. Methods We did a systematic review and meta-analysis of randomised controlled trials undertaken in Bangladesh, India, Malawi, and Nepal in which the effects of women's groups practising participatory learning and action were assessed to identify population-level predictors of effect on maternal mortality, neonatal mortality, and stillbirths. We also reviewed the cost-effectiveness of the women's group intervention and estimated its potential effect at scale in Countdown countries. Findings Seven trials (119 428 births) met the inclusion criteria. Meta-analyses of all trials showed that exposure to women's groups was associated with a 37% reduction in maternal mortality (odds ratio 0.63, 95% CI 0.32-0.94), a 23% reduction in neonatal mortality (0.77, 0.65-0.90), and a 9% non-significant reduction in stillbirths (0.91, 0.79-1.03), with high heterogeneity for maternal (I-2=58.8%, p=0.024) and neonatal results (I-2=64.7%, p=0.009). In the meta-regression analyses, the proportion of pregnant women in groups was linearly associated with reduction in both maternal and neonatal mortality (p=0.026 and p=0.011, respectively). A subgroup analysis of the four studies in which at least 30% of pregnant women participated in groups showed a 55% reduction in maternal mortality (0.45, 0.17-0.73) and a 33% reduction in neonatal mortality (0.67, 0.59-0.74). The intervention was cost effective by WHO standards and could save an estimated 283 000 newborn infants and 41 100 mothers per year if implemented in rural areas of 74 Countdown countries. Interpretation With the participation of at least a third of pregnant women and adequate population coverage, women's groups practising participatory learning and action are a cost-effective strategy to improve maternal and neonatal survival in low-resource settings.	[Prost, Audrey; Colbourn, Tim; Seward, Nadine; Houweling, Tanja A. J.; Fottrell, Edward; Lewycka, Sonia; Morrison, Joanna; Nambiar, Bejoy; Osrin, David; Pulkki-Braennstroem, Anni-Maria; Rosato, Mikey; Skordis-Worrall, Jolene; Saville, Naomi; Costello, Anthony] UCL, Inst Global Hlth, London WC1N 1EH, England; [Azad, Kishwar; Kuddus, Abdul] Diabet Assoc Bangladesh, Perinatal Care Project, Dhaka, Bangladesh; [Coomarasamy, Arri; MacArthur, Christine; Wilson, Amie] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Copas, Andrew] UCL, Mortimer Market Ctr, Ctr Sexual Hlth & HIV Res, London, England; [Houweling, Tanja A. J.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Lewycka, Sonia; Phiri, Tambosi; Rosato, Mikey] MaiMwana Project, Mchinji, Malawi; [Manandhar, Dharma; Morrison, Joanna; Saville, Naomi; Shrestha, Bhim] Mother Infant Res Act, Kathmandu, Nepal; [Mwansambo, Charles] Govt Malawi, Minist Hlth, Lilongwe, Malawi; [Nair, Nirmala; Tripathy, Prasanta] Ekjut, Jharkhand, India; [Nambiar, Bejoy] Parent & Child Hlth Initiat, Lilongwe, Malawi; [Pagel, Christina] UCL, Dept Math, Clin Operat Res Unit, London, England	University of London; University College London; University of Birmingham; University of London; University College London; Erasmus University Rotterdam; Erasmus MC; University of London; University College London	Prost, A (corresponding author), UCL, Inst Global Hlth, 30 Guilford St, London WC1N 1EH, England.	audrey.prost@ucl.ac.uk	Houweling, Tanja/GRF-6127-2022; Lewycka, Sonia/J-1234-2019; Colbourn, Tim/AAE-6645-2019; Wilson, Amie/HHS-0117-2022; MacArthur, Christine/ABA-8601-2021; Saville, Naomi/J-7244-2015	Lewycka, Sonia/0000-0002-5923-9468; Colbourn, Tim/0000-0002-6917-6552; Wilson, Amie/0000-0002-1015-3786; MacArthur, Christine/0000-0003-0434-2158; Copas, Andrew/0000-0001-8968-5963; Skordis, Jolene/0000-0002-8633-0208; Pulkki-Brannstrom, Anni-Maria/0000-0001-8723-8131; Morrison, Joanna/0000-0002-9241-8863; Houweling, Tanja AJ/0000-0001-6090-4376; Pagel, Christina/0000-0002-2857-1628; Nambiar, Bejoy/0000-0002-1742-522X; Saville, Naomi/0000-0002-1735-3684; Fottrell, Edward/0000-0003-0518-7161	Wellcome Trust [085417MA/Z/08/Z]; Ammalife (UK) [1120236]; National Institute for Health Research; Black Country programme; ESRC [ES/I033572/1] Funding Source: UKRI; Economic and Social Research Council [ES/I033572/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Ammalife (UK); National Institute for Health Research(National Institute for Health Research (NIHR)); Black Country programme; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The study was funded by a Wellcome Trust Strategic Award (number 085417MA/Z/08/Z). AW's PhD, to which this work is related, is funded by Ammalife (UK registered charity number 1120236), and CMa is part funded by the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care for Birmingham and the Black Country programme. We thank Neha Batura and Hassan Haghparast-Bidgoli for their assistance in preparing the cost-effectiveness analysis.	[Anonymous], LEV TRENDS CHILD MOR; Azad K, 2010, LANCET, V375, P1193, DOI 10.1016/S0140-6736(10)60142-0; Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS92, DOI 10.1038/sj.jp.7211277; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Bhutta ZA, 2011, LANCET, V377, P403, DOI 10.1016/S0140-6736(10)62274-X; Borghi J, 2005, LANCET, V366, P1882, DOI 10.1016/S0140-6736(05)67758-6; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Colbourn T, INT HLTH IN PRESS; Costello A, 2012, INDIAN PEDIATR, V49, P73; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fottrell E, JAMA IN PRESS; Gogia S, 2011, INDIAN PEDIATR, V48, P537, DOI 10.1007/s13312-011-0096-8; Harbord R, 2009, METAANALYSIS STATA U, P70; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Houweling TAJ, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-208; Howard-Grabman L., 2003, MOBILIZE COMMUNITIES; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Lassi Z, 2010, COCHRANE DB SYST REV, V11; Laverack G, 1999, THESIS DEAKIN U; Lee ACC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S10; Lewycka S, 2013, LANCET, V381, P1721, DOI 10.1016/S0140-6736(12)61959-X; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; More NS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001257; Morrison J, 2010, INT HEALTH, V2, P25, DOI 10.1016/j.inhe.2009.11.004; Rath S, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-25; Rosato M, 2010, UMODZI TOGETHER FILM; Rosato M, 2012, THESIS U COLL LONDON; Rosato M, 2008, LANCET, V372, P962, DOI 10.1016/S0140-6736(08)61406-3; Tripathy P, 2010, LANCET, V375, P1182, DOI 10.1016/S0140-6736(09)62042-0; UCL, 2012, WOM CHILDR 1 COMM MO; Wallerstein N, 1992, Am J Health Promot, V6, P197; WHO, 2002, RED RISKS PROM HLTH, P108; WHO UNICEF, COUNTD 2015 BUILD FU; World Health Organization, 1993, INT CLASS DIS REL HL, V2	37	374	373	0	68	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 18	2013	381	9879					1736	1746		10.1016/S0140-6736(13)60685-6	http://dx.doi.org/10.1016/S0140-6736(13)60685-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146TA	23683640	Green Accepted, Green Published			2022-12-28	WOS:000319112800038
J	Cheung, WWL; Watson, R; Pauly, D				Cheung, William W. L.; Watson, Reg; Pauly, Daniel			Signature of ocean warming in global fisheries catch	NATURE			English	Article							CLIMATE-CHANGE; FISH ASSEMBLAGE; IMPACTS; SHIFTS; VULNERABILITY; SEA	Marine fishes and invertebrates respond to ocean warming through distribution shifts, generally to higher latitudes and deeper waters. Consequently, fisheries should be affected by 'tropicalization' of catch(1-4) (increasing dominance of warm-water species). However, a signature of such climate-change effects on global fisheries catch has so far not been detected. Here we report such an index, the mean temperature of the catch (MTC), that is calculated from the average inferred temperature preference of exploited species weighted by their annual catch. Our results show that, after accounting for the effects of fishing and large-scale oceanographic variability, global MTC increased at a rate of 0.19 degrees Celsius per decade between 1970 and 2006, and non-tropical MTC increased at a rate of 0.23 degrees Celsius per decade. In tropical areas, MTC increased initially because of the reduction in the proportion of subtropical species catches, but subsequently stabilized as scope for further tropicalization of communities became limited. Changes in MTC in 52 large marine ecosystems, covering the majority of the world's coastal and shelf areas, are significantly and positively related to regional changes in sea surface temperature(5). This study shows that ocean warming has already affected global fisheries in the past four decades, highlighting the immediate need to develop adaptation plans to minimize the effect of such warming on the economy and food security of coastal communities, particularly in tropical regions(6,7).	[Cheung, William W. L.] Univ British Columbia, Changing Ocean Res Unit, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada; [Watson, Reg] Univ Tasmania, Inst Marine & Antarctic Studies, Taroona, Tas 7001, Australia; [Pauly, Daniel] Univ British Columbia, Sea Us Project, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of Tasmania; University of British Columbia	Cheung, WWL (corresponding author), Univ British Columbia, Changing Ocean Res Unit, Fisheries Ctr, Vancouver, BC V6T 1Z4, Canada.	w.cheung@fisheries.ubc.ca	Watson, Reg A/F-4850-2012; Cheung, William/F-5104-2013; Pauly, Daniel Marc/AAY-2316-2021	Watson, Reg A/0000-0001-7201-8865; Cheung, William/0000-0003-3626-1045; Pauly, Daniel/0000-0003-3756-4793	National Geographic Society; Natural Sciences and Engineering Research Council of Canada; Pew Charitable Trust through the Sea Around Us project	National Geographic Society(National Geographic Society); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Pew Charitable Trust through the Sea Around Us project	W.W.L.C. acknowledges funding support from the National Geographic Society and the Natural Sciences and Engineering Research Council of Canada. R. W. and D. P. were supported by the Pew Charitable Trust through the Sea Around Us project. We are grateful to S. Pauly and D. Palomares for reviewing the manuscript and providing the Aquamap distributions from FishBase, respectively.	Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Blanchard JL, 2012, PHILOS T R SOC B, V367, P2979, DOI 10.1098/rstb.2012.0231; Cheung WWL, 2007, MAR ECOL PROG SER, V333, P1, DOI 10.3354/meps333001; Cheung WWL, 2013, NAT CLIM CHANGE, V3, P254, DOI 10.1038/NCLIMATE1691; Cheung WWL, 2012, AQUAT CONSERV, V22, P368, DOI 10.1002/aqc.2248; Cheung WWL, 2012, MAR FRESHWATER RES, V63, P415, DOI 10.1071/MF11205; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Collie JS, 2008, CAN J FISH AQUAT SCI, V65, P1352, DOI 10.1139/F08-048; Costello C., 2012, SCIENCE; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Harley CDG, 2011, SCIENCE, V334, P1124, DOI 10.1126/science.1210199; Howell P, 2012, MAR COAST FISH, V4, P481, DOI 10.1080/19425120.2012.685144; Jones MC, 2012, ECOL MODEL, V225, P133, DOI 10.1016/j.ecolmodel.2011.11.003; Lasram FB, 2010, GLOBAL CHANGE BIOL, V16, P3233, DOI 10.1111/j.1365-2486.2010.02224.x; McGowan JA, 1998, SCIENCE, V281, P210, DOI 10.1126/science.281.5374.210; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pinsky ML, 2012, CLIMATIC CHANGE, V115, P883, DOI 10.1007/s10584-012-0599-x; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Rockmann C, 2011, ICES J MAR SCI, V68, P537, DOI 10.1093/icesjms/fsq171; Simpson SD, 2011, CURR BIOL, V21, P1565, DOI 10.1016/j.cub.2011.08.016; Sumaila UR, 2011, NAT CLIM CHANGE, V1, P449, DOI 10.1038/NCLIMATE1301; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Watson R, 2004, FISH FISH, V5, P168, DOI 10.1111/j.1467-2979.2004.00142.x; Watson R, 2001, NATURE, V414, P534, DOI 10.1038/35107050; Watson R. A., 2012, FISH FISH; Wernberg T, 2013, NAT CLIM CHANGE, V3, P78, DOI [10.1038/NCLIMATE1627, 10.1038/nclimate1627]	30	491	515	16	521	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 16	2013	497	7449					365	+		10.1038/nature12156	http://dx.doi.org/10.1038/nature12156			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23676754				2022-12-28	WOS:000318952000037
J	Bergmann, O; Frisen, J				Bergmann, Olaf; Frisen, Jonas			Why Adults Need New Brain Cells	SCIENCE			English	Editorial Material							SPINAL-CORD; NEUROGENESIS; NEURONS; ORIGIN; SCAR		[Bergmann, Olaf; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet	Bergmann, O (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	jonas.frisen@ki.se	Bergmann, Olaf/A-5706-2009	Bergmann, Olaf/0000-0003-1065-4107				Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Bergmann O, 2012, NEURON, V74, P634, DOI 10.1016/j.neuron.2012.03.030; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Fields RD, 2010, SCIENCE, V330, P768, DOI 10.1126/science.1199139; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Freund J, 2013, SCIENCE, V340, P756, DOI 10.1126/science.1235294; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Kheirbek MA, 2012, NAT NEUROSCI, V15, P1613, DOI 10.1038/nn.3262; Lindvall O, 2011, STROKE, V42, P2369, DOI 10.1161/STROKEAHA.110.599654; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	15	12	12	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					695	696		10.1126/science.1237976	http://dx.doi.org/10.1126/science.1237976			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661750				2022-12-28	WOS:000318619000026
J	Green, P; Ewing, B				Green, Phil; Ewing, Brent			Comment on "Evidence of Abundant Purifying Selection in Humans for Recently Acquired Regulatory Functions"	SCIENCE			English	Editorial Material							GENOME	Ward and Kellis (Reports, 28 September 2012, p. 1675; published online 5 September 2012) found altered patterns of human polymorphism in biochemically active but non-mammalian-conserved genomic regions relative to control regions and interpreted this as due to lineage-specific purifying selection. We find on closer inspection of their data that the polymorphism trends are primarily attributable to mutational variation and technical artifacts rather than selection.	[Green, Phil; Ewing, Brent] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Green, P (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	phg@uw.edu						Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; *ENCODE PROJ CON, 2012, NATURE, V57, P489; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	7	13	13	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133								10.1126/science.1233195	http://dx.doi.org/10.1126/science.1233195			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661742				2022-12-28	WOS:000318619000045
J	Shitrit, N; Yulevich, I; Maguid, E; Ozeri, D; Veksler, D; Kleiner, V; Hasman, E				Shitrit, Nir; Yulevich, Igor; Maguid, Elhanan; Ozeri, Dror; Veksler, Dekel; Kleiner, Vladimir; Hasman, Erez			Spin-Optical Metamaterial Route to Spin-Controlled Photonics	SCIENCE			English	Article							LIGHT; REFRACTION; PHASE	Spin optics provides a route to control light, whereby the photon helicity (spin angular momentum) degeneracy is removed due to a geometric gradient onto a metasurface. The alliance of spin optics and metamaterials offers the dispersion engineering of a structured matter in a polarization helicity-dependent manner. We show that polarization-controlled optical modes of metamaterials arise where the spatial inversion symmetry is violated. The emerged spin-split dispersion of spontaneous emission originates from the spin-orbit interaction of light, generating a selection rule based on symmetry restrictions in a spin-optical metamaterial. The inversion asymmetric metasurface is obtained via anisotropic optical antenna patterns. This type of metamaterial provides a route for spin-controlled nanophotonic applications based on the design of the metasurface symmetry properties.	[Hasman, Erez] Technion Israel Inst Technol, Fac Mech Engn, Micro & Nanoopt Lab, IL-32000 Haifa, Israel; Technion Israel Inst Technol, Russell Berrie Nanotechnol Inst, IL-32000 Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology	Hasman, E (corresponding author), Technion Israel Inst Technol, Fac Mech Engn, Micro & Nanoopt Lab, IL-32000 Haifa, Israel.	mehasman@technion.ac.il	Shitrit, Nir/HHC-8556-2022	Shitrit, Nir/0000-0003-2929-9707	Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	This research was supported by the Israel Science Foundation.	Barnard ES, 2011, NAT NANOTECHNOL, V6, P588, DOI [10.1038/nnano.2011.131, 10.1038/NNANO.2011.131]; BERRY MV, 1987, J MOD OPTIC, V34, P1401, DOI 10.1080/09500348714551321; Bliokh KY, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.030404; Bliokh KY, 2008, NAT PHOTONICS, V2, P748, DOI 10.1038/nphoton.2008.229; Bomzon Z, 2001, OPT LETT, V26, P1424, DOI 10.1364/OL.26.001424; Cai WS, 2007, NAT PHOTONICS, V1, P224, DOI 10.1038/nphoton.2007.28; Collett E., 1993, POLARIZED LIGHT FUND; Dahan N, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136402; Ebbesen TW, 1998, NATURE, V391, P667, DOI 10.1038/35570; Frischwasser K, 2011, OPT EXPRESS, V19, P23475, DOI 10.1364/OE.19.023475; Gansel JK, 2009, SCIENCE, V325, P1513, DOI 10.1126/science.1177031; Gorodetski Y, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.043903; Grohol D, 2005, NAT MATER, V4, P323, DOI 10.1038/nmat1353; Hosten O, 2008, SCIENCE, V319, P787, DOI 10.1126/science.1152697; Ishizaka K, 2011, NAT MATER, V10, P521, DOI [10.1038/NMAT3051, 10.1038/nmat3051]; Jacob Z, 2006, OPT EXPRESS, V14, P8247, DOI 10.1364/OE.14.008247; King PDC, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.096802; Krishnamoorthy HNS, 2012, SCIENCE, V336, P205, DOI 10.1126/science.1219171; LIBERMAN VS, 1992, PHYS REV A, V46, P5199, DOI 10.1103/PhysRevA.46.5199; Litchinitser NM, 2012, SCIENCE, V337, P1054, DOI 10.1126/science.1226204; Moessner R, 2006, PHYS TODAY, V59, P24, DOI 10.1063/1.2186278; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; RASHBA EI, 1960, SOV PHYS-SOL STATE, V2, P1109; Rogacheva AV, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.177401; Schiffrin A, 2013, NATURE, V493, P70, DOI 10.1038/nature11567; Schweika W, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.067201; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Shitrit N, 2011, NANO LETT, V11, P2038, DOI 10.1021/nl2004835; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713; Zhang S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.023901	31	367	379	11	402	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					724	726		10.1126/science.1234892	http://dx.doi.org/10.1126/science.1234892			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661756				2022-12-28	WOS:000318619000033
J	Weaire, D				Weaire, Denis			A Fresh Start for Foam Physics	SCIENCE			English	Editorial Material									Trinity Coll Dublin, Sch Phys, Dublin 2, Ireland	Trinity College Dublin	Weaire, D (corresponding author), Trinity Coll Dublin, Sch Phys, Dublin 2, Ireland.	dweaire@tcd.ie						Brakke K.A., 1992, EXP MATH, V1, P141, DOI [DOI 10.1080/10586458.1992.10504253, 10.1080/10586458.1992.10504253]; Kelvin L., 1887, PHILOS MAG, V24, P503, DOI [10.1080, 10.1080/14786448708628135, DOI 10.1080/14786448708628135]; Plateau J., 1873, STATIQUE EXPT THEORI; Saye RI, 2013, SCIENCE, V340, P720, DOI 10.1126/science.1230623; Stevenson P., 2012, FOAM ENG FUNDAMENTAL	5	1	2	3	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					693	694		10.1126/science.1238247	http://dx.doi.org/10.1126/science.1238247			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661748				2022-12-28	WOS:000318619000024
J	Zhang, G; Li, JX; Purkayastha, S; Tang, YZ; Zhang, H; Yin, Y; Li, B; Liu, G; Cai, DS				Zhang, Guo; Li, Juxue; Purkayastha, Sudarshana; Tang, Yizhe; Zhang, Hai; Yin, Ye; Li, Bo; Liu, Gang; Cai, Dongsheng			Hypothalamic programming of systemic ageing involving IKK-beta, NF-kappa B and GnRH	NATURE			English	Article							TUMOR-NECROSIS-FACTOR; EXTENDS LIFE-SPAN; MOUSE MODEL; NEURONS; MICROGLIA; LONGEVITY; OBESITY; MICE; INFLAMMATION; NEUROGENESIS	Ageing is a result of gradual and overall functional deteriorations across the body; however, it is unknown whether an individual tissue primarily works to mediate the ageing progress and control lifespan. Here we show that the hypothalamus is important for the development of whole-body ageing in mice, and that the underlying basis involves hypothalamic immunity mediated by I kappa B kinase-beta (IKK-beta), nuclear factor kappa B (NF-kappa B) and related microglianeuron immune crosstalk. Several interventional models were developed showing that ageing retardation and lifespan extension are achieved in mice by preventing ageing-related hypothalamic or brain IKK-beta and NF-kappa B activation. Mechanistic studies further revealed that IKK-beta and NF-kappa B inhibit gonadotropin-releasing hormone (GnRH) to mediate ageing-related hypothalamic GnRH decline, and GnRH treatment amends ageing-impaired neurogenesis and decelerates ageing. In conclusion, the hypothalamus has a programmatic role in ageing development via immune-neuroendocrine integration, and immune inhibition or GnRH restoration in the hypothalamus/brain represent two potential strategies for optimizing lifespan and combating ageing-related health problems.	[Zhang, Guo; Li, Juxue; Purkayastha, Sudarshana; Tang, Yizhe; Zhang, Hai; Yin, Ye; Li, Bo; Liu, Gang; Cai, Dongsheng] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Zhang, Guo; Li, Juxue; Purkayastha, Sudarshana; Tang, Yizhe; Zhang, Hai; Yin, Ye; Li, Bo; Liu, Gang; Cai, Dongsheng] Albert Einstein Coll Med, Diabet Res Ctr, Bronx, NY 10461 USA; [Zhang, Guo; Li, Juxue; Purkayastha, Sudarshana; Tang, Yizhe; Zhang, Hai; Yin, Ye; Li, Bo; Liu, Gang; Cai, Dongsheng] Albert Einstein Coll Med, Inst Aging, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Cai, DS (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA.	dongsheng.cai@einstein.yu.edu	Tang, Yizhe/A-8682-2014; Zhang, Guo/Q-8513-2016	Tang, Yizhe/0000-0001-5354-478X; Zhang, Guo/0000-0002-3880-6996; Zhang, Guo/0000-0003-0841-4710; Li, Bo/0000-0003-2783-9300	National Institutes of Health (NIH) [R01 AG031774, R01 DK078750]; American Diabetes Association [1-12-BS-20]; Irma T. Hirschl Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031774] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Irma T. Hirschl Scholarship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank other Cai laboratory members for technical assistance, and L. Farhana, D. Stocco, L. Eckhardt, T. Ohshima, A. Lin and D. Tantin for reagents. This study was supported by National Institutes of Health (NIH) grants R01 AG031774, R01 DK078750, and American Diabetes Association grant 1-12-BS-20 (all to D. C.). D. C. is a recipient of Irma T. Hirschl Scholarship.	Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507; Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Banks WA, 2010, P NATL ACAD SCI USA, V107, P22272, DOI 10.1073/pnas.1016369107; BARGER SW, 1995, P NATL ACAD SCI USA, V92, P9328, DOI 10.1073/pnas.92.20.9328; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Finch C E, 2002, Adv Gerontol, V10, P35; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Fridell YWC, 2005, CELL METAB, V1, P145, DOI 10.1016/j.cmet.2005.01.005; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Huang W, 2009, MOL CELL, V35, P48, DOI 10.1016/j.molcel.2009.05.023; Kaltschmidt B, 2006, MOL CELL BIOL, V26, P2936, DOI 10.1128/MCB.26.8.2936-2946.2006; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Li JX, 2012, NAT CELL BIOL, V14, P999, DOI 10.1038/ncb2562; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Martin GM, 2009, AGING CELL, V8, P761, DOI 10.1111/j.1474-9726.2009.00515.x; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Meng QY, 2011, J BIOL CHEM, V286, P32324, DOI 10.1074/jbc.M111.254417; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Miller RA, 2012, J GERONTOL A-BIOL, V67, P495, DOI 10.1093/gerona/gls082; Mueller JM, 2000, METH MOL B, V99, P205; O'Mahony A, 2006, MOL CELL BIOL, V26, P7283, DOI 10.1128/MCB.00510-06; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Peng BL, 2010, P NATL ACAD SCI USA, V107, P15193, DOI 10.1073/pnas.1005533107; Purkayastha S, 2011, NAT MED, V17, P883, DOI 10.1038/nm.2372; Purkayastha S, 2011, P NATL ACAD SCI USA, V108, P2939, DOI 10.1073/pnas.1006875108; Ramanadham S, 2008, AM J PATHOL, V172, P868, DOI 10.2353/ajpath.2008.070756; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Saijo K, 2011, CELL, V145, P584, DOI 10.1016/j.cell.2011.03.050; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Taoufik E, 2011, BRAIN, V134, P2722, DOI 10.1093/brain/awr203; Tillerson JL, 2003, J NEUROSCI METH, V123, P189, DOI 10.1016/S0165-0270(02)00360-6; Villeda S, 2008, NEURON, V59, P527, DOI 10.1016/j.neuron.2008.08.005; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Wang CX, 2004, MECH AGEING DEV, V125, P629, DOI 10.1016/j.mad.2004.07.003; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zitnik G, 2002, J NEUROSCI RES, V70, P258, DOI 10.1002/jnr.10384	44	574	600	7	191	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 9	2013	497	7448					211	+		10.1038/nature12143	http://dx.doi.org/10.1038/nature12143			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23636330	Green Accepted			2022-12-28	WOS:000318558200030
J	Gasparini, M; Proclemer, A; Klersy, C; Kloppe, A; Lunati, M; Ferrer, JBM; Hersi, A; Gulaj, M; Wijfels, MCEF; Santi, E; Manotta, L; Arenal, A				Gasparini, Maurizio; Proclemer, Alessandro; Klersy, Catherine; Kloppe, Axel; Lunati, Maurizio; Martinez Ferrer, Jose Bautista; Hersi, Ahmad; Gulaj, Marcin; Wijfels, Maurits C. E. F.; Santi, Elisabetta; Manotta, Laura; Arenal, Angel			Effect of Long-Detection Interval vs Standard-Detection Interval for Implantable Cardioverter-Defibrillators on Antitachycardia Pacing and Shock Delivery The ADVANCE III Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEART-FAILURE; PRIMARY PREVENTION; THERAPY; ICD; TACHYCARDIA; AMIODARONE; REDUCTION; SURVIVAL	Importance Using more intervals to detect ventricular tachyarrhythmias has been associated with reducing unnecessary implantable cardioverter-defibrillator (ICD) therapies. Objective To determine whether using 30 of 40 intervals to detect ventricular arrhythmias (VT) (long detection) during spontaneous fast VT episodes reduces antitachycardia pacing (ATP) and shock delivery more than 18 of 24 intervals (standard detection). Design, Setting, and Participants Randomized, single-blind, parallel-group trial that enrolled 1902 primary and secondary prevention patients (mean [SD] age, 65 [11] years; 84% men; 75% primary prevention ICD) with ischemic and nonischemic etiology undergoing first ICD implant at 1 of 94 international centers (March 2008-December 2010). Interventions Patients were randomized 1: 1 to programming with long- (n=948) or standard-detection (n=954) intervals. Main Outcomes and Measures Total number of ATPs and shocks delivered for all episodes (primary outcomes) and inappropriate shocks, mortality, and syncopal rate (secondary outcomes). Results During a median follow-up of 12 months (interquartile range, 11-13), long-detection group had 346 delivered therapies (42 therapies per 100 person-years, 95% CI, 38-47) vs 557 in the standard-detection group (67 therapies per 100 person-years [95% CI, 62-73]; incident rate ratio [IRR], 0.63 [95% CI, 0.51-0.78]; P<.001). The long- vs the standard-detection group experienced 23 ATPs per 100 person-years (95% CI, 20-27) vs 37 ATPs per 100 person-years (95% CI, 33-41; IRR, 0.58 [95% CI, 0.47-0.72]; P<.001); 19 shocks per 100 person-years (95% CI, 16-22) vs 30 shocks per 100 person-years (95% CI, 26-34; IRR, 0.77 [95% CI, 0.59-1.01]; P=.06), with a significant difference in the probability of therapy occurrence (P<.001); and a reduction in first occurrence of inappropriate shock (5.1 per 100 patient-years [95% CI, 3.7-6.9] vs 11.6 [95% CI, 9.4-14.1]; IRR, 0.55 [95% CI, 0.36-0.85]; P=.008). Mortality (5.5 [95% CI, 4.0-7.2] vs 6.3 [95% CI, 4.8-8.2] per 100 patient-years; HR, 0.87; P=.50) and arrhythmic syncope rates (3.1 [95% CI, 2.6-4.6] vs 1.9 [95% CI, 1.1-3.1] per 100 patient-years; IRR, 1.60 [95% CI, 0.76-3.41]; P=.22) did not differ significantly between groups. Conclusions and Relevance Among patients receiving an ICD, the use of a long- vs standard-detection interval resulted in a lower rate of ATP and shocks, and inappropriate shocks. This programming strategy may be an appropriate alternative.	[Gasparini, Maurizio] Humanitas Clin & Res Ctr, I-20089 Rozzano, MI, Italy; [Proclemer, Alessandro] Azienda Osped Univ S Maria della Misericordia, Udine, Italy; [Klersy, Catherine] IRCCS Policlin San Matteo, Pavia, Italy; [Kloppe, Axel] Berufsgenossenschaftliches Univ Klinikum Bergmann, Med Klin 2, Bochum, Germany; [Lunati, Maurizio] Piazza Osped Maggiore, Azienda Osped Niguarda Ca Granda, Milan, Italy; [Martinez Ferrer, Jose Bautista] Hosp Txagorritxu, Vitoria, Spain; [Hersi, Ahmad] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia; [Gulaj, Marcin] MSWiA Hosp, Bialystok, Poland; [Wijfels, Maurits C. E. F.] St Antonius Ziekenhuis Hosp, Nieuwegein, Netherlands; [Santi, Elisabetta] Medtron Clin Res Inst, Rome, Italy; [Manotta, Laura] Medtron Clin Res Inst, Sesto San Giovanni, Italy; [Arenal, Angel] Hosp Gen Univ Gregorio Maranon, Madrid, Spain	IRCCS Humanitas Research Hospital; Hospital Santa Maria della Misericordia; IRCCS Fondazione San Matteo; Ruhr University Bochum; University of Hamburg; University Medical Center Hamburg-Eppendorf; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; University Hospital of Araba; King Saud University; St. Antonius Hospital Utrecht; General University Gregorio Maranon Hospital	Gasparini, M (corresponding author), Humanitas Clin & Res Ctr, Electrophysiol & Pacing Unit, Via Manzoni 56, I-20089 Rozzano, MI, Italy.	maurizio.gasparini@humanitas.it	Hersi, Ahmad/ABC-9266-2020; klersy, catherine/AAA-3003-2019; Gasparini, Maurizio/GZL-4963-2022	klersy, catherine/0000-0003-0314-8548; Gasparini, Maurizio/0000-0002-1365-7357; Arenal Maiz, Angel/0000-0001-6636-5473	Biosense-Webster; Medtronic Inc.	Biosense-Webster; Medtronic Inc.(Medtronic)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Gasparini reports serving on the advisory board for Medtronic and Boston SCI. Dr Proclemer reports serving on the advisory board for Medtronic. Dr Klersy reports serving as a statistical consultant for Medtronic. Dr Kloppe reports serving as speaker for Medtronic. Dr Martinez Ferrer reports serving as lecturer and consultant for Medtronic. Dr Lunati reports serving as a consultant for Medtronic, Sorin, Boston SCI, and St Jude Medical. Dr Hersi reports serving as a lecturer for Boehringer-Ingelheim. Dr Gulaj reports serving as a consultant for Biotronik, Medtronic, and Boston SCI, and as a lecturer for Medtronic. Dr Wijffels reports serving as proctor and lecturer for Medtronic. Dr Arenal reports serving as a consultant for Boston SCI and receiving a grant from Biosense-Webster.; The ADVANCE III study was supported financially by Medtronic Inc.	Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Dichtl W, 2011, CLIN CARDIOL, V34, P433, DOI 10.1002/clc.20910; Friedman PA, 2006, CIRCULATION, V113, P2871, DOI 10.1161/CIRCULATIONAHA.105.594531; Gasparini M, 2008, AM HEART J, V156, P847, DOI 10.1016/j.ahj.2008.06.035; Gasparini M, 2010, AM HEART J, V159, P1116, DOI 10.1016/j.ahj.2010.02.007; Gasparini M, 2009, EUR HEART J, V30, P2758, DOI 10.1093/eurheartj/ehp247; Gilliam FR, 2011, J CARDIOVASC ELECTR, V22, P1023, DOI 10.1111/j.1540-8167.2011.02086.x; Mansour F, 2011, PACE, V34, P506, DOI 10.1111/j.1540-8159.2011.03037.x; Mark DB, 2008, NEW ENGL J MED, V359, P999, DOI 10.1056/NEJMoa0706719; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Moss AJ, 2012, NEW ENGL J MED, V367, P2275, DOI 10.1056/NEJMoa1211107; Poole JE, 2008, NEW ENGL J MED, V359, P1009, DOI 10.1056/NEJMoa071098; Santini M, 2010, J INTERV CARD ELECTR, V27, P127, DOI 10.1007/s10840-009-9454-z; Saxon LA, 2010, CIRCULATION, V122, P2359, DOI 10.1161/CIRCULATIONAHA.110.960633; Schwab JO, 2009, J CARDIOVASC ELECTR, V20, P663, DOI 10.1111/j.1540-8167.2008.01415.x; Soundarraj D, 2006, PACE, V29, P810, DOI 10.1111/j.1540-8159.2006.00445.x; Sweeney MO, 2010, HEART RHYTHM, V7, P353, DOI 10.1016/j.hrthm.2009.11.027; Wathen MS, 2001, CIRCULATION, V104, P796, DOI 10.1161/hc3101.093906; Wilkoff BL, 2008, J AM COLL CARDIOL, V52, P541, DOI 10.1016/j.jacc.2008.05.011	20	281	283	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2013	309	18					1903	1911		10.1001/jama.2013.4598	http://dx.doi.org/10.1001/jama.2013.4598			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138AZ	23652522				2022-12-28	WOS:000318481900025
J	Palczewski, K; Kiser, PD				Palczewski, Krzysztof; Kiser, Philip D.			As Good as Chocolate	SCIENCE			English	Editorial Material							PROTEIN-COUPLED RECEPTOR; DRUG; DISCOVERY; SEROTONIN; RHODOPSIN; BIOLOGY		[Palczewski, Krzysztof; Kiser, Philip D.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 2109 Adelbert Rd, Cleveland, OH 44106 USA.	kxp65@case.edu; pdk7@case.edu			NATIONAL EYE INSTITUTE [R01EY008061, R29EY008061] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY008061, EY008061] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Boughner DR, 1997, CAN MED ASSOC J, V157, P705; Bruinsma K, 1999, J AM DIET ASSOC, V99, P1249, DOI 10.1016/S0002-8223(99)00307-7; Cowley G, 1997, Newsweek, V130, P46; ERSPAMER V, 1952, NATURE, V169, P800, DOI 10.1038/169800b0; Humphrey PPA, 2007, HEADACHE, V47, pS10, DOI 10.1111/j.1526-4610.2007.00672.x; Meyler WJ, 1996, CEPHALALGIA, V16, P5, DOI 10.1046/j.1468-2982.1996.1601005.x; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; RAPPORT MM, 1948, SCIENCE, V108, P329, DOI 10.1126/science.108.2804.329; REID G, 1952, NATURE, V169, P801, DOI 10.1038/169801a0; Roth BL, 2011, NEUROPHARMACOLOGY, V61, P348, DOI 10.1016/j.neuropharm.2011.01.012; Salon JA, 2011, PHARMACOL REV, V63, P901, DOI 10.1124/pr.110.003350; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807	15	3	3	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2013	340	6132					562	563		10.1126/science.1238521	http://dx.doi.org/10.1126/science.1238521			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23641106	Green Accepted			2022-12-28	WOS:000318268900037
J	Anger, AM; Armache, JP; Berninghausen, O; Habeck, M; Subklewe, M; Wilson, DN; Beckmann, R				Anger, Andreas M.; Armache, Jean-Paul; Berninghausen, Otto; Habeck, Michael; Subklewe, Marion; Wilson, Daniel N.; Beckmann, Roland			Structures of the human and Drosophila 80S ribosome	NATURE			English	Article							SECONDARY STRUCTURE; ELECTRON-MICROSCOPY; ATOMIC STRUCTURES; CRYSTAL-STRUCTURE; MESSENGER-RNA; SEQUENCE; SUBUNIT; INITIATION; VISUALIZATION; TRANSLATION	Protein synthesis in all cells is carried out by macromolecular machines called ribosomes. Although the structures of prokaryotic, yeast and protist ribosomes have been determined, the more complex molecular architecture of metazoan 80S ribosomes has so far remained elusive. Here we present structures of Drosophila melanogaster and Homo sapiens 80S ribosomes in complex with the translation factor eEF2, E-site transfer RNA and Stm1-like proteins, based on high-resolution cryo-electron-microscopy density maps. These structures not only illustrate the co-evolution of metazoan-specific ribosomal RNA with ribosomal proteins but also reveal the presence of two additional structural layers in metazoan ribosomes, a well-ordered inner layer covered by a flexible RNA outer layer. The human and Drosophila ribosome structures will provide the basis for more detailed structural, biochemical and genetic experiments.	[Anger, Andreas M.; Armache, Jean-Paul; Berninghausen, Otto; Wilson, Daniel N.; Beckmann, Roland] Univ Munich, Dept Biochem, Gene Ctr, D-81377 Munich, Germany; [Anger, Andreas M.; Armache, Jean-Paul; Berninghausen, Otto; Wilson, Daniel N.; Beckmann, Roland] Univ Munich, Ctr Integrated Prot Sci Munich CiPSM, D-81377 Munich, Germany; [Habeck, Michael] Max Planck Inst Biol Cybernet, Dept Empir Inference, D-72076 Tubingen, Germany; [Habeck, Michael] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany; [Subklewe, Marion] Klinikum Univ Munchen, Dept Internal Med 3, D-81377 Munich, Germany; [Subklewe, Marion] Helmholtz Inst Munich, Clin Cooperat Grp Immunotherapy, D-81377 Munich, Germany	University of Munich; University of Munich; Max Planck Society; Max Planck Society; University of Munich	Beckmann, R (corresponding author), Univ Munich, Dept Biochem, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	beckmann@lmb.uni-muenchen.de	Subklewe, Marion/N-5873-2014; Armache, Jean-Paul/U-3113-2019; Wilson, Daniel/AAE-8504-2019	Subklewe, Marion/0000-0001-9154-9469; Wilson, Daniel/0000-0003-3816-3828; Armache, Jean-Paul/0000-0001-9195-2282; Habeck, Michael/0000-0002-2188-5667	Deutsche Forschungsgemeinschaft [SFB594, SFB646, GRK 1721, FOR1805]; European Molecular Biology Organization (EMBO); European Research Council (ERC)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); European Research Council (ERC)(European Research Council (ERC))	We thank C. Ungewickell for assistance with cryo-EM data collection and P. Palluch for preparation of peripheral blood mononucleic cells. We thank M. Yusupov, A. Ben-Shem, N. Garreau de Loubresse and S. Melnikov for sharing S. cerevisiae X-ray data before publication. We thank P. Becker for access to his fly facility and help with embryo collection, and V. Marquez, T. Frohlich, G. Arnold, I. Forne and A. Imhof for mass-spectrometry analysis. This research was supported by grants from the Deutsche Forschungsgemeinschaft SFB594, SFB646 and GRK 1721 (to R.B.), and FOR1805 (to R. B. and D. N. W.). D. N. W. is supported by the European Molecular Biology Organization (EMBO) young investigator program. This work was supported by a European Research Council (ERC) Advanced Grant (to R.B.).	Alkemar G, 2006, BIOCHEMISTRY-US, V45, P8067, DOI 10.1021/bi052149z; Andersen CBF, 2006, NATURE, V443, P663, DOI 10.1038/nature05126; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19754, DOI 10.1073/pnas.1010005107; Balagopal V, 2011, RNA, V17, P835, DOI 10.1261/rna.2677311; Becker T, 2012, NATURE, V482, P501, DOI 10.1038/nature10829; Becker T, 2011, NAT STRUCT MOL BIOL, V18, P715, DOI 10.1038/nsmb.2057; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Blau M, 2005, NAT STRUCT MOL BIOL, V12, P1015, DOI 10.1038/nsmb998; Boehringer D, 2005, STRUCTURE, V13, P1695, DOI 10.1016/j.str.2005.08.008; Bradatsch B, 2012, NAT STRUCT MOL BIOL, V19, P1234, DOI 10.1038/nsmb.2438; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Chandramouli P, 2008, STRUCTURE, V16, P535, DOI 10.1016/j.str.2008.01.007; Demeshkina N, 2012, NATURE, V484, P256, DOI 10.1038/nature10913; Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706; Dube P, 1998, J MOL BIOL, V279, P403, DOI 10.1006/jmbi.1998.1804; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Fields DS, 1996, FOLD DES, V1, P419, DOI 10.1016/S1359-0278(96)00058-2; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fuss IJ, 2009, CURR PROTOC IMMUNOL, V85, DOI DOI 10.1002/0471142735.IM0701S85; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Gebauer F, 1999, EMBO J, V18, P6146, DOI 10.1093/emboj/18.21.6146; Gerbi S.A., 1996, RIBOSOMAL RNA STRUCT, P71; Greber BJ, 2012, NAT STRUCT MOL BIOL, V19, P1228, DOI 10.1038/nsmb.2425; HAGA JY, 1970, J CELL BIOL, V47, P211, DOI 10.1083/jcb.47.1.211; Harms JM, 2008, MOL CELL, V30, P26, DOI 10.1016/j.molcel.2008.01.009; Hirsch M, 2011, J COMPUT BIOL, V18, P335, DOI 10.1089/cmb.2010.0264; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jenner L, 2010, NAT STRUCT MOL BIOL, V17, P1072, DOI 10.1038/nsmb.1880; Jossinet F, 2005, BIOINFORMATICS, V21, P3320, DOI 10.1093/bioinformatics/bti504; Jossinet F, 2010, BIOINFORMATICS, V26, P2057, DOI 10.1093/bioinformatics/btq321; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Klinge S, 2012, TRENDS BIOCHEM SCI, V37, P189, DOI 10.1016/j.tibs.2012.02.007; Klinge S, 2011, SCIENCE, V334, P941, DOI 10.1126/science.1211204; Koyama Y, 1999, GENE, V226, P339, DOI 10.1016/S0378-1119(98)00529-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Leidig C, 2013, NAT STRUCT MOL BIOL, V20, P23, DOI 10.1038/nsmb.2447; Lu H, 2004, J PROTEOME RES, V3, P949, DOI 10.1021/pr0499592; MADEN BEH, 1987, BIOCHEM J, V246, P519, DOI 10.1042/bj2460519; Marquez V, 2011, J MOL BIOL, V405, P1215, DOI 10.1016/j.jmb.2010.11.055; Melnikov S, 2012, NAT STRUCT MOL BIOL, V19, P560, DOI 10.1038/nsmb.2313; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; NIERHAUS KH, 1974, P NATL ACAD SCI USA, V71, P4713, DOI 10.1073/pnas.71.12.4713; Norousi R., 2013, J STRUCT BIOL; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Ramakrishnan V, 1997, ANNU REV BIOPH BIOM, V26, P83, DOI 10.1146/annurev.biophys.26.1.83; ROUSSET F, 1991, P NATL ACAD SCI USA, V88, P10032, DOI 10.1073/pnas.88.22.10032; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; SRIVASTAVA S, 1992, J MOL BIOL, V226, P301, DOI 10.1016/0022-2836(92)90946-H; SWEENEY R, 1994, MOL CELL BIOL, V14, P4203, DOI 10.1128/MCB.14.6.4203; TAUTZ D, 1988, MOL BIOL EVOL, V5, P366; Taylor DJ, 2007, EMBO J, V26, P2421, DOI 10.1038/sj.emboj.7601677; Taylor DJ, 2009, STRUCTURE, V17, P1591, DOI 10.1016/j.str.2009.09.015; THOMPSON JF, 1981, J MOL BIOL, V147, P417, DOI 10.1016/0022-2836(81)90493-9; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wilson DN, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011536; Yu YP, 2011, NUCLEIC ACIDS RES, V39, P4851, DOI 10.1093/nar/gkr045	72	356	509	4	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					80	+		10.1038/nature12104	http://dx.doi.org/10.1038/nature12104			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23636399				2022-12-28	WOS:000318221500037
J	Ellis, O				Ellis, Oliver			Portfolio of pap	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												oli.ellis@googlemail.com						Booth S., 2011, RELATIONSHIP COMMUNI	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2013	346								f2708	10.1136/bmj.f2708	http://dx.doi.org/10.1136/bmj.f2708			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139EK	23635542				2022-12-28	WOS:000318564300017
J	Paneth, N				Paneth, Nigel			Restoring Science to the National Children's Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Paneth, Nigel] Michigan State Univ, Coll Human Med, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Paneth, Nigel] Michigan State Univ, Coll Human Med, Dept Pediat & Human Dev, E Lansing, MI 48824 USA	Michigan State University; Michigan State University College of Human Medicine; Michigan State University; Michigan State University College of Human Medicine	Paneth, N (corresponding author), Michigan State Univ, Coll Human Med, Dept Epidemiol & Biostat, 909 Fee Rd,Room 218, E Lansing, MI 48824 USA.	paneth@msu.edu						Annett R, COST EFFECTIVE FEASI; [Anonymous], 2010, NAT CHILDR STUD FED, P10; [Anonymous], 2013, FED REG; Belanger K, 2013, PAEDIATR PERINAT EP, V27, P20, DOI 10.1111/ppe.12005; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Kaiser J, 2013, SCIENCE, V339, P133, DOI 10.1126/science.339.6116.133; Manolio TA, 2012, AM J EPIDEMIOL, V175, P859, DOI 10.1093/aje/kwr453; National Aboriginal Community Controlled Health Organisation, 2011, CONC NAT CH IN PRESS, P5; National Institutes of Health Office of the Director, FY 2013 BUDG, P34; WEINBERG AM, 1961, SCIENCE, V134, P161, DOI 10.1126/science.134.3473.161	10	4	4	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2013	309	17					1775	1776		10.1001/jama.2013.3870	http://dx.doi.org/10.1001/jama.2013.3870			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134SU	23632717				2022-12-28	WOS:000318235600021
J	Fei, YW				Fei, Yingwei			Melting Earth's Core	SCIENCE			English	Editorial Material							IRON		Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA	Carnegie Institution for Science	Fei, YW (corresponding author), Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.	fei@gl.ciw.edu	Fei, Yingwei/F-3709-2011	Fei, Yingwei/0000-0001-9955-5353	Directorate For Geosciences [0963396] Funding Source: National Science Foundation; Division Of Earth Sciences [1144422] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Alfe D, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.165118; Anzellini S, 2013, SCIENCE, V340, P464, DOI 10.1126/science.1233514; BIRCH F, 1964, J GEOPHYS RES, V69, P4377, DOI 10.1029/JZ069i020p04377; BOEHLER R, 1993, NATURE, V363, P534, DOI 10.1038/363534a0; BROWN JM, 1986, J GEOPHYS RES-SOLID, V91, P7485, DOI 10.1029/JB091iB07p07485; Hemley RJ, 2001, INT GEOL REV, V43, P1; Komabayashi T, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006442; Sola E, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.078501; WILLIAMS Q, 1987, SCIENCE, V236, P181, DOI 10.1126/science.236.4798.181	9	7	7	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					442	443		10.1126/science.1236304	http://dx.doi.org/10.1126/science.1236304			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620044				2022-12-28	WOS:000318016700031
J	Cabral, RA; Jackson, MG; Rose-Koga, EF; Koga, KT; Whitehouse, MJ; Antonelli, MA; Farquhar, J; Day, JMD; Hauri, EH				Cabral, Rita A.; Jackson, Matthew G.; Rose-Koga, Estelle F.; Koga, Kenneth T.; Whitehouse, Martin J.; Antonelli, Michael A.; Farquhar, James; Day, James M. D.; Hauri, Erik H.			Anomalous sulphur isotopes in plume lavas reveal deep mantle storage of Archaean crust	NATURE			English	Article							MICROBIAL SULFATE REDUCTION; OCEANIC ISLAND BASALTS; MELT INCLUSIONS; ORIGIN; GEOCHEMISTRY; LITHOSPHERE; EVOLUTION; PLATEAU; DIAMOND; HIMU	Basaltic lavas erupted at some oceanic intraplate hotspot volcanoes are thought to sample ancient subducted crustal materials(1,2). However, the residence time of these subducted materials in the mantle is uncertain and model-dependent(3), and compelling evidence for their return to the surface in regions of mantle upwelling beneath hotspots is lacking. Here we report anomalous sulphur isotope signatures indicating mass-independent fractionation (MIF) in olivine-hosted sulphides from 20-million-year-old ocean island basalts from Mangaia, Cook Islands (Polynesia), which have been suggested to sample recycled oceanic crust(3,4). Terrestrial MIF sulphur isotope signatures (in which the amount of fractionation does not scale in proportion with the difference in the masses of the isotopes) were generated exclusively through atmospheric photochemical reactions until about 2.45 billion years ago(5-7). Therefore, the discovery of MIF sulphur in these young plume lavas suggests that sulphur-probably derived from hydrothermally altered oceanic crust-was subducted into the mantle before 2.45 billion years ago and recycled into the mantle source of Mangaia lavas. These new data provide evidence for ancient materials, with negative Delta S-33 values, in the mantle source for Mangaia lavas. Our data also complement evidence for recycling of the sulphur content of ancient sedimentary materials to the subcontinental lithospheric mantle that has been identified in diamond-hosted sulphide inclusions(8,9). This Archaean age for recycled oceanic crust also provides key constraints on the length of time that subducted crustal material can survive in the mantle, and on the timescales of mantle convection from subduction to upwelling beneath hotspots.	[Cabral, Rita A.; Jackson, Matthew G.] Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA; [Rose-Koga, Estelle F.; Koga, Kenneth T.] Univ Blaise Pascal, CNRS, UMR6524, Lab Magmas & Volcans,IRD R163, F-63038 Clermont Ferrand, France; [Whitehouse, Martin J.] Swedish Museum Nat Hist, SE-10405 Stockholm, Sweden; [Whitehouse, Martin J.] Stockholm Univ, Dept Geol Sci, SE-10691 Stockholm, Sweden; [Antonelli, Michael A.; Farquhar, James] Univ Maryland, Dept Geol, College Pk, MD 20742 USA; [Antonelli, Michael A.; Farquhar, James] Univ Maryland, ESSIC, College Pk, MD 20742 USA; [Day, James M. D.] Univ Calif San Diego, Scripps Inst Oceanog, Geosci Res Div, La Jolla, CA 92093 USA; [Hauri, Erik H.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA	Boston University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); Universite Clermont Auvergne (UCA); Swedish Museum of Natural History; Stockholm University; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University of California System; University of California San Diego; Scripps Institution of Oceanography; Carnegie Institution for Science	Cabral, RA (corresponding author), Boston Univ, Dept Earth & Environm, 675 Commonwealth Ave, Boston, MA 02215 USA.	racabral@bu.edu	Whitehouse, Martin J/E-1425-2013; Koga, Kenneth T./D-8170-2017; Rose-Koga, Estelle/AAM-5589-2021; Rose-Koga, Estelle F./H-5372-2018; Day, James/A-5099-2010	Whitehouse, Martin J/0000-0003-2227-577X; Koga, Kenneth T./0000-0002-0862-6804; Rose-Koga, Estelle/0000-0001-9704-5819; Rose-Koga, Estelle F./0000-0001-9704-5819; Day, James/0000-0001-9520-3465; Antonelli, Michael A./0000-0001-9587-7937; Jackson, Matthew/0000-0002-4557-6578	Boston University; NSF [EAR-1145202]; EU SYNTHESYS; French ANR SlabFlux; joint Nordic contract; Directorate For Geosciences [1116089] Funding Source: National Science Foundation	Boston University; NSF(National Science Foundation (NSF)); EU SYNTHESYS; French ANR SlabFlux(French National Research Agency (ANR)); joint Nordic contract; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	M.G.J. acknowledges Boston University start-up funds and NSF grant EAR-1145202 that supported this work. E.F.R.-K. and K. T. K. acknowledge support from EU SYNTHESYS and French ANR SlabFlux, this is Laboratory of Excellence ClerVolc contribution number 54. The NordSIMS facility is financed and operated under a joint Nordic contract; this is NordSIMS contribution number 337. We thank B. White for his review of the manuscript, and P. Cartigny and J. Labidi for discussion. We thank D. T. Johnston, D. Papineau, O. J. Rouxel and S. Ono for advice in compiling the global S-isotope database. We also thank N. Shimizu, B. D. Monteleone, E. A. Price, and P. Schiano for assistance with sample preparation.	Bao HM, 2007, GEOCHIM COSMOCHIM AC, V71, P4868, DOI 10.1016/j.gca.2007.05.032; Bekker A, 2009, SCIENCE, V326, P1086, DOI 10.1126/science.1177742; CHAUSSIDON M, 1989, EARTH PLANET SC LETT, V92, P144, DOI 10.1016/0012-821X(89)90042-3; Crowe DE, 1996, AM MINERAL, V81, P187; Farquhar J, 2005, GEOL SOC SPEC PUBL, V248, P167, DOI 10.1144/GSL.SP.2005.248.01.09; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2002, SCIENCE, V298, P2369, DOI 10.1126/science.1078617; Farquhar J, 2011, PHOTOSYNTH RES, V107, P11, DOI 10.1007/s11120-010-9594-0; FORREST J, 1977, ANAL CHEM, V49, P1579, DOI 10.1021/ac50019a030; Frey FA, 2000, EARTH PLANET SC LETT, V176, P73, DOI 10.1016/S0012-821X(99)00315-5; Grove TL, 2004, EARTH PLANET SC LETT, V219, P173, DOI 10.1016/S0012-821X(04)00002-0; Hanyu T, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003252; HAURI EH, 1993, EARTH PLANET SC LETT, V114, P353, DOI 10.1016/0012-821X(93)90036-9; HOFMANN AW, 1982, EARTH PLANET SC LETT, V57, P421, DOI 10.1016/0012-821X(82)90161-3; Jamieson JW, 2006, ECON GEOL, V101, P1055, DOI 10.2113/gsecongeo.101.5.1055; Johnston DT, 2011, EARTH-SCI REV, V106, P161, DOI 10.1016/j.earscirev.2011.02.003; Kamber BS, 2007, GEOBIOLOGY, V5, P5, DOI 10.1111/j.1472-4669.2006.00091.x; Kamenetsky VS, 2001, GEOLOGY, V29, P243, DOI 10.1130/0091-7613(2001)029<0243:ROGCLI>2.0.CO;2; Kelley KA, 2005, EARTH PLANET SC LETT, V234, P369, DOI 10.1016/j.epsl.2005.03.005; McLoughlin N, 2012, GEOLOGY, V40, P1031, DOI 10.1130/G33313.1; Niu YL, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002048; Ono S, 2006, GEOCHIM COSMOCHIM AC, V70, P2238, DOI 10.1016/j.gca.2006.01.022; Pilet S, 2008, SCIENCE, V320, P916, DOI 10.1126/science.1156563; Rose-Koga EF, 2012, CHEM GEOL, V334, P266, DOI 10.1016/j.chemgeo.2012.10.033; Rouxel O, 2008, EARTH PLANET SC LETT, V268, P110, DOI 10.1016/j.epsl.2008.01.010; Saal AE, 1998, SCIENCE, V282, P1481, DOI 10.1126/science.282.5393.1481; Shen YA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1217; Taylor B, 2006, EARTH PLANET SC LETT, V241, P372, DOI 10.1016/j.epsl.2005.11.049; Thomassot E, 2009, EARTH PLANET SC LETT, V282, P79, DOI 10.1016/j.epsl.2009.03.001; TURNER DL, 1982, J VOLCANOL GEOTH RES, V12, P187, DOI 10.1016/0377-0273(82)90027-0; Ueno Y, 2008, GEOCHIM COSMOCHIM AC, V72, P5675, DOI 10.1016/j.gca.2008.08.026; WHITE WM, 1982, NATURE, V296, P821, DOI 10.1038/296821a0; Whitehouse M. J., GEOSTAND GEOANAL RES; Yurimoto H, 2004, PHYS EARTH PLANET IN, V146, P231, DOI 10.1016/j.pepi.2003.08.013; ZINDLER A, 1986, ANNU REV EARTH PL SC, V14, P493, DOI 10.1146/annurev.ea.14.050186.002425	35	170	173	6	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2013	496	7446					490	+		10.1038/nature12020	http://dx.doi.org/10.1038/nature12020			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23619695				2022-12-28	WOS:000317984400038
J	Kolodkin, AL; Pasterkamp, RJ				Kolodkin, Alex L.; Pasterkamp, R. Jeroen			SnapShot: Axon Guidance II	CELL			English	Editorial Material									[Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, HHMI, Dept Neurosci, Baltimore, MD 21212 USA; [Pasterkamp, R. Jeroen] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, NL-3584 CG Utrecht, Netherlands	Howard Hughes Medical Institute; Johns Hopkins University; Utrecht University; Utrecht University Medical Center	Kolodkin, AL (corresponding author), Johns Hopkins Univ, Sch Med, HHMI, Dept Neurosci, Baltimore, MD 21212 USA.			Pasterkamp, Jeroen/0000-0003-1631-6440	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bashaw G. J., 2012, COLD SPRING HARB PER, V2; Charron F, 2007, ADV EXP MED BIOL, V621, P116, DOI 10.1007/978-0-387-76715-4_9; Pasterkamp RJ, 2012, NAT REV NEUROSCI, V13, P605, DOI 10.1038/nrn3302; Salinas PC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008003; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Ypsilanti AR, 2010, DEVELOPMENT, V137, P1939, DOI 10.1242/dev.044511; Zou YM, 2012, CURR TOP DEV BIOL, V101, P141, DOI 10.1016/B978-0-12-394592-1.00009-0	8	14	14	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 25	2013	153	3					722	U2	722.e1	10.1016/j.cell.2013.04.004	http://dx.doi.org/10.1016/j.cell.2013.04.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622251	Bronze			2022-12-28	WOS:000318063500022
J	Kassim-Lakha, S; Bennett, J				Kassim-Lakha, Shamsh; Bennett, Jennifer			Philanthropic funding for health in Pakistan	LANCET			English	Editorial Material									[Kassim-Lakha, Shamsh; Bennett, Jennifer] Pakistan Ctr Philanthropy, Islamabad, Pakistan		Kassim-Lakha, S (corresponding author), Pakistan Ctr Philanthropy, 1-A,St 14,F-8-3, Islamabad, Pakistan.	skassim.lakha@gmail.com						Bonbright D, 2000, PHILANTHROPY IN PAKI; Committee Encouraging Corporate Philanthropy, 2010, BENCHMARKING TABLES; Edhi Welfare Organization, FOUR PRINCIPLES FOR; Hussain SD, 2012, THE NATION; Nishtar S, 2013, LANCET; Pakistan Centre for Philanthropy, 2012, 10 YEARS OF BUILDING; Pakistan Centre for Philanthropy, 2010, INDIVIDUAL PHILANTHR; Pakistan Centre for Philanthropy, 2010, FAMILY FOUNDATIONS I; Pakistan Centre for Philanthropy, CORPORATE PHILANTHRO; Shaukat Khanum Memorial Cancer Hospital and Research Centre, 2011, ANNUAL REPORT 2010; State Bank of Pakistan, 2010, HANDBOOK OF STATISTI	11	7	7	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 29	2013	381	9885					2236	2237		10.1016/S0140-6736(13)60678-9	http://dx.doi.org/10.1016/S0140-6736(13)60678-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	173SU	23684255				2022-12-28	WOS:000321100300010
J	Leontjevas, R; Gerritsen, DL; Smalbrugge, M; Teerenstra, S; Vernooij-Dassen, MJFJ; Koopmans, RTCM				Leontjevas, Ruslan; Gerritsen, Debby L.; Smalbrugge, Martin; Teerenstra, Steven; Vernooij-Dassen, Myrra J. F. J.; Koopmans, Raymond T. C. M.			A structural multidisciplinary approach to depression management in nursing-home residents: a multicentre, stepped-wedge cluster-randomised trial	LANCET			English	Article							CORNELL SCALE; CARE; DEMENTIA	Background Depression in nursing-home residents is often under-recognised. We aimed to establish the effectiveness of a structural approach to its management. Methods Between May 15, 2009, and April 30, 2011, we undertook a multicentre, stepped-wedge cluster-randomised trial in four provinces of the Netherlands. A network of nursing homes was invited to enrol one dementia and one somatic unit per nursing home. In enrolled units, nursing-home staff recruited residents, who were eligible as long as we had received written informed consent. Units were randomly allocated to one of five groups with computer-generated random numbers. A multidisciplinary care programme, Act in Case of Depression (AiD), was implemented at different timepoints in each group: at baseline, no groups were implenting the programme (usual care); the first group implemented it shortly after baseline; and other groups sequentially began implementation after assessments at intervals of roughly 4 months. Residents did not know when the intervention was being implemented or what the programme elements were; research staff were masked to intervention implementation, depression treatment, and results of previous assessments; and data analysts were masked to intervention implementation. The primary endpoint was depression prevalence in units, which was the proportion of residents per unit with a score of more than seven on the proxy-based Cornell scale for depression in dementia. Analyses were by intention to treat. This trial is registered with the Netherlands National Trial Register, number NTR1477. Findings 16 dementia units (403 residents) and 17 somatic units (390 residents) were enrolled in the course of the study. In somatic units, AiD reduced prevalence of depression (adjusted effect size -7.3%, 95% CI -13.7 to -0.9). The effect was not significant in dementia units (0.6, -5.6 to 6.8) and differed significantly from that in somatic units (p=0.031). Adherence to depression assessment procedures was lower in dementia units (69% [SD 19%]) than in somatic units (82% [15%]; p=0.045). Adherence to treatment pathways did not differ between dementia units (43% [SD 33%]) and somatic units (38% [40%]; p=0.745). Interpretation A structural approach to management of depression in nursing homes that includes assessment procedures can reduce depression prevalence in somatic units. Improvements are needed in depression screening in dementia units and in implementation of nursing-home treatment protocols generally.	[Leontjevas, Ruslan; Gerritsen, Debby L.; Vernooij-Dassen, Myrra J. F. J.; Koopmans, Raymond T. C. M.] Radboud Univ Nijmegen, Med Ctr, Ctr Family Med Geriatr Care & Publ Hlth, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands; [Leontjevas, Ruslan; Gerritsen, Debby L.; Vernooij-Dassen, Myrra J. F. J.] Radboud Univ Nijmegen, Med Ctr, Radboud Alzheimer Ctr, NL-6525 ED Nijmegen, Netherlands; [Teerenstra, Steven] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & HTA, NL-6525 ED Nijmegen, Netherlands; [Vernooij-Dassen, Myrra J. F. J.] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare, NL-6525 ED Nijmegen, Netherlands; [Leontjevas, Ruslan] Open Univ Netherlands, Sch Psychol, NL-6401 DL Heerlen, Netherlands; [Smalbrugge, Martin] Vrije Univ Amsterdam, Med Ctr, Dept Nursing Home Med, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Vernooij-Dassen, Myrra J. F. J.] Kalorama Fdn, Beek Ubbergen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Open University Netherlands; Vrije Universiteit Amsterdam	Leontjevas, R (corresponding author), Open Univ Netherlands, Sch Psychol, POB 2960, NL-6401 DL Heerlen, Netherlands.	roeslan.leontjevas@ou.nl	Smallbrugge, Martin/ABH-8286-2020; Koopmans, R.T.C.M./H-8062-2014; Vernooij-Dassen, M.J.F.J./H-8107-2014; Gerritsen, D.L./L-4318-2015; Teerenstra, Steven/C-2870-2018	Smallbrugge, Martin/0000-0003-0538-4843; Teerenstra, Steven/0000-0003-4103-7451	Netherlands Organization for Health Research and Development	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development)	The Netherlands Organization for Health Research and Development.	ALEXOPOULOS GS, 1988, J AM GERIATR SOC, V36, P230, DOI 10.1111/j.1532-5415.1988.tb01806.x; ALEXOPOULOS GS, 1988, BIOL PSYCHIAT, V23, P271, DOI 10.1016/0006-3223(88)90038-8; Amer Geriatrics Soc, 2003, J AM GERIATR SOC, V51, P1299; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barca ML, 2010, J AFFECT DISORDERS, V120, P141, DOI 10.1016/j.jad.2009.04.028; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Brodaty H, 2003, J CLIN PSYCHIAT, V64, P63, DOI 10.4088/JCP.v64n0113; Collet J, 2010, INT J GERIATR PSYCH, V25, P3, DOI 10.1002/gps.2307; Davison TE, 2013, AGING MENT HEALTH, V17, P449, DOI 10.1080/13607863.2012.738412; Dorland L, 2007, MONITOR GEESTELIJKE, P37; Fullerton CA, 2009, PSYCHIAT SERV, V60, P965, DOI 10.1176/appi.ps.60.7.965; Gerritsen DL, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-91; Hannan PJ, 1996, EVALUATION REV, V20, P338, DOI 10.1177/0193841X9602000306; Hussey MA, 2007, CONTEMP CLIN TRIALS, V28, P182, DOI 10.1016/j.cct.2006.05.007; Jongenelis K, 2007, INT J GERIATR PSYCH, V22, P837, DOI 10.1002/gps.1748; Kallenbach LE, 2006, J AM MED DIR ASSOC, V7, P448, DOI 10.1016/j.jamda.2006.04.007; KAZDIN AE, 1989, J CONSULT CLIN PSYCH, V57, P138, DOI 10.1037/0022-006X.57.1.138; Kramer D, 2009, INT J PSYCHIAT MED, V39, P345, DOI 10.2190/PM.39.4.a; Leontjevas R, 2012, J AM MED DIR ASSOC, V13; Leontjevas R, 2012, AM J GERIAT PSYCHIAT, V20, P985, DOI 10.1097/JGP.0b013e318233152b; Leontjevas R, 2012, INT J GERIATR PSYCH, V27, P1036, DOI 10.1002/gps.2819; Mitchell AJ, 2011, INT J NURS STUD, V48, P359, DOI 10.1016/j.ijnurstu.2010.05.012; Molenberghs G., 2007, MISSING DATA CLIN ST; MOLLOY DW, 1991, AM J PSYCHIAT, V148, P102; Olin JT, 2002, AM J GERIAT PSYCHIAT, V10, P125; Proctor R, 1999, LANCET, V354, P26, DOI 10.1016/S0140-6736(98)08237-3; Smalbrugge M, 2006, INT J GERIATR PSYCH, V21, P325, DOI 10.1002/gps.1466; Smalbrugge M, 2008, AGING MENT HEALTH, V12, P244, DOI 10.1080/13607860801987238; Towsley G, 2012, AGING MENT HEALTH, V16, P892, DOI 10.1080/13607863.2012.667785; Verbeke G, 2000, LINEAR MIXED MODELS; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	32	59	59	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 29	2013	381	9885					2255	2264		10.1016/S0140-6736(13)60590-5	http://dx.doi.org/10.1016/S0140-6736(13)60590-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	173SU	23643110				2022-12-28	WOS:000321100300029
J	Hawkes, S; Buse, K				Hawkes, Sarah; Buse, Kent			Gender and global health: evidence, policy, and inconvenient truths	LANCET			English	Editorial Material							SYSTEMATIC ANALYSIS; DISEASE; BURDEN; MASCULINITY; COUNTRIES; MORTALITY; INJURY; WOMEN; RISK		[Hawkes, Sarah] UCL, Inst Global Hlth, London WC1N 1EH, England; [Buse, Kent] UNAIDS, Geneva, Switzerland	University of London; University College London; UNAIDS	Hawkes, S (corresponding author), UCL, Inst Global Hlth, 30 Guilford St, London WC1N 1EH, England.	s.hawkes@ucl.ac.uk	Hawkes, Sarah/AAK-7375-2020; Buse, Kent/AAK-6688-2020	Buse, Kent/0000-0002-5485-0110; Hawkes, Sarah/0000-0003-1062-3538				Adamson J, 2003, SOC SCI MED, V57, P895, DOI 10.1016/S0277-9536(02)00458-6; Bill & Melinda Gates Foundation, TOB STRAT OV; Blanc AK, 2001, STUD FAMILY PLANN, V32, P189, DOI 10.1111/j.1728-4465.2001.00189.x; Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Butler Judith, 1999, GENDER TROUBLE FEMIN; Chan M, 2011, RISE CHRONIC NONCOMM; Connell RW, 2005, GENDER SOC, V19, P829, DOI 10.1177/0891243205278639; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Darlington R, 2011, TEENAGE GIRLS SELF E; De Vogli R, 2005, J HEALTH POPUL NUTR, V23, P105; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Gita Sen, 2007, Economic and Political Weekly, V42, P682; Government of India Ministry of Home Affairs, 2011, CENS DAT 2011; Hawkes S, 2000, TROP MED INT HEALTH, V5, pA37, DOI 10.1046/j.1365-3156.2000.00594.x; Hibell B., 2009, 2007 ESPAD REPORT SU, P1; Institute of Medicine, 2011, HLTH LESB GAY BIS TR; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Juni P, 2010, OSTEOARTHR CARTILAGE, V18, P640, DOI 10.1016/j.joca.2009.12.010; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Muehlenhard CL, 2011, SEX ROLES, V64, P791, DOI 10.1007/s11199-011-9932-5; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Sen A, 2003, BMJ-BRIT MED J, V327, P1297, DOI 10.1136/bmj.327.7427.1297; Sen G., 2007, UNEQUAL UNFAIR INEFF; Sridhar D, 2008, LANCET, V372, P1185, DOI 10.1016/S0140-6736(08)61485-3; UN General Assembly, REP EC SOC COUNC 199; United Nations, 2011, MILL DEV GOALS REP 2; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; WHO Department of Gender Women and Health, 2013, WHAT DO WE MEAN SEX; WHO Division of Reproductive Health, 1999, DALYS REPR HLTH REP; Wilsnack R. W., 2005, Alcohol, gender and drinking problems: perspectives from low and middle income countries, P1; Wyke S, 1998, SOC SCI MED, V46, P901, DOI 10.1016/S0277-9536(97)00217-7; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Youde Jeremy, 2010, WORLD POLITICS  1214; [No title captured]	36	134	135	1	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 18	2013	381	9879					1783	1787		10.1016/S0140-6736(13)60253-6	http://dx.doi.org/10.1016/S0140-6736(13)60253-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146TA	23683645				2022-12-28	WOS:000319112800043
J	Boland, B; Burnage, J; Chowhan, H				Boland, Billy; Burnage, Jemima; Chowhan, Hasan			Safeguarding adults at risk of harm	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ELDER ABUSE; PREVALENCE; CAREGIVERS; PEOPLE		[Boland, Billy; Burnage, Jemima] Hertfordshire Partnership NHS Fdn Trust, St Albans AL3 5TL, England; [Chowhan, Hasan] Creffield Med Ctr, Colchester CO2 7GH, Essex, England		Boland, B (corresponding author), Hertfordshire Partnership NHS Fdn Trust, St Albans AL3 5TL, England.	billy.boland@hertspartsft.nhs.uk						[Anonymous], 2010, SAF CHILDR YOUNG PEO; Care Quality Commission, 2013, OUR SAF PROT CAR QUA; Cooper C, 2008, AGE AGEING, V37, P151, DOI 10.1093/ageing/afm194; Cooper C, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b155; Department of Constitutional Affairs, 2007, MENTAL CAPACITY ACT; Department of Health, 2000, NO SECR GUID DEV IMP; Department of Health, 2011, STAT GOV POL AD SAF; Department of Health Home Office and Criminal Justice System, 2009, REP CONS REV NO SECR; Department of Health Social Services and Public Safety, 2010, AD SAF NO IR REG LOC; Flynn, 2012, WINTERBOURNE VIEW HO; Forder J., 2012, EVALUATION PERSONAL; Francis R., 2013, REPORT MID STAFFORDS; General Medical Council, 2012, RAIS ACT CONC PAT SA; General Medical Council, 2009, CONF; Law Commission, 2011, AD SOC CAR; Manthorpe J, 2011, BRIT J SOC WORK, V41, P224, DOI 10.1093/bjsw/bcq100; Martin SL, 2006, VIOLENCE AGAINST WOM, V12, P823, DOI 10.1177/1077801206292672; Morgan A., 2010, CLIN GOVERNANCE ADUL; NHS Information Centre, 2012, AB VULN AD ENGL 2010; Sasaki M, 2007, INT J GERIATR PSYCH, V22, P250, DOI 10.1002/gps.1670; Yan ECW, 2004, J FAM VIOLENCE, V19, P269, DOI 10.1023/B:JOFV.0000042077.95692.71	21	5	5	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2013	346								f2716	10.1136/bmj.f2716	http://dx.doi.org/10.1136/bmj.f2716			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148OF	23674331				2022-12-28	WOS:000319253900003
J	Kennedy, A; Bower, P; Reeves, D; Blakeman, T; Bowen, R; Chew-Graham, C; Eden, M; Fullwood, C; Gaffney, H; Gardner, C; Lee, V; Morris, R; Protheroe, J; Richardson, G; Sanders, C; Swallow, A; Thompson, D; Rogers, A				Kennedy, Anne; Bower, Peter; Reeves, David; Blakeman, Tom; Bowen, Robert; Chew-Graham, Carolyn; Eden, Martin; Fullwood, Catherine; Gaffney, Hannah; Gardner, Caroline; Lee, Victoria; Morris, Rebecca; Protheroe, Joanne; Richardson, Gerry; Sanders, Caroline; Swallow, Angela; Thompson, David; Rogers, Anne		Salford Natl Inst Hlth Res Gastroi	Implementation of self management support for long term conditions in routine primary care settings: cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GLYCEMIC CONTROL; PRACTICE NURSES; CHRONIC DISEASE; ULCERATIVE-COLITIS; COST-EFFECTIVENESS; HEALTH-CARE; FOLLOW-UP; PROGRAMS; INTERVENTION; PERFORMANCE	Objective To determine the effectiveness of an intervention to enhance self management support for patients with chronic conditions in UK primary care. Design Pragmatic, two arm, cluster randomised controlled trial. Setting General practices, serving a population in northwest England with high levels of deprivation. Participants 5599 patients with a diagnosis of diabetes (n=2546), chronic obstructive pulmonary disease (n=1634), and irritable bowel syndrome (n=1419) from 43 practices (19 intervention and 22 control practices). Intervention Practice level training in a whole systems approach to self management support. Practices were trained to use a range of resources: a tool to assess the support needs of patients, guidebooks on self management, and a web based directory of local self management resources. Training facilitators were employed by the health management organisation. Main outcome measures Primary outcomes were shared decision making, self efficacy, and generic health related quality of life measured at 12 months. Secondary outcomes were general health, social or role limitations, energy and vitality, psychological wellbeing, self care activity, and enablement. Results We randomised 44 practices and recruited 5599 patients, representing 43% of the eligible population on the practice lists. 4533 patients (81.0%) completed the six month follow-up and 4076 (72.8%) the 12 month follow-up. No statistically significant differences were found between patients attending trained practices and those attending control practices on any of the primary or secondary outcomes. All effect size estimates were well below the prespecified threshold of clinically important difference. Conclusions An intervention to enhance self management support in routine primary care did not add noticeable value to existing care for long term conditions. The active components required for effective self management support need to be better understood, both within primary care and in patients' everyday lives. Trial registration Current Controlled Trials ISRCTN90940049.	[Kennedy, Anne; Rogers, Anne] Univ Southampton, Fac Hlth Sci, Southampton SO17 1BJ, Hants, England; [Bower, Peter; Reeves, David; Blakeman, Tom; Bowen, Robert; Eden, Martin; Gaffney, Hannah; Gardner, Caroline; Lee, Victoria; Morris, Rebecca; Sanders, Caroline; Swallow, Angela] Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Primary Care, Natl Inst Hlth Res,Sch Primary Care Res, Manchester, Lancs, England; [Chew-Graham, Carolyn; Protheroe, Joanne; Swallow, Angela] Keele Univ, Res Inst Primary Care & Hlth Sci, Keele, Staffs, England; [Fullwood, Catherine] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester Biomed Res Ctr, Manchester, Lancs, England; [Richardson, Gerry] Univ York, Ctr Hlth Econ, York YO10 5DD, N Yorkshire, England; [Richardson, Gerry] Univ York, NIHR Res Design Serv Yorkshire & Humber, York YO10 5DD, N Yorkshire, England; [Thompson, David] Univ Manchester, Salford Royal Hosp, Fac Med & Human Sci, Inst Inflammat & Repair, Salford, Lancs, England	University of Southampton; University of Manchester; Keele University; University of Manchester; University of York - UK; University of York - UK; Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Manchester	Kennedy, A (corresponding author), Univ Southampton, Fac Hlth Sci, Highfield Campus, Southampton SO17 1BJ, Hants, England.	a.kennedy@soton.ac.uk	Sanders, Caroline/G-8021-2014; Reeves, David/H-6203-2014; Fullwood, Catherine/AAM-7281-2020; Bower, Peter/A-1508-2011; Morris, Rebecca/A-1940-2019	Sanders, Caroline/0000-0002-0539-928X; Reeves, David/0000-0001-6377-6859; Bower, Peter/0000-0001-9558-3349; Eden, Martin/0000-0002-1542-2527; Gaffney, Hannah/0000-0001-9561-2488; Fullwood, Catherine/0000-0003-4136-2027; Lee, Victoria/0000-0001-9578-3260; Morris, Rebecca/0000-0003-1587-0802; Gardner, Caroline/0000-0003-0487-3979	National Primary Care Research and Development Centre; Department of Health; National Institute for Health Research [RP-PG-0407-10136]; National Institute for Health Research [CL-2009-06-004] Funding Source: researchfish	National Primary Care Research and Development Centre; Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The trial was funded by the National Institute for Health Research and The National Primary Care Research and Development Centre (funded by the Department of Health). This paper presents independent research commissioned by the National Institute for Health Research under its programme grants for applied research funding scheme (RP-PG-0407-10136). The views expressed in this paper are those of the authors and not necessarily those of the National Health Service, National Institute for Health Research, or the Department of Health.	Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Blakeman T, 2006, BRIT J GEN PRACT, V56, P407; Bodenheimar T, 2005, HELPING PATIENTS MAN; Bodenheimer T, 2008, NEW ENGL J MED, V359, P2086, DOI 10.1056/NEJMp0805631; Bodenheimer Thomas, 2003, Dis Manag, V6, P63, DOI 10.1089/109350703321908441; Bower P, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-7; Campbell SA, 2008, ANN FAM MED, V6, P228, DOI 10.1370/afm.844; Chodosh J, 2005, ANN INTERN MED, V143, P427, DOI 10.7326/0003-4819-143-6-200509200-00007; Communities and Local Government (CLG), 2013, IND DEPR 2007 DAT PR; Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2; Department of Health, 2010, EQ EXC LIB NHS; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Effing T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002990.pub2; Egginton JS, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-72; Furler J, 2011, CHRONIC ILLN, V7, P3, DOI 10.1177/1742395310386978; Goodyear-Smith F, 2009, FAM PRACT, V26, P128, DOI 10.1093/fampra/cmp015; Groenwold RHH, 2012, AM J EPIDEMIOL, V175, P210, DOI 10.1093/aje/kwr302; Hornsten A, 2008, DIABETES RES CLIN PR, V81, P50, DOI 10.1016/j.diabres.2008.02.005; Jones R, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-5; Kennedy A, 2003, PATIENT EDUC COUNS, V50, P303, DOI 10.1016/S0738-3991(03)00054-5; Kennedy A, 2003, HEALTH SOC CARE COMM, V11, P64, DOI 10.1046/j.1365-2524.2003.00399.x; Kennedy A, 2007, BMJ-BRIT MED J, V335, P968, DOI 10.1136/bmj.39372.540903.94; Kennedy A, 2007, J EPIDEMIOL COMMUN H, V61, P254, DOI 10.1136/jech.2006.053538; Kennedy A, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-7; Kennedy AP, 2004, GUT, V53, P1639, DOI 10.1136/gut.2003.034256; Kind P, 1996, QUALITY LIFE PHARMAC; Lorig K., 1996, OUTCOME MEASURES HLT, VVol. 2019; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Macdonald W, 2008, J ADV NURS, V62, P191, DOI 10.1111/j.1365-2648.2007.04585.x; May C, 2009, SOCIOLOGY, V43, P535, DOI 10.1177/0038038509103208; McCall N, 2011, NEW ENGL J MED, V365, P1704, DOI 10.1056/NEJMsa1011785; McDonald AM, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-9; McDonald R, 2009, SOC SCI MED, V68, P1206, DOI 10.1016/j.socscimed.2009.01.039; McGregor W, 2008, BRIT J GEN PRACT, V58, P711, DOI 10.3399/bjgp08X342183; Motheral Brenda R, 2011, Am J Manag Care, V17, pe10; Murray E, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-63; Parchman ML, 2006, ANN FAM MED, V4, P40, DOI 10.1370/afm.422; Partners in Salford, 2013, OUR VIS HLTH CIT; Powell LH, 2010, JAMA-J AM MED ASSOC, V304, P1331, DOI 10.1001/jama.2010.1362; Protheroe J, 2012, J HLTH PSYCHOL; Protheroe J, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-206; Protheroe J, 2009, BRIT J GEN PRACT, V59, P721, DOI 10.3399/bjgp09X472584; Ritter PL, 2001, J CLIN EPIDEMIOL, V54, P136, DOI 10.1016/S0895-4356(00)00261-4; Robinson A, 2006, GUT, V55, P643, DOI 10.1136/gut.2004.062901; Robinson A, 2001, LANCET, V358, P976, DOI 10.1016/S0140-6736(01)06105-0; Ryan A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-96; Salmon P, 2007, FAM PRACT, V24, P269, DOI 10.1093/fampra/cmm015; Shojania KG, 2006, JAMA-J AM MED ASSOC, V296, P427, DOI 10.1001/jama.296.4.427; Stange KC, 2010, J GEN INTERN MED, V25, P601, DOI 10.1007/s11606-010-1291-3; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Steventon A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3874; Torgerson DJ, 2001, BMJ-BRIT MED J, V322, P355, DOI 10.1136/bmj.322.7282.355; Trento M, 2010, DIABETES CARE, V33, P745, DOI 10.2337/dc09-2024; Vassilev I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059723; Warsi A, 2004, ARCH INTERN MED, V164, P1641, DOI 10.1001/archinte.164.15.1641; Williams AM, 2011, CHRONIC ILLN, V7, P20, DOI 10.1177/1742395310383339; Williams GC, 2005, PATIENT EDUC COUNS, V57, P39, DOI 10.1016/j.pec.2004.04.001; Williams GC, 2004, HEALTH PSYCHOL, V23, P58, DOI 10.1037/0278-6133.23.1.58; Woolhandler S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5015; Zwar N, 2006, SYSTEMATIC REV CHRON	60	151	157	1	61	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2013	346								f2882	10.1136/bmj.f2882	http://dx.doi.org/10.1136/bmj.f2882			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148OC	23670660	Green Published, Green Accepted			2022-12-28	WOS:000319253600002
J	Lin, CD; Chu, WC				Lin, C. D.; Chu, Wei-Chun			Controlling Atomic Line Shapes	SCIENCE			English	Editorial Material									[Lin, C. D.; Chu, Wei-Chun] Kansas State Univ, Dept Phys, Manhattan, KS 66506 USA	Kansas State University	Lin, CD (corresponding author), Kansas State Univ, Dept Phys, Cardwell Hall, Manhattan, KS 66506 USA.	cdlin@phys.ksu.edu	Lin, c d/D-7312-2012	Lin, c d/0000-0003-4847-8938				Chu WC, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.013415; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; Harris SE, 1997, PHYS TODAY, V50, P36, DOI 10.1063/1.881806; Khurgin JB, 2010, ADV OPT PHOTONICS, V2, P287, DOI 10.1364/AOP.2.000287; Ott C, 2013, SCIENCE, V340, P716, DOI 10.1126/science.1234407	5	15	15	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					694	695		10.1126/science.1238396	http://dx.doi.org/10.1126/science.1238396			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661749				2022-12-28	WOS:000318619000025
J	Leppek, K; Schott, J; Reitter, S; Poetz, F; Hammond, MC; Stoecklin, G				Leppek, Kathrin; Schott, Johanna; Reitter, Sonja; Poetz, Fabian; Hammond, Ming C.; Stoecklin, Georg			Roquin Promotes Constitutive mRNA Decay via a Conserved Class of Stem-Loop Recognition Motifs	CELL			English	Article							TUMOR-NECROSIS-FACTOR; T-CELLS; AUTOIMMUNITY; DEGRADATION; TRISTETRAPROLIN; EXPRESSION; REPRESSION; MICRORNAS; STABILITY; PROTEIN	Tumor necrosis factor-alpha (INF-alpha) is the most potent proinflammatory cytokine in mammals. The degradation of TNF-alpha mRNA is critical for restricting TNF-alpha synthesis and involves a constitutive decay element (CDE) in the 3' UTR of the mRNA. Here, we demonstrate that the CDE folds into an RNA stem-loop motif that is specifically recognized by Roquin and Roquin2. Binding of Roquin initiates degradation of TNF-alpha mRNA and limits TNF- alpha production in macrophages. Roquin proteins promote mRNA degradation by recruiting the Ccr4-Caf1-Not deadenylase complex. CDE sequences are highly conserved and are found in more than 50 vertebrate mRNAs, many of which encode regulators of development and inflammation. In macrophages, CDE-containing mRNAs were identified as the primary targets of Roquin on a transcriptome-wide scale. Thus, Roquin proteins act broadly as mediators of mRNA deadenylation by recognizing a conserved class of stem-loop RNA degradation motifs.	[Leppek, Kathrin; Schott, Johanna; Reitter, Sonja; Poetz, Fabian; Stoecklin, Georg] DKFZ ZMBH Alliance, German Canc Res Ctr, Helmholtz Jr Res Grp Posttranscript Control Gene, D-69120 Heidelberg, Germany; [Hammond, Ming C.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Hammond, Ming C.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Helmholtz Association; German Cancer Research Center (DKFZ); University of California System; University of California Berkeley; University of California System; University of California Berkeley	Stoecklin, G (corresponding author), DKFZ ZMBH Alliance, German Canc Res Ctr, Helmholtz Jr Res Grp Posttranscript Control Gene, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	g.stoecklin@dkfz.de		Leppek, Kathrin/0000-0002-8012-8076; Stoecklin, Georg/0000-0001-9284-9834; Poetz, Fabian/0000-0002-5278-8931	Helmholtz Gemeinschaft [HZ-NG-210]; Deutsche Forschungsgemeinschaft [SFB 1036/TP07, STO 859/2-1, STO 859/3-1]; Helmholtz International Graduate School for Cancer Research; CASI (Career Awards at the Scientific Interface) award from the Burroughs Wellcome Fund	Helmholtz Gemeinschaft(Helmholtz Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz International Graduate School for Cancer Research; CASI (Career Awards at the Scientific Interface) award from the Burroughs Wellcome Fund	We would like to thank Bernd Rattenbacher and Christoph Moroni (University of Basel, Basel, Switzerland) for sharing unpublished information. We are grateful to Vigo Heissmeyer (Helmholtz Center Munich, Munich, Germany) for providing the Dicer mouse embryonic fibroblasts (MEFs) and the plasmids encoding EGFP-Roquin and His-Roquin-N; Witold Filipowicz (Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland) for the Dicer antibody; Ann-Bin Shyu (University of Texas Medical School at Houston, Houston, TX, USA) for the Caf1a antibody and the NIH 3T3 B2A2 cell line; Takbum Ohn, Nancy Kedersha, and Paul Anderson (Harvard Medical School, Boston, MA, USA) for Flag-Roquin plasmids; Adelheid Cerwenka (German Cancer Research Center, Heidelberg, Germany) for providing mouse bone marrow; Ivana Cado for generating stable cell lines; and Alexandra Kurz (German Cancer Research Center, Heidelberg) for help with ELISA. We would like to thank David Ibberson and Sasithorn Chotewutmontri of the Heidelberg University Deep Sequencing Core Facility, the Genomics Core Facility at the European Molecular Biology Laboratory, and Thomas Ruppert from the ZMBH (Zentrum fur Molekulare Biologie der Universitat Heidelberg) Mass Spectrometry Core Facility for extensive support. We also thank Ingrid Grummt and Aurelio Teleman (German Cancer Research Center, Heidelberg) for critical reading of the manuscript. This work was supported by Young Investigator Grant HZ-NG-210 from the Helmholtz Gemeinschaft to G.S.; SFB 1036/TP07 as well as research grants STO 859/2-1 and STO 859/3-1 from the Deutsche Forschungsgemeinschaft to G.S.; a PhD stipend from the Helmholtz International Graduate School for Cancer Research to K.L.; and a CASI (Career Awards at the Scientific Interface) award from the Burroughs Wellcome Fund to M.C.H. K.L. designed and performed experiments, analyzed the data, prepared figures, and cowrote the manuscript; J.S. carried out bioinformatics analysis and performed experiments; S.R. and F.P. performed experiments; M.C.H. performed in-line probing; and G.S. supervised the study, designed experiments, analyzed the data, and cowrote the manuscript.	Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Arlt A, 2011, EUR J CELL BIOL, V90, P545, DOI 10.1016/j.ejcb.2010.10.002; Athanasopoulos V, 2010, FEBS J, V277, P2109, DOI 10.1111/j.1742-4658.2010.07628.x; Bertossi A, 2011, J EXP MED, V208, P1749, DOI 10.1084/jem.20110578; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Collart MA, 2012, GENE, V492, P42, DOI 10.1016/j.gene.2011.09.033; Fenger-Gron M, 2005, MOL CELL, V20, P905, DOI 10.1016/j.molcel.2005.10.031; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Glasmacher E, 2010, NAT IMMUNOL, V11, P725, DOI 10.1038/ni.1902; Goodarzi H, 2012, NATURE, V485, P264, DOI 10.1038/nature11013; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ji YR, 2012, J BIOL CHEM, V287, P42269, DOI 10.1074/jbc.M112.374835; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Parker BJ, 2011, GENOME RES, V21, P1929, DOI 10.1101/gr.112516.110; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Renner F, 2009, TRENDS BIOCHEM SCI, V34, P128, DOI 10.1016/j.tibs.2008.12.003; Sandler H, 2011, NUCLEIC ACIDS RES, V39, P4373, DOI 10.1093/nar/gkr011; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shu ZY, 1999, BIOCHEMISTRY-US, V38, P15369, DOI 10.1021/bi991774z; Srisawat C, 2001, RNA, V7, P632, DOI 10.1017/S135583820100245X; Stoecklin G, 2003, MOL CELL BIOL, V23, P3506, DOI 10.1128/MCB.23.10.3506-3515.2003; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253	28	203	217	2	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 9	2013	153	4					869	881		10.1016/j.cell.2013.04.016	http://dx.doi.org/10.1016/j.cell.2013.04.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663784	Bronze			2022-12-28	WOS:000318844000015
J	Yang, HJ; Rudge, DG; Koos, JD; Vaidialingam, B; Yang, HJ; Pavletich, NP				Yang, Haijuan; Rudge, Derek G.; Koos, Joseph D.; Vaidialingam, Bhamini; Yang, Hyo J.; Pavletich, Nikola P.			mTOR kinase structure, mechanism and regulation	NATURE			English	Article							P70 S6 KINASE; MAMMALIAN TARGET; CELL-GROWTH; BINDING PARTNER; RAG GTPASES; RAPAMYCIN; RAPTOR; TOR; RHEB; PATHWAY	The mammalian target of rapamycin (mTOR), a phosphoinositide 3-kinase-related protein kinase, controls cell growth in response to nutrients and growth factors and is frequently deregulated in cancer. Here we report co-crystal structures of a complex of truncated mTOR and mammalian lethal with SEC13 protein 8 (mLST8) with an ATP transition state mimic and with ATP-site inhibitors. The structures reveal an intrinsically active kinase conformation, with catalytic residues and a catalytic mechanism remarkably similar to canonical protein kinases. The active site is highly recessed owing to the FKBP12-rapamycin-binding (FRB) domain and an inhibitory helix protruding from the catalytic cleft. mTOR-activating mutations map to the structural framework that holds these elements in place, indicating that the kinase is controlled by restricted access. In vitro biochemistry shows that the FRB domain acts as a gatekeeper, with its rapamycin-binding site interacting with substrates to grant them access to the restricted active site. Rapamycin-FKBP12 inhibits the kinase by directly blocking substrate recruitment and by further restricting active-site access. The structures also reveal active-site residues and conformational changes that underlie inhibitor potency and specificity.	[Yang, Haijuan; Rudge, Derek G.; Koos, Joseph D.; Vaidialingam, Bhamini; Yang, Hyo J.; Pavletich, Nikola P.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Pavletich, Nikola P.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Pavletich, NP (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pavletin@mskcc.org		Koos, Joseph/0000-0001-9613-7949; Yang, Hyo/0000-0001-5279-3194	Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. King for mass spectroscopic analysis, H. Erdjument-Bromage for N-terminal sequencing, the staff of the Advanced Photon Source ID24 beamlines for help with data collection and D. Tzvetkova-Robev for help with protein expression in HEK293 cells. This work was supported by the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Apsel B, 2008, NAT CHEM BIOL, V4, P691, DOI 10.1038/nchembio.117; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bao ZQ, 2011, STRUCTURE, V19, P675, DOI 10.1016/j.str.2011.02.016; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Chen EJ, 2003, J CELL BIOL, V161, P333, DOI 10.1083/jcb.200210141; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Edinger AL, 2004, ONCOGENE, V23, P5654, DOI 10.1038/sj.onc.1207738; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Liu QS, 2011, J MED CHEM, V54, P1473, DOI 10.1021/jm101520v; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; McMahon LP, 2002, MOL CELL BIOL, V22, P7428, DOI 10.1128/MCB.22.21.7428-7438.2002; Miller S, 2010, SCIENCE, V327, P1638, DOI 10.1126/science.1184429; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Ohne Y, 2008, J BIOL CHEM, V283, P31861, DOI 10.1074/jbc.M801546200; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200; Rodriguez A, 2009, MOL CELL, V33, P616, DOI 10.1016/j.molcel.2009.01.030; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sato T, 2009, J BIOL CHEM, V284, P12783, DOI 10.1074/jbc.M809207200; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Sekulic A, 2000, CANCER RES, V60, P3504; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shor B, 2008, CANCER RES, V68, P2934, DOI 10.1158/0008-5472.CAN-07-6487; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Vilella-Bach M, 1999, J BIOL CHEM, V274, P4266, DOI 10.1074/jbc.274.7.4266; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Wander SA, 2011, J CLIN INVEST, V121, P1231, DOI 10.1172/JCI44145; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	53	635	671	6	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2013	497	7448					217	+		10.1038/nature12122	http://dx.doi.org/10.1038/nature12122			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23636326	Green Accepted			2022-12-28	WOS:000318558200031
J	Devon, KM				Devon, Karen Michelle			Status Update: Whose Photo Is That?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ETHICAL CONDUCT		[Devon, Karen Michelle] Univ Toronto, Womens Coll Hosp, Dept Surg, Toronto, ON, Canada; [Devon, Karen Michelle] Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Devon, KM (corresponding author), Univ Toronto, Womens Coll Hosp, Dept Surg, Toronto, ON, Canada.	karen.devon@wchospital.ca						Chretien KC, 2009, JAMA-J AM MED ASSOC, V302, P1309, DOI 10.1001/jama.2009.1387; Holt GR, 2012, ARCH FACIAL PLAST S, V14, P295, DOI 10.1001/archfacial.2011.1646; Holt GR, 2012, ARCH FACIAL PLAST S, V14, P215, DOI 10.1001/archfacial.2011.1643; Kirby SG, 2011, PRACTICING MED FACEB; Thompson LA, 2011, J MED INTERNET RES, V13, P3, DOI 10.2196/jmir.1590	5	5	5	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2013	309	18					1901	1902		10.1001/jama.2013.2776	http://dx.doi.org/10.1001/jama.2013.2776			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138AZ	23652521				2022-12-28	WOS:000318481900024
J	Spence, D				Spence, Des			FROM THE FRONTLINE Who's to blame for overcrowding in accident and emergency departments?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Devlin K., 2008, TELEGRAPH; Winnet R., 2013, TELEGRAPH	2	2	3	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2013	346								f2871	10.1136/bmj.f2871	http://dx.doi.org/10.1136/bmj.f2871			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	144BQ	23653136				2022-12-28	WOS:000318914800005
J	Byers, J; Dunn, S				Byers, John; Dunn, Stacey			Response to Comments on "Bateman in Nature: Predation on Offspring Reduces the Potential for Sexual Selection"	SCIENCE			English	Editorial Material							GRADIENTS		[Byers, John; Dunn, Stacey] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA	Idaho; University of Idaho	Byers, J (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA.	jbyers@uidaho.edu						Andrade MCB, 2005, INTEGR COMP BIOL, V45, P838, DOI 10.1093/icb/45.5.838; Arnqvist G, 2013, SCIENCE, V340, DOI 10.1126/science.1233413; Bergeron P, 2013, SCIENCE, V340, DOI 10.1126/science.1233246; Bergeron P, 2012, BEHAV ECOL SOCIOBIOL, V66, P1125, DOI 10.1007/s00265-012-1364-x; Byers J.A., 1997, AM PRONGHORN SOCIAL; Byers J, 2012, SCIENCE, V338, P802, DOI 10.1126/science.1224660; Byers JA, 2006, P NATL ACAD SCI USA, V103, P16343, DOI 10.1073/pnas.0608184103; Carling MD, 2003, J MAMMAL, V84, P1237, DOI 10.1644/BRB-116; Coltman DW, 1999, MOL ECOL, V8, P1199, DOI 10.1046/j.1365-294x.1999.00683.x; Jones AG, 2002, P ROY SOC B-BIOL SCI, V269, P2533, DOI 10.1098/rspb.2002.2177; Lorch PD, 2005, INTEGR COMP BIOL, V45, P924, DOI 10.1093/icb/45.5.924; OGARA BW, 1969, AM J ANAT, V125, P217, DOI 10.1002/aja.1001250206; Pelissie B, 2012, EVOLUTION, V66, P66, DOI 10.1111/j.1558-5646.2011.01442.x; Ramm SA, 2013, SCIENCE, V340, DOI [10.1126/science.1233298, 10.1126/science.1233413]	14	3	3	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 3	2013	340	6132								10.1126/science.1233500	http://dx.doi.org/10.1126/science.1233500			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23641096				2022-12-28	WOS:000318268900027
J	Roland, M; Paddison, C				Roland, Martin; Paddison, Charlotte			Better management of patients with multimorbidity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INVERSE CARE LAW; CLINICAL GUIDELINES; CONTINUITY; OUTCOMES; QUALITY; PAY; EPIDEMIOLOGY; PHYSICIANS; DISEASES; ENGLAND		[Roland, Martin; Paddison, Charlotte] Univ Cambridge, Cambridge Inst Publ Hlth, Cambridge CB2 0SR, England	University of Cambridge	Roland, M (corresponding author), Univ Cambridge, Cambridge Inst Publ Hlth, Cambridge CB2 0SR, England.	mr108@cam.ac.uk		Roland, Martin/0000-0002-8533-3060				Aboulghate A, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X653624; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bayliss EA, 2007, ANN FAM MED, V5, P395, DOI 10.1370/afm.722; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Campbell SM, 2010, ANN FAM MED, V8, P499, DOI 10.1370/afm.1145; Doran T, 2008, NEW ENGL J MED, V359, P274, DOI 10.1056/NEJMsa0800310; Doran T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2405; Fletcher KE, 2011, J HOSP MED, V6, P438, DOI 10.1002/jhm.916; Guthrie B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6341; Haggerty JL, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5915; Hill A, 2012, PROMOTING CONTINUITY; HJORTDAHL P, 1992, BRIT MED J, V304, P1287, DOI 10.1136/bmj.304.6837.1287; Hsiao CJ, 2008, AM J MED QUAL, V23, P302, DOI 10.1177/1062860608315643; Hughes LD, 2013, AGE AGEING, V42, P62, DOI 10.1093/ageing/afs100; Jamous H, 1970, PROFESSIONS PROFESSI, P115; Mercer SW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4152; Reuben DB, 2012, NEW ENGL J MED, V366, P777, DOI 10.1056/NEJMp1113631; Ridd M, 2006, FAM PRACT, V23, P461, DOI 10.1093/fampra/cml010; Royal College of Physicians, 2005, DOCT SOC MED PROF CH; Rubin G, 2006, BRIT J GEN PRACT, V56, P743; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Saultz JW, 2005, ANN FAM MED, V3, P159, DOI 10.1370/afm.285; Sharma G, 2009, JAMA-J AM MED ASSOC, V301, P1671, DOI 10.1001/jama.2009.517; Shippee ND, 2012, J CLIN EPIDEMIOL, V65, P1041, DOI 10.1016/j.jclinepi.2012.05.005; Smith SM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5205; Stokes T, 2005, ANN FAM MED, V3, P353, DOI 10.1370/afm.351; Turner David, 2007, J Health Serv Res Policy, V12, P132, DOI 10.1258/135581907781543021; Watt G, 2002, LANCET, V360, P252, DOI 10.1016/S0140-6736(02)09466-7; Weyrauch K F, 1996, J Am Board Fam Pract, V9, P31	29	84	87	1	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 2	2013	346								f2510	10.1136/bmj.f2510	http://dx.doi.org/10.1136/bmj.f2510			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139ET	23641032				2022-12-28	WOS:000318565300001
J	Wachman, EM; Hayes, MJ; Brown, MS; Paul, J; Harvey-Wilkes, K; Terrin, N; Huggins, GS; Aranda, JV; Davis, JM				Wachman, Elisha M.; Hayes, Marie J.; Brown, Mark S.; Paul, Jonathan; Harvey-Wilkes, Karen; Terrin, Norma; Huggins, Gordon S.; Aranda, Jacob V.; Davis, Jonathan M.			Association of OPRM1 and COMT Single-Nucleotide Polymorphisms With Hospital Length of Stay and Treatment of Neonatal Abstinence Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENETIC-VARIABILITY; A118G POLYMORPHISM; CLINICAL-EFFICACY; CANCER PAIN; METHADONE; MORPHINE; REQUIREMENTS; DEPENDENCE; BINDING	Importance Neonatal abstinence syndrome (NAS) caused by in utero opioid exposure is a growing problem; genetic factors influencing the incidence and severity have not been previously examined. Single-nucleotide polymorphisms (SNPs) in the mu-opioid receptor (OPRM1), multidrug resistance (ABCB1), and catechol-o-methyltransferase (COMT) genes are associated with risk for opioid addiction in adults. Objective To determine whether SNPs in the OPRM1, ABCB1, and COMT genes are associated with length of hospital stay and the need for treatment of NAS. Design, Setting, and Participants Prospective multicenter cohort study conducted at 5 tertiary care centers and community hospitals in Massachusetts and Maine between July 2011 and July 2012. DNA samples were genotyped for SNPs, and then NAS outcomes were correlated with genotype. Eighty-six of 140 eligible mother-infant dyads were enrolled. Infants were eligible if they were 36 weeks' gestational age or older and exposed to methadone or buprenorphine in utero. Main Outcomes and Measures Primary outcome measure was length of hospital stay, with between-group differences expressed as beta and calculated with linear regression models. Secondary outcome measures included need for any medical treatment for NAS and treatment with 2 or more medications. Results Infants with the OPRM1 118A > G AG/GG genotype had shortened length of stay (beta = -8.5 days; 95% CI, -14.9 to -2.1 days; P = .009) and were less likely to receive any treatment than AA infants (48% vs 72%; adjusted odds ratio, 0.76; 95% CI, 0.63-0.96; P = .006). The COMT 158A > G AG/GG genotype was associated with shortened length of stay (beta = -10.8 days; 95% CI, -18.2 to -3.4 days; P = .005) and less treatment with 2 or more medications (18% vs 56%; adjusted odds ratio, 0.68; 95% CI, 0.55-0.86; P = .001) than the AA genotype. Associations with the ABCB1 SNPs were not significant. Conclusions and Relevance Among infants with NAS, variants in the OPRM1 and COMT genes were associated with a shorter length of hospital stay and less need for treatment. These preliminary findings may provide insight into the mechanisms underlying NAS. JAMA. 2013;309(17):1821-1827	[Wachman, Elisha M.; Harvey-Wilkes, Karen; Davis, Jonathan M.] Tufts Med Ctr, Floating Hosp Children, Dept Pediat, Boston, MA 02111 USA; [Terrin, Norma] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA; [Huggins, Gordon S.] Tufts Med Ctr, Ctr Translat Genom, Mol Cardiol Res Inst, Boston, MA 02111 USA; [Terrin, Norma; Davis, Jonathan M.] Tufts Univ, Tufts Clin & Translat Sci Inst, Boston, MA 02111 USA; [Hayes, Marie J.] Univ Maine, Orono, ME USA; [Hayes, Marie J.] Univ Maine, Grad Sch Biomed Sci, Orono, ME USA; [Brown, Mark S.] Eastern Maine Med Ctr, Dept Pediat, Bangor, Gwynedd, Wales; [Paul, Jonathan] Univ Texas Med Branch, Dept Obstet & Gynecol, Galveston, TX 77555 USA; [Aranda, Jacob V.] SUNY Downstate Brooklyn, Brooklyn, NY USA	Floating Hospital For Children; Tufts Medical Center; Tufts Medical Center; Tufts Medical Center; Tufts University; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University of Texas System; University of Texas Medical Branch Galveston; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Davis, JM (corresponding author), Tufts Med Ctr, Floating Hosp Children, TMC 44, Div Newborn Med, 800 Washington St, Boston, MA 02111 USA.	jdavis@tuftsmedicalcenter.org			Winchester Hospital; Medical University of South Carolina; National Institutes of Health (NIH) [DA024806-01A2, R01DA032889-01A1]; Tufts Medical Center; National Research Service from the Eunice Kennedy Shriver National Institute of Child Health [T32HD055163]; National Center for Advancing Translational Sciences NIH through the Tufts Clinical and Translational Science Institute [UL1 TR000073]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD055163] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000073] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA024806, R01DA032889] Funding Source: NIH RePORTER	Winchester Hospital; Medical University of South Carolina; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts Medical Center; National Research Service from the Eunice Kennedy Shriver National Institute of Child Health; National Center for Advancing Translational Sciences NIH through the Tufts Clinical and Translational Science Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Davis reported receiving payment for lectures at Winchester Hospital and the Medical University of South Carolina. No other disclosures were reported.; This study was supported in part by National Institutes of Health (NIH) funding of data collection, single-nucleotide polymorphism genotyping, and data analyses (DA024806-01A2 to Dr Hayes and R01DA032889-01A1 to Dr Davis); the Tufts Medical Center's Natalie Zucker and Susan Saltonstall Grants to Dr Wachman, which supported laboratory analyses; National Research Service Award T32HD055163 from the Eunice Kennedy Shriver National Institute of Child Health to Dr Paul, which supported graduate education and training; and a National Center for Advancing Translational Sciences NIH grant UL1 TR000073 through the Tufts Clinical and Translational Science Institute to Drs Terrin and Davis.	[Anonymous], 2009, PAXGENE BLOOD DNA KI; [Anonymous], 2011, OR DNA COLL KIT PROT; Bond C, 1998, P NATL ACAD SCI USA, V95, P9608, DOI 10.1073/pnas.95.16.9608; Coller JK, 2006, CLIN PHARMACOL THER, V80, P682, DOI 10.1016/j.clpt.2006.09.011; Finnegan LP., 1992, PRIMARY PEDIAT CARE, P1367; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Hosak L, 2007, EUR PSYCHIAT, V22, P276, DOI 10.1016/j.eurpsy.2007.02.002; Jones HE, 2010, NEW ENGL J MED, V363, P2320, DOI 10.1056/NEJMoa1005359; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P261, DOI 10.1001/archpsyc.57.3.261; Klepstad P, 2005, ACTA ANAESTH SCAND, V49, P902, DOI 10.1111/j.1399-6576.2005.00772.x; Levran O, 2008, HUM MOL GENET, V17, P2219, DOI 10.1093/hmg/ddn122; Lotsch J, 2004, CLIN PHARMACOKINET, V43, P983; Mague SD, 2010, DRUG ALCOHOL DEPEN, V108, P172, DOI 10.1016/j.drugalcdep.2009.12.016; Mague SD, 2009, P NATL ACAD SCI USA, V106, P10847, DOI 10.1073/pnas.0901800106; Patrick SW, 2012, JAMA-J AM MED ASSOC, V307, P1934, DOI 10.1001/jama.2012.3951; Pritham UA, 2012, JOGNN-J OBST GYN NEO, V41, P180, DOI 10.1111/j.1552-6909.2011.01330.x; Rakvag TT, 2005, PAIN, V116, P73, DOI 10.1016/j.pain.2005.03.032; Ray R, 2011, P NATL ACAD SCI USA, V108, P9268, DOI 10.1073/pnas.1018699108; Reyes-Gibby CC, 2007, PAIN, V130, P25, DOI 10.1016/j.pain.2006.10.023; Seligman NS, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.088; US Department of Health and Human Services Substance Abuse and Mental Health Administration, 2009, RES 2009 NAT SURV DR; Zhang W, 2011, MINERVA ANESTESIOL, V77, P33; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546	23	134	135	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2013	309	17					1821	1827		10.1001/jama.2013.3411	http://dx.doi.org/10.1001/jama.2013.3411			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134SU	23632726	Green Accepted, Bronze			2022-12-28	WOS:000318235600030
J	Immel, J				Immel, Joe			Root Cause Analysis for Young Engineers	SCIENCE			English	Editorial Material									Technol High Sch, Rohnert Pk, CA 94928 USA		Immel, J (corresponding author), Technol High Sch, Rohnert Pk, CA 94928 USA.	immel@immel.com						Gano D.L., 2008, APOLLO ROOT CAUSE AN; Kephart Immel B., 2007, MINNEAPOLIS I 35W BR; National Transportation Safety Board, 2008, NTSBHAR0803; NTSB, 2007, NTSBAAR0701; Roberto M. A., 2005, 305032HTMENG HARV BU	5	0	0	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					444	445		10.1126/science.1229907	http://dx.doi.org/10.1126/science.1229907			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	131SQ	23626998				2022-12-28	WOS:000318016700032
J	Wilusz, JE; Sharp, PA				Wilusz, Jeremy E.; Sharp, Phillip A.			A Circuitous Route to Noncoding RNA	SCIENCE			English	Editorial Material							CIRCULAR RNAS		[Wilusz, Jeremy E.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Wilusz, JE (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	wilusz@mit.edu; sharppa@mit.edu		Wilusz, Jeremy/0000-0001-6929-8755	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM104166, R01GM034277] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM034277, K99 GM104166] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; CHEN CY, 1995, SCIENCE, V268, P415, DOI 10.1126/science.7536344; COCQUERELLE C, 1993, FASEB J, V7, P155, DOI 10.1096/fasebj.7.1.7678559; Danan M, 2012, NUCLEIC ACIDS RES, V40, P3131, DOI 10.1093/nar/gkr1009; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; WANG KS, 1986, NATURE, V323, P508, DOI 10.1038/323508a0; Wilusz JE, 2012, GENE DEV, V26, P2392, DOI 10.1101/gad.204438.112	14	376	418	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					440	441		10.1126/science.1238522	http://dx.doi.org/10.1126/science.1238522			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620042	Green Submitted, Green Accepted			2022-12-28	WOS:000318016700029
J	Rasella, D; Aquino, R; Santos, CAT; Paes-Sousa, R; Barreto, ML				Rasella, Davide; Aquino, Rosana; Santos, Carlos A. T.; Paes-Sousa, Romulo; Barreto, Mauricio L.			Effect of a conditional cash transfer programme on childhood mortality: a nationwide analysis of Brazilian municipalities	LANCET			English	Article								Background In the past 15 years, Brazil has undergone notable social and public health changes, including a large reduction in child mortality. The Bolsa Familia Programme (BFP) is a widespread conditional cash transfer programme, launched in 2003, which transfers cash to poor households (maximum income US$70 per person a month) when they comply with conditions related to health and education. Transfers range from $18 to $175 per month, depending on the income and composition of the family. We aimed to assess the effect of the BFP on deaths of children younger than 5 years (under-5), overall and resulting from specific causes associated with poverty: malnutrition, diarrhoea, and lower respiratory infections. Methods The study had a mixed ecological design. It covered the period from 2004-09 and included 2853 (of 5565) municipalities with death and livebirth statistics of adequate quality. We used government sources to calculate all-cause under-5 mortality rates and under-5 mortality rates for selected causes. BFP coverage was classified as low (0.0-17.1%), intermediate (17.2-32.0%), high (>32.0%), or consolidated (>32.0% and target population coverage >= 100% for at least 4 years). We did multivariable regression analyses of panel data with fixed-effects negative binomial models, adjusted for relevant social and economic covariates, and for the effect of the largest primary health-care scheme in the country (Family Health Programme). Findings Under-5 mortality rate, overall and resulting from poverty-related causes, decreased as BFP coverage increased. The rate ratios (RR) for the effect of the BFP on overall under-5 mortality rate were 0.94 (95% CI 0.92-0.96) for intermediate coverage, 0.88 (0.85-0.91) for high coverage, and 0.83 (0.79-0.88) for consolidated coverage. The effect of consolidated BFP coverage was highest on under-5 mortality resulting from malnutrition (RR 0.35; 95% CI 0.24-0.50) and diarrhoea (0.47; 0.37-0.61). Interpretation A conditional cash transfer programme can greatly contribute to a decrease in childhood mortality overall, and in particular for deaths attributable to poverty-related causes such as malnutrition and diarrhoea, in a large middle-income country such as Brazil.	[Rasella, Davide; Aquino, Rosana; Santos, Carlos A. T.; Barreto, Mauricio L.] Univ Fed Bahia, Inst Saude Colet, BR-41110040 Salvador, BA, Brazil; [Santos, Carlos A. T.] State Univ Feira de Santana, Dept Exact Sci, Feira De Santana, BA, Brazil; [Paes-Sousa, Romulo] Univ Sussex, Inst Dev Studies, Brighton, E Sussex, England; [Barreto, Mauricio L.] INCT CITECS, Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade Estadual de Feira de Santana; University of Sussex	Barreto, ML (corresponding author), Univ Fed Bahia, Inst Saude Colet, BR-41110040 Salvador, BA, Brazil.	mauricio@ufba.br	Rasella, Davide/ABG-4182-2020; Paes de Sousa, Romulo/ABE-3987-2021; Aquino, Rosana/M-2240-2013; Barreto, Mauricio L/B-1752-2008	Rasella, Davide/0000-0002-7260-4386; Paes de Sousa, Romulo/0000-0002-3384-6657; Aquino, Rosana/0000-0003-3906-5170; Barreto, Mauricio L/0000-0002-0215-4930	National Institutes of Science and Technology Programme; Ministry of Science and Technology; Council for Scientific and Technological Development Programme (CNPq), Brazil	National Institutes of Science and Technology Programme; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Council for Scientific and Technological Development Programme (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	National Institutes of Science and Technology Programme, Ministry of Science and Technology, and Council for Scientific and Technological Development Programme (CNPq), Brazil.		0	257	291	5	85	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 6	2013	382	9886					57	64		10.1016/S0140-6736(13)60715-1	http://dx.doi.org/10.1016/S0140-6736(13)60715-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177AD	23683599	Green Published			2022-12-28	WOS:000321347000029
J	Jafar, TH; Haaland, BA; Rahman, A; Razzak, JA; Bilger, M; Naghavi, M; Mokdad, AH; Hyder, AA				Jafar, Tazeen H.; Haaland, Benjamin A.; Rahman, Atif; Razzak, Junaid A.; Bilger, Marcel; Naghavi, Mohsen; Mokdad, Ali H.; Hyder, Adnan A.			Non-communicable diseases and injuries in Pakistan: strategic priorities	LANCET			English	Article							NATIONAL DIABETES SURVEY; MIDDLE-INCOME COUNTRIES; BLOOD-PRESSURE CONTROL; ROAD TRAFFIC INJURIES; RISK-FACTORS; PSYCHIATRIC-DISORDER; GLUCOSE-INTOLERANCE; MOUNTAIN VILLAGES; MENTAL-DISORDERS; HEALTH	Non-communicable diseases, including cardiovascular diseases, cancers, respiratory diseases, diabetes, and mental disorders, and injuries have become the major causes of morbidity and mortality in Pakistan. Tobacco use and hypertension are the leading attributable risk factors for deaths due to cardiovascular diseases, cancers, and respiratory diseases. Pakistan has the sixth highest number of people in the world with diabetes; every fourth adult is overweight or obese; cigarettes are cheap; antismoking and road safety laws are poorly enforced; and a mixed public-private health-care system provides suboptimum care. Furthermore, almost three decades of exposure to sociopolitical instability, economic uncertainty, violence, regional conflict, and dislocation have contributed to a high prevalence of mental health disorders. Projection models based on the Global Burden of Disease 2010 data suggest that there will be about 3.87 million premature deaths by 2025 from cardiovascular diseases, cancers, and chronic respiratory diseases in people aged 30-69 years in Pakistan, with serious economic consequences. Modelling of risk factor reductions also indicate that Pakistan could achieve at least a 20% reduction in the number of these deaths by 2025 by targeting of the major risk factors. We call for policy and legislative changes, and health-system interventions to target readily preventable non-communicable diseases in Pakistan.	[Jafar, Tazeen H.; Bilger, Marcel] Duke NUS Grad Med Sch, 8 Coll Rd, Singapore 169857, Singapore; [Haaland, Benjamin A.] Duke NUS Grad Med Sch, Ctr Quantitat Med, Off Clin Sci, Singapore 169857, Singapore; [Jafar, Tazeen H.] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Jafar, Tazeen H.] Aga Khan Univ, Dept Med, Karachi, Pakistan; [Haaland, Benjamin A.] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Rahman, Atif] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Rahman, Atif] Inst Psychiat, Rawalpindi, Pakistan; [Razzak, Junaid A.; Hyder, Adnan A.] Aga Khan Univ, Dept Emergency Med, Karachi, Pakistan; [Razzak, Junaid A.] Aman Hlth Care Serv, Karachi, Pakistan; [Naghavi, Mohsen; Mokdad, Ali H.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Hyder, Adnan A.] Johns Hopkins Bloomberg Sch Publ Hlth, Int Injury Res Unit, Baltimore, MD USA	National University of Singapore; National University of Singapore; Aga Khan University; Aga Khan University; National University of Singapore; University of Liverpool; Aga Khan University; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Jafar, TH (corresponding author), Duke NUS Grad Med Sch, 8 Coll Rd, Singapore 169857, Singapore.	tazeen.jafar@duke-nus.edu.sg	Hyder, Adnan/AAT-9503-2021; Razzak, Junaid/ABE-3549-2020; Mokdad, Ali H./AAD-1232-2022	Mokdad, Ali H./0000-0002-4994-3339; Bilger, Marcel/0000-0002-2872-6597; Razzak, Junaid/0000-0003-0735-9094; Hyder, Adnan/0000-0002-7292-577X				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Afukaar Francis K, 2003, Inj Control Saf Promot, V10, P77, DOI 10.1076/icsp.10.1.77.14113; Ali Badar Sabir, 2003, American Journal of Psychotherapy, V57, P324; Beaglehole R, 2003, LANCET, V362, P903, DOI 10.1016/S0140-6736(03)14335-8; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Beaglehole R, 2013, LANCET, V381, P602, DOI 10.1016/S0140-6736(13)60101-4; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bishai D, 2003, HEALTH POLICY PLANN, V18, P232, DOI 10.1093/heapol/czg028; Bloom DE, 2011, GLOBAL EC BURDEN NON; Bradbury K, 1999, J PEDIATR PSYCHOL, V24, P423, DOI 10.1093/jpepsy/24.5.423; Chaloupka FJ, 2012, TOB CONTROL, V21, P172, DOI 10.1136/tobaccocontrol-2011-050417; Chisholm D, 2000, BRIT J PSYCHIAT, V176, P581, DOI 10.1192/bjp.176.6.581; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Engelgau MM, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-9; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Gadit A A, 2004, J Pak Med Assoc, V54, P43; Ghaffar A, 2004, PUBLIC HEALTH, V118, P211, DOI 10.1016/j.puhe.2003.05.003; Govt of Pakistan, 2010, PAK EC SURV; Hall JN, 2009, AM J PREV MED, V36, P402, DOI 10.1016/j.amepre.2009.01.029; Heartfile Ministry of Health WHO, MEM UND DEV NAT ACT; Husain N, 2007, BRIT J PSYCHIAT, V190, P36, DOI 10.1192/bjp.bp.106.022913; Husain N, 2000, PSYCHOL MED, V30, P395, DOI 10.1017/S0033291700001707; Institute of Medicine, PROMOTING CARDIOVASC; Islam A, 2002, J Pak Med Assoc, V52, P2; Ismail J, 2004, HEART, V90, P259, DOI 10.1136/hrt.2003.013631; Jafar TH, 2006, CAN MED ASSOC J, V175, P1071, DOI 10.1503/cmaj.060464; Jafar TH, 2012, AM J KIDNEY DIS, V60, P731, DOI 10.1053/j.ajkd.2012.08.007; Jafar TH, 2011, CIRCULATION, V124, P1615, DOI 10.1161/CIRCULATIONAHA.111.039990; Jafar TH, 2009, ANN INTERN MED, V151, P593, DOI 10.7326/0003-4819-151-9-200911030-00004; Jafar TH, 2005, CIRCULATION, V111, P1278, DOI 10.1161/01.CIR.0000157698.78949.D7; Jafar TH, 2003, J HYPERTENS, V21, P905, DOI 10.1097/00004872-200305000-00014; Levy DT, 2008, TOB CONTROL, V17, P53, DOI 10.1136/tc.2007.022319; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MACKAY JM, 1986, BRIT MED J, V292, P1435, DOI 10.1136/bmj.292.6533.1435; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mirza I, 2004, BMJ-BRIT MED J, V328, P794, DOI 10.1136/bmj.328.7443.794; Mumford DB, 1997, BRIT J PSYCHIAT, V170, P473, DOI 10.1192/bjp.170.5.473; Mumford DB, 1996, BRIT J PSYCHIAT, V168, P299, DOI 10.1192/bjp.168.3.299; Nishtar S., HLTH INDICATORS PAKI; Nishtar S, 2013, LANCET; Nishtar Sania, 2006, Prev Chronic Dis, V3, pA14; Nishtar S, 2010, LANCET, V376, P874, DOI 10.1016/S0140-6736(10)61413-4; Patel V, 2003, B WORLD HEALTH ORGAN, V81, P609; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Peden M, 2002, INJURY CHART BOOK GR, P5; Poureslami Iraj M, 2004, MedGenMed, V6, P51; Rahman A, 2009, CHILD CARE HLTH DEV, V35, P56, DOI 10.1111/j.1365-2214.2008.00897.x; Rahman A, 2003, PSYCHOL MED, V33, P1161, DOI 10.1017/S0033291703008286; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Razzak JA, 2004, PUBLIC HEALTH, V118, P114, DOI 10.1016/S0033-3506(03)00147-1; Razzak JA, 2011, J PAK MED ASSOC, V61, P640; Shah SM, 2004, TROP MED INT HEALTH, V9, P526, DOI 10.1111/j.1365-3156.2004.01220.x; Shah SMA, 2001, J HUM HYPERTENS, V15, P107, DOI 10.1038/sj.jhh.1001131; Shaikh BT, 2005, J PUBLIC HEALTH-UK, V27, P49, DOI 10.1093/pubmed/fdh207; Shamim Muhammad S, 2011, J Emerg Trauma Shock, V4, P147, DOI 10.4103/0974-2700.76817; Shera AS, 2007, DIABETES RES CLIN PR, V76, P219, DOI 10.1016/j.diabres.2006.08.011; Shera AS, 1999, DIABETES RES CLIN PR, V44, P49, DOI 10.1016/S0168-8227(99)00017-0; Shera AS, 1995, DIABETIC MED, V12, P1116, DOI 10.1111/j.1464-5491.1995.tb00430.x; UN, 2011, 2011 HIGH LEV M PREV; Unal B, 2003, TOB INDUC DIS, V3, P185; WHO, REP PAK; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Willett W. C., 2006, Disease control priorities in developing countries, P833; World Bank, 2009, WORLD DEV IND; World Health Organization, 2019, WHO REPORT GLOBAL TO; World Health Organization (WHO), ACT PLAN PR IN PRESS; Yach D, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-10	74	60	60	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 29	2013	381	9885					2281	2290		10.1016/S0140-6736(13)60646-7	http://dx.doi.org/10.1016/S0140-6736(13)60646-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	173SU	23684257				2022-12-28	WOS:000321100300033
J	Stewart, R				Stewart, Robert			Reducing depression in nursing homes: so little, so late	LANCET			English	Editorial Material							CARE; ANXIETY		Kings Coll London, Inst Psychiat, London SE5 8AF, England	University of London; King's College London	Stewart, R (corresponding author), Kings Coll London, Inst Psychiat, London SE5 8AF, England.	r.stewart@iop.kcl.ac.uk	Stewart, Robert/B-1667-2010	Stewart, Robert/0000-0002-4435-6397				Barca ML, 2010, J AFFECT DISORDERS, V120, P141, DOI 10.1016/j.jad.2009.04.028; Barca ML, 2009, INT J GERIATR PSYCH, V24, P417, DOI 10.1002/gps.2139; Bergh S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1566; Bharucha AJ, 2006, J AM MED DIR ASSOC, V7, P568, DOI 10.1016/j.jamda.2006.08.003; Boorsma M, 2012, AM J GERIAT PSYCHIAT, V20, P932, DOI 10.1097/JGP.0b013e31825d08ac; Boyce RD, 2012, J AM MED DIR ASSOC, V13, P326, DOI 10.1016/j.jamda.2011.08.009; Dozeman E, 2012, INT PSYCHOGERIATR, V24, P1242, DOI 10.1017/S1041610212000178; Leontjevas R, 2013, LANCET; Proctor R, 1999, LANCET, V354, P26, DOI 10.1016/S0140-6736(98)08237-3; Smalbrugge M, 2006, INT J GERIATR PSYCH, V21, P325, DOI 10.1002/gps.1466; Teresi J, 2001, SOC PSYCH PSYCH EPID, V36, P613, DOI 10.1007/s127-001-8202-7; Tiong WW, 2013, AGING MENT HEALTH, V17, P724, DOI 10.1080/13607863.2013.775638	12	4	4	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 29	2013	381	9885					2227	2228		10.1016/S0140-6736(13)60939-3	http://dx.doi.org/10.1016/S0140-6736(13)60939-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	173SU	23643108				2022-12-28	WOS:000321100300005
J	Trempe, JF; Sauve, V; Grenier, K; Seirafi, M; Tang, MY; Menade, M; Al-Abdul-Wahid, S; Krett, J; Wong, K; Kozlov, G; Nagar, B; Fon, EA; Gehring, K				Trempe, Jean-Francois; Sauve, Veronique; Grenier, Karl; Seirafi, Marjan; Tang, Matthew Y.; Menade, Marie; Al-Abdul-Wahid, Sameer; Krett, Jonathan; Wong, Kathy; Kozlov, Guennadi; Nagar, Bhushan; Fon, Edward A.; Gehring, Kalle			Structure of Parkin Reveals Mechanisms for Ubiquitin Ligase Activation	SCIENCE			English	Article							RING DOMAIN; DISEASE; MITOCHONDRIA; PHOSPHORYLATION; ASSOCIATION; DYSFUNCTION; MUTATIONS	Mutations in the PARK2 (parkin) gene are responsible for an autosomal recessive form of Parkinson's disease. The parkin protein is a RING-in-between-RING E3 ubiquitin ligase that exhibits low basal activity. We describe the crystal structure of full-length rat parkin. The structure shows parkin in an autoinhibited state and provides insight into how it is activated. RING0 occludes the ubiquitin acceptor site Cys(431) in RING2, whereas a repressor element of parkin binds RING1 and blocks its E2-binding site. Mutations that disrupted these inhibitory interactions activated parkin both in vitro and in cells. Parkin is neuroprotective, and these findings may provide a structural and mechanistic framework for enhancing parkin activity.	[Trempe, Jean-Francois; Grenier, Karl; Tang, Matthew Y.; Krett, Jonathan; Fon, Edward A.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, McGill Parkinson Program, Montreal, PQ H3A 2B4, Canada; [Sauve, Veronique; Seirafi, Marjan; Menade, Marie; Al-Abdul-Wahid, Sameer; Wong, Kathy; Kozlov, Guennadi; Nagar, Bhushan; Gehring, Kalle] McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ H3G 1Y6, Canada; [Sauve, Veronique; Seirafi, Marjan; Menade, Marie; Al-Abdul-Wahid, Sameer; Wong, Kathy; Kozlov, Guennadi; Nagar, Bhushan; Gehring, Kalle] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; McGill University	Fon, EA (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, McGill Parkinson Program, Montreal, PQ H3A 2B4, Canada.	ted.fon@mcgill.ca; kalle.gehring@mcgill.ca	Gehring, Kalle/N-2945-2019; Gehring, Kalle/I-4403-2013	Gehring, Kalle/0000-0001-6500-1184; Gehring, Kalle/0000-0001-6500-1184; Krett, Jonathan/0000-0003-4964-3341; Al-Abdul-Wahid, Mohamed Sameer/0000-0001-7925-5863	Parkinson Society Canada; Canadian Institutes of Health Research [MOP-62714, MOP-14219]	Parkinson Society Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank C. Arrowsmith for the His<INF>6</INF>-UbcH7 construct, the Canadian Light Source and CHESS for data acquisition, and group members for insights and helpful discussion. We acknowledge support from Parkinson Society Canada and from Canadian Institutes of Health Research grants MOP-62714 (E.A.F.) and MOP-14219 (K.G.). Coordinates and structure factors of the R0-RBR and full-length parkin crystal structures were deposited in the Protein Data Bank under accession codes 4K7D and 4K95.	Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Hristova VA, 2009, J BIOL CHEM, V284, P14978, DOI 10.1074/jbc.M808700200; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Ko HS, 2010, P NATL ACAD SCI USA, V107, P16691, DOI 10.1073/pnas.1006083107; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Lazarou M, 2013, J CELL BIOL, V200, P163, DOI 10.1083/jcb.201210111; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Mata IF, 2004, HUM MOL GENET, V13, pR127, DOI 10.1093/hmg/ddh089; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Safadi SS, 2010, J BIOL CHEM, V285, P1424, DOI 10.1074/jbc.M109.041970; Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Stieglitz B, 2012, EMBO REP, V13, P840, DOI 10.1038/embor.2012.105; Trempe JF, 2009, MOL CELL, V36, P1034, DOI 10.1016/j.molcel.2009.11.021; Vandiver MS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2623; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Walden H, 2012, CELL MOL LIFE SCI, V69, P3053, DOI 10.1007/s00018-012-0978-5; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Yamamoto A, 2005, J BIOL CHEM, V280, P3390, DOI 10.1074/jbc.M407724200; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	29	347	356	2	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	2013	340	6139					1451	1455		10.1126/science.1237908	http://dx.doi.org/10.1126/science.1237908			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23661642				2022-12-28	WOS:000320647000042
J	Dean, CR; Wang, L; Maher, P; Forsythe, C; Ghahari, F; Gao, Y; Katoch, J; Ishigami, M; Moon, P; Koshino, M; Taniguchi, T; Watanabe, K; Shepard, KL; Hone, J; Kim, P				Dean, C. R.; Wang, L.; Maher, P.; Forsythe, C.; Ghahari, F.; Gao, Y.; Katoch, J.; Ishigami, M.; Moon, P.; Koshino, M.; Taniguchi, T.; Watanabe, K.; Shepard, K. L.; Hone, J.; Kim, P.			Hofstadter's butterfly and the fractal quantum Hall effect in moire superlattices	NATURE			English	Article							SCANNING-TUNNELING-MICROSCOPY; HEXAGONAL BORON-NITRIDE; MAGNETORESISTANCE OSCILLATIONS; ENERGY-SPECTRUM; MAGNETIC-FIELDS; BLOCH ELECTRONS; GRAPHENE; CONDUCTANCE	Electrons moving through a spatially periodic lattice potential develop a quantized energy spectrum consisting of discrete Bloch bands. In two dimensions, electrons moving through a magnetic field also develop a quantized energy spectrum, consisting of highly degenerate Landau energy levels. When subject to both a magnetic field and a periodic electrostatic potential, two-dimensional systems of electrons exhibit a self-similar recursive energy spectrum(1). Known as Hofstadter's butterfly, this complex spectrum results from an interplay between the characteristic lengths associated with the two quantizing fields(1-10), and is one of the first quantum fractals discovered in physics. In the decades since its prediction, experimental attempts to study this effect have been limited by difficulties in reconciling the two length scales. Typical atomic lattices (with periodicities of less than one nanometre) require unfeasibly large magnetic fields to reach the commensurability condition, and in artificially engineered structures (with periodicities greater than about 100 nanometres) the corresponding fields are too small to overcome disorder completely(11-17). Here we demonstrate that moire superlattices arising in bilayer graphene coupled to hexagonal boron nitride provide a periodic modulation with ideal length scales of the order of ten nanometres, enabling unprecedented experimental access to the fractal spectrum. We confirm that quantum Hall features associated with the fractal gaps are described by two integer topological quantum numbers, and report evidence of their recursive structure. Observation of a Hofstadter spectrum in bilayer graphene means that it is possible to investigate emergent behaviour within a fractal energy landscape in a system with tunable internal degrees of freedom.	[Dean, C. R.] CUNY, Dept Phys, New York, NY 10031 USA; [Wang, L.; Gao, Y.; Hone, J.] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Maher, P.; Forsythe, C.; Ghahari, F.; Kim, P.] Columbia Univ, Dept Phys, New York, NY 10027 USA; [Katoch, J.; Ishigami, M.] Univ Cent Florida, Dept Phys, Orlando, FL 32816 USA; [Katoch, J.; Ishigami, M.] Univ Cent Florida, Nanosci Technol Ctr, Orlando, FL 32816 USA; [Moon, P.; Koshino, M.] Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan; [Taniguchi, T.; Watanabe, K.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Shepard, K. L.] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA	City University of New York (CUNY) System; Columbia University; Columbia University; State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; Tohoku University; National Institute for Materials Science; Columbia University	Kim, P (corresponding author), Columbia Univ, Dept Phys, 538 W 120th St, New York, NY 10027 USA.	pk2015@columbia.edu	TANIGUCHI, Takashi/H-2718-2011; WATANABE, Kenji/H-2825-2011; Koshino, Mikito/C-2550-2012; Moon, Pilkyung/A-2930-2010; Katoch, Jyoti/S-1459-2018; Ishigami, Masahiro/AAO-2083-2021; Wang, Lei/K-1160-2012; Kim, Philip/N-1886-2013; Hone, James C/E-1879-2011	WATANABE, Kenji/0000-0003-3701-8119; Koshino, Mikito/0000-0002-5911-7532; Moon, Pilkyung/0000-0003-3994-4255; Katoch, Jyoti/0000-0002-3678-1780; Wang, Lei/0000-0002-1919-9107; Kim, Philip/0000-0002-8255-0086; Hone, James C/0000-0002-8084-3301; Ghahari Kermani, Fereshte/0000-0003-0317-4009	US National Science Foundation [DMR-0654118, 0955625]; State of Florida; US Department of Energy [DE-FG02-05ER46215]; AFOSR MURI; DARPA under Office of Naval Research [N00014-1210814]; Grants-in-Aid for Scientific Research [24740193] Funding Source: KAKEN	US National Science Foundation(National Science Foundation (NSF)); State of Florida; US Department of Energy(United States Department of Energy (DOE)); AFOSR MURI(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); DARPA under Office of Naval Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank A. MacDonald for discussions. A portion of this work was performed at the National High Magnetic Field Laboratory, which is supported by US National Science Foundation cooperative agreement no. DMR-0654118, the State of Florida and the US Department of Energy. This work is supported by AFOSR MURI. J.K. and M.I. were supported by the US National Science Foundation under grant no. 0955625. K.L.S. was supported by DARPA under Office of Naval Research contract N00014-1210814. P.K. and F.G. acknowledge sole support from the US Department of Energy (DE-FG02-05ER46215).	Albrecht C, 2001, PHYS REV LETT, V86, P147, DOI 10.1103/PhysRevLett.86.147; Albrecht C, 1999, PHYS REV LETT, V83, P2234, DOI 10.1103/PhysRevLett.83.2234; Beugeling W, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.075118; Bistritzer R, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.035440; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Decker R, 2011, NANO LETT, V11, P2291, DOI 10.1021/nl2005115; Geisler MC, 2004, PHYSICA E, V25, P227, DOI 10.1016/j.physe.2004.06.021; GERHARDTS RR, 1991, PHYS REV B, V43, P5192, DOI 10.1103/PhysRevB.43.5192; Giovannetti G, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.073103; HARPER PG, 1955, P PHYS SOC LOND A, V68, P874, DOI 10.1088/0370-1298/68/10/304; HOFSTADTER DR, 1976, PHYS REV B, V14, P2239, DOI 10.1103/PhysRevB.14.2239; Jaksch D, 2003, NEW J PHYS, V5, DOI 10.1088/1367-2630/5/1/356; Koshino M, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.155304; Kuhl U, 1998, PHYS REV LETT, V80, P3232, DOI 10.1103/PhysRevLett.80.3232; Melinte S, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.036802; Moon P, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.195458; Nakamura Y, 1998, PHYSICA E, V2, P944, DOI 10.1016/S1386-9477(98)00193-3; Nemec N, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.201404; Ramasubramaniam A, 2011, NANO LETT, V11, P1070, DOI 10.1021/nl1039499; Schlosser T, 1996, SEMICOND SCI TECH, V11, P1582, DOI 10.1088/0268-1242/11/11S/022; STREDA P, 1982, J PHYS C SOLID STATE, V15, P1299, DOI 10.1088/0022-3719/15/36/006; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; Wallbank J. R., 2012, PREPRINT; WANNIER GH, 1978, PHYS STATUS SOLIDI B, V88, P757, DOI 10.1002/pssb.2220880243; Xue JM, 2011, NAT MATER, V10, P282, DOI 10.1038/NMAT2968	30	1105	1115	23	666	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2013	497	7451					598	602		10.1038/nature12186	http://dx.doi.org/10.1038/nature12186			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23676673	Green Submitted			2022-12-28	WOS:000319556100039
J	Ponomarenko, LA; Gorbachev, RV; Yu, GL; Elias, DC; Jalil, R; Patel, AA; Mishchenko, A; Mayorov, AS; Woods, CR; Wallbank, JR; Mucha-Kruczynski, M; Piot, BA; Potemski, M; Grigorieva, IV; Novoselov, KS; Guinea, F; Fal'ko, VI; Geim, AK				Ponomarenko, L. A.; Gorbachev, R. V.; Yu, G. L.; Elias, D. C.; Jalil, R.; Patel, A. A.; Mishchenko, A.; Mayorov, A. S.; Woods, C. R.; Wallbank, J. R.; Mucha-Kruczynski, M.; Piot, B. A.; Potemski, M.; Grigorieva, I. V.; Novoselov, K. S.; Guinea, F.; Fal'ko, V. I.; Geim, A. K.			Cloning of Dirac fermions in graphene superlattices	NATURE			English	Article							SCANNING-TUNNELING-MICROSCOPY; HEXAGONAL BORON-NITRIDE; MAGNETOTRANSPORT	Superlattices have attracted great interest because their use may make it possible to modify the spectra of two-dimensional electron systems and, ultimately, create materials with tailored electronic properties(1-8). In previous studies (see, for example, refs 1-8), it proved difficult to realize superlattices with short periodicities and weak disorder, and most of their observed features could be explained in terms of cyclotron orbits commensurate with the superlattice(1-4). Evidence for the formation of superlattice mini-bands (forming a fractal spectrum known as Hofstadter's butterfly(9)) has been limited to the observation of new low-field oscillations(5) and an internal structure within Landau levels(6-8). Here we report transport properties of graphene placed on a boron nitride substrate and accurately aligned along its crystallographic directions. The substrate's moire potential(10-12) acts as a superlattice and leads to profound changes in the graphene's electronic spectrum. Second-generation Dirac points(13-22) appear as pronounced peaks in resistivity, accompanied by reversal of the Hall effect. The latter indicates that the effective sign of the charge carriers changes within graphene's conduction and valence bands. Strong magnetic fields lead to Zak-type cloning(23) of the third generation of Dirac points, which are observed as numerous neutrality points in fields where a unit fraction of the flux quantum pierces the superlattice unit cell. Graphene superlattices such as this one provide a way of studying the rich physics expected in incommensurable quantum systems(7-9,22-24) and illustrate the possibility of controllably modifying the electronic spectra of two-dimensional atomic crystals by varying their crystallographic alignment within van der Waals heterostuctures(25).	[Ponomarenko, L. A.; Yu, G. L.; Elias, D. C.; Mishchenko, A.; Mayorov, A. S.; Woods, C. R.; Grigorieva, I. V.; Novoselov, K. S.; Geim, A. K.] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Gorbachev, R. V.; Jalil, R.; Geim, A. K.] Univ Manchester, Ctr Mesosci & Nanotechnol, Manchester M13 9PL, Lancs, England; [Patel, A. A.; Wallbank, J. R.; Mucha-Kruczynski, M.; Fal'ko, V. I.] Univ Lancaster, Dept Phys, Lancaster LA1 4YB, England; [Piot, B. A.; Potemski, M.] CNRS UJF UPS INSA, Lab Natl Champs Magnet Intenses, F-38042 Grenoble, France; [Guinea, F.] Inst Ciencia Mat Madrid, Madrid 28049, Spain	University of Manchester; University of Manchester; Lancaster University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM)	Gorbachev, RV (corresponding author), Univ Manchester, Ctr Mesosci & Nanotechnol, Manchester M13 9PL, Lancs, England.	blizza@gmail.com	Mishchenko, Artem/C-7561-2011; Novoselov, Kostya S/G-9581-2014; Geim, Andre K/J-7888-2012; Patel, Aavishkar/K-9655-2019; Cunha Elias, Daniel/A-7494-2013; Jalil, Rashid/Z-2262-2019; Gorbachev, Roman/I-2512-2013; Mayorov, Alexander/P-4737-2015; Guinea, Francisco/A-7122-2008; Mucha-Kruczynski, Marcin/K-4063-2015; Ponomarenko, Leonid/AAF-1731-2021	Mishchenko, Artem/0000-0002-0427-5664; Novoselov, Kostya S/0000-0003-4972-5371; Geim, Andre K/0000-0003-2861-8331; Patel, Aavishkar/0000-0001-7857-8724; Cunha Elias, Daniel/0000-0002-0878-1409; Jalil, Rashid/0000-0002-8347-9955; Gorbachev, Roman/0000-0003-3604-5617; Mayorov, Alexander/0000-0003-4558-3425; Guinea, Francisco/0000-0001-5915-5427; Mucha-Kruczynski, Marcin/0000-0002-6597-3888; Fal'ko, Vladimir/0000-0003-0828-0310; Potemski, Marek/0000-0001-8881-6618; hai yan, he/0000-0003-0366-6185	European Research Council; Korber Foundation; Office of Naval Research; Air Force Office of Scientific Research; Royal Society; EPSRC [EP/G02491X/1, EP/K005014/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1240086, EP/G02491X/1] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Korber Foundation; Office of Naval Research(Office of Naval Research); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Royal Society(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank D. Weiss, A. MacDonald and F. Peeters for discussions. This work was supported by the European Research Council, the Korber Foundation, the Office of Naval Research, the Air Force Office of Scientific Research and the Royal Society.	Albrecht C, 2001, PHYS REV LETT, V86, P147, DOI 10.1103/PhysRevLett.86.147; Albrecht C, 1999, PHYS REV LETT, V83, P2234, DOI 10.1103/PhysRevLett.83.2234; Bistritzer R, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.035440; Bliokh YP, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.075123; Burset P, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.195434; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Decker R, 2011, NANO LETT, V11, P2291, DOI 10.1021/nl2005115; FERRY DK, 1992, PROG QUANT ELECTRON, V16, P251, DOI 10.1016/0079-6727(92)90005-G; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Geisler MC, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.256801; Haigh SJ, 2012, NAT MATER, V11, P764, DOI [10.1038/nmat3386, 10.1038/NMAT3386]; HOFSTADTER DR, 1976, PHYS REV B, V14, P2239, DOI 10.1103/PhysRevB.14.2239; Kindermann M, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.115415; Li GH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.176804; Mayorov AS, 2012, NANO LETT, V12, P4629, DOI 10.1021/nl301922d; Mayorov AS, 2011, NANO LETT, V11, P2396, DOI 10.1021/nl200758b; Ortix C, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.081405; PFANNKUCHE D, 1992, PHYS REV B, V46, P12606, DOI 10.1103/PhysRevB.46.12606; Schlosser T, 1996, EUROPHYS LETT, V33, P683, DOI 10.1209/epl/i1996-00399-6; Wallbank J. R., 2012, PREPRINT; WEISS D, 1991, PHYS REV LETT, V66, P2790, DOI 10.1103/PhysRevLett.66.2790; WEISS D, 1989, EUROPHYS LETT, V8, P179, DOI 10.1209/0295-5075/8/2/012; Xue JM, 2011, NAT MATER, V10, P282, DOI 10.1038/NMAT2968; ZAK J, 1964, PHYS REV, V134, P1602, DOI 10.1103/PhysRev.134.A1602; Zarenia M, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.085451	30	891	901	15	783	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2013	497	7451					594	597		10.1038/nature12187	http://dx.doi.org/10.1038/nature12187			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23676678	Green Submitted			2022-12-28	WOS:000319556100038
J	Cuzick, J; Sestak, I; Bonanni, B; Costantino, JP; Cummings, S; DeCensi, A; Dowsett, M; Forbes, JF; Ford, L; LaCroix, AZ; Mershon, J; Mitlak, BH; Powles, T; Veronesi, U; Vogel, V; Wickerham, DL				Cuzick, Jack; Sestak, Ivana; Bonanni, Bernardo; Costantino, Joseph P.; Cummings, Steve; DeCensi, Andrea; Dowsett, Mitch; Forbes, John F.; Ford, Leslie; LaCroix, Andrea Z.; Mershon, John; Mitlak, Bruce H.; Powles, Trevor; Veronesi, Umberto; Vogel, Victor; Wickerham, D. Lawrence		SERM Chemoprevention Breast Canc O	Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data	LANCET			English	Article							SURGICAL ADJUVANT BREAST; POSTMENOPAUSAL OSTEOPOROTIC WOMEN; BOWEL PROJECT P-1; RANDOMIZED-TRIAL; FOLLOW-UP; TAMOXIFEN; RALOXIFENE; RISK; OUTCOMES; CHEMOPREVENTION	Background Tamoxifen and raloxifene reduce the risk of breast cancer in women at elevated risk of disease, but the duration of the effect is unknown. We assessed the effectiveness of selective oestrogen receptor modulators (SERMs) on breast cancer incidence. Methods We did a meta-analysis with individual participant data from nine prevention trials comparing four selective oestrogen receptor modulators (SERMs; tamoxifen, raloxifene, arzoxifene, and lasofoxifene) with placebo, or in one study with tamoxifen. Our primary endpoint was incidence of all breast cancer (including ductal carcinoma in situ) during a 10 year follow-up period. Analysis was by intention to treat. Results We analysed data for 83 399 women with 306 617 women-years of follow-up. Median follow-up was 65 months (IQR 54-93). Overall, we noted a 38% reduction (hazard ratio [HR] 0.62, 95% CI 0.56-0.69) in breast cancer incidence, and 42 women would need to be treated to prevent one breast cancer event in the first 10 years of follow-up. The reduction was larger in the first 5 years of follow-up than in years 5-10 (42%, HR 0.58, 0.51-0.66; p<0.0001 vs 25%, 0.75, 0.61-0.93; p=0.007), but we noted no heterogeneity between time periods. Thromboembolic events were significantly increased with all SERMs (odds ratio 1.73, 95% CI 1.47-2.05; p<0.0001). We recorded a significant reduction of 34% in vertebral fractures (0.66, 0.59-0.73), but only a small effect for non-vertebral fractures (0.93, 0.87-0.99). Interpretation For all SERMs, incidence of invasive oestrogen (ER)-positive breast cancer was reduced both during treatment and for at least 5 years after completion. Similar to other preventive interventions, careful consideration of risks and benefits is needed to identify women who are most likely to benefit from these drugs.	[Cuzick, Jack; Sestak, Ivana] Queen Mary Univ London, Ctr Canc Prevent, Wolfson Inst Prevent Med, London EC1M 6BQ, England; [Bonanni, Bernardo] European Inst Oncol, Milan, Italy; [Costantino, Joseph P.] Ctr Biostat, Natl Surg Adjuvant Breast & Bowel Project NSABP, Pittsburgh, PA USA; [Cummings, Steve] Calif Pacific Med Ctr, Res Inst, San Francisco Coordinating Ctr, San Francisco, CA USA; [DeCensi, Andrea] EO Osped Galliera, Div Med Oncol, Genoa, Italy; [Dowsett, Mitch] Royal Marsden Hosp, Dept Acad Biochem, London SW3 6JJ, England; [Forbes, John F.] Univ Newcastle, Newcastle Mater Hosp, Dept Surg Oncol, Newcastle, NSW 2300, Australia; [Ford, Leslie] NCI, Canc Prevent Div, Bethesda, MD 20892 USA; [LaCroix, Andrea Z.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Mershon, John] Abbott Labs, Abbott Pk, IL 60064 USA; [Mitlak, Bruce H.] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Powles, Trevor] Inst Canc Res, London SW3 6JB, England; [Veronesi, Umberto] European Inst Oncol, Milan, Italy; [Vogel, Victor] Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA USA; [Wickerham, D. Lawrence] Univ Pittsburgh, Dept Human Oncol, Pittsburgh, PA USA	University of London; Queen Mary University London; IRCCS European Institute of Oncology (IEO); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Surgical Adjuvant Breast & Bowel Project; California Pacific Medical Center; California Pacific Medical Center Research Institute; Ente Ospedaliero Ospedali Galliera; Royal Marsden NHS Foundation Trust; Calvary Mater Newcastle Hospital; University of Newcastle; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fred Hutchinson Cancer Center; Abbott Laboratories; Eli Lilly; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; IRCCS European Institute of Oncology (IEO); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cuzick, J (corresponding author), Queen Mary Univ London, Ctr Canc Prevent, Wolfson Inst Prevent Med, London EC1M 6BQ, England.	j.cuzick@qmul.ac.uk	DeCensi, Andrea/AEF-2941-2022; LaCroix, Andrea/N-9880-2018; Sestak, Ivana/H-7305-2014; Bonanni, Bernardo/AAM-7928-2020	DeCensi, Andrea/0000-0003-2635-4491; LaCroix, Andrea/0000-0002-9532-976X; Sestak, Ivana/0000-0001-6999-2851; 	Cancer Research UK; AstraZeneca; National Institute for Health Research [NF-SI-0512-10122] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); AstraZeneca(AstraZeneca); National Institute for Health Research(National Institute for Health Research (NIHR))	Cancer Research UK.; JC has received a grant from AstraZeneca for chemoprevention trials. BHM is, and JM was, an employee and shareholder of Eli Lilly. IS, BB, JPC, VV, MD, TP, DLW, LF, SC, JFF, ADC, AZLC, UV declare that they have no conflicts of interest.	Barrett-Connor E, 2006, NEW ENGL J MED, V355, P125, DOI 10.1056/NEJMoa062462; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Cauley JA, 2001, BREAST CANCER RES TR, V65, P125, DOI 10.1023/A:1006478317173; Clarke M, 1998, LANCET, V351, P1451; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Cummings SR, 2011, J BONE MINER RES, V26, P397, DOI 10.1002/jbmr.191; Cummings SR, 2010, NEW ENGL J MED, V362, P686, DOI 10.1056/NEJMoa0808692; Cuzick J, 2002, LANCET, V360, P817; Cuzick J, 2003, RECENT RES CANCER, V163, P96; Cuzick J, 2003, LANCET, V361, P296, DOI 10.1016/S0140-6736(03)12342-2; CUZICK J, 1985, LANCET, V2, P282; Cuzick J, 2007, JNCI-J NATL CANCER I, V99, P272, DOI 10.1093/jnci/djk049; Evans DGR, 2012, CANCER PREV RES, V5, P943, DOI 10.1158/1940-6207.CAPR-11-0458; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Goss PE, 2011, NEW ENGL J MED, V364, P2381, DOI 10.1056/NEJMoa1103507; Jordan VC, 2007, NAT REV CANCER, V7, P46, DOI 10.1038/nrc2048; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LaCroix AZ, 2010, JNCI-J NATL CANCER I, V102, P1706, DOI 10.1093/jnci/djq415; Martino S, 2004, J NATL CANCER I, V96, P1751, DOI 10.1093/jnci/djh319; Powles T, 1998, LANCET, V352, P98; Powles TJ, 2007, JNCI-J NATL CANCER I, V99, P283, DOI 10.1093/jnci/djk050; Powles TJ, 2012, BREAST CANCER RES TR, V134, P299, DOI 10.1007/s10549-012-2041-5; Veronesi U, 1998, LANCET, V352, P93; Veronesi U, 2007, J NATL CANCER I, V99, P727, DOI 10.1093/jnci/djk154; Vogel VG, 2010, CANCER PREV RES, V3, P696, DOI 10.1158/1940-6207.CAPR-10-0076; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074	27	299	308	0	65	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 25	2013	381	9880					1827	1834		10.1016/S0140-6736(13)60140-3	http://dx.doi.org/10.1016/S0140-6736(13)60140-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	151EO	23639488	Green Published			2022-12-28	WOS:000319443700028
J	Souza, JP; Gulmezoglu, AM; Vogel, J; Carroli, G; Lumbiganon, P; Qureshi, Z; Costa, MJ; Fawole, B; Mugerwa, Y; Nafiou, I; Neves, I; Wolomby-Molondo, JJ; Bang, HT; Cheang, K; Chuyun, K; Jayaratne, K; Jayathilaka, CA; Mazhar, SB; Mori, R; Mustafa, ML; Pathak, LR; Perera, D; Rathavy, T; Recidoro, Z; Roy, M; Ruyan, P; Shrestha, N; Taneepanichsku, S; Tien, NV; Ganchimeg, T; Wehbe, M; Yadamsuren, B; Yan, W; Yunis, K; Bataglia, V; Cecatti, JG; Hernandez-Prado, B; Nardin, JM; Narvaez, A; Ortiz-Panozo, E; Perez-Cuevas, R; Valladares, E; Zavaleta, N; Armson, A; Crowther, C; Hogue, C; Lindmark, G; Mittal, S; Pattinson, R; Stanton, ME; Campodonico, L; Cuesta, C; Giordano, D; Intarut, N; Laopaiboon, M; Bahl, R; Martines, J; Mathai, M; Merialdi, M; Say, L				Souza, Joao Paulo; Guelmezoglu, Ahmet Metin; Vogel, Joshua; Carroli, Guillermo; Lumbiganon, Pisake; Qureshi, Zahida; Costa, Maria Jose; Fawole, Bukola; Mugerwa, Yvonne; Nafiou, Idi; Neves, Isilda; Wolomby-Molondo, Jean-Jose; Hoang Thi Bang; Cheang, Kannitha; Chuyun, Kang; Jayaratne, Kapila; Jayathilaka, Chandani Anoma; Mazhar, Syeda Batool; Mori, Rintaro; Mustafa, Mir Lais; Pathak, Laxmi Raj; Perera, Deepthi; Rathavy, Tung; Recidoro, Zenaida; Roy, Malabika; Ruyan, Pang; Shrestha, Naveen; Taneepanichsku, Surasak; Nguyen Viet Tien; Ganchimeg, Togoobaatar; Wehbe, Mira; Yadamsuren, Buyanjargal; Yan, Wang; Yunis, Khalid; Bataglia, Vicente; Cecatti, Jose Guilherme; Hernandez-Prado, Bernardo; Manuel Nardin, Juan; Narvaez, Alberto; Ortiz-Panozo, Eduardo; Perez-Cuevas, Ricardo; Valladares, Eliette; Zavaleta, Nelly; Armson, Anthony; Crowther, Caroline; Hogue, Carol; Lindmark, Gunilla; Mittal, Suneeta; Pattinson, Robert; Stanton, Mary Ellen; Campodonico, Liana; Cuesta, Cristina; Giordano, Daniel; Intarut, Nirun; Laopaiboon, Malinee; Bahl, Rajiv; Martines, Jose; Mathai, Matthews; Merialdi, Mario; Say, Lale			Moving beyond essential interventions for reduction of maternal mortality (the WHO Multicountry Survey on Maternal and Newborn Health): a cross-sectional study	LANCET			English	Article								Background We report the main findings of the WHO Multicountry Survey on Maternal and Newborn Health (WHOMCS), which aimed to assess the burden of complications related to pregnancy, the coverage of key maternal health interventions, and use of the maternal severity index (MSI) in a global network of health facilities. Methods In our cross-sectional study, we included women attending health facilities in Africa, Asia, Latin America, and the Middle East that dealt with at least 1000 childbirths per year and had the capacity to provide caesarean section. We obtained data from analysis of hospital records for all women giving birth and all women who had a severe maternal outcome (SMO; ie, maternal death or maternal near miss). We regarded coverage of key maternal health interventions as the proportion of the target population who received an indicated intervention (eg, the proportion of women with eclampsia who received magnesium sulphate). We used areas under the receiver operator characteristic curves (AUROC) with 95% CI to externally validate a previously reported MSI as an indicator of severity. We assessed the overall performance of care (ie, the ability to produce a positive effect on health outcomes) through standardised mortality ratios. Results From May 1, 2010, to Dec 31, 2011, we included 314 623 women attending 357 health facilities in 29 countries (2538 had a maternal near miss and 486 maternal deaths occurred). The mean period of data collection in each health facility was 89 days (SD 21). 23 015 (7.3%) women had potentially life-threatening disorders and 3024 (1.0%) developed an SMO. 808 (26.7%) women with an SMO had post-partum haemorrhage and 784 (25.9%) had pre-eclampsia or eclampsia. Cardiovascular, respiratory, and coagulation dysfunctions were the most frequent organ dysfunctions in women who had an SMO. Reported mortality in countries with a high or very high maternal mortality ratio was two-to-three-times higher than that expected for the assessed severity despite a high coverage of essential interventions. The MSI had good accuracy for maternal death prediction in women with markers of organ dysfunction (AUROC 0.826 [95% CI 0.802-0.851]). Interpretation High coverage of essential interventions did not imply reduced maternal mortality in the health-care facilities we studied. If substantial reductions in maternal mortality are to be achieved, universal coverage of life-saving interventions need to be matched with comprehensive emergency care and overall improvements in the quality of maternal health care. The MSI could be used to assess the performance of health facilities providing care to women with complications related to pregnancy.	[Souza, Joao Paulo; Guelmezoglu, Ahmet Metin; Vogel, Joshua; Merialdi, Mario; Say, Lale] WHO, UNDP UNFPA UNICEF WHO Word Bank Special Programme, CH-1211 Geneva, Switzerland; [Carroli, Guillermo; Manuel Nardin, Juan; Campodonico, Liana; Cuesta, Cristina; Giordano, Daniel] Ctr Rosarino Estudios Perinatales, Rosario, Santa Fe, Argentina; [Lumbiganon, Pisake; Laopaiboon, Malinee] Khon Kaen Univ, Khon Kaen, Thailand; [Qureshi, Zahida] Univ Nairobi, Nairobi, Kenya; [Costa, Maria Jose] WHO Angola, Luanda, Angola; [Fawole, Bukola] Univ Ibadan, Ibadan, Nigeria; [Mugerwa, Yvonne] Makerere Univ, Makerere, Uganda; [Nafiou, Idi] Univ Abdou Moumouni Niamey, Niamey, Niger; [Neves, Isilda] Delegacao Prov Saude Luanda, Luanda, Angola; [Wolomby-Molondo, Jean-Jose] Clin Univ Kinshasa, Kinshasa, DEM REP CONGO; [Hoang Thi Bang] WHO, Hanoi, Vietnam; [Cheang, Kannitha] WHO, Phnom Penh, Cambodia; [Chuyun, Kang; Ruyan, Pang; Yan, Wang] Peking Univ, Beijing 100871, Peoples R China; [Jayaratne, Kapila; Perera, Deepthi] Govt Sri Lanka, Minist Hlth, Colombo, Sri Lanka; [Jayathilaka, Chandani Anoma] WHO, Colombo, Sri Lanka; [Mazhar, Syeda Batool] Pakistan Inst Med Sci, Islamabad, Pakistan; [Mori, Rintaro] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan; [Mustafa, Mir Lais] Afghan Publ Hlth Inst, Kabul, Afghanistan; [Pathak, Laxmi Raj] Govt Nepal, Minist Hlth & Populat, Kathmandu, Nepal; [Rathavy, Tung] Natl Maternal & Child Hlth Ctr, Phnom Penh, Cambodia; [Recidoro, Zenaida] Natl Ctr Dis Prevent & Control, Manila, Philippines; [Roy, Malabika] Indian Council Med Res, New Delhi, India; [Shrestha, Naveen] Pokhara Univ, Cent Inst Sci & Technol CIST Coll, Kathmandu, Nepal; [Taneepanichsku, Surasak; Intarut, Nirun] Chulalongkorn Univ, Bangkok, Thailand; [Nguyen Viet Tien] Natl Obstet & Gynaecol Hosp, Hanoi, Vietnam; [Ganchimeg, Togoobaatar] Univ Tokyo, Tokyo, Japan; [Wehbe, Mira; Yunis, Khalid] Amer Univ Beirut, Beirut, Lebanon; [Yadamsuren, Buyanjargal] Govt Mongolia, Minist Hlth, Ulaanbaatar, Mongolia; [Bataglia, Vicente] Hosp Nacl Itaugua, Itaugua, Paraguay; [Cecatti, Jose Guilherme] Univ Estadual Campinas, Campinas, SP, Brazil; [Hernandez-Prado, Bernardo] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Narvaez, Alberto] Colegio Med Pichincha, Pichincha, Ecuador; [Narvaez, Alberto] Fdn Salud Ambiente & Desarollo, Pichincha, Ecuador; [Ortiz-Panozo, Eduardo] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Perez-Cuevas, Ricardo] Inter Amer Dev Bank, Social Protect & Hlth Div, Mexico City, DF, Mexico; [Valladares, Eliette] Univ Nacl Autonoma Nicaragua, Leon, Nicaragua; [Zavaleta, Nelly] Inst Invest Nutr, Lima, Peru; [Armson, Anthony] Dalhousie Univ, Halifax, NS, Canada; [Crowther, Caroline] Univ Adelaide, Adelaide, SA, Australia; [Hogue, Carol] Emory Univ, Atlanta, GA 30322 USA; [Lindmark, Gunilla] Uppsala Univ, Uppsala, Sweden; [Mittal, Suneeta] All India Inst Med Sci, New Delhi, India; [Pattinson, Robert] Univ Pretoria, ZA-0002 Pretoria, South Africa; [Stanton, Mary Ellen] US Agcy Int Dev, Washington, DC 20523 USA; [Bahl, Rajiv; Martines, Jose; Mathai, Matthews] WHO, CH-1211 Geneva, Switzerland	United Nations Population Fund; World Health Organization; Khon Kaen University; University of Nairobi; University of Ibadan; Makerere University; Universite de Kinshasa; World Health Organization; World Health Organization; Peking University; World Health Organization; Pakistan Institute of Medical Sciences; National Center for Child Health & Development - Japan; Indian Council of Medical Research (ICMR); Chulalongkorn University; University of Tokyo; American University of Beirut; Ministry of Health Mongolia; Universidade Estadual de Campinas; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Instituto Nacional de Salud Publica; Dalhousie University; University of Adelaide; Emory University; Uppsala University; All India Institute of Medical Sciences (AIIMS) New Delhi; University of Pretoria; United States Agency for International Development (USAID); World Health Organization	Souza, JP (corresponding author), WHO, UNDP UNFPA UNICEF WHO Word Bank Special Programme, CH-1211 Geneva, Switzerland.	souzaj@who.int	Lumbiganon, Pisake/E-8634-2010; Souza, João Paulo/G-1982-2010; Vogel, Joshua/K-7649-2019; Cecatti, Jose Guilherme/M-5945-2013; , lalesay/AAG-1912-2021; Ortiz-Panozo, Eduardo/AAY-7743-2020; Hogue, Carol J/H-5442-2012; Jayaratne, Kapila/ABC-9841-2020	Lumbiganon, Pisake/0000-0001-9372-0071; Souza, João Paulo/0000-0002-2288-4244; Vogel, Joshua/0000-0002-3214-7096; Cecatti, Jose Guilherme/0000-0003-1285-8445; Jayaratne, Kapila/0000-0001-9795-4342; Intarut, Nirun/0000-0002-1068-4843; , Cristina/0000-0002-6127-5601; Mori, Rintaro/0000-0001-7656-6156; Shrestha, Naveen/0000-0002-9325-598X; Perez-Cuevas, Ricardo/0000-0002-5564-5821; Zavaleta, Nelly/0000-0002-6929-5834; Yunis, Khalid/0000-0002-6384-2745; Ortiz-Panozo, Eduardo/0000-0002-3141-210X	UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP); WHO; USAID; Ministry of Health, Labour and Welfare of Japan; Gynuity Health Projects	UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP); WHO(World Health Organization); USAID(United States Agency for International Development (USAID)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Gynuity Health Projects	UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP); WHO; USAID; Ministry of Health, Labour and Welfare of Japan; Gynuity Health Projects.	Campbell MK, 2000, FAM PRACT, V17, P192, DOI 10.1093/fampra/17.2.192; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Cecatti JG, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-22; Darmstadt GL, 2009, INT J GYNECOL OBSTET, V107, pS89, DOI 10.1016/j.ijgo.2009.07.010; DONNER A, 1994, AM J EPIDEMIOL, V140, P279, DOI 10.1093/oxfordjournals.aje.a117247; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Higgins Thomas L, 2007, J Intensive Care Med, V22, P141, DOI 10.1177/0885066607299520; Pattinson R, 2009, BEST PRACT RES CL OB, V23, P285, DOI 10.1016/j.bpobgyn.2009.01.013; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; Say Lale, 2004, Reprod Health, V1, P3, DOI 10.1186/1742-4755-1-3; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Shah A, 2008, B WORLD HEALTH ORGAN, V86, P126, DOI 10.2471/BLT.06.039842; Souza JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044129; Souza JP, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-286; Souza JP, 2010, B WORLD HEALTH ORGAN, V88, P113, DOI 10.2471/BLT.08.057828; Strand K, 2008, ACTA ANAESTH SCAND, V52, P467, DOI 10.1111/j.1399-6576.2008.01586.x; Tuncalp O, 2012, BJOG-INT J OBSTET GY, V119, P653, DOI 10.1111/j.1471-0528.2012.03294.x; United Nations, GLOBAL STRATEGY FOR; Wall SN, 2010, SEMIN PERINATOL, V34, P395, DOI 10.1053/j.semperi.2010.09.009; WHO, EVALUATING THE QUALI; WHO, SYSTEMS THINKING FOR; WHO, QUALITY OF CARE A PR; World Health Organization, 2015, TRENDS IN MATERNAL M	23	460	476	8	100	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 18	2013	381	9879					1747	1755		10.1016/S0140-6736(13)60686-8	http://dx.doi.org/10.1016/S0140-6736(13)60686-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146TA	23683641				2022-12-28	WOS:000319112800039
J	Victora, CG; Barros, FC				Victora, Cesar G.; Barros, Fernando C.			Participatory women's groups: ready for prime time?	LANCET			English	Editorial Material									[Victora, Cesar G.] Univ Fed Pelotas, BR-96001970 Pelotas, RS, Brazil; [Barros, Fernando C.] Univ Catolica Pelotas, Pelotas, Brazil	Universidade Federal de Pelotas; Universidade Catolica de Pelotas; Universidade Federal de Pelotas	Victora, CG (corresponding author), Univ Fed Pelotas, CP 464, BR-96001970 Pelotas, RS, Brazil.	cvictora@gmail.com	Victora, Cesar G/D-4476-2013; Barros, Fernando C/D-4857-2013; Victora, Cesar Gomes/Y-2455-2019	Victora, Cesar G/0000-0002-2465-2180; Victora, Cesar Gomes/0000-0002-2465-2180				Azad K, 2010, LANCET, V375, P1193, DOI 10.1016/S0140-6736(10)60142-0; Freire P., 1968, PEDAGOGIA OPRIMIDO; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Victora CG, 2013, INT J EPIDEMIOL, V42, P503, DOI 10.1093/ije/dyt044; Victora CG, 2005, HEALTH POLICY PLANN, V20, pI18, DOI 10.1093/heapol/czi050	5	14	14	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 18	2013	381	9879					1693	1694		10.1016/S0140-6736(13)61029-6	http://dx.doi.org/10.1016/S0140-6736(13)61029-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146TA	23683618				2022-12-28	WOS:000319112800009
J	Polly, PD				Polly, P. David			EVOLUTION Stuck between the teeth	NATURE			English	Editorial Material									[Polly, P. David] Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA; [Polly, P. David] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Polly, P. David] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Polly, PD (corresponding author), Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA.	pdpolly@indiana.edu	Polly, P. David/ABC-6597-2020	Polly, P. David/0000-0001-7338-8526				Alfaro ME, 2005, AM NAT, V165, pE140, DOI 10.1086/429564; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P14444, DOI 10.1073/pnas.97.26.14444; Polly P. D., 2004, PALAEONTOL ELECTRON, V2; Salazar-Ciudad I, 2004, EVOL DEV, V6, P6, DOI 10.1111/j.1525-142X.2004.04002.x; Salazar-Ciudad I, 2013, NATURE, V497, P361, DOI 10.1038/nature12142; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380; Ungar P. S., 2000, MAMMAL TEETH ORIGIN; Van Valen L., 1974, Journal Herpet, V8, P109; Whitlock MC, 2000, TRENDS ECOL EVOL, V15, P347, DOI 10.1016/S0169-5347(00)01930-3; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	10	2	2	2	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2013	497	7449					325	326		10.1038/nature12099	http://dx.doi.org/10.1038/nature12099			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	144PN	23636323				2022-12-28	WOS:000318952000028
J	Salazar-Ciudad, I; Marin-Riera, M				Salazar-Ciudad, Isaac; Marin-Riera, Miquel			Adaptive dynamics under development-based genotype-phenotype maps	NATURE			English	Article							PATTERN-FORMATION; EVOLUTION; MODEL; ADAPTATION; MECHANISMS; RNA	It is not known whether natural selection can encounter any given phenotype that can be produced by genetic variation. There has been a long-lasting debate about the processes that limit adaptation(1-6) and, consequently, about how well adapted phenotypes are. Here we examine how development may affect adaptation, by decomposing the genotype-fitness map-the association between each genotype and its fitness-into two: one mapping genotype to phenotype by means of a computational model of organ development(7), and one mapping phenotype to fitness. In the map of phenotype and fitness, the fitness of each individual is based on the similarity between realized morphology and optimal morphology. We use three different simulations to map phenotype to fitness, and these differ in the way in which similarity is calculated: similarity is calculated for each trait (in terms of each cell position individually), for a large or a small number of phenotypic landmarks (the 'many-traits' and 'few-traits' phenotype-fitness maps), and by measuring the overall surface roughness of morphology (the 'roughness' phenotype-fitness map). Evolution is simulated by applying the genotype-phenotype map and one phenotype-fitness map to each individual in the population, as well as random mutation and drift. We show that the complexity of the genotype-phenotype map prevents substantial adaptation in some of the phenotype-fitness maps: sustained adaptation is only possible using 'roughness' or 'few-traits' phenotype-fitness maps. The results contribute developmental understanding to the long-standing question of which aspects of phenotype can be effectively optimized by natural selection.	[Salazar-Ciudad, Isaac] Univ Helsinki, Inst Biotechnol, Dev Biol Program, Evolutionary Phen Grp, FIN-00014 Helsinki, Finland; [Salazar-Ciudad, Isaac; Marin-Riera, Miquel] Univ Autonoma Barcelona, Dept Genet & Microbiol, Genom Bioinformat & Evolut Grp, Cerdanyola Del Valles 08193, Spain	University of Helsinki; Autonomous University of Barcelona	Salazar-Ciudad, I (corresponding author), Univ Helsinki, Inst Biotechnol, Dev Biol Program, Evolutionary Phen Grp, POB 56, FIN-00014 Helsinki, Finland.	isaac.salazar@uab.cat	Salazar-Ciudad, Isaac/R-2238-2018	Salazar Ciudad, Isaac/0000-0003-1607-0962	Finnish Academy [WBS 1250271]; Spanish Ministry of Science and Innovation [BFU2010-17044]	Finnish Academy(Academy of Finland); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	We thank J. Jernvall, M. Brun Usan, I. Salvador Martinez, A. Matamoro, S. Newman and R. Zimm for comments and the CSC (IT Center for Science). This research was funded by the Finnish Academy (WBS 1250271) and the Spanish Ministry of Science and Innovation (BFU2010-17044).	Alberch P., 1982, EVOL DEV, P313, DOI DOI 10.1007/978-3-642-45532-2-15; Alfaro ME, 2005, AM NAT, V165, pE140, DOI 10.1086/429564; Bunn JM, 2011, AM J PHYS ANTHROPOL, V145, P247, DOI 10.1002/ajpa.21489; Charles C, 2011, DEVELOPMENT, V138, P4063, DOI 10.1242/dev.069195; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; Ferrada E, 2012, BIOPHYS J, V102, P1916, DOI 10.1016/j.bpj.2012.01.047; Fontana W, 2002, BIOESSAYS, V24, P1164, DOI 10.1002/bies.10190; Godfrey LR, 2012, AM J PHYS ANTHROPOL, V148, P215, DOI 10.1002/ajpa.21615; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Haldane JB., 1990, CAUSES EVOLUTION; Hansen TF, 2001, THEOR POPUL BIOL, V59, P61, DOI 10.1006/tpbi.2000.1508; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Kauffman S. A., 1993, ORIGINS ORDER; Klingenberg CP, 2002, GENE, V287, P3, DOI 10.1016/S0378-1119(01)00867-8; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.2307/2408842; Orr HA, 2006, EVOLUTION, V60, P1113; ORZACK SH, 1994, AM NAT, V143, P361, DOI 10.1086/285608; Polly P. David, 2005, Journal of Mammalian Evolution, V12, P283, DOI 10.1007/s10914-005-4866-8; Salazar-Ciudad I, 2006, J EXP ZOOL PART B, V306B, P107, DOI 10.1002/jez.b.21078; Salazar-Ciudad I, 2004, EVOL DEV, V6, P6, DOI 10.1111/j.1525-142X.2004.04002.x; Salazar-Ciudad I, 2010, NATURE, V464, P583, DOI 10.1038/nature08838; Santana SE, 2011, FUNCT ECOL, V25, P839, DOI 10.1111/j.1365-2435.2011.01832.x; SMITH JM, 1978, ANNU REV ECOL SYST, V9, P31, DOI 10.1146/annurev.es.09.110178.000335; Tenaillon O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000217; Waddington C., 1957, STRATEGY GENES; WAGNER A, 1994, P NATL ACAD SCI USA, V91, P4387, DOI 10.1073/pnas.91.10.4387; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	29	65	69	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2013	497	7449					361	+		10.1038/nature12142	http://dx.doi.org/10.1038/nature12142			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23636325				2022-12-28	WOS:000318952000036
J	Lane, R				Lane, Richard			Nick Craddock: a world leader in psychiatric genetics	LANCET			English	Biographical-Item																		CRADDOCK N, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 11	2013	381	9878					1617	1617		10.1016/S0140-6736(13)61012-0	http://dx.doi.org/10.1016/S0140-6736(13)61012-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146SX	23663940	Bronze			2022-12-28	WOS:000319112400012
J	Chiu, CQ; Lur, G; Morse, TM; Carnevale, NT; Ellis-Davies, GCR; Higley, MJ				Chiu, Chiayu Q.; Lur, Gyorgy; Morse, Thomas M.; Carnevale, Nicholas T.; Ellis-Davies, Graham C. R.; Higley, Michael J.			Compartmentalization of GABAergic Inhibition by Dendritic Spines	SCIENCE			English	Article							CALCIUM SIGNALS; PREFRONTAL CORTEX; PYRAMIDAL NEURONS; CEREBRAL-CORTEX; VISUAL-CORTEX; PLASTICITY; INTERNEURONS; SYNAPSES; GABA; POTENTIATION	gamma-aminobutyric acid-mediated (GABAergic) inhibition plays a critical role in shaping neuronal activity in the neocortex. Numerous experimental investigations have examined perisomatic inhibitory synapses, which control action potential output from pyramidal neurons. However, most inhibitory synapses in the neocortex are formed onto pyramidal cell dendrites, where theoretical studies suggest they may focally regulate cellular activity. The precision of GABAergic control over dendritic electrical and biochemical signaling is unknown. By using cell type-specific optical stimulation in combination with two-photon calcium (Ca2+) imaging, we show that somatostatin-expressing interneurons exert compartmentalized control over postsynaptic Ca2+ signals within individual dendritic spines. This highly focal inhibitory action is mediated by a subset of GABAergic synapses that directly target spine heads. GABAergic inhibition thus participates in localized control of dendritic electrical and biochemical signaling.	[Chiu, Chiayu Q.; Lur, Gyorgy; Morse, Thomas M.; Carnevale, Nicholas T.; Higley, Michael J.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Chiu, Chiayu Q.; Lur, Gyorgy; Higley, Michael J.] Yale Univ, Sch Med, Yale Program Cellular Neurosci Neurodegenerat & R, New Haven, CT 06510 USA; [Ellis-Davies, Graham C. R.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA	Yale University; Yale University; Icahn School of Medicine at Mount Sinai	Higley, MJ (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	m.higley@yale.edu		Chiu, Chiayu/0000-0001-5809-6306	Epilepsy Foundation; Yale Brown-Coxe Memorial Fund; Klingenstein Foundation; Sloan Foundation; Human Frontier Science Project; NIH [NS011613, DC009977, MH099045, GM053395, NS069720]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099045, K01MH097961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069720, R01NS011613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009977] Funding Source: NIH RePORTER	Epilepsy Foundation; Yale Brown-Coxe Memorial Fund; Klingenstein Foundation(Klingenstein Philanthropies); Sloan Foundation(Alfred P. Sloan Foundation); Human Frontier Science Project(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The authors thank G. M. Shepherd for discussions of spine function and P. DeCamilli, S. Tomita, J. Cardin, and members of the Higley laboratory for comments during the preparation of this manuscript. ChR2 plasmids were a gift from K. Deisseroth, Stanford University; TTA-A2 was a gift from B. Bean, Harvard Medical School; SOM-Cre mice were provided by J. Huang, Cold Spring Harbor Laboratory. The work was funded by grants from the Epilepsy Foundation (C. Q. C. and M. J. H.), the Yale Brown-Coxe Memorial Fund (G. L.), the Klingenstein Foundation (M. J. H.), the Sloan Foundation (M. J. H.), the Human Frontier Science Project (G.C.R.E.-D.), and awards from the NIH: NS011613 (N.T.C.), DC009977 (N.T.C. and T. M. M.), MH099045 (M. J. H.), and GM053395 and NS069720 (G.C.R.E.-D.).	Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Baho E, 2012, J NEUROSCI, V32, P911, DOI 10.1523/JNEUROSCI.4352-11.2012; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Bloodgood BL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000190; Chalifoux JR, 2010, NEURON, V66, P101, DOI 10.1016/j.neuron.2010.03.012; Chen JL, 2012, NEURON, V74, P361, DOI 10.1016/j.neuron.2012.02.030; Couey JJ, 2007, NEURON, V54, P73, DOI 10.1016/j.neuron.2007.03.006; Dumitriu D, 2007, CEREB CORTEX, V17, P81, DOI 10.1093/cercor/bhj126; Ellis-Davies GCR, 2007, J NEUROSCI, V27, P6601, DOI 10.1523/JNEUROSCI.1519-07.2007; Fishell G, 2011, ANNU REV NEUROSCI, V34, P535, DOI 10.1146/annurev-neuro-061010-113717; Fiumelli H, 2007, CURR OPIN NEUROBIOL, V17, P81, DOI 10.1016/j.conb.2007.01.002; Gonzalez-Burgos G, 2010, CURR PSYCHIAT REP, V12, P335, DOI 10.1007/s11920-010-0124-8; Grunditz A, 2008, J NEUROSCI, V28, P13457, DOI 10.1523/JNEUROSCI.2702-08.2008; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Harnett MT, 2012, NATURE, V491, P599, DOI 10.1038/nature11554; Jadi M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002550; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; KOCH C, 1983, PROC R SOC SER B-BIO, V218, P455, DOI 10.1098/rspb.1983.0051; Kubota Y, 2007, J NEUROSCI, V27, P1139, DOI 10.1523/JNEUROSCI.3846-06.2007; Lu H, 2010, NEURON, V67, P821, DOI 10.1016/j.neuron.2010.08.012; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Matsuzaki M, 2010, NAT CHEM BIOL, V6, P255, DOI [10.1038/nchembio.321, 10.1038/NCHEMBIO.321]; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; QIAN N, 1990, P NATL ACAD SCI USA, V87, P8145, DOI 10.1073/pnas.87.20.8145; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; SEGEV I, 1988, J NEUROPHYSIOL, V60, P499, DOI 10.1152/jn.1988.60.2.499; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; van Versendaal D, 2012, NEURON, V74, P374, DOI 10.1016/j.neuron.2012.03.015; Verde EMR, 2008, FRONT NEURAL CIRCUIT, V2, DOI 10.3389/neuro.04.002.2008; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; WIGSTROM H, 1983, NATURE, V301, P603, DOI 10.1038/301603a0; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	37	179	179	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					759	762		10.1126/science.1234274	http://dx.doi.org/10.1126/science.1234274			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661763	Green Accepted			2022-12-28	WOS:000318619000043
J	Fisher, JK; Bourniquel, A; Witz, G; Weiner, B; Prentiss, M; Kleckner, N				Fisher, Jay K.; Bourniquel, Aude; Witz, Guillaume; Weiner, Beth; Prentiss, Mara; Kleckner, Nancy			Four-Dimensional Imaging of E. coli Nucleoid Organization and Dynamics in Living Cells	CELL			English	Article							ESCHERICHIA-COLI; CHROMOSOME SEGREGATION; SPATIAL-ORGANIZATION; DNA; COMPACTION; SEPARATION; DIVISOME; PROTEIN	Visualization of living E. coli nucleoids, defined by HupA-mCherry, reveals a discrete, dynamic helical ellipsoid. Three basic features emerge. (1) Nucleoid density coalesces into longitudinal bundles, giving a stiff, low-DNA-density ellipsoid. (2) This ellipsoid is radially confined within the cell cylinder. Radial confinement gives helical shape and directs global nucleoid dynamics, including sister segregation. (3) Longitudinal density waves flux back and forth along the nucleoid, with 5%-10% of density shifting within 5 s, enhancing internal nucleoid mobility. Furthermore, sisters separate end-to-end in sequential discontinuous pulses, each elongating the nucleoid by 5%-15%. Pulses occur at 20 min intervals, at defined cell-cycle times. This progression includes sequential installation and release of programmed tethers, implying cyclic accumulation and relief of intranucleoid mechanical stress. These effects could comprise a chromosome-based cell-cycle engine. Overall, the presented results suggest a general conceptual framework for bacterial nucleoid nnorphogenesis and dynamics.	[Fisher, Jay K.; Bourniquel, Aude; Witz, Guillaume; Weiner, Beth; Kleckner, Nancy] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Prentiss, Mara] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University	Kleckner, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	kleckner@fas.harvard.edu	Prentiss, Mara/AAU-2940-2021	Witz, Guillaume/0000-0003-1562-4265	NIH [NIH/NIGMS-R01-GM025326, NIBEB-5-P41-EB002025]; Swiss National Science Foundation [PBELP3-135860]; Center for Nanoscale Systems (CNS) at Harvard University; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025326, R01GM044794] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Center for Nanoscale Systems (CNS) at Harvard University; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Guidotti, K. Mizuuchi, E. Garner, and Kleckner laboratory members for helpful comments; D. Jeruzalmi and J. Vertrees for adaptation of PyMOL to nucleoid images; and R. Johnson for a FIS-GFP plasmid. Research was supported by NIH grant NIH/NIGMS-R01-GM025326 to N.K. and Swiss National Science Foundation grant PBELP3-135860 to G.W. We acknowledge the Center for Computer Integrated Systems for Microscopy and Manipulation at UNC Chapel Hill, funded by NIH grant NIBEB-5-P41-EB002025, and the Center for Nanoscale Systems (CNS) at Harvard University, a member of the National Nanotechnology Infrastructure Network.	Adams M, 1998, BIOPHYS J, V74, P669, DOI 10.1016/S0006-3495(98)77826-9; Banigan EJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002145; Bates D, 2005, CELL, V121, P899, DOI 10.1016/j.cell.2005.04.013; Bates D, 2005, MOL MICROBIOL, V57, P380, DOI 10.1111/j.1365-2958.2005.04693.x; Bates D, 2008, MOL MICROBIOL, V69, P1341, DOI 10.1111/j.1365-2958.2008.06378.x; Berlatzky IA, 2008, P NATL ACAD SCI USA, V105, P14136, DOI 10.1073/pnas.0804982105; Chaudhuri D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.268305; Cunha S, 2001, J STRUCT BIOL, V136, P53, DOI 10.1006/jsbi.2001.4420; Espeli O, 2012, EMBO J, V31, P3198, DOI 10.1038/emboj.2012.128; Joshi MC, 2011, P NATL ACAD SCI USA, V108, P2765, DOI 10.1073/pnas.1019593108; Jun S, 2006, P NATL ACAD SCI USA, V103, P12388, DOI 10.1073/pnas.0605305103; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Kuhlman TE, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.42; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Lemon KP, 2001, GENE DEV, V15, P2031, DOI 10.1101/gad.913301; Marceau AH, 2011, EMBO J, V30, P4236, DOI 10.1038/emboj.2011.305; NORRIS V, 1995, MOL MICROBIOL, V16, P1051, DOI 10.1111/j.1365-2958.1995.tb02330.x; Odijk T, 1998, BIOPHYS CHEM, V73, P23, DOI 10.1016/S0301-4622(98)00115-X; Reyes-Larnothe R, 2008, TRENDS MICROBIOL, V16, P238, DOI 10.1016/j.tim.2008.02.003; Rovinskiy N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002845; Swulius MT, 2012, J BACTERIOL, V194, P6382, DOI 10.1128/JB.00505-12; Toro E, 2008, P NATL ACAD SCI USA, V105, P15435, DOI 10.1073/pnas.0807448105; Toro E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000349; Umbarger MA, 2011, MOL CELL, V44, P252, DOI 10.1016/j.molcel.2011.09.010; Vecchiarelli AG, 2010, MOL MICROBIOL, V78, P78, DOI 10.1111/j.1365-2958.2010.07314.x; Wang WQ, 2011, SCIENCE, V333, P1445, DOI 10.1126/science.1204697; Wang XD, 2005, GENE DEV, V19, P2367, DOI 10.1101/gad.345305; Wang XD, 2006, GENE DEV, V20, P1727, DOI 10.1101/gad.388406; Weber SC, 2012, P NATL ACAD SCI USA, V109, P7338, DOI 10.1073/pnas.1119505109; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wiggins PA, 2010, P NATL ACAD SCI USA, V107, P4991, DOI 10.1073/pnas.0912062107; Yazdi NH, 2012, MOL MICROBIOL, V86, P1318, DOI 10.1111/mmi.12071	32	190	191	0	74	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 9	2013	153	4					882	895		10.1016/j.cell.2013.04.006	http://dx.doi.org/10.1016/j.cell.2013.04.006			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23623305	Bronze, Green Accepted			2022-12-28	WOS:000318844000016
J	Nick, FM; Vieli, A; Andersen, ML; Joughin, I; Payne, A; Edwards, TL; Pattyn, F; van de Wal, RSW				Nick, Faezeh M.; Vieli, Andreas; Andersen, Morten Langer; Joughin, Ian; Payne, Antony; Edwards, Tamsin L.; Pattyn, Frank; van de Wal, Roderik S. W.			Future sea-level rise from Greenland's main outlet glaciers in a warming climate	NATURE			English	Article							JAKOBSHAVN ISBRAE; ICE; STABILITY; ACCELERATION; DYNAMICS	Over the past decade, ice loss from the Greenland Ice Sheet increased as a result of both increased surface melting and ice discharge to the ocean(1,2). The latter is controlled by the acceleration of ice flow and subsequent thinning of fast-flowing marine-terminating outlet glaciers(3). Quantifying the future dynamic contribution of such glaciers to sea-level rise (SLR) remains a major challenge because outlet glacier dynamics are poorly understood(4). Here we present a glacier flow model that includes a fully dynamic treatment of marine termini. We use this model to simulate behaviour of four major marine-terminating outlet glaciers, which collectively drain about 22 per cent of the Greenland Ice Sheet. Using atmospheric and oceanic forcing from a mid-range future warming scenario that predicts warming by 2.8 degrees Celsius by 2100, we project a contribution of 19 to 30 millimetres to SLR from these glaciers by 2200. This contribution is largely (80 per cent) dynamic in origin and is caused by several episodic retreats past overdeepenings in outlet glacier troughs. After initial increases, however, dynamic losses from these four outlets remain relatively constant and contribute to SLR individually at rates of about 0.01 to 0.06 millimetres per year. These rates correspond to ice fluxes that are less than twice those of the late 1990s, well below previous upper bounds(5). For a more extreme future warming scenario (warming by 4.5 degrees Celsius by 2100), the projected losses increase by more than 50 per cent, producing a cumulative SLR of 29 to 49 millimetres by 2200.	[Nick, Faezeh M.; Pattyn, Frank] Univ Libre Bruxelles, Lab Glaciol, B-1050 Brussels, Belgium; [Nick, Faezeh M.; van de Wal, Roderik S. W.] Univ Utrecht, Inst Marine & Atmospher Res, NL-3508 TA Utrecht, Netherlands; [Nick, Faezeh M.] Univ Ctr Svalbard, Dept Geol, NO-9171 Longyearbyen, Norway; [Vieli, Andreas] Univ Durham, Dept Geog, Durham DH1 3LE, England; [Vieli, Andreas] Univ Zurich, Dept Geog, CH-8057 Zurich, Switzerland; [Andersen, Morten Langer] Geol Survey Denmark & Greenland, DK-1350 Copenhagen, Denmark; [Joughin, Ian] Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98108 USA; [Payne, Antony; Edwards, Tamsin L.] Univ Bristol, Bristol Glaciol Ctr, Bristol BS8 1SS, Avon, England	Universite Libre de Bruxelles; Utrecht University; University Centre Svalbard (UNIS); Durham University; University of Zurich; Geological Survey Of Denmark & Greenland; University of Washington; University of Washington Seattle; University of Bristol	Nick, FM (corresponding author), Univ Libre Bruxelles, Lab Glaciol, B-1050 Brussels, Belgium.	faezeh.nick@unis.no	Joughin, Ian/AAR-7778-2021; Joughin, Ian R/A-2998-2008; Pattyn, Frank/AAA-9640-2019; van de wal, roderik/D-1705-2011; Edwards, Tamsin/H-6462-2019; payne, antony/A-8916-2008; Andersen, Morten/E-5509-2012	Joughin, Ian/0000-0001-6229-679X; Joughin, Ian R/0000-0001-6229-679X; Pattyn, Frank/0000-0003-4805-5636; van de wal, roderik/0000-0003-2543-3892; Edwards, Tamsin/0000-0002-4760-4704; payne, antony/0000-0001-8825-8425; Vieli, Andreas/0000-0002-2870-5921	ice2sea programme of the European Union 7th Framework Programme [226375]; Netherlands Polar Programme (NPP); European Union 6th Framework Programme Integrated Project ENSEMBLES [505539]; US NSF [ANT-0424589]	ice2sea programme of the European Union 7th Framework Programme; Netherlands Polar Programme (NPP); European Union 6th Framework Programme Integrated Project ENSEMBLES; US NSF(National Science Foundation (NSF))	This research was financially supported by the ice2sea programme of the European Union 7th Framework Programme, grant number 226375 (ice2sea publication 118), and the Netherlands Polar Programme (NPP), and contributes to the Knowledge for Climate (KvK) programme in the Netherlands. The ENSEMBLES data used in this work was funded by the European Union 6th Framework Programme Integrated Project ENSEMBLES (contract number 505539). Support for I.J. was provided by US NSF grant ANT-0424589.	Amundson JM, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001405; Cuffey K. M., 2010, PHYS GLACIERS, P575; Fettweis X, 2013, CRYOSPHERE, V7, P469, DOI 10.5194/tc-7-469-2013; Gogineni P., 2012, CRESIS RADAR DEPTH S; Holland DM, 2008, NAT GEOSCI, V1, P659, DOI 10.1038/ngeo316; Howat IM, 2007, SCIENCE, V315, P1559, DOI 10.1126/science.1138478; Howat IM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047565; Jamieson SSR, 2012, NAT GEOSCI, V5, P799, DOI [10.1038/ngeo1600, 10.1038/NGEO1600]; Jenkins A, 2011, J PHYS OCEANOGR, V41, P2279, DOI 10.1175/JPO-D-11-03.1; Joughin I, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000837; Joughin I, 2012, SCIENCE, V338, P1172, DOI 10.1126/science.1226481; Joughin I, 2010, J GLACIOL, V56, P415, DOI 10.3189/002214310792447734; Joughin I, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2008JF001023; Moon T, 2012, SCIENCE, V336, P576, DOI 10.1126/science.1219985; Motyka RJ, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2009JF001632; Murray T, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001522; Nick FM, 2012, J GLACIOL, V58, P229, DOI 10.3189/2012JoG11J242; Nick FM, 2010, J GLACIOL, V56, P781, DOI 10.3189/002214310794457344; Nick FM, 2009, NAT GEOSCI, V2, P110, DOI 10.1038/NGEO394; Pattyn F, 2012, CRYOSPHERE, V6, P573, DOI 10.5194/tc-6-573-2012; Pfeffer WT, 2008, SCIENCE, V321, P1340, DOI 10.1126/science.1159099; Price SF, 2011, P NATL ACAD SCI USA, V108, P8978, DOI 10.1073/pnas.1017313108; Rignot E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031765; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Solomon S., 2007, PHYS SCI BASIS WORKI; van den Broeke M, 2009, SCIENCE, V326, P984, DOI 10.1126/science.1178176; van der Veen CJ, 2011, J GLACIOL, V57, P770, DOI 10.3189/002214311797409776; van der Veen CJ, 1998, COLD REG SCI TECHNOL, V27, P31, DOI 10.1016/S0165-232X(97)00022-0; Vieli A, 2011, SURV GEOPHYS, V32, P437, DOI 10.1007/s10712-011-9132-4; Zwally HJ, 2002, SCIENCE, V297, P218, DOI 10.1126/science.1072708	30	198	202	1	220	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2013	497	7448					235	238		10.1038/nature12068	http://dx.doi.org/10.1038/nature12068			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23657350	Green Accepted			2022-12-28	WOS:000318558200035
J	Behrman, S				Behrman, Sophie			PERSONAL VIEW Have you heard the one about the man with Alzheimer's disease?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Littlemore Mental Hlth Ctr, Oxford Clin, Oxford OX4 4XN, England		Behrman, S (corresponding author), Littlemore Mental Hlth Ctr, Oxford Clin, Oxford OX4 4XN, England.	sophie.behrman@doctors.org.uk						Blake W, 2006, CARE GIVING DEMENTIA, V4; Flynn, 2012, WINTERBOURNE VIEW HO; Hulse J R, 1994, Geriatr Nurs, V15, P88; Low LF, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002072; Moos I, 2011, AGEING SOC, V31, P328, DOI 10.1017/S0144686X10001054; Reisberg B, 1999, Int Psychogeriatr, V11, P7, DOI 10.1017/S1041610299005554; Reisberg Barry, 2002, Am J Alzheimers Dis Other Demen, V17, P202, DOI 10.1177/153331750201700411; Saunders PA, 1998, HEALTH COMMUN, V10, P357, DOI 10.1207/s15327027hc1004_4	8	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	2013	346								f2872	10.1136/bmj.f2872	http://dx.doi.org/10.1136/bmj.f2872			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	144BQ	23653137				2022-12-28	WOS:000318914800006
J	Mandel, J; Poch, D				Mandel, Jess; Poch, David			Pulmonary Hypertension	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INTRAVENOUS EPOPROSTENOL PROSTACYCLIN; BRAIN NATRIURETIC PEPTIDE; ARTERIAL-HYPERTENSION; HEART-FAILURE; INHALED ILOPROST; CONTROLLED-TRIAL; COMBINATION THERAPY; AMBRISENTAN THERAPY; SILDENAFIL CITRATE; EXERCISE CAPACITY							Mandel, Jess/0000-0002-2658-6025				Andreassen AK, 2006, AM J CARDIOL, V98, P525, DOI 10.1016/j.amjcard.2006.02.061; Archer SL, 1996, CHEST, V109, P750, DOI 10.1378/chest.109.3.750; Archibald CJ, 1999, AM J RESP CRIT CARE, V160, P523, DOI 10.1164/ajrccm.160.2.9808109; Badesch DB, 2007, J RHEUMATOL, V34, P2417; Badesch DB, 2007, CHEST, V131, P1917, DOI 10.1378/chest.06-2674; Badesch DB, 2000, ANN INTERN MED, V132, P425, DOI 10.7326/0003-4819-132-6-200003210-00002; Badesch DB, 2004, CHEST, V126, p35S, DOI 10.1378/chest.126.1_suppl.35S; Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; Barst RJ, 2011, J HEART LUNG TRANSPL, V30, P632, DOI 10.1016/j.healun.2010.11.009; Benza RL, 2012, CHEST, V141, P354, DOI 10.1378/chest.11-0676; Benza RL, 2010, CIRCULATION, V122, P164, DOI 10.1161/CIRCULATIONAHA.109.898122; Brown LM, 2011, CHEST, V140, P19, DOI 10.1378/chest.10-1166; Califf RM, 1997, AM HEART J, V134, P44, DOI 10.1016/S0002-8703(97)70105-4; Cappola TP, 2002, CIRCULATION, V105, P1663, DOI 10.1161/01.CIR.0000013771.30198.82; Channick RN, 2001, LANCET, V358, P1119, DOI 10.1016/S0140-6736(01)06250-X; Doran AK, 2008, INT J CLIN PRACT, V62, P5, DOI 10.1111/j.1742-1241.2008.01811.x; Fawzy ME, 2004, J HEART VALVE DIS, V13, P942; Fijalkowska A, 2006, CHEST, V129, P1313, DOI 10.1378/chest.129.5.1313; Frank H, 1997, CHEST, V112, P714, DOI 10.1378/chest.112.3.714; Galie N, 2008, LANCET, V371, P2093, DOI 10.1016/S0140-6736(08)60919-8; Galie N, 2005, J AM COLL CARDIOL, V46, P529, DOI 10.1016/j.jacc.2005.04.050; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Galie N, 2008, CIRCULATION, V117, P3010, DOI 10.1161/CIRCULATIONAHA.107.742510; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Galie N, 2009, CIRCULATION, V119, P2894, DOI 10.1161/CIRCULATIONAHA.108.839274; Ghio S, 2001, J AM COLL CARDIOL, V37, P183, DOI 10.1016/S0735-1097(00)01102-5; Ghofrani HA, 2002, LANCET, V360, P895, DOI 10.1016/S0140-6736(02)11024-5; GIAID A, 1993, NEW ENGL J MED, V328, P1732, DOI 10.1056/NEJM199306173282402; Gomberg-Maitland M, 2005, AM J RESP CRIT CARE, V172, P1586, DOI 10.1164/rccm.200505-766OC; Grunig E, 2011, RESPIRATION, V81, P394, DOI 10.1159/000322475; Guazzi M, 2011, CIRCULATION, V124, P164, DOI 10.1161/CIRCULATIONAHA.110.983866; Halpern SD, 2009, CHEST, V136, P37, DOI 10.1378/chest.08-2784; Hoeper MM, 2006, EUR RESPIR J, V28, P691, DOI 10.1183/09031936.06.00057906; Hoeper MM, 2006, J AM COLL CARDIOL, V48, P2546, DOI 10.1016/j.jacc.2006.07.061; Humbert M, 2004, EUR RESPIR J, V24, P353, DOI 10.1183/09031936.04.00028404; Huppmann P, 2012, EUR RESP J; Hurdman J, 2012, EUR RESPIR J, V39, P945, DOI 10.1183/09031936.00078411; Iversen K, 2010, EUR HEART J, V31, P1124, DOI 10.1093/eurheartj/ehq011; King TE, 2011, AM J RESP CRIT CARE, V184, P92, DOI 10.1164/rccm.201011-1874OC; Krowka MJ, 1999, HEPATOLOGY, V30, P641, DOI 10.1002/hep.510300307; Krum H, 2011, LANCET, V378, P713, DOI 10.1016/S0140-6736(11)61038-6; Madani MM, 2012, ANN THORAC SURG, V94, P97, DOI 10.1016/j.athoracsur.2012.04.004; McLaughlin VV, 2006, AM J RESP CRIT CARE, V174, P1257, DOI 10.1164/rccm.200603-358OC; McLaughlin VV, 2010, J AM COLL CARDIOL, V55, P1915, DOI 10.1016/j.jacc.2010.01.027; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Mereles D, 2006, CIRCULATION, V114, P1482, DOI 10.1161/CIRCULATIONAHA.106.618397; Meyer T, 2013, ANN INTERN MED, V158, DOI 10.7326/0003-4819-158-1-201301010-01001; Nagaya N, 2000, CIRCULATION, V102, P865; Olschewski H, 2002, NEW ENGL J MED, V347, P322, DOI 10.1056/NEJMoa020204; Oudiz RJ, 2009, J AM COLL CARDIOL, V54, P1971, DOI 10.1016/j.jacc.2009.07.033; Packer M, 2005, J CARD FAIL, V11, P12, DOI 10.1016/j.cardfail.2004.05.006; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Raghu G, 2013, ANN INTERN MED, V158, P641, DOI 10.7326/0003-4819-158-9-201305070-00003; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; Rich S, 1998, CHEST, V114, P787, DOI 10.1378/chest.114.3.787; RICH S, 1992, NEW ENGL J MED, V327, P76, DOI 10.1056/NEJM199207093270203; Rosenzweig EB, 1999, CIRCULATION, V99, P1858, DOI 10.1161/01.CIR.99.14.1858; Rubin LJ, 2011, CHEST, V140, P1274, DOI 10.1378/chest.10-0969; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; RUBIN LJ, 1990, ANN INTERN MED, V112, P485, DOI 10.7326/0003-4819-112-7-485; Simonneau G, 2008, ANN INTERN MED, V149, P521, DOI 10.7326/0003-4819-149-8-200810210-00004; WEITZENBLUM E, 1985, AM REV RESPIR DIS, V131, P493, DOI 10.1164/arrd.1985.131.4.493; Zhu B, 2012, J CARDIOVASC PHARM, V60, P342, DOI 10.1097/FJC.0b013e318262a793	63	10	10	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 7	2013	158	9					ITC51	ITC516		10.7326/0003-4819-158-9-201305070-01005	http://dx.doi.org/10.7326/0003-4819-158-9-201305070-01005			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V45HL	23648959				2022-12-28	WOS:000209807600001
J	Stevens, NJ; Seiffert, ER; O'Connor, PM; Roberts, EM; Schmitz, MD; Krause, C; Gorscak, E; Ngasala, S; Hieronymus, TL; Temu, J				Stevens, Nancy J.; Seiffert, Erik R.; O'Connor, Patrick M.; Roberts, Eric M.; Schmitz, Mark D.; Krause, Cornelia; Gorscak, Eric; Ngasala, Sifa; Hieronymus, Tobin L.; Temu, Joseph			Palaeontological evidence for an Oligocene divergence between Old World monkeys and apes	NATURE			English	Article							RUKWA RIFT BASIN; PRIMATE EVOLUTION; EARLY MIOCENE; VICTORIAPITHECUS; PALEOGENE; GENUS	Apes and Old World monkeys are prominent components of modern African and Asian ecosystems, yet the earliest phases of their evolutionary history have remained largely undocumented(1). The absence of crown catarrhine fossils older than similar to 20 million years (Myr) has stood in stark contrast to molecular divergence estimates of similar to 25-30 Myr for the split between Cercopithecoidea (Old World monkeys) and Hominoidea (apes), implying long ghost lineages for both clades(2-4). Here we describe the oldest known fossil 'ape', represented by a partial mandible preserving dental features that place it with 'nyanzapithecine' stem hominoids. Additionally, we report the oldest stem member of the Old World monkey clade, represented by a lower third molar. Both specimens were recovered from a precisely dated 25.2-Myr-old stratum in the Rukwa Rift, a segment of the western branch of the East African Rift in Tanzania. These finds extend the fossil record of apes and Old World monkey swell into the Oligocene epoch of Africa, suggesting a possible link between diversification of crown catarrhines and changes in the African landscape brought about by previously unrecognized tectonic activity(5) in the East African rift system.	[Stevens, Nancy J.; O'Connor, Patrick M.; Krause, Cornelia] Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA; [Stevens, Nancy J.; O'Connor, Patrick M.; Krause, Cornelia] Ohio Univ, Ctr Ecol & Evolutionary Studies, Athens, OH 45701 USA; [Seiffert, Erik R.] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [Roberts, Eric M.] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia; [Schmitz, Mark D.] Boise State Univ, Sch Geosci, Boise, ID 83725 USA; [Gorscak, Eric] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA; [Ngasala, Sifa] Michigan State Univ, Dept Geol Sci, E Lansing, MI 48824 USA; [Hieronymus, Tobin L.] Northeast Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH 44272 USA; [Temu, Joseph] Tanzania Antiqu Unit, Dar Es Salaam, Tanzania	University System of Ohio; Ohio University; University System of Ohio; Ohio University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; James Cook University; Idaho; Boise State University; University System of Ohio; Ohio University; Michigan State University; Northeast Ohio Medical University (NEOMED)	Stevens, NJ (corresponding author), Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA.	stevensn@ohio.edu	OConnor, Patrick M/I-9383-2012; Schmitz, Mark D/A-2540-2012; Stevens, Nancy J/E-6928-2013; Roberts, Eric/J-1836-2014	OConnor, Patrick M/0000-0002-6762-3806; Roberts, Eric/0000-0002-8583-7437; Hieronymus, Tobin/0000-0002-0483-5350	Tanzania Commission for Science and Technology; US National Science Foundation [EAR-0617561, EAR/IF-0933619, BCS-1127164]; National Geographic Society (CRE); Louis B. Leakey Foundation; Ohio University Heritage College of Osteopathic Medicine; Ohio University Office of Research and Sponsored Programs; Direct For Social, Behav & Economic Scie [1127164] Funding Source: National Science Foundation	Tanzania Commission for Science and Technology; US National Science Foundation(National Science Foundation (NSF)); National Geographic Society (CRE)(National Geographic Society); Louis B. Leakey Foundation; Ohio University Heritage College of Osteopathic Medicine; Ohio University Office of Research and Sponsored Programs; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	We thank D. Kamamba, F. Ndunguru, J. Temba, P. Msemwa, I. Marobhe, E. Mbede and the Tanzania Commission for Science and Technology for support; E. Lund for assisting with specimen preparation; S. Egberts, R. Felice, E. Lund, H. O'Brien and J. Sidote for field assistance in 2011 and/or 2012; M. Gottfried for earlier project contributions; H. Fassler, T. Plattner, A. Njao and S. and T. Greenaway for their support; M. Cortese-Hering, M. Dawson, J. Eastman, J. Fleagle, G. Gunnell, J.A. Holman, D. Krause, S. Howard, L. Jolley, D. Miles, L. Robbins, N. Sauer, C. Seiffert, E. Simons and P. Wright for helpful discussions; G. Gunnell, F. Manthi, E. Mbua and M. Muungu for specimen access; E. Delson for Victoriapithecus mu CT data; L. Halenar, W. Holloway and S. Maiolino for mu CT assistance; J. Sattler for specimen photography; and M. Anton for scientific artwork. D. DeBlieux and V. Simons discovered the Nsungwe 2 locality in 2007; R. Felice co-discovered RRBP 11178. Research was supported by US National Science Foundation (EAR-0617561, EAR/IF-0933619, BCS-1127164), National Geographic Society (CRE), Louis B. Leakey Foundation, Ohio University Heritage College of Osteopathic Medicine, and Ohio University Office of Research and Sponsored Programs.	ANDREWS P, 1974, NATURE, V249, P188, DOI 10.1038/249188a0; Benefit B.R., 2008, GEOLOGY E LIBIA, V3, P247; Benefit BR, 1999, EVOL ANTHROPOL, V7, P155, DOI 10.1002/(SICI)1520-6505(1999)7:5<155::AID-EVAN2>3.0.CO;2-D; BENEFIT BR, 1993, J HUM EVOL, V25, P83, DOI 10.1006/jhev.1993.1041; DELSON E, 1979, Geobios (Villeurbanne), V12, P725, DOI 10.1016/S0016-6995(79)80099-6; Ducrocq S, 2011, J HUM EVOL, V61, P327, DOI 10.1016/j.jhevol.2011.04.011; Fourtau R., 1918, CONTRIBUTION LETUDE; Harrison T, 2002, CAM S BIO EVOL ANTHR, V33, P311; Harrison Terry, 2010, P429; Jablonski Nina G., 2010, P393; Leakey M, 2011, EVOL ANTHROPOL, V20, P238, DOI 10.1002/evan.20338; LEAKEY MG, 1995, J HUM EVOL, V28, P519, DOI 10.1006/jhev.1995.1040; Miller ER, 2009, J HUM EVOL, V57, P195, DOI 10.1016/j.jhevol.2009.06.006; NENGO IO, 1992, J HUM EVOL, V23, P423, DOI 10.1016/0047-2484(92)90090-V; O'Connor PM, 2010, NATURE, V466, P748, DOI 10.1038/nature09061; Roberts EM, 2012, NAT GEOSCI, V5, P289, DOI [10.1038/ngeo1432, 10.1038/NGEO1432]; Roberts EM, 2010, J AFR EARTH SCI, V57, P179, DOI 10.1016/j.jafrearsci.2009.09.002; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rossie JB, 2006, J HUM EVOL, V50, P568, DOI 10.1016/j.jhevol.2005.12.007; Seiffert ER, 2012, EVOL ANTHROPOL, V21, P239, DOI 10.1002/evan.21335; Sepulchre P, 2006, SCIENCE, V313, P1419, DOI 10.1126/science.1129158; Springer MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049521; Steiper ME, 2008, EVOL ANTHROPOL, V17, P179, DOI 10.1002/evan.20177; Stevens NJ, 2008, DEV PRIMATOL-PROG PR, P159, DOI 10.1007/978-0-387-73896-3_12; Stevens NJ, 2005, J VERTEBR PALEONTOL, V25, P986, DOI 10.1671/0272-4634(2005)025[0986:AAPHFT]2.0.CO;2; Swofford D. L., 1998, PAUP PHYLOGENETIC AN; Von Koenigswald G. H. R., 1969, FOSSIL VERTEBRATES A, P39; Wilkinson RD, 2011, SYST BIOL, V60, P16, DOI 10.1093/sysbio/syq054; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zalmout IS, 2010, NATURE, V466, P360, DOI 10.1038/nature09094	30	120	121	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2013	497	7451					611	614		10.1038/nature12161	http://dx.doi.org/10.1038/nature12161			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23676680	Green Accepted			2022-12-28	WOS:000319556100042
J	Molina-Cruz, A; Garver, LS; Alabaster, A; Bangiolo, L; Haile, A; Winikor, J; Ortega, C; van Schaijk, BL; Sauerwein, RW; Taylor-Salmon, E; Barillas-Mury, C				Molina-Cruz, Alvaro; Garver, Lindsey S.; Alabaster, Amy; Bangiolo, Lois; Haile, Ashley; Winikor, Jared; Ortega, Corrie; van Schaijk, Ben C. L.; Sauerwein, Robert W.; Taylor-Salmon, Emma; Barillas-Mury, Carolina			The Human Malaria Parasite Pfs47 Gene Mediates Evasion of the Mosquito Immune System	SCIENCE			English	Article							VECTOR ANOPHELES-GAMBIAE; PLASMODIUM-FALCIPARUM; SURFACE PROTEIN; SELECTION; FERTILITY; NITRATION; INVASION; PFS48/45	Plasmodium falciparum transmission by Anopheles gambiae mosquitoes is remarkably efficient, resulting in a very high prevalence of human malaria infection in sub-Saharan Africa. A combination of genetic mapping, linkage group selection, and functional genomics was used to identify Pfs47 as a P. falciparum gene that allows the parasite to infect A. gambiae without activating the mosquito immune system. Disruption of Pfs47 greatly reduced parasite survival in the mosquito, and this phenotype could be reverted by genetic complementation of the parasite or by disruption of the mosquito complement-like system. Pfs47 suppresses midgut nitration responses that are critical to activate the complement-like system. We provide direct experimental evidence that immune evasion mediated by Pfs47 is critical for efficient human malaria transmission by A. gambiae.	[Molina-Cruz, Alvaro; Garver, Lindsey S.; Alabaster, Amy; Bangiolo, Lois; Haile, Ashley; Winikor, Jared; Ortega, Corrie; Taylor-Salmon, Emma; Barillas-Mury, Carolina] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20892 USA; [van Schaijk, Ben C. L.; Sauerwein, Robert W.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Radboud University Nijmegen	Barillas-Mury, C (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20892 USA.	cbarillas@niaid.nih.gov	Sauerwein, Robert/C-8519-2013		Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000947] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH. We thank K. Hayton and T. Wellems for advice with the genetic cross, A. Laughinghouse and K. Lee for technical support, and B. Marshall for editorial assistance. This work is subject to U.S. Patent no 61/684,333, filed 17 August 2012, "Transmission-blocking malaria vaccine." There are material transfer agreements or patents restricting use of Pfs48/45 and Pfs47 KO parasites.	Anthony TG, 2007, MOL BIOCHEM PARASIT, V156, P117, DOI 10.1016/j.molbiopara.2007.07.008; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Carter R, 2007, INT J PARASITOL, V37, P285, DOI 10.1016/j.ijpara.2006.11.013; Cohuet A, 2006, EMBO REP, V7, P1285, DOI 10.1038/sj.embor.7400831; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; FELDMANN AM, 1989, MED VET ENTOMOL, V3, P41, DOI 10.1111/j.1365-2915.1989.tb00473.x; Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335; Hayton K, 2008, CELL HOST MICROBE, V4, P40, DOI 10.1016/j.chom.2008.06.001; Kumar S, 2004, J BIOL CHEM, V279, P53475, DOI 10.1074/jbc.M409905200; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Mitri C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000576; Molina-Cruz A, 2012, P NATL ACAD SCI USA, V109, pE1957, DOI 10.1073/pnas.1121183109; Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; van Schaijk BCL, 2006, MOL BIOCHEM PARASIT, V149, P216, DOI 10.1016/j.molbiopara.2006.05.015	15	150	155	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2013	340	6135					984	987		10.1126/science.1235264	http://dx.doi.org/10.1126/science.1235264			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	149TK	23661646	Green Accepted			2022-12-28	WOS:000319344100049
J	Hollands, H; Johnson, D; Hollands, S; Simel, DL; Jinapriya, D; Sharma, S				Hollands, Hussein; Johnson, Davin; Hollands, Simon; Simel, David L.; Jinapriya, Delan; Sharma, Sanjay			Do Findings on Routine Examination Identify Patients at Risk for Primary Open-Angle Glaucoma? The Rational Clinical Examination Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BALTIMORE EYE SURVEY; BLUE MOUNTAINS EYE; VISUAL IMPAIRMENT PROJECT; SINGAPORE-MALAY-EYE; OPTIC-NERVE DAMAGE; INTRAOCULAR-PRESSURE; BEIJING EYE; PREVALENCE FINDINGS; DEFINED POPULATION; THESSALONIKI EYE	Importance Glaucoma is the second leading cause of blindness worldwide, and its insidious onset is often associated with diagnostic delay. Since glaucoma progression can often be effectively diminished when treated, identifying individuals at risk for glaucoma could potentially lead to earlier detection and prevent associated vision loss. Objective To quantify the diagnostic accuracy of examination findings and relevant risk factors in identifying individuals with primary open-angle glaucoma (POAG), the most common form of glaucoma in North America. Data Sources Structured Medline (January 1950-January 2013) search and a hand search of references and citations of retrieved articles yielding 57 articles from 41 studies. Study Selection Population-based studies of high-level methods relating relevant examination findings of cup-to-disc ratio (CDR), CDR asymmetry, intraocular pressure (IOP), and demographic risk factors to the presence of POAG. Results The summary prevalence of glaucoma in the highest-quality studies was 2.6% (95% CI, 2.1%-3.1%). Amongrisk factors evaluated, high myopia (>= 6 diopters; odds ratio [OR], 5.7; 95% CI, 3.1-11) and family history (OR, 3.3; 95% CI, 2.0-5.6) had the strongest association with glaucoma. Black race (OR, 2.9; 95% CI, 1.4-5.9) and increasing age (especially age >80years; OR, 2.9; 95% CI, 1.9-4.3) werealso associated with an increased risk. As CDR increased, the likelihood for POAG increased with a likelihood ratio (LR) of 14 (95% CI, 5.3-39) for CDR of 0.7 or greater. Increasing CDR asymmetry was also associated with an increased likelihood for POAG (CDR asymmetry >= 0.3; LR, 7.3; 95% CI, 3.3-16). No single threshold for CDR or asymmetry ruled out glaucoma. The presence of a disc hemorrhage (LR, 12; 95% CI, 2.9-48) was highly suggestive of glaucoma, but the absence of a hemorrhage was nondiagnostic (LR, 0.94; 95% CI, 0.83-0.98). At the commonly used cutoff for high IOP (>= 22), the LR was 13 (95% CI, 8.2-17), while lower IOP made glaucoma less likely (LR, 0.65; 95% CI, 0.55-0.76). We found no studies of screening examinations performed by generalist physicians in a routine setting. Conclusions and Relevance Individual findings of increased CDR, CDR asymmetry, disc hemorrhage, and elevated IOP, as well as demographic risk factors of family history, black race, and advanced age are associated with increased risk for POAG, but their absence does not effectively rule out POAG. The best available data support examination by an ophthalmologist as the most accurate way to detect glaucoma.	[Hollands, Hussein; Johnson, Davin; Hollands, Simon; Jinapriya, Delan; Sharma, Sanjay] Queens Univ, Dept Ophthalmol, Kingston, ON, Canada; [Simel, David L.] Duke Univ, Durham Vet Affairs Med Ctr, Durham, NC USA; [Simel, David L.] Duke Univ, Dept Med, Durham, NC USA	Queens University - Canada; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University	Hollands, H (corresponding author), Hop Hotel Dieu, Dept Ophthalmol, 166 Brock St, Kingston, ON K7L 5S9, Canada.	hussein.hollands@yahoo.com			Allergan	Allergan(AbbVieAllergan)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Simel reports receipt of honoraria for contributions to JAMAevidence. Dr Jinapriya reports receipt of a grant or pending grant from Allergan and receipt of honoraria for continuing medical education talks from Alcon, Allergan, and Pfizer. The other authors report no disclosures.	Agbeja-Baiyeroju A M, 2003, Afr J Med Med Sci, V32, P371; Allingham RR, 2011, SHIELDS TXB GLAUCOMA; Alward WL, 1998, AM J OPHTHALMOL, V126, P498; American Academy of Ophthalmology Glaucoma Panel, PREF PRACT PATT GUID; American Academy of Ophthalmology Preferred Practice Patterns Committee, PREF PRACT PATT GUID; Anton A, 2004, J GLAUCOMA, V13, P371; BANKES JLK, 1968, BRIT MED J, V1, P791, DOI 10.1136/bmj.1.5595.791; Beneyto P, 2007, BRIT J GEN PRACT, V57, P653; BENGTSSON B, 1980, ACTA OPHTHALMOL, V58, P20; Bonomi L, 2000, OPHTHALMOLOGY, V107, P1287, DOI 10.1016/S0161-6420(00)00138-X; Bonomi L, 1998, OPHTHALMOLOGY, V105, P209, DOI 10.1016/S0161-6420(98)92665-3; BOOTHE WA, 1988, ARCH OPHTHALMOL-CHIC, V106, P1214, DOI 10.1001/archopht.1988.01060140374035; Borenstein M., 2005, COMPREHENSIVE META A; Cedrone C, 1997, Ophthalmic Epidemiol, V4, P59; COFFEY M, 1993, BRIT J OPHTHALMOL, V77, P17, DOI 10.1136/bjo.77.1.17; CRICK RP, 1980, INT OPHTHALMOL, V3, P37, DOI 10.1007/BF00136212; Dandona L, 2000, OPHTHALMOLOGY, V107, P1702, DOI 10.1016/S0161-6420(00)00275-X; DIELEMANS I, 1994, OPHTHALMOLOGY, V101, P1851; Fraser S, 1999, INVEST OPHTH VIS SCI, V40, P2251; Fraser S, 2001, BMJ-BRIT MED J, V322, P639, DOI 10.1136/bmj.322.7287.639; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; GIUFFRE G, 1995, ACTA OPHTHALMOL SCAN, V73, P222; HAMMOND EA, 1979, NURS RES, V28, P371; Harper RA, 1999, OPTOMETRY VISION SCI, V76, P537, DOI 10.1097/00006324-199908000-00022; He MG, 2006, INVEST OPHTH VIS SCI, V47, P2782, DOI 10.1167/iovs.06-0051; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; HIRVELA H, 1994, INT OPHTHALMOL, V18, P299; HOLLOWS FC, 1966, BRIT J OPHTHALMOL, V50, P570, DOI 10.1136/bjo.50.10.570; Ivers RQ, 2001, OPHTHALMOLOGY, V108, P968, DOI 10.1016/S0161-6420(00)00649-7; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Jeganathan VSE, 2009, ARCH OPHTHALMOL-CHIC, V127, P888, DOI 10.1001/archophthalmol.2009.136; Jonas JB, 1998, AM J OPHTHALMOL, V125, P137, DOI 10.1016/S0002-9394(99)80083-X; Jonasson F, 2003, EYE, V17, P747, DOI 10.1038/sj.eye.6700374; KAHN HA, 1977, AM J EPIDEMIOL, V106, P17, DOI 10.1093/oxfordjournals.aje.a112428; Kerrigan-Baumrind LA, 2000, INVEST OPHTH VIS SCI, V41, P741; Khandekar R., 2008, Eastern Mediterranean Health Journal, V14, P1360; Kim CS, 2011, OPHTHALMOLOGY, V118, P1024, DOI 10.1016/j.ophtha.2010.10.016; Kim M, 2012, JPN J OPHTHALMOL, V56, P324, DOI 10.1007/s10384-012-0153-4; KLEIN BEK, 1992, OPHTHALMOLOGY, V99, P1499; Kozobolis VP, 2000, J GLAUCOMA, V9, P143; KRUEGER DE, 1980, SURV OPHTHALMOL, V24, P614, DOI 10.1016/0039-6257(80)90122-8; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918, DOI 10.1001/archopht.1995.01100070092031; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; LESKE MC, 1994, ARCH OPHTHALMOL-CHIC, V112, P821, DOI 10.1001/archopht.1994.01090180121046; MASON RP, 1989, OPHTHALMOLOGY, V96, P1363; Menke J, 2010, METHOD INFORM MED, V49, P54, DOI 10.3414/ME09-01-0001; Menke J, 2010, METHOD INFORM MED, V49, P64; Mitchell P, 1996, OPHTHALMOLOGY, V103, P1661, DOI 10.1016/S0161-6420(96)30449-1; Mitchell P, 1997, OPHTHALMOLOGY, V104, P712, DOI 10.1016/S0161-6420(97)30247-4; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Ong LS, 1999, INVEST OPHTH VIS SCI, V40, P849; Pandit RJ, 2000, DIABETIC MED, V17, P693, DOI 10.1046/j.1464-5491.2000.00368.x; QUIGLEY HA, 1980, ARCH OPHTHALMOL-CHIC, V98, P1564; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; QUIGLEY HA, 1982, ARCH OPHTHALMOL-CHIC, V100, P135, DOI 10.1001/archopht.1982.01030030137016; QUIGLEY HA, 1989, AM J OPHTHALMOL, V107, P453, DOI 10.1016/0002-9394(89)90488-1; Robin TA, 2005, OPHTHAL EPIDEMIOL, V12, P167, DOI 10.1080/09286580590969716; Rotchford AP, 2002, ARCH OPHTHALMOL-CHIC, V120, P471, DOI 10.1001/archopht.120.4.471; Schultz R O, 1995, J Glaucoma, V4, P177; Shen SY, 2008, INVEST OPHTH VIS SCI, V49, P3846, DOI 10.1167/iovs.08-1759; Simel DL, 2009, J CLIN EPIDEMIOL, V62, P1292, DOI 10.1016/j.jclinepi.2009.02.007; Simel DLK, 2009, UPDATE PRIMER PRECIS; SOMMER A, 1979, ARCH OPHTHALMOL-CHIC, V97, P1449, DOI 10.1001/archopht.1979.01020020111003; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P1090, DOI 10.1001/archopht.1991.01080080050026; Song WL, 2011, OPHTHALMOLOGY, V118, P1982, DOI 10.1016/j.ophtha.2011.02.050; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; TIELSCH JM, 1995, OPHTHALMOLOGY, V102, P48; TIELSCH JM, 1991, AM J EPIDEMIOL, V134, P1102, DOI 10.1093/oxfordjournals.aje.a116013; TIELSCH JM, 1994, ARCH OPHTHALMOL-CHIC, V112, P69, DOI 10.1001/archopht.1994.01090130079022; Topouzis F, 2007, AM J OPHTHALMOL, V144, P511, DOI 10.1016/j.ajo.2007.06.029; Topouzis F, 2011, AM J OPHTHALMOL, V152, P219, DOI 10.1016/j.ajo.2011.01.032; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Varma R, 2004, OPHTHALMOLOGY, V111, P1439, DOI 10.1016/j.ophtha.2004.01.025; VERNON SA, 1990, EYE, V4, P89, DOI 10.1038/eye.1990.126; Vijaya L, 2008, OPHTHALMOLOGY, V115, P648, DOI 10.1016/j.ophtha.2007.04.062; WALLACE J, 1969, AM J OPHTHALMOL, V67, P93, DOI 10.1016/0002-9394(69)90013-0; Wang F, 1998, Ophthalmic Epidemiol, V5, P69, DOI 10.1076/opep.5.2.69.1575; Wang Y, 2006, AM J OPHTHALMOL, V142, P241, DOI 10.1016/j.ajo.2006.02.032; Weih LM, 2001, OPHTHALMOLOGY, V108, P1966, DOI 10.1016/S0161-6420(01)00799-0; Wensor MD, 1998, OPHTHALMOLOGY, V105, P733, DOI 10.1016/S0161-6420(98)94031-3; Wong TY, 2003, OPHTHALMOLOGY, V110, P211, DOI 10.1016/S0161-6420(02)01260-5; Xu L, 2008, ACTA OPHTHALMOL, V86, P229, DOI 10.1111/j.1600-0420.2007.01026.x; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050	83	76	81	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2013	309	19					2035	2042		10.1001/jama.2013.5099	http://dx.doi.org/10.1001/jama.2013.5099			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143GQ	23677315				2022-12-28	WOS:000318855500026
J	Ritz, R; Halder, M; Wagner, M; Franz, C; Bauer, A; Pfleiderer, C				Ritz, R.; Halder, M.; Wagner, M.; Franz, C.; Bauer, A.; Pfleiderer, C.			Formation of a topological non-Fermi liquid in MnSi	NATURE			English	Article							QUANTUM PHASE-TRANSITION; STATE; BREAKDOWN	Fermi liquid theory provides a remarkably powerful framework for the description of the conduction electrons in metals and their ordering phenomena, such as superconductivity, ferromagnetism, and spin-and charge-density-wave order. A different class of ordering phenomena of great interest concerns spin configurations that are topologically protected, that is, their topology can be destroyed only by forcing the average magnetization locally to zero(1). Examples of such configurations are hedgehogs (points at which all spins are either pointing inwards or outwards) and vortices. A central question concerns the nature of the metallic state in the presence of such topologically distinct spin textures. Here we report a high-pressure study of the metallic state at the border of the skyrmion lattice in MnSi, which represents a new form of magnetic order composed of topologically non-trivial vortices(2). When long-range magnetic order is suppressed under pressure, the key characteristic of the skyrmion lattice-that is, the topological Hall signal due to the emergent magnetic flux associated with the topological winding-is unaffected in sign or magnitude and becomes an important characteristic of the metallic state. The regime of the topological Hall signal in temperature, pressure and magnetic field coincides thereby with the exceptionally extended regime of a pronounced non-Fermi-liquid resistivity(3,30). The observation of this topological Hall signal in the regime of the NFL resistivity suggests empirically that spin correlations with non-trivial topological character may drive a breakdown of Fermi liquid theory in pure metals.	[Ritz, R.; Halder, M.; Wagner, M.; Franz, C.; Bauer, A.; Pfleiderer, C.] Tech Univ Munich, Phys Dept E21, D-85748 Garching, Germany	Technical University of Munich	Ritz, R (corresponding author), Tech Univ Munich, Phys Dept E21, D-85748 Garching, Germany.	robert.ritz@frm2.tum.de; christian.pfleiderer@frm2.tum.de	Franz, Christian/G-2223-2019; Pfleiderer, Christian/P-3575-2014	Franz, Christian/0000-0001-6820-2774; Pfleiderer, Christian/0000-0001-7749-7965; Bauer, Andreas/0000-0002-1070-9748; Halder, Marco/0000-0002-9807-5400	TUM Graduate School; DFG [TRR80, FOR960]; ERC-AdG [291079 TOPFIT]	TUM Graduate School; DFG(German Research Foundation (DFG)); ERC-AdG	We wish to thank P. Boni, K. Everschor, M. Garst, M. Janoschek, S. Mayr and A. Rosch for discussions and support. R. R., M. H., A. B., M. W. and C. F. acknowledge financial support through the TUM Graduate School. Financial support through DFG TRR80 and DFG FOR960 as well as ERC-AdG (291079 TOPFIT) are gratefully acknowledged.	Adams T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.237204; Belitz D, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.247202; Binz B, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.207202; Chaikin P. M., 1995, PRINCIPLES CONDENSED; Conduit GJ, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.207201; Doiron-Leyraud N, 2003, NATURE, V425, P595, DOI 10.1038/nature01968; Janoschek M., 2012, PHYS REV B IN PRESS; Kirkpatrick TR, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.256404; Landau L.D., 1980, COURSE THEORETICAL P, V8; Lee M, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.172403; Lee M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.186601; LONZARICH GG, 1985, J PHYS C SOLID STATE, V18, P4339, DOI 10.1088/0022-3719/18/22/017; Muhlbauer S, 2009, SCIENCE, V323, P915, DOI 10.1126/science.1166767; Munzer W, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.041203; Neubauer A, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3523056; Neubauer A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.186602; Pfleiderer C, 2007, SCIENCE, V316, P1871, DOI 10.1126/science.1142644; Pfleiderer C, 2004, NATURE, V427, P227, DOI 10.1038/nature02232; Pfleiderer C, 1997, PHYS REV B, V55, P8330, DOI 10.1103/PhysRevB.55.8330; Pfleiderer C, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.156406; Pfleiderer C, 2001, NATURE, V414, P427, DOI 10.1038/35106527; Ritz R., PHYS REV B UNPUB; Rossler UK, 2006, NATURE, V442, P797, DOI 10.1038/nature05056; Seki S, 2012, SCIENCE, V336, P198, DOI 10.1126/science.1214143; Smith RP, 2008, NATURE, V455, P1220, DOI 10.1038/nature07401; Tewari S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.047207; Thessieu C, 1997, J PHYS-CONDENS MAT, V9, P6677, DOI 10.1088/0953-8984/9/31/019; Uemura YJ, 2007, NAT PHYS, V3, P29, DOI 10.1038/nphys488; Yu XZ, 2011, NAT MATER, V10, P106, DOI 10.1038/nmat2916; Yu XZ, 2010, NATURE, V465, P901, DOI 10.1038/nature09124	30	97	99	2	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2013	497	7448					231	234		10.1038/nature12023	http://dx.doi.org/10.1038/nature12023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23636328	Green Submitted			2022-12-28	WOS:000318558200034
J	Husten, CG; Deyton, LR				Husten, Corinne G.; Deyton, Lawrence R.			Tobacco Control 1 Understanding the Tobacco Control Act: efforts by the US Food and Drug Administration to make tobacco-related morbidity and mortality part of the USA's past, not its future	LANCET			English	Article							SMOKING-CESSATION; CONTROL PROGRAM; IMPACT; CIGARETTES; BENEFITS; HEALTH	The USA has a rich history of public health efforts to reduce morbidity and mortality from tobacco use. Comprehensive tobacco-prevention programmes, when robustly implemented, reduce the prevalence of youth and adult smoking, decrease cigarette consumption, accelerate declines in tobacco-related deaths, and diminish healthcare costs from tobacco-related diseases. Effective public health interventions include raising the price of tobacco products, smoke-free policies, counter-marketing campaigns, advertising restrictions, augmenting access to treatment for tobacco use through insurance coverage and telephone help lines, and comprehensive approaches to prevent children and adolescents from accessing tobacco products. The US Food and Drug Administration (FDA) has six major areas of regulatory authority: regulation of tobacco products; regulation of the advertising, marketing, and promotion of tobacco products; regulation of the distribution and sales of tobacco products; enforcement of the provisions of the Tobacco Control Act and tobacco regulations; regulatory science to support FDA authorities and activities; and public education about the harms of tobacco products and to support FDA regulatory actions. With passing of the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act) in June, 2009, important new regulatory approaches were added to the tobacco prevention and control arsenal.	[Husten, Corinne G.] US FDA, Ctr Tobacco Prod, Rockville, MD 20850 USA; [Deyton, Lawrence R.] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20037 USA	US Food & Drug Administration (FDA); FDA Center for Tobacco Products (CTP); George Washington University	Husten, CG (corresponding author), US FDA, Ctr Tobacco Prod, Rockville, MD 20850 USA.	corinne.husten@fda.hhs.gov						American Lung Association, 2013, STAT TOB CONTR 2013; [Anonymous], [No title captured]; [Anonymous], 2011, GUID IND FOOD DRUG A; [Anonymous], FED REG; California Department of Health Services, 2006, CAL TOB CONTR UPD 20; Campaign for Tobacco-Free Kids, 2022, BROK PROM OUR CHILDR; CDC, 2007, BEST PRACT COMPR TOB; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P1066; Farrelly MC, 2008, AM J PUBLIC HEALTH, V98, P304, DOI 10.2105/AJPH.2006.106377; Farrelly MC, 2013, AM J PUBLIC HEALTH, V103, P549, DOI 10.2105/AJPH.2012.300948; Farrelly MC, 2003, J HEALTH ECON, V22, P843, DOI 10.1016/S0167-6296(03)00057-2; Fichtenberg CM, 2000, NEW ENGL J MED, V343, P1772, DOI 10.1056/NEJM200012143432406; Institute of Medicine, 2012, SCI STAND STUD MOD R; King B, 2005, TOB CONTROL, V14, P214, DOI 10.1136/tc.2005.011692; Lightwood JM, 1999, PEDIATRICS, V104, P1312, DOI 10.1542/peds.104.6.1312; Lightwood JM, 1997, CIRCULATION, V96, P1089, DOI 10.1161/01.CIR.96.4.1089; National Institutes of Health, 2012, FUND OPP; National Institutes of Health, 2012, POP ASS TOB HLTH PAT; Sarkar A., 2000, EXP COMM EC TOB IND; Tauras JA, 2005, AM J PUBLIC HEALTH, V95, P338, DOI 10.2105/AJPH.2004.039727; U.S. Food and Drug Administration, 2011, GUID IND APPL PREM R; U.S. Food and Drug Administration-FDA, 2010, PROT KIDS TOB REG RE; U.S. Food & Drug Administration, INSP COMPL ENF CRIM; United States Consumer Product Safety Commission, REG MAND STAND BANS; United States Food and Drug Administration, 2012, HARMF POT HARMF CONS; US Department of Health and Human Services, 2000, RED TOB US REP SURG; US Department of Health and Human Services, 2013, FED REG 8; US Food and Drug Administration, 2012, FDA TOB RET INSP CON; US Food and Drug Administration, COMM ISS ID FDAS SCI; US Food and Drug Administration, 2011, EST TOB PROD WAS COM; US Food and Drug Administration, 2009, GUID IND FDA STAFF G; US Food and Drug Administration, 2011, REQ WARN CIG PACK AD; US Food and Drug Administration, 2009, GUID IND REG PROD LI; US Food and Drug Administration, 2011, LETT TOB PROD REG ES; US Food and Drug Administration, 2010, GUID IND FDA STAFF U; US Food and Drug Administration, 2009, GUID IND LIST INGR T; US Food and Drug Administration, 2012, GUID IND MOD RISK TO; US Food and Drug Administration, 2013, REP POT TOB PROD VIO; US Food and Drug Administration, 2013, FDA REG PROT PUBL HL; US Government, 2009, FAM SMOK PREV TOB CO; World Trade Organization, 2012, US MEAS AFF PROD SAL; Yong HH, 2011, ADDICTION, V106, P2204, DOI 10.1111/j.1360-0443.2011.03533.x; 2000, FED REG	43	50	50	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 4	2013	381	9877					1570	1580		10.1016/S0140-6736(13)60735-7	http://dx.doi.org/10.1016/S0140-6736(13)60735-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139UF	23642698				2022-12-28	WOS:000318609600032
J	Benenson, Y				Benenson, Yaakov			Recombinatorial Logic	SCIENCE			English	Editorial Material							CELLS; GENE		Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland	ETH Zurich	Benenson, Y (corresponding author), Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland.	kobi.benenson@bsse.ethz.ch						Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Benenson Y, 2012, NAT REV GENET, V13, P455, DOI 10.1038/nrg3197; Bonnet J, 2013, SCIENCE, V340, P599, DOI 10.1126/science.1232758; Bonnet J, 2012, P NATL ACAD SCI USA, V109, P8884, DOI 10.1073/pnas.1202344109; DALE EC, 1991, P NATL ACAD SCI USA, V88, P10558, DOI 10.1073/pnas.88.23.10558; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Ham TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002815; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; MCCLAIN MS, 1991, J BACTERIOL, V173, P5308, DOI 10.1128/jb.173.17.5308-5314.1991; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Valiant LG, 2009, J ACM, V56, DOI 10.1145/1462153.1462156; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527	13	5	5	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2013	340	6132					554	555		10.1126/science.1237738	http://dx.doi.org/10.1126/science.1237738			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23641100				2022-12-28	WOS:000318268900031
J	Kabalah-Amitai, L; Mayzel, B; Kauffmann, Y; Fitch, AN; Bloch, L; Gilbert, PUPA; Pokroy, B				Kabalah-Amitai, Lee; Mayzel, Boaz; Kauffmann, Yaron; Fitch, Andrew N.; Bloch, Leonid; Gilbert, Pupa U. P. A.; Pokroy, Boaz			Vaterite Crystals Contain Two Interspersed Crystal Structures	SCIENCE			English	Article							CALCITE; CACO3; DISORDER	Calcite, aragonite, and vaterite are the three anhydrous polymorphs of calcium carbonate, in order of decreasing thermodynamic stability. Although vaterite is not commonly found in geological settings, it is an important precursor in several carbonate-forming systems and can be found in biological settings. Because of difficulties in obtaining large, pure, single crystals, the crystal structure of vaterite has been elusive for almost a century. Using aberration-corrected high-resolution transmission electron microscopy, we found that vaterite is actually composed of at least two different crystallographic structures that coexist within a pseudo-single crystal. The major structure exhibits hexagonal symmetry; the minor structure, existing as nanodomains within the major matrix, is still unknown.	[Kabalah-Amitai, Lee; Kauffmann, Yaron; Bloch, Leonid; Pokroy, Boaz] Technion Israel Inst Technol, Dept Mat Sci & Engn, IL-32000 Haifa, Israel; [Kabalah-Amitai, Lee; Pokroy, Boaz] Technion Israel Inst Technol, Russell Berrie Nanotechnol Inst, IL-32000 Haifa, Israel; [Mayzel, Boaz] Tel Aviv Univ, Dept Biol, IL-69978 Tel Aviv, Israel; [Fitch, Andrew N.] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Gilbert, Pupa U. P. A.] Univ Wisconsin, Dept Phys, Madison, WI 53706 USA; [Gilbert, Pupa U. P. A.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Tel Aviv University; European Synchrotron Radiation Facility (ESRF); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Pokroy, B (corresponding author), Technion Israel Inst Technol, Dept Mat Sci & Engn, IL-32000 Haifa, Israel.	bpokroy@tx.technion.ac.il	Kauffmann, Yaron/B-7301-2013; Bloch, Leonid/J-8103-2017; Gilbert, Pupa/A-6299-2010; Bloch, Leonid/AAR-2751-2021	Bloch, Leonid/0000-0002-9433-7653; Gilbert, Pupa/0000-0002-0139-2099; Bloch, Leonid/0000-0002-9433-7653; Kauffmann, Yaron/0000-0002-0117-6222	U.S.-Israel Binational Science Foundation [2010065]; Israel Science Foundation [98/10]; German-Israeli Foundation for Scientific Research and Development [2278/2010]; U.S. Department of Energy [DE-FG02-07ER15899]; NSF [DMR-1105167]; Direct For Mathematical & Physical Scien [1105167] Funding Source: National Science Foundation	U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank E. Zolotoyabko and W. D. Kaplan for helpful discussions, and T. Haim-Cohen and M. Kalina for help in preparing the TEM samples. Supported primarily by U.S.-Israel Binational Science Foundation grant 2010065 (B. P. and P. U. P. A. G.). Also supported by Israel Science Foundation grant 98/10 and German-Israeli Foundation for Scientific Research and Development grant 2278/2010 (B. P.), U.S. Department of Energy grant DE-FG02-07ER15899, and NSF grant DMR-1105167 (P. U. P. A. G.). High-resolution powder diffraction measurements described in this paper were carried out at beamline ID31 of ESRF (Grenoble, France).	Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; Bryce DL, 2008, J AM CHEM SOC, V130, P9282, DOI 10.1021/ja8017253; Demichelis R, 2012, CRYSTENGCOMM, V14, P44, DOI 10.1039/c1ce05976a; DUFRESNE ER, 1962, GEOCHIM COSMOCHIM AC, V26, P251, DOI 10.1016/0016-7037(62)90015-7; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; FRIEDMAN GM, 1994, MINERAL MAG, V58, P401, DOI 10.1180/minmag.1994.058.392.05; Gibson RE, 1925, AM J SCI, V10, P325; Gong YUT, 2012, P NATL ACAD SCI USA, V109, P6088, DOI 10.1073/pnas.1118085109; Isaure MP, 2010, GEOCHIM COSMOCHIM AC, V74, P5817, DOI 10.1016/j.gca.2010.07.011; KAMHI SR, 1963, ACTA CRYSTALLOGR, V16, P770, DOI 10.1107/S0365110X63002000; Lakshminarayanan R, 2005, BIOMACROMOLECULES, V6, P1429, DOI 10.1021/bm049276f; Le Bail A, 2011, POWDER DIFFR, V26, P16, DOI 10.1154/1.3552994; LOWENSTAM HA, 1975, SCIENCE, V188, P363, DOI 10.1126/science.1118730; McConnell J. V., 1960, PSYCCRITIQUES, V5, P180; MEYER HJ, 1959, ANGEW CHEM INT EDIT, V71, P678; MEYER HJ, 1969, Z KRISTALLOGR KRIST, V128, P183, DOI 10.1524/zkri.1969.128.3-6.183; Mugnaioli E, 2012, ANGEW CHEM INT EDIT, V51, P7041, DOI 10.1002/anie.201200845; Olshausen S., 1925, Z KRISTALLOGR, V61, P463; Politi Y, 2004, SCIENCE, V306, P1161, DOI 10.1126/science.1102289; Pouget EM, 2009, SCIENCE, V323, P1455, DOI 10.1126/science.1169434; Qiao L, 2007, CRYST GROWTH DES, V7, P275, DOI 10.1021/cg060309f; Stadelmann P., 2006, JEMS VERSION 3 1102W; SUTOR DJ, 1968, SCIENCE, V159, P1113, DOI 10.1126/science.159.3819.1113; Wang JW, 2009, AM MINERAL, V94, P380, DOI 10.2138/am.2009.2939; Wehrmeister U, 2011, J RAMAN SPECTROSC, V42, P926, DOI 10.1002/jrs.2835; Wehrmeister U, 2010, J RAMAN SPECTROSC, V41, P193, DOI 10.1002/jrs.2438; Xu AW, 2006, ADV FUNCT MATER, V16, P903, DOI 10.1002/adfm.200500716	27	123	127	5	243	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					454	457		10.1126/science.1232139	http://dx.doi.org/10.1126/science.1232139			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620047				2022-12-28	WOS:000318016700035
J	Meissner, F; Scheltema, RA; Mollenkopf, HJ; Mann, M				Meissner, Felix; Scheltema, Richard A.; Mollenkopf, Hans-Joachim; Mann, Matthias			Direct Proteomic Quantification of the Secretome of Activated Immune Cells	SCIENCE			English	Article							IDENTIFICATION; MYD88	Protein secretion allows communication of distant cells in an organism and controls a broad range of physiological functions. We describe a quantitative, high-resolution mass spectrometric workflow to detect and quantify proteins that are released from immune cells upon receptor ligation. We quantified the time-resolved release of 775 proteins, including 52 annotated cytokines from only 150,000 primary Toll-like receptor 4-activated macrophages per condition. Achieving low picogram sensitivity, we detected secreted proteins whose abundance increased by a factor of more than 10,000 upon stimulation. Secretome to transcriptome comparisons revealed the transcriptionally decoupled release of lysosomal proteins. From genetic models, we defined secretory profiles that depended on distinct intracellular signaling adaptors and showed that secretion of many proinflammatory proteins is safeguarded by redundant mechanisms, whereas signaling adaptor synergy promoted the release of anti-inflammatory proteins.	[Meissner, Felix; Scheltema, Richard A.; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Mollenkopf, Hans-Joachim] Max Planck Inst Infect Biol, Microarray Core Facil, Berlin, Germany	Max Planck Society; Max Planck Society	Mann, M (corresponding author), Max Planck Inst Biochem, Dept Prote & Signal Transduct, Klopferspitz 18A, D-82152 Martinsried, Germany.	mmann@biochem.mpg.de	MEISSNER, Felix/C-8767-2015; Mollenkopf, Hans-Joachim/AAH-2500-2019; Mann, Matthias/A-3454-2013; Scheltema, Richard A/I-3856-2016	MEISSNER, Felix/0000-0003-1000-7989; Mann, Matthias/0000-0003-1292-4799; Scheltema, Richard A/0000-0002-1668-0253; Mollenkopf, Hans-Joachim/0000-0003-1167-4783				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Azuma YT, 2011, J PHARMACOL SCI, V115, P105, DOI 10.1254/jphs.10R02CR; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Buchholz BM, 2010, AM J PHYSIOL-GASTR L, V299, pG531, DOI 10.1152/ajpgi.00060.2010; Butler GS, 2009, NAT REV DRUG DISCOV, V8, P935, DOI 10.1038/nrd2945; Chevrier N, 2011, CELL, V147, P853, DOI 10.1016/j.cell.2011.10.022; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cyktor JC, 2011, INFECT IMMUN, V79, P2964, DOI 10.1128/IAI.00047-11; Esparza GA, 2012, INNATE IMMUN-LONDON, V18, P478, DOI 10.1177/1753425911422723; Gioannini TL, 2007, IMMUNOL RES, V39, P249, DOI 10.1007/s12026-007-0069-0; Hirotani T, 2005, BIOCHEM BIOPH RES CO, V328, P383, DOI 10.1016/j.bbrc.2004.12.184; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Mallick P, 2010, NAT BIOTECHNOL, V28, P695, DOI 10.1038/nbt.1658; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Nagaraj N, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013722; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Papin JA, 2004, J THEOR BIOL, V227, P283, DOI 10.1016/j.jtbi.2003.11.016; Thakur SS, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003699; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Watarai H, 2005, PROTEOMICS, V5, P4001, DOI 10.1002/pmic.200401258	24	147	147	1	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					475	478		10.1126/science.1232578	http://dx.doi.org/10.1126/science.1232578			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620052				2022-12-28	WOS:000318016700041
J	Frances, A				Frances, Allen			The New Crisis of Confidence in Psychiatric Diagnosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Duke Univ, Durham, NC 27710 USA	Duke University	Frances, A (corresponding author), Duke Univ, POB 39950, Durham, NC 27710 USA.							Batstra L, 2012, DEV MED CHILD NEUROL, V54, P492, DOI 10.1111/j.1469-8749.2011.04176.x; Centers for Disease Control and Prevention (CDC), 2012, INT CLASS DIS 9 REV; Division 32 Committee on DSM-5, 2012, OP LETT DSM 5 TASK F; Frances A, 2012, BLOOMBERG VIEW; Frances A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1580; Frances AJ, 2012, ANNU REV CLIN PSYCHO, V8, P109, DOI 10.1146/annurev-clinpsy-032511-143102; KENDELL RE, 1971, ARCH GEN PSYCHIAT, V25, P123, DOI 10.1001/archpsyc.1971.01750140027006; Leucht S, 2012, BRIT J PSYCHIAT, V200, P97, DOI 10.1192/bjp.bp.111.096594; ROSENHAN DL, 1973, SCIENCE, V179, P250, DOI 10.1126/science.179.4070.250; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7	10	33	37	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 6	2013	159	3					221	+		10.7326/0003-4819-159-3-201308060-00655	http://dx.doi.org/10.7326/0003-4819-159-3-201308060-00655			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	201RD	23685989				2022-12-28	WOS:000323159800009
J	Gottesman, MM				Gottesman, Michael M.			The Role of the NIH in Nurturing Clinician-Scientists	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Gottesman, MM (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.				Intramural NIH HHS [Z99 OD999999] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010830] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Flier JS, 2013, SCIENCE, V339, P140, DOI 10.1126/science.339.6116.140; Goldstein JL, 2012, SCIENCE, V338, P1033, DOI 10.1126/science.1231699; Ley TJ, 2005, JAMA-J AM MED ASSOC, V294, P1343, DOI 10.1001/jama.294.11.1343; Schafer AI, 2009, VANISHING PHYS SCI; WYNGAARDEN JB, 1979, NEW ENGL J MED, V301, P1254, DOI 10.1056/NEJM197912063012303	5	16	16	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 13	2013	368	24					2249	2251		10.1056/NEJMp1302969	http://dx.doi.org/10.1056/NEJMp1302969			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	161YN	23675642	Green Accepted			2022-12-28	WOS:000320230500015
J	Zaidi, S; Choi, M; Wakimoto, H; Ma, LJ; Jiang, JM; Overton, JD; Romano-Adesman, A; Bjornson, RD; Breitbart, RE; Brown, KK; Carriero, NJ; Cheung, YH; Deanfield, J; DePalma, S; Fakhro, KA; Glessner, J; Hakonarson, H; Italia, MJ; Kaltman, JR; Kaski, J; Kim, R; Kline, JK; Lee, T; Leipzig, J; Lopez, A; Mane, SM; Mitchell, LE; Newburger, JW; Parfenov, M; Pe'er, I; Porter, G; Roberts, AE; Sachidanandam, R; Sanders, SJ; Seiden, HS; State, MW; Subramanian, S; Tikhonova, IR; Wang, W; Warburton, D; White, PS; Williams, IA; Zhao, HY; Seidman, JG; Brueckner, M; Chung, WK; Gelb, BD; Goldmuntz, E; Seidman, CE; Lifton, RP				Zaidi, Samir; Choi, Murim; Wakimoto, Hiroko; Ma, Lijiang; Jiang, Jianming; Overton, John D.; Romano-Adesman, Angela; Bjornson, Robert D.; Breitbart, Roger E.; Brown, Kerry K.; Carriero, Nicholas J.; Cheung, Yee Him; Deanfield, John; DePalma, Steve; Fakhro, Khalid A.; Glessner, Joseph; Hakonarson, Hakon; Italia, Michael J.; Kaltman, Jonathan R.; Kaski, Juan; Kim, Richard; Kline, Jennie K.; Lee, Teresa; Leipzig, Jeremy; Lopez, Alexander; Mane, Shrikant M.; Mitchell, Laura E.; Newburger, Jane W.; Parfenov, Michael; Pe'er, Itsik; Porter, George; Roberts, Amy E.; Sachidanandam, Ravi; Sanders, Stephan J.; Seiden, Howard S.; State, Mathew W.; Subramanian, Sailakshmi; Tikhonova, Irina R.; Wang, Wei; Warburton, Dorothy; White, Peter S.; Williams, Ismee A.; Zhao, Hongyu; Seidman, Jonathan G.; Brueckner, Martina; Chung, Wendy K.; Gelb, Bruce D.; Goldmuntz, Elizabeth; Seidman, Christine E.; Lifton, Richard P.			De novo mutations in histone-modifying genes in congenital heart disease	NATURE			English	Article							COPY-NUMBER VARIANTS; AUTISM SPECTRUM; FAMILY; RISK	Congenital heart disease (CHD) is the most frequent birth defect, affecting 0.8% of live births(1). Many cases occur sporadically and impair reproductive fitness, suggesting a role for de novo mutations. Here we compare the incidence of de novo mutations in 362 severe CHD cases and 264 controls by analysing exome sequencing of parent-offspring trios. CHD cases show a significant excess of protein-altering de novo mutations in genes expressed in the developing heart, with an odds ratio of 7.5 for damaging (premature termination, frameshift, splice site) mutations. Similar odds ratios are seen across the main classes of severe CHD. We find a marked excess of de novo mutations in genes involved in the production, removal or reading of histone 3 lysine 4 (H3K4) methylation, or ubiquitination of H2BK120, which is required for H3K4 methylation(2-4). There are also two de novo mutations in SMAD2, which regulates H3K27 methylation in the embryonic left-right organizer(5). The combination of both activating (H3K4 methylation) and inactivating (H3K27 methylation) chromatin marks characterizes 'poised' promoters and enhancers, which regulate expression of key developmental genes(6). These findings implicate de novo point mutations in several hundreds of genes that collectively contribute to approximately 10% of severe CHD.	[Zaidi, Samir; Choi, Murim; Overton, John D.; Fakhro, Khalid A.; Lopez, Alexander; Mane, Shrikant M.; Sanders, Stephan J.; State, Mathew W.; Tikhonova, Irina R.; Zhao, Hongyu; Brueckner, Martina; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06504 USA; [Zaidi, Samir; Choi, Murim; Fakhro, Khalid A.; Lifton, Richard P.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Wakimoto, Hiroko; Jiang, Jianming; Brown, Kerry K.; DePalma, Steve; Parfenov, Michael; Seidman, Jonathan G.; Seidman, Christine E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Ma, Lijiang; Lee, Teresa; Warburton, Dorothy; Williams, Ismee A.; Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Jiang, Jianming; Seidman, Christine E.] Harvard Univ, Howard Hughes Med Inst, Boston, MA 02115 USA; [Overton, John D.; Lopez, Alexander; Mane, Shrikant M.; Tikhonova, Irina R.; Lifton, Richard P.] Yale Ctr Mendelian Genom, New Haven, CT 06510 USA; [Overton, John D.; Bjornson, Robert D.; Carriero, Nicholas J.; Lopez, Alexander; Mane, Shrikant M.; Tikhonova, Irina R.; Lifton, Richard P.] Yale Univ, Yale Ctr Genome Anal, New Haven, CT 06511 USA; [Romano-Adesman, Angela] Steven & Alexandra Cohen Childrens Med Ctr New Yo, New Hyde Pk, NY 11040 USA; [Bjornson, Robert D.; Carriero, Nicholas J.] Yale Univ, Dept Comp Sci, New Haven, CT 06511 USA; [Breitbart, Roger E.; Newburger, Jane W.; Roberts, Amy E.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Cheung, Yee Him] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY 10032 USA; [Deanfield, John; Kaski, Juan] Great Ormond St Hosp Sick Children, Univ Coll London, Dept Cardiol, London WC1N 3JH, England; [Glessner, Joseph; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Hakonarson, Hakon; White, Peter S.; Goldmuntz, Elizabeth] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Italia, Michael J.; Leipzig, Jeremy; Wang, Wei; White, Peter S.] Childrens Hosp Philadelphia, Ctr Biomed Informat, Philadelphia, PA 19104 USA; [Kaltman, Jonathan R.] NHLBI, NIH, Bethesda, MD 20892 USA; [Kim, Richard] Univ So Calif, Keck Sch Med, Sect Cardiothorac Surg, Los Angeles, CA 90089 USA; [Kline, Jennie K.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA; [Mitchell, Laura E.] Univ Texas Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Pe'er, Itsik] Columbia Univ, Dept Comp Sci, New York, NY 10032 USA; [Porter, George] Univ Rochester, Sch Med & Dent, Med Ctr, Dept Pediat, Rochester, NY 14611 USA; [Sachidanandam, Ravi; Subramanian, Sailakshmi; Gelb, Bruce D.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Sanders, Stephan J.; State, Mathew W.] Yale Univ, Dept Psychiat, Ctr Child Study, Program Neurogenet, New Haven, CT 06510 USA; [Seiden, Howard S.; Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Wang, Wei] New Jersey Inst Technol, Dept Comp Sci, Newark, NJ 07102 USA; [Warburton, Dorothy] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; [Zhao, Hongyu] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT 06510 USA; [Brueckner, Martina] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Chung, Wendy K.] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA; [Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Goldmuntz, Elizabeth] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Div Cardiol, Philadelphia, PA 19104 USA; [Seidman, Christine E.] Harvard Univ, Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Lifton, Richard P.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	Yale University; Howard Hughes Medical Institute; Yale University; Harvard University; Harvard Medical School; Columbia University; Harvard University; Howard Hughes Medical Institute; Yale University; Northwell Health; North Shore University Hospital; Steven & Alexandra Cohen Children's Medical Center of New York; Yale University; Harvard University; Boston Children's Hospital; Columbia University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Southern California; Columbia University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Columbia University; University of Rochester; Icahn School of Medicine at Mount Sinai; Yale University; Icahn School of Medicine at Mount Sinai; New Jersey Institute of Technology; Columbia University; Yale University; Yale University; Columbia University; Icahn School of Medicine at Mount Sinai; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Brigham & Women's Hospital; Yale University	Brueckner, M (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06504 USA.	martina.brueckner@yale.edu; wkc15@cumc.columbia.edu; bruce.gelb@mssm.edu; goldmuntz@email.chop.edu; csediman@genetics.med.harvard.edu; richard.lifton@yale.edu	State, Matthew/W-2256-2019; sachidanandam, ravi/Q-6916-2019; Sanders, Stephan/S-8645-2019; Kaski, Juan Pablo/AAX-8649-2020; Wang, Guilin/G-8794-2018; George A, Porter/E-7315-2013; jiang, jianming/B-3421-2012; Choi, Murim/AAP-9120-2021	sachidanandam, ravi/0000-0001-9844-4459; Kaski, Juan Pablo/0000-0002-0014-9927; George A, Porter/0000-0003-0726-9988; jiang, jianming/0000-0003-3251-2716; Choi, Murim/0000-0002-9195-1455; Glessner, Joseph/0000-0001-5131-2811; Italia, Michael/0000-0002-6941-6181; Leipzig, Jeremy/0000-0001-7224-9620; State, Matthew/0000-0003-1624-8302; Deanfield, John/0000-0001-8806-6052; Subramanian, Sai Lakshmi/0000-0003-1384-0722; Sanders, Stephan/0000-0001-9112-5148; DePalma, Steven/0000-0002-0381-5016	National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) Pediatric Cardiac Genomics Consortium [U01-HL098188, U01-HL098147, U01-HL098153, U01-HL098163, U01-HL098123, U01-HL098162]; Simons Foundation for Autism Research; NIH Centers for Mendelian Genomics [5U54HG006504]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL123238, U01HL098147, U01HL098188, U01HL098123, U01HL098153, U01HL098162, U01HL098163] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006546, U54HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) Pediatric Cardiac Genomics Consortium; Simons Foundation for Autism Research; NIH Centers for Mendelian Genomics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to the patients and families who participated in this research. We thank the following team members for contributions to patient recruitment: D. Awad, K. Celia, D. Etwaru, R. Korsin, A. Lanz, E. Marquez, J. K. Sond, A. Wilpers, R. Yee (Columbia Medical School); K. Boardman, J. Geva, J. Gorham, B. McDonough, A. Monafo, J. Stryker (Harvard Medical School); N. Cross (Yale School of Medicine); S. M. Edman, J. L. Garbarini, J. E. Tusi, S. H. Woyciechowski (Children's Hospital of Philadelphia); J. Ellashek and N. Tran (Children's Hospital of Los Angeles); K. Flack (University College London); D. Gruber, N. Stellato (Steve and Alexandra Cohen Children's Medical Center of New York); D. Guevara, A. Julian, M. Mac Neal, C. Mintz (Icahn School of Medicine at Mount Sinai); and E. Taillie (University of Rochester School of Medicine and Dentistry). We also thank V. Spotlow, P. Candrea, K. Pavlik and M. Sotiropoulos for their expert production of exome sequences. We thank B. Bernstein and R. Ryan (Massachusetts General Hospital) and B. Bruneau (Gladstone Institute and University of California, San Francisco) for discussions. This work was supported by the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) Pediatric Cardiac Genomics Consortium (U01-HL098188, U01-HL098147, U01-HL098153, U01-HL098163, U01-HL098123, U01-HL098162) and in part by the Simons Foundation for Autism Research and the NIH Centers for Mendelian Genomics (5U54HG006504).	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Christodoulou D. C., 2011, CURR PROTOC MOL BIOL, V94, P4121, DOI DOI 10.1002/0471142727.MB0412S94; Dahle O, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000841; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Fuchs G, 2012, MOL CELL, V46, P662, DOI 10.1016/j.molcel.2012.05.023; Gelb B, 2013, CIRC RES, V112, P698, DOI 10.1161/CIRCRESAHA.111.300297; Gendron RL, 2000, DEV DYNAM, V218, P300, DOI 10.1002/(SICI)1097-0177(200006)218:2<300::AID-DVDY5>3.0.CO;2-K; Ghebranious N, 2007, AM J MED GENET A, V143A, P1462, DOI 10.1002/ajmg.a.31837; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Lederer D, 2012, AM J HUM GENET, V90, P119, DOI 10.1016/j.ajhg.2011.11.021; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Paige SL, 2012, CELL, V151, P221, DOI 10.1016/j.cell.2012.08.027; Pedersen MT, 2010, TRENDS CELL BIOL, V20, P662, DOI 10.1016/j.tcb.2010.08.011; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Soemedi R, 2012, AM J HUM GENET, V91, P489, DOI 10.1016/j.ajhg.2012.08.003; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Vorstman JAS, 2013, SCHIZOPHR RES, V143, P55, DOI 10.1016/j.schres.2012.10.010; Wamstad JA, 2012, CELL, V151, P206, DOI 10.1016/j.cell.2012.07.035	30	589	601	1	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 13	2013	498	7453					220	+		10.1038/nature12141	http://dx.doi.org/10.1038/nature12141			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	162RR	23665959	Green Submitted, Green Accepted			2022-12-28	WOS:000320283400046
J	Ley, TJ; Miller, C; Ding, L; Raphael, BJ; Mungall, AJ; Robertson, AG; Hoadley, K; Triche, TJ; Laird, PW; Baty, JD; Fulton, LL; Fulton, R; Heath, SE; Kalicki-Veizer, J; Kandoth, C; Klco, JM; Koboldt, DC; Kanchi, KL; Kulkarni, S; Lamprecht, TL; Larson, DE; Lin, L; Lu, C; McLellan, MD; McMichael, JF; Payton, J; Schmidt, H; Spencer, DH; Tomasson, MH; Wallis, JW; Wartman, LD; Watson, MA; Welch, J; Wendl, MC; Ally, A; Balasundaram, M; Birol, I; Butterfield, Y; Chiu, R; Chu, A; Chuah, E; Chun, HJ; Corbett, R; Dhalla, N; Guin, R; He, A; Hirst, C; Hirst, M; Holt, RA; Jones, S; Karsan, A; Lee, D; Li, HI; Marra, MA; Mayo, M; Moore, RA; Mungall, K; Parker, J; Pleasance, E; Plettner, P; Schein, J; Stoll, D; Swanson, L; Tam, A; Thiessen, N; Varhol, R; Wye, N; Zhao, YJ; Gabriel, S; Getz, G; Sougnez, C; Zou, LH; Leiserson, MDM; Vandin, F; Wu, HT; Applebaum, F; Baylin, SB; Akbani, R; Broom, BM; Chen, K; Motter, TC; Nguyen, K; Weinstein, JN; Zhang, NZ; Ferguson, ML; Adams, C; Black, A; Bowen, J; Gastier-Foster, J; Grossman, T; Lichten-Berg, T; Wise, L; Davidsen, T; Demchok, JA; Shaw, KRM; Sheth, M; Sofia, HJ; Yang, LM; Downing, JR; Eley, G; Alonso, S; Ayala, B; Baboud, J; Backus, M; Barletta, SP; Berton, DL; Chu, AL; Girshik, S; Jensen, MA; Kahn, A; Kothiyal, P; Nicholls, MC; Pihl, TD; Pot, DA; Raman, R; Sanbhadti, RN; Snyder, EE; Srinivasan, D; Walton, JS; Wan, YH; Wang, ZN; Issa, JPJ; Le Beau, M; Carroll, M; Kantarjian, H; Kornblau, S; Bootwalla, MS; Lai, PH; Shen, H; Van den Berg, DJ; Weisenberger, DJ; Link, DC; Walter, MJ; Ozenberger, BA; Mardis, ER; Westervelt, P; Graubert, TA; DiPersio, JF; Wilson, RK				Ley, Timothy J.; Miller, Christopher; Ding, Li; Raphael, Benjamin J.; Mungall, Andrew J.; Robertson, A. Gordon; Hoadley, Katherine; Triche, Timothy J., Jr.; Laird, Peter W.; Baty, Jack D.; Fulton, Lucinda L.; Fulton, Robert; Heath, Sharon E.; Kalicki-Veizer, Joelle; Kandoth, Cyriac; Klco, Jeffery M.; Koboldt, Daniel C.; Kanchi, Krishna-Latha; Kulkarni, Shashikant; Lamprecht, Tamara L.; Larson, David E.; Lin, Ling; Lu, Charles; McLellan, Michael D.; McMichael, Joshua F.; Payton, Jacqueline; Schmidt, Heather; Spencer, David H.; Tomasson, Michael H.; Wallis, John W.; Wartman, Lukas D.; Watson, Mark A.; Welch, John; Wendl, Michael C.; Ally, Adrian; Balasundaram, Miruna; Birol, Inanc; Butterfield, Yaron; Chiu, Readman; Chu, Andy; Chuah, Eric; Chun, Hye-Jung; Corbett, Richard; Dhalla, Noreen; Guin, Ranabir; He, An; Hirst, Carrie; Hirst, Martin; Holt, Robert A.; Jones, Steven; Karsan, Aly; Lee, Darlene; Li, Haiyan I.; Marra, Marco A.; Mayo, Michael; Moore, Richard A.; Mungall, Karen; Parker, Jeremy; Pleasance, Erin; Plettner, Patrick; Schein, Jacquie; Stoll, Dominik; Swanson, Lucas; Tam, Angela; Thiessen, Nina; Varhol, Richard; Wye, Natasja; Zhao, Yongjun; Gabriel, Stacey; Getz, Gad; Sougnez, Carrie; Zou, Lihua; Leiserson, Mark D. M.; Vandin, Fabio; Wu, Hsin-Ta; Applebaum, Frederick; Baylin, Stephen B.; Akbani, Rehan; Broom, Bradley M.; Chen, Ken; Motter, Thomas C.; Nguyen, Khanh; Weinstein, John N.; Zhang, Nianziang; Ferguson, Martin L.; Adams, Christopher; Black, Aaron; Bowen, Jay; Gastier-Foster, Julie; Grossman, Thomas; Lichten-Berg, Tara; Wise, Lisa; Davidsen, Tanja; Demchok, John A.; Shaw, Kenna R. Mills; Sheth, Margi; Sofia, Heidi J.; Yang, Liming; Downing, James R.; Eley, Greg; Alonso, Shelley; Ayala, Brenda; Baboud, Julien; Backus, Mark; Barletta, Sean P.; Berton, Dominique L.; Chu, Anna L.; Girshik, Stanley; Jensen, Mark A.; Kahn, Ari; Kothiyal, Prachi; Nicholls, Matthew C.; Pihl, Todd D.; Pot, David A.; Raman, Rohini; Sanbhadti, Rashmi N.; Snyder, Eric E.; Srinivasan, Deepak; Walton, Jes-Sica; Wan, Yunhu; Wang, Zhining; Issa, Jean-Pierre J.; Le Beau, Michelle; Carroll, Martin; Kantarjian, Hagop; Kornblau, Steven; Bootwalla, Moiz S.; Lai, Phillip H.; Shen, Hui; Van den Berg, David J.; Weisenberger, Daniel J.; Link, Daniel C.; Walter, Matthew J.; Ozenberger, Bradley A.; Mardis, Elaine R.; Westervelt, Peter; Graubert, Timothy A.; DiPersio, John F.; Wilson, Richard K.		Canc Genome Atlas Res Network	Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COPY NUMBER ALTERATIONS; EXPRESSION PROFILES; MONOSOMAL KARYOTYPE; MICRORNA EXPRESSION; MUTATIONS; CANCER; GENE; HYPERMETHYLATION; TRANSCRIPTION; EVOLUTION	BACKGROUND Many mutations that contribute to the pathogenesis of acute myeloid leukemia (AML) are undefined. The relationships between patterns of mutations and epigenetic phenotypes are not yet clear. METHODS We analyzed the genomes of 200 clinically annotated adult cases of de novo AML, using either whole-genome sequencing (50 cases) or whole-exome sequencing (150 cases), along with RNA and microRNA sequencing and DNA-methylation analysis. RESULTS AML genomes have fewer mutations than most other adult cancers, with an average of only 13 mutations found in genes. Of these, an average of 5 are in genes that are recurrently mutated in AML. A total of 23 genes were significantly mutated, and another 237 were mutated in two or more samples. Nearly all samples had at least 1 nonsynonymous mutation in one of nine categories of genes that are almost certainly relevant for pathogenesis, including transcription-factor fusions (18% of cases), the gene encoding nucleophosmin (NPM1) (27%), tumor-suppressor genes (16%), DNA-methylation-related genes (44%), signaling genes (59%), chromatin-modifying genes (30%), myeloid transcription-factor genes (22%), cohesin-complex genes (13%), and spliceosome-complex genes (14%). Patterns of cooperation and mutual exclusivity suggested strong biologic relationships among several of the genes and categories. CONCLUSIONS We identified at least one potential driver mutation in nearly all AML samples and found that a complex interplay of genetic events contributes to AML pathogenesis in individual patients. The databases from this study are widely available to serve as a foundation for further investigations of AML pathogenesis, classification, and risk stratification.	[Ley, Timothy J.; Miller, Christopher; Ding, Li; Fulton, Lucinda L.; Fulton, Robert; Kalicki-Veizer, Joelle; Kandoth, Cyriac; Koboldt, Daniel C.; Kanchi, Krishna-Latha; Larson, David E.; Lin, Ling; Lu, Charles; McLellan, Michael D.; McMichael, Joshua F.; Schmidt, Heather; Wallis, John W.; Wendl, Michael C.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Genome Inst, St Louis, MO 63110 USA; [Ley, Timothy J.; Tomasson, Michael H.; Link, Daniel C.; Walter, Matthew J.; Westervelt, Peter; Graubert, Timothy A.; DiPersio, John F.] Siteman Canc Ctr, St Louis, MO USA; [Raphael, Benjamin J.; Leiserson, Mark D. M.; Vandin, Fabio; Wu, Hsin-Ta] Brown Univ, Providence, RI 02912 USA; [Raphael, Benjamin J.; Leiserson, Mark D. M.; Vandin, Fabio; Wu, Hsin-Ta] Ctr Computat Mol Biol, Providence, RI USA; [Mungall, Andrew J.; Robertson, A. Gordon; Ally, Adrian; Balasundaram, Miruna; Birol, Inanc; Butterfield, Yaron; Chiu, Readman; Chu, Andy; Chuah, Eric; Chun, Hye-Jung; Corbett, Richard; Dhalla, Noreen; Guin, Ranabir; Hirst, Carrie; Hirst, Martin; Holt, Robert A.; Jones, Steven; Karsan, Aly; Lee, Darlene; Li, Haiyan I.; Marra, Marco A.; Mayo, Michael; Moore, Richard A.; Mungall, Karen; Parker, Jeremy; Pleasance, Erin; Plettner, Patrick; Schein, Jacquie; Stoll, Dominik; Swanson, Lucas; Tam, Angela; Thiessen, Nina; Varhol, Richard; Wye, Natasja; Zhao, Yongjun] British Columbia Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4E6, Canada; [Hoadley, Katherine] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Triche, Timothy J., Jr.; Laird, Peter W.; Bootwalla, Moiz S.; Lai, Phillip H.; Shen, Hui; Van den Berg, David J.; Weisenberger, Daniel J.] Univ So Calif, Epigenome Ctr, Los Angeles, CA USA; [Baty, Jack D.; Heath, Sharon E.; Klco, Jeffery M.; Kulkarni, Shashikant; Lamprecht, Tamara L.; Payton, Jacqueline; Spencer, David H.; Tomasson, Michael H.; Wartman, Lukas D.; Watson, Mark A.; Welch, John; Link, Daniel C.; Walter, Matthew J.; Westervelt, Peter; Graubert, Timothy A.; DiPersio, John F.] Washington Univ, St Louis, MO 63110 USA; [Gabriel, Stacey; Getz, Gad; Sougnez, Carrie; Zou, Lihua] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA; [Applebaum, Frederick] Fred Hutchinson Canc Res Ctr, Div Med Oncol, Seattle Canc Care Alliance, Seattle, WA 98104 USA; [Baylin, Stephen B.] Johns Hopkins Univ, Baltimore, MD USA; [Akbani, Rehan; Broom, Bradley M.; Chen, Ken; Motter, Thomas C.; Nguyen, Khanh; Weinstein, John N.; Zhang, Nianziang; Kantarjian, Hagop; Kornblau, Steven] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Ferguson, Martin L.] MLF Consulting, Boston, MA USA; [Adams, Christopher; Black, Aaron; Bowen, Jay; Gastier-Foster, Julie; Grossman, Thomas; Lichten-Berg, Tara; Wise, Lisa] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Davidsen, Tanja; Demchok, John A.; Shaw, Kenna R. Mills; Sheth, Margi; Yang, Liming] NCI, Bethesda, MD 20892 USA; [Sofia, Heidi J.; Ozenberger, Bradley A.] NHGRI, Bethesda, MD 20892 USA; [Downing, James R.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Eley, Greg] Sciementis LLC, Statham, GA USA; [Alonso, Shelley; Ayala, Brenda; Baboud, Julien; Backus, Mark; Barletta, Sean P.; Berton, Dominique L.; Chu, Anna L.; Girshik, Stanley; Jensen, Mark A.; Kahn, Ari; Kothiyal, Prachi; Nicholls, Matthew C.; Pihl, Todd D.; Pot, David A.; Raman, Rohini; Sanbhadti, Rashmi N.; Snyder, Eric E.; Srinivasan, Deepak; Walton, Jes-Sica; Wan, Yunhu; Wang, Zhining] SRA Int, Fairfax, VA USA; [Issa, Jean-Pierre J.] Temple Univ, Philadelphia, PA 19122 USA; [Le Beau, Michelle] Univ Chicago, Chicago, IL 60637 USA; [Carroll, Martin] Univ Penn, Philadelphia, PA 19104 USA	Washington University (WUSTL); Siteman Cancer Center; Brown University; British Columbia Cancer Agency; University of North Carolina; University of North Carolina Chapel Hill; University of Southern California; Washington University (WUSTL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Fred Hutchinson Cancer Center; Seattle Cancer Care Alliance; Johns Hopkins University; University of Texas System; UTMD Anderson Cancer Center; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); St Jude Children's Research Hospital; SRA International; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Chicago; University of Pennsylvania	Ley, TJ (corresponding author), Washington Univ, Sch Med, Div Oncol, Stem Cell Biol Sect, Campus Box 8007,660 S Euclid Ave, St Louis, MO 63110 USA.	timley@wustl.edu	Wilson, Richard K./AAF-4139-2019; Birol, Inanc/G-5440-2011; Akbani, Rehan/AAG-1490-2019; Schein, Jacquie E/G-3674-2015; Weisenberger, Daniel/AAA-8314-2020; Shen, Hui/AAO-4387-2020; Mungall, Andrew J./U-7067-2018; Walter, Matthew J/S-7758-2018; Downing, James R./N-8102-2018; Laird, Peter W/G-8683-2012; Jones, Steven J/C-3621-2009; Miller, Christopher A./A-1060-2009; Van Den Berg, David J/G-8598-2017; Chen, Ken/AAU-1432-2021; Karsan, Aly/K-2067-2015; Hirst, Martin/B-7684-2016; Marra, Marco A/B-5987-2008; Holt, Robert A/C-3303-2009; Mardis, Elaine/W-2202-2019; Klco, Jeffery/M-9717-2018	Wilson, Richard K./0000-0002-1992-1358; Birol, Inanc/0000-0003-0950-7839; Weisenberger, Daniel/0000-0001-8303-2603; Mungall, Andrew J./0000-0002-0905-2742; Laird, Peter W/0000-0001-9117-3641; Jones, Steven J/0000-0003-3394-2208; Miller, Christopher A./0000-0003-4266-6700; Van Den Berg, David J/0000-0002-5404-5218; Chen, Ken/0000-0003-4013-5279; Marra, Marco A/0000-0001-7146-7175; Holt, Robert A/0000-0002-7259-1247; Klco, Jeffery/0000-0003-2961-6960; Parker, Jeremy/0000-0001-8319-5891; Pot, David/0000-0002-1480-9826; Weinstein, John/0000-0001-9401-6908; Issa, Jean-Pierre/0000-0003-2258-5030; Bowen, Jay/0000-0001-6861-9043; Westover, Tamara/0000-0002-1000-6698; Jensen, Mark/0000-0001-5215-101X; Larson, David/0000-0001-7934-5906; Stoll, Dominik/0000-0003-0701-4301; MCLELLAN, MICHAEL/0000-0002-2703-8784; Graubert, Timothy/0000-0002-7710-1171; Triche, Tim/0000-0001-5665-946X; Tomasson, Michael/0000-0003-4518-7123; Hoadley, Katherine/0000-0002-1216-477X; Shen, Hui/0000-0001-9767-4084; Kandoth, Cyriac/0000-0002-1345-3573	National Institutes of Health [U24CA143845, U24CA143858, U24CA144025, U24CA143882, U24CA143866, U24CA143867, U24CA143848, U24CA143840, U24CA143835, U24CA143799, U24CA143883, U24CA143843, U54HG003067, U54HG003079, U54HG003273, P01CA101937]; NATIONAL CANCER INSTITUTE [U24CA143882, U24CA144025, P30CA016672, U24CA143848, P01CA101937, U24CA143835, U24CA143866, R01CA083962, U24CA143799, U24CA143867, U24CA143845, P30CA091842, U24CA143843, R01CA162086, U24CA143840, U24CA143858, U24CA143883] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, U54HG003273, R01HG005690, U54HG003079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Supported by grants from the National Institutes of Health (U24CA143845, U24CA143858, U24CA144025, U24CA143882, U24CA143866, U24CA143867, U24CA143848, U24CA143840, U24CA143835, U24CA143799, U24CA143883, U24CA143843, U54HG003067, U54HG003079, U54HG003273, and P01CA101937).; Funded by the National Institutes of Health.	Bacher U, 2010, CURR OPIN ONCOL, V22, P646, DOI 10.1097/CCO.0b013e32833ed806; Bellon M, 2009, BLOOD, V113, P4914, DOI 10.1182/blood-2008-11-189845; Breems DA, 2008, J CLIN ONCOL, V26, P4791, DOI 10.1200/JCO.2008.16.0259; Bryant A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-8; Bullinger L, 2010, LEUKEMIA, V24, P438, DOI 10.1038/leu.2009.263; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Faraoni I, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-26; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Figueroa ME, 2009, BLOOD, V114, P3448, DOI 10.1182/blood-2009-01-200519; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Higuchi M, 2002, CANCER CELL, V1, P63, DOI 10.1016/S1535-6108(02)00016-8; Ju XL, 2009, PEDIATR HEMAT ONCOL, V26, P1, DOI 10.1080/08880010802378338; Kelly LM, 2002, ANNU REV GENOM HUM G, V3, P179, DOI 10.1146/annurev.genom.3.032802.115046; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuo YH, 2006, CANCER CELL, V9, P57, DOI 10.1016/j.ccr.2005.12.014; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Lv M, 2012, LEUKEMIA, V26, P769, DOI 10.1038/leu.2011.273; Marcucci G, 2011, BLOOD, V117, P1121, DOI 10.1182/blood-2010-09-191312; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Mrozek K, 2004, BLOOD REV, V18, P115, DOI 10.1016/S0268-960X(03)00040-7; Mrozek K, 2012, J CLIN ONCOL, V30, P4515, DOI 10.1200/JCO.2012.43.4738; Ovcharenko D, 2011, EXP HEMATOL, V39, P1030, DOI 10.1016/j.exphem.2011.07.008; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Payton JE, 2009, J CLIN INVEST, V119, P1714, DOI 10.1172/JCI38248; Ramkissoon SH, 2006, LEUKEMIA RES, V30, P643, DOI 10.1016/j.leukres.2005.09.001; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Rowley JD, 2008, BLOOD, V112, P2183, DOI 10.1182/blood-2008-04-097931; Ruckner FG, 2012, BLOOD, V119, P2114, DOI 10.1182/blood-2011-08-375758; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Shen Y, 2011, BLOOD, V118, P5593, DOI 10.1182/blood-2011-03-343988; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stirewalt DL, 2003, NAT REV CANCER, V3, P650, DOI 10.1038/nrc1169; Suela J, 2007, CYTOGENET GENOME RES, V118, P304, DOI 10.1159/000108314; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Valleron W, 2012, LEUKEMIA, V26, P2052, DOI 10.1038/leu.2012.111; Vandin F, 2011, J COMPUT BIOL, V18, P507, DOI 10.1089/cmb.2010.0265; Verhaak RGW, 2009, HAEMATOL-HEMATOL J, V94, P131, DOI 10.3324/haematol.13299; Walter MJ, 2009, P NATL ACAD SCI USA, V106, P12950, DOI 10.1073/pnas.0903091106; Wang XS, 2012, BLOOD, V119, P4992, DOI 10.1182/blood-2011-10-385716; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Westervelt P, 2003, BLOOD, V102, P1857, DOI 10.1182/blood-2002-12-3779; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Yamashita Y, 2010, ONCOGENE, V29, P3723, DOI 10.1038/onc.2010.117	49	3130	3188	20	380	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2013	368	22					2059	2074		10.1056/NEJMoa1301689	http://dx.doi.org/10.1056/NEJMoa1301689			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	153AT	23634996	Green Accepted, Green Published			2022-12-28	WOS:000319574200004
J	Hannan, FM; Thakker, RV				Hannan, Fadil M.; Thakker, Rajesh V.			RATIONAL TESTING Investigating hypocalcaemia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VITAMIN-D DEFICIENCY; CALCIUM; SERUM; DIAGNOSIS; MANAGEMENT		[Hannan, Fadil M.; Thakker, Rajesh V.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Acad Endocrine Unit,Nuffield Dept Clin Med, Oxford OX3 7LJ, England; [Hannan, Fadil M.] John Radcliffe Hosp, Dept Clin Biochem, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Thakker, RV (corresponding author), Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Acad Endocrine Unit,Nuffield Dept Clin Med, S Parks Rd, Oxford OX3 7LJ, England.	rajesh.thakker@ndm.ox.ac.uk		Hannan, Fadil/0000-0002-2975-5170; Thakker, Rajesh/0000-0002-1438-3220	Medical Research Council [G1000467] Funding Source: Medline; MRC [G1000467] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agus ZS, 1999, J AM SOC NEPHROL, V10, P1616; Barth JH, 1996, ANN CLIN BIOCHEM, V33, P55, DOI 10.1177/000456329603300108; BOINK ABTJ, 1991, J AUTOM CHEM, V13, P235, DOI 10.1155/S1463924691000391; Cooper MS, 2008, BRIT MED J, V336, P1298, DOI 10.1136/bmj.39582.589433.BE; Hashemipour S, 2006, J BONE MINER METAB, V24, P213, DOI 10.1007/s00774-005-0674-8; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; KRAPF R, 1992, KIDNEY INT, V42, P727, DOI 10.1038/ki.1992.340; Langman CB, 2010, CLIN J AM SOC NEPHRO, V5, pS1, DOI 10.2215/CJN.06140809; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Liamis G, 2009, J BONE MINER METAB, V27, P635, DOI 10.1007/s00774-009-0119-x; PAYNE RB, 1973, BMJ-BRIT MED J, V4, P643, DOI 10.1136/bmj.4.5893.643; Pearce SHS, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5664; POCOCK SJ, 1989, J CLIN PATHOL, V42, P172, DOI 10.1136/jcp.42.2.172; Slomp J, 2003, CRIT CARE MED, V31, P1389, DOI 10.1097/01.CCM.0000063044.55669.3C; Thakker R., 2003, OXFORD TXB MED; Thomusch O, 2003, SURGERY, V133, P180, DOI 10.1067/msy.2003.61	16	27	27	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 9	2013	346								f2213	10.1136/bmj.f2213	http://dx.doi.org/10.1136/bmj.f2213			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144BU	23661111				2022-12-28	WOS:000318915200001
J	Stanworth, SJ; Estcourt, LJ; Powter, G; Kahan, BC; Dyer, C; Choo, L; Bakrania, L; Llewelyn, C; Littlewood, T; Soutar, R; Norfolk, D; Copplestone, A; Smith, N; Kerr, P; Jones, G; Raj, K; Westerman, DA; Szer, J; Jackson, N; Bardy, PG; Plews, D; Lyons, S; Bielby, L; Wood, EM; Murphy, MF				Stanworth, Simon J.; Estcourt, Lise J.; Powter, Gillian; Kahan, Brennan C.; Dyer, Claire; Choo, Louise; Bakrania, Lekha; Llewelyn, Charlotte; Littlewood, Timothy; Soutar, Richard; Norfolk, Derek; Copplestone, Adrian; Smith, Neil; Kerr, Paul; Jones, Gail; Raj, Kavita; Westerman, David A.; Szer, Jeffrey; Jackson, Nicholas; Bardy, Peter G.; Plews, Dianne; Lyons, Simon; Bielby, Linley; Wood, Erica M.; Murphy, Michael F.		TOPPS Investigators	A No-Prophylaxis Platelet-Transfusion Strategy for Hematologic Cancers	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MALIGNANCIES; TRIAL	BACKGROUND The effectiveness of platelet transfusions to prevent bleeding in patients with hematologic cancers remains unclear. This trial assessed whether a policy of not giving prophylactic platelet transfusions was as effective and safe as a policy of providing prophylaxis. METHODS We conducted this randomized, open-label, noninferiority trial at 14 centers in the United Kingdom and Australia. Patients were randomly assigned to receive, or not to receive, prophylactic platelet transfusions when morning platelet counts were less than 10x10(9) per liter. Eligible patients were persons 16 years of age or older who were receiving chemotherapy or undergoing stem-cell transplantation and who had or were expected to have thrombocytopenia. The primary end point was bleeding of World Health Organization (WHO) grade 2, 3, or 4 up to 30 days after randomization. RESULTS A total of 600 patients (301 in the no-prophylaxis group and 299 in the prophylaxis group) underwent randomization between 2006 and 2011. Bleeding of WHO grade 2, 3, or 4 occurred in 151 of 300 patients (50%) in the no-prophylaxis group, as compared with 128 of 298 (43%) in the prophylaxis group (adjusted difference in proportions, 8.4 percentage points; 90% confidence interval, 1.7 to 15.2; P = 0.06 for noninferiority). Patients in the no-prophylaxis group had more days with bleeding and a shorter time to the first bleeding episode than did patients in the prophylaxis group. Platelet use was markedly reduced in the no-prophylaxis group. A prespecified subgroup analysis identified similar rates of bleeding in the two study groups among patients undergoing autologous stem-cell transplantation. CONCLUSIONS The results of our study support the need for the continued use of prophylaxis with platelet transfusion and show the benefit of such prophylaxis for reducing bleeding, as compared with no prophylaxis. A significant number of patients had bleeding despite prophylaxis. (Funded by the National Health Service Blood and Transplant Research and Development Committee and the Australian Red Cross Blood Service; TOPPS Controlled-Trials. com number, ISRCTN08758735.)	[Stanworth, Simon J.; Estcourt, Lise J.; Powter, Gillian; Dyer, Claire; Murphy, Michael F.] John Radcliffe Hosp, NHS Blood & Transplant, Oxford Univ Hosp NHS Trust, Oxford OX3 9BQ, England; [Stanworth, Simon J.; Estcourt, Lise J.; Murphy, Michael F.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Littlewood, Timothy] Churchill Hosp, Oxford Univ Hosp NHS Trust, Oxford OX3 7LJ, England; [Kahan, Brennan C.; Choo, Louise] MRC, Clin Trials Unit, London, England; [Raj, Kavita] Guys & St Thomas Hosp, London SE1 9RT, England; [Powter, Gillian; Dyer, Claire; Bakrania, Lekha; Llewelyn, Charlotte] MRC, Clin Studies Unit, NHS Blood & Transplant, Cambridge, England; [Soutar, Richard] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland; [Norfolk, Derek] Leeds Teaching Hosp, Leeds, W Yorkshire, England; [Copplestone, Adrian] Plymouth Derriford Hosp, Plymouth, Devon, England; [Smith, Neil] Birmingham Heartlands Hosp, Birmingham B9 5ST, W Midlands, England; [Kerr, Paul] Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England; [Jones, Gail] Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Jackson, Nicholas] Univ Hosp, Coventry, W Midlands, England; [Plews, Dianne] James Cook Univ Hosp, Middlesbrough, Cleveland, England; [Lyons, Simon] Sunderland City Hosp, Sunderland, England; [Westerman, David A.; Wood, Erica M.] Peter MacCallum Canc Ctr, East Melbourne, Vic, Australia; [Szer, Jeffrey; Wood, Erica M.] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Bielby, Linley; Wood, Erica M.] Australian Red Cross Blood Serv, Melbourne, Vic, Australia; [Bardy, Peter G.] Royal Adelaide Hosp, Adelaide, SA 5000, Australia	Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Medical Research Council Clinical Trials Unit; Guy's & St Thomas' NHS Foundation Trust; Beatson Oncology Centre; University of Leeds; Derriford Hospital; Heart of England NHS Foundation Trust; University of Birmingham; University of Exeter; Newcastle Freeman Hospital; Newcastle University - UK; University of Warwick; James Cook University Hospital; Peter Maccallum Cancer Center; Royal Melbourne Hospital; Australian Red Cross Blood Service; Royal Adelaide Hospital	Stanworth, SJ (corresponding author), John Radcliffe Hosp, NHS Blood & Transplant, Level 2, Oxford OX3 9BQ, England.		Jackson, Nicholas/A-4609-2016; Wood, Erica M/I-1956-2014; Estcourt, Lise/B-6995-2013	Wood, Erica M/0000-0001-7527-2340; Estcourt, Lise/0000-0003-4309-9162; Choo, Louise/0000-0003-4040-1522; Szer, Jeff/0000-0001-6783-2301; Raj, Kavita/0000-0002-8258-354X; Casbard, Angela/0000-0001-6241-3052	National Health Service Blood and Transplant Research and Development Committee; Australian Red Cross Blood Service [ISRCTN08758735]; National Health Service Blood and Transplant Research and Development Committee [PG04-05]; Chugai Pharmaceutical; Celgene; MRC [MC_U122870183] Funding Source: UKRI; Cancer Research UK [15954] Funding Source: researchfish; Medical Research Council [MC_U122870183] Funding Source: researchfish	National Health Service Blood and Transplant Research and Development Committee; Australian Red Cross Blood Service; National Health Service Blood and Transplant Research and Development Committee; Chugai Pharmaceutical; Celgene(Bristol-Myers SquibbCelgene Corporation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funded by the National Health Service Blood and Transplant Research and Development Committee and the Australian Red Cross Blood Service; TOPPS Controlled-Trials.com number, ISRCTN08758735.; Supported by grants from the National Health Service Blood and Transplant Research and Development Committee (PG04-05) and the Australian Red Cross Blood Service.; Dr. Soutar reports serving on an advisory board for Celgene and receiving lecture fees from Chugai Pharmaceutical. Dr. Raj reports receiving lecture fees from Celgene and travel support from Therakos, a Johnson & Johnson company. Dr. Plews reports receiving travel support from Roche. No other potential conflict of interest relevant to this article was reported.	Altman DG, 2005, BRIT MED J, V330, P843, DOI 10.1136/bmj.330.7495.843; Estcourt LJ, 2012, VOX SANG, V103, P284, DOI 10.1111/j.1423-0410.2012.01627.x; Estcourt L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004269.pub3; Estcourt LJ, 2013, TRANSFUSION; Heddle NM, 2011, TRANSFUSION, V51, P430, DOI 10.1111/j.1537-2995.2010.02982.x; Heddle NM, 2009, BLOOD, V113, P1564, DOI 10.1182/blood-2008-09-178236; HIGBY DJ, 1974, TRANSFUSION, V14, P440, DOI 10.1111/j.1537-2995.1974.tb04558.x; Jones B, 1996, BRIT MED J, V313, P550; Jones E, 1996, BMJ-BRIT MED J, V313, P36, DOI 10.1136/bmj.313.7048.36; Kahan BC, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5840; Kahan BC, 2012, STAT MED, V31, P328, DOI 10.1002/sim.4431; Kelsey P, 2003, BRIT J HAEMATOL, V122, P10; MURPHY S, 1982, AM J HEMATOL, V12, P347, DOI 10.1002/ajh.2830120406; Rebulla P, 1997, NEW ENGL J MED, V337, P1870, DOI 10.1056/NEJM199712253372602; Schiffer CA, 2001, J CLIN ONCOL, V19, P1519, DOI 10.1200/JCO.2001.19.5.1519; Slichter SJ, 2010, NEW ENGL J MED, V362, P600, DOI 10.1056/NEJMoa0904084; Slichter Sherrill J, 2007, Hematology Am Soc Hematol Educ Program, P172, DOI 10.1182/asheducation-2007.1.172; SOLOMON J, 1978, LANCET, V1, P267; Stanworth SJ, 2010, TRANSFUS MED REV, V24, P163, DOI 10.1016/j.tmrv.2009.11.002; Stanworth SJ, 2006, VOX SANG, V91, P63, DOI 10.1111/j.1423-0410.2006.00785.x; Wandt H, 2012, LANCET, V380, P1309, DOI 10.1016/S0140-6736(12)60689-8; WHO, 1979, WHO HDB REP RES CANC; Wiens BL, 2007, CLIN TRIALS, V4, P286, DOI 10.1177/1740774507079443	23	278	284	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2013	368	19					1771	1780		10.1056/NEJMoa1212772	http://dx.doi.org/10.1056/NEJMoa1212772			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138WA	23656642				2022-12-28	WOS:000318540000005
J	Cruz, M; Coontz, R				Cruz, Maria; Coontz, Robert			Alien Worlds Galore INTRODUCTION	SCIENCE			English	Editorial Material																			0	1	1	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2013	340	6132					565	565		10.1126/science.340.6132.565	http://dx.doi.org/10.1126/science.340.6132.565			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	135EA	23641107				2022-12-28	WOS:000318268900038
J	Seager, S				Seager, Sara			Exoplanet Habitability	SCIENCE			English	Review							PLANETS; EARTH; LIFE; BIOSIGNATURES; WATER; ATMOSPHERE; EVOLUTION; SPECTRUM; HYDROGEN; SURFACE	The search for exoplanets includes the promise to eventually find and identify habitable worlds. The thousands of known exoplanets and planet candidates are extremely diverse in terms of their masses or sizes, orbits, and host star type. The diversity extends to new kinds of planets, which are very common yet have no solar system counterparts. Even with the requirement that a planet's surface temperature must be compatible with liquid water (because all life on Earth requires liquid water), a new emerging view is that planets very different from Earth may have the right conditions for life. The broadened possibilities will increase the future chances of discovering an inhabited world.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Seager, S (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	seager@mit.edu						Abe Y, 2011, ASTROBIOLOGY, V11, P443, DOI 10.1089/ast.2010.0545; Bahcall JN, 2001, ASTROPHYS J, V555, P990, DOI 10.1086/321493; Bains W, 2004, ASTROBIOLOGY, V4, P137, DOI 10.1089/153110704323175124; Baross J., 2007, COMMITTEE LIMITS ORG; Bean JL, 2010, NATURE, V468, P669, DOI 10.1038/nature09596; Borysow A, 2002, ASTRON ASTROPHYS, V390, P779, DOI 10.1051/0004-6361:20020555; BORYSOW J, 1988, ASTROPHYS J, V326, P509, DOI 10.1086/166112; Cassan A, 2012, NATURE, V481, P167, DOI 10.1038/nature10684; Christensen PR, 1997, J GEOPHYS RES-PLANET, V102, P10875, DOI 10.1029/97JE00637; DEBERGH C, 1991, SCIENCE, V251, P547, DOI 10.1126/science.251.4993.547; Deming D, 2009, PUBL ASTRON SOC PAC, V121, P952, DOI 10.1086/605913; Des Marais DJ, 2002, ASTROBIOLOGY, V2, P153, DOI 10.1089/15311070260192246; Domagal-Goldman SD, 2011, ASTROBIOLOGY, V11, P419, DOI 10.1089/ast.2010.0509; Elkins-Tanton LT, 2008, ASTROPHYS J, V685, P1237, DOI 10.1086/591433; Fassett CI, 2008, ICARUS, V198, P37, DOI 10.1016/j.icarus.2008.06.016; Ford EB, 2001, NATURE, V412, P885, DOI 10.1038/35091009; Gillmann C, 2009, EARTH PLANET SC LETT, V286, P503, DOI 10.1016/j.epsl.2009.07.016; HART MH, 1978, ICARUS, V33, P23, DOI 10.1016/0019-1035(78)90021-0; Howard AW, 2013, SCIENCE, V340, P572, DOI 10.1126/science.1233545; HUANG SS, 1959, AM SCI, V47, P397; Kaltenegger L, 2009, ASTROPHYS J, V698, P519, DOI 10.1088/0004-637X/698/1/519; Kasting JF, 2003, ANNU REV ASTRON ASTR, V41, P429, DOI 10.1146/annurev.astro.41.071601.170049; Lammer H, 2012, EARTH PLANETS SPACE, V64, P179, DOI 10.5047/eps.2011.04.002; Lang E W, 1986, Adv Space Res, V6, P251, DOI 10.1016/0273-1177(86)90093-1; Lawrence DJ, 2013, SCIENCE, V339, P292, DOI 10.1126/science.1229953; LEDERBERG J, 1965, NATURE, V207, P9, DOI 10.1038/207009a0; LOVELOCK JE, 1965, NATURE, V207, P568, DOI 10.1038/207568a0; Lubow S. H., 2011, EXOPLANETS, P347; Nutzman P, 2008, PUBL ASTRON SOC PAC, V120, P317, DOI 10.1086/533420; O'Neill C, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030598; Pierrehumbert R, 2011, ASTROPHYS J LETT, V734, DOI 10.1088/2041-8205/734/1/L13; Pilcher CB, 2003, ASTROBIOLOGY, V3, P471, DOI 10.1089/153110703322610582; Raymond SN, 2004, ICARUS, V168, P1, DOI 10.1016/j.icarus.2003.11.019; Robinson TD, 2011, ASTROBIOLOGY, V11, P393, DOI 10.1089/ast.2011.0642; Rogers LA, 2010, ASTROPHYS J, V716, P1208, DOI 10.1088/0004-637X/716/2/1208; Schaefer L, 2010, ICARUS, V208, P438, DOI 10.1016/j.icarus.2010.01.026; Schrenk MO, 2003, APPL ENVIRON MICROB, V69, P3580, DOI 10.1128/AEM.69.6.3580-3592.2003; Seager S., 2011, EXOPLANETS, P111; Seager S, 2012, ASTROBIOLOGY, V12, P61, DOI 10.1089/ast.2010.0489; Segura A, 2007, ASTRON ASTROPHYS, V472, P665, DOI 10.1051/0004-6361:20066663; Segura A, 2005, ASTROBIOLOGY, V5, P706, DOI 10.1089/ast.2005.5.706; Selsis F, 2002, ASTRON ASTROPHYS, V388, P985, DOI 10.1051/0004-6361:20020527; SEWARD TM, 1981, BER BUNSEN PHYS CHEM, V85, P2, DOI 10.1002/bbpc.19810850103; Snellen IAG, 2013, ASTROPHYS J, V764, DOI 10.1088/0004-637X/764/2/182; Stevenson DJ, 1999, NATURE, V400, P32, DOI 10.1038/21811; Takai K, 2008, P NATL ACAD SCI USA, V105, P10949, DOI 10.1073/pnas.0712334105; Turnbull MC, 2006, ASTROPHYS J, V644, P551, DOI 10.1086/503322; Valencia D, 2007, ASTROPHYS J, V670, pL45, DOI 10.1086/524012; Wagner W, 2002, J PHYS CHEM REF DATA, V31, P387, DOI 10.1063/1.1461829; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; Williams DM, 2008, ICARUS, V195, P927, DOI 10.1016/j.icarus.2008.01.002; Winn J.N., 2011, EXOPLANETS, P55	54	142	145	6	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 3	2013	340	6132					577	581		10.1126/science.1232226	http://dx.doi.org/10.1126/science.1232226			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23641111				2022-12-28	WOS:000318268900040
J	Zhang, M; Schekman, R				Zhang, Min; Schekman, Randy			Unconventional Secretion, Unconventional Solutions	SCIENCE			English	Editorial Material							PROTEIN SECRETION; MURINE MACROPHAGES; IL-1-BETA; RELEASE; INTERLEUKIN-1-BETA; ACTIVATION; MECHANISMS; AUTOPHAGY; TRANSPORT; GRASP		[Zhang, Min; Schekman, Randy] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Zhang, M (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	schekman@berkeley.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Brough D, 2003, J IMMUNOL, V170, P3029, DOI 10.4049/jimmunol.170.6.3029; Bruns C, 2011, J CELL BIOL, V195, P979, DOI 10.1083/jcb.201106098; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; Giuliani F, 2011, CURR OPIN CELL BIOL, V23, P498, DOI 10.1016/j.ceb.2011.04.005; Kaushik S, 2012, TRENDS CELL BIOL, V22, P407, DOI 10.1016/j.tcb.2012.05.006; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Manjithaya R, 2010, J CELL BIOL, V188, P537, DOI 10.1083/jcb.200911149; MCGRATH JP, 1989, NATURE, V340, P400, DOI 10.1038/340400a0; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Nickel W, 2011, TRAFFIC, V12, P799, DOI 10.1111/j.1600-0854.2011.01187.x; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Rabouille C, 2012, J CELL SCI, V125, P5251, DOI 10.1242/jcs.103630; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Verhoef PA, 2003, J IMMUNOL, V170, P5728, DOI 10.4049/jimmunol.170.11.5728	19	123	126	0	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2013	340	6132					559	561		10.1126/science.1234740	http://dx.doi.org/10.1126/science.1234740			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23641104				2022-12-28	WOS:000318268900035
J	Jakab, Z; Salisbury, DM				Jakab, Zsuzsanna; Salisbury, David M.			Back to basics: the miracle and tragedy of measles vaccine	LANCET			English	Editorial Material									[Jakab, Zsuzsanna] WHO, Reg Off Europe, DK-2100 Copenhagen, Denmark; [Salisbury, David M.] Dept Hlth, London SE1 6TE, England	World Health Organization	Jakab, Z (corresponding author), WHO, Reg Off Europe, DK-2100 Copenhagen, Denmark.	zja@euro.who.int						Measles and Rubella Initiative, 2013, FACT SHEET; PAHO, 2012, PLAN OF ACTION FOR M; Perry RT, 2013, MMWR-MORBID MORTAL W, V62, P27; Public Health England, 2013, NUMBER OF LABORATORY; Simons Emily, 2012, Lancet, V379, P2173, DOI 10.1016/S0140-6736(12)60522-4; WHO, 2010, SIXTIETH SESSION REN; WHO, 2010, GLOBAL ERADICATION O; WHO Regional Office for Europe, CENTRALIZED INFORMAT	8	10	10	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 27	2013	381	9876					1433	1434		10.1016/S0140-6736(13)60908-3	http://dx.doi.org/10.1016/S0140-6736(13)60908-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139TK	23623213				2022-12-28	WOS:000318607300008
J	Le Sage, D; Arai, K; Glenn, DR; DeVience, SJ; Pham, LM; Rahn-Lee, L; Lukin, MD; Yacoby, A; Komeili, A; Walsworth, RL				Le Sage, D.; Arai, K.; Glenn, D. R.; DeVience, S. J.; Pham, L. M.; Rahn-Lee, L.; Lukin, M. D.; Yacoby, A.; Komeili, A.; Walsworth, R. L.			Optical magnetic imaging of living cells	NATURE			English	Article							MAGNETOTACTIC BACTERIA; SPIN; RESONANCE; ELECTRON	Magnetic imaging is a powerful tool for probing biological and physical systems. However, existing techniques either have poor spatial resolution compared to optical microscopy and are hence not generally applicable to imaging of sub-cellular structure (for example, magnetic resonance imaging(1)), or entail operating conditions that preclude application to living biological samples while providing submicrometre resolution (for example, scanning superconducting quantum interference device microscopy(2), electron holography(3) and magnetic resonance force microscopy(4)). Here we demonstrate magnetic imaging of living cells (magnetotactic bacteria) under ambient laboratory conditions and with sub-cellular spatial resolution (400 nanometres), using an optically detected magnetic field imaging array consisting of a nanometre-scale layer of nitrogen-vacancy colour centres implanted at the surface of a diamond chip. With the bacteria placed on the diamond surface, we optically probe the nitrogen-vacancy quantum spin states and rapidly reconstruct images of the vector components of the magnetic field created by chains of magnetic nanoparticles (magnetosomes) produced in the bacteria. We also spatially correlate these magnetic field maps with optical images acquired in the same apparatus. Wide-field microscopy allows parallel optical and magnetic imaging of multiple cells in a population with submicrometre resolution and a field of view in excess of 100 micrometres. Scanning electron microscope images of the bacteria confirm that the correlated optical and magnetic images can be used to locate and characterize the magnetosomes in each bacterium. Our results provide a new capability for imaging bio-magnetic structures in living cells under ambient conditions with high spatial resolution, and will enable the mapping of a wide range of magnetic signals within cells and cellular networks(5,6).	[Le Sage, D.; Glenn, D. R.; Walsworth, R. L.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Le Sage, D.; Glenn, D. R.; Lukin, M. D.; Yacoby, A.; Walsworth, R. L.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Arai, K.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Glenn, D. R.; Walsworth, R. L.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [DeVience, S. J.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Pham, L. M.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Rahn-Lee, L.; Komeili, A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Harvard University; University of California System; University of California Berkeley	Walsworth, RL (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	rwalsworth@cfa.harvard.edu	DeVience, Stephen J/D-7274-2012	DeVience, Stephen J/0000-0003-3142-7296; Arai, Keigo/0000-0002-7676-5726; Le Sage, David/0000-0003-1678-9491	David and Lucille Packard Foundation Fellowship in Science and Engineering; National Institutes of Health [R01GM084122]; NSF; DARPA QuASAR programme; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084122] Funding Source: NIH RePORTER	David and Lucille Packard Foundation Fellowship in Science and Engineering; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); DARPA QuASAR programme; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Qian for discussions about related experiments using a scanning SQUID microscope in the laboratory of K. A. Moler, J. W. Lichtman and R. Schalek for access to the SEM, S. G. Turney for access to the water-immersion objective and advice regarding cell immobilization, and P. R. Hemmer and H. Park for technical discussions. A. K. was supported by a David and Lucille Packard Foundation Fellowship in Science and Engineering and by the National Institutes of Health (R01GM084122). This work was supported by the NSF and the DARPA QuASAR programme.	Balasubramanian G, 2008, NATURE, V455, P648, DOI 10.1038/nature07278; Childress L, 2006, SCIENCE, V314, P281, DOI 10.1126/science.1131871; Degen CL, 2009, P NATL ACAD SCI USA, V106, P1313, DOI 10.1073/pnas.0812068106; Dobson J, 2004, ANN NY ACAD SCI, V1012, P183, DOI 10.1196/annals.1306.016; Draper O, 2011, MOL MICROBIOL, V82, P342, DOI 10.1111/j.1365-2958.2011.07815.x; Dunin-Borkowski RE, 1998, SCIENCE, V282, P1868, DOI 10.1126/science.282.5395.1868; Eder SHK, 2012, P NATL ACAD SCI USA, V109, P12022, DOI 10.1073/pnas.1205653109; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; Finkler A, 2010, NANO LETT, V10, P1046, DOI 10.1021/nl100009r; Grinolds MS, 2013, NAT PHYS, V9, P215, DOI [10.1038/NPHYS2543, 10.1038/nphys2543]; Hall LT, 2010, P NATL ACAD SCI USA, V107, P18777, DOI 10.1073/pnas.1002562107; Hanson R, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.087601; Komeili A, 2004, P NATL ACAD SCI USA, V101, P3839, DOI 10.1073/pnas.0400391101; Komeili A, 2012, FEMS MICROBIOL REV, V36, P232, DOI 10.1111/j.1574-6976.2011.00315.x; Krichevsky A, 2007, J APPL PHYS, V101, DOI 10.1063/1.2405730; Lam KP, 2010, CHEM GEOL, V270, P110, DOI 10.1016/j.chemgeo.2009.11.009; Le Sage D, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.121202; Lee SC, 2009, MAGN RESON IMAGING, V27, P828, DOI 10.1016/j.mri.2009.01.002; Maletinsky P, 2012, NAT NANOTECHNOL, V7, P320, DOI [10.1038/nnano.2012.50, 10.1038/NNANO.2012.50]; Mamin HJ, 2013, SCIENCE, V339, P557, DOI 10.1126/science.1231540; Matsunaga T, 2007, TRENDS BIOTECHNOL, V25, P182, DOI 10.1016/j.tibtech.2007.02.002; Maze JR, 2008, NATURE, V455, P644, DOI 10.1038/nature07279; Mora CV, 2004, NATURE, V432, P508, DOI 10.1038/nature03077; MOSKOWITZ BM, 1993, EARTH PLANET SC LETT, V120, P283, DOI 10.1016/0012-821X(93)90245-5; Murat D, 2010, P NATL ACAD SCI USA, V107, P5593, DOI 10.1073/pnas.0914439107; Pham LM, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/4/045021; Posfai M, 2009, ELEMENTS, V5, P235, DOI 10.2113/gselements.5.4.235; PROKSCH RB, 1995, APPL PHYS LETT, V66, P2582, DOI 10.1063/1.113508; Qian L., 2011, APS MARCH M 2011; Staudacher T, 2013, SCIENCE, V339, P561, DOI 10.1126/science.1231675; Zurkiya O, 2008, MAGN RESON MED, V59, P1225, DOI 10.1002/mrm.21606	32	423	433	21	553	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2013	496	7446					486	U105		10.1038/nature12072	http://dx.doi.org/10.1038/nature12072			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23619694	Green Submitted, Green Accepted			2022-12-28	WOS:000317984400037
J	Li, F; Mao, GG; Tong, D; Huang, J; Gu, LY; Yang, W; Li, GM				Li, Feng; Mao, Guogen; Tong, Dan; Huang, Jian; Gu, Liya; Yang, Wei; Li, Guo-Min			The Histone Mark H3K36me3 Regulates Human DNA Mismatch Repair through Its Interaction with MutS alpha	CELL			English	Article							IDENTIFIES FREQUENT MUTATION; CELL NUCLEAR ANTIGEN; PWWP DOMAIN; REPLICATION; RECOGNITION; CANCER; DEFICIENCY; EXTRACTS; MSH6; GENE	DNA mismatch repair (MMR) ensures replication fidelity by correcting mismatches generated during DNA replication. Although human MMR has been reconstituted in vitro, how MMR occurs in vivo is unknown. Here, we show that an epigenetic histone mark, H3K36me3, is required in vivo to recruit the mismatch recognition protein hMutS alpha (hMSH2-hMSH6) onto chromatin through direct interactions with the hMSH6 PWWP domain. The abundance of H3K36me3 in G1 and early S phases ensures that hMutS alpha is enriched on chromatin before mispairs are introduced during DNA replication. Cells lacking the H3K36 trimethyltransferase SETD2 display microsatellite instability (MSI) and an elevated spontaneous mutation frequency, characteristic of MMR-deficient cells. This work reveals that a histone mark regulates MMR in human cells and explains the long-standing puzzle of MSI-positive cancer cells that lack detectable mutations in known MMR genes.	[Li, Feng; Mao, Guogen; Gu, Liya; Li, Guo-Min] Univ Kentucky, Coll Med, Markey Canc Ctr, Grad Ctr Toxicol, Lexington, KY 40506 USA; [Tong, Dan; Huang, Jian] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Tong, Dan; Li, Guo-Min] Tsinghua Univ, Sch Med, Beijing 10084, Peoples R China; [Yang, Wei] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	University of Kentucky; Wuhan University; Tsinghua University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Gu, LY (corresponding author), Univ Kentucky, Coll Med, Markey Canc Ctr, Grad Ctr Toxicol, Lexington, KY 40506 USA.	lgu0@uky.edu; gmli@uky.edu	Li, Guo-Min/I-5016-2014; Yang, Wei/ABB-4785-2020; Yang, Wei/D-4926-2011	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195; Li, Feng/0000-0002-9201-1668; Li, Guo-Min/0000-0002-9842-4578	National Institutes of Health [CA167181, CA115942, GM089684, CA104333]; National Institute of Diabetes and Digestive and Kidney Diseases intramural research fund; Kentucky Lung Cancer Research Program; NATIONAL CANCER INSTITUTE [R01CA167181, R01CA115942, R01CA104333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases intramural research fund; Kentucky Lung Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Richard Kolodner, Tom Misteli, Jeffrey Parvin, Youfeng Yang, and Akira Yasui for reagents and Yang Shi, Dangsheng Li, Charles Ensor, and Nathan Vanderford for stimulating discussions and helpful comments. This work was supported in part by grants from the National Institutes of Health (CA167181, CA115942, and GM089684 to G.-M.L.) (CA104333 to L.G.), the National Institute of Diabetes and Digestive and Kidney Diseases intramural research fund (to W.Y.), and a grant from the Kentucky Lung Cancer Research Program. G.-M.L. holds the James-Gardner Chair in Cancer Research.	Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; Bonenfant D, 2007, MOL CELL PROTEOMICS, V6, P1917, DOI 10.1074/mcp.M700070-MCP200; Clark AB, 2000, J BIOL CHEM, V275, P36498, DOI 10.1074/jbc.C000513200; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Drummond JT, 1997, P NATL ACAD SCI USA, V94, P10144, DOI 10.1073/pnas.94.19.10144; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Duns G, 2010, CANCER RES, V70, P4287, DOI 10.1158/0008-5472.CAN-10-0120; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; FISHEL R, 1995, CURR OPIN GENET DEV, V5, P382, DOI 10.1016/0959-437X(95)80055-7; Flores-Rozas H, 2000, NAT GENET, V26, P375, DOI 10.1038/81708; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gorman J, 2007, MOL CELL, V28, P359, DOI 10.1016/j.molcel.2007.09.008; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gu LY, 2002, ONCOGENE, V21, P5758, DOI 10.1038/sj.onc.1205695; Harrington JA, 2007, MOL CELL BIOL, V27, P6546, DOI 10.1128/MCB.00855-07; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Hombauer H, 2011, SCIENCE, V334, P1713, DOI 10.1126/science.1210770; Hombauer H, 2011, CELL, V147, P1040, DOI 10.1016/j.cell.2011.10.025; Hong Z, 2008, J CELL SCI, V121, P3146, DOI 10.1242/jcs.026393; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Javaid S, 2009, MOL CELL, V36, P1086, DOI 10.1016/j.molcel.2009.12.010; Kadyrova LY, 2011, P NATL ACAD SCI USA, V108, P2753, DOI 10.1073/pnas.1015914108; Kane MF, 1997, CANCER RES, V57, P808; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Laguri C, 2008, BIOCHEMISTRY-US, V47, P6199, DOI 10.1021/bi7024639; Li F, 2009, J BIOL CHEM, V284, P33056, DOI 10.1074/jbc.M109.049874; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Marra G, 1998, P NATL ACAD SCI USA, V95, P8568, DOI 10.1073/pnas.95.15.8568; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Rodriguez-Collazo P, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp273; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Schopf B, 2012, P NATL ACAD SCI USA, V109, P1895, DOI 10.1073/pnas.1106696109; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Shell SS, 2007, MOL CELL, V26, P565, DOI 10.1016/j.molcel.2007.04.024; Simmons LA, 2008, MOL CELL, V29, P291, DOI 10.1016/j.molcel.2007.10.036; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; THOMAS DC, 1991, J BIOL CHEM, V266, P3744; UMAR A, 1994, J BIOL CHEM, V269, P14367; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; WANSINK DG, 1994, J CELL SCI, V107, P1449; Wu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018919; Yoh SM, 2008, GENE DEV, V22, P3422, DOI 10.1101/gad.1720008; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	59	394	414	1	110	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 25	2013	153	3					590	600		10.1016/j.cell.2013.03.025	http://dx.doi.org/10.1016/j.cell.2013.03.025			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622243	Green Accepted, Bronze			2022-12-28	WOS:000318063500012
J	Maxwell, E				Maxwell, Elaine			Francis inquiry: compulsory work as healthcare assistants won't make better nurses	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Hlth Fdn, London WC2E 9RA, England		Maxwell, E (corresponding author), Hlth Fdn, London WC2E 9RA, England.	Elaine.Maxwell@health.org.uk						Aiken LH, 2008, J NURS ADMIN, V38, P223, DOI 10.1097/01.NNA.0000312773.42352.d7; Buchan J, 2012, OVERSTRETCHED UNDER; Jarman B, 1999, BMJ-BRIT MED J, V318, P1515, DOI 10.1136/bmj.318.7197.1515; Nursing and Midwifery Council, STAT AN REG 1 APR 20; Royal College of Nursing, 2012, QUAL COMP FUT NURS E	5	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2013	346								f2480	10.1136/bmj.f2480	http://dx.doi.org/10.1136/bmj.f2480			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	134PN	23620583				2022-12-28	WOS:000318225000003
J	van Heijst, JWJ; Pamer, EG				van Heijst, Jeroen W. J.; Pamer, Eric G.			Radical Host-Specific Therapies for TB	CELL			English	Editorial Material								Although proinflammatory cytokines such as TNF are critical for containment of tuberculosis, they can also exacerbate disease when produced at high levels. In this issue of Cell, Roca and Ramakrishnan demonstrate that high TNF production induces reactive oxygen species in infected macrophages, ultimately leading to macrophage necrosis and bacterial dissemination.	[van Heijst, Jeroen W. J.; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Immunol, New York, NY 10021 USA; [Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	van Heijst, JWJ (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Immunol, 1275 York Ave, New York, NY 10021 USA.	vanheijj@mskcc.org						Derrick SC, 2011, VACCINE, V29, P2902, DOI 10.1016/j.vaccine.2011.02.010; Gallegos AM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002052; Roca FJ, 2013, CELL, V153, P521, DOI 10.1016/j.cell.2013.03.022; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Serhan CN, 2000, J EXP MED, V192, pF5, DOI 10.1084/jem.192.3.F5; Simeone R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002507; Skerry C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039680; Tager AM, 2003, NAT IMMUNOL, V4, P982, DOI 10.1038/ni970; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059	10	4	4	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 25	2013	153	3					507	508		10.1016/j.cell.2013.04.019	http://dx.doi.org/10.1016/j.cell.2013.04.019			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622234	Bronze			2022-12-28	WOS:000318063500002
J	Murray, CJL; Frenk, J; Piot, P; Mundel, T				Murray, Christopher J. L.; Frenk, Julio; Piot, Peter; Mundel, Trevor			GBD 2.0: a continuously updated global resource	LANCET			English	Editorial Material							SYSTEMATIC ANALYSIS; 187 COUNTRIES; 21 REGIONS; DISEASE; BURDEN; MORTALITY; INJURIES		[Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Frenk, Julio] Univ Washington, Inst Hlth Metr & Evaluat Board, Seattle, WA 98121 USA; [Piot, Peter] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Mundel, Trevor] Bill & Melinda Gates Fdn, Seattle, WA USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of London; London School of Hygiene & Tropical Medicine; Bill & Melinda Gates Foundation	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.	cjlm@uw.edu						Achoki T, 2011, MATERNAL CHILD HLTH; [Anonymous], 2012, FIN GLOB HLTH 2012 E; Johns Hopkins Bloomberg School of Public Health. PERCH: Pneumonia Etiology Research for Child Health, PERCH PNEUM ET RES C; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; University of Maryland School of Medicine. Global Enterics Multi-Center Study (GEMS): project description, GLOB ENT MULT STUD G; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X	12	21	21	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 6	2013	382	9886					9	11		10.1016/S0140-6736(13)60225-1	http://dx.doi.org/10.1016/S0140-6736(13)60225-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177AD	23684252				2022-12-28	WOS:000321347000008
J	Ghaffar, A; Zaidi, S; Qureshi, H; Hafeez, A				Ghaffar, Abdul; Zaidi, Shehla; Qureshi, Huma; Hafeez, Assad			Medical education and research in Pakistan	LANCET			English	Editorial Material									[Ghaffar, Abdul] WHO, Alliance Hlth Policy & Syst Res, CH-1211 Geneva 27, Switzerland; [Zaidi, Shehla] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Qureshi, Huma] Pakistan Med Res Council, Islamabad, Pakistan; [Hafeez, Assad] Hlth Serv Acad, Islamabad, Pakistan	World Health Organization; Aga Khan University; Pakistan Medical Research Council; Health Services Academy	Ghaffar, A (corresponding author), WHO, Alliance Hlth Policy & Syst Res, CH-1211 Geneva 27, Switzerland.	ghaffara@who.int		Zaidi, Shehla/0000-0001-7620-9247				Health Services Academy, 2011, CONS RES POL MAK PRO; HEC, 2011, RES PUBL U DAIS PAK; Mamoona N, 2011, J PAK MED ASSOC, V61, P808; Mushtaq A, 2012, J PAK MED ASSOC, V62, P628; PMDC. Pakistan Medical and Dental Council, 2012, STATISTICS; PMRC, 2007, ANN BUDG 2007 12; Shiwani M H, 2007, J Pak Med Assoc, V57, P166	7	21	21	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 29	2013	381	9885					2234	2236		10.1016/S0140-6736(13)60146-4	http://dx.doi.org/10.1016/S0140-6736(13)60146-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	173SU	23684262	Green Published			2022-12-28	WOS:000321100300009
J	Van Ranst, M; Lemey, P				Van Ranst, Marc; Lemey, Philippe			Genesis of avian-origin H7N9 influenza A viruses	LANCET			English	Editorial Material									[Van Ranst, Marc; Lemey, Philippe] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Lab Clin & Epidemiol Virol, B-3000 Louvain, Belgium; [Van Ranst, Marc] Katholieke Univ Leuven Hosp, Dept Clin Lab Med, Lab Clin Virol, Louvain, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven	Van Ranst, M (corresponding author), Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res, Lab Clin & Epidemiol Virol, B-3000 Louvain, Belgium.	marc.vanranst@uzleuven.be	Van Ranst, Marc/P-7522-2017; Lemey, Philippe/C-3755-2018	Van Ranst, Marc/0000-0002-1674-4157; Lemey, Philippe/0000-0003-2826-5353				Belser JA, 2009, EMERG INFECT DIS, V15, P859, DOI 10.3201/eid1506.090072; Chen Y, 2013, CC, DOI DOI 10.1016/S0140-6736(13)60903-4; European Centre for Disease Prevention and Control, 2013, CC; Gao R, 2013, CC, DOI [10.1056/NEJMoa1304459, DOI 10.1056/NEJM0A1304459]; Kupferschmidt K, CHINESE H7N9 VIRUS M; Li A, 2013, CC, DOI [10.1056/NEJMoa1304617, DOI 10.1056/NEJM0A1304617]; Liu D, 2013, CC, DOI DOI 10.1016/S0140-6736(13)60938-; Mu X., 2013, XINHUA; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; WHO Disease Outbreak News, 2013, SS	10	21	21	0	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 1	2013	381	9881					1883	1885		10.1016/S0140-6736(13)60959-9	http://dx.doi.org/10.1016/S0140-6736(13)60959-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	163EV	23643449				2022-12-28	WOS:000320319500008
J	Daniel, R; Rubens, JR; Sarpeshkar, R; Lu, TK				Daniel, Ramiz; Rubens, Jacob R.; Sarpeshkar, Rahul; Lu, Timothy K.			Synthetic analog computation in living cells	NATURE			English	Article							BIOLOGY; CIRCUIT; NETWORK; MOTIFS	A central goal of synthetic biology is to achieve multi-signal integration and processing in living cells for diagnostic, therapeutic and biotechnology applications(1). Digital logic has been used to build small-scale circuits, but other frameworks may be needed for efficient computation in the resource-limited environments of cells(2,3). Here we demonstrate that synthetic analog gene circuits can be engineered to execute sophisticated computational functions in living cells using just three transcription factors. Such synthetic analog gene circuits exploit feedback to implement logarithmically linear sensing, addition, ratiometric and power-law computations. The circuits exhibit Weber's law behaviour as in natural biological systems(4), operate over a wide dynamic range of up to four orders of magnitude and can be designed to have tunable transfer functions. Our circuits can be composed to implement higher-order functions that are well described by both intricate biochemical models and simple mathematical functions. By exploiting analog building-block functions that are already naturally present in cells(3,5), this approach efficiently implements arithmetic operations and complex functions in the logarithmic domain. Such circuits may lead to new applications for synthetic biology and biotechnology that require complex computations with limited parts, need wide-dynamic-range biosensing or would benefit from the fine control of gene expression.	[Daniel, Ramiz; Sarpeshkar, Rahul] MIT, Elect Res Lab, Analog Circuits & Biol Syst Grp, Cambridge, MA 02139 USA; [Daniel, Ramiz; Rubens, Jacob R.; Lu, Timothy K.] MIT, Elect Res Lab, Synthet Biol Grp, Cambridge, MA 02139 USA; [Daniel, Ramiz; Rubens, Jacob R.; Sarpeshkar, Rahul; Lu, Timothy K.] MIT, Synthet Biol Ctr, Cambridge, MA 02139 USA; [Rubens, Jacob R.; Sarpeshkar, Rahul; Lu, Timothy K.] MIT, MIT Microbiol Program, Cambridge, MA 02139 USA; [Sarpeshkar, Rahul; Lu, Timothy K.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Sarpeshkar, Rahul; Lu, Timothy K.] MIT, MIT Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Sarpeshkar, Rahul] MIT, MIT Biophys Program, Cambridge, MA 02139 USA; [Lu, Timothy K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sarpeshkar, R (corresponding author), MIT, Elect Res Lab, Analog Circuits & Biol Syst Grp, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rahuls@mit.edu; timlu@mit.edu		Lu, Timothy/0000-0002-3918-8923; /0000-0003-1304-0151	campus collaboration initiative from Lincoln Labs; US National Science Foundation [1124247]; Office of Naval Research [N000141110725]; Direct For Computer & Info Scie & Enginr [1124247] Funding Source: National Science Foundation	campus collaboration initiative from Lincoln Labs; US National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We would like to thank J. Nungesser for assistance with figures and members of the Lu and Sarpeshkar laboratories for discussions. This work was supported in part by a campus collaboration initiative from Lincoln Labs (R.D. and R.S.), the US National Science Foundation (R.D., J.R.R., R.S. and T.K.L.) under grant number 1124247, and the Office of Naval Research (J.R.R. and T.K.L.) under grant number N000141110725.	Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Cardinale S, 2012, BIOTECHNOL J, V7, P856, DOI 10.1002/biot.201200085; Chen YY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-240; Clark B, 2006, CURR BIOL, V16, pR585, DOI 10.1016/j.cub.2006.07.007; Daniel R, 2011, BIOMED CIRC SYST C, P333, DOI 10.1109/BioCAS.2011.6107795; Dueber JE, 2003, SCIENCE, V301, P1904, DOI 10.1126/science.1085945; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Ferrell JE, 2009, MOL CELL, V36, P724, DOI 10.1016/j.molcel.2009.11.032; Giorgetti L, 2010, MOL CELL, V37, P418, DOI 10.1016/j.molcel.2010.01.016; Hahnloser RHR, 2000, NATURE, V405, P947, DOI 10.1038/35016072; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Khalil AS, 2012, CELL, V150, P647, DOI 10.1016/j.cell.2012.05.045; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; Madar D, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-111; McMillen D, 2002, P NATL ACAD SCI USA, V99, P679, DOI 10.1073/pnas.022642299; Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Sarpeshkar R, 1998, NEURAL COMPUT, V10, P1601, DOI 10.1162/089976698300017052; Sarpeshkar R., 2010, ULTRALOW POWER BIOEL, P753; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; Tavakoli M, 2005, IEEE J SOLID-ST CIRC, V40, P536, DOI 10.1109/JSSC.2004.841015; Wild J, 2002, GENOME RES, V12, P1434, DOI 10.1101/gr.130502; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491	30	270	293	4	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2013	497	7451					619	+		10.1038/nature12148	http://dx.doi.org/10.1038/nature12148			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23676681				2022-12-28	WOS:000319556100044
J	Nygaard, I; Brubaker, L; Zyczynski, HM; Cundiff, G; Richter, H; Gantz, M; Fine, P; Menefee, S; Ridgeway, B; Visco, A; Warren, LK; Zhang, M; Meikle, S				Nygaard, Ingrid; Brubaker, Linda; Zyczynski, Halina M.; Cundiff, Geoffrey; Richter, Holly; Gantz, Marie; Fine, Paul; Menefee, Shawn; Ridgeway, Beri; Visco, Anthony; Warren, Lauren Klein; Zhang, Min; Meikle, Susan			Long-term Outcomes Following Abdominal Sacrocolpopexy for Pelvic Organ Prolapse	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SIMULTANEOUS SPLENECTOMY; RANDOMIZED-TRIAL; UNITED-STATES; SURGERY; INDEX; BURCH; RISK	Importance More than 225 000 surgeries are performed annually in the United States for pelvic organ prolapse (POP). Abdominal sacrocolpopexy is considered the most durable POP surgery, but little is known about safety and long-term effectiveness. Objectives To describe anatomic and symptomatic outcomes up to 7 years after abdominal sacrocolpopexy, and to determine whether these are affected by concomitant anti-incontinence surgery (Burch urethropexy). Design, Setting, and Participants Long-term follow-up of the randomized, masked 2-year Colpopexy and Urinary Reduction Efforts (CARE) trial of women with stress continence who underwent abdominal sacrocolpopexy between 2002 and 2005 for symptomatic POP and also received either concomitant Burch urethropexy or no urethropexy. Ninety-two percent (215/233) of eligible 2-year CARE trial completers were enrolled in the extended CARE study; and 181 (84%) and 126 (59%) completed 5 and 7 years of follow-up, respectively. The median follow-up was 7 years. Main Outcomes and Measures Symptomatic POP failure requiring retreatment or self-reported bulge; or anatomic POP failure requiring retreatment or Pelvic Organ Prolapse Quantification evaluation demonstrating descent of the vaginal apex below the upper third of the vagina, or anterior or posterior vaginal wall prolapse beyond the hymen. Stress urinary incontinence (SUI) with more than 1 symptom or interval treatment; or overall UI score of 3 or greater on the Incontinence Severity Index. Results Of 215 women enrolled in the extended CARE study, 104 had undergone abdominal sacrocolpopexy plus Burch urethropexy and 111 had undergone abdominal sacrocolpopexy alone. Pelvic organ prolapse and urinary incontinence failure rates gradually increased during 7 years of follow-up. [GRAPHICS] Probability of mesh erosion at 7 years (estimated by the Kaplan-Meier method) was 10.5% (95% CI, 6.8% to 16.1%). Conclusions and Relevance During 7 years of follow-up, abdominal sacrocolpopexy failure rates increased in both groups. Urethropexy prevented SUI longer than no urethropexy. Abdominal sacrocolpopexy effectiveness should be balanced with long-term risks of mesh or suture erosion. Trial Registration clinicaltrials.gov Identifier: NCT00099372	[Nygaard, Ingrid] Univ Utah, Sch Med, Salt Lake City, UT 84132 USA; [Brubaker, Linda] Loyola Univ, Chicago, IL 60611 USA; [Zyczynski, Halina M.] Univ Pittsburgh, Pittsburgh, PA USA; [Cundiff, Geoffrey] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Richter, Holly] Univ Alabama Birmingham, Birmingham, AL USA; [Gantz, Marie; Warren, Lauren Klein] RTI Int, Res Triangle Pk, NC USA; [Fine, Paul] Baylor Coll Med, Houston, TX 77030 USA; [Menefee, Shawn] Kaiser Permanente, San Diego, CA USA; [Ridgeway, Beri] Cleveland Clin, Cleveland, OH 44106 USA; [Visco, Anthony] Duke Univ, Durham, NC USA; [Zhang, Min] Univ Michigan, Ann Arbor, MI 48109 USA; [Meikle, Susan] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA	Utah System of Higher Education; University of Utah; Loyola University Chicago; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of British Columbia; University of Alabama System; University of Alabama Birmingham; Research Triangle Institute; Baylor College of Medicine; Kaiser Permanente; Cleveland Clinic Foundation; Duke University; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Nygaard, I (corresponding author), Univ Utah, Sch Med, 30 N 1900 E, Salt Lake City, UT 84132 USA.	ingrid.nygaard@hsc.utah.edu	Cundiff, Geoffrey/HGD-1512-2022; Zhang, Min/ACY-2759-2022; Brubaker, Linda/J-5918-2019	Zhang, Min/0000-0003-3331-3583; Brubaker, Linda/0000-0002-8598-2589; Cundiff, Geoffrey/0000-0002-5777-7836; Gantz, Marie/0000-0001-8528-0184; Warren, Lauren/0000-0002-0965-767X; Richter, Holly E/0000-0001-7741-5771	Eunice Kennedy Shriver National Institute of Child Health and Human Development [U01 HD41249, U10 HD41250, U10 HD41261, U10 HD41267, U10 HD54136, U10 HD54214, U10 HD54215, U10 HD54241, U10 HD054136, U10 HD054215, U10 HD041261, U10 HD041267, U10 HD069006, U10 HD054214, U10 HD041250, U01 HD069031]; Office of Research on Women's Health at the National Institutes of Health; Pelvalon; Astellas; University of Califonia/Pfizer; Pfizer; Warner Chilcott; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD041250, U10HD054241, U10HD069006, U01HD069031, U10HD041261, U10HD054214, U10HD054215, U10HD041267, UG1HD041267, U10HD054136] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD041249, U10HD041263] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of Research on Women's Health at the National Institutes of Health; Pelvalon; Astellas(Astellas Pharmaceuticals); University of Califonia/Pfizer; Pfizer(Pfizer); Warner Chilcott; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Zyczynski reported serving as a consultant to Johnson & Johnson and Key Tech. Dr Richter reported receiving research grants from Pelvalon, Astellas, University of Califonia/Pfizer, Pfizer, and Warner Chilcott; and serving as a consultant to Astellas (advisory board), GlaxoSmithKline, Uromedica, IDEO, Pfizer, and Xanodyne. Dr Visco reported serving as a consultant to Intuitive Surgical. No other disclosures were reported.; This research was supported by grants U01 HD41249, U10 HD41250, U10 HD41261, U10 HD41267, U10 HD54136, U10 HD54214, U10 HD54215, U10 HD54241, U10 HD054136, U10 HD054215, U10 HD041261, U10 HD041267, U10 HD069006, U10 HD054214, U10 HD041250, and U01 HD069031 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the Office of Research on Women's Health at the National Institutes of Health.	Barber MD, 2009, OBSTET GYNECOL, V114, P600, DOI 10.1097/AOG.0b013e3181b2b1ae; Barber MD, 2001, AM J OBSTET GYNECOL, V185, P1388, DOI 10.1067/mob.2001.118659; Boyles SH, 2003, AM J OBSTET GYNECOL, V188, P108, DOI 10.1067/mob.2003.101; Bradley CS, 2005, OBSTET GYNECOL, V106, P759, DOI 10.1097/01.AOG.0000180183.03897.72; Brown JS, 2002, AM J OBSTET GYNECOL, V186, P712, DOI 10.1067/mob.2002.121897; Brubaker L, 2006, NEW ENGL J MED, V354, P1557, DOI 10.1056/NEJMoa054208; Brubaker L, 2003, CONTROL CLIN TRIALS, V24, P629, DOI 10.1016/S0197-2456(03)00073-4; Brubaker L, 2008, OBSTET GYNECOL, V112, P49, DOI 10.1097/AOG.0b013e3181778d2a; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; Costantini E, 2011, J UROLOGY, V185, P2236, DOI 10.1016/j.juro.2011.01.078; Cundiff GW, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.07.029; Gutman RE, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.07.028; Maher C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004014.pub4; Neumann UP, 2002, TRANSPLANT INT, V15, P226, DOI 10.1007/s00147-002-0399-8; Nygaard IE, 2004, OBSTET GYNECOL, V104, P805, DOI 10.1097/01.AOG.0000139514.90897.07; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; Sandvik H, 2006, INT UROGYNECOL J, V17, P520, DOI 10.1007/s00192-005-0060-z; Siddiqui NY, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.035; Slieker-ten Hove MCP, 2009, INT UROGYNECOL J, V20, P1013, DOI 10.1007/s00192-009-0903-0; Smith FJ, 2010, OBSTET GYNECOL, V116, P1096, DOI 10.1097/AOG.0b013e3181f73729; Subak LL, 2001, OBSTET GYNECOL, V98, P646, DOI 10.1016/S0029-7844(01)01472-7; Tate SB, 2011, INT UROGYNECOL J, V22, P137, DOI 10.1007/s00192-010-1249-3; Visco AG, 2008, OBSTET GYNECOL, V112, P1369, DOI 10.1097/AOG.0b013e31818f3c17; Wu JM, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.046; Yoshizumi T, 2008, TRANSPL INT, V21, P833, DOI 10.1111/j.1432-2277.2008.00678.x	25	343	361	2	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2013	309	19					2016	2024		10.1001/jama.2013.4919	http://dx.doi.org/10.1001/jama.2013.4919			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143GQ	23677313	Green Accepted, Bronze			2022-12-28	WOS:000318855500024
J	West, R				West, Robert			Introduce standard cigarette packets now	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									UCL, Hlth Behav Res Ctr, Canc Res UK, London WC1E 6BT, England	Cancer Research UK; University of London; University College London	West, R (corresponding author), UCL, Hlth Behav Res Ctr, Canc Res UK, Mortimer St, London WC1E 6BT, England.	robert.west@ucl.ac.uk	West, Robert/B-5414-2009	West, Robert/0000-0001-6398-0921				[Anonymous], REP YOUGOV POLL ASH; [Anonymous], COMMUNICATION; Buxton R, 2008, LAWFULNESS REQUIRING; Cancer Research UK, SETT STAND PLAIN CIG; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Fidler J, ADDICTION IN PRESS; Moodie C, 2012, PLAIN TOBACCO PACKAG; Office for National Statistics, 2011, DEATHS REL DRUG POIS; West R, 2013, SMOKING PIPE MODEL 2	9	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 15	2013	346								f3145	10.1136/bmj.f3145	http://dx.doi.org/10.1136/bmj.f3145			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148OH	23676428				2022-12-28	WOS:000319254200020
J	Moore, JD; Deschenes, M; Furuta, T; Huber, D; Smear, MC; Demers, M; Kleinfeld, D				Moore, Jeffrey D.; Deschenes, Martin; Furuta, Takahiro; Huber, Daniel; Smear, Matthew C.; Demers, Maxime; Kleinfeld, David			Hierarchy of orofacial rhythms revealed through whisking and breathing	NATURE			English	Article							VIBRISSA MOVEMENT; MOTOR CORTEX; MOTONEURONS; NEURONS; RAT; MODULATION; INGESTION; PATTERNS; MEDULLA; NUCLEUS	Whisking and sniffing are predominant aspects of exploratory behaviour in rodents. Yet the neural mechanisms that generate and coordinate these and other orofacial motor patterns remain largely uncharacterized. Here we use anatomical, behavioural, electrophysiological and pharmacological tools to show that whisking and sniffing are coordinated by respiratory centres in the ventral medulla. We delineate a distinct region in the ventral medulla that provides rhythmic input to the facial motor neurons that drive protraction of the vibrissae. Neuronal output from this region is reset at each inspiration by direct input from the pre-Botzinger complex, such that high-frequency sniffing has a one-to-one relationship with whisking, whereas basal respiration is accompanied by intervening whisks that occur between breaths. We conjecture that the respiratory nuclei, which project to other premotor regions for oral and facial control, function as a master clock for behaviours that coordinate with breathing.	[Moore, Jeffrey D.; Kleinfeld, David] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Deschenes, Martin; Demers, Maxime] Ctr Rech Univ Laval Robert Giffard, Dept Psychiat & Neurosci, Quebec City, PQ G1J 2G3, Canada; [Furuta, Takahiro] Kyoto Univ, Grad Sch Med, Dept Morphol Brain Sci, Sakyo Ku, Kyoto 6068501, Japan; [Huber, Daniel; Smear, Matthew C.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Kleinfeld, David] Univ Calif San Diego, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Laval University; Kyoto University; Howard Hughes Medical Institute; University of California System; University of California San Diego	Deschenes, M (corresponding author), Ctr Rech Univ Laval Robert Giffard, Dept Psychiat & Neurosci, 2601 Canardiere, Quebec City, PQ G1J 2G3, Canada.	martin.deschenes@crulrg.ulaval.ca; dk@physics.ucsd.edu	Huber, Daniel/C-2932-2013	Huber, Daniel/0000-0002-0744-7679	Canadian Institutes of Health Research [MT-5877]; Howard Hughes Medical Institute; Japan Society for the Promotion of Science (KAKENHI) [23135519, 24500409]; National Institutes of Health [NS058668, NS066664, NS047101]; US-Israeli Binational Science Foundation [2003222]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058668, P30NS047101, F31NS066664] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US-Israeli Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Kepecs and F. Wang for sharing unpublished work, and these colleagues as well as M. S. Fee, J. L. Feldman, H. J. Karten, P. M. Knutsen, D. W. Matthews and K. Svoboda for discussions. We also thank K. Svoboda for sponsorship of the mouse experiments, M. Agrochao and B. el Jundi for assistance with these experiments, T. Ito and D. L. Oliver for use of their GlyT2 probe, K. K. Baldwin for the gift of the Sindbis viral vector and K. Yang for assistance with behavioural training. We are grateful to the Canadian Institutes of Health Research (grant MT-5877), the Howard Hughes Medical Institute, the Japan Society for the Promotion of Science (KAKENHI grants 23135519 and 24500409), the National Institutes of Health (grants NS058668, NS066664 and NS047101) and the US-Israeli Binational Science Foundation (grant 2003222).	Alheid GF, 2008, RESP PHYSIOL NEUROBI, V164, P3, DOI 10.1016/j.resp.2008.07.014; Berg RW, 2003, J NEUROPHYSIOL, V89, P104, DOI 10.1152/jn.00600.2002; BIEGER D, 1987, J COMP NEUROL, V262, P546, DOI 10.1002/cne.902620408; Bouvier J, 2010, NAT NEUROSCI, V13, P1066, DOI 10.1038/nn.2622; Brecht M, 2012, CURR OPIN NEUROBIOL, V22, P259, DOI 10.1016/j.conb.2011.12.003; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Chen ZX, 2001, AM J PHYSIOL-REG I, V280, pR1085, DOI 10.1152/ajpregu.2001.280.4.R1085; Depuy SD, 2011, J NEUROSCI, V31, P1981, DOI 10.1523/JNEUROSCI.4639-10.2011; Deschenes M, 2003, J NEUROSCI, V23, P6778; DOBBINS EG, 1994, J COMP NEUROL, V347, P64, DOI 10.1002/cne.903470106; Doi A, 2008, RESP PHYSIOL NEUROBI, V164, P96, DOI 10.1016/j.resp.2008.06.007; DORFL J, 1982, J ANAT, V135, P147; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; Feldman JL, 2013, ANNU REV PHYSIOL, V75, P423, DOI 10.1146/annurev-physiol-040510-130049; FUKUDA Y, 1982, JPN J PHYSIOL, V32, P387; Furuta T, 2008, J NEUROSCI, V28, P1789, DOI 10.1523/JNEUROSCI.4627-07.2008; Ganguly K, 2004, P NATL ACAD SCI USA, V101, P12348, DOI 10.1073/pnas.0308470101; Gao PH, 2001, J NEUROSCI, V21, P5374, DOI 10.1523/JNEUROSCI.21-14-05374.2001; Garcia AJ, 2011, PROG BRAIN RES, V188, P31, DOI 10.1016/B978-0-444-53825-3.00008-5; Ghosh S, 2011, NATURE, V472, P217, DOI 10.1038/nature09945; Gray PA, 2010, J NEUROSCI, V30, P14883, DOI 10.1523/JNEUROSCI.4031-10.2010; Haidarliu S, 2012, ANAT REC, V295, P1181, DOI 10.1002/ar.22501; Harish O, 2010, J NEUROPHYSIOL, V103, P2684, DOI 10.1152/jn.01016.2009; Hattox A, 2003, NEURON, V39, P343, DOI 10.1016/S0896-6273(03)00391-X; Hill DN, 2008, J NEUROSCI, V28, P3438, DOI 10.1523/JNEUROSCI.5008-07.2008; Hill DN, 2011, NEURON, V72, P344, DOI 10.1016/j.neuron.2011.09.020; HUANGFU D, 1993, NEUROSCI LETT, V151, P224, DOI 10.1016/0304-3940(93)90025-G; ISOKAWAAKESSON M, 1987, EXP BRAIN RES, V65, P385; Ito T, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00135; KLEIN BG, 1985, J COMP NEUROL, V232, P55, DOI 10.1002/cne.902320106; Kleinfeld D, 2002, NEURON, V34, P1021, DOI 10.1016/S0896-6273(02)00732-8; Knutsen PM, 2005, J NEUROPHYSIOL, V93, P2294, DOI 10.1152/jn.00718.2004; Koizumi H, 2008, J NEUROSCI, V28, P2353, DOI 10.1523/JNEUROSCI.3553-07.2008; LAWSON EE, 1991, J APPL PHYSIOL, V70, P2742, DOI 10.1152/jappl.1991.70.6.2742; Lewis TL, 2009, NAT NEUROSCI, V12, P568, DOI 10.1038/nn.2318; NAKAMURA Y, 1995, NEUROSCI RES, V23, P1, DOI 10.1016/0168-0102(95)00925-J; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Onimaru H, 2006, J NEUROPHYSIOL, V96, P55, DOI 10.1152/jn.01175.2005; Ono T, 1998, J NEUROPHYSIOL, V80, P48, DOI 10.1152/jn.1998.80.1.48; Pagliardini S, 2011, J NEUROSCI, V31, P2895, DOI 10.1523/JNEUROSCI.5338-10.2011; PAXINOS G, 1985, J NEUROSCI METH, V13, P139, DOI 10.1016/0165-0270(85)90026-3; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Saito Y, 2003, BRAIN DEV-JPN, V25, P338, DOI 10.1016/S0387-7604(03)00008-1; SEMBA K, 1984, NEUROSCIENCE, V12, P761, DOI 10.1016/0306-4522(84)90168-4; SHERREY JH, 1977, ELECTROEN CLIN NEURO, V43, P218, DOI 10.1016/0013-4694(77)90129-8; Shusterman R, 2011, NAT NEUROSCI, V14, P1039, DOI 10.1038/nn.2877; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Smith JC, 2009, PHILOS T R SOC B, V364, P2577, DOI 10.1098/rstb.2009.0081; Takatoh J, 2013, NEURON, V77, P346, DOI 10.1016/j.neuron.2012.11.010; Tan WB, 2008, NAT NEUROSCI, V11, P538, DOI 10.1038/nn.2104; Travers JB, 1997, NEUROSCI BIOBEHAV R, V21, P631, DOI 10.1016/S0149-7634(96)00045-0; Travers JB, 2000, EXP BRAIN RES, V130, P78, DOI 10.1007/s002219900223; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; VANDERMAELEN CP, 1980, NATURE, V287, P346, DOI 10.1038/287346a0; Vincent S. B., 1912, BEHAV MONOGR, V1, P7; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; WELZL H, 1977, PHYSIOL BEHAV, V18, P751, DOI 10.1016/0031-9384(77)90079-8	57	183	184	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2013	497	7448					205	+		10.1038/nature12076	http://dx.doi.org/10.1038/nature12076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139CD	23624373	Green Accepted			2022-12-28	WOS:000318558200029
J	Ahmed, QA; Nishtar, S; Memish, ZA				Ahmed, Qanta A.; Nishtar, Sania; Memish, Ziad A.			Poliomyelitis in Pakistan: time for the Muslim world to step in	LANCET			English	Editorial Material							HEALTH; ERADICATION; WORKERS; HAJJ		[Ahmed, Qanta A.] SUNY Stony Brook, Dept Med, Winthrop Univ Hosp, Div Pulm Dis & Crit Care Med, Stony Brook, NY 11794 USA; [Nishtar, Sania] Heartfile, Islamabad, Pakistan; [Memish, Ziad A.] WHO, Collaborating Ctr Mass Gathering Med, Publ Hlth Directorate, Minist Hlth, Riyadh 11179, Saudi Arabia; [Memish, Ziad A.] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Winthrop University Hospital; World Health Organization; Alfaisal University	Memish, ZA (corresponding author), WHO, Collaborating Ctr Mass Gathering Med, Publ Hlth Directorate, Minist Hlth, Riyadh 11179, Saudi Arabia.	zmemish@yahoo.com	Memish, Ziad Ahmed/AEJ-9424-2022	Memish, Ziad Ahmed/0000-0002-5099-0714				Ahmed QA, 2006, LANCET, V367, P1025, DOI 10.1016/S0140-6736(06)68431-6; Al-Tawfiq JA, 2012, EUROSURVEILLANCE, V17, P6; Al-Tawfiq JA, 2012, INFECT DIS CLIN N AM, V26, P725, DOI 10.1016/j.idc.2012.05.005; Albar M, 2012, SAUDI J KIDNEY DIS T, V23, P817, DOI 10.4103/1319-2442.98169; [Anonymous], 2013, LANCET, V381, P1; Arie S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f954; Ebrahim SH, 2009, SCIENCE, V326, P938, DOI 10.1126/science.1183210; Gulland A, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5061; Larson HJ, 2011, NATURE, V473, P446, DOI 10.1038/473446a; Memish ZA, 2009, LANCET, V374, P1786, DOI 10.1016/S0140-6736(09)61927-9; Nature Reviews Microbiology, 2013, NAT REV MICROBIOL, V11, P67; Pew Research Center, 2009, PEW FORUM RELIG PUBL; The Lancet Infectious Diseases, 2013, LANCET INFECT DIS, V13, P183; Webster PC, 2013, CAN MED ASSOC J, V185, pE101, DOI 10.1503/cmaj.109-4364	14	13	13	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 4	2013	381	9877					1521	1523		10.1016/S0140-6736(13)60764-3	http://dx.doi.org/10.1016/S0140-6736(13)60764-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139UF	23623055				2022-12-28	WOS:000318609600009
J	Ma, KY; Chirarattananon, P; Fuller, SB; Wood, RJ				Ma, Kevin Y.; Chirarattananon, Pakpong; Fuller, Sawyer B.; Wood, Robert J.			Controlled Flight of a Biologically Inspired, Insect-Scale Robot	SCIENCE			English	Article							MICRO-AIR VEHICLES; DROSOPHILA-MELANOGASTER; WING ROTATION; AERODYNAMICS; STABILITY; MANEUVERS; MECHANICS; DIPTERA; SYSTEMS; SPEED	Flies are among the most agile flying creatures on Earth. To mimic this aerial prowess in a similarly sized robot requires tiny, high-efficiency mechanical components that pose miniaturization challenges governed by force-scaling laws, suggesting unconventional solutions for propulsion, actuation, and manufacturing. To this end, we developed high-power-density piezoelectric flight muscles and a manufacturing methodology capable of rapidly prototyping articulated, flexure-based sub-millimeter mechanisms. We built an 80-milligram, insect-scale, flapping-wing robot modeled loosely on the morphology of flies. Using a modular approach to flight control that relies on limited information about the robot's dynamics, we demonstrated tethered but unconstrained stable hovering and basic controlled flight maneuvers. The result validates a sufficient suite of innovations for achieving artificial, insect-like flight.	[Ma, Kevin Y.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA	Harvard University; Harvard University	Ma, KY (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	kevinma@seas.harvard.edu	Chirarattananon, Pakpong/N-3910-2016	Chirarattananon, Pakpong/0000-0003-0142-8394	National Science Foundation [CCF-0926148]; Office of Naval Research [N00014-08-1-0919]; Wyss Institute for Biologically Inspired Engineering	National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Wyss Institute for Biologically Inspired Engineering	This material is based on work supported by the National Science Foundation under grant CCF-0926148, the Office of Naval Research under grant N00014-08-1-0919, and the Wyss Institute for Biologically Inspired Engineering. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation.	Abzug MJ., 2005, AIRPLANE STABILITY C, V2nd ed, P121; Altshuler DL, 2005, P NATL ACAD SCI USA, V102, P18213, DOI 10.1073/pnas.0506590102; Bergou AJ, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.148101; Cheng B, 2011, J EXP BIOL, V214, P4092, DOI 10.1242/jeb.062760; DAVID CT, 1978, PHYSIOL ENTOMOL, V3, P191, DOI 10.1111/j.1365-3032.1978.tb00148.x; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Dickinson MH, 1999, PHILOS T ROY SOC B, V354, P903, DOI 10.1098/rstb.1999.0442; Dickinson MH, 1997, COMP BIOCHEM PHYS A, V116, P223, DOI 10.1016/S0300-9629(96)00162-4; Dudley R, 2002, BIOMECHANICS INSECT; Ellington CP, 1999, J EXP BIOL, V202, P3439; ENNOS AR, 1989, J EXP BIOL, V142, P49; ENNOS AR, 1988, J EXP BIOL, V140, P161; Finio BM, 2011, IEEE INT C INT ROBOT, P1107, DOI 10.1109/IROS.2011.6048067; Fry SN, 2003, SCIENCE, V300, P495, DOI 10.1126/science.1081944; Hoburg W., 2009, P AIAA INF AER C AIA; Karpelson M, 2008, IEEE INT CONF ROBOT, P779, DOI 10.1109/ROBOT.2008.4543300; Ma KY, 2012, IEEE INT C INT ROBOT, P1133, DOI 10.1109/IROS.2012.6386192; Oppenheimer M W, 2010, P 48 AIAA AER SCI M; Orlowski CT, 2012, PROG AEROSP SCI, V51, P18, DOI 10.1016/j.paerosci.2012.01.001; Ristroph L, 2010, P NATL ACAD SCI USA, V107, P4820, DOI 10.1073/pnas.1000615107; Taylor GK, 2001, BIOL REV, V76, P449, DOI 10.1017/S1464793101005759; Taylor GK, 2007, ADV INSECT PHYSIOL, V34, P231, DOI 10.1016/S0065-2806(07)34005-8; TRIMMER WSN, 1989, SENSOR ACTUATOR, V19, P267, DOI 10.1016/0250-6874(89)87079-9; Whitney JP, 2010, J FLUID MECH, V660, P197, DOI 10.1017/S002211201000265X; Wood RJ, 2012, INT J ROBOT RES, V31, P1292, DOI 10.1177/0278364912455073; Wood RJ, 2008, J MECH DESIGN, V130, DOI 10.1115/1.2885509; Wood RJ, 2005, SENSOR ACTUAT A-PHYS, V119, P476, DOI 10.1016/j.sna.2004.10.024; Wood RJ, 2008, IEEE T ROBOT, V24, P341, DOI 10.1109/TRO.2008.916997; ZANKER JM, 1988, PHYSIOL ENTOMOL, V13, P351, DOI 10.1111/j.1365-3032.1988.tb00485.x	29	641	668	71	895	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2013	340	6132					603	607		10.1126/science.1231806	http://dx.doi.org/10.1126/science.1231806			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23641114				2022-12-28	WOS:000318268900046
J	Lowenthal, ED; Ellenberg, JH; Machine, E; Sagdeo, A; Boiditswe, S; Steenhoff, AP; Rutstein, R; Anabwani, G; Gross, R				Lowenthal, Elizabeth D.; Ellenberg, Jonas H.; Machine, Edwin; Sagdeo, Aditi; Boiditswe, Sefelani; Steenhoff, Andrew P.; Rutstein, Richard; Anabwani, Gabriel; Gross, Robert			Association Between Efavirenz-Based Compared With Nevirapine-Based Antiretroviral Regimens and Virological Failure in HIV-Infected Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DISEASE PROGRESSION; THERAPY; OUTCOMES; SUBTYPE; COHORT; ADULTS	Importance Worldwide, the nonnucleoside reverse transcriptase inhibitors (NNRTIs) efavirenz and nevirapine are commonly used in first-line antiretroviral regimens in both adults and children with human immunodeficiency virus (HIV) infection. Data on the comparative effectiveness of these medications in children are limited. Objective To investigate whether virological failure is more likely among children who initiated 1 or the other NNRTI-based HIV treatment. Design, Setting, and Participants Retrospective cohort study of children (aged 3-16 years) who initiated efavirenz-based (n=421) or nevirapine-based (n=383) treatment between April 2002 and January 2011 at a large pediatric HIV care setting in Botswana. Main Outcomes and Measures The primary outcome was time from initiation of therapy to virological failure. Virological failure was defined as lack of plasma HIV RNA suppression to less than 400 copies/mL by 6 months or confirmed HIV RNA of 400 copies/mL or greater after suppression. Cox proportional hazards regression analysis compared time to virological failure by regimen. Multivariable Cox regression controlled for age, sex, baseline immunologic category, baseline clinical category, baseline viral load, nutritional status, NRTIs used, receipt of single-dose nevirapine, and treatment for tuberculosis. Results With a median follow-up time of 69 months (range, 6-112 months; inter-quartile range, 23-87 months), 57 children (13.5%; 95% CI, 10.4%-17.2%) initiating treatment with efavirenz and 101 children (26.4%; 95% CI, 22.0%-31.1%) initiating treatment with nevirapine had virological failure. There were 11 children (2.6%; 95% CI, 1.3%-4.6%) receiving efavirenz and 20 children (5.2%; 95% CI, 3.2%-7.9%) receiving nevirapine who never achieved virological suppression. The Cox proportional hazard ratio for the combined virological failure end point was 2.0 (95% CI, 1.4-2.7; log rank P < .001, favoring efavirenz). None of the measured covariates affected the estimated hazard ratio in the multivariable analyses. Conclusions and Relevance Among children aged 3 to 16 years infected with HIV and treated at a clinic in Botswana, the use of efavirenz compared with nevirapine as initial antiretroviral treatment was associated with less virological failure. These findings may warrant additional research evaluating the use of efavirenz and nevirapine for pediatric patients. JAMA. 2013;309(17):1803-1809	[Lowenthal, Elizabeth D.; Sagdeo, Aditi; Steenhoff, Andrew P.; Rutstein, Richard] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Lowenthal, Elizabeth D.; Ellenberg, Jonas H.] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Gross, Robert] Univ Penn, Perelman Sch Med, Dept Med & Epidemiol, Philadelphia, PA 19104 USA; [Lowenthal, Elizabeth D.; Steenhoff, Andrew P.; Rutstein, Richard] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Lowenthal, Elizabeth D.; Steenhoff, Andrew P.; Gross, Robert] Botswana UPenn Partnership, Gaborone, Botswana; [Machine, Edwin; Boiditswe, Sefelani; Anabwani, Gabriel] Botswana Baylor Childrens Clin Ctr Excellence, Gaborone, Botswana; [Machine, Edwin; Anabwani, Gabriel] Baylor Coll Med, Houston, TX 77030 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Baylor College of Medicine; Baylor College of Medicine	Lowenthal, ED (corresponding author), Univ Penn, Perelman Sch Med, 3535 Market St,Room 1513, Philadelphia, PA 19104 USA.	lowenthale@email.chop.edu	Anabwani, Gabriel/I-2371-2016	Anabwani, Gabriel/0000-0002-8555-4373; Machine, Edwin/0000-0001-8564-6000	Bristol-Myers Squibb; National Institutes of Health; Boehringer Ingelheim; Viral Ed; International Association of Providers of AIDS Care; Health Resources and Services Administration [T32 HP10026]; Penn Center for AIDS Research [P30 AI 045008]; National Institute of Mental Health [K23 MH095669]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH095669] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim(Boehringer Ingelheim); Viral Ed; International Association of Providers of AIDS Care; Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Penn Center for AIDS Research; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Lowenthal reported receiving grant support from Bristol-Myers Squibb. Dr Ellenberg reported serving on data and safety monitoring boards and mock advisory committees for Bristol-Myers Squibb, Eli Lilly, Pfizer, EMD Serono, and Roche; and receiving grants from the National Institutes of Health. Dr Anabwani reported receiving research support from Boehringer Ingelheim. Dr Gross reported receiving grant support from the National Institutes of Health; serving on a data and safety monitoring board for Pfizer; providing expert testimony to Lewis Saul LLP; receiving payment for lectures from Viral Ed; and receiving honoraria and reimbursement for travel expenses from the International Association of Providers of AIDS Care. No other author reported disclosures.; This study was supported in part by Health Resources and Services Administration grant T32 HP10026 (funding to Dr Lowenthal), funding from Bristol-Myers Squibb (awarded to Dr Lowenthal and provided funding to Drs Lowenthal and Gross), and grant P30 AI 045008 from the Penn Center for AIDS Research (awarded to Dr Gross). Dr Lowenthal is currently receiving research career development support from National Institute of Mental Health grant K23 MH095669.	[Anonymous], 1994, MMWR Recomm Rep, V43, P1; Baeten JM, 2007, J INFECT DIS, V195, P1177, DOI 10.1086/512682; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Botswana Ministry of Health, 2008, BOTSWANA NATIONAL HI; Botswana Ministry of Health, 2005, BOTSWANA GUIDELINES; Carlin JB, 2008, STATA J, V8, P49, DOI 10.1177/1536867X0800800104; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; de Onis M, 2006, PUBLIC HEALTH NUTR, V9, P942, DOI 10.1017/PHN20062005; Easterbrook PJ, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-4; Geretti AM, 2006, CURR OPIN INFECT DIS, V19, P1, DOI 10.1097/01.qco.0000200293.45532.68; Hartmann M, 2005, INT J STD AIDS, V16, P404, DOI 10.1258/0956462054094060; Kamya MR, 2007, JAIDS-J ACQ IMM DEF, V46, P187, DOI 10.1097/QAI.0b013e31814278c0; Lapphra K, 2008, INT J INFECT DIS, V12, pE33, DOI 10.1016/j.ijid.2007.10.008; Little K, 2007, CURR HIV RES, V5, P139, DOI 10.2174/157016207780077002; Lowenthal ED, 2005, SOUTH AFR J HIV MED, V6, P42; Manosuthi W, 2009, CLIN INFECT DIS, V48, P1752, DOI 10.1086/599114; Mbuagbaw LCE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004246.pub3; Nachega JB, 2008, AIDS, V22, P2117, DOI 10.1097/QAD.0b013e328310407e; Ouattara EN, 2012, AIDS, V26, P625, DOI 10.1097/QAD.0b013e328350fbfb; Patel A K, 2006, J Assoc Physicians India, V54, P915; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Southern African Journal of HIV Medicine, SOUTHERN AFRICAN JOU; Tolle Michael, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P260, DOI 10.1177/1545109711422273; UNAIDS and WHO, AIDS EPIDEMIC UPDATE; UNICEF, 2010, CHILDREN AND AIDS FI; Uthman O, 2012, AIDS, V26, P639, DOI 10.1097/QAD.0b013e3283509a40; Walters E, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-1; WHO UNAIDS UNICEF, GLOBAL HIV AIDS RESP; Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children, GUIDELINES FOR THE U; World Health Organization, 2010, ANTIRETROVIRAL THERA	31	37	37	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2013	309	17					1803	1809		10.1001/jama.2013.3710	http://dx.doi.org/10.1001/jama.2013.3710			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134SU	23632724	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000318235600028
J	Antoniadis, J; Freire, PCC; Wex, N; Tauris, TM; Lynch, RS; van Kerkwijk, MH; Kramer, M; Bassa, C; Dhillon, VS; Driebe, T; Hessels, JWT; Kaspi, VM; Kondratiev, VI; Langer, N; Marsh, TR; McLaughlin, MA; Pennucci, TT; Ransom, SM; Stairs, IH; van Leeuwen, J; Verbiest, JPW; Whelan, DG				Antoniadis, John; Freire, Paulo C. C.; Wex, Norbert; Tauris, Thomas M.; Lynch, Ryan S.; van Kerkwijk, Marten H.; Kramer, Michael; Bassa, Cees; Dhillon, Vik S.; Driebe, Thomas; Hessels, Jason W. T.; Kaspi, Victoria M.; Kondratiev, Vladislav I.; Langer, Norbert; Marsh, Thomas R.; McLaughlin, Maura A.; Pennucci, Timothy T.; Ransom, Scott M.; Stairs, Ingrid H.; van Leeuwen, Joeri; Verbiest, Joris P. W.; Whelan, David G.			A Massive Pulsar in a Compact Relativistic Binary	SCIENCE			English	Article							WHITE-DWARF COMPANIONS; MILLISECOND PULSARS; NEUTRON-STAR; GENERAL-RELATIVITY; GRAVITY; EVOLUTION; SYSTEMS; HELIUM; ACCRETION; DISCOVERY	Many physically motivated extensions to general relativity (GR) predict substantial deviations in the properties of spacetime surrounding massive neutron stars. We report the measurement of a 2.01 +/- 0.04 solar mass (M-circle dot) pulsar in a 2.46-hour orbit with a 0.172 +/- 0.003 M-circle dot white dwarf. The high pulsar mass and the compact orbit make this system a sensitive laboratory of a previously untested strong-field gravity regime. Thus far, the observed orbital decay agrees with GR, supporting its validity even for the extreme conditions present in the system. The resulting constraints on deviations support the use of GR-based templates for ground-based gravitational wave detectors. Additionally, the system strengthens recent constraints on the properties of dense matter and provides insight to binary stellar astrophysics and pulsar recycling.	[Antoniadis, John; Freire, Paulo C. C.; Wex, Norbert; Tauris, Thomas M.; Kramer, Michael; Verbiest, Joris P. W.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Tauris, Thomas M.; Langer, Norbert] Argelander Inst Astron, D-53121 Bonn, Germany; [Lynch, Ryan S.; Kaspi, Victoria M.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; [van Kerkwijk, Marten H.] Univ Toronto, Dept Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Kramer, Michael; Bassa, Cees] Univ Manchester, Ctr Astrophys, Jodrell Bank, Manchester M13 9PL, Lancs, England; [Dhillon, Vik S.] Univ Sheffield, Dept Phys & Astron, Sheffield S3 7RH, S Yorkshire, England; [Driebe, Thomas] Deutsch Zentrum Luft & Raumfahrt eV DLR, D-53227 Bonn, Germany; [Hessels, Jason W. T.; Kondratiev, Vladislav I.; van Leeuwen, Joeri] ASTRON, NL-7990 AA Dwingeloo, Netherlands; [Hessels, Jason W. T.; van Leeuwen, Joeri] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 XH Amsterdam, Netherlands; [Kondratiev, Vladislav I.] PN Lebedev Phys Inst, Ctr Astro Space, Moscow 117997, Russia; [Marsh, Thomas R.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [McLaughlin, Maura A.] W Virginia Univ, Dept Phys, Morgantown, WV 26506 USA; [Pennucci, Timothy T.; Whelan, David G.] Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA; [Ransom, Scott M.] Natl Radio Astron Observ, Charlottesville, VA 22903 USA; [Stairs, Ingrid H.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada	Max Planck Society; University of Bonn; McGill University; University of Toronto; University of Manchester; Jodrell Bank Centre for Astrophysics; University of Sheffield; Helmholtz Association; German Aerospace Centre (DLR); University of Amsterdam; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute; University of Warwick; West Virginia University; University of Virginia; National Radio Astronomy Observatory (NRAO); University of British Columbia	Antoniadis, J (corresponding author), Max Planck Inst Radioastron, Hugel 69, D-53121 Bonn, Germany.	jantoniadis@mpifr-bonn.mpg.de	Kondratiev, Vladislav I./N-1105-2015; Pennucci, Timothy/J-3688-2018; Antoniadis, John/N-9318-2015; Hessels, Jason/GTO-3261-2022; Freire, Paulo/ABE-8926-2021; Langer, Norbert/ABD-7263-2021; Verbiest, Joris PW/X-4941-2019; Dhillon, Vikram/AAB-5180-2019	Kondratiev, Vladislav I./0000-0001-8864-7471; Pennucci, Timothy/0000-0001-5465-2889; Antoniadis, John/0000-0003-4453-3776; Hessels, Jason/0000-0003-2317-1446; Freire, Paulo/0000-0003-1307-9435; Verbiest, Joris PW/0000-0002-4088-896X; Dhillon, Vikram/0000-0003-4236-9642; Ransom, Scott/0000-0001-5799-9714; van Leeuwen, Joeri/0000-0001-8503-6958; Kramer, Michael/0000-0002-4175-2271; McLaughlin, Maura/0000-0001-7697-7422; Whelan, David/0000-0002-6006-0537; Bassa, Cees/0000-0002-1429-9010; Tauris, Thomas/0000-0002-3865-7265	European Research Council for the ERC Starting Grant BEACON [279702]; West Virginia Experimental Program to Stimulate Competitive Research Challenge Grant; Natural Sciences and Engineering Research Council of Canada (NSERC); Fonds Quebecois de la Recherche sur la Nature et les Technologies via le Centre de Recherche Astrophysique du Quebec; Canadian Institute for Advanced Research; NSERC; Science and Technology Facilities Council; VLT of the European Southern Observatory (ESO) [088.D-0138A]; STFC [ST/I001719/1, ST/K002783/1, ST/J001589/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/I001719/1, ST/K002783/1, ST/J001589/1] Funding Source: researchfish	European Research Council for the ERC Starting Grant BEACON(European Research Council (ERC)); West Virginia Experimental Program to Stimulate Competitive Research Challenge Grant; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds Quebecois de la Recherche sur la Nature et les Technologies via le Centre de Recherche Astrophysique du Quebec; Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); VLT of the European Southern Observatory (ESO); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	J.A. is a member of the International Max Planck research school for Astronomy and Astrophysics at the Universities of Bonn and Cologne. P. C. C. F. and J.P.W.V. gratefully acknowledge financial support by the European Research Council for the ERC Starting Grant BEACON under contract no. 279702. M. A. M. acknowledges support from a West Virginia Experimental Program to Stimulate Competitive Research Challenge Grant. J.W.T.H. is a Veni Fellow of the Netherlands Foundation for Scientific Research. V. M. K. holds the Lorne Trottier Chair in Astrophysics and Cosmology, a Canada Research Chair, and a Killam Research Fellowship and acknowledges additional support from a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant, from Fonds Quebecois de la Recherche sur la Nature et les Technologies via le Centre de Recherche Astrophysique du Quebec and the Canadian Institute for Advanced Research. M. H. v. K. and I. H. S. acknowledge support from NSERC Discovery Grants. V. S. D., T. R. M., and ULTRACAM are supported by the Science and Technology Facilities Council. This work is based on data collected with the VLT of the European Southern Observatory (ESO) under program 088.D-0138A and observations with the 100-m Effelsberg telescope of the Max Planck Institute for Radioastronomy. The Arecibo Observatory is operated by SRI International under a cooperative agreement with the NSF (AST-1100968) and in alliance with Ana G. Mendez-Universidad Metropolitana and the Universities Space Research Association. The National Radio Astronomy Observatory is a facility of the NSF operated under cooperative agreement by Associated Universities, Incorporated. We are grateful to D. Koester and J. Panei et al. for providing models presented in their publications. We are obliged to J. Smoker (ESO) for his help during the VLT observations and D. Champion for assistance with the Effelsberg observations and useful discussions. We also thank D. Lorimer, J. Bell-Burnell, G. Esposito-Farese, E. Keane, P. Podsiadlowski, and B. Schutz for helpful discussions. This research made use of NASA's Astrophysics Data System and M. T. Flanagan's Java Scientific Library (www.ee.ucl.ac.uk/similar to mflanaga).	Alsing J, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.064041; Antoniadis J, 2012, MON NOT R ASTRON SOC, V423, P3316, DOI 10.1111/j.1365-2966.2012.21124.x; Appenzeller I., 1998, MSNGR, V94, P1; Bailes M, 2011, SCIENCE, V333, P1717, DOI 10.1126/science.1208890; Blanchet L, 2006, LIVING REV RELATIV, V9, DOI [10.12942/lrr-2002-3, 10.12942/lrr-2006-4]; Boyles J, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/2/80; Breton RP, 2007, ASTROPHYS J, V661, P1073, DOI 10.1086/515392; CHEVALIER RA, 1993, ASTROPHYS J, V411, pL33, DOI 10.1086/186905; Damour T, 1996, PHYS REV D, V54, P1474, DOI 10.1103/PhysRevD.54.1474; Damour T, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.042001; DAMOUR T, 1993, PHYS REV LETT, V70, P2220, DOI 10.1103/PhysRevLett.70.2220; DAMOUR T, 1992, PHYS REV D, V45, P1840, DOI 10.1103/PhysRevD.45.1840; Damour T, 2009, ASTROPHYS SPACE SC L, V359, P1; Demorest PB, 2010, NATURE, V467, P1081, DOI 10.1038/nature09466; Dermer CD, 2006, ASTROPHYS J, V643, pL13, DOI 10.1086/504895; Dhillon VS, 2007, MON NOT R ASTRON SOC, V378, P825, DOI 10.1111/j.1365-2966.2007.11881.x; Dowd A, 2000, ASTR SOC P, V202, P275; Folkner W.M., 2009, INTERPLANETARY NETWO, V178, pC1; Freire PCC, 2008, ASTROPHYS J, V675, P670, DOI 10.1086/526338; Freire PCC, 2012, MON NOT R ASTRON SOC, V423, P3328, DOI 10.1111/j.1365-2966.2012.21253.x; FRUCHTER AS, 1988, NATURE, V334, P686, DOI 10.1038/334686a0; Fujii Y., 2003, CAMBRIDGE MONOGRAPHS; Goenner H, 2012, GEN RELAT GRAVIT, V44, P2077, DOI 10.1007/s10714-012-1378-8; Gray D. F., 2005, OBSERVATION ANAL STE; HAENSEL P, 1981, ASTRON ASTROPHYS, V102, P299; Hobbs D., 2010, IAU S, V261, P315; Hobbs GB, 2006, MON NOT R ASTRON SOC, V369, P655, DOI 10.1111/j.1365-2966.2006.10302.x; IBEN I, 1993, PUBL ASTRON SOC PAC, V105, P1373, DOI 10.1086/133321; Jacoby BA, 2005, ASTROPHYS J, V629, pL113, DOI 10.1086/449311; Kilic M, 2010, ASTROPHYS J, V716, P122, DOI 10.1088/0004-637X/716/1/122; Kim C, 2004, ASTROPHYS J, V616, P1109, DOI 10.1086/424954; Kramer M, 2006, SCIENCE, V314, P97, DOI 10.1126/science.1132305; Lange C, 2001, MON NOT R ASTRON SOC, V326, P274, DOI 10.1046/j.1365-8711.2001.04606.x; Lattimer JM, 2004, SCIENCE, V304, P536, DOI 10.1126/science.1090720; Lynch RS, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/2/81; Maggiore M., 2008, GRAVITATIONAL WAVES, V1; Nice DJ, 2007, AIP CONF PROC, V983, P453; Ozel F, 2010, ASTROPHYS J LETT, V724, pL199, DOI 10.1088/2041-8205/724/2/L199; Panei JA, 2007, MON NOT R ASTRON SOC, V382, P779, DOI 10.1111/j.1365-2966.2007.12400.x; Paxton B, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/1/3; Podsiadlowski P, 2002, ASTROPHYS J, V565, P1107, DOI 10.1086/324686; PYLYSER EHP, 1989, ASTRON ASTROPHYS, V208, P52; Romani RW, 2012, ASTROPHYS J LETT, V760, DOI 10.1088/2041-8205/760/2/L36; Sathyaprakash BS, 2009, LIVING REV RELATIV, V12, DOI 10.12942/lrr-2009-2; Serenelli AM, 2001, MON NOT R ASTRON SOC, V325, P607, DOI 10.1046/j.1365-8711.2001.04449.x; Stairs Ingrid H, 2003, Living Rev Relativ, V6, P5, DOI 10.12942/lrr-2003-5; Tauris TM, 2012, MON NOT R ASTRON SOC, V425, P1601, DOI 10.1111/j.1365-2966.2012.21446.x; Tauris TM, 2011, MON NOT R ASTRON SOC, V416, P2130, DOI 10.1111/j.1365-2966.2011.19189.x; Tauris TM, 2012, SCIENCE, V335, P561, DOI 10.1126/science.1216355; Tauris TM, 1999, ASTRON ASTROPHYS, V350, P928; Tremblay PE, 2009, ASTROPHYS J, V696, P1755, DOI 10.1088/0004-637X/696/2/1755; van der Sluys MV, 2005, ASTRON ASTROPHYS, V440, P973, DOI 10.1051/0004-6361:20052696; van Haaften LM, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201218798; van Kerkwijk MH, 2011, ASTROPHYS J, V728, DOI 10.1088/0004-637X/728/2/95; van Kerkwijk M. H., 2005, ASP C SER, V328, P357; Will CM, 2006, LIVING REV RELATIV, V9, DOI 10.12942/lrr-2006-3; Will CM, 2011, P NATL ACAD SCI USA, V108, P5938, DOI 10.1073/pnas.1103127108; WILL CM, 1994, PHYS REV D, V50, P6058, DOI 10.1103/PhysRevD.50.6058; WILL CM, 1993, THEORY EXPT GRAVITAT	59	2313	2339	5	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131							1233232	10.1126/science.1233232	http://dx.doi.org/10.1126/science.1233232			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620056	Green Submitted			2022-12-28	WOS:000318016700033
J	Harder, B				Harder, Ben			Are MOOCs the future of medical education?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material											Harder, B (corresponding author), 1050 Thomas Jefferson St NW, Washington, DC 20007 USA.	benharder@gmail.com						Lucey CR, CLIN PROBLEM SOLVING; Prober CG, 2012, NEW ENGL J MED, V366, P1657, DOI 10.1056/NEJMp1202451	2	49	51	0	57	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 26	2013	346								f2666	10.1136/bmj.f2666	http://dx.doi.org/10.1136/bmj.f2666			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	134PO	23624666				2022-12-28	WOS:000318225100001
J	Jacques, T; Abed, T; Sharma, S; Philpott, J				Jacques, Thomas; Abed, Tarik; Sharma, Sunil; Philpott, Jonathan			Hoarseness in a 79 year old woman	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Jacques, Thomas; Abed, Tarik; Sharma, Sunil; Philpott, Jonathan] Southend Univ Hosp, Dept Otolaryngol, Westcliff On Sea SS0 0RY, England		Jacques, T (corresponding author), Southend Univ Hosp, Dept Otolaryngol, Westcliff On Sea SS0 0RY, England.	Thomas.Jacques@southend.nhs.uk						Birchall MA, 2007, SCOTT BROWNS OTORHIN, P2603; Carding P, 2007, SCOTT BROWNS OTORHIN, P2165; Donne AJ, 2010, INT J PEDIATR OTORHI, V74, P7, DOI 10.1016/j.ijporl.2009.09.004; Eagleton MJ, 2010, J CARDIOVASC SURG, V51, P807; Isshiki N, 2000, ACTA OTO-LARYNGOL, V120, P120, DOI 10.1080/000164800750000748; Kwon Tack-Kyun, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P538, DOI 10.1097/01.moo.0000144393.40874.98; Miller S, 2004, OTOLARYNG CLIN N AM, V37, P105, DOI 10.1016/S0030-6665(03)00163-4; O'Neill JP, 2008, SURG-J R COLL SURG E, V6, P373; Sinnatamby CS, 2006, LASTS ANATOMY REGION, P381; Tsikoudas A, 2012, J LARYNGOL OTOL, V126, P570, DOI 10.1017/S0022215112000576; Williams NS, 2008, BAILEY LOVES SHORT P, P872	12	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 25	2013	346								f2305	10.1136/bmj.f2305	http://dx.doi.org/10.1136/bmj.f2305			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134PN	23620585				2022-12-28	WOS:000318225000002
J	Reichardt, BW; Unger, F; Vazirani, U				Reichardt, Ben W.; Unger, Falk; Vazirani, Umesh			Classical command of quantum systems	NATURE			English	Article							KEY DISTRIBUTION; BELLS-INEQUALITY; COMPUTATION; SECURITY; STATES; PROOF	Quantum computation and cryptography both involve scenarios in which a user interacts with an imperfectly modelled or 'untrusted' system. It is therefore of fundamental and practical interest to devise tests that reveal whether the system is behaving as instructed. In 1969, Clauser, Horne, Shimony and Holt proposed an experimental test that can be passed by a quantum-mechanical system but not by a system restricted to classical physics. Here we extend this test to enable the characterization of a large quantum system. We describe a scheme that can be used to determine the initial state and to classically command the system to evolve according to desired dynamics. The bipartite system is treated as two black boxes, with no assumptions about their inner workings except that they obey quantum physics. The scheme works even if the system is explicitly designed to undermine it; any misbehaviour is detected. Among its applications, our scheme makes it possible to test whether a claimed quantum computer is truly quantum. It also advances towards a goal of quantum cryptography: namely, the use of 'untrusted' devices to establish a shared random key, with security based on the validity of quantum physics.	[Reichardt, Ben W.] Univ So Calif, Dept Elect Engn, Los Angeles, CA 90089 USA; [Unger, Falk] Knight Capital Grp Inc, Santa Clara, CA 95054 USA; [Vazirani, Umesh] Univ Calif Berkeley, Div Comp Sci, Berkeley, CA 94720 USA	University of Southern California; University of California System; University of California Berkeley	Reichardt, BW (corresponding author), Univ So Calif, Dept Elect Engn, Los Angeles, CA 90089 USA.	ben.reichardt@usc.edu			NSERC; ARO-DTO; Mitacs; US NSF [CCF-0905626]; Templeton grant [21674]; Division of Computing and Communication Foundations [1254119] Funding Source: National Science Foundation	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); ARO-DTO; Mitacs; US NSF(National Science Foundation (NSF)); Templeton grant; Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We thank E. Bering, A. Broadbent, A. Chailloux, M. Christandl, R. Colbeck, T. Ito, R. Konig, M. McKague, V. Madhavan, R. Renner, S. Sondhi and T. Vidick for discussions. Part of this work was conducted while F. U. was at the University of California Berkeley and B. W. R. was at the Institute for Quantum Computing, University of Waterloo. B. W. R. acknowledges support from NSERC, ARO-DTO and Mitacs. U. V. acknowledges support from US NSF grant CCF-0905626 and Templeton grant 21674	Acin A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.230501; Acin A, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/8/126; Aharonov D., 2010, INNOVATIONS COMPUTER, P453; Barrett J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.010503; Barz S, 2012, SCIENCE, V335, P303, DOI 10.1126/science.1214707; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; Bennett CH., 1984, P IEEE INT C COMP SY, P175; BRAUNSTEIN SL, 1992, PHYS REV LETT, V68, P3259, DOI 10.1103/PhysRevLett.68.3259; Broadbent A., 2010, QMIP MIP; Broadbent A, 2009, ANN IEEE SYMP FOUND, P517, DOI 10.1109/FOCS.2009.36; CIRELSON BS, 1980, LETT MATH PHYS, V4, P93, DOI 10.1007/BF00417500; EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; Fitzsimons J. F., 2012, UNCONDITIONALLY VERI; Gerhardt I, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1348; Gottesman D., 1997, THESIS CALIFORNIA I; Hanggi E, 2010, LECT NOTES COMPUT SC, V6110, P216; Hanggi E., 2010, DEVICE INDEPENDENT Q; Holevo A. S., 1973, PROBL INF T, V9, P177; Jordan, 1875, B SOC MATH FRANCE, V3, P103, DOI [DOI 10.24033/BSMF.90, 10.24033/bsmf.90]; Kempe J, 2009, COMPUT COMPLEX, V18, P273, DOI 10.1007/s00037-009-0275-3; Lo HK, 1999, SCIENCE, V283, P2050, DOI 10.1126/science.283.5410.2050; Lydersen L, 2010, NAT PHOTONICS, V4, P686, DOI 10.1038/NPHOTON.2010.214; Magniez F, 2006, LECT NOTES COMPUT SC, V4051, P72, DOI 10.1007/11786986_8; MASANES L, 2006, UNCONDITIONAL SECURI; Masanes L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1244; Masanes L, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.140501; Mayers D, 1998, ANN IEEE SYMP FOUND, P503, DOI 10.1109/SFCS.1998.743501; McKague M, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/45/455304; McKague M., 2010, THESIS U WATERLOO; McKague M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/10/103037; Miller C., 2012, ROBUST SELF TESTING; Mossel E, 2010, ANN MATH, V171, P295, DOI 10.4007/annals.2010.171.295; Pironio S, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/4/045021; POPESCU S, 1992, PHYS LETT A, V169, P411, DOI 10.1016/0375-9601(92)90819-8; Reichardt B. W., 2012, CLASSICAL LEASH QUAN; Watrous J, 2003, THEOR COMPUT SCI, V292, P575, DOI 10.1016/S0304-3975(01)00375-9; Zhao Y, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.042333	40	208	211	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 25	2013	496	7446					456	460		10.1038/nature12035	http://dx.doi.org/10.1038/nature12035			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131HU	23619692				2022-12-28	WOS:000317984400032
J	Cottrell, E; Kelley, KA				Cottrell, Elizabeth; Kelley, Katherine A.			Redox Heterogeneity in Mid-Ocean Ridge Basalts as a Function of Mantle Source	SCIENCE			English	Article							EARTHS UPPER-MANTLE; OXIDATION-STATE; OXYGEN FUGACITY; CARBON-DIOXIDE; MORB GLASSES; MAGMAS; MELTS; INTERIOR; WATER; GPA	The oxidation state of Earth's upper mantle both influences and records mantle evolution, but systematic fine-scale variations in upper mantle oxidation state have not previously been recognized in mantle-derived lavas from mid-ocean ridges. Through a global survey of mid-ocean ridge basalt glasses, we show that mantle oxidation state varies systematically as a function of mantle source composition. Negative correlations between Fe3+/Sigma Fe ratios and indices of mantle enrichment-such as Sr-87/Sr-86, Pb-208/Pb-204, Ba/La, and Nb/Zr ratios-reveal that enriched mantle is more reduced than depleted mantle. Because carbon may act to simultaneously reduce iron and generate melts that share geochemical traits with our reduced samples, we propose that carbon creates magmas at ridges that are reduced and enriched.	[Cottrell, Elizabeth] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA; [Kelley, Katherine A.] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; University of Rhode Island	Cottrell, E (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA.	cottrelle@si.edu	Kelley, Katherine A/J-3728-2013	Kelley, Katherine A/0000-0002-7516-2683; Cottrell, Elizabeth/0000-0002-9402-9394	Deep Carbon Observatory; NSF [EAR-0841006, EAR-0841108]; U.S. Department of Energy [DE-AC02-98CH10886, DE-FG02-92ER14244]; Division Of Earth Sciences [0841108] Funding Source: National Science Foundation	Deep Carbon Observatory; NSF(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Data described in this paper are presented in the supplementary materials and are archived in the PetDB database (www.earthchem.org/petdb). We thank F. Davis for discussion and are grateful for support from the Deep Carbon Observatory and NSF awards EAR-0841006 (E. C.) and EAR-0841108 (K. A. K.). Use of the National Synchrotron Light Source was supported by U.S. Department of Energy under contracts DE-AC02-98CH10886 and DE-FG02-92ER14244.	Bali E, 2013, NATURE, V495, P220, DOI 10.1038/nature11908; BALLHAUS C, 1993, CONTRIB MINERAL PETR, V114, P331, DOI 10.1007/BF01046536; Bezos A, 2005, GEOCHIM COSMOCHIM AC, V69, P711, DOI 10.1016/j.gca.2004.07.026; BLUNDY JD, 1991, NATURE, V349, P321, DOI 10.1038/349321a0; Canil D, 1997, NATURE, V389, P842, DOI 10.1038/39860; CARMICHAEL ISE, 1991, CONTRIB MINERAL PETR, V106, P129, DOI 10.1007/BF00306429; Cartigny P, 2008, EARTH PLANET SC LETT, V265, P672, DOI 10.1016/j.epsl.2007.11.011; CHRISTIE DM, 1986, EARTH PLANET SC LETT, V79, P397, DOI 10.1016/0012-821X(86)90195-0; Cottrell E, 2011, EARTH PLANET SC LETT, V305, P270, DOI 10.1016/j.epsl.2011.03.014; Cottrell E, 2009, CHEM GEOL, V268, P167, DOI 10.1016/j.chemgeo.2009.08.008; Dasgupta R, 2006, NATURE, V440, P659, DOI 10.1038/nature04612; Dasgupta R, 2004, EARTH PLANET SC LETT, V227, P73, DOI 10.1016/j.epsl.2004.08.004; Dasgupta R, 2013, NATURE, V493, P211, DOI 10.1038/nature11731; Dasgupta R, 2010, EARTH PLANET SC LETT, V298, P1, DOI 10.1016/j.epsl.2010.06.039; Dasgupta R, 2009, CHEM GEOL, V262, P57, DOI 10.1016/j.chemgeo.2009.02.004; DIXON JE, 1988, EARTH PLANET SC LETT, V90, P87, DOI 10.1016/0012-821X(88)90114-8; FROST BR, 1991, REV MINERAL, V25, P1; Frost DJ, 2008, ANNU REV EARTH PL SC, V36, P389, DOI 10.1146/annurev.earth.36.031207.124322; Girnis AV, 2013, LITHOS, V160, P183, DOI 10.1016/j.lithos.2012.11.027; KASTING JF, 1993, J GEOL, V101, P245, DOI 10.1086/648219; Kelley KA, 2009, SCIENCE, V325, P605, DOI 10.1126/science.1174156; KRESS VC, 1991, CONTRIB MINERAL PETR, V108, P82, DOI 10.1007/BF00307328; MOORE JG, 1979, NATURE, V282, P250, DOI 10.1038/282250a0; Niu YL, 1999, J GEOPHYS RES-SOL EA, V104, P7067, DOI 10.1029/1998JB900037; Rohrbach A, 2011, NATURE, V472, P209, DOI 10.1038/nature09899; Saal AE, 2002, NATURE, V419, P451, DOI 10.1038/nature01073; Stagno V, 2013, NATURE, V493, P84, DOI 10.1038/nature11679; Stagno V, 2010, EARTH PLANET SC LETT, V300, P72, DOI 10.1016/j.epsl.2010.09.038	30	64	68	0	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1314	1317		10.1126/science.1233299	http://dx.doi.org/10.1126/science.1233299			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23641060				2022-12-28	WOS:000320320200040
J	Sidorenkov, LA; Tey, MK; Grimm, R; Hou, YH; Pitaevskii, L; Stringari, S				Sidorenkov, Leonid A.; Tey, Meng Khoon; Grimm, Rudolf; Hou, Yan-Hua; Pitaevskii, Lev; Stringari, Sandro			Second sound and the superfluid fraction in a Fermi gas with resonant interactions	NATURE			English	Article							BOSE-EINSTEIN CONDENSATE; HELIUM II; LIQUID-HELIUM; LAMBDA-POINT; THERMODYNAMICS; VISCOSITY; TRANSPORT; FLOW	Superfluidity is a macroscopic quantum phenomenon occurring in systems as diverse as liquid helium and neutron stars. It occurs below a critical temperature(1,2) and leads to peculiar behaviour such as frictionless flow, the formation of quantized vortices and quenching of the moment of inertia. Ultracold atomic gases offer control of interactions and external confinement, providing unique opportunities to explore superfluid phenomena. Many such (finite-temperature) phenomena can be explained in terms of a two-fluid mixture(3,4) comprising a normal component, which behaves like an ordinary fluid, and a superfluid component with zero viscosity and zero entropy. The two-component nature of a superfluid is manifest in 'second sound', an entropy wave in which the superfluid and the non-superfluid components oscillate with opposite phases (as opposed to ordinary 'first sound', where they oscillate in phase). Here we report the observation of second sound in an ultracold Fermi gas with resonant interactions. The speed of second sound depends explicitly on the value of the superfluid fraction(5), a quantity that is sensitive to the spectrum of elementary excitations(6). Our measurements allow us to extract the temperature dependence of the superfluid fraction, a previously inaccessible quantity that will provide a benchmark for theories of strongly interacting quantum gases.	[Sidorenkov, Leonid A.; Tey, Meng Khoon; Grimm, Rudolf] Austrian Acad Sci, Inst Quantenopt & Quanteninformat, A-6020 Innsbruck, Austria; [Sidorenkov, Leonid A.; Tey, Meng Khoon; Grimm, Rudolf] Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria; [Sidorenkov, Leonid A.; Tey, Meng Khoon; Grimm, Rudolf] Univ Innsbruck, Zentrum Quantenphys, A-6020 Innsbruck, Austria; [Hou, Yan-Hua; Pitaevskii, Lev; Stringari, Sandro] Univ Trent, Dipartimento Fis, I-38123 Povo, Italy; [Hou, Yan-Hua; Pitaevskii, Lev; Stringari, Sandro] INO CNR BEC Ctr, I-38123 Povo, Italy; [Pitaevskii, Lev] Russian Acad Sci, Kapitza Inst Phys Problems, Moscow 119334, Russia	Austrian Academy of Sciences; University of Innsbruck; University of Innsbruck; University of Trento; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR); PL Kapitza Institute for Physical Problems of Russian Academy of Sciences; Russian Academy of Sciences	Tey, MK (corresponding author), Austrian Acad Sci, Inst Quantenopt & Quanteninformat, A-6020 Innsbruck, Austria.	mengkhoon.tey@ultracold.at	Tey, Meng Khoon/D-4651-2016; Grimm, Rudolf/D-2864-2009	Grimm, Rudolf/0000-0003-1085-5558	Austrian Science Fund (FWF) within SFB FoQuS [F4004-N16]; European Research Council; Provincia Autonoma di Trento	Austrian Science Fund (FWF) within SFB FoQuS(Austrian Science Fund (FWF)); European Research Council(European Research Council (ERC)European Commission); Provincia Autonoma di Trento(Autonomous Province of Trento)	We thank E. R. Sanchez Guajardo for his contributions in the early stage of this work, and P. van der Straten for discussions. The Innsbruck team acknowledges support from the Austrian Science Fund (FWF) within SFB FoQuS (project no. F4004-N16). The Trento team acknowledges support from the European Research Council through the project QGBE and from the Provincia Autonoma di Trento. We dedicate the present work to our late friend and colleague A. Griffin, who enthusiastically promoted the idea of measuring second sound in Fermi gases.	Allen JF, 1938, NATURE, V142, P643, DOI 10.1038/142643a0; Andrews MR, 1997, PHYS REV LETT, V79, P553, DOI 10.1103/PhysRevLett.79.553; Arahata E, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.043613; Atkins K. R., 1959, LIQUID HELIUM; Bertaina G, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.150402; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; DASH JG, 1957, PHYS REV, V105, P7, DOI 10.1103/PhysRev.105.7; Giorgini S, 2008, REV MOD PHYS, V80, P1215, DOI 10.1103/RevModPhys.80.1215; Heiselberg H, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.013607; Ho TL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.090402; Horikoshi M, 2010, SCIENCE, V327, P442, DOI 10.1126/science.1183012; Hou Y.-H., 2013, PREPRINT; Hu H, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/043040; Jochim S, 2003, SCIENCE, V302, P2101, DOI 10.1126/science.1093280; Joseph J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.170401; Kapitza P, 1938, NATURE, V141, P74, DOI 10.1038/141074a0; Khalatnikov I. M., 1965, INTRO THEORY SUPERFL; Kinast J, 2005, SCIENCE, V307, P1296, DOI 10.1126/science.1109220; Ku MJH, 2012, SCIENCE, V335, P563, DOI 10.1126/science.1214987; Landau L, 1941, J PHYS-USSR, V5, P71; Landau L. D., 1947, J PHYS USSR, V11, P91; Meppelink R, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.265301; Meppelink R, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.043605; Nascimbene S, 2010, NATURE, V463, P1057, DOI 10.1038/nature08814; Nascimbene S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.170402; Peshkor V, 1944, J PHYS-USSR, V8, P381; Sommer A, 2011, NATURE, V472, P201, DOI 10.1038/nature09989; Stadler D, 2012, NATURE, V491, P736, DOI 10.1038/nature11613; Stamper-Kurn DM, 1998, PHYS REV LETT, V81, P500, DOI 10.1103/PhysRevLett.81.500; Tey MK, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.055303; Tisza L, 1938, NATURE, V141, P913, DOI 10.1038/141913a0	31	133	133	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 6	2013	498	7452					78	+		10.1038/nature12136	http://dx.doi.org/10.1038/nature12136			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	158DC	23676679				2022-12-28	WOS:000319947800036
J	Arnold, C				Arnold, Carrie			Susheela Singh and Jacqueline Darroch: turning research into advocacy for reproductive health	LANCET			English	Biographical-Item																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 18	2013	381	9879					1711	1711		10.1016/S0140-6736(13)61064-8	http://dx.doi.org/10.1016/S0140-6736(13)61064-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146TA	23683625				2022-12-28	WOS:000319112800019
J	Sebelius, K				Sebelius, Kathleen			Shared commitment to women's health abroad and at home	LANCET			English	Editorial Material									US Dept HHS, Off Global Affairs, Washington, DC 20201 USA		Sebelius, K (corresponding author), US Dept HHS, Off Global Affairs, Washington, DC 20201 USA.	kenneth.goldman@hhs.gov						[Anonymous], STRONG START MOTH NE; US Department of Health and Human Services Health Resources and Services Administration Maternal and Child Health Bureau, 2013, WOM HLTH US 2012; WHO, 2012, MAT MORT	3	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 18	2013	381	9879					1689	1689		10.1016/S0140-6736(13)60905-8	http://dx.doi.org/10.1016/S0140-6736(13)60905-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146TA	23683615				2022-12-28	WOS:000319112800006
J	Donelan, K; DesRoches, CM; Dittus, RS; Buerhaus, P				Donelan, Karen; DesRoches, Catherine M.; Dittus, Robert S.; Buerhaus, Peter			Perspectives of Physicians and Nurse Practitioners on Primary Care Practice	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DIRECTIONS	BACKGROUND The U.S. health care system is at a critical juncture in health care workforce planning. The nation has a shortage of primary care physicians. Policy analysts have proposed expanding the supply and scope of practice of nurse practitioners to address increased demand for primary care providers. These proposals are controversial. METHODS From November 23, 2011, to April 9, 2012, we conducted a national postal-mail survey of 972 clinicians (505 physicians and 467 nurse practitioners) in primary care practice. Questionnaire domains included scope of work, practice characteristics, and attitudes about the effect of expanding the role of nurse practitioners in primary care. The response rate was 61.2%. RESULTS Physicians reported working longer hours, seeing more patients, and earning higher incomes than did nurse practitioners. A total of 80.9% of nurse practitioners reported working in a practice with a physician, as compared with 41.4% of physicians who reported working with a nurse practitioner. Nurse practitioners were more likely than physicians to believe that they should lead medical homes, be allowed hospital admitting privileges, and be paid equally for the same clinical services. When asked whether they agreed with the statement that physicians provide a higher-quality examination and consultation than do nurse practitioners during the same type of primary care visit, 66.1% of physicians agreed and 75.3% of nurse practitioners disagreed. CONCLUSIONS Current policy recommendations that are aimed at expanding the supply and scope of practice of primary care nurse practitioners are controversial. Physicians and nurse practitioners do not agree about their respective roles in the delivery of primary care. (Funded by the Gordon and Betty Moore Foundation and others.)	[Donelan, Karen] Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Boston, MA 02114 USA; [Donelan, Karen] Harvard Univ, Sch Med, Boston, MA USA; [DesRoches, Catherine M.] Math Policy Res, Cambridge, MA USA; [Dittus, Robert S.] Vanderbilt Univ, Dept Med, Inst Med & Publ Hlth, Nashville, TN USA; [Dittus, Robert S.] VA Tennessee Valley Geriatr Res Educ & Clin Ctr, Nashville, TN USA; [Buerhaus, Peter] Vanderbilt Univ, Med Ctr, Ctr Interdisciplinary Hlth Workforce Studies, Nashville, TN USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Mathematica; Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Donelan, K (corresponding author), Massachusetts Gen Hosp, Mongan Inst Hlth Policy, 50 Staniford St,9th Fl, Boston, MA 02114 USA.	kdonelan@partners.org	Donelan, Karen/R-6162-2019; DesRoches, Catherine/ABC-9869-2020	DesRoches, Catherine/0000-0001-5373-855X	Gordon and Betty Moore Foundation; Johnson & Johnson Campaign for Nursing's Future; Robert Wood Johnson Foundation	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Johnson & Johnson Campaign for Nursing's Future; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	Funded by the Gordon and Betty Moore Foundation and others.; Supported by the Gordon and Betty Moore Foundation, the Johnson & Johnson Campaign for Nursing's Future, and the Robert Wood Johnson Foundation.	American Academy of Family Physicians, 2012, PRIM CAR 21 CENT ENS; American Association for Public Opinion Research (AAPOR), 2016, STAND DEF FIN DISP C; American Journal for Nurse Practitioners, AM J NURSE PRACTITIO; [Anonymous], 2012, PERF REP GRANTS COOP; Cooper RA, 2007, ACAD MED, V82, P827, DOI 10.1097/ACM.0b013e31812f7939; Council of Medical Specialty Societies, 2010, CMSS RESP FUT NURS R; Fairman JA, 2011, NEW ENGL J MED, V364, P193, DOI 10.1056/NEJMp1012121; Government Accountability Office, 2008, GOV ACC OFF PUBL; Iglehart JK, 2008, NEW ENGL J MED, V359, P643, DOI 10.1056/NEJMhpr0803754; Institute of Medicine, 2011, FUT NURS LEAD CHANG; Ku L, 2011, NEW ENGL J MED, V364, P493, DOI 10.1056/NEJMp1011623; Medicare Payment Advisory Commission, 2008, REP C REF DEL SYST; Park Melissa, 2011, NCHS Data Brief, P1; The Josiah Macy Jr. Foundation, GRANTS INT ED TEAMW	14	135	134	1	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2013	368	20					1898	1906		10.1056/NEJMsa1212938	http://dx.doi.org/10.1056/NEJMsa1212938			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	143VK	23675658				2022-12-28	WOS:000318896200009
J	Salichos, L; Rokas, A				Salichos, Leonidas; Rokas, Antonis			Inferring ancient divergences requires genes with strong phylogenetic signals	NATURE			English	Article							EVOLUTION; SEQUENCE; PHYLOGENOMICS; INCONGRUENCE; INFERENCE; NETWORKS; MODEL; POWER; TAXA; TREE	To tackle incongruence, the topological conflict between different gene trees, phylogenomic studies couple concatenation with practices such as rogue taxon removal or the use of slowly evolving genes. Phylogenomic analysis of 1,070 orthologues from 23 yeast genomes identified 1,070 distinct gene trees, which were all incongruent with the phylogeny inferred from concatenation. Incongruence severity increased for shorter internodes located deeper in the phylogeny. Notably, whereas most practices had little or negative impact on the yeast phylogeny, the use of genes or internodes with high average internode support significantly improved the robustness of inference. We obtained similar results in analyses of vertebrate and metazoan phylogenomic data sets. These results question the exclusive reliance on concatenation and associated practices, and argue that selecting genes with strong phylogenetic signals and demonstrating the absence of significant incongruence are essential for accurately reconstructing ancient divergences.	[Salichos, Leonidas; Rokas, Antonis] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Rokas, A (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	antonis.rokas@vanderbilt.edu	Rokas, Antonis/A-9775-2008	Rokas, Antonis/0000-0002-7248-6551	National Science Foundation [DEB-0844968]	National Science Foundation(National Science Foundation (NSF))	We thank K. Polzin for providing a script that identified alignment sites that contained single substitutions between amino acids that differ in their physicochemical properties. We thank members of the Rokas laboratory and B. O'Meara for valuable comments on this work. This work was conducted in part using the resources of the Advanced Computing Center for Research and Education at Vanderbilt University. This work was supported by the National Science Foundation (DEB-0844968).	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Alix B, 2012, NUCLEIC ACIDS RES, V40, pW573, DOI 10.1093/nar/gks485; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baker RH, 1997, SYST BIOL, V46, P654, DOI 10.2307/2413499; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Belinky F, 2010, MOL BIOL EVOL, V27, P441, DOI 10.1093/molbev/msp263; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Bryant D., 2003, BIOCONSENSUS, P163; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Cunningham CW, 1997, MOL BIOL EVOL, V14, P733, DOI 10.1093/oxfordjournals.molbev.a025813; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Dujon B, 2010, NAT REV GENET, V11, P512, DOI 10.1038/nrg2811; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J, 2004, INFERRING PHYLOGENIE; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Fitzpatrick DA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-290; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; Hess J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022783; Hittinger CT, 2010, P NATL ACAD SCI USA, V107, P1476, DOI 10.1073/pnas.0910449107; Hittinger CT, 2004, P NATL ACAD SCI USA, V101, P14144, DOI 10.1073/pnas.0404319101; Holland BR, 2004, MOL BIOL EVOL, V21, P1459, DOI 10.1093/molbev/msh145; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; Kumar S, 2012, MOL BIOL EVOL, V29, P457, DOI 10.1093/molbev/msr202; League GP, 2012, FEMS YEAST RES, V12, P859, DOI 10.1111/j.1567-1364.2012.00828.x; Liu L, 2009, SYST BIOL, V58, P468, DOI 10.1093/sysbio/syp031; Mossel E, 2004, MATH BIOSCI, V187, P189, DOI 10.1016/j.mbs.2003.10.004; Novo M, 2009, P NATL ACAD SCI USA, V106, P16333, DOI 10.1073/pnas.0904673106; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Regier JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023408; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; RODRIGO AG, 1993, NEW ZEAL J BOT, V31, P257, DOI 10.1080/0028825X.1993.10419503; Rogozin IB, 2007, MOL BIOL EVOL, V24, P1080, DOI 10.1093/molbev/msm029; Rokas A, 2005, SCIENCE, V310, P1933, DOI 10.1126/science.1116759; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Rokas A, 2005, MOL BIOL EVOL, V22, P1337, DOI 10.1093/molbev/msi121; Rokas A, 2006, PLOS BIOL, V4, P1899, DOI 10.1371/journal.pbio.0040352; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salichos L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018755; Scannell DR, 2007, YEAST, V24, P929, DOI 10.1002/yea.1515; Scannell DR, 2011, G3-GENES GENOM GENET, V1, P11, DOI 10.1534/g3.111.000273; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Schierwater B, 2009, PLOS BIOL, V7, P36, DOI 10.1371/journal.pbio.1000020; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Slot JC, 2010, P NATL ACAD SCI USA, V107, P10136, DOI 10.1073/pnas.0914418107; Smith SA, 2011, NATURE, V480, P364, DOI 10.1038/nature10526; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x; Townsend JP, 2012, SYST BIOL, V61, P835, DOI 10.1093/sysbio/sys036; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yu Y, 2012, PLOS GENET, V8, P456, DOI 10.1371/journal.pgen.1002660; Zwickl DJ, 2006, THESIS	63	421	426	1	153	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2013	497	7449					327	+		10.1038/nature12130	http://dx.doi.org/10.1038/nature12130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23657258				2022-12-28	WOS:000318952000029
J	Mitchell, CJ; Ahmad, Z; Khan, MS				Mitchell, C. J.; Ahmad, Z.; Khan, M. S.			An unusual burn	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ELECTRICAL INJURIES; RESUSCITATION; MANAGEMENT		[Mitchell, C. J.; Ahmad, Z.; Khan, M. S.] Salisbury Dist Hosp, Dept Burns Plast & Reconstruct Surg, Salisbury SP2 8BJ, Wilts, England	Salisbury District Hospital	Mitchell, CJ (corresponding author), Dorset Cty Hosp, Dept Orthopaed, Dorchester DT1 2JY, England.	cjmitchell@doctors.org.uk						Agarwal P, 2010, INDIAN J PLAST SURG, V43, P49, DOI 10.4103/0970-0358.63962; Arnoldo BD, 2004, J BURN CARE REHABIL, V25, P479, DOI 10.1097/01.BCR.0000144536.22284.5C; Arnoldo BD, 2009, HAND CLIN, V25, P469, DOI 10.1016/j.hcl.2009.06.001; Baker RHJ, 2007, J PLAST RECONSTR AES, V60, P682, DOI 10.1016/j.bjps.2006.09.003; Boldt J, 2008, BURNS, V34, P328, DOI 10.1016/j.burns.2007.09.005; Chung KK, 2010, J TRAUMA, V69, pS49, DOI 10.1097/TA.0b013e3181e425f1; Hettiaratchy H, 2005, ABC BURNS; Lund CC., SURG GYNECOL OBSTET, V79, P352; Luz DP, 2009, BURNS, V35, P1015, DOI 10.1016/j.burns.2009.01.014; Maghsoudi H, 2007, J BURN CARE RES, V28, P255, DOI 10.1097/BCR.0b013E318031A11C; Pham TN, 2008, J BURN CARE RES, V29, P257, DOI 10.1097/BCR.0b013e31815f3876; PURDUE GF, 1986, J TRAUMA, V26, P166, DOI 10.1097/00005373-198602000-00013	12	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 15	2013	346								f2856	10.1136/bmj.f2856	http://dx.doi.org/10.1136/bmj.f2856			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148OH	23676620				2022-12-28	WOS:000319254200001
J	Blanken, MO; Rovers, MM; Molenaar, JM; Winkler-Seinstra, PL; Meijer, A; Kimpen, JLL; Bont, L				Blanken, Maarten O.; Rovers, Maroeska M.; Molenaar, Jorine M.; Winkler-Seinstra, Pauline L.; Meijer, Adam; Kimpen, Jan L. L.; Bont, Louis		Dutch RSV Neonatal Network	Respiratory Syncytial Virus and Recurrent Wheeze in Healthy Preterm Infants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AIRWAY HYPERRESPONSIVENESS; PRESCHOOL-CHILDREN; RSV BRONCHIOLITIS; 1ST YEAR; INFECTION; ASTHMA; HOSPITALIZATION; DISORDERS; ILLNESSES; ALLERGY	Background Respiratory syncytial virus (RSV) infection is associated with subsequent recurrent wheeze. Observational studies cannot determine whether RSV infection is the cause of recurrent wheeze or the first indication of preexistent pulmonary vulnerability in preterm infants. The monoclonal antibody palivizumab has shown efficacy in preventing severe RSV infection in high-risk infants. Methods In the double-blind, placebo-controlled MAKI trial, we randomly assigned 429 otherwise healthy preterm infants born at a gestational age of 33 to 35 weeks to receive either monthly palivizumab injections (214 infants) or placebo (215 infants) during the RSV season. The prespecified primary outcome was the total number of parent-reported wheezing days in the first year of life. Nasopharyngeal swabs were taken during respiratory episodes for viral analysis. Results Palivizumab treatment resulted in a relative reduction of 61% (95% confidence interval, 56 to 65) in the total number of wheezing days during the first year of life (930 of 53,075 days in the RSV-prevention group [1.8%] vs. 2309 of 51,726 days [4.5%] in the placebo group). During this time, the proportion of infants with recurrent wheeze was 10 percentage points lower in patients treated with palivizumab (11% vs. 21%, P = 0.01). Conclusions In otherwise healthy preterm infants, palivizumab treatment resulted in a significant reduction in wheezing days during the first year of life, even after the end of treatment. These findings implicate RSV infection as an important mechanism of recurrent wheeze during the first year of life in such infants. (Funded by Abbott Laboratories and by the Netherlands Organization for Health Research and Development; MAKI Controlled Clinical Trials number, ISRCTN73641710.)	[Blanken, Maarten O.; Molenaar, Jorine M.; Winkler-Seinstra, Pauline L.; Kimpen, Jan L. L.; Bont, Louis] Univ Med Ctr Utrecht, Div Pediat Immunol & Infect Dis, NL-3508 AB Utrecht, Netherlands; Univ Med Ctr Utrecht, Dept Operating Rooms, Julius Ctr Hlth Sci & Primary Care, NL-3508 AB Utrecht, Netherlands; Univ Med Ctr Utrecht, Dept Epidemiol Biostat & HTA, Julius Ctr Hlth Sci & Primary Care, NL-3508 AB Utrecht, Netherlands; [Rovers, Maroeska M.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Meijer, Adam] Natl Inst Publ Hlth & Environm, Dept Virol, NL-3720 BA Bilthoven, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Netherlands National Institute for Public Health & the Environment	Bont, L (corresponding author), Univ Med Ctr Utrecht, POB 85090, NL-3508 AB Utrecht, Netherlands.	l.bont@umcutrecht.nl	Rovers, Maroeska/F-2969-2014	Rovers, Maroeska/0000-0002-3095-170X; Blanken, Maarten O./0000-0003-4065-7368	Abbott Laboratories; Netherlands Organization for Health Research and Development [ISRCTN73641710]; Netherlands Organization for Health Research and Development (NWO-AGIKO) [920-035-89]	Abbott Laboratories(Abbott Laboratories); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Organization for Health Research and Development (NWO-AGIKO)	Funded by Abbott Laboratories and by the Netherlands Organization for Health Research and Development; MAKI Controlled Clinical Trials number, ISRCTN73641710.; Supported by an unrestricted grant from Abbott Laboratories and by a grant from the Netherlands Organization for Health Research and Development (NWO-AGIKO grant 920-035-89, to Dr. Blanken).	Bacharier LB, 2012, J ALLERGY CLIN IMMUN, V130, P91, DOI 10.1016/j.jaci.2012.02.010; Bermejo-Martin JF, 2007, J ALLERGY CLIN IMMUN, V119, P1547, DOI 10.1016/j.jaci.2007.03.014; Bloemers BLP, 2007, PEDIATRICS, V120, pE1076, DOI 10.1542/peds.2007-0788; Bont L, 2000, AM J RESP CRIT CARE, V161, P1518, DOI 10.1164/ajrccm.161.5.9904078; Bont L, 2004, THORAX, V59, P512, DOI 10.1136/thx.2003.013391; Bont L, 2004, PEDIATR INFECT DIS J, V23, P414, DOI 10.1097/01.inf.0000122604.32137.29; Bont L, 2000, Paediatr Respir Rev, V1, P221, DOI 10.1053/prrv.2000.0052; Bont L, 2001, PEDIATR INFECT DIS J, V20, P277, DOI 10.1097/00006454-200103000-00012; Brand PLP, 2008, EUR RESPIR J, V32, P1096, DOI 10.1183/09031936.00002108; Carroll KN, 2009, J ALLERGY CLIN IMMUN, V123, P964, DOI 10.1016/j.jaci.2008.12.011; Casalegno JS, 2009, EURO SURVEILL, V14; Colin AA, 2010, PEDIATRICS, V126, P115, DOI 10.1542/peds.2009-1381; Edwards MR, 2012, NAT REV MICROBIOL, V10, P459, DOI 10.1038/nrmicro2801; EISEN AH, 1963, PEDIATRICS, V31, P859; Elphick HE, 2001, ARCH DIS CHILD, V84, P35, DOI 10.1136/adc.84.1.35; Ermers MJJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b897; Gern JE, 2002, NAT REV IMMUNOL, V2, P132, DOI 10.1038/nri725; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; HALL CB, 1984, J PEDIATR-US, V105, P358, DOI 10.1016/S0022-3476(84)80005-0; Heddini A, 2009, EUROSURVEILLANCE, V14; Henderson J, 2005, PEDIAT ALLERG IMM-UK, V16, P386, DOI 10.1111/j.1399-3038.2005.00298.x; Hu AZ, 2003, J CLIN MICROBIOL, V41, P149, DOI 10.1128/JCM.41.1.149-154.2003; Jafri HS, 2004, J INFECT DIS, V189, P1856, DOI 10.1086/386372; Kuehni CE, 2001, LANCET, V357, P1821, DOI 10.1016/S0140-6736(00)04958-8; Loebbermann J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032371; Loens K, 2012, J CLIN MICROBIOL, V50, P977, DOI 10.1128/JCM.00200-11; Makela MJ, 2002, AM J RESP CRIT CARE, V165, P824, DOI 10.1164/rccm.2105062; Makela MJ, 2000, P NATL ACAD SCI USA, V97, P6007, DOI 10.1073/pnas.100118997; Martinez FD, 2003, PEDIATR INFECT DIS J, V22, pS76, DOI 10.1097/00006454-200302001-00011; Mejias A, 2005, ANTIMICROB AGENTS CH, V49, P4700, DOI 10.1128/AAC.49.11.4700-4707.2005; Miedema CJ, 2001, PEDIATR INFECT DIS J, V20, P160, DOI 10.1097/00006454-200102000-00008; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; PULLAN CR, 1982, BRIT MED J, V284, P1665, DOI 10.1136/bmj.284.6330.1665; Schuurhof A, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-121; Sigurs N, 2010, THORAX, V65, P1045, DOI 10.1136/thx.2009.121582; Simoes EAF, 2007, J PEDIATR-US, V151, P34, DOI 10.1016/j.jpeds.2007.02.032; Simoes EAF, 2010, J ALLERGY CLIN IMMUN, V126, P256, DOI 10.1016/j.jaci.2010.05.026; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Stensballe LG, 2009, J ALLERGY CLIN IMMUN, V123, P131, DOI 10.1016/j.jaci.2008.10.042; van der Zalm MM, 2009, PEDIATR INFECT DIS J, V28, P472, DOI 10.1097/INF.0b013e318195e26e; van der Zalm MM, 2006, J ALLERGY CLIN IMMUN, V117, P955, DOI 10.1016/j.jaci.2006.01.006; WELLIVER RC, 1995, LANCET, V346, P789, DOI 10.1016/S0140-6736(95)91615-6; Wu PS, 2011, EXPERT REV ANTI-INFE, V9, P731, DOI [10.1586/eri.11.92, 10.1586/ERI.11.92]; Wu PS, 2008, AM J RESP CRIT CARE, V178, P1123, DOI 10.1164/rccm.200804-579OC	44	432	452	3	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2013	368	19					1791	1799		10.1056/NEJMoa1211917	http://dx.doi.org/10.1056/NEJMoa1211917			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138WA	23656644	Green Published			2022-12-28	WOS:000318540000007
J	Maxson, JE; Gotlib, J; Pollyea, DA; Fleischman, AG; Agarwal, A; Eide, CA; Bottomly, D; Wilmot, B; McWeeney, SK; Tognon, CE; Pond, JB; Collins, RH; Goueli, B; Oh, ST; Deininger, MW; Chang, BH; Loriaux, MM; Druker, BJ; Tyner, JW				Maxson, Julia E.; Gotlib, Jason; Pollyea, Daniel A.; Fleischman, Angela G.; Agarwal, Anupriya; Eide, Christopher A.; Bottomly, Daniel; Wilmot, Beth; McWeeney, Shannon K.; Tognon, Cristina E.; Pond, J. Blake; Collins, Robert H.; Goueli, Basem; Oh, Stephen T.; Deininger, Michael W.; Chang, Bill H.; Loriaux, Marc M.; Druker, Brian J.; Tyner, Jeffrey W.			Oncogenic CSF3R Mutations in Chronic Neutrophilic Leukemia and Atypical CML	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLONY-STIMULATING-FACTOR; SEVERE CONGENITAL NEUTROPENIA; ACUTE MYELOID-LEUKEMIA; TYROSINE KINASE JAK2; FACTOR-RECEPTOR; MYELOPROLIFERATIVE-DISORDERS; ACTIVATING MUTATION; POLYCYTHEMIA-VERA; C-KIT; MICE	Background The molecular causes of many hematologic cancers remain unclear. Among these cancers are chronic neutrophilic leukemia (CNL) and atypical (BCR-ABL1-negative) chronic myeloid leukemia (CML), both of which are diagnosed on the basis of neoplastic expansion of granulocytic cells and exclusion of genetic drivers that are known to occur in other myeloproliferative neoplasms and myeloproliferative-myelodysplastic overlap neoplasms. Methods To identify potential genetic drivers in these disorders, we used an integrated approach of deep sequencing coupled with the screening of primary leukemia cells obtained from patients with CNL or atypical CML against panels of tyrosine kinase-specific small interfering RNAs or small-molecule kinase inhibitors. We validated candidate oncogenes using in vitro transformation assays, and drug sensitivities were validated with the use of assays of primary-cell colonies. Results We identified activating mutations in the gene encoding the receptor for colony-stimulating factor 3 (CSF3R) in 16 of 27 patients (59%) with CNL or atypical CML. These mutations segregate within two distinct regions of CSF3R and lead to preferential downstream kinase signaling through SRC family-TNK2 or JAK kinases and differential sensitivity to kinase inhibitors. A patient with CNL carrying a JAK-activating CSF3R mutation had marked clinical improvement after the administration of the JAK1/2 inhibitor ruxolitinib. Conclusions Mutations in CSF3R are common in patients with CNL or atypical CML and represent a potentially useful criterion for diagnosing these neoplasms. (Funded by the Leukemia and Lymphoma Society and others.)	[Maxson, Julia E.; Fleischman, Angela G.; Agarwal, Anupriya; Eide, Christopher A.; Tognon, Cristina E.; Druker, Brian J.] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97239 USA; [Maxson, Julia E.; Fleischman, Angela G.; Agarwal, Anupriya; Eide, Christopher A.; Bottomly, Daniel; Wilmot, Beth; McWeeney, Shannon K.; Tognon, Cristina E.; Chang, Bill H.; Loriaux, Marc M.; Druker, Brian J.; Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97239 USA; [Bottomly, Daniel; Wilmot, Beth; McWeeney, Shannon K.] Oregon Hlth & Sci Univ, Oregon Clin & Translat Res Inst, Portland, OR 97239 USA; [McWeeney, Shannon K.] Oregon Hlth & Sci Univ, Div Bioinformat & Computat Biol, Portland, OR 97239 USA; [Chang, Bill H.] Oregon Hlth & Sci Univ, Div Pediat Hematol & Oncol, Dept Pediat, Portland, OR 97239 USA; [Loriaux, Marc M.] Oregon Hlth & Sci Univ, Dept Anat Pathol, Portland, OR 97239 USA; [Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA; [Gotlib, Jason] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [Pollyea, Daniel A.] Univ Colorado, Sch Med, Div Hematol Oncol & Bone Marrow Transplantat, Aurora, CO USA; [Pond, J. Blake; Collins, Robert H.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Goueli, Basem] St Lukes Reg Canc Ctr, Duluth, MN USA; [Oh, Stephen T.] Washington Univ, Sch Med, Dept Med, Div Hematol, St Louis, MO 63130 USA; [Deininger, Michael W.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Stanford Cancer Institute; Stanford University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Texas System; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL); Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Tyner, JW (corresponding author), Oregon Hlth & Sci Univ, BRB 511,Mailcode L592,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	tynerj@ohsu.edu		Fleischman, Angela/0000-0002-3701-6079; Chang, Bill/0000-0003-3783-1820; Eide, Christopher/0000-0001-8835-8928; Tyner, Jeffrey/0000-0002-2133-0960; Druker, Brian/0000-0001-8331-8206; McWeeney, Shannon/0000-0001-8333-6607	Leukemia and Lymphoma Society; Training Program in Molecular Hematology [5T32HL007781-20]; Charles and Ann Johnson Foundation; National Cancer Institute [1-K99-CA151670-01A1, 5P30CA069533-13, 4 R00CA151457-03]; National Center for Advancing Translational Sciences [5UL1RR024140]; National Heart, Lung, and Blood Institute [K08 HL106576]; St. Baldricks Foundation; V Foundation for Cancer Research; Gabrielle's Angel Foundation for Cancer Research; William Lawrence and Blanche Hughes Fund; NATIONAL CANCER INSTITUTE [K99CA151670, P30CA069533, R00CA151457] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007781, K08HL106576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Training Program in Molecular Hematology; Charles and Ann Johnson Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); St. Baldricks Foundation; V Foundation for Cancer Research; Gabrielle's Angel Foundation for Cancer Research; William Lawrence and Blanche Hughes Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by the Leukemia and Lymphoma Society and others.; Supported in part by grants from the Leukemia and Lymphoma Society, the Training Program in Molecular Hematology (5T32HL007781-20, to Dr. Maxson), the Charles and Ann Johnson Foundation (to Dr. Gotlib), the National Cancer Institute (1-K99-CA151670-01A1, to Dr. Agarwal), the National Center for Advancing Translational Sciences (5UL1RR024140) and the National Cancer Institute (5P30CA069533-13) (both to Mr. Bottomly and Drs. Wilmot and McWeeney), the National Heart, Lung, and Blood Institute (K08 HL106576, to Dr. Oh), and the St. Baldricks Foundation (to Dr. Chang), and by grants from the V Foundation for Cancer Research, Gabrielle's Angel Foundation for Cancer Research, the William Lawrence and Blanche Hughes Fund, and the National Cancer Institute (4 R00CA151457-03) (all to Dr. Tyner). Dr. Druker is an investigator of the Howard Hughes Medical Institute, and Dr. Deininger is a Scholar in Clinical Research of the Leukemia and Lymphoma Society.	Bain BJ, 2008, WHO CLASSIFICATION T, P38; Baxter EJ, 2005, LANCET, V366, P122; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Beekman R, 2012, BLOOD, V119, P5071, DOI 10.1182/blood-2012-01-406116; Beekman R, 2010, BLOOD, V115, P5131, DOI 10.1182/blood-2010-01-234120; Bicocca VT, 2012, CANCER CELL, V22, P656, DOI 10.1016/j.ccr.2012.08.027; Corey SJ, 1998, J BIOL CHEM, V273, P3230, DOI 10.1074/jbc.273.6.3230; COREY SJ, 1994, P NATL ACAD SCI USA, V91, P4683, DOI 10.1073/pnas.91.11.4683; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; DONG F, 1995, NEW ENGL J MED, V333, P487, DOI 10.1056/NEJM199508243330804; DONG F, 1994, P NATL ACAD SCI USA, V91, P4480, DOI 10.1073/pnas.91.10.4480; Dong F, 2001, J IMMUNOL, V167, P6447, DOI 10.4049/jimmunol.167.11.6447; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Froberg MK, 1998, LEUKEMIA, V12, P623, DOI 10.1038/sj.leu.2400938; Futami M, 2011, BLOOD, V118, P1077, DOI 10.1182/blood-2009-12-261636; Germeshausen M, 2007, BLOOD, V109, P93, DOI 10.1182/blood-2006-02-004275; Hermans MHA, 1998, BLOOD, V92, P32, DOI 10.1182/blood.V92.1.32.413k42_32_39; Hernandez JM, 2000, ANN ONCOL, V11, P441, DOI 10.1023/A:1008393002748; Hunter MG, 1999, BLOOD, V93, P440, DOI 10.1182/blood.V93.2.440.402k23_440_446; Hunter MG, 2000, BLOOD, V95, P2132, DOI 10.1182/blood.V95.6.2132; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Kunter G, 2011, EXP HEMATOL, V39, P1136, DOI 10.1016/j.exphem.2011.08.013; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; Longley BJ, 1996, NAT GENET, V12, P312, DOI 10.1038/ng0396-312; Matano S, 1997, AM J HEMATOL, V54, P72, DOI 10.1002/(SICI)1096-8652(199701)54:1<72::AID-AJH11>3.0.CO;2-C; Mitsui T, 2003, BLOOD, V101, P2990, DOI 10.1182/blood.V101.8.2990; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; Piazza R, 2013, NAT GENET, V45, P18, DOI 10.1038/ng.2495; Plo I, 2009, J EXP MED, V206, P1701, DOI 10.1084/jem.20090693; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; Steensma DP, 2005, BLOOD, V106, P1207, DOI 10.1182/blood-2005-03-1183; Tyner JW, 2013, CANCER RES, V73, P285, DOI 10.1158/0008-5472.CAN-12-1906; Tyner JW, 2009, P NATL ACAD SCI USA, V106, P8695, DOI 10.1073/pnas.0903233106; van de Geijn GJM, 2004, BLOOD, V104, P667, DOI 10.1182/blood-2003-08-2913; Vardiman JW, 2008, WHO CLASSIFICATION T, P80; Ward AC, 1999, BLOOD, V93, P447, DOI 10.1182/blood.V93.2.447; Zhu QS, 2004, BLOOD, V103, P3305, DOI 10.1182/blood-2003-06-1861	41	353	394	4	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2013	368	19					1781	1790		10.1056/NEJMoa1214514	http://dx.doi.org/10.1056/NEJMoa1214514			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138WA	23656643	Bronze, Green Accepted			2022-12-28	WOS:000318540000006
J	Dawson, AL; Dellavalle, RP				Dawson, Annelise L.; Dellavalle, Robert P.			Acne vulgaris	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ADAPALENE GEL 0.1-PERCENT; BENZOYL PEROXIDE GEL; DOUBLE-BLIND; FACIAL ACNE; TOPICAL ANTIBIOTICS; SYSTEMATIC REVIEWS; IMPROVE OUTCOMES; GLOBAL ALLIANCE; CLINDAMYCIN GEL; EFFICACY		[Dawson, Annelise L.] Brigham & Womens Hosp, Dept Internal Med, Boston, MA 02115 USA; [Dellavalle, Robert P.] Univ Colorado Denver, Dept Dermatol, Aurora, CO USA; [Dellavalle, Robert P.] Dept Vet Affairs Med Ctr, Dermatol Serv, Denver, CO 80220 USA; [Dellavalle, Robert P.] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA	Harvard University; Brigham & Women's Hospital; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Dellavalle, RP (corresponding author), Dept Vet Affairs Med Ctr, Dermatol Serv, Denver, CO 80220 USA.	robert.dellavalle@ucdenver.edu	Dellavalle, Robert/L-2020-2013	Dellavalle, Robert/0000-0001-8132-088X				Abad-Casintahan F, 2011, J DERMATOL, V38, P1041, DOI 10.1111/j.1346-8138.2011.01266.x; Archer CB, 2012, CLIN EXP DERMATOL, V37, P1, DOI 10.1111/j.1365-2230.2012.04335.x; Arowojolu AO, 2007, COCHRANE DB SYST REV, V1; Arowojolu AO, 2012, COCHRANE DB SYST REV, V7; Barnes LE, 2012, DERMATOL CLIN, V30, P293, DOI 10.1016/j.det.2011.11.001; Bossuyt L, 2003, EUR J DERMATOL, V13, P130; Bowe WP, 2008, SEMIN CUTAN MED SURG, V27, P170, DOI 10.1016/j.sder.2008.07.004; Bowe WP, 2010, J AM ACAD DERMATOL, V63, P124, DOI 10.1016/j.jaad.2009.07.043; Brown SK, 1998, LANCET, V351, P1871, DOI 10.1016/S0140-6736(98)01046-0; Chen WC, 2002, J INVEST DERMATOL, V119, P992, DOI 10.1046/j.1523-1747.2002.00613.x; Chivot M, 2005, AM J CLIN DERMATOL, V6, P13, DOI 10.2165/00128071-200506010-00002; Committee on Comparative Effectiveness Research Prioritization Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Cunliffe WJ, 2003, J AM ACAD DERMATOL, V49, pS218, DOI 10.1067/S0190-9622(03)01153-8; Cunliffe WJ, 2002, EUR J DERMATOL, V12, P350; Cunliffe WJ, 2002, CLIN THER, V24, P1117, DOI 10.1016/S0149-2918(02)80023-6; Cunliffe WJ, 1998, BRIT J DERMATOL, V139, P48; Del Rosso JQ, 2009, DERMATOL CLIN, V27, P33, DOI 10.1016/j.det.2008.07.006; DiGiovanna JJ, 2001, DERMATOL CLIN, V19, P161, DOI 10.1016/S0733-8635(05)70237-0; Dunn Lauren K, 2011, Dermatol Online J, V17, P1; Elston DM, 2009, DERMATOL CLIN, V27, P25, DOI 10.1016/j.det.2008.07.004; Fakhouri T, 2009, J DRUGS DERMATOL, V8, P657; Fitz-Gibbon S, 2013, J INVEST DERMATOL; Friedlander SF, 2011, SEMIN CUTAN MED SURG, V30, pS6, DOI 10.1016/j.sder.2011.07.002; Galvin SA, 1998, BRIT J DERMATOL, V139, P34; Gamble R, 2012, AM J CLIN DERMATOL, V13, P141, DOI 10.2165/11597880-000000000-00000; Garner SE, 2012, COCHRANE DB SYST REV, V8; George R, 2008, SEMIN CUTAN MED SURG, V27, P188, DOI 10.1016/j.sder.2008.06.002; Gold LS, 2010, CUTIS, V85, P94; Goldsmith LA, 2004, J AM ACAD DERMATOL, V50, P900, DOI 10.1016/j.jaad.2004.02.012; Gollnick H, 2003, J AM ACAD DERMATOL, V49, pS1, DOI 10.1067/mjd.2003.618; Gollnick HPM, 2008, AM J CLIN DERMATOL, V9, P279, DOI 10.2165/00128071-200809050-00001; Goodman Greg, 2009, Am J Clin Dermatol, V10 Suppl 1, P1, DOI 10.2165/0128071-200910001-00001; Goulden V, 1999, J AM ACAD DERMATOL, V41, P577, DOI 10.1016/S0190-9622(99)70300-2; Hahm BJ, 2009, J DERMATOL, V36, P255, DOI 10.1111/j.1346-8138.2009.00635.x; Haider A, 2004, JAMA-J AM MED ASSOC, V292, P726, DOI 10.1001/jama.292.6.726; Harper JC, 2004, J AM ACAD DERMATOL, V51, pS36, DOI 10.1016/j.jaad.2004.01.023; HUGHES BR, 1992, CLIN EXP DERMATOL, V17, P165, DOI 10.1111/j.1365-2230.1992.tb00196.x; Ingram JR, 2010, CLIN EXP DERMATOL, V35, P351, DOI 10.1111/j.1365-2230.2009.03683.x; Iraji F, 2007, INDIAN J DERMATOL VE, V73, P94, DOI 10.4103/0378-6323.31892; Jacobs DG, 2001, J AM ACAD DERMATOL, V45, pS168, DOI 10.1067/mjd.2001.118233; James WD, 2005, NEW ENGL J MED, V352, P1463, DOI 10.1056/NEJMcp033487; Knutsen-Larson S, 2012, DERMATOL CLIN, V30, P99, DOI 10.1016/j.det.2011.09.001; Leyden James J, 2002, Cutis, V69, P12; Leyden JJ, 2009, DERMATOL CLIN, V27, P1, DOI 10.1016/j.det.2008.07.008; Leyden JJ, 2006, J AM ACAD DERMATOL, V54, P73, DOI 10.1016/j.jaad.2005.04.046; Lookingbill DP, 1997, J AM ACAD DERMATOL, V37, P590, DOI 10.1016/S0190-9622(97)70177-4; Magin P, 2005, FAM PRACT, V22, P62, DOI 10.1093/fampra/cmh715; Marqueling AL, 2007, SEMIN CUTAN MED SURG, V26, P210, DOI 10.1016/j.sder.2008.03.005; Nast A, 2012, J EUR ACAD DERMATOL, V26, P1, DOI 10.1111/j.1468-3083.2011.04374.x; Newman MD, 2011, AM J CLIN DERMATOL, V12, P7, DOI 10.2165/11532280-000000000-00000; Newton JN, 1997, DERMATOLOGY, V195, P10, DOI 10.1159/000246014; Ozolins M, 2004, LANCET, V364, P2188, DOI 10.1016/S0140-6736(04)17591-0; Popescu, 2003, COCHRANE COLLABORATI; Purdy S, 2006, BMJ-BRIT MED J, V333, P949, DOI 10.1136/bmj.38987.606701.80; Ramanathan S, 2011, J PEDIATR HEALTH CAR, V25, P332, DOI 10.1016/j.pedhc.2011.05.007; Schafer T, 2001, BRIT J DERMATOL, V145, P100, DOI 10.1046/j.1365-2133.2001.04290.x; Simonart T, 2008, BRIT J DERMATOL, V158, P208, DOI 10.1111/j.1365-2133.2007.08286.x; Simonart T, 2005, BRIT J DERMATOL, V153, P395, DOI 10.1111/j.1365-2133.2005.06614.x; Simpson RC, 2011, CLIN EXP DERMATOL, V36, P840, DOI 10.1111/j.1365-2230.2011.04218.x; Smith EV, 2011, CLIN EXP DERMATOL, V36, P119, DOI 10.1111/j.1365-2230.2010.03921.x; Smith RN, 2007, J AM ACAD DERMATOL, V57, P247, DOI 10.1016/j.jaad.2007.01.046; Spencer EH, 2009, INT J DERMATOL, V48, P339, DOI 10.1111/j.1365-4632.2009.04002.x; STAINFORTH JM, 1993, BRIT J DERMATOL, V129, P297, DOI 10.1111/j.1365-2133.1993.tb11850.x; Strauss JS, 2007, J AM ACAD DERMATOL, V56, P651, DOI 10.1016/j.jaad.2006.08.048; Tan HH, 2004, AM J CLIN DERMATOL, V5, P79, DOI 10.2165/00128071-200405020-00002; Tanghetti E, 2010, J DRUGS DERMATOL, V9, P549; Thiboutot D, 2008, J DRUGS DERMATOL, V7, P13; Thiboutot D, 2009, J AM ACAD DERMATOL, V60, pS1, DOI 10.1016/j.jaad.2009.01.019; Thiboutot Diane M, 2005, Skinmed, V4, P138; Thielitz A, 2008, AM J CLIN DERMATOL, V9, P369, DOI 10.2165/0128071-200809060-00003; van Vloten WA, 2004, AM J CLIN DERMATOL, V5, P435, DOI 10.2165/00128071-200405060-00008; Webster Guy F, 2002, Cutis, V69, P4; Wessels F, 1999, S AFR MED J, V89, P780; White G M, 1999, Adv Dermatol, V14, P29; White GM, 1998, ARCH DERMATOL, V134, P376, DOI 10.1001/archderm.134.3.376; White GM, 1999, ADV DERMATOL, V14, P59; Williams HC, 2012, LANCET, V379, P361, DOI 10.1016/S0140-6736(11)60321-8; Yentzer BA, 2010, CUTIS, V86, P103; Yentzer BA, 2010, CUTIS, V86, P94	79	72	77	0	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 8	2013	346								f2634	10.1136/bmj.f2634	http://dx.doi.org/10.1136/bmj.f2634			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144BS	23657180				2022-12-28	WOS:000318915000008
J	Holmes, D				Holmes, David			Judith MacKay: self-made scourge of the tobacco industry Profile	LANCET			English	Biographical-Item																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 4	2013	381	9877					1531	1531		10.1016/S0140-6736(13)60969-1	http://dx.doi.org/10.1016/S0140-6736(13)60969-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139UF	23642690				2022-12-28	WOS:000318609600014
J	Islam, R; Senko, C; Campbell, WC; Korenblit, S; Smith, J; Lee, A; Edwards, EE; Wang, CCJ; Freericks, JK; Monroe, C				Islam, R.; Senko, C.; Campbell, W. C.; Korenblit, S.; Smith, J.; Lee, A.; Edwards, E. E.; Wang, C. -C. J.; Freericks, J. K.; Monroe, C.			Emergence and Frustration of Magnetism with Variable-Range Interactions in a Quantum Simulator	SCIENCE			English	Article							TRAPPED IONS; SPINS	Frustration, or the competition between interacting components of a network, is often responsible for the emergent complexity of many-body systems. For instance, frustrated magnetism is a hallmark of poorly understood systems such as quantum spin liquids, spin glasses, and spin ices, whose ground states can be massively degenerate and carry high degrees of quantum entanglement. Here, we engineer frustrated antiferromagnetic interactions between spins stored in a crystal of up to 16 trapped Yb-171(+) atoms. We control the amount of frustration by continuously tuning the range of interaction and directly measure spin correlation functions and their coherent dynamics. This prototypical quantum simulation points the way toward a new probe of frustrated quantum magnetism and perhaps the design of new quantum materials.	[Islam, R.; Senko, C.; Campbell, W. C.; Korenblit, S.; Smith, J.; Lee, A.; Edwards, E. E.; Monroe, C.] Univ Maryland, Dept Phys, Joint Quantum Inst, College Pk, MD 20742 USA; [Islam, R.; Senko, C.; Campbell, W. C.; Korenblit, S.; Smith, J.; Lee, A.; Edwards, E. E.; Monroe, C.] NIST, College Pk, MD 20742 USA; [Wang, C. -C. J.; Freericks, J. K.] Georgetown Univ, Dept Phys, Washington, DC 20057 USA	University System of Maryland; University of Maryland College Park; National Institute of Standards & Technology (NIST) - USA; Georgetown University	Monroe, C (corresponding author), Univ Maryland, Dept Phys, Joint Quantum Inst, College Pk, MD 20742 USA.	monroe@umd.edu	Monroe, Christopher R/G-8105-2011; Freericks, James K/D-7502-2011	Freericks, James K/0000-0002-6232-9165; Campbell, Wesley/0000-0003-1578-906X	U.S. Army Research Office (ARO) [W911NF0710576]; Defense Advanced Research Projects Agency Optical Lattice Emulator Program, ARO [W911NF0410234]; Intelligence Advanced Research Projects Activity; NSF Physics Frontier Center at the Joint Quantum Institute; McDevitt bequest at Georgetown; Direct For Mathematical & Physical Scien [0822671] Funding Source: National Science Foundation	U.S. Army Research Office (ARO); Defense Advanced Research Projects Agency Optical Lattice Emulator Program, ARO; Intelligence Advanced Research Projects Activity; NSF Physics Frontier Center at the Joint Quantum Institute; McDevitt bequest at Georgetown; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank E. Demler, L. Duan, D. Huse, K. Kim, P. Richerme, R. Sensarma, and P. Zoller for critical discussions. This work is supported by the U.S. Army Research Office (ARO) award W911NF0710576 with funds from the Defense Advanced Research Projects Agency Optical Lattice Emulator Program, ARO award W911NF0410234 with funds from the Intelligence Advanced Research Projects Activity, and the NSF Physics Frontier Center at the Joint Quantum Institute. J.K.F. was also supported by the McDevitt bequest at Georgetown.	BINDER K, 1981, PHYS REV LETT, V47, P693, DOI 10.1103/PhysRevLett.47.693; Bloch I, 2012, NAT PHYS, V8, P267, DOI [10.1038/nphys2259, 10.1038/NPHYS2259]; Britton JW, 2012, NATURE, V484, P489, DOI 10.1038/nature10981; Campbell WC, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.090502; Diep HT, 2005, FRUSTRATED SPIN SYSTEMS, P1, DOI 10.1142/9789812567819; Edwards EE, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.060412; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Friedenauer A, 2008, NAT PHYS, V4, P757, DOI 10.1038/nphys1032; Islam R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1374; Jo GB, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.045305; Khromova A, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.220502; Kim K, 2010, NATURE, V465, P590, DOI 10.1038/nature09071; Kim K, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.120502; Moessner R, 2006, PHYS TODAY, V59, P24, DOI 10.1063/1.2186278; Moessner R, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.224401; Olmschenk S, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.052314; Porras D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.207901; Sachdev S., 1999, QUANTUM PHASE TRANSI; Sandvik AW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.137204; Shen C, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/5/053053; Simon J, 2011, NATURE, V472, P307, DOI 10.1038/nature09994; Wang CCJ, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.032329	23	314	314	5	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2013	340	6132					583	587		10.1126/science.1232296	http://dx.doi.org/10.1126/science.1232296			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23641112	Green Submitted			2022-12-28	WOS:000318268900041
J	Thomas, KS; Crook, AM; Nunn, AJ; Foster, KA; Mason, JM; Chalmers, JR; Nasr, IS; Brindle, RJ; English, J; Meredith, SK; Reynolds, NJ; de Berker, D; Mortimer, PS; Williams, HC				Thomas, Kim S.; Crook, Angela M.; Nunn, Andrew J.; Foster, Katharine A.; Mason, James M.; Chalmers, Joanne R.; Nasr, Ibrahim S.; Brindle, Richard J.; English, John; Meredith, Sarah K.; Reynolds, Nicholas J.; de Berker, David; Mortimer, Peter S.; Williams, Hywel C.		UK Dermatology Clinical Trials Net	Penicillin to Prevent Recurrent Leg Cellulitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOWER-LIMB CELLULITIS; ERYSIPELAS; PROPHYLAXIS; TRIALS	BACKGROUND Cellulitis of the leg is a common bacterial infection of the skin and underlying tissue. We compared prophylactic low-dose penicillin with placebo for the prevention of recurrent cellulitis. METHODS We conducted a double-blind, randomized, controlled trial involving patients with two or more episodes of cellulitis of the leg who were recruited in 28 hospitals in the United Kingdom and Ireland. Randomization was performed according to a computer-generated code, and study medications (penicillin [250 mg twice a day] or placebo for 12 months) were dispensed by a central pharmacy. The primary outcome was the time to a first recurrence. Participants were followed for up to 3 years. Because the risk of recurrence was not constant over the 3-year period, the primary hypothesis was tested during prophylaxis only. RESULTS A total of 274 patients were recruited. Baseline characteristics were similar in the two groups. The median time to a first recurrence of cellulitis was 626 days in the penicillin group and 532 days in the placebo group. During the prophylaxis phase, 30 of 136 participants in the penicillin group (22%) had a recurrence, as compared with 51 of 138 participants in the placebo group (37%) (hazard ratio, 0.55; 95% confidence interval [CI], 0.35 to 0.86; P = 0.01), yielding a number needed to treat to prevent one recurrent cellulitis episode of 5 (95% CI, 4 to 9). During the no-intervention follow-up period, there was no difference between groups in the rate of a first recurrence (27% in both groups). Overall, participants in the penicillin group had fewer repeat episodes than those in the placebo group (119 vs. 164, P = 0.02 for trend). There was no significant between-group difference in the number of participants with adverse events (37 in the penicillin group and 48 in the placebo group, P = 0.50). CONCLUSIONS In patients with recurrent cellulitis of the leg, penicillin was effective in preventing subsequent attacks during prophylaxis, but the protective effect diminished progressively once drug therapy was stopped. (Funded by Action Medical Research; PATCH I Controlled-Trials.com number, ISRCTN34716921.)	[Thomas, Kim S.; Foster, Katharine A.; Chalmers, Joanne R.; Williams, Hywel C.] Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham NG7 2NR, England; [English, John] Nottingham Univ Hosp Natl Hlth Serv Trust, Dept Dermatol, Nottingham, England; [Crook, Angela M.; Nunn, Andrew J.; Meredith, Sarah K.] St Georges Univ London, Clin Trials Unit, MRC, London, England; [Mortimer, Peter S.] St Georges Univ London, Div Clin Sci, London, England; [Mason, James M.] Univ Durham, Sch Med Pharm & Hlth, Durham, England; [Nasr, Ibrahim S.] Royal Berkshire Hosp, Dept Dermatol, Reading RG1 5AN, Berks, England; [Brindle, Richard J.] Bristol Royal Infirm & Gen Hosp, Dept Microbiol, Bristol, Avon, England; [de Berker, David] Bristol Royal Infirm & Gen Hosp, Dept Dermatol, Bristol, Avon, England; [Reynolds, Nicholas J.] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Nottingham; Nottingham University Hospital NHS Trust; Medical Research Council Clinical Trials Unit; St Georges University London; St Georges University London; Durham University; Royal Berkshire Hospital; Bristol Royal Infirmary; Bristol Royal Infirmary; Newcastle University - UK	Williams, HC (corresponding author), Univ Nottingham, Ctr Evidence Based Dermatol, Kings Meadow Campus, Nottingham NG7 2NR, England.	hywel.williams@nottingham.ac.uk	Mason, James M/D-9904-2011	Mason, James M/0000-0001-9210-4082; Chalmers, Joanne/0000-0002-2281-7367; Nasr, Ibrahim/0000-0001-7105-2594; Nunn, Andrew/0000-0002-9158-4595; Reynolds, Nick/0000-0002-6484-825X; Levell, Nick/0000-0003-3393-8305; williams, hywel/0000-0002-5646-3093; Layton, Alison/0000-0003-0473-3319; Thomas, Kim/0000-0001-7785-7465	Action Medical Research [SP4063]; Medical Research Council [MC_UU_12010/5, G0701693, G1000800h, MC_U137881017] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10246] Funding Source: researchfish; Alzheimer&quot;s Society [1651] Funding Source: researchfish; MRC [G0701693, MC_U137881017, MC_UU_12010/5] Funding Source: UKRI	Action Medical Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Alzheimer&quot;s Society; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by a grant from Action Medical Research (SP4063).	[Anonymous], 2010, CONS DOC MAN CELL LY; [Anonymous], 2010, UN COSTS HLTH SOC CA; [Anonymous], 2011, RES SURV WEBS BACT S; [Anonymous], 2010, PRESCR COST AN ENGL; [Anonymous], 2011, NAT SCHED REF COSTS; Barber JA, 2000, STAT MED, V19, P3219, DOI 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P; BERNARD P, 1989, ARCH DERMATOL, V125, P779, DOI 10.1001/archderm.125.6.779; CHAKROUN M, 1994, MED MALADIES INFECT, V24, P894, DOI 10.1016/S0399-077X(05)80579-7; Clinical Resource Efficiency Support Team, 2005, GUID MAN CELL AD; Cox NH, 2006, BRIT J DERMATOL, V155, P947, DOI 10.1111/j.1365-2133.2006.07419.x; Cox NH, 1998, J ROY SOC MED, V91, P634, DOI 10.1177/014107689809101206; Dalal A, 2012, COCHRANE DB SYST REV, V4; Damstra RJ, 2008, BRIT J DERMATOL, V158, P1210, DOI 10.1111/j.1365-2133.2008.08503.x; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Jeng A, 2010, MEDICINE, V89, P217, DOI 10.1097/MD.0b013e3181e8d635; JORUPRONSTROM C, 1987, INFECTION, V15, P105, DOI 10.1007/BF01650206; KREMER M, 1991, J INFECTION, V22, P37, DOI 10.1016/0163-4453(91)90898-3; Levell NJ, 2011, BRIT J DERMATOL, V164, P1326, DOI 10.1111/j.1365-2133.2011.10275.x; SJOBLOM AC, 1993, INFECTION, V21, P390, DOI 10.1007/BF01728920; Soo JK, 2008, BRIT J DERMATOL, V158, P1350, DOI 10.1111/j.1365-2133.2007.08423.x; Thomas K, 2012, BRIT J DERMATOL, V166, P169, DOI 10.1111/j.1365-2133.2011.10586.x	21	96	96	0	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 2	2013	368	18					1695	1703		10.1056/NEJMoa1206300	http://dx.doi.org/10.1056/NEJMoa1206300			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134MN	23635049	Green Published			2022-12-28	WOS:000318214400003
J	McKenna, LA; Drummond, RS; Drummond, S; Talwar, D; Lean, MEJ				McKenna, Louise A.; Drummond, Russell S.; Drummond, Suzannah; Talwar, Dinesh; Lean, Michael E. J.			Seeing double: the low carb diet	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							THIAMIN; RELEVANCE		[McKenna, Louise A.; Drummond, Russell S.] Glasgow Royal Infirm, Dept Diabet & Endocrinol, Glasgow G4 0SF, Lanark, Scotland; [Drummond, Suzannah] Glasgow Royal Infirm, Dept Ophthalmol, Glasgow G4 0SF, Lanark, Scotland; [Talwar, Dinesh] Glasgow Royal Infirm, Dept Pathol Biochem, Glasgow G4 0SF, Lanark, Scotland; [Lean, Michael E. J.] Glasgow Royal Infirm, Dept Human Nutr, Glasgow G4 0SF, Lanark, Scotland	University of Glasgow; University of Glasgow; University of Glasgow; University of Glasgow	McKenna, LA (corresponding author), Glasgow Royal Infirm, Dept Diabet & Endocrinol, Glasgow G4 0SF, Lanark, Scotland.	louise.mckenna@glasgow.ac.uk						Ahmed W, 2001, AM J MED SCI, V321, P280, DOI 10.1097/00000441-200104000-00007; Betrosian AP, 2004, AM J MED SCI, V327, P250, DOI 10.1097/00000441-200405000-00020; Department of Health. Dietary reference values for food energy and nutrients for the United Kingdom, 1991, REP HLTH SOC SUBJ LO, V41, P1; Depeint F, 2006, CHEM-BIOL INTERACT, V163, P94, DOI 10.1016/j.cbi.2006.04.014; Eisinger Jean, 1994, Magnesium Research, V7, P59; Electronic Medicines Compendium, PABR INTR HIGH POT I; Erlinger S, 2000, EUR J GASTROEN HEPAT, V12, P1347, DOI 10.1097/00042737-200012120-00015; Galvin R, 2010, EUR J NEUROL, V17, P1408, DOI 10.1111/j.1468-1331.2010.03153.x; Hazell AS, 2009, NEUROCHEM INT, V55, P129, DOI 10.1016/j.neuint.2009.02.020; Lau S, 2011, B R COLL PATHOL, V155, P172; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241; *NAT OB FOR, 2010, POS STAT APPL VER LO; Porfido D, 2010, EYE BRAIN, V2, P95; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Sole MJ, 2002, HERZ, V27, P174, DOI 10.1007/s00059-002-2360-0; Talwar D, 2000, CLIN CHEM, V46, P704; Vezina WC, 1998, DIGEST DIS SCI, V43, P554, DOI 10.1023/A:1018863108262; Vognar L, 2009, J AM GERIATR SOC, V57, P2166, DOI 10.1111/j.1532-5415.2009.02542.x; Wooley JA, 2008, NUTR CLIN PRACT, V23, P487, DOI 10.1177/0884533608323430; [No title captured]	20	7	7	0	33	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2013	346								f2563	10.1136/bmj.f2563	http://dx.doi.org/10.1136/bmj.f2563			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139EK	23635648	Green Submitted, Green Accepted			2022-12-28	WOS:000318564300009
J	Shabiyulla, RR				Shabiyulla, Rafiqu Rahman			A pain in the neck type of headache	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTRACRANIAL CAVERNOUS MALFORMATIONS; PONTINE-HEMORRHAGE; CAPILLARY TELANGIECTASIA; CLINICAL-FEATURES; BRAIN		Crosshouse Hosp, Dept Anaesthet, Kilmarnock KA2 0BE, Scotland		Shabiyulla, RR (corresponding author), Crosshouse Hosp, Dept Anaesthet, Kilmarnock KA2 0BE, Scotland.	r.shabiyulla@nhs.net						Abdulrauf SI, 1999, NEUROSURGERY, V44, P41, DOI 10.1097/00006123-199901000-00020; Arboix A, 2008, MED CLIN-BARCELONA, V130, P339, DOI 10.1157/13117356; Bertalanffy H, 2002, NEUROSURG REV, V25, P1, DOI 10.1007/s101430100179; Broyd C, 2006, EMERG MED J, V23, DOI 10.1136/emj.2005.031690; Castillo M, 2001, AM J NEURORADIOL, V22, P1553; Chen LA, 2011, NEUROSURGERY, V68, P609, DOI 10.1227/NEU.0b013e3182077531; Gaillard F, PONTINE HAEMORRHAGE; Garrett M, 2009, SURG NEUROL, V72, P3, DOI 10.1016/j.surneu.2009.05.031; Hsiao MC, 2006, NEUROL INDIA, V54, P431; Jumani MI, 2010, JCPSP-J COLL PHYSICI, V20, P692, DOI 10.2010/JCPSP.692694; Kim YK, 2009, THROMB RES, V123, P810, DOI 10.1016/j.thromres.2009.01.013; Lee C, 1996, AM J NEURORADIOL, V17, P61; Lee RR, 1997, RADIOLOGY, V205, P797, DOI 10.1148/radiology.205.3.9393538; Liebeskind D, BRAINSTEM HAEMORRHAG; Marcoux M., 2000, CNI REV MED J, V11; MCCORMICK WF, 1966, J NEUROSURG, V24, P807, DOI 10.3171/jns.1966.24.4.0807; Miyashita Tomoko, 2007, J Forensic Leg Med, V14, P444, DOI 10.1016/j.jflm.2007.01.006; Moriarity JL, 1999, NEUROSURGERY, V44, P1166, DOI 10.1097/00006123-199906000-00003; Niknejad MT, CEREBRAL ARTERIOVENO; Novak-Grubic V, 2001, ACTA PSYCHIAT SCAND, V103, P400, DOI 10.1034/j.1600-0447.2001.00246.x; Park DH, 2007, CLIN NEUROL NEUROSUR, V109, P803, DOI 10.1016/j.clineuro.2007.06.006; Rabinstein AA, 2004, CEREBROVASC DIS, V17, P66, DOI 10.1159/000073900; Riagamonti D, 1988, ACTA NEUROCHIR, V92, P100; Rivera PP, 2003, NEUROIMAG CLIN N AM, V13, P27, DOI 10.1016/S1052-5149(02)00060-6; ROBINSON JR, 1993, NEUROSURGERY, V33, P547, DOI 10.1227/00006123-199310000-00001; Stanislavsky A, CEREBRAL CAVERNOUS M; Weerakkody Y, DEV VENOUS ANOMALY; Wessels T, 2004, AM J NEURORADIOL, V25, P257; Yeh YF, 1996, BRIT J RADIOL, V69, P368, DOI 10.1259/0007-1285-69-820-368; Zhao Y, 2007, SURG NEUROL, V68, P493, DOI 10.1016/j.surneu.2007.02.044	30	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2013	346								f2509	10.1136/bmj.f2509	http://dx.doi.org/10.1136/bmj.f2509			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139DK	23628749				2022-12-28	WOS:000318561600001
J	Ota, H; Sakurai, M; Gupta, R; Valente, L; Wulff, BE; Ariyoshi, K; Iizasa, H; Davuluri, RV; Nishikura, K				Ota, Hiromitsu; Sakurai, Masayuki; Gupta, Ravi; Valente, Louis; Wulff, Bjorn-Erik; Ariyoshi, Kentaro; Iizasa, Hisashi; Davuluri, Ramana V.; Nishikura, Kazuko			ADAR1 Forms a Complex with Dicer to Promote MicroRNA Processing and RNA-Induced Gene Silencing	CELL			English	Article							DOUBLE-STRANDED-RNA; INDUCED APOPTOSIS; DEAMINASES; DOMAIN; TRBP; CLEAVAGE; INTERFERENCE; DIMERIZATION; SUPPRESSION; BIOGENESIS	Adenosine deaminases acting on RNA (ADARs) are involved in RNA editing that converts adenosine residues to inosine specifically in double-stranded RNAs. In this study, we investigated the interaction of the RNA editing mechanism with the RNA interference (RNAi) machinery and found that ADAR1 forms a complex with Dicer through direct protein-protein interaction. Most importantly, ADAR1 increases the maximum rate (V-max) of pre-microRNA (miRNA) cleavage by Dicer and facilitates loading of miRNA onto RNA-induced silencing complexes, identifying a new role of ADAR1 in miRNA processing and RNAi mechanisms. ADAR1 differentiates its functions in RNA editing and RNAi by the formation of either ADAR1/ADAR1 homodimer or Dicer/ADAR1 heterodimer complexes, respectively. As expected, the expression of miRNAs is globally inhibited in ADAR1(-/-) mouse embryos, which, in turn, alters the expression of their target genes and might contribute to their embryonic lethal phenotype.	[Ota, Hiromitsu; Sakurai, Masayuki; Gupta, Ravi; Valente, Louis; Wulff, Bjorn-Erik; Ariyoshi, Kentaro; Iizasa, Hisashi; Davuluri, Ramana V.; Nishikura, Kazuko] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	The Wistar Institute	Nishikura, K (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	kazuko@wistar.org	Iizasa, Hisashi/A-9821-2012; Sakurai, Masayuki/AAR-8939-2021; Ariyoshi, Kentaro/L-8742-2018	Sakurai, Masayuki/0000-0002-6920-1746; Ariyoshi, Kentaro/0000-0002-4639-6130; Gupta, Ravi/0000-0001-5242-9528	National Institutes of Health [GM040536, HL070045, HL099342]; Ellison Medical Foundation [AG-55-2281-09]; Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health; University of Pennsylvania, Vagelos scholarship; Japan Society for the Promotion of Science (JSPS) [2010-22]; National Cancer Institute [P30 CA010815]; NATIONAL CANCER INSTITUTE [P30CA010815, P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070045, RC1HL099342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040536] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health; University of Pennsylvania, Vagelos scholarship; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank Jennifer A. Doudna for the pre-let-7a template plasmid, Zissimos Mourelatos for discussion on RISC loading analysis, and John M. Murray for discussion on enzyme kinetics analysis and also critical reading of the manuscript. This work was supported by grants from the National Institutes of Health (GM040536, HL070045, and HL099342), the Ellison Medical Foundation (AG-55-2281-09), and the Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health (to K.N.). B.-E.W. is a recipient of a University of Pennsylvania, Vagelos scholarship. M.S. is supported in part by a fellowship from the Japan Society for the Promotion of Science (JSPS 2010-22). We are also grateful for services provided by the Protein Expression, Genomics, and Bioinformatics Shared Facilities of The Wistar Cancer Center, which are supported by the National Cancer Institute (P30 CA010815).	Chakravarthy S, 2010, J MOL BIOL, V404, P392, DOI 10.1016/j.jmb.2010.09.030; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cho DSC, 2003, J BIOL CHEM, V278, P17093, DOI 10.1074/jbc.M213127200; Daniels SM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-38; Dlakic M, 2006, BIOINFORMATICS, V22, P2711, DOI 10.1093/bioinformatics/btl468; FerreDAmare AR, 1996, NUCLEIC ACIDS RES, V24, P977, DOI 10.1093/nar/24.5.977; Fritz J, 2009, MOL CELL BIOL, V29, P1487, DOI 10.1128/MCB.01519-08; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Hitti EG, 2004, FEBS LETT, V574, P25, DOI 10.1016/j.febslet.2004.07.080; Hood JL, 2012, CURR TOP MICROBIOL, V353, P61, DOI 10.1007/82_2011_157; Iizasa H, 2010, J BIOL CHEM, V285, P33358, DOI 10.1074/jbc.M110.138362; Kawahara Y, 2008, NUCLEIC ACIDS RES, V36, P5270, DOI 10.1093/nar/gkn479; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Koscianska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028548; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; LAI F, 1995, J BIOL CHEM, V270, P17098, DOI 10.1074/jbc.270.29.17098; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Nasser MW, 2008, J BIOL CHEM, V283, P33394, DOI 10.1074/jbc.M804788200; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/NMETH.1982, 10.1038/nmeth.1982]; Rowe TM, 2006, P NATL ACAD SCI USA, V103, P5823, DOI 10.1073/pnas.0601287103; Scadden ADJ, 2005, NAT STRUCT MOL BIOL, V12, P489, DOI 10.1038/nsmb936; Valente L, 2007, J BIOL CHEM, V282, P16054, DOI 10.1074/jbc.M611392200; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Wu CN, 2012, J LIPID RES, V53, P2355, DOI 10.1194/jlr.M028878; Wu D, 2011, NAT STRUCT MOL BIOL, V18, P1094, DOI 10.1038/nsmb.2129; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhong J, 1999, NAT GENET, V22, P171, DOI 10.1038/9684	39	223	231	1	51	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 25	2013	153	3					575	589		10.1016/j.cell.2013.03.024	http://dx.doi.org/10.1016/j.cell.2013.03.024			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622242	Green Accepted, Bronze			2022-12-28	WOS:000318063500011
J	Waight, AB; Pedersen, BP; Schlessinger, A; Bonomi, M; Chau, BH; Roe-Zurz, Z; Risenmay, AJ; Sali, A; Stroud, RM				Waight, Andrew B.; Pedersen, Bjorn Panyella; Schlessinger, Avner; Bonomi, Massimiliano; Chau, Bryant H.; Roe-Zurz, Zygy; Risenmay, Aaron J.; Sali, Andrej; Stroud, Robert M.			Structural basis for alternating access of a eukaryotic calcium/proton exchanger	NATURE			English	Article							CATION/H+ EXCHANGER; MOLECULAR-DYNAMICS; MEMBRANE-PROTEINS; INTERNAL REPEATS; VACUOLAR; CA2+; IDENTIFICATION; TRANSPORT; RESIDUES; YEAST	Eukaryotic Ca2+ regulation involves sequestration into intracellular organelles, and expeditious Ca2+ release into the cytosol is a hallmark of key signalling transduction pathways. Bulk removal of Ca2+ after such signalling events is accomplished by members of the Ca2+: cation (CaCA) superfamily(1-5). The CaCA superfamily includes the Na+/Ca2+ (NCX) and Ca2+/H+ (CAX) antiporters, and in mammals the NCX and related proteins constitute families SLC8 and SLC24, and are responsible for the re-establishment of Ca2+ resting potential in muscle cells, neuronal signalling and Ca2+ reabsorption in the kidney(1,6). The CAX family members maintain cytosolic Ca2+ homeostasis in plants and fungi during steep rises in intracellular Ca2+ due to environmental changes, or following signal transduction caused by events such as hyperosmotic shock, hormone response and response to mating pheromones(7-13). The cytosol-facing conformations within the CaCA superfamily are unknown, and the transport mechanism remains speculative. Here we determine a crystal structure of the Saccharomyces cerevisiae vacuolar Ca2+/H+ exchanger (Vcx1) at 2.3 angstrom resolution in a cytosol-facing, substrate-bound conformation. Vcx1 is the first structure, to our knowledge, within the CAX family, and it describes the key cytosol-facing conformation of the CaCA superfamily, providing the structural basis for a novel alternating access mechanism by which the CaCA superfamily performs high-throughput Ca2+ transport across membranes.	[Waight, Andrew B.; Pedersen, Bjorn Panyella; Chau, Bryant H.; Roe-Zurz, Zygy; Risenmay, Aaron J.; Stroud, Robert M.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Schlessinger, Avner; Bonomi, Massimiliano; Sali, Andrej] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, Dept Pharmaceut Chem, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stroud, RM (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	stroud@msg.ucsf.edu	Pedersen, Bjørn/H-4128-2017; Pedersen, Bjørn/AAT-2409-2021	Pedersen, Bjørn/0000-0001-7860-7230; Pedersen, Bjørn/0000-0001-7860-7230; Bonomi, Massimiliano/0000-0002-7321-0004	Carlsberg Foundation; Danish Cancer Society; NIH [U54 GM094625, U01 GM61390, GM24485, GM073210]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061390, T32GM008284, R01GM024485, P50GM073210, U54GM094625, R37GM024485, U19GM061390] Funding Source: NIH RePORTER	Carlsberg Foundation(Carlsberg Foundation); Danish Cancer Society(Danish Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Holton, G. Meigs, C. Ogata, N. Venugopalan and T. Doukov for assistance with synchrotron data collection at Advanced Light Source, Advanced Photon Source and Stanford Synchrotron Radiation Lightsource; and C. Waddling and P. Wassam for technical assistance. B. P. P. was supported by a postdoctoral fellowship from the Carlsberg Foundation and later by a fellowship from the Danish Cancer Society; A. S. by NIH grants U54 GM094625 and U01 GM61390; R. M. S. by NIH grants U54 GM094625, GM24485 and GM073210.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], PYMOL MOL GRAPH SYST; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Cheng NH, 2003, PLANT CELL, V15, P347, DOI 10.1105/tpc.007385; Cho D, 2012, PLANT PHYSIOL, V160, P1293, DOI 10.1104/pp.112.201442; CRESPO LM, 1990, NATURE, V345, P618, DOI 10.1038/345618a0; Cui J, 2009, CELL CALCIUM, V45, P123, DOI 10.1016/j.ceca.2008.07.005; Cunningham KW, 2011, CELL CALCIUM, V50, P129, DOI 10.1016/j.ceca.2011.01.010; Denis V, 2002, J CELL BIOL, V156, P29, DOI 10.1083/jcb.200111004; DUNN T, 1994, J BIOL CHEM, V269, P7273; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hirschi KD, 1996, P NATL ACAD SCI USA, V93, P8782, DOI 10.1073/pnas.93.16.8782; IVEY DM, 1993, J BIOL CHEM, V268, P11296; Iwamoto T, 1999, FEBS LETT, V446, P264, DOI 10.1016/S0014-5793(99)00218-5; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamiya T, 2004, J BIOL CHEM, V279, P812, DOI 10.1074/jbc.M309726200; Kang KJ, 2005, J BIOL CHEM, V280, P6823, DOI 10.1074/jbc.M407933200; Li M, 2009, J MOL BIOL, V385, P820, DOI 10.1016/j.jmb.2008.11.021; Liao J, 2012, SCIENCE, V335, P686, DOI 10.1126/science.1215759; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Lytton J, 2007, BIOCHEM J, V406, P365, DOI 10.1042/BJ20070619; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; MATSUOKA S, 1993, P NATL ACAD SCI USA, V90, P3870, DOI 10.1073/pnas.90.9.3870; Miseta A, 1999, FEBS LETT, V451, P132, DOI 10.1016/S0014-5793(99)00519-0; Nicoll DA, 1996, J BIOL CHEM, V271, P13385, DOI 10.1074/jbc.271.23.13385; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; OHSUMI Y, 1983, J BIOL CHEM, V258, P5614; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Pittman JK, 2002, PLANT PHYSIOL, V130, P1054, DOI 10.1104/pp.008193; Pittman JK, 2001, PLANT PHYSIOL, V127, P1020, DOI 10.1104/pp.010409; Pozos TC, 1996, MOL CELL BIOL, V16, P3730; Ridilla M, 2012, BIOCHEMISTRY-US, V51, P9603, DOI 10.1021/bi3012109; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schwarz EM, 1997, P NATL ACAD SCI USA, V94, P10249, DOI 10.1073/pnas.94.19.10249; Shigaki T, 2006, J MOL EVOL, V63, P815, DOI 10.1007/s00239-006-0048-4; Shigaki T, 2005, J BIOL CHEM, V280, P30136, DOI 10.1074/jbc.M503610200; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Winkfein RJ, 2003, BIOCHEMISTRY-US, V42, P543, DOI 10.1021/bi026982x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	53	66	68	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 4	2013	499	7456					107	110		10.1038/nature12233	http://dx.doi.org/10.1038/nature12233			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23685453	Green Accepted, Green Submitted			2022-12-28	WOS:000321285600043
J	Bhutta, ZA; Hafeez, A; Rizvi, A; Ali, N; Khan, A; Ahmad, F; Bhutta, S; Hazir, T; Zaidi, A; Jafarey, SN				Bhutta, Zulfiqar A.; Hafeez, Assad; Rizvi, Arjumand; Ali, Nabeela; Khan, Amanullah; Ahmad, Faatehuddin; Bhutta, Shereen; Hazir, Tabish; Zaidi, Anita; Jafarey, Sadequa N.			Reproductive, maternal, newborn, and child health in Pakistan: challenges and opportunities	LANCET			English	Article							COMMUNITY CASE-MANAGEMENT; AGED 2-59 MONTHS; ORAL AMOXICILLIN; SEVERE PNEUMONIA; INTERVENTIONS; COUNTRIES; MORTALITY; SURVIVAL; DECADE; CARE	Globally, Pakistan has the third highest burden of maternal, fetal, and child mortality. It has made slow progress in achieving the Millennium Development Goals (MDGs) 4 and 5 and in addressing common social determinants of health. The country also has huge challenges of political fragility, complex security issues, and natural disasters. We undertook an in-depth analysis of Pakistan's progress towards MDGs 4 and 5 and the principal determinants of health in relation to reproductive, maternal, newborn, and child health and nutrition. We reviewed progress in relation to new and existing public sector programmes and the challenges posed by devolution in Pakistan. Notwithstanding the urgent need to tackle social determinants such as girls' education, empowerment, and nutrition in Pakistan, we assessed the effect of systematically increasing coverage of various evidence-based interventions on populations at risk (by residence or poverty indices). We specifically focused on scaling up interventions using delivery platforms to reach poor and rural populations through community-based strategies. Our model indicates that with successful implementation of these strategies, 58% of an estimated 367 900 deaths (15 900 maternal, 169 000 newborn, 183 000 child deaths) and 49% of an estimated 180 000 stillbirths could be prevented in 2015.	[Bhutta, Zulfiqar A.; Rizvi, Arjumand; Zaidi, Anita] Aga Khan Univ, Div Women & Child Hlth, Dept Paediat & Child Hlth, Karachi 74800, Pakistan; [Hafeez, Assad] Hlth Serv Acad, Islamabad, Pakistan; [Ali, Nabeela] John Snow, Islamabad, Pakistan; [Khan, Amanullah] Save Children, Islamabad, Pakistan; [Ahmad, Faatehuddin] Natl Inst Populat Studies, Islamabad, Pakistan; [Bhutta, Shereen] Jinnah Postgrad Med Ctr, Karachi, Pakistan; [Hazir, Tabish] Pakistan Inst Med Sci, Islamabad, Pakistan; [Jafarey, Sadequa N.] Ziauddin Med Univ, Karachi, Pakistan	Aga Khan University; Health Services Academy; Save the Children; Pakistan Institute of Medical Sciences; Ziauddin University	Bhutta, ZA (corresponding author), Aga Khan Univ, Ctr Excellence Women & Child Hlth, Stadium Rd, Karachi 74800, Pakistan.	zulfiqar.bhutta@aku.edu		Rizvi, Arjumand/0000-0003-4553-8130				Acuin CS, 2011, LANCET, V377, P516, DOI 10.1016/S0140-6736(10)62049-1; Bari A, 2011, LANCET, V378, P1796, DOI 10.1016/S0140-6736(11)61140-9; Bhutta Z A, 1997, J Perinatol, V17, P54; Bhutta ZA, 2004, MATERNAL CHILD HLTH, V1st; Bhutta ZA, 2007, CONT ISSUES PERINATA; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; Bhutta ZA, 2006, BMJ-BRIT MED J, V333, P839, DOI 10.1136/bmj.38979.379641.68; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bhutta ZA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f280; Bhutta ZA, 2011, LANCET, V378, P549, DOI 10.1016/S0140-6736(11)60744-7; Bhutta ZA, 2011, LANCET, V377, P403, DOI 10.1016/S0140-6736(10)62274-X; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Bhutto ZA, 2011, LANCET, V377, P1523, DOI 10.1016/S0140-6736(10)62269-6; Bhutto ZA, 2010, LANCET, V376, P664, DOI 10.1016/S0140-6736(10)61306-2; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Boschi-Pinto C, 2010, INT J EPIDEMIOL, V39, P3, DOI 10.1093/ije/dyq018; Cousens S, 2011, LANCET, V377, P1319, DOI 10.1016/S0140-6736(10)62310-0; Federal Bureau of Statistics, PSLMS PAK SOC LIV ST; Fox MJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-I1; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Gill CJ, 2013, LANCET; Government of Pakistan Planning and Development Division Nutrition Cell, 1967, NUTR SURV W PAK 1965; Government of Pakistan Planning and Development Division Nutrition Cell, 1977, MICR SURV PAK 1976 7; Hamad R, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.108399; Interagency Group on Child Mortality, UND 5 MORT RAT; Jafar TH, 2013, LANCET; Jafarey S N, 2002, J Pak Med Assoc, V52, P539; Khan GA, 2011, WORKING PAPER SERIES, V119; Lassi ZS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007754.pub3; Macro International National Institute of Population Studies, 1992, PAK DEM HLTH SURV 19; Macro International National Institute of Population Studies, 2007, PAK DEM HLTH SURV 20; Ministry of Finance Government of Pakistan, EC SURV PAK 2011 12; Mohammadi D, 2012, LANCET, V380, P460, DOI 10.1016/S0140-6736(12)61279-3; National Institute of Population Studies, 1998, PAK FERT FAM PLANN S; National Institute of Population Studies, 2002, PAK REPR HLTH FAM PL; National Institute of Population Studies, 2003, STAT WOM REPR HLTH F; Nishtar S, 2013, LANCET; Oxford Policy Management, LAD HLTH WORK PROGR; Oxford Poverty and Human Development Initiative, 2010, MULT POV IND; Pakistan Medical Research Council, 1994, NAT HLTH SURV PAK; Paul VK, 2011, LANCET, V377, P332, DOI 10.1016/S0140-6736(10)61492-4; Planning Commission Government of Pakistan, 2011, PAK FRAM EC GROWTH; Planning Commission Government of Pakistan, 2012, PROGR REP MDGS; Planning Commission Government of Pakistan and National Institute of Health, 1987, NAT NUTR SURV 1987; Planning Commission Government of Pakistan Pakistan Institute of Development Economics, 2003, NAT NUTR SURV 2001; PMNCH, 2011, ESS INT COMM GUID RE; Population Council Ministry of Population Welfare UN Population Fund, 1998, PAK CONTR PREV SURV; Population Welfare Division, 1986, PAK CONTR PREV SURV; Pradhan YV, 2012, HEALTH POLICY PLANN, V27, P57, DOI 10.1093/heapol/czs052; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Riaz H, 2013, LANCET, V381, P189, DOI 10.1016/S0140-6736(13)60072-0; Rubayet S, 2012, HEALTH POLICY PLANN, V27, P40, DOI 10.1093/heapol/czs044; Salt R, 2011, PUBLIC HEALTH NURS, V28, P281, DOI 10.1111/j.1525-1446.2010.00927.x; Sheikh S, 2011, VACCINE, V29, P3419, DOI 10.1016/j.vaccine.2011.02.087; Soofi S, 2012, LANCET, V379, P729, DOI 10.1016/S0140-6736(11)61714-5; UN-Habitat, 2006, AS PAC MIN C HOUS HU; UNESCO, 2010, WHY GEND EQ BAS ED P; UNICEF Government of Pakistan, 2003, MULT IND CLUST SURV; UNICEF Government of Pakistan, 2002, MULT IND CLUST SURV; UNICEF Government of Pakistan, 2008, MULT IND CLUST SURV; UNICEF Government of Pakistan, 2001, MULT IND CLUST SURV; UNICEF Nutrition Wing Planning Commission Government of Pakistan Aga Khan University, 2011, PAK NAT NUTR SURV 20; UNICEF Planning Department Government of Punjab, 2009, MULT IND CLUST SURV; UNICEF Planning Department Government of Punjab, 2003, MULT IND CLUST SURV; United Nations Development Program, 2003, PAK HUM DEV REP PAK HUM DEV REP; Victora CG, 2012, LANCET, V380, P1149, DOI 10.1016/S0140-6736(12)61427-5; WHO UNICEF, BUILD FUT WOM CHILDR; World Health Organization, 2012, WEEKL AFP SURV UPD P, V52; World Health Organization, 2012, WORLD HLTH STAT; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; Zaidi S, RESULT BASED FINANCI	72	83	83	2	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 22	2013	381	9884					2207	2218		10.1016/S0140-6736(12)61999-0	http://dx.doi.org/10.1016/S0140-6736(12)61999-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KH	23684261				2022-12-28	WOS:000320925600037
J	Law, JA; Du, JM; Hale, CJ; Feng, SH; Krajewski, K; Palanca, AMS; Strahl, BD; Patel, DJ; Jacobsen, SE				Law, Julie A.; Du, Jiamu; Hale, Christopher J.; Feng, Suhua; Krajewski, Krzysztof; Palanca, Ana Marie S.; Strahl, Brian D.; Patel, Dinshaw J.; Jacobsen, Steven E.			Polymerase IV occupancy at RNA-directed DNA methylation sites requires SHH1	NATURE			English	Article							ARABIDOPSIS; ASSOCIATION; ARGONAUTE4; PATTERNS; BINDING	DNA methylation is an epigenetic modification that has critical roles in gene silencing, development and genome integrity. In Arabidopsis, DNA methylation is established by DOMAINS REARRANGED METHYLTRANSFERASE 2 (DRM2) and targeted by 24-nucleotide small interfering RNAs (siRNAs) through a pathway termed RNA-directed DNA methylation (RdDM)(1). This pathway requires two plant-specific RNA polymerases: Pol-IV, which functions to initiate siRNA biogenesis, and Pol-V, which functions to generate scaffold transcripts that recruit downstream RdDM factors(1,2). To understand the mechanisms controlling Pol-IV targeting we investigated the function of SAWADEE HOMEODOMAIN HOMOLOG 1 (SHH1)(3,4), a Pol-IV-interacting protein(3). Here we show that SHH1 acts upstream in the RdDM pathway to enable siRNA production from a large subset of the most active RdDM targets, and that SHH1 is required for Pol-IV occupancy at these same loci. We also show that the SHH1 SAWADEE domain is a novel chromatin-binding module that adopts a unique tandem Tudor-like fold and functions as a dual lysine reader, probing for both unmethylated K4 and methylated K9 modifications on the histone 3 (H3) tail. Finally, we show that key residues within both lysine-binding pockets of SHH1 are required in vivo to maintain siRNA and DNA methylation levels as well as Pol-IV occupancy at RdDM targets, demonstrating a central role for methylated H3K9 binding in SHH1 function and providing the first insights into the mechanism of Pol-IV targeting. Given the parallels between methylation systems in plants and mammals(1,5), a further understanding of this early targeting step may aid our ability to control the expression of endogenous and newly introduced genes, which has broad implications for agriculture and gene therapy.	[Law, Julie A.; Hale, Christopher J.; Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Du, Jiamu; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Krajewski, Krzysztof; Strahl, Brian D.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Palanca, Ana Marie S.] Salk Inst Biol Studies, La Jolla, CA 92037 USA	University of California System; University of California Los Angeles; Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of North Carolina; University of North Carolina Chapel Hill; Salk Institute	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	pateld@mskcc.org; jacobsen@ucla.edu	Du, Jiamu/I-1334-2013; Peptide Synthesis and Array Facility, High-Throughput/AFI-7866-2022; Law, Julie A/A-9566-2011; Du, Jiamu/G-3308-2010; Strahl, Brian D/C-7601-2012	Du, Jiamu/0000-0002-1337-0786; Law, Julie A/0000-0001-7472-7753; Krajewski, Krzysztof/0000-0001-7159-617X; Strahl, Brian D/0000-0002-4947-6259	Abby Rockefeller Mauze Trust; Maloris Foundation; STARR Foundation; NIH [GM60398, GM85394]; Damon Runyon postdoctoral fellowship; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085394, R01GM060398, R37GM060398] Funding Source: NIH RePORTER	Abby Rockefeller Mauze Trust; Maloris Foundation; STARR Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon postdoctoral fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the staff of beamlines 24ID-C/E at the Argonne National Laboratory and X29A at the Brookhaven National Laboratory for support in diffraction data collection, to M. Akhavan and S. Fuchs for technical assistance, and to the UCLA BSCRC BioSequencing Core Facility for DNA sequencing. This work was supported by funds from the Abby Rockefeller Mauze Trust and Maloris and STARR Foundations to D.J.P. Work in the Jacobsen laboratory was supported by NIH grant GM60398. C.J.H. is supported by the Damon Runyon postdoctoral fellowship. S. F. is a Special Fellow of the Leukemia & Lymphoma Society. B. D. S. is supported by NIH grant GM85394. S.E.J. is an Investigator of the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Cairns J, 2011, BIOINFORMATICS, V27, P713, DOI 10.1093/bioinformatics/btq685; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chen PY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-203; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Du JM, 2012, CELL, V151, P167, DOI 10.1016/j.cell.2012.07.034; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng SH, 2011, METHODS MOL BIOL, V733, P223, DOI 10.1007/978-1-61779-089-8_16; Haag JR, 2011, NAT REV MOL CELL BIO, V12, P483, DOI 10.1038/nrm3152; Heisel SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002871; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Johnson LM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000280; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Law JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002195; Law JA, 2010, CURR BIOL, V20, P951, DOI 10.1016/j.cub.2010.03.062; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Liu J, 2011, CELL RES, V21, P1691, DOI 10.1038/cr.2011.173; Mosher RA, 2008, P NATL ACAD SCI USA, V105, P3145, DOI 10.1073/pnas.0709632105; Mukherjee K, 2009, MOL BIOL EVOL, V26, P2775, DOI 10.1093/molbev/msp201; Nady N, 2011, J BIOL CHEM, V286, P24300, DOI 10.1074/jbc.M111.234104; Olovnikov I, 2012, CURR OPIN GENET DEV, V22, P164, DOI 10.1016/j.gde.2012.01.002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Spyrou C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-299; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zhang XY, 2007, P NATL ACAD SCI USA, V104, P4536, DOI 10.1073/pnas.0611456104; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhang XY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r62; Zhong XH, 2012, NAT STRUCT MOL BIOL, V19, P870, DOI 10.1038/nsmb.2354; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	36	221	229	3	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 20	2013	498	7454					385	+		10.1038/nature12178	http://dx.doi.org/10.1038/nature12178			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	166XI	23636332	Green Accepted, Green Submitted			2022-12-28	WOS:000320592900045
J	Szekeres, C; Galletout, P; Jaureguiberry, S; Crickx, E; Monsel, G; Chabriat, H; Jouvent, E				Szekeres, Cecilia; Galletout, Philippe; Jaureguiberry, Stephane; Crickx, Etienne; Monsel, Gentiane; Chabriat, Hugues; Jouvent, Eric			Neurological presentation of schistosomiasis	LANCET			English	Editorial Material							NEUROSCHISTOSOMIASIS		[Szekeres, Cecilia; Galletout, Philippe; Chabriat, Hugues; Jouvent, Eric] Lariboisiere Hosp, AP HP, Dept Neurol, F-75475 Paris, France; [Jaureguiberry, Stephane; Crickx, Etienne] Salpetriere Hosp, AP HP, Dept Infect & Trop Dis, Paris, France; [Jaureguiberry, Stephane] Univ Paris 06, INSERM, UMRs945, Paris, France; [Monsel, Gentiane] St Louis Hosp, AP HP, Dept Dermatol, Paris, France; [Chabriat, Hugues; Jouvent, Eric] Univ Paris Diderot, INSERM, UMR 740, F-75205 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Jouvent, E (corresponding author), Hop Lariboisiere, Serv Neurol, 2 Rue Ambroise Pare, F-75010 Paris, France.	eric.jouvent@lrb.aphp.fr	Jauréguiberry, Stéphane/GWZ-9904-2022; Jouvent, Eric/B-4320-2014; Chabriat, Hugues/G-5699-2010	Jauréguiberry, Stéphane/0000-0003-0057-5464; Jouvent, Eric/0000-0001-7797-2236; Chabriat, Hugues/0000-0001-8436-6074				Carod-Artal FJ, 2008, T ROY SOC TROP MED H, V102, P107, DOI 10.1016/j.trstmh.2007.08.004; Ferrari TCA, 2011, LANCET NEUROL, V10, P853, DOI 10.1016/S1474-4422(11)70170-3; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Jaureguiberry S, 2007, AM J TROP MED HYG, V76, P964, DOI 10.4269/ajtmh.2007.76.964; VAZQUEZ ML, 1987, NEUROLOGY, V37, P1561, DOI 10.1212/WNL.37.9.1561	5	7	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 18	2013	381	9879					1788	1788		10.1016/S0140-6736(13)60317-7	http://dx.doi.org/10.1016/S0140-6736(13)60317-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146TA	23683646				2022-12-28	WOS:000319112800044
J	Clarke, J				Clarke, Julia			Feathers Before Flight	SCIENCE			English	Editorial Material							EVOLUTION; ARCHOSAURS; DINOSAUR; PLUMAGE		Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Clarke, J (corresponding author), Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA.	julia_clarke@jsg.utexas.edu						Chinsamy A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2377; Cubo J, 2012, PALEOBIOLOGY, V38, P335, DOI 10.1666/08093.1; Heers AM, 2012, TRENDS ECOL EVOL, V27, P296, DOI 10.1016/j.tree.2011.12.003; Hutchinson JR, 2006, CR PALEVOL, V5, P519, DOI 10.1016/j.crpv.2005.09.002; Kellner AWA, 2010, P ROY SOC B-BIOL SCI, V277, P321, DOI 10.1098/rspb.2009.0846; Li QG, 2012, SCIENCE, V335, P1215, DOI 10.1126/science.1213780; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; Longrich NR, 2012, CURR BIOL, V22, P2262, DOI 10.1016/j.cub.2012.09.052; Norell MA, 2005, ANNU REV EARTH PL SC, V33, P277, DOI 10.1146/annurev.earth.33.092203.122511; Nudds RL, 2010, SCIENCE, V328, P887, DOI 10.1126/science.1188895; Persons WS, 2014, ACTA PALAEONTOL POL, V59, P553, DOI 10.4202/app.2012.0093; Prum RO, 1999, J EXP ZOOL, V285, P291; Xu X, 2009, P NATL ACAD SCI USA, V106, P832, DOI 10.1073/pnas.0810055106; Zheng XT, 2009, NATURE, V458, P333, DOI 10.1038/nature07856; Zheng XT, 2013, SCIENCE, V339, P1309, DOI 10.1126/science.1228753	15	37	38	1	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					690	692		10.1126/science.1235463	http://dx.doi.org/10.1126/science.1235463			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661746				2022-12-28	WOS:000318619000022
J	Ji, X; Zhou, Y; Pandit, S; Huang, JE; Li, HR; Lin, CY; Xiao, R; Burge, CB; Fu, XD				Ji, Xiong; Zhou, Yu; Pandit, Shatakshi; Huang, Jie; Li, Hairi; Lin, Charles Y.; Xiao, Rui; Burge, Christopher B.; Fu, Xiang-Dong			SR Proteins Collaborate with 7SK and Promoter-Associated Nascent RNA to Release Paused Polymerase	CELL			English	Article							TRANSCRIPTION ELONGATION; SPLICING FACTORS; GENE-EXPRESSION; P-TEFB; HIV-1 TAT; COMPLEX; RECRUITMENT; ACTIVATION; ENHANCERS; DYNAMICS	RNAP II is frequently paused near gene promoters in mammals, and its transition to productive elongation requires active recruitment of P-TEFb, a cyclin-dependent kinase for RNAP II and other key transcription elongation factors. A fraction of P-TEFb is sequestered in an inhibitory complex containing the 7SK noncoding RNA, but it has been unclear how P-TEFb is switched from the 7SK complex to RNAP II during transcription activation. We report that SRSF2 (also known as SC35, an SR-splicing factor) is part of the 7SK complex assembled at gene promoters and plays a direct role in transcription pause release. We demonstrate RNA-dependent, coordinated release of SRSF2 and P-TEFb from the 7SK complex and transcription activation via SRSF2 binding to promoter-associated nascent RNA. These findings reveal an unanticipated SR protein function, a role for promoter-proximal nascent RNA in gene activation, and an analogous mechanism to HIV Tat/TAR for activating cellular genes.	[Ji, Xiong; Huang, Jie; Fu, Xiang-Dong] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Zhou, Yu; Pandit, Shatakshi; Li, Hairi; Xiao, Rui; Fu, Xiang-Dong] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Fu, Xiang-Dong] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Lin, Charles Y.; Burge, Christopher B.] MIT, Dept Biol, Cambridge, MA 02142 USA	Wuhan University; University of California System; University of California San Diego; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT)	Fu, XD (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	xdfu@ucsd.edu	Pandit, Sakshi/I-3152-2014; Zhou, Yu/AAP-9964-2021; Burge, Christopher B./AAH-2177-2020	Zhou, Yu/0000-0002-2102-9377; Xiao, Rui/0000-0002-9477-1054; Huang, Jie/0000-0003-3842-6181	China 973 program [2011CB811300, 2012CB910800]; China 111 project [B06018]; NIH [GM049369, GM052872, HG004659]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052872, R01GM049369] Funding Source: NIH RePORTER	China 973 program(National Basic Research Program of China); China 111 project; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Dr. David H. Price for anti-cyclin T1 and anti-LARP7 antibodies, to Dr. Qiang Zhou for luciferase reporters, to Drs. Wen Liu and Wenbo Li for sharing many reagents, to Dr. Zefeng Wang for expert help on the PUF system, and to Dr. Pingping Wang for artwork. We are extremely indebted to Drs. Chris Glass, Manuel Ares Jr., and Joan Steitz for critical comments on the manuscript. This work was supported by the China 973 program (2011CB811300 and 2012CB910800), the China 111 project (B06018), and NIH grants (GM049369, GM052872, HG004659) to X.-D.F.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; BERKHOUT B, 1990, CELL, V62, P757, DOI 10.1016/0092-8674(90)90120-4; Byun JS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1652; Cavaloc Y, 1999, RNA, V5, P468, DOI 10.1017/S1355838299981967; Cernilogar FM, 2011, NATURE, V480, P391, DOI 10.1038/nature10492; CHAMPLIN DT, 1991, GENE DEV, V5, P1611, DOI 10.1101/gad.5.9.1611; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Czudnochowski N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1846; D'Orso I, 2010, NAT STRUCT MOL BIOL, V17, P815, DOI 10.1038/nsmb.1827; Daubner GM, 2012, EMBO J, V31, P162, DOI 10.1038/emboj.2011.367; Dundr M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000711; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fox-Walsh K, 2011, GENOMICS, V98, P266, DOI 10.1016/j.ygeno.2011.04.003; Han JH, 2011, TRENDS CELL BIOL, V21, P336, DOI 10.1016/j.tcb.2011.03.003; He NH, 2010, MOL CELL, V38, P428, DOI 10.1016/j.molcel.2010.04.013; Krueger BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012335; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; Lin SR, 2005, MOL CELL, V20, P413, DOI 10.1016/j.molcel.2005.09.015; Luo ZJ, 2012, MOL CELL BIOL, V32, P2608, DOI 10.1128/MCB.00182-12; Misteli T, 1999, MOL CELL, V3, P697, DOI 10.1016/S1097-2765(01)80002-2; Ott M, 2011, CELL HOST MICROBE, V10, P426, DOI 10.1016/j.chom.2011.11.002; Pandit S, 2013, MOL CELL, V50, P223, DOI 10.1016/j.molcel.2013.03.001; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Prasanth KV, 2010, MOL BIOL CELL, V21, P4184, DOI 10.1091/mbc.E10-02-0105; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; Sapra AK, 2009, MOL CELL, V34, P179, DOI 10.1016/j.molcel.2009.02.031; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Sawarkar R, 2012, CELL, V149, P807, DOI 10.1016/j.cell.2012.02.061; Schaal TD, 1999, MOL CELL BIOL, V19, P261; Singer RH, 1997, CELL, V91, P291, DOI 10.1016/S0092-8674(00)80411-0; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Tripathi V, 2012, MOL BIOL CELL, V23, P3694, DOI 10.1091/mbc.E12-03-0206; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang Y, 2009, NAT METHODS, V6, P825, DOI [10.1038/nmeth.1379, 10.1038/NMETH.1379]; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Young TM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001010; Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910; Zobeck KL, 2010, MOL CELL, V40, P965, DOI 10.1016/j.molcel.2010.11.022	49	218	223	2	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 9	2013	153	4					855	868		10.1016/j.cell.2013.04.028	http://dx.doi.org/10.1016/j.cell.2013.04.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663783	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000318844000014
J	Loffredo, FS; Steinhauser, ML; Jay, SM; Gannon, J; Pancoast, JR; Yalamanchi, P; Sinha, M; Dall'Osso, C; Khong, D; Shadrach, JL; Miller, CM; Singer, BS; Stewart, A; Psychogios, N; Gerszten, RE; Hartigan, AJ; Kim, MJ; Serwold, T; Wagers, AJ; Lee, RT				Loffredo, Francesco S.; Steinhauser, Matthew L.; Jay, Steven M.; Gannon, Joseph; Pancoast, James R.; Yalamanchi, Pratyusha; Sinha, Manisha; Dall'Osso, Claudia; Khong, Danika; Shadrach, Jennifer L.; Miller, Christine M.; Singer, Britta S.; Stewart, Alex; Psychogios, Nikolaos; Gerszten, Robert E.; Hartigan, Adam J.; Kim, Mi-Jeong; Serwold, Thomas; Wagers, Amy J.; Lee, Richard T.			Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy	CELL			English	Article							DIASTOLIC HEART-FAILURE; HEMATOPOIETIC STEM-CELLS; SKELETAL-MUSCLE; BLOOD-PRESSURE; MYOSTATIN; PROTEIN; MICE; REJUVENATION; EPIDEMIOLOGY; CARDIOLOGY	The most common form of heart failure occurs with normal systolic function and often involves cardiac hypertrophy in the elderly. To clarify the biological mechanisms that drive cardiac hypertrophy in aging, we tested the influence of circulating factors using heterochronic parabiosis, a surgical technique in which joining of animals of different ages leads to a shared circulation. After 4 weeks of exposure to the circulation of young mice, cardiac hypertrophy in old mice dramatically regressed, accompanied by reduced cardiomyocyte size and molecular remodeling. Reversal of age-related hypertrophy was not attributable to hemodynamic or behavioral effects of parabiosis, implicating a blood-borne factor. Using modified aptamer-based proteomics, we identified the TGF-beta superfamily member GDF11 as a circulating factor in young mice that declines with age. Treatment of old mice to restore GDF11 to youthful levels recapitulated the effects of parabiosis and reversed age-related hypertrophy, revealing a therapeutic opportunity for cardiac aging.	[Loffredo, Francesco S.; Jay, Steven M.; Sinha, Manisha; Dall'Osso, Claudia; Khong, Danika; Shadrach, Jennifer L.; Miller, Christine M.; Hartigan, Adam J.; Kim, Mi-Jeong; Serwold, Thomas; Wagers, Amy J.; Lee, Richard T.] Brigham & Womens Hosp, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Loffredo, Francesco S.; Steinhauser, Matthew L.; Jay, Steven M.; Gannon, Joseph; Pancoast, James R.; Yalamanchi, Pratyusha; Lee, Richard T.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Sinha, Manisha; Dall'Osso, Claudia; Khong, Danika; Shadrach, Jennifer L.; Wagers, Amy J.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Sinha, Manisha; Dall'Osso, Claudia; Khong, Danika; Shadrach, Jennifer L.; Wagers, Amy J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Miller, Christine M.; Hartigan, Adam J.; Kim, Mi-Jeong; Serwold, Thomas; Wagers, Amy J.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Singer, Britta S.; Stewart, Alex] SomaLogic Inc, Boulder, CO 80301 USA; [Psychogios, Nikolaos; Gerszten, Robert E.] Massachusetts Gen Hosp, Dept Med, Div Cardiol, Charlestown, MA 02129 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Massachusetts General Hospital	Wagers, AJ (corresponding author), Brigham & Womens Hosp, Harvard Stem Cell Inst, 75 Francis St, Boston, MA 02115 USA.	amy_wagers@harvard.edu; rlee@partners.org	Loffredo, Francesco S/F-6638-2014; Loffredo, Francesco/P-1389-2019; Steinhauser, Matthew L./GVT-6393-2022; Jay, Steven/ABD-4344-2021	Loffredo, Francesco S/0000-0001-5911-780X; Loffredo, Francesco/0000-0001-5911-780X; Steinhauser, Matthew L./0000-0001-5287-9246; Jay, Steven/0000-0002-3827-5988; Lee, Richard/0000-0003-4687-1381; Khong, Danika/0000-0002-2128-8619; Psychogios, Nikolaos/0000-0002-2747-6012; Yalamanchi, Pratyusha/0000-0003-0776-3759	NIH [P30DK036836, 1RO1 AG033053, 1DP2 OD004345, 5U01 HL100402, R01 AG032977 1R01 AG040019, KO8 DK090147]; American Heart Association; Glenn Foundation; Watkins Cardiovascular Leadership Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL112905, U01HL100402, K99HL112905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, K08DK090147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040019, R01AG033053, R01AG032977] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004345] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Glenn Foundation; Watkins Cardiovascular Leadership Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors gratefully acknowledge the HSCI and DRC (NIH Award Number P30DK036836) Flow Cytometry Cores for excellent cytometry support. This work was funded in part by grants from the American Heart Association to F.S.L. (postdoctoral fellowship) and M.L.S. (AHA FTF), Glenn Foundation and NIH (1RO1 AG033053, 1DP2 OD004345, and 5U01 HL100402) to A.J.W., NIH (R01 AG032977 1R01 AG040019) to R.T.L., and NIH (KO8 DK090147) to M.L.S. M.L.S. is supported by the Watkins Cardiovascular Leadership Award. A.J.W. is an Early Career Scientist of the Howard Hughes Medical Institute. Content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or other funding agencies. SOMAscan and SOMAmers are trademarks of Soma Logic, Inc.	Aurigemma GP, 2006, NEW ENGL J MED, V355, P308, DOI 10.1056/NEJMe068128; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Bunster E, 1933, ANAT REC, V57, P339, DOI 10.1002/ar.1090570404; Cohn RD, 2007, NEUROMUSCULAR DISORD, V17, P290, DOI 10.1016/j.nmd.2007.01.011; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; Eggan K, 2006, NATURE, V441, P1109, DOI 10.1038/nature04929; FINERTY JC, 1952, PHYSIOL REV, V32, P277, DOI 10.1152/physrev.1952.32.3.277; Foryst-Ludwig A, 2011, AM J PHYSIOL-HEART C, V301, pH115, DOI 10.1152/ajpheart.01222.2010; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Gustafson-Wagner EA, 2007, AM J PHYSIOL-HEART C, V293, pH2680, DOI 10.1152/ajpheart.00806.2007; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Jackson MF, 2012, J ENDOCRINOL, V213, P263, DOI 10.1530/JOE-11-0455; Johnston RK, 2009, FASEB J, V23, P2759, DOI 10.1096/fj.08-127480; Kitzman DW, 2007, CLIN GERIATR MED, V23, P83, DOI 10.1016/j.cger.2006.09.002; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Lakatta EG, 2003, CIRCULATION, V107, P346, DOI 10.1161/01.CIR.0000048893.62841.F7; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; McPherron Alexandra C., 2010, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V10, P217; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; OLIVETTI G, 1995, J AM COLL CARDIOL, V26, P1068, DOI 10.1016/0735-1097(95)00282-8; Owan TE, 2005, PROG CARDIOVASC DIS, V47, P320, DOI 10.1016/j.pcad.2005.02.010; Pietramaggiori G, 2009, J INVEST DERMATOL, V129, P2265, DOI 10.1038/jid.2009.60; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schocken DD, 2008, CIRCULATION, V117, P2544, DOI 10.1161/CIRCULATIONAHA.107.188965; Seki K, 2009, CIRC-HEART FAIL, V2, P684, DOI 10.1161/CIRCHEARTFAILURE.109.873240; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Souza TA, 2008, MOL ENDOCRINOL, V22, P2689, DOI 10.1210/me.2008-0290; Tsuchida K, 2008, ENDOCR J, V55, P11, DOI 10.1507/endocrj.KR-110; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; YIN FCP, 1982, AM J PHYSIOL, V243, pH941, DOI 10.1152/ajpheart.1982.243.6.H941; Yoshioka J, 2007, CIRC RES, V101, P1328, DOI 10.1161/CIRCRESAHA.106.160515; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	38	628	701	10	224	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 9	2013	153	4					828	839		10.1016/j.cell.2013.04.015	http://dx.doi.org/10.1016/j.cell.2013.04.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663781	Green Accepted, Bronze			2022-12-28	WOS:000318844000012
J	Kasliwal, MM				Kasliwal, Mansi M.			Seeing Gravitational Waves	SCIENCE			English	Editorial Material							ELECTROMAGNETIC COUNTERPARTS; MERGERS		Carnegie Inst Sci, Pasadena, CA 91101 USA	Carnegie Institution for Science	Kasliwal, MM (corresponding author), Carnegie Inst Sci, 813 Santa Barbara St, Pasadena, CA 91101 USA.	mansi@obs.carnegiescience.edu		Kasliwal, Tamay/0000-0001-5634-7167				Aasi J., 2013, P1200087 LIGO; Abadie J, 2010, CLASSICAL QUANT GRAV, V27, DOI 10.1088/0264-9381/27/17/173001; Accadia T, 2011, CLASSICAL QUANT GRAV, V28, DOI 10.1088/0264-9381/28/11/114002; Harry GM, 2010, CLASSICAL QUANT GRAV, V27, DOI 10.1088/0264-9381/27/8/084006; Iyer B., 2011, M1100296 LIGO; Kasliwal MM, 2012, PUBL ASTRON SOC AUST, V29, P482, DOI 10.1071/AS11061; Li LX, 1998, ASTROPHYS J, V507, pL59, DOI 10.1086/311680; Metzger BD, 2010, MON NOT R ASTRON SOC, V406, P2650, DOI 10.1111/j.1365-2966.2010.16864.x; Misner C.W., 1973, GRAVITATION; Nissanke S, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/124; Schutz BF, 2011, CLASSICAL QUANT GRAV, V28, DOI 10.1088/0264-9381/28/12/125023; Somiya C., 2012, CLASSICAL QUANT GRAV, V29	12	3	3	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 3	2013	340	6132					555	556		10.1126/science.1235956	http://dx.doi.org/10.1126/science.1235956			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23641101				2022-12-28	WOS:000318268900032
J	Song, YM; Xie, YZ; Malyarchuk, V; Xiao, JL; Jung, I; Choi, KJ; Liu, ZJ; Park, H; Lu, CF; Kim, RH; Li, R; Crozier, KB; Huang, YG; Rogers, JA				Song, Young Min; Xie, Yizhu; Malyarchuk, Viktor; Xiao, Jianliang; Jung, Inhwa; Choi, Ki-Joong; Liu, Zhuangjian; Park, Hyunsung; Lu, Chaofeng; Kim, Rak-Hwan; Li, Rui; Crozier, Kenneth B.; Huang, Yonggang; Rogers, John A.			Digital cameras with designs inspired by the arthropod eye	NATURE			English	Article							SUPERPOSITION EYE; OPTICS	In arthropods, evolution has created a remarkably sophisticated class of imaging systems, with a wide-angle field of view, low aberrations, high acuity to motion and an infinite depth of field(1-3). A challenge in building digital cameras with the hemispherical, compound apposition layouts of arthropod eyes is that essential design requirements cannot be met with existing planar sensor technologies or conventional optics. Here we present materials, mechanics and integration schemes that afford scalable pathways to working, arthropod-inspired cameras with nearly full hemispherical shapes (about 160 degrees). Their surfaces are densely populated by imaging elements (artificial ommatidia), which are comparable in number (180) to those of the eyes of fire ants (Solenopsis fugax) and bark beetles(4,5) (Hylastes nigrinus). The devices combine elastomeric compound optical elements with deformable arrays of thin silicon photodetectors into integrated sheets that can be elastically transformed from the planar geometries in which they are fabricated to hemispherical shapes for integration into apposition cameras. Our imaging results and quantitative ray-tracing-based simulations illustrate key features of operation. These general strategies seem to be applicable to other compound eye devices, such as those inspired by moths and lacewings(6,7) (refracting superposition eyes), lobster and shrimp(8) (reflecting superposition eyes), and houseflies(9) (neural superposition eyes).	[Song, Young Min; Xie, Yizhu; Malyarchuk, Viktor; Kim, Rak-Hwan; Rogers, John A.] Univ Illinois, Dept Mat Sci & Engn, Beckman Inst Adv Sci & Technol, 1304 W Green St, Urbana, IL 61801 USA; [Song, Young Min; Xie, Yizhu; Malyarchuk, Viktor; Kim, Rak-Hwan; Rogers, John A.] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL 61801 USA; [Xiao, Jianliang] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA; [Jung, Inhwa] Kyung Hee Univ, Dept Mech Engn, Yongin 446701, Gyeonggi Do, South Korea; [Choi, Ki-Joong; Rogers, John A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Liu, Zhuangjian] ASTAR, Inst High Performance Comp, Singapore 138632, Singapore; [Park, Hyunsung; Crozier, Kenneth B.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Lu, Chaofeng] Zhejiang Univ, Dept Civil Engn, Hangzhou 310058, Zhejiang, Peoples R China; [Lu, Chaofeng] Zhejiang Univ, Soft Matter Res Ctr, Hangzhou 310058, Zhejiang, Peoples R China; [Lu, Chaofeng; Li, Rui; Huang, Yonggang] Northwestern Univ, Dept Civil & Environm Engn, Dept Mech Engn, Evanston, IL 60208 USA; [Li, Rui] Dalian Univ Technol, Dept Engn Mech, State Key Lab Struct Anal Ind Equipment, Dalian 116024, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Colorado System; University of Colorado Boulder; Kyung Hee University; University of Illinois System; University of Illinois Urbana-Champaign; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC); Harvard University; Zhejiang University; Zhejiang University; Northwestern University; Dalian University of Technology	Rogers, JA (corresponding author), Univ Illinois, Dept Mat Sci & Engn, Beckman Inst Adv Sci & Technol, 1304 W Green St, Urbana, IL 61801 USA.	jrogers@illinois.edu	Huang, Yonggang/B-6998-2009; Kim, Rak-Hwan/A-6155-2012; huang, yonggang/O-6236-2019; Li, Rui/C-2155-2009; Song, Young Min/B-2215-2010; Rogers, John/L-2798-2016; Jung, Inhwa/AAI-8615-2020; Xiao, Jianliang/B-4535-2008; CROZIER, KENNETH/J-7143-2016	Song, Young Min/0000-0002-4473-6883; CROZIER, KENNETH/0000-0003-0947-001X; Li, Rui/0000-0001-6051-4204; Jung, Inhwa/0000-0002-0235-7383	Defense Advanced Research Projects Agency (DARPA) Nanoelectromechanical /Microelectromechanical Science AMP; Technology (N/MEMS SAMP;T) Fundamentals programme by the Space and Naval Warfare Systems Center Pacific (SPAWAR) [N66001-10-1-4008]; National Science Foundation through an Emerging Frontiers in Research and Innovation (EFRI) programme	Defense Advanced Research Projects Agency (DARPA) Nanoelectromechanical /Microelectromechanical Science AMP; Technology (N/MEMS SAMP;T) Fundamentals programme by the Space and Naval Warfare Systems Center Pacific (SPAWAR); National Science Foundation through an Emerging Frontiers in Research and Innovation (EFRI) programme	The work on integration schemes and mechanical designs was supported by the Defense Advanced Research Projects Agency (DARPA) Nanoelectromechanical /Microelectromechanical Science & Technology (N/MEMS S&T) Fundamentals programme under grant number N66001-10-1-4008 issued by the Space and Naval Warfare Systems Center Pacific (SPAWAR). The work on materials, optical modelling and imaging aspects was supported by the National Science Foundation through an Emerging Frontiers in Research and Innovation (EFRI) programme.	Afshari H., 2012, J SIGN PROCESS SYST; BARROSPITA JC, 1970, Z VERGL PHYSIOL, V67, P79, DOI 10.1007/BF00298120; CHAPMAN JA, 1972, ANN ENTOMOL SOC AM, V65, P550, DOI 10.1093/aesa/65.3.550; Dinyari R., 2008, APPL PHYS LETT, V92; Dudley R., 2000, BIOMECHANICS INSECT; Duparre J, 2005, OPT EXPRESS, V13, P10539, DOI 10.1364/OPEX.13.010539; Floreano D, 2009, FLYING INSECTS AND ROBOTS, P1; FRANCESCHINI N, 1992, PHILOS T R SOC B, V337, P283, DOI 10.1098/rstb.1992.0106; HORRIDGE GA, 1977, PROC R SOC SER B-BIO, V196, P233, DOI 10.1098/rspb.1977.0039; Hung PJ, 2004, APPL PHYS LETT, V85, P6051, DOI 10.1063/1.1835553; Jeong KH, 2006, SCIENCE, V312, P557, DOI 10.1126/science.1123053; Jung IW, 2011, P NATL ACAD SCI USA, V108, P1788, DOI 10.1073/pnas.1015440108; Ko HC, 2008, NATURE, V454, P748, DOI 10.1038/nature07113; Kral K, 1998, EUR J ENTOMOL, V95, P327; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; LAND MF, 1988, CONTEMP PHYS, V29, P435, DOI 10.1080/00107518808222601; Land MF, 2002, ANIMAL EYES; Li L, 2010, OPT EXPRESS, V18, P18125, DOI 10.1364/OE.18.018125; Lu CF, 2013, J APPL MECH-T ASME, V80, DOI 10.1115/1.4023962; NILSSON DE, 1988, NATURE, V332, P76, DOI 10.1038/332076a0; NILSSON DE, 1989, BIOSCIENCE, V39, P298, DOI 10.2307/1311112; Someya T., 2013, STRETCHABLE ELECT; Street RA, 2009, J APPL PHYS, V105, DOI 10.1063/1.3129315; Tanida J, 2001, APPL OPTICS, V40, P1806, DOI 10.1364/AO.40.001806; Wang SD, 2010, SOFT MATTER, V6, P5757, DOI 10.1039/c0sm00579g; Warrant E, 2006, INVERTEBRATE VISION, pXIX; Wheeler W.M., 1910, ANTS THEIR STRUCTURE; Wild A, 2007, TAXONOMIC REVISION A; Xu X, 2008, ORG ELECTRON, V9, P1122, DOI 10.1016/j.orgel.2008.07.011; ZEIL J, 1979, NATURE, V278, P249, DOI 10.1038/278249a0	30	758	794	43	799	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					95	99		10.1038/nature12083	http://dx.doi.org/10.1038/nature12083			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23636401				2022-12-28	WOS:000318221500040
J	Whitty, CJM; Jones, M; Tollervey, A; Wheeler, T				Whitty, Christopher J. M.; Jones, Monty; Tollervey, Alan; Wheeler, Tim			Africa and Asia need a rational debate on GM crops	NATURE			English	Editorial Material							BETA-CAROTENE; VITAMIN-A; CHILDREN		[Whitty, Christopher J. M.] UK Dept Int Dev DFID, London, England; [Whitty, Christopher J. M.] London Sch Hyg & Trop Med, London, England; [Jones, Monty] Forum Agr Res Africa, Accra, Ghana; [Wheeler, Tim] Univ Reading, Reading RG6 2AH, Berks, England	University of London; London School of Hygiene & Tropical Medicine; University of Reading	Whitty, CJM (corresponding author), UK Dept Int Dev DFID, London, England.	c-whitty@dfid.gov.uk		Whitty, Christopher/0000-0002-6076-5027				Hotz C, 2012, J NUTR, V142, P1871, DOI 10.3945/jn.111.151829; Kijima Y, 2006, DEV ECON, V44, P252, DOI 10.1111/j.1746-1049.2006.00016.x; Owino O, 2012, NATURE; Renkow M, 2010, FOOD POLICY, V35, P391, DOI 10.1016/j.foodpol.2010.04.006; Tang GW, 2012, AM J CLIN NUTR, V96, P658, DOI 10.3945/ajcn.111.030775; Varshney RK, 2011, TRENDS PLANT SCI, V16, P363, DOI 10.1016/j.tplants.2011.03.004	6	20	23	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					31	33		10.1038/497031a	http://dx.doi.org/10.1038/497031a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	134OK	23636380	Bronze			2022-12-28	WOS:000318221500016
J	Stoll, BJ; Stevenson, DK; Wise, PH				Stoll, Barbara J.; Stevenson, David K.; Wise, Paul H.			The Transformation of Child Health Research Innovation, Market Failure, and the Public Good	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHALLENGES		[Stoll, Barbara J.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Stoll, Barbara J.] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Stevenson, David K.; Wise, Paul H.] Stanford Univ, Sch Med, Dept Pediat, Palo Alto, CA 94304 USA	Emory University; Children's Healthcare of Atlanta (CHOA); Stanford University	Stoll, BJ (corresponding author), Emory Univ, Sch Med, Dept Pediat, 2015 Uppergate Dr, Atlanta, GA 30322 USA.	barbara_stoll@oz.ped.emory.edu						Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Caldwell PHY, 2004, LANCET, V364, P803, DOI 10.1016/S0140-6736(04)16942-0; Hartling L, 2012, PEDIATRICS, V129, pS112, DOI 10.1542/peds.2012-0055C; Simpson LA, 2010, HEALTH AFFAIR, V29, P1849, DOI 10.1377/hlthaff.2010.0594; Thorat C, 2012, PEDIATRICS, V129, P516, DOI 10.1542/peds.2011-1798; Zylke JW, 2012, JAMA-J AM MED ASSOC, V308, P1040, DOI 10.1001/2012.jama.10982	6	7	7	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2013	309	17					1779	1780		10.1001/jama.2013.3257	http://dx.doi.org/10.1001/jama.2013.3257			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134SU	23632719				2022-12-28	WOS:000318235600023
J	Inomata, T; Triadan, D; Aoyama, K; Castillo, V; Yonenobu, H				Inomata, Takeshi; Triadan, Daniela; Aoyama, Kazuo; Castillo, Victor; Yonenobu, Hitoshi			Early Ceremonial Constructions at Ceibal, Guatemala, and the Origins of Lowland Maya Civilization	SCIENCE			English	Article								The spread of plaza-pyramid complexes across southern Mesoamerica during the early Middle Preclassic period (1000 to 700 BCE) provides critical information regarding the origins of lowland Maya civilization and the role of the Gulf Coast Olmec. Recent excavations at the Maya site of Ceibal, Guatemala, documented the growth of a formal ceremonial space into a plaza-pyramid complex that predated comparable buildings at other lowland Maya sites and major occupations at the Olmec center of La Venta. The development of lowland Maya civilization did not result from one-directional influence from La Venta, but from interregional interactions, involving groups in the southwestern Maya lowlands, Chiapas, the Pacific Coast, and the southern Gulf Coast.	[Inomata, Takeshi; Triadan, Daniela; Castillo, Victor] Univ Arizona, Sch Anthropol, Tucson, AZ 85721 USA; [Aoyama, Kazuo] Ibaraki Univ, Fac Humanities, Mito, Ibaraki 3108512, Japan; [Yonenobu, Hitoshi] Naruto Univ Educ, Grad Sch Educ, Tokushima 7728502, Japan	University of Arizona; Ibaraki University; Naruto University of Education	Inomata, T (corresponding author), Univ Arizona, Sch Anthropol, Tucson, AZ 85721 USA.	inomata@email.arizona.edu	Yonenobu, Hitoshi/AAB-1500-2021	Yonenobu, Hitoshi/0000-0002-1596-7543	National Geographic Society; NSF [BCS-0750808]; National Endowment for the Humanities [RZ-51209-10]; Ministry of Education, Culture, Sports, Science and Technology-Japan KAKENHI [21101003, 21101002]; Japan Society for the Promotion of Science KAKENHI [21402008]; Alphawood Foundation; Grants-in-Aid for Scientific Research [21402008, 23240116] Funding Source: KAKEN	National Geographic Society(National Geographic Society); NSF(National Science Foundation (NSF)); National Endowment for the Humanities; Ministry of Education, Culture, Sports, Science and Technology-Japan KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Alphawood Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Investigations at Ceibal were carried out with permits generously issued by the Instituto de Antropologia e Historia de Guatemala. We thank its directors, el Maestro Erick Ponciano and la Licenciada Ivon Putzey. Investigations at Ceibal were supported by the National Geographic Society; NSF (grant BCS-0750808); the National Endowment for the Humanities (grant RZ-51209-10); Ministry of Education, Culture, Sports, Science and Technology-Japan KAKENHI (grants 21101003 and 21101002); Japan Society for the Promotion of Science KAKENHI (grant 21402008); and the Alphawood Foundation. We thank B. Bachand, J. Hodgson, M. Love, M. Pye, and R. Rosenswig for information on their radiocarbon dates and excavations and W. Andrews and J. Clark for comments.	Agrinier Pierre, 2000, MOUND 27 MIDDLE PREC; Barba de Pina Chan B., 1980, BIBLIOTECA ENCICLOPE; Blomster JP, 2005, SCIENCE, V307, P1068, DOI 10.1126/science.1107599; Bryant U. B., 2005, CERAMIC SEQUENCE UPP; Burger Richard L., 2012, EARLY NEW WORLD MONU; Cheetham D., 2010, THESIS ARIZONA STATE; Clark J.E., 2002, ARCHAEOLOGY TRIBAL S, pag, DOI [DOI 10.2307/J.CTV8BT29Z.18, 10.2307/j.ctv8bt29z.18]; Clark John E., 2000, OLMEC ART ARCHAEOLOG, P217; Clark John E., 2001, ROYAL COURTS ANCIENT, V2, P1; Coe Michael D., 1980, LAND OLMEC; Coe MichaelD, 1977, ORIGINS MAYA CIVILIZ, P183; Cyphers A., 2009, ART URBANISM MESOAME, P21; Cyphers A., 1997, OLMEC AZTEC SETTLEME, P96; Estrada Belli Francisco, 2011, 1 MAYA CIVILIZATION; Garber James F., 2004, ANCIENT MAYA BELIZE, P25; Gonzalez Lauck R., 1996, OLMEC ART ANCIENT ME, P73; Grove D.C., 1987, ANCIENT CHALCATZINGO; Hammond Norman, 1991, CUELLO EARLY MAYA CO, P225; Hammond Norman, 1989, Q REV ARCHAEOLOGY, V9, P1; Hansen Richard D., 2005, BAR INT SERIES, V1377, P51; Healy PaulF., 1995, BELIZE VALLEY PRECLA; Hendon Julia A., 2004, MESOAMERICAN ARCHAEO, P43; Hodgson JohnG., 2010, MEXICON, V32, P139; Joyce RA, 2004, J ARCHAEOL METHOD TH, V11, P5, DOI 10.1023/B:JARM.0000014346.87569.4a; Laporte Juan Pedro, 1995, ANCIENT MESOAM, V6, P41, DOI 10.1017/S0956536100002108; Lohse JC, 2010, LAT AM ANTIQ, V21, P312, DOI 10.7183/1045-6635.21.3.312; Love Michael, 1999, SOCIAL PATTERNS PREC, P127; Lowe G., 2007, ARCHAEOLOGY ART ETHN, P63; Lowe G.W., 1960, MOUND 1 CHIAPA CORZO; Lowe GW, 1977, ORIGINS MAYA CIVILIZ, P197; Lowe GW, 1981, OLMEC THEIR NEIGHBOR, P231; Lowe L., 2012, 25 S INV ARQ GUAT 20, P285; Marcus Joyce, 1996, ZAPOTEC CIVILIZATION; McDonald A. J., 1983, TZUTZUCULI MIDDLE PR; Prince M. D., 2002, THESIS DUKE U; Rosenswig Robert M, 2010, BEGINNINGS MESOAMERI; Rust William F., 2008, THESIS U PENNSYLVANI; Sabloff Jeremy A., 1975, EXCAVATIONS SEIBAL D; Von Nagy Christopher L., 2003, THESIS TULANE U NEW; Willey Gordon., 1975, EXCAVATIONS SEIBAL D	40	111	111	7	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 26	2013	340	6131					467	471		10.1126/science.1234493	http://dx.doi.org/10.1126/science.1234493			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131SQ	23620050				2022-12-28	WOS:000318016700039
J	Riou, P; Kjaer, S; Garg, R; Purkiss, A; George, R; Cain, RJ; Bineva, G; Reymond, N; McColl, B; Thompson, AJ; O'Reilly, N; McDonald, NQ; Parker, PJ; Ridley, AJ				Riou, Philippe; Kjaer, Svend; Garg, Ritu; Purkiss, Andrew; George, Roger; Cain, Robert J.; Bineva, Ganka; Reymond, Nicolas; McColl, Brad; Thompson, Andrew J.; O'Reilly, Nicola; McDonald, Neil Q.; Parker, Peter J.; Ridley, Anne J.			14-3-3 Proteins Interact with a Hybrid Prenyl-Phosphorylation Motif to Inhibit G Proteins	CELL			English	Article							RHO-FAMILY; CELL-MIGRATION; CAAX MOTIF; BINDING; RAS; ORGANIZATION; GTPASES; KINASE; RAP1A; CYTOSKELETON	Signaling through G proteins normally involves conformational switching between GTP- and GDP-bound states. Several Rho GTPases are also regulated by RhoGDI binding and sequestering in the cytosol. Rnd proteins are atypical constitutively GTP- bound Rho proteins, whose regulation remains elusive. Here, we report a high-affinity 14-3-3-binding site at the C terminus of Rnd3 consisting of both the Cys241-farnesyl moiety and a Rho-associated coiled coil containing protein kinase (ROCK)-dependent Ser240 phosphorylation site. 14-3-3-binding to Rnd3 also involves phosphorylation of Ser218 by ROCK and/or Ser210 by protein kinase C (PKC). The crystal structure of a phosphorylated, farnesylated Rnd3 peptide with 14-3-3 reveals a hydrophobic groove in 14-3-3 proteins accommodating the farnesyl moiety. Functionally, 14-3-3 inhibits Rnd3-induced cell rounding by translocating it from the plasma membrane to the cytosol. Rnd1, Rnd2, and geranylgeranylated Rap1A interact similarly with 14-3-3. In contrast to the canonical GTP/GDP switch that regulates most Ras superfamily members, our results reveal an unprecedented mechanism for G protein inhibition by 14-3-3 proteins.	[Riou, Philippe; Garg, Ritu; Cain, Robert J.; Reymond, Nicolas; McColl, Brad; Ridley, Anne J.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Parker, Peter J.] Kings Coll London, Div Canc Studies, London SE1 1UL, England; [Thompson, Andrew J.] Kings Coll London, MRC, Ctr Neurodegenerat Res, London SE5 8AF, England; [Riou, Philippe; Parker, Peter J.] Canc Res UK London Res Inst, Prot Phosphorylat Lab, London WC2A 3LY, England; [Kjaer, Svend; George, Roger] Canc Res UK London Res Inst, Prot Purificat Facil, London WC2A 3LY, England; [Purkiss, Andrew; McDonald, Neil Q.] Canc Res UK London Res Inst, Struct Biol Lab, London WC2A 3LY, England; [Bineva, Ganka; O'Reilly, Nicola] Canc Res UK London Res Inst, Peptide Synth Lab, London WC2A 3LY, England; [Thompson, Andrew J.] Inst Canc Res, Chester Beatty Labs, London SW3 6JB, England; [McDonald, Neil Q.] Univ London Birkbeck Coll, Dept Biol Sci, Inst Struct & Mol Biol, London WC1E 7HX, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; Cancer Research UK; Cancer Research UK; Cancer Research UK; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; Birkbeck University London	Parker, PJ (corresponding author), Kings Coll London, Div Canc Studies, New Hunts House,Guys Campus, London SE1 1UL, England.	peter.parker@cancer.org.uk; anne.ridley@kcl.ac.uk	Thompson, Andrew/B-1463-2014; Parker, Peter j/D-5192-2013	Thompson, Andrew/0000-0003-2413-3281; Bineva-Todd, Ganka/0000-0001-8926-9417; parker, peter/0000-0002-6218-2933; Ridley, Anne/0000-0001-8186-5708; O'Reilly, Nicola/0000-0002-4204-6491	BBSRC; MRC; King's College London Wellcome Trust VIP Award; Cancer Research UK; King's College London BHF Centre of Excellence; CJ Martin fellowship; BBSRC [BB/E004083/2, BB/E004083/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E004083/1, BB/E004083/2] Funding Source: researchfish; Cancer Research UK [10747, 15683, 15961] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); King's College London Wellcome Trust VIP Award; Cancer Research UK(Cancer Research UK); King's College London BHF Centre of Excellence; CJ Martin fellowship(National Health and Medical Research Council (NHMRC) of Australia); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	We thank Michael Yaffe (MIT) for communicating the interaction between 14-3-3 epsilon and Rnd3, providing 14-3-3 constructs, and discussions; Steen Hansen for the p190RhoGAP-B construct; Steve Lynham (Centre for Excellence in Mass Spectrometry, King's College London) for expert mass spectrometry assistance; Gavin Kelly (Cancer Research UK London Research Laboratories) for help with statistical analysis; and Jeroen Claus for designing the graphical abstract. We are grateful to members of the Ridley laboratory for helpful discussions. This work was supported by the BBSRC, MRC, a King's College London Wellcome Trust VIP Award, Cancer Research UK, and the King's College London BHF Centre of Excellence. B.M. was supported by a CJ Martin fellowship.	Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; BOKOCH GM, 1991, SCIENCE, V254, P1794, DOI 10.1126/science.1763330; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; Chandra A, 2012, NAT CELL BIOL, V14, P148, DOI 10.1038/ncb2394; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Foster R, 1996, MOL CELL BIOL, V16, P2689; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Hu CD, 1999, J BIOL CHEM, V274, P48, DOI 10.1074/jbc.274.1.48; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Kostelecky B, 2009, EMBO REP, V10, P983, DOI 10.1038/embor.2009.150; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Madigan JP, 2009, BIOCHEM J, V424, P153, DOI 10.1042/BJ20082377; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Nancy V, 2002, J BIOL CHEM, V277, P15076, DOI 10.1074/jbc.M109983200; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Ottmann C, 2007, EMBO J, V26, P902, DOI 10.1038/sj.emboj.7601530; Pacary E, 2011, NEURON, V69, P1069, DOI 10.1016/j.neuron.2011.02.018; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; QUILLIAM LA, 1991, J IMMUNOL, V147, P1628; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Riou P, 2010, BIOESSAYS, V32, P986, DOI 10.1002/bies.201000060; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Thorson JA, 1998, MOL CELL BIOL, V18, P5229, DOI 10.1128/MCB.18.9.5229; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; van Hennik PB, 2003, J BIOL CHEM, V278, P39166, DOI 10.1074/jbc.M307001200; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4	37	69	71	0	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 25	2013	153	3					640	653		10.1016/j.cell.2013.03.044	http://dx.doi.org/10.1016/j.cell.2013.03.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622247	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000318063500016
J	Schmidt, CK; Jackson, SP				Schmidt, Christine K.; Jackson, Stephen P.			On Your MARK, Get SET(D2), Go! H3K36me3 Primes DNA Mismatch Repair	CELL			English	Editorial Material							HISTONE; CHROMATIN	Trimethylation of histone H3 on Lys36 (H3K36me3) by SETD2 is linked to actively transcribed regions. Li et al. identify a novel role for H3K36me3 that facilitates DNA mismatch repair (MMR) in cells by targeting the MMR machinery to chromatin during the cell cycle, thereby explaining certain cases of MMR-defective cancers.	[Schmidt, Christine K.; Jackson, Stephen P.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Schmidt, Christine K.; Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England; [Jackson, Stephen P.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute	Jackson, SP (corresponding author), Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England.	s.jackson@gurdon.cam.ac.uk	Jackson, Stephen Philip/R-4548-2019; Dry, Kate/I-2328-2014; Schmidt, Christine/AAF-2625-2021	Jackson, Stephen Philip/0000-0001-9317-7937; Schmidt, Christine/0000-0002-8363-7933	Cancer Research UK [11224] Funding Source: Medline; Wellcome Trust [092096] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Li F, 2009, J BIOL CHEM, V284, P33056, DOI 10.1074/jbc.M109.049874; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Miller KM, 2012, BIOCHEM SOC T, V40, P370, DOI 10.1042/BST20110747; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Tornaletti S, 2009, CELL MOL LIFE SCI, V66, P1010, DOI 10.1007/s00018-009-8738-x; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274	10	12	13	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 25	2013	153	3					513	515		10.1016/j.cell.2013.04.018	http://dx.doi.org/10.1016/j.cell.2013.04.018			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622237	Bronze			2022-12-28	WOS:000318063500005
J	Saal, AE; Hauri, EH; Van Orman, JA; Rutherford, MJ				Saal, Alberto E.; Hauri, Erik H.; Van Orman, James A.; Rutherford, Malcolm J.			Hydrogen Isotopes in Lunar Volcanic Glasses and Melt Inclusions Reveal a Carbonaceous Chondrite Heritage	SCIENCE			English	Article							TERRESTRIAL PLANETS; SILICATE MELTS; SOURCE REGIONS; WATER; MOON; EARTH; ABUNDANCES; VOLATILES; EVOLUTION; DELIVERY	Water is perhaps the most important molecule in the solar system, and determining its origin and distribution in planetary interiors has important implications for understanding the evolution of planetary bodies. Here we report in situ measurements of the isotopic composition of hydrogen dissolved in primitive volcanic glass and olivine-hosted melt inclusions recovered from the Moon by the Apollo 15 and 17 missions. After consideration of cosmic-ray spallation and degassing processes, our results demonstrate that lunar magmatic water has an isotopic composition that is indistinguishable from that of the bulk water in carbonaceous chondrites and similar to that of terrestrial water, implying a common origin for the water contained in the interiors of Earth and the Moon.	[Saal, Alberto E.; Rutherford, Malcolm J.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Hauri, Erik H.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Van Orman, James A.] Case Western Reserve Univ, Dept Geol Sci, Cleveland, OH 44106 USA	Brown University; Carnegie Institution for Science; Case Western Reserve University	Saal, AE (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.	asaal@brown.edu		Van Orman, James/0000-0001-8741-0288	NASA [NNX12AH62G, NNX08AY97G]; Brown-Massachusetts Institute of Technology NASA Lunar Science Institute [NNA09DB34A]	NASA(National Aeronautics & Space Administration (NASA)); Brown-Massachusetts Institute of Technology NASA Lunar Science Institute	We are grateful to A. Halliday, P. Warren, D. Stevenson, A. Morbidelli, K. Walsh, C. Alexander, A. Davis, and B. Marty for discussion, and thank the anonymous reviewers for discussion, criticism, and advice. We thank J. Wang for expert assistance with the NanoSIMS. This work was funded by NASA Cosmochemistry NNX12AH62G and LASER NNX08AY97G programs, and by the Brown-Massachusetts Institute of Technology NASA Lunar Science Institute NNA09DB34A.	Alexander CMO, 2012, SCIENCE, V337, P721, DOI 10.1126/science.1223474; Andrews-Hanna JC, 2013, SCIENCE, V339, P675, DOI 10.1126/science.1231753; Boyce JW, 2010, NATURE, V466, P466, DOI 10.1038/nature09274; Cuk M, 2012, SCIENCE, V338, P1047, DOI 10.1126/science.1225542; Eugster O., 1981, P LUNAR PLANET SCI B, V12, P541; Greenwood JP, 2011, NAT GEOSCI, V4, P79, DOI 10.1038/NGEO1050; Hauri E, 2002, CHEM GEOL, V183, P115, DOI 10.1016/S0009-2541(01)00374-6; Hauri EH, 2011, SCIENCE, V333, P213, DOI 10.1126/science.1204626; Hirschmann MM, 2012, EARTH PLANET SC LETT, V345, P38, DOI 10.1016/j.epsl.2012.06.031; Hui HJ, 2013, NAT GEOSCI, V6, P177, DOI 10.1038/ngeo1735; Lauretta D. S., 2006, METEORITES EARLY SOL, P341; Lodders K, 1999, SPACE SCI REV, V90, P289, DOI 10.1023/A:1005226921031; Marty B, 2003, SPACE SCI REV, V106, P175, DOI 10.1023/A:1024689721371; Marty B, 2012, EARTH PLANET SC LETT, V313, P56, DOI 10.1016/j.epsl.2011.10.040; McCubbin FM, 2010, P NATL ACAD SCI USA, V107, P11223, DOI 10.1073/pnas.1006677107; Merlivat L., 1976, P LUNAR PLANET SCI C, P649; Pahlevan K, 2011, EARTH PLANET SC LETT, V301, P433, DOI 10.1016/j.epsl.2010.10.036; Reedy R. C., 1981, P LUNAR PLANET SCI C, V12, P871; Robert F, 2001, SCIENCE, V293, P1056, DOI 10.1126/science.1064051; Saal AE, 2008, NATURE, V454, P192, DOI 10.1038/nature07047; Shearer CK, 2006, REV MINERAL GEOCHEM, V60, P365, DOI 10.2138/rmg.2006.60.4; Solomon S. C., 1976, P LUNAR PLANET SCI C, V7, P541; Spangler R. R., 1984, P LUNAR PLANET SCI C, V14, P487; Walsh KJ, 2012, METEORIT PLANET SCI, V47, P1941, DOI 10.1111/j.1945-5100.2012.01418.x; Weitz CM, 1999, METEORIT PLANET SCI, V34, P527, DOI 10.1111/j.1945-5100.1999.tb01361.x; Zhang YX, 2010, REV MINERAL GEOCHEM, V72, P171, DOI 10.2138/rmg.2010.72.5	31	155	160	1	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1317	1320		10.1126/science.1235142	http://dx.doi.org/10.1126/science.1235142			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23661641				2022-12-28	WOS:000320320200041
J	Rigotti, M; Barak, O; Warden, MR; Wang, XJ; Daw, ND; Miller, EK; Fusi, S				Rigotti, Mattia; Barak, Omri; Warden, Melissa R.; Wang, Xiao-Jing; Daw, Nathaniel D.; Miller, Earl K.; Fusi, Stefano			The importance of mixed selectivity in complex cognitive tasks	NATURE			English	Article							INFORMATION; CORTEX; MODEL	Single-neuron activity in the prefrontal cortex (PFC) is tuned to mixtures of multiple task-related aspects. Such mixed selectivity is highly heterogeneous, seemingly disordered and therefore difficult to interpret. We analysed the neural activity recorded in monkeys during an object sequence memory task to identify a role of mixed selectivity in subserving the cognitive functions ascribed to the PFC. We show that mixed selectivity neurons encode distributed information about all task-relevant aspects. Each aspect can be decoded from the population of neurons even when single-cell selectivity to that aspect is eliminated. Moreover, mixed selectivity offers a significant computational advantage over specialized responses in terms of the repertoire of input-output functions implementable by readout neurons. This advantage originates from the highly diverse nonlinear selectivity to mixtures of task-relevant variables, a signature of high-dimensional neural representations. Crucially, this dimensionality is predictive of animal behaviour as it collapses in error trials. Our findings recommend a shift of focus for future studies from neurons that have easily interpretable response tuning to the widely observed, but rarely analysed, mixed selectivity neurons.	[Rigotti, Mattia; Barak, Omri; Fusi, Stefano] Columbia Univ Coll Phys & Surg, Ctr Theoret Neurosci, New York, NY 10032 USA; [Rigotti, Mattia; Wang, Xiao-Jing; Daw, Nathaniel D.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Rigotti, Mattia; Daw, Nathaniel D.] NYU, Dept Psychol, New York, NY 10003 USA; [Warden, Melissa R.; Miller, Earl K.] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Warden, Melissa R.; Miller, Earl K.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Warden, Melissa R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Wang, Xiao-Jing] Yale Univ, Sch Med, Dept Neurobiol, Kavli Inst Neurosci, New Haven, CT 06525 USA	Columbia University; New York University; New York University; Massachusetts Institute of Technology (MIT); Northwell Health; Massachusetts Institute of Technology (MIT); Stanford University; Yale University	Fusi, S (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Theoret Neurosci, 630 W 168th St, New York, NY 10032 USA.	sf2237@columbia.edu	Wang, Xiao-Jing/D-2722-2009; Rigotti, Mattia/H-7252-2019; Miller, Earl K./AAE-8187-2019; Warden, Melissa R/M-9300-2016; Fusi, Stefano/E-9109-2011	Rigotti, Mattia/0000-0001-6466-2810; Miller, Earl K./0000-0002-0582-6958; Warden, Melissa R/0000-0003-2240-3997; Fusi, Stefano/0000-0002-3035-6652; Barak, Omri/0000-0002-7894-6344	Gatsby Foundation; Swartz Foundation; Kavli Foundation; Swiss National Science Foundation [PBSKP3-133357]; Janggen-Poehn Foundation; McKnight Foundation; McDonnell Foundation; NIMH [5-R37-MH087027-04]; Picower Foundation; Brain & Behavior Research Foundation; NARSAD; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091174, R37MH087027] Funding Source: NIH RePORTER	Gatsby Foundation; Swartz Foundation; Kavli Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Janggen-Poehn Foundation; McKnight Foundation; McDonnell Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Picower Foundation; Brain & Behavior Research Foundation(NARSAD); NARSAD(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to L.F. Abbott for comments on the manuscript and for discussions. Work supported by the Gatsby Foundation, the Swartz Foundation and the Kavli Foundation. M.R. is supported by Swiss National Science Foundation grant PBSKP3-133357 and the Janggen-Poehn Foundation; N.D.D. is supported by the McKnight Foundation and the McDonnell Foundation; E.K.M. is supported by NIMH grant 5-R37-MH087027-04 and The Picower Foundation; M.R.W. from the Brain & Behavior Research Foundation and the NARSAD Young Investigator grant.	Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Barak O, 2013, J NEUROSCI, V33, P3844, DOI 10.1523/JNEUROSCI.2753-12.2013; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Churchland MM, 2006, J NEUROSCI, V26, P3697, DOI 10.1523/JNEUROSCI.3762-05.2006; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; DiCarlo JJ, 2012, NEURON, V73, P415, DOI 10.1016/j.neuron.2012.01.010; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Jaeger H, 2004, SCIENCE, V304, P78, DOI 10.1126/science.1091277; Klampfl S, 2012, J NEUROPHYSIOL, V108, P1366, DOI 10.1152/jn.00935.2011; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Machens CK, 2010, J NEUROSCI, V30, P350, DOI 10.1523/JNEUROSCI.3276-09.2010; Mansouri FA, 2006, J NEUROSCI, V26, P2745, DOI 10.1523/JNEUROSCI.5238-05.2006; Meyers EM, 2008, J NEUROPHYSIOL, V100, P1407, DOI 10.1152/jn.90248.2008; Pascanu R, 2011, NEURAL NETWORKS, V24, P199, DOI 10.1016/j.neunet.2010.10.003; Rigotti M, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00024; Rosenblatt F., 1962, PRINCIPLES NEURODYNA, DOI 10.21236/AD0256582; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; Sussillo D, 2009, NEURON, V63, P544, DOI 10.1016/j.neuron.2009.07.018; Warden MR, 2007, CEREB CORTEX, V17, pI41, DOI 10.1093/cercor/bhm070; Warden MR, 2010, J NEUROSCI, V30, P15801, DOI 10.1523/JNEUROSCI.1569-10.2010; Yuste R, 2011, NEURON, V71, P772, DOI 10.1016/j.neuron.2011.07.024	23	695	699	4	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2013	497	7451					585	590		10.1038/nature12160	http://dx.doi.org/10.1038/nature12160			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23685452	Green Accepted, Green Submitted			2022-12-28	WOS:000319556100036
J	Sanders, TA; Llagostera, E; Barna, M				Sanders, Timothy A.; Llagostera, Esther; Barna, Maria			Specialized filopodia direct long-range transport of SHH during vertebrate tissue patterning	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; SONIC-HEDGEHOG; MYOSIN-X; F-ACTIN; CHOLESTEROL MODIFICATION; CHICK LIMB; IN-VIVO; CELLS; CYTONEMES; PATHWAY	The ability of signalling proteins to traverse tissues containing tightly packed cells is of fundamental importance for cell specification and tissue development; however, how this is achieved at a cellular level remains poorly understood(1). For more than a century, the vertebrate limb bud has served as a model for studying cell signalling during embryonic development(2). Here we optimize single-cell real-time imaging to delineate the cellular mechanisms for how signalling proteins, such as sonic hedgehog (SHH), that possess membrane-bound covalent lipid modifications traverse long distances within the vertebrate limb bud in vivo. By directly imaging SHH ligand production under native regulatory control in chick (Gallus gallus) embryos, our findings show that SHH is unexpectedly produced in the form of a particle that remains associated with the cell via long cytoplasmic extensions that span several cell diameters. We show that these cellular extensions are a specialized class of actin-based filopodia with novel cytoskeletal features that have not been previously described. Notably, particles containing SHH travel along these extensions with a net anterograde movement within the field of SHH cell signalling. We further show that in SHH-responding cells, specific subsets of SHH co-receptors, including cell adhesion molecule downregulated by oncogenes (CDO) and brother of CDO (BOC), actively distribute and co-localize in specific micro-domains within filopodial extensions, far from the cell body. Stabilized interactions are formed between filopodia containing SHH ligand and those containing co-receptors over a long range. These results suggest that contact-mediated release propagated by specialized filopodia contributes to the delivery of SHH at a distance. Together, these studies identify an important mode of communication between cells that considerably extends our understanding of ligand movement and reception during vertebrate tissue patterning.	[Sanders, Timothy A.; Llagostera, Esther; Barna, Maria] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Sanders, Timothy A.] Univ Calif San Francisco, Div Neonatol, Dept Pediat, San Francisco, CA 94158 USA; [Llagostera, Esther; Barna, Maria] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Llagostera, Esther; Barna, Maria] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Stanford University	Barna, M (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	mbarna@stanford.edu			Spanish Ministry of Education and Science; Program for Breakthrough Biomedical Research, UCSF; March of Dimes Basil O'Connor Scholar Research Award; National Institute of Arthritis and Musculoskeletal and Skin Disease, part of NIH [NIH R21AR062262]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR062262] Funding Source: NIH RePORTER	Spanish Ministry of Education and Science(Spanish Government); Program for Breakthrough Biomedical Research, UCSF; March of Dimes Basil O'Connor Scholar Research Award(March of Dimes); National Institute of Arthritis and Musculoskeletal and Skin Disease, part of NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank D. Mullins for discussion on the actin cytoskeleton, as well as G. Martin and members of the Barna laboratory for discussion and critical reading of the manuscript. We thank K. Cabaltera for technical assistance. This work was supported by Spanish Ministry of Education and Science (E.L.), Program for Breakthrough Biomedical Research, UCSF (M.B.), the March of Dimes Basil O'Connor Scholar Research Award (M.B.), and the National Institute of Arthritis and Musculoskeletal and Skin Disease, part of NIH, under award number NIH R21AR062262 (M.B.).	Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Allen BL, 2011, DEV CELL, V20, P775, DOI 10.1016/j.devcel.2011.04.018; AUERBACH R, 1974, DEV BIOL, V41, P391, DOI 10.1016/0012-1606(74)90316-9; Barna M, 2007, DEV CELL, V12, P931, DOI 10.1016/j.devcel.2007.04.016; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; Boehm B, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000420; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; Breitsprecher D, 2011, J CELL SCI, V124, P3305, DOI 10.1242/jcs.086934; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Callejo Ainhoa, 2007, V397, P91; Cao DH, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-142; Chamberlain CE, 2008, DEVELOPMENT, V135, P1097, DOI 10.1242/dev.013086; Chen L, 2006, P NATL ACAD SCI USA, V103, P16520, DOI 10.1073/pnas.0603533103; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Hamburger V., 1951, J MORPHOL, V195, P231; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Hesselson D, 2009, P NATL ACAD SCI USA, V106, P14896, DOI 10.1073/pnas.0906348106; Hsiung F, 2005, NATURE, V437, P560, DOI 10.1038/nature03951; Ingham PW, 2001, SCIENCE, V294, P1879, DOI 10.1126/science.1064115; Kaddoum L, 2010, BIOTECHNIQUES, V49, P727, DOI 10.2144/000113512; Kavran JM, 2010, J BIOL CHEM, V285, P24584, DOI 10.1074/jbc.M110.131680; KELLEY RO, 1978, J EMBRYOL EXP MORPH, V46, P99; Kerber ML, 2011, J CELL SCI, V124, P3733, DOI 10.1242/jcs.023549; Krull CE, 2004, DEV DYNAM, V229, P433, DOI 10.1002/dvdy.10473; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Li X, 2005, INSECT MOL BIOL, V14, P17, DOI 10.1111/j.1365-2583.2004.00525.x; Li YN, 2006, P NATL ACAD SCI USA, V103, P6548, DOI 10.1073/pnas.0600124103; Maas SA, 2011, DEV DYNAM, V240, P1212, DOI 10.1002/dvdy.22634; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; MILLER J, 1995, DEVELOPMENT, V121, P2501; Mogilner A, 2005, BIOPHYS J, V89, P782, DOI 10.1529/biophysj.104.056515; Munsie LN, 2009, NAT METHODS, V6, P317, DOI 10.1038/nmeth0509-317; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Niswander L, 2003, NAT REV GENET, V4, P133, DOI 10.1038/nrg1001; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pinaud F, 2011, P NATL ACAD SCI USA, V108, pE201, DOI 10.1073/pnas.1101929108; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Riedl J, 2010, NAT METHODS, V7, P168, DOI 10.1038/nmeth0310-168; Roy S, 2011, SCIENCE, V332, P354, DOI 10.1126/science.1198949; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Vincent S, 2003, NAT BIOTECHNOL, V21, P936, DOI 10.1038/nbt844; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Vyas N, 2008, CELL, V133, P1214, DOI 10.1016/j.cell.2008.05.026; Yang Y, 1997, DEVELOPMENT, V124, P4393; Yao SQ, 2006, CELL, V125, P343, DOI 10.1016/j.cell.2006.02.040; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zhu AJ, 2004, GENE DEV, V18, P2985, DOI 10.1101/gad.1233104	57	257	258	0	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2013	497	7451					628	+		10.1038/nature12157	http://dx.doi.org/10.1038/nature12157			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23624372	Green Accepted			2022-12-28	WOS:000319556100046
J	Margolin, DH; Kousi, M; Chan, YM; Lim, ET; Schmahmann, JD; Hadjivassiliou, M; Hall, JE; Adam, I; Dwyer, A; Plummer, L; Aldrin, SV; O'Rourke, J; Kirby, A; Lage, K; Milunsky, A; Milunsky, JM; Chan, J; Hedley-Whyte, ET; Daly, MJ; Katsanis, N; Seminara, SB				Margolin, David H.; Kousi, Maria; Chan, Yee-Ming; Lim, Elaine T.; Schmahmann, Jeremy D.; Hadjivassiliou, Marios; Hall, Janet E.; Adam, Ibrahim; Dwyer, Andrew; Plummer, Lacey; Aldrin, Stephanie V.; O'Rourke, Julia; Kirby, Andrew; Lage, Kasper; Milunsky, Aubrey; Milunsky, Jeff M.; Chan, Jennifer; Hedley-Whyte, E. Tessa; Daly, Mark J.; Katsanis, Nicholas; Seminara, Stephanie B.			Ataxia, Dementia, and Hypogonadotropism Caused by Disordered Ubiquitination	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GONADOTROPIN-RELEASING-HORMONE; BARDET-BIEDL-SYNDROME; FAMILIAL CEREBELLAR-ATAXIA; TRIALLELIC INHERITANCE; PARKINSONS-DISEASE; HOLMES TYPE; HYPOGONADISM; DEFICIENCY; PROTEIN; DEGENERATION	BACKGROUND The combination of ataxia and hypogonadism was first described more than a century ago, but its genetic basis has remained elusive. METHODS We performed whole-exome sequencing in a patient with ataxia and hypogonadotropic hypogonadism, followed by targeted sequencing of candidate genes in similarly affected patients. Neurologic and reproductive endocrine phenotypes were characterized in detail. The effects of sequence variants and the presence of an epistatic interaction were tested in a zebrafish model. RESULTS Digenic homozygous mutations in RNF216 and OTUD4, which encode a ubiquitin E3 ligase and a deubiquitinase, respectively, were found in three affected siblings in a consanguineous family. Additional screening identified compound heterozygous truncating mutations in RNF216 in an unrelated patient and single heterozygous deleterious mutations in four other patients. Knockdown of rnf216 or otud4 in zebrafish embryos induced defects in the eye, optic tectum, and cerebellum; combinatorial suppression of both genes exacerbated these phenotypes, which were rescued by nonmutant, but not mutant, human RNF216 or OTUD4 messenger RNA. All patients had progressive ataxia and dementia. Neuronal loss was observed in cerebellar pathways and the hippocampus; surviving hippocampal neurons contained ubiquitin-immunoreactive intranuclear inclusions. Defects were detected at the hypothalamic and pituitary levels of the reproductive endocrine axis. CONCLUSIONS The syndrome of hypogonadotropic hypogonadism, ataxia, and dementia can be caused by inactivating mutations in RNF216 or by the combination of mutations in RNF216 and OTUD4. These findings link disordered ubiquitination to neurodegeneration and reproductive dysfunction and highlight the power of whole-exome sequencing in combination with functional studies to unveil genetic interactions that cause disease.	[Margolin, David H.; Schmahmann, Jeremy D.] Massachusetts Gen Hosp, Dept Neurol, Harvard Reprod Sci Ctr, Boston, MA 02115 USA; [Chan, Yee-Ming; Hall, Janet E.; Dwyer, Andrew; Plummer, Lacey; Aldrin, Stephanie V.; O'Rourke, Julia; Seminara, Stephanie B.] Massachusetts Gen Hosp, Reprod Endocrine Unit, Boston, MA 02115 USA; [Lim, Elaine T.; Kirby, Andrew; Lage, Kasper; Daly, Mark J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02115 USA; [Lage, Kasper] Massachusetts Gen Hosp, Dept Med, Pediat Surg Res Labs, Boston, MA 02115 USA; [Hedley-Whyte, E. Tessa] Massachusetts Gen Hosp, Dept Neuropathol, Boston, MA 02115 USA; [Chan, Yee-Ming] Boston Childrens Hosp, Div Endocrinol, Dept Med, Boston, MA USA; [Chan, Jennifer] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Milunsky, Aubrey; Milunsky, Jeff M.] Ctr Human Genet, Cambridge, MA USA; [Kousi, Maria; Katsanis, Nicholas] Duke Univ, Med Ctr, Dept Cell Biol, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Katsanis, Nicholas] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Hadjivassiliou, Marios] Royal Hallamshire Hosp, Dept Neurol, Sheffield S10 2JF, S Yorkshire, England; [Adam, Ibrahim] Specialty Hosp, Amman, Jordan; Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Lage, Kasper] Univ Copenhagen, Ctr Prot Res, Copenhagen, Denmark	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Duke University; Duke University; University of Sheffield; Technical University of Denmark; University of Copenhagen	Seminara, SB (corresponding author), Massachusetts Gen Hosp, Reprod Endocrine Unit, Boston, MA 02115 USA.	katsanis@cellbio.duke.edu; seminara.stephanie@mgh.harvard.edu	Lim, Elaine/H-9032-2016; Hedley-Whyte, E Tessa/AAJ-9975-2021; Daly, Mark J/B-2453-2017; Dwyer, Andrew A./D-8099-2012; Hall, Janet E/F-3516-2019; Schmahmann, Jeremy/ABF-1215-2021	Hedley-Whyte, E Tessa/0000-0002-1687-8905; Daly, Mark J/0000-0002-0949-8752; Dwyer, Andrew A./0000-0002-7023-6794; Hall, Janet E/0000-0003-4644-3061; Schmahmann, Jeremy/0000-0003-0706-5125; Milunsky, Aubrey/0000-0003-2114-4823; Katsanis, Nicholas/0000-0002-2480-0171; Lim, Teng Ting/0000-0003-3651-0654	National Institutes of Health; Eunice K. Shriver National Institute for Child Health and Human Development [K24 HD067388, R01 HD043341, R01 HD042601, U54 HD028138]; National Institute of Diabetes and Digestive and Kidney Diseases [P50 DK096415]; Harvard Catalyst; Harvard Clinical and Translational Science Center; National Center for Research Resources; National Center for Advancing Translational Sciences [UL1TR025758, M01RR01066]; Harvard University; National Human Genome Research Institute to the Broad Institute [U54 HG003967]; National Heart, Lung, and Blood Institute for the Exome Sequencing Project [HL102923, HL102924, HL102925, HL102926, HL103010]; Charles A. King Trust postdoctoral fellowship; Career Development Award from Boston Children's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028138, K24HD067388, R01HD042601, R01HD043341] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001066, UL1RR025758] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UC2HL103010, RC2HL102923, UC2HL102926, RC2HL102924, UC2HL102923, UC2HL102924, RC2HL103010, UC2HL102925, RC2HL102925, RC2HL102926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK096415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice K. Shriver National Institute for Child Health and Human Development; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Harvard Catalyst; Harvard Clinical and Translational Science Center; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Harvard University; National Human Genome Research Institute to the Broad Institute; National Heart, Lung, and Blood Institute for the Exome Sequencing Project; Charles A. King Trust postdoctoral fellowship; Career Development Award from Boston Children's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institutes of Health and others.; Supported by grants from the Eunice K. Shriver National Institute for Child Health and Human Development (K24 HD067388, R01 HD043341, R01 HD042601, and U54 HD028138); from the National Institute of Diabetes and Digestive and Kidney Diseases (P50 DK096415); by Harvard Catalyst and the Harvard Clinical and Translational Science Center (funded by the National Center for Research Resources and the National Center for Advancing Translational Sciences [UL1TR025758 and M01RR01066] and Harvard University and its affiliated academic health care centers); by a grant from the National Human Genome Research Institute to the Broad Institute (U54 HG003967); and by grants from the National Heart, Lung, and Blood Institute for the Exome Sequencing Project (HL102923, HL102924, HL102925, HL102926, and HL103010). Dr. Chan is the recipient of a Charles A. King Trust postdoctoral fellowship and a Career Development Award from Boston Children's Hospital.	ABS R, 1990, J NEUROL SCI, V98, P259, DOI 10.1016/0022-510X(90)90267-Q; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Aerts S, 2006, NAT BIOTECHNOL, V24, P719, DOI 10.1038/nbt0606-719d; [Anonymous], 2011, MOL CELL ENDOCRINOL, V346, P4; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; BERCIANO J, 1982, J NEUROL NEUROSUR PS, V45, P747, DOI 10.1136/jnnp.45.8.747; BERCIANO J, 1983, J NEUROL NEUROSUR PS, V46, P472; Chen DY, 2002, J BIOL CHEM, V277, P15985, DOI 10.1074/jbc.M108675200; Chuang TH, 2004, NAT IMMUNOL, V5, P968, DOI 10.1038/ni0904-968; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; de Pontual L, 2009, P NATL ACAD SCI USA, V106, P13921, DOI 10.1073/pnas.0901219106; DEMICHELE G, 1990, CLIN NEUROL NEUROSUR, V92, P67, DOI 10.1016/0303-8467(90)90010-3; DEMICHELE G, 1993, CLIN NEUROL NEUROSUR, V95, P23, DOI 10.1016/0303-8467(93)90087-W; Durcan TM, 2012, J BIOL CHEM, V287, P531, DOI 10.1074/jbc.M111.288449; Fearns C, 2006, J BIOL CHEM, V281, P34592, DOI 10.1074/jbc.M604019200; FOK ACK, 1989, J NEUROL NEUROSUR PS, V52, P407, DOI 10.1136/jnnp.52.3.407; Holmes G, 1907, BRAIN, V30, P466; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 2002, AM J HUM GENET, V71, P22, DOI 10.1086/341031; Kumar P, 2012, J NEUROCHEM, V120, P350, DOI 10.1111/j.1471-4159.2011.07588.x; Lage K, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.36; Lavoie HB, 1998, J CLIN ENDOCR METAB, V83, P241, DOI 10.1210/jc.83.1.241; Longoni M, 2012, AM J MED GENET A, V158A, P3148, DOI 10.1002/ajmg.a.35665; LOWENTHAL A, 1979, J NEUROL, V222, P75, DOI 10.1007/BF00313001; Miah SMS, 2011, J IMMUNOL, V186, P2959, DOI 10.4049/jimmunol.1000112; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Nozu K, 2008, J MED GENET, V45, P182, DOI 10.1136/jmg.2007.052944; Pilsl A, 2012, ACTA NEUROPATHOL, V123, P173, DOI 10.1007/s00401-011-0902-3; Quinton R, 1999, CLIN ENDOCRINOL, V51, P525, DOI 10.1046/j.1365-2265.1999.00859.x; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Sailer A, 2012, CURR NEUROL NEUROSCI, V12, P227, DOI 10.1007/s11910-012-0267-6; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Schlingmann KP, 2004, NEW ENGL J MED, V350, P1314, DOI 10.1056/NEJMoa032843; Seminara SB, 2002, J CLIN ENDOCR METAB, V87, P1607, DOI 10.1210/jc.87.4.1607; Sykiotis GP, 2010, P NATL ACAD SCI USA, V107, P15140, DOI 10.1073/pnas.1009622107; Vielhaber S, 2000, CLIN NEUROL NEUROSUR, V102, P102, DOI 10.1016/S0303-8467(00)00068-8; VOLPE R, 1963, J CLIN ENDOCR METAB, V23, P107, DOI 10.1210/jcem-23-1-107; Zaghloul NA, 2011, METHOD CELL BIOL, V105, P257, DOI 10.1016/B978-0-12-381320-6.00011-4	40	136	141	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2013	368	21					1992	2003		10.1056/NEJMoa1215993	http://dx.doi.org/10.1056/NEJMoa1215993			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148TJ	23656588	Green Published, Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000319270200001
J	Livio, M				Livio, Mario			Don't bristle at blunders	NATURE			English	Editorial Material							PSR1829-10		Space Telescope Sci Inst, Baltimore, MD 21218 USA	Space Telescope Science Institute	Livio, M (corresponding author), Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA.	mlivio@stsci.edu						BAILES M, 1991, NATURE, V352, P311, DOI 10.1038/352311a0; LYNE AG, 1992, NATURE, V355, P213, DOI 10.1038/355213b0; THOMSON W. L. K., 2011, P R SOC EDINB, V6, P94; Wolfe-Simon F, 2011, SCIENCE, V332, P1163, DOI 10.1126/science.1197258	4	1	1	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2013	497	7449					309	310		10.1038/497309a	http://dx.doi.org/10.1038/497309a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	144PN	23676737	Bronze			2022-12-28	WOS:000318952000013
J	Bleich, SN; Rutkow, L				Bleich, Sara N.; Rutkow, Lainie			Improving Obesity Prevention at the Local Level - Emerging Opportunities	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bleich, Sara N.; Rutkow, Lainie] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bleich, SN (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA.			Rutkow, Helaine/0000-0001-6423-7291				Agency for Healthcare Research and Quality, 2011, AHRQ PUBLICATION, V10; Bleich SN, 2012, AM J PUBLIC HEALTH, V102, P329, DOI 10.2105/AJPH.2011.300350; Downs JS, 2009, AM ECON REV, V99, P159, DOI 10.1257/aer.99.2.159; Dowray S, 2013, APPETITE, V62, P173, DOI 10.1016/j.appet.2012.11.013; Jargon J., 2009, WALL STREET J	5	7	7	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2013	368	19					1761	1763		10.1056/NEJMp1301685	http://dx.doi.org/10.1056/NEJMp1301685			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	138WA	23656641				2022-12-28	WOS:000318540000001
J	Tubo, NJ; Pagan, AJ; Taylor, JJ; Nelson, RW; Linehan, JL; Ertelt, JM; Huseby, ES; Way, SS; Jenkins, MK				Tubo, Noah J.; Pagan, Antonio J.; Taylor, Justin J.; Nelson, Ryan W.; Linehan, Jonathan L.; Ertelt, James M.; Huseby, Eric S.; Way, Sing Sing; Jenkins, Marc K.			Single Naive CD4(+) T Cells from a Diverse Repertoire Produce Different Effector Cell Types during Infection	CELL			English	Article							LISTERIA-MONOCYTOGENES INFECTION; FOLLICULAR HELPER-CELL; MEDIATED-IMMUNITY; IN-VIVO; VIRAL-INFECTION; TRANSGENIC MICE; ANTIGEN; TCR; EXPRESSION; RESPONSES	A naive CD4(+) T cell population specific for a microbial peptide:major histocompatibility complex II ligand (p:MHCII) typically consists of about 100 cells, each with a different T cell receptor (TCR). Following infection, this population produces a consistent ratio of effector cells that activate microbicidal functions of macrophages or help B cells make antibodies. We studied the mechanism that underlies this division of labor by tracking the progeny of single naive T cells. Different naive cells produced distinct ratios of macrophage and B cell helpers but yielded the characteristic ratio when averaged together. The effector cell pattern produced by a given naive cell correlated with the TCR-p:MHCII dwell time or the amount of p:MHCII. Thus, the consistent production of effector cell subsets by a polyclonal population of naive cells results from averaging the diverse behaviors of individual clones, which are instructed in part by the strength of TCR signaling.	[Tubo, Noah J.; Pagan, Antonio J.; Taylor, Justin J.; Nelson, Ryan W.; Linehan, Jonathan L.; Jenkins, Marc K.] Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol, Minneapolis, MN 55455 USA; [Ertelt, James M.; Way, Sing Sing] Univ Minnesota, Sch Med, Ctr Infect Dis & Microbiol Translat Res, Dept Pediat, Minneapolis, MN 55455 USA; [Huseby, Eric S.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Massachusetts System; University of Massachusetts Worcester	Jenkins, MK (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol, Minneapolis, MN 55455 USA.	jenki002@umn.eau	Jenkins, Marc K/G-1063-2012; Pagan, Antonio/AAB-1604-2019	Jenkins, Marc K/0000-0001-8009-7655; Nelson, Ryan/0000-0003-2327-9481; Way, Sing Sing/0000-0001-8948-1952	National Institutes of Health [R01-AI39614, R37-AI27998, R01-AI66018, T32-HD060536, T32-AI07313, F30-DK093242, R01-AI087830, R01-AI100934]; Kunze Fellowship; Irvington Fellowship from the Cancer Research Institute; Burroughs Wellcome Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060536] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035296, R37AI027998, R01AI039614, R01AI103760, T32AI007313, R01AI087830, R56AI066018, R01AI100934, R01AI066018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095077, F30DK093242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kunze Fellowship; Irvington Fellowship from the Cancer Research Institute; Burroughs Wellcome Fund(Burroughs Wellcome Fund); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Walter and R. Speier for technical assistance and T. Martin and the University of Minnesota Flow Cytometry Facility for cell sorting. This work was supported by grants from the National Institutes of Health (R01-AI39614, R37-AI27998, and R01-AI66018 to M.K.J.; T32-HD060536 to N.J.T.; T32-AI07313 to A.J.P.; F30-DK093242 to R.W.N.; R01-AI087830 and R01-AI100934 to S.S.W.; and T32-AI07313 to J.L.L.). This work was also supported by the Kunze Fellowship (to A.J.P.), the Irvington Fellowship from the Cancer Research Institute (to J.J.T.), and the Burroughs Wellcome Fund (to S.S.W.).	Aleksic M, 2010, IMMUNITY, V32, P163, DOI 10.1016/j.immuni.2009.11.013; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; BRETSCHER PA, 1992, SCIENCE, V257, P539, DOI 10.1126/science.1636090; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Chen HB, 2012, NAT IMMUNOL, V13, P691, DOI 10.1038/ni.2342; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Derby MA, 2001, INT IMMUNOL, V13, P817, DOI 10.1093/intimm/13.6.817; Ertelt JM, 2009, J IMMUNOL, V182, P3032, DOI 10.4049/jimmunol.0803402; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Geginat G, 2001, J IMMUNOL, V166, P1877, DOI 10.4049/jimmunol.166.3.1877; Gerlach C, 2010, J EXP MED, V207, P1235, DOI 10.1084/jem.20091175; Govern CC, 2010, P NATL ACAD SCI USA, V107, P8724, DOI 10.1073/pnas.1000966107; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Itano AA, 2003, NAT IMMUNOL, V4, P733, DOI 10.1038/ni957; Jenkins MK, 2010, ANNU REV IMMUNOL, V28, P275, DOI 10.1146/annurev-immunol-030409-101253; Johanns TM, 2010, J IMMUNOL, V184, P869, DOI 10.4049/jimmunol.0901804; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; King CG, 2012, IMMUNITY, V37, P709, DOI 10.1016/j.immuni.2012.06.021; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Lee SK, 2011, J EXP MED, V208, P1377, DOI 10.1084/jem.20102065; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; McSorley SJ, 2002, IMMUNITY, V16, P365, DOI 10.1016/S1074-7613(02)00289-3; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2011, P NATL ACAD SCI USA, V108, P14602, DOI 10.1073/pnas.1109806108; Nakayamada S, 2011, IMMUNITY, V35, P919, DOI 10.1016/j.immuni.2011.11.012; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; OESTREICH KJ, 2012, NAT IMMUNOL, V13, P405, DOI DOI 10.1038/ni.2242; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O; PARISH CR, 1972, J EXP MED, V135, P298, DOI 10.1084/jem.135.2.298; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Pepper M, 2011, NAT IMMUNOL, V12, P467, DOI 10.1038/ni.2038; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Rees W, 1999, P NATL ACAD SCI USA, V96, P9781, DOI 10.1073/pnas.96.17.9781; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Speiser DE, 2008, P NATL ACAD SCI USA, V105, P3849, DOI 10.1073/pnas.0800080105; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Stetson DB, 2002, IMMUNITY, V17, P191, DOI 10.1016/S1074-7613(02)00363-1; TASWELL C, 1981, J IMMUNOL, V126, P1614; UTZ U, 1993, NATURE, V364, P243, DOI 10.1038/364243a0; Vanguri V, 2013, P NATL ACAD SCI USA, V110, P288, DOI 10.1073/pnas.1208328110; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	57	310	314	1	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 9	2013	153	4					785	796		10.1016/j.cell.2013.04.007	http://dx.doi.org/10.1016/j.cell.2013.04.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663778	Green Accepted, Bronze			2022-12-28	WOS:000318844000009
J	Kim, J; DeBerardinis, RJ				Kim, Jiyeon; DeBerardinis, Ralph J.			Silencing a Metabolic Oncogene	SCIENCE			English	Editorial Material							IDH2 MUTATIONS; DIFFERENTIATION; SUFFICIENT; PHENOTYPE		[Kim, Jiyeon; DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Childrens Med Ctr, Res Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Kim, J (corresponding author), Univ Texas SW Med Ctr Dallas, Childrens Med Ctr, Res Inst, Dallas, TX 75390 USA.	ralph.deberardinis@utsouthwestern.edu			NCI NIH HHS [R01 CA157996] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA157996] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Kranendijk M, 2012, J INHERIT METAB DIS, V35, P571, DOI 10.1007/s10545-012-9462-5; Losman JA, 2013, SCIENCE, V339, P1621, DOI 10.1126/science.1231677; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Pietrak B, 2011, BIOCHEMISTRY-US, V50, P4804, DOI 10.1021/bi200499m; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	11	9	10	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 3	2013	340	6132					558	559		10.1126/science.1238523	http://dx.doi.org/10.1126/science.1238523			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23641103	Green Accepted			2022-12-28	WOS:000318268900034
J	Schouten, HJ; Geersing, GJ; Koek, HL; Zuithoff, NPA; Janssen, KJM; Douma, RA; van Delden, JJM; Moons, KGM; Reitsma, JB				Schouten, Henrike J.; Geersing, G. J.; Koek, H. L.; Zuithoff, Nicolaas P. A.; Janssen, Kristel J. M.; Douma, Renee A.; van Delden, Johannes J. M.; Moons, Karel G. M.; Reitsma, Johannes B.			Diagnostic accuracy of conventional or age adjusted D-dimer cut-off values in older patients with suspected venous thromboembolism: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DEEP-VEIN THROMBOSIS; EXCLUDING PULMONARY-EMBOLISM; CLINICAL PROBABILITY SCORE; ELDERLY-PATIENTS; COMPUTED-TOMOGRAPHY; COST-EFFECTIVENESS; DECISION RULES; PRIMARY-CARE; MANAGEMENT; EXCLUSION	Objective To review the diagnostic accuracy of D-dimer testing in older patients (>50 years) with suspected venous thromboembolism, using conventional or age adjusted D-dimer cut-off values. Design Systematic review and bivariate random effects meta-analysis. Data sources We searched Medline and Embase for studies published before 21 June 2012 and we contacted the authors of primary studies. Study selection Primary studies that enrolled older patients with suspected venous thromboembolism in whom D-dimer testing, using both conventional (500 mu g/L) and age adjusted (age x 10 mu g/L) cut-off values, and reference testing were performed. For patients with a non-high clinical probability, 2x2 tables were reconstructed and stratified by age category and applied D-dimer cut-off level. Results 13 cohorts including 12 497 patients with a non-high clinical probability were included in the meta-analysis. The specificity of the conventional cut-off value decreased with increasing age, from 57.6% (95% confidence interval 51.4% to 63.6%) in patients aged 51-60 years to 39.4% (33.5% to 45.6%) in those aged 61-70, 24.5% (20.0% to 29.7% in those aged 71-80, and 14.7% (11.3% to 18.6%) in those aged >80. Age adjusted cut-off values revealed higher specificities over all age categories: 62.3% (56.2% to 68.0%), 49.5% (43.2% to 55.8%), 44.2% (38.0% to 50.5%), and 35.2% (29.4% to 41.5%), respectively. Sensitivities of the age adjusted cut-off remained above 97% in all age categories. Conclusions The application of age adjusted cut-off values for D-dimer tests substantially increases specificity without modifying sensitivity, thereby improving the clinical utility of D-dimer testing in patients aged 50 or more with a non-high clinical probability.	[Schouten, Henrike J.; Geersing, G. J.; Zuithoff, Nicolaas P. A.; van Delden, Johannes J. M.; Moons, Karel G. M.; Reitsma, Johannes B.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Schouten, Henrike J.; Koek, H. L.] Univ Med Ctr Utrecht, Dept Geriatr, NL-3508 GA Utrecht, Netherlands; [Janssen, Kristel J. M.] Mapi Consultancy, Houten, Netherlands; [Douma, Renee A.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	Schouten, HJ (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, POB 85500, NL-3508 GA Utrecht, Netherlands.	h.j.schouten-3@umcutrecht.nl	Geersing, Geert-Jan/AAY-1119-2021	Reitsma, Johannes/0000-0003-4026-4345	Netherlands Organization for Scientific Research (ZonMw) [9120-8004, 918-10-615, 17088-2502, 917-46-360, 945-04-009]	Netherlands Organization for Scientific Research (ZonMw)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development)	This study was supported by the Netherlands Organization for Scientific Research (ZonMw project No 9120-8004, 918-10-615, and 17088-2502). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: all authors had financial support from the Netherlands Organization for Scientific Research (ZonMw project No 17088-2502, 917-46-360, and 945-04-009) for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	Aguilar C, 2001, Haematologica, V86, pE28; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Barro C, 1999, THROMB RES, V95, P263, DOI 10.1016/S0049-3848(99)00042-0; Bates SM, 2003, ANN INTERN MED, V138, P787, DOI 10.7326/0003-4819-138-10-200305200-00006; Bernardi E, 2008, JAMA-J AM MED ASSOC, V300, P1653, DOI 10.1001/jama.300.14.1653; Bounameaux H, 2010, J INTERN MED, V268, P218, DOI 10.1111/j.1365-2796.2010.02254.x; Di Nisio M, 2007, J THROMB HAEMOST, V5, P296, DOI 10.1111/j.1538-7836.2007.02328.x; Douma RA, 2012, HAEMATOL-HEMATOL J, V97, P1507, DOI 10.3324/haematol.2011.060657; Douma RA, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-11-201106070-00002; Douma RA, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1475; Geersing GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2990; Gibson NS, 2008, CHEST, V134, P789, DOI 10.1378/chest.08-0344; Gill TM, 2011, J GERONTOL A-BIOL, V66, P1238, DOI 10.1093/gerona/glr142; Haas FJLM, 2009, AM J HEMATOL, V84, P488, DOI 10.1002/ajh.21455; Hamza TH, 2008, MED DECIS MAKING, V28, P639, DOI 10.1177/0272989X08323917; Harper PL, 2007, INTERN MED J, V37, P607, DOI 10.1111/j.1445-5994.2007.01388.x; Heim SW, 2004, CLIN CHEM, V50, P1136, DOI 10.1373/clinchem.2004.031765; Kline JA, 2008, J THROMB HAEMOST, V6, P772, DOI 10.1111/j.1538-7836.2008.02944.x; Koffijberg H, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-12; Le Blanche AF, 1999, ANGIOLOGY, V50, P873, DOI 10.1177/000331979905001101; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; Legnani C, 2010, THROMB RES, V125, P398, DOI 10.1016/j.thromres.2009.07.013; Lucassen W, 2011, ANN INTERN MED, V155, P448, DOI 10.7326/0003-4819-155-7-201110040-00007; Mitchell AM, 2012, ACAD EMERG MED, V19, P618, DOI 10.1111/j.1553-2712.2012.01374.x; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Oudega R, 2005, THROMB HAEMOSTASIS, V94, P200, DOI 10.1160/TH04-12-0829; Penaloza A, 2012, J THROMB HAEMOST, V10, P1291, DOI 10.1111/j.1538-7836.2012.04769.x; Penaloza A, 2012, J THROMB HAEMOST, V10, P375, DOI 10.1111/j.1538-7836.2012.04631.x; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Reitsma JB, 2012, CLIN CHEM, V58, P1534, DOI 10.1373/clinchem.2012.182568; Righini M, 2000, AM J MED, V109, P357, DOI 10.1016/S0002-9343(00)00493-9; Righini M, 2007, J THROMB HAEMOST, V5, P1869, DOI 10.1111/j.1538-7836.2007.02667.x; Righini M, 2005, J AM GERIATR SOC, V53, P1039, DOI 10.1111/j.1532-5415.2005.53309.x; Righini M, 2004, ARCH INTERN MED, V164, P2483, DOI 10.1001/archinte.164.22.2483; Righini M, 2001, THROMB HAEMOSTASIS, V85, P744, DOI 10.1055/s-0037-1615663; Righini M, 2008, LANCET, V371, P1343, DOI 10.1016/S0140-6736(08)60594-2; Roy PM, 2009, ANN INTERN MED, V151, P677, DOI 10.7326/0003-4819-151-10-200911170-00003; Roy PM, 2006, ANN INTERN MED, V144, P157, DOI 10.7326/0003-4819-144-3-200602070-00003; Schaafsma JD, 2009, J CLIN EPIDEMIOL, V62, P1248, DOI 10.1016/j.jclinepi.2009.01.008; Schouten HJ, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2985; Schutgens REG, 2005, BRIT J HAEMATOL, V129, P653, DOI 10.1111/j.1365-2141.2005.05515.x; Schutgens REG, 2003, CIRCULATION, V107, P593, DOI 10.1161/01.CIR.0000045670.12988.1E; Stein PD, 2004, ANN INTERN MED, V140, P589, DOI 10.7326/0003-4819-140-8-200404200-00005; Tardy B, 1998, THROMB HAEMOSTASIS, V79, P38, DOI 10.1055/s-0037-1614215; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; van de Glind EMM, 2012, J AM MED INFORM ASSN, V19, P468, DOI 10.1136/amiajnl-2011-000319; van Es J, 2012, THROMB HAEMOSTASIS, V107, P167, DOI 10.1160/TH11-08-0587; Wells PS, 2007, J THROMB HAEMOST, V5, P41, DOI 10.1111/j.1538-7836.2007.02493.x; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009	56	185	205	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 3	2013	346								f2492	10.1136/bmj.f2492	http://dx.doi.org/10.1136/bmj.f2492			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139FC	23645857	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000318566200001
J	Zylke, JW; Rivara, FP; Bauchner, H				Zylke, Jody W.; Rivara, Frederick P.; Bauchner, Howard			Contrasts in Child Health Care and Child Health Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VALPROATE; EXPOSURE; MIGRAINE		[Rivara, Frederick P.] Univ Washington, Inst Child Hlth, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle		jody.zylke@jamanetwork.org		Bauchner, Howard/0000-0002-8368-9805				Abrams SA, 2013, JAMA-J AM MED ASSOC, V309, P1830, DOI 10.1001/jama.2013.4149; Blennow M, 2009, JAMA-J AM MED ASSOC, V301, P2225, DOI 10.1001/jama.2009.771; Brent DA, 2013, JAMA-J AM MED ASSOC, V309, P1777, DOI 10.1001/jama.2013.4220; Christensen J, 2013, JAMA-J AM MED ASSOC, V309, P1696, DOI 10.1001/jama.2013.2270; Cornfield DN, 2013, JAMA-J AM MED ASSOC, V309, P1781, DOI 10.1001/jama.2013.2258; Dobson SRM, 2013, JAMA-J AM MED ASSOC, V309, P1793, DOI 10.1001/jama.2013.1625; Epstein LG, 2013, JAMA-J AM MED ASSOC, V309, P1636, DOI 10.1001/jama.2013.3873; Gallo S, 2013, JAMA-J AM MED ASSOC, V309, P1785, DOI 10.1001/jama.2013.3404; Kahn JA, 2013, JAMA-J AM MED ASSOC, V309, P1832, DOI 10.1001/jama.2013.4147; Lowenthal ED, 2013, JAMA-J AM MED ASSOC, V309, P1803, DOI 10.1001/jama.2013.3710; Meador KJ, 2013, JAMA-J AM MED ASSOC, V309, P1730, DOI 10.1001/jama.2013.4001; Paneth N, 2013, JAMA-J AM MED ASSOC, V309, P1775, DOI 10.1001/jama.2013.3870; Patrick SW, 2012, JAMA-J AM MED ASSOC, V307, P1934, DOI 10.1001/jama.2012.3951; Romanello S, 2013, JAMA-J AM MED ASSOC, V309, P1607, DOI 10.1001/jama.2013.747; Serenius F, 2013, JAMA-J AM MED ASSOC, V309, P1810, DOI 10.1001/jama.2013.3786; Stoll BJ, 2013, JAMA-J AM MED ASSOC, V309, P1779, DOI 10.1001/jama.2013.3257; Wachman EM, 2013, JAMA-J AM MED ASSOC, V309, P1821, DOI 10.1001/jama.2013.3411; Zylke JW, 2012, JAMA-J AM MED ASSOC, V308, P1040, DOI 10.1001/2012.jama.10982	18	1	1	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 1	2013	309	17					1834	1836		10.1001/jama.2013.4284	http://dx.doi.org/10.1001/jama.2013.4284			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134SU	23632730				2022-12-28	WOS:000318235600034
J	Honigsbaum, M				Honigsbaum, Mark			The art of medicine "An inexpressible dread": psychoses of influenza at fin-de-siecle	LANCET			English	Editorial Material									Univ Zurich, Inst & Museum Med Hist, CH-8001 Zurich, Switzerland	University of Zurich	Honigsbaum, M (corresponding author), Univ Zurich, Inst & Museum Med Hist, CH-8001 Zurich, Switzerland.	m.honigsbaum@mhiz.uzh.ch		honigsbaum, mark/0000-0002-1891-8763					0	26	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 23	2013	381	9871					988	989		10.1016/S0140-6736(13)60701-1	http://dx.doi.org/10.1016/S0140-6736(13)60701-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	117EU	23668571	Bronze			2022-12-28	WOS:000316936800017
J	Wu, LF; Candille, SI; Choi, Y; Xie, D; Jiang, LH; Li-Pook-Than, J; Tang, H; Snyder, M				Wu, Linfeng; Candille, Sophie I.; Choi, Yoonha; Xie, Dan; Jiang, Lihua; Li-Pook-Than, Jennifer; Tang, Hua; Snyder, Michael			Variation and genetic control of protein abundance in humans	NATURE			English	Article							EXPRESSION; POPULATION; DATABASE; MAP	Gene expression differs among individuals and populations and is thought to be a major determinant of phenotypic variation. Although variation and genetic loci responsible for RNA expression levels have been analysed extensively in human populations(1-5), our knowledge is limited regarding the differences in human protein abundance and the genetic basis for this difference. Variation in messenger RNA expression is not a perfect surrogate for protein expression because the latter is influenced by an array of post-transcriptional regulatory mechanisms, and, empirically, the correlation between protein and mRNA levels is generally modest(6,7). Here we used isobaric tag-based quantitative mass spectrometry to determine relative protein levels of 5,953 genes in lymphoblastoid cell lines from 95 diverse individuals genotyped in the HapMap Project(8,9). We found that protein levels are heritable molecular phenotypes that exhibit considerable variation between individuals, populations and sexes. Levels of specific sets of proteins involved in the same biological process covary among individuals, indicating that these processes are tightly regulated at the protein level. We identified cis-pQTLs (protein quantitative trait loci), including variants not detected by previous transcriptome studies. This study demonstrates the feasibility of high-throughput human proteome quantification that, when integrated with DNA variation and transcriptome information, adds a new dimension to the characterization of gene expression regulation.	[Wu, Linfeng; Candille, Sophie I.; Choi, Yoonha; Xie, Dan; Jiang, Lihua; Li-Pook-Than, Jennifer; Tang, Hua; Snyder, Michael] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University	Snyder, M (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	huatang@stanford.edu; mpsnyder@stanford.edu		Snyder, Michael/0000-0003-0784-7987; Tang, Hua/0000-0002-0177-8864	NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL107393] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073059] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Montgomery for providing gene-level RNA sequencing measurements of CEU LCLs. This work was supported by NIH grants to M.S. and H.T.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Agam G, 2009, BIOCHEM SOC T, V37, P1121, DOI 10.1042/BST0371121; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bonnevie-Nielsen V, 2005, AM J HUM GENET, V76, P623, DOI 10.1086/429391; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Karp NA, 2010, MOL CELL PROTEOMICS, V9, P1885, DOI 10.1074/mcp.M900628-MCP200; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Li JJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000910; Lim JK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000321; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Ow SY, 2009, J PROTEOME RES, V8, P5347, DOI 10.1021/pr900634c; Pai AA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003000; Peng J, 2009, J AM STAT ASSOC, V104, P735, DOI 10.1198/jasa.2009.0126; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sjoholt G, 2004, MOL PSYCHIATR, V9, P621, DOI 10.1038/sj.mp.4001460; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639	24	246	250	0	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 4	2013	499	7456					79	82		10.1038/nature12223	http://dx.doi.org/10.1038/nature12223			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	176ED	23676674	Green Accepted			2022-12-28	WOS:000321285600037
J	Zhang, W; Shi, Y; Lu, XS; Shu, YL; Qi, JX; Gao, GF				Zhang, Wei; Shi, Yi; Lu, Xishan; Shu, Yuelong; Qi, Jianxun; Gao, George F.			An Airborne Transmissible Avian Influenza H5 Hemagglutinin Seen at the Atomic Level	SCIENCE			English	Article							A VIRUSES; RECEPTOR-BINDING; SWINE-ORIGIN	Recent studies have identified several mutations in the hemagglutinin (HA) protein that allow the highly pathogenic avian H5N1 influenza A virus to transmit between mammals by airborne route. Here, we determined the complex structures of wild-type and mutant HAs derived from an Indonesia H5N1 virus bound to either avian or human receptor sialic acid analogs. A cis/trans conformational change in the glycosidic linkage of the receptor analog was observed, which explains how the H5N1 virus alters its receptor-binding preference. Furthermore, the mutant HA possessed low affinities for both avian and human receptors. Our findings provide a structural and biophysical basis for the H5N1 adaptation to acquire human, but maintain avian, receptor-binding properties.	[Zhang, Wei; Shi, Yi; Qi, Jianxun; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Shi, Yi; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth RNIH, Beijing 100101, Peoples R China; [Zhang, Wei; Gao, George F.] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Lu, Xishan; Gao, George F.] China Agr Univ, Coll Vet Med, Beijing 100193, Peoples R China; [Shu, Yuelong; Gao, George F.] Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; China Agricultural University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.	gaof@im.ac.cn	Gao, George Fu/ABD-5229-2021; Qi, Jianxun/ABF-1646-2021		National 973 Project [2011CB504703]; National Natural Science Foundation of China (NSFC) [81290342]; China National Grand S&T Special Project [2013ZX10004-611]; NSFC [81021003]	National 973 Project(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China National Grand S&T Special Project; NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by the National 973 Project (grant 2011CB504703), the National Natural Science Foundation of China (NSFC, grant 81290342), and the China National Grand S&T Special Project (grant 2013ZX10004-611). G.F.G. is a leading principal investigator of the NSFC Innovative Research Group (grant 81021003). Assistance by the staff at the Shanghai Synchrotron Radiation Facility (SSRF-beamline 17U) and the KEK Synchrotron Radiation Facility (beamline 17A) is acknowledged. We are grateful to the Consortium for Functional Glycomics for providing the biotinylated SA analogs. Coordinates and structure factors have been deposited in the Protein Data Bank (PDB code 4K62 for InH5, 4K63 for InH5/LSTa, 4K64 for InH5/LSTc, 4K65 for InH5mut, 4K66 for InH5mut/LSTa, and 4K67 for InH5mut/LSTc).	Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Bragstad K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-43; Brown IH, 2010, AVIAN DIS, V54, P187, DOI 10.1637/8949-053109-Reg.1; Chutinimitkul S, 2010, J VIROL, V84, P6825, DOI 10.1128/JVI.02737-09; Eisen MB, 1997, VIROLOGY, V232, P19, DOI 10.1006/viro.1997.8526; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Gao RB., 2013, NEW ENGL J MED, V368, P1888; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Liu JF, 2009, P NATL ACAD SCI USA, V106, P17175, DOI 10.1073/pnas.0906849106; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Zhang W, 2013, J VIROL, V87, P5949, DOI 10.1128/JVI.00545-13; Zhang W, 2010, PROTEIN CELL, V1, P459, DOI 10.1007/s13238-010-0059-1	25	96	110	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 21	2013	340	6139					1463	1467		10.1126/science.1236787	http://dx.doi.org/10.1126/science.1236787			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	167QL	23641058				2022-12-28	WOS:000320647000045
J	Spence, D				Spence, Des			War of the words	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						BBC, 2013, BBC; Plain English Campaign, QUOT PLAIN ENGL	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 15	2013	346								f3021	10.1136/bmj.f3021	http://dx.doi.org/10.1136/bmj.f3021			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148OH	23676425				2022-12-28	WOS:000319254200006
J	Dennis, J; Ramsay, T; Turgeon, AF; Zarychanski, R				Dennis, Jessica; Ramsay, Tim; Turgeon, Alexis F.; Zarychanski, Ryan			Helmet legislation and admissions to hospital for cycling related head injuries in Canadian provinces and territories: interrupted time series analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IMPROVE PUBLIC-HEALTH; CHILDREN; TRAUMA; IMPACT; BICYCLISTS; TRENDS; COUNTY; RISK	Objective To investigate the association between helmet legislation and admissions to hospital for cycling related head injuries among young people and adults in Canada. Design Interrupted time series analysis using data from the National Trauma Registry Minimum Data Set. Setting Canadian provinces and territories; between 1994 and 2003, six of 10 provinces implemented helmet legislation. Participants All admissions (n=66 716) to acute care hospitals in Canada owing to cycling related injury between 1994 and 2008. Main outcome measure Rate of admissions to hospital for cycling related head injuries before and after the implementation of provincial helmet legislation. Results Between 1994 and 2008, 66 716 hospital admissions were for cycling related injuries in Canada. Between 1994 and 2003, the rate of head injuries among young people decreased by 54.0% (95% confidence interval 48.2% to 59.8%) in provinces with helmet legislation compared with 33.1% (23.3% to 42.9%) in provinces and territories without legislation. Among adults, the rate of head injuries decreased by 26.0% (16.0% to 36.3%) in provinces with legislation but remained constant in provinces and territories without legislation. After taking baseline trends into consideration, however, we were unable to detect an independent effect of legislation on the rate of hospital admissions for cycling related head injuries. Conclusions Reductions in the rates of admissions to hospital for cycling related head injuries were greater in provinces with helmet legislation, but injury rates were already decreasing before the implementation of legislation and the rate of decline was not appreciably altered on introduction of legislation. While helmets reduce the risk of head injuries and we encourage their use, in the Canadian context of existing safety campaigns, improvements to the cycling infrastructure, and the passive uptake of helmets, the incremental contribution of provincial helmet legislation to reduce hospital admissions for head injuries seems to have been minimal.	[Dennis, Jessica] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON M5T 3M7, Canada; [Ramsay, Tim] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Turgeon, Alexis F.] Univ Laval, Dept Anesthesiol, Div Crit Care Med, Populat Hlth Practice Changing Res Unit Trauma Em, Quebec City, PQ G1K 7P4, Canada; [Zarychanski, Ryan] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada; [Zarychanski, Ryan] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada	University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; Laval University; University of Manitoba; University of Manitoba	Dennis, J (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, 155 Coll St, Toronto, ON M5T 3M7, Canada.	jessica.dennis@mail.utoronto.ca	Zarychanski, Ryan/AAB-6369-2022	Ramsay, Tim/0000-0001-8478-8170; Zarychanski, Ryan/0000-0001-9455-6138; Dennis, Jessica/0000-0002-8507-9699	Fonds de la Recherche du Quebec-Sante; Canadian Institute of Health Research	Fonds de la Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	JD is a Canadian Institute of Health Research Vanier graduate scholar, AFT is a recipient of a research career award from the Fonds de la Recherche du Quebec-Sante, and RZ is a recipient of a RCT-mentorship award from the Canadian Institute of Health Research. None of the funders influenced the conduct of this research. None of the funders influenced the conduct of this research.	Amoros E, 2012, INJURY PREV, V18, P27, DOI 10.1136/ip.2011.031815; [Anonymous], 1992, LAW REND WEAR BIC HE; Association of Registered Nurses of Newfoundland and Labrador, 2005, MAND BIC HELM US NEW; Beck LF, 2007, AM J EPIDEMIOL, V166, P212, DOI 10.1093/aje/kwm064; Borglund S T, 1999, J Emerg Nurs, V25, P496, DOI 10.1016/S0099-1767(99)70013-9; Bunn F., 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003110, DOI 10.1002/14651858.CD003110]; CAMERON MH, 1994, ACCIDENT ANAL PREV, V26, P325, DOI 10.1016/0001-4575(94)90006-X; Canadian Cycling Association, 2012, CAN BIKE PROGR; Castle SL, 2012, J SURG RES, V173, P327, DOI 10.1016/j.jss.2010.10.031; CHOW TK, 1993, WESTERN J MED, V159, P145; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; DeMarco TJ, 2002, CAN MED ASSOC J, V167, P337; Dennis J, 2010, INJURY PREV, V16, P219, DOI 10.1136/ip.2009.025353; Elvik R, 2011, ACCIDENT ANAL PREV, V43, P1245, DOI 10.1016/j.aap.2011.01.007; Farley C, 1996, AM J PUBLIC HEALTH, V86, P46, DOI 10.2105/AJPH.86.1.46; Finch C F, 1996, Inj Prev, V2, P126, DOI 10.1136/ip.2.2.126; Foss R, 2000, BICYCLE HELMET USE B; Guerchani S., 2012, J MONTREAL; Hagel B, 2006, BMJ-BRIT MED J, V332, P725, DOI 10.1136/bmj.332.7543.725; Hagel BE, 2006, INJURY PREV, V12, P262, DOI 10.1136/ip.2006.012112; Hannay C., 2012, GLOBE MAIL; Ji M, 2006, ACCIDENT ANAL PREV, V38, P128, DOI 10.1016/j.aap.2005.08.002; Karkhaneh M, 2006, INJURY PREV, V12, P76, DOI 10.1136/ip.2005.010942; Kim JK, 2007, ACCIDENT ANAL PREV, V39, P238, DOI 10.1016/j.aap.2006.07.002; LeBlanc JC, 2002, CAN MED ASSOC J, V166, P592; Lee BHY, 2005, ACCIDENT ANAL PREV, V37, P93, DOI 10.1016/j.aap.2004.07.001; Liller KD, 2003, INJ PREV, V9, P177, DOI 10.1136/ip.9.2.177; Linn S, 1998, Inj Prev, V4, P122; Lusk AC, 2011, INJURY PREV, V17, P131, DOI 10.1136/ip.2010.028696; Macpherson A K, 2001, Inj Prev, V7, P228, DOI 10.1136/ip.7.3.228; Macpherson AK, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e60; Macpherson A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005401.pub3; Mehan TJ, 2009, CLIN PEDIATR, V48, P166, DOI 10.1177/0009922808324952; Parkin PC, 2003, PEDIATRICS, V112, pE192, DOI 10.1542/peds.112.3.e192; PARKIN PC, 1993, PEDIATRICS, V91, P772; Pucher J, 2003, AM J PUBLIC HEALTH, V93, P1509, DOI 10.2105/AJPH.93.9.1509; Reynolds CCO, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-47; Rivara FP, 1997, J FAM PRACTICE, V44, P481; Robinson DL, 2006, BMJ-BRIT MED J, V332, P722, DOI 10.1136/bmj.332.7543.722-a; Romanow NTR, 2012, INT J INJ CONTROL SA, P1; Rosenkranz KA, 2003, INJURY, V34, P825, DOI 10.1016/S0020-1383(02)00389-3; ROWE BH, 1995, CAN MED ASSOC J, V152, P45; Safe Kids Canada, 2011, BIC HELM LEG CHART; Scuffham P, 2000, ACCIDENT ANAL PREV, V32, P565, DOI 10.1016/S0001-4575(99)00081-0; Shah S, 2007, INJURY PREV, V13, P316, DOI 10.1136/ip.2007.016048; Shardell M, 2007, CLIN INFECT DIS, V45, P901, DOI 10.1086/521255; SPENCE LJ, 1993, J PEDIATR SURG, V28, P214, DOI 10.1016/S0022-3468(05)80278-7; Statistics Canada, 2010, TABL 510001 EST POP; Tator CH, 2010, CAN J NEUROL SCI, V37, P714, DOI 10.1017/S0317167100051337; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1974, DOI 10.1001/jama.276.24.1974; Thompson DC, 1999, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001855, DOI 10.1002/14651858.CD001855]; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Walter SR, 2011, ACCIDENT ANAL PREV, V43, P2064, DOI 10.1016/j.aap.2011.05.029; Wardlaw M, 2002, CAN MED ASSOC J, V167, P337; Wardlaw M., 2002, CMAJ, V167, P338; Wesson DE, 2008, PEDIATRICS, V122, P605, DOI 10.1542/peds.2007-1776; Zhang F, 2011, J CLIN EPIDEMIOL, V64, P1252, DOI 10.1016/j.jclinepi.2011.02.007	57	45	45	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2013	346								f2674	10.1136/bmj.f2674	http://dx.doi.org/10.1136/bmj.f2674			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148OF	23674137	Green Published, hybrid			2022-12-28	WOS:000319253900002
J	Baxt, LA; Garza-Mayers, AC; Goldberg, MB				Baxt, Leigh A.; Garza-Mayers, Anna Cristina; Goldberg, Marcia B.			Subversion of Host Innate Immune Pathways	SCIENCE			English	Review							NF-KAPPA-B; PHOSPHOTHREONINE LYASE ACTIVITY; EFFECTOR; AUTOPHAGY; KINASE; GTPASE; INACTIVATION; CONTRIBUTES; TRAFFICKING; ACTIVATION	The pathogenesis of infection is a continuously evolving battle between the human host and the infecting microbe. The past decade has brought a burst of insights into the molecular mechanisms of innate immune responses to bacterial pathogens. In parallel, multiple specific mechanisms by which microorganisms subvert these host responses have been uncovered. This Review highlights recently characterized mechanisms by which bacterial pathogens avoid killing by innate host responses, including autophagy pathways and a proinflammatory cytokine transcriptional response, and by the manipulation of vesicular trafficking to avoid the toxicity of lysosomal enzymes.	[Baxt, Leigh A.; Goldberg, Marcia B.] Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Cambridge, MA 02139 USA; [Garza-Mayers, Anna Cristina; Goldberg, Marcia B.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Goldberg, MB (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Infect Dis, Cambridge, MA 02139 USA.	mgoldberg1@partners.org	Goldberg, Marcia/U-8604-2019	Baxt, Leigh/0000-0001-8286-3907	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI081724] Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Ashida H, 2010, NAT CELL BIOL, V12, P66, DOI 10.1038/ncb2006; Auerbuch V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000686; Bakowski MA, 2010, CELL HOST MICROBE, V7, P453, DOI 10.1016/j.chom.2010.05.011; Beare PA, 2011, MBIO, V2, DOI 10.1128/mBio.00175-11; Mestre MB, 2012, AUTOPHAGY, V8, P1865, DOI 10.4161/auto.22161; Chargui A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051727; Choy A, 2012, SCIENCE, V338, P1072, DOI 10.1126/science.1227026; Cui JX, 2010, SCIENCE, V329, P1215, DOI 10.1126/science.1193844; Deuretzbacher A, 2009, J IMMUNOL, V183, P5847, DOI 10.4049/jimmunol.0804242; Dong N, 2012, CELL, V150, P1029, DOI 10.1016/j.cell.2012.06.050; Dortet L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002168; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Ge JN, 2009, P NATL ACAD SCI USA, V106, P13725, DOI 10.1073/pnas.0907200106; Gong L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017852; Haneda T, 2012, CELL MICROBIOL, V14, P485, DOI 10.1111/j.1462-5822.2011.01733.x; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Ivanov SS, 2009, CELL MICROBIOL, V11, P261, DOI 10.1111/j.1462-5822.2008.01251.x; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Kramer RW, 2007, PLOS PATHOG, V3, P179, DOI 10.1371/journal.ppat.0030021; Lad SP, 2007, P NATL ACAD SCI USA, V104, P2933, DOI 10.1073/pnas.0608393104; LaRock CN, 2012, CELL HOST MICROBE, V12, P799, DOI 10.1016/j.chom.2012.10.020; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Marches O, 2008, CELL MICROBIOL, V10, P1104, DOI 10.1111/j.1462-5822.2007.01112.x; Campoy EM, 2011, INFECT IMMUN, V79, P402, DOI 10.1128/IAI.00688-10; Mazurkiewicz P, 2008, MOL MICROBIOL, V67, P1371, DOI 10.1111/j.1365-2958.2008.06134.x; McGourty K, 2012, SCIENCE, V338, P963, DOI 10.1126/science.1227037; Meinzer U, 2012, CELL HOST MICROBE, V11, P337, DOI 10.1016/j.chom.2012.02.009; Mesquita FS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002743; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Newton HJ, 2011, MBIO, V2, DOI 10.1128/mBio.00226-11; Niu H, 2012, P NATL ACAD SCI USA, V109, P20800, DOI 10.1073/pnas.1218674109; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Pujol C, 2009, INFECT IMMUN, V77, P2251, DOI 10.1128/IAI.00068-09; Randow F, 2013, SCIENCE, V340, P701, DOI 10.1126/science.1233028; Romagnoli A, 2012, AUTOPHAGY, V8, P1357, DOI 10.4161/auto.20881; Romano PS, 2007, CELL MICROBIOL, V9, P891, DOI 10.1111/j.1462-5822.2006.00838.x; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Schnaith A, 2007, J BIOL CHEM, V282, P2695, DOI 10.1074/jbc.M609784200; Selyunin AS, 2011, NATURE, V469, P107, DOI 10.1038/nature09593; Trosky JE, 2007, J BIOL CHEM, V282, P34299, DOI 10.1074/jbc.M706970200; Vladimer GI, 2013, CURR OPIN MICROBIOL, V16, P23, DOI 10.1016/j.mib.2012.11.008; Yen HL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001231; Yoshikawa Y, 2009, NAT CELL BIOL, V11, P1233, DOI 10.1038/ncb1967	50	138	141	0	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2013	340	6133					697	701		10.1126/science.1235771	http://dx.doi.org/10.1126/science.1235771			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	139XR	23661751				2022-12-28	WOS:000318619000027
J	Hackett, JA; Surani, MA				Hackett, Jamie A.; Surani, M. Azim			Beyond DNA: Programming and Inheritance of Parental Methylomes	CELL			English	Editorial Material							5-HYDROXYMETHYLCYTOSINE		[Hackett, Jamie A.; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Hackett, Jamie A.; Surani, M. Azim] Univ Cambridge, Wellcome Trust MRC Stem Cell Inst, Cambridge CB2 1QN, England; [Hackett, Jamie A.; Surani, M. Azim] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge; University of Cambridge	Surani, MA (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England.	a.surani@gurdon.cam.ac.uk		Hackett, Jamie/0000-0002-6237-3684; Surani, Azim/0000-0002-8640-4318	Wellcome Trust [096738, 092096, 079249] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Jiang L, 2013, CELL, V153, P773, DOI 10.1016/j.cell.2013.04.041; Potok ME, 2013, CELL, V153, P759, DOI 10.1016/j.cell.2013.04.030; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240	11	62	65	0	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 9	2013	153	4					737	739		10.1016/j.cell.2013.04.044	http://dx.doi.org/10.1016/j.cell.2013.04.044			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663772	Bronze, Green Accepted			2022-12-28	WOS:000318844000002
J	Penson, RT; Goodman, A; Growdon, WB; Borger, DR; Lee, SI; Oliva, E				Penson, Richard T.; Goodman, Annekathryn; Growdon, Whitfield B.; Borger, Darrell R.; Lee, Susanna I.; Oliva, Esther			Case 14-2013: A 70-Year-Old Woman with Vaginal Bleeding	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-III TRIAL; UTERINE SARCOMAS; ENDOMETRIAL CANCER; TUMORS; CARCINOSARCOMAS; PACLITAXEL; MUTATIONS; SURVIVAL; UTERUS; DOXORUBICIN		[Penson, Richard T.; Borger, Darrell R.] Massachusetts Gen Hosp, Div Hematol & Oncol, Boston, MA 02114 USA; [Goodman, Annekathryn; Growdon, Whitfield B.] Massachusetts Gen Hosp, Div Gynecol Oncol, Boston, MA 02114 USA; [Lee, Susanna I.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Oliva, Esther] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Penson, Richard T.; Borger, Darrell R.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Goodman, Annekathryn; Growdon, Whitfield B.] Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [Lee, Susanna I.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Oliva, Esther] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Penson, RT (corresponding author), Massachusetts Gen Hosp, Div Hematol & Oncol, Boston, MA 02114 USA.			Lee, Susanna I/0000-0003-2195-2943	Apotex; Genentech; AstraZeneca; Lifecore Biomedical; BioMarin Pharmaceuticals; Clovis Oncology; Seattle Genetics; ImClone Systems; Endocyte; Eisai Pharmaceuticals; Amgen; Leerink Swann Laboratory; Prous Science Laboratory; Bio-Reference Laboratory	Apotex; Genentech(Roche HoldingGenentech); AstraZeneca(AstraZeneca); Lifecore Biomedical; BioMarin Pharmaceuticals; Clovis Oncology; Seattle Genetics; ImClone Systems(Eli Lilly); Endocyte(Novartis); Eisai Pharmaceuticals(Eisai Co Ltd); Amgen(Amgen); Leerink Swann Laboratory; Prous Science Laboratory; Bio-Reference Laboratory	Dr. Penson reports receiving payment from Apotex for providing expert testimony in a case of Aventis Pharma S. A. v. Apotex Inc.; payment for serving on scientific advisory boards from Genentech, AstraZeneca, Lifecore Biomedical, BioMarin Pharmaceuticals, Clovis Oncology, and Seattle Genetics; and grant support through his institution from ImClone Systems, Endocyte, AstraZeneca, Eisai Pharmaceuticals, and Amgen. Dr. Borger reports receiving consulting fees from Leerink Swann, Prous Science, and Bio-Reference Laboratories. Dr. Oliva reports providing expert opinions in legal cases on behalf of patients or physicians. No other potential conflict of interest relevant to this article was reported.	Amant F, 2002, GYNECOL ONCOL, V85, P165, DOI 10.1006/gyno.2002.6601; Castilla MA, 2011, J PATHOL, V223, P72, DOI 10.1002/path.2802; Benedet JL, 2000, INT J GYNECOL OBSTET, V70, P209; BITTERMAN P, 1990, AM J SURG PATHOL, V14, P317, DOI 10.1097/00000478-199004000-00002; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Callister M, 2004, INT J RADIAT ONCOL, V58, P786, DOI 10.1016/S0360-3016(03)01561-X; CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8; de Jong RA, 2011, MODERN PATHOL, V24, P1368, DOI 10.1038/modpathol.2011.88; Dedes KJ, 2011, NAT REV CLIN ONCOL, V8, P261, DOI 10.1038/nrclinonc.2010.216; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; DISAIA PJ, 1973, AM J ROENTGENOL, V117, P632, DOI 10.2214/ajr.117.3.632; Doubilet PM, 2011, MENOPAUSE, V18, P421, DOI 10.1097/gme.0b013e3181fedfc0; Duska LR, 2005, GYNECOL ONCOL, V96, P198, DOI 10.1016/j.ygyno.2004.09.022; Etemadmoghadam D, 2009, CLIN CANCER RES, V15, P1417, DOI 10.1158/1078-0432.CCR-08-1564; Ferguson SE, 2007, AM J SURG PATHOL, V31, P1653, DOI 10.1097/PAS.0b013e3181161ba3; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Fleming GF, 2011, J CLIN ONCOL, V29S, P5014; Fleming GF, 2010, GYNECOL ONCOL, V116, P15, DOI 10.1016/j.ygyno.2009.09.025; Growdon WB, 2011, GYNECOL ONCOL, V121, P212, DOI 10.1016/j.ygyno.2010.11.039; Hamilton CA, 2006, BRIT J CANCER, V94, P642, DOI 10.1038/sj.bjc.6603012; HARLOW BL, 1986, J NATL CANCER I, V76, P399; Homesley HD, 2007, J CLIN ONCOL, V25, P526, DOI 10.1200/JCO.2006.06.4907; Huh WK, 2010, GYNECOL ONCOL, V117, P248, DOI 10.1016/j.ygyno.2010.01.002; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Kloos I, 2002, INT J GYNECOL CANCER, V12, P496, DOI 10.1046/j.1525-1438.2002.01134.x; Kuo DYS, 2006, GYNECOL ONCOL, V100, P160, DOI 10.1016/j.ygyno.2005.08.033; Lassen U, 2010, BRIT J CANCER, V103, P12, DOI 10.1038/sj.bjc.6605726; Mariani A, 2008, GYNECOL ONCOL, V109, P11, DOI 10.1016/j.ygyno.2008.01.023; McCluggage WG, 2002, J CLIN PATHOL, V55, P321, DOI 10.1136/jcp.55.5.321; McCluggage WG, 2003, PATHOLOGY GENETICS T, P245; MEREDITH RF, 1986, CANCER, V58, P2003, DOI 10.1002/1097-0142(19861101)58:9<2003::AID-CNCR2820580908>3.0.CO;2-2; Miller D, 2012, SOC GYN ONC ANN M WO; Nimeiri HS, 2010, GYNECOL ONCOL, V117, P37, DOI 10.1016/j.ygyno.2010.01.013; OMURA GA, 1985, J CLIN ONCOL, V3, P1240, DOI 10.1200/JCO.1985.3.9.1240; Pignata S, 2011, J CLIN ONCOL, V29, P3628, DOI 10.1200/JCO.2010.33.8566; Roy RN, 2000, CANCER LETT, V153, P67, DOI 10.1016/S0304-3835(00)00347-5; SALAZAR OM, 1978, CANCER-AM CANCER SOC, V42, P1152, DOI 10.1002/1097-0142(197809)42:3<1152::AID-CNCR2820420319>3.0.CO;2-L; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; SILVERBERG SG, 1990, INT J GYNECOL PATHOL, V9, P1, DOI 10.1097/00004347-199001000-00001; STERNBERG WH, 1954, CANCER, V7, P704, DOI 10.1002/1097-0142(195407)7:4<704::AID-CNCR2820070411>3.0.CO;2-D; Walker, 2012, J CLIN ONCOL, V30, P1570, DOI 10.1200/JCO.2012.43.3417; Walker JL, 2012, J CLIN ONCOL, V30, P695, DOI 10.1200/JCO.2011.38.8645; Wolfson AH, 2007, GYNECOL ONCOL, V107, P177, DOI 10.1016/j.ygyno.2007.07.070; Yamada SD, 2000, CANCER, V88, P2782, DOI 10.1002/1097-0142(20000615)88:12<2782::AID-CNCR17>3.0.CO;2-K	44	1	1	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2013	368	19					1827	1835		10.1056/NEJMcpc1209276	http://dx.doi.org/10.1056/NEJMcpc1209276			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138WA	23656649	Green Published			2022-12-28	WOS:000318540000014
J	Yang, CF; Chiang, MC; Gray, DC; Prabhakaran, M; Alvarado, M; Juntti, SA; Unger, EK; Wells, JA; Shah, NM				Yang, Cindy F.; Chiang, Michael C.; Gray, Daniel C.; Prabhakaran, Mahalakshmi; Alvarado, Maricruz; Juntti, Scott A.; Unger, Elizabeth K.; Wells, James A.; Shah, Nirao M.			Sexually Dimorphic Neurons in the Ventromedial Hypothalamus Govern Mating in Both Sexes and Aggression in Males	CELL			English	Article							PROGESTERONE-RECEPTOR IMMUNOREACTIVITY; FEMALE GUINEA-PIGS; MALE-RATS; ESTROGEN-RECEPTOR; GENE-EXPRESSION; LORDOSIS REFLEX; REPRODUCTIVE-BEHAVIOR; EFFERENT CONNECTIONS; OVARIECTOMIZED RATS; MEDIAL AMYGDALA	Sexual dimorphisms in the brain underlie behavioral sex differences, but the function of individual sexually dimorphic neuronal populations is poorly understood. Neuronal sexual dimorphisms typically represent quantitative differences in cell number, gene expression, or other features, and it is unknown whether these dimorphisms control sex-typical behavior exclusively in one sex or in both sexes. The progesterone receptor (PR) controls female sexual behavior, and we find many sex differences in number, distribution, or projections of PR-expressing neurons in the adult mouse brain. Using a genetic strategy we developed, we have ablated one such dimorphic PR-expressing neuronal population located in the ventromedial hypothalamus (VMH). Ablation of these neurons in females greatly diminishes sexual receptivity. Strikingly, the corresponding ablation in males reduces mating and aggression. Our findings reveal the functions of a molecularly defined, sexually dimorphic neuronal population in the brain. Moreover, we show that sexually dimorphic neurons can control distinct sex-typical behaviors in both sexes.	[Yang, Cindy F.; Juntti, Scott A.; Shah, Nirao M.] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94158 USA; [Yang, Cindy F.; Chiang, Michael C.; Prabhakaran, Mahalakshmi; Alvarado, Maricruz; Shah, Nirao M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Gray, Daniel C.; Wells, James A.] Univ Calif San Francisco, Program Chem & Chem Biol, San Francisco, CA 94158 USA; [Unger, Elizabeth K.; Shah, Nirao M.] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94158 USA; [Wells, James A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Wells, James A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shah, NM (corresponding author), Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94158 USA.	nms@ucsf.edu	Wells, Jim A/O-9854-2016; Core, Vector/CAF-4832-2022	Juntti, Scott/0000-0001-7634-1395; Yang, Cindy/0000-0001-6144-4658; Unger, Elizabeth/0000-0002-8235-7534	Genentech Graduate Fellowship; National Science Foundation Graduate Fellowship; National Institutes of Health (NIH) [F31N5078959]; Brain and Behavior Research Foundation Program in Biomedical Breakthrough Research; Ellison Medical Foundation; NIH [R01N5049488, DP1MH099900]; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH099900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083872, F31NS078959, R01NS049488] Funding Source: NIH RePORTER	Genentech Graduate Fellowship; National Science Foundation Graduate Fellowship(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain and Behavior Research Foundation Program in Biomedical Breakthrough Research; Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Saper for sharing reagents; A. Lasek and U. Heberlein for a practical on stereotaxis; R. Axel for discussions; R. Axel, T. Clandinin, H. Ingraham, S. Lomvardas, C. Saper, and members of the Shah lab for comments on the manuscript; and N. Agarwal, A. Wang, and M. Bonus for technical support. This work was supported by a Genentech Graduate Fellowship (C.F.Y.); a National Science Foundation Graduate Fellowship (S.A.J.); the National Institutes of Health (NIH) grant F31N5078959 (E.K.U.); the Brain and Behavior Research Foundation Program in Biomedical Breakthrough Research, Ellison Medical Foundation; and NIH grants R01N5049488 and DP1MH099900 (N.M.S.).	Allen E, 1922, AM J ANAT, V30, P297, DOI 10.1002/aja.1000300303; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Bard P, 1928, AM J PHYSIOL, V84, P490, DOI 10.1152/ajplegacy.1928.84.3.490; BARDE I, 2001, CURRENT PROTOCOLS NE; Becker JB, 1999, PHARMACOL BIOCHEM BE, V64, P803, DOI 10.1016/S0091-3057(99)00168-9; BLAUSTEIN JD, 1980, NEUROENDOCRINOLOGY, V31, P403, DOI 10.1159/000123110; BLAUSTEIN JD, 1979, BRAIN RES, V169, P481, DOI 10.1016/0006-8993(79)90398-6; Blaustein JD, 2008, ANNU REV PSYCHOL, V59, P93, DOI 10.1146/annurev.psych.59.103006.093556; BRENOWITZ EA, 1991, SCIENCE, V251, P303, DOI 10.1126/science.1987645; Brown TJ, 1996, BRAIN RES, V725, P37, DOI 10.1016/0006-8993(96)00241-7; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Chappell PE, 1997, ENDOCRINOLOGY, V138, P4147, DOI 10.1210/en.138.10.4147; CLEMENTE CD, 1973, ANNU REV PHYSIOL, V35, P329, DOI 10.1146/annurev.ph.35.030173.001553; COHEN RS, 1992, PROG NEUROBIOL, V38, P423, DOI 10.1016/0301-0082(92)90045-G; COLPAERT FC, 1976, BEHAV BIOL, V16, P117, DOI 10.1016/S0091-6773(76)91225-6; Cooke B, 1998, FRONT NEUROENDOCRIN, V19, P323, DOI 10.1006/frne.1998.0171; Darwin C., 1871, P475; De Vries GJ, 2006, NEUROSCIENCE, V138, P947, DOI 10.1016/j.neuroscience.2005.07.050; De Vries GJ, 1998, BEHAV BRAIN RES, V92, P205, DOI 10.1016/S0166-4328(97)00192-7; DESJARDINS C, 1973, SCIENCE, V182, P939, DOI 10.1126/science.182.4115.939; DEVRIES GJ, 1990, J NEUROENDOCRINOL, V2, P1, DOI 10.1111/j.1365-2826.1990.tb00385.x; Dewing P, 2003, MOL BRAIN RES, V118, P82, DOI 10.1016/S0169-328X(03)00339-5; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Dugger BN, 2007, HORM BEHAV, V51, P195, DOI 10.1016/j.yhbeh.2006.10.001; FERVEUR JF, 1995, SCIENCE, V267, P902, DOI 10.1126/science.7846534; Flanagan-Cato LM, 2006, HORM BEHAV, V50, P52, DOI 10.1016/j.yhbeh.2006.01.012; Flanagan-Cato LM, 2011, FRONT NEUROENDOCRIN, V32, P124, DOI 10.1016/j.yfrne.2011.02.008; Gagnidze K, 2010, PROG BRAIN RES, V186, P97, DOI 10.1016/B978-0-444-53630-3.00007-5; GORSKI RA, 1980, J COMP NEUROL, V193, P529, DOI 10.1002/cne.901930214; GOY RW, 1963, J REPROD FERTIL, V5, P23, DOI 10.1530/jrf.0.0050023; Gray DC, 2010, CELL, V142, P637, DOI 10.1016/j.cell.2010.07.014; Grgurevic N, 2012, HORM BEHAV, V61, P719, DOI 10.1016/j.yhbeh.2012.03.008; GROSSMAN SP, 1972, J COMP PHYSIOL PSYCH, V78, P274, DOI 10.1037/h0032284; Harvey W., 1651, WORKS W HARVEY, P186; HESS WR, 1955, ARCH NEURO PSYCHIATR, V73, P127, DOI 10.1001/archneurpsyc.1955.02330080005003; Hetherington AW, 1940, ANAT REC, V78, P149, DOI 10.1002/ar.1090780203; Jazin E, 2010, NAT REV NEUROSCI, V11, P9, DOI 10.1038/nrn2754; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Juntti SA, 2010, NEURON, V66, P260, DOI 10.1016/j.neuron.2010.03.024; Kelley DB, 1997, CURR OPIN NEUROBIOL, V7, P839, DOI 10.1016/S0959-4388(97)80144-4; KIMURA T, 1985, HORM BEHAV, V19, P64, DOI 10.1016/0018-506X(85)90006-6; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017; KOLLACKWALKER S, 1995, NEUROSCIENCE, V66, P721, DOI 10.1016/0306-4522(94)00563-K; KONISHI M, 1989, NEURON, V3, P541, DOI 10.1016/0896-6273(89)90264-X; KOW LM, 1985, BRAIN RES, V341, P26, DOI 10.1016/0006-8993(85)91468-4; KRIEGER MS, 1979, J COMP NEUROL, V183, P785, DOI 10.1002/cne.901830408; KRUK MR, 1979, BEHAVIOUR, V70, P292, DOI 10.1163/156853979X00106; Kudwa AE, 2009, PHYSIOL BEHAV, V97, P146, DOI 10.1016/j.physbeh.2009.02.023; Kurrasch DM, 2007, J NEUROSCI, V27, P13624, DOI 10.1523/JNEUROSCI.2858-07.2007; LAVAQUE TJ, 1975, PHYSIOL BEHAV, V14, P59, DOI 10.1016/0031-9384(75)90142-0; Leal S, 1998, J COMP NEUROL, V401, P65, DOI 10.1002/(SICI)1096-9861(19981109)401:1<65::AID-CNE5>3.0.CO;2-D; LEEDY MG, 1985, BEHAV NEUROSCI, V99, P936, DOI 10.1037/0735-7044.99.5.936; Levine JE, 2001, FRONT NEUROENDOCRIN, V22, P69, DOI 10.1006/frne.2001.0210; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Majdic G, 2002, ENDOCRINOLOGY, V143, P607, DOI 10.1210/en.143.2.607; Mani SK, 1997, HORM BEHAV, V31, P244, DOI 10.1006/hbeh.1997.1393; MANI SK, 1994, ENDOCRINOLOGY, V135, P1409, DOI 10.1210/en.135.4.1409; MANI SK, 1994, SCIENCE, V265, P1246, DOI 10.1126/science.7915049; MATHEWS D, 1977, HORM BEHAV, V8, P40, DOI 10.1016/0018-506X(77)90019-8; MATHEWS D, 1977, PHYSIOL BEHAV, V19, P319, DOI 10.1016/0031-9384(77)90345-6; MATSUMOTO A, 1986, NEUROENDOCRINOLOGY, V42, P232, DOI 10.1159/000124445; MATSUMOTO A, 1983, ENDOCRINOL JAPON, V30, P277; MAXWELL IH, 1986, CANCER RES, V46, P4660; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; McGILL THOMAS E., 1962, BEHAVIOUR, V19, P341, DOI 10.1163/156853962X00087; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; Morris JA, 2008, J COMP NEUROL, V506, P851, DOI 10.1002/cne.21536; Musatov S, 2007, P NATL ACAD SCI USA, V104, P2501, DOI 10.1073/pnas.0610787104; Musatov S, 2006, P NATL ACAD SCI USA, V103, P10456, DOI 10.1073/pnas.0603045103; Ng L, 2009, NAT NEUROSCI, V12, P356, DOI 10.1038/nn.2281; NYBY J, 1977, ANIM BEHAV, V25, P333, DOI 10.1016/0003-3472(77)90009-4; OGAWA S, 1994, J NEUROSCI, V14, P1766, DOI 10.1523/JNEUROSCI.14-03-01766.1994; OLIVIER B, 1974, BRAIN RES, V65, P521, DOI 10.1016/0006-8993(74)90241-8; OLSTER DH, 1990, J NEUROBIOL, V21, P768, DOI 10.1002/neu.480210510; Patisaul HB, 2008, ENDOCRINOLOGY, V149, P397, DOI 10.1210/en.2007-0666; PFAFF DW, 1979, J PHYSIOL-LONDON, V288, P203; PFAFF DW, 1979, J PHYSIOL-LONDON, V288, P189; Phelps SM, 1998, HORM BEHAV, V34, P294, DOI 10.1006/hbeh.1998.1485; POLLIO G, 1993, MOL BRAIN RES, V19, P135, DOI 10.1016/0169-328X(93)90158-L; POWER RF, 1991, SCIENCE, V254, P1636, DOI 10.1126/science.1749936; Quadros PS, 2008, DEV NEUROBIOL, V68, P1378, DOI 10.1002/dneu.20664; Quadros PS, 2002, ENDOCRINOLOGY, V143, P3727, DOI 10.1210/en.2002-211438; REEVES AG, 1969, ARCH NEUROL-CHICAGO, V20, P616, DOI 10.1001/archneur.1969.00480120062005; RICCIARDI KHN, 1994, J NEUROENDOCRINOL, V6, P135, DOI 10.1111/j.1365-2826.1994.tb00564.x; Robarts DW, 2007, HORM BEHAV, V51, P104, DOI 10.1016/j.yhbeh.2006.08.009; RUBIN BS, 1983, NEUROENDOCRINOLOGY, V37, P218, DOI 10.1159/000123546; SAKUMA Y, 1979, AM J PHYSIOL, V237, pR278, DOI 10.1152/ajpregu.1979.237.5.R278; SAPER CB, 1976, J COMP NEUROL, V169, P409, DOI 10.1002/cne.901690403; Schneider JS, 2009, BEHAV BRAIN RES, V199, P340, DOI 10.1016/j.bbr.2008.12.019; Schneider JS, 2005, ENDOCRINOLOGY, V146, P4340, DOI 10.1210/en.2005-0490; Schober J, 2011, HORM BEHAV, V59, P689, DOI 10.1016/j.yhbeh.2010.10.005; Shah NM, 2004, NEURON, V43, P313, DOI 10.1016/j.neuron.2004.07.008; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; SMITH RL, 1995, J VIROL, V69, P4593, DOI 10.1128/JVI.69.8.4593-4599.1995; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Swaab D., 2003, HUMAN HYPOTHALAMUS 1, P239; Tsutsui K, 2012, CEREBELLUM, V11, P414, DOI 10.1007/s12311-011-0341-7; Veening JG, 2005, EUR J PHARMACOL, V526, P226, DOI 10.1016/j.ejphar.2005.09.041; von Philipsborn AC, 2011, NEURON, V69, P509, DOI 10.1016/j.neuron.2011.01.011; Wheatley MD, 1944, ARCH NEURO PSYCHIATR, V52, P296, DOI 10.1001/archneurpsyc.1944.02290340043004; WITT DM, 1995, PHYSIOL BEHAV, V57, P307, DOI 10.1016/0031-9384(94)00247-3; Wu MV, 2009, CELL, V139, P61, DOI 10.1016/j.cell.2009.07.036; Xu XH, 2012, CELL, V148, P596, DOI 10.1016/j.cell.2011.12.018; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506	108	340	343	3	59	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 9	2013	153	4					896	909		10.1016/j.cell.2013.04.017	http://dx.doi.org/10.1016/j.cell.2013.04.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663785	Bronze, Green Accepted			2022-12-28	WOS:000318844000017
J	Cohen, JE				Cohen, Joanna E.			Saving lives with the US Tobacco Control Act	LANCET			English	Editorial Material									Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Inst Global Tobacco Control, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Cohen, JE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Inst Global Tobacco Control, Baltimore, MD 21205 USA.	jocohen@jhsph.edu						Husten CG, 2013, LANCET, V381, P1570, DOI 10.1016/S0140-6736(13)60735-7; Ministerial Advisory Council on Tobacco Control, 2002, PUTTING AN END TO DE; Orleans CT, 1993, NICOTINE ADDICTION P; POLLAY RW, 2002, TOBACCO CONTROL S1, V11, P18; World Health Organization, 2011, WHO REPORT ON THE GL; World Health Organization (WHO), 2003, WHO FRAMEWORK CONVEN	6	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 4	2013	381	9877					1513	1514		10.1016/S0140-6736(13)60945-9	http://dx.doi.org/10.1016/S0140-6736(13)60945-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139UF	23642686				2022-12-28	WOS:000318609600004
J	Helbing, D				Helbing, Dirk			Globally networked risks and how to respond	NATURE			English	Article							COMPLEX NETWORKS; SYSTEMIC RISK; INNOVATION; CASCADES; FAILURES; DYNAMICS; SPREAD	Today's strongly connected, global networks have produced highly interdependent systems that we do not understand and cannot control well. These systems are vulnerable to failure at all scales, posing serious threats to society, even when external shocks are absent. As the complexity and interaction strengths in our networked world increase, man-made systems can become unstable, creating uncontrollable situations even when decision-makers are well-skilled, have all data and technology at their disposal, and do their best. To make these systems manageable, a fundamental redesign is needed. A 'Global Systems Science' might create the required knowledge and paradigm shift in thinking.	[Helbing, Dirk] ETH, CH-8092 Zurich, Switzerland; [Helbing, Dirk] ETH, Swiss Fed Inst Technol, Risk Ctr, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Helbing, D (corresponding author), ETH, Clausiusstr 50, CH-8092 Zurich, Switzerland.	dhelbing@ethz.ch			FET Flagship Pilot Project FuturICT [284709]; ETH project "Systemic Risks-Systemic Solutions'' (CHIRP II project) [ETH 48 12-1]	FET Flagship Pilot Project FuturICT; ETH project "Systemic Risks-Systemic Solutions'' (CHIRP II project)	This work has been supported partially by the FET Flagship Pilot Project FuturICT (grant number 284709) and the ETH project "Systemic Risks-Systemic Solutions'' (CHIRP II project ETH 48 12-1). I thank L. Bottcher, T. Grund, M. Kaninia, S. Rustler and C. Waloszek for producing the cascade spreading movies and figures. I also thank the FuturICT community for many inspiring discussions.	Achlioptas D, 2009, SCIENCE, V323, P1453, DOI 10.1126/science.1167782; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; ALLEN PM, 1976, P NATL ACAD SCI USA, V73, P665, DOI 10.1073/pnas.73.3.665; Amin S. M., 2005, IEEE POWER ENERGY M, V3, P34, DOI [DOI 10.1109/MPAE.2005.1507024, 10.1109/MPAE.2005.150702]; Axelrod R., 2000, HARNESSING COMPLEXIT; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Bak P, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.178501; Ball P., 2012, WHY SOCIETY IS A COM; Battiston S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00541; Battiston S, 2012, J FINANC STABIL, V8, P138, DOI 10.1016/j.jfs.2012.01.002; Beale N, 2011, P NATL ACAD SCI USA, V108, P12647, DOI 10.1073/pnas.1105882108; Beck Ulrich., 1992, RISK SOC NEW MODERNI; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Buzna L, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.056107; Cederman LE, 2002, P NATL ACAD SCI USA, V99, P7296, DOI 10.1073/pnas.082081099; Clarke L., 2006, WORST CASES; Comfort L. K., 2010, DESIGNING RESILIENCE; Cox Jr L. A., 2009, RISK ANALYSIS OF COM; Crutzen P, 2000, GLOBAL CHANGE NEWSLE, V41, P17; de Freitas S, 2011, NATURE, V470, P330, DOI 10.1038/470330a; Dorner D., 1996, THE LOGIC OF FAILURE; Epstein J.M., 1996, GROWING ARTIFICIAL S; Epstein JM, 2009, NATURE, V460, P687, DOI 10.1038/460687a; Farmer JD, 2009, NATURE, V460, P685, DOI 10.1038/460685a; Floriano D., 2008, BIO INSPIRED ARTIFIC; Fowler JH, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2338; Gao J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.092002; Gilbert N, 2002, P NATL ACAD SCI USA, V99, P7197, DOI 10.1073/pnas.072079499; Grund T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01480; Haldane AG, 2011, NATURE, V469, DOI 10.1038/nature09659; Helbing D, 2001, REV MOD PHYS, V73, P1067, DOI 10.1103/RevModPhys.73.1067; Helbing D., 2005, NETWORKS INTERACTING, P33; Helbing D., 2012, EUROPEAN PHYS J SPEC, V214, P1; Helbing D., 2012, SOCIAL SELF ORGANIZA; Helbing D, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds7; Helbing D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012530; HUNTINGTON SP, 1993, FOREIGN AFF, V72, P22, DOI 10.2307/20045621; Jentsch V., 2010, EXTREME EVENTS IN NA; Johansson A, 2008, ADV COMPLEX SYST, V11, P497, DOI 10.1142/S0219525908001854; Johnson N, 2011, SCIENCE, V333, P81, DOI 10.1126/science.1205068; Kesting A, 2008, TRANSPORT RES C-EMER, V16, P668, DOI 10.1016/j.trc.2007.12.004; Kroger W, 2011, VULNERABLE SYSTEMS, P1; Kun F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.094301; Lammer S, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/04/P04019; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lin N., 2010, SOCIAL CAPITAL; Little RG, 2002, J URBAN TECHNOL, V9, P109, DOI 10.1080/106307302317379855; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Lorenz J, 2009, EUR PHYS J B, V71, P441, DOI 10.1140/epjb/e2009-00347-4; Lozano S, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-30209-9; McNeil AJ, 2005, PRINC SER FINANC, P1; Montanari A, 2010, P NATL ACAD SCI USA, V107, P20196, DOI 10.1073/pnas.1004098107; Motter AE, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098701; Nicolis G., 1995, INTRODUCTION TO NONL; Nowak MA, 2006, EVOLUTIONARY DYNAMIC, DOI DOI 10.2307/J.CTVJGHW98; Pentland A, 2012, COMPUTER, V45, P31, DOI 10.1109/MC.2011.299; Perkins CE, 1999, WMCSA '99, SECOND IEEE WORKSHOP ON MOBILE COMPUTING SYSTEMS AND APPLICATIONS, PROCEEDINGS, P90, DOI 10.1109/MCSA.1999.749281; Peters G. A., 2006, HUMAN ERROR CAUSES A; Pikovsky A., 2003, SYNCHRONIZATION; Preis T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00752; Rinaldi SA, 2001, IEEE CONTR SYST MAG, V21, P11, DOI 10.1109/37.969131; Rodriguez H., 2007, HDB DISASTER RES; Rosato V, 2008, INT J CRIT INFRASTRU, V4, P63, DOI 10.1504/IJCIS.2008.016092; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schneider CM, 2011, P NATL ACAD SCI USA, V108, P3838, DOI 10.1073/pnas.1009440108; Schuster HG, 2005, DETERMINISTIC CHAOS: AN INTRODUCTION, 4TH EDITION, P1, DOI 10.1002/3527604804; Seydel R., 2009, PRACTICAL BIFURCATIO, DOI [10.1007/978-1-4419-1740-9, DOI 10.1007/978-1-4419-1740-9]; Simonsen I, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.218701; Sornette D, 2012, EUR PHYS J-SPEC TOP, V205, P1, DOI 10.1140/epjst/e2012-01559-5; Stanley H. E., 1987, INTRODUCTION TO PHAS; Sterman JD., 2000, BUSINESS DYNAMICS SY; Stiglitz Joseph, 2010, FREEFALL AMERICA FRE; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Szell M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00457; Tainter J., 1988, COLLAPSE COMPLEX SOC; The World Economic Forum, 2011, GLOBAL RISKS 2011; Tumer K., 2004, COLLECTIVES AND THE; Vespignani A, 2010, NATURE, V464, P984, DOI 10.1038/464984a; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; Vinnem J. E., 2007, RISK RELIABILITY AND, V1-3; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Wiener N, 1965, CYBERNETICS; World Economic Forum, 2012, GLOBAL RISKS 2012 AN; World Economic Forum, 2013, GLOBAL RISKS 2012 AN; Young HP, 2009, AM ECON REV, V99, P1899, DOI 10.1257/aer.99.5.1899; Zeeman E. C., 1977, CATASTROPHE THEORY	89	565	596	19	348	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					51	59		10.1038/nature12047	http://dx.doi.org/10.1038/nature12047			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23636396				2022-12-28	WOS:000318221500033
J	McCartney, M				McCartney, Margaret			The private clinics that advertise unlicensed measles jabs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material													mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Advertising Standards Authority, 2012, ASA ADJ BABYJABS LTD; Beck S, 2006, DAILY MAIL; Bignell P., 2012, INDEPENDENT; Bloom Sharon, 2005, BMJ, V331, pE363, DOI 10.1136/bmj.331.7508.E363; Children's Immunisation Centre, AUTISM; Clarion Health, MMR SINGL VACC; General Medical Council, 2013, GOOD MED PRACTICE; Independent Family Healthcare, YOUR HLTH YOUR CHOIC; MHRA, ADV COMPL BREAKSP ME; MHRA, 2012, MED MUMPS VACC; MHRA, 2008, ADV COMPL SINGL COMP; MMR Single Vaccination Clinic, WELC; Reid S, 2012, DAILY MAIL	13	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 1	2013	346								f2830	10.1136/bmj.f2830	http://dx.doi.org/10.1136/bmj.f2830			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139EK	23635546				2022-12-28	WOS:000318564300022
J	Montgomery, TA; Ruvkun, G				Montgomery, Taiowa A.; Ruvkun, Gary			MicroRNAs Visit the ER	CELL			English	Editorial Material							TRANSLATION; PROTEIN; FAMILY	Little is known about where microRNAs (miRNAs) regulate their targets within the cell. In this issue, Li et al. identify a new player in the plant miRNA pathway that implicates the endoplasmic reticulum in miRNA-mediated gene silencing.	[Montgomery, Taiowa A.; Ruvkun, Gary] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol,Dept Genet, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Ruvkun, G (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol,Dept Genet, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu		Montgomery, Taiowa/0000-0001-7857-3253				Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Carbonell A, 2012, PLANT CELL, V24, P3613, DOI 10.1105/tpc.112.099945; Cikaluk DE, 1999, MOL BIOL CELL, V10, P3357, DOI 10.1091/mbc.10.10.3357; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Eulalio A, 2009, RNA, V15, P1433, DOI 10.1261/rna.1703809; Li SB, 2013, CELL, V153, P562, DOI 10.1016/j.cell.2013.04.005; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Stalder L., 2013, EMBO J; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	10	7	7	1	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 25	2013	153	3					511	512		10.1016/j.cell.2013.04.014	http://dx.doi.org/10.1016/j.cell.2013.04.014			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622236	Bronze			2022-12-28	WOS:000318063500004
J	Yates, LA; Norbury, CJ; Gilbert, RJC				Yates, Luke A.; Norbury, Chris J.; Gilbert, Robert J. C.			The Long and Short of MicroRNA	CELL			English	Review							LET-7 MICRORNAS; PRE-MICRORNA; RNA; DICER; DROSOPHILA; LIN28; URIDYLATION; BIOGENESIS; EFFICIENT; LENGTH	MicroRNAs (miRNAs) are versatile regulators of gene expression in higher eukaryotes. In order to silence many different mRNAs in a precise manner, miRNA stability and efficacy is controlled by highly developed regulatory pathways and fine-tuning mechanisms both affecting miRNA processing and altering mature miRNA target specificity.	[Yates, Luke A.; Gilbert, Robert J. C.] Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Norbury, Chris J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Gilbert, RJC (corresponding author), Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.	gilbert@strubi.ox.ac.uk		Gilbert, Robert/0000-0001-9336-5604; Yates, Luke/0000-0002-5023-0803	Cancer Research UK; Oxford Division of Structural Biology is part of the Wellcome Trust Centre for Human Genetics, Wellcome Trust Core Award [090532/Z/09/Z]; Cancer Research UK [13070] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Oxford Division of Structural Biology is part of the Wellcome Trust Centre for Human Genetics, Wellcome Trust Core Award; Cancer Research UK(Cancer Research UK)	We apologize to all those whose work we could not cite directly due to space restrictions. We gratefully acknowledge financial support from Cancer Research UK. The Oxford Division of Structural Biology is part of the Wellcome Trust Centre for Human Genetics, Wellcome Trust Core Award Grant Number 090532/Z/09/Z.	Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Fukunaga R, 2012, CELL, V151, P533, DOI 10.1016/j.cell.2012.09.027; Gu S, 2012, CELL, V151, P900, DOI 10.1016/j.cell.2012.09.042; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Han BW, 2011, CURR BIOL, V21, P1878, DOI 10.1016/j.cub.2011.09.034; Heo I, 2012, CELL, V151, P521, DOI 10.1016/j.cell.2012.09.022; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jones MR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003105; Juvvuna PK, 2012, NUCLEIC ACIDS RES, V40, P6808, DOI 10.1093/nar/gks293; Lau PW, 2012, NAT STRUCT MOL BIOL, V19, P436, DOI 10.1038/nsmb.2268; Lee HY, 2012, RNA, V18, P2012, DOI 10.1261/rna.035501.112; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Liu N, 2011, CURR BIOL, V21, P1888, DOI 10.1016/j.cub.2011.10.006; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Park JE, 2011, NATURE, V475, P201, DOI 10.1038/nature10198; Rissland OS, 2007, MOL CELL BIOL, V27, P3612, DOI 10.1128/MCB.02209-06; Thornton JE, 2012, RNA, V18, P1875, DOI 10.1261/rna.034538.112; Tsutsumi A, 2011, NAT STRUCT MOL BIOL, V18, P1153, DOI 10.1038/nsmb.2125; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Yates LA, 2012, NAT STRUCT MOL BIOL, V19, P782, DOI 10.1038/nsmb.2329	21	572	604	9	217	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 25	2013	153	3					516	519		10.1016/j.cell.2013.04.003	http://dx.doi.org/10.1016/j.cell.2013.04.003			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	132JK	23622238	Bronze			2022-12-28	WOS:000318063500006
J	Boyce, N				Boyce, Niall			Profile David Nutt: making the medical case for addiction	LANCET			English	Biographical-Item																		NUTT D, PUBLICATION LIST	1	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 23	2013	381	9871					987	987		10.1016/S0140-6736(13)60700-X	http://dx.doi.org/10.1016/S0140-6736(13)60700-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	117EU	23668570				2022-12-28	WOS:000316936800016
J	Ek, O; Muhr, M; Hulting, AL; Jansson, KA				Ek, Oskar; Muhr, Madeleine; Hulting, Anna-Lena; Jansson, Karl-Ake			Traumatic brain injury and fracture	LANCET			English	Editorial Material							GROWTH-HORMONE		[Ek, Oskar; Muhr, Madeleine; Hulting, Anna-Lena; Jansson, Karl-Ake] Karolinska Inst, Karolinska Univ Hosp, Dept Mol Med & Surg, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Jansson, KA (corresponding author), Karolinska Univ Hosp, Dept Orthopaed Surg, S-17176 Stockholm, Sweden.	karl-ake.jansson@karolinska.se						Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; CARPENTER JE, 1992, J BONE JOINT SURG AM, V74A, P359, DOI 10.2106/00004623-199274030-00006; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Weiss S, 2008, GROWTH HORM IGF RES, V18, P205, DOI 10.1016/j.ghir.2007.09.002; Wildburger R, 2001, WIEN KLIN WOCHENSCHR, V113, P119	5	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 9	2013	381	9869					874	874		10.1016/S0140-6736(12)62173-4	http://dx.doi.org/10.1016/S0140-6736(12)62173-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105IL	23668516				2022-12-28	WOS:000316060600036
J	Kotloff, KL; Nataro, JP; Blackwelder, WC; Nasrin, D; Farag, TH; Panchalingam, S; Wu, Y; Sow, SO; Sur, D; Breiman, RF; Faruque, ASG; Zaidi, AKM; Saha, D; Alonso, PL; Tamboura, B; Sanogo, D; Onwuchekwa, U; Manna, B; Ramamurthy, T; Kanungo, S; Ochieng, JB; Omore, R; Oundo, JO; Hossain, A; Das, SK; Ahmed, S; Qureshi, S; Quadri, F; Adegbola, RA; Antonio, M; Hossain, MJ; Akinsola, A; Mandomando, I; Nhampossa, T; Acacio, S; Biswas, K; O'Reilly, CE; Mintz, ED; Berkeley, LY; Muhsen, K; Sommerfelt, H; Robins-Browne, RM; Levine, MM				Kotloff, Karen L.; Nataro, James P.; Blackwelder, William C.; Nasrin, Dilruba; Farag, Tamer H.; Panchalingam, Sandra; Wu, Yukun; Sow, Samba O.; Sur, Dipika; Breiman, Robert F.; Faruque, Abu S. G.; Zaidi, Anita K. M.; Saha, Debasish; Alonso, Pedro L.; Tamboura, Boubou; Sanogo, Doh; Onwuchekwa, Uma; Manna, Byomkesh; Ramamurthy, Thandavarayan; Kanungo, Suman; Ochieng, John B.; Omore, Richard; Oundo, Joseph O.; Hossain, Anowar; Das, Sumon K.; Ahmed, Shahnawaz; Qureshi, Shahida; Quadri, Farheen; Adegbola, Richard A.; Antonio, Martin; Hossain, M. Jahangir; Akinsola, Adebayo; Mandomando, Inacio; Nhampossa, Tacilta; Acacio, Sozinho; Biswas, Kousick; O'Reilly, Ciara E.; Mintz, Eric D.; Berkeley, Lynette Y.; Muhsen, Khitam; Sommerfelt, Halvor; Robins-Browne, Roy M.; Levine, Myron M.			Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study	LANCET			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; SUB-SAHARAN AFRICA; ROTAVIRUS VACCINATION; CHILDHOOD MORTALITY; ATTRIBUTABLE RISK; EPIDEMIOLOGY; CASE/CONTROL; CRYPTOSPORIDIOSIS; PERFORMANCE; POPULATION	Background Diarrhoeal diseases cause illness and death among children younger than 5 years in low-income countries. We designed the Global Enteric Multicenter Study (GEMS) to identify the aetiology and population-based burden of paediatric diarrhoeal disease in sub-Saharan Africa and south Asia. Methods The GEMS is a 3-year, prospective, age-stratified, matched case-control study of moderate-to-severe diarrhoea in children aged 0-59 months residing in censused populations at four sites in Africa and three in Asia. We recruited children with moderate-to-severe diarrhoea seeking care at health centres along with one to three randomly selected matched community control children without diarrhoea. From patients with moderate-to-severe diarrhoea and controls, we obtained clinical and epidemiological data, anthropometric measure ments, and a faecal sample to identify enteropathogens at enrolment; one follow-up home visit was made about 60 days later to ascertain vital status, clinical outcome, and interval growth. Findings We enrolled 9439 children with moderate-to-severe diarrhoea and 13 129 control children without diarrhoea. By analysing adjusted population attributable fractions, most attributable cases of moderate-to-severe diarrhoea were due to four pathogens: rotavirus, Cryptosporidium, enterotoxigenic Escherichia coli producing heat-stable toxin (ST-ETEC; with or without co-expression of heat-labile enterotoxin), and Shigella. Other pathogens were important in selected sites (eg, Aeromonas, Vibrio cholerae O1, Campylobacter jejuni). Odds of dying during follow-up were 8.5-fold higher in patients with moderate-to-severe diarrhoea than in controls (odd ratio 8.5, 95% CI 5.8-12.5, p<0.0001); most deaths (167 [87.9%]) occurred during the first 2 years of life. Pathogens associated with increased risk of case death were ST-ETEC (hazard ratio [HR] 1.9; 0.99-3.5) and typical enteropathogenic E coli (HR 2.6; 1.6-4.1) in infants aged 0-11 months, and Cryptosporidium (HR 2.3; 1.3-4.3) in toddlers aged 12-23 months. Interpretation Interventions targeting five pathogens (rotavirus, Shigella, ST-ETEC, Cryptosporidium, typical enteropathogenic E coli) can substantially reduce the burden of moderate-to-severe diarrhoea. New methods and accelerated implementation of existing interventions (rotavirus vaccine and zinc) are needed to prevent disease and improve outcomes.	[Kotloff, Karen L.; Nataro, James P.; Blackwelder, William C.; Nasrin, Dilruba; Farag, Tamer H.; Panchalingam, Sandra; Wu, Yukun; Berkeley, Lynette Y.; Muhsen, Khitam; Levine, Myron M.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Kotloff, Karen L.; Nataro, James P.; Levine, Myron M.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Kotloff, Karen L.; Nataro, James P.; Blackwelder, William C.; Nasrin, Dilruba; Farag, Tamer H.; Panchalingam, Sandra; Wu, Yukun; Muhsen, Khitam; Levine, Myron M.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Nataro, James P.] Univ Virginia, Sch Med, Dept Pediat, Charlottesville, VA 22908 USA; [Sow, Samba O.; Tamboura, Boubou; Sanogo, Doh; Onwuchekwa, Uma] Ctr Dev Vaccins, Bamako, Mali; [Sur, Dipika; Manna, Byomkesh; Ramamurthy, Thandavarayan; Kanungo, Suman] Natl Inst Cholera & Enter Dis, Kolkata, India; [Breiman, Robert F.] US Ctr Dis Control & Prevent, Kenya Off, Global Dis Detect Div, Nairobi, Kenya; [Faruque, Abu S. G.; Hossain, Anowar; Das, Sumon K.; Ahmed, Shahnawaz] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Zaidi, Anita K. M.; Qureshi, Shahida; Quadri, Farheen] Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan; [Saha, Debasish; Adegbola, Richard A.; Antonio, Martin; Hossain, M. Jahangir; Akinsola, Adebayo] Med Res Council UK Unit, Fajara, Gambia; [Alonso, Pedro L.; Mandomando, Inacio; Nhampossa, Tacilta; Acacio, Sozinho] Ctr Invest Saude Manhica, Maputo, Mozambique; [Alonso, Pedro L.] Hosp Clin Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Ochieng, John B.; Omore, Richard; Oundo, Joseph O.] Ctr Dis Control & Prevent KEMRI CDC, Kenya Med Res Inst, Kisumu, Kenya; [Adegbola, Richard A.] GlaxoSmithKline Biol, Global Med Affairs, Wavre, Belgium; [Akinsola, Adebayo] Daffodils Pediat & Family Med, Tucker, GA USA; [Mandomando, Inacio; Nhampossa, Tacilta; Acacio, Sozinho] Minist Saude, Inst Nacl Saude, Maputo, Mozambique; [Biswas, Kousick] US Dept Vet Affairs, Cooperat Studies Program Coordinating Ctr, Perry Point, MD USA; [O'Reilly, Ciara E.; Mintz, Eric D.] US Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA; [Berkeley, Lynette Y.] Ctr Drug Evaluat & Res, Off Antimicrobial Prod, Div Antiinfect Prod, Silver Spring, MD USA; [Sommerfelt, Halvor] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Sommerfelt, Halvor] Norwegian Inst Publ Hlth, Div Infect Dis Control, Oslo, Norway; [Robins-Browne, Roy M.] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Virginia; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); International Centre for Diarrhoeal Disease Research (ICDDR); Aga Khan University; University of London; London School of Hygiene & Tropical Medicine; Centro de Investigacao em Saude de Manhica; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Kenya Medical Research Institute; GlaxoSmithKline; US Department of Veterans Affairs; Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA); University of Bergen; Norwegian Institute of Public Health (NIPH); Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Kotloff, KL (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.	kkotloff@medicine.umaryland.edu	Alonso, Pedro L/AAZ-3645-2020; Robinsbrowne, Roy/ABF-8434-2020; Das, Sumon Kumar/T-6384-2019; Kanungo, Sloka/HHM-7508-2022; kotloff, karen l/E-7768-2012; Mandomando, Inacio/ABD-8007-2020; Das, Sumon Kumar/AAD-1551-2019; Sommerfelt, Halvor/ABD-3552-2020; PANCHALINGAM, SANDRA/W-2663-2019	Alonso, Pedro L/0000-0003-3292-3443; Robinsbrowne, Roy/0000-0001-9179-7884; kotloff, karen l/0000-0003-1808-6431; Mandomando, Inacio/0000-0002-1078-2187; Sommerfelt, Halvor/0000-0002-5670-9786; Ahmed, Shahnawaz/0000-0001-8339-4137; Kanungo, Suman/0000-0003-4441-4443; Farag, Tamer/0000-0003-1826-6600; Panchalingam, Sandra/0000-0003-3526-1457	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The Bill & Melinda Gates Foundation.	Amadi B, 2005, J TROP PEDIATRICS, V51, P5, DOI 10.1093/tropej/fmh064; [Anonymous], WHO CHILD GROWTH STA; Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Atherly DE, 2012, VACCINE, V30, pA7, DOI 10.1016/j.vaccine.2011.12.096; BAQUI AH, 1991, INT J EPIDEMIOL, V20, P1057, DOI 10.1093/ije/20.4.1057; Biswas K, 2012, CLIN INFECT DIS, V55, pS254, DOI 10.1093/cid/cis755; Blackwelder WC, 2012, CLIN INFECT DIS, V55, pS246, DOI 10.1093/cid/cis788; Breslow NE, 1980, IARC SCI PUBL, P5; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Farag TH, 2012, CLIN INFECT DIS, V55, pS225, DOI 10.1093/cid/cis787; Figueras MI, 2007, J MED MICROBIOL, V56, P996, DOI 10.1099/jmm.0.47062-0; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.1093/biomet/80.1.27; GART JJ, 1990, BIOMETRICS, V46, P637, DOI 10.2307/2532084; Gladstone BP, 2011, NEW ENGL J MED, V365, P337, DOI 10.1056/NEJMoa1006261; Jiang V, 2010, HUM VACCINES, V6, P532, DOI 10.4161/hv.6.7.11278; Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753; LEVINE MM, 1984, EPIDEMIOL REV, V6, P31, DOI 10.1093/oxfordjournals.epirev.a036274; LEVINE MM, 1978, LANCET, V1, P1119; Levine MM, 2012, CLIN INFECT DIS, V55, pS215, DOI 10.1093/cid/cis761; Levine MM, 2012, CLIN INFECT DIS, V55, pS303, DOI 10.1093/cid/cis789; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lopman BA, 2011, J INFECT DIS, V204, P980, DOI 10.1093/infdis/jir492; MOLBAK K, 1993, BRIT MED J, V307, P417, DOI 10.1136/bmj.307.6901.417; Mor SM, 2008, CLIN INFECT DIS, V47, P915, DOI 10.1086/591539; Nasrin D, 2013, AM J TROP MED HYG, V89, P3, DOI 10.4269/ajtmh.12-0749; Okeke IN, 2009, J INFECT DEV COUNTR, V3, P817, DOI 10.3855/jidc.586; Panchalingam S, 2012, CLIN INFECT DIS, V55, pS294, DOI 10.1093/cid/cis754; Robins-Browne RM, 2012, CLIN INFECT DIS, V55, pS312, DOI 10.1093/cid/cis756; SANTOSHAM M, 1985, J INFECT DIS, V152, P778, DOI 10.1093/infdis/152.4.778; Trabulsi LR, 2002, EMERG INFECT DIS, V8, P508, DOI 10.3201/eid0805.010385; Valentiner-Branth P, 2003, J CLIN MICROBIOL, V41, P4238, DOI 10.1128/JCM.41.9.4238-4245.2003; Walker CLF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-220; WHO, 2009, WHO ANTHR PERS COMP; You D, 2010, LANCET, V375, P100, DOI 10.1016/S0140-6736(09)61601-9	36	2076	2148	11	301	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 20	2013	382	9888					209	222		10.1016/S0140-6736(13)60844-2	http://dx.doi.org/10.1016/S0140-6736(13)60844-2			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	193FL	23680352				2022-12-28	WOS:000322543700031
J	Sultan, F; Khan, A				Sultan, Faisal; Khan, Aamir			Infectious diseases in Pakistan: a clear and present danger	LANCET			English	Editorial Material									[Sultan, Faisal] Shaukat Khanum Mem Canc Hosp & Res Ctr, Lahore 54770, Pakistan; [Khan, Aamir] Interact Res & Dev, Karachi, Pakistan	Shaukat Khanum Memorial Cancer Hospital & Research Centre	Sultan, F (corresponding author), Shaukat Khanum Mem Canc Hosp & Res Ctr, Lahore 54770, Pakistan.	faisal@skm.org.pk						Burki T, 2008, LANCET INFECT DIS, V8, P413, DOI 10.1016/S1473-3099(08)70145-2; Creswell J, 2012, LANCET INFECT DIS, V12, P909, DOI 10.1016/S1473-3099(12)70262-1; Directorate of Malaria Control Ministry of Interprovincial Coordination Islamabad, MAL CONTR PROGR PAK; Global Polio Eradication Initiative, 2012, INF COUNTR PAK; Kassi M, 2011, TRANSFUSION MED, V21, P57, DOI 10.1111/j.1365-3148.2010.01042.x; Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; National AIDS Control Program Ministry of Health Islamabad, 2008, REP RAP SIT AN HIV O; Nishtar S, 2013, LANCET; PMRC, 2009, PREV HEP B C PAK; Qureshi H, 2010, East Mediterr Health J, V16 Suppl, pS15; UNAIDS, COUNTR PROGR REP PAK; WHO, GLOB TUB REP 2012 AN; WHO Regional Office of the Eastern Mediterranean, 2011, WHO SUPP PAK DENG FE	14	25	25	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 22	2013	381	9884					2138	2140		10.1016/S0140-6736(13)60248-2	http://dx.doi.org/10.1016/S0140-6736(13)60248-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	171KH	23684256				2022-12-28	WOS:000320925600006
J	Britnell, L; Ribeiro, RM; Eckmann, A; Jalil, R; Belle, BD; Mishchenko, A; Kim, YJ; Gorbachev, RV; Georgiou, T; Morozov, SV; Grigorenko, AN; Geim, AK; Casiraghi, C; Castro Neto, AH; Novoselov, KS				Britnell, L.; Ribeiro, R. M.; Eckmann, A.; Jalil, R.; Belle, B. D.; Mishchenko, A.; Kim, Y. -J.; Gorbachev, R. V.; Georgiou, T.; Morozov, S. V.; Grigorenko, A. N.; Geim, A. K.; Casiraghi, C.; Castro Neto, A. H.; Novoselov, K. S.			Strong Light-Matter Interactions in Heterostructures of Atomically Thin Films	SCIENCE			English	Article							TRANSITION-METAL DICHALCOGENIDES; DOUBLE-LAYER GRAPHENE; ELECTRONICS; SEMICONDUCTORS; SPECTROSCOPY; MOS2; SE	The isolation of various two-dimensional (2D) materials, and the possibility to combine them in vertical stacks, has created a new paradigm in materials science: heterostructures based on 2D crystals. Such a concept has already proven fruitful for a number of electronic applications in the area of ultrathin and flexible devices. Here, we expand the range of such structures to photoactive ones by using semiconducting transition metal dichalcogenides (TMDCs)/graphene stacks. Van Hove singularities in the electronic density of states of TMDC guarantees enhanced light-matter interactions, leading to enhanced photon absorption and electron-hole creation (which are collected in transparent graphene electrodes). This allows development of extremely efficient flexible photovoltaic devices with photoresponsivity above 0.1 ampere per watt (corresponding to an external quantum efficiency of above 30%).	[Britnell, L.; Mishchenko, A.; Kim, Y. -J.; Gorbachev, R. V.; Georgiou, T.; Grigorenko, A. N.; Novoselov, K. S.] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Ribeiro, R. M.; Castro Neto, A. H.] Natl Univ Singapore, Graphene Res Ctr, Singapore 117546, Singapore; [Ribeiro, R. M.] Univ Minho, Dept Fis, P-4710057 Braga, Portugal; [Ribeiro, R. M.] Univ Minho, Ctr Fis, P-4710057 Braga, Portugal; [Eckmann, A.; Casiraghi, C.] Univ Manchester, Sch Chem, Manchester M13 9PL, Lancs, England; [Eckmann, A.; Casiraghi, C.] Univ Manchester, Photon Sci Inst, Manchester M13 9PL, Lancs, England; [Jalil, R.; Belle, B. D.; Geim, A. K.] Univ Manchester, Manchester Ctr Mesosci & Nanotechnol, Manchester M13 9PL, Lancs, England; [Kim, Y. -J.] Seoul Natl Univ, Coll Nat Sci, Dept Chem, Seoul 151747, South Korea; [Morozov, S. V.] Russian Acad Sci, Inst Microelect Technol, Chernogolovka 142432, Russia; [Casiraghi, C.] Free Univ Berlin, Dept Phys, D-14195 Berlin, Germany	University of Manchester; National University of Singapore; Universidade do Minho; Universidade do Minho; University of Manchester; University of Manchester; University of Manchester; Seoul National University (SNU); Russian Academy of Sciences; Free University of Berlin	Castro Neto, AH (corresponding author), Natl Univ Singapore, Graphene Res Ctr, 6 Sci Dr 2, Singapore 117546, Singapore.	phycastr@nus.edu.sg	Gorbachev, Roman/I-2512-2013; Morozov, Sergey V/H-3171-2014; Jalil, Rashid/Z-2262-2019; Kim, Yong-Jin/D-2550-2009; Novoselov, Kostya S/G-9581-2014; Mishchenko, Artem/C-7561-2011; Castro Neto, Antonio/C-8363-2014; Geim, Andre K/J-7888-2012; Ribeiro, Ricardo Mendes/I-6885-2013	Gorbachev, Roman/0000-0003-3604-5617; Morozov, Sergey V/0000-0003-3075-7787; Jalil, Rashid/0000-0002-8347-9955; Novoselov, Kostya S/0000-0003-4972-5371; Mishchenko, Artem/0000-0002-0427-5664; Castro Neto, Antonio/0000-0003-0613-4010; Geim, Andre K/0000-0003-2861-8331; Ribeiro, Ricardo Mendes/0000-0002-1485-6809; hai yan, he/0000-0003-0366-6185	Royal Society; European Research Council; U.S. Army; EPSRC; European Science Foundation (ESF) under the EUROCORES Programme EuroGRAPHENE (GOSPEL); Swiss National Science Foundation; National Research Foundation (NRF) of Singapore through NRF-CRP [R-144-000-295-281]; Global Research Laboratory (GRL) Program of the Ministry of Education, Science and Technology, Korea [2011-0021972]; Portuguese FCT [SFRH/BSAB/1249/2012]; EPSRC [EP/K005014/1] Funding Source: UKRI	Royal Society(Royal Society of London); European Research Council(European Research Council (ERC)European Commission); U.S. Army(United States Department of DefenseUnited States Army); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Science Foundation (ESF) under the EUROCORES Programme EuroGRAPHENE (GOSPEL); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Research Foundation (NRF) of Singapore through NRF-CRP; Global Research Laboratory (GRL) Program of the Ministry of Education, Science and Technology, Korea; Portuguese FCT(Portuguese Foundation for Science and Technology); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Royal Society, European Research Council, U.S. Army, EPSRC and European Science Foundation (ESF) under the EUROCORES Programme EuroGRAPHENE (GOSPEL). A. M. acknowledges support from the Swiss National Science Foundation. A.H.C.N. acknowledges support from the National Research Foundation (NRF) of Singapore through NRF-CRP award "Novel 2D materials with tailored properties: Beyond graphene" (R-144-000-295-281). Y.-J.K.'s work was supported by the Global Research Laboratory (GRL) Program (2011-0021972) of the Ministry of Education, Science and Technology, Korea. R. M. R. is thankful for the financial support of the Portuguese FCT under grant SFRH/BSAB/1249/2012.	[Anonymous], 2007, WILEY SERIES PURE AP; Atwater HA, 2010, NAT MATER, V9, P205, DOI [10.1038/nmat2629, 10.1038/NMAT2629]; Ayari A, 2007, J APPL PHYS, V101, DOI 10.1063/1.2407388; Ballif C, 1996, APPL PHYS A-MATER, V62, P543, DOI 10.1007/BF01571690; Blake P, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2768624; Britnell L, 2012, SCIENCE, V335, P947, DOI 10.1126/science.1218461; Castellanos-Gomez A, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-233; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Castro Neto AH, 2001, PHYS REV LETT, V86, P4382, DOI 10.1103/PhysRevLett.86.4382; Cohen SR, 1998, THIN SOLID FILMS, V324, P190, DOI 10.1016/S0040-6090(97)01218-2; Coleman JN, 2011, SCIENCE, V331, P568, DOI 10.1126/science.1194975; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Dresselhaus MS, 2002, ACCOUNTS CHEM RES, V35, P1070, DOI 10.1021/ar0101537; Echtermeyer TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1464; FORTIN E, 1982, J PHYS CHEM SOLIDS, V43, P881, DOI 10.1016/0022-3697(82)90037-3; Furchi M, 2012, NANO LETT, V12, P2773, DOI 10.1021/nl204512x; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Geim AK, 2011, REV MOD PHYS, V83, P851, DOI 10.1103/RevModPhys.83.851; Georgiou T, 2013, NAT NANOTECHNOL, V8, P100, DOI [10.1038/NNANO.2012.224, 10.1038/nnano.2012.224]; Gorbachev RV, 2012, NAT PHYS, V8, P896, DOI [10.1038/NPHYS2441, 10.1038/nphys2441]; Gorbachev RV, 2011, SMALL, V7, P465, DOI 10.1002/smll.201001628; Haigh SJ, 2012, NAT MATER, V11, P764, DOI [10.1038/nmat3386, 10.1038/NMAT3386]; Hess O, 2012, NAT MATER, V11, P573, DOI [10.1038/nmat3356, 10.1038/NMAT3356]; HILTON MR, 1992, SURF COAT TECH, V55, P435, DOI 10.1016/S0257-8972(07)80062-4; KAM KK, 1982, J PHYS CHEM-US, V86, P463, DOI 10.1021/j100393a010; Kumar A, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-30070-x; Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996; MATTHEIS.LF, 1973, PHYS REV B, V8, P3719, DOI 10.1103/PhysRevB.8.3719; Mayorov AS, 2011, NANO LETT, V11, P2396, DOI 10.1021/nl200758b; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Novoselov KS, 2011, REV MOD PHYS, V83, P837, DOI 10.1103/RevModPhys.83.837; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Ponomarenko LA, 2011, NAT PHYS, V7, P958, DOI [10.1038/nphys2114, 10.1038/NPHYS2114]; Sachs B., 2013, ARXIV13042236; Sobolev V. V., 1994, Journal of Applied Spectroscopy, V61, P532, DOI 10.1007/BF02606398; TRIBUTSCH H, 1979, BER BUNSEN PHYS CHEM, V83, P655, DOI 10.1002/bbpc.19790830703; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]	40	1881	1919	70	2348	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2013	340	6138					1311	1314		10.1126/science.1235547	http://dx.doi.org/10.1126/science.1235547			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	163FC	23641062	Green Submitted			2022-12-28	WOS:000320320200039
J	Zheng, HJ; Wisedchaisri, G; Gonen, T				Zheng, Hongjin; Wisedchaisri, Goragot; Gonen, Tamir			Crystal structure of a nitrate/nitrite exchanger	NATURE			English	Article							MAJOR FACILITATOR SUPERFAMILY; ESCHERICHIA-COLI; NITRATE UPTAKE; NITRITE TRANSPORT; MECHANISM; NARK; DENITRIFICATION; CHANNEL; PROTEIN; SYSTEM	Mineral nitrogen in nature is often found in the form of nitrate (NO3-). Numerous microorganisms evolved to assimilate nitrate and use it as a major source of mineral nitrogen uptake(1). Nitrate, which is central in nitrogen metabolism, is first reduced to nitrite (NO2-) through a two-electron reduction reaction(2,3). The accumulation of cellular nitrite can be harmful because nitrite can be reduced to the cytotoxic nitric oxide. Instead, nitrite is rapidly removed from the cell by channels and transporters, or reduced to ammonium or dinitrogen through the action of assimilatory enzymes(3). Despite decades of effort no structure is currently available for any nitrate transport protein and the mechanism by which nitrate is transported remains largely unknown. Here we report the structure of a bacterial nitrate/nitrite transport protein, NarK, from Escherichia coli, with and without substrate. The structures reveal a positively charged substrate-translocation pathway lacking protonatable residues, suggesting that NarK functions as a nitrate/nitrite exchanger and that protons are unlikely to be co-transported. Conserved arginine residues comprise the substrate-binding pocket, which is formed by association of helices from the two halves of NarK. Key residues that are important for substrate recognition and transport are identified and related to extensive mutagenesis and functional studies. We propose that NarK exchanges nitrate for nitrite by a rocker switch mechanism facilitated by inter-domain hydrogen bond networks.	[Zheng, Hongjin; Wisedchaisri, Goragot; Gonen, Tamir] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Gonen, T (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	gonent@janelia.hhmi.org		Wisedchaisri, Goragot/0000-0002-6967-5925	Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; Howard Hughes Medical Institute	Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank E. McCleskey for critically reading this manuscript and for discussions. We thank D. Cawley for development and production of monoclonal antibodies, and staff at the Advanced Light Source, Lawrence Berkeley National Laboratory for assistance with X-ray data collection. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under Contract no. DE-AC02-05CH11231. Research in the Gonen laboratory is funded by the Howard Hughes Medical Institute.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; [Anonymous], PYMOL MOL GRAPH SYST; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; DEMOSS JA, 1991, J BACTERIOL, V173, P3303, DOI 10.1128/jb.173.11.3303-3310.1991; Einsle O, 2004, BIOL CHEM, V385, P875, DOI 10.1515/BC.2004.115; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fokin AV, 2000, BIOORG KHIM+, V26, P571; Harlow E., 1988, ANTIBODIES LAB MANUA; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Jia W, 2005, BIOCHEM SOC T, V33, P159, DOI 10.1042/BST0330159; Jia WJ, 2009, BIOCHEM J, V417, P297, DOI 10.1042/BJ20080746; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Lu W, 2012, P NATL ACAD SCI USA, V109, P18395, DOI 10.1073/pnas.1210793109; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mirza O, 2006, EMBO J, V25, P1177, DOI 10.1038/sj.emboj.7601028; Moir JWB, 2001, CELL MOL LIFE SCI, V58, P215, DOI 10.1007/PL00000849; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qin LZ, 2012, P NATL ACAD SCI USA, V109, P13434, DOI 10.1073/pnas.1116633109; ROWE JJ, 1994, MOL MICROBIOL, V12, P579, DOI 10.1111/j.1365-2958.1994.tb01044.x; Saier MH, 1999, BBA-REV BIOMEMBRANES, V1422, P1, DOI 10.1016/S0304-4157(98)00023-9; Solcan N, 2012, EMBO J, V31, P3411, DOI 10.1038/emboj.2012.157; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Trueman LJ, 1996, GENE, V175, P223, DOI 10.1016/0378-1119(96)00154-0; Wang YY, 2012, TRENDS PLANT SCI, V17, P458, DOI 10.1016/j.tplants.2012.04.006; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X	34	78	81	5	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2013	497	7451					647	+		10.1038/nature12139	http://dx.doi.org/10.1038/nature12139			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	152UF	23665960	Green Accepted, Green Submitted			2022-12-28	WOS:000319556100050
J	Hsu, J; Berman, P; Mills, A				Hsu, Justine; Berman, Peter; Mills, Anne			Reproductive health priorities: evidence from a resource tracking analysis of official development assistance in 2009 and 2010	LANCET			English	Article							CHILD HEALTH; COUNTDOWN; NEWBORN	Background Information is scarce about the extent to which official development assistance (ODA) is spent on reproductive health to provide childbirth care; support family planning; address sexual health; and prevent, treat, and care for sexually transmitted infections, including HIV. We analysed flows of ODA to reproductive health for 2009 and 2010, assessed their distribution by donor type and purpose, and investigated the extent to which disbursements respond to need. We aimed to provide global estimates of aid to reproductive health, to assess the allocation of resources across reproductive health activities, and to encourage donor accountability in targeting aid flows to those most in need. Methods We applied a standard definition of reproductive health across all donors, including a portion of disease-specific activities and health systems development. We analysed disbursements to reproductive health by donor type and purpose (eg, family planning). We also reported on an indicator to monitor donor disbursements: ODA to reproductive health per woman aged 15-49 years. We analysed the extent to which funding is targeted to countries most in need, proxied by female life expectancy at birth and prevalence of HIV infection in adults. Findings Donor disbursements to reproductive health activities in all countries amounted to US$5579 million in 2009 and US$5637 million in 2010-an increase of 1.0%. ODA for such activities in the 74 Countdown priority countries increased more rapidly at 5.3%. More than half of the funding was directed towards prevention, treatment, and care of HIV infection for women of reproductive age (15-49 years of age). On average, ODA to general reproductive health activities amounted to 15.9% and ODA to family planning 7.2%. Aid to reproductive health was heavily dependent on the USA, the Global Fund, the UK, the United Nations Population Fund, and the World Bank. Interpretation Donors are prioritising reproductive health, and the slight increase in funding in 2009-10 is welcome, especially in the present economic climate. The large share of such funding for activities related to HIV infection in women of reproductive age affects the amount of ODA received by priority countries. It should thus be distinguished from resources directed to other reproductive health activities, such as family planning, which has been the focus of recent worldwide advocacy efforts. Tracking of donor aid to reproductive health should continue to allow investigation of the allocation of resources across reproductive health activities, and to encourage donor accountability in targeting aid flows to those most in need.	[Hsu, Justine; Mills, Anne] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1H 9SH, England; [Berman, Peter] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	University of London; London School of Hygiene & Tropical Medicine; Harvard University; Harvard T.H. Chan School of Public Health	Hsu, J (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, 15-17 Tavistock Pl, London WC1H 9SH, England.	justine.hsu@lshtm.ac.uk		Hsu, Justine/0000-0002-1228-4042; Mills, Anne/0000-0001-9863-9950	Bill & Melinda Gates Foundation; World Bank; Government of Australia; Government of Canada; Government of Norway; Government of Sweden; Government of UK; Countdown to 2015 for Maternal, Newborn and Child Survival by the Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); World Bank(The World Bank India); Government of Australia; Government of Canada(CGIAR); Government of Norway; Government of Sweden; Government of UK; Countdown to 2015 for Maternal, Newborn and Child Survival by the Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation, World Bank, and the Governments of Australia, Canada, Norway, Sweden, and the UK.; This work was supported through the Countdown to 2015 for Maternal, Newborn and Child Survival by the Bill & Melinda Gates Foundation; the World Bank; and the Governments of Australia, Canada, Norway, Sweden, and the UK. We thank members of the Countdown to 2015 Steering Group and the Countdown to 2015 Financing Working Group and the anonymous reviewers for their comments on the report.	Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; [Anonymous], 2011, PREVALENCE INCIDENCE; Chesson HW, 2004, PERSPECT SEX REPRO H, V36, P11, DOI 10.1363/3601104; DfID and Gates Foundation, LOND SUMM FAM PLANN; Fathalla MF, 2006, LANCET, V368, P2095, DOI 10.1016/S0140-6736(06)69483-X; Gates Foundation, 2012, FAM PLANN STRAT OV; Glasier A, 2006, LANCET, V368, P1595, DOI 10.1016/S0140-6736(06)69478-6; Global Fund, 2011, NSA APPR 2 WAV; Global Health Resource Tracking Working Group, 2007, FOLL MON BETT TRACK; Greco G, 2008, LANCET, V371, P1268, DOI 10.1016/S0140-6736(08)60561-9; Hsu J, 2012, LANCET, V380, P1157, DOI 10.1016/S0140-6736(12)61415-9; IHME, 2011, FIN GLOB HLTH 2011 C; Leach-Kemon K, 2012, HEALTH AFFAIR, V31, P228, DOI 10.1377/hlthaff.2011.1154; Netherlands Interdisciplinary Demographic Institute, 2010, FIN RES FLOWS POP AC; OECD, DAC GLOSS KEY TERMS; OECD, INF NOT DAC DEFL; OECD, CRED REP SYST CRS AI; Patel P, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000090; Pitt C, 2010, LANCET, V376, P1485, DOI 10.1016/S0140-6736(10)61302-5; Powell-Jackson T, 2006, LANCET, V368, P1077, DOI 10.1016/S0140-6736(06)69338-0; Schaferhoff M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000305; Schwartlander B, 2011, LANCET, V377, P2031, DOI 10.1016/S0140-6736(11)60702-2; Starrs AM, 2006, LANCET, V368, P1130, DOI 10.1016/S0140-6736(06)69385-9; The Global Campaign, 2010, PUTT GLOB STRAT WOM; *UN, 1995, INT C POP DEV CAIR 5; UN, 2007, REP SECR GEN WORK S1; UNAIDS, 2010, UNAIDS REP GLOB AIDS; UNFPA, 2011, MAT HLTH THEM FUND A; WHO, 2006, SEX REPR HLTH WOM LI; WHO, HIV PREV AD AG 15 49; World Health Organization (WHO), 2011, WORLD HLTH STAT 2012	31	24	24	1	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 18	2013	381	9879					1772	1782		10.1016/S0140-6736(13)60762-X	http://dx.doi.org/10.1016/S0140-6736(13)60762-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146TA	23683644				2022-12-28	WOS:000319112800042
J	Osotimehin, B				Osotimehin, Babatunde			Obstetric fistula: ending the health and human rights tragedy	LANCET			English	Editorial Material									UN Populat Fund, New York, NY 10158 USA	United Nations Population Fund	Osotimehin, B (corresponding author), UN Populat Fund, New York, NY 10158 USA.	osotimehin@unfpa.org						[Anonymous], 2012, LANCET, V380, P1881; Harland-Scott C., 2013, ADDRESSING INEQUALIT; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Stanton C, 2007, INT J GYNECOL OBSTET, V99, pS4, DOI 10.1016/j.ijgo.2007.06.010; UN, UNITED NATIONS SECRE; UN, 2012, SUPPORTING EFFORTS T; van Beekhuizen, 2006, LANCET, V368, P1210; Wall LL, 2006, LANCET, V368, P1201, DOI 10.1016/S0140-6736(06)69476-2; WHO, 2010, 10 FACTS ON OBSTETRI; WHO U. UNFPA The World Bank, 2012, TRENDS MAT MORT 1990	10	14	14	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 18	2013	381	9879					1702	1703		10.1016/S0140-6736(13)61001-6	http://dx.doi.org/10.1016/S0140-6736(13)61001-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146TA	23683623				2022-12-28	WOS:000319112800014
J	[Anonymous]				[Anonymous]			Women Deliver post-2015	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 18	2013	381	9879					1687	1687						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146TA	23683612				2022-12-28	WOS:000319112800003
J	Kaspi, Y; Showman, AP; Hubbard, WB; Aharonson, O; Helled, R				Kaspi, Yohai; Showman, Adam P.; Hubbard, William B.; Aharonson, Oded; Helled, Ravit			Atmospheric confinement of jet streams on Uranus and Neptune	NATURE			English	Article							DEEP ZONAL FLOWS; INTERIOR STRUCTURE; CLOUD FEATURES; GIANT PLANETS; JUPITER; CIRCULATION; MODELS; SATURN; WINDS; DYNAMICS	The observed cloud-level atmospheric circulation on the outer planets of the Solar System is dominated by strong east-west jet streams. The depth of these winds is a crucial unknown in constraining their overall dynamics, energetics and internal structures. There are two approaches to explaining the existence of these strong winds. The first suggests that the jets are driven by shallow atmospheric processes near the surface(1-3), whereas the second suggests that the atmospheric dynamics extend deeply into the planetary interiors(4,5). Here we report that on Uranus and Neptune the depth of the atmospheric dynamics can be revealed by the planets' respective gravity fields. We show that the measured fourth-order gravity harmonic, J(4), constrains the dynamics to the outermost 0.15 per cent of the total mass of Uranus and the outermost 0.2 per cent of the total mass of Neptune. This provides a stronger limit to the depth of the dynamical atmosphere than previously suggested(6), and shows that the dynamics are confined to a thin weather layer no more than about 1,000 kilometres deep on both planets.	[Kaspi, Yohai; Aharonson, Oded] Weizmann Inst Sci, Dept Environm Sci, IL-76100 Rehovot, Israel; [Kaspi, Yohai; Aharonson, Oded] Weizmann Inst Sci, Ctr Planetary Sci, IL-76100 Rehovot, Israel; [Showman, Adam P.; Hubbard, William B.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Aharonson, Oded] CALTECH, Dept Geol & Planetary Sci, Pasadena, CA 91125 USA; [Helled, Ravit] Tel Aviv Univ, Dept Geophys & Planetary Sci, IL-69978 Tel Aviv, Israel	Weizmann Institute of Science; Weizmann Institute of Science; University of Arizona; California Institute of Technology; Tel Aviv University	Kaspi, Y (corresponding author), Weizmann Inst Sci, Dept Environm Sci, IL-76100 Rehovot, Israel.	yohai.kaspi@weizmann.ac.il		Aharonson, Oded/0000-0001-9930-2495; Helled, Ravit/0000-0001-5555-2652; Kaspi, Yohai/0000-0003-4089-0020	Helen Kimmel Center for Planetary Science at the Weizmann Institute of Science; NASA	Helen Kimmel Center for Planetary Science at the Weizmann Institute of Science; NASA(National Aeronautics & Space Administration (NASA))	Y.K. and O.A. thank the Helen Kimmel Center for Planetary Science at the Weizmann Institute of Science for support. A. P. S. and W. B. H. acknowledge support by NASA.	Aurnou J, 2007, ICARUS, V190, P110, DOI 10.1016/j.icarus.2007.02.024; Hammel HB, 2005, ICARUS, V175, P534, DOI 10.1016/j.icarus.2004.11.012; Helled R, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/1/15; Helled R, 2010, ICARUS, V210, P446, DOI 10.1016/j.icarus.2010.06.037; Hubbard W. B., 1984, PLANETARY INTERIORS; Hubbard WB, 1999, ICARUS, V137, P357, DOI 10.1006/icar.1998.6064; HUBBARD WB, 1991, SCIENCE, V253, P648, DOI 10.1126/science.253.5020.648; HUBBARD WB, 1989, ICARUS, V78, P102, DOI 10.1016/0019-1035(89)90072-9; Jacobson RA, 2009, ASTRON J, V137, P4322, DOI 10.1088/0004-6256/137/5/4322; Jacobson R.A., 2007, B AM ASTRON SOC, V39, P453; Karkoschka E, 2011, ICARUS, V215, P439, DOI 10.1016/j.icarus.2011.05.013; Kaspi Y, 2013, GEOPHYS RES LETT, V40, P676, DOI 10.1029/2012GL053873; Kaspi Y, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041385; Kaspi Y, 2009, ICARUS, V202, P525, DOI 10.1016/j.icarus.2009.03.026; Kong DL, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/2/143; Lian Y, 2010, ICARUS, V207, P373, DOI 10.1016/j.icarus.2009.10.006; Liu J, 2008, ICARUS, V196, P653, DOI 10.1016/j.icarus.2007.11.036; Liu JJ, 2010, J ATMOS SCI, V67, P3652, DOI 10.1175/2010JAS3492.1; Nettelmann N, 2013, PLANET SPACE SCI, V77, P143, DOI 10.1016/j.pss.2012.06.019; PEARL JC, 1991, J GEOPHYS RES-PLANET, V96, P18921, DOI 10.1029/91JA01087; Pedlosky J., 1987, GEOPHYS FLUID DYN, VVolume 710; Podolak M, 1995, PLANET SPACE SCI, V43, P1517, DOI 10.1016/0032-0633(95)00061-5; READ PL, 1987, NATURE, V325, P197, DOI 10.1038/325197a0; Schneider T, 2009, J ATMOS SCI, V66, P579, DOI 10.1175/2008JAS2798.1; Sromovsky LA, 2005, ICARUS, V179, P459, DOI 10.1016/j.icarus.2005.07.022; SROMOVSKY LA, 1993, ICARUS, V105, P110, DOI 10.1006/icar.1993.1114; Sromovsky LA, 2001, ICARUS, V150, P244, DOI 10.1006/icar.2000.6574; SUOMI VE, 1991, SCIENCE, V251, P929, DOI 10.1126/science.251.4996.929; Zharkov V. N., 1978, PHYS PLANETARY INTER	30	49	50	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2013	497	7449					344	347		10.1038/nature12131	http://dx.doi.org/10.1038/nature12131			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	144PN	23676751				2022-12-28	WOS:000318952000032
J	Henao-Mejia, J; Strowig, T; Flavell, RA				Henao-Mejia, Jorge; Strowig, Till; Flavell, Richard A.			Microbiota Keep the Intestinal Clock Ticking	CELL			English	Editorial Material							GUT MICROBIOTA; OBESITY		[Henao-Mejia, Jorge; Strowig, Till; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Flavell, Richard A.] Howard Hughes Med Inst, Chevy Chase, MD USA	Yale University; Howard Hughes Medical Institute	Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	richard.flavell@yale.edu		Strowig, Till/0000-0003-0185-1459	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ASFELDT VH, 1971, SCAND J CLIN LAB INV, V28, P61, DOI 10.3109/00365517109090664; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Kino T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003333; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Mukherji A, 2013, CELL, V153, P812, DOI 10.1016/j.cell.2013.04.020; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721	9	14	15	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 9	2013	153	4					741	743		10.1016/j.cell.2013.04.043	http://dx.doi.org/10.1016/j.cell.2013.04.043			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663774	Bronze			2022-12-28	WOS:000318844000004
J	Mayerle, J; den Hoed, CM; Schurmann, C; Stolk, L; Homuth, G; Peters, MJ; Capelle, LG; Zimmermann, K; Rivadeneira, F; Gruska, S; Volzke, H; de Vries, AC; Volker, U; Teumer, A; van Meurs, JBJ; Steinmetz, I; Nauck, M; Ernst, F; Weiss, FU; Hofman, A; Zenker, M; Kroemer, HK; Prokisch, H; Uitterlinden, AG; Lerch, MM; Kuipers, E				Mayerle, Julia; den Hoed, Caroline M.; Schurmann, Claudia; Stolk, Lisette; Homuth, Georg; Peters, Marjolein J.; Capelle, Lisette G.; Zimmermann, Kathrin; Rivadeneira, Fernando; Gruska, Sybille; Voelzke, Henry; de Vries, Annemarie C.; Voelker, Uwe; Teumer, Alexander; van Meurs, Joyce B. J.; Steinmetz, Ivo; Nauck, Matthias; Ernst, Florian; Weiss, Frank-Ulrich; Hofman, Albert; Zenker, Martin; Kroemer, Heyo K.; Prokisch, Holger; Uitterlinden, Andre G.; Lerch, Markus M.; Kuipers, Ernst			Identification of Genetic Loci Associated With Helicobacter pylori Serologic Status	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; GASTRIC-CANCER; INCREASED RISK; INFECTION; POLYMORPHISMS; TOOL; METAANALYSES; EPIDEMIOLOGY; POPULATIONS; RECEPTORS	Importance Helicobacter pylori is a major cause of gastritis and gastroduodenal ulcer disease and can cause cancer. H pylori prevalence is as high as 90% in some developing countries but 10% of a given population is never colonized, regardless of exposure. Genetic factors are hypothesized to confer H pylori susceptibility. Objective To identify genetic loci associated with H pylori seroprevalence in 2 independent population-based cohorts and to determine their putative pathophysiological role by whole-blood RNA gene expression profiling. Design, Setting, and Participants Two independent genome-wide association studies (GWASs) and a subsequent meta-analysis were conducted for anti-H pylori IgG serology in the Study of Health in Pomerania (SHIP) (recruitment, 1997-2001 [n=3830]) as well as the Rotterdam Study (RS-I) (recruitment, 1990-1993) and RS-II (recruitment, 2000-2001 [n=7108]) populations. Whole-blood RNA gene expression profiles were analyzed in RS-III (recruitment, 2006-2008 [n=762]) and SHIP-TREND (recruitment, 2008-2012 [n=991]), and fecal H pylori antigen in SHIP-TREND (n=961). Main Outcomes and Measures H pylori seroprevalence. Results Of 10 938 participants, 6160 (56.3%) were seropositive for H pylori. GWASs identified the toll-like receptor (TLR) locus (4p14; top-ranked single-nucleotide polymorphism (SNP), rs10004195; P=1.4 x 10(-18); odds ratio, 0.70 [95% CI, 0.65 to 0.76]) and the FCGR2A locus (1q23.3; top-ranked SNP, rs368433; P=2.1 x 10(-8); odds ratio, 0.73 [95% CI, 0.65 to 0.81]) as associated with H pylori seroprevalence. Among the 3 TLR genes at 4p14, only TLR1 was differentially expressed per copy number of the minor rs10004195-A allele (beta =-0.23 [95% CI, -0.34 to -0.11]; P=2.1 x 10(-4)). Individuals with high fecal H pylori antigen titers (optical density >1) also exhibited the highest 25% of TLR1 expression levels (P=.01 by chi(2) test). Furthermore, TLR1 exhibited an Asn248Ser substitution in the extracellular domain strongly linked to the rs10004195 SNP. Conclusions and Relevance GWAS meta-analysis identified an association between TLR1 and H pylori seroprevalence, a finding that requires replication in non-white populations. If confirmed, genetic variations in TLR1 may help explain some of the observed variation in individual risk for H pylori infection. JAMA. 2013;309(18):1912-1920 www.jama.com	[Mayerle, Julia; Gruska, Sybille; Weiss, Frank-Ulrich; Lerch, Markus M.] Univ Med Greifswald, Dept Med A, D-17475 Greifswald, Germany; [Schurmann, Claudia; Homuth, Georg; Voelker, Uwe; Teumer, Alexander; Ernst, Florian] Univ Med Greifswald, Interfac Inst Genet & Funct Genom, D-17475 Greifswald, Germany; [Zimmermann, Kathrin; Steinmetz, Ivo] Univ Med Greifswald, Friedrich Loeffler Inst Med Microbiol, D-17475 Greifswald, Germany; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, D-17475 Greifswald, Germany; [Nauck, Matthias] Univ Med Greifswald, Inst Clin Chem & Lab Med, D-17475 Greifswald, Germany; [Kroemer, Heyo K.] Univ Med Greifswald, Dept Pharmacol, CDAT, D-17475 Greifswald, Germany; [den Hoed, Caroline M.; Capelle, Lisette G.; de Vries, Annemarie C.; Kuipers, Ernst] Erasmus Univ, Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Stolk, Lisette; Peters, Marjolein J.; Rivadeneira, Fernando; van Meurs, Joyce B. J.; Uitterlinden, Andre G.; Kuipers, Ernst] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Hofman, Albert; Uitterlinden, Andre G.] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Stolk, Lisette; Peters, Marjolein J.; Rivadeneira, Fernando; van Meurs, Joyce B. J.; Hofman, Albert; Uitterlinden, Andre G.] Netherlands Consortium Hlth Aging, Leiden, Netherlands; [Zenker, Martin] Otto Von Guericke Univ, Inst Human Genet, Magdeburg, Germany; [Prokisch, Holger] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Humangenet, Neuherberg, Germany; [Prokisch, Holger] Tech Univ Munich, Inst Humangenet, D-80290 Munich, Germany	Greifswald Medical School; Greifswald Medical School; Friedrich Loeffler Institute; Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Otto von Guericke University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Lerch, MM (corresponding author), Univ Med Greifswald, Dept Med A, Ferdinand Sauerbruchstr, D-17475 Greifswald, Germany.	lerch@uni-greifswald.de	Lerch, Markus M./E-2206-2016; Rivadeneira, Fernando/O-5385-2015; Mayerle, Julia/W-7907-2019; Kuipers, Ernst J/H-3293-2019; Prokisch, Holger/N-8964-2013; Teumer, Alexander/S-7438-2019; Schurmann, Claudia/L-1204-2016; Weiss, Frank Ulrich/A-6386-2009	Lerch, Markus M./0000-0002-9643-8263; Rivadeneira, Fernando/0000-0001-9435-9441; Kuipers, Ernst J/0000-0002-0633-3098; Teumer, Alexander/0000-0002-8309-094X; Schurmann, Claudia/0000-0003-4158-9192; Weiss, Frank Ulrich/0000-0003-3369-6369; Volker, Uwe/0000-0002-5689-3448; Steinmetz, Ivo/0000-0003-0510-7336; Peters, Marjolein/0000-0003-3167-9063; Prokisch, Holger/0000-0003-2379-6286; van Meurs, Joyce/0000-0001-6245-2123; Mayerle, Julia/0000-0002-3666-6459	Federal Ministry of Education and Research (BMBF) [01ZZ9603]; Ministry of Cultural Affairs [01ZZ0103]; Social Ministry of the Federal State of Mecklenberg-West Pomerania [01ZZ0403]; Falk Foundation; Center of Knowledge Interchange program of the Siemens AG; Cache-Campus program of the InterSystems GmbH; Netherlands Organisation of Scientific Research (NWO) Investments; Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative/NWO	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenberg-West Pomerania; Falk Foundation; Center of Knowledge Interchange program of the Siemens AG(Siemens AG); Cache-Campus program of the InterSystems GmbH; Netherlands Organisation of Scientific Research (NWO) Investments(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative/NWO(Netherlands Organization for Scientific Research (NWO))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Volzke reported receiving a grant from the Federal Ministry of Education and Research (BMBF). Dr Volker reported receiving a grant from BMBF. Dr Nauck reported receiving grants from BMBF (01ZZ9603), the Ministry of Cultural Affairs (01ZZ0103), and the Social Ministry of the Federal State of Mecklenberg-West Pomerania (01ZZ0403). Dr Weiss reported receiving a grant pending from EFRE/TBI. Dr Mayerle reported providing expert testimony on behalf of AstraZeneca and Novartis; and receiving payment for lectures from the Falk Foundation.; This study was funded by BMBF, the Center of Knowledge Interchange program of the Siemens AG, and the Cache-Campus program of the InterSystems GmbH. The Rotterdam Study is supported by the Netherlands Organisation of Scientific Research (NWO) Investments, the Research Institute for Diseases in the Elderly, and the Netherlands Genomics Initiative/NWO. Further funding and support is described in the eAppendix.	Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; Bardhan PK, 1997, CLIN INFECT DIS, V25, P973, DOI 10.1086/516067; El-Omar EM, 2003, GASTROENTEROLOGY, V124, P1193, DOI 10.1016/S0016-5085(03)00157-4; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Estrada K, 2009, BIOINFORMATICS, V25, P2750, DOI 10.1093/bioinformatics/btp497; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Gautam JK, 2006, J BIOL CHEM, V281, P30132, DOI 10.1074/jbc.M602057200; GRAHAM DY, 1991, GASTROENTEROLOGY, V100, P1495, DOI 10.1016/0016-5085(91)90644-Z; Hanvivatvong O, 2004, CLIN DIAGN LAB IMMUN, V11, P618, DOI 10.1128/CDLI.11.3.618-620.2004; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Hofman A, 2009, EUR J EPIDEMIOL, V24, P553, DOI 10.1007/s10654-009-9386-z; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kao JY, 2010, GASTROENTEROLOGY, V138, P1046, DOI 10.1053/j.gastro.2009.11.043; KUIPERS EJ, 1993, LANCET, V342, P328, DOI 10.1016/0140-6736(93)91473-Y; KUIPERS EJ, 1995, LANCET, V345, P1525, DOI 10.1016/S0140-6736(95)91084-0; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Lehrnbecher T, 1999, BLOOD, V94, P4220, DOI 10.1182/blood.V94.12.4220.424k08_4220_4232; MALATY HM, 1994, ANN INTERN MED, V120, P982, DOI 10.7326/0003-4819-120-12-199406150-00002; Malaty HM, 2002, LANCET, V359, P931, DOI 10.1016/S0140-6736(02)08025-X; Miranda-Hernandez S, 2011, J IMMUNOL, V187, P791, DOI 10.4049/jimmunol.1001992; Montecucco C, 2001, NAT REV MOL CELL BIO, V2, P457, DOI 10.1038/35073084; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Queiroz DMM, 2009, MICROBES INFECT, V11, P980, DOI 10.1016/j.micinf.2009.07.008; Rad R, 2007, GASTROENTEROLOGY, V133, P150, DOI 10.1053/j.gastro.2007.04.071; Rad R, 2009, GASTROENTEROLOGY, V136, P2247, DOI 10.1053/j.gastro.2009.02.066; Rehnberg-Laiho L, 2004, APMIS, V112, P34, DOI 10.1111/j.1600-0463.2004.apm1120106.x; SALMON JE, 1992, J CLIN INVEST, V89, P1274, DOI 10.1172/JCI115712; Schurmann C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050938; Suda Y, 1997, J BIOCHEM-TOKYO, V121, P1129; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Taylor BD, 2012, J INFECT DIS, V205, P603, DOI 10.1093/infdis/jir822; Teumer A, 2011, AM J HUM GENET, V88, P664, DOI 10.1016/j.ajhg.2011.04.015; Tonkic A, 2012, HELICOBACTER, V17, P1, DOI 10.1111/j.1523-5378.2012.00975.x; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wong SH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000979; Zambon CF, 2005, CYTOKINE, V29, P141, DOI 10.1016/j.cyto.2004.10.013; Zhang JY, 2011, IMMUNOBIOLOGY, V216, P803, DOI 10.1016/j.imbio.2010.12.006; Zheng ZL, 2009, HELICOBACTER, V14, P120, DOI 10.1111/j.1523-5378.2009.00708.x	44	115	120	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 8	2013	309	18					1912	1920		10.1001/jama.2013.4350	http://dx.doi.org/10.1001/jama.2013.4350			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	138AZ	23652523	Bronze			2022-12-28	WOS:000318481900026
J	Raghu, G; Behr, J; Brown, KK; Egan, JJ; Kawut, SM; Flaherty, KR; Martinez, FJ; Nathan, SD; Wells, AU; Collard, HR; Costabel, U; Richeldi, L; de Andrade, J; Khalil, N; Morrison, LD; Lederer, DJ; Shao, LX; Li, XM; Pedersen, PS; Montgomery, AB; Chien, JW; O'Riordan, TG				Raghu, Ganesh; Behr, Juergen; Brown, Kevin K.; Egan, Jim J.; Kawut, Steven M.; Flaherty, Kevin R.; Martinez, Fernando J.; Nathan, Steven D.; Wells, Athol U.; Collard, Harold R.; Costabel, Ulrich; Richeldi, Luca; de Andrade, Joao; Khalil, Nasreen; Morrison, Lake D.; Lederer, David J.; Shao, Lixin; Li, Xiaoming; Pedersen, Patty S.; Montgomery, A. Bruce; Chien, Jason W.; O'Riordan, Thomas G.		ARTEMIS-IPF Investigators	Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan A Parallel, Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							ARTERIAL-HYPERTENSION; ENDOTHELIN; BOSENTAN; THERAPY; LUNG	Background: Idiopathic pulmonary fibrosis (IPF) is characterized by formation and proliferation of fibroblast foci. Endothelin-1 induces lung fibroblast proliferation and contractile activity via the endothelin A (ETA) receptor. Objective: To determine whether ambrisentan, an ETA receptor-selective antagonist, reduces the rate of IPF progression. Design: Randomized, double-blind, placebo-controlled, event-driven trial. (ClinicalTrials.gov: NCT00768300) Setting: Academic and private hospitals. Participants: Patients with IPF aged 40 to 80 years with minimal or no honeycombing on high-resolution computed tomography scans. Intervention: Ambrisentan, 10 mg/d, or placebo. Measurements: Time to disease progression, defined as death, respiratory hospitalization, or a categorical decrease in lung function. Results: The study was terminated after enrollment of 492 patients (75% of intended enrollment; mean duration of exposure to study medication, 34.7 weeks) because an interim analysis indicated a low likelihood of showing efficacy for the end point by the scheduled end of the study. Ambrisentan-treated patients were more likely to meet the prespecified criteria for disease progression (90 [27.4%] vs. 28 [17.2%] patients; P = 0.010; hazard ratio, 1.74 [95% CI, 1.14 to 2.66]). Lung function decline was seen in 55 (16.7%) ambrisentan-treated patients and 19 (11.7%) placebo-treated patients (P = 0.109). Respiratory hospitalizations were seen in 44 (13.4%) and 9 (5.5%) patients in the ambrisentan and placebo groups, respectively (P = 0.007). Twenty-six (7.9%) patients who received ambrisentan and 6 (3.7%) who received placebo died (P = 0.100). Thirty-two (10%) ambrisentan-treated patients and 16 (10%) placebo-treated patients had pulmonary hypertension at baseline, and analysis stratified by the presence of pulmonary hypertension revealed similar results for the primary end point. Limitation: The study was terminated early. Conclusion: Ambrisentan was not effective in treating IPF and may be associated with an increased risk for disease progression and respiratory hospitalizations.	Univ Washington, Gilead Sci, Seattle, WA 98195 USA; Cardeas Pharma, Seattle, WA 98121 USA; Univ Hosp Bergmannsheil, Bochum, Germany; Univ Klin, Ruhrlandklin Essen, Essen, Germany; Univ Colorado, Denver, CO 80202 USA; Mater Misericordiae Univ Hosp, Dublin 7, Ireland; Univ Penn, Philadelphia, PA 19104 USA; Univ Michigan, Ann Arbor, MI 48109 USA; Inova Fairfax Hosp, Falls Church, VA 22042 USA; Royal Brompton Hosp, London SW3 6NP, England; Univ Calif San Francisco, San Francisco, CA 94143 USA; Azienda Osped Univ Modena Policlin, Modena, Italy; Univ Alabama Birmingham, Birmingham Hosp, Birmingham, AL 35294 USA; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Duke Univ, Med Ctr, Durham, NC 27710 USA; Columbia Univ, Med Ctr, New York, NY 10032 USA	Gilead Sciences; University of Washington; University of Washington Seattle; Ruhr University Bochum; University of Duisburg Essen; University of Colorado System; University of Colorado Denver; Mater Misericordiae University Hospital; University College Dublin; University of Pennsylvania; University of Michigan System; University of Michigan; Inova Fairfax Hospital; Royal Brompton Hospital; University of California System; University of California San Francisco; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; University of Alabama System; University of Alabama Birmingham; University of British Columbia; Duke University; Columbia University	Raghu, G (corresponding author), Univ Washington, Med Ctr, Div Pulm & Crit Care Med, 1959 NE Pacific,Campus Box 356175, Seattle, WA 98195 USA.	Thomas.ORiordan@gilead.com	Hopkins, Peter/B-1329-2011; de Heredia, Cristina Diaz/G-4016-2016; Richeldi, Luca/ABF-2486-2020; Brown, Kevin/ABF-2544-2020; De Andrade, Joao/X-5042-2019; Richeldi, Luca/B-6243-2019; Lederer, David/W-7957-2018; Poletti, Venerino/K-8821-2016; Pesek, Milos/J-4658-2017	de Heredia, Cristina Diaz/0000-0001-8086-296X; Richeldi, Luca/0000-0001-8594-1448; De Andrade, Joao/0000-0002-3743-4561; Lederer, David/0000-0001-5258-0228; Glaspole, Ian/0000-0002-5118-2890; marchand-adam, sylvain/0000-0002-9522-3738; Poletti, Venerino/0000-0002-8634-2284; Pesek, Milos/0000-0002-4664-7614; ISRAEL-BIET, Dominique/0000-0003-4308-4411; Herth, Felix/0000-0002-7638-2506; Agostini, Carlo/0000-0001-7786-3574; chanez, pascal/0000-0003-4059-0917; Haddad, MD, Tarik/0000-0001-8185-8524; Maher, Toby/0000-0001-7192-9149	Gilead Sciences	Gilead Sciences(Gilead Sciences)	Gilead Sciences.	Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Badesch DB, 2012, CARDIOVASC THER, V30, P93, DOI 10.1111/j.1755-5922.2011.00279.x; Fonseca C, 2011, AM J RESP CELL MOL, V44, P1, DOI 10.1165/rcmb.2009-0388TR; Galie N, 2008, CIRCULATION, V117, P3010, DOI 10.1161/CIRCULATIONAHA.107.742510; Gallelli L, 2005, J CELL BIOCHEM, V96, P858, DOI 10.1002/jcb.20608; Gunther A, 2007, EUR RESPIR J, V29, P713, DOI 10.1183/09031936.00149205; Hamada K, 2007, CHEST, V131, P650, DOI 10.1378/chest.06-1466; Henderson WR, 2011, AM J RESP CRIT CARE, V183; Henderson WR, 2010, EUR RESP SOC ANN C B; Jain R, 2007, AM J RESP CELL MOL, V37, P38, DOI 10.1165/rcmb.2006-0353OC; King TE, 2008, AM J RESP CRIT CARE, V177, P75, DOI 10.1164/rccm.200705-732OC; King TE, 2011, AM J RESP CRIT CARE, V184, P92, DOI 10.1164/rccm.201011-1874OC; Kingman M, 2009, EXPERT OPIN PHARMACO, V10, P1847, DOI 10.1517/14656560903061275; Lachin JM, 2005, STAT MED, V24, P2747, DOI 10.1002/sim.2151; Nathan SD, 2007, AM J RESP CRIT CARE, V175, P875, DOI 10.1164/rccm.200608-1153CC; Opitz CF, 2008, EUR HEART J, V29, P1936, DOI 10.1093/eurheartj/ehn234; Oudiz RJ, 2009, J AM COLL CARDIOL, V54, P1971, DOI 10.1016/j.jacc.2009.07.033; Park SH, 1997, AM J RESP CRIT CARE, V156, P600, DOI 10.1164/ajrccm.156.2.9607123; Patel NM, 2007, CHEST, V132, P998, DOI 10.1378/chest.06-3087; Raghu G, 2012, AM J RESP CRIT CARE, V185, pA3631; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; UGUCCIONI M, 1995, J CLIN PATHOL, V48, P330, DOI 10.1136/jcp.48.4.330; Wells AU, 2003, AM J RESP CRIT CARE, V167, P962, DOI 10.1164/rccm.2111053; Xu SW, 2004, MOL BIOL CELL, V15, P2707, DOI 10.1091/mbc.E03-12-0902	25	323	333	0	32	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 7	2013	158	9					641	+		10.7326/0003-4819-158-9-201305070-00003	http://dx.doi.org/10.7326/0003-4819-158-9-201305070-00003			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146WV	23648946				2022-12-28	WOS:000319126900001
J	Chan, M				Chan, Margaret			Linking child survival and child development for health, equity, and sustainable development	LANCET			English	Editorial Material									WHO, CH-1211 Geneva 27, Switzerland	World Health Organization	Chan, M (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.	porria@who.int						Hill Z, 2004, FAMILY AND COMMUNITY; Irwin L, 2007, EARLY CHILD DEVELOPM; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Shonkoff JP, 2012, PEDIATRICS, V129, pE460, DOI 10.1542/peds.2011-0366; UNICEF World Health Organization World Bank United Nations, 2012, REPORT 2012; WHO UNICEF, 2012, CARE FOR CHILD DEVEL; World Health Organization, 1999, CRIT LINK INT PHYS G	7	35	37	1	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 4	2013	381	9877					1514	1515		10.1016/S0140-6736(13)60944-7	http://dx.doi.org/10.1016/S0140-6736(13)60944-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139UF	23642687				2022-12-28	WOS:000318609600005
J	Getz, G; Gabriel, SB; Cibulskis, K; Lander, E; Sivachenko, A; Sougnez, C; Lawrence, M; Kandoth, C; Dooling, D; Fulton, R; Fulton, L; Kalicki-Veizer, J; McLellan, MD; O'Laughlin, M; Schmidt, H; Wilson, RK; Ye, K; Ding, L; Mardis, ER; Ally, A; Balasundaram, M; Birol, I; Butterfield, YSN; Carlsen, R; Carter, C; Chu, A; Chuah, E; Chun, HJE; Dhalla, N; Guin, R; Hirst, C; Holt, RA; Jones, SJM; Lee, D; Li, HI; Marra, MA; Mayo, M; Moore, RA; Mungall, AJ; Plettner, P; Schein, JE; Sipahimalani, P; Tam, A; Varhol, RJ; Robertson, AG; Pashtan, I; Saksena, G; Onofrio, RC; Schumacher, SE; Tabak, B; Carter, SL; Hernandez, B; Gentry, J; Salvesen, HB; Ardlie, K; Getz, G; Winckler, W; Beroukhim, R; Gabriel, SB; Meyerson, M; Hadjipanayis, A; Lee, S; Mahadeshwar, HS; Park, P; Protopopov, A; Ren, XJ; Seth, S; Song, XZ; Tang, JB; Xi, RB; Yang, LX; Zeng, D; Kucherlapati, R; Chin, L; Zhang, JH; Auman, JT; Balu, S; Bodenheimer, T; Buda, E; Hayes, DN; Hoyle, AP; Jefferys, SR; Jones, CD; Meng, SW; Mieczkowski, PA; Mose, LE; Parker, JS; Perou, CM; Roach, J; Shi, Y; Simons, JV; Soloway, MG; Tan, DH; Topal, MD; Waring, S; Wu, JY; Hoadley, KA; Baylin, SB; Bootwalla, MS; Lai, PH; Triche, TJ; Van Den Berg, D; Weisenberger, DJ; Laird, PW; Shen, H; Chin, L; Zhang, JH; Getz, G; Cho, J; DiCara, D; Frazer, S; Heiman, D; Jing, R; Lin, P; Mallard, W; Stojanov, P; Voet, D; Zhang, HL; Zou, LH; Noble, M; Lawrence, M; Reynolds, SM; Shmulevich, I; Aksoy, BA; Antipin, Y; Ciriello, G; Dresdner, G; Gao, JJ; Gross, B; Jacobsen, A; Ladanyi, M; Reva, B; Sander, C; Sinha, R; Sumer, SO; Taylor, BS; Cerami, E; Weinhold, N; Schultz, N; Shen, RL; Benz, S; Goldstein, T; Haussler, D; Ng, S; Szeto, C; Stuart, J; Benz, CC; Yau, C; Zhang, W; Annala, M; Broom, BM; Casasent, TD; Ju, ZL; Liang, H; Liu, GY; Lu, YL; Unruh, AK; Wakefield, C; Weinstein, JN; Zhang, NX; Liu, YX; Broaddus, R; Akbani, R; Mills, GB; Adams, C; Barr, T; Black, AD; Bowen, J; Deardurff, J; Frick, J; Gastier-Foster, JM; Grossman, T; Harper, HA; Hart-Kothari, M; Helsel, C; Hobensack, A; Kuck, H; Kneile, K; Leraas, K; Lichtenberg, TM; McAllister, C; Pyatt, RE; Ramirez, NC; Tabler, TR; Vanhoose, N; White, P; Wise, L; Zmuda, E; Barnabas, N; Berry-Green, C; Blanc, V; Boice, L; Button, M; Farkas, A; Green, A; MacKenzie, J; Nicholson, D; Kalloger, SE; Gilks, CB; Karlan, BY; Lester, J; Orsulic, S; Borowsky, M; Cadungog, M; Czerwinski, C; Huelsenbeck-Dill, L; Iacocca, M; Petrelli, N; Petrelli, N; Witkin, G; Nemirovich-Danchenko, E; Potapova, O; Rotin, D; Berchuck, A; Birrer, M; DiSaia, P; Monovich, L; Curley, E; Gardner, J; Mallery, D; Penny, R; Dowdy, SC; Winterhoff, B; Dao, L; Gostout, B; Meuter, A; Teoman, A; Dao, F; Olvera, N; Bogomolniy, F; Garg, K; Soslow, RA; Levine, DA; Abramov, M; Bartlett, JMS; Kodeeswaran, S; Parfitt, J; Moiseenko, F; Clarke, BA; Goodman, MT; Carney, ME; Matsuno, RK; Fisher, J; Huang, M; Rathmell, WK; Thorne, L; Van Le, L; Dhir, R; Edwards, R; Elishaev, E; Zorn, K; Broaddus, R; Goodfellow, PJ; Mutch, D; Schultz, N; Liu, YX; Akbani, R; Cherniack, AD; Cerami, E; Weinhold, N; Shen, H; Hoadley, KA; Kahn, AB; Bell, DW; Pollock, PM; Wang, C; Wheeler, DA; Shinbrot, E; Karlan, BY; Berchuck, A; Dowdy, SC; Winterhoff, B; Goodman, MT; Robertson, AG; Beroukhim, R; Pashtan, I; Salvesen, HB; Laird, PW; Noble, M; Stuart, J; Ding, L; Kandoth, C; Gilks, CB; Soslow, RA; Goodfellow, PJ; Mutch, D; Broaddus, R; Zhang, W; Mills, GB; Kucherlapati, R; Mardis, ER; Levine, DA; Ayala, B; Chu, AL; Jensen, MA; Kothiyal, P; Pihl, TD; Pontius, J; Pot, DA; Snyder, EE; Srinivasan, D; Kahn, AB; Shaw, KRM; Sheth, M; Davidsen, T; Eley, G; Ferguson, ML; Demchok, JA; Yang, LM; Guyer, MS; Ozenberger, BA; Sofia, HJ; Kandoth, C; Schultz, N; Cherniack, AD; Akbani, R; Liu, YX; Shen, H; Robertson, AG; Pashtan, I; Shen, R; Benz, CC; Yau, C; Laird, PW; Ding, L; Zhang, W; Mills, GB; Kucherlapati, R; Mardis, ER; Levine, DA				Getz, Gad; Gabriel, Stacey B.; Cibulskis, Kristian; Lander, Eric; Sivachenko, Andrey; Sougnez, Carrie; Lawrence, Mike; Kandoth, Cyriac; Dooling, David; Fulton, Robert; Fulton, Lucinda; Kalicki-Veizer, Joelle; McLellan, Michael D.; O'Laughlin, Michelle; Schmidt, Heather; Wilson, Richard K.; Ye, Kai; Ding, Li; Mardis, Elaine R.; Ally, Adrian; Balasundaram, Miruna; Birol, Inanc; Butterfield, Yaron S. N.; Carlsen, Rebecca; Carter, Candace; Chu, Andy; Chuah, Eric; Chun, Hye-Jung E.; Dhalla, Noreen; Guin, Ranabir; Hirst, Carrie; Holt, Robert A.; Jones, Steven J. M.; Lee, Darlene; Li, Haiyan I.; Marra, Marco A.; Mayo, Michael; Moore, Richard A.; Mungall, Andrew J.; Plettner, Patrick; Schein, Jacqueline E.; Sipahimalani, Payal; Tam, Angela; Varhol, Richard J.; Robertson, A. Gordon; Pashtan, Itai; Saksena, Gordon; Onofrio, Robert C.; Schumacher, Steven E.; Tabak, Barbara; Carter, Scott L.; Hernandez, Bryan; Gentry, Jeff; Salvesen, Helga B.; Ardlie, Kristin; Getz, Gad; Winckler, Wendy; Beroukhim, Rameen; Gabriel, Stacey B.; Meyerson, Matthew; Hadjipanayis, Angela; Lee, Semin; Mahadeshwar, Harshad S.; Park, Peter; Protopopov, Alexei; Ren, Xiaojia; Seth, Sahil; Song, Xingzhi; Tang, Jiabin; Xi, Ruibin; Yang, Lixing; Zeng, Dong; Kucherlapati, Raju; Chin, Lynda; Zhang, Jianhua; Auman, J. Todd; Balu, Saianand; Bodenheimer, Tom; Buda, Elizabeth; Hayes, D. Neil; Hoyle, Alan P.; Jefferys, Stuart R.; Jones, Corbin D.; Meng, Shaowu; Mieczkowski, Piotr A.; Mose, Lisle E.; Parker, Joel S.; Perou, Charles M.; Roach, Jeff; Shi, Yan; Simons, Janae V.; Soloway, Mathew G.; Tan, Donghui; Topal, Michael D.; Waring, Scot; Wu, Junyuan; Hoadley, Katherine A.; Baylin, Stephen B.; Bootwalla, Moiz S.; Lai, Phillip H.; Triche, Timothy J., Jr.; Van Den Berg, DavidJ.; Weisenberger, Daniel J.; Laird, Peter W.; Shen, Hui; Chin, Lynda; Zhang, Jianhua; Getz, Gad; Cho, Juok; DiCara, Daniel; Frazer, Scott; Heiman, David; Jing, Rui; Lin, Pei; Mallard, Will; Stojanov, Petar; Voet, Doug; Zhang, Hailei; Zou, Lihua; Noble, Michael; Lawrence, Mike; Reynolds, Sheila M.; Shmulevich, Ilya; Aksoy, B. Arman; Antipin, Yevgeniy; Ciriello, Giovanni; Dresdner, Gideon; Gao, Jianjiong; Gross, Benjamin; Jacobsen, Anders; Ladanyi, Marc; Reva, Boris; Sander, Chris; Sinha, Rileen; Sumer, S. Onur; Taylor, Barry S.; Cerami, Ethan; Weinhold, Nils; Schultz, Nikolaus; Shen, Ronglai; Benz, Stephen; Goldstein, Ted; Haussler, David; Sam Ng; Szeto, Christopher; Stuart, Joshua; Benz, Christopher C.; Yau, Christina; Zhang, Wei; Annala, Matti; Broom, Bradley M.; Casasent, Tod D.; Ju, Zhenlin; Liang, Han; Liu, Guoyan; Lu, Yiling; Unruh, Anna K.; Wakefield, Chris; Weinstein, John N.; Zhang, Nianxiang; Liu, Yuexin; Broaddus, Russell; Akbani, Rehan; Mills, Gordon B.; Adams, Christopher; Barr, Thomas; Black, Aaron D.; Bowen, Jay; Deardurff, John; Frick, Jessica; Gastier-Foster, Julie M.; Grossman, Thomas; Harper, Hollie A.; Hart-Kothari, Melissa; Helsel, Carmen; Hobensack, Aaron; Kuck, Harkness; Kneile, Kelley; Leraas, KristenM.; Lichtenberg, Tara M.; McAllister, Cynthia; Pyatt, Robert E.; Ramirez, Nilsa C.; Tabler, Teresa R.; Vanhoose, Nathan; White, Peter; Wise, Lisa; Zmuda, Erik; Barnabas, Nandita; Berry-Green, Charlenia; Blanc, Victoria; Boice, Lori; Button, Michael; Farkas, Adam; Green, Alex; MacKenzie, Jean; Nicholson, Dana; Kalloger, Steve E.; Gilks, C. Blake; Karlan, Beth Y.; Lester, Jenny; Orsulic, Sandra; Borowsky, Mark; Cadungog, Mark; Czerwinski, Christine; Huelsenbeck-Dill, Lori; Iacocca, Mary; Petrelli, Nicholas; Petrelli, Nicholas; Witkin, Gary; Nemirovich-Danchenko, Elena; Potapova, Olga; Rotin, Daniil; Berchuck, Andrew; Birrer, Michael; DiSaia, Phillip; Monovich, Laura; Curley, Erin; Gardner, Johanna; Mallery, David; Penny, Robert; Dowdy, Sean C.; Winterhoff, Boris; Dao, Linda; Gostout, Bobbie; Meuter, Alexandra; Teoman, Attila; Dao, Fanny; Olvera, Narciso; Bogomolniy, Faina; Garg, Karuna; Soslow, Robert A.; Levine, Douglas A.; Abramov, Mikhail; Bartlett, John M. S.; Kodeeswaran, Sugy; Parfitt, Jeremy; Moiseenko, Fedor; Clarke, Blaise A.; Goodman, Marc T.; Carney, Michael E.; Matsuno, Rayna K.; Fisher, Jennifer; Huang, Mei; Rathmell, W. Kimryn; Thorne, Leigh; Van Le, Linda; Dhir, Rajiv; Edwards, Robert; Elishaev, Esther; Zorn, Kristin; Broaddus, Russell; Goodfellow, Paul J.; Mutch, David; Schultz, Nikolaus; Liu, Yuexin; Akbani, Rehan; Cherniack, Andrew D.; Cerami, Ethan; Weinhold, Nils; Shen, Hui; Hoadley, Katherine A.; Kahn, Ari B.; Bell, Daphne W.; Pollock, Pamela M.; Wang, Chen; Wheeler, David A.; Shinbrot, Eve; Karlan, Beth Y.; Berchuck, Andrew; Dowdy, Sean C.; Winterhoff, Boris; Goodman, Marc T.; Robertson, A. Gordon; Beroukhim, Rameen; Pashtan, Itai; Salvesen, Helga B.; Laird, Peter W.; Noble, Michael; Stuart, Joshua; Ding, Li; Kandoth, Cyriac; Gilks, C. Blake; Soslow, Robert A.; Goodfellow, Paul J.; Mutch, David; Broaddus, Russell; Zhang, Wei; Mills, Gordon B.; Kucherlapati, Raju; Mardis, Elaine R.; Levine, Douglas A.; Ayala, Brenda; Chu, Anna L.; Jensen, Mark A.; Kothiyal, Prachi; Pihl, Todd D.; Pontius, Joan; Pot, David A.; Snyder, Eric E.; Srinivasan, Deepak; Kahn, Ari B.; Shaw, Kenna R. Mills; Sheth, Margi; Davidsen, Tanja; Eley, Greg; Ferguson, Martin L.; Demchok, John A.; Yang, Liming; Guyer, Mark S.; Ozenberger, Bradley A.; Sofia, Heidi J.; Kandoth, Cyriac; Schultz, Nikolaus; Cherniack, Andrew D.; Akbani, Rehan; Liu, Yuexin; Shen, Hui; Robertson, A. Gordon; Pashtan, Itai; Shen, Ronglai; Benz, Christopher C.; Yau, Christina; Laird, Peter W.; Ding, Li; Zhang, Wei; Mills, Gordon B.; Kucherlapati, Raju; Mardis, Elaine R.; Levine, Douglas A.		Canc Genome Atlas Res Network	Integrated genomic characterization of endometrial carcinoma	NATURE			English	Article							MICROSATELLITE INSTABILITY; SOMATIC MUTATIONS; HIGH-FREQUENCY; LUNG-CANCER; PROTEIN; PIK3R1; TUMORS; GRADE; MODEL	We performed an integrated genomic, transcriptomic and proteomic characterization of 373 endometrial carcinomas using array- and sequencing-based technologies. Uterine seroustumours and similar to 25% of high-grade endometrioid tumours had extensive copy number alterations, few DNA methylation changes, low oestrogen receptor/progesterone receptor levels, and frequent TP53 mutations. Most endometrioid tumours had few copy number alterations or TP53 mutations, but frequent mutations in PTEN, CTNNB1, PIK3CA, ARID1A and KRAS and novel mutations in the SWI/SNF chromatin remodelling complex gene ARID5B. A subset of endometrioid tumours that we identified had a markedly increased transversion mutation frequency and newly identified hotspot mutations in POLE. Our results classified endometrial cancers into four categories: POLE ultramutated, microsatellite instability hypermutated, copy-number low, and copy-number high. Uterine serous carcinomas share genomic features with ovarian serous and basal-like breast carcinomas. We demonstrated that the genomic features of endometrial carcinomas permit a reclassification that may affect post-surgical adjuvant treatment for women with aggressive tumours.	[Getz, Gad; Gabriel, Stacey B.; Cibulskis, Kristian; Lander, Eric; Sivachenko, Andrey; Sougnez, Carrie; Lawrence, Mike; Pashtan, Itai; Saksena, Gordon; Onofrio, Robert C.; Schumacher, Steven E.; Tabak, Barbara; Carter, Scott L.; Hernandez, Bryan; Gentry, Jeff; Salvesen, Helga B.; Ardlie, Kristin; Winckler, Wendy; Beroukhim, Rameen; Meyerson, Matthew; Chin, Lynda; Cho, Juok; DiCara, Daniel; Frazer, Scott; Heiman, David; Jing, Rui; Lin, Pei; Mallard, Will; Stojanov, Petar; Voet, Doug; Zhang, Hailei; Zou, Lihua; Noble, Michael; Cherniack, Andrew D.] MIT, Eli & Edythe L Broad Inst, Cambridge, MA 02139 USA; [Kandoth, Cyriac; Dooling, David; Fulton, Robert; Fulton, Lucinda; Kalicki-Veizer, Joelle; McLellan, Michael D.; O'Laughlin, Michelle; Schmidt, Heather; Wilson, Richard K.; Ye, Kai; Ding, Li; Mardis, Elaine R.] Washington Univ, Genome Inst, St Louis, MO 63108 USA; [Mardis, Elaine R.; Ally, Adrian; Balasundaram, Miruna; Birol, Inanc; Butterfield, Yaron S. N.; Carlsen, Rebecca; Carter, Candace; Chu, Andy; Chuah, Eric; Chun, Hye-Jung E.; Dhalla, Noreen; Guin, Ranabir; Hirst, Carrie; Holt, Robert A.; Jones, Steven J. M.; Lee, Darlene; Li, Haiyan I.; Marra, Marco A.; Mayo, Michael; Moore, Richard A.; Mungall, Andrew J.; Plettner, Patrick; Schein, Jacqueline E.; Sipahimalani, Payal; Tam, Angela; Varhol, Richard J.; Robertson, A. Gordon] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02215 USA; Haukeland Hosp, Dept Obstet & Gynecol, N-5021 Bergen, Norway; Univ Bergen, Dept Clin Med, N-5020 Bergen, Norway; [Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Hadjipanayis, Angela; Ren, Xiaojia; Kucherlapati, Raju] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Lee, Semin; Park, Peter; Xi, Ruibin; Yang, Lixing] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Mahadeshwar, Harshad S.; Protopopov, Alexei; Seth, Sahil; Song, Xingzhi; Tang, Jiabin; Zeng, Dong; Zhang, Jianhua] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Inst Appl Canc Sci, Houston, TX 77054 USA; [Park, Peter] Boston Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Auman, J. Todd] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA; [Auman, J. Todd] Univ N Carolina, Inst Pharmacogenet & Individualized Therapy, Chapel Hill, NC 27599 USA; [Balu, Saianand; Bodenheimer, Tom; Buda, Elizabeth; Hayes, D. Neil; Hoyle, Alan P.; Jefferys, Stuart R.; Meng, Shaowu; Mose, Lisle E.; Parker, Joel S.; Perou, Charles M.; Shi, Yan; Simons, Janae V.; Soloway, Mathew G.; Tan, Donghui; Topal, Michael D.; Waring, Scot; Wu, Junyuan; Rathmell, W. Kimryn] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Hayes, D. Neil] Univ N Carolina, Div Med Oncol, Dept Internal Med, Chapel Hill, NC 27599 USA; [Jones, Corbin D.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Mieczkowski, Piotr A.; Perou, Charles M.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Perou, Charles M.; Topal, Michael D.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Roach, Jeff] Univ N Carolina, Res Comp Ctr, Chapel Hill, NC 27599 USA; [Baylin, Stephen B.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Canc Biol Div, Baltimore, MD 21231 USA; [Bootwalla, Moiz S.; Lai, Phillip H.; Triche, Timothy J., Jr.; Van Den Berg, DavidJ.; Weisenberger, Daniel J.; Laird, Peter W.; Shen, Hui] Univ So Calif, Epigenome Ctr, Los Angeles, CA 90089 USA; [Reynolds, Sheila M.; Shmulevich, Ilya] Inst Syst Biol, Seattle, WA 98109 USA; [Aksoy, B. Arman; Antipin, Yevgeniy; Ciriello, Giovanni; Dresdner, Gideon; Gao, Jianjiong; Gross, Benjamin; Jacobsen, Anders; Reva, Boris; Sander, Chris; Sinha, Rileen; Sumer, S. Onur; Cerami, Ethan; Weinhold, Nils; Schultz, Nikolaus] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Ladanyi, Marc] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Taylor, Barry S.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94158 USA; [Shen, Ronglai] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Benz, Stephen; Goldstein, Ted; Haussler, David; Sam Ng; Szeto, Christopher; Stuart, Joshua] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Benz, Stephen; Goldstein, Ted; Sam Ng; Szeto, Christopher; Stuart, Joshua] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Benz, Christopher C.; Yau, Christina] Buck Inst Age Res, Novato, CA 94945 USA; [Zhang, Wei; Annala, Matti; Liu, Guoyan; Liu, Yuexin] Univ Texas MD Anderson Canc Ctr, Canc Genom Core Lab, Houston, TX 77054 USA; [Liu, Guoyan; Liu, Yuexin; Broaddus, Russell] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; Tampere Univ Technol, FI-33720 Tampere, Finland; [Bootwalla, Moiz S.; Van Den Berg, DavidJ.; Weisenberger, Daniel J.; Broom, Bradley M.; Ju, Zhenlin; Liang, Han; Unruh, Anna K.; Wakefield, Chris; Akbani, Rehan] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Lu, Yiling; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Adams, Christopher; Barr, Thomas; Black, Aaron D.; Bowen, Jay; Deardurff, John; Frick, Jessica; Gastier-Foster, Julie M.; Grossman, Thomas; Harper, Hollie A.; Hart-Kothari, Melissa; Helsel, Carmen; Hobensack, Aaron; Kuck, Harkness; Kneile, Kelley; Leraas, KristenM.; Lichtenberg, Tara M.; McAllister, Cynthia; Pyatt, Robert E.; Ramirez, Nilsa C.; Tabler, Teresa R.; Vanhoose, Nathan; White, Peter; Wise, Lisa; Zmuda, Erik] Nationwide Childrens Hosp, Res Inst, Columbus, OH 43205 USA; [Gastier-Foster, Julie M.; Ramirez, Nilsa C.; Goodfellow, Paul J.] Ohio State Univ, Columbus, OH 43210 USA; [Barnabas, Nandita; Berry-Green, Charlenia; Blanc, Victoria; Button, Michael; Farkas, Adam; Green, Alex; MacKenzie, Jean; Nicholson, Dana] Asterand, Detroit, MI 48202 USA; [Boice, Lori; Fisher, Jennifer; Huang, Mei; Thorne, Leigh; Van Le, Linda] Univ N Carolina, Chapel Hill, NC 27599 USA; [Kalloger, Steve E.; Gilks, C. Blake] British Columbia Canc Agcy, OvCaRe British Columbia, Vancouver, BC V5Z 4E6, Canada; [Kalloger, Steve E.; Gilks, C. Blake] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Karlan, Beth Y.; Lester, Jenny; Orsulic, Sandra] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Womens Canc Program, Los Angeles, CA 90048 USA; [Borowsky, Mark; Cadungog, Mark; Czerwinski, Christine; Huelsenbeck-Dill, Lori; Iacocca, Mary; Petrelli, Nicholas; Witkin, Gary] Helen F Graham Canc Ctr Christiana Care, Newark, DC 19713 USA; [Nemirovich-Danchenko, Elena; Potapova, Olga; Rotin, Daniil] Cureline Inc, San Francisco, CA 94080 USA; [Berchuck, Andrew] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC 27710 USA; [Birrer, Michael] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [DiSaia, Phillip] Univ Calif Irvine, Med Ctr, Orange, CA 92868 USA; [Monovich, Laura] Nationwide Childrens Hosp, Res Inst, GOG Tissue Bank, Columbus, OH 43205 USA; [Curley, Erin; Gardner, Johanna; Mallery, David; Penny, Robert] Int Genom Consortium, Phoenix, AZ 85004 USA; [Dowdy, Sean C.; Winterhoff, Boris; Gostout, Bobbie; Meuter, Alexandra; Teoman, Attila] Mayo Clin, Div Gynecol Oncol, Dept OB Gyn, Rochester, MN 55905 USA; [Dao, Linda] Mayo Clin, Dept Pathol, Rochester, MN 55905 USA; [Dao, Fanny; Olvera, Narciso; Bogomolniy, Faina; Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10065 USA; [Garg, Karuna; Soslow, Robert A.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Abramov, Mikhail] NN Blokhin Russian Canc Res Ctr RAMS, Moscow 115478, Russia; [Bartlett, John M. S.; Kodeeswaran, Sugy] Ontario Inst Canc Res, Ontario Tumour Bank, Toronto, ON M5G 0A3, Canada; [Parfitt, Jeremy] London Hlth Sci Ctr, Ontario Tumour Bank, London, ON N6A 5A5, Canada; [Moiseenko, Fedor] St Petersburg Acad Univ, St Petersburg 199034, Russia; [Clarke, Blaise A.; Demchok, John A.; Yang, Liming] Univ Hlth Network, Dept Pathol, Toronto, ON M5G 2C4, Canada; [Goodman, Marc T.; Carney, Michael E.; Matsuno, Rayna K.; Eley, Greg] Univ Hawaii, Honolulu, HI 96813 USA; [Goodman, Marc T.] Cedars Sinai Med Ctr, Los Angeles, CA 90024 USA; [Dhir, Rajiv; Edwards, Robert; Elishaev, Esther; Zorn, Kristin] Univ Pittsburgh, Pittsburgh, PA 15213 USA; [Goodfellow, Paul J.; Mutch, David] Washington Univ, Sch Med, St Louis, MO 63110 USA; [Kahn, Ari B.; Ayala, Brenda; Chu, Anna L.; Jensen, Mark A.; Kothiyal, Prachi; Pihl, Todd D.; Pontius, Joan; Pot, David A.; Snyder, Eric E.; Srinivasan, Deepak] SRA Int, Fairfax, VA 22033 USA; [Bell, Daphne W.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Pollock, Pamela M.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia; [Wang, Chen] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN 55905 USA; [Wheeler, David A.; Shinbrot, Eve] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Shaw, Kenna R. Mills; Sheth, Margi; Davidsen, Tanja] NCI, Canc Genome Atlas Program Off, NIH, Bethesda, MD 20892 USA; Scimentis LLC, Atlanta, GA 30666 USA; [Ferguson, Martin L.] MLF Consulting, Arlington, MD 02474 USA; [Guyer, Mark S.; Ozenberger, Bradley A.; Sofia, Heidi J.] NHGRI, NIH, Bethesda, MD 20892 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Washington University (WUSTL); British Columbia Cancer Agency; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; University of Bergen; Haukeland University Hospital; University of Bergen; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Boston Children's Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins Medicine; University of Southern California; Institute for Systems Biology (ISB); Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Buck Institute for Research on Aging; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Tampere University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; British Columbia Cancer Agency; University of British Columbia; Cedars Sinai Medical Center; Christiana Care Health System; Helen F. Graham Cancer Center & Research Institute; Duke University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of California System; University of California Irvine; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; International Genomics Consortium; Mayo Clinic; Mayo Clinic; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; N.N. Blokhin Russian Cancer Research Center; Russian Academy of Medical Sciences; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; London Health Sciences Centre; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; St Petersburg Academic University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Hawaii System; Cedars Sinai Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL); SRA International; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Queensland University of Technology (QUT); Mayo Clinic; Baylor College of Medicine; International Genomics Consortium; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Getz, G (corresponding author), MIT, Eli & Edythe L Broad Inst, Cambridge, MA 02139 USA.		Wang, Chen/B-3244-2011; Gao, JianJiong/B-5673-2016; Ye, Kai/GSD-9856-2022; Moiseenko, Fedor/E-1775-2014; Schumacher, Steven/E-9821-2013; White, Peter/E-4301-2011; Auman, James/AAY-7748-2020; Akbani, Rehan/AAG-1490-2019; Cibulskis, Kristian/AAC-7380-2019; Shinbrot, Eve/V-2784-2019; Perou, Charles M/H-9934-2014; Jones, Steven J/C-3621-2009; Birol, Inanc/G-5440-2011; Ladanyi, Marc/AAG-8585-2019; Schein, Jacquie E/G-3674-2015; Wilson, Richard K./AAF-4139-2019; Holt, Robert A/C-3303-2009; Schultz, Nikolaus/ABE-6347-2020; Kucherlapati, Raju/ABC-8807-2021; Mardis, Elaine/W-2202-2019; Cherniack, Andrew/AAC-5310-2019; Reva, Boris A./B-6436-2014; Van Den Berg, David J/G-8598-2017; Seth, Sahil/I-5809-2019; Wheeler, David A/M-9740-2018; Skanderup, Anders Jacobsen/K-1081-2013; Stojanov, Petar/GQI-4462-2022; Laird, Peter W/G-8683-2012; Cherniack, Andrew D./AAY-8132-2020; Mungall, Andrew J./U-7067-2018; , Pathology Services Core/CEZ-2246-2022; Lee, Semin/S-2629-2016; Reva, Boris/AAB-8932-2022; Shen, Hui/AAO-4387-2020; Marra, Marco A/B-5987-2008; Ye, Kai/B-3640-2012; Parker, Joel/AAG-1108-2019; Weisenberger, Daniel/AAA-8314-2020; salvesen, Helga B/C-1187-2017; wang, chen/GWM-9481-2022	Wang, Chen/0000-0003-2638-3081; Gao, JianJiong/0000-0002-5739-1781; Ye, Kai/0000-0002-2851-6741; Moiseenko, Fedor/0000-0003-2544-9042; Schumacher, Steven/0000-0002-6819-5647; White, Peter/0000-0002-5218-5903; Shinbrot, Eve/0000-0002-8879-3150; Perou, Charles M/0000-0001-9827-2247; Jones, Steven J/0000-0003-3394-2208; Birol, Inanc/0000-0003-0950-7839; Wilson, Richard K./0000-0002-1992-1358; Holt, Robert A/0000-0002-7259-1247; Reva, Boris A./0000-0002-8805-389X; Van Den Berg, David J/0000-0002-5404-5218; Seth, Sahil/0000-0003-4579-3959; Wheeler, David A/0000-0002-9056-6299; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Stojanov, Petar/0000-0001-7815-776X; Laird, Peter W/0000-0001-9117-3641; Cherniack, Andrew D./0000-0003-0470-0111; Mungall, Andrew J./0000-0002-0905-2742; Lee, Semin/0000-0002-9015-6046; Marra, Marco A/0000-0001-7146-7175; Weisenberger, Daniel/0000-0001-8303-2603; salvesen, Helga B/0000-0002-4438-8831; Cibulskis, Kristian/0000-0003-1343-1582; Schultz, Nikolaus/0000-0002-0131-4904; Meyerson, Matthew/0000-0002-9133-8108; Sinha, Rileen/0000-0001-5497-5055; Kandoth, Cyriac/0000-0002-1345-3573; Liang, Han/0000-0001-7633-286X; Soslow, Robert/0000-0002-7269-5898; Pollock, Pamela/0000-0001-8420-1026; Ciriello, Giovanni/0000-0003-2021-8683; Clarke, Blaise/0000-0002-2585-8391; MCLELLAN, MICHAEL/0000-0002-2703-8784; Bowen, Jay/0000-0001-6861-9043; Benz, Stephen/0000-0002-4067-0602; Triche, Tim/0000-0001-5665-946X; Goodman, Marc/0000-0002-4839-3021; Zorn, Kristin/0000-0003-2143-8979; Levine, Douglas/0000-0003-1038-8232; Auman, James/0000-0002-9328-8829; Stuart, Joshua/0000-0002-2171-565X; Xi, Ruibin/0000-0001-7545-7361; Heiman, David/0000-0001-7895-4259; Bootwalla, Moiz/0000-0001-6158-7114; Jensen, Mark/0000-0001-5215-101X; Hoadley, Katherine/0000-0002-1216-477X; Shen, Hui/0000-0001-9767-4084; Rotin, Daniil/0000-0003-3386-0077; Mieczkowski, Piotr/0000-0003-2418-0096; Casasent, Anna/0000-0002-7857-179X; Pot, David/0000-0002-1480-9826; Weinstein, John/0000-0001-9401-6908	US National Institutes of Health [5U24CA143799-04, 5U24CA143835-04, 5U24CA143840-04, 5U24CA143843-04, 5U24CA143845-04, 5U24CA143848-04, 5U24CA143858-04, 5U24CA143866-04, 5U24CA143867-04, 5U24CA143882-04, 5U24CA143883-04, 5U24CA144025-04, U54HG003067-11, U54HG003079-10, U54HG003273-10]; NATIONAL CANCER INSTITUTE [U24CA143866, P30CA016056, U24CA143882, U24CA143845, P30CA008748, U24CA144025, P30CA016086, U24CA143858, R01CA180006, U24CA143843, U24CA143867, U24CA143840, P50CA098258, U24CA143848, U24CA143883, U24CA143835, P30CA016672, U24CA143799] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, U54HG003067, ZIAHG200338, U54HG003079] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We wish to thank all patients and families who contributed to this study. We thank M. Sheth and L. Lund for administrative coordination of TCGA activities, G. Monemvasitis for editing the manuscript, and C. Gunter for critical reading of the manuscript. This work was supported by the following grants from the US National Institutes of Health: 5U24CA143799-04, 5U24CA143835-04, 5U24CA143840-04, 5U24CA143843-04, 5U24CA143845-04, 5U24CA143848-04, 5U24CA143858-04, 5U24CA143866-04, 5U24CA143867-04, 5U24CA143882-04, 5U24CA143883-04, 5U24CA144025-04, U54HG003067-11, U54HG003079-10 and U54HG003273-10.	Bartosch C, 2011, ADV ANAT PATHOL, V18, P415, DOI 10.1097/PAP.0b013e318234ab18; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Byron SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030801; Cheung LWT, 2011, CANCER DISCOV, V1, P170, DOI 10.1158/2159-8290.CD-11-0039; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Clarke BA, 2010, J CLIN PATHOL, V63, P410, DOI 10.1136/jcp.2009.071225; Cowin PA, 2012, CANCER RES, V72, P4060, DOI 10.1158/0008-5472.CAN-12-0203; Fleming GF, 2004, J CLIN ONCOL, V22, P2159, DOI 10.1200/JCO.2004.07.184; Fleming GF, 2010, GYNECOL ONCOL, V116, P15, DOI 10.1016/j.ygyno.2009.09.025; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Gilks C.B., 2012, AM J SURG PATHOL, V91, p248A; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Houseman EA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-365; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuhn E, 2012, JNCI-J NATL CANCER I, V104, P1503, DOI 10.1093/jnci/djs345; Lax S F, 1997, Verh Dtsch Ges Pathol, V81, P228; Le Gallo M, 2012, NAT GENET, V44, P1310, DOI 10.1038/ng.2455; Levine RL, 1998, CANCER RES, V58, P3254; Li JN, 2005, GASTROENTEROLOGY, V128, P1907, DOI 10.1053/j.gastro.2005.02.067; McConechy MK, 2012, J PATHOL, V228, P20, DOI 10.1002/path.4056; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.1210529; Salvesen HB, 2009, P NATL ACAD SCI USA, V106, P4834, DOI 10.1073/pnas.0806514106; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Sutton G, 2005, GYNECOL ONCOL, V97, P755, DOI 10.1016/j.ygyno.2005.03.011; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Urick ME, 2011, CANCER RES, V71, P4061, DOI 10.1158/0008-5472.CAN-11-0549; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Yemelyanova A, 2009, AM J SURG PATHOL, V33, P1504, DOI 10.1097/PAS.0b013e3181ac35f5; Zighelboim I, 2007, J CLIN ONCOL, V25, P2042, DOI 10.1200/JCO.2006.08.2107; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	40	2800	2861	19	344	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 2	2013	497	7447					67	73		10.1038/nature12113	http://dx.doi.org/10.1038/nature12113			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	134OK	23636398	Green Submitted, hybrid, Green Published, Green Accepted			2022-12-28	WOS:000318221500035
J	Svanstrom, H; Pasternak, B; Hviid, A				Svanstrom, Henrik; Pasternak, Bjorn; Hviid, Anders			Use of Azithromycin and Death from Cardiovascular Causes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RISK; SAFETY; PROLONGATION; ANTIBIOTICS; POINTES	BACKGROUND Azithromycin use is associated with an increased risk of death from cardiovascular causes among patients at high baseline risk. Whether azithromycin confers a similar risk in the unselected general population is unknown. METHODS We conducted a nationwide historical cohort study involving Danish adults (18 to 64 years of age), linking registry data on filled prescriptions, causes of death, and patient characteristics for the period from 1997 through 2010. We estimated rate ratios for death from cardiovascular causes, comparing 1,102,050 episodes of azithromycin use with no use of antibiotic agents (matched in a 1: 1 ratio according to propensity score, for a total of 2,204,100 episodes) and comparing 1,102,419 episodes of azithromycin use with 7,364,292 episodes of penicillin V use (an antibiotic with similar indications; analysis was conducted with adjustment for propensity score). RESULTS The risk of death from cardiovascular causes was significantly increased with current use of azithromycin (defined as a 5-day treatment episode), as compared with no use of antibiotics (rate ratio, 2.85; 95% confidence interval [CI], 1.13 to 7.24). The analysis relative to an antibiotic comparator included 17 deaths from cardiovascular causes during current azithromycin use (crude rate, 1.1 per 1000 person-years) and 146 during current penicillin V use (crude rate, 1.5 per 1000 person-years). With adjustment for propensity scores, current azithromycin use was not associated with an increased risk of cardiovascular death, as compared with penicillin V (rate ratio, 0.93; 95% CI, 0.56 to 1.55). The adjusted absolute risk difference for current use of azithromycin, as compared with penicillin V, was -1 cardiovascular death (95% CI, -9 to 11) per 1 million treatment episodes. CONCLUSIONS Azithromycin use was not associated with an increased risk of death from cardiovascular causes in a general population of young and middle-aged adults. (Funded by the Danish Medical Research Council.)	[Svanstrom, Henrik; Pasternak, Bjorn; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark	Statens Serum Institut	Svanstrom, H (corresponding author), Statens Serum Inst, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	htr@ssi.dk	Hviid, Anders/AAH-4319-2020; Pasternak, Bjorn/H-5739-2012	Hviid, Anders/0000-0002-7509-9127; Pasternak, Bjorn/0000-0002-2097-8466	Danish Medical Research Council	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by grants from the Danish Medical Research Council.	Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; HOPKINS S, 1991, AM J MED, V91, pS40, DOI 10.1016/0002-9343(91)90401-I; Ioannidis JPA, 2001, J ANTIMICROB CHEMOTH, V48, P677, DOI 10.1093/jac/48.5.677; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Louie R, 2012, NEW ENGL J MED, V367, P774, DOI 10.1056/NEJMc1207269; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Milberg P, 2002, J PHARMACOL EXP THER, V303, P218, DOI 10.1124/jpet.102.037911; Owens RC, 2006, CLIN INFECT DIS, V43, P1603, DOI 10.1086/508873; Parson LS, 2001, P 26 ANN SAS US GROU; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Ray WA, 2004, NEW ENGL J MED, V351, P1089, DOI 10.1056/NEJMoa040582; Schneeweiss S, 2010, PHARMACOEPIDEM DR S, V19, P858, DOI 10.1002/pds.1926; Shaffer D, 2002, CLIN INFECT DIS, V35, P197, DOI 10.1086/340861; Straus SMJM, 2005, EUR HEART J, V26, P2007, DOI 10.1093/eurheartj/ehi312; Sturmer T, 2011, EPIDEMIOLOGY, V22, P298, DOI 10.1097/EDE.0b013e318212640c	17	176	190	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 2	2013	368	18					1704	1712		10.1056/NEJMoa1300799	http://dx.doi.org/10.1056/NEJMoa1300799			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	134MN	23635050				2022-12-28	WOS:000318214400004
J	Windsor, R; Petchey, W				Windsor, Richard; Petchey, Will			Metabolic alkalosis in a patient with dyspnoea	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Windsor, Richard] Queen Elizabeth Hosp, Kings Lynn PE30 4ET, England; [Petchey, Will] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England	Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital	Windsor, R (corresponding author), Queen Elizabeth Hosp, Kings Lynn PE30 4ET, England.	Richard.windsor@doctors.org.uk						Budweiser S, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-92; Faisy C, 2010, INTENS CARE MED, V36, P859, DOI 10.1007/s00134-010-1795-7; Floege J, 2010, COMPREHENSIVE CLIN N, P167; Khanna A, 2001, Respir Care, V46, P354; Okada H, 1999, NEPHROL DIAL TRANSPL, V14, P452, DOI 10.1093/ndt/14.2.452; Palmer BF, 1997, J AM SOC NEPHROL, V8, P1462; Palmer BF, 2011, SEMIN NEPHROL, V31, P542, DOI 10.1016/j.semnephrol.2011.09.009; SCHWARTZ WB, 1968, NEW ENGL J MED, V279, P630, DOI 10.1056/NEJM196809192791204	8	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 2	2013	346								f2710	10.1136/bmj.f2710	http://dx.doi.org/10.1136/bmj.f2710			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139ET	23641034				2022-12-28	WOS:000318565300003
J	Bhumbra, R; Aston, W; Pollock, R				Bhumbra, Rej; Aston, William; Pollock, Rob			"It's just a muscle sprain"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EARLIER DIAGNOSIS; BONE		[Bhumbra, Rej; Aston, William; Pollock, Rob] Royal Natl Orthopaed Hosp, London Sarcoma Serv, Stanmore HA7 4LP, Middx, England	University of London; University College London; Royal National Orthopaedic Hospital NHS Trust	Bhumbra, R (corresponding author), Royal Natl Orthopaed Hosp, London Sarcoma Serv, Stanmore HA7 4LP, Middx, England.	bhumbra@hotmail.com						Grimer RJ, 2010, J BONE JOINT SURG BR, V92B, P1489, DOI 10.1302/0301-620X.92B11.24326; Mazrani W, 2007, ARCH DIS CHILD, V92, P1127, DOI 10.1136/adc.2006.101782; National Cancer Institute, SEER STAT FACT SHEET; National Institute for Health Care and Excellence, 2006, IMPR OUTC PEOPL SARC; Smith GM, 2011, ANN ROY COLL SURG, V93, P542, DOI 10.1308/147870811X13137608455055; Widhe B, 2000, J BONE JOINT SURG AM, V82A, P667, DOI 10.2106/00004623-200005000-00007	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2013	346								f2503	10.1136/bmj.f2503	http://dx.doi.org/10.1136/bmj.f2503			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139DR	23633041				2022-12-28	WOS:000318562300003
J	Ellis, C				Ellis, Chris			HIV in Africa demands complex cultural responses	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												cristobalellis@gmail.com							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 29	2013	346								f2517	10.1136/bmj.f2517	http://dx.doi.org/10.1136/bmj.f2517			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139DK	23628874				2022-12-28	WOS:000318561600002
J	Eastell, R; Walsh, JS				Eastell, Richard; Walsh, Jennifer S.			Is it time to combine osteoporosis therapies?	LANCET			English	Editorial Material							BONE TURNOVER MARKERS; POSTMENOPAUSAL OSTEOPOROSIS; PARATHYROID-HORMONE; MINERAL DENSITY; ALENDRONATE; WOMEN; TERIPARATIDE; DENOSUMAB		[Eastell, Richard; Walsh, Jennifer S.] No Gen Hosp, Metab Bone Ctr, Acad Unit Bone Metab, Sheffield S5 7AU, S Yorkshire, England; [Eastell, Richard; Walsh, Jennifer S.] Univ Sheffield, Mellanby Ctr Bone Res, Sheffield, S Yorkshire, England	Northern General Hospital; University of Sheffield; University of Sheffield	Eastell, R (corresponding author), No Gen Hosp, Metab Bone Ctr, Acad Unit Bone Metab, Sheffield S5 7AU, S Yorkshire, England.	r.eastell@sheffield.ac.uk	Eastell, Richard/G-5851-2011	Eastell, Richard/0000-0002-0323-3366; Walsh, Jennifer/0000-0002-7122-2650				Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975; Cosman F, 2011, J BONE MINER RES, V26, P503, DOI 10.1002/jbmr.238; Delmas PD, 2009, J BONE MINER RES, V24, P1544, DOI [10.1359/JBMR.090310, 10.1359/jbmr.090310]; Eastell R, 2011, J BONE MINER RES, V26, P530, DOI 10.1002/jbmr.251; Finkelstein JS, 2006, J CLIN ENDOCR METAB, V91, P2882, DOI 10.1210/jc.2006-0190; Finkelstein JS, 2010, J CLIN ENDOCR METAB, V95, P1838, DOI 10.1210/jc.2009-1703; Martin TJ, 2006, ANN NY ACAD SCI, V1068, P458, DOI 10.1196/annals.1346.043; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Obermayer-Pietsch BM, 2008, J BONE MINER RES, V23, P1591, DOI 10.1359/JBMR.080506; Pierroz DD, 2010, J BIOL CHEM, V285, P28164, DOI 10.1074/jbc.M110.101964; Saag K, 2007, BONE, V40, P1238, DOI 10.1016/j.bone.2007.01.016; Tsai JN, 2013, LANCET	12	6	6	2	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 6	2013	382	9886					5	7		10.1016/S0140-6736(13)60984-8	http://dx.doi.org/10.1016/S0140-6736(13)60984-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	177AD	23683601	Green Published			2022-12-28	WOS:000321347000006
J	Staal, JB; Nelemans, PJ; de Bie, RA				Staal, J. Bart; Nelemans, Patty J.; de Bie, Rob A.			Spinal Injection Therapy for Low Back Pain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MANAGEMENT		[Staal, J. Bart] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare, NL-6500 HB Nijmegen, Netherlands; [Nelemans, Patty J.; de Bie, Rob A.] Univ Limburg, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands; [Nelemans, Patty J.; de Bie, Rob A.] Caphri Res Sch, Maastricht, Netherlands	Radboud University Nijmegen; Hasselt University; Maastricht University	Staal, JB (corresponding author), Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare IQ Healthcare, POB 9101,114 IQ Healthcare, NL-6500 HB Nijmegen, Netherlands.	b.staal@iq.umcn.nl	Staal, J. Bart/A-9632-2014; Staal, Bart/ABA-4313-2020	Staal, J. Bart/0000-0002-0083-6380; Staal, Bart/0000-0002-0083-6380				Abbott ZI, 2012, SPINE J, V12, P35, DOI 10.1016/j.spinee.2011.10.005; Dagenais S, 2010, SPINE J, V10, P514, DOI 10.1016/j.spinee.2010.03.032; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; Pinto RZ, 2012, ANN INTERN MED, V157, P865, DOI 10.7326/0003-4819-157-12-201212180-00564; Staal JB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001824.pub3; Wilson LE, 2012, JAMA-J AM MED ASSOC, V308, P2461, DOI 10.1001/jama.2012.47932	7	13	13	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 19	2013	309	23					2439	2440		10.1001/jama.2013.5892	http://dx.doi.org/10.1001/jama.2013.5892			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	165SW	23681274				2022-12-28	WOS:000320505100020
J	Kirkwood, B; Bahl, R				Kirkwood, Betty; Bahl, Rajiv			Can women's groups reduce maternal and newborn deaths?	LANCET			English	Editorial Material									[Kirkwood, Betty] Univ London London Sch Hyg & Trop Med, Dept Populat Hlth, Maternal & Child Hlth Intervent Res Grp, London WC1E 7HT, England; [Bahl, Rajiv] WHO, Dept Maternal Newborn Child & Adolescent Hlth, CH-1211 Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Kirkwood, B (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Populat Hlth, Maternal & Child Hlth Intervent Res Grp, Keppel St, London WC1E 7HT, England.	betty.kirkwood@lshtm.ac.uk		Kirkwood, Betty/0000-0001-5274-6072				Kirkwood BR, 2003, ESSENTIAL MED STAT; Lewycka S, 2013, LANCET, V381, P1721, DOI 10.1016/S0140-6736(12)61959-X; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; UNICEF, 2012, COUNTD 2015 MAT NEWB	4	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAY 18	2013	381	9879					E12	E14		10.1016/S0140-6736(13)60985-X	http://dx.doi.org/10.1016/S0140-6736(13)60985-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146TA	23683647				2022-12-28	WOS:000319112800001
J	Ferner, R				Ferner, Robin			DRUG TALES AND OTHER STORIES Piquancy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TOPICAL CAPSAICIN; RECEPTOR		Birmingham City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England		Ferner, R (corresponding author), Birmingham City Hosp, West Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England.	R.E.Ferner@bham.ac.uk		Ferner, Robin/0000-0003-3769-1346				Anand P, 2011, BRIT J ANAESTH, V107, P490, DOI 10.1093/bja/aer260; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Derry S, 2009, COCHRANE DB SYST REV, V4; Derry S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007393.pub3; DIB B, 1990, PHARMACOL BIOCHEM BE, V37, P649, DOI 10.1016/0091-3057(90)90541-O; Karai L, 2004, J CLIN INVEST, V113, P1344, DOI 10.1172/JCI200420449; Lefebvre T, 2006, REV HIST PHARM, V350, P288; Mason L, 2004, BMJ-BRIT MED J, V328, P991, DOI 10.1136/bmj.38042.506748.EE; O'Neill J, 2012, PHARMACOL REV, V64, P939, DOI 10.1124/pr.112.006163	9	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2013	346								f2938	10.1136/bmj.f2938	http://dx.doi.org/10.1136/bmj.f2938			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	148OF	23674333				2022-12-28	WOS:000319253900008
J	Young, K				Young, Kelly			PERSONAL VIEW Doctors' understanding of rheumatoid disease does not align with patients' experiences	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Rheumatoid Patient Fdn, Cocoa, FL 32923 USA		Young, K (corresponding author), Rheumatoid Patient Fdn, POB 235251, Cocoa, FL 32923 USA.	kelly@rheum4us.org						Calleja M., 2011, RHEUMATOID ARTHRITIS; Rheumatoid Patient Foundation, 2013, BEL PAT VOIC; Rheumatoid Patient Foundation, 2013, UNM RHEUM DIS PAT EX; Singh JA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007848.pub2; Strand V, 2010, AM COLL RHEUM ASS RH; Wolfe F., 2011, AM I DOING ARE WE DO; Young K., 2010, UNWILLING E PATIENT; Young K., 2012, 10 FUNDAMENTALS CARE; Young K., 2012, J PARTICIPATORY MED, V4; Young K., 2009, WHAT IS 1 SYMPTOM RH; Young K., 2012, SUSTAINED RHEUMATOID; Young K., 2011, DOES IT MATTER WHETH	12	5	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2013	346								f2901	10.1136/bmj.f2901	http://dx.doi.org/10.1136/bmj.f2901			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	148OF	23674140	Bronze			2022-12-28	WOS:000319253900006
J	Jiang, L; Zhang, J; Wang, JJ; Wang, L; Zhang, L; Li, GQ; Yang, XD; Ma, X; Sun, X; Cai, J; Zhang, J; Huang, XX; Yu, M; Wang, XG; Liu, F; Wu, CI; He, C; Zhang, B; Ci, WM; Liu, J				Jiang, Lan; Zhang, Jing; Wang, Jing-Jing; Wang, Lu; Zhang, Li; Li, Guoqiang; Yang, Xiaodan; Ma, Xin; Sun, Xin; Cai, Jun; Zhang, Jun; Huang, Xingxu; Yu, Miao; Wang, Xuegeng; Liu, Feng; Wu, Chung-I; He, Chuan; Zhang, Bo; Ci, Weimin; Liu, Jiang			Sperm, but Not Oocyte, DNA Methylome Is Inherited by Zebrafish Early Embryos	CELL			English	Article							TRANSGENERATIONAL EPIGENETIC INHERITANCE; GENOMIC METHYLATION; 5-HYDROXYMETHYLCYTOSINE; DEMETHYLATION; EXPRESSION	5-methylcytosine is a major epigenetic modification that is sometimes called "the fifth nucleotide.'' However, our knowledge of how offspring inherit the DNA methylonne from parents is limited. We generated nine single-base resolution DNA methylomes, including zebrafish gametes and early embryos. The oocyte methylome is significantly hypomethylated compared to sperm. Strikingly, the paternal DNA methylation pattern is maintained throughout early embryogenesis. The maternal DNA methylation pattern is maintained until the 16-cell stage. Then, the oocyte methylome is gradually discarded through cell division and is progressively reprogrammed to a pattern similar to that of the sperm methylonne. The passive demethylation rate and the de novo methylation rate are similar in the maternal DNA. By the midblastula stage, the embryo's methylome is virtually identical to the sperm methylome. Moreover, inheritance of the sperm methylonne facilitates the epigenetic regulation of embryogenesis. Therefore, besides DNA sequences, sperm DNA methylome is also inherited in zebrafish early embryos.	[Jiang, Lan; Zhang, Jing; Wang, Jing-Jing; Wang, Lu; Zhang, Li; Li, Guoqiang; Ma, Xin; Sun, Xin; Cai, Jun; Wu, Chung-I; Ci, Weimin; Liu, Jiang] Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing 100101, Peoples R China; [Yang, Xiaodan; Liu, Feng] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100101, Peoples R China; [Jiang, Lan; Wang, Jing-Jing; Wang, Lu; Li, Guoqiang; Ma, Xin] Beijing Univ, Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhang, Jun; Huang, Xingxu] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Peoples R China; [Yu, Miao; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Yu, Miao; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Wang, Xuegeng; Zhang, Bo] Peking Univ, Key Lab Cell Proliferat, Beijing 100871, Peoples R China; [Wang, Xuegeng; Zhang, Bo] Peking Univ, Coll Life Sci, Differentiat Minist Educ, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Peking University; Nanjing University; University of Chicago; University of Chicago; Peking University; Peking University	Ci, WM (corresponding author), Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing 100101, Peoples R China.	ciwm@big.ac.cn; liuj@big.ac.cn	Li, Guoqiang/K-2850-2016; jiang, lan/C-1077-2009; Jiang, Lan/K-6869-2014; Zhang, Jing/F-4707-2015; Wang, Xuegeng/AAF-6714-2020; WANG, JINGYI/GSJ-1241-2022; Liu, Feng/B-9985-2015; wang, jing/GRS-7509-2022; Wang, Lu/I-8245-2018; jiang, lan/T-3965-2019; Ci, Weimin/AAS-5984-2021	Li, Guoqiang/0000-0001-5303-5707; jiang, lan/0000-0003-2008-9631; Jiang, Lan/0000-0003-2008-9631; Zhang, Jing/0000-0001-5903-6487; Wang, Xuegeng/0000-0003-4159-5402; Liu, Feng/0000-0003-3228-0943; Wang, Lu/0000-0002-8896-0115; Ci, Weimin/0000-0002-4111-5360; Ma, Xin/0000-0001-6383-8706; huang, xingxu/0000-0001-8934-1247; Liu, Jiang/0000-0002-5687-5047	973 Program of China [2011CB510101]; National Natural Science Foundation of China (NSFC) [91219104, 81171902]; CAS [XDA01040407]; 100 Talents Project; NSFC [91231112, 31171244, 31200958]; CAS Excellent Youth Scholars [KSCX2-EW-Q-5-2]; National Institutes of Health [HG006827]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006827] Funding Source: NIH RePORTER	973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences); 100 Talents Project(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC)); CAS Excellent Youth Scholars; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grants to J.L. from the 973 Program of China (2011CB510101), National Natural Science Foundation of China (NSFC) (91219104 and 81171902), CAS (XDA01040407), and 100 Talents Project. W.C. is supported by NSFC (91231112 and 31171244) and CAS Excellent Youth Scholars (KSCX2-EW-Q-5-2). J.Z. is supported by NSFC (31200958). C.H. is supported by National Institutes of Health (HG006827). Sarah F. Reichard and Li Lan contributed to the editing.	Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Arteaga-Vazquez MA, 2010, CURR OPIN GENET DEV, V20, P156, DOI 10.1016/j.gde.2010.01.008; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Calarco JP, 2012, CELL, V151, P194, DOI 10.1016/j.cell.2012.09.001; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Daxinger L, 2010, GENOME RES, V20, P1623, DOI 10.1101/gr.106138.110; De Carvalho DD, 2010, TRENDS CELL BIOL, V20, P609, DOI 10.1016/j.tcb.2010.08.003; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Huang HG, 2003, CLONING STEM CELLS, V5, P333, DOI 10.1089/153623003772032835; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Korzh V, 2009, ZEBRAFISH, V6, P295, DOI 10.1089/zeb.2008.0573; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; MacKay AB, 2007, GENOME, V50, P778, DOI 10.1139/G07-055; Macleod D, 1999, NAT GENET, V23, P139, DOI 10.1038/13767; Mhanni AA, 2004, DEV GENES EVOL, V214, P412, DOI 10.1007/s00427-004-0418-0; Molaro A, 2011, CELL, V146, P1028, DOI 10.1016/j.cell.2011.08.016; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; ONEILL GT, 1991, MOL REPROD DEV, V30, P214, DOI 10.1002/mrd.1080300308; Prince VE, 1998, DEVELOPMENT, V125, P407; Rai K, 2006, MOL CELL BIOL, V26, P7077, DOI 10.1128/MCB.00312-06; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Robertson AB, 2012, NAT PROTOC, V7, P340, DOI 10.1038/nprot.2011.443; Smallwood SA, 2012, TRENDS GENET, V28, P33, DOI 10.1016/j.tig.2011.09.004; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Veenstra GJC, 2001, BBA-GENE STRUCT EXPR, V1521, P39, DOI 10.1016/S0167-4781(01)00280-9; Walker Charline, 2009, J Vis Exp, DOI 10.3791/1396; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; YASUDA GK, 1992, TRENDS GENET, V8, P124; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	45	310	334	6	167	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 9	2013	153	4					773	784		10.1016/j.cell.2013.04.041	http://dx.doi.org/10.1016/j.cell.2013.04.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	143CN	23663777	Bronze, Green Accepted			2022-12-28	WOS:000318844000008
J	Britton, J; Bogdanovica, I				Britton, John; Bogdanovica, Ilze			Tobacco Control 3 Tobacco control efforts in Europe	LANCET			English	Article							SMOKE-FREE LEGISLATION; INDUSTRY GAINED ENTRY; FORMER SOVIET-UNION; SECONDHAND SMOKE; EMERGING MARKETS; HEALTH SURVEY; MOVING EAST; CIGARETTE; PREVALENCE; IMPACT	Smoking is prevalent across Europe, but the severity and stage of the smoking epidemic, and policy responses to it, vary substantially between countries. Much progress is now being made in prohibition of paid-for advertising and in promotion of smoke-free policies, but mass media campaigns are widely underused, provision of services for smokers trying to quit is generally poor, and price policies are undermined by licit and illicit cheap supplies. Monitoring of prevalence is inadequate in many countries, as is investment in research and capacity to address this largest avoidable cause of death and disability across Europe. However, grounds for optimism are provided by progress in implementation of the WHO Framework Convention on Tobacco Control, and in the development of a new generation of nicotine-containing devices that could enable more widespread adoption of harm-reduction strategies. The effect of commercial vested interests has been and remains a major barrier to progress.	[Britton, John; Bogdanovica, Ilze] Univ Nottingham, Div Epidemiol & Publ Hlth, UK Ctr Tobacco Control Studies, Nottingham NG5 1PB, England	University of Nottingham	Britton, J (corresponding author), Univ Nottingham, City Hosp, Div Epidemiol & Publ Hlth, UK Ctr Tobacco Control Studies, Clin Sci Bldg, Nottingham NG5 1PB, England.	j.britton@virgin.net		BOGDANOVICA, ILZE/0000-0002-2662-6293	British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; Department of Health under UK Clinical Research Collaboration	British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health under UK Clinical Research Collaboration	We thank Ann McNeill for her comments on the manuscript. There was no external funding source for this review. Both authors are employed by the University of Nottingham. The UK Centre for Tobacco Control Studies is supported by core funding from the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, Medical Research Council, and Department of Health under the auspices of the UK Clinical Research Collaboration.	[Anonymous], 2008, INDEPENDENT; Bajoga U, 2011, ADDICTION, V106, P1346, DOI 10.1111/j.1360-0443.2011.03446.x; Bobak M, 2006, TOB CONTROL, V15, P131, DOI 10.1136/tc.2005.014274; Bogdanovica I, 2012, ADDICTION, V107, P188, DOI 10.1111/j.1360-0443.2011.03588.x; Bogdanovica I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023889; Bogdanovica I, 2011, TOB CONTROL, V20, DOI 10.1136/tc.2010.036103; Callard C, 2010, TOB CONTROL, V19, P285, DOI 10.1136/tc.2009.035071; Callinan JE, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005992.pub2; Chaloupka FJ, 2012, TOB CONTROL, V21, P172, DOI 10.1136/tobaccocontrol-2011-050417; Cobb NK, 2011, NEW ENGL J MED, V365, P193, DOI 10.1056/NEJMp1105249; Currie C, 2012, SOCIAL DETERMINANTS; Department of Health, 2011, IMP SMOK FREE LEG EV; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Durkin S, 2012, TOB CONTROL, V21, P127, DOI 10.1136/tobaccocontrol-2011-050345; European Commission, 2011, OV SMOK FREE LEG EU; Federico B, 2012, ADDICTION, V107, P1677, DOI 10.1111/j.1360-0443.2012.03853.x; Fichtenberg CM, 2002, BMJ-BRIT MED J, V325, P188, DOI 10.1136/bmj.325.7357.188; Gartner CE, 2007, LANCET, V369, P2010, DOI 10.1016/S0140-6736(07)60677-1; Gilmore A, 2006, AM J PUBLIC HEALTH, V97, P2001; Gilmore AB, 2005, LANCET, V365, P1354, DOI 10.1016/S0140-6736(05)61035-5; Gilmore AB, 2004, TOB CONTROL, V13, P151, DOI 10.1136/tc.2003.005207; Gilmore AB, 2004, TOB CONTROL, V13, P143, DOI 10.1136/tc.2003.005108; Gilmore AB, 2013, ADDICTION, DOI 10.1111.12159; Gilmore AB, 2010, TOB CONTROL, V19, P423, DOI 10.1136/tc.2009.034470; Government of the Russian Federation, 2010, CONCEPT CREAT PUBL P; Grant-Braham B, 2012, TOB CONTROL, V21, P529, DOI 10.1136/tc.2011.043448; Gruning T, 2006, AM J PUBLIC HEALTH, V96, P20, DOI 10.2105/AJPH.2004.061507; Hibell B, 2013, SUBSTANCE USE STUDEN; Howell F, 2012, TOB CONTROL, V21, P514, DOI 10.1136/tobaccocontrol-2011-050146; Irish Tobacco Manufacturers Advisory Committee, 2013, PRIC COMP CIG EUR RE; Jarvis MJ, 2012, TOB CONTROL, V21, P18, DOI 10.1136/tc.2010.041608; Joossens L, 2008, TOB CONTROL, V17, P399, DOI 10.1136/tc.2008.026567; Joossens L, 2011, TOBACCO CONTROL SCAL; Joossens L, 2000, ISSUES SMUGGLING TOB; Joossens L, 2012, TOB CONTROL, V21, P230, DOI 10.1136/tobaccocontrol-2011-050205; Lader D., 2009, SMOKING RELATED BEHA; Lum KL, 2008, TOB CONTROL, V17, P313, DOI 10.1136/tc.2008.025445; Lyons A, 2011, THORAX, V66, P844, DOI 10.1136/thoraxjnl-2011-200789; Mackay D, 2010, NEW ENGL J MED, V363, P1139, DOI 10.1056/NEJMoa1002861; McNeill A, 2012, EUR J PUBLIC HEALTH, V22, P1, DOI 10.1093/eurpub/ckr201; McNeill A, 2011, TOB CONTROL, V20, P137, DOI 10.1136/tc.2010.038141; Millett C, 2011, THORAX, V66, P862, DOI 10.1136/thx.2010.154963; Moodie C, 2012, PLAIN TOBACCO PACKAG; Neuman M, 2002, LANCET, V359, P1323, DOI 10.1016/S0140-6736(02)08275-2; NICE, 2012, TOB HARM RED; Pell JP, 2008, NEW ENGL J MED, V359, P482, DOI 10.1056/NEJMsa0706740; Peto R, MORTALITY SMOKING DE; Quinn C, 2011, TOB CONTROL, V20, P151, DOI 10.1136/tc.2010.039602; Roberts B, 2012, AM J PUBLIC HEALTH, V102, P1320, DOI 10.2105/AJPH.2011.300547; *ROYAL COLL PHYS, 2000, NIC ADD BRIT REP TOB; Royal College of Physicians, 2010, PASS SMOK CHILDR REP; Royal College of Physicians, 2005, GOING SMOK FREE MED; Royal College of Physicians, 1962, SMOKING HLTH REPORT; Scientific Committee on Emerging and Newly Identified Health Risks, 2008, HLTH EFF SMOK TOB PR; Scuderia Ferrari, 2013, SPONS; Sims M, 2012, ENVIRON HEALTH PERSP, V120, P425, DOI 10.1289/ehp.1103680; Sims M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2161; Smith KE, 2013, TOB CONTROL, V22, P144, DOI 10.1136/tobaccocontrol-2011-050098; Smith KE, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000202; Spanopoulos D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029871; Szatkowski L, 2011, ADDICTION, V106, P1827, DOI 10.1111/j.1360-0443.2011.03494.x; The Cochrane Collaboration, 2013, COCHR REV SMOK CESS; The Information Centre, 2011, SMOK DRINK DRUG YOUN; The Information Centre, 2012, STAT NHS STOP SMOK S; TNS Opinion & Social, 2012, ATT EUR TOB SPEC EUR; Tobacco Advisory Group of the Royal College of Physicians, 2007, HARM RED NIC ADD; United Nations, 2012, PROT EL ILL TRAD TOB; US Surgeon General, 2006, HLTH CONS INV EXP TO; Vansickel AR, 2013, NICOTINE TOB RES, V15, P267, DOI 10.1093/ntr/ntr316; Wakefield MA, 2013, NICOTINE TOB RES, V15, P385, DOI 10.1093/ntr/nts134; West R, 2013, MONTHLY TRACKING KEY; WHO, 2011, GUID IMPL ART 11 WHO; World Health Organisation. Geneva Switzerland, 2018, NOT FUS PROT WORK GR; World Health Organization, 2008, WHO REP GLOB TOB EP; World Health Organization, 2013, WHO FRAM CONV TOB CO; World Health Organization, 2003, WHO FRAM CONV TOB CO; World Health Organization (WHO), 2012, MORT ATTR TOB	77	19	20	1	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 4	2013	381	9877					1588	1595		10.1016/S0140-6736(13)60814-4	http://dx.doi.org/10.1016/S0140-6736(13)60814-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	139UF	23642700				2022-12-28	WOS:000318609600034
J	Sun, QW; Csorba, T; Skourti-Stathaki, K; Proudfoot, NJ; Dean, C				Sun, Qianwen; Csorba, Tibor; Skourti-Stathaki, Konstantina; Proudfoot, Nicholas J.; Dean, Caroline			R-Loop Stabilization Represses Antisense Transcription at the Arabidopsis FLC Locus	SCIENCE			English	Article							NATURAL VARIATION; RNA-BINDING; VERNALIZATION; REGIONS	Roles for long noncoding RNAs (lncRNAs) in gene expression are emerging, but regulation of the lncRNA itself is poorly understood. We have identified a homeodomain protein, AtNDX, that regulates COOLAIR, a set of antisense transcripts originating from the 3' end of Arabidopsis FLOWERING LOCUS C (FLC). AtNDX associates with single-stranded DNA rather than double-stranded DNA non-sequence-specifically in vitro, and localizes to a heterochromatic region in the COOLAIR promoter in vivo. Single-stranded DNA was detected in vivo as part of an RNA-DNA hybrid, or R-loop, that covers the COOLAIR promoter. R-loop stabilization mediated by AtNDX inhibits COOLAIR transcription, which in turn modifies FLC expression. Differential stabilization of R-loops could be a general mechanism influencing gene expression in many organisms.	[Sun, Qianwen; Csorba, Tibor; Dean, Caroline] John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; [Skourti-Stathaki, Konstantina; Proudfoot, Nicholas J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Oxford	Dean, C (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	caroline.dean@jic.ac.uk	Csorba, Tibor/A-2359-2014	Csorba, Tibor/0000-0003-4185-1496; Proudfoot, Nicholas/0000-0001-8646-3222; Dean, Caroline/0000-0002-6555-3525; Sun, Qianwen/0000-0003-0111-5400	Wellcome Trust; UK Biotechnology and Biological Sciences Research Council (BBSRC); European Research Council; BBSRC [BBS/E/J/000CA369] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000CA369] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank all the members of the Dean lab for useful discussions; G. Calder and S. Rosa for help with microscopy; and the Nottingham Arabidopsis Stock Centre (NASC) and Institut National de la Recherche Agronomique (INRA) for Arabidopsis lines. Supported by a Wellcome Trust programme grant (K.S.-S. and N.J.P.). The Dean lab is supported by the UK Biotechnology and Biological Sciences Research Council (BBSRC) and a European Research Council advanced investigator grant. C.D. holds stock in Mendel Biotechnology.	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Angel A, 2011, NATURE, V476, P105, DOI 10.1038/nature10241; BOGUSLAWSKI SJ, 1986, J IMMUNOL METHODS, V89, P123, DOI 10.1016/0022-1759(86)90040-2; Coustham V, 2012, SCIENCE, V337, P584, DOI 10.1126/science.1221881; Crevillen P, 2013, EMBO J, V32, P140, DOI 10.1038/emboj.2012.324; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Finnegan EJ, 2005, PLANT J, V44, P420, DOI 10.1111/j.1365-313X.2005.02541.x; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Ietswaart R, 2012, TRENDS GENET, V28, P445, DOI 10.1016/j.tig.2012.06.002; Jorgensen JE, 1999, PLANT MOL BIOL, V40, P65, DOI 10.1023/A:1026463506376; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Liu FQ, 2007, MOL CELL, V28, P398, DOI 10.1016/j.molcel.2007.10.018; Liu FQ, 2012, SCIENCE, V335, P1621, DOI 10.1126/science.1214402; Liu FQ, 2010, SCIENCE, V327, P94, DOI 10.1126/science.1180278; Mukherjee K, 2009, MOL BIOL EVOL, V26, P2775, DOI 10.1093/molbev/msp201; PROUDFOOT NJ, 1989, TRENDS BIOCHEM SCI, V14, P105, DOI 10.1016/0968-0004(89)90132-1; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; RiveraPomar R, 1996, NATURE, V379, P746, DOI 10.1038/379746a0; Rondon AG, 2010, BBA-GENE REGUL MECH, V1799, P533, DOI 10.1016/j.bbagrm.2010.06.002; Shindo C, 2006, GENE DEV, V20, P3079, DOI 10.1101/gad.405306; Skourti-Stathaki K, 2011, MOL CELL, V42, P794, DOI 10.1016/j.molcel.2011.04.026; Song J, 2012, J CELL SCI, V125, P3723, DOI 10.1242/jcs.084764; Swiezewski S, 2007, P NATL ACAD SCI USA, V104, P3633, DOI 10.1073/pnas.0611459104; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919	26	239	250	4	158	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 3	2013	340	6132					619	621		10.1126/science.1234848	http://dx.doi.org/10.1126/science.1234848			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	135EA	23641115	Green Accepted			2022-12-28	WOS:000318268900050
J	Lynch, HF				Lynch, Holly Fernandez			Discrimination at the Doctor's Office	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Law, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA 02138 USA	Harvard University	Lynch, HF (corresponding author), Harvard Univ, Sch Law, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA 02138 USA.							Cross P, 2012, WCVB            0824; Korn Jane, 2010, VA J SOC POLY L, V17, P209; Michon K., HLTH CARE ANTIDISCRI; Rhode DL, 2009, STANFORD LAW REV, V61, P1033; Sabin JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048448	5	8	8	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 2	2013	368	18					1668	1670		10.1056/NEJMp1211375	http://dx.doi.org/10.1056/NEJMp1211375			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	134MN	23635047				2022-12-28	WOS:000318214400015
J	Lavigne, E; Holowaty, EJ; Pan, SY; Villeneuve, PJ; Johnson, KC; Fergusson, DA; Morrison, H; Brisson, J				Lavigne, Eric; Holowaty, Eric J.; Pan, Sai Yi; Villeneuve, Paul J.; Johnson, Kenneth C.; Fergusson, Dean A.; Morrison, Howard; Brisson, Jacques			Breast cancer detection and survival among women with cosmetic breast implants: systematic review and meta-analysis of observational studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							AUGMENTATION MAMMAPLASTY; FOLLOW-UP; DIAGNOSIS; RISK; PROGNOSIS; STAGE; POPULATION; MAMMOGRAPHY; UPDATE	Objectives To evaluate whether the stage distribution among women diagnosed as having breast cancer differs between those who have received breast implants for cosmetic purposes and those with no implants and to evaluate whether cosmetic breast augmentation before the detection of breast cancer is a predictor of post-diagnosis survival. Design Systematic review of observational studies with two meta-analyses. Data sources Systematic search of the literature published before September 2012 conducted in Medline, Embase, Global health, CINAHL, IPAB, and PsycINFO. Study selection Eligible publications were those that included women diagnosed as having breast cancer and who had had augmentation mammaplasty for cosmetic purposes. Results The overall odds ratio of the first meta-analysis based on 12 studies was 1.26 (95% confidence interval 0.99 to 1.60; P=0.058; I-2=35.6%) for a non-localized stage of breast cancer at diagnosis comparing women with implants who had breast cancer and women without implants who had breast cancer. The second meta-analysis, based on five studies, evaluated the relation between cosmetic breast implantation and survival. This meta-analysis showed reduced survival after breast cancer among women who had implants compared with those who did not (overall hazard ratio for breast cancer specific mortality 1.38, 95% confidence interval 1.08 to 1.75). Conclusions The research published to date suggests that cosmetic breast augmentation adversely affects the survival of women who are subsequently diagnosed as having breast cancer. These findings should be interpreted with caution, as some studies included in the meta-analysis on survival did not adjust for potential confounders. Further investigations are warranted regarding diagnosis and prognosis of breast cancer among women with breast implants.	[Lavigne, Eric; Brisson, Jacques] Univ Laval, Fac Med, Ctr Rech, CHU Quebec, Quebec City, PQ G1K 7P4, Canada; [Lavigne, Eric; Pan, Sai Yi; Morrison, Howard] Publ Hlth Agcy Canada, Ottawa, ON, Canada; [Holowaty, Eric J.; Villeneuve, Paul J.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Villeneuve, Paul J.] Hlth Canada, Populat Studies Div, Ottawa, ON K1A 0L2, Canada; [Johnson, Kenneth C.] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Fergusson, Dean A.] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada	Laval University; Public Health Agency of Canada; University of Toronto; Health Canada; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Lavigne, E (corresponding author), CHU Quebec, Ctr Rech, Hop St Sacrement, Unite Rech Sante Populat URESP, 1050 Chemin St Foy, Quebec City, PQ G1S 4L8, Canada.	elavigne@uresp.ulaval.ca	Lavigne, Eric/E-2948-2013	Lavigne, Eric/0000-0001-6146-9839; Villeneuve, Paul/0000-0001-7786-7997; Fergusson, Dean/0000-0002-3389-2485	Unite de Recherche en Sante des Populations, Cancer Care Ontario; Public Health Agency of Canada	Unite de Recherche en Sante des Populations, Cancer Care Ontario; Public Health Agency of Canada	This work was supported through scholarship grants by the Unite de Recherche en Sante des Populations, Cancer Care Ontario, and the Public Health Agency of Canada.	American Joint Committee on Cancer AJCC, 1997, AJCC CANC STAGING MA; [Anonymous], 2012, 2011 TOP 5 COSM SURG; BIRDSELL DC, 1993, PLAST RECONSTR SURG, V92, P795, DOI 10.1097/00006534-199392050-00003; Borenstein M, 2009, INTRO META ANAL; Brinton LA, 2000, CANCER CAUSE CONTROL, V11, P819, DOI 10.1023/A:1008941110816; Brinton LA, 1996, PLAST RECONSTR SURG, V97, P269, DOI 10.1097/00006534-199602000-00001; Brinton LA, 2000, PLAST RECONSTR SURG, V105, P919, DOI 10.1097/00006534-200003000-00014; Brisson J, 2006, INT J CANCER, V118, P2854, DOI 10.1002/ijc.21711; CAHAN AC, 1995, ANN SURG ONCOL, V2, P121, DOI 10.1007/BF02303626; Carlson RW, 2010, J NATL COMPR CANC NE, V8, P1182, DOI 10.6004/jnccn.2010.0087; CLARK CP, 1993, CANCER, V72, P2170, DOI 10.1002/1097-0142(19931001)72:7<2170::AID-CNCR2820720717>3.0.CO;2-1; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Cunningham B, 2006, PLAST RECONSTR SURG, V118, P587; Deapen D, 2000, PLAST RECONSTR SURG, V105, P535, DOI 10.1097/00006534-200002000-00009; Deapen D, 2007, PLAST RECONSTR SURG, V120, p70S, DOI 10.1097/01.prs.0000286577.70026.5d; Deapen DM, 2007, PLAST RECONSTR SURG, V119, P1987, DOI 10.1097/01.prs.0000260582.23971.02; DEAPEN DM, 1986, PLAST RECONSTR SURG, V77, P361, DOI 10.1097/00006534-198603000-00001; Deapen DM, 1997, PLAST RECONSTR SURG, V99, P1346, DOI 10.1097/00006534-199704001-00022; DEAPEN DM, 1992, PLAST RECONSTR SURG, V89, P660, DOI 10.1097/00006534-199204000-00010; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Edge SB, 2002, AJCC CANC STAGING MA; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EKLUND GW, 1988, AM J ROENTGENOL, V151, P469, DOI 10.2214/ajr.151.3.469; FAJARDO LL, 1995, RADIOLOGY, V194, P859, DOI 10.1148/radiology.194.3.7862991; Friis S, 2006, INT J CANCER, V118, P998, DOI 10.1002/ijc.21433; Friis S, 1997, INT J CANCER, V71, P956, DOI 10.1002/(SICI)1097-0215(19970611)71:6<956::AID-IJC8>3.3.CO;2-8; GALBRAITH RF, 1988, TECHNOMETRICS, V30, P271, DOI 10.2307/1270081; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; HANDEL N, 1992, JAMA-J AM MED ASSOC, V268, P1913, DOI 10.1001/jama.268.14.1913; Handel N, 2007, PLAST RECONSTR SURG, V120, p81S, DOI 10.1097/01.prs.0000286578.94102.2b; Handel N, 2006, PLAST RECONSTR SURG, V118, P587, DOI 10.1097/01.prs.0000233038.47009.04; HAYES H, 1988, PLAST RECONSTR SURG, V82, P1, DOI 10.1097/00006534-198882010-00001; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Holmich LR, 2003, BRIT J CANCER, V88, P832, DOI 10.1038/sj.bjc.6600819; Hoshaw SJ, 2001, PLAST RECONSTR SURG, V107, P1393, DOI 10.1097/00006534-200105000-00012; Howlader N, 2012, SEER CANC STAT REV 1; Jakub JW, 2004, PLAST RECONSTR SURG, V114, P1737, DOI 10.1097/01.PRS.0000142482.08917.24; Juanpere S, 2011, INSIGHTS IMAGING, V2, P653, DOI 10.1007/s13244-011-0122-3; Kjoller K, 2003, ANN PLAS SURG, V50, P6, DOI 10.1097/00000637-200301000-00002; Lavigne E, 2012, CANCER EPIDEM BIOMAR, V21, P1868, DOI 10.1158/1055-9965.EPI-12-0484; Lipworth L, 2009, INT J CANCER, V124, P490, DOI 10.1002/ijc.23932; Littell J.H., 2008, SYSTEMATIC REV META; Love S, 2000, VARIATIONS DEV SUSAN; MALONE KE, 1992, LANCET, V339, P1365, DOI 10.1016/0140-6736(92)92021-7; McIntosh SA, 2008, J PLAST RECONSTR AES, V61, P124, DOI 10.1016/j.bjps.2007.06.035; McIntosh SA, 2007, J PLAST RECONSTR AES, V60, P1127, DOI 10.1016/j.bjps.2007.03.017; McLaughlin JK, 2006, J NATL CANCER I, V98, P557, DOI 10.1093/jnci/djj134; McLaughlin JK, 1998, J NATL CANCER I, V90, P156, DOI 10.1093/jnci/90.2.156; McLaughlin JK, 2007, ANN PLAS SURG, V59, P569, DOI 10.1097/SAP.0b013e318066f0bd; McManus RJ, 1998, BMJ-BRIT MED J, V317, P1562, DOI 10.1136/bmj.317.7172.1562; Mellemkjaer L, 2000, INT J CANCER, V88, P301, DOI 10.1002/1097-0215(20001015)88:2<301::AID-IJC24>3.3.CO;2-7; Meunier A, 2005, Ann Chir Plast Esthet, V50, P595, DOI 10.1016/j.anplas.2005.07.015; Miglioretti DL, 2004, JAMA-J AM MED ASSOC, V291, P442, DOI 10.1001/jama.291.4.442; Orel SG, 2001, RADIOLOGY, V220, P13, DOI 10.1148/radiology.220.1.r01jl3113; Ottawa Hospital Research Institute, NEWC OTT SCAL NOS AS; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Pukkala E, 2002, J LONG-TERM EFF MED, V12, P251; Sarwer DB, 2007, AM J PSYCHIAT, V164, P1006, DOI 10.1176/appi.ajp.164.7.1006; Schumann D, 1994, Nurse Pract, V19, P19, DOI 10.1097/00006205-199407000-00007; Shambaugh EM, 1977, SUMMARY STAGING GUID; SILVERSTEIN MJ, 1988, ARCH SURG-CHICAGO, V123, P681; SILVERSTEIN MJ, 1990, PLAST RECONSTR SURG, V86, P1126, DOI 10.1097/00006534-199012000-00014; SILVERSTEIN MJ, 1991, CANCER, V68, P1159, DOI 10.1002/1097-0142(19910901)68:5+<1159::AID-CNCR2820681306>3.0.CO;2-V; Silverstein MJ, CANCER, V66, P97; Skinner KA, 2001, ANN SURG ONCOL, V8, P138; Smalley SM, 2003, J MIDWIFERY WOM HEAL, V48, P329, DOI 10.1016/S1526-9523(03)00280-0; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tang SSK, 2011, ANN SURG ONCOL, V18, P2173, DOI 10.1245/s10434-011-1578-6; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tuli R, 2006, BREAST J, V12, P343, DOI 10.1111/j.1075-122X.2006.00273.x; Uematsu T, 2008, BREAST CANCER-TOKYO, V15, P159, DOI 10.1007/s12282-008-0036-1; Williamson PR, 2002, STAT MED, V21, P3337, DOI 10.1002/sim.1303; Xie L, 2010, INT J CANCER, V126, P2182, DOI 10.1002/ijc.24697	73	31	31	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 30	2013	346								f2399	10.1136/bmj.f2399	http://dx.doi.org/10.1136/bmj.f2399			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	139DR	23637132	hybrid			2022-12-28	WOS:000318562300001
